id,Compound_CID,Data_Source,Compound,Source_Chemical_ID,Source_Chemical,Source_Chemical_URL,Source_Target_ID,Source_Target,Source_Target_URL,Protein_Accession,Protein,Gene_ID,Gene,Taxonomy_ID,Taxonomy,Action,Activity_Name,Activity,Evidence_IDs,Evidence_URLs,Evidence_PMIDs,Evidence_DOIs,pmcids,pclids,References
81778,6,Comparative Toxicogenomics Database (CTD),Dinitrochlorobenzene,D004137,Dinitrochlorobenzene,https://ctdbase.org/detail.go?type=chem&acc=D004137,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dinitrochlorobenzene binds to PARP1 protein,,,PMID:32991956,https://www.ncbi.nlm.nih.gov/pubmed/32991956,32991956,,,12210744,"Parkinson E, Aleksic M, Kukic P, Bailey A, Cubberley R, Skipp P. Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 01;445():152603. doi: 10.1016/j.tox.2020.152603. PMID: 32991956."
355,137,Comparative Toxicogenomics Database (CTD),Aminolevulinic Acid,D000622,Aminolevulinic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000622,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),FADD mutant form inhibits the reaction [aminolevulinic acid analog results in increased cleavage of PARP1 protein]|aminolevulinic acid analog results in increased cleavage of PARP1 protein,,,PMID:21138480,https://www.ncbi.nlm.nih.gov/pubmed/21138480,21138480,,,1076250,"Chen HM, Liu CM, Yang H, Chou HY, Chiang CP, Kuo MY. 5-aminolevulinic acid induce apoptosis via NF-?B/JNK pathway in human oral cancer Ca9-22 cells. J Oral Pathol Med. 2011 Jul;40(6):483–9. doi: 10.1111/j.1600-0714.2010.00973.x. PMID: 21138480."
79675,177,Comparative Toxicogenomics Database (CTD),Acetaldehyde,D000079,Acetaldehyde,https://ctdbase.org/detail.go?type=chem&acc=D000079,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Silybin inhibits the reaction [staurosporine promotes the reaction [acetaldehyde results in increased cleavage of PARP1 protein]]|staurosporine promotes the reaction [acetaldehyde results in increased cleavage of PARP1 protein]|acetaldehyde results in increased cleavage of PARP1 protein|silybin inhibits the reaction [acetaldehyde results in increased cleavage of PARP1 protein],,,PMID:35158046,https://www.ncbi.nlm.nih.gov/pubmed/35158046,35158046,,,33888318,"Song XY, Liu PC, Liu WW, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Protective effects of silibinin against ethanol- or acetaldehyde-caused damage in liver cell lines involve the repression of mitochondrial fission. Toxicol In Vitro. 2022 Apr;80():105330. doi: 10.1016/j.tiv.2022.105330. PMID: 35158046."
77027,192,Comparative Toxicogenomics Database (CTD),Adenosine diphosphate ribose,D011064,Poly Adenosine Diphosphate Ribose,https://ctdbase.org/detail.go?type=chem&acc=D011064,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein results in increased chemical synthesis of poly adenosine diphosphate ribose|[arsenite results in decreased activity of PARP1 protein] which results in decreased chemical synthesis of poly adenosine diphosphate ribose,,,PMID:22387748,https://www.ncbi.nlm.nih.gov/pubmed/22387748,22387748,,PMC3327874,24903500,"Qin XJ, Liu W, Li YN, Sun X, Hai CX, Hudson LG, Liu KJ. Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicol Sci. 2012 May;127(1):120–9. PMID: 22387748; PMCID: PMC3327874."
77028,192,Comparative Toxicogenomics Database (CTD),Adenosine diphosphate ribose,D011064,Poly Adenosine Diphosphate Ribose,https://ctdbase.org/detail.go?type=chem&acc=D011064,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"PARP1 protein mutant form promotes the reaction [hydrogen peroxide results in increased abundance of poly adenosine diphosphate ribose]|poly adenosine diphosphate ribose binds to PARP1 protein|parp1 protein mutant form affects the abundance of poly adenosine diphosphate ribose|poly adenosine diphosphate ribose inhibits the reaction [PARP1 protein binds to nucleic acids, nucleotides, and nucleosides]|parp1 protein promotes the reaction [hydrogen peroxide results in increased abundance of poly adenosine diphosphate ribose]|parp1 protein promotes the reaction [camptothecin results in increased abundance of poly adenosine diphosphate ribose]",,,PMID:27694308,https://www.ncbi.nlm.nih.gov/pubmed/27694308,27694308,,PMC5137445,29679245,"Rank L, Veith S, Gwosch EC, Demgenski J, Ganz M, Jongmans MC, Vogel C, Fischbach A, Buerger S, Fischer JM, Zubel T, Stier A, Renner C, Schmalz M, Beneke S, Groettrup M, Kuiper RP, Bürkle A, Ferrando-May E, Mangerich A. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells. Nucleic Acids Res. 2016 Dec 01;44(21):10386–405. PMID: 27694308; PMCID: PMC5137445."
77029,192,Comparative Toxicogenomics Database (CTD),Adenosine diphosphate ribose,D011064,Poly Adenosine Diphosphate Ribose,https://ctdbase.org/detail.go?type=chem&acc=D011064,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 gene mutant form results in decreased abundance of poly adenosine diphosphate ribose,,,PMID:18093987,https://www.ncbi.nlm.nih.gov/pubmed/18093987,18093987,,,26182767,"von Lukowicz T, Hassa PO, Lohmann C, Borén J, Braunersreuther V, Mach F, Odermatt B, Gersbach M, Camici GG, Stähli BE, Tanner FC, Hottiger MO, Lüscher TF, Matter CM. PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovasc Res. 2008 Apr 01;78(1):158–66. doi: 10.1093/cvr/cvm110. PMID: 18093987."
77030,192,Comparative Toxicogenomics Database (CTD),Adenosine diphosphate ribose,D011064,Poly Adenosine Diphosphate Ribose,https://ctdbase.org/detail.go?type=chem&acc=D011064,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"PARP1 protein results in increased abundance of poly adenosine diphosphate ribose|5-chloro-2-(3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl)-4(3H)-quinazolinone inhibits the reaction [PARP1 protein results in increased abundance of poly adenosine diphosphate ribose]",,,PMID:15075382,https://www.ncbi.nlm.nih.gov/pubmed/15075382,15075382,,,13914481,"Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S. A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia. The Journal of Pharmacology and Experimental Therapeutics. 2004 Aug;310(2):425–36. doi: 10.1124/jpet.104.066944."
77163,192,Comparative Toxicogenomics Database (CTD),Adenosine diphosphate ribose,D011064,Poly Adenosine Diphosphate Ribose,https://ctdbase.org/detail.go?type=chem&acc=D011064,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in decreased activity of PARP1 protein] which results in decreased abundance of poly adenosine diphosphate ribose|[ino 1001 results in decreased activity of PARP1 protein] which results in decreased abundance of poly adenosine diphosphate ribose",,,PMID:15829224,https://www.ncbi.nlm.nih.gov/pubmed/15829224,15829224,,,317011,"Besson VC, Zsengellér Z, Plotkine M, Szabó C, Marchand-Verrecchia C. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat. Brain Res. 2005 Apr 18;1041(2):149–56. doi: 10.1016/j.brainres.2005.01.096. PMID: 15829224."
96196,222,Comparative Toxicogenomics Database (CTD),Ammonia,D000641,Ammonia,https://ctdbase.org/detail.go?type=chem&acc=D000641,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),PARP1 protein affects the susceptibility to ammonia,,,PMID:15147502,https://www.ncbi.nlm.nih.gov/pubmed/15147502,15147502,,,9200090,"Kosenko E, Montoliu C, Giordano G, Kaminsky Y, Venediktova N, Buryanov Y, Felipo V. Acute ammonia intoxication induces an NMDA receptor-mediated increase in poly(ADP-ribose) polymerase level and NAD<sup>+</sup> metabolism in nuclei of rat brain cells. Journal of Neurochemistry. 2004 Apr 27;89(5):1101–10. doi: 10.1111/j.1471-4159.2004.02426.x."
91204,234,Toxin and Toxin Target Database (T3DB),Arsenic Acid,T3D0223,Arsenate,http://www.t3db.ca/toxins/T3D0223,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
99987,237,Comparative Toxicogenomics Database (CTD),Quinacrine,D011796,Quinacrine,https://ctdbase.org/detail.go?type=chem&acc=D011796,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quinacrine results in increased cleavage of PARP1 protein,,,PMID:28867437,https://www.ncbi.nlm.nih.gov/pubmed/28867437,28867437,,,27693129,"Huang CH, Lee YC, Chen YJ, Wang LJ, Shi YJ, Chang LS. Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3/miR-183/ß-TrCP/SP1 axis-mediated BAX upregulation. Toxicol Appl Pharmacol. 2017 Nov 01;334():35–46. doi: 10.1016/j.taap.2017.08.019. PMID: 28867437."
105041,241,Comparative Toxicogenomics Database (CTD),Benzene,D001554,Benzene,https://ctdbase.org/detail.go?type=chem&acc=D001554,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzene analog results in increased cleavage of PARP1 protein,,,PMID:15826604,https://www.ncbi.nlm.nih.gov/pubmed/15826604,15826604,,,314567,"Kim YH, Shin KJ, Lee TG, Kim E, Lee MS, Ryu SH, Suh PG. G2 arrest and apoptosis by 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS), a novel cytotoxic compound. Biochem Pharmacol. 2005 May 01;69(9):1333–41. doi: 10.1016/j.bcp.2004.12.019. PMID: 15826604."
105042,241,Comparative Toxicogenomics Database (CTD),Benzene,D001554,Benzene,https://ctdbase.org/detail.go?type=chem&acc=D001554,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trichostatin A inhibits the reaction [benzene results in increased methylation of PARP1 promoter]|decitabine inhibits the reaction [benzene results in decreased expression of PARP1 mrna]|trichostatin A inhibits the reaction [benzene results in decreased expression of PARP1 mrna]|benzene results in decreased expression of PARP1 mrna|decitabine inhibits the reaction [benzene results in increased methylation of PARP1 promoter]|benzene results in increased methylation of PARP1 promoter,,,PMID:20230882,https://www.ncbi.nlm.nih.gov/pubmed/20230882,20230882,,,6562335,"Gao A, Zuo X, Liu Q, Lu X, Guo W, Tian L. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. Toxicol Lett. 2010 Jun 02;195(2-3):114–8. doi: 10.1016/j.toxlet.2010.03.005. PMID: 20230882."
73928,242,Comparative Toxicogenomics Database (CTD),"Benzoic acid, ion(1-)",D001565,Benzoates,https://ctdbase.org/detail.go?type=chem&acc=D001565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoates analog results in increased cleavage of PARP1 protein,,,PMID:29472718,https://www.ncbi.nlm.nih.gov/pubmed/29472718,29472718,,PMC5940656,33090788,2018; 32(5):1135-1146
119818,264,Comparative Toxicogenomics Database (CTD),Butyric Acid,D020148,Butyric Acid,https://ctdbase.org/detail.go?type=chem&acc=D020148,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Butyric acid results in increased cleavage of PARP1 protein,,,PMID:27830268,https://www.ncbi.nlm.nih.gov/pubmed/27830268,27830268,,,26361869,2016; 91(5):2135-2150
1282,286,Comparative Toxicogenomics Database (CTD),Aminooxyacetic Acid,D000625,Aminooxyacetic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000625,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[aminooxyacetic acid results in decreased metabolism of selenomethylselenocysteine] which results in decreased expression of PARP1 protein modified form,,,PMID:25321483,https://www.ncbi.nlm.nih.gov/pubmed/25321483,25321483,,PMC4237248,5265836,"Kang Y, Nian H, Rajendran P, Kim E, Dashwood WM, Pinto JT, Boardman LA, Thibodeau SN, Limburg PJ, Löhr CV, Bisson WH, Williams DE, Ho E, Dashwood RH. HDAC8 and STAT3 repress BMF gene activity in colon cancer cells. Cell Death & Disease. 2014 Oct 16;5(10):e1476. doi: 10.1038/cddis.2014.422."
118546,299,Comparative Toxicogenomics Database (CTD),Chlordecone,D007631,Chlordecone,https://ctdbase.org/detail.go?type=chem&acc=D007631,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Chlordecone results in increased expression of PARP1 mRNA,,,PMID:33711761,https://www.ncbi.nlm.nih.gov/pubmed/33711761,33711761,,,14947287,"Legoff L, D'Cruz SC, Lebosq M, Gely-Pernot A, Bouchekhchoukha K, Monfort C, Kernanec PY, Tevosian S, Multigner L, Smagulova F. Developmental exposure to chlordecone induces transgenerational effects in somatic prostate tissue which are associated with epigenetic histone trimethylation changes. Environ Int. 2021 Jul;152():106472. doi: 10.1016/j.envint.2021.106472. PMID: 33711761."
1313,300,Comparative Toxicogenomics Database (CTD),Chloroacetic acid,C006972,chloroacetic acid,https://ctdbase.org/detail.go?type=chem&acc=C006972,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Chloroacetic acid results in increased cleavage of PARP1 protein,,,PMID:23103613,https://www.ncbi.nlm.nih.gov/pubmed/23103613,23103613,,,30972499,2013; 303 72-82
118221,323,Comparative Toxicogenomics Database (CTD),Coumarin,C030123,coumarin,https://ctdbase.org/detail.go?type=chem&acc=C030123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Coumarin analog results in decreased expression of PARP1 mRNA,,,PMID:32578917,https://www.ncbi.nlm.nih.gov/pubmed/32578917,32578917,,,13581682,"Umar S, Soni R, Durgapal SD, Soman S, Balakrishnan S. A synthetic coumarin derivative (4-flourophenylacetamide-acetyl coumarin) impedes cell cycle at G0/G1 stage, induces apoptosis, and inhibits metastasis via ROS-mediated p53 and AKT signaling pathways in A549 cells. J Biochem Mol Toxicol. 2020 Oct;34(10):e22553. doi: 10.1002/jbt.22553. PMID: 32578917."
118222,323,Comparative Toxicogenomics Database (CTD),Coumarin,C030123,coumarin,https://ctdbase.org/detail.go?type=chem&acc=C030123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Coumarin analog results in increased cleavage of PARP1 protein,,,PMID:31199928,https://www.ncbi.nlm.nih.gov/pubmed/31199928,31199928,,,14235345,"Lin MH, Wang JS, Hsieh YC, Zheng JH, Cho EC. NO2 functionalized coumarin derivatives suppress cancer progression and facilitate apoptotic cell death in KRAS mutant colon cancer. Chem Biol Interact. 2019 Aug 25;309():108708. doi: 10.1016/j.cbi.2019.06.021. PMID: 31199928."
118223,323,Comparative Toxicogenomics Database (CTD),Coumarin,C030123,coumarin,https://ctdbase.org/detail.go?type=chem&acc=C030123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Coumarin results in decreased activity of PARP1 protein|[coumarin results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of nad]|[coumarin results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of NADP],,,PMID:17669606,https://www.ncbi.nlm.nih.gov/pubmed/17669606,17669606,,,22728614,"Lin PH, Lin CH, Huang CC, Chuang MC, Lin P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 2007 Aug;172(3):146–58. doi: 10.1016/j.toxlet.2007.06.003. PMID: 17669606."
109981,359,Comparative Toxicogenomics Database (CTD),Phloroglucinol,D010696,Phloroglucinol,https://ctdbase.org/detail.go?type=chem&acc=D010696,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10029,Cricetulus griseus (Chinese hamster),Phloroglucinol results in decreased expression of PARP1 protein modified form,,,PMID:20188716,https://www.ncbi.nlm.nih.gov/pubmed/20188716,20188716,,,12686767,"Kang KA, Zhang R, Chae S, Lee SJ, Kim J, Kim J, Jeong J, Lee J, Shin T, Lee NH, Hyun JW. Phloroglucinol (1,3,5-trihydroxybenzene) protects against ionizing radiation-induced cell damage through inhibition of oxidative stress in vitro and in vivo. Chem Biol Interact. 2010 May 14;185(3):215–26. doi: 10.1016/j.cbi.2010.02.031. PMID: 20188716."
109982,359,Comparative Toxicogenomics Database (CTD),Phloroglucinol,D010696,Phloroglucinol,https://ctdbase.org/detail.go?type=chem&acc=D010696,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Phloroglucinol analog results in increased cleavage of PARP1 protein,,,PMID:23178381,https://www.ncbi.nlm.nih.gov/pubmed/23178381,23178381,,,14064681,"Sun Y, Gao C, Luo M, Wang W, Gu C, Zu Y, Li J, Efferth T, Fu Y. Aspidin PB, a phloroglucinol derivative, induces apoptosis in human hepatocarcinoma HepG2 cells by modulating PI3K/Akt/GSK3ß pathway. Chem Biol Interact. 2013 Jan 25;201(1-3):1–8. doi: 10.1016/j.cbi.2012.11.005. PMID: 23178381."
109983,359,Comparative Toxicogenomics Database (CTD),Phloroglucinol,D010696,Phloroglucinol,https://ctdbase.org/detail.go?type=chem&acc=D010696,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Phloroglucinol metabolite results in increased cleavage of PARP1 protein,,,PMID:22796323,https://www.ncbi.nlm.nih.gov/pubmed/22796323,22796323,,,1121127,"Zhang Y, Luo M, Zu Y, Fu Y, Gu C, Wang W, Yao L, Efferth T. Dryofragin, a phloroglucinol derivative, induces apoptosis in human breast cancer MCF-7 cells through ROS-mediated mitochondrial pathway. Chem Biol Interact. 2012 Aug 30;199(2):129–36. doi: 10.1016/j.cbi.2012.06.007. PMID: 22796323."
105997,370,Comparative Toxicogenomics Database (CTD),Gallic Acid,D005707,Gallic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005707,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Gallic acid results in increased cleavage of PARP1 protein|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [gallic acid results in increased cleavage of PARP1 protein]",,,PMID:27060209,https://www.ncbi.nlm.nih.gov/pubmed/27060209,27060209,,,22243021,"Hsu SS, Chou CT, Liao WC, Shieh P, Kuo DH, Kuo CC, Jan CR, Liang WZ. The effect of gallic acid on cytotoxicity, Ca(2+) homeostasis and ROS production in DBTRG-05MG human glioblastoma cells and CTX TNA2 rat astrocytes. Chem Biol Interact. 2016 May 25;252():61–73. doi: 10.1016/j.cbi.2016.04.010. PMID: 27060209."
116678,449,Comparative Toxicogenomics Database (CTD),Mevalonic Acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mevalonic acid inhibits the reaction [TNFSF10 protein promotes the reaction [simvastatin results in increased cleavage of PARP1 protein]]|mevalonic acid inhibits the reaction [simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:21910007,https://www.ncbi.nlm.nih.gov/pubmed/21910007,21910007,,PMC4372201,23502040,2011; 16(12):1268-1284
116679,449,Comparative Toxicogenomics Database (CTD),Mevalonic Acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin results in increased cleavage of PARP1 protein],,,PMID:20045437,https://www.ncbi.nlm.nih.gov/pubmed/20045437,20045437,,,32241704,"Ghavami S, Mutawe MM, Hauff K, Stelmack GL, Schaafsma D, Sharma P, McNeill KD, Hynes TS, Kung SK, Unruh H, Klonisch T, Hatch GM, Los M, Halayko AJ. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2010 Apr;1803(4):452–67. doi: 10.1016/j.bbamcr.2009.12.005."
129136,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),CAT protein inhibits the reaction [[epigallocatechin gallate co-treated with arsenite] results in increased cleavage of PARP1 protein]|[epigallocatechin gallate co-treated with arsenite] results in increased cleavage of PARP1 protein,,,PMID:26375285,https://www.ncbi.nlm.nih.gov/pubmed/26375285,26375285,,PMC4574201,33717518,"Kim J, Choi J, Lee H, Byun CJ, Park J, Park JH, Cho H, Cho S, Jo SA, Jo I. The Green Tea Component (-)-Epigallocatechin-3-Gallate Sensitizes Primary Endothelial Cells to Arsenite-Induced Apoptosis by Decreasing c-Jun N-Terminal Kinase-Mediated Catalase Activity. PLoS ONE. 2015 Sep 16;10(9):e0138590. doi: 10.1371/journal.pone.0138590."
129137,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetovanillone inhibits the reaction [arsenite results in increased oxidation of PARP1 protein]|arsenite results in increased oxidation of PARP1 protein,,,PMID:34798142,https://www.ncbi.nlm.nih.gov/pubmed/34798142,34798142,,PMC10115133,12958291,"Cooper KL, Volk LB, Dominguez DR, Duran AD, Ke Jian Liu KJ, Hudson LG. Contribution of NADPH oxidase to the retention of UVR-induced DNA damage by arsenic. Toxicology and Applied Pharmacology. 2022 Jan;434():115799. doi: 10.1016/j.taap.2021.115799."
129138,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenite results in decreased activity of PARP1 protein,,,PMID:17011244|PMID:18707137|PMID:22387748,https://www.ncbi.nlm.nih.gov/pubmed/17011244|https://www.ncbi.nlm.nih.gov/pubmed/18707137|https://www.ncbi.nlm.nih.gov/pubmed/22387748,17011244|18707137|22387748,,PMC3327874|PMC3606021,5823358|24903500|25134446,"Qin XJ, Liu W, Li YN, Sun X, Hai CX, Hudson LG, Liu KJ. Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicol Sci. 2012 May;127(1):120–9. PMID: 22387748; PMCID: PMC3327874.|Qin XJ, Hudson LG, Liu W, Ding W, Cooper KL, Liu KJ. Dual actions involved in arsenite-induced oxidative DNA damage. Chem Res Toxicol. 2008 Sep;21(9):1806–13. PMID: 18707137; PMCID: PMC3606021.|Walter I, Schwerdtle T, Thuy C, Parsons JL, Dianov GL, Hartwig A. Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells. DNA Repair. 2007 Jan;6(1):61–70. doi: 10.1016/j.dnarep.2006.08.008."
129139,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenite results in decreased cleavage of PARP1 protein|[arsenite results in decreased activity of PARP1 protein] which results in decreased cleavage of and results in decreased activity of CASP7 protein|[arsenite results in decreased activity of PARP1 protein] which affects the localization of CYCS protein|[arsenite results in decreased activity of PARP1 protein] which results in decreased cleavage of and results in decreased activity of CASP3 protein|[arsenite results in decreased activity of PARP1 protein] which results in decreased cleavage of and results in decreased activity of CASP9 protein|parp1 protein affects the susceptibility to arsenite|[arsenite results in decreased activity of PARP1 protein] which affects the localization of AIFM1 protein|[arsenite results in decreased activity of PARP1 protein] which results in decreased chemical synthesis of poly adenosine diphosphate ribose,,,PMID:22387748,https://www.ncbi.nlm.nih.gov/pubmed/22387748,22387748,,PMC3327874,24903500,"Qin XJ, Liu W, Li YN, Sun X, Hai CX, Hudson LG, Liu KJ. Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicol Sci. 2012 May;127(1):120–9. PMID: 22387748; PMCID: PMC3327874."
129140,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenite results in increased cleavage of PARP1 protein,,,PMID:20083129|PMID:22260869,https://www.ncbi.nlm.nih.gov/pubmed/20083129|https://www.ncbi.nlm.nih.gov/pubmed/22260869,20083129|22260869,,,16779507|21453390,"Keim A, Rössler OG, Rothhaar TL, Thiel G. Arsenite-induced apoptosis of human neuroblastoma cells requires p53 but occurs independently of c-Jun. Neuroscience. 2012 Mar 29;206():25–38. doi: 10.1016/j.neuroscience.2012.01.001. PMID: 22260869.|Yadav S, Shi Y, Wang F, Wang H. Arsenite induces apoptosis in human mesenchymal stem cells by altering Bcl-2 family proteins and by activating intrinsic pathway. Toxicol Appl Pharmacol. 2010 May 01;244(3):263–72. doi: 10.1016/j.taap.2010.01.001. PMID: 20083129."
129141,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenite results in increased expression of PARP1 protein|curcumin promotes the reaction [arsenite results in increased expression of PARP1 protein],,,PMID:18392098,https://www.ncbi.nlm.nih.gov/pubmed/18392098,18392098,,PMC2274986,8592709,"Mukherjee S, Roy M, Dey S, Bhattacharya RK. A Mechanistic Approach for Modulation of Arsenic Toxicity in Human Lymphocytes by Curcumin, an Active Constituent of Medicinal Herb Curcuma longa Linn. J Clin Biochem Nutr. 2007 Jul;41(1):32–42. PMID: 18392098; PMCID: PMC2274986."
129142,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TP53 mutant form inhibits the reaction [arsenite results in increased cleavage of PARP1 protein],,,PMID:22260869,https://www.ncbi.nlm.nih.gov/pubmed/22260869,22260869,,,16779507,"Keim A, Rössler OG, Rothhaar TL, Thiel G. Arsenite-induced apoptosis of human neuroblastoma cells requires p53 but occurs independently of c-Jun. Neuroscience. 2012 Mar 29;206():25–38. doi: 10.1016/j.neuroscience.2012.01.001. PMID: 22260869."
129143,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc inhibits the reaction [arsenite results in decreased activity of PARP1 protein],,,PMID:18707137,https://www.ncbi.nlm.nih.gov/pubmed/18707137,18707137,,PMC3606021,5823358,"Qin XJ, Hudson LG, Liu W, Ding W, Cooper KL, Liu KJ. Dual actions involved in arsenite-induced oxidative DNA damage. Chem Res Toxicol. 2008 Sep;21(9):1806–13. PMID: 18707137; PMCID: PMC3606021."
129144,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Arsenite results in increased cleavage of PARP1 protein,,,PMID:23396362|PMID:32980394,https://www.ncbi.nlm.nih.gov/pubmed/23396362|https://www.ncbi.nlm.nih.gov/pubmed/32980394,23396362|32980394,,PMC3883870,12915031|17453143,"Lou B, Hu Y, Lu X, Zhang X, Li Y, Pi J, Xu Y. Long-isoform NRF1 protects against arsenic cytotoxicity in mouse bone marrow-derived mesenchymal stem cells by suppressing mitochondrial ROS and facilitating arsenic efflux. Toxicol Appl Pharmacol. 2020 Nov 15;407():115251. doi: 10.1016/j.taap.2020.115251. PMID: 32980394.|Yu Y, Zhang D, Huang H, Li J, Zhang M, Wan Y, Gao J, Huang C. NF-?B1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1. Oncogene. 2014 Feb 20;33(8):996–1005. PMID: 23396362; PMCID: PMC3883870."
129332,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PHLPP1 protein affects the reaction [NFKB1 protein affects the reaction [arsenite results in increased cleavage of PARP1 protein]]|nfkb1 protein affects the reaction [arsenite results in increased cleavage of PARP1 protein]|mir190a affects the reaction [NFKB1 protein affects the reaction [arsenite results in increased cleavage of PARP1 protein]],,,PMID:23396362,https://www.ncbi.nlm.nih.gov/pubmed/23396362,23396362,,PMC3883870,17453143,"Yu Y, Zhang D, Huang H, Li J, Zhang M, Wan Y, Gao J, Huang C. NF-?B1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1. Oncogene. 2014 Feb 20;33(8):996–1005. PMID: 23396362; PMCID: PMC3883870."
129333,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),NFE2L1 alternative form affects the reaction [arsenite results in increased cleavage of PARP1 protein],,,PMID:32980394,https://www.ncbi.nlm.nih.gov/pubmed/32980394,32980394,,,12915031,"Lou B, Hu Y, Lu X, Zhang X, Li Y, Pi J, Xu Y. Long-isoform NRF1 protects against arsenic cytotoxicity in mouse bone marrow-derived mesenchymal stem cells by suppressing mitochondrial ROS and facilitating arsenic efflux. Toxicol Appl Pharmacol. 2020 Nov 15;407():115251. doi: 10.1016/j.taap.2020.115251. PMID: 32980394."
129334,544,Comparative Toxicogenomics Database (CTD),Arsenite ion,C015001,arsenite,https://ctdbase.org/detail.go?type=chem&acc=C015001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenite results in increased degradation of PARP1 protein,,,PMID:9766529,https://www.ncbi.nlm.nih.gov/pubmed/9766529,9766529,,,18533621,"Chen YC, Lin-Shiau SY, Lin JK. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol. 1998 Nov;177(2):324–33. doi: 10.1002/(sici)1097-4652(199811)177:2<324::aid-jcp14>3.0.co;2-9. PMID: 9766529."
163058,545,Toxin and Toxin Target Database (T3DB),Arsenous acid,T3D0282,Arsenous acid,http://www.t3db.ca/toxins/T3D0282,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
80526,547,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxyphenylacetic Acid",D015102,"3,4-Dihydroxyphenylacetic Acid",https://ctdbase.org/detail.go?type=chem&acc=D015102,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[PARP1 protein results in increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] which results in increased abundance of 3,4-dihydroxyphenylacetic acid",,,PMID:10318960,https://www.ncbi.nlm.nih.gov/pubmed/10318960,10318960,,PMC21936,33415557,"Mandir AS, Przedborski S, Jackson-Lewis V, Wang ZQ, Simbulan-Rosenthal CM, Smulson ME, Hoffman BE, Guastella DB, Dawson VL, Dawson TM. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5774–9. PMID: 10318960; PMCID: PMC21936."
76536,670,Comparative Toxicogenomics Database (CTD),Dihydroxyacetone,D004098,Dihydroxyacetone,https://ctdbase.org/detail.go?type=chem&acc=D004098,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dihydroxyacetone results in increased cleavage of PARP1 protein,,,PMID:29193605|PMID:38867704,https://www.ncbi.nlm.nih.gov/pubmed/29193605|https://www.ncbi.nlm.nih.gov/pubmed/38867704,29193605|38867704,,PMC11347775|PMC5809210,28382952|37322303,"Hernandez A, Hedlich-Dwyer J, Hussain S, Levi H, Sonavane M, Suzuki T, Kamiya H, Gassman NR. Acute exposure to dihydroxyacetone promotes genotoxicity and chromosomal instability in lung, cardiac, and liver cell models. Toxicol Sci. 2024 Sep 01;201(1):85–102. PMID: 38867704; PMCID: PMC11347775.|Smith KR, Granberry M, Tan MCB, Daniel CL, Gassman NR. Dihydroxyacetone induces G2/M arrest and apoptotic cell death in A375P melanoma cells. Environmental Toxicology. 2017 Nov 29;33(3):333–42. doi: 10.1002/tox.22520."
76537,670,Comparative Toxicogenomics Database (CTD),Dihydroxyacetone,D004098,Dihydroxyacetone,https://ctdbase.org/detail.go?type=chem&acc=D004098,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Dihydroxyacetone results in increased cleavage of PARP1 protein,,,PMID:38582340,https://www.ncbi.nlm.nih.gov/pubmed/38582340,38582340,,PMC11069339,37119666,"Hernandez A, Belfleur L, Migaud M, Gassman NR. A tipping point in dihydroxyacetone exposure: mitochondrial stress and metabolic reprogramming alter survival in rat cardiomyocytes H9c2 cells. Chemico-Biological Interactions. 2024 May;394():110991. doi: 10.1016/j.cbi.2024.110991."
132310,679,Comparative Toxicogenomics Database (CTD),Dimethyl Sulfoxide,D004121,Dimethyl Sulfoxide,https://ctdbase.org/detail.go?type=chem&acc=D004121,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dimethyl sulfoxide results in increased cleavage of PARP1 protein,,,PMID:22535522,https://www.ncbi.nlm.nih.gov/pubmed/22535522,22535522,,PMC3374744,18777117,"Tang HL, Tang HM, Mak KH, Hu S, Wang SS, Wong KM, Wong CS, Wu HY, Law HT, Liu K, Talbot CC, Lau WK, Montell DJ, Fung MC. Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol Biol Cell. 2012 Jun;23(12):2240–52. PMID: 22535522; PMCID: PMC3374744."
109512,681,Comparative Toxicogenomics Database (CTD),Dopamine,D004298,Dopamine,https://ctdbase.org/detail.go?type=chem&acc=D004298,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PRKN protein inhibits the reaction [dopamine results in increased cleavage of PARP1 protein],,,PMID:15198987,https://www.ncbi.nlm.nih.gov/pubmed/15198987,15198987,,,8547151,"Jiang H, Ren Y, Zhao J, Feng J. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet. 2004 Aug 15;13(16):1745–54. doi: 10.1093/hmg/ddh180. PMID: 15198987."
109924,681,Comparative Toxicogenomics Database (CTD),Dopamine,D004298,Dopamine,https://ctdbase.org/detail.go?type=chem&acc=D004298,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dopamine promotes the reaction [zinc deficiency results in increased cleavage of PARP1 protein]|zinc deficiency promotes the reaction [dopamine results in increased cleavage of PARP1 protein],,,PMID:23377617,https://www.ncbi.nlm.nih.gov/pubmed/23377617,23377617,,PMC3627551,17435572,"Omata Y, Salvador GA, Supasai S, Keenan AH, Oteiza PI. Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain. Toxicol Sci. 2013 May;133(1):90–100. PMID: 23377617; PMCID: PMC3627551."
109925,681,Comparative Toxicogenomics Database (CTD),Dopamine,D004298,Dopamine,https://ctdbase.org/detail.go?type=chem&acc=D004298,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dopamine results in increased cleavage of PARP1 protein,,,PMID:15198987|PMID:17603292|PMID:19410601|PMID:22987761|PMID:23377617,https://www.ncbi.nlm.nih.gov/pubmed/15198987|https://www.ncbi.nlm.nih.gov/pubmed/17603292|https://www.ncbi.nlm.nih.gov/pubmed/19410601|https://www.ncbi.nlm.nih.gov/pubmed/22987761|https://www.ncbi.nlm.nih.gov/pubmed/23377617,15198987|17603292|19410601|22987761|23377617,,PMC3627551,2361708|8547151|17435572|28187087|32959147,"Omata Y, Salvador GA, Supasai S, Keenan AH, Oteiza PI. Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain. Toxicol Sci. 2013 May;133(1):90–100. PMID: 23377617; PMCID: PMC3627551.|Li F, Tian X, Zhou Y, Zhu L, Wang B, Ding M, Pang H. Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis. J Neurosci Res. 2012 Dec;90(12):2237–46. doi: 10.1002/jnr.23121. PMID: 22987761.|Giménez-Xavier P, Francisco R, Santidrián AF, Gil J, Ambrosio S. Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model. Neurotoxicology. 2009 Jul;30(4):658–65. doi: 10.1016/j.neuro.2009.04.007. PMID: 19410601.|Lee MK, Kang SJ, Poncz M, Song K, Park KS. Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Experimental & Molecular Medicine. 2007 Jun 01;39(3):376–84. doi: 10.1038/emm.2007.42.|Jiang H, Ren Y, Zhao J, Feng J. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet. 2004 Aug 15;13(16):1745–54. doi: 10.1093/hmg/ddh180. PMID: 15198987."
109926,681,Comparative Toxicogenomics Database (CTD),Dopamine,D004298,Dopamine,https://ctdbase.org/detail.go?type=chem&acc=D004298,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol inhibits the reaction [dopamine results in increased cleavage of PARP1 protein],,,PMID:17603292,https://www.ncbi.nlm.nih.gov/pubmed/17603292,17603292,,,2361708,"Lee MK, Kang SJ, Poncz M, Song K, Park KS. Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Experimental & Molecular Medicine. 2007 Jun 01;39(3):376–84. doi: 10.1038/emm.2007.42."
109927,681,Comparative Toxicogenomics Database (CTD),Dopamine,D004298,Dopamine,https://ctdbase.org/detail.go?type=chem&acc=D004298,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[PARP1 protein results in increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] which results in increased abundance of dopamine",,,PMID:10318960,https://www.ncbi.nlm.nih.gov/pubmed/10318960,10318960,,PMC21936,33415557,"Mandir AS, Przedborski S, Jackson-Lewis V, Wang ZQ, Simbulan-Rosenthal CM, Smulson ME, Hoffman BE, Guastella DB, Dawson VL, Dawson TM. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5774–9. PMID: 10318960; PMCID: PMC21936."
90144,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ethanol results in increased cleavage of PARP1 protein,,,PMID:21410490|PMID:24374569|PMID:33516933|PMID:35158046,https://www.ncbi.nlm.nih.gov/pubmed/21410490|https://www.ncbi.nlm.nih.gov/pubmed/24374569|https://www.ncbi.nlm.nih.gov/pubmed/33516933|https://www.ncbi.nlm.nih.gov/pubmed/35158046,21410490|24374569|33516933|35158046,,,20174455|25089196|28903644|33888318,"Song XY, Liu PC, Liu WW, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Protective effects of silibinin against ethanol- or acetaldehyde-caused damage in liver cell lines involve the repression of mitochondrial fission. Toxicol In Vitro. 2022 Apr;80():105330. doi: 10.1016/j.tiv.2022.105330. PMID: 35158046.|Xia Z, Wang C, Wang X, Yu H, Yao H, Shen H, Lan X, Wu X, Zhang G. NCX3 alleviates ethanol-induced apoptosis of SK-N-SH cells via the elimination of intracellular calcium ions. Toxicol In Vitro. 2021 Apr;72():105104. doi: 10.1016/j.tiv.2021.105104. PMID: 33516933.|Clave S, Joya X, Salat-Batlle J, Garcia-Algar O, Vall O. Ethanol cytotoxic effect on trophoblast cells. Toxicol Lett. 2014 Mar 03;225(2):216–21. doi: 10.1016/j.toxlet.2013.12.018. PMID: 24374569.|von Haefen C, Sifringer M, Menk M, Spies CD. Ethanol enhances susceptibility to apoptotic cell death via down-regulation of autophagy-related proteins. Alcohol Clin Exp Res. 2011 Aug;35(8):1381–91. doi: 10.1111/j.1530-0277.2011.01473.x. PMID: 21410490."
90145,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ethanol results in increased expression of and results in increased cleavage of PARP1 protein,,,PMID:35149083,https://www.ncbi.nlm.nih.gov/pubmed/35149083,35149083,,,33888189,"Chen W, Zhang Q, Ding M, Yao J, Guo Y, Yan W, Yu S, Shen Q, Huang M, Zheng Y, Lin Y, Wang Y, Liu Z, Lu L. Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression. Chem Biol Interact. 2022 Apr 01;356():109847. doi: 10.1016/j.cbi.2022.109847. PMID: 35149083."
90342,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Silybin inhibits the reaction [ethanol results in increased cleavage of PARP1 protein],,,PMID:35158046,https://www.ncbi.nlm.nih.gov/pubmed/35158046,35158046,,,33888318,"Song XY, Liu PC, Liu WW, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Protective effects of silibinin against ethanol- or acetaldehyde-caused damage in liver cell lines involve the repression of mitochondrial fission. Toxicol In Vitro. 2022 Apr;80():105330. doi: 10.1016/j.tiv.2022.105330. PMID: 35158046."
90343,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [ethanol results in increased cleavage of PARP1 protein],,,PMID:21410490,https://www.ncbi.nlm.nih.gov/pubmed/21410490,21410490,,,28903644,"von Haefen C, Sifringer M, Menk M, Spies CD. Ethanol enhances susceptibility to apoptotic cell death via down-regulation of autophagy-related proteins. Alcohol Clin Exp Res. 2011 Aug;35(8):1381–91. doi: 10.1111/j.1530-0277.2011.01473.x. PMID: 21410490."
90348,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"PARP1 protein affects the reaction [ethanol results in increased expression of CYBB mrna]|parp1 protein affects the reaction [ethanol results in increased expression of GCK mrna]|parp1 protein affects the reaction [ethanol results in increased expression of NCF1 mrna]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [ethanol results in increased activity of PARP1 protein]|parp1 protein affects the reaction [ethanol results in increased expression of TNF mrna]|parp1 protein affects the reaction [ethanol results in increased expression of ICAM1 mrna]|parp1 protein affects the reaction [ethanol results in increased expression of CCL3 mrna]|parp1 protein affects the reaction [ethanol results in increased expression of MPO mrna]|parp1 protein affects the reaction [ethanol results in increased expression of G6PC1 mrna]|ethanol results in increased activity of PARP1 protein|parp1 protein affects the reaction [ethanol results in increased expression of GPT protein]|parp1 protein affects the reaction [ethanol results in increased expression of IFNG mrna]|parp1 protein affects the reaction [ethanol results in increased expression of NOS2 mrna]|parp1 protein affects the reaction [ethanol results in increased expression of IL1B mrna]|parp1 protein affects the reaction [ethanol results in increased expression of ACACB mrna]|parp1 protein affects the reaction [ethanol results in increased expression of SREBF1 mrna]|5-aminoisoquinolinone inhibits the reaction [ethanol results in increased activity of PARP1 protein]|parp1 protein affects the reaction [ethanol results in increased expression of CCR2 mrna]|parp1 protein affects the reaction [ethanol results in increased expression of CXCL2 mrna]|parp1 protein affects the reaction [ethanol results in increased expression of ACACA mrna]",,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,,31061321,"Mukhopadhyay P, Horváth B, Rajesh M, Varga ZV, Gariani K, Ryu D, Cao Z, Holovac E, Park O, Zhou Z, Xu MJ, Wang W, Godlewski G, Paloczi J, Nemeth BT, Persidsky Y, Liaudet L, Haskó G, Bai P, Boulares AH, Auwerx J, Gao B, Pacher P. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. J Hepatol. 2017 Mar;66(3):589–600. doi: 10.1016/j.jhep.2016.10.023. PMID: 27984176."
90349,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dioscin inhibits the reaction [ethanol results in increased expression of PARP1 protein],,,PMID:24146112,https://www.ncbi.nlm.nih.gov/pubmed/24146112,24146112,,,22837839,2013; 88(3):739-753
90516,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Ethanol affects the splicing of PARP1 mRNA,,,PMID:30319688,https://www.ncbi.nlm.nih.gov/pubmed/30319688,30319688,,PMC6166094,16902753,"O’Brien MA, Weston RM, Sheth NU, Bradley S, Bigbee J, Pandey A, Williams RW, Wolstenholme JT, Miles MF. Ethanol-Induced Behavioral Sensitization Alters the Synaptic Transcriptome and Exon Utilization in DBA/2J Mice. Front. Genet. 2018 Sep 24;9(). doi: 10.3389/fgene.2018.00402."
90517,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Ethanol results in increased cleavage of PARP1 protein,,,PMID:22535522|PMID:34116071,https://www.ncbi.nlm.nih.gov/pubmed/22535522|https://www.ncbi.nlm.nih.gov/pubmed/34116071,22535522|34116071,,PMC3374744,13612608|18777117,"Sun J, Hong Z, Shao S, Li L, Yang B, Hou Y, Wang H, Xu Y, Zhang Q, Pi J, Fu J. Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo. Toxicol Appl Pharmacol. 2021 Sep 01;426():115617. doi: 10.1016/j.taap.2021.115617. PMID: 34116071.|Tang HL, Tang HM, Mak KH, Hu S, Wang SS, Wong KM, Wong CS, Wu HY, Law HT, Liu K, Talbot CC, Lau WK, Montell DJ, Fung MC. Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol Biol Cell. 2012 Jun;23(12):2240–52. PMID: 22535522; PMCID: PMC3374744."
90518,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Ethanol results in increased expression of PARP1 protein,,,PMID:24146112|PMID:29317476|PMID:37939858,https://www.ncbi.nlm.nih.gov/pubmed/24146112|https://www.ncbi.nlm.nih.gov/pubmed/29317476|https://www.ncbi.nlm.nih.gov/pubmed/37939858,24146112|29317476|37939858,,,18247668|22837839|36361141,"Sandhu M, Irfan HM, Arshad L, Ullah A, Shah SA, Ali H. Friedelin and Glutinol induce neuroprotection against ethanol induced neurotoxicity in pup's brain through reduction of TNF-a, NF-kB, caspase-3 and PARP-1. Neurotoxicology. 2023 Dec;99():274–81. doi: 10.1016/j.neuro.2023.11.002. PMID: 37939858.|Huang S, Zhang B, Chen Y, Liu H, Liu Y, Li X, Bao Z, Song Z, Wang Z. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice. The Journal of Pharmacology and Experimental Therapeutics. 2018 Mar;364(3):452–61. doi: 10.1124/jpet.117.243105.|2013; 88(3):739-753"
90519,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Glutinol inhibits the reaction [ethanol results in increased expression of PARP1 protein]|friedelin inhibits the reaction [ethanol results in increased expression of PARP1 protein],,,PMID:37939858,https://www.ncbi.nlm.nih.gov/pubmed/37939858,37939858,,,36361141,"Sandhu M, Irfan HM, Arshad L, Ullah A, Shah SA, Ali H. Friedelin and Glutinol induce neuroprotection against ethanol induced neurotoxicity in pup's brain through reduction of TNF-a, NF-kB, caspase-3 and PARP-1. Neurotoxicology. 2023 Dec;99():274–81. doi: 10.1016/j.neuro.2023.11.002. PMID: 37939858."
90520,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),NFE2L2 gene mutant form promotes the reaction [ethanol results in increased cleavage of PARP1 protein],,,PMID:34116071,https://www.ncbi.nlm.nih.gov/pubmed/34116071,34116071,,,13612608,"Sun J, Hong Z, Shao S, Li L, Yang B, Hou Y, Wang H, Xu Y, Zhang Q, Pi J, Fu J. Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo. Toxicol Appl Pharmacol. 2021 Sep 01;426():115617. doi: 10.1016/j.taap.2021.115617. PMID: 34116071."
90521,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-dichlorophenoxyacetic acid] which results in increased expression of PARP1 mrna]|[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-dichlorophenoxyacetic acid] promotes the reaction [ethanol results in increased expression of PARP1 mrna]",,,PMID:36085217,https://www.ncbi.nlm.nih.gov/pubmed/36085217,36085217,,,35015623,2022; 30(4):10710-10723
90522,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Docosahexaenoic acids inhibits the reaction [ethanol results in increased expression of PARP1 protein],,,PMID:25029343,https://www.ncbi.nlm.nih.gov/pubmed/25029343,25029343,,PMC4100731,10043632,"Tajuddin N, Moon K, Marshall SA, Nixon K, Neafsey EJ, Kim H, Collins MA. Neuroinflammation and Neurodegeneration in Adult Rat Brain from Binge Ethanol Exposure: Abrogation by Docosahexaenoic Acid. PLoS ONE. 2014 Jul 16;9(7):e101223. doi: 10.1371/journal.pone.0101223."
90523,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Hesperidin inhibits the reaction [ethanol results in increased activity of PARP1 protein]|ethanol results in increased activity of PARP1 protein,,,PMID:30368987,https://www.ncbi.nlm.nih.gov/pubmed/30368987,30368987,,,587470,"Gaballah HH, Ghanem HB, Tahoon NM, Mohamed DA, Ebeid AM. Hesperidin promotes lysosomal biogenesis in chronically ethanol-induced cardiotoxicity in rats: A proposed mechanisms of protection. J Biochem Mol Toxicol. 2019 Mar;33(3):e22253. doi: 10.1002/jbt.22253. PMID: 30368987."
90524,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Ethanol results in increased expression of PARP1 mRNA,,,PMID:15353170|PMID:36085217,https://www.ncbi.nlm.nih.gov/pubmed/15353170|https://www.ncbi.nlm.nih.gov/pubmed/36085217,15353170|36085217,,,12589130|35015623,"2022; 30(4):10710-10723|Deaciuc IV, Arteel GE, Peng X, Hill DB, McClain CJ. Gene expression in the liver of rats fed alcohol by means of intragastric infusion. Alcohol. 2004 May;33(1):17–30. doi: 10.1016/j.alcohol.2004.04.001. PMID: 15353170."
90525,702,Comparative Toxicogenomics Database (CTD),Ethanol,D000431,Ethanol,https://ctdbase.org/detail.go?type=chem&acc=D000431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Ethanol results in increased expression of PARP1 protein,,,PMID:24146112|PMID:25029343|PMID:29339456,https://www.ncbi.nlm.nih.gov/pubmed/24146112|https://www.ncbi.nlm.nih.gov/pubmed/25029343|https://www.ncbi.nlm.nih.gov/pubmed/29339456,24146112|25029343|29339456,,PMC4100731|PMC5830636,10043632|22837839|29717727,"Tajuddin N, Kim H, Collins MA. PARP Inhibition Prevents Ethanol-Induced Neuroinflammatory Signaling and Neurodegeneration in Rat Adult-Age Brain Slice Cultures. The Journal of Pharmacology and Experimental Therapeutics. 2018 Apr;365(1):117–26. doi: 10.1124/jpet.117.245290.|Tajuddin N, Moon K, Marshall SA, Nixon K, Neafsey EJ, Kim H, Collins MA. Neuroinflammation and Neurodegeneration in Adult Rat Brain from Binge Ethanol Exposure: Abrogation by Docosahexaenoic Acid. PLoS ONE. 2014 Jul 16;9(7):e101223. doi: 10.1371/journal.pone.0101223.|2013; 88(3):739-753"
101651,712,Comparative Toxicogenomics Database (CTD),Formaldehyde,D005557,Formaldehyde,https://ctdbase.org/detail.go?type=chem&acc=D005557,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Formaldehyde results in increased expression of PARP1 protein modified form|ddah1 protein inhibits the reaction [formaldehyde results in increased expression of PARP1 protein modified form],,,PMID:24140967,https://www.ncbi.nlm.nih.gov/pubmed/24140967,24140967,,,25632959,"Lim SK, Choi H, Park MJ, Kim DI, Kim JC, Kim GY, Jeong SY, Rodionov RN, Han HJ, Yoon KC, Park SH. The ER stress-mediated decrease in DDAH1 expression is involved in formaldehyde-induced apoptosis in lung epithelial cells. Food Chem Toxicol. 2013 Dec;62():763–9. doi: 10.1016/j.fct.2013.10.014. PMID: 24140967."
101839,712,Comparative Toxicogenomics Database (CTD),Formaldehyde,D005557,Formaldehyde,https://ctdbase.org/detail.go?type=chem&acc=D005557,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Formaldehyde results in decreased expression of PARP1 mRNA,,,PMID:17285311,https://www.ncbi.nlm.nih.gov/pubmed/17285311,17285311,,,3737975,2007; 81(8):589-597
169908,772,Comparative Toxicogenomics Database (CTD),Lovenox,D006493,Heparin,https://ctdbase.org/detail.go?type=chem&acc=D006493,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Heparin promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:30377735,https://www.ncbi.nlm.nih.gov/pubmed/30377735,30377735,,,8127370,2018; 93(2):533-546
172892,783,Comparative Toxicogenomics Database (CTD),Hydrogen,D006859,Hydrogen,https://ctdbase.org/detail.go?type=chem&acc=D006859,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydrogen inhibits the reaction [APP protein results in increased cleavage of PARP1 protein],,,PMID:26271894,https://www.ncbi.nlm.nih.gov/pubmed/26271894,26271894,,,28991853,Lin CL et al; Chem Biol Interact 240: 12-21 (2015)
94469,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:11217149,https://www.ncbi.nlm.nih.gov/pubmed/11217149,11217149,,,2257485,"Kamp DW, Srinivasan M, Weitzman SA. Cigarette Smoke and Asbestos Activate Poly-ADP-Ribose Polymerase in Alveolar Epithelial Cells. Journal of Investigative Medicine. 2001 Jan;49(1):68–76. doi: 10.2310/6650.2001.34092."
94470,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydrogen peroxide results in decreased expression of and results in increased cleavage of PARP1 protein|hgf protein inhibits the reaction [hydrogen peroxide results in decreased expression of and results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:31313457,https://www.ncbi.nlm.nih.gov/pubmed/31313457,31313457,,,32448241,"Choi YJ, Lee CM, Lee JH, Park SH, Nam MJ. Protective effects of hepatocyte growth factor gene overexpression against hydrogen peroxide-induced apoptosis in mesenchymal stem cells. Environ Toxicol. 2019 Nov;34(11):1236–45. doi: 10.1002/tox.22824. PMID: 31313457."
94471,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:38104653,https://www.ncbi.nlm.nih.gov/pubmed/38104653,38104653,,,36378967,"Maeyama R, Segawa R, Onodera R, Hiratsuka M, Hirasawa N. Caspases downregulate nickel and hydrogen peroxide-induced IL-8 production via modification of c-Jun N-terminal kinases. Toxicology. 2024 Jan;501():153710. doi: 10.1016/j.tox.2023.153710. PMID: 38104653."
94472,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[BIN1 protein binds to PARP1 protein] inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:21447800,https://www.ncbi.nlm.nih.gov/pubmed/21447800,21447800,,,30941876,"Pyndiah S, Tanida S, Ahmed KM, Cassimere EK, Choe C, Sakamuro D. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance. Sci Signal. 2011 Mar 29;4(166):ra19. doi: 10.1126/scisignal.2001556. PMID: 21447800."
94473,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cordycepin inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:21607289,https://www.ncbi.nlm.nih.gov/pubmed/21607289,21607289,,PMC3188885,9334512,2011; 17(9-10):893-900
94614,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Monomethylarsonous acid inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein]|dimethylarsinous acid inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:17011244,https://www.ncbi.nlm.nih.gov/pubmed/17011244,17011244,,,25134446,"Walter I, Schwerdtle T, Thuy C, Parsons JL, Dianov GL, Hartwig A. Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells. DNA Repair. 2007 Jan;6(1):61–70. doi: 10.1016/j.dnarep.2006.08.008."
94615,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Homoeriodictyol inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:29902531,https://www.ncbi.nlm.nih.gov/pubmed/29902531,29902531,,,12852916,"Shen T, Li HZ, Li AL, Li YR, Wang XN, Ren DM. Homoeriodictyol protects human endothelial cells against oxidative insults through activation of Nrf2 and inhibition of mitochondrial dysfunction. Vascul Pharmacol. 2018 Oct;109():72–82. doi: 10.1016/j.vph.2018.06.007. PMID: 29902531."
94616,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[hydrogen peroxide results in increased activity of and results in increased ADP-ribosylation of PARP1 protein] which results in increased ADP-ribosylation of and results in decreased activity of SP1 protein|hydrogen peroxide affects the expression of PARP1 protein|[hydrogen peroxide results in increased activity of PARP1 protein] which results in decreased activity of SP1 protein|hydrogen peroxide results in increased activity of and results in increased ADP-ribosylation of PARP1 protein,,,PMID:17961220,https://www.ncbi.nlm.nih.gov/pubmed/17961220,17961220,,PMC2175517,18041632,2007; 8(1):96
94617,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Veliparib inhibits the reaction [hydrogen peroxide affects the reaction [PARP1 protein mutant form affects the abundance of NAD]]|PARP1 protein mutant form promotes the reaction [hydrogen peroxide results in increased abundance of poly adenosine diphosphate ribose]|hydrogen peroxide results in increased ADP-ribosylation of PARP1 protein|parp1 protein promotes the reaction [hydrogen peroxide results in decreased abundance of NAD]|PARP1 protein promotes the reaction [hydrogen peroxide results in increased abundance of poly adenosine diphosphate ribose]|hydrogen peroxide affects the reaction [PARP1 protein mutant form affects the abundance of NAD],,,PMID:27694308,https://www.ncbi.nlm.nih.gov/pubmed/27694308,27694308,,PMC5137445,29679245,"Rank L, Veith S, Gwosch EC, Demgenski J, Ganz M, Jongmans MC, Vogel C, Fischbach A, Buerger S, Fischer JM, Zubel T, Stier A, Renner C, Schmalz M, Beneke S, Groettrup M, Kuiper RP, Bürkle A, Ferrando-May E, Mangerich A. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells. Nucleic Acids Res. 2016 Dec 01;44(21):10386–405. PMID: 27694308; PMCID: PMC5137445."
94618,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydrogen peroxide promotes the reaction [niclosamide results in increased cleavage of PARP1 protein],,,PMID:24750999,https://www.ncbi.nlm.nih.gov/pubmed/24750999,24750999,,,1833952,"Lee SL, Son AR, Ahn J, Song JY. Niclosamide enhances ROS-mediated cell death through c-Jun activation. Biomed Pharmacother. 2014 Jun;68(5):619–24. doi: 10.1016/j.biopha.2014.03.018. PMID: 24750999."
94619,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [hydrogen peroxide promotes the reaction [PARP1 protein binds to ATM protein]]|hydrogen peroxide promotes the reaction [PARP1 protein binds to ATM protein]|parp1 protein affects the reaction [hydrogen peroxide results in increased phosphorylation of AKT1 protein]",,,PMID:30296409,https://www.ncbi.nlm.nih.gov/pubmed/30296409,30296409,,,22308622,"Tapodi A, Bognar Z, Szabo C, Gallyas F, Sumegi B, Hocsak E. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome. Biochem Pharmacol. 2019 Apr;162():98–108. doi: 10.1016/j.bcp.2018.10.005. PMID: 30296409."
94620,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydrogen peroxide results in increased activity of PARP1 protein,,,PMID:11217149|PMID:17961220|PMID:18239155|PMID:20953586|PMID:21347231|PMID:21447800|PMID:21607289|PMID:23726866|PMID:25280774|PMID:33645215,https://www.ncbi.nlm.nih.gov/pubmed/11217149|https://www.ncbi.nlm.nih.gov/pubmed/17961220|https://www.ncbi.nlm.nih.gov/pubmed/18239155|https://www.ncbi.nlm.nih.gov/pubmed/20953586|https://www.ncbi.nlm.nih.gov/pubmed/21347231|https://www.ncbi.nlm.nih.gov/pubmed/21447800|https://www.ncbi.nlm.nih.gov/pubmed/21607289|https://www.ncbi.nlm.nih.gov/pubmed/23726866|https://www.ncbi.nlm.nih.gov/pubmed/25280774|https://www.ncbi.nlm.nih.gov/pubmed/33645215,11217149|17961220|18239155|20953586|21347231|21447800|21607289|23726866|25280774|33645215,,PMC2175517|PMC3039651|PMC3188885,1703284|2257485|3168148|9334512|14704910|18041632|23020905|24264007|30941876|32938915,"Wedler N, Matthäus T, Strauch B, Dilger E, Waterstraat M, Mangerich A, Hartwig A. Impact of the Cellular Zinc Status on PARP-1 Activity and Genomic Stability in HeLa S3 Cells. Chem Res Toxicol. 2021 Mar 15;34(3):839–48. doi: 10.1021/acs.chemrestox.0c00452. PMID: 33645215.|Batnasan E, Wang R, Wen J, Ke Y, Li X, Bohio AA, Zeng X, Huo H, Han L, Boldogh I, Ba X. 17-beta estradiol inhibits oxidative stress-induced accumulation of AIF into nucleolus and PARP1-dependent cell death via estrogen receptor alpha. Toxicol Lett. 2015 Jan 05;232(1):1–9. doi: 10.1016/j.toxlet.2014.09.024. PMID: 25280774.|Ashabi G, Ahmadiani A, Abdi A, Abraki SB, Khodagholi F. Time course study of Aß formation and neurite outgrowth disruption in differentiated human neuroblastoma cells exposed to H2O2: protective role of autophagy. Toxicol In Vitro. 2013 Sep;27(6):1780–8. doi: 10.1016/j.tiv.2013.05.005. PMID: 23726866.|2011; 17(9-10):893-900|Pyndiah S, Tanida S, Ahmed KM, Cassimere EK, Choe C, Sakamuro D. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance. Sci Signal. 2011 Mar 29;4(166):ra19. doi: 10.1126/scisignal.2001556. PMID: 21447800.|Ho JQ, Asagiri M, Hoffmann A, Ghosh G. NF-?B Potentiates Caspase Independent Hydrogen Peroxide Induced Cell Death. PLoS ONE. 2011 Feb 15;6(2):e16815. doi: 10.1371/journal.pone.0016815.|2010; 85(6):669-679|Mathews MT, Berk BC. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):711–7. doi: 10.1161/atvbaha.107.156406. PMID: 18239155.|2007; 8(1):96|Kamp DW, Srinivasan M, Weitzman SA. Cigarette Smoke and Asbestos Activate Poly-ADP-Ribose Polymerase in Alveolar Epithelial Cells. Journal of Investigative Medicine. 2001 Jan;49(1):68–76. doi: 10.2310/6650.2001.34092."
94778,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydrogen peroxide results in increased cleavage of PARP1 protein,,,PMID:19815691|PMID:29061316|PMID:29902531|PMID:30661989|PMID:31306736|PMID:38104653,https://www.ncbi.nlm.nih.gov/pubmed/19815691|https://www.ncbi.nlm.nih.gov/pubmed/29061316|https://www.ncbi.nlm.nih.gov/pubmed/29902531|https://www.ncbi.nlm.nih.gov/pubmed/30661989|https://www.ncbi.nlm.nih.gov/pubmed/31306736|https://www.ncbi.nlm.nih.gov/pubmed/38104653,19815691|29061316|29902531|30661989|31306736|38104653,,PMC6557261,12852916|18889095|30427533|30902122|32441726|36378967,"Maeyama R, Segawa R, Onodera R, Hiratsuka M, Hirasawa N. Caspases downregulate nickel and hydrogen peroxide-induced IL-8 production via modification of c-Jun N-terminal kinases. Toxicology. 2024 Jan;501():153710. doi: 10.1016/j.tox.2023.153710. PMID: 38104653.|Fürstenau CR, de Souza ICC, de Oliveira MR. The effects of kahweol, a diterpene present in coffee, on the mitochondria of the human neuroblastoma SH-SY5Y cells exposed to hydrogen peroxide. Toxicol In Vitro. 2019 Dec;61():104601. doi: 10.1016/j.tiv.2019.104601. PMID: 31306736.|Ye Q, Zhang Y, Cao Y, Wang X, Guo Y, Chen J, Horn J, Ponomareva LV, Chaiswing L, Shaaban KA, Wei Q, Anderson BD, St Clair DK, Zhu H, Leggas M, Thorson JS, She Q. Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects. Cell Chemical Biology. 2019 Mar;26(3):366–377.e12. doi: 10.1016/j.chembiol.2018.11.013.|Shen T, Li HZ, Li AL, Li YR, Wang XN, Ren DM. Homoeriodictyol protects human endothelial cells against oxidative insults through activation of Nrf2 and inhibition of mitochondrial dysfunction. Vascul Pharmacol. 2018 Oct;109():72–82. doi: 10.1016/j.vph.2018.06.007. PMID: 29902531.|Qi G, Mi Y, Fan R, Zhao B, Ren B, Liu X. Tea polyphenols ameliorates neural redox imbalance and mitochondrial dysfunction via mechanisms linking the key circadian regular Bmal1. Food Chem Toxicol. 2017 Dec;110():189–99. doi: 10.1016/j.fct.2017.10.031. PMID: 29061316.|Franco JL, Posser T, Gordon SL, Bobrovskaya L, Schneider JJ, Farina M, Dafre AL, Dickson PW, Dunkley PR. Expression of tyrosine hydroxylase increases the resistance of human neuroblastoma cells to oxidative insults. Toxicol Sci. 2010 Jan;113(1):150–7. doi: 10.1093/toxsci/kfp245. PMID: 19815691."
94779,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydrogen peroxide results in increased expression of PARP1 protein modified form,,,PMID:16709600|PMID:23726866,https://www.ncbi.nlm.nih.gov/pubmed/16709600|https://www.ncbi.nlm.nih.gov/pubmed/23726866,16709600|23726866,,,3168148|13962627,"Ashabi G, Ahmadiani A, Abdi A, Abraki SB, Khodagholi F. Time course study of Aß formation and neurite outgrowth disruption in differentiated human neuroblastoma cells exposed to H2O2: protective role of autophagy. Toxicol In Vitro. 2013 Sep;27(6):1780–8. doi: 10.1016/j.tiv.2013.05.005. PMID: 23726866.|Kajihara T, Jones M, Fusi L, Takano M, Feroze-Zaidi F, Pirianov G, Mehmet H, Ishihara O, Higham JM, Lam EW, Brosens JJ. Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization. Mol Endocrinol. 2006 Oct;20(10):2444–55. doi: 10.1210/me.2006-0118. PMID: 16709600."
94780,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Kahweol inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:31306736,https://www.ncbi.nlm.nih.gov/pubmed/31306736,31306736,,,32441726,"Fürstenau CR, de Souza ICC, de Oliveira MR. The effects of kahweol, a diterpene present in coffee, on the mitochondria of the human neuroblastoma SH-SY5Y cells exposed to hydrogen peroxide. Toxicol In Vitro. 2019 Dec;61():104601. doi: 10.1016/j.tiv.2019.104601. PMID: 31306736."
94781,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein]|zinc chloride promotes the reaction [hydrogen peroxide results in increased activity of PARP1 protein]",,,PMID:33645215,https://www.ncbi.nlm.nih.gov/pubmed/33645215,33645215,,,23020905,"Wedler N, Matthäus T, Strauch B, Dilger E, Waterstraat M, Mangerich A, Hartwig A. Impact of the Cellular Zinc Status on PARP-1 Activity and Genomic Stability in HeLa S3 Cells. Chem Res Toxicol. 2021 Mar 15;34(3):839–48. doi: 10.1021/acs.chemrestox.0c00452. PMID: 33645215."
94782,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein]",,,PMID:18239155,https://www.ncbi.nlm.nih.gov/pubmed/18239155,18239155,,,1703284,"Mathews MT, Berk BC. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):711–7. doi: 10.1161/atvbaha.107.156406. PMID: 18239155."
94783,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),XRCC1 protein affects the reaction [PARP1 protein affects the reaction [hydrogen peroxide results in decreased abundance of NAD]]|PARP1 protein affects the reaction [hydrogen peroxide results in decreased abundance of NAD],,,PMID:35778544,https://www.ncbi.nlm.nih.gov/pubmed/35778544,35778544,,PMC10042965,34003347,2022; 39(1):345-364
94784,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to hydrogen peroxide,,,PMID:19111594|PMID:27694308,https://www.ncbi.nlm.nih.gov/pubmed/19111594|https://www.ncbi.nlm.nih.gov/pubmed/27694308,19111594|27694308,,PMC5137445,27536756|29679245,"Rank L, Veith S, Gwosch EC, Demgenski J, Ganz M, Jongmans MC, Vogel C, Fischbach A, Buerger S, Fischer JM, Zubel T, Stier A, Renner C, Schmalz M, Beneke S, Groettrup M, Kuiper RP, Bürkle A, Ferrando-May E, Mangerich A. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells. Nucleic Acids Res. 2016 Dec 01;44(21):10386–405. PMID: 27694308; PMCID: PMC5137445.|Jowsey PA, Williams FM, Blain PG. DNA damage, signalling and repair after exposure of cells to the sulphur mustard analogue 2-chloroethyl ethyl sulphide. Toxicology. 2009 Mar 29;257(3):105–12. doi: 10.1016/j.tox.2008.12.001. PMID: 19111594."
94785,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sodium arsenite co-treated with hydrogen peroxide] results in increased cleavage of PARP1 protein,,,PMID:18977016,https://www.ncbi.nlm.nih.gov/pubmed/18977016,18977016,,,22109660,"Wen G, Partridge MA, Calaf GM, Meador JA, Hu B, Echiburú-Chau C, Hong M, Hei TK. Increased susceptibility of human small airway epithelial cells to apoptosis after long term arsenate treatment. Sci Total Environ. 2009 Jan 15;407(3):1174–81. doi: 10.1016/j.scitotenv.2008.09.045. PMID: 18977016."
94786,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TH protein inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:19815691,https://www.ncbi.nlm.nih.gov/pubmed/19815691,19815691,,,30902122,"Franco JL, Posser T, Gordon SL, Bobrovskaya L, Schneider JJ, Farina M, Dafre AL, Dickson PW, Dunkley PR. Expression of tyrosine hydroxylase increases the resistance of human neuroblastoma cells to oxidative insults. Toxicol Sci. 2010 Jan;113(1):150–7. doi: 10.1093/toxsci/kfp245. PMID: 19815691."
94974,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzamide inhibits the reaction [[hydrogen peroxide results in increased activity of PARP1 protein] which results in decreased abundance of nad]|[benzamide results in decreased activity of PARP1 protein] which results in decreased susceptibility to hydrogen peroxide|hydrolyzable tannins inhibits the reaction [[hydrogen peroxide results in increased activity of PARP1 protein] which results in decreased abundance of nad]|[hydrogen peroxide results in increased activity of PARP1 protein] which results in decreased abundance of NAD,,,PMID:11593040,https://www.ncbi.nlm.nih.gov/pubmed/11593040,11593040,,PMC59796,29402615,"Ying W, Sevigny MB, Chen Y, Swanson RA. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. U.S.A. 2001 Oct 09;98(21):12227–32. doi: 10.1073/pnas.211202598."
94975,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Erigeroflavanone inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:19557877,https://www.ncbi.nlm.nih.gov/pubmed/19557877,19557877,,,18066132,"Kim OS, Kim YS, Jang DS, Yoo NH, Kim JS. Cytoprotection against hydrogen peroxide-induced cell death in cultured mouse mesangial cells by erigeroflavanone, a novel compound from the flowers of Erigeron annuus. Chem Biol Interact. 2009 Aug 14;180(3):414–20. doi: 10.1016/j.cbi.2009.03.021. PMID: 19557877."
94976,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Hydrogen peroxide results in decreased expression of PARP1 protein,,,PMID:26218895,https://www.ncbi.nlm.nih.gov/pubmed/26218895,26218895,,PMC4517814,33034597,"Oláh G, Szczesny B, Brunyánszki A, López-García IA, Gerö D, Radák Z, Szabo C. Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress. PLoS ONE. 2015 Jul 28;10(7):e0134227. doi: 10.1371/journal.pone.0134227."
94977,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Hydrogen peroxide results in increased activity of PARP1 protein,,,PMID:11593040|PMID:24814482,https://www.ncbi.nlm.nih.gov/pubmed/11593040|https://www.ncbi.nlm.nih.gov/pubmed/24814482,11593040|24814482,,PMC4047186|PMC59796,2692609|29402615,"Pirinen E, Cantó C, Jo YS, Morato L, Zhang H, Menzies KJ, Williams EG, Mouchiroud L, Moullan N, Hagberg C, Li W, Timmers S, Imhof R, Verbeek J, Pujol A, van Loon B, Viscomi C, Zeviani M, Schrauwen P, Sauve AA, Schoonjans K, Auwerx J. Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 2014 Jun 03;19(6):1034–41. PMID: 24814482; PMCID: PMC4047186.|Ying W, Sevigny MB, Chen Y, Swanson RA. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. U.S.A. 2001 Oct 09;98(21):12227–32. doi: 10.1073/pnas.211202598."
94978,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Hydrogen peroxide results in increased cleavage of PARP1 protein,,,PMID:15876423|PMID:19557877|PMID:20878536|PMID:23542513|PMID:24740755,https://www.ncbi.nlm.nih.gov/pubmed/15876423|https://www.ncbi.nlm.nih.gov/pubmed/19557877|https://www.ncbi.nlm.nih.gov/pubmed/20878536|https://www.ncbi.nlm.nih.gov/pubmed/23542513|https://www.ncbi.nlm.nih.gov/pubmed/24740755,15876423|19557877|20878536|23542513|24740755,,PMC3064896,1824279|7315936|18066132|22792573|27455432,"2014; 393(1-2):69-76|Kang CH, Kim MJ, Seo MJ, Choi YH, Jo WS, Lee KT, Jeong YK, Kim GY. 5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via NF-?B suppression and Nrf-2-dependent heme oxygenase-1 induction. Food Chem Toxicol. 2013 Jul;57():119–25. doi: 10.1016/j.fct.2013.03.019. PMID: 23542513.|2010; 68(8):1455-1466|Kim OS, Kim YS, Jang DS, Yoo NH, Kim JS. Cytoprotection against hydrogen peroxide-induced cell death in cultured mouse mesangial cells by erigeroflavanone, a novel compound from the flowers of Erigeron annuus. Chem Biol Interact. 2009 Aug 14;180(3):414–20. doi: 10.1016/j.cbi.2009.03.021. PMID: 19557877.|Chow JM, Shen SC, Huan SK, Lin HY, Chen YC. Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem Pharmacol. 2005 Jun 15;69(12):1839–51. doi: 10.1016/j.bcp.2005.03.017. PMID: 15876423."
94979,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Olaparib inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:24814482,https://www.ncbi.nlm.nih.gov/pubmed/24814482,24814482,,PMC4047186,2692609,"Pirinen E, Cantó C, Jo YS, Morato L, Zhang H, Menzies KJ, Williams EG, Mouchiroud L, Moullan N, Hagberg C, Li W, Timmers S, Imhof R, Verbeek J, Pujol A, van Loon B, Viscomi C, Zeviani M, Schrauwen P, Sauve AA, Schoonjans K, Auwerx J. Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 2014 Jun 03;19(6):1034–41. PMID: 24814482; PMCID: PMC4047186."
94980,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 gene mutant form results in decreased susceptibility to hydrogen peroxide,,,PMID:17438151,https://www.ncbi.nlm.nih.gov/pubmed/17438151,17438151,,,337498,"Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation. 2007 May 08;115(18):2442–50. doi: 10.1161/circulationaha.106.668756. PMID: 17438151."
94981,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein promotes the reaction [hydrogen peroxide results in increased cleavage of CASP9 protein]|parp1 protein promotes the reaction [hydrogen peroxide results in increased cleavage of CASP3 protein]|parp1 protein promotes the reaction [hydrogen peroxide results in increased uptake of calcium]|parp1 protein promotes the reaction [hydrogen peroxide results in increased cleavage of CASP6 protein],,,PMID:20878536,https://www.ncbi.nlm.nih.gov/pubmed/20878536,20878536,,PMC3064896,22792573,2010; 68(8):1455-1466
94982,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein results in increased susceptibility to hydrogen peroxide,,,PMID:20878536|PMID:26218895,https://www.ncbi.nlm.nih.gov/pubmed/20878536|https://www.ncbi.nlm.nih.gov/pubmed/26218895,20878536|26218895,,PMC3064896|PMC4517814,22792573|33034597,"Oláh G, Szczesny B, Brunyánszki A, López-García IA, Gerö D, Radák Z, Szabo C. Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress. PLoS ONE. 2015 Jul 28;10(7):e0134227. doi: 10.1371/journal.pone.0134227.|2010; 68(8):1455-1466"
95140,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Quercetin inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:15876423,https://www.ncbi.nlm.nih.gov/pubmed/15876423,15876423,,,27455432,"Chow JM, Shen SC, Huan SK, Lin HY, Chen YC. Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem Pharmacol. 2005 Jun 15;69(12):1839–51. doi: 10.1016/j.bcp.2005.03.017. PMID: 15876423."
95141,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),SOD2 mutant form inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:24740755,https://www.ncbi.nlm.nih.gov/pubmed/24740755,24740755,,,1824279,2014; 393(1-2):69-76
95142,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Calycopterin results in decreased susceptibility to [hydrogen peroxide results in increased cleavage of PARP1 protein]|hydrogen peroxide results in increased expression of PARP1 protein modified form|calycopterin results in decreased susceptibility to [hydrogen peroxide results in increased expression of PARP1 protein modified form],,,PMID:22081883,https://www.ncbi.nlm.nih.gov/pubmed/22081883,22081883,,,3149788,"Farimani MM, Sarvestani NN, Ansari N, Khodagholi F. Calycopterin promotes survival and outgrowth of neuron-like PC12 cells by attenuation of oxidative- and ER-stress-induced apoptosis along with inflammatory response. Chem Res Toxicol. 2011 Dec 19;24(12):2280–92. doi: 10.1021/tx200420a. PMID: 22081883."
95143,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[rotenone results in increased abundance of hydrogen peroxide] which results in increased cleavage of PARP1 protein|cat protein inhibits the reaction [[rotenone results in increased abundance of hydrogen peroxide] which results in increased cleavage of PARP1 protein],,,PMID:25304210,https://www.ncbi.nlm.nih.gov/pubmed/25304210,25304210,,PMC4274383,5249779,"Zhou Q, Liu C, Liu W, Zhang H, Zhang R, Liu J, Zhang J, Xu C, Liu L, Huang S, Chen L. Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis. Toxicol Sci. 2015 Jan;143(1):81–96. PMID: 25304210; PMCID: PMC4274383."
95144,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),FOXO1 mRNA inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:26354380,https://www.ncbi.nlm.nih.gov/pubmed/26354380,26354380,,,33697755,"Ning Y, Li Z, Qiu Z. FOXO1 silence aggravates oxidative stress-promoted apoptosis in cardiomyocytes by reducing autophagy. J Toxicol Sci. 2015;40(5):637–45. doi: 10.2131/jts.40.637. PMID: 26354380."
95146,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Hydrogen peroxide results in increased cleavage of PARP1 protein,,,PMID:14505808|PMID:15228596|PMID:22081883|PMID:26354380,https://www.ncbi.nlm.nih.gov/pubmed/14505808|https://www.ncbi.nlm.nih.gov/pubmed/15228596|https://www.ncbi.nlm.nih.gov/pubmed/22081883|https://www.ncbi.nlm.nih.gov/pubmed/26354380,14505808|15228596|22081883|26354380,,,3149788|14592968|32160502|33697755,"Ning Y, Li Z, Qiu Z. FOXO1 silence aggravates oxidative stress-promoted apoptosis in cardiomyocytes by reducing autophagy. J Toxicol Sci. 2015;40(5):637–45. doi: 10.2131/jts.40.637. PMID: 26354380.|Farimani MM, Sarvestani NN, Ansari N, Khodagholi F. Calycopterin promotes survival and outgrowth of neuron-like PC12 cells by attenuation of oxidative- and ER-stress-induced apoptosis along with inflammatory response. Chem Res Toxicol. 2011 Dec 19;24(12):2280–92. doi: 10.1021/tx200420a. PMID: 22081883.|Fragoso G, Martínez-Bermúdez AK, Liu H, Khorchid A, Chemtob S, Mushynski WE, Almazan G. Developmental differences in H<sub>2</sub>O<sub>2</sub>-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3. Journal of Neurochemistry. 2004 Jun 10;90(2):392–404. doi: 10.1111/j.1471-4159.2004.02488.x.|Park C, So HS, Shin CH, Baek SH, Moon BS, Shin SH, Lee HS, Lee DW, Park R. Quercetin protects the hydrogen peroxide-induced apoptosis via inhibition of mitochondrial dysfunction in H9c2 cardiomyoblast cells. Biochem Pharmacol. 2003 Oct 01;66(7):1287–95. doi: 10.1016/s0006-2952(03)00478-7. PMID: 14505808."
95147,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Hydrogen peroxide results in increased degradation of PARP1 protein,,,PMID:16157298,https://www.ncbi.nlm.nih.gov/pubmed/16157298,16157298,,,30163251,"Yaniv G, Shilkrut M, Larisch S, Binah O. Hydrogen peroxide predisposes neonatal rat ventricular myocytes to Fas-mediated apoptosis. Biochemical and Biophysical Research Communications. 2005 Oct;336(3):740–6. doi: 10.1016/j.bbrc.2005.08.167."
95148,784,Comparative Toxicogenomics Database (CTD),Hydrogen Peroxide,D006861,Hydrogen Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D006861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:14505808,https://www.ncbi.nlm.nih.gov/pubmed/14505808,14505808,,,14592968,"Park C, So HS, Shin CH, Baek SH, Moon BS, Shin SH, Lee HS, Lee DW, Park R. Quercetin protects the hydrogen peroxide-induced apoptosis via inhibition of mitochondrial dysfunction in H9c2 cardiomyoblast cells. Biochem Pharmacol. 2003 Oct 01;66(7):1287–95. doi: 10.1016/s0006-2952(03)00478-7. PMID: 14505808."
138418,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the reaction [hydroquinone results in increased expression of AATF protein]|parp1 protein affects the reaction [hydroquinone results in increased expression of H2AX protein]|hydroquinone results in decreased expression of PARP1 protein,,,PMID:26822515,https://www.ncbi.nlm.nih.gov/pubmed/26822515,26822515,,,5988195,"Ling XX, Liu JX, Yun L, DU YJ, Chen SQ, Chen JL, Tang HW, Liu LH. Poly(ADP-ribosyl)ation of Apoptosis Antagonizing Transcription Factor Involved in Hydroquinone-Induced DNA Damage Response. Biomed Environ Sci. 2016 Jan;29(1):80–4. doi: 10.3967/bes2016.008. PMID: 26822515."
138419,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydroquinone results in increased cleavage of PARP1 protein,,,PMID:19064679|PMID:23288922|PMID:28843007|PMID:28886972,https://www.ncbi.nlm.nih.gov/pubmed/19064679|https://www.ncbi.nlm.nih.gov/pubmed/23288922|https://www.ncbi.nlm.nih.gov/pubmed/28843007|https://www.ncbi.nlm.nih.gov/pubmed/28886972,19064679|23288922|28843007|28886972,,PMC2639759,7926786|8103080|8685772|27711271,"Li J, Jiang S, Chen Y, Ma R, Chen J, Qian S, Shi Y, Han Y, Zhang S, Yu K. Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of ß-catenin signaling. Toxicol In Vitro. 2018 Feb;46():361–9. doi: 10.1016/j.tiv.2017.08.018. PMID: 28886972.|Chen Y, Chen S, Liang H, Yang H, Liu L, Zhou K, Xu L, Liu J, Yun L, Lai B, Song L, Luo H, Peng J, Liu Z, Xiao Y, Chen W, Tang H. Bcl-2 protects TK6 cells against hydroquinone-induced apoptosis through PARP-1 cytoplasm translocation and stabilizing mitochondrial membrane potential. Environ Mol Mutagen. 2018 Jan;59(1):49–59. doi: 10.1002/em.22126. PMID: 28843007.|Liu WH, Chou WM, Chang LS. p38 MAPK/PP2Aca/TTP pathway on the connection of TNF-a and caspases activation on hydroquinone-induced apoptosis. Carcinogenesis. 2013 Apr;34(4):818–27. doi: 10.1093/carcin/bgs409. PMID: 23288922.|Ren X, Lim S, Smith MT, Zhang L. Werner syndrome protein, WRN, protects cells from DNA damage induced by the benzene metabolite hydroquinone. Toxicol Sci. 2009 Feb;107(2):367–75. PMID: 19064679; PMCID: PMC2639759."
138420,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NOX4 protein promotes the reaction [hydroquinone results in increased degradation of PARP1 protein]|hydroquinone results in increased degradation of PARP1 protein,,,PMID:35302183,https://www.ncbi.nlm.nih.gov/pubmed/35302183,35302183,,,13644423,2022; 39(5):2207-2225
138600,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydroquinone results in increased expression of and results in increased cleavage of PARP1 protein,,,PMID:29421518,https://www.ncbi.nlm.nih.gov/pubmed/29421518,29421518,,,26364619,"Luo H, Liang H, Chen Y, Chen S, Xu Y, Xu L, Liu J, Zhou K, Peng J, Guo G, Lai B, Song L, Yang H, Liu L, Peng J, Liu Z, Tang L, Chen W, Tang H. miR-7-5p overexpression suppresses cell proliferation and promotes apoptosis through inhibiting the ability of DNA damage repair of PARP-1 and BRCA1 in TK6 cells exposed to hydroquinone. Chem Biol Interact. 2018 Mar 01;283():84–90. doi: 10.1016/j.cbi.2018.01.019. PMID: 29421518."
139146,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydroquinone affects the expression of PARP1 protein|hydroquinone promotes the reaction [PARP1 protein binds to and results in increased ADP-ribosylation of and results in increased expression of HRAS protein]|doxorubicin inhibits the reaction [hydroquinone results in decreased expression of PARP1 protein]|parp1 protein promotes the reaction [hydroquinone results in increased expression of HRAS protein]|parp1 protein results in increased susceptibility to hydroquinone|3-aminobenzamide inhibits the reaction [hydroquinone results in increased expression of PARP1 protein],,,PMID:26047893,https://www.ncbi.nlm.nih.gov/pubmed/26047893,26047893,,,18181592,"Liu L, Ling X, Tang H, Chen J, Wen Q, Zou F. Poly(ADP-ribosyl)ation enhances H-RAS protein stability and causes abnormal cell cycle progression in human TK6 lymphoblastoid cells treated with hydroquinone. Chem Biol Interact. 2015 Aug 05;238():1–8. doi: 10.1016/j.cbi.2015.05.019. PMID: 26047893."
139147,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydroquinone results in increased expression of and affects the localization of PARP1 protein|[abt-737 co-treated with hydroquinone] results in increased cleavage of PARP1 protein|abt-737 inhibits the reaction [hydroquinone affects the localization of PARP1 protein],,,PMID:28843007,https://www.ncbi.nlm.nih.gov/pubmed/28843007,28843007,,,8103080,"Chen Y, Chen S, Liang H, Yang H, Liu L, Zhou K, Xu L, Liu J, Yun L, Lai B, Song L, Luo H, Peng J, Liu Z, Xiao Y, Chen W, Tang H. Bcl-2 protects TK6 cells against hydroquinone-induced apoptosis through PARP-1 cytoplasm translocation and stabilizing mitochondrial membrane potential. Environ Mol Mutagen. 2018 Jan;59(1):49–59. doi: 10.1002/em.22126. PMID: 28843007."
139148,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydroquinone results in increased expression of PARP1 protein,,,PMID:28263894|PMID:28983606|PMID:30448557|PMID:33771647|PMID:39029599,https://www.ncbi.nlm.nih.gov/pubmed/28263894|https://www.ncbi.nlm.nih.gov/pubmed/28983606|https://www.ncbi.nlm.nih.gov/pubmed/30448557|https://www.ncbi.nlm.nih.gov/pubmed/33771647|https://www.ncbi.nlm.nih.gov/pubmed/39029599,28263894|28983606|30448557|33771647|39029599,,PMC5779892,2582162|11553988|21597095|25033983|37485003,"Chen L, Guo P, Zhai L, Yu L, Zhu D, Hu X, Li Z, Chen Y, Sun Q, Sun L, Luo H, Tang H. Nrf2 affects DNA damage repair and cell apoptosis through regulating HR and the intrinsic Caspase-dependent apoptosis pathway in TK6 cells exposed to hydroquinone. Toxicol In Vitro. 2024 Oct;100():105901. doi: 10.1016/j.tiv.2024.105901. PMID: 39029599.|Zhai L, Liang H, Du J, Sun M, Qiu W, Tang H, Luo H. PARP-1 via regulation of p53 and p16, is involved in the hydroquinone-induced malignant transformation of TK6 cells by decelerating the cell cycle. Toxicol In Vitro. 2021 Aug;74():105153. doi: 10.1016/j.tiv.2021.105153. PMID: 33771647.|Gui Z, Zhang H, Tan Q, Ling X, Liu Z, Peng J, Shao J, Wu M, Yuan Q, Li J, Pan Z, Zhong B, Liu L. Poly(ADP-ribose) polymerase-1 promotes expression of miR-155 by the up-regulation of methyl-CpG binding domain protein 2 in TK6 cells exposed to hydroquinone. Toxicol In Vitro. 2019 Mar;55():51–7. doi: 10.1016/j.tiv.2018.11.007. PMID: 30448557.|Liu J, Yuan Q, Ling X, Tan Q, Liang H, Chen J, Lin L, Xiao Y, Chen W, Liu L, Tang H. PARP-1 may be involved in hydroquinone-induced apoptosis by poly ADP-ribosylation of ZO-2. Mol Med Rep. 2017 Dec;16(6):8076–84. PMID: 28983606; PMCID: PMC5779892.|Xu L, Liu J, Chen Y, Yun L, Chen S, Zhou K, Lai B, Song L, Yang H, Liang H, Tang H. Inhibition of autophagy enhances Hydroquinone-induced TK6 cell death. Toxicol In Vitro. 2017 Jun;41():123–32. doi: 10.1016/j.tiv.2017.02.024. PMID: 28263894."
139149,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lithium chloride inhibits the reaction [hydroquinone results in increased cleavage of PARP1 protein],,,PMID:28886972,https://www.ncbi.nlm.nih.gov/pubmed/28886972,28886972,,,27711271,"Li J, Jiang S, Chen Y, Ma R, Chen J, Qian S, Shi Y, Han Y, Zhang S, Yu K. Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of ß-catenin signaling. Toxicol In Vitro. 2018 Feb;46():361–9. doi: 10.1016/j.tiv.2017.08.018. PMID: 28886972."
139150,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NFE2L2 protein promotes the reaction [hydroquinone results in increased expression of PARP1 protein],,,PMID:39029599,https://www.ncbi.nlm.nih.gov/pubmed/39029599,39029599,,,37485003,"Chen L, Guo P, Zhai L, Yu L, Zhu D, Hu X, Li Z, Chen Y, Sun Q, Sun L, Luo H, Tang H. Nrf2 affects DNA damage repair and cell apoptosis through regulating HR and the intrinsic Caspase-dependent apoptosis pathway in TK6 cells exposed to hydroquinone. Toxicol In Vitro. 2024 Oct;100():105901. doi: 10.1016/j.tiv.2024.105901. PMID: 39029599."
139151,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the reaction [hydroquinone results in decreased expression of TJP2 mrna]|parp1 protein affects the reaction [hydroquinone results in decreased expression of BCL2 protein],,,PMID:28983606,https://www.ncbi.nlm.nih.gov/pubmed/28983606,28983606,,PMC5779892,2582162,"Liu J, Yuan Q, Ling X, Tan Q, Liang H, Chen J, Lin L, Xiao Y, Chen W, Liu L, Tang H. PARP-1 may be involved in hydroquinone-induced apoptosis by poly ADP-ribosylation of ZO-2. Mol Med Rep. 2017 Dec;16(6):8076–84. PMID: 28983606; PMCID: PMC5779892."
139152,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the reaction [hydroquinone results in increased cleavage of CASP3 protein],,,PMID:26335980,https://www.ncbi.nlm.nih.gov/pubmed/26335980,26335980,,,1850309,"Sha Y, Zhou W, Yang Z, Zhu X, Yang X, Li TD, Zhu D. Down-regulation of poly (ADP-ribose) polymerase 1 leads to change of hydroquinone cytotoxicity in TK6 cells. Toxicol Mech Methods. 2015;25(6):467–77. doi: 10.3109/15376516.2015.1070222. PMID: 26335980."
139324,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the reaction [hydroquinone results in increased expression of MIR155 mrna]|parp1 protein affects the reaction [hydroquinone results in increased expression of MBD2 protein],,,PMID:30448557,https://www.ncbi.nlm.nih.gov/pubmed/30448557,30448557,,,25033983,"Gui Z, Zhang H, Tan Q, Ling X, Liu Z, Peng J, Shao J, Wu M, Yuan Q, Li J, Pan Z, Zhong B, Liu L. Poly(ADP-ribose) polymerase-1 promotes expression of miR-155 by the up-regulation of methyl-CpG binding domain protein 2 in TK6 cells exposed to hydroquinone. Toxicol In Vitro. 2019 Mar;55():51–7. doi: 10.1016/j.tiv.2018.11.007. PMID: 30448557."
139325,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the reaction [hydroquinone results in increased expression of MMP9 mrna]|parp1 protein inhibits the reaction [hydroquinone results in decreased expression of CDKN2A protein]|[parp1 protein co-treated with hydroquinone] results in increased expression of BCL2 protein|parp1 protein inhibits the reaction [hydroquinone results in decreased expression of RB1 protein]|parp1 protein inhibits the reaction [hydroquinone results in increased expression of MMP9 protein]|parp1 protein inhibits the reaction [hydroquinone results in decreased expression of BAX protein]|parp1 protein inhibits the reaction [hydroquinone results in decreased expression of TP53 protein],,,PMID:33771647,https://www.ncbi.nlm.nih.gov/pubmed/33771647,33771647,,,11553988,"Zhai L, Liang H, Du J, Sun M, Qiu W, Tang H, Luo H. PARP-1 via regulation of p53 and p16, is involved in the hydroquinone-induced malignant transformation of TK6 cells by decelerating the cell cycle. Toxicol In Vitro. 2021 Aug;74():105153. doi: 10.1016/j.tiv.2021.105153. PMID: 33771647."
139326,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to hydroquinone,,,PMID:26335980|PMID:28444915,https://www.ncbi.nlm.nih.gov/pubmed/26335980|https://www.ncbi.nlm.nih.gov/pubmed/28444915,26335980|28444915,,,1850309|7405412,"Luo H, Liang H, Chen J, Xu Y, Chen Y, Xu L, Yun L, Liu J, Yang H, Liu L, Peng J, Liu Z, Tang L, Chen W, Tang H. Hydroquinone induces TK6 cell growth arrest and apoptosis through PARP-1/p53 regulatory pathway. Environ Toxicol. 2017 Sep;32(9):2163–71. doi: 10.1002/tox.22429. PMID: 28444915.|Sha Y, Zhou W, Yang Z, Zhu X, Yang X, Li TD, Zhu D. Down-regulation of poly (ADP-ribose) polymerase 1 leads to change of hydroquinone cytotoxicity in TK6 cells. Toxicol Mech Methods. 2015;25(6):467–77. doi: 10.3109/15376516.2015.1070222. PMID: 26335980."
139327,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of BCL2 protein|[parp1 protein affects the susceptibility to hydroquinone] which affects the expression of FAS protein|[parp1 protein affects the susceptibility to hydroquinone] which affects the expression of KRAS protein|[parp1 protein affects the susceptibility to hydroquinone] which affects the expression of and affects the activity of CASP3 protein|[parp1 protein affects the susceptibility to hydroquinone] which affects the expression of TP53 protein,,,PMID:28444915,https://www.ncbi.nlm.nih.gov/pubmed/28444915,28444915,,,7405412,"Luo H, Liang H, Chen J, Xu Y, Chen Y, Xu L, Yun L, Liu J, Yang H, Liu L, Peng J, Liu Z, Tang L, Chen W, Tang H. Hydroquinone induces TK6 cell growth arrest and apoptosis through PARP-1/p53 regulatory pathway. Environ Toxicol. 2017 Sep;32(9):2163–71. doi: 10.1002/tox.22429. PMID: 28444915."
139328,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein promotes the reaction [hydroquinone results in increased expression of BECN1 mrna]|parp1 protein promotes the reaction [hydroquinone results in increased expression of ATG5 mrna],,,PMID:28263894,https://www.ncbi.nlm.nih.gov/pubmed/28263894,28263894,,,21597095,"Xu L, Liu J, Chen Y, Yun L, Chen S, Zhou K, Lai B, Song L, Yang H, Liang H, Tang H. Inhibition of autophagy enhances Hydroquinone-induced TK6 cell death. Toxicol In Vitro. 2017 Jun;41():123–32. doi: 10.1016/j.tiv.2017.02.024. PMID: 28263894."
139329,785,Comparative Toxicogenomics Database (CTD),Hydroquinone,C031927,hydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C031927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),WRN protein inhibits the reaction [hydroquinone results in increased cleavage of PARP1 protein],,,PMID:19064679,https://www.ncbi.nlm.nih.gov/pubmed/19064679,19064679,,PMC2639759,7926786,"Ren X, Lim S, Smith MT, Zhang L. Werner syndrome protein, WRN, protects cells from DNA damage induced by the benzene metabolite hydroquinone. Toxicol Sci. 2009 Feb;107(2):367–75. PMID: 19064679; PMCID: PMC2639759."
156346,880,Comparative Toxicogenomics Database (CTD),Pyruvaldehyde,D011765,Pyruvaldehyde,https://ctdbase.org/detail.go?type=chem&acc=D011765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased cleavage of PARP1 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,,9506434,"de Oliveira MR, Custódio de Souza IC, Fürstenau CR. Promotion of mitochondrial protection by naringenin in methylglyoxal-treated SH-SY5Y cells: Involvement of the Nrf2/GSH axis. Chem Biol Interact. 2019 Sep 01;310():108728. doi: 10.1016/j.cbi.2019.108728. PMID: 31254498."
156716,880,Comparative Toxicogenomics Database (CTD),Pyruvaldehyde,D011765,Pyruvaldehyde,https://ctdbase.org/detail.go?type=chem&acc=D011765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pterostilbene inhibits the reaction [pyruvaldehyde results in increased cleavage of PARP1 protein]|pimagedine inhibits the reaction [pyruvaldehyde results in increased cleavage of PARP1 protein],,,PMID:33930484,https://www.ncbi.nlm.nih.gov/pubmed/33930484,33930484,,,18336339,"Tang D, Xiao W, Gu WT, Zhang ZT, Xu SH, Chen ZQ, Xu YH, Zhang LY, Wang SM, Nie H. Pterostilbene prevents methylglyoxal-induced cytotoxicity in endothelial cells by regulating glyoxalase, oxidative stress and apoptosis. Food Chem Toxicol. 2021 Jul;153():112244. doi: 10.1016/j.fct.2021.112244. PMID: 33930484."
156717,880,Comparative Toxicogenomics Database (CTD),Pyruvaldehyde,D011765,Pyruvaldehyde,https://ctdbase.org/detail.go?type=chem&acc=D011765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyruvaldehyde results in increased cleavage of PARP1 protein,,,PMID:31254498|PMID:33930484,https://www.ncbi.nlm.nih.gov/pubmed/31254498|https://www.ncbi.nlm.nih.gov/pubmed/33930484,31254498|33930484,,,9506434|18336339,"Tang D, Xiao W, Gu WT, Zhang ZT, Xu SH, Chen ZQ, Xu YH, Zhang LY, Wang SM, Nie H. Pterostilbene prevents methylglyoxal-induced cytotoxicity in endothelial cells by regulating glyoxalase, oxidative stress and apoptosis. Food Chem Toxicol. 2021 Jul;153():112244. doi: 10.1016/j.fct.2021.112244. PMID: 33930484.|de Oliveira MR, Custódio de Souza IC, Fürstenau CR. Promotion of mitochondrial protection by naringenin in methylglyoxal-treated SH-SY5Y cells: Involvement of the Nrf2/GSH axis. Chem Biol Interact. 2019 Sep 01;310():108728. doi: 10.1016/j.cbi.2019.108728. PMID: 31254498."
97870,890,Comparative Toxicogenomics Database (CTD),Phytic Acid,D010833,Phytic Acid,https://ctdbase.org/detail.go?type=chem&acc=D010833,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Phytic acid inhibits the reaction [smoke analog results in increased activity of PARP1 protein]|phytic acid inhibits the reaction [asbestos, amosite results in increased activity of PARP1 protein]",,,PMID:11217149,https://www.ncbi.nlm.nih.gov/pubmed/11217149,11217149,,,2257485,"Kamp DW, Srinivasan M, Weitzman SA. Cigarette Smoke and Asbestos Activate Poly-ADP-Ribose Polymerase in Alveolar Epithelial Cells. Journal of Investigative Medicine. 2001 Jan;49(1):68–76. doi: 10.2310/6650.2001.34092."
158756,896,Comparative Toxicogenomics Database (CTD),Melatonin,D008550,Melatonin,https://ctdbase.org/detail.go?type=chem&acc=D008550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Melatonin inhibits the reaction [bisphenol A results in decreased expression of PARP1 mrna],,,PMID:36633214,https://www.ncbi.nlm.nih.gov/pubmed/36633214,36633214,,,35252068,"Yao Y, Zhu W, Han D, Shi X, Xu S. New Insights into How Melatonin Ameliorates Bisphenol A-Induced Colon Damage: Inhibition of NADPH Oxidase. J Agric Food Chem. 2023 Feb 08;71(5):2566–78. doi: 10.1021/acs.jafc.2c07236. PMID: 36633214."
158757,896,Comparative Toxicogenomics Database (CTD),Melatonin,D008550,Melatonin,https://ctdbase.org/detail.go?type=chem&acc=D008550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Melatonin inhibits the reaction [atrazine results in increased cleavage of PARP1 protein],,,PMID:25259610,https://www.ncbi.nlm.nih.gov/pubmed/25259610,25259610,,PMC4178181,19531073,"Sharma S, Sarkar J, Haldar C, Sinha S. Melatonin Reverses Fas, E2F-1 and Endoplasmic Reticulum Stress Mediated Apoptosis and Dysregulation of Autophagy Induced by the Herbicide Atrazine in Murine Splenocytes. PLoS ONE. 2014 Sep 26;9(9):e108602. doi: 10.1371/journal.pone.0108602."
158758,896,Comparative Toxicogenomics Database (CTD),Melatonin,D008550,Melatonin,https://ctdbase.org/detail.go?type=chem&acc=D008550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Melatonin inhibits the reaction [doxorubicin results in increased expression of PARP1 protein modified form],,,PMID:29966675,https://www.ncbi.nlm.nih.gov/pubmed/29966675,29966675,,,6750795,"Govender J, Loos B, Marais E, Engelbrecht AM. Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity? Toxicol Appl Pharmacol. 2018 Nov 01;358():86–101. doi: 10.1016/j.taap.2018.06.031. PMID: 29966675."
158759,896,Comparative Toxicogenomics Database (CTD),Melatonin,D008550,Melatonin,https://ctdbase.org/detail.go?type=chem&acc=D008550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Melatonin inhibits the reaction [tenofovir results in increased expression of PARP1 protein],,,PMID:33146023,https://www.ncbi.nlm.nih.gov/pubmed/33146023,33146023,,,19663176,"Ramamoorthy H, Abraham P, Isaac B. Melatonin protects against tenofovir-induced nephrotoxicity in rats by targeting multiple cellular pathways. Hum Exp Toxicol. 2021 May;40(5):826–50. doi: 10.1177/0960327120968860. PMID: 33146023."
152100,935,Comparative Toxicogenomics Database (CTD),Nickel,D009532,Nickel,https://ctdbase.org/detail.go?type=chem&acc=D009532,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein|luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein],,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,PMC5746289,30392830,"Wang Y, Su H, Song X, Fiati Kenston SS, Zhao J, Gu Y. Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway. Int J Mol Med. 2018 Jan;41(1):233–41. PMID: 29115570; PMCID: PMC5746289."
152101,935,Comparative Toxicogenomics Database (CTD),Nickel,D009532,Nickel,https://ctdbase.org/detail.go?type=chem&acc=D009532,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nickel results in decreased expression of PARP1 mRNA,,,PMID:23195993,https://www.ncbi.nlm.nih.gov/pubmed/23195993,23195993,,PMC3565097,14080375,"Arita A, Muñoz A, Chervona Y, Niu J, Qu Q, Zhao N, Ruan Y, Kiok K, Kluz T, Sun H, Clancy HA, Shamy M, Costa M. Gene expression profiles in peripheral blood mononuclear cells of Chinese nickel refinery workers with high exposures to nickel and control subjects. Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):261–9. PMID: 23195993; PMCID: PMC3565097."
152102,935,Comparative Toxicogenomics Database (CTD),Nickel,D009532,Nickel,https://ctdbase.org/detail.go?type=chem&acc=D009532,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein modified form binds to nickel,,,PMID:25549802,https://www.ncbi.nlm.nih.gov/pubmed/25549802,25549802,,,497628,"Bossak K, Goch W, Piatek K, Fraczyk T, Poznanski J, Bonna A, Keil C, Hartwig A, Bal W: Unusual Zn(II) Affinities of Zinc Fingers of Poly(ADP-ribose)Polymerase 1 (PARP-1) Nuclear Protein. Chem Res Toxicol. 2015 Feb 16;28(2):191-201."
81618,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [sodium arsenite results in decreased expression of PARP1 protein],,,PMID:36958258,https://www.ncbi.nlm.nih.gov/pubmed/36958258,36958258,,,34734926,"So K, Oh S. Arsenite-induced cytotoxicity is regulated by poly-ADP ribose polymerase 1 activation and parthanatos in p53-deficient H1299 cells: The roles of autophagy and p53. Biochemical and Biophysical Research Communications. 2023 May;656():78–85. doi: 10.1016/j.bbrc.2023.03.018."
155342,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:11752352|PMID:25041433|PMID:22419041|PMID:18809672|PMID:12825952|PMID:20364863|PMID:23481647,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://www.ncbi.nlm.nih.gov/pubmed/12825952|https://www.ncbi.nlm.nih.gov/pubmed/20364863|https://www.ncbi.nlm.nih.gov/pubmed/23481647,11752352|25041433|22419041|18809672|12825952|20364863|23481647,,PMC99057,5137304|10054779|12048484|13204825|15894887|16091523|19438596,"Schulz AM, Terne C, Jankowski V, Cohen G, Schaefer M, Boehringer F, Tepel M, Kunkel D, Zidek W, Jankowski J; European Uremic Toxin Work Group (EUTox). Modulation of NADPH oxidase activity by known uraemic retention solutes. Eur J Clin Invest. 2014 Aug;44(8):802–11. doi: 10.1111/eci.12297. PMID: 25041433.|Zhu Q, Wang X, Chu Z, He G, Dong G, Xu Y. Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2013 Apr;23(7):1993–6. doi: 10.1016/j.bmcl.2013.02.032.|Young GH, Wu VC. KLOTHO methylation is linked to uremic toxins and chronic kidney disease. Kidney Int. 2012 Apr;81(7):611–2. doi: 10.1038/ki.2011.461. PMID: 22419041.|Ferraris DV. Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic. J Med Chem. 2010 Jun 24;53(12):4561–84. doi: 10.1021/jm100012m. PMID: 20364863.|Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672.|Ferraris D, Ko YS, Pahutski T, Ficco RP, Serdyuk L, Alemu C, Bradford C, Chiou T, Hoover R, Huang S, Lautar S, Liang S, Lin Q, Lu MX, Mooney M, Morgan L, Qian Y, Tran S, Williams LR, Wu QY, Zhang J, Zou Y, Kalish V. Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries. J Med Chem. 2003 Jul 03;46(14):3138–51. doi: 10.1021/jm030109s. PMID: 12825952.|Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5."
157629,936,Drug Gene Interaction database (DGIdb),Niacinamide,,NIACINAMIDE,https://www.dgidb.org/drugs/rxcui:7405,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
159110,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Binder,,,PMID:37713619|PMID:11752352,https://www.ncbi.nlm.nih.gov/pubmed/37713619|https://www.ncbi.nlm.nih.gov/pubmed/11752352,37713619|11752352,,PMC10767903|PMC99057,13204825|36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751.|Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5."
173968,936,Therapeutic Target Database (TTD),Niacinamide,D06NVJ,Nicotinamide,https://idrblab.net/ttd/data/drug/details/D06NVJ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Binder,,,,,,,,,
176287,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased cleavage of PARP1 protein|niacinamide results in increased cleavage of PARP1 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,,6682874,"Shukla S, Sharma A, Pandey VK, Raisuddin S, Kakkar P. Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells. Toxicol Appl Pharmacol. 2016 Jan 15;291():70–83. doi: 10.1016/j.taap.2015.12.006. PMID: 26712469."
176288,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niacinamide results in increased expression of PARP1 mrna|niacinamide results in increased expression of PARP1 protein,,,PMID:29143419,https://www.ncbi.nlm.nih.gov/pubmed/29143419,29143419,,,11452876,"Banerjee P, Surendran H, Bharti K, Morishita K, Varshney A, Pal R. Long Noncoding RNA RP11-380D23.2 Drives Distal-Proximal Patterning of the Lung by Regulating PITX2 Expression. Stem Cells. 2018 Feb;36(2):218–29. doi: 10.1002/stem.2740. PMID: 29143419."
176445,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [excitatory amino acid agonists results in decreased expression of PARP1 protein]|niacinamide inhibits the reaction [excitatory amino acid agonists results in increased activity of PARP1 protein]|niacinamide results in decreased activity of PARP1 protein,,,PMID:19288225,https://www.ncbi.nlm.nih.gov/pubmed/19288225,19288225,,PMC2677622,18708454,2009; 11(1):28-42
176446,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased activity of PARP1 protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,,30173715,"Uehara N, Miki K, Tsukamoto R, Matsuoka Y, Tsubura A. Nicotinamide blocks N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in rats through poly (ADP-ribose) polymerase activity and Jun N-terminal kinase/activator protein-1 pathway inhibition. Exp Eye Res. 2006 Mar;82(3):488–95. doi: 10.1016/j.exer.2005.08.006. PMID: 16168987."
176447,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niacinamide results in decreased activity of PARP1 protein,,,PMID:7590113|PMID:8742498,https://www.ncbi.nlm.nih.gov/pubmed/7590113|https://www.ncbi.nlm.nih.gov/pubmed/8742498,7590113|8742498,,,1517677|11763752,"Kröger H, Klewer M, Grätz R, Dietrich A, Ehrlich W, Altrichter S, Kurpisz M, Miesel R. Influence of diet free of nad-precursors on acetaminophen hepatotoxicity in mice. General Pharmacology: The Vascular System. 1996 Jan;27(1):79–82. doi: 10.1016/0306-3623(95)00033-x.|Kröger H, Klewer M, Grätz R, Dietrich A, Ockenfels H, Miesel R. Exacerbation of acetaminophen hepatotoxicity by thalidomide and protection by nicotinic acid amide. General Pharmacology: The Vascular System. 1995 Oct;26(6):1243–7. doi: 10.1016/0306-3623(95)00019-w."
176448,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the chemical synthesis of niacinamide,,,PMID:16026317,https://www.ncbi.nlm.nih.gov/pubmed/16026317,16026317,,,25477407,Virág L. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol. 2005 Jul;3(3):209–14. doi: 10.2174/1570161054368625. PMID: 16026317.
187300,936,BindingDB,Niacinamide,27507,3-Pyridinecarboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27507,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),50119,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
86834,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[niacin co-treated with ubiquinone co-treated with riboflavin] results in increased expression of PARP1 protein,,,PMID:18377693,https://www.ncbi.nlm.nih.gov/pubmed/18377693,18377693,,,9280470,"Premkumar VG, Yuvaraj S, Shanthi P, Sachdanandam P. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. Br J Nutr. 2008 Dec;100(6):1179–82. doi: 10.1017/s0007114508968276. PMID: 18377693."
86835,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacin deficiency affects the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:17516866,https://www.ncbi.nlm.nih.gov/pubmed/17516866,17516866,,,27505879,"Spronck JC, Nickerson JL, Kirkland JB. Niacin Deficiency Alters p53 Expression and Impairs Etoposide-Induced Cell Cycle Arrest and Apoptosis in Rat Bone Marrow Cells. Nutrition and Cancer. 2007 May 04;57(1):88–99. doi: 10.1080/01635580701268337."
198106,943,Comparative Toxicogenomics Database (CTD),Nitrate,D009566,Nitrates,https://ctdbase.org/detail.go?type=chem&acc=D009566,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[particulate matter results in increased abundance of nitrates] which results in increased expression of PARP1 mRNA,,,PMID:35964746,https://www.ncbi.nlm.nih.gov/pubmed/35964746,35964746,,,34748668,"Zhang J, Cheng H, Di Narzo A, Zhu Y, Shan M, Zhang Z, Shao X, Chen J, Wang C, Hao K. Within- and cross-tissue gene regulations were disrupted by PM2.5 nitrate exposure and associated with respiratory functions. Sci Total Environ. 2022 Dec 01;850():157977. doi: 10.1016/j.scitotenv.2022.157977. PMID: 35964746."
5076,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AHR mutant form promotes the reaction [oxygen results in increased cleavage of PARP1 protein]|oxygen results in increased cleavage of PARP1 protein,,,PMID:25831079,https://www.ncbi.nlm.nih.gov/pubmed/25831079,25831079,,PMC4458211,14800623,"Zhang S, Patel A, Chu C, Jiang W, Wang L, Welty SE, Moorthy B, Shivanna B. Aryl hydrocarbon receptor is necessary to protect fetal human pulmonary microvascular endothelial cells against hyperoxic injury: Mechanistic roles of antioxidant enzymes and RelB. Toxicology and Applied Pharmacology. 2015 Jul;286(2):92–101. doi: 10.1016/j.taap.2015.03.023."
5077,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oxygen deficiency results in increased expression of PARP1 protein modified form|betulin analog promotes the reaction [oxygen deficiency results in increased expression of PARP1 protein modified form],,,PMID:26540049,https://www.ncbi.nlm.nih.gov/pubmed/26540049,26540049,,PMC4661812,32372832,"Bache M, Münch C, Güttler A, Wichmann H, Theuerkorn K, Emmerich D, Paschke R, Vordermark D. Betulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells. Int J Mol Sci. 2015 Nov 03;16(11):26249–62. PMID: 26540049; PMCID: PMC4661812."
5078,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[betulinic acid co-treated with oxygen] results in increased cleavage of PARP1 protein|[betulin co-treated with oxygen] results in increased cleavage of PARP1 protein,,,PMID:33181113,https://www.ncbi.nlm.nih.gov/pubmed/33181113,33181113,,,24409193,"Kutkowska J, Strzadala L, Rapak A. Hypoxia increases the apoptotic response to betulinic acid and betulin in human non-small cell lung cancer cells. Chem Biol Interact. 2021 Jan 05;333():109320. doi: 10.1016/j.cbi.2020.109320. PMID: 33181113."
5079,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oxygen deficiency results in increased activity of PARP1 protein|[glucose co-treated with oxygen deficiency] results in increased activity of PARP1 protein,,,PMID:27288104,https://www.ncbi.nlm.nih.gov/pubmed/27288104,27288104,,,2530008,"Zhou X, Patel D, Sen S, Shanmugam V, Sidawy A, Mishra L, Nguyen BN. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis. J Vasc Surg. 2017 Apr;65(4):1161–9. doi: 10.1016/j.jvs.2016.03.407. PMID: 27288104."
5080,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Oxygen deficiency results in increased cleavage of PARP1 protein|n-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide promotes the reaction [oxygen deficiency results in increased cleavage of PARP1 protein]",,,PMID:20530905,https://www.ncbi.nlm.nih.gov/pubmed/20530905,20530905,,,15368861,"LOU J, ZHOU X, WENG Q, WANG D, XIA Q, HU Y, HE Q, YANG B, LUO P. XQ2, a Novel TPZ Derivative, Induced G2/M Phase Arrest and Apoptosis under Hypoxia in Non-Small Cell Lung Cancer Cells. Bioscience, Biotechnology, and Biochemistry. 2010 Jun 23;74(6):1181–7. doi: 10.1271/bbb.90889."
5081,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oxygen deficiency inhibits the reaction [nickel monoxide analog results in increased cleavage of PARP1 protein],,,PMID:27270449,https://www.ncbi.nlm.nih.gov/pubmed/27270449,27270449,,,16167571,"Pandey N, Dhiman S, Srivastava T, Majumder S. Transition metal oxide nanoparticles are effective in inhibiting lung cancer cell survival in the hypoxic tumor microenvironment. Chem Biol Interact. 2016 Jul 25;254():221–30. doi: 10.1016/j.cbi.2016.06.006. PMID: 27270449."
5082,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oxygen deficiency results in decreased expression of PARP1 mRNA,,,PMID:38909692,https://www.ncbi.nlm.nih.gov/pubmed/38909692,38909692,,,37395516,"Zhou Y, Ye F, Zhang L, Kang Q, Luo Y, Jiang N, Lou L, Mao Y, Wang L, Jin F. The role of DNA damage response in human embryonic stem cells exposed to atmospheric oxygen tension: Implications for embryo development and differentiation. Reprod Toxicol. 2024 Sep;128():108648. doi: 10.1016/j.reprotox.2024.108648. PMID: 38909692."
5083,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 gene mutant form inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of CXCL1 protein],,,PMID:15696051,https://www.ncbi.nlm.nih.gov/pubmed/15696051,15696051,,,15271211,"Casey PJ, Black JH, Szabo C, Frosch M, Albadawi H, Chen M, Cambria RP, Watkins MT. Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion. Journal of Vascular Surgery. 2005 Jan;41(1):99–107. doi: 10.1016/j.jvs.2004.10.040."
5084,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of PARP1 protein modified form]]|nfe2l2 protein promotes the reaction [diosmetin inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of PARP1 protein modified form]]|diosmetin inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of PARP1 protein modified form],,,PMID:35191607,https://www.ncbi.nlm.nih.gov/pubmed/35191607,35191607,,,7536038,"Shi M, Wang J, Bi F, Bai Z. Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition. Environmental Toxicology. 2022 Feb 22;37(6):1529–42. doi: 10.1002/tox.23504."
5085,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride affects the susceptibility to oxygen deficiency] which results in increased expression of PARP1 protein",,,PMID:17131054,https://www.ncbi.nlm.nih.gov/pubmed/17131054,17131054,,PMC11136184,5815176,2006; 63(24):3061-3071
5086,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of PARP1 protein modified form]",,,PMID:25221900,https://www.ncbi.nlm.nih.gov/pubmed/25221900,25221900,,PMC4160283,5956195,"Hatachi G, Tsuchiya T, Miyazaki T, Matsumoto K, Yamasaki N, Okita N, Nanashima A, Higami Y, Nagayasu T. The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats. Transplantation. 2014 Sep 27;98(6):618–24. PMID: 25221900; PMCID: PMC4160283."
5087,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of PARP1 protein,,,PMID:29605020,https://www.ncbi.nlm.nih.gov/pubmed/29605020,29605020,,,1918265,"Li X, Ling Y, Cao Z, Shen J, Chen S, Liu W, Yuan B, Wen S. Targeting intestinal epithelial cell–programmed necrosis alleviates tissue injury after intestinal ischemia/reperfusion in rats. Journal of Surgical Research. 2018 May;225():108–17. doi: 10.1016/j.jss.2018.01.007."
5088,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of PARP1 protein modified form,,,PMID:25221900|PMID:29605020,https://www.ncbi.nlm.nih.gov/pubmed/25221900|https://www.ncbi.nlm.nih.gov/pubmed/29605020,25221900|29605020,,PMC4160283,1918265|5956195,"Li X, Ling Y, Cao Z, Shen J, Chen S, Liu W, Yuan B, Wen S. Targeting intestinal epithelial cell–programmed necrosis alleviates tissue injury after intestinal ischemia/reperfusion in rats. Journal of Surgical Research. 2018 May;225():108–17. doi: 10.1016/j.jss.2018.01.007.|Hatachi G, Tsuchiya T, Miyazaki T, Matsumoto K, Yamasaki N, Okita N, Nanashima A, Higami Y, Nagayasu T. The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats. Transplantation. 2014 Sep 27;98(6):618–24. PMID: 25221900; PMCID: PMC4160283."
5089,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[oxygen deficiency co-treated with glucose deficiency] results in increased expression of PARP1 protein modified form,,,PMID:22639866|PMID:35191607,https://www.ncbi.nlm.nih.gov/pubmed/22639866|https://www.ncbi.nlm.nih.gov/pubmed/35191607,22639866|35191607,,,7536038|11343819,"Shi M, Wang J, Bi F, Bai Z. Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition. Environmental Toxicology. 2022 Feb 22;37(6):1529–42. doi: 10.1002/tox.23504.|Gerace E, Scartabelli T, Formentini L, Landucci E, Moroni F, Chiarugi A, Pellegrini-Giampietro DE. Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance. Eur J Neurosci. 2012 Jul;36(1):1993–2005. doi: 10.1111/j.1460-9568.2012.08116.x. PMID: 22639866."
5090,977,Comparative Toxicogenomics Database (CTD),Oxygen,D010100,Oxygen,https://ctdbase.org/detail.go?type=chem&acc=D010100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Phenylephrine inhibits the reaction [oxygen deficiency results in increased cleavage of PARP1 protein]|oxygen deficiency results in increased cleavage of PARP1 protein,,,PMID:11042672,https://www.ncbi.nlm.nih.gov/pubmed/11042672,11042672,,,217298,"Zhu H, McElwee-Witmer S, Perrone M, Clark KL, Zilberstein A. Phenylephrine protects neonatal rat cardiomyocytes from hypoxia and serum deprivation-induced apoptosis. Cell Death Differ. 2000 Sep;7(9):773–84. doi: 10.1038/sj.cdd.4400721. PMID: 11042672."
142153,985,Comparative Toxicogenomics Database (CTD),Palmitic Acid,D010168,Palmitates,https://ctdbase.org/detail.go?type=chem&acc=D010168,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),GW 3965 inhibits the reaction [palmitates results in increased cleavage of PARP1 protein]|palmitates results in increased cleavage of PARP1 protein|srebf1 protein affects the reaction [palmitates results in increased cleavage of PARP1 protein]|t0901317 inhibits the reaction [palmitates results in increased cleavage of PARP1 protein]|palmitates results in increased expression of PARP1 protein modified form,,,PMID:21209018,https://www.ncbi.nlm.nih.gov/pubmed/21209018,21209018,,,29566128,"Choi SE, Jung IR, Lee YJ, Lee SJ, Lee JH, Kim Y, Jun HS, Lee KW, Park CB, Kang Y. Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 beta-cell death. Endocrinology. 2011 Mar;152(3):816–27. doi: 10.1210/en.2010-0924. PMID: 21209018."
192567,985,Comparative Toxicogenomics Database (CTD),Palmitic Acid,D019308,Palmitic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019308,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Carnosol inhibits the reaction [palmitic acid results in increased expression of PARP1 protein modified form]|palmitic acid results in increased expression of PARP1 protein modified form|prdx3 protein promotes the reaction [carnosol inhibits the reaction [palmitic acid results in increased expression of PARP1 protein modified form]]|prdx3 protein inhibits the reaction [palmitic acid results in increased expression of PARP1 protein modified form],,,PMID:34678374,https://www.ncbi.nlm.nih.gov/pubmed/34678374,34678374,,,26476154,"Geng Y, Wang Y, Sun R, Kang X, Zhao H, Zhu M, Sun Y, Hu Y, Wang Z, Tian X, Zhao Y, Yao J. Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3. Toxicol Appl Pharmacol. 2021 Dec 01;432():115758. doi: 10.1016/j.taap.2021.115758. PMID: 34678374."
192568,985,Comparative Toxicogenomics Database (CTD),Palmitic Acid,D019308,Palmitic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019308,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Trigonelline inhibits the reaction [palmitic acid results in increased cleavage of PARP1 protein]|palmitic acid results in increased cleavage of PARP1 protein,,,PMID:30208301,https://www.ncbi.nlm.nih.gov/pubmed/30208301,30208301,,,3974089,"Sharma L, Lone NA, Knott RM, Hassan A, Abdullah T. Trigonelline prevents high cholesterol and high fat diet induced hepatic lipid accumulation and lipo-toxicity in C57BL/6J mice, via restoration of hepatic autophagy. Food Chem Toxicol. 2018 Nov;121():283–96. doi: 10.1016/j.fct.2018.09.011. PMID: 30208301."
192569,985,Comparative Toxicogenomics Database (CTD),Palmitic Acid,D019308,Palmitic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019308,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Palmitic acid results in increased expression of PARP1 protein|palmitic acid results in increased expression of PARP1 mRNA,,,PMID:19513971,https://www.ncbi.nlm.nih.gov/pubmed/19513971,19513971,,,1048228,"Mao X, Wang S, Pan Y, He B, Chen J, Jiang H, Zeng Q, Xu X. Roles of inhibitors of poly(ADP-ribose) polymerase in protecting rat RINm5F cell line against free fatty acid-induced apoptosis. Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):274–82. doi: 10.1055/s-0029-1202794. PMID: 19513971."
217964,992,Comparative Toxicogenomics Database (CTD),Pentachlorophenol,D010416,Pentachlorophenol,https://ctdbase.org/detail.go?type=chem&acc=D010416,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Pentachlorophenol results in increased expression of PARP1 mRNA,,,PMID:23892564,https://www.ncbi.nlm.nih.gov/pubmed/23892564,23892564,,,16787098,"Kanno J, Aisaki K, Igarashi K, Kitajima S, Matsuda N, Morita K, Tsuji M, Moriyama N, Furukawa Y, Otsuka M, Tachihara E, Nakatsu N, Kodama Y. Oral administration of pentachlorophenol induces interferon signaling mRNAs in C57BL/6 male mouse liver. J Toxicol Sci. 2013;38(4):643–54. doi: 10.2131/jts.38.643. PMID: 23892564."
206644,995,Comparative Toxicogenomics Database (CTD),Phenanthrene,C031181,phenanthrene,https://ctdbase.org/detail.go?type=chem&acc=C031181,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Phenanthrene results in increased cleavage of PARP1 protein,,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
175383,1024,Comparative Toxicogenomics Database (CTD),Pyrroloquinoline Quinone,D045542,PQQ Cofactor,https://ctdbase.org/detail.go?type=chem&acc=D045542,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PQQ cofactor results in decreased expression of and results in increased cleavage of PARP1 protein|pqq cofactor analog results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:32068067,https://www.ncbi.nlm.nih.gov/pubmed/32068067,32068067,,,25753515,"Peng Y, Xu D, Mao S, Zhou X. Neurotoxicity and apoptosis induced by pyrroloquinoline quinone and its ester derivative on primary cortical neurons. Neurotoxicology. 2020 May;78():47–56. doi: 10.1016/j.neuro.2020.02.005. PMID: 32068067."
196758,1123,Comparative Toxicogenomics Database (CTD),Taurine,D013654,Taurine,https://ctdbase.org/detail.go?type=chem&acc=D013654,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Taurine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:19616567,https://www.ncbi.nlm.nih.gov/pubmed/19616567,19616567,,,10619164,"Ghosh J, Das J, Manna P, Sil PC. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. Toxicol Appl Pharmacol. 2009 Oct 01;240(1):73–87. doi: 10.1016/j.taap.2009.07.008. PMID: 19616567."
196945,1123,Comparative Toxicogenomics Database (CTD),Taurine,D013654,Taurine,https://ctdbase.org/detail.go?type=chem&acc=D013654,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Taurine inhibits the reaction [sodium arsenite results in increased degradation of PARP1 protein],,,PMID:20830294,https://www.ncbi.nlm.nih.gov/pubmed/20830294,20830294,,PMC2935368,25548009,"Das J, Ghosh J, Manna P, Sil PC. Protective Role of Taurine against Arsenic-Induced Mitochondria-Dependent Hepatic Apoptosis via the Inhibition of PKCd-JNK Pathway. PLoS ONE. 2010 Sep 07;5(9):e12602. doi: 10.1371/journal.pone.0012602."
190242,1175,Comparative Toxicogenomics Database (CTD),Uric Acid,D014527,Uric Acid,https://ctdbase.org/detail.go?type=chem&acc=D014527,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Uric acid inhibits the reaction [sodium arsenite inhibits the reaction [PARP1 protein binds to zinc]]|uric acid inhibits the reaction [sodium arsenite results in decreased activity of and results in increased nitrosation of PARP1 protein],,,PMID:31152818,https://www.ncbi.nlm.nih.gov/pubmed/31152818,31152818,,PMC6991161,33792783,"Zhou X, Ding X, Shen J, Yang D, Hudson LG, Liu KJ. Peroxynitrite contributes to arsenic-induced PARP-1 inhibition through ROS/RNS generation. Toxicology and Applied Pharmacology. 2019 Sep;378():114602. doi: 10.1016/j.taap.2019.114602."
163299,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"1,2-dimethylhydrazine results in increased expression of PARP1 mrna|folic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of PARP1 mrna]",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,PMC3259116,22158599,2011; 30(1):116
163300,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"1,2-dimethylhydrazine results in decreased expression of PARP1 mRNA",,,PMID:32387197,https://www.ncbi.nlm.nih.gov/pubmed/32387197,32387197,,,18296227,"Ramos Caetano BF, Baptista Tablas M, Ribeiro Romualdo G, Marchesan Rodrigues MA, Barbisan LF. Early molecular events associated with liver and colon sub-acute responses to 1,2-dimethylhydrazine: Potential implications on preneoplastic and neoplastic lesion development. Toxicol Lett. 2020 Sep 01;329():67–79. doi: 10.1016/j.toxlet.2020.04.009. PMID: 32387197."
180628,1340,Comparative Toxicogenomics Database (CTD),"1,5-Dihydroxyisoquinoline",C095653,"1,5-dihydroxyisoquinoline",https://ctdbase.org/detail.go?type=chem&acc=C095653,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,5-dihydroxyisoquinoline results in decreased activity of PARP1 protein|1,5-dihydroxyisoquinoline inhibits the reaction [lipopolysaccharide, E coli O55-B5 promotes the reaction [PARP1 protein binds to SIRT1 protein]]",,,PMID:25517228,https://www.ncbi.nlm.nih.gov/pubmed/25517228,25517228,,PMC4365057,16829045,2014; 20(1):612-624
180629,1340,Comparative Toxicogenomics Database (CTD),"1,5-Dihydroxyisoquinoline",C095653,"1,5-dihydroxyisoquinoline",https://ctdbase.org/detail.go?type=chem&acc=C095653,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"1,5-dihydroxyisoquinoline inhibits the reaction [vancomycin results in increased expression of PARP1 protein]",,,PMID:19833176,https://www.ncbi.nlm.nih.gov/pubmed/19833176,19833176,,,30917735,2010; 192(2):91-96
180630,1340,Comparative Toxicogenomics Database (CTD),"1,5-Dihydroxyisoquinoline",C095653,"1,5-dihydroxyisoquinoline",https://ctdbase.org/detail.go?type=chem&acc=C095653,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"1,5-dihydroxyisoquinoline results in decreased activity of PARP1 protein|1,5-dihydroxyisoquinoline results in decreased expression of PARP1 protein",,,PMID:12824290,https://www.ncbi.nlm.nih.gov/pubmed/12824290,12824290,,,15893273,"Minchenko AG, Stevens MJ, White L, Abatan OI, Komjáti K, Pacher P, Szabó C, Obrosova IG. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J. 2003 Aug;17(11):1514–6. doi: 10.1096/fj.03-0013fje. PMID: 12824290."
191191,1340,BindingDB,"1,5-Dihydroxyisoquinoline",27501,"1,5-dihydroxyisoquinoline",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27501,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),151,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
184684,1388,Comparative Toxicogenomics Database (CTD),"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",D015632,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",https://ctdbase.org/detail.go?type=chem&acc=D015632,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[PARP1 protein results in increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] which results in increased abundance of 3,4-dihydroxyphenylacetic acid|parp1 protein results in increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|[parp1 protein results in increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] which results in increased abundance of dopamine|[parp1 protein results in increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] which results in increased abundance of homovanillic acid",,,PMID:10318960,https://www.ncbi.nlm.nih.gov/pubmed/10318960,10318960,,PMC21936,33415557,"Mandir AS, Przedborski S, Jackson-Lewis V, Wang ZQ, Simbulan-Rosenthal CM, Smulson ME, Hoffman BE, Guastella DB, Dawson VL, Dawson TM. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5774–9. PMID: 10318960; PMCID: PMC21936."
181332,1401,Comparative Toxicogenomics Database (CTD),PD-173074,C115711,PD 173074,https://ctdbase.org/detail.go?type=chem&acc=C115711,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[arsenic trioxide results in increased susceptibility to PD 173074] which results in increased expression of PARP1 protein modified form|[arsenic trioxide co-treated with PD 173074] results in increased expression of PARP1 protein modified form|[pd 173074 results in increased susceptibility to arsenic trioxide] which results in increased expression of PARP1 protein modified form,,,PMID:27794399,https://www.ncbi.nlm.nih.gov/pubmed/27794399,27794399,,,31730449,"Lam SK, Leung LL, Li YY, Zheng CY, Ho JC. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma. Lung Cancer. 2016 Nov;101():111–9. doi: 10.1016/j.lungcan.2016.10.001. PMID: 27794399."
187157,1486,Comparative Toxicogenomics Database (CTD),"2,4-Dichlorophenoxyacetic Acid",D015084,"2,4-Dichlorophenoxyacetic Acid",https://ctdbase.org/detail.go?type=chem&acc=D015084,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-dichlorophenoxyacetic acid] which results in increased expression of PARP1 mrna]|[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-dichlorophenoxyacetic acid] which results in increased expression of PARP1 mrna|[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-dichlorophenoxyacetic acid] promotes the reaction [ethanol results in increased expression of PARP1 mrna]",,,PMID:36085217,https://www.ncbi.nlm.nih.gov/pubmed/36085217,36085217,,,35015623,2022; 30(4):10710-10723
93860,1511,Therapeutic Target Database (TTD),2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,D01YIR,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,https://idrblab.net/ttd/data/drug/details/D01YIR,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
198720,1511,DrugBank,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,DB04010,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,https://www.drugbank.ca/drugs/DB04010,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/37713619|https://www.ncbi.nlm.nih.gov/pubmed/10592235,37713619|10592235,,PMC102472|PMC10767903,12499145|36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
155987,1530,Comparative Toxicogenomics Database (CTD),"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C049584,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",https://ctdbase.org/detail.go?type=chem&acc=C049584,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
213923,1615,Comparative Toxicogenomics Database (CTD),"3,4-Methylenedioxymethamphetamine",D018817,"N-Methyl-3,4-methylenedioxyamphetamine",https://ctdbase.org/detail.go?type=chem&acc=D018817,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-methyl-3,4-methylenedioxyamphetamine results in increased expression of PARP1 mRNA",,,PMID:20188158,https://www.ncbi.nlm.nih.gov/pubmed/20188158,20188158,,,12686221,"Eun JW, Kwack SJ, Noh JH, Jung KH, Kim JK, Bae HJ, Xie H, Ryu JC, Ahn YM, Park WS, Lee JY, Rhee GS, Nam SW. Identification of post-generation effect of 3,4-methylenedioxymethamphetamine on the mouse brain by large-scale gene expression analysis. Toxicol Lett. 2010 May 19;195(1):60–7. doi: 10.1016/j.toxlet.2010.02.013. PMID: 20188158."
213924,1615,Comparative Toxicogenomics Database (CTD),"3,4-Methylenedioxymethamphetamine",D018817,"N-Methyl-3,4-methylenedioxyamphetamine",https://ctdbase.org/detail.go?type=chem&acc=D018817,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"N-methyl-3,4-methylenedioxyamphetamine results in decreased cleavage of PARP1 protein",,,PMID:26068050,https://www.ncbi.nlm.nih.gov/pubmed/26068050,26068050,,,29649457,"García-Cabrerizo R, García-Fuster MJ. Chronic MDMA induces neurochemical changes in the hippocampus of adolescent and young adult rats: Down-regulation of apoptotic markers. Neurotoxicology. 2015 Jul;49():104–13. doi: 10.1016/j.neuro.2015.06.001. PMID: 26068050."
156816,1645,Therapeutic Target Database (TTD),3-Aminobenzamide,D0K2PD,3-aminobenzamide,https://idrblab.net/ttd/data/drug/details/D0K2PD,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
192650,1645,BindingDB,3-Aminobenzamide,27506,3-AB,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27506,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),12882,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
192812,1645,BindingDB,3-Aminobenzamide,27506,3-AB,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27506,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),30000,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
192813,1645,BindingDB,3-Aminobenzamide,27506,3-AB,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27506,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),11200,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
222695,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide results in decreased activity of PARP1 protein,,,PMID:15075382|PMID:15670817|PMID:17669606|PMID:19056730|PMID:20493934|PMID:21370912|PMID:21399878|PMID:27026705|PMID:27233451,https://www.ncbi.nlm.nih.gov/pubmed/15075382|https://www.ncbi.nlm.nih.gov/pubmed/15670817|https://www.ncbi.nlm.nih.gov/pubmed/17669606|https://www.ncbi.nlm.nih.gov/pubmed/19056730|https://www.ncbi.nlm.nih.gov/pubmed/20493934|https://www.ncbi.nlm.nih.gov/pubmed/21370912|https://www.ncbi.nlm.nih.gov/pubmed/21399878|https://www.ncbi.nlm.nih.gov/pubmed/27026705|https://www.ncbi.nlm.nih.gov/pubmed/27233451,15075382|15670817|17669606|19056730|20493934|21370912|21399878|27026705|27233451,,PMC2652344|PMC4900266,3711640|3799141|7919891|13366100|13914481|20893705|22728614|24977016|28893483,"Chen K et al; Biochim Biophys Acta 1860 (9): 1836-44 (2016)|Shrestha E, Hussein MA, Savas JN, Ouimet M, Barrett TJ, Leone S, Yates JR, Moore KJ, Fisher EA, Garabedian MJ. Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages. Journal of Biological Chemistry. 2016 May;291(21):11172–84. doi: 10.1074/jbc.m116.726729.|Zheng YD, Xu XQ, Peng F, Yu JZ, Wu H. The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells. Oncol Rep. 2011 May;25(5):1399–405. doi: 10.3892/or.2011.1212. PMID: 21399878.|Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ, Casini A. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem. 2011 Apr 14;54(7):2196–206. doi: 10.1021/jm2000135. PMID: 21370912.|Rudolf E, Cervinka M. Nickel modifies the cytotoxicity of hexavalent chromium in human dermal fibroblasts. Toxicol Lett. 2010 Aug 16;197(2):143–50. doi: 10.1016/j.toxlet.2010.05.011. PMID: 20493934.|Ding W, Liu W, Cooper KL, Qin X, de Souza Bergo PL, Hudson LG, Liu KJ. Inhibition of Poly(ADP-ribose) Polymerase-1 by Arsenite Interferes with Repair of Oxidative DNA Damage. Journal of Biological Chemistry. 2009 Mar;284(11):6809–17. doi: 10.1074/jbc.m805566200.|Lin PH, Lin CH, Huang CC, Chuang MC, Lin P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 2007 Aug;172(3):146–58. doi: 10.1016/j.toxlet.2007.06.003. PMID: 17669606.|De Blasio A, Messina C, Santulli A, Mangano V, Di Leonardo E, D'Anneo A, Tesoriere G, Vento R. Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells. FEBS Lett. 2005 Jan 31;579(3):615–20. doi: 10.1016/j.febslet.2004.12.028. PMID: 15670817.|Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S. A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia. The Journal of Pharmacology and Experimental Therapeutics. 2004 Aug;310(2):425–36. doi: 10.1124/jpet.104.066944."
223068,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3-aminobenzamide inhibits the reaction [smoke analog results in increased activity of PARP1 protein]|3-aminobenzamide inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein]|3-aminobenzamide inhibits the reaction [asbestos, amosite results in increased activity of PARP1 protein]",,,PMID:11217149,https://www.ncbi.nlm.nih.gov/pubmed/11217149,11217149,,,2257485,"Kamp DW, Srinivasan M, Weitzman SA. Cigarette Smoke and Asbestos Activate Poly-ADP-Ribose Polymerase in Alveolar Epithelial Cells. Journal of Investigative Medicine. 2001 Jan;49(1):68–76. doi: 10.2310/6650.2001.34092."
223069,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3-aminobenzamide inhibits the reaction [asbestos, crocidolite results in increased activity of PARP1 protein]",,,PMID:21543585,https://www.ncbi.nlm.nih.gov/pubmed/21543585,21543585,,,14053556,"Tomasetti M, Amati M, Nocchi L, Saccucci F, Strafella E, Staffolani S, Tarquini LM, Carbonari D, Alleva R, Borghi B, Neuzil J, Bracci M, Santarelli L. Asbestos exposure affects poly(ADP-ribose) polymerase-1 activity: role in asbestos-induced carcinogenesis. Mutagenesis. 2011 Sep;26(5):585–91. doi: 10.1093/mutage/ger020. PMID: 21543585."
223070,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide inhibits the reaction [benzoyl peroxide results in increased activity of PARP1 protein]|3-aminobenzamide inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of PARP1 protein],,,PMID:2120135|PMID:2126186,https://www.ncbi.nlm.nih.gov/pubmed/2120135|https://www.ncbi.nlm.nih.gov/pubmed/2126186,2120135|2126186,,PMC2002381,2055236|15702803,Singh N. Effect of tumour promoters on poly ADP-ribosylation in human epidermoid carcinoma HeP2 cells. Int J Exp Pathol. 1990 Dec;71(6):809–14. PMID: 2126186; PMCID: PMC2002381.|Singh N. A comparative study on the effect of tumor promoters on poly ADP-ribosylation in A431 cells. Int J Cancer. 1990 Oct 15;46(4):648–52. doi: 10.1002/ijc.2910460416. PMID: 2120135.
223071,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]|3-aminobenzamide inhibits the reaction [capsaicin results in increased ADP-ribosylation of PARP1 protein modified form]|3-aminobenzamide promotes the reaction [capsaicin results in increased expression of PARP1 protein],,,PMID:22226932,https://www.ncbi.nlm.nih.gov/pubmed/22226932,22226932,,,22176951,"Yoon JH, Ahn SG, Lee BH, Jung SH, Oh SH. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. Biochem Pharmacol. 2012 Mar 15;83(6):747–57. doi: 10.1016/j.bcp.2011.12.029. PMID: 22226932."
223218,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide inhibits the reaction [hydroquinone results in increased expression of PARP1 protein],,,PMID:26047893,https://www.ncbi.nlm.nih.gov/pubmed/26047893,26047893,,,18181592,"Liu L, Ling X, Tang H, Chen J, Wen Q, Zou F. Poly(ADP-ribosyl)ation enhances H-RAS protein stability and causes abnormal cell cycle progression in human TK6 lymphoblastoid cells treated with hydroquinone. Chem Biol Interact. 2015 Aug 05;238():1–8. doi: 10.1016/j.cbi.2015.05.019. PMID: 26047893."
223219,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide inhibits the reaction [mezerein results in increased activity of PARP1 protein]|3-aminobenzamide inhibits the reaction [lithocholic acid analog results in increased activity of PARP1 protein],,,PMID:2120135,https://www.ncbi.nlm.nih.gov/pubmed/2120135,2120135,,,15702803,Singh N. A comparative study on the effect of tumor promoters on poly ADP-ribosylation in A431 cells. Int J Cancer. 1990 Oct 15;46(4):648–52. doi: 10.1002/ijc.2910460416. PMID: 2120135.
223220,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide inhibits the reaction [PARP1 protein results in increased susceptibility to [potassium dichromate co-treated with nickel sulfate]],,,PMID:20493934,https://www.ncbi.nlm.nih.gov/pubmed/20493934,20493934,,,3799141,"Rudolf E, Cervinka M. Nickel modifies the cytotoxicity of hexavalent chromium in human dermal fibroblasts. Toxicol Lett. 2010 Aug 16;197(2):143–50. doi: 10.1016/j.toxlet.2010.05.011. PMID: 20493934."
223221,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide inhibits the reaction [sodium arsenite results in decreased expression of PARP1 protein],,,PMID:36958258,https://www.ncbi.nlm.nih.gov/pubmed/36958258,36958258,,,34734926,"So K, Oh S. Arsenite-induced cytotoxicity is regulated by poly-ADP ribose polymerase 1 activation and parthanatos in p53-deficient H1299 cells: The roles of autophagy and p53. Biochemical and Biophysical Research Communications. 2023 May;656():78–85. doi: 10.1016/j.bbrc.2023.03.018."
223222,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of NADP]|[3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of NAD],,,PMID:17669606,https://www.ncbi.nlm.nih.gov/pubmed/17669606,17669606,,,22728614,"Lin PH, Lin CH, Huang CC, Chuang MC, Lin P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 2007 Aug;172(3):146–58. doi: 10.1016/j.toxlet.2007.06.003. PMID: 17669606."
223223,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[3-aminobenzamide results in decreased activity of PARP1 protein] which results in increased susceptibility to cisplatin,,,PMID:21399878,https://www.ncbi.nlm.nih.gov/pubmed/21399878,21399878,,,28893483,"Zheng YD, Xu XQ, Peng F, Yu JZ, Wu H. The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells. Oncol Rep. 2011 May;25(5):1399–405. doi: 10.3892/or.2011.1212. PMID: 21399878."
223224,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),3-aminobenzamide inhibits the reaction [PARP1 protein results in increased susceptibility to acetaminophen],,,PMID:15601672,https://www.ncbi.nlm.nih.gov/pubmed/15601672,15601672,,,5084555,"Cover C, Fickert P, Knight TR, Fuchsbichler A, Farhood A, Trauner M, Jaeschke H. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice. Toxicol Sci. 2005 Mar;84(1):201–8. doi: 10.1093/toxsci/kfi065. PMID: 15601672."
223225,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),3-aminobenzamide results in decreased activity of PARP1 protein,,,PMID:27026705,https://www.ncbi.nlm.nih.gov/pubmed/27026705,27026705,,PMC4900266,20893705,"Shrestha E, Hussein MA, Savas JN, Ouimet M, Barrett TJ, Leone S, Yates JR, Moore KJ, Fisher EA, Garabedian MJ. Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages. Journal of Biological Chemistry. 2016 May;291(21):11172–84. doi: 10.1074/jbc.m116.726729."
223226,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),3-aminobenzamide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased cleavage of PARP1 protein]|3-aminobenzamide inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:28283887,https://www.ncbi.nlm.nih.gov/pubmed/28283887,28283887,,,17522612,2017; 55(3):2125-2149
223411,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),3-aminobenzamide results in decreased activity of PARP1 protein,,,PMID:18815186,https://www.ncbi.nlm.nih.gov/pubmed/18815186,18815186,,,11569368,"Huang D, Yang C, Wang Y, Liao Y, Huang K. PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts. Cardiovasc Res. 2009 Jan 01;81(1):98–107. doi: 10.1093/cvr/cvn264. PMID: 18815186."
223412,1645,Comparative Toxicogenomics Database (CTD),3-Aminobenzamide,C025160,3-aminobenzamide,https://ctdbase.org/detail.go?type=chem&acc=C025160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide results in decreased activity of PARP1 protein,,,PMID:12006805|PMID:12824290|PMID:17884996|PMID:19962977,https://www.ncbi.nlm.nih.gov/pubmed/12006805|https://www.ncbi.nlm.nih.gov/pubmed/12824290|https://www.ncbi.nlm.nih.gov/pubmed/17884996|https://www.ncbi.nlm.nih.gov/pubmed/19962977,12006805|12824290|17884996|19962977,,,4471418|8487661|15893273|20060229,"Geraets L, Haegens A, Weseler AR, Brauers K, Vernooy JHJ, Wouters EFM, Bast A, Hageman GJ. Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine. European Journal of Pharmacology. 2010 Mar;629(1-3):132–9. doi: 10.1016/j.ejphar.2009.11.064.|Geraets L, Moonen HJJ, Brauers K, Wouters EFM, Bast A, Hageman GJ. Dietary Flavones and Flavonoles Are Inhibitors of Poly(ADP-ribose)polymerase-1 in Pulmonary Epithelial Cells , The Journal of Nutrition. 2007 Oct;137(10):2190–5. doi: 10.1093/jn/137.10.2190.|Minchenko AG, Stevens MJ, White L, Abatan OI, Komjáti K, Pacher P, Szabó C, Obrosova IG. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J. 2003 Aug;17(11):1514–6. doi: 10.1096/fj.03-0013fje. PMID: 12824290.|Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó E, Haskó G, Marton A, Lorigados CB, Gallyas F, Sümegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, Southan GJ, Szabó C. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med. 2002 May;30(5):1071–82. doi: 10.1097/00003246-200205000-00019. PMID: 12006805."
210338,1674,Comparative Toxicogenomics Database (CTD),Methylcholanthrene,D008748,Methylcholanthrene,https://ctdbase.org/detail.go?type=chem&acc=D008748,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Methylcholanthrene inhibits the reaction [3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in increased cleavage of PARP1 protein]",,,PMID:11999409,https://www.ncbi.nlm.nih.gov/pubmed/11999409,11999409,,,8480595,"SHIOTANI B, NONAKA Y, KANAZAWA K, DANNO G, ASHIDA H. Evoking Cytochrome P450 1A Activity Interferes with Apoptosis Induced by 3-Amino-1,4-dimethyl-5<i>H</i>-pyrido [4,3-<i>b</i>]indole (Trp-P-1) in Rat Hepatocytes under the<i>Ex Vivo</i>System. Bioscience, Biotechnology, and Biochemistry. 2002 Jan;66(2):356–62. doi: 10.1271/bbb.66.356."
94186,1720,Therapeutic Target Database (TTD),"4-Amino-1,8-naphthalimide",D03JTS,"4-amino-1,8-naphthalimide",https://idrblab.net/ttd/data/drug/details/D03JTS,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
193554,1720,BindingDB,"4-Amino-1,8-naphthalimide",27498,"10-amino-3-azatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11-pentaene-2,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27498,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),22,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
209166,1720,Comparative Toxicogenomics Database (CTD),"4-Amino-1,8-naphthalimide",C086538,"4-amino-1,8-naphthalimide",https://ctdbase.org/detail.go?type=chem&acc=C086538,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4-amino-1,8-naphthalimide inhibits the reaction [doxorubicin results in increased activity of PARP1 protein]",,,PMID:15456408,https://www.ncbi.nlm.nih.gov/pubmed/15456408,15456408,,PMC1134773,7184973,"Muñoz-Gámez JA, Martín-Oliva D, Aguilar-Quesada R, Cañuelo A, Nuñez MI, Valenzuela MT, Ruiz de Almodóvar JM, De Murcia G, Oliver FJ. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochem J. 2005 Feb 15;386(Pt 1):119–25. PMID: 15456408; PMCID: PMC1134773."
209167,1720,Comparative Toxicogenomics Database (CTD),"4-Amino-1,8-naphthalimide",C086538,"4-amino-1,8-naphthalimide",https://ctdbase.org/detail.go?type=chem&acc=C086538,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4-amino-1,8-naphthalimide results in decreased expression of PARP1 protein",,,PMID:25499136,https://www.ncbi.nlm.nih.gov/pubmed/25499136,25499136,,,16814506,"Luo Q, Li Y, Deng J, Zhang Z. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair. Chem Biol Interact. 2015 Jan 25;226():12–22. doi: 10.1016/j.cbi.2014.12.007. PMID: 25499136."
209168,1720,Comparative Toxicogenomics Database (CTD),"4-Amino-1,8-naphthalimide",C086538,"4-amino-1,8-naphthalimide",https://ctdbase.org/detail.go?type=chem&acc=C086538,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein|parp1 protein affects the reaction [4-amino-1,8-naphthalimide results in increased phosphorylation of CHEK2 protein]|parp1 protein affects the reaction [4-amino-1,8-naphthalimide results in increased phosphorylation of ATM protein]|atm protein affects the reaction [4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein]|prkdc protein affects the reaction [4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein]",,,PMID:16556909,https://www.ncbi.nlm.nih.gov/pubmed/16556909,16556909,,PMC1410911,13294148,"Bryant HE, Helleday T. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Nucleic Acids Res. 2006;34(6):1685–91. PMID: 16556909; PMCID: PMC1410911."
209169,1720,Comparative Toxicogenomics Database (CTD),"4-Amino-1,8-naphthalimide",C086538,"4-amino-1,8-naphthalimide",https://ctdbase.org/detail.go?type=chem&acc=C086538,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein",,,PMID:14769338,https://www.ncbi.nlm.nih.gov/pubmed/14769338,14769338,,,29442128,"Putt KS, Hergenrother PJ. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors. Anal Biochem. 2004 Mar 01;326(1):78–86. doi: 10.1016/j.ab.2003.11.015. PMID: 14769338."
209173,1720,DrugBank,"4-Amino-1,8-naphthalimide",DB07096,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",https://www.drugbank.ca/drugs/DB07096,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/37713619|https://www.ncbi.nlm.nih.gov/pubmed/10592235,37713619|10592235,,PMC102472|PMC10767903,12499145|36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
193660,1738,Comparative Toxicogenomics Database (CTD),Homovanillic Acid,D006719,Homovanillic Acid,https://ctdbase.org/detail.go?type=chem&acc=D006719,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[PARP1 protein results in increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] which results in increased abundance of homovanillic acid",,,PMID:10318960,https://www.ncbi.nlm.nih.gov/pubmed/10318960,10318960,,PMC21936,33415557,"Mandir AS, Przedborski S, Jackson-Lewis V, Wang ZQ, Simbulan-Rosenthal CM, Smulson ME, Hoffman BE, Guastella DB, Dawson VL, Dawson TM. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5774–9. PMID: 10318960; PMCID: PMC21936."
195174,1853,BindingDB,Phenanthridone,27500,"5,6-dihydrophenanthridin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27500,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),85,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
225960,1853,Comparative Toxicogenomics Database (CTD),Phenanthridone,C040601,phenanthridone,https://ctdbase.org/detail.go?type=chem&acc=C040601,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[eprenetapopt co-treated with phenanthridone] results in increased cleavage of PARP1 protein,,,PMID:29416738,https://www.ncbi.nlm.nih.gov/pubmed/29416738,29416738,,PMC5788606,31757916,"Yin ZX, Hang W, Liu G, Wang YS, Shen XF, Sun QH, Li DD, Jian YP, Zhang YH, Quan CS, Zeng Q, Li YL, Zhao RX, Ding Q, Xu ZX. PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation. Oncotarget. 2018 Jan 05;9(2):1885–97. PMID: 29416738; PMCID: PMC5788606."
225961,1853,Comparative Toxicogenomics Database (CTD),Phenanthridone,C040601,phenanthridone,https://ctdbase.org/detail.go?type=chem&acc=C040601,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Phenanthridone results in decreased activity of PARP1 protein,,,PMID:12411406,https://www.ncbi.nlm.nih.gov/pubmed/12411406,12411406,,PMC1573557,19283716,Chiarugi A. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. British J Pharmacology. 2002 Nov;137(6):761–70. doi: 10.1038/sj.bjp.0704934.
225962,1853,Comparative Toxicogenomics Database (CTD),Phenanthridone,C040601,phenanthridone,https://ctdbase.org/detail.go?type=chem&acc=C040601,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Phenanthridone results in decreased activity of PARP1 protein,,,PMID:14769338|PMID:17579050|PMID:8645333,https://www.ncbi.nlm.nih.gov/pubmed/14769338|https://www.ncbi.nlm.nih.gov/pubmed/17579050|https://www.ncbi.nlm.nih.gov/pubmed/8645333,14769338|17579050|8645333,,,13124687|15992016|29442128,"Aldinucci A, Gerlini G, Fossati S, Cipriani G, Ballerini C, Biagioli T, Pimpinelli N, Borgognoni L, Massacesi L, Moroni F, Chiarugi A. A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation. J Immunol. 2007 Jul 01;179(1):305–12. doi: 10.4049/jimmunol.179.1.305. PMID: 17579050.|Putt KS, Hergenrother PJ. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors. Anal Biochem. 2004 Mar 01;326(1):78–86. doi: 10.1016/j.ab.2003.11.015. PMID: 14769338.|1996; 51(9):1123-1129"
198525,1880,Comparative Toxicogenomics Database (CTD),"7,8-Dihydroxyflavone",C485383,"6,7-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C485383,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"6,7-dihydroxyflavone inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein]",,,PMID:38053484,https://www.ncbi.nlm.nih.gov/pubmed/38053484,38053484,,,36263529,"Chen TX, Wang SK, Zhang YQ, Wang W, Wang Q, Yu JC, Zhao SC, Xi GL, Jin Z, Chen ZS, Tang YZ. 7,8-dihydroxyflavone displayed antioxidant effect through activating HO-1 expression and inhibiting caspase-3/PARP activation in RAW264.7 cells. J Biochem Mol Toxicol. 2024 Jan;38(1):e23602. doi: 10.1002/jbt.23602. PMID: 38053484."
301983,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rifampin inhibits the reaction [[acetaminophen co-treated with [ferric nitrate results in increased abundance of iron]] results in increased cleavage of PARP1 protein]|[acetaminophen co-treated with [ferric nitrate results in increased abundance of iron]] results in increased cleavage of PARP1 protein,,,PMID:31678598,https://www.ncbi.nlm.nih.gov/pubmed/31678598,31678598,,,5377777,"Lee EH, Baek SY, Park JY, Kim YW. Rifampicin activates AMPK and alleviates oxidative stress in the liver as mediated with Nrf2 signaling. Chem Biol Interact. 2020 Jan 05;315():108889. doi: 10.1016/j.cbi.2019.108889. PMID: 31678598."
301984,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetaminophen results in decreased expression of PARP1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,,28913399,"Elferink MG, Olinga P, van Leeuwen EM, Bauerschmidt S, Polman J, Schoonen WG, Heisterkamp SH, Groothuis GM. Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57–69. doi: 10.1016/j.taap.2011.03.010. PMID: 21420995."
302195,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetaminophen results in increased cleavage of PARP1,,,PMID:12005112,https://www.ncbi.nlm.nih.gov/pubmed/12005112,12005112,,,8486023,"Boulares AH, Zoltoski AJ, Stoica BA, Cuvillier O, Smulson ME. Acetaminophen Induces a Caspase-Dependent and Bcl-x<sub>L</sub>Sensitive Apoptosis in Human Hepatoma Cells and Lymphocytes. Pharmacology & Toxicology. 2002 Jan;90(1):38–50. doi: 10.1034/j.1600-0773.2002.900108.x."
302196,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetaminophen results in increased cleavage of PARP1 protein,,,PMID:14725611,https://www.ncbi.nlm.nih.gov/pubmed/14725611,14725611,,,976918,"Boulares AH, Ren T. Mechanism of Acetaminophen-Induced Apoptosis in Cultured Cells: Roles of Caspase-3, DNA Fragmentation Factor, and the Ca<sup>2+</sup>and Mg<sup>2+</sup>Endonuclease DNAS1L3. Basic Clin Pharma Tox. 2004 Jan;94(1):19–29. doi: 10.1111/j.1742-7843.2004.pto_940105.x."
302198,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [acetaminophen results in increased expression of PARP1 mrna]|acetaminophen results in increased expression of PARP1 mRNA,,,PMID:33971260,https://www.ncbi.nlm.nih.gov/pubmed/33971260,33971260,,,10880503,"Viswanathan P, Gupta P, Sharma Y, Maisuradze L, Bandi S, Gupta S. Caffeine disrupts ataxia telangiectasia mutated gene-related pathways and exacerbates acetaminophen toxicity in human fetal immortalized hepatocytes. Toxicology. 2021 Jun 15;457():152811. doi: 10.1016/j.tox.2021.152811. PMID: 33971260."
302199,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein results in increased susceptibility to acetaminophen|3-aminobenzamide inhibits the reaction [PARP1 protein results in increased susceptibility to acetaminophen]|5-aminoisoquinolinone inhibits the reaction [PARP1 protein results in increased susceptibility to acetaminophen]|acetaminophen results in increased activity of PARP1 protein,,,PMID:15601672,https://www.ncbi.nlm.nih.gov/pubmed/15601672,15601672,,,5084555,"Cover C, Fickert P, Knight TR, Fuchsbichler A, Farhood A, Trauner M, Jaeschke H. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice. Toxicol Sci. 2005 Mar;84(1):201–8. doi: 10.1093/toxsci/kfi065. PMID: 15601672."
302200,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetaminophen results in increased expression of and affects the localization of PARP1 mRNA,,,PMID:29540258,https://www.ncbi.nlm.nih.gov/pubmed/29540258,29540258,,PMC5954624,29062212,"Borude P, Bhushan B, Apte U. DNA Damage Response Regulates Initiation of Liver Regeneration Following Acetaminophen Overdose. gene expr. 2018 May 18;18(2):115–23. doi: 10.3727/105221618x15205260749346."
302201,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PARP1 mRNA,,,PMID:16751229,https://www.ncbi.nlm.nih.gov/pubmed/16751229,16751229,,PMC1805881,8899097,"Powell CL, Kosyk O, Ross PK, Schoonhoven R, Boysen G, Swenberg JA, Heinloth AN, Boorman GA, Cunningham ML, Paules RS, Rusyn I. Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol Sci. 2006 Sep;93(1):213–22. PMID: 16751229; PMCID: PMC1805881."
337488,1985,Toxin and Toxin Target Database (T3DB),Acetarsol,T3D1293,Acetarsol,http://www.t3db.ca/toxins/T3D1293,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
295872,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased cleavage of PARP1 protein]|acetochlor results in increased cleavage of PARP1 protein,,,PMID:25291404,https://www.ncbi.nlm.nih.gov/pubmed/25291404,25291404,,,24273997,"Zerin T, Song HY, Kim YS. Extracellular signal-regulated kinase pathway play distinct role in acetochlor-mediated toxicity and intrinsic apoptosis in A549 cells. Toxicol In Vitro. 2015 Feb;29(1):85–92. doi: 10.1016/j.tiv.2014.09.011. PMID: 25291404."
223145,2072,BindingDB,5-aminoisoquinolin-1(2H)-one,27503,5-AIQ,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27503,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),1175,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
226131,2072,Therapeutic Target Database (TTD),5-aminoisoquinolin-1(2H)-one,D07WPL,5-aminoisoquinolin-1(2H)-one,https://idrblab.net/ttd/data/drug/details/D07WPL,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
226721,2072,Comparative Toxicogenomics Database (CTD),5-aminoisoquinolin-1(2H)-one,C411425,5-aminoisoquinolinone,https://ctdbase.org/detail.go?type=chem&acc=C411425,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),5-aminoisoquinolinone inhibits the reaction [ethanol results in increased activity of PARP1 protein],,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,,31061321,"Mukhopadhyay P, Horváth B, Rajesh M, Varga ZV, Gariani K, Ryu D, Cao Z, Holovac E, Park O, Zhou Z, Xu MJ, Wang W, Godlewski G, Paloczi J, Nemeth BT, Persidsky Y, Liaudet L, Haskó G, Bai P, Boulares AH, Auwerx J, Gao B, Pacher P. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. J Hepatol. 2017 Mar;66(3):589–600. doi: 10.1016/j.jhep.2016.10.023. PMID: 27984176."
226722,2072,Comparative Toxicogenomics Database (CTD),5-aminoisoquinolin-1(2H)-one,C411425,5-aminoisoquinolinone,https://ctdbase.org/detail.go?type=chem&acc=C411425,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),5-aminoisoquinolinone inhibits the reaction [PARP1 protein results in increased susceptibility to acetaminophen],,,PMID:15601672,https://www.ncbi.nlm.nih.gov/pubmed/15601672,15601672,,,5084555,"Cover C, Fickert P, Knight TR, Fuchsbichler A, Farhood A, Trauner M, Jaeschke H. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice. Toxicol Sci. 2005 Mar;84(1):201–8. doi: 10.1093/toxsci/kfi065. PMID: 15601672."
226723,2072,Comparative Toxicogenomics Database (CTD),5-aminoisoquinolin-1(2H)-one,C411425,5-aminoisoquinolinone,https://ctdbase.org/detail.go?type=chem&acc=C411425,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),5-aminoisoquinolinone results in decreased activity of PARP1 protein,,,PMID:21417348,https://www.ncbi.nlm.nih.gov/pubmed/21417348,21417348,,,28909941,"Sunderland PT, Woon EC, Dhami A, Bergin AB, Mahon MF, Wood PJ, Jones LA, Tully SR, Lloyd MD, Thompson AS, Javaid H, Martin NM, Threadgill MD. 5-Benzamidoisoquinolin-1-ones and 5-(?-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2). J Med Chem. 2011 Apr 14;54(7):2049–59. doi: 10.1021/jm1010918. PMID: 21417348."
217405,2088,Comparative Toxicogenomics Database (CTD),Alendronic Acid,D019386,Alendronate,https://ctdbase.org/detail.go?type=chem&acc=D019386,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Alendronate results in increased cleavage of PARP1 protein,,,PMID:39137827,https://www.ncbi.nlm.nih.gov/pubmed/39137827,39137827,,,37596533,"Feng Y, Tu S, Hou Y, Shao Y, Chen L, Mai Z, Wang Y, Wei J, Zhang S, Ai H, Chen Z. Alendronate sodium induces G1 phase arrest and apoptosis in human umbilical vein endothelial cells by inhibiting ROS-mediated ERK1/2 signaling. Toxicology. 2024 Nov;508():153917. doi: 10.1016/j.tox.2024.153917."
227329,2118,Comparative Toxicogenomics Database (CTD),Alprazolam,D000525,Alprazolam,https://ctdbase.org/detail.go?type=chem&acc=D000525,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[caffeine co-treated with alprazolam] results in increased activity of PARP1 protein,,,PMID:19490937,https://www.ncbi.nlm.nih.gov/pubmed/19490937,19490937,,,20096082,"Saha B, Mukherjee A, Samanta S, Saha P, Ghosh AK, Santra CR, Karmakar P. Caffeine augments Alprazolam induced cytotoxicity in human cell lines. Toxicol In Vitro. 2009 Sep;23(6):1100–9. doi: 10.1016/j.tiv.2009.05.018. PMID: 19490937."
7305,2125,Comparative Toxicogenomics Database (CTD),AM 251,C103505,AM 251,https://ctdbase.org/detail.go?type=chem&acc=C103505,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AM 251 inhibits the reaction [HU 211 results in increased cleavage of PARP1 protein],,,PMID:19509271,https://www.ncbi.nlm.nih.gov/pubmed/19509271,19509271,,,1046822,"Oesch S, Walter D, Wachtel M, Pretre K, Salazar M, Guzmán M, Velasco G, Schäfer BW. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Mol Cancer Ther. 2009 Jul;8(7):1838–45. doi: 10.1158/1535-7163.mct-08-1147. PMID: 19509271."
148316,2146,Comparative Toxicogenomics Database (CTD),Aminoguanidine,C004479,pimagedine,https://ctdbase.org/detail.go?type=chem&acc=C004479,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pimagedine inhibits the reaction [pyruvaldehyde results in increased cleavage of PARP1 protein],,,PMID:33930484,https://www.ncbi.nlm.nih.gov/pubmed/33930484,33930484,,,18336339,"Tang D, Xiao W, Gu WT, Zhang ZT, Xu SH, Chen ZQ, Xu YH, Zhang LY, Wang SM, Nie H. Pterostilbene prevents methylglyoxal-induced cytotoxicity in endothelial cells by regulating glyoxalase, oxidative stress and apoptosis. Food Chem Toxicol. 2021 Jul;153():112244. doi: 10.1016/j.fct.2021.112244. PMID: 33930484."
230864,2148,Comparative Toxicogenomics Database (CTD),p-Aminohippuric acid,D011084,Polycyclic Aromatic Hydrocarbons,https://ctdbase.org/detail.go?type=chem&acc=D011084,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10041,Peromyscus leucopus (white-footed mouse),Polycyclic aromatic hydrocarbons results in increased cleavage of PARP1 protein,,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
218014,2153,Comparative Toxicogenomics Database (CTD),Theophylline,D013806,Theophylline,https://ctdbase.org/detail.go?type=chem&acc=D013806,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[colforsin co-treated with theophylline] inhibits the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:9454737,https://www.ncbi.nlm.nih.gov/pubmed/9454737,9454737,,,4746394,"García-Bermejo L, Pérez C, Vilaboa NE, de Blas E, Aller P. cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells. J Cell Sci. 1998 Mar;111 ( Pt 5)():637–44. doi: 10.1242/jcs.111.5.637. PMID: 9454737."
218015,2153,Comparative Toxicogenomics Database (CTD),Theophylline,D013806,Theophylline,https://ctdbase.org/detail.go?type=chem&acc=D013806,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Theophylline binds to PARP1 protein,,,PMID:18951874,https://www.ncbi.nlm.nih.gov/pubmed/18951874,18951874,,,20767768,"Marwick JA, Wallis G, Meja K, Kuster B, Bouwmeester T, Chakravarty P, Fletcher D, Whittaker PA, Barnes PJ, Ito K, Adcock IM, Kirkham PA: Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802. doi: 10.1016/j.bbrc.2008.10.065. Epub 2008 Oct 23."
226485,2153,DrugBank,Theophylline,DB00277,Theophylline,https://www.drugbank.ca/drugs/DB00277,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:18951874,https://www.ncbi.nlm.nih.gov/pubmed/18951874,18951874,,,20767768,"Marwick JA, Wallis G, Meja K, Kuster B, Bouwmeester T, Chakravarty P, Fletcher D, Whittaker PA, Barnes PJ, Ito K, Adcock IM, Kirkham PA: Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802. doi: 10.1016/j.bbrc.2008.10.065. Epub 2008 Oct 23."
307509,2214,Comparative Toxicogenomics Database (CTD),Acetovanillone,C056165,acetovanillone,https://ctdbase.org/detail.go?type=chem&acc=C056165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetovanillone inhibits the reaction [arsenite results in increased oxidation of PARP1 protein],,,PMID:34798142,https://www.ncbi.nlm.nih.gov/pubmed/34798142,34798142,,PMC10115133,12958291,"Cooper KL, Volk LB, Dominguez DR, Duran AD, Ke Jian Liu KJ, Hudson LG. Contribution of NADPH oxidase to the retention of UVR-induced DNA damage by arsenic. Toxicology and Applied Pharmacology. 2022 Jan;434():115799. doi: 10.1016/j.taap.2021.115799."
307510,2214,Comparative Toxicogenomics Database (CTD),Acetovanillone,C056165,acetovanillone,https://ctdbase.org/detail.go?type=chem&acc=C056165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetovanillone inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein],,,PMID:29111459,https://www.ncbi.nlm.nih.gov/pubmed/29111459,29111459,,,14871116,"Chen H, Song Z, Ying S, Yang X, Wu W, Tan Q, Ju X, Wu W, Zhang X, Qu J, Wang Y. Myeloid differentiation protein 2 induced retinal ischemia reperfusion injury via upregulation of ROS through a TLR4-NOX4 pathway. Toxicol Lett. 2018 Jan 05;282():109–20. doi: 10.1016/j.toxlet.2017.10.018. PMID: 29111459."
307511,2214,Comparative Toxicogenomics Database (CTD),Acetovanillone,C056165,acetovanillone,https://ctdbase.org/detail.go?type=chem&acc=C056165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetovanillone inhibits the reaction [AGT protein results in increased activity of PARP1 protein],,,PMID:15502880,https://www.ncbi.nlm.nih.gov/pubmed/15502880,15502880,,PMC1431352,5775817,2004; 10(1-6):28-35
307512,2214,Comparative Toxicogenomics Database (CTD),Acetovanillone,C056165,acetovanillone,https://ctdbase.org/detail.go?type=chem&acc=C056165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetovanillone inhibits the reaction [zinc chloride results in increased activity of PARP1 protein],,,PMID:18509044,https://www.ncbi.nlm.nih.gov/pubmed/18509044,18509044,,PMC2680357,9912436,"Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagasawa K, Swanson RA. Zinc Triggers Microglial Activation. J. Neurosci. 2008 May 28;28(22):5827–35. doi: 10.1523/jneurosci.1236-08.2008."
307513,2214,Comparative Toxicogenomics Database (CTD),Acetovanillone,C056165,acetovanillone,https://ctdbase.org/detail.go?type=chem&acc=C056165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[polyethylene glycol-superoxide dismutase co-treated with acetovanillone] inhibits the reaction [EDN1 protein results in increased expression of and results in increased cleavage of PARP1 protein],,,PMID:24932781,https://www.ncbi.nlm.nih.gov/pubmed/24932781,24932781,,PMC4116760,32330629,"Yilmaz B, Sahin P, Ordueri E, Celik-Ozenci C, Tasatargil A. Poly(ADP-ribose) polymerase inhibition improves endothelin-1-induced endothelial dysfunction in rat thoracic aorta. Upsala Journal of Medical Sciences. 2014 Jun 16;119(3):215–22. doi: 10.3109/03009734.2014.908253."
265300,2236,Comparative Toxicogenomics Database (CTD),Aristolochic acid,C000228,aristolochic acid I,https://ctdbase.org/detail.go?type=chem&acc=C000228,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Aristolochic acid I results in increased expression of PARP1 protein modified form,,,PMID:26656393,https://www.ncbi.nlm.nih.gov/pubmed/26656393,26656393,,,12795951,"Kwak DH, Lee S. Aristolochic Acid I Causes Testis Toxicity by Inhibiting Akt and ERK1/2 Phosphorylation. Chem Res Toxicol. 2016 Jan 19;29(1):117–24. doi: 10.1021/acs.chemrestox.5b00467. PMID: 26656393."
265301,2236,Comparative Toxicogenomics Database (CTD),Aristolochic acid,C000228,aristolochic acid I,https://ctdbase.org/detail.go?type=chem&acc=C000228,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Aristolochic acid I results in increased cleavage of PARP1 protein|3-methyladenine inhibits the reaction [aristolochic acid I results in increased cleavage of PARP1 protein]|atg5 affects the reaction [aristolochic acid I results in increased cleavage of PARP1 protein],,,PMID:23939141,https://www.ncbi.nlm.nih.gov/pubmed/23939141,23939141,,,469151,"Yang CC, Wu CT, Chen LP, Hung KY, Liu SH, Chiang CK. Autophagy induction promotes aristolochic acid-I-induced renal injury in vivo and in vitro. Toxicology. 2013 Oct 04;312():63–73. doi: 10.1016/j.tox.2013.07.017. PMID: 23939141."
317928,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[aspirin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:18483385,https://www.ncbi.nlm.nih.gov/pubmed/18483385,18483385,,,17347317,"Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Clin Cancer Res. 2008 May 15;14(10):3168–76. doi: 10.1158/1078-0432.ccr-07-4362. PMID: 18483385."
317929,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aspirin inhibits the reaction [deoxycholic acid results in increased cleavage of PARP1 protein],,,PMID:17644113,https://www.ncbi.nlm.nih.gov/pubmed/17644113,17644113,,,25504018,"Redlak MJ, Power JJ, Miller TA. Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66–73. doi: 10.1016/j.jss.2007.04.039. PMID: 17644113."
317930,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BCL2 protein inhibits the reaction [aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:16199534,https://www.ncbi.nlm.nih.gov/pubmed/16199534,16199534,,,11235091,"Kim KM, Song JJ, An JY, Kwon YT, Lee YJ. Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression. Journal of Biological Chemistry. 2005 Dec;280(49):41047–56. doi: 10.1074/jbc.m503713200."
317931,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Troglitazone promotes the reaction [aspirin results in increased cleavage of PARP1 protein]|aspirin promotes the reaction [troglitazone results in increased cleavage of PARP1 protein],,,PMID:19908241,https://www.ncbi.nlm.nih.gov/pubmed/19908241,19908241,,,14008511,"Yan KH, Yao CJ, Chang HY, Lai GM, Cheng AL, Chuang SE. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells. Mol Carcinog. 2010 Mar;49(3):235–46. doi: 10.1002/mc.20593. PMID: 19908241."
317932,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aspirin results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:15481331,https://www.ncbi.nlm.nih.gov/pubmed/15481331,15481331,,,23402038,2004; 49(9):1518-1525
317933,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aspirin results in increased cleavage of PARP1 protein,,,PMID:11228543|PMID:11532860|PMID:19595669|PMID:19908241|PMID:9694730,https://www.ncbi.nlm.nih.gov/pubmed/11228543|https://www.ncbi.nlm.nih.gov/pubmed/11532860|https://www.ncbi.nlm.nih.gov/pubmed/19595669|https://www.ncbi.nlm.nih.gov/pubmed/19908241|https://www.ncbi.nlm.nih.gov/pubmed/9694730,11228543|11532860|19595669|19908241|9694730,,PMC1508093,921582|14008511|25337060|25372632|29549071,"Yan KH, Yao CJ, Chang HY, Lai GM, Cheng AL, Chuang SE. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells. Mol Carcinog. 2010 Mar;49(3):235–46. doi: 10.1002/mc.20593. PMID: 19908241.|Kim S, Bae M, Kim J, Wee H, Yoo M, Bae S. Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells. Biochemical and Biophysical Research Communications. 2009 Sep;387(2):342–7. doi: 10.1016/j.bbrc.2009.07.022.|Zhou XM, Wong BC, Fan XM, Zhang HB, Lin MC, Kung HF, Fan DM, Lam SK. Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis. 2001 Sep;22(9):1393–7. doi: 10.1093/carcin/22.9.1393. PMID: 11532860.|Zimmermann KC, Waterhouse NJ, Goldstein JC, Schuler M, Green DR. Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia. 2000 Nov;2(6):505–13. PMID: 11228543; PMCID: PMC1508093.|Bellosillo B, Pique´ M, Barraga´n M, Castan~o E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J. Aspirin and Salicylate Induce Apoptosis and Activation of Caspases in B-Cell Chronic Lymphocytic Leukemia Cells. 1998 Aug 15;92(4):1406–14. doi: 10.1182/blood.v92.4.1406.416k17_1406_1414."
201239,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9544,Macaca mulatta (Rhesus monkey),Atrazine results in increased expression of PARP1 mRNA,,,PMID:29505797,https://www.ncbi.nlm.nih.gov/pubmed/29505797,29505797,,PMC5898618,13528673,"Midic U, Goheen B, Vincent KA, VandeVoort CA, Latham KE. Changes in gene expression following long-term in vitro exposure of Macaca mulatta trophoblast stem cells to biologically relevant levels of endocrine disruptors. Reproductive Toxicology. 2018 Apr;77():154–65. doi: 10.1016/j.reprotox.2018.02.012."
201240,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Atrazine results in increased cleavage of PARP1 protein|melatonin inhibits the reaction [atrazine results in increased cleavage of PARP1 protein],,,PMID:25259610,https://www.ncbi.nlm.nih.gov/pubmed/25259610,25259610,,PMC4178181,19531073,"Sharma S, Sarkar J, Haldar C, Sinha S. Melatonin Reverses Fas, E2F-1 and Endoplasmic Reticulum Stress Mediated Apoptosis and Dysregulation of Autophagy Induced by the Herbicide Atrazine in Murine Splenocytes. PLoS ONE. 2014 Sep 26;9(9):e108602. doi: 10.1371/journal.pone.0108602."
291242,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzalkonium compounds analog results in increased cleavage of PARP1 protein|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [benzalkonium compounds analog results in increased cleavage of PARP1 protein],,,PMID:31982400,https://www.ncbi.nlm.nih.gov/pubmed/31982400,31982400,,,25060943,"Kanno S, Hirano S, Kato H, Fukuta M, Mukai T, Aoki Y. Benzalkonium chloride and cetylpyridinium chloride induce apoptosis in human lung epithelial cells and alter surface activity of pulmonary surfactant monolayers. Chem Biol Interact. 2020 Feb 01;317():108962. doi: 10.1016/j.cbi.2020.108962. PMID: 31982400."
294996,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzamide inhibits the reaction [PARP1 protein binds to MOR enhancer mutant form]|benzamide inhibits the reaction [TNF protein promotes the reaction [[PARP1 protein binds to MOR enhancer mutant form] which results in increased expression of MOR mrna]]|benzamide inhibits the reaction [[PARP1 protein binds to MOR enhancer mutant form] which results in increased expression of MOR mrna],,,PMID:19447888,https://www.ncbi.nlm.nih.gov/pubmed/19447888,19447888,,PMC2740444,26855302,"Ono T, Kaneda T, Muto A, Yoshida T. Positive Transcriptional Regulation of the Human µ Opioid Receptor Gene by Poly(ADP-ribose) Polymerase-1 and Increase of Its DNA Binding Affinity Based on Polymorphism of G-172 ? T. Journal of Biological Chemistry. 2009 Jul;284(30):20175–83. doi: 10.1074/jbc.m109.019414."
294997,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzamide results in decreased activity of PARP1 protein,,,PMID:17669606|PMID:18695944,https://www.ncbi.nlm.nih.gov/pubmed/17669606|https://www.ncbi.nlm.nih.gov/pubmed/18695944,17669606|18695944,,,22728614|23459566,"2008; 320(1-2):15-23|Lin PH, Lin CH, Huang CC, Chuang MC, Lin P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 2007 Aug;172(3):146–58. doi: 10.1016/j.toxlet.2007.06.003. PMID: 17669606."
294998,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[benzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of nad]|[benzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of NADP],,,PMID:17669606,https://www.ncbi.nlm.nih.gov/pubmed/17669606,17669606,,,22728614,"Lin PH, Lin CH, Huang CC, Chuang MC, Lin P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 2007 Aug;172(3):146–58. doi: 10.1016/j.toxlet.2007.06.003. PMID: 17669606."
294999,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzamide inhibits the reaction [[methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of nad]|[benzamide results in decreased activity of PARP1 protein] which results in decreased susceptibility to methylnitronitrosoguanidine|benzamide inhibits the reaction [[hydrogen peroxide results in increased activity of PARP1 protein] which results in decreased abundance of nad]|[benzamide results in decreased activity of PARP1 protein] which results in decreased susceptibility to hydrogen peroxide|benzamide results in decreased activity of PARP1 protein,,,PMID:11593040,https://www.ncbi.nlm.nih.gov/pubmed/11593040,11593040,,PMC59796,29402615,"Ying W, Sevigny MB, Chen Y, Swanson RA. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. U.S.A. 2001 Oct 09;98(21):12227–32. doi: 10.1073/pnas.211202598."
295000,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzamide results in decreased expression of PARP1 protein,,,PMID:19998477,https://www.ncbi.nlm.nih.gov/pubmed/19998477,19998477,,,8612359,"Yokoyama H, Kuroiwa H, Tsukada T, Uchida H, Kato H, Araki T. Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. J Neurosci Res. 2010 May 15;88(7):1522–36. doi: 10.1002/jnr.22310. PMID: 19998477."
295001,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzamide results in decreased activity of PARP1 protein,,,PMID:12411406,https://www.ncbi.nlm.nih.gov/pubmed/12411406,12411406,,PMC1573557,19283716,Chiarugi A. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. British J Pharmacology. 2002 Nov;137(6):761–70. doi: 10.1038/sj.bjp.0704934.
295002,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzamide results in decreased activity of PARP1 protein,,,PMID:14769338,https://www.ncbi.nlm.nih.gov/pubmed/14769338,14769338,,,29442128,"Putt KS, Hergenrother PJ. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors. Anal Biochem. 2004 Mar 01;326(1):78–86. doi: 10.1016/j.ab.2003.11.015. PMID: 14769338."
290145,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [benzo(a)pyrene results in increased cleavage of PARP1 protein]|3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [benzo(a)pyrene results in increased cleavage of PARP1 protein]",,,PMID:20840854,https://www.ncbi.nlm.nih.gov/pubmed/20840854,20840854,,,25557153,"Al-Anati L, Högberg J, Stenius U. Non-dioxin-like PCBs interact with benzo[a]pyrene-induced p53-responses and inhibit apoptosis. Toxicol Appl Pharmacol. 2010 Dec 01;249(2):166–77. doi: 10.1016/j.taap.2010.09.004. PMID: 20840854."
290149,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|[[abt-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein|mcl1 protein inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|usp7 protein affects the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein promotes the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|akt1 protein modified form inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein inhibits the reaction [sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|mcl1 protein affects the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein],,,PMID:32802178,https://www.ncbi.nlm.nih.gov/pubmed/32802178,32802178,,PMC7415806,9544165,"Yang P, Xie J, Li Y, Lin HP, Fenske W, Clementino M, Jiang Y, Yang C, Wang Z. Deubiquitinase USP7-mediated MCL-1 up-regulation enhances Arsenic and Benzo(a)pyrene co-exposure-induced Cancer Stem Cell-like property and Tumorigenesis. Theranostics. 2020;10(20):9050–65. PMID: 32802178; PMCID: PMC7415806."
290440,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PARP1 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,,21436600,"Sparfel L, Pinel-Marie ML, Boize M, Koscielny S, Desmots S, Pery A, Fardel O. Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci. 2010 Apr;114(2):247–59. doi: 10.1093/toxsci/kfq007. PMID: 20064835."
290441,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PARP1 protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,,4030900,"Wang Z, Karkossa I, Großkopf H, Rolle-Kampczyk U, Hackermüller J, von Bergen M, Schubert K. Comparison of quantitation methods in proteomics to define relevant toxicological information on AhR activation of HepG2 cells by BaP. Toxicology. 2021 Jan 30;448():152652. doi: 10.1016/j.tox.2020.152652. PMID: 33278487."
290442,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzo(a)pyrene results in increased cleavage of PARP1 protein,,,PMID:20840854|PMID:24685774,https://www.ncbi.nlm.nih.gov/pubmed/20840854|https://www.ncbi.nlm.nih.gov/pubmed/24685774,20840854|24685774,,,25557153|28973781,"Bölck B, Ibrahim M, Steinritz D, Morguet C, Dühr S, Suhr F, Lu-Hesselmann J, Bloch W. Detection of key enzymes, free radical reaction products and activated signaling molecules as biomarkers of cell damage induced by benzo[a]pyrene in human keratinocytes. Toxicol In Vitro. 2014 Aug;28(5):875–84. doi: 10.1016/j.tiv.2014.03.010. PMID: 24685774.|Al-Anati L, Högberg J, Stenius U. Non-dioxin-like PCBs interact with benzo[a]pyrene-induced p53-responses and inhibit apoptosis. Toxicol Appl Pharmacol. 2010 Dec 01;249(2):166–77. doi: 10.1016/j.taap.2010.09.004. PMID: 20840854."
290443,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PARP1 protein|vitamin E inhibits the reaction [benzo(a)pyrene results in increased expression of PARP1 protein]|curcumin inhibits the reaction [benzo(a)pyrene results in increased expression of PARP1 protein],,,PMID:24664296,https://www.ncbi.nlm.nih.gov/pubmed/24664296,24664296,,PMC3963982,28953785,"Zhu W, Cromie MM, Cai Q, Lv T, Singh K, Gao W. Curcumin and Vitamin E Protect against Adverse Effects of Benzo[a]pyrene in Lung Epithelial Cells. PLoS ONE. 2014 Mar 24;9(3):e92992. doi: 10.1371/journal.pone.0092992."
290444,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PARP1 exon|benzo(a)pyrene results in increased methylation of PARP1 promoter|benzo(a)pyrene results in decreased methylation of PARP1 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,PMC5352062,13506037,"Jiang CL, He SW, Zhang YD, Duan HX, Huang T, Huang YC, Li GF, Wang P, Ma LJ, Zhou GB, Cao Y. Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 03;8(1):1369–91. PMID: 27901495; PMCID: PMC5352062."
290445,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein results in decreased susceptibility to benzo(a)pyrene,,,PMID:19247804,https://www.ncbi.nlm.nih.gov/pubmed/19247804,19247804,,,25544811,2009; 36(8):2413-2422
290446,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to PARP1 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,PMC2717142,31567380,"Sartor MA, Schnekenburger M, Marlowe JL, Reichard JF, Wang Y, Fan Y, Ma C, Karyala S, Halbleib D, Liu X, Medvedovic M, Puga A. Genomewide analysis of aryl hydrocarbon receptor binding targets reveals an extensive array of gene clusters that control morphogenetic and developmental programs. Environ Health Perspect. 2009 Jul;117(7):1139–46. PMID: 19654925; PMCID: PMC2717142."
290447,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PARP1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,,13357082,"Mathijs K, Brauers KJ, Jennen DG, Boorsma A, van Herwijnen MH, Gottschalk RW, Kleinjans JC, van Delft JH. Discrimination for genotoxic and nongenotoxic carcinogens by gene expression profiling in primary mouse hepatocytes improves with exposure time. Toxicol Sci. 2009 Dec;112(2):374–84. doi: 10.1093/toxsci/kfp229. PMID: 19770486."
290448,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzo(a)pyrene results in increased cleavage of PARP1 protein,,,PMID:19041363|PMID:32061149,https://www.ncbi.nlm.nih.gov/pubmed/19041363|https://www.ncbi.nlm.nih.gov/pubmed/32061149,19041363|32061149,,,375421|2641332,"Islam J, Shree A, Afzal SM, Vafa A, Sultana S. Protective effect of Diosmin against benzo(a)pyrene-induced lung injury in Swiss Albino Mice. Environ Toxicol. 2020 Jul;35(7):747–57. doi: 10.1002/tox.22909. PMID: 32061149.|Asare N, Låg M, Lagadic-Gossmann D, Rissel M, Schwarze P, Holme JA. 3-Nitrofluoranthene (3-NF) but not 3-aminofluoranthene (3-AF) elicits apoptosis as well as programmed necrosis in Hepa1c1c7 cells. Toxicology. 2009 Jan 31;255(3):140–50. doi: 10.1016/j.tox.2008.10.021. PMID: 19041363."
290449,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PARP1 mRNA,,,PMID:35567930,https://www.ncbi.nlm.nih.gov/pubmed/35567930,35567930,,,34282201,"Wu SE, Hsu JC, Chang YL, Chuang HC, Chiu YL, Chen WL. Benzo[a]pyrene exposure in muscle triggers sarcopenia through aryl hydrocarbon receptor-mediated reactive oxygen species production. Ecotoxicol Environ Saf. 2022 Jul 01;239():113599. doi: 10.1016/j.ecoenv.2022.113599. PMID: 35567930."
290653,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Diosmin inhibits the reaction [benzo(a)pyrene results in increased cleavage of PARP1 protein],,,PMID:32061149,https://www.ncbi.nlm.nih.gov/pubmed/32061149,32061149,,,2641332,"Islam J, Shree A, Afzal SM, Vafa A, Sultana S. Protective effect of Diosmin against benzo(a)pyrene-induced lung injury in Swiss Albino Mice. Environ Toxicol. 2020 Jul;35(7):747–57. doi: 10.1002/tox.22909. PMID: 32061149."
232560,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[camptothecin co-treated with azoxymethane co-treated with dextran sulfate] results in increased cleavage of PARP1 protein|[plant extracts co-treated with azoxymethane co-treated with dextran sulfate] results in increased cleavage of PARP1 protein,,,PMID:25449198,https://www.ncbi.nlm.nih.gov/pubmed/25449198,25449198,,,20878823,"Chung KS, Choi HE, Shin JS, Cho EJ, Cho YW, Choi JH, Baek NI, Lee KT. Chemopreventive effects of standardized ethanol extract from the aerial parts of Artemisia princeps Pampanini cv. Sajabal via NF-?B inactivation on colitis-associated colon tumorigenesis in mice. Food Chem Toxicol. 2015 Jan;75():14–23. doi: 10.1016/j.fct.2014.11.007. PMID: 25449198."
232561,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dextran sulfate results in increased cleavage of PARP1 protein|plant extracts inhibits the reaction [dextran sulfate results in increased cleavage of PARP1 protein],,,PMID:21989142,https://www.ncbi.nlm.nih.gov/pubmed/21989142,21989142,,PMC3207919,19468762,2011; 11(1):91
273454,2353,Comparative Toxicogenomics Database (CTD),Berberine,D001599,Berberine,https://ctdbase.org/detail.go?type=chem&acc=D001599,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[berberine co-treated with cisplatin] results in increased cleavage of PARP1 protein]|[berberine co-treated with cisplatin] results in increased cleavage of PARP1 protein,,,PMID:36070022,https://www.ncbi.nlm.nih.gov/pubmed/36070022,36070022,,,35282806,2022; 39(4):1297-1317
273455,2353,Comparative Toxicogenomics Database (CTD),Berberine,D001599,Berberine,https://ctdbase.org/detail.go?type=chem&acc=D001599,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased cleavage of PARP1 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,,6682874,"Shukla S, Sharma A, Pandey VK, Raisuddin S, Kakkar P. Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells. Toxicol Appl Pharmacol. 2016 Jan 15;291():70–83. doi: 10.1016/j.taap.2015.12.006. PMID: 26712469."
273456,2353,Comparative Toxicogenomics Database (CTD),Berberine,D001599,Berberine,https://ctdbase.org/detail.go?type=chem&acc=D001599,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Berberine results in increased cleavage of PARP1 protein,,,PMID:16505103,https://www.ncbi.nlm.nih.gov/pubmed/16505103,16505103,,,32839273,2006; 5(2):296-308
339207,2375,Comparative Toxicogenomics Database (CTD),Bicalutamide,C053541,bicalutamide,https://ctdbase.org/detail.go?type=chem&acc=C053541,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bicalutamide promotes the reaction [niclosamide results in increased expression of PARP1 protein modified form],,,PMID:28500234,https://www.ncbi.nlm.nih.gov/pubmed/28500234,28500234,,PMC5544572,6007007,"Liu C, Armstrong CM, Lou W, Lombard AP, Cucchiara V, Gu X, Yang JC, Nadiminty N, Pan CX, Evans CP, Gao AC. Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. Mol Cancer Ther. 2017 Aug;16(8):1521–30. PMID: 28500234; PMCID: PMC5544572."
251506,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide I,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisindolylmaleimide I inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,PMC1458365,10558450,"Kim HJ, Chakravarti N, Oridate N, Choe C, Claret FX, Lotan R. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene. 2006 May 04;25(19):2785–94. PMID: 16407847; PMCID: PMC1458365."
251507,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide I,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Bisindolylmaleimide I inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein],,,PMID:22155090,https://www.ncbi.nlm.nih.gov/pubmed/22155090,22155090,,,15398108,"Sarró E, Jacobs-Cachá C, Itarte E, Meseguer A. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275–87. doi: 10.1016/j.taap.2011.11.007. PMID: 22155090."
253739,2399,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide IV,C088060,bisindolylmaleimide,https://ctdbase.org/detail.go?type=chem&acc=C088060,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bisindolylmaleimide affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein],,,PMID:31396050,https://www.ncbi.nlm.nih.gov/pubmed/31396050,31396050,,PMC6667551,10151887,"Kim JE, Kang TC. PKC, AKT and ERK1/2-Mediated Modulations of PARP1, NF-?B and PEA15 Activities Distinctly Regulate Regional Specific Astroglial Responses Following Status Epilepticus. Front Mol Neurosci. 2019;12():180. PMID: 31396050; PMCID: PMC6667551."
405138,2478,Comparative Toxicogenomics Database (CTD),Busulfan,D002066,Busulfan,https://ctdbase.org/detail.go?type=chem&acc=D002066,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Busulfan results in increased cleavage of PARP1 protein,,,PMID:18339423,https://www.ncbi.nlm.nih.gov/pubmed/18339423,18339423,,PMC2633244,4436891,"Valdez BC, Murray D, Ramdas L, de Lima M, Jones R, Kornblau S, Betancourt D, Li Y, Champlin RE, Andersson BS. Altered gene expression in busulfan-resistant human myeloid leukemia. Leukemia Research. 2008 Nov;32(11):1684–97. doi: 10.1016/j.leukres.2008.01.016."
405139,2478,Comparative Toxicogenomics Database (CTD),Busulfan,D002066,Busulfan,https://ctdbase.org/detail.go?type=chem&acc=D002066,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[clofarabine co-treated with fludarabine co-treated with busulfan] results in increased cleavage of PARP1 protein,,,PMID:20933509,https://www.ncbi.nlm.nih.gov/pubmed/20933509,20933509,,PMC3006064,18751816,"Valdez BC, Li Y, Murray D, Champlin RE, Andersson BS. The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling. Biochemical Pharmacology. 2011 Jan;81(2):222–32. doi: 10.1016/j.bcp.2010.09.027."
405140,2478,Comparative Toxicogenomics Database (CTD),Busulfan,D002066,Busulfan,https://ctdbase.org/detail.go?type=chem&acc=D002066,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [[decitabine co-treated with busulfan] results in increased cleavage of PARP1 protein]|[decitabine co-treated with busulfan] results in increased cleavage of PARP1 protein,,,PMID:19732952,https://www.ncbi.nlm.nih.gov/pubmed/19732952,19732952,,PMC2823987,32916323,"Valdez BC, Li Y, Murray D, Corn P, Champlin RE, Andersson BS. 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis. Leukemia Research. 2010 Mar;34(3):364–72. doi: 10.1016/j.leukres.2009.08.014."
259312,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Caffeine affects the cleavage of PARP1 protein,,,PMID:19242509,https://www.ncbi.nlm.nih.gov/pubmed/19242509,19242509,,PMC2829385,25539858,"Heffernan TP, Kawasumi M, Blasina A, Anderes K, Conney AH, Nghiem P. ATR–Chk1 Pathway Inhibition Promotes Apoptosis after UV Treatment in Primary Human Keratinocytes: Potential Basis for the UV Protective Effects of Caffeine. Journal of Investigative Dermatology. 2009 Jul;129(7):1805–15. doi: 10.1038/jid.2008.435."
259313,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[caffeine co-treated with alprazolam] results in increased activity of PARP1 protein,,,PMID:19490937,https://www.ncbi.nlm.nih.gov/pubmed/19490937,19490937,,,20096082,"Saha B, Mukherjee A, Samanta S, Saha P, Ghosh AK, Santra CR, Karmakar P. Caffeine augments Alprazolam induced cytotoxicity in human cell lines. Toxicol In Vitro. 2009 Sep;23(6):1100–9. doi: 10.1016/j.tiv.2009.05.018. PMID: 19490937."
259314,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Caffeine promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:22226932,https://www.ncbi.nlm.nih.gov/pubmed/22226932,22226932,,,22176951,"Yoon JH, Ahn SG, Lee BH, Jung SH, Oh SH. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. Biochem Pharmacol. 2012 Mar 15;83(6):747–57. doi: 10.1016/j.bcp.2011.12.029. PMID: 22226932."
259315,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Caffeine results in increased cleavage of and results in increased expression of PARP1 protein,,,PMID:16522534,https://www.ncbi.nlm.nih.gov/pubmed/16522534,16522534,,,32855568,"Matsuoka S, Moriyama T, Ohara N, Tanimura K, Maruo T. Caffeine induces apoptosis of human umbilical vein endothelial cells through the caspase-9 pathway. Gynecol Endocrinol. 2006 Jan;22(1):48–53. doi: 10.1080/09513590500476198. PMID: 16522534."
259505,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Caffeine results in increased cleavage of PARP1 protein,,,PMID:21229324,https://www.ncbi.nlm.nih.gov/pubmed/21229324,21229324,,PMC3932700,29583976,2011; 31(3):275-279
259506,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Caffeine results in increased phosphorylation of PARP1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,,34251403,"Zhang Z, Zhang Y, Li Y, Jiang S, Xu F, Li K, Chang L, Gao H, Kukic P, Carmichael PL, Liddell M, Li J, Zhang Q, Lyu Z, Peng S, Zuo T, Tulum L, Xu P. Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449():116110. doi: 10.1016/j.taap.2022.116110. PMID: 35688186."
259507,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"PARP1 protein results in decreased susceptibility to caffeine|[parp1 protein results in decreased susceptibility to caffeine] promotes the reaction [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in increased expression of CDKN1A mrna]",,,PMID:21840268,https://www.ncbi.nlm.nih.gov/pubmed/21840268,21840268,,PMC3185120,12029770,"Madison DL, Stauffer D, Lundblad JR. The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest. DNA Repair. 2011 Oct;10(10):1003–13. doi: 10.1016/j.dnarep.2011.07.006."
259508,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Caffeine inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:30377735,https://www.ncbi.nlm.nih.gov/pubmed/30377735,30377735,,,8127370,2018; 93(2):533-546
220510,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein]|[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein],,,PMID:24373880,https://www.ncbi.nlm.nih.gov/pubmed/24373880,24373880,,,20173790,"Liu N, Huang H, Liu S, Li X, Yang C, Dou QP, Liu J. Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation. Toxicol In Vitro. 2014 Apr;28(3):419–25. doi: 10.1016/j.tiv.2013.12.008. PMID: 24373880."
220511,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Verapamil inhibits the reaction [PARP1 gene mutant form results in decreased uptake of doxorubicin],,,PMID:15861398,https://www.ncbi.nlm.nih.gov/pubmed/15861398,15861398,,,7877358,Wesierska-Gadek J. Major contribution of the multidrug transporter P-glycoprotein to reduced susceptibility of poly(ADP-ribose) polymerase-1 knock-out cells to doxorubicin action. J Cell Biochem. 2005 Aug 01;95(5):1012–28. doi: 10.1002/jcb.20467. PMID: 15861398.
12210,2526,Comparative Toxicogenomics Database (CTD),Glycerol 2-phosphate,C031463,beta-glycerophosphoric acid,https://ctdbase.org/detail.go?type=chem&acc=C031463,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of PARP1 protein modified form|parp1 mRNA promotes the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of RUNX2 mrna]|parg mRNA inhibits the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of PARP1 protein],,,PMID:22940495,https://www.ncbi.nlm.nih.gov/pubmed/22940495,22940495,,,31637292,"Robaszkiewicz A, Erdélyi K, Kovács K, Kovács I, Bai P, Rajnavölgyi E, Virág L. Hydrogen peroxide-induced poly(ADP-ribosyl)ation regulates osteogenic differentiation-associated cell death. Free Radic Biol Med. 2012 Oct 15;53(8):1552–64. doi: 10.1016/j.freeradbiomed.2012.08.567. PMID: 22940495."
12211,2526,Comparative Toxicogenomics Database (CTD),Glycerol 2-phosphate,C031463,beta-glycerophosphoric acid,https://ctdbase.org/detail.go?type=chem&acc=C031463,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,PMC4632778,8743897,"Kishi Y, Fujihara H, Kawaguchi K, Yamada H, Nakayama R, Yamamoto N, Fujihara Y, Hamada Y, Satomura K, Masutani M. PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway. Int J Mol Sci. 2015 Oct 19;16(10):24820–38. PMID: 26492236; PMCID: PMC4632778."
255205,2533,Comparative Toxicogenomics Database (CTD),"1-[3,10-Dihydroxy-12-(2-{[(4-hydroxyphenoxy)carbonyl]oxy}propyl)-2,6,7,11-tetramethoxy-4,9-dioxo-4,9-dihydroperylen-1-yl]propan-2-yl benzoate",C538949,PKF115-584,https://ctdbase.org/detail.go?type=chem&acc=C538949,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PKF115-584 results in increased cleavage of PARP1 protein,,,PMID:17452641|PMID:19067737,https://www.ncbi.nlm.nih.gov/pubmed/17452641|https://www.ncbi.nlm.nih.gov/pubmed/19067737,17452641|19067737,,PMC1863489,351008|7929679,"Minke KS, Staib P, Puetter A, Gehrke I, Gandhirajan RK, Schlösser A, Schmitt EK, Hallek M, Kreuzer KA. Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells. Eur J Haematol. 2009 Mar;82(3):165–75. doi: 10.1111/j.1600-0609.2008.01188.x. PMID: 19067737.|Sukhdeo K, Mani M, Zhang Y, Dutta J, Yasui H, Rooney MD, Carrasco DE, Zheng M, He H, Tai YT, Mitsiades C, Anderson KC, Carrasco DR. Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma. Proc Natl Acad Sci U S A. 2007 May 01;104(18):7516–21. PMID: 17452641; PMCID: PMC1863489."
339236,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Carbamazepine affects the expression of PARP1 mRNA,,,PMID:24752500|PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/24752500|https://www.ncbi.nlm.nih.gov/pubmed/25979313,24752500|25979313,,,1835374|20207729,"Schulpen SH, Pennings JL, Piersma AH. Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311–20. doi: 10.1093/toxsci/kfv094. PMID: 25979313.|Fredriksson L, Wink S, Herpers B, Benedetti G, Hadi M, de Bont H, Groothuis G, Luijten M, Danen E, de Graauw M, Meerman J, van de Water B. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFa-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144–59. doi: 10.1093/toxsci/kfu072. PMID: 24752500."
333524,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Carboplatin results in increased cleavage of PARP1 protein,,,PMID:15996812,https://www.ncbi.nlm.nih.gov/pubmed/15996812,15996812,,,2345625,"Singh S, Chhipa RR, Vijayakumar MV, Bhat MK. DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells. Cancer Lett. 2006 May 18;236(2):213–21. doi: 10.1016/j.canlet.2005.05.024. PMID: 15996812."
342077,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Disulfiram promotes the reaction [carmustine results in increased cleavage of PARP1 protein]|carmustine results in increased cleavage of PARP1 protein,,,PMID:24193513,https://www.ncbi.nlm.nih.gov/pubmed/24193513,24193513,,PMC3941740,18806017,"Paranjpe A, Zhang R, Ali-Osman F, Bobustuc GC, Srivenugopal KS. Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage. Carcinogenesis. 2013 Nov 05;35(3):692–702. doi: 10.1093/carcin/bgt366."
275878,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[atorvastatin co-treated with celecoxib] results in increased cleavage of PARP1 protein,,,PMID:18172863,https://www.ncbi.nlm.nih.gov/pubmed/18172863,18172863,,,28843101,"Xiao H, Zhang Q, Lin Y, Reddy BS, Yang CS. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer. 2008 May 01;122(9):2115–24. doi: 10.1002/ijc.23315. PMID: 18172863."
275879,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Celecoxib analog affects the cleavage of PARP1 protein,,,PMID:18485224,https://www.ncbi.nlm.nih.gov/pubmed/18485224,18485224,,PMC2396175,17349085,2008; 7(1):38
275880,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Celecoxib inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein],,,PMID:17461495,https://www.ncbi.nlm.nih.gov/pubmed/17461495,17461495,,PMC4146971,7889868,"Lim YJ, Rhee JC, Bae YM, Chun WJ. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. World J Gastroenterol. 2007 Apr 07;13(13):1947–52. PMID: 17461495; PMCID: PMC4146971."
275881,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Celecoxib promotes the reaction [docetaxel results in increased cleavage of and results in increased expression of PARP1 protein]|celecoxib results in increased cleavage of and results in increased expression of PARP1 protein|tetracycline CMT-3 promotes the reaction [celecoxib results in increased cleavage of and results in increased expression of PARP1 protein]|docetaxel promotes the reaction [celecoxib results in increased cleavage of and results in increased expression of PARP1 protein]|celecoxib promotes the reaction [tetracycline CMT-3 results in increased cleavage of and results in increased expression of PARP1 protein],,,PMID:15688368,https://www.ncbi.nlm.nih.gov/pubmed/15688368,15688368,,,15264006,"Dandekar DS, Lopez M, Carey RI, Lokeshwar BL. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells. Int J Cancer. 2005 Jun 20;115(3):484–92. doi: 10.1002/ijc.20878. PMID: 15688368."
275882,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Celecoxib results in increased activity of PARP1 protein,,,PMID:12824303,https://www.ncbi.nlm.nih.gov/pubmed/12824303,12824303,,,15893286,"Jendrossek V, Handrick R, Belka C. Celecoxib activates a novel mitochondrial apoptosis signaling pathway. FASEB J. 2003 Aug;17(11):1547–9. doi: 10.1096/fj.02-0947fje. PMID: 12824303."
275883,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Celecoxib results in increased cleavage of PARP1 protein,,,PMID:15572759|PMID:15911099|PMID:16123214|PMID:17612393|PMID:18202791|PMID:18485224|PMID:19665451,https://www.ncbi.nlm.nih.gov/pubmed/15572759|https://www.ncbi.nlm.nih.gov/pubmed/15911099|https://www.ncbi.nlm.nih.gov/pubmed/16123214|https://www.ncbi.nlm.nih.gov/pubmed/17612393|https://www.ncbi.nlm.nih.gov/pubmed/18202791|https://www.ncbi.nlm.nih.gov/pubmed/18485224|https://www.ncbi.nlm.nih.gov/pubmed/19665451,15572759|15911099|16123214|17612393|18202791|18485224|19665451,,PMC2206712|PMC2396175,2370252|14615843|17349085|24094418|24760002|30873324|31577332,"Rudner J, Elsaesser SJ, Müller AC, Belka C, Jendrossek V. Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis. Biochem Pharmacol. 2010 Jan 01;79(1):10–20. doi: 10.1016/j.bcp.2009.07.021. PMID: 19665451.|2008; 7(1):38|Ko SH, Choi GJ, Lee JH, Han YA, Lim SJ, Kim SH. Differential effects of selective cyclooxygenase-2 inhibitors in inhibiting proliferation and induction of apoptosis in oral squamous cell carcinoma. Oncol Rep. 2008 Feb;19(2):425–33. PMID: 18202791.|2007; 9(4):r41|Kardosh A, Soriano N, Liu YT, Uddin J, Petasis NA, Hofman FM, Chen TC, Schönthal AH. Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib. Blood. 2005 Dec 15;106(13):4330–8. doi: 10.1182/blood-2005-07-2819. PMID: 16123214.|Subhashini J, Mahipal SV, Reddanna P. Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro. Cancer Lett. 2005 Jun 16;224(1):31–43. doi: 10.1016/j.canlet.2004.11.002. PMID: 15911099.|Liu X, Yue P, Zhou Z, Khuri FR, Sun S-. Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells. JNCI Journal of the National Cancer Institute. 2004 Nov 30;96(23):1769–80. doi: 10.1093/jnci/djh322."
276047,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),FADD mutant form inhibits the reaction [celecoxib results in increased cleavage of PARP1 protein]|tnfrsf10b mutant form inhibits the reaction [celecoxib results in increased cleavage of PARP1 protein]|tnfsf10 protein promotes the reaction [celecoxib results in increased cleavage of PARP1 protein],,,PMID:15572759,https://www.ncbi.nlm.nih.gov/pubmed/15572759,15572759,,,24094418,"Liu X, Yue P, Zhou Z, Khuri FR, Sun S-. Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells. JNCI Journal of the National Cancer Institute. 2004 Nov 30;96(23):1769–80. doi: 10.1093/jnci/djh322."
276048,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Celecoxib promotes the reaction [dihematoporphyrin ether results in increased cleavage of PARP1 protein],,,PMID:16230411,https://www.ncbi.nlm.nih.gov/pubmed/16230411,16230411,,,28145768,"Ferrario A, Fisher AM, Rucker N, Gomer CJ. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res. 2005 Oct 15;65(20):9473–8. doi: 10.1158/0008-5472.can-05-1659. PMID: 16230411."
276049,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Celecoxib results in decreased activity of PARP1 protein,,,PMID:19706164,https://www.ncbi.nlm.nih.gov/pubmed/19706164,19706164,,PMC2741461,26214223,2009; 8(1):66
276050,2662,Comparative Toxicogenomics Database (CTD),Celecoxib,D000068579,Celecoxib,https://ctdbase.org/detail.go?type=chem&acc=D000068579,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Celecoxib results in increased cleavage of PARP1 protein,,,PMID:17717820,https://www.ncbi.nlm.nih.gov/pubmed/17717820,17717820,,,21730034,"Xu Y, Zhao YM, Huang H. [Celecoxib-induced apoptosis in acute promyelocytic leukemia cell line MR2 and its mechanism]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Jul;36(4):319–24. doi: 10.3785/j.issn.1008-9292.2007.04.002. PMID: 17717820."
379746,2683,Comparative Toxicogenomics Database (CTD),Cetylpyridinium,D002594,Cetylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D002594,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cetylpyridinium results in increased cleavage of PARP1 protein|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [cetylpyridinium results in increased cleavage of PARP1 protein],,,PMID:31982400,https://www.ncbi.nlm.nih.gov/pubmed/31982400,31982400,,,25060943,"Kanno S, Hirano S, Kato H, Fukuta M, Mukai T, Aoki Y. Benzalkonium chloride and cetylpyridinium chloride induce apoptosis in human lung epithelial cells and alter surface activity of pulmonary surfactant monolayers. Chem Biol Interact. 2020 Feb 01;317():108962. doi: 10.1016/j.cbi.2020.108962. PMID: 31982400."
403508,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenic trioxide promotes the reaction [chloroquine results in increased cleavage of PARP1 protein],,,PMID:30338810,https://www.ncbi.nlm.nih.gov/pubmed/30338810,30338810,,,16920591,"Liu DM, Zhang XD, Yang L. Chloroquine aggravates the arsenic trioxide (As2O3)-induced apoptosis of acute promyelocytic leukemia NB4 cells via inhibiting lysosomal degradation in vitro. Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6412–21. doi: 10.26355/eurrev_201810_16054. PMID: 30338810."
403509,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[chloroquine co-treated with 3-methyladenine] results in increased cleavage of PARP1 protein,,,PMID:30025493,https://www.ncbi.nlm.nih.gov/pubmed/30025493,30025493,,PMC6152528,23661645,"Wang J, Qi Q, Zhou W, Feng Z, Huang B, Chen A, Zhang D, Li W, Zhang Q, Jiang Z, Bjerkvig R, Prestegarden L, Thorsen F, Wang X, Li X, Wang J. Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy. Autophagy. 2018 Aug 17;14(11):2007–22. doi: 10.1080/15548627.2018.1501133."
403510,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloroquine inhibits the reaction [betulin results in increased cleavage of PARP1 protein],,,PMID:32190974,https://www.ncbi.nlm.nih.gov/pubmed/32190974,32190974,,,14927468,"Lin YC, Chen HY, Hsieh CP, Huang YF, Chang IL. Betulin inhibits mTOR and induces autophagy to promote apoptosis in human osteosarcoma cell lines. Environ Toxicol. 2020 Aug;35(8):879–87. doi: 10.1002/tox.22924. PMID: 32190974."
403511,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloroquine inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:30985881,https://www.ncbi.nlm.nih.gov/pubmed/30985881,30985881,,,26417983,"Gu J, Wang Y, Liu Y, Shi M, Yin L, Hou Y, Zhou Y, Chu Wong CK, Chen D, Guo Z, Shi H. Inhibition of Autophagy Alleviates Cadmium-Induced Mouse Spleen and Human B Cells Apoptosis. Toxicol Sci. 2019 Jul 01;170(1):109–22. doi: 10.1093/toxsci/kfz089. PMID: 30985881."
403512,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloroquine promotes the reaction [[cysteine proteinase inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]|[cysteine proteinase inhibitors results in decreased activity of USP8 protein] promotes the reaction [chloroquine results in increased cleavage of PARP1 protein],,,PMID:35022897,https://www.ncbi.nlm.nih.gov/pubmed/35022897,35022897,,,10229733,2022; 39(5):2011-2032
403513,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NDRG1 protein affects the reaction [chloroquine promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein]]|ndrg1 protein affects the reaction [chloroquine results in increased cleavage of PARP1 protein]|chloroquine promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein],,,PMID:28906492,https://www.ncbi.nlm.nih.gov/pubmed/28906492,28906492,,PMC5636982,25001871,"Wang H, Li W, Xu J, Zhang T, Zuo D, Zhou Z, Lin B, Wang G, Wang Z, Sun W, Sun M, Chang S, Cai Z, Hua Y. NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy. Cell Death & Disease. 2017 Sep 14;8(9):e3048. doi: 10.1038/cddis.2017.438."
403675,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloroquine promotes the reaction [SC-66 compound results in increased cleavage of PARP1 protein],,,PMID:37741534,https://www.ncbi.nlm.nih.gov/pubmed/37741534,37741534,,,36551503,"Wang L, Song R, Ma M, Chen Y, Jiang Y, Li J, Yang Z, Zhang L, Jing M, Wang X, Zhang M, Fan J. Inhibition of autophagy can promote the apoptosis of bladder cancer cells induced by SC66 through the endoplasmic reticulum stress pathway. Chem Biol Interact. 2023 Oct 01;384():110725. doi: 10.1016/j.cbi.2023.110725. PMID: 37741534."
403676,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloroquine promotes the reaction [sodium arsenite results in increased activity of PARP1 protein],,,PMID:36958258,https://www.ncbi.nlm.nih.gov/pubmed/36958258,36958258,,,34734926,"So K, Oh S. Arsenite-induced cytotoxicity is regulated by poly-ADP ribose polymerase 1 activation and parthanatos in p53-deficient H1299 cells: The roles of autophagy and p53. Biochemical and Biophysical Research Communications. 2023 May;656():78–85. doi: 10.1016/j.bbrc.2023.03.018."
403677,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloroquine results in increased cleavage of PARP1 protein,,,PMID:28906492|PMID:30338810|PMID:35022897,https://www.ncbi.nlm.nih.gov/pubmed/28906492|https://www.ncbi.nlm.nih.gov/pubmed/30338810|https://www.ncbi.nlm.nih.gov/pubmed/35022897,28906492|30338810|35022897,,PMC5636982,10229733|16920591|25001871,"2022; 39(5):2011-2032|Liu DM, Zhang XD, Yang L. Chloroquine aggravates the arsenic trioxide (As2O3)-induced apoptosis of acute promyelocytic leukemia NB4 cells via inhibiting lysosomal degradation in vitro. Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6412–21. doi: 10.26355/eurrev_201810_16054. PMID: 30338810.|Wang H, Li W, Xu J, Zhang T, Zuo D, Zhou Z, Lin B, Wang G, Wang Z, Sun W, Sun M, Chang S, Cai Z, Hua Y. NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy. Cell Death & Disease. 2017 Sep 14;8(9):e3048. doi: 10.1038/cddis.2017.438."
403678,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the reaction [chloroquine promotes the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased lipidation of MAP1LC3B protein]],,,PMID:34826546,https://www.ncbi.nlm.nih.gov/pubmed/34826546,34826546,,,7531872,"Zhou Y, Zhao X, Zhang L, Xia Q, Peng Y, Zhang H, Yan D, Yang Z, Li J. Iron overload inhibits cell proliferation and promotes autophagy via PARP1/SIRT1 signaling in endometriosis and adenomyosis. Toxicology. 2022 Jan 15;465():153050. doi: 10.1016/j.tox.2021.153050. PMID: 34826546."
403679,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Chloroquine inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
403680,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Chloroquine results in increased cleavage of PARP1 protein,,,PMID:31310755,https://www.ncbi.nlm.nih.gov/pubmed/31310755,31310755,,,32445610,"Stamenkovic M, Janjetovic K, Paunovic V, Ciric D, Kravic-Stevovic T, Trajkovic V. Comparative analysis of cell death mechanisms induced by lysosomal autophagy inhibitors. Eur J Pharmacol. 2019 Sep 15;859():172540. doi: 10.1016/j.ejphar.2019.172540. PMID: 31310755."
403681,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Chloroquine promotes the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,,18200010,"So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547."
403682,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Chloroquine promotes the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:34374793,https://www.ncbi.nlm.nih.gov/pubmed/34374793,34374793,,,25810524,2021; 95(10):3263-3284
403683,2719,Comparative Toxicogenomics Database (CTD),Chloroquine,D002738,Chloroquine,https://ctdbase.org/detail.go?type=chem&acc=D002738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),Chloroquine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein],,,PMID:30287338,https://www.ncbi.nlm.nih.gov/pubmed/30287338,30287338,,,22300257,"Qian G, Liu D, Hou L, Hamid M, Chen X, Gan F, Song S, Huang K. Ochratoxin A induces cytoprotective autophagy via blocking AKT/mTOR signaling pathway in PK-15 cells. Food Chem Toxicol. 2018 Dec;122():120–31. doi: 10.1016/j.fct.2018.09.070. PMID: 30287338."
287206,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chlorpyrifos results in increased cleavage of PARP1 protein,,,PMID:24793810,https://www.ncbi.nlm.nih.gov/pubmed/24793810,24793810,,,14099132,"Lee JE, Park JH, Jang SJ, Koh HC. Rosiglitazone inhibits chlorpyrifos-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells. Toxicol Appl Pharmacol. 2014 Jul 15;278(2):159–71. doi: 10.1016/j.taap.2014.04.021. PMID: 24793810."
287207,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chlorpyrifos results in increased expression of PARP1 mrna|chlorpyrifos results in increased expression of PARP1 protein,,,PMID:28887667,https://www.ncbi.nlm.nih.gov/pubmed/28887667,28887667,,,27711936,2017; 441(1-2):201-216
287376,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chlorpyrifos results in increased expression of PARP1 protein modified form,,,PMID:23416140,https://www.ncbi.nlm.nih.gov/pubmed/23416140,23416140,,,10013087,"Ki YW, Park JH, Lee JE, Shin IC, Koh HC. JNK and p38 MAPK regulate oxidative stress and the inflammatory response in chlorpyrifos-induced apoptosis. Toxicol Lett. 2013 Apr 26;218(3):235–45. doi: 10.1016/j.toxlet.2013.02.003. PMID: 23416140."
287377,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Chlorpyrifos results in increased cleavage of PARP1 protein,,,PMID:34289071|PMID:36252918,https://www.ncbi.nlm.nih.gov/pubmed/34289071|https://www.ncbi.nlm.nih.gov/pubmed/36252918,34289071|36252918,,PMC8634496,4720533|35115828,"Lin JW, Fu SC, Liu JM, Liu SH, Lee KI, Fang KM, Hsu RJ, Huang CF, Liu KM, Chang KC, Su CC, Chen YW. Chlorpyrifos induces neuronal cell death via both oxidative stress and Akt activation downstream-regulated CHOP-triggered apoptotic pathways. Toxicol In Vitro. 2023 Feb;86():105483. doi: 10.1016/j.tiv.2022.105483. PMID: 36252918.|Anderson FL, von Herrmann KM, Young AL, Havrda MC. Bbc3 Loss Enhances Survival and Protein Clearance in Neurons Exposed to the Organophosphate Pesticide Chlorpyrifos. Toxicol Sci. 2021 Sep 28;183(2):378–92. PMID: 34289071; PMCID: PMC8634496."
287378,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Acetylcysteine inhibits the reaction [chlorpyrifos results in increased cleavage of PARP1 protein],,,PMID:22714038,https://www.ncbi.nlm.nih.gov/pubmed/22714038,22714038,,,26921209,"Lee JE, Park JH, Shin IC, Koh HC. Reactive oxygen species regulated mitochondria-mediated apoptosis in PC12 cells exposed to chlorpyrifos. Toxicol Appl Pharmacol. 2012 Sep 01;263(2):148–62. doi: 10.1016/j.taap.2012.06.005. PMID: 22714038."
287379,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased cleavage of PARP1 protein,,,PMID:22714038|PMID:29859868,https://www.ncbi.nlm.nih.gov/pubmed/22714038|https://www.ncbi.nlm.nih.gov/pubmed/29859868,22714038|29859868,,PMC6108448,10122140|26921209,"Singh N, Lawana V, Luo J, Phong P, Abdalla A, Palanisamy B, Rokad D, Sarkar S, Jin H, Anantharam V, Kanthasamy AG, Kanthasamy A. Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: Implications for mitochondria mediated oxidative stress signaling events. Neurobiology of Disease. 2018 Sep;117():82–113. doi: 10.1016/j.nbd.2018.05.019.|Lee JE, Park JH, Shin IC, Koh HC. Reactive oxygen species regulated mitochondria-mediated apoptosis in PC12 cells exposed to chlorpyrifos. Toxicol Appl Pharmacol. 2012 Sep 01;263(2):148–62. doi: 10.1016/j.taap.2012.06.005. PMID: 22714038."
287380,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[hesperidin co-treated with chlorpyrifos] results in increased expression of PARP1 protein|chlorpyrifos results in increased expression of PARP1 mrna|[hesperidin co-treated with chlorpyrifos] results in increased expression of PARP1 mrna|chlorpyrifos results in increased expression of PARP1 protein,,,PMID:33908150,https://www.ncbi.nlm.nih.gov/pubmed/33908150,33908150,,,18316735,"Küçükler S, Çomakli S, Özdemir S, Çaglayan C, Kandemir FM. Hesperidin protects against the chlorpyrifos-induced chronic hepato-renal toxicity in rats associated with oxidative stress, inflammation, apoptosis, autophagy, and up-regulation of <i>PARP-1</i>/<i>VEGF</i>. Environmental Toxicology. 2021 Apr 28;36(8):1600–17. doi: 10.1002/tox.23156."
287381,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),STAT1 protein affects the reaction [chlorpyrifos results in increased cleavage of PARP1 protein],,,PMID:29859868,https://www.ncbi.nlm.nih.gov/pubmed/29859868,29859868,,PMC6108448,10122140,"Singh N, Lawana V, Luo J, Phong P, Abdalla A, Palanisamy B, Rokad D, Sarkar S, Jin H, Anantharam V, Kanthasamy AG, Kanthasamy A. Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: Implications for mitochondria mediated oxidative stress signaling events. Neurobiology of Disease. 2018 Sep;117():82–113. doi: 10.1016/j.nbd.2018.05.019."
395199,2749,IUPHAR/BPS Guide to PHARMACOLOGY,Ciclopirox,11349,ciclopirox,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11349,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,6.8,PMID:18713665,https://www.ncbi.nlm.nih.gov/pubmed/18713665,18713665,,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
285754,2750,Comparative Toxicogenomics Database (CTD),Ciglitazone,C039671,ciglitazone,https://ctdbase.org/detail.go?type=chem&acc=C039671,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ciglitazone promotes the reaction [niflumic acid results in increased cleavage of PARP1 protein]]|benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [niflumic acid promotes the reaction [ciglitazone results in increased cleavage of PARP1 protein]]|ddit3 mutant form inhibits the reaction [niflumic acid promotes the reaction [ciglitazone results in increased cleavage of PARP1 protein]]|ciglitazone results in increased cleavage of PARP1 protein|niflumic acid promotes the reaction [ciglitazone results in increased cleavage of PARP1 protein]|ddit3 mutant form inhibits the reaction [ciglitazone promotes the reaction [niflumic acid results in increased cleavage of PARP1 protein]]|ciglitazone promotes the reaction [niflumic acid results in increased cleavage of PARP1 protein],,,PMID:21067863,https://www.ncbi.nlm.nih.gov/pubmed/21067863,21067863,,,28245364,"Kim BM, Maeng K, Lee KH, Hong SH. Combined treatment with the Cox-2 inhibitor niflumic acid and PPAR? ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells. Cancer Lett. 2011 Jan 28;300(2):134–44. doi: 10.1016/j.canlet.2010.09.014. PMID: 21067863."
285755,2750,Comparative Toxicogenomics Database (CTD),Ciglitazone,C039671,ciglitazone,https://ctdbase.org/detail.go?type=chem&acc=C039671,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ciglitazone results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:15492468,https://www.ncbi.nlm.nih.gov/pubmed/15492468,15492468,,,5766112,"Konturek PC, Kania J, Kukharsky V, Raithel M, Ocker M, Rembiasz K, Hahn EG, Konturek SJ. Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection. J Pharmacol Sci. 2004 Oct;96(2):134–43. doi: 10.1254/jphs.fpj04016x. PMID: 15492468."
412665,2764,Comparative Toxicogenomics Database (CTD),Ciprofloxacin,D002939,Ciprofloxacin,https://ctdbase.org/detail.go?type=chem&acc=D002939,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ciprofloxacin results in increased cleavage of PARP1 protein,,,PMID:10741713,https://www.ncbi.nlm.nih.gov/pubmed/10741713,10741713,,,5689268,"Aranha O, Wood DP, Sarkar FH. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891–900. PMID: 10741713."
416505,2771,Comparative Toxicogenomics Database (CTD),Citalopram,D015283,Citalopram,https://ctdbase.org/detail.go?type=chem&acc=D015283,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Citalopram results in increased cleavage of PARP1 protein,,,PMID:10487422,https://www.ncbi.nlm.nih.gov/pubmed/10487422,10487422,,,21258990,"Xia Z, Bergstrand A, DePierre JW, Nässberger L. The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol. 1999;13(6):338–47. doi: 10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7. PMID: 10487422."
410107,2797,Comparative Toxicogenomics Database (CTD),Clofibric Acid,D002995,Clofibric Acid,https://ctdbase.org/detail.go?type=chem&acc=D002995,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of PARP1 mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,,2360653,"Michel C, Desdouets C, Slaoui M, Isaacs KR, Roberts RA, Boitier E. Diethylnitrosamine initiation does not alter clofibric acid-induced hepatocarcinogenesis in the rat. Toxicol Sci. 2007 Sep;99(1):58–69. doi: 10.1093/toxsci/kfm168. PMID: 17602206."
419563,2801,Comparative Toxicogenomics Database (CTD),Clomipramine,D002997,Clomipramine,https://ctdbase.org/detail.go?type=chem&acc=D002997,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Clomipramine results in increased cleavage of PARP1 protein,,,PMID:10487422,https://www.ncbi.nlm.nih.gov/pubmed/10487422,10487422,,,21258990,"Xia Z, Bergstrand A, DePierre JW, Nässberger L. The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol. 1999;13(6):338–47. doi: 10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7. PMID: 10487422."
307234,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cladribine co-treated with cyclophosphamide co-treated with mitoxantrone] results in decreased expression of PARP1 protein|[cladribine co-treated with cyclophosphamide] results in decreased expression of PARP1 protein,,,PMID:15582267,https://www.ncbi.nlm.nih.gov/pubmed/15582267,15582267,,,24103334,"Rogalinska M, Blonski JZ, Hanausek M, Walaszek Z, Robak T, Kilianska ZM. 2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo. Cancer Detection and Prevention. 2004 Jan;28(6):433–42. doi: 10.1016/j.cdp.2004.08.001."
307235,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cyclophosphamide results in increased cleavage of PARP1 protein,,,PMID:17898787,https://www.ncbi.nlm.nih.gov/pubmed/17898787,17898787,,,20071928,"Wang M, Han XH, Zhang L, Yang J, Qian JF, Shi YK, Kwak LW, Romaguera J, Yi Q. Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo. Leukemia. 2008 Jan;22(1):179–85. doi: 10.1038/sj.leu.2404959. PMID: 17898787."
307236,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased expression of PARP1 protein|chrysin inhibits the reaction [cyclophosphamide results in increased expression of PARP1 protein],,,PMID:37263553,https://www.ncbi.nlm.nih.gov/pubmed/37263553,37263553,,,35714303,"Saleh DO, El-Nasr NMEA, Fayez AM, Ahmed KA, Mohamed RA. Uro-protective role of chrysin against cyclophosphamide-induced hemorrhagic cystitis in rats involving the turning-off NF-?B/P38-MAPK, NO/PARP-1 and STAT-3 signaling cascades. Chem Biol Interact. 2023 Sep 01;382():110585. doi: 10.1016/j.cbi.2023.110585. PMID: 37263553."
307237,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cyclophosphamide results in decreased expression of PARP1 mRNA,,,PMID:11906922,https://www.ncbi.nlm.nih.gov/pubmed/11906922,11906922,,,13876601,"Aguilar-Mahecha A, Hales BF, Robaire B. Chronic cyclophosphamide treatment alters the expression of stress response genes in rat male germ cells. Biol Reprod. 2002 Apr;66(4):1024–32. doi: 10.1095/biolreprod66.4.1024. PMID: 11906922."
307408,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased cleavage of PARP1 protein,,,PMID:11723234,https://www.ncbi.nlm.nih.gov/pubmed/11723234,11723234,,,32771093,"Schwartz PS, Waxman DJ. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. Mol Pharmacol. 2001 Dec;60(6):1268–79. doi: 10.1124/mol.60.6.1268. PMID: 11723234."
307409,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased expression of PARP1 mRNA,,,PMID:11599041,https://www.ncbi.nlm.nih.gov/pubmed/11599041,11599041,,,29408208,"Aguilar-Mahecha A, Hales BF, Robaire B. Acute cyclophosphamide exposure has germ cell specific effects on the expression of stress response genes during rat spermatogenesis. Molecular Reproduction Devel. 2001 Sep 28;60(3):302–11. doi: 10.1002/mrd.1092."
346974,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cypermethrin inhibits the reaction [docosahexaenoic acids results in increased degradation of PARP1 protein],,,PMID:11341974,https://www.ncbi.nlm.nih.gov/pubmed/11341974,11341974,,,14541089,"Siddiqui RA, Jenski LJ, Neff K, Harvey K, Kovacs RJ, Stillwell W. Docosahexaenoic acid induces apoptosis in Jurkat cells by a protein phosphatase-mediated process. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2001 Jan;1499(3):265–75. doi: 10.1016/s0167-4889(00)00128-2."
346975,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cypermethrin results in decreased expression of PARP1 mRNA,,,PMID:27704156,https://www.ncbi.nlm.nih.gov/pubmed/27704156,27704156,,,29687866,2016; 91(5):2151-2164
225361,2973,Comparative Toxicogenomics Database (CTD),Deferoxamine,D003676,Deferoxamine,https://ctdbase.org/detail.go?type=chem&acc=D003676,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indomethacin promotes the reaction [deferoxamine results in increased cleavage of PARP1 protein]|deferoxamine results in increased cleavage of PARP1 protein|sulindac promotes the reaction [deferoxamine results in increased cleavage of PARP1 protein],,,PMID:21882223,https://www.ncbi.nlm.nih.gov/pubmed/21882223,21882223,,,7282905,"Liu C, Tsai AL, Chen YC, Fan SC, Huang CH, Wu CC, Chang CH. Facilitation of human osteoblast apoptosis by sulindac and indomethacin under hypoxic injury. J Cell Biochem. 2012 Jan;113(1):148–55. doi: 10.1002/jcb.23338. PMID: 21882223."
409555,3025,Comparative Toxicogenomics Database (CTD),Dibucaine,D003992,Dibucaine,https://ctdbase.org/detail.go?type=chem&acc=D003992,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Dibucaine inhibits the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:25947082,https://www.ncbi.nlm.nih.gov/pubmed/25947082,25947082,,,26976018,2015; 53(4):2169-2188
407107,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dibutyl phthalate results in decreased expression of PARP1 mRNA,,,PMID:33120273,https://www.ncbi.nlm.nih.gov/pubmed/33120273,33120273,,,6096946,"Lu C, Luo J, Liu Y, Yang X. The oxidative stress responses caused by phthalate acid esters increases mRNA abundance of base excision repair (BER) genes in vivo and in vitro. Ecotoxicol Environ Saf. 2021 Jan 15;208():111525. doi: 10.1016/j.ecoenv.2020.111525. PMID: 33120273."
407108,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PARP1 mrna|dibutyl phthalate results in increased expression of PARP1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,PMC3061485,31585436,"Johnson KJ, McDowell EN, Viereck MP, Xia JQ. Species-specific dibutyl phthalate fetal testis endocrine disruption correlates with inhibition of SREBP2-dependent gene expression pathways. Toxicol Sci. 2011 Apr;120(2):460–74. PMID: 21266533; PMCID: PMC3061485."
387306,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Diclofenac affects the expression of PARP1 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,,1835374,"Fredriksson L, Wink S, Herpers B, Benedetti G, Hadi M, de Bont H, Groothuis G, Luijten M, Danen E, de Graauw M, Meerman J, van de Water B. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFa-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144–59. doi: 10.1093/toxsci/kfu072. PMID: 24752500."
233742,3035,Comparative Toxicogenomics Database (CTD),"P,P'-dde",D003633,Dichlorodiphenyl Dichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D003633,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dichlorodiphenyl dichloroethylene results in increased activity of PARP1 protein,,,PMID:19545618,https://www.ncbi.nlm.nih.gov/pubmed/19545618,19545618,,,18054578,"Alegría-Torres JA, Díaz-Barriga F, Gandolfi AJ, Pérez-Maldonado IN. Mechanisms of p,p'-DDE-induced apoptosis in human peripheral blood mononuclear cells. Toxicol In Vitro. 2009 Sep;23(6):1000–6. doi: 10.1016/j.tiv.2009.06.021. PMID: 19545618."
477408,3039,Comparative Toxicogenomics Database (CTD),Dichlorvos,D004006,Dichlorvos,https://ctdbase.org/detail.go?type=chem&acc=D004006,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Dichlorvos results in increased cleavage of PARP1 protein|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [dichlorvos results in increased activity of PARP1 protein]|dichlorvos results in increased activity of PARP1 protein",,,PMID:24231740,https://www.ncbi.nlm.nih.gov/pubmed/24231740,24231740,,,14773724,"Wani WY, Sunkaria A, Sharma DR, Kandimalla RJ, Kaushal A, Gerace E, Chiarugi A, Gill KD: Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation. Neuroscience. 2014 Jan 31;258:1-15. doi: 10.1016/j.neuroscience.2013.11.004. Epub 2013 Nov 11."
368209,3053,Comparative Toxicogenomics Database (CTD),Pentetic Acid,D004369,Pentetic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004369,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pentetic acid inhibits the reaction [pyrithione zinc results in increased activity of PARP1 protein],,,PMID:21424779,https://www.ncbi.nlm.nih.gov/pubmed/21424779,21424779,,PMC4169675,28916913,2011; 24(5):875-890
14444,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[3,3'-diindolylmethane co-treated with paclitaxel] results in increased cleavage of and results in increased activity of PARP1 protein",,,PMID:16580691,https://www.ncbi.nlm.nih.gov/pubmed/16580691,16580691,,,28817172,"McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. J Surg Res. 2006 May 15;132(2):208–13. doi: 10.1016/j.jss.2006.02.008. PMID: 16580691."
373356,3101,Comparative Toxicogenomics Database (CTD),Diphenyleneiodonium,C007517,diphenyleneiodonium,https://ctdbase.org/detail.go?type=chem&acc=C007517,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Diphenyleneiodonium inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein],,,PMID:14687664,https://www.ncbi.nlm.nih.gov/pubmed/14687664,14687664,,,20010454,"Rockwell P, Martinez J, Papa L, Gomes E. Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell Signal. 2004 Mar;16(3):343–53. doi: 10.1016/j.cellsig.2003.08.006. PMID: 14687664."
373357,3101,Comparative Toxicogenomics Database (CTD),Diphenyleneiodonium,C007517,diphenyleneiodonium,https://ctdbase.org/detail.go?type=chem&acc=C007517,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Diphenyleneiodonium inhibits the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:25947082,https://www.ncbi.nlm.nih.gov/pubmed/25947082,25947082,,,26976018,2015; 53(4):2169-2188
468908,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[copper co-treated with disulfiram] results in increased cleavage of PARP1 protein,,,PMID:23033007,https://www.ncbi.nlm.nih.gov/pubmed/23033007,23033007,,PMC3493777,13406869,"Liu P, Brown S, Goktug T, Channathodiyil P, Kannappan V, Hugnot J, Guichet P, Bian X, Armesilla AL, Darling JL, Wang W. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. British Journal of Cancer. 2012 Oct 02;107(9):1488–97. doi: 10.1038/bjc.2012.442."
468909,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[disulfiram binds to copper] which results in increased cleavage of PARP1 protein,,,PMID:17079463|PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/17079463|https://www.ncbi.nlm.nih.gov/pubmed/24690739,17079463|24690739,,PMC3972204,23413235|30982098,"Cheriyan VT, Wang Y, Muthu M, Jamal S, Chen D, Yang H, Polin LA, Tarca AL, Pass HI, Dou QP, Sharma S, Wali A, Rishi AK. Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis. PLoS ONE. 2014 Apr 01;9(4):e93711. doi: 10.1371/journal.pone.0093711.|2006; 66(21):10425-10433"
468910,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[disulfiram co-treated with cupric chloride] results in increased cleavage of PARP1 protein,,,PMID:19789329,https://www.ncbi.nlm.nih.gov/pubmed/19789329,19789329,,,28875025,"Iljin K, Ketola K, Vainio P, Halonen P, Kohonen P, Fey V, Grafström RC, Perälä M, Kallioniemi O. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res. 2009 Oct 01;15(19):6070–8. doi: 10.1158/1078-0432.ccr-09-1035. PMID: 19789329."
469109,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Disulfiram promotes the reaction [carmustine results in increased cleavage of PARP1 protein],,,PMID:24193513,https://www.ncbi.nlm.nih.gov/pubmed/24193513,24193513,,PMC3941740,18806017,"Paranjpe A, Zhang R, Ali-Osman F, Bobustuc GC, Srivenugopal KS. Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage. Carcinogenesis. 2013 Nov 05;35(3):692–702. doi: 10.1093/carcin/bgt366."
469110,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Disulfiram results in increased cleavage of PARP1 protein,,,PMID:17079463|PMID:24193513|PMID:34182011,https://www.ncbi.nlm.nih.gov/pubmed/17079463|https://www.ncbi.nlm.nih.gov/pubmed/24193513|https://www.ncbi.nlm.nih.gov/pubmed/34182011,17079463|24193513|34182011,,PMC3941740,1981487|18806017|23413235,"Nasrollahzadeh A, Momeny M, Fasehee H, Yaghmaie M, Bashash D, Hassani S, Mousavi SA, Ghaffari SH. Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2021 Sep;1868(10):119087. doi: 10.1016/j.bbamcr.2021.119087.|Paranjpe A, Zhang R, Ali-Osman F, Bobustuc GC, Srivenugopal KS. Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage. Carcinogenesis. 2013 Nov 05;35(3):692–702. doi: 10.1093/carcin/bgt366.|2006; 66(21):10425-10433"
469111,3117,Comparative Toxicogenomics Database (CTD),Disulfiram,D004221,Disulfiram,https://ctdbase.org/detail.go?type=chem&acc=D004221,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[disulfiram binds to copper] which results in increased cleavage of PARP1 protein,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,PMC3972204,30982098,"Cheriyan VT, Wang Y, Muthu M, Jamal S, Chen D, Yang H, Polin LA, Tarca AL, Pass HI, Dou QP, Sharma S, Wali A, Rishi AK. Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis. PLoS ONE. 2014 Apr 01;9(4):e93711. doi: 10.1371/journal.pone.0093711."
333969,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of PARP1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,PMC1762324,24117346,"Arce C, Pérez-Plasencia C, González-Fierro A, de la Cruz-Hernández E, Revilla-Vázquez A, Chávez-Blanco A, Trejo-Becerril C, Pérez-Cárdenas E, Taja-Chayeb L, Bargallo E, Villarreal P, Ramírez T, Vela T, Candelaria M, Camargo MF, Robles E, Dueñas-González A. A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer. PLoS ONE. 2006 Dec 20;1(1):e98. doi: 10.1371/journal.pone.0000098."
333970,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Valproic acid results in increased cleavage of PARP1 protein,,,PMID:24913804,https://www.ncbi.nlm.nih.gov/pubmed/24913804,24913804,,PMC4833099,8726557,"Lamparter C, Winn LM. Tissue-specific effects of valproic acid on DNA repair genes and apoptosis in postimplantation mouse embryos. Toxicol Sci. 2014 Sep;141(1):59–67. PMID: 24913804; PMCID: PMC4833099."
333971,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Valproic acid results in decreased cleavage of PARP1 protein|vitamin U inhibits the reaction [valproic acid results in decreased cleavage of PARP1 protein],,,PMID:34420476,https://www.ncbi.nlm.nih.gov/pubmed/34420476,34420476,,,21714550,"Celik E, Tunali S, Gezginci-Oktayoglu S, Bolkent S, Can A, Yanardag R. Vitamin U prevents valproic acid-induced liver injury through supporting enzymatic antioxidant system and increasing hepatocyte proliferation triggered by inflammation and apoptosis. Toxicology Mechanisms and Methods. 2021 Aug 22;31(8):600–8. doi: 10.1080/15376516.2021.1943089."
435785,3213,Comparative Toxicogenomics Database (CTD),Ellipticine,C034192,ellipticine,https://ctdbase.org/detail.go?type=chem&acc=C034192,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ellipticine results in increased cleavage of PARP1 protein,,,PMID:21843585,https://www.ncbi.nlm.nih.gov/pubmed/21843585,21843585,,,6585662,"Kim JY, Lee SG, Chung JY, Kim YJ, Park JE, Koh H, Han MS, Park YC, Yoo YH, Kim JM. Ellipticine induces apoptosis in human endometrial cancer cells: the potential involvement of reactive oxygen species and mitogen-activated protein kinases. Toxicology. 2011 Nov 18;289(2-3):91–102. doi: 10.1016/j.tox.2011.07.014. PMID: 21843585."
436798,3218,Comparative Toxicogenomics Database (CTD),Embelin,C010945,embelin,https://ctdbase.org/detail.go?type=chem&acc=C010945,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [embelin results in increased cleavage of PARP1 protein],,,PMID:28722333,https://www.ncbi.nlm.nih.gov/pubmed/28722333,28722333,,PMC6472881,20929699,"Lee Y, Park B, Park H, Yu S, Kang H, Kim I. <scp>XIAP</scp> inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells. Environmental Toxicology. 2017 Jul 19;32(11):2371–8. doi: 10.1002/tox.22450."
436799,3218,Comparative Toxicogenomics Database (CTD),Embelin,C010945,embelin,https://ctdbase.org/detail.go?type=chem&acc=C010945,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Embelin results in increased cleavage of PARP1 protein,,,PMID:24694877|PMID:28722333,https://www.ncbi.nlm.nih.gov/pubmed/24694877|https://www.ncbi.nlm.nih.gov/pubmed/28722333,24694877|28722333,,PMC3973629|PMC6472881,20929699|30985956,"Lee Y, Park B, Park H, Yu S, Kang H, Kim I. <scp>XIAP</scp> inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells. Environmental Toxicology. 2017 Jul 19;32(11):2371–8. doi: 10.1002/tox.22450.|Huang M, Tang S, Upadhyay G, Marsh JL, Jackman CP, Shankar S, Srivastava RK. Embelin Suppresses Growth of Human Pancreatic Cancer Xenografts, and Pancreatic Cancer Cells Isolated from KrasG12D Mice by Inhibiting Akt and Sonic Hedgehog Pathways. PLoS ONE. 2014 Apr 02;9(4):e92161. doi: 10.1371/journal.pone.0092161."
443106,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [emodin results in increased cleavage of PARP1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [emodin results in increased cleavage of PARP1 protein]|[u 0126 co-treated with emodin] results in increased cleavage of PARP1 protein|sb 203580 inhibits the reaction [emodin results in increased cleavage of PARP1 protein],,,PMID:27032576,https://www.ncbi.nlm.nih.gov/pubmed/27032576,27032576,,,20899140,"Cui Y, Lu P, Song G, Liu Q, Zhu D, Liu X. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis. Food Chem Toxicol. 2016 Jun;92():26–37. doi: 10.1016/j.fct.2016.03.013. PMID: 27032576."
443107,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Emodin results in increased activity of PARP1 protein,,,PMID:23848338,https://www.ncbi.nlm.nih.gov/pubmed/23848338,23848338,,PMC3799595,20857720,"Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Hui KM, Sethi G. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of <scp>STAT3</scp>. British J Pharmacology. 2013 Oct;170(4):807–21. doi: 10.1111/bph.12302."
443108,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Emodin results in increased cleavage of PARP1 protein,,,PMID:27032576|PMID:34492313|PMID:36893906,https://www.ncbi.nlm.nih.gov/pubmed/27032576|https://www.ncbi.nlm.nih.gov/pubmed/34492313|https://www.ncbi.nlm.nih.gov/pubmed/36893906,27032576|34492313|36893906,,,11566279|20899140|35039273,"Das A, Prajapati A, Karna A, Sharma HK, Uppal S, Lather V, Pandita D, Agarwal P. Structure-based virtual screening of chemical libraries as potential MELK inhibitors and their therapeutic evaluation against breast cancer. Chem Biol Interact. 2023 May 01;376():110443. doi: 10.1016/j.cbi.2023.110443. PMID: 36893906.|Zhang T, He X, Sun L, Wang D, Zhang S, Mao J, Zhang F. Insight into the practical models for prediciting the essential role of the cytochrome P450-mediated biotransformation in emodin-associated hepatotoxicity. Toxicology. 2021 Oct;462():152930. doi: 10.1016/j.tox.2021.152930. PMID: 34492313.|Cui Y, Lu P, Song G, Liu Q, Zhu D, Liu X. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis. Food Chem Toxicol. 2016 Jun;92():26–37. doi: 10.1016/j.fct.2016.03.013. PMID: 27032576."
353438,3278,Comparative Toxicogenomics Database (CTD),Ethacrynic Acid,D004976,Ethacrynic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004976,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein]|mcl1 mutant form promotes the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein]|[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein]|gstp1 mutant form promotes the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein],,,PMID:23082001,https://www.ncbi.nlm.nih.gov/pubmed/23082001,23082001,,PMC3525753,30952329,"Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y. Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1. 2012 Dec 15;18(24):6690–701. doi: 10.1158/1078-0432.ccr-12-0770."
455827,3314,Comparative Toxicogenomics Database (CTD),Eugenol,D005054,Eugenol,https://ctdbase.org/detail.go?type=chem&acc=D005054,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Eugenol affects the reaction [methylnitronitrosoguanidine affects the cleavage of PARP1 protein],,,PMID:20434464,https://www.ncbi.nlm.nih.gov/pubmed/20434464,20434464,,,5180562,"Manikandan P, Murugan RS, Priyadarsini RV, Vinothini G, Nagini S. Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. Life Sci. 2010 Jun 19;86(25-26):936–41. doi: 10.1016/j.lfs.2010.04.010. PMID: 20434464."
500220,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Fenvalerate results in increased cleavage of PARP1 protein|cat protein inhibits the reaction [fenvalerate results in increased cleavage of PARP1 protein],,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,,22319122,"Qiu LL, Wang C, Yao S, Li N, Hu Y, Yu Y, Xia R, Zhu J, Ji M, Zhang Z, Wang SL. Fenvalerate induces oxidative hepatic lesions through an overload of intracellular calcium triggered by the ERK/IKK/NF-?B pathway. FASEB J. 2019 Feb;33(2):2782–95. doi: 10.1096/fj.201801289r. PMID: 30307764."
532686,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7955,Danio rerio (zebrafish),Fipronil results in decreased expression of PARP1 mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,,12912048,"Eadie A, Vasquez IC, Liang X, Wang X, Souders CL, El Chehouri J, Hoskote R, Feswick A, Cowie AM, Loughery JR, Martyniuk CJ. Residual molecular and behavioral effects of the phenylpyrazole pesticide fipronil in larval zebrafish (Danio rerio) following a pulse embryonic exposure. Comparative Biochemistry and Physiology Part D: Genomics and Proteomics. 2020 Dec;36():100743. doi: 10.1016/j.cbd.2020.100743."
402078,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein]|fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:19116755,https://www.ncbi.nlm.nih.gov/pubmed/19116755,19116755,,,27541600,2008; 16(3):761-771
402249,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),S100A11 mutant form promotes the reaction [fluorouracil results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to fluorouracil] which results in increased cleavage of PARP1 protein]|[s100a11 mutant form results in increased susceptibility to fluorouracil] which results in increased cleavage of PARP1 protein,,,PMID:25940438,https://www.ncbi.nlm.nih.gov/pubmed/25940438,25940438,,PMC4494929,26969758,"Zagryazhskaya A, Surova O, Akbar NS, Allavena G, Gyuraszova K, Zborovskaya IB, Tchevkina EM, Zhivotovsky B. Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11. Oncotarget. 2015 May 20;6(14):12156–73. PMID: 25940438; PMCID: PMC4494929."
402250,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Celecoxib inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein],,,PMID:17461495,https://www.ncbi.nlm.nih.gov/pubmed/17461495,17461495,,PMC4146971,7889868,"Lim YJ, Rhee JC, Bae YM, Chun WJ. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. World J Gastroenterol. 2007 Apr 07;13(13):1947–52. PMID: 17461495; PMCID: PMC4146971."
402251,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),IGF1 protein inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein]|mt2a protein affects the reaction [EGF protein inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein]]|egf protein inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein]|il6 protein inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein]|tgfb1 protein inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein],,,PMID:28507149,https://www.ncbi.nlm.nih.gov/pubmed/28507149,28507149,,PMC5465913,6013626,"Shin CH, Lee MG, Han J, Jeong SI, Ryu BK, Chi SG. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683–8. PMID: 28507149; PMCID: PMC5465913."
402252,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fluorouracil affects the expression of PARP1 mRNA,,,PMID:34151400,https://www.ncbi.nlm.nih.gov/pubmed/34151400,34151400,,PMC8298376,17657053,2021; 95(8):2691-2718
402253,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[fluorouracil co-treated with genistein] results in increased cleavage of PARP1 protein,,,PMID:15896711,https://www.ncbi.nlm.nih.gov/pubmed/15896711,15896711,,,27474486,"Hwang J, Ha J, Park OJ. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochemical and Biophysical Research Communications. 2005 Jul;332(2):433–40. doi: 10.1016/j.bbrc.2005.04.143."
402254,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fluorouracil promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]|fluorouracil promotes the reaction [gambogic acid results in decreased expression of PARP1 mrna],,,PMID:19084572,https://www.ncbi.nlm.nih.gov/pubmed/19084572,19084572,,,7945427,"Wang J, Liu W, Zhao Q, Qi Q, Lu N, Yang Y, Nei FF, Rong JJ, You QD, Guo QL. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. Toxicology. 2009 Feb 04;256(1-2):135–40. doi: 10.1016/j.tox.2008.11.014. PMID: 19084572."
402255,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fluorouracil results in increased cleavage of PARP1 protein,,,PMID:15996812|PMID:16525653|PMID:17461495|PMID:17982676|PMID:19816940|PMID:21036698|PMID:24095863|PMID:25940438|PMID:26544897|PMID:28507149,https://www.ncbi.nlm.nih.gov/pubmed/15996812|https://www.ncbi.nlm.nih.gov/pubmed/16525653|https://www.ncbi.nlm.nih.gov/pubmed/17461495|https://www.ncbi.nlm.nih.gov/pubmed/17982676|https://www.ncbi.nlm.nih.gov/pubmed/19816940|https://www.ncbi.nlm.nih.gov/pubmed/21036698|https://www.ncbi.nlm.nih.gov/pubmed/24095863|https://www.ncbi.nlm.nih.gov/pubmed/25940438|https://www.ncbi.nlm.nih.gov/pubmed/26544897|https://www.ncbi.nlm.nih.gov/pubmed/28507149,15996812|16525653|17461495|17982676|19816940|21036698|24095863|25940438|26544897|28507149,,PMC4146971|PMC4494929|PMC4791259|PMC5465913,2345625|2487008|6013626|7889868|11334250|21554637|26969758|29509865|30903283|32858394,"Shin CH, Lee MG, Han J, Jeong SI, Ryu BK, Chi SG. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683–8. PMID: 28507149; PMCID: PMC5465913.|Akpinar B, Bracht EV, Reijnders D, Safarikova B, Jelinkova I, Grandien A, Vaculova AH, Zhivotovsky B, Olsson M. 5-Fluorouracil-induced RNA stress engages a TRAIL-DISC-dependent apoptosis axis facilitated by p53. Oncotarget. 2015 Oct 24;6(41):43679–97. doi: 10.18632/oncotarget.6030.|Zagryazhskaya A, Surova O, Akbar NS, Allavena G, Gyuraszova K, Zborovskaya IB, Tchevkina EM, Zhivotovsky B. Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11. Oncotarget. 2015 May 20;6(14):12156–73. PMID: 25940438; PMCID: PMC4494929.|Dinicola S, Morini V, Coluccia P, Proietti S, D'Anselmi F, Pasqualato A, Masiello MG, Palombo A, De Toma G, Bizzarri M, Cucina A. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs. Toxicol In Vitro. 2013 Dec;27(8):2256–63. doi: 10.1016/j.tiv.2013.09.020. PMID: 24095863.|Aresvik DM, Pettersen RD, Abrahamsen TG, Wright MS. 5-fluorouracil-induced death of Jurkat T-cells--a role for caspases and MCL-1. Anticancer Res. 2010 Oct;30(10):3879–87. PMID: 21036698.|Bijnsdorp IV, Peters GJ, Temmink OH, Fukushima M, Kruyt FA: Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells. Int J Cancer. 2010 May 15;126(10):2457-68. doi: 10.1002/ijc.24943.|Adamsen BL, Kravik KL, Clausen OP, De Angelis PM. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Int J Oncol. 2007 Dec;31(6):1491–500. PMID: 17982676.|Lim YJ, Rhee JC, Bae YM, Chun WJ. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. World J Gastroenterol. 2007 Apr 07;13(13):1947–52. PMID: 17461495; PMCID: PMC4146971.|Singh S, Chhipa RR, Vijayakumar MV, Bhat MK. DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells. Cancer Lett. 2006 May 18;236(2):213–21. doi: 10.1016/j.canlet.2005.05.024. PMID: 15996812.|Fauvet R, Dufournet Etienne C, Poncelet C, Bringuier AF, Feldmann G, Daraï E. Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3. Oncol Rep. 2006 Apr;15(4):743–8. PMID: 16525653."
402256,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fluorouracil results in increased expression of PARP1,,,PMID:11300326,https://www.ncbi.nlm.nih.gov/pubmed/11300326,11300326,,,18567364,"Backus HH, Dukers DF, van Groeningen CJ, Vos W, Bloemena E, Wouters D, van Riel JM, Smid K, Giaccone G, Pinedo HM, Peters GJ. 5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients. Ann Oncol. 2001 Feb;12(2):209–16. doi: 10.1023/a:1008331525368. PMID: 11300326."
402449,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SM-1 compound promotes the reaction [fluorouracil results in increased expression of PARP1 mrna]|[sm-1 compound co-treated with fluorouracil] results in increased expression of PARP1 protein|fluorouracil results in increased expression of PARP1 mRNA,,,PMID:28599477,https://www.ncbi.nlm.nih.gov/pubmed/28599477,28599477,,PMC5452999,5317112,"Wang Y, Yuan S, Li L, Yang D, Xu C, Wang S, Zhang D. Novel proapoptotic agent SM-1 enhances the inhibitory effect of 5-fluorouracil on colorectal cancer cells in vitro and in vivo. Oncol Lett. 2017 Jun;13(6):4762–8. PMID: 28599477; PMCID: PMC5452999."
402450,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nicotine inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein],,,PMID:24095863,https://www.ncbi.nlm.nih.gov/pubmed/24095863,24095863,,,2487008,"Dinicola S, Morini V, Coluccia P, Proietti S, D'Anselmi F, Pasqualato A, Masiello MG, Palombo A, De Toma G, Bizzarri M, Cucina A. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs. Toxicol In Vitro. 2013 Dec;27(8):2256–63. doi: 10.1016/j.tiv.2013.09.020. PMID: 24095863."
402451,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TNFRSF10B mutant form inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein],,,PMID:26544897,https://www.ncbi.nlm.nih.gov/pubmed/26544897,26544897,,PMC4791259,21554637,"Akpinar B, Bracht EV, Reijnders D, Safarikova B, Jelinkova I, Grandien A, Vaculova AH, Zhivotovsky B, Olsson M. 5-Fluorouracil-induced RNA stress engages a TRAIL-DISC-dependent apoptosis axis facilitated by p53. Oncotarget. 2015 Oct 24;6(41):43679–97. doi: 10.18632/oncotarget.6030."
402452,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TP53 protein promotes the reaction [fluorouracil results in increased cleavage of PARP1 protein],,,PMID:17982676,https://www.ncbi.nlm.nih.gov/pubmed/17982676,17982676,,,29509865,"Adamsen BL, Kravik KL, Clausen OP, De Angelis PM. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Int J Oncol. 2007 Dec;31(6):1491–500. PMID: 17982676."
402453,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Fluorouracil results in increased cleavage of PARP1 protein,,,PMID:32270916,https://www.ncbi.nlm.nih.gov/pubmed/32270916,32270916,,,28437556,"Cheng ZY, Chueh FS, Peng SF, Lin CH, Kuo CL, Huang WW, Chen PY, Way TD, Chung JG. Combinational treatment of 5-fluorouracil and casticin induces apoptosis in mouse leukemia WEHI-3 cells in vitro. Environ Toxicol. 2020 Sep;35(9):911–21. doi: 10.1002/tox.22927. PMID: 32270916."
399734,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of PARP1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,,25628430,"Laifenfeld D, Qiu L, Swiss R, Park J, Macoritto M, Will Y, Younis HS, Lawton M. Utilization of Causal Reasoning of Hepatic Gene Expression in Rats to Identify Molecular Pathways of Idiosyncratic Drug-Induced Liver Injury. 2013 Oct 17;137(1):234–48. doi: 10.1093/toxsci/kft232."
546860,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased activity of PARP1 protein|acetylcysteine inhibits the reaction [gentamicins results in increased activity of PARP1 protein],,,PMID:11470263,https://www.ncbi.nlm.nih.gov/pubmed/11470263,11470263,,,26728765,"Mazzon E, Britti D, De Sarro A, Caputi AP, Cuzzocrea S. Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Pharmacol. 2001 Jul 13;424(1):75–83. doi: 10.1016/s0014-2999(01)01130-x. PMID: 11470263."
546861,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of PARP1 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,,5213593,"Com E, Boitier E, Marchandeau JP, Brandenburg A, Schroeder S, Hoffmann D, Mally A, Gautier JC. Integrated transcriptomic and proteomic evaluation of gentamicin nephrotoxicity in rats. Toxicol Appl Pharmacol. 2012 Jan 01;258(1):124–33. doi: 10.1016/j.taap.2011.10.015. PMID: 22061828."
356908,3496,Comparative Toxicogenomics Database (CTD),Glyphosate,D000097797,Glyphosate,https://ctdbase.org/detail.go?type=chem&acc=D000097797,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Glyphosate results in decreased expression of PARP1 mRNA,,,PMID:31295307,https://www.ncbi.nlm.nih.gov/pubmed/31295307,31295307,,PMC6622539,8844367,"Stur E, Aristizabal-Pachon AF, Peronni KC, Agostini LP, Waigel S, Chariker J, Miller DM, Thomas SD, Rezzoug F, Detogni RS, Reis RSD, Silva Junior WA, Louro ID. Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines. PLoS ONE. 2019 Jul 11;14(7):e0219610. doi: 10.1371/journal.pone.0219610."
356909,3496,Comparative Toxicogenomics Database (CTD),Glyphosate,D000097797,Glyphosate,https://ctdbase.org/detail.go?type=chem&acc=D000097797,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Glyphosate results in increased cleavage of PARP1 protein|xaf1 protein affects the reaction [glyphosate results in increased cleavage of PARP1 protein],,,PMID:29908847,https://www.ncbi.nlm.nih.gov/pubmed/29908847,29908847,,,12858961,"Jiang X, Zhang N, Yin L, Zhang WL, Han F, Liu WB, Chen HQ, Cao J, Liu JY. A commercial Roundup® formulation induced male germ cell apoptosis by promoting the expression of XAF1 in adult mice. Toxicol Lett. 2018 Oct 15;296():163–72. doi: 10.1016/j.toxlet.2018.06.1067. PMID: 29908847."
398199,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Go 6976 inhibits the reaction [[cholix toxin, vibrio cholerae co-treated with TNF protein] results in increased cleavage of PARP1 protein]",,,PMID:28087840,https://www.ncbi.nlm.nih.gov/pubmed/28087840,28087840,,PMC5837519,14162527,"Ogura K, Terasaki Y, Miyoshi-Akiyama T, Terasaki M, Moss J, Noda M, Yahiro K. Vibrio cholerae Cholix Toxin-Induced HepG2 Cell Death is Enhanced by Tumor Necrosis Factor-Alpha Through ROS and Intracellular Signal-Regulated Kinases. Toxicol Sci. 2017 Apr 01;156(2):455–68. PMID: 28087840; PMCID: PMC5837519."
399522,3503,Comparative Toxicogenomics Database (CTD),Gossypol,D006072,Gossypol,https://ctdbase.org/detail.go?type=chem&acc=D006072,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[gossypol co-treated with epirubicin] results in increased cleavage of PARP1 protein,,,PMID:35872041,https://www.ncbi.nlm.nih.gov/pubmed/35872041,35872041,,,35415475,"Jiang W, Wang W, Sun L, Xiao Y, Ma T, Li B, Yan X, Wu Y, Li H, Lian J, He F. (-)-Gossypol enhances the anticancer activity of epirubicin via downregulating survivin in hepatocellular carcinoma. Chem Biol Interact. 2022 Sep 01;364():110060. doi: 10.1016/j.cbi.2022.110060. PMID: 35872041."
539620,3549,Comparative Toxicogenomics Database (CTD),Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate,C456800,ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate,https://ctdbase.org/detail.go?type=chem&acc=C456800,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[alvocidib co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased cleavage of PARP1 protein,,,PMID:15634644,https://www.ncbi.nlm.nih.gov/pubmed/15634644,15634644,,,3032332,"Pei X, Dai Y, Grant S. The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH2-terminal kinase–dependent mechanism. 2004 Dec 01;3(12):1513–24. doi: 10.1158/1535-7163.1513.3.12."
477512,3637,Comparative Toxicogenomics Database (CTD),Hydralazine,D006830,Hydralazine,https://ctdbase.org/detail.go?type=chem&acc=D006830,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of PARP1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,PMC1762324,24117346,"Arce C, Pérez-Plasencia C, González-Fierro A, de la Cruz-Hernández E, Revilla-Vázquez A, Chávez-Blanco A, Trejo-Becerril C, Pérez-Cárdenas E, Taja-Chayeb L, Bargallo E, Villarreal P, Ramírez T, Vela T, Candelaria M, Camargo MF, Robles E, Dueñas-González A. A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer. PLoS ONE. 2006 Dec 20;1(1):e98. doi: 10.1371/journal.pone.0000098."
529009,3652,Comparative Toxicogenomics Database (CTD),Hydroxychloroquine,D006886,Hydroxychloroquine,https://ctdbase.org/detail.go?type=chem&acc=D006886,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydroxychloroquine inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein],,,PMID:36843289,https://www.ncbi.nlm.nih.gov/pubmed/36843289,36843289,,,34977749,"Hou T, Wang Y, Dan W, Wei Y, Liu B, Que T, Lei Y, Yu B, Zeng J, Fan Y, Li L. ß-Ionone represses renal cell carcinoma progression through activating LKB1/AMPK-triggered autophagy. J Biochem Mol Toxicol. 2023 Jun;37(6):e23331. doi: 10.1002/jbt.23331. PMID: 36843289."
516317,3696,Comparative Toxicogenomics Database (CTD),Imipramine,D007099,Imipramine,https://ctdbase.org/detail.go?type=chem&acc=D007099,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Imipramine results in increased cleavage of PARP1 protein,,,PMID:10487422,https://www.ncbi.nlm.nih.gov/pubmed/10487422,10487422,,,21258990,"Xia Z, Bergstrand A, DePierre JW, Nässberger L. The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol. 1999;13(6):338–47. doi: 10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7. PMID: 10487422."
493838,3712,Comparative Toxicogenomics Database (CTD),Indole-3-Carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [indole-3-carbinol results in increased cleavage of PARP1 protein]|indole-3-carbinol results in increased cleavage of PARP1 protein,,,PMID:33118390,https://www.ncbi.nlm.nih.gov/pubmed/33118390,33118390,,,6095252,"Lim HM, Park SH, Nam MJ. Induction of apoptosis in indole-3-carbinol-treated lung cancer H1299 cells via ROS level elevation. Hum Exp Toxicol. 2021 May;40(5):812–25. doi: 10.1177/0960327120969968. PMID: 33118390."
493839,3712,Comparative Toxicogenomics Database (CTD),Indole-3-Carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indole-3-carbinol promotes the reaction [TNF protein results in increased cleavage of PARP1 protein],,,PMID:15811958,https://www.ncbi.nlm.nih.gov/pubmed/15811958,15811958,,PMC1895177,300959,"Takada Y, Andreeff M, Aggarwal BB. Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood. 2005 Jul 15;106(2):641–9. PMID: 15811958; PMCID: PMC1895177."
493840,3712,Comparative Toxicogenomics Database (CTD),Indole-3-Carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indole-3-carbinol results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:29992829|PMID:34085558,https://www.ncbi.nlm.nih.gov/pubmed/29992829|https://www.ncbi.nlm.nih.gov/pubmed/34085558,29992829|34085558,,,7437059|25816670,"Lee JY, Lim HM, Lee CM, Park SH, Nam MJ. Indole-3-carbinol inhibits the proliferation of colorectal carcinoma LoVo cells through activation of the apoptotic signaling pathway. Hum Exp Toxicol. 2021 Dec;40(12):2099–112. doi: 10.1177/09603271211021475. PMID: 34085558.|Lee CM, Park SH, Nam MJ. Anticarcinogenic effect of indole-3-carbinol (I3C) on human hepatocellular carcinoma SNU449 cells. Hum Exp Toxicol. 2019 Jan;38(1):136–47. doi: 10.1177/0960327118785235. PMID: 29992829."
493841,3712,Comparative Toxicogenomics Database (CTD),Indole-3-Carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Indole-3-carbinol results in increased cleavage of PARP1 protein,,,PMID:29775573,https://www.ncbi.nlm.nih.gov/pubmed/29775573,29775573,,,32415199,"Hajra S, Patra AR, Basu A, Saha P, Bhattacharya S. Indole-3-Carbinol (I3C) enhances the sensitivity of murine breast adenocarcinoma cells to doxorubicin (DOX) through inhibition of NF-?ß, blocking angiogenesis and regulation of mitochondrial apoptotic pathway. Chem Biol Interact. 2018 Jun 25;290():19–36. doi: 10.1016/j.cbi.2018.05.005. PMID: 29775573."
375932,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid promotes the reaction [indomethacin results in increased cleavage of PARP1 protein]|gw 501516 promotes the reaction [indomethacin results in increased cleavage of PARP1 protein]",,,PMID:21400612,https://www.ncbi.nlm.nih.gov/pubmed/21400612,21400612,,PMC3482838,28894176,"Foreman JE, Chang WL, Palkar PS, Zhu B, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM. Functional characterization of peroxisome proliferator-activated receptor-ß/d expression in colon cancer. Molecular Carcinogenesis. 2011 Mar 11;50(11):884–900. doi: 10.1002/mc.20757."
375933,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indomethacin inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of PARP1 protein],,,PMID:2126186,https://www.ncbi.nlm.nih.gov/pubmed/2126186,2126186,,PMC2002381,2055236,Singh N. Effect of tumour promoters on poly ADP-ribosylation in human epidermoid carcinoma HeP2 cells. Int J Exp Pathol. 1990 Dec;71(6):809–14. PMID: 2126186; PMCID: PMC2002381.
375934,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indomethacin promotes the reaction [deferoxamine results in increased cleavage of PARP1 protein],,,PMID:21882223,https://www.ncbi.nlm.nih.gov/pubmed/21882223,21882223,,,7282905,"Liu C, Tsai AL, Chen YC, Fan SC, Huang CH, Wu CC, Chang CH. Facilitation of human osteoblast apoptosis by sulindac and indomethacin under hypoxic injury. J Cell Biochem. 2012 Jan;113(1):148–55. doi: 10.1002/jcb.23338. PMID: 21882223."
375935,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indomethacin promotes the reaction [LTA protein results in increased cleavage of PARP1 protein],,,PMID:17873517,https://www.ncbi.nlm.nih.gov/pubmed/17873517,17873517,,,26848803,"Shen Y, Yang T, Wang J, Xu Q, Li R, Pan W, Li G, Wang Z, Tan J, Wu J, Wu F, Wang L, Liu Y. Indomethacin enhances the cytotoxicity of recombinant human lymphotoxin alpha on tumor cells by suppressing NFkappaB signaling. Cancer Biol Ther. 2007 Sep;6(9):1428–33. doi: 10.4161/cbt.6.9.4559. PMID: 17873517."
375936,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indomethacin results in increased cleavage of PARP1 protein,,,PMID:11532860|PMID:12663503|PMID:15804060|PMID:15812552|PMID:21400612,https://www.ncbi.nlm.nih.gov/pubmed/11532860|https://www.ncbi.nlm.nih.gov/pubmed/12663503|https://www.ncbi.nlm.nih.gov/pubmed/15804060|https://www.ncbi.nlm.nih.gov/pubmed/15812552|https://www.ncbi.nlm.nih.gov/pubmed/21400612,11532860|12663503|15804060|15812552|21400612,,PMC2361992|PMC3482838,921582|8898653|16578829|16656036|28894176,"Foreman JE, Chang WL, Palkar PS, Zhu B, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM. Functional characterization of peroxisome proliferator-activated receptor-ß/d expression in colon cancer. Molecular Carcinogenesis. 2011 Mar 11;50(11):884–900. doi: 10.1002/mc.20757.|de Groot DJA, Timmer T, Spierings DCJ, Le TKP, de Jong S, de Vries EGE. Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells. British Journal of Cancer. 2005 Apr 05;92(8):1459–66. doi: 10.1038/sj.bjc.6602516.|Zhang GS, Liu DS, Xia M. [Indomethacin-induced HL-60 leukemic cell apoptosis and the activation of C-jun NH2- terminal kinase signal transduction pathway]. Hunan Yi Ke Da Xue Xue Bao. 2003 Dec;28(6):557–62. PMID: 15804060.|Reinacher-Schick A, Schoeneck A, Graeven U, Schwarte-Waldhoff I, Schmiegel W. Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis. 2003 Mar;24(3):443–51. doi: 10.1093/carcin/24.3.443. PMID: 12663503.|Zhou XM, Wong BC, Fan XM, Zhang HB, Lin MC, Kung HF, Fan DM, Lam SK. Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis. 2001 Sep;22(9):1393–7. doi: 10.1093/carcin/22.9.1393. PMID: 11532860."
506069,3744,Comparative Toxicogenomics Database (CTD),3-(Indol-3-yl)propionic acid,C015292,indolepropionic acid,https://ctdbase.org/detail.go?type=chem&acc=C015292,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indolepropionic acid analog results in increased cleavage of PARP1 protein,,,PMID:23499788,https://www.ncbi.nlm.nih.gov/pubmed/23499788,23499788,,PMC3648619,6616389,"Zhang Z, Bi C, Buac D, Fan Y, Zhang X, Zuo J, Zhang P, Zhang N, Dong L, Dou QP. Organic cadmium complexes as proteasome inhibitors and apoptosis inducers in human breast cancer cells. Journal of Inorganic Biochemistry. 2013 Jun;123():1–10. doi: 10.1016/j.jinorgbio.2013.02.004."
453134,3758,Comparative Toxicogenomics Database (CTD),Isobutylmethylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased cleavage of PARP1 protein|2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased cleavage of PARP1 protein]",,,PMID:29704545,https://www.ncbi.nlm.nih.gov/pubmed/29704545,29704545,,,9462705,"Kim YA, Kim HY, Oh YJ, Kwon WY, Lee MH, Bae JY, Woo MS, Kim JM, Yoo YH. Polychlorinated biphenyl 138 exposure-mediated lipid droplet enlargement endows adipocytes with resistance to TNF-a-induced cell death. Toxicol Lett. 2018 Aug;292():55–62. doi: 10.1016/j.toxlet.2018.04.029. PMID: 29704545."
453135,3758,Comparative Toxicogenomics Database (CTD),Isobutylmethylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[INS1 protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased activity of PARP1 protein,,,PMID:2523799,https://www.ncbi.nlm.nih.gov/pubmed/2523799,2523799,,,10294012,"JANSSEN OE, HILZ H. Differentiation of 3T3-L1 pre-adipocytes induced by inhibitors of poly(ADP-ribose) polymerase and by related noninhibitory acids. European Journal of Biochemistry. 1989 Apr;180(3):595–602. doi: 10.1111/j.1432-1033.1989.tb14686.x."
414498,3779,Comparative Toxicogenomics Database (CTD),Isoproterenol,D007545,Isoproterenol,https://ctdbase.org/detail.go?type=chem&acc=D007545,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Isoproterenol results in decreased expression of PARP1 protein,,,PMID:29438734,https://www.ncbi.nlm.nih.gov/pubmed/29438734,29438734,,,26380539,"Thomas M, Palombo P, Schuhmacher T, von Scheven G, Bazylianska V, Salzwedel J, Schäfer N, Bürkle A, Moreno-Villanueva M. Impaired PARP activity in response to the ß-adrenergic receptor agonist isoproterenol. Toxicol In Vitro. 2018 Aug;50():29–39. doi: 10.1016/j.tiv.2018.02.001. PMID: 29438734."
414499,3779,Comparative Toxicogenomics Database (CTD),Isoproterenol,D007545,Isoproterenol,https://ctdbase.org/detail.go?type=chem&acc=D007545,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Isoproterenol results in increased cleavage of PARP1 protein|bmp10 protein inhibits the reaction [isoproterenol results in increased cleavage of PARP1 protein],,,PMID:31712309,https://www.ncbi.nlm.nih.gov/pubmed/31712309,31712309,,PMC6937579,3328262,"Qu X, Liu Y, Cao D, Chen J, Liu Z, Ji H, Chen Y, Zhang W, Zhu P, Xiao D, Li X, Shou W, Chen H. BMP10 preserves cardiac function through its dual activation of SMAD-mediated and STAT3-mediated pathways. Journal of Biological Chemistry. 2019 Dec;294(52):19877–88. doi: 10.1074/jbc.ra119.010943."
414694,3779,Comparative Toxicogenomics Database (CTD),Isoproterenol,D007545,Isoproterenol,https://ctdbase.org/detail.go?type=chem&acc=D007545,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Erdosteine affects the reaction [isoproterenol results in increased expression of PARP1 protein]|isoproterenol results in increased expression of PARP1 protein,,,PMID:33210414,https://www.ncbi.nlm.nih.gov/pubmed/33210414,33210414,,,5402141,"Mutneja E, Verma VK, Malik S, Sahu AK, Ray R, Bhatia J, Arya DS. Erdosteine salvages cardiac necrosis: Novel effect through modulation of MAPK and Nrf-2/HO-1 pathway. J Biochem Mol Toxicol. 2020 Dec;34(12):e22590. doi: 10.1002/jbt.22590. PMID: 33210414."
491744,3806,Comparative Toxicogenomics Database (CTD),Juglone,C005134,juglone,https://ctdbase.org/detail.go?type=chem&acc=C005134,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased degradation of PARP1 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,,7436917,"Gaikwad S, Chakraborty A, Salwe S, Patel V, Kulkarni S, Banerjee S. Juglone-ascorbic acid synergy inhibits metastasis and induces apoptotic cell death in poorly differentiated thyroid carcinoma by perturbing SOD and catalase activities. J Biochem Mol Toxicol. 2018 Sep;32(9):e22176. doi: 10.1002/jbt.22176. PMID: 29992683."
534851,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10029,Cricetulus griseus (Chinese hamster),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [dactinomycin results in increased cleavage of PARP1 protein],,,PMID:14640974,https://www.ncbi.nlm.nih.gov/pubmed/14640974,14640974,,PMC1223985,26766801,"Yamada M, Banno Y, Takuwa Y, Koda M, Hara A, Nozawa Y. Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells. Biochem J. 2004 Mar 01;378(Pt 2):649–56. PMID: 14640974; PMCID: PMC1223985."
534852,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FAM168A results in decreased susceptibility to cisplatin]] which results in increased cleavage of PARP1 protein,,,PMID:23251525,https://www.ncbi.nlm.nih.gov/pubmed/23251525,23251525,,PMC3519677,9352407,"Peng B, Gu Y, Xiong Y, Zheng G, He Z. Microarray-Assisted Pathway Analysis Identifies MT1X & NF?B as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma. PLoS ONE. 2012 Dec 10;7(12):e51413. doi: 10.1371/journal.pone.0051413."
535017,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:22226932,https://www.ncbi.nlm.nih.gov/pubmed/22226932,22226932,,,22176951,"Yoon JH, Ahn SG, Lee BH, Jung SH, Oh SH. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. Biochem Pharmacol. 2012 Mar 15;83(6):747–57. doi: 10.1016/j.bcp.2011.12.029. PMID: 22226932."
535018,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [emodin results in increased cleavage of PARP1 protein],,,PMID:27032576,https://www.ncbi.nlm.nih.gov/pubmed/27032576,27032576,,,20899140,"Cui Y, Lu P, Song G, Liu Q, Zhu D, Liu X. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis. Food Chem Toxicol. 2016 Jun;92():26–37. doi: 10.1016/j.fct.2016.03.013. PMID: 27032576."
535019,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein],,,PMID:34165247,https://www.ncbi.nlm.nih.gov/pubmed/34165247,34165247,,,31166243,"Ho H, Chen P, Lo Y, Lin C, Chuang Y, Hsieh M, Chen M. <scp>Luteolin-7-O</scp>-glucoside inhibits cell proliferation and modulates apoptosis through the <scp>AKT</scp> signaling pathway in human nasopharyngeal carcinoma. Environmental Toxicology. 2021 Jun 24;36(10):2013–24. doi: 10.1002/tox.23319."
535020,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [morusin results in increased cleavage of PARP1 protein],,,PMID:33035517,https://www.ncbi.nlm.nih.gov/pubmed/33035517,33035517,,,6804631,"Wang J, Liu X, Zheng H, Liu Q, Zhang H, Wang X, Shen T, Wang S, Ren D. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells. Chem Biol Interact. 2020 Nov 01;331():109279. doi: 10.1016/j.cbi.2020.109279. PMID: 33035517."
535021,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [oligopeptides analog results in increased cleavage of PARP1 protein],,,PMID:24875536,https://www.ncbi.nlm.nih.gov/pubmed/24875536,24875536,,,9393305,"Zhang L, Wang H, Xu J, Zhu J, Ding K. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Toxicol Lett. 2014 Aug 04;228(3):248–59. doi: 10.1016/j.toxlet.2014.05.015. PMID: 24875536."
535022,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [pachastrissamine analog results in increased cleavage of PARP1 protein],,,PMID:35123989,https://www.ncbi.nlm.nih.gov/pubmed/35123989,35123989,,,30530582,"Xu F, Xie Q, Li YW, Jing QQ, Liu XJ, Xu YC, Wang X, Liu L, Kim G, Choi Y, Guo Y, Zhang E, Jin CY. Suppression of JNK/ERK dependent autophagy enhances Jaspine B derivative-induced gastric cancer cell death via attenuation of p62/Keap1/Nrf2 pathways. Toxicol Appl Pharmacol. 2022 Mar 01;438():115908. doi: 10.1016/j.taap.2022.115908. PMID: 35123989."
535023,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [ZH-2 compound results in increased cleavage of PARP1 protein],,,PMID:32877639,https://www.ncbi.nlm.nih.gov/pubmed/32877639,32877639,,,21679988,"Yao M, Li R, Yang Z, Ding Y, Zhang W, Li W, Liu M, Zhao C, Wang Y, Tang H, Wang J, Wen A. PP9, a steroidal saponin, induces G2/M arrest and apoptosis in human colorectal cancer cells by inhibiting the PI3K/Akt/GSK3ß pathway. Chem Biol Interact. 2020 Nov 01;331():109246. doi: 10.1016/j.cbi.2020.109246. PMID: 32877639."
535024,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased cleavage of PARP1 protein,,,PMID:14688022|PMID:16412023|PMID:20386985|PMID:23219847|PMID:30542770|PMID:34165247|PMID:35123989,https://www.ncbi.nlm.nih.gov/pubmed/14688022|https://www.ncbi.nlm.nih.gov/pubmed/16412023|https://www.ncbi.nlm.nih.gov/pubmed/20386985|https://www.ncbi.nlm.nih.gov/pubmed/23219847|https://www.ncbi.nlm.nih.gov/pubmed/30542770|https://www.ncbi.nlm.nih.gov/pubmed/34165247|https://www.ncbi.nlm.nih.gov/pubmed/35123989,14688022|16412023|20386985|23219847|30542770|34165247|35123989,,PMC3593966,4515470|10562268|20010805|24171575|25734843|30530582|31166243,"Xu F, Xie Q, Li YW, Jing QQ, Liu XJ, Xu YC, Wang X, Liu L, Kim G, Choi Y, Guo Y, Zhang E, Jin CY. Suppression of JNK/ERK dependent autophagy enhances Jaspine B derivative-induced gastric cancer cell death via attenuation of p62/Keap1/Nrf2 pathways. Toxicol Appl Pharmacol. 2022 Mar 01;438():115908. doi: 10.1016/j.taap.2022.115908. PMID: 35123989.|Ho H, Chen P, Lo Y, Lin C, Chuang Y, Hsieh M, Chen M. <scp>Luteolin-7-O</scp>-glucoside inhibits cell proliferation and modulates apoptosis through the <scp>AKT</scp> signaling pathway in human nasopharyngeal carcinoma. Environmental Toxicology. 2021 Jun 24;36(10):2013–24. doi: 10.1002/tox.23319.|2018; 83(3):519-530|Ivanov VN, Hei TK. Induction of apoptotic death and retardation of neuronal differentiation of human neural stem cells by sodium arsenite treatment. Experimental Cell Research. 2013 Apr;319(6):875–87. doi: 10.1016/j.yexcr.2012.11.019.|2010; 15(7):850-863|Georgakis GV, Li Y, Rassidakis GZ, Medeiros LJ, Mills GB, Younes A. Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma. Br J Haematol. 2006 Feb;132(4):503–11. doi: 10.1111/j.1365-2141.2005.05881.x. PMID: 16412023.|Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004 May;25(5):647–59. doi: 10.1093/carcin/bgh052. PMID: 14688022."
535208,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenic disulfide promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased cleavage of PARP1 protein],,,PMID:30542770,https://www.ncbi.nlm.nih.gov/pubmed/30542770,30542770,,,25734843,2018; 83(3):519-530
535209,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TNFSF10 protein co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased cleavage of PARP1 protein,,,PMID:19261616,https://www.ncbi.nlm.nih.gov/pubmed/19261616,19261616,,PMC2670117,22758336,"Chen K, Yeh P, Hsu C, Hsu C, Lu Y, Hsieh H, Chen P, Cheng A. Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway. Journal of Biological Chemistry. 2009 Apr;284(17):11121–33. doi: 10.1074/jbc.m806268200."
535210,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein],,,PMID:14687664,https://www.ncbi.nlm.nih.gov/pubmed/14687664,14687664,,,20010454,"Rockwell P, Martinez J, Papa L, Gomes E. Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell Signal. 2004 Mar;16(3):343–53. doi: 10.1016/j.cellsig.2003.08.006. PMID: 14687664."
535211,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein],,,PMID:23143138,https://www.ncbi.nlm.nih.gov/pubmed/23143138,23143138,,PMC3552097,1805296,2012; 18(2):188-200
535212,3973,Comparative Toxicogenomics Database (CTD),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,,18200010,"So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547."
460282,4004,Comparative Toxicogenomics Database (CTD),Malathion,D008294,Malathion,https://ctdbase.org/detail.go?type=chem&acc=D008294,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Metoclopramide inhibits the reaction [malathion results in increased cleavage of PARP1 protein]|malathion results in increased cleavage of PARP1 protein,,,PMID:29027213,https://www.ncbi.nlm.nih.gov/pubmed/29027213,29027213,,,22929616,"Jaber BM, Petroianu GA, Rizvi SA, Borai A, Saleh NA, Hala SM, Saleh AM. Protective effect of metoclopramide against organophosphate-induced apoptosis in the murine skin fibroblast L929. J Appl Toxicol. 2018 Mar;38(3):329–40. doi: 10.1002/jat.3543. PMID: 29027213."
515566,4021,Comparative Toxicogenomics Database (CTD),Edaravone,D000077553,Edaravone,https://ctdbase.org/detail.go?type=chem&acc=D000077553,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Edaravone analog results in increased cleavage of PARP1 protein,,,PMID:25684395,https://www.ncbi.nlm.nih.gov/pubmed/25684395,25684395,,,16152512,"Zhao J, Zhang L, Li J, Wu T, Wang M, Xu G, Zhang F, Liu L, Yang J, Sun S. A novel pyrazolone-based derivative induces apoptosis in human esophageal cells via reactive oxygen species (ROS) generation and caspase-dependent mitochondria-mediated pathway. Chem Biol Interact. 2015 Apr 25;231():1–9. doi: 10.1016/j.cbi.2015.02.004. PMID: 25684395."
448366,4055,Comparative Toxicogenomics Database (CTD),Menadione,D024483,Vitamin K 3,https://ctdbase.org/detail.go?type=chem&acc=D024483,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sodium arsenite co-treated with vitamin K 3] results in increased cleavage of PARP1 protein,,,PMID:19082730,https://www.ncbi.nlm.nih.gov/pubmed/19082730,19082730,,,7943657,2008; 14(1):108-123
448549,4055,Comparative Toxicogenomics Database (CTD),Menadione,D024483,Vitamin K 3,https://ctdbase.org/detail.go?type=chem&acc=D024483,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein affects the susceptibility to vitamin K 3,,,PMID:21124846,https://www.ncbi.nlm.nih.gov/pubmed/21124846,21124846,,PMC2991347,20129723,"Dai C, Liang D, Li H, Sasaki M, Dawson TM, Dawson VL. Functional Identification of Neuroprotective Molecules. PLoS ONE. 2010 Nov 24;5(11):e15008. doi: 10.1371/journal.pone.0015008."
581538,4075,Comparative Toxicogenomics Database (CTD),Mesalamine,D019804,Mesalamine,https://ctdbase.org/detail.go?type=chem&acc=D019804,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mesalamine results in increased cleavage of PARP1 protein,,,PMID:12663503,https://www.ncbi.nlm.nih.gov/pubmed/12663503,12663503,,,16578829,"Reinacher-Schick A, Schoeneck A, Graeven U, Schwarte-Waldhoff I, Schmiegel W. Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis. 2003 Mar;24(3):443–51. doi: 10.1093/carcin/24.3.443. PMID: 12663503."
585041,4114,Comparative Toxicogenomics Database (CTD),Methoxsalen,D008730,Methoxsalen,https://ctdbase.org/detail.go?type=chem&acc=D008730,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methoxsalen inhibits the reaction [aflatoxin B1 results in increased expression of PARP1 protein modified form],,,PMID:22743290,https://www.ncbi.nlm.nih.gov/pubmed/22743290,22743290,,,20146966,"Yang XJ, Lu HY, Li ZY, Bian Q, Qiu LL, Li Z, Liu Q, Li J, Wang X, Wang SL. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells. Toxicology. 2012 Oct 28;300(3):138–48. doi: 10.1016/j.tox.2012.06.010. PMID: 22743290."
550915,4122,Comparative Toxicogenomics Database (CTD),Nocodazole,D015739,Nocodazole,https://ctdbase.org/detail.go?type=chem&acc=D015739,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nocodazole analog results in increased cleavage of PARP1 protein,,,PMID:28412508,https://www.ncbi.nlm.nih.gov/pubmed/28412508,28412508,,,6713300,"Zuo D, Jiang X, Han M, Shen J, Lang B, Guan Q, Bai Z, Han C, Li Z, Zhang W, Wu Y. Methyl 5-[(1H-indol-3-yl)selanyl]-1H-benzoimidazol-2-ylcarbamate (M-24), a novel tubulin inhibitor, causes G2/M arrest and cell apoptosis by disrupting tubulin polymerization in human cervical and breast cancer cells. Toxicol In Vitro. 2017 Aug;42():139–49. doi: 10.1016/j.tiv.2017.04.019. PMID: 28412508."
550916,4122,Comparative Toxicogenomics Database (CTD),Nocodazole,D015739,Nocodazole,https://ctdbase.org/detail.go?type=chem&acc=D015739,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nocodazole results in increased cleavage of PARP1 protein,,,PMID:15907805|PMID:21903591,https://www.ncbi.nlm.nih.gov/pubmed/15907805|https://www.ncbi.nlm.nih.gov/pubmed/21903591,15907805|21903591,,PMC3207393,7302160|27485126,"Puliyappadamba VT, Wu W, Bevis D, Zhang L, Polin L, Kilkuskie R, Finley RL, Larsen SD, Levi E, Miller FR, Wali A, Rishi AK. Antagonists of Anaphase-promoting Complex (APC)-2-Cell Cycle and Apoptosis Regulatory Protein (CARP)-1 Interaction Are Novel Regulators of Cell Growth and Apoptosis. Journal of Biological Chemistry. 2011 Nov;286(44):38000–17. doi: 10.1074/jbc.m111.222398.|Jeung HC, Che XF, Haraguchi M, Furukawa T, Zheng CL, Sumizawa T, Rha SY, Roh JK, Akiyama S. Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents. Biochem Pharmacol. 2005 Jul 01;70(1):13–21. doi: 10.1016/j.bcp.2005.04.017. PMID: 15907805."
550917,4122,Comparative Toxicogenomics Database (CTD),Nocodazole,D015739,Nocodazole,https://ctdbase.org/detail.go?type=chem&acc=D015739,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TYMP inhibits the reaction [nocodazole results in increased cleavage of PARP1 protein],,,PMID:15907805,https://www.ncbi.nlm.nih.gov/pubmed/15907805,15907805,,,27485126,"Jeung HC, Che XF, Haraguchi M, Furukawa T, Zheng CL, Sumizawa T, Rha SY, Roh JK, Akiyama S. Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents. Biochem Pharmacol. 2005 Jul 01;70(1):13–21. doi: 10.1016/j.bcp.2005.04.017. PMID: 15907805."
448486,4156,Comparative Toxicogenomics Database (CTD),Methyl Methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of PARP1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,,19505353,2013; 87(11):1999-2012
448487,4156,Comparative Toxicogenomics Database (CTD),Methyl Methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to methyl methanesulfonate,,,PMID:19111594,https://www.ncbi.nlm.nih.gov/pubmed/19111594,19111594,,,27536756,"Jowsey PA, Williams FM, Blain PG. DNA damage, signalling and repair after exposure of cells to the sulphur mustard analogue 2-chloroethyl ethyl sulphide. Toxicology. 2009 Mar 29;257(3):105–12. doi: 10.1016/j.tox.2008.12.001. PMID: 19111594."
560196,4168,Comparative Toxicogenomics Database (CTD),Metoclopramide,D008787,Metoclopramide,https://ctdbase.org/detail.go?type=chem&acc=D008787,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Metoclopramide inhibits the reaction [paraoxon results in increased cleavage of PARP1 protein]|metoclopramide inhibits the reaction [malathion results in increased cleavage of PARP1 protein],,,PMID:29027213,https://www.ncbi.nlm.nih.gov/pubmed/29027213,29027213,,,22929616,"Jaber BM, Petroianu GA, Rizvi SA, Borai A, Saleh NA, Hala SM, Saleh AM. Protective effect of metoclopramide against organophosphate-induced apoptosis in the murine skin fibroblast L929. J Appl Toxicol. 2018 Mar;38(3):329–40. doi: 10.1002/jat.3543. PMID: 29027213."
629955,4212,Comparative Toxicogenomics Database (CTD),Mitoxantrone,D008942,Mitoxantrone,https://ctdbase.org/detail.go?type=chem&acc=D008942,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BCL2 protein inhibits the reaction [mitoxantrone results in increased degradation of PARP1 protein]|bcl2l1 protein inhibits the reaction [mitoxantrone results in increased degradation of PARP1 protein],,,PMID:8840993,https://www.ncbi.nlm.nih.gov/pubmed/8840993,8840993,,,4251819,"Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res. 1996 Oct 15;56(20):4743–8. PMID: 8840993."
629956,4212,Comparative Toxicogenomics Database (CTD),Mitoxantrone,D008942,Mitoxantrone,https://ctdbase.org/detail.go?type=chem&acc=D008942,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cladribine co-treated with cyclophosphamide co-treated with mitoxantrone] results in decreased expression of PARP1 protein,,,PMID:15582267,https://www.ncbi.nlm.nih.gov/pubmed/15582267,15582267,,,24103334,"Rogalinska M, Blonski JZ, Hanausek M, Walaszek Z, Robak T, Kilianska ZM. 2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo. Cancer Detection and Prevention. 2004 Jan;28(6):433–42. doi: 10.1016/j.cdp.2004.08.001."
343101,4276,Comparative Toxicogenomics Database (CTD),Myristicin,C005246,myristicin,https://ctdbase.org/detail.go?type=chem&acc=C005246,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Myristicin results in increased cleavage of PARP1 protein,,,PMID:24792648,https://www.ncbi.nlm.nih.gov/pubmed/24792648,24792648,,,14098040,"Martins C, Doran C, Silva IC, Miranda C, Rueff J, Rodrigues AS. Myristicin from nutmeg induces apoptosis via the mitochondrial pathway and down regulates genes of the DNA damage response pathways in human leukaemia K562 cells. Chem Biol Interact. 2014 Jul 25;218():1–9. doi: 10.1016/j.cbi.2014.04.014. PMID: 24792648."
590340,4477,Comparative Toxicogenomics Database (CTD),Niclosamide,D009534,Niclosamide,https://ctdbase.org/detail.go?type=chem&acc=D009534,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"TP53 gene mutant form promotes the reaction [niclosamide results in increased cleavage of PARP1 protein]|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [niclosamide results in increased cleavage of PARP1 protein]|[tp53 protein mutant form results in increased susceptibility to niclosamide] which results in increased cleavage of PARP1 protein",,,PMID:30258081,https://www.ncbi.nlm.nih.gov/pubmed/30258081,30258081,,PMC6158291,20954282,"Kumar R, Coronel L, Somalanka B, Raju A, Aning OA, An O, Ho YS, Chen S, Mak SY, Hor PY, Yang H, Lakshmanan M, Itoh H, Tan SY, Lim YK, Wong APC, Chew SH, Huynh TH, Goh BC, Lim CY, Tergaonkar V, Cheok CF. Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers. Nature Communications. 2018 Sep 26;9(1):3931. doi: 10.1038/s41467-018-05805-1."
590342,4477,Comparative Toxicogenomics Database (CTD),Niclosamide,D009534,Niclosamide,https://ctdbase.org/detail.go?type=chem&acc=D009534,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bicalutamide promotes the reaction [niclosamide results in increased expression of PARP1 protein modified form]|niclosamide results in increased expression of PARP1 protein modified form,,,PMID:28500234,https://www.ncbi.nlm.nih.gov/pubmed/28500234,28500234,,PMC5544572,6007007,"Liu C, Armstrong CM, Lou W, Lombard AP, Cucchiara V, Gu X, Yang JC, Nadiminty N, Pan CX, Evans CP, Gao AC. Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. Mol Cancer Ther. 2017 Aug;16(8):1521–30. PMID: 28500234; PMCID: PMC5544572."
590343,4477,Comparative Toxicogenomics Database (CTD),Niclosamide,D009534,Niclosamide,https://ctdbase.org/detail.go?type=chem&acc=D009534,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),JUN protein affects the reaction [niclosamide results in increased cleavage of PARP1 protein]|hydrogen peroxide promotes the reaction [niclosamide results in increased cleavage of PARP1 protein],,,PMID:24750999,https://www.ncbi.nlm.nih.gov/pubmed/24750999,24750999,,,1833952,"Lee SL, Son AR, Ahn J, Song JY. Niclosamide enhances ROS-mediated cell death through c-Jun activation. Biomed Pharmacother. 2014 Jun;68(5):619–24. doi: 10.1016/j.biopha.2014.03.018. PMID: 24750999."
590344,4477,Comparative Toxicogenomics Database (CTD),Niclosamide,D009534,Niclosamide,https://ctdbase.org/detail.go?type=chem&acc=D009534,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niclosamide results in decreased expression of PARP1 protein,,,PMID:26917416,https://www.ncbi.nlm.nih.gov/pubmed/26917416,26917416,,PMC4766699,5295997,2016; 16(1):25
590345,4477,Comparative Toxicogenomics Database (CTD),Niclosamide,D009534,Niclosamide,https://ctdbase.org/detail.go?type=chem&acc=D009534,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niclosamide results in increased cleavage of PARP1 protein,,,PMID:24750999|PMID:25174399|PMID:30258081|PMID:30329025,https://www.ncbi.nlm.nih.gov/pubmed/24750999|https://www.ncbi.nlm.nih.gov/pubmed/25174399|https://www.ncbi.nlm.nih.gov/pubmed/30258081|https://www.ncbi.nlm.nih.gov/pubmed/30329025,24750999|25174399|30258081|30329025,,PMC4345161|PMC6158291|PMC6378864,1833952|7363751|16911309|20954282,"Sekulovski N, Whorton AE, Shi M, MacLean JA, Hayashi K. Endometriotic inflammatory microenvironment induced by macrophages can be targeted by niclosamide†. Biol Reprod. 2019 Feb 01;100(2):398–408. PMID: 30329025; PMCID: PMC6378864.|Kumar R, Coronel L, Somalanka B, Raju A, Aning OA, An O, Ho YS, Chen S, Mak SY, Hor PY, Yang H, Lakshmanan M, Itoh H, Tan SY, Lim YK, Wong APC, Chew SH, Huynh TH, Goh BC, Lim CY, Tergaonkar V, Cheok CF. Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers. Nature Communications. 2018 Sep 26;9(1):3931. doi: 10.1038/s41467-018-05805-1.|King ML, Lindberg ME, Stodden GR, Okuda H, Ebers SD, Johnson A, Montag A, Lengyel E, MacLean Ii JA, Hayashi K. WNT7A/ß-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer. Oncogene. 2015 Jun;34(26):3452–62. PMID: 25174399; PMCID: PMC4345161.|Lee SL, Son AR, Ahn J, Song JY. Niclosamide enhances ROS-mediated cell death through c-Jun activation. Biomed Pharmacother. 2014 Jun;68(5):619–24. doi: 10.1016/j.biopha.2014.03.018. PMID: 24750999."
590346,4477,Comparative Toxicogenomics Database (CTD),Niclosamide,D009534,Niclosamide,https://ctdbase.org/detail.go?type=chem&acc=D009534,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),WNT7A protein affects the reaction [niclosamide results in increased cleavage of PARP1 protein],,,PMID:25174399,https://www.ncbi.nlm.nih.gov/pubmed/25174399,25174399,,PMC4345161,7363751,"King ML, Lindberg ME, Stodden GR, Okuda H, Ebers SD, Johnson A, Montag A, Lengyel E, MacLean Ii JA, Hayashi K. WNT7A/ß-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer. Oncogene. 2015 Jun;34(26):3452–62. PMID: 25174399; PMCID: PMC4345161."
543024,4488,Comparative Toxicogenomics Database (CTD),Niflumic Acid,D009544,Niflumic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009544,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ciglitazone promotes the reaction [niflumic acid results in increased cleavage of PARP1 protein]]|benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [niflumic acid promotes the reaction [ciglitazone results in increased cleavage of PARP1 protein]]|ddit3 mutant form inhibits the reaction [niflumic acid promotes the reaction [ciglitazone results in increased cleavage of PARP1 protein]]|niflumic acid promotes the reaction [ciglitazone results in increased cleavage of PARP1 protein]|ddit3 mutant form inhibits the reaction [ciglitazone promotes the reaction [niflumic acid results in increased cleavage of PARP1 protein]]|ciglitazone promotes the reaction [niflumic acid results in increased cleavage of PARP1 protein]|niflumic acid results in increased cleavage of PARP1 protein,,,PMID:21067863,https://www.ncbi.nlm.nih.gov/pubmed/21067863,21067863,,,28245364,"Kim BM, Maeng K, Lee KH, Hong SH. Combined treatment with the Cox-2 inhibitor niflumic acid and PPAR? ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells. Cancer Lett. 2011 Jan 28;300(2):134–44. doi: 10.1016/j.canlet.2010.09.014. PMID: 21067863."
497040,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nimesulide results in increased cleavage of PARP1 protein,,,PMID:19360361,https://www.ncbi.nlm.nih.gov/pubmed/19360361,19360361,,,30225064,"Kim BM, Won J, Maeng KA, Han YS, Yun YS, Hong SH. Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3. Int J Oncol. 2009 May;34(5):1467–73. PMID: 19360361."
497041,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Nimesulide results in increased expression of PARP1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,,25628430,"Laifenfeld D, Qiu L, Swiss R, Park J, Macoritto M, Will Y, Younis HS, Lawton M. Utilization of Causal Reasoning of Hepatic Gene Expression in Rats to Identify Molecular Pathways of Idiosyncratic Drug-Induced Liver Injury. 2013 Oct 17;137(1):234–48. doi: 10.1093/toxsci/kft232."
573769,4510,Comparative Toxicogenomics Database (CTD),Nitroglycerin,D005996,Nitroglycerin,https://ctdbase.org/detail.go?type=chem&acc=D005996,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nitroglycerin results in decreased expression of PARP1 protein alternative form,,,PMID:17322376,https://www.ncbi.nlm.nih.gov/pubmed/17322376,17322376,,PMC1864864,15308529,"Belkacemi L, Bainbridge SA, Dickinson MA, Smith GN, Graham CH. Glyceryl trinitrate inhibits hypoxia/reoxygenation-induced apoptosis in the syncytiotrophoblast of the human placenta: therapeutic implications for preeclampsia. Am J Pathol. 2007 Mar;170(3):909–20. PMID: 17322376; PMCID: PMC1864864."
665704,4553,Comparative Toxicogenomics Database (CTD),NS-398,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C080955,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [dihematoporphyrin ether results in increased cleavage of PARP1 protein],,,PMID:16230411,https://www.ncbi.nlm.nih.gov/pubmed/16230411,16230411,,,28145768,"Ferrario A, Fisher AM, Rucker N, Gomer CJ. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res. 2005 Oct 15;65(20):9473–8. doi: 10.1158/0008-5472.can-05-1659. PMID: 16230411."
547586,4594,Comparative Toxicogenomics Database (CTD),Omeprazole,D009853,Omeprazole,https://ctdbase.org/detail.go?type=chem&acc=D009853,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Omeprazole results in increased cleavage of PARP1 protein,,,PMID:15461867,https://www.ncbi.nlm.nih.gov/pubmed/15461867,15461867,,,23383837,"Scaringi L, Cornacchione P, Ayroldi E, Corazzi L, Capodicasa E, Rossi R, Marconi P. Omeprazole induces apoptosis in jurkat cells. Int J Immunopathol Pharmacol. 2004 Sep;17(3):331–42. doi: 10.1177/039463200401700313. PMID: 15461867."
542825,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oxidopamine affects the cleavage of PARP1 protein|aureusidin inhibits the reaction [oxidopamine affects the cleavage of PARP1 protein],,,PMID:38056806,https://www.ncbi.nlm.nih.gov/pubmed/38056806,38056806,,,36430919,"Hu K, Zhu S, Wu F, Zhang Y, Li M, Yuan L, Huang W, Zhang Y, Wang J, Ren J, Yang H. Aureusidin ameliorates 6-OHDA-induced neurotoxicity via activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway in SH-SY5Y cells and Caenorhabditis elegans. Chem Biol Interact. 2024 Jan 05;387():110824. doi: 10.1016/j.cbi.2023.110824. PMID: 38056806."
542826,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),OPA1 protein affects the reaction [salvin inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein]],,,PMID:31705926,https://www.ncbi.nlm.nih.gov/pubmed/31705926,31705926,,,3322047,"Lin CY, Chen WJ, Fu RH, Tsai CW. Upregulation of OPA1 by carnosic acid is mediated through induction of IKK? ubiquitination by parkin and protects against neurotoxicity. Food Chem Toxicol. 2020 Feb;136():110942. doi: 10.1016/j.fct.2019.110942. PMID: 31705926."
542827,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Salvin inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein]|oxidopamine results in increased cleavage of PARP1 protein,,,PMID:25446857|PMID:30707903|PMID:31705926,https://www.ncbi.nlm.nih.gov/pubmed/25446857|https://www.ncbi.nlm.nih.gov/pubmed/30707903|https://www.ncbi.nlm.nih.gov/pubmed/31705926,25446857|30707903|31705926,,,3322047|11504347|20876534,"Lin CY, Chen WJ, Fu RH, Tsai CW. Upregulation of OPA1 by carnosic acid is mediated through induction of IKK? ubiquitination by parkin and protects against neurotoxicity. Food Chem Toxicol. 2020 Feb;136():110942. doi: 10.1016/j.fct.2019.110942. PMID: 31705926.|Lin CY, Tsai CW. PINK1/parkin-mediated mitophagy pathway is related to neuroprotection by carnosic acid in SH-SY5Y cells. Food Chem Toxicol. 2019 Mar;125():430–7. doi: 10.1016/j.fct.2019.01.027. PMID: 30707903.|Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC, Tsai CW. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. Chem Biol Interact. 2015 Jan 05;225():40–6. doi: 10.1016/j.cbi.2014.11.011. PMID: 25446857."
542828,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tricetin inhibits the reaction [oxidopamine results in increased expression of PARP1 protein]|oxidopamine results in increased expression of PARP1 protein,,,PMID:31176653,https://www.ncbi.nlm.nih.gov/pubmed/31176653,31176653,,,14212967,"Ren J, Yuan L, Wang W, Zhang M, Wang Q, Li S, Zhang L, Hu K. Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway. Toxicol Appl Pharmacol. 2019 Sep 01;378():114617. doi: 10.1016/j.taap.2019.114617. PMID: 31176653."
542829,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PINK1 protein affects the reaction [salvin inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein]],,,PMID:30707903,https://www.ncbi.nlm.nih.gov/pubmed/30707903,30707903,,,11504347,"Lin CY, Tsai CW. PINK1/parkin-mediated mitophagy pathway is related to neuroprotection by carnosic acid in SH-SY5Y cells. Food Chem Toxicol. 2019 Mar;125():430–7. doi: 10.1016/j.fct.2019.01.027. PMID: 30707903."
542952,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oxidopamine results in increased cleavage of PARP1 protein|salvin inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein]|sb 203580 inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein],,,PMID:25446857,https://www.ncbi.nlm.nih.gov/pubmed/25446857,25446857,,,20876534,"Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC, Tsai CW. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. Chem Biol Interact. 2015 Jan 05;225():40–6. doi: 10.1016/j.cbi.2014.11.011. PMID: 25446857."
542953,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TH protein inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein],,,PMID:19815691,https://www.ncbi.nlm.nih.gov/pubmed/19815691,19815691,,,30902122,"Franco JL, Posser T, Gordon SL, Bobrovskaya L, Schneider JJ, Farina M, Dafre AL, Dickson PW, Dunkley PR. Expression of tyrosine hydroxylase increases the resistance of human neuroblastoma cells to oxidative insults. Toxicol Sci. 2010 Jan;113(1):150–7. doi: 10.1093/toxsci/kfp245. PMID: 19815691."
542954,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),2-chloro-5-hydroxyphenylglycine affects the reaction [oxidopamine results in increased cleavage of PARP1 protein]|gopc protein affects the reaction [oxidopamine results in increased cleavage of PARP1 protein]|gopc protein affects the reaction [2-chloro-5-hydroxyphenylglycine affects the reaction [oxidopamine results in increased cleavage of PARP1 protein]]|gopc protein affects the reaction [6-methyl-2-(phenylethynyl)pyridine promotes the reaction [oxidopamine results in increased cleavage of PARP1 protein]]|6-methyl-2-(phenylethynyl)pyridine promotes the reaction [oxidopamine results in increased cleavage of PARP1 protein],,,PMID:33571554,https://www.ncbi.nlm.nih.gov/pubmed/33571554,33571554,,,660076,"Wang Y, Gu L, Yang HM, Zhang H. Cystic fibrosis transmembrane conductance regulator-associated ligand protects dopaminergic neurons by differentially regulating metabotropic glutamate receptor 5 in the progression of neurotoxin 6-hydroxydopamine-induced Parkinson's disease model. Neurotoxicology. 2021 May;84():14–29. doi: 10.1016/j.neuro.2021.02.003. PMID: 33571554."
542955,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Oxidopamine results in increased cleavage of PARP1 protein,,,PMID:10397638|PMID:33571554,https://www.ncbi.nlm.nih.gov/pubmed/10397638|https://www.ncbi.nlm.nih.gov/pubmed/33571554,10397638|33571554,,,660076|9109971,"Wang Y, Gu L, Yang HM, Zhang H. Cystic fibrosis transmembrane conductance regulator-associated ligand protects dopaminergic neurons by differentially regulating metabotropic glutamate receptor 5 in the progression of neurotoxin 6-hydroxydopamine-induced Parkinson's disease model. Neurotoxicology. 2021 May;84():14–29. doi: 10.1016/j.neuro.2021.02.003. PMID: 33571554.|Choi WS, Yoon SY, Oh TH, Choi EJ, O'Malley KL, Oh YJ. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res. 1999 Jul 01;57(1):86–94. doi: 10.1002/(sici)1097-4547(19990701)57:1<86::aid-jnr9>3.0.co;2-e. PMID: 10397638."
542956,4624,Comparative Toxicogenomics Database (CTD),Oxidopamine,D016627,Oxidopamine,https://ctdbase.org/detail.go?type=chem&acc=D016627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Oxidopamine results in increased activity of PARP1 protein|5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(iii) chloride inhibits the reaction [oxidopamine results in increased activity of PARP1 protein]",,,PMID:21397656,https://www.ncbi.nlm.nih.gov/pubmed/21397656,21397656,,,28891878,"Lee C, Park GH, Jang JH. Cellular antioxidant adaptive survival response to 6-hydroxydopamine-induced nitrosative cell death in C6 glioma cells. Toxicology. 2011 May 10;283(2-3):118–28. doi: 10.1016/j.tox.2011.03.004. PMID: 21397656."
530019,4674,Comparative Toxicogenomics Database (CTD),Pamidronic Acid,D000077268,Pamidronate,https://ctdbase.org/detail.go?type=chem&acc=D000077268,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pamidronate results in increased cleavage of PARP1 protein,,,PMID:10780527|PMID:15346059,https://www.ncbi.nlm.nih.gov/pubmed/10780527|https://www.ncbi.nlm.nih.gov/pubmed/15346059,10780527|15346059,,PMC2363380,12582847|19267778,"Chang SS, Suratwala SJ, Jung KM, Doppelt JD, Zhang HZ, Blaine TA, Kim TW, Winchester RJ, Lee FY. Bisphosphonates May Reduce Recurrence in Giant Cell Tumor by Inducing Apoptosis. Clinical Orthopaedics and Related Research. 2004 Sep;426():103–9. doi: 10.1097/01.blo.0000141372.54456.80.|Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW. Bisphosphonates induce apoptosis in human breast cancer cell lines. British Journal of Cancer. 2000 Mar 21;82(8):1459–68. doi: 10.1054/bjoc.1999.1131."
530020,4674,Comparative Toxicogenomics Database (CTD),Pamidronic Acid,D000077268,Pamidronate,https://ctdbase.org/detail.go?type=chem&acc=D000077268,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[pamidronate co-treated with ultra-high molecular weight polyethylene] results in increased cleavage of PARP1 protein,,,PMID:12507583,https://www.ncbi.nlm.nih.gov/pubmed/12507583,12507583,,,2968650,"Huk OL, Zukor DJ, Antoniou J, Petit A. Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis. J Orthop Res. 2003 Jan;21(1):81–7. doi: 10.1016/s0736-0266(02)00099-2. PMID: 12507583."
460892,4687,Comparative Toxicogenomics Database (CTD),"1,7-Dimethylxanthine",C021183,"1,7-dimethylxanthine",https://ctdbase.org/detail.go?type=chem&acc=C021183,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,7-dimethylxanthine results in decreased activity of PARP1 protein",,,PMID:19962977,https://www.ncbi.nlm.nih.gov/pubmed/19962977,19962977,,,4471418,"Geraets L, Haegens A, Weseler AR, Brauers K, Vernooy JHJ, Wouters EFM, Bast A, Hageman GJ. Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine. European Journal of Pharmacology. 2010 Mar;629(1-3):132–9. doi: 10.1016/j.ejphar.2009.11.064."
469218,4705,Comparative Toxicogenomics Database (CTD),PD-153035,C088860,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",https://ctdbase.org/detail.go?type=chem&acc=C088860,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline results in increased cleavage of PARP1 protein",,,PMID:22493441,https://www.ncbi.nlm.nih.gov/pubmed/22493441,22493441,,PMC3365735,22813197,"Guturi KKN, Mandal T, Chatterjee A, Sarkar M, Bhattacharya S, Chatterjee U, Ghosh MK. Mechanism of ß-Catenin-mediated Transcriptional Regulation of Epidermal Growth Factor Receptor Expression in Glycogen Synthase Kinase 3 ß-inactivated Prostate Cancer Cells. Journal of Biological Chemistry. 2012 May;287(22):18287–96. doi: 10.1074/jbc.m111.324798."
19520,4712,Comparative Toxicogenomics Database (CTD),PD-169316,C408604,2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole,https://ctdbase.org/detail.go?type=chem&acc=C408604,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein],,,PMID:14724571,https://www.ncbi.nlm.nih.gov/pubmed/14724571,14724571,,,975980,"Wang Q, Wieder R. All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene. 2004 Jan 15;23(2):426–33. doi: 10.1038/sj.onc.1207040. PMID: 14724571."
19521,4712,Comparative Toxicogenomics Database (CTD),PD-169316,C408604,2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole,https://ctdbase.org/detail.go?type=chem&acc=C408604,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,PMC1458365,10558450,"Kim HJ, Chakravarti N, Oridate N, Choe C, Claret FX, Lotan R. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene. 2006 May 04;25(19):2785–94. PMID: 16407847; PMCID: PMC1458365."
19522,4712,Comparative Toxicogenomics Database (CTD),PD-169316,C408604,2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole,https://ctdbase.org/detail.go?type=chem&acc=C408604,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [lapatinib results in increased cleavage of PARP1 protein],,,PMID:29387217,https://www.ncbi.nlm.nih.gov/pubmed/29387217,29387217,,PMC5768102,10816814,"Liu L, Zhong L, Zhao Y, Chen M, Yao S, Li L, Xiao C, Shan Z, Gan L, Xu T, Liu B. Effects of lapatinib on cell proliferation and apoptosis in NB4 cells. Oncol Lett. 2018 Jan;15(1):235–42. PMID: 29387217; PMCID: PMC5768102."
672426,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased cleavage of PARP1 protein],,,PMID:25291404,https://www.ncbi.nlm.nih.gov/pubmed/25291404,25291404,,,24273997,"Zerin T, Song HY, Kim YS. Extracellular signal-regulated kinase pathway play distinct role in acetochlor-mediated toxicity and intrinsic apoptosis in A549 cells. Toxicol In Vitro. 2015 Feb;29(1):85–92. doi: 10.1016/j.tiv.2014.09.011. PMID: 25291404."
672427,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased cleavage of PARP1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [BPDE-II results in increased cleavage of PARP1 protein]",,,PMID:15572374,https://www.ncbi.nlm.nih.gov/pubmed/15572374,15572374,,,24094048,"Chen S, Operaña T, Bonzo J, Nguyen N, Tukey RH. ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. J Biol Chem. 2005 Feb 11;280(6):4350–9. doi: 10.1074/jbc.m411554200. PMID: 15572374."
672428,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,PMC1458365,10558450,"Kim HJ, Chakravarti N, Oridate N, Choe C, Claret FX, Lotan R. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene. 2006 May 04;25(19):2785–94. PMID: 16407847; PMCID: PMC1458365."
672429,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [licochalcone B results in increased cleavage of PARP1 protein],,,PMID:35948134,https://www.ncbi.nlm.nih.gov/pubmed/35948134,35948134,,,34627529,"Zhang YY, Feng PP, Wang HF, Zhang H, Liang T, Hao XS, Wang FZ, Fei HR. Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells. Chem Biol Interact. 2022 Sep 25;365():110076. doi: 10.1016/j.cbi.2022.110076. PMID: 35948134."
672430,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[LM-1685 co-treated with carboxyamido-triazole] results in increased cleavage of PARP1 protein],,,PMID:15867384,https://www.ncbi.nlm.nih.gov/pubmed/15867384,15867384,,,7883012,"Winters ME, Mehta AI, Petricoin EF, Kohn EC, Liotta LA. Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res. 2005 May 01;65(9):3853–60. doi: 10.1158/0008-5472.can-04-1989. PMID: 15867384."
672431,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:14688022|PMID:21165570,https://www.ncbi.nlm.nih.gov/pubmed/14688022|https://www.ncbi.nlm.nih.gov/pubmed/21165570,14688022|21165570,,,1101035|20010805,"Lee WJ, Chen YR, Tseng TH. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583–91. doi: 10.3892/or.2010.1097. PMID: 21165570.|Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004 May;25(5):647–59. doi: 10.1093/carcin/bgh052. PMID: 14688022."
672432,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [scutebarbatine A results in increased cleavage of PARP1 protein],,,PMID:37072049,https://www.ncbi.nlm.nih.gov/pubmed/37072049,37072049,,,35743292,"Hao XS, Feng PP, Zhang YY, Wang FZ, Wang GL, Fei HR. Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway. Chem Biol Interact. 2023 Jun 01;378():110487. doi: 10.1016/j.cbi.2023.110487. PMID: 37072049."
672433,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sodium arsenite co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in increased cleavage of PARP1 protein,,,PMID:15028728,https://www.ncbi.nlm.nih.gov/pubmed/15028728,15028728,,PMC4389905,1644545,"Ivanov VN, Hei TK. Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor a-mediated Pathway. Journal of Biological Chemistry. 2004 May;279(21):22747–58. doi: 10.1074/jbc.m314131200."
672677,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:18775851,https://www.ncbi.nlm.nih.gov/pubmed/18775851,18775851,,PMC2614569,24141278,"Liu J, Mao W, Ding B, Liang C. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 2008 Nov;295(5):H1956–65. doi: 10.1152/ajpheart.00407.2008."
467622,4740,Comparative Toxicogenomics Database (CTD),Pentoxifylline,D010431,Pentoxifylline,https://ctdbase.org/detail.go?type=chem&acc=D010431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[pentoxifylline co-treated with doxorubicin] results in increased cleavage of PARP1 protein,,,PMID:33775688,https://www.ncbi.nlm.nih.gov/pubmed/33775688,33775688,,,11557155,"Abdin SM, Tolba MF, Zaher DM, Omar HA. Nuclear factor-?B signaling inhibitors revert multidrug-resistance in breast cancer cells. Chem Biol Interact. 2021 May 01;340():109450. doi: 10.1016/j.cbi.2021.109450. PMID: 33775688."
467623,4740,Comparative Toxicogenomics Database (CTD),Pentoxifylline,D010431,Pentoxifylline,https://ctdbase.org/detail.go?type=chem&acc=D010431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pentoxifylline promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:20804743,https://www.ncbi.nlm.nih.gov/pubmed/20804743,20804743,,,2419928,"Gahlot S, Khan MA, Rishi L, Majumdar S. Pentoxifylline augments TRAIL/Apo2L mediated apoptosis in cutaneous T cell lymphoma (HuT-78 and MyLa) by modulating the expression of antiapoptotic proteins and death receptors. Biochem Pharmacol. 2010 Dec 01;80(11):1650–61. doi: 10.1016/j.bcp.2010.08.018. PMID: 20804743."
467624,4740,Comparative Toxicogenomics Database (CTD),Pentoxifylline,D010431,Pentoxifylline,https://ctdbase.org/detail.go?type=chem&acc=D010431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pentoxifylline results in increased cleavage of PARP1 protein,,,PMID:18851957|PMID:33775688,https://www.ncbi.nlm.nih.gov/pubmed/18851957|https://www.ncbi.nlm.nih.gov/pubmed/33775688,18851957|33775688,,,3093802|11557155,"Abdin SM, Tolba MF, Zaher DM, Omar HA. Nuclear factor-?B signaling inhibitors revert multidrug-resistance in breast cancer cells. Chem Biol Interact. 2021 May 01;340():109450. doi: 10.1016/j.cbi.2021.109450. PMID: 33775688.|Rishi L, Gahlot S, Kathania M, Majumdar S. Pentoxifylline induces apoptosis in vitro in cutaneous T cell lymphoma (HuT-78) and enhances FasL mediated killing by upregulating Fas expression. Biochem Pharmacol. 2009 Jan 01;77(1):30–45. doi: 10.1016/j.bcp.2008.09.018. PMID: 18851957."
556050,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Phenobarbital affects the expression of PARP1 mRNA,,,PMID:19159669,https://www.ncbi.nlm.nih.gov/pubmed/19159669,19159669,,,16011739,"Lambert CB, Spire C, Renaud MP, Claude N, Guillouzo A. Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466–75. doi: 10.1016/j.tiv.2008.12.018. PMID: 19159669."
556051,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Phenobarbital results in increased expression of PARP1 mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,,16014137,"Ren H, Vallanat B, Nelson DM, Yeung LWY, Guruge KS, Lam PKS, Lehman-McKeeman LD, Corton JC. Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species. Reprod Toxicol. 2009 Jun;27(3-4):266–77. doi: 10.1016/j.reprotox.2008.12.011. PMID: 19162173."
572527,4775,Comparative Toxicogenomics Database (CTD),Phenylbutyric acid,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [acrylamide results in increased cleavage of PARP1 protein],,,PMID:27634458,https://www.ncbi.nlm.nih.gov/pubmed/27634458,27634458,,,1202792,"Komoike Y, Matsuoka M. Endoplasmic reticulum stress-mediated neuronal apoptosis by acrylamide exposure. Toxicol Appl Pharmacol. 2016 Nov 01;310():68–77. doi: 10.1016/j.taap.2016.09.005. PMID: 27634458."
572528,4775,Comparative Toxicogenomics Database (CTD),Phenylbutyric acid,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [pendulone results in increased cleavage of PARP1 protein],,,PMID:35288263,https://www.ncbi.nlm.nih.gov/pubmed/35288263,35288263,,,4076996,"Cheng WC, Wen Y, Chiu YS, Chou CH, Lim CJ, Lin SH, Chang JM, Lin CC. Pendulone induces apoptosis via the ROS-mediated ER-stress pathway in human non-small cell lung cancer cells. Toxicol In Vitro. 2022 Jun;81():105346. doi: 10.1016/j.tiv.2022.105346. PMID: 35288263."
572529,4775,Comparative Toxicogenomics Database (CTD),Phenylbutyric acid,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased cleavage of PARP1 protein],,,PMID:37741534,https://www.ncbi.nlm.nih.gov/pubmed/37741534,37741534,,,36551503,"Wang L, Song R, Ma M, Chen Y, Jiang Y, Li J, Yang Z, Zhang L, Jing M, Wang X, Zhang M, Fan J. Inhibition of autophagy can promote the apoptosis of bladder cancer cells induced by SC66 through the endoplasmic reticulum stress pathway. Chem Biol Interact. 2023 Oct 01;384():110725. doi: 10.1016/j.cbi.2023.110725. PMID: 37741534."
572530,4775,Comparative Toxicogenomics Database (CTD),Phenylbutyric acid,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein],,,PMID:29981725,https://www.ncbi.nlm.nih.gov/pubmed/29981725,29981725,,,29154984,"Zhang M, Du H, Huang Z, Zhang P, Yue Y, Wang W, Liu W, Zeng J, Ma J, Chen G, Wang X, Fan J. Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway. Chem Biol Interact. 2018 Aug 25;292():65–75. doi: 10.1016/j.cbi.2018.06.013. PMID: 29981725."
572531,4775,Comparative Toxicogenomics Database (CTD),Phenylbutyric acid,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),4-phenylbutyric acid inhibits the reaction [bilirubin results in increased expression of PARP1 protein modified form],,,PMID:27578021,https://www.ncbi.nlm.nih.gov/pubmed/27578021,27578021,,,27019438,2016; 91(4):1847-1858
572785,4775,Comparative Toxicogenomics Database (CTD),Phenylbutyric acid,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),4-phenylbutyric acid inhibits the reaction [tunicamycin results in increased expression of PARP1 protein modified form],,,PMID:32407927,https://www.ncbi.nlm.nih.gov/pubmed/32407927,32407927,,,29765151,"Jegal KH, Kim EO, Kim JK, Park SM, Jung DH, Lee GH, Ki SH, Byun SH, Ku SK, Cho IJ, Kim SC. Luteolin prevents liver from tunicamycin-induced endoplasmic reticulum stress via nuclear factor erythroid 2-related factor 2-dependent sestrin 2 induction. Toxicol Appl Pharmacol. 2020 Jul 15;399():115036. doi: 10.1016/j.taap.2020.115036. PMID: 32407927."
572786,4775,Comparative Toxicogenomics Database (CTD),Phenylbutyric acid,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),4-phenylbutyric acid inhibits the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:34214594,https://www.ncbi.nlm.nih.gov/pubmed/34214594,34214594,,,33842765,"Tan X, Cai D, Chen N, Du S, Qiao D, Yue X, Wang T, Li J, Xie W, Wang H. Methamphetamine mediates apoptosis of vascular smooth muscle cells via the chop-related endoplasmic reticulum stress pathway. Toxicol Lett. 2021 Oct 10;350():98–110. doi: 10.1016/j.toxlet.2021.06.019. PMID: 34214594."
571593,4778,Comparative Toxicogenomics Database (CTD),Phenylarsine Oxide,C029341,oxophenylarsine,https://ctdbase.org/detail.go?type=chem&acc=C029341,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oxophenylarsine results in increased cleavage of PARP1 protein,,,PMID:10515888,https://www.ncbi.nlm.nih.gov/pubmed/10515888,10515888,,,17193292,"Estrov Z, Manna SK, Harris D, Van Q, Estey EH, Kantarjian HM, Talpaz M, Aggarwal BB. Phenylarsine Oxide Blocks Interleukin-1ß–Induced Activation of the Nuclear Transcription Factor NF-?B, Inhibits Proliferation, and Induces Apoptosis of Acute Myelogenous Leukemia Cells. 1999 Oct 15;94(8):2844–53. doi: 10.1182/blood.v94.8.2844.420k43_2844_2853."
473022,4858,DrugBank,"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",https://www.drugbank.ca/drugs/DB08348,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619,https://www.ncbi.nlm.nih.gov/pubmed/37713619,37713619,,PMC10767903,36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751."
493853,4858,Therapeutic Target Database (TTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",D04WDX,PJ34,https://idrblab.net/ttd/data/drug/details/D04WDX,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
493854,4858,BindingDB,"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",27497,"2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27497,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),20,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
493856,4858,BindingDB,"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",27497,"2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27497,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),19,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
613826,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in increased cleavage of PARP1 protein",,,PMID:15778700,https://www.ncbi.nlm.nih.gov/pubmed/15778700,15778700,,PMC1576060,16632491,"Crocker IP, Kenny LC, Thornton WA, Szabo C, Baker PN. Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia. British J Pharmacology. 2005 Mar;144(6):772–80. doi: 10.1038/sj.bjp.0706055."
613827,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[cisplatin co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in decreased activity of PARP1 protein",,,PMID:23410825,https://www.ncbi.nlm.nih.gov/pubmed/23410825,23410825,,,10007975,"Olaussen KA, Adam J, Vanhecke E, Vielh P, Pirker R, Friboulet L, Popper H, Robin A, Commo F, Thomale J, Kayitalire L, Filipits M, Le Chevalier T, André F, Brambilla E, Soria JC. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs. Lung Cancer. 2013 May;80(2):216–22. doi: 10.1016/j.lungcan.2013.01.014. PMID: 23410825."
613828,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride binds to and results in decreased activity of PARP1 protein",,,PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
613829,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride binds to PARP1 protein",,,PMID:23025350,https://www.ncbi.nlm.nih.gov/pubmed/23025350,23025350,,,13399877,"Antolín AA, Jalencas X, Yélamos J, Mestres J. Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biology. ACS Chem Biol. 2012 Dec 21;7(12):1962–7. doi: 10.1021/cb300317y. PMID: 23025350."
613830,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein",,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,PMC4273972,480295,"Karpel-Massler G, Pareja F, Aimé P, Shu C, Chau L, Westhoff M, Halatsch M, Crary JF, Canoll P, Siegelin MD. PARP Inhibition Restores Extrinsic Apoptotic Sensitivity in Glioblastoma. PLoS ONE. 2014 Dec 22;9(12):e114583. doi: 10.1371/journal.pone.0114583."
613831,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [topotecan promotes the reaction [TP53 protein binds to PARP1 protein modified form]]|tp53 protein promotes the reaction [[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with topotecan] results in increased cleavage of PARP1 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [topotecan results in increased cleavage of PARP1 protein]|[n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with topotecan] results in increased cleavage of PARP1 protein|tp63 protein alternative form promotes the reaction [[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with topotecan] results in increased cleavage of PARP1 protein]|[tp63 protein alternative form co-treated with TP53 protein] promotes the reaction [[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with topotecan] results in increased cleavage of PARP1 protein]",,,PMID:25667043,https://www.ncbi.nlm.nih.gov/pubmed/25667043,25667043,,,16136207,"Montariello D, Troiano A, Di Girolamo D, Beneke S, Calabrò V, Quesada P. Effect of poly(ADP-ribose)polymerase and DNA topoisomerase I inhibitors on the p53/p63-dependent survival of carcinoma cells. Biochem Pharmacol. 2015 Apr 01;94(3):212–9. doi: 10.1016/j.bcp.2015.01.012. PMID: 25667043."
613832,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [topotecan results in increased ADP-ribosylation of and results in increased degradation of PARP1 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [camptothecin results in increased ADP-ribosylation of and results in increased degradation of PARP1 protein]",,,PMID:23376119,https://www.ncbi.nlm.nih.gov/pubmed/23376119,23376119,,,17434127,"Montariello D, Troiano A, Malanga M, Calabrò V, Quesada P. p63 involvement in poly(ADP-ribose) polymerase 1 signaling of topoisomerase I-dependent DNA damage in carcinoma cells. Biochem Pharmacol. 2013 Apr 01;85(7):999–1006. doi: 10.1016/j.bcp.2013.01.019. PMID: 23376119."
614111,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [cisplatin results in increased activity of PARP1 protein]",,,PMID:18468580|PMID:25806124,https://www.ncbi.nlm.nih.gov/pubmed/18468580|https://www.ncbi.nlm.nih.gov/pubmed/25806124,18468580|25806124,,PMC4371183,18842010|21427129,"Park S, Yoon SP, Kim J. Cisplatin induces primary necrosis through poly(ADP-ribose) polymerase 1 activation in kidney proximal tubular cells. Anat Cell Biol. 2015 Mar;48(1):66–74. PMID: 25806124; PMCID: PMC4371183.|Gambi N, Tramontano F, Quesada P. Poly(ADPR)polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines. Biochem Pharmacol. 2008 Jun 15;75(12):2356–63. doi: 10.1016/j.bcp.2008.03.015. PMID: 18468580."
614112,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [glucose results in increased activity of PARP1 protein]",,,PMID:21031461,https://www.ncbi.nlm.nih.gov/pubmed/21031461,21031461,,,11329167,"Pang J, Gong H, Xi C, Fan W, Dai Y, Zhang TM. Poly(ADP-ribose) polymerase 1 is involved in glucose toxicity through SIRT1 modulation in HepG2 hepatocytes. J Cell Biochem. 2011 Jan;112(1):299–306. doi: 10.1002/jcb.22919. PMID: 21031461."
614113,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [hydrogen peroxide promotes the reaction [PARP1 protein binds to ATM protein]]",,,PMID:30296409,https://www.ncbi.nlm.nih.gov/pubmed/30296409,30296409,,,22308622,"Tapodi A, Bognar Z, Szabo C, Gallyas F, Sumegi B, Hocsak E. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome. Biochem Pharmacol. 2019 Apr;162():98–108. doi: 10.1016/j.bcp.2018.10.005. PMID: 30296409."
614114,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [peroxynitrous acid results in increased activity of PARP1 protein]",,,PMID:18239155,https://www.ncbi.nlm.nih.gov/pubmed/18239155,18239155,,,1703284,"Mathews MT, Berk BC. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):711–7. doi: 10.1161/atvbaha.107.156406. PMID: 18239155."
614115,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased expression of PARP1 protein]",,,PMID:23011206,https://www.ncbi.nlm.nih.gov/pubmed/23011206,23011206,,,32980482,2012; 38(1):50-58
614116,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [oleic acid results in increased activity of PARP1 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[NAD co-treated with oleic acid] results in increased activity of PARP1 protein]",,,PMID:25536389,https://www.ncbi.nlm.nih.gov/pubmed/25536389,25536389,,,484878,"Pang J, Cui J, Gong H, Xi C, Zhang TM. Effect of NAD on PARP-mediated insulin sensitivity in oleic acid treated hepatocytes. J Cell Physiol. 2015 Jul;230(7):1607–13. doi: 10.1002/jcp.24907. PMID: 25536389."
614117,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [PARP1 protein mutant form inhibits the reaction [TNFRSF10B protein affects the cleavage of CASP3 protein]]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [PARP1 protein mutant form inhibits the reaction [TNFRSF10B protein affects the cleavage of CASP8 protein]]",,,PMID:30614530,https://www.ncbi.nlm.nih.gov/pubmed/30614530,30614530,,PMC6592026,18929933,"Xu F, Sun Y, Yang SZ, Zhou T, Jhala N, McDonald J, Chen Y. Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance. Int J Cancer. 2019 Jul 15;145(2):474–83. PMID: 30614530; PMCID: PMC6592026."
614311,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in decreased activity of PARP1 protein",,,PMID:15075382|PMID:23410825|PMID:31303961,https://www.ncbi.nlm.nih.gov/pubmed/15075382|https://www.ncbi.nlm.nih.gov/pubmed/23410825|https://www.ncbi.nlm.nih.gov/pubmed/31303961,15075382|23410825|31303961,,PMC6611509,10007975|13914481|32439054,"Mann M, Kumar S, Sharma A, Chauhan SS, Bhatla N, Kumar S, Bakhshi S, Gupta R, Kumar L. PARP-1 inhibitor modulate ß-catenin signaling to enhance cisplatin sensitivity in cancer cervix. Oncotarget. 2019 Jul 02;10(42):4262–75. PMID: 31303961; PMCID: PMC6611509.|Olaussen KA, Adam J, Vanhecke E, Vielh P, Pirker R, Friboulet L, Popper H, Robin A, Commo F, Thomale J, Kayitalire L, Filipits M, Le Chevalier T, André F, Brambilla E, Soria JC. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs. Lung Cancer. 2013 May;80(2):216–22. doi: 10.1016/j.lungcan.2013.01.014. PMID: 23410825.|Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S. A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia. The Journal of Pharmacology and Experimental Therapeutics. 2004 Aug;310(2):425–36. doi: 10.1124/jpet.104.066944."
614312,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in increased cleavage of PARP1 protein",,,PMID:24897387,https://www.ncbi.nlm.nih.gov/pubmed/24897387,24897387,,,8711092,"Gangopadhyay NN, Luketich JD, Opest A, Landreneau R, Schuchert MJ. PARP inhibitor activates the intrinsic pathway of apoptosis in primary lung cancer cells. Cancer Invest. 2014 Aug;32(7):339–48. doi: 10.3109/07357907.2014.919303. PMID: 24897387."
614313,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[PARP1 protein results in decreased susceptibility to caffeine] promotes the reaction [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in increased expression of CDKN1A mrna]",,,PMID:21840268,https://www.ncbi.nlm.nih.gov/pubmed/21840268,21840268,,PMC3185120,12029770,"Madison DL, Stauffer D, Lundblad JR. The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest. DNA Repair. 2011 Oct;10(10):1003–13. doi: 10.1016/j.dnarep.2011.07.006."
614314,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [AGT protein results in increased activity of PARP1 protein]",,,PMID:15502880,https://www.ncbi.nlm.nih.gov/pubmed/15502880,15502880,,PMC1431352,5775817,2004; 10(1-6):28-35
614315,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,PMC4632778,8743897,"Kishi Y, Fujihara H, Kawaguchi K, Yamada H, Nakayama R, Yamamoto N, Fujihara Y, Hamada Y, Satomura K, Masutani M. PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway. Int J Mol Sci. 2015 Oct 19;16(10):24820–38. PMID: 26492236; PMCID: PMC4632778."
614316,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [carbon tetrachloride results in increased expression of PARP1 protein]",,,PMID:27318789,https://www.ncbi.nlm.nih.gov/pubmed/27318789,27318789,,,2554722,"Wang S, Shi XL, Feng M, Wang X, Zhang ZH, Zhao X, Han B, Ma HC, Dai B, Ding YT. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition. Int Immunopharmacol. 2016 Sep;38():238–45. doi: 10.1016/j.intimp.2016.06.008. PMID: 27318789."
614317,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [cisplatin results in increased activity of PARP1 protein]",,,PMID:25806124,https://www.ncbi.nlm.nih.gov/pubmed/25806124,25806124,,PMC4371183,18842010,"Park S, Yoon SP, Kim J. Cisplatin induces primary necrosis through poly(ADP-ribose) polymerase 1 activation in kidney proximal tubular cells. Anat Cell Biol. 2015 Mar;48(1):66–74. PMID: 25806124; PMCID: PMC4371183."
614510,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[dietary fats co-treated with dietary sucrose] results in increased expression of PARP1 protein]",,,PMID:31273855,https://www.ncbi.nlm.nih.gov/pubmed/31273855,31273855,,,8823622,"Wang S, Yang FJ, Shang LC, Zhang YH, Zhou Y, Shi XL. Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis. Phytother Res. 2019 Sep;33(9):2347–59. doi: 10.1002/ptr.6417. PMID: 31273855."
614511,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [oleic acid results in increased activity of PARP1 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [dietary fats results in increased activity of PARP1 protein]",,,PMID:30165350,https://www.ncbi.nlm.nih.gov/pubmed/30165350,30165350,,,3287389,"Pang J, Cui J, Xi C, Shen T, Gong H, Dou L, Lin Y, Zhang T. Inhibition of Poly(ADP-Ribose) Polymerase Increased Lipid Accumulation Through SREBP1 Modulation. Cell Physiol Biochem. 2018;49(2):645–52. doi: 10.1159/000493028."
614512,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [ethanol results in increased activity of PARP1 protein]",,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,,31061321,"Mukhopadhyay P, Horváth B, Rajesh M, Varga ZV, Gariani K, Ryu D, Cao Z, Holovac E, Park O, Zhou Z, Xu MJ, Wang W, Godlewski G, Paloczi J, Nemeth BT, Persidsky Y, Liaudet L, Haskó G, Bai P, Boulares AH, Auwerx J, Gao B, Pacher P. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. J Hepatol. 2017 Mar;66(3):589–600. doi: 10.1016/j.jhep.2016.10.023. PMID: 27984176."
614513,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [PARP1 protein results in increased ADP-ribosylation of PARP1 protein]|[n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in increased activity of SP1 protein] which results in increased expression of PARP1 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [PARP1 protein results in increased ADP-ribosylation of and results in decreased activity of SP1 protein]",,,PMID:17961220,https://www.ncbi.nlm.nih.gov/pubmed/17961220,17961220,,PMC2175517,18041632,2007; 8(1):96
614514,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [streptozocin results in increased activity of PARP1 protein]",,,PMID:27288104,https://www.ncbi.nlm.nih.gov/pubmed/27288104,27288104,,,2530008,"Zhou X, Patel D, Sen S, Shanmugam V, Sidawy A, Mishra L, Nguyen BN. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis. J Vasc Surg. 2017 Apr;65(4):1161–9. doi: 10.1016/j.jvs.2016.03.407. PMID: 27288104."
614515,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]",,,PMID:18509044,https://www.ncbi.nlm.nih.gov/pubmed/18509044,18509044,,PMC2680357,9912436,"Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagasawa K, Swanson RA. Zinc Triggers Microglial Activation. J. Neurosci. 2008 May 28;28(22):5827–35. doi: 10.1523/jneurosci.1236-08.2008."
614516,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in decreased activity of PARP1 protein",,,PMID:11861791|PMID:28600955,https://www.ncbi.nlm.nih.gov/pubmed/11861791|https://www.ncbi.nlm.nih.gov/pubmed/28600955,11861791|28600955,,,5318529|33437211,"Baldassarro VA, Marchesini A, Giardino L, Calzà L. PARP activity and inhibition in fetal and adult oligodendrocyte precursor cells: Effect on cell survival and differentiation. Stem Cell Res. 2017 Jul;22():54–60. doi: 10.1016/j.scr.2017.05.011. PMID: 28600955.|Pacher P, Liaudet L, Bai P, Virag L, Mabley JG, Haskó G, Szabó C. Activation of Poly(ADP-Ribose) Polymerase Contributes to Development of Doxorubicin-Induced Heart Failure. The Journal of Pharmacology and Experimental Therapeutics. 2002 Mar;300(3):862–7. doi: 10.1124/jpet.300.3.862."
614709,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride affects the susceptibility to oxygen deficiency] which results in increased expression of PARP1 protein",,,PMID:17131054,https://www.ncbi.nlm.nih.gov/pubmed/17131054,17131054,,PMC11136184,5815176,2006; 63(24):3061-3071
614710,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [AGT protein results in increased activity of PARP1 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [AGT protein results in increased expression of PARP1 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [AGT protein results in increased expression of PARP1 mrna]",,,PMID:21613793,https://www.ncbi.nlm.nih.gov/pubmed/21613793,21613793,,,9340212,"Zhu H, Jiang Z, Lei P, Huang W, Yu X. Poly(ADP-Ribose) Polymerase-1 Mediates Angiotensin II-Induced Expression of Plasminogen Activator Inhibitor-1 and Fibronectin in Rat Mesangial Cells. Kidney Blood Press Res. 2011;34(5):320–7. doi: 10.1159/000327344."
614711,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [dichlorvos results in increased activity of PARP1 protein]",,,PMID:24231740,https://www.ncbi.nlm.nih.gov/pubmed/24231740,24231740,,,14773724,"Wani WY, Sunkaria A, Sharma DR, Kandimalla RJ, Kaushal A, Gerace E, Chiarugi A, Gill KD: Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation. Neuroscience. 2014 Jan 31;258:1-15. doi: 10.1016/j.neuroscience.2013.11.004. Epub 2013 Nov 11."
614712,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [EDN1 protein results in increased expression of and results in increased cleavage of PARP1 protein]",,,PMID:24932781,https://www.ncbi.nlm.nih.gov/pubmed/24932781,24932781,,PMC4116760,32330629,"Yilmaz B, Sahin P, Ordueri E, Celik-Ozenci C, Tasatargil A. Poly(ADP-ribose) polymerase inhibition improves endothelin-1-induced endothelial dysfunction in rat thoracic aorta. Upsala Journal of Medical Sciences. 2014 Jun 16;119(3):215–22. doi: 10.3109/03009734.2014.908253."
614713,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of PARP1 protein modified form]",,,PMID:25221900,https://www.ncbi.nlm.nih.gov/pubmed/25221900,25221900,,PMC4160283,5956195,"Hatachi G, Tsuchiya T, Miyazaki T, Matsumoto K, Yamasaki N, Okita N, Nanashima A, Higami Y, Nagayasu T. The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats. Transplantation. 2014 Sep 27;98(6):618–24. PMID: 25221900; PMCID: PMC4160283."
614714,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in decreased activity of PARP1 protein",,,PMID:15829224|PMID:18815186,https://www.ncbi.nlm.nih.gov/pubmed/15829224|https://www.ncbi.nlm.nih.gov/pubmed/18815186,15829224|18815186,,,317011|11569368,"Huang D, Yang C, Wang Y, Liao Y, Huang K. PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts. Cardiovasc Res. 2009 Jan 01;81(1):98–107. doi: 10.1093/cvr/cvn264. PMID: 18815186.|Besson VC, Zsengellér Z, Plotkine M, Szabó C, Marchand-Verrecchia C. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat. Brain Res. 2005 Apr 18;1041(2):149–56. doi: 10.1016/j.brainres.2005.01.096. PMID: 15829224."
614715,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in decreased activity of PARP1 protein] which results in decreased abundance of poly adenosine diphosphate ribose",,,PMID:15829224,https://www.ncbi.nlm.nih.gov/pubmed/15829224,15829224,,,317011,"Besson VC, Zsengellér Z, Plotkine M, Szabó C, Marchand-Verrecchia C. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat. Brain Res. 2005 Apr 18;1041(2):149–56. doi: 10.1016/j.brainres.2005.01.096. PMID: 15829224."
614922,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [NAD results in increased activity of PARP1 protein]",,,PMID:25440059,https://www.ncbi.nlm.nih.gov/pubmed/25440059,25440059,,PMC4261735,20870164,"Scheibye-Knudsen M, Mitchell S, Fang E, Iyama T, Ward T, Wang J, Dunn C, Singh N, Veith S, Hasan-Olive M, Mangerich A, Wilson M, Mattson M, Bergersen L, Cogger V, Warren A, Le Couteur D, Moaddel R, Wilson D, Croteau D, de Cabo R, Bohr V. A High-Fat Diet and NAD + Activate Sirt1 to Rescue Premature Aging in Cockayne Syndrome. Cell Metabolism. 2014 Nov;20(5):840–55. doi: 10.1016/j.cmet.2014.10.005."
614923,4858,Comparative Toxicogenomics Database (CTD),"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",C434926,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",https://ctdbase.org/detail.go?type=chem&acc=C434926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in decreased activity of PARP1 protein",,,PMID:12006805|PMID:15710350|PMID:17884996|PMID:21417348|PMID:31494107,https://www.ncbi.nlm.nih.gov/pubmed/12006805|https://www.ncbi.nlm.nih.gov/pubmed/15710350|https://www.ncbi.nlm.nih.gov/pubmed/17884996|https://www.ncbi.nlm.nih.gov/pubmed/21417348|https://www.ncbi.nlm.nih.gov/pubmed/31494107,12006805|15710350|17884996|21417348|31494107,,PMC2756478,8487661|15284647|19009047|20060229|28909941,"Martín-Guerrero SM, Casado P, Muñoz-Gámez JA, Carrasco M, Navascués J, Cuadros MA, López-Giménez JF, Cutillas PR, Martín-Oliva D. Poly(ADP-Ribose) Polymerase-1 inhibition potentiates cell death and phosphorylation of DNA damage response proteins in oxidative stressed retinal cells. Experimental Eye Research. 2019 Nov;188():107790. doi: 10.1016/j.exer.2019.107790.|Sunderland PT, Woon EC, Dhami A, Bergin AB, Mahon MF, Wood PJ, Jones LA, Tully SR, Lloyd MD, Thompson AS, Javaid H, Martin NM, Threadgill MD. 5-Benzamidoisoquinolin-1-ones and 5-(?-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2). J Med Chem. 2011 Apr 14;54(7):2049–59. doi: 10.1021/jm1010918. PMID: 21417348.|Geraets L, Moonen HJJ, Brauers K, Wouters EFM, Bast A, Hageman GJ. Dietary Flavones and Flavonoles Are Inhibitors of Poly(ADP-ribose)polymerase-1 in Pulmonary Epithelial Cells , The Journal of Nutrition. 2007 Oct;137(10):2190–5. doi: 10.1093/jn/137.10.2190.|Szenczi O, Kemecsei P, Holthuijsen MFJ, Riel NAWV, Vusse GJVD, Pacher P, Szabó C, Kollai M, Ligeti L, Ivanics T. Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure. Biochemical Pharmacology. 2005 Mar;69(5):725–32. doi: 10.1016/j.bcp.2004.11.023.|Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó E, Haskó G, Marton A, Lorigados CB, Gallyas F, Sümegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, Southan GJ, Szabó C. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med. 2002 May;30(5):1071–82. doi: 10.1097/00003246-200205000-00019. PMID: 12006805."
693187,4858,IUPHAR/BPS Guide to PHARMACOLOGY,"N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide",11348,PJ34,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11348,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,7.7,PMID:18713665,https://www.ncbi.nlm.nih.gov/pubmed/18713665,18713665,,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
644225,4875,Comparative Toxicogenomics Database (CTD),Potassium Iodide,D011193,Potassium Iodide,https://ctdbase.org/detail.go?type=chem&acc=D011193,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Potassium iodide results in increased expression of PARP1 protein modified form,,,PMID:32593569,https://www.ncbi.nlm.nih.gov/pubmed/32593569,32593569,,,23068905,"Chakraborty A, Singh V, Singh K, Rajender S. Excess iodine impairs spermatogenesis by inducing oxidative stress and perturbing the blood testis barrier. Reprod Toxicol. 2020 Sep;96():128–40. doi: 10.1016/j.reprotox.2020.06.012. PMID: 32593569."
20513,4881,Comparative Toxicogenomics Database (CTD),Ppads,C077792,"pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid",https://ctdbase.org/detail.go?type=chem&acc=C077792,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]",,,PMID:22253048,https://www.ncbi.nlm.nih.gov/pubmed/22253048,22253048,,,16772070,"Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 2011 Dec;59(12):1933–45. doi: 10.1002/glia.21235. PMID: 22253048."
510903,4911,Comparative Toxicogenomics Database (CTD),Probenecid,D011339,Probenecid,https://ctdbase.org/detail.go?type=chem&acc=D011339,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Probenecid promotes the reaction [10-nitro-oleic acid results in increased cleavage of PARP1 protein],,,PMID:29158255,https://www.ncbi.nlm.nih.gov/pubmed/29158255,29158255,,PMC5787792,11466637,"Woodcock CC, Huang Y, Woodcock SR, Salvatore SR, Singh B, Golin-Bisello F, Davidson NE, Neumann CA, Freeman BA, Wendell SG. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth. Journal of Biological Chemistry. 2018 Jan;293(4):1120–37. doi: 10.1074/jbc.m117.814368."
554141,4943,Comparative Toxicogenomics Database (CTD),Propofol,D015742,Propofol,https://ctdbase.org/detail.go?type=chem&acc=D015742,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[propofol results in increased susceptibility to STA 9090] which results in increased cleavage of PARP1 protein,,,PMID:24784839,https://www.ncbi.nlm.nih.gov/pubmed/24784839,24784839,,,33693246,"Acquaviva J, He S, Zhang C, Jimenez JP, Nagai M, Sang J, Sequeira M, Smith DL, Ogawa LS, Inoue T, Tatsuta N, Knowles MA, Bates RC, Proia DA. FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism. Mol Cancer Res. 2014 Jul;12(7):1042–54. doi: 10.1158/1541-7786.mcr-14-0004. PMID: 24784839."
700963,5004,Comparative Toxicogenomics Database (CTD),Quinalizarin,C543211,"1,2,5,8-tetrahydroxy anthraquinone",https://ctdbase.org/detail.go?type=chem&acc=C543211,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,2,5,8-tetrahydroxy anthraquinone results in decreased expression of and results in increased cleavage of PARP1 protein",,,PMID:33030807,https://www.ncbi.nlm.nih.gov/pubmed/33030807,33030807,,,6800460,"Zang Y, Zhai Y, Feng Y, Ju X, Zuo F. Molecular mechanisms of quinalizarin induces apoptosis and <scp>G0</scp>/<scp>G1</scp> cell cycle of human esophageal cancer <scp>HCE</scp>-4 cells depends on <scp>MAPK</scp>, <scp>STAT3,</scp> and <scp>NF-?B</scp> signaling pathways. Environmental Toxicology. 2020 Oct 08;36(2):276–86. doi: 10.1002/tox.23033."
656719,5104,Toxin and Toxin Target Database (T3DB),Roxarsone,T3D0311,Roxarsone,http://www.t3db.ca/toxins/T3D0311,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
689574,5169,Comparative Toxicogenomics Database (CTD),Sb-202190,C090942,4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole,https://ctdbase.org/detail.go?type=chem&acc=C090942,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein],,,PMID:14687664,https://www.ncbi.nlm.nih.gov/pubmed/14687664,14687664,,,20010454,"Rockwell P, Martinez J, Papa L, Gomes E. Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell Signal. 2004 Mar;16(3):343–53. doi: 10.1016/j.cellsig.2003.08.006. PMID: 14687664."
477453,5202,Comparative Toxicogenomics Database (CTD),Serotonin,D012701,Serotonin,https://ctdbase.org/detail.go?type=chem&acc=D012701,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 affects the abundance of serotonin,,,PMID:21990073,https://www.ncbi.nlm.nih.gov/pubmed/21990073,21990073,,,19469588,"Jiang YC, Wu HM, Cheng KH, Sunny Sun H. Menstrual cycle-dependent febrile episode mediated by sequence-specific repression of poly(ADP-ribose) polymerase-1 on the transcription of the human serotonin receptor 1A gene. Hum Mutat. 2012 Jan;33(1):209–17. doi: 10.1002/humu.21622. PMID: 21990073."
629169,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Silymarin results in increased cleavage of PARP1 protein,,,PMID:19168119,https://www.ncbi.nlm.nih.gov/pubmed/19168119,19168119,,,16019810,"Wills PJ, Asha VV. Chemopreventive action of Lygodium flexuosum extract in human hepatoma PLC/PRF/5 and Hep 3B cells. J Ethnopharmacol. 2009 Mar 18;122(2):294–303. doi: 10.1016/j.jep.2009.01.006. PMID: 19168119."
629170,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Silymarin inhibits the reaction [doxorubicin results in increased expression of PARP1 protein]|silymarin results in decreased expression of PARP1 protein,,,PMID:20144634,https://www.ncbi.nlm.nih.gov/pubmed/20144634,20144634,,,9955480,"Patel N, Joseph C, Corcoran GB, Ray SD. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicol Appl Pharmacol. 2010 Jun 01;245(2):143–52. doi: 10.1016/j.taap.2010.02.002. PMID: 20144634."
593871,5219,Comparative Toxicogenomics Database (CTD),Linsidomine,C002385,linsidomine,https://ctdbase.org/detail.go?type=chem&acc=C002385,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bosutinib co-treated with linsidomine] affects the expression of PARP1 protein|bosutinib affects the reaction [linsidomine results in increased cleavage of PARP1 protein]|linsidomine results in increased cleavage of PARP1 protein,,,PMID:34519134,https://www.ncbi.nlm.nih.gov/pubmed/34519134,34519134,,,4753466,"Yilmaz S, Alkan T, Ballar Kirmizibayrak P. A new underlying mechanism for the neuroprotective effect of bosutinib: Reverting toxicity-induced PARylation in SIN1-mediated neurotoxicity. J Biochem Mol Toxicol. 2021 Dec;35(12):e22915. doi: 10.1002/jbt.22915. PMID: 34519134."
593872,5219,Comparative Toxicogenomics Database (CTD),Linsidomine,C002385,linsidomine,https://ctdbase.org/detail.go?type=chem&acc=C002385,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Linsidomine results in decreased activity of PARP1 protein|linsidomine inhibits the reaction [PARP1 protein binds to zinc]|linsidomine results in decreased folding of PARP1 protein|linsidomine results in decreased activity of and results in increased nitrosation of PARP1 protein,,,PMID:31152818,https://www.ncbi.nlm.nih.gov/pubmed/31152818,31152818,,PMC6991161,33792783,"Zhou X, Ding X, Shen J, Yang D, Hudson LG, Liu KJ. Peroxynitrite contributes to arsenic-induced PARP-1 inhibition through ROS/RNS generation. Toxicology and Applied Pharmacology. 2019 Sep;378():114602. doi: 10.1016/j.taap.2019.114602."
594060,5219,Comparative Toxicogenomics Database (CTD),Linsidomine,C002385,linsidomine,https://ctdbase.org/detail.go?type=chem&acc=C002385,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Selegiline inhibits the reaction [linsidomine results in decreased expression of PARP1 protein]|linsidomine results in decreased expression of PARP1 protein,,,PMID:12880480,https://www.ncbi.nlm.nih.gov/pubmed/12880480,12880480,,,2289928,"Sharma SK, Ebadi M. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons. Antioxid Redox Signal. 2003 Jun;5(3):251–64. doi: 10.1089/152308603322110832. PMID: 12880480."
573780,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium fluoride results in increased cleavage of PARP1 protein,,,PMID:28962382,https://www.ncbi.nlm.nih.gov/pubmed/28962382,28962382,,PMC5598532,2562133,"Podder S, Ghoshal N, Banerjee A, Ganguly B, Upadhyay R, Chatterjee A. Interaction of DNA-lesions induced by sodium fluoride and radiation and its influence in apoptotic induction in cancer cell lines. Toxicology Reports. 2015;2():461–71. doi: 10.1016/j.toxrep.2015.02.001."
573781,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [sodium fluoride results in increased cleavage of PARP1 protein],,,PMID:24296261,https://www.ncbi.nlm.nih.gov/pubmed/24296261,24296261,,PMC3913072,11384282,"Suzuki M, Bartlett JD. Sirtuin1 and autophagy protect cells from fluoride-induced cell stress. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2014 Feb;1842(2):245–55. doi: 10.1016/j.bbadis.2013.11.023."
573782,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sodium fluoride results in increased cleavage of PARP1 protein,,,PMID:24296261|PMID:30130527,https://www.ncbi.nlm.nih.gov/pubmed/24296261|https://www.ncbi.nlm.nih.gov/pubmed/30130527,24296261|30130527,,PMC3913072,11384282|24370263,"Ni J, Li Y, Zhang W, Shu R, Zhong Z. Sodium fluoride causes oxidative stress and apoptosis in cementoblasts. Chem Biol Interact. 2018 Oct 01;294():34–9. doi: 10.1016/j.cbi.2018.08.021. PMID: 30130527.|Suzuki M, Bartlett JD. Sirtuin1 and autophagy protect cells from fluoride-induced cell stress. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2014 Feb;1842(2):245–55. doi: 10.1016/j.bbadis.2013.11.023."
573783,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of PARP1 protein]|sodium fluoride results in increased expression of PARP1 protein,,,PMID:29758312,https://www.ncbi.nlm.nih.gov/pubmed/29758312,29758312,,,8812048,"Ameeramja J, Kanagaraj VV, Perumal E. Protocatechuic acid methyl ester modulates fluoride induced pulmonary toxicity in rats. Food Chem Toxicol. 2018 Aug;118():235–44. doi: 10.1016/j.fct.2018.05.031. PMID: 29758312."
706972,5240,Comparative Toxicogenomics Database (CTD),Iodoacetic Acid,D019807,Iodoacetic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019807,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Iodoacetic acid results in increased expression of PARP1 protein modified form,,,PMID:25944804,https://www.ncbi.nlm.nih.gov/pubmed/25944804,25944804,,,2709984,"Bazzocco S, Dopeso H, Carton-Garcia F, Macaya I, Andretta E, Chionh F, Rodrigues P, Garrido M, Alazzouzi H, Nieto R, Sanchez A, Schwartz S, Bilic J, Mariadason JM, Arango D. Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment. 2015 Aug 13;21(16):3695–704. doi: 10.1158/1078-0432.ccr-14-2457."
591103,5291,Comparative Toxicogenomics Database (CTD),Imatinib,D000068877,Imatinib Mesylate,https://ctdbase.org/detail.go?type=chem&acc=D000068877,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[BIX 01294 results in increased susceptibility to imatinib mesylate] which results in increased cleavage of PARP1 protein,,,PMID:25079219,https://www.ncbi.nlm.nih.gov/pubmed/25079219,25079219,,PMC4117596,12063054,"Loh SW, Ng WL, Yeo KS, Lim Y, Ea C. Inhibition of Euchromatic Histone Methyltransferase 1 and 2 Sensitizes Chronic Myeloid Leukemia Cells to Interferon Treatment. PLoS ONE. 2014 Jul 31;9(7):e103915. doi: 10.1371/journal.pone.0103915."
591104,5291,Comparative Toxicogenomics Database (CTD),Imatinib,D000068877,Imatinib Mesylate,https://ctdbase.org/detail.go?type=chem&acc=D000068877,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[PLK1 mutant form results in increased susceptibility to imatinib mesylate] which results in increased cleavage of PARP1 protein|imatinib mesylate promotes the reaction [ON 01910 results in increased cleavage of PARP1 protein]|plk1 protein affects the reaction [imatinib mesylate results in increased cleavage of PARP1 protein]|on 01910 promotes the reaction [imatinib mesylate results in increased cleavage of PARP1 protein],,,PMID:26008977,https://www.ncbi.nlm.nih.gov/pubmed/26008977,26008977,,PMC4653000,1168522,"Okabe S, Tauchi T, Tanaka Y, Sakuta J, Ohyashiki K. Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with Abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells. Oncotarget. 2015 Aug 21;6(24):20231–40. PMID: 26008977; PMCID: PMC4653000."
591276,5291,Comparative Toxicogenomics Database (CTD),Imatinib,D000068877,Imatinib Mesylate,https://ctdbase.org/detail.go?type=chem&acc=D000068877,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ovatodiolide promotes the reaction [imatinib mesylate results in increased cleavage of PARP1 protein]|imatinib mesylate promotes the reaction [ovatodiolide results in increased cleavage of PARP1 protein],,,PMID:38000454,https://www.ncbi.nlm.nih.gov/pubmed/38000454,38000454,,,36430276,"Xia Q, Xie J, Zhang J, Zhang L, Zhou Y, Zhu B, Wu Y, Yang Z, Li J. Ovatodiolide induces autophagy-mediated cell death through the p62-Keap1-Nrf2 signaling pathway in chronic myeloid leukemia cells. Chem Biol Interact. 2024 Jan 05;387():110819. doi: 10.1016/j.cbi.2023.110819. PMID: 38000454."
591277,5291,Comparative Toxicogenomics Database (CTD),Imatinib,D000068877,Imatinib Mesylate,https://ctdbase.org/detail.go?type=chem&acc=D000068877,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Imatinib mesylate results in increased cleavage of PARP1 protein,,,PMID:26008977|PMID:38000454,https://www.ncbi.nlm.nih.gov/pubmed/26008977|https://www.ncbi.nlm.nih.gov/pubmed/38000454,26008977|38000454,,PMC4653000,1168522|36430276,"Xia Q, Xie J, Zhang J, Zhang L, Zhou Y, Zhu B, Wu Y, Yang Z, Li J. Ovatodiolide induces autophagy-mediated cell death through the p62-Keap1-Nrf2 signaling pathway in chronic myeloid leukemia cells. Chem Biol Interact. 2024 Jan 05;387():110819. doi: 10.1016/j.cbi.2023.110819. PMID: 38000454.|Okabe S, Tauchi T, Tanaka Y, Sakuta J, Ohyashiki K. Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with Abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells. Oncotarget. 2015 Aug 21;6(24):20231–40. PMID: 26008977; PMCID: PMC4653000."
591278,5291,Comparative Toxicogenomics Database (CTD),Imatinib,D000068877,Imatinib Mesylate,https://ctdbase.org/detail.go?type=chem&acc=D000068877,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[platycodin D co-treated with imatinib mesylate] results in increased cleavage of and results in decreased expression of PARP1 protein,,,PMID:29552859,https://www.ncbi.nlm.nih.gov/pubmed/29552859,29552859,,,31078293,"Dai Q, Ge YQ. [Inhibitory effect and mechanism of platycodin D combined with imatinib on K562/R]. Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(2):385–9. doi: 10.19540/j.cnki.cjcmm.20171027.012. PMID: 29552859."
21639,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BCL2 protein inhibits the reaction [vorinostat results in increased cleavage of PARP1 protein],,,PMID:21527555,https://www.ncbi.nlm.nih.gov/pubmed/21527555,21527555,,PMC3129427,14038465,"Ramsey MR, He L, Forster N, Ory B, Ellisen LW. Physical Association of HDAC1 and HDAC2 with p63 Mediates Transcriptional Repression and Tumor Maintenance in Squamous Cell Carcinoma. 2011 Jun 30;71(13):4373–9. doi: 10.1158/0008-5472.can-11-0046."
21640,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib co-treated with vorinostat] results in increased degradation of PARP1 protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,,25406599,"Yu C, Rahmani M, Conrad D, Subler M, Dent P, Grant S. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571. Blood. 2003 Nov 15;102(10):3765–74. doi: 10.1182/blood-2003-03-0737. PMID: 12893773."
21641,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CDKN1C mutant form inhibits the reaction [[(+)-JQ1 compound co-treated with vorinostat] results in increased cleavage of PARP1 protein]|[(+)-JQ1 compound co-treated with vorinostat] results in increased cleavage of PARP1 protein,,,PMID:26390243,https://www.ncbi.nlm.nih.gov/pubmed/26390243,26390243,,PMC4959788,14128717,2015; 21(10):1163-1171
21642,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[vorinostat co-treated with resveratrol] results in increased cleavage of PARP1 protein,,,PMID:22923501,https://www.ncbi.nlm.nih.gov/pubmed/22923501,22923501,,PMC3502626,31621272,"Yaseen A, Chen S, Hock S, Rosato R, Dent P, Dai Y, Grant S. Resveratrol Sensitizes Acute Myelogenous Leukemia Cells to Histone Deacetylase Inhibitors through Reactive Oxygen Species-Mediated Activation of the Extrinsic Apoptotic Pathway. Molecular Pharmacology. 2012 Dec;82(6):1030–41. doi: 10.1124/mol.112.079624."
21643,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]],,,PMID:19631782,https://www.ncbi.nlm.nih.gov/pubmed/19631782,19631782,,,10633424,"Lee JS, Jeong SH, Soung YH, Kim TH, Choi HJ, Park BS, Kwon TK, Yoo YH. SAHA treatment overcomes the anti-apoptotic effects of Bcl-2 and is associated with the formation of mature PML nuclear bodies in human leukemic U937 cells. Chem Biol Interact. 2009 Sep 14;181(1):61–70. doi: 10.1016/j.cbi.2009.02.007. PMID: 19631782."
21644,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vorinostat promotes the reaction [TNF protein results in increased cleavage of PARP1 protein],,,PMID:16377638,https://www.ncbi.nlm.nih.gov/pubmed/16377638,16377638,,,29475496,"Takada Y, Gillenwater A, Ichikawa H, Aggarwal BB. Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation. J Biol Chem. 2006 Mar 03;281(9):5612–22. doi: 10.1074/jbc.m507213200. PMID: 16377638."
21645,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vorinostat results in increased cleavage of PARP1 protein,,,PMID:15897598|PMID:17431121|PMID:18025281|PMID:19631782|PMID:20145270|PMID:21527555|PMID:27163855,https://www.ncbi.nlm.nih.gov/pubmed/15897598|https://www.ncbi.nlm.nih.gov/pubmed/17431121|https://www.ncbi.nlm.nih.gov/pubmed/18025281|https://www.ncbi.nlm.nih.gov/pubmed/19631782|https://www.ncbi.nlm.nih.gov/pubmed/20145270|https://www.ncbi.nlm.nih.gov/pubmed/21527555|https://www.ncbi.nlm.nih.gov/pubmed/27163855,15897598|17431121|18025281|19631782|20145270|21527555|27163855,,PMC2895038|PMC3129427,330899|8079050|9956089|10604948|10633424|14038465|27475350,"Reddy ND, Shoja MH, Biswas S, Nayak PG, Kumar N, Rao CM. An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells. Chem Biol Interact. 2016 Jun 25;253():112–24. doi: 10.1016/j.cbi.2016.05.008. PMID: 27163855.|Ramsey MR, He L, Forster N, Ory B, Ellisen LW. Physical Association of HDAC1 and HDAC2 with p63 Mediates Transcriptional Repression and Tumor Maintenance in Squamous Cell Carcinoma. 2011 Jun 30;71(13):4373–9. doi: 10.1158/0008-5472.can-11-0046.|Stamatopoulos B, Meuleman N, De Bruyn C, Delforge A, Bron D, Lagneaux L. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells. Haematologica. 2010 Feb 09;95(7):1136–43. doi: 10.3324/haematol.2009.013847.|Lee JS, Jeong SH, Soung YH, Kim TH, Choi HJ, Park BS, Kwon TK, Yoo YH. SAHA treatment overcomes the anti-apoptotic effects of Bcl-2 and is associated with the formation of mature PML nuclear bodies in human leukemic U937 cells. Chem Biol Interact. 2009 Sep 14;181(1):61–70. doi: 10.1016/j.cbi.2009.02.007. PMID: 19631782.|Gillenwater AM, Zhong M, Lotan R. Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells. Mol Cancer Ther. 2007 Nov;6(11):2967–75. doi: 10.1158/1535-7163.mct-04-0344. PMID: 18025281.|De los Santos M, Zambrano A, Aranda A. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. Mol Cancer Ther. 2007 Apr;6(4):1425–32. doi: 10.1158/1535-7163.mct-06-0623. PMID: 17431121.|Mitsiades CS, Poulaki V, McMullan C, Negri J, Fanourakis G, Goudopoulou A, Richon VM, Marks PA, Mitsiades N. Novel histone deacetylase inhibitors in the treatment of thyroid cancer. Clin Cancer Res. 2005 May 15;11(10):3958–65. doi: 10.1158/1078-0432.ccr-03-0776. PMID: 15897598."
21646,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Vorinostat results in increased expression of PARP1 mRNA,,,PMID:32512035,https://www.ncbi.nlm.nih.gov/pubmed/32512035,32512035,,,26432763,"Attia SM, Al-Khalifa MK, Al-Hamamah MA, Alotaibi MR, Attia MSM, Ahmad SF, Ansari MA, Nadeem A, Bakheet SA. Vorinostat is genotoxic and epigenotoxic in the mouse bone marrow cells at the human equivalent doses. Toxicology. 2020 Aug;441():152507. doi: 10.1016/j.tox.2020.152507. PMID: 32512035."
490231,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[sulforaphane co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]|[sulforaphane co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein,,,PMID:22922937,https://www.ncbi.nlm.nih.gov/pubmed/22922937,22922937,,PMC3981004,31620738,"Doudican NA, Wen SY, Mazumder A, Orlow SJ. Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways. Oncol Rep. 2012 Nov;28(5):1851–8. PMID: 22922937; PMCID: PMC3981004."
490232,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sulforaphane co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:29792947,https://www.ncbi.nlm.nih.gov/pubmed/29792947,29792947,,,32431315,"Jin CY, Molagoda IMN, Karunarathne WAHM, Kang SH, Park C, Kim GY, Choi YH. TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells. Toxicol Appl Pharmacol. 2018 Aug 01;352():132–41. doi: 10.1016/j.taap.2018.05.022. PMID: 29792947."
490424,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sulforaphane results in increased expression of PARP1 protein modified form,,,PMID:33894213,https://www.ncbi.nlm.nih.gov/pubmed/33894213,33894213,,,1323615,"Yang PM, Cheng KC, Huang JY, Wang SY, Lin YN, Tseng YT, Hsieh CW, Wung BS. Sulforaphane inhibits blue light-induced inflammation and apoptosis by upregulating the SIRT1/PGC-1a/Nrf2 pathway and autophagy in retinal pigment epithelial cells. Toxicol Appl Pharmacol. 2021 Jun 15;421():115545. doi: 10.1016/j.taap.2021.115545. PMID: 33894213."
490425,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sulforaphane inhibits the reaction [cyanoginosin LR results in increased cleavage of PARP1 protein],,,PMID:21684301,https://www.ncbi.nlm.nih.gov/pubmed/21684301,21684301,,PMC3577421,21464766,"Sun X, Mi L, Liu J, Song L, Chung F, Gan N. Sulforaphane prevents microcystin-LR-induced oxidative damage and apoptosis in BALB/c mice. Toxicology and Applied Pharmacology. 2011 Aug;255(1):9–17. doi: 10.1016/j.taap.2011.05.011."
516096,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene affects the expression of PARP1 protein",,,PMID:32123963,https://www.ncbi.nlm.nih.gov/pubmed/32123963,32123963,,,27815923,2020; 94(4):1265-1278
461956,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),LINC00511 inhibits the reaction [temozolomide results in increased cleavage of PARP1 protein]|temozolomide results in increased cleavage of PARP1 protein,,,PMID:34328678,https://www.ncbi.nlm.nih.gov/pubmed/34328678,34328678,,,9564182,"Lu Y, Tian M, Liu J, Wang K. LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/ß-catenin signaling. J Biochem Mol Toxicol. 2021 Sep;35(9):e22848. doi: 10.1002/jbt.22848. PMID: 34328678."
461957,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to [temozolomide co-treated with veliparib],,,PMID:19825992,https://www.ncbi.nlm.nih.gov/pubmed/19825992,19825992,,,30911884,"Liu X, Han EK, Anderson M, Shi Y, Semizarov D, Wang G, McGonigal T, Roberts L, Lasko L, Palma J, Zhu GD, Penning T, Rosenberg S, Giranda VL, Luo Y, Leverson J, Johnson EF, Shoemaker AR. Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways. Mol Cancer Res. 2009 Oct;7(10):1686–92. doi: 10.1158/1541-7786.mcr-09-0299. PMID: 19825992."
462135,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sanggenone C co-treated with temozolomide] results in increased expression of and results in increased cleavage of PARP1 protein,,,PMID:37346933,https://www.ncbi.nlm.nih.gov/pubmed/37346933,37346933,,PMC10279945,35751716,"Chang H, Hou J, Shao Y, Xu M, Weng X, Du Y, Shi J, Zhang L, Cui H. Sanggenon C inhibits cell proliferation and induces apoptosis by regulating the MIB1/DAPK1 axis in glioblastoma. MedComm (2020). 2023 Aug;4(4):e281. PMID: 37346933; PMCID: PMC10279945."
462136,5394,Comparative Toxicogenomics Database (CTD),Temozolomide,D000077204,Temozolomide,https://ctdbase.org/detail.go?type=chem&acc=D000077204,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein results in decreased susceptibility to temozolomide,,,PMID:21555580,https://www.ncbi.nlm.nih.gov/pubmed/21555580,21555580,,PMC3102364,4477378,"Revet I, Feeney L, Bruguera S, Wilson W, Dong TK, Oh DH, Dankort D, Cleaver JE. Functional relevance of the histone gammaH2Ax in the response to DNA damaging agents. Proc Natl Acad Sci U S A. 2011 May 24;108(21):8663–7. PMID: 21555580; PMCID: PMC3102364."
634623,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[curcumin co-treated with thalidomide] results in increased cleavage of PARP1 protein,,,PMID:19372569,https://www.ncbi.nlm.nih.gov/pubmed/19372569,19372569,,PMC2694943,30236431,"Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S, Aggarwal BB. Curcumin circumvents chemoresistance <i>in vitro</i> and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. 2009 Apr 01;8(4):959–70. doi: 10.1158/1535-7163.mct-08-0905."
634624,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Thalidomide analog results in increased cleavage of PARP1 protein,,,PMID:15858615,https://www.ncbi.nlm.nih.gov/pubmed/15858615,15858615,,,7874809,"Kumar S, Raje N, Hideshima T, Ishitsuka K, Roccaro A, Shiraishi N, Hamasaki M, Yasui H, Munshi NC, Richardson P, Figg WD, Anderson KC. Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs. Leukemia. 2005 Jul;19(7):1253–61. doi: 10.1038/sj.leu.2403776. PMID: 15858615."
721679,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Thiabendazole results in increased cleavage of PARP1 protein,,,PMID:39207506,https://www.ncbi.nlm.nih.gov/pubmed/39207506,39207506,,PMC11489238,37659783,2024; 98(11):3641-3658
646945,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9031,Gallus gallus (chicken),Thiram results in increased cleavage of PARP1 protein,,,PMID:36288636,https://www.ncbi.nlm.nih.gov/pubmed/36288636,36288636,,,35222153,"Mo Q, Kulyar MF, Ding Y, Zhang Y, Pan H, Li J. Thiram induces myocardial oxidative damage and apoptosis in broilers via interfering their cardiac metabolism. Ecotoxicol Environ Saf. 2022 Dec 01;247():114225. doi: 10.1016/j.ecoenv.2022.114225. PMID: 36288636."
647135,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Thiram results in decreased expression of PARP1 mRNA,,,PMID:38568856,https://www.ncbi.nlm.nih.gov/pubmed/38568856,38568856,,PMC10990114,37067324,"Sala-Hamrick KE, Tapaswi A, Polemi KM, Nguyen VK, Colacino JA. High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals. Environ Health Perspect. 2024 Apr;132(4):47002. PMID: 38568856; PMCID: PMC10990114."
751763,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine affects the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein]",,,PMID:15966574,https://www.ncbi.nlm.nih.gov/pubmed/15966574,15966574,,,15970553,"Rudolf E, Cervinka M, Cerman J. Zinc has ambiguous effects on chromium (VI)-induced oxidative stress and apoptosis. Journal of Trace Elements in Medicine and Biology. 2005 May;18(3):251–60. doi: 10.1016/j.jtemb.2004.09.004."
751764,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein]",,,PMID:33645215,https://www.ncbi.nlm.nih.gov/pubmed/33645215,33645215,,,23020905,"Wedler N, Matthäus T, Strauch B, Dilger E, Waterstraat M, Mangerich A, Hartwig A. Impact of the Cellular Zinc Status on PARP-1 Activity and Genomic Stability in HeLa S3 Cells. Chem Res Toxicol. 2021 Mar 15;34(3):839–48. doi: 10.1021/acs.chemrestox.0c00452. PMID: 33645215."
751765,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [zinc binds to PARP1 protein]|n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased activity of PARP1 protein",,,PMID:24275069,https://www.ncbi.nlm.nih.gov/pubmed/24275069,24275069,,PMC3891920,30330910,"Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 2014 Jan;274(2):313–8. doi: 10.1016/j.taap.2013.11.010."
751953,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]",,,PMID:22253048,https://www.ncbi.nlm.nih.gov/pubmed/22253048,22253048,,,16772070,"Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 2011 Dec;59(12):1933–45. doi: 10.1002/glia.21235. PMID: 22253048."
756771,5521,Comparative Toxicogenomics Database (CTD),Tpmpa,C101879,"(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid",https://ctdbase.org/detail.go?type=chem&acc=C101879,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid inhibits the reaction [4-aminocrotonic acid inhibits the reaction [ammonium chloride results in increased cleavage of PARP1 protein]]",,,PMID:14535961,https://www.ncbi.nlm.nih.gov/pubmed/14535961,14535961,,,30137740,"Yang L, Omori K, Omori K, Otani H, Suzukawa J, Inagaki C. GABA<sub>C</sub> receptor agonist suppressed ammonia-induced apoptosis in cultured rat hippocampal neurons by restoring phosphorylated BAD level. Journal of Neurochemistry. 2003 Sep 30;87(3):791–800. doi: 10.1046/j.1471-4159.2003.02069.x."
754688,5526,Comparative Toxicogenomics Database (CTD),Tranexamic acid,D014148,Tranexamic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014148,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tranexamic acid inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:19539006,https://www.ncbi.nlm.nih.gov/pubmed/19539006,19539006,,,1071373,"Kim HJ, Park HJ, Park HK, Chung JH. Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Toxicology. 2009 Aug 03;262(2):171–4. doi: 10.1016/j.tox.2009.06.004. PMID: 19539006."
489315,5566,Comparative Toxicogenomics Database (CTD),Trifluoperazine,D014268,Trifluoperazine,https://ctdbase.org/detail.go?type=chem&acc=D014268,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trifluoperazine inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:21544200,https://www.ncbi.nlm.nih.gov/pubmed/21544200,21544200,,PMC3081326,14054107,"Xu B, Chen S, Luo Y, Chen Z, Liu L, Zhou H, Chen W, Shen T, Han X, Chen L, Huang S. Calcium Signaling Is Involved in Cadmium-Induced Neuronal Apoptosis via Induction of Reactive Oxygen Species and Activation of MAPK/mTOR Network. PLoS ONE. 2011 Apr 22;6(4):e19052. doi: 10.1371/journal.pone.0019052."
491191,5570,Comparative Toxicogenomics Database (CTD),Trigonelline,C009560,trigonelline,https://ctdbase.org/detail.go?type=chem&acc=C009560,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[trigonelline co-treated with etoposide] results in increased cleavage of PARP1 protein|[trigonelline co-treated with cisplatin] results in increased cleavage of PARP1 protein,,,PMID:33148531,https://www.ncbi.nlm.nih.gov/pubmed/33148531,33148531,,,19665370,"Fouzder C, Mukhuty A, Mukherjee S, Malick C, Kundu R. Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells. Toxicol In Vitro. 2021 Feb;70():105038. doi: 10.1016/j.tiv.2020.105038. PMID: 33148531."
491192,5570,Comparative Toxicogenomics Database (CTD),Trigonelline,C009560,trigonelline,https://ctdbase.org/detail.go?type=chem&acc=C009560,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Trigonelline inhibits the reaction [palmitic acid results in increased cleavage of PARP1 protein],,,PMID:30208301,https://www.ncbi.nlm.nih.gov/pubmed/30208301,30208301,,,3974089,"Sharma L, Lone NA, Knott RM, Hassan A, Abdullah T. Trigonelline prevents high cholesterol and high fat diet induced hepatic lipid accumulation and lipo-toxicity in C57BL/6J mice, via restoration of hepatic autophagy. Food Chem Toxicol. 2018 Nov;121():283–96. doi: 10.1016/j.fct.2018.09.011. PMID: 30208301."
504252,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Troglitazone promotes the reaction [aspirin results in increased cleavage of PARP1 protein]|troglitazone results in increased cleavage of PARP1 protein|aspirin promotes the reaction [troglitazone results in increased cleavage of PARP1 protein],,,PMID:19908241,https://www.ncbi.nlm.nih.gov/pubmed/19908241,19908241,,,14008511,"Yan KH, Yao CJ, Chang HY, Lai GM, Cheng AL, Chuang SE. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells. Mol Carcinog. 2010 Mar;49(3):235–46. doi: 10.1002/mc.20593. PMID: 19908241."
504253,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Troglitazone results in increased expression of PARP1,,,PMID:12680223,https://www.ncbi.nlm.nih.gov/pubmed/12680223,12680223,,,16594668,"Yoshida K, Tanabe K, Fujii D, Oue N, Yasui W, Toge T. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells. Anticancer Res. 2003 Jan;23(1A):267–73. PMID: 12680223."
504254,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Troglitazone results in increased expression of PARP1 mrna|troglitazone results in increased expression of and affects the cleavage of PARP1 protein|2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in increased expression of PARP1 protein]|troglitazone results in increased cleavage of PARP1 protein|2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in increased expression of PARP1 mrna],,,PMID:28283887,https://www.ncbi.nlm.nih.gov/pubmed/28283887,28283887,,,17522612,2017; 55(3):2125-2149
689312,5646,Comparative Toxicogenomics Database (CTD),Usnic Acid,C073339,usnic acid,https://ctdbase.org/detail.go?type=chem&acc=C073339,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Usnic acid results in increased cleavage of PARP1 protein,,,PMID:31715134,https://www.ncbi.nlm.nih.gov/pubmed/31715134,31715134,,,3330915,"Kumar K, Mishra JPN, Singh RP. Usnic acid induces apoptosis in human gastric cancer cells through ROS generation and DNA damage and causes up-regulation of DNA-PKcs and ?-H2A.X phosphorylation. Chem Biol Interact. 2020 Jan 05;315():108898. doi: 10.1016/j.cbi.2019.108898. PMID: 31715134."
701147,5665,Comparative Toxicogenomics Database (CTD),Vigabatrin,D020888,Vigabatrin,https://ctdbase.org/detail.go?type=chem&acc=D020888,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of PARP1 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,PMC3071501,33618358,"Singh P, Mohammad F, Sharma A. Transcriptomic analysis in a Drosophila model identifies previously implicated and novel pathways in the therapeutic mechanism in neuropsychiatric disorders. Front Neurosci. 2011;5():161. PMID: 21503142; PMCID: PMC3071501."
498925,5694,Comparative Toxicogenomics Database (CTD),Pirinixic Acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of PARP1 mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,PMC2244803,13988946,"Sanderson LM, de Groot PJ, Hooiveld GJEJ, Koppen A, Kalkhoven E, Müller M, Kersten S. Effect of Synthetic Dietary Triglycerides: A Novel Research Paradigm for Nutrigenomics. PLoS ONE. 2008 Feb 27;3(2):e1681. doi: 10.1371/journal.pone.0001681."
498926,5694,Comparative Toxicogenomics Database (CTD),Pirinixic Acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9986,Oryctolagus cuniculus (rabbit),Pirinixic acid affects the expression of PARP1 protein,,,PMID:16912651,https://www.ncbi.nlm.nih.gov/pubmed/16912651,16912651,,,17339190,"Yeh CH, Chen TP, Lee CH, Wu YC, Lin YM, Lin PJ. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators. Shock. 2006 Sep;26(3):262–70. doi: 10.1097/01.shk.0000225863.56714.96. PMID: 16912651."
498927,5694,Comparative Toxicogenomics Database (CTD),Pirinixic Acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pirinixic acid results in decreased expression of PARP1 mRNA,,,PMID:16940010,https://www.ncbi.nlm.nih.gov/pubmed/16940010,16940010,,,9905568,"Werle-Schneider G, Wölfelschneider A, von Brevern MC, Scheel J, Storck T, Müller D, Glöckner R, Bartsch H, Bartelmann M. Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol. Int J Toxicol. 2006 Sep;25(5):379–95. doi: 10.1080/10915810600846963. PMID: 16940010."
695534,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]],,,PMID:19714248,https://www.ncbi.nlm.nih.gov/pubmed/19714248,19714248,,PMC2729407,32898850,"Nardinocchi L, Puca R, Sacchi A, Rechavi G, Givol D, D'Orazi G. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha. PLoS One. 2009 Aug 28;4(8):e6819. PMID: 19714248; PMCID: PMC2729407."
695535,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc chloride inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein],,,PMID:19056730,https://www.ncbi.nlm.nih.gov/pubmed/19056730,19056730,,PMC2652344,7919891,"Ding W, Liu W, Cooper KL, Qin X, de Souza Bergo PL, Hudson LG, Liu KJ. Inhibition of Poly(ADP-ribose) Polymerase-1 by Arsenite Interferes with Repair of Oxidative DNA Damage. Journal of Biological Chemistry. 2009 Mar;284(11):6809–17. doi: 10.1074/jbc.m805566200."
695536,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc chloride promotes the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:33645215,https://www.ncbi.nlm.nih.gov/pubmed/33645215,33645215,,,23020905,"Wedler N, Matthäus T, Strauch B, Dilger E, Waterstraat M, Mangerich A, Hartwig A. Impact of the Cellular Zinc Status on PARP-1 Activity and Genomic Stability in HeLa S3 Cells. Chem Res Toxicol. 2021 Mar 15;34(3):839–48. doi: 10.1021/acs.chemrestox.0c00452. PMID: 33645215."
695725,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Zinc chloride results in increased expression of PARP1 protein|periodate-oxidized adenosine 5'-triphosphate inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]|cibacron blue F 3GA inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]|n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]|pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]|coomassie brilliant blue inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]",,,PMID:22253048,https://www.ncbi.nlm.nih.gov/pubmed/22253048,22253048,,,16772070,"Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 2011 Dec;59(12):1933–45. doi: 10.1002/glia.21235. PMID: 22253048."
695726,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL3 protein]|parp1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein]|zinc chloride results in increased activity of PARP1 protein|parp1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1A protein]|parp1 results in increased susceptibility to zinc chloride|parp1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1B protein]|acetovanillone inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]|ncf1 gene mutant form inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]|parp1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]",,,PMID:18509044,https://www.ncbi.nlm.nih.gov/pubmed/18509044,18509044,,PMC2680357,9912436,"Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagasawa K, Swanson RA. Zinc Triggers Microglial Activation. J. Neurosci. 2008 May 28;28(22):5827–35. doi: 10.1523/jneurosci.1236-08.2008."
560580,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of PARP1 protein modified form|parp1 mRNA promotes the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of RUNX2 mrna]|parg mRNA inhibits the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of PARP1 protein],,,PMID:22940495,https://www.ncbi.nlm.nih.gov/pubmed/22940495,22940495,,,31637292,"Robaszkiewicz A, Erdélyi K, Kovács K, Kovács I, Bai P, Rajnavölgyi E, Virág L. Hydrogen peroxide-induced poly(ADP-ribosyl)ation regulates osteogenic differentiation-associated cell death. Free Radic Biol Med. 2012 Oct 15;53(8):1552–64. doi: 10.1016/j.freeradbiomed.2012.08.567. PMID: 22940495."
560581,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dexamethasone inhibits the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:16144937,https://www.ncbi.nlm.nih.gov/pubmed/16144937,16144937,,,30152806,"Runnebaum IB, Brüning A. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Clin Cancer Res. 2005 Sep 01;11(17):6325–32. doi: 10.1158/1078-0432.ccr-05-0182. PMID: 16144937."
560582,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Dexamethasone promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein]",,,PMID:23318440,https://www.ncbi.nlm.nih.gov/pubmed/23318440,23318440,,,32297339,"Munugalavadla V, Mariathasan S, Slaga D, Du C, Berry L, Del Rosario G, Yan Y, Boe M, Sun L, Friedman LS, Chesi M, Leif Bergsagel P, Ebens A. The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma. Oncogene. 2014 Jan 16;33(3):316–25. doi: 10.1038/onc.2012.594. PMID: 23318440."
560583,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dexamethasone results in increased cleavage of PARP1 protein,,,PMID:25447644,https://www.ncbi.nlm.nih.gov/pubmed/25447644,25447644,,,20877302,"El Zaoui I, Behar-Cohen F, Torriglia A. Glucocorticoids exert direct toxicity on microvasculature: analysis of cell death mechanisms. Toxicol Sci. 2015 Feb;143(2):441–53. doi: 10.1093/toxsci/kfu243. PMID: 25447644."
560584,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased cleavage of PARP1 protein|2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased cleavage of PARP1 protein]",,,PMID:29704545,https://www.ncbi.nlm.nih.gov/pubmed/29704545,29704545,,,9462705,"Kim YA, Kim HY, Oh YJ, Kwon WY, Lee MH, Bae JY, Woo MS, Kim JM, Yoo YH. Polychlorinated biphenyl 138 exposure-mediated lipid droplet enlargement endows adipocytes with resistance to TNF-a-induced cell death. Toxicol Lett. 2018 Aug;292():55–62. doi: 10.1016/j.toxlet.2018.04.029. PMID: 29704545."
560585,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,PMC4632778,8743897,"Kishi Y, Fujihara H, Kawaguchi K, Yamada H, Nakayama R, Yamamoto N, Fujihara Y, Hamada Y, Satomura K, Masutani M. PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway. Int J Mol Sci. 2015 Oct 19;16(10):24820–38. PMID: 26492236; PMCID: PMC4632778."
560586,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dexamethasone results in increased cleavage of PARP1 protein|mifepristone inhibits the reaction [dexamethasone results in increased cleavage of PARP1 protein],,,PMID:16644695,https://www.ncbi.nlm.nih.gov/pubmed/16644695,16644695,,,1675037,"Ranta F, Avram D, Berchtold S, Düfer M, Drews G, Lang F, Ullrich S. Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes. 2006 May;55(5):1380–90. doi: 10.2337/db05-1220. PMID: 16644695."
560587,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[INS1 protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased activity of PARP1 protein,,,PMID:2523799,https://www.ncbi.nlm.nih.gov/pubmed/2523799,2523799,,,10294012,"JANSSEN OE, HILZ H. Differentiation of 3T3-L1 pre-adipocytes induced by inhibitors of poly(ADP-ribose) polymerase and by related noninhibitory acids. European Journal of Biochemistry. 1989 Apr;180(3):595–602. doi: 10.1111/j.1432-1033.1989.tb14686.x."
615285,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloramphenicol inhibits the reaction [mitomycin results in increased activity of PARP1 protein]|cdkn1a mutant form inhibits the reaction [chloramphenicol inhibits the reaction [mitomycin results in increased activity of PARP1 protein]]|mitomycin results in increased activity of PARP1 protein,,,PMID:15905168,https://www.ncbi.nlm.nih.gov/pubmed/15905168,15905168,,,27482608,"Li CH, Tzeng SL, Cheng YW, Kang JJ. Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway. J Biol Chem. 2005 Jul 15;280(28):26193–9. doi: 10.1074/jbc.m501371200. PMID: 15905168."
615450,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mitomycin promotes the reaction [ouabain results in increased cleavage of PARP1 protein]|ouabain promotes the reaction [mitomycin results in increased cleavage of PARP1 protein]|mitomycin results in increased cleavage of PARP1 protein,,,PMID:24124520,https://www.ncbi.nlm.nih.gov/pubmed/24124520,24124520,,PMC3790830,25617769,"Wha Jun D, Hwang M, Kim HJ, Hwang SK, Kim S, Lee C. Ouabain, a Cardiac Glycoside, Inhibits the Fanconi Anemia/BRCA Pathway Activated by DNA Interstrand Cross-Linking Agents. PLoS ONE. 2013 Oct 04;8(10):e75905. doi: 10.1371/journal.pone.0075905."
615451,5746,Comparative Toxicogenomics Database (CTD),Mitomycin,D016685,Mitomycin,https://ctdbase.org/detail.go?type=chem&acc=D016685,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein results in decreased susceptibility to mitomycin,,,PMID:28757444,https://www.ncbi.nlm.nih.gov/pubmed/28757444,28757444,,,22280449,"Gong C, Yang L, Zhou J, Guo X, Zhuang Z. Possible role of PAPR-1 in protecting human HaCaT cells against cytotoxicity of SiO2 nanoparticles. Toxicol Lett. 2017 Oct 05;280():213–21. doi: 10.1016/j.toxlet.2017.07.213. PMID: 28757444."
675457,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [[ESR2 protein results in increased susceptibility to estradiol] which results in increased cleavage of PARP1 protein]|fulvestrant inhibits the reaction [estradiol results in increased cleavage of PARP1 protein]|[esr2 protein results in increased susceptibility to estradiol] which results in increased cleavage of PARP1 protein|estradiol results in increased cleavage of PARP1 protein,,,PMID:21732360,https://www.ncbi.nlm.nih.gov/pubmed/21732360,21732360,,,17416701,"Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, Marino M. The pro-apoptotic effect of quercetin in cancer cell lines requires ERß-dependent signals. Journal Cellular Physiology. 2012 Jan 23;227(5):1891–8. doi: 10.1002/jcp.22917."
675649,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Estradiol promotes the reaction [PARP1 protein binds to HTR1A promoter mutant form]|[estradiol promotes the reaction [PARP1 protein binds to HTR1A promoter mutant form]] which results in decreased expression of HTR1A mRNA,,,PMID:21990073,https://www.ncbi.nlm.nih.gov/pubmed/21990073,21990073,,,19469588,"Jiang YC, Wu HM, Cheng KH, Sunny Sun H. Menstrual cycle-dependent febrile episode mediated by sequence-specific repression of poly(ADP-ribose) polymerase-1 on the transcription of the human serotonin receptor 1A gene. Hum Mutat. 2012 Jan;33(1):209–17. doi: 10.1002/humu.21622. PMID: 21990073."
675650,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[estradiol results in increased expression of PARP1 mrna] which results in increased susceptibility to cisplatin|[estradiol results in increased expression of PARP1 mrna] which results in increased susceptibility to doxorubicin,,,PMID:28323900,https://www.ncbi.nlm.nih.gov/pubmed/28323900,28323900,,PMC5360320,10102322,"Chang Y, Singh KP. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells. PLoS ONE. 2017 Mar 21;12(3):e0174227. doi: 10.1371/journal.pone.0174227."
675651,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Estradiol results in increased expression of PARP1 mRNA,,,PMID:39298647,https://www.ncbi.nlm.nih.gov/pubmed/39298647,39298647,,PMC11412574,37758763,"Wang Q, Gao S, Chen B, Zhao J, Li W, Wu L. Evaluating the Effects of Perinatal Exposures to BPSIP on Hepatic Cholesterol Metabolism in Female and Male Offspring ICR Mice. Environ Health Perspect. 2024 Sep;132(9):97011. PMID: 39298647; PMCID: PMC11412574."
675652,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased cleavage of PARP1 protein|resveratrol inhibits the reaction [estradiol results in decreased cleavage of PARP1 protein],,,PMID:24894866,https://www.ncbi.nlm.nih.gov/pubmed/24894866,24894866,,PMC4123650,8708839,"Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, Bhat HK. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis. 2014 Aug;35(8):1872–80. PMID: 24894866; PMCID: PMC4123650."
675653,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of PARP1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,,18950591,"Nguyen HT, Yamamoto K, Iida M, Agusa T, Ochiai M, Guo J, Karthikraj R, Kannan K, Kim EY, Iwata H. Effects of prenatal bisphenol A exposure on the hepatic transcriptome and proteome in rat offspring. Sci Total Environ. 2020 Jun 10;720():137568. doi: 10.1016/j.scitotenv.2020.137568. PMID: 32145629."
775900,5781,Comparative Toxicogenomics Database (CTD),Alloxan,D000496,Alloxan,https://ctdbase.org/detail.go?type=chem&acc=D000496,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Alloxan results in increased degradation of PARP1 protein|d-glucaric acid, 1,4-lactone inhibits the reaction [alloxan results in increased degradation of PARP1 protein]",,,PMID:21982801,https://www.ncbi.nlm.nih.gov/pubmed/21982801,21982801,,,19463044,"Bhattacharya S, Manna P, Gachhui R, Sil PC. D-saccharic acid-1,4-lactone ameliorates alloxan-induced diabetes mellitus and oxidative stress in rats through inhibiting pancreatic ß-cells from apoptosis via mitochondrial dependent pathway. Toxicol Appl Pharmacol. 2011 Dec 01;257(2):272–83. doi: 10.1016/j.taap.2011.09.013. PMID: 21982801."
642025,5790,Comparative Toxicogenomics Database (CTD),Floxuridine,D005467,Floxuridine,https://ctdbase.org/detail.go?type=chem&acc=D005467,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein results in decreased susceptibility to floxuridine,,,PMID:21613406,https://www.ncbi.nlm.nih.gov/pubmed/21613406,21613406,,PMC3138894,9339838,"Huehls AM, Wagner JM, Huntoon CJ, Geng L, Erlichman C, Patel AG, Kaufmann SH, Karnitz LM. Poly(ADP-Ribose) Polymerase Inhibition Synergizes with 5-Fluorodeoxyuridine but not 5-Fluorouracil in Ovarian Cancer Cells. 2011 Jul 14;71(14):4944–54. doi: 10.1158/0008-5472.can-11-0814."
570463,5816,Comparative Toxicogenomics Database (CTD),Epinephrine,D004837,Epinephrine,https://ctdbase.org/detail.go?type=chem&acc=D004837,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Epinephrine results in decreased cleavage of PARP1 protein,,,PMID:36423730,https://www.ncbi.nlm.nih.gov/pubmed/36423730,36423730,,,35012051,"Tiwari RK, Rawat SG, Gupta VK, Jaiswara PK, Sonker P, Kumar S, Gautam V, Mishra MK, Kumar A. Epinephrine facilitates the growth of T cell lymphoma by altering cell proliferation, apoptosis, and glucose metabolism. Chem Biol Interact. 2023 Jan 05;369():110278. doi: 10.1016/j.cbi.2022.110278. PMID: 36423730."
490721,5852,Comparative Toxicogenomics Database (CTD),Penicillamine,D010396,Penicillamine,https://ctdbase.org/detail.go?type=chem&acc=D010396,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Penicillamine results in increased cleavage of PARP1 protein,,,PMID:22843330,https://www.ncbi.nlm.nih.gov/pubmed/22843330,22843330,,PMC3779642,18136560,2012; 17(10):1079-1094
644347,5886,Comparative Toxicogenomics Database (CTD),Nadp+,D009249,NADP,https://ctdbase.org/detail.go?type=chem&acc=D009249,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of nadp]|[benzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of nadp]|[coumarin results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of NADP],,,PMID:17669606,https://www.ncbi.nlm.nih.gov/pubmed/17669606,17669606,,,22728614,"Lin PH, Lin CH, Huang CC, Chuang MC, Lin P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 2007 Aug;172(3):146–58. doi: 10.1016/j.toxlet.2007.06.003. PMID: 17669606."
648605,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[2,5,2',5'-tetrachlorobiphenyl results in increased activity of PARP1 protein] which results in decreased abundance of NAD|[3,4,3',4'-tetrachlorobiphenyl results in increased activity of PARP1 protein] which results in decreased abundance of NAD",,,PMID:19433264,https://www.ncbi.nlm.nih.gov/pubmed/19433264,19433264,,,28208088,"Lin CH, Huang CL, Chuang MC, Wang YJ, Chen DR, Chen ST, Lin PH. Protective role of estrogen receptor-alpha on lower chlorinated PCB congener-induced DNA damage and repair in human tumoral breast cells. Toxicol Lett. 2009 Jul 10;188(1):11–9. doi: 10.1016/j.toxlet.2009.02.009. PMID: 19433264."
648606,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[coumarin results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of nad]|[benzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of NAD]|[3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of NAD],,,PMID:17669606,https://www.ncbi.nlm.nih.gov/pubmed/17669606,17669606,,,22728614,"Lin PH, Lin CH, Huang CC, Chuang MC, Lin P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 2007 Aug;172(3):146–58. doi: 10.1016/j.toxlet.2007.06.003. PMID: 17669606."
648802,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"ERCC6 inhibits the reaction [NAD results in increased activity of PARP1 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [NAD results in increased activity of PARP1 protein]|nad results in increased activity of and results in increased ADP-ribosylation of PARP1 protein",,,PMID:25440059,https://www.ncbi.nlm.nih.gov/pubmed/25440059,25440059,,PMC4261735,20870164,"Scheibye-Knudsen M, Mitchell S, Fang E, Iyama T, Ward T, Wang J, Dunn C, Singh N, Veith S, Hasan-Olive M, Mangerich A, Wilson M, Mattson M, Bergersen L, Cogger V, Warren A, Le Couteur D, Moaddel R, Wilson D, Croteau D, de Cabo R, Bohr V. A High-Fat Diet and NAD + Activate Sirt1 to Rescue Premature Aging in Cockayne Syndrome. Cell Metabolism. 2014 Nov;20(5):840–55. doi: 10.1016/j.cmet.2014.10.005."
649290,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Veliparib inhibits the reaction [hydrogen peroxide affects the reaction [PARP1 protein mutant form affects the abundance of nad]]|veliparib inhibits the reaction [PARP1 protein mutant form affects the abundance of NAD]|PARP1 protein promotes the reaction [hydrogen peroxide results in decreased abundance of nad]|hydrogen peroxide affects the reaction [PARP1 protein mutant form affects the abundance of NAD]|PARP1 protein mutant form affects the abundance of NAD,,,PMID:27694308,https://www.ncbi.nlm.nih.gov/pubmed/27694308,27694308,,PMC5137445,29679245,"Rank L, Veith S, Gwosch EC, Demgenski J, Ganz M, Jongmans MC, Vogel C, Fischbach A, Buerger S, Fischer JM, Zubel T, Stier A, Renner C, Schmalz M, Beneke S, Groettrup M, Kuiper RP, Bürkle A, Ferrando-May E, Mangerich A. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells. Nucleic Acids Res. 2016 Dec 01;44(21):10386–405. PMID: 27694308; PMCID: PMC5137445."
649291,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[NAD co-treated with oleic acid] results in increased activity of PARP1 protein]|[nad co-treated with oleic acid] results in increased activity of PARP1 protein",,,PMID:25536389,https://www.ncbi.nlm.nih.gov/pubmed/25536389,25536389,,,484878,"Pang J, Cui J, Gong H, Xi C, Zhang TM. Effect of NAD on PARP-mediated insulin sensitivity in oleic acid treated hepatocytes. J Cell Physiol. 2015 Jul;230(7):1607–13. doi: 10.1002/jcp.24907. PMID: 25536389."
649292,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),XRCC1 protein affects the reaction [PARP1 protein affects the reaction [hydrogen peroxide results in decreased abundance of NAD]]|PARP1 protein affects the reaction [hydrogen peroxide results in decreased abundance of NAD],,,PMID:35778544,https://www.ncbi.nlm.nih.gov/pubmed/35778544,35778544,,PMC10042965,34003347,2022; 39(1):345-364
649293,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzamide inhibits the reaction [[methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of nad]|[methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of nad|[hydrogen peroxide results in increased activity of PARP1 protein] which results in decreased abundance of nad|benzamide inhibits the reaction [[hydrogen peroxide results in increased activity of PARP1 protein] which results in decreased abundance of nad]|hydrolyzable tannins inhibits the reaction [[methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of nad]|hydrolyzable tannins inhibits the reaction [[hydrogen peroxide results in increased activity of PARP1 protein] which results in decreased abundance of NAD],,,PMID:11593040,https://www.ncbi.nlm.nih.gov/pubmed/11593040,11593040,,PMC59796,29402615,"Ying W, Sevigny MB, Chen Y, Swanson RA. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. U.S.A. 2001 Oct 09;98(21):12227–32. doi: 10.1073/pnas.211202598."
649294,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"5-chloro-2-(3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl)-4(3H)-quinazolinone inhibits the reaction [PARP1 protein results in decreased abundance of NAD]|PARP1 protein results in decreased abundance of NAD",,,PMID:15075382,https://www.ncbi.nlm.nih.gov/pubmed/15075382,15075382,,,13914481,"Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S. A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia. The Journal of Pharmacology and Experimental Therapeutics. 2004 Aug;310(2):425–36. doi: 10.1124/jpet.104.066944."
649295,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),PARP1 protein affects the abundance of NAD,,,PMID:15147502,https://www.ncbi.nlm.nih.gov/pubmed/15147502,15147502,,,9200090,"Kosenko E, Montoliu C, Giordano G, Kaminsky Y, Venediktova N, Buryanov Y, Felipo V. Acute ammonia intoxication induces an NMDA receptor-mediated increase in poly(ADP-ribose) polymerase level and NAD<sup>+</sup> metabolism in nuclei of rat brain cells. Journal of Neurochemistry. 2004 Apr 27;89(5):1101–10. doi: 10.1111/j.1471-4159.2004.02426.x."
649296,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the metabolism of and results in increased cleavage of NAD,,,PMID:16026317,https://www.ncbi.nlm.nih.gov/pubmed/16026317,16026317,,,25477407,Virág L. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol. 2005 Jul;3(3):209–14. doi: 10.2174/1570161054368625. PMID: 16026317.
649514,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein results in decreased abundance of NAD,,,PMID:17430113,https://www.ncbi.nlm.nih.gov/pubmed/17430113,17430113,,,329967,Penberthy WT. Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease. Curr Drug Metab. 2007 Apr;8(3):245–66. doi: 10.2174/138920007780362545. PMID: 17430113.
651521,5892,Comparative Toxicogenomics Database (CTD),Nadide,D009243,NAD,https://ctdbase.org/detail.go?type=chem&acc=D009243,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[PARP1 protein co-treated with NAD] results in increased ADP-ribosylation of NR1H3 protein,,,PMID:27026705,https://www.ncbi.nlm.nih.gov/pubmed/27026705,27026705,,PMC4900266,20893705,"Shrestha E, Hussein MA, Savas JN, Ouimet M, Barrett TJ, Leone S, Yates JR, Moore KJ, Fisher EA, Garabedian MJ. Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages. Journal of Biological Chemistry. 2016 May;291(21):11172–84. doi: 10.1074/jbc.m116.726729."
720650,5894,Comparative Toxicogenomics Database (CTD),Dichlororibofuranosylbenzimidazole,D004004,Dichlororibofuranosylbenzimidazole,https://ctdbase.org/detail.go?type=chem&acc=D004004,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[dichlororibofuranosylbenzimidazole co-treated with bortezomib] results in increased cleavage of PARP1 protein,,,PMID:15039284,https://www.ncbi.nlm.nih.gov/pubmed/15039284,15039284,,,1654354,"Dai Y, Rahmani M, Pei XY, Dent P, Grant S. Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms. Blood. 2004 Jul 15;104(2):509–18. doi: 10.1182/blood-2003-12-4121. PMID: 15039284."
535810,5909,Comparative Toxicogenomics Database (CTD),Pilocarpine Hydrochloride,D010862,Pilocarpine,https://ctdbase.org/detail.go?type=chem&acc=D010862,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),U 0126 affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein]|[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein|3-chloroacetylindole affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein]|bisindolylmaleimide affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein],,,PMID:31396050,https://www.ncbi.nlm.nih.gov/pubmed/31396050,31396050,,PMC6667551,10151887,"Kim JE, Kang TC. PKC, AKT and ERK1/2-Mediated Modulations of PARP1, NF-?B and PEA15 Activities Distinctly Regulate Regional Specific Astroglial Responses Following Status Epilepticus. Front Mol Neurosci. 2019;12():180. PMID: 31396050; PMCID: PMC6667551."
535811,5909,Comparative Toxicogenomics Database (CTD),Pilocarpine Hydrochloride,D010862,Pilocarpine,https://ctdbase.org/detail.go?type=chem&acc=D010862,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pilocarpine affects the expression of PARP1 protein,,,PMID:25101675,https://www.ncbi.nlm.nih.gov/pubmed/25101675,25101675,,PMC4454306,12082823,"Kim JE, Kim YJ, Kim JY, Kang TC. PARP1 activation/expression modulates regional-specific neuronal and glial responses to seizure in a hemodynamic-independent manner. Cell Death Dis. 2014 Aug 07;5():e1362. PMID: 25101675; PMCID: PMC4454306."
621858,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of PARP1 mrna|pentylenetetrazole affects the expression of PARP1 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,PMC3071501,33618358,"Singh P, Mohammad F, Sharma A. Transcriptomic analysis in a Drosophila model identifies previously implicated and novel pathways in the therapeutic mechanism in neuropsychiatric disorders. Front Neurosci. 2011;5():161. PMID: 21503142; PMCID: PMC3071501."
595601,5921,Comparative Toxicogenomics Database (CTD),Diethylnitrosamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of PARP1 mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,,2360653,"Michel C, Desdouets C, Slaoui M, Isaacs KR, Roberts RA, Boitier E. Diethylnitrosamine initiation does not alter clofibric acid-induced hepatocarcinogenesis in the rat. Toxicol Sci. 2007 Sep;99(1):58–69. doi: 10.1093/toxsci/kfm168. PMID: 17602206."
673756,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [carbon tetrachloride results in increased expression of PARP1 protein]|carbon tetrachloride results in increased expression of PARP1 protein|puerarin inhibits the reaction [carbon tetrachloride results in increased expression of PARP1 protein]",,,PMID:27318789,https://www.ncbi.nlm.nih.gov/pubmed/27318789,27318789,,,2554722,"Wang S, Shi XL, Feng M, Wang X, Zhang ZH, Zhao X, Han B, Ma HC, Dai B, Ding YT. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition. Int Immunopharmacol. 2016 Sep;38():238–45. doi: 10.1016/j.intimp.2016.06.008. PMID: 27318789."
673757,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[dimethylformamide co-treated with carbon tetrachloride] results in increased cleavage of PARP1 protein,,,PMID:20097184,https://www.ncbi.nlm.nih.gov/pubmed/20097184,20097184,,,17372896,Kim TH et al; Chem Biol Interact 184 (3): 492-501 (2010)
812957,5944,Comparative Toxicogenomics Database (CTD),Cantharidin,D002193,Cantharidin,https://ctdbase.org/detail.go?type=chem&acc=D002193,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cantharidin results in increased cleavage of PARP1 protein,,,PMID:27113412,https://www.ncbi.nlm.nih.gov/pubmed/27113412,27113412,,,16863473,"Li CC, Yu FS, Fan MJ, Chen YY, Lien JC, Chou YC, Lu HF, Tang NY, Peng SF, Huang WW, Chung JG. Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo. Environ Toxicol. 2017 Mar;32(3):723–38. doi: 10.1002/tox.22273. PMID: 27113412."
822258,5954,Comparative Toxicogenomics Database (CTD),Benz(a)anthracene,C030935,benz(a)anthracene,https://ctdbase.org/detail.go?type=chem&acc=C030935,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benz(a)anthracene results in increased cleavage of PARP1 protein,,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
523867,5957,Comparative Toxicogenomics Database (CTD),Adenosine Triphosphate,D000255,Adenosine Triphosphate,https://ctdbase.org/detail.go?type=chem&acc=D000255,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 mutant form inhibits the reaction [cadmium results in decreased abundance of adenosine triphosphate],,,PMID:21767558,https://www.ncbi.nlm.nih.gov/pubmed/21767558,21767558,,PMC3439510,9987473,"Son Y, Wang X, Hitron JA, Zhang Z, Cheng S, Budhraja A, Ding S, Lee J, Shi X. Cadmium induces autophagy through ROS-dependent activation of the LKB1–AMPK signaling in skin epidermal cells. Toxicology and Applied Pharmacology. 2011 Sep;255(3):287–96. doi: 10.1016/j.taap.2011.06.024."
523868,5957,Comparative Toxicogenomics Database (CTD),Adenosine Triphosphate,D000255,Adenosine Triphosphate,https://ctdbase.org/detail.go?type=chem&acc=D000255,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Adenosine triphosphate results in increased expression of PARP1 protein,,,PMID:22253048,https://www.ncbi.nlm.nih.gov/pubmed/22253048,22253048,,,16772070,"Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 2011 Dec;59(12):1933–45. doi: 10.1002/glia.21235. PMID: 22253048."
523869,5957,Comparative Toxicogenomics Database (CTD),Adenosine Triphosphate,D000255,Adenosine Triphosphate,https://ctdbase.org/detail.go?type=chem&acc=D000255,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein affects the reaction [pyrithione zinc results in decreased abundance of adenosine triphosphate],,,PMID:19809895,https://www.ncbi.nlm.nih.gov/pubmed/19809895,19809895,,PMC2866994,30897287,2010; 15(3):309-322
523870,5957,Comparative Toxicogenomics Database (CTD),Adenosine Triphosphate,D000255,Adenosine Triphosphate,https://ctdbase.org/detail.go?type=chem&acc=D000255,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein affects the reaction [zinc results in decreased abundance of adenosine triphosphate],,,PMID:17728843,https://www.ncbi.nlm.nih.gov/pubmed/17728843,17728843,,PMC1952665,14644235,2007; 13(7-8):344-349
524068,5957,Comparative Toxicogenomics Database (CTD),Adenosine Triphosphate,D000255,Adenosine Triphosphate,https://ctdbase.org/detail.go?type=chem&acc=D000255,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Adenosine triphosphate results in decreased activity of PARP1 protein,,,PMID:16012769,https://www.ncbi.nlm.nih.gov/pubmed/16012769,16012769,,,25464712,"Bauer P, Kenesi E, Mendeleyev J, Kun E. The influence of ATP on poly(ADP-ribose) metabolism. Int J Mol Med. 2005 Aug 01;(). doi: 10.3892/ijmm.16.2.321."
528533,5959,Comparative Toxicogenomics Database (CTD),Chloramphenicol,D002701,Chloramphenicol,https://ctdbase.org/detail.go?type=chem&acc=D002701,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloramphenicol inhibits the reaction [mitomycin results in increased activity of PARP1 protein]|cdkn1a mutant form inhibits the reaction [chloramphenicol inhibits the reaction [mitomycin results in increased activity of PARP1 protein]],,,PMID:15905168,https://www.ncbi.nlm.nih.gov/pubmed/15905168,15905168,,,27482608,"Li CH, Tzeng SL, Cheng YW, Kang JJ. Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway. J Biol Chem. 2005 Jul 15;280(28):26193–9. doi: 10.1074/jbc.m501371200. PMID: 15905168."
672459,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Puerarin inhibits the reaction [[dietary fats co-treated with dietary sucrose] results in increased expression of PARP1 protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[dietary fats co-treated with dietary sucrose] results in increased expression of PARP1 protein]|[dietary fats co-treated with dietary sucrose] results in increased expression of PARP1 protein",,,PMID:31273855,https://www.ncbi.nlm.nih.gov/pubmed/31273855,31273855,,,8823622,"Wang S, Yang FJ, Shang LC, Zhang YH, Zhou Y, Shi XL. Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis. Phytother Res. 2019 Sep;33(9):2347–59. doi: 10.1002/ptr.6417. PMID: 31273855."
630303,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of PARP1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,,18024134,"Boverhof DR, Burgoon LD, Williams KJ, Zacharewski TR. Inhibition of estrogen-mediated uterine gene expression responses by dioxin. Mol Pharmacol. 2008 Jan;73(1):82–93. doi: 10.1124/mol.107.040451. PMID: 17942748."
881032,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [bisphenol A promotes the reaction [cholesterol results in increased cleavage of PARP1 protein]]|bisphenol A promotes the reaction [cholesterol results in increased cleavage of PARP1 protein]|cholesterol results in increased cleavage of PARP1 protein,,,PMID:33239236,https://www.ncbi.nlm.nih.gov/pubmed/33239236,33239236,,,3347969,"Yang Y, Liu C, Yang J, Yuan F, Cheng R, Chen R, Shen Y, Huang L. Impairment of sirtuin 1-mediated DNA repair is involved in bisphenol A-induced aggravation of macrophage inflammation and atherosclerosis. Chemosphere. 2021 Feb;265():128997. doi: 10.1016/j.chemosphere.2020.128997. PMID: 33239236."
712019,6001,Comparative Toxicogenomics Database (CTD),"7,12-Dimethylbenz[a]anthracene",D015127,"9,10-Dimethyl-1,2-benzanthracene",https://ctdbase.org/detail.go?type=chem&acc=D015127,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10036,Mesocricetus auratus (golden hamster),"9,10-dimethyl-1,2-benzanthracene results in decreased cleavage of PARP1 protein|quercetin inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased cleavage of PARP1 protein]",,,PMID:21294050,https://www.ncbi.nlm.nih.gov/pubmed/21294050,21294050,,,31610521,"Priyadarsini RV, Vinothini G, Murugan RS, Manikandan P, Nagini S. The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors. Nutr Cancer. 2011;63(2):218–26. doi: 10.1080/01635581.2011.523503. PMID: 21294050."
712020,6001,Comparative Toxicogenomics Database (CTD),"7,12-Dimethylbenz[a]anthracene",D015127,"9,10-Dimethyl-1,2-benzanthracene",https://ctdbase.org/detail.go?type=chem&acc=D015127,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"9,10-dimethyl-1,2-benzanthracene results in increased expression of PARP1 mrna|9,10-dimethyl-1,2-benzanthracene results in increased expression of PARP1 protein|9,10-dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 mrna]|9,10-dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 protein]",,,PMID:25448685,https://www.ncbi.nlm.nih.gov/pubmed/25448685,25448685,,PMC4275104,20878319,"Ganesan S, Nteeba J, Keating AF. Enhanced susceptibility of ovaries from obese mice to 7,12-dimethylbenz[a]anthracene-induced DNA damage. Toxicology and Applied Pharmacology. 2014 Dec;281(2):203–10. doi: 10.1016/j.taap.2014.10.004."
712021,6001,Comparative Toxicogenomics Database (CTD),"7,12-Dimethylbenz[a]anthracene",D015127,"9,10-Dimethyl-1,2-benzanthracene",https://ctdbase.org/detail.go?type=chem&acc=D015127,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"9,10-dimethyl-1,2-benzanthracene results in decreased expression of PARP1 mrna|9,10-dimethyl-1,2-benzanthracene results in increased expression of PARP1 protein",,,PMID:23969067,https://www.ncbi.nlm.nih.gov/pubmed/23969067,23969067,,PMC3885336,8027391,"Ganesan S, Bhattacharya P, Keating AF. 7,12-Dimethylbenz[a]anthracene exposure induces the DNA repair response in neonatal rat ovaries. Toxicology and Applied Pharmacology. 2013 Nov;272(3):690–6. doi: 10.1016/j.taap.2013.08.013."
729423,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Testosterone results in increased expression of PARP1 protein|resveratrol inhibits the reaction [testosterone results in increased expression of PARP1 protein],,,PMID:25714330,https://www.ncbi.nlm.nih.gov/pubmed/25714330,25714330,,,2527546,"Chung K, Cheon S, An H. Effects of Resveratrol on Benign Prostatic Hyperplasia by the Regulation of Inflammatory and Apoptotic Proteins. J. Nat. Prod. 2015 Feb 25;78(4):689–94. doi: 10.1021/np500810c."
686749,6017,Toxin and Toxin Target Database (T3DB),"10,10'-Oxybisphenoxarsine",T3D1321,Phenarsazine oxide,http://www.t3db.ca/toxins/T3D1321,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
831810,6041,Comparative Toxicogenomics Database (CTD),Phenylephrine,D010656,Phenylephrine,https://ctdbase.org/detail.go?type=chem&acc=D010656,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Phenylephrine inhibits the reaction [oxygen deficiency results in increased cleavage of PARP1 protein],,,PMID:11042672,https://www.ncbi.nlm.nih.gov/pubmed/11042672,11042672,,,217298,"Zhu H, McElwee-Witmer S, Perrone M, Clark KL, Zilberstein A. Phenylephrine protects neonatal rat cardiomyocytes from hypoxia and serum deprivation-induced apoptosis. Cell Death Differ. 2000 Sep;7(9):773–84. doi: 10.1038/sj.cdd.4400721. PMID: 11042672."
936334,6167,Comparative Toxicogenomics Database (CTD),Colchicine,D003078,Colchicine,https://ctdbase.org/detail.go?type=chem&acc=D003078,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Colchicine results in increased cleavage of PARP1 protein,,,PMID:33684465,https://www.ncbi.nlm.nih.gov/pubmed/33684465,33684465,,,18985334,"Ergul M, Bakar-Ates F. Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol In Vitro. 2021 Jun;73():105138. doi: 10.1016/j.tiv.2021.105138. PMID: 33684465."
721574,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),ITPK1 inhibits the reaction [[cycloheximide co-treated with TNF] results in increased cleavage of PARP1 protein]|[cycloheximide co-treated with TNF protein] results in increased cleavage of PARP1 protein|itpk1 mutant form promotes the reaction [[cycloheximide co-treated with TNF protein] results in increased cleavage of PARP1 protein],,,PMID:12925536,https://www.ncbi.nlm.nih.gov/pubmed/12925536,12925536,,,22634211,"Sun Y, Mochizuki Y, Majerus PW. Inositol 1,3,4-Trisphosphate 5/6-Kinase Inhibits Tumor Necrosis Factor-induced Apoptosis. Journal of Biological Chemistry. 2003 Oct;278(44):43645–53. doi: 10.1074/jbc.m300674200."
721575,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cycloheximide co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:18222423,https://www.ncbi.nlm.nih.gov/pubmed/18222423,18222423,,PMC3738302,30892116,"Ivanov VN, Partridge MA, Johnson GE, Huang SXL, Zhou H, Hei TK. Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Experimental Cell Research. 2008 Mar;314(5):1163–76. doi: 10.1016/j.yexcr.2007.12.012."
721738,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cycloheximide results in increased cleavage of PARP1 protein,,,PMID:16051428,https://www.ncbi.nlm.nih.gov/pubmed/16051428,16051428,,,22701327,"Vanderlaag K, Samudio I, Burghardt R, Barhoumi R, Safe S. Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3'-indolyl)methane (DIM) and 5,5'-dibromoDIM. Cancer Lett. 2006 May 18;236(2):198–212. doi: 10.1016/j.canlet.2005.05.036. PMID: 16051428."
721739,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cycloheximide inhibits the reaction [ammonium acetate results in increased expression of PARP1 protein],,,PMID:15147502,https://www.ncbi.nlm.nih.gov/pubmed/15147502,15147502,,,9200090,"Kosenko E, Montoliu C, Giordano G, Kaminsky Y, Venediktova N, Buryanov Y, Felipo V. Acute ammonia intoxication induces an NMDA receptor-mediated increase in poly(ADP-ribose) polymerase level and NAD<sup>+</sup> metabolism in nuclei of rat brain cells. Journal of Neurochemistry. 2004 Apr 27;89(5):1101–10. doi: 10.1111/j.1471-4159.2004.02426.x."
849146,6207,Comparative Toxicogenomics Database (CTD),Egtazic Acid,D004533,Egtazic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004533,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Egtazic acid inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:21544200,https://www.ncbi.nlm.nih.gov/pubmed/21544200,21544200,,PMC3081326,14054107,"Xu B, Chen S, Luo Y, Chen Z, Liu L, Zhou H, Chen W, Shen T, Han X, Chen L, Huang S. Calcium Signaling Is Involved in Cadmium-Induced Neuronal Apoptosis via Induction of Reactive Oxygen Species and Activation of MAPK/mTOR Network. PLoS ONE. 2011 Apr 22;6(4):e19052. doi: 10.1371/journal.pone.0019052."
849147,6207,Comparative Toxicogenomics Database (CTD),Egtazic Acid,D004533,Egtazic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004533,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with egtazic acid] inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|egtazic acid inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]",,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
545270,6213,Comparative Toxicogenomics Database (CTD),Dimethyl Sulfone,C025910,dimethyl sulfone,https://ctdbase.org/detail.go?type=chem&acc=C025910,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[doxorubicin co-treated with dimethyl sulfone] results in increased expression of PARP1 mrna|dimethyl sulfone promotes the reaction [doxorubicin results in increased expression of PARP1 mrna]|doxorubicin affects the reaction [dimethyl sulfone results in increased cleavage of PARP1 protein]|dimethyl sulfone affects the reaction [doxorubicin results in increased cleavage of PARP1 protein]|dimethyl sulfone results in increased expression of PARP1 mrna|dimethyl sulfone affects the cleavage of PARP1 protein,,,PMID:32562081,https://www.ncbi.nlm.nih.gov/pubmed/32562081,32562081,,PMC8012311,20367195,2020; 37(2):261-275
621341,6228,Comparative Toxicogenomics Database (CTD),"N,N-Dimethylformamide",D004126,Dimethylformamide,https://ctdbase.org/detail.go?type=chem&acc=D004126,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[dimethylformamide co-treated with carbon tetrachloride] results in increased cleavage of PARP1 protein,,,PMID:20097184,https://www.ncbi.nlm.nih.gov/pubmed/20097184,20097184,,,17372896,Kim TH et al; Chem Biol Interact 184 (3): 492-501 (2010)
707193,6234,Comparative Toxicogenomics Database (CTD),Cycloserine,D003523,Cycloserine,https://ctdbase.org/detail.go?type=chem&acc=D003523,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cycloserine inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein],,,PMID:24264887,https://www.ncbi.nlm.nih.gov/pubmed/24264887,24264887,,,30321197,2013; 19(3):527-541
728902,6253,Comparative Toxicogenomics Database (CTD),Cytarabine,D003561,Cytarabine,https://ctdbase.org/detail.go?type=chem&acc=D003561,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BCL2 protein inhibits the reaction [cytarabine results in increased degradation of PARP1 protein]|bcl2l1 protein inhibits the reaction [cytarabine results in increased degradation of PARP1 protein]|cytarabine results in increased degradation of PARP1 protein,,,PMID:8840993,https://www.ncbi.nlm.nih.gov/pubmed/8840993,8840993,,,4251819,"Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res. 1996 Oct 15;56(20):4743–8. PMID: 8840993."
728903,6253,Comparative Toxicogenomics Database (CTD),Cytarabine,D003561,Cytarabine,https://ctdbase.org/detail.go?type=chem&acc=D003561,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cytarabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:12780785,https://www.ncbi.nlm.nih.gov/pubmed/12780785,12780785,,,27422129,"Jones DT, Ganeshaguru K, Mitchell WA, Foroni L, Baker RJ, Prentice HG, Mehta AB, Wickremasinghe RG. Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. Br J Haematol. 2003 Jun;121(5):713–20. doi: 10.1046/j.1365-2141.2003.04340.x. PMID: 12780785."
733480,6256,Comparative Toxicogenomics Database (CTD),Trifluridine,D014271,Trifluridine,https://ctdbase.org/detail.go?type=chem&acc=D014271,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trifluridine results in increased cleavage of PARP1 protein,,,PMID:19816940,https://www.ncbi.nlm.nih.gov/pubmed/19816940,19816940,,,30903283,"Bijnsdorp IV, Peters GJ, Temmink OH, Fukushima M, Kruyt FA: Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells. Int J Cancer. 2010 May 15;126(10):2457-68. doi: 10.1002/ijc.24943."
790775,6277,Toxin and Toxin Target Database (T3DB),Cobaltous acetate,T3D0653,Cobalt(II) acetate,http://www.t3db.ca/toxins/T3D0653,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
754477,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cordycepin inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:21607289,https://www.ncbi.nlm.nih.gov/pubmed/21607289,21607289,,PMC3188885,9334512,2011; 17(9-10):893-900
754478,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cordycepin results in increased cleavage of PARP1 protein,,,PMID:21196698|PMID:23941773|PMID:35732609,https://www.ncbi.nlm.nih.gov/pubmed/21196698|https://www.ncbi.nlm.nih.gov/pubmed/23941773|https://www.ncbi.nlm.nih.gov/pubmed/35732609,21196698|23941773|35732609,,,471566|18106298|33954777,"Zhang X, Zhou X, Gao M, Lyu Y, Wang Y, Yang C, Piao Y, Ren X. [Cordycepin inhibits the proliferation and migration of human gastric cancer cells by suppressing lipid metabolism via AMPK and MAPK activation]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022 Jun;38(6):513–21. PMID: 35732609.|Lee SY, Debnath T, Kim SK, Lim BO. Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colonic cancer cell HT-29. Food Chem Toxicol. 2013 Oct;60():439–47. doi: 10.1016/j.fct.2013.07.068. PMID: 23941773.|Imesch P, Hornung R, Fink D, Fedier A. Cordycepin (3'-Deoxyadenosine), an Inhibitor of mRNA Polyadenylation, Suppresses Proliferation and Activates Apoptosis in Human Epithelial Endometriotic Cells in vitro. Gynecol Obstet Invest. 2010 Dec 24;72(1):43–9. doi: 10.1159/000322395."
754479,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Cordycepin results in increased cleavage of PARP1 protein,,,PMID:26303320,https://www.ncbi.nlm.nih.gov/pubmed/26303320,26303320,,PMC4548195,31025129,2015; 5(1):13372
754480,6303,Comparative Toxicogenomics Database (CTD),Cordycepin,C058120,cordycepin,https://ctdbase.org/detail.go?type=chem&acc=C058120,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),ADORA2A mutant form inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]|pifithrin inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]|cordycepin results in increased cleavage of PARP1 protein|tp53 mutant form inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]|acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein]|zm 241385 inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein],,,PMID:24704558,https://www.ncbi.nlm.nih.gov/pubmed/24704558,24704558,,,30995102,"Chen Y, Yang SH, Hueng DY, Syu JP, Liao CC, Wu YC. Cordycepin induces apoptosis of C6 glioma cells through the adenosine 2A receptor-p53-caspase-7-PARP pathway. Chem Biol Interact. 2014 Jun 05;216():17–25. doi: 10.1016/j.cbi.2014.03.010. PMID: 24704558."
779466,6336,Comparative Toxicogenomics Database (CTD),Myclobutanil,C446685,systhane,https://ctdbase.org/detail.go?type=chem&acc=C446685,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Systhane results in increased expression of PARP1 mRNA,,,PMID:32268158,https://www.ncbi.nlm.nih.gov/pubmed/32268158,32268158,,,28434908,"LaRocca J, Costa E, Sriram S, Hannas BR, Johnson KJ. Short-term toxicogenomics as an alternative approach to chronic in vivo studies for derivation of points of departure: A case study in the rat with a triazole fungicide. Regul Toxicol Pharmacol. 2020 Jun;113():104655. doi: 10.1016/j.yrtph.2020.104655. PMID: 32268158."
32883,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein]|acetovanillone inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein]|ly96 protein affects the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein]|1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein]",,,PMID:29111459,https://www.ncbi.nlm.nih.gov/pubmed/29111459,29111459,,,14871116,"Chen H, Song Z, Ying S, Yang X, Wu W, Tan Q, Ju X, Wu W, Zhang X, Qu J, Wang Y. Myeloid differentiation protein 2 induced retinal ischemia reperfusion injury via upregulation of ROS through a TLR4-NOX4 pathway. Toxicol Lett. 2018 Jan 05;282():109–20. doi: 10.1016/j.toxlet.2017.10.018. PMID: 29111459."
32884,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Drugs, chinese herbal inhibits the reaction [tert-butylhydroperoxide results in decreased expression of PARP1 protein]|tert-butylhydroperoxide results in decreased expression of PARP1 protein",,,PMID:28733231,https://www.ncbi.nlm.nih.gov/pubmed/28733231,28733231,,,20939654,"Lee KM, Kwon TY, Kang U, Seo EK, Yun JH, Nho CW, Kim YS. Tussilagonone-induced Nrf2 pathway activation protects HepG2 cells from oxidative injury. Food Chem Toxicol. 2017 Oct;108(Pt A):120–7. doi: 10.1016/j.fct.2017.07.035. PMID: 28733231."
32885,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nectandrin-B inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein],,,PMID:27511913,https://www.ncbi.nlm.nih.gov/pubmed/27511913,27511913,,,11445507,"Song JS, Kim EK, Choi YW, Oh WK, Kim YM. Hepatocyte-protective effect of nectandrin B, a nutmeg lignan, against oxidative stress: Role of Nrf2 activation through ERK phosphorylation and AMPK-dependent inhibition of GSK-3ß. Toxicol Appl Pharmacol. 2016 Sep 15;307():138–49. doi: 10.1016/j.taap.2016.08.003. PMID: 27511913."
32886,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein]|plant extracts inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein],,,PMID:27050144,https://www.ncbi.nlm.nih.gov/pubmed/27050144,27050144,,,20915893,"Wang A, Wang S, Jiang Y, Chen M, Wang Y, Lin L. Bio-assay guided identification of hepatoprotective polyphenols from Penthorum chinense Pursh on t-BHP induced oxidative stress injured L02 cells. Food Funct. 2016 Apr;7(4):2074–83. doi: 10.1039/c6fo00110f. PMID: 27050144."
32887,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tert-butylhydroperoxide results in increased cleavage of PARP1 protein,,,PMID:27050144|PMID:27511913|PMID:29111459,https://www.ncbi.nlm.nih.gov/pubmed/27050144|https://www.ncbi.nlm.nih.gov/pubmed/27511913|https://www.ncbi.nlm.nih.gov/pubmed/29111459,27050144|27511913|29111459,,,11445507|14871116|20915893,"Chen H, Song Z, Ying S, Yang X, Wu W, Tan Q, Ju X, Wu W, Zhang X, Qu J, Wang Y. Myeloid differentiation protein 2 induced retinal ischemia reperfusion injury via upregulation of ROS through a TLR4-NOX4 pathway. Toxicol Lett. 2018 Jan 05;282():109–20. doi: 10.1016/j.toxlet.2017.10.018. PMID: 29111459.|Song JS, Kim EK, Choi YW, Oh WK, Kim YM. Hepatocyte-protective effect of nectandrin B, a nutmeg lignan, against oxidative stress: Role of Nrf2 activation through ERK phosphorylation and AMPK-dependent inhibition of GSK-3ß. Toxicol Appl Pharmacol. 2016 Sep 15;307():138–49. doi: 10.1016/j.taap.2016.08.003. PMID: 27511913.|Wang A, Wang S, Jiang Y, Chen M, Wang Y, Lin L. Bio-assay guided identification of hepatoprotective polyphenols from Penthorum chinense Pursh on t-BHP induced oxidative stress injured L02 cells. Food Funct. 2016 Apr;7(4):2074–83. doi: 10.1039/c6fo00110f. PMID: 27050144."
32888,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"6,7-dihydroxyflavone inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein]",,,PMID:38053484,https://www.ncbi.nlm.nih.gov/pubmed/38053484,38053484,,,36263529,"Chen TX, Wang SK, Zhang YQ, Wang W, Wang Q, Yu JC, Zhao SC, Xi GL, Jin Z, Chen ZS, Tang YZ. 7,8-dihydroxyflavone displayed antioxidant effect through activating HO-1 expression and inhibiting caspase-3/PARP activation in RAW264.7 cells. J Biochem Mol Toxicol. 2024 Jan;38(1):e23602. doi: 10.1002/jbt.23602. PMID: 38053484."
32889,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Catechin inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein],,,PMID:16753784,https://www.ncbi.nlm.nih.gov/pubmed/16753784,16753784,,,9223569,"Huang Q, Wu L, Tashiro S, Onodera S, Ikejima T. Elevated levels of DNA repair enzymes and antioxidative enzymes by (+)-catechin in murine microglia cells after oxidative stress. Journal of Asian Natural Products Research. 2006 Jan;8(1-2):61–71. doi: 10.1080/10286020500209087."
32890,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tert-butylhydroperoxide results in increased cleavage of PARP1 protein,,,PMID:16753784|PMID:38053484,https://www.ncbi.nlm.nih.gov/pubmed/16753784|https://www.ncbi.nlm.nih.gov/pubmed/38053484,16753784|38053484,,,9223569|36263529,"Chen TX, Wang SK, Zhang YQ, Wang W, Wang Q, Yu JC, Zhao SC, Xi GL, Jin Z, Chen ZS, Tang YZ. 7,8-dihydroxyflavone displayed antioxidant effect through activating HO-1 expression and inhibiting caspase-3/PARP activation in RAW264.7 cells. J Biochem Mol Toxicol. 2024 Jan;38(1):e23602. doi: 10.1002/jbt.23602. PMID: 38053484.|Huang Q, Wu L, Tashiro S, Onodera S, Ikejima T. Elevated levels of DNA repair enzymes and antioxidative enzymes by (+)-catechin in murine microglia cells after oxidative stress. Journal of Asian Natural Products Research. 2006 Jan;8(1-2):61–71. doi: 10.1080/10286020500209087."
32891,6410,Comparative Toxicogenomics Database (CTD),tert-Butyl Hydroperoxide,D020122,tert-Butylhydroperoxide,https://ctdbase.org/detail.go?type=chem&acc=D020122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Tert-butylhydroperoxide results in increased cleavage of PARP1 protein|curcumin inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein],,,PMID:15569404,https://www.ncbi.nlm.nih.gov/pubmed/15569404,15569404,,,24091207,"Zhu YG, Chen XC, Chen ZZ, Zeng YQ, Shi GB, Su YH, Peng X. Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons. Acta Pharmacol Sin. 2004 Dec;25(12):1606–12. PMID: 15569404."
725523,6423,Comparative Toxicogenomics Database (CTD),Chloropicrin,C100187,chloropicrin,https://ctdbase.org/detail.go?type=chem&acc=C100187,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloropicrin results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [chloropicrin results in increased cleavage of PARP1 protein],,,PMID:31884112,https://www.ncbi.nlm.nih.gov/pubmed/31884112,31884112,,PMC11249040,598240,"Goswami DG, Kant R, Ammar DA, Agarwal C, Gomez J, Agarwal R, Saba LM, Fritz KS, Tewari-Singh N. Toxic consequences and oxidative protein carbonylation from chloropicrin exposure in human corneal epithelial cells. Toxicology Letters. 2020 Apr;322():1–11. doi: 10.1016/j.toxlet.2019.12.023."
849710,6496,Comparative Toxicogenomics Database (CTD),Divinyl sulfone,C009873,divinyl sulfone,https://ctdbase.org/detail.go?type=chem&acc=C009873,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Divinyl sulfone analog results in increased cleavage of PARP1 protein|3-methyladenine inhibits the reaction [divinyl sulfone analog results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [divinyl sulfone analog results in increased cleavage of PARP1 protein],,,PMID:24875536,https://www.ncbi.nlm.nih.gov/pubmed/24875536,24875536,,,9393305,"Zhang L, Wang H, Xu J, Zhu J, Ding K. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Toxicol Lett. 2014 Aug 04;228(3):248–59. doi: 10.1016/j.toxlet.2014.05.015. PMID: 24875536."
725121,6562,Comparative Toxicogenomics Database (CTD),Methacrolein,C039175,methacrylaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C039175,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of PARP1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of PARP1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,PMC7376215,33827165,2020; 3(1):392
732819,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of PARP1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,PMC7859602,27147867,"Rawls KD, Dougherty BV, Vinnakota KC, Pannala VR, Wallqvist A, Kolling GL, Papin JA. Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. Toxicology and Applied Pharmacology. 2021 Feb;412():115390. doi: 10.1016/j.taap.2020.115390."
828278,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [acrylamide results in increased cleavage of PARP1 protein]|acrylamide results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [acrylamide results in increased cleavage of PARP1 protein],,,PMID:27634458,https://www.ncbi.nlm.nih.gov/pubmed/27634458,27634458,,,1202792,"Komoike Y, Matsuoka M. Endoplasmic reticulum stress-mediated neuronal apoptosis by acrylamide exposure. Toxicol Appl Pharmacol. 2016 Nov 01;310():68–77. doi: 10.1016/j.taap.2016.09.005. PMID: 27634458."
828279,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acrylamide results in increased expression of PARP1 protein,,,PMID:36565847,https://www.ncbi.nlm.nih.gov/pubmed/36565847,36565847,,,34873189,"Zhang J, Zhu X, Xu W, Hu J, Shen Q, Zhu D, Xu X, Wei Z, Zhou P, Cao Y. Exposure to acrylamide inhibits testosterone production in mice testes and Leydig cells by activating ERK1/2 phosphorylation. Food Chem Toxicol. 2023 Feb;172():113576. doi: 10.1016/j.fct.2022.113576. PMID: 36565847."
791643,6597,Comparative Toxicogenomics Database (CTD),Dichloroacetic Acid,D003999,Dichloroacetic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003999,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dichloroacetic acid results in increased expression of and results in increased cleavage of PARP1 protein,,,PMID:25630799,https://www.ncbi.nlm.nih.gov/pubmed/25630799,25630799,,PMC4339541,24942616,"Rellinger EJ, Romain C, Choi S, Qiao J, Chung DH. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells. Pediatr Blood Cancer. 2015 Apr;62(4):581–6. PMID: 25630799; PMCID: PMC4339541."
582368,6618,Comparative Toxicogenomics Database (CTD),Tetrabromobisphenol A,C020806,tetrabromobisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C020806,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tetrabromobisphenol A results in decreased expression of PARP1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,PMC7024050,5374756,"Sheller-Miller S, Radnaa E, Arita Y, Getahun D, Jones RJ, Peltier MR, Menon R. Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 01;89():42–9. PMID: 31675489; PMCID: PMC7024050."
832024,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7955,Danio rerio (zebrafish),Bisphenol A affects the expression of PARP1 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,,12696098,"Villeneuve DL, Garcia-Reyero N, Escalon BL, Jensen KM, Cavallin JE, Makynen EA, Durhan EJ, Kahl MD, Thomas LM, Perkins EJ, Ankley GT. Ecotoxicogenomics to support ecological risk assessment: a case study with bisphenol A in fish. Environ Sci Technol. 2012 Jan 03;46(1):51–9. doi: 10.1021/es201150a. PMID: 21786754."
832025,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7955,Danio rerio (zebrafish),Bisphenol A results in increased expression of PARP1 mRNA,,,PMID:29027980,https://www.ncbi.nlm.nih.gov/pubmed/29027980,29027980,,PMC5664119,22930358,"Renaud L, Silveira WAD, Hazard ES, Simpson J, Falcinelli S, Chung D, Carnevali O, Hardiman G. The Plasticizer Bisphenol A Perturbs the Hepatic Epigenome: A Systems Level Analysis of the miRNome. Genes (Basel). 2017 Oct 13;8(10). PMID: 29027980; PMCID: PMC5664119."
832026,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisphenol A affects the expression of PARP1 mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,,10825043,"Kim BY, Kim M, Jeong JS, Jee SH, Park IH, Lee BC, Chung SK, Lim KM, Lee YS. Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173():124–34. doi: 10.1016/j.envres.2019.03.035. PMID: 30903817."
832027,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisphenol A results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:38372072,https://www.ncbi.nlm.nih.gov/pubmed/38372072,38372072,,,36916674,"Song JH, Hwang B, Park S, Kim S, Kim DH, Choi YH, Kim WJ, Moon SK. Bisphenol A regulates bladder cells responses via control of G2/M-phase cell cycle, apoptotic signaling, MAPK pathway, and transcription factor-associated MMP modulation. J Biochem Mol Toxicol. 2024 Mar;38(3):e23662. doi: 10.1002/jbt.23662. PMID: 38372072."
832028,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisphenol A results in decreased expression of PARP1 mRNA,,,PMID:29275510|PMID:36633214,https://www.ncbi.nlm.nih.gov/pubmed/29275510|https://www.ncbi.nlm.nih.gov/pubmed/36633214,29275510|36633214,,,1230861|35252068,"Yao Y, Zhu W, Han D, Shi X, Xu S. New Insights into How Melatonin Ameliorates Bisphenol A-Induced Colon Damage: Inhibition of NADPH Oxidase. J Agric Food Chem. 2023 Feb 08;71(5):2566–78. doi: 10.1021/acs.jafc.2c07236. PMID: 36633214.|2017; 92(4):1453-1469"
832029,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisphenol A results in decreased expression of PARP1 protein,,,PMID:31675489|PMID:37567409,https://www.ncbi.nlm.nih.gov/pubmed/31675489|https://www.ncbi.nlm.nih.gov/pubmed/37567409,31675489|37567409,,PMC7024050,5374756|35594414,"Lamberto F, Shashikadze B, Elkhateib R, Lombardo SD, Horánszky A, Balogh A, Kistamás K, Zana M, Menche J, Fröhlich T, Dinnyés A. Low-dose Bisphenol A exposure alters the functionality and cellular environment in a human cardiomyocyte model. Environ Pollut. 2023 Oct 15;335():122359. doi: 10.1016/j.envpol.2023.122359. PMID: 37567409.|Sheller-Miller S, Radnaa E, Arita Y, Getahun D, Jones RJ, Peltier MR, Menon R. Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 01;89():42–9. PMID: 31675489; PMCID: PMC7024050."
832030,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisphenol A results in increased expression of PARP1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,,1984355,"Schaffert A, Krieg L, Weiner J, Schlichting R, Ueberham E, Karkossa I, Bauer M, Landgraf K, Junge KM, Wabitsch M, Lehmann J, Escher BI, Zenclussen AC, Körner A, Blüher M, Heiker JT, von Bergen M, Schubert K. Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156():106730. doi: 10.1016/j.envint.2021.106730. PMID: 34186270."
832031,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Melatonin inhibits the reaction [bisphenol A results in decreased expression of PARP1 mrna]|bisphenol A results in decreased expression of PARP1 mRNA,,,PMID:36633214,https://www.ncbi.nlm.nih.gov/pubmed/36633214,36633214,,,35252068,"Yao Y, Zhu W, Han D, Shi X, Xu S. New Insights into How Melatonin Ameliorates Bisphenol A-Induced Colon Damage: Inhibition of NADPH Oxidase. J Agric Food Chem. 2023 Feb 08;71(5):2566–78. doi: 10.1021/acs.jafc.2c07236. PMID: 36633214."
832157,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [bisphenol A promotes the reaction [cholesterol results in increased cleavage of PARP1 protein]]|bisphenol A promotes the reaction [cholesterol results in increased cleavage of PARP1 protein],,,PMID:33239236,https://www.ncbi.nlm.nih.gov/pubmed/33239236,33239236,,,3347969,"Yang Y, Liu C, Yang J, Yuan F, Cheng R, Chen R, Shen Y, Huang L. Impairment of sirtuin 1-mediated DNA repair is involved in bisphenol A-induced aggravation of macrophage inflammation and atherosclerosis. Chemosphere. 2021 Feb;265():128997. doi: 10.1016/j.chemosphere.2020.128997. PMID: 33239236."
832158,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Bisphenol A results in increased cleavage of PARP1 protein,,,PMID:39260547,https://www.ncbi.nlm.nih.gov/pubmed/39260547,39260547,,,37753189,"Das S, Mukherjee U, Biswas S, Banerjee S, Karmakar S, Maitra S. Unravelling bisphenol A-induced hepatotoxicity: Insights into oxidative stress, inflammation, and energy dysregulation. Environ Pollut. 2024 Dec 01;362():124922. doi: 10.1016/j.envpol.2024.124922. PMID: 39260547."
832159,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of PARP1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,PMC4152015,23563990,"Ali S, Steinmetz G, Montillet G, Perrard M, Loundou A, Durand P, Guichaoua M, Prat O. Exposure to Low-Dose Bisphenol A Impairs Meiosis in the Rat Seminiferous Tubule Culture Model: A Physiotoxicogenomic Approach. PLoS ONE. 2014 Sep 02;9(9):e106245. doi: 10.1371/journal.pone.0106245."
832160,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with tributyltin] results in increased expression of PARP1 mRNA,,,PMID:31129395,https://www.ncbi.nlm.nih.gov/pubmed/31129395,31129395,,,1940181,"Yang Z, Shi J, Guo Z, Chen M, Wang C, He C, Zuo Z. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats. Chemosphere. 2019 Sep;231():151–60. doi: 10.1016/j.chemosphere.2019.05.129. PMID: 31129395."
832161,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased cleavage of PARP1 protein|genistein inhibits the reaction [bisphenol A results in decreased cleavage of PARP1 protein],,,PMID:24884420,https://www.ncbi.nlm.nih.gov/pubmed/24884420,24884420,,PMC4049406,9400635,2014; 14(1):379
832162,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of PARP1 mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,PMC8708761,11578789,"Kanlayaprasit S, Thongkorn S, Panjabud P, Jindatip D, Hu VW, Kikkawa T, Osumi N, Sarachana T. Autism-Related Transcription Factors Underlying the Sex-Specific Effects of Prenatal Bisphenol A Exposure on Transcriptome-Interactome Profiles in the Offspring Prefrontal Cortex. Int J Mol Sci. 2021 Dec 08;22(24). PMID: 34947998; PMCID: PMC8708761."
832163,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of PARP1 protein,,,PMID:27189055,https://www.ncbi.nlm.nih.gov/pubmed/27189055,27189055,,,27668511,"Wang C, Qi S, Liu C, Yang A, Fu W, Quan C, Duan P, Yu T, Yang K. Mitochondrial Dysfunction and Ca2+ Overload in Injured Sertoli Cells Exposed to Bisphenol A. Environ Toxicol. 2017 Mar;32(3):823–31. doi: 10.1002/tox.22282. PMID: 27189055."
832164,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased cleavage of PARP1 protein,,,PMID:35567931|PMID:35887390,https://www.ncbi.nlm.nih.gov/pubmed/35567931|https://www.ncbi.nlm.nih.gov/pubmed/35887390,35567931|35887390,,PMC9321671,34282202|35428193,"Liu R, Liu B, Tian L, Jiang X, Li X, Cai D, Sun J, Bai W, Jin Y. Exposure to Bisphenol A Caused Hepatoxicity and Intestinal Flora Disorder in Rats. Int J Mol Sci. 2022 Jul 21;23(14). PMID: 35887390; PMCID: PMC9321671.|Liu R, Cai D, Li X, Liu B, Chen J, Jiang X, Li H, Li Z, Teerds K, Sun J, Bai W, Jin Y. Effects of Bisphenol A on reproductive toxicity and gut microbiota dysbiosis in male rats. Ecotoxicol Environ Saf. 2022 Jul 01;239():113623. doi: 10.1016/j.ecoenv.2022.113623. PMID: 35567931."
832165,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of PARP1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,PMC5448018,6011720,"Jadhav RR, Santucci-Pereira J, Wang YV, Liu J, Nguyen TD, Wang J, Jenkins S, Russo J, Huang TH, Jin VX, Lamartiniere CA. DNA Methylation Targets Influenced by Bisphenol A and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients. Genes (Basel). 2017 May 15;8(5). PMID: 28505145; PMCID: PMC5448018."
908119,6626,Comparative Toxicogenomics Database (CTD),Bisphenol S,C543008,bisphenol S,https://ctdbase.org/detail.go?type=chem&acc=C543008,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisphenol S results in increased expression of PARP1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,,1984355,"Schaffert A, Krieg L, Weiner J, Schlichting R, Ueberham E, Karkossa I, Bauer M, Landgraf K, Junge KM, Wabitsch M, Lehmann J, Escher BI, Zenclussen AC, Körner A, Blüher M, Heiker JT, von Bergen M, Schubert K. Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156():106730. doi: 10.1016/j.envint.2021.106730. PMID: 34186270."
908120,6626,Comparative Toxicogenomics Database (CTD),Bisphenol S,C543008,bisphenol S,https://ctdbase.org/detail.go?type=chem&acc=C543008,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Bisphenol S results in increased expression of PARP1 mRNA,,,PMID:39298647,https://www.ncbi.nlm.nih.gov/pubmed/39298647,39298647,,PMC11412574,37758763,"Wang Q, Gao S, Chen B, Zhao J, Li W, Wu L. Evaluating the Effects of Perinatal Exposures to BPSIP on Hepatic Cholesterol Metabolism in Female and Male Offspring ICR Mice. Environ Health Perspect. 2024 Sep;132(9):97011. PMID: 39298647; PMCID: PMC11412574."
979976,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of PARP1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of PARP1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,PMC7376215,33827165,2020; 3(1):392
807529,6736,Comparative Toxicogenomics Database (CTD),Skatole,D012862,Skatole,https://ctdbase.org/detail.go?type=chem&acc=D012862,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Skatole results in increased cleavage of PARP1 protein,,,PMID:19700606,https://www.ncbi.nlm.nih.gov/pubmed/19700606,19700606,,PMC2769061,26209069,"Weems JM, Cutler NS, Moore C, Nichols WK, Martin D, Makin E, Lamb JG, Yost GS. 3-Methylindole is mutagenic and a possible pulmonary carcinogen. Toxicol Sci. 2009 Nov;112(1):59–67. PMID: 19700606; PMCID: PMC2769061."
953056,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),ATG5 protein affects the reaction [sirolimus inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]]|sirolimus inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:19682553,https://www.ncbi.nlm.nih.gov/pubmed/19682553,19682553,,,26192256,"Pan T, Rawal P, Wu Y, Xie W, Jankovic J, Le W. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience. 2009 Dec 01;164(2):541–51. doi: 10.1016/j.neuroscience.2009.08.014. PMID: 19682553."
954072,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BECN1 protein affects the reaction [resveratrol inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]]|3-methyladenine inhibits the reaction [resveratrol inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]]|resveratrol inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:21778691,https://www.ncbi.nlm.nih.gov/pubmed/21778691,21778691,,PMC3699815,9998083,"Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T. Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease. Neurosignals. 2011;19(3):163–74. doi: 10.1159/000328516."
954073,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aspartyl-glutamyl-valyl-aspartal inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:14976342,https://www.ncbi.nlm.nih.gov/pubmed/14976342,14976342,,,28797949,"Newhouse K, Hsuan SL, Chang SH, Cai B, Wang Y, Xia Z: Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells. Toxicol Sci. 2004 May;79(1):137-46. Epub 2004 Feb 19."
954074,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rotenone results in increased expression of PARP1 protein modified form|fmc1 protein promotes the reaction [rotenone results in increased expression of PARP1 protein modified form],,,PMID:29371327,https://www.ncbi.nlm.nih.gov/pubmed/29371327,29371327,,PMC5836091,10802462,2018; 19(3)
954075,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[PSME4 protein affects the susceptibility to rotenone] which results in decreased expression of PARP1 protein modified form,,,PMID:32368861,https://www.ncbi.nlm.nih.gov/pubmed/32368861,32368861,,PMC7299700,1301527,"Douida A, Batista F, Robaszkiewicz A, Boto P, Aladdin A, Szenykiv M, Czinege R, Virág L, Tar K. The proteasome activator PA200 regulates expression of genes involved in cell survival upon selective mitochondrial inhibition in neuroblastoma cells. J Cellular Molecular Medi. 2020 May 05;24(12):6716–30. doi: 10.1111/jcmm.15323."
954076,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]|sb 203580 inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:19777565,https://www.ncbi.nlm.nih.gov/pubmed/19777565,19777565,,,28863898,"Deng YT, Huang HC, Lin JK. Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol Carcinog. 2010 Feb;49(2):141–51. doi: 10.1002/mc.20583. PMID: 19777565."
954077,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ranitidine inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:19723537,https://www.ncbi.nlm.nih.gov/pubmed/19723537,19723537,,,32907541,"Park HJ, Kim HJ, Park HK, Chung JH. Protective effect of histamine H2 receptor antagonist ranitidine against rotenone-induced apoptosis. Neurotoxicology. 2009 Nov;30(6):1114–9. doi: 10.1016/j.neuro.2009.08.005. PMID: 19723537."
954078,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rotenone inhibits the reaction [evodiamine results in increased cleavage of PARP1 protein],,,PMID:34808100,https://www.ncbi.nlm.nih.gov/pubmed/34808100,34808100,,,32517841,"Liu L, Sun X, Guo Y, Ge K. Evodiamine induces ROS-Dependent cytotoxicity in human gastric cancer cells via TRPV1/Ca2+ pathway. Chem Biol Interact. 2022 Jan 05;351():109756. doi: 10.1016/j.cbi.2021.109756. PMID: 34808100."
954079,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rotenone results in increased cleavage of PARP1 protein,,,PMID:14976342|PMID:19539006|PMID:19682553|PMID:19723537|PMID:19777565|PMID:21778691,https://www.ncbi.nlm.nih.gov/pubmed/14976342|https://www.ncbi.nlm.nih.gov/pubmed/19539006|https://www.ncbi.nlm.nih.gov/pubmed/19682553|https://www.ncbi.nlm.nih.gov/pubmed/19723537|https://www.ncbi.nlm.nih.gov/pubmed/19777565|https://www.ncbi.nlm.nih.gov/pubmed/21778691,14976342|19539006|19682553|19723537|19777565|21778691,,PMC3699815,1071373|9998083|26192256|28797949|28863898|32907541,"Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T. Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease. Neurosignals. 2011;19(3):163–74. doi: 10.1159/000328516.|Pan T, Rawal P, Wu Y, Xie W, Jankovic J, Le W. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience. 2009 Dec 01;164(2):541–51. doi: 10.1016/j.neuroscience.2009.08.014. PMID: 19682553.|Park HJ, Kim HJ, Park HK, Chung JH. Protective effect of histamine H2 receptor antagonist ranitidine against rotenone-induced apoptosis. Neurotoxicology. 2009 Nov;30(6):1114–9. doi: 10.1016/j.neuro.2009.08.005. PMID: 19723537.|Deng YT, Huang HC, Lin JK. Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol Carcinog. 2010 Feb;49(2):141–51. doi: 10.1002/mc.20583. PMID: 19777565.|Kim HJ, Park HJ, Park HK, Chung JH. Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Toxicology. 2009 Aug 03;262(2):171–4. doi: 10.1016/j.tox.2009.06.004. PMID: 19539006.|Newhouse K, Hsuan SL, Chang SH, Cai B, Wang Y, Xia Z: Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells. Toxicol Sci. 2004 May;79(1):137-46. Epub 2004 Feb 19."
954080,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tranexamic acid inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:19539006,https://www.ncbi.nlm.nih.gov/pubmed/19539006,19539006,,,1071373,"Kim HJ, Park HJ, Park HK, Chung JH. Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Toxicology. 2009 Aug 03;262(2):171–4. doi: 10.1016/j.tox.2009.06.004. PMID: 19539006."
954271,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Rotenone inhibits the reaction [arsenic trioxide results in increased expression of PARP1 protein modified form],,,PMID:29095437,https://www.ncbi.nlm.nih.gov/pubmed/29095437,29095437,,PMC5775401,14856065,"Ling S, Shan Q, Liu P, Feng T, Zhang X, Xiang P, Chen K, Xie H, Song P, Zhou L, Liu J, Zheng S, Xu X. Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I. Cell Death & Disease. 2017 Nov 02;8(11):e3159. doi: 10.1038/cddis.2017.482."
954272,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),SNCAIP protein inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]|rotenone results in increased cleavage of PARP1 protein,,,PMID:19857556,https://www.ncbi.nlm.nih.gov/pubmed/19857556,19857556,,PMC6424117,1735047,"Li X, Liu Z, Tamashiro K, Shi B, Rudnicki DD, Ross CA, Moran TH, Smith WW. Synphilin-1 exhibits trophic and protective effects against Rotenone toxicity. Neuroscience. 2010 Jan;165(2):455–62. doi: 10.1016/j.neuroscience.2009.10.042."
954274,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[rotenone results in increased abundance of hydrogen peroxide] which results in increased cleavage of PARP1 protein|cat protein inhibits the reaction [[rotenone results in increased abundance of hydrogen peroxide] which results in increased cleavage of PARP1 protein],,,PMID:25304210,https://www.ncbi.nlm.nih.gov/pubmed/25304210,25304210,,PMC4274383,5249779,"Zhou Q, Liu C, Liu W, Zhang H, Zhang R, Liu J, Zhang J, Xu C, Liu L, Huang S, Chen L. Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis. Toxicol Sci. 2015 Jan;143(1):81–96. PMID: 25304210; PMCID: PMC4274383."
954275,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]|rotenone results in increased cleavage of PARP1 protein,,,PMID:25247703,https://www.ncbi.nlm.nih.gov/pubmed/25247703,25247703,,,19520169,"Kabiraj P, Marin JE, Varela-Ramirez A, Zubia E, Narayan M. Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers. ACS Chem Neurosci. 2014 Dec 17;5(12):1209–20. doi: 10.1021/cn500214k. PMID: 25247703."
904602,6781,Comparative Toxicogenomics Database (CTD),Diethyl Phthalate,C007379,diethyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C007379,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Diethyl phthalate results in increased expression of and results in increased cleavage of PARP1 protein,,,PMID:37942807,https://www.ncbi.nlm.nih.gov/pubmed/37942807,37942807,,,36172402,"Mondal S, Basu S, Ghosh S, Guria S, Mukherjee S. Diethyl phthalate, a plasticizer, induces adipocyte inflammation and apoptosis in mice after long-term dietary administration. J Biochem Mol Toxicol. 2024 Jan;38(1):e23561. doi: 10.1002/jbt.23561. PMID: 37942807."
934061,6795,Comparative Toxicogenomics Database (CTD),Diquat,D004178,Diquat,https://ctdbase.org/detail.go?type=chem&acc=D004178,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Diquat results in increased cleavage of PARP1 protein,,,PMID:25693864,https://www.ncbi.nlm.nih.gov/pubmed/25693864,25693864,,PMC4572080,2706388,2015; 89(10):1811-1825
944071,7046,Comparative Toxicogenomics Database (CTD),"1,2,3,4-Tetrahydroisoquinoline",D044005,Tetrahydroisoquinolines,https://ctdbase.org/detail.go?type=chem&acc=D044005,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tetrahydroisoquinolines results in increased cleavage of PARP1 protein,,,PMID:30342220,https://www.ncbi.nlm.nih.gov/pubmed/30342220,30342220,,,16923883,"Cao FJ, Xu MX, Zhou BH, Du YS, Yao JH, Zhou L. Effects of 2-aryl-1-cyano-1,2,3,4-tetrohydroisoquinolines on apoptosis induction mechanism in NB4 and MKN-45 cells. Toxicol In Vitro. 2019 Feb;54():295–303. doi: 10.1016/j.tiv.2018.10.007. PMID: 30342220."
43224,7127,Comparative Toxicogenomics Database (CTD),Methyleugenol,C005223,methyleugenol,https://ctdbase.org/detail.go?type=chem&acc=C005223,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methyleugenol results in increased cleavage of PARP1 protein,,,PMID:28818686,https://www.ncbi.nlm.nih.gov/pubmed/28818686,28818686,,,548891,"Groh IAM, Esselen M. Methyleugenol and selected oxidative metabolites affect DNA-Damage signalling pathways and induce apoptosis in human colon tumour HT29 cells. Food Chem Toxicol. 2017 Oct;108(Pt A):267–75. doi: 10.1016/j.fct.2017.08.014. PMID: 28818686."
950403,7187,Comparative Toxicogenomics Database (CTD),Benzoyl Peroxide,D001585,Benzoyl Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D001585,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide inhibits the reaction [benzoyl peroxide results in increased activity of PARP1 protein]|benzoyl peroxide results in increased activity of PARP1 protein,,,PMID:2120135|PMID:2126186,https://www.ncbi.nlm.nih.gov/pubmed/2120135|https://www.ncbi.nlm.nih.gov/pubmed/2126186,2120135|2126186,,PMC2002381,2055236|15702803,Singh N. Effect of tumour promoters on poly ADP-ribosylation in human epidermoid carcinoma HeP2 cells. Int J Exp Pathol. 1990 Dec;71(6):809–14. PMID: 2126186; PMCID: PMC2002381.|Singh N. A comparative study on the effect of tumor promoters on poly ADP-ribosylation in A431 cells. Int J Cancer. 1990 Oct 15;46(4):648–52. doi: 10.1002/ijc.2910460416. PMID: 2120135.
950404,7187,Comparative Toxicogenomics Database (CTD),Benzoyl Peroxide,D001585,Benzoyl Peroxide,https://ctdbase.org/detail.go?type=chem&acc=D001585,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CAT protein inhibits the reaction [benzoyl peroxide results in increased activity of PARP1 protein]|butylated hydroxytoluene inhibits the reaction [benzoyl peroxide results in increased activity of PARP1 protein],,,PMID:2126186,https://www.ncbi.nlm.nih.gov/pubmed/2126186,2126186,,PMC2002381,2055236,Singh N. Effect of tumour promoters on poly ADP-ribosylation in human epidermoid carcinoma HeP2 cells. Int J Exp Pathol. 1990 Dec;71(6):809–14. PMID: 2126186; PMCID: PMC2002381.
1142849,7276,Comparative Toxicogenomics Database (CTD),Styrene Oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Styrene oxide results in increased cleavage of PARP1 protein,,,PMID:11929631,https://www.ncbi.nlm.nih.gov/pubmed/11929631,11929631,,,4310329,"Daré E, Tofighi R, Vettori MV, Momoi T, Poli D, Saido TC, Mutti A, Ceccatelli S. Styrene 7,8-oxide induces caspase activation and regular DNA fragmentation in neuronal cells. Brain Res. 2002 Apr 12;933(1):12–22. doi: 10.1016/s0006-8993(02)02274-6. PMID: 11929631."
1142850,7276,Comparative Toxicogenomics Database (CTD),Styrene Oxide,C013690,styrene oxide,https://ctdbase.org/detail.go?type=chem&acc=C013690,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Styrene oxide results in increased cleavage of PARP1 protein,,,PMID:17662326,https://www.ncbi.nlm.nih.gov/pubmed/17662326,17662326,,,22721915,"Corsi P, D'Aprile A, Nico B, Costa GL, Assennato G. Synaptic contacts impaired by styrene-7,8-oxide toxicity. Toxicol Appl Pharmacol. 2007 Oct 01;224(1):49–59. doi: 10.1016/j.taap.2007.06.021. PMID: 17662326."
736895,7289,Comparative Toxicogenomics Database (CTD),"1,3-Dichloro-2-propanol",C033489,"1,3-dichloro-2-propanol",https://ctdbase.org/detail.go?type=chem&acc=C033489,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased cleavage of PARP1 protein]|1,3-dichloro-2-propanol results in increased cleavage of PARP1 protein",,,PMID:29248572,https://www.ncbi.nlm.nih.gov/pubmed/29248572,29248572,,,20270741,"Xiao C, He P, Han J, Tang M, Wang Z, Mi Y, Liu X. 1,3-Dichloro-2-propanol evokes inflammation and apoptosis in BV-2 microglia via MAPKs and NF-?B signaling pathways mediated by reactive oxygen species. Toxicol Lett. 2018 Mar 01;284():103–12. doi: 10.1016/j.toxlet.2017.12.011. PMID: 29248572."
979313,7305,Comparative Toxicogenomics Database (CTD),Soman,D012999,Soman,https://ctdbase.org/detail.go?type=chem&acc=D012999,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Soman results in decreased expression of PARP1 mRNA,,,PMID:19281266,https://www.ncbi.nlm.nih.gov/pubmed/19281266,19281266,,,18702056,"Dillman JF, Phillips CS, Kniffin DM, Tompkins CP, Hamilton TA, Kan RK. Gene expression profiling of rat hippocampus following exposure to the acetylcholinesterase inhibitor soman. Chem Res Toxicol. 2009 Apr;22(4):633–8. doi: 10.1021/tx800466v. PMID: 19281266."
902140,7365,Toxin and Toxin Target Database (T3DB),Benzenearsonic acid,T3D0310,Benzenearsonic acid,http://www.t3db.ca/toxins/T3D0310,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
903555,7389,Toxin and Toxin Target Database (T3DB),Arsanilic Acid,T3D0300,Arsanilic acid,http://www.t3db.ca/toxins/T3D0300,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
44224,7427,Comparative Toxicogenomics Database (CTD),Trehalose,D014199,Trehalose,https://ctdbase.org/detail.go?type=chem&acc=D014199,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trehalose inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased expression of PARP1 protein],,,PMID:23011206,https://www.ncbi.nlm.nih.gov/pubmed/23011206,23011206,,,32980482,2012; 38(1):50-58
44225,7427,Comparative Toxicogenomics Database (CTD),Trehalose,D014199,Trehalose,https://ctdbase.org/detail.go?type=chem&acc=D014199,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trehalose promotes the reaction [ovatodiolide results in increased cleavage of PARP1 protein],,,PMID:38000454,https://www.ncbi.nlm.nih.gov/pubmed/38000454,38000454,,,36430276,"Xia Q, Xie J, Zhang J, Zhang L, Zhou Y, Zhu B, Wu Y, Yang Z, Li J. Ovatodiolide induces autophagy-mediated cell death through the p62-Keap1-Nrf2 signaling pathway in chronic myeloid leukemia cells. Chem Biol Interact. 2024 Jan 05;387():110819. doi: 10.1016/j.cbi.2023.110819. PMID: 38000454."
913449,7452,Comparative Toxicogenomics Database (CTD),"1,3-Dinitrobenzene",C017906,3-dinitrobenzene,https://ctdbase.org/detail.go?type=chem&acc=C017906,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Pyrazolanthrone inhibits the reaction [3-dinitrobenzene results in increased cleavage of PARP1 protein]|3-dinitrobenzene results in increased cleavage of PARP1 protein,,,PMID:19477251,https://www.ncbi.nlm.nih.gov/pubmed/19477251,19477251,,,20083392,"Lee YS, Yoon HJ, Oh JH, Park HJ, Lee EH, Song CW, Yoon S. 1,3-Dinitrobenzene induces apoptosis in TM4 mouse Sertoli cells: Involvement of the c-Jun N-terminal kinase (JNK) MAPK pathway. Toxicol Lett. 2009 Sep 10;189(2):145–51. doi: 10.1016/j.toxlet.2009.05.014. PMID: 19477251."
44266,7526,Comparative Toxicogenomics Database (CTD),N-Nitrosopiperidine,C002743,N-nitrosopiperidine,https://ctdbase.org/detail.go?type=chem&acc=C002743,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),N-nitrosopiperidine results in increased cleavage of PARP1 protein,,,PMID:17929238,https://www.ncbi.nlm.nih.gov/pubmed/17929238,17929238,,,1034371,2007; 28(4):455-465
965507,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in increased expression of PARP1 mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,,7223744,"Kwon SB, Park JS, Yi JY, Hwang JW, Kim M, Lee MO, Lee BH, Kim HL, Kim JH, Chung H, Kong G, Kang KS, Yoon BI. Time- and dose-based gene expression profiles produced by a bile-duct-damaging chemical, 4,4'-methylene dianiline, in mouse liver in an acute phase. Toxicol Pathol. 2008 Jul;36(5):660–73. doi: 10.1177/0192623308320272. PMID: 18648102."
990329,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10029,Cricetulus griseus (Chinese hamster),Acrolein results in increased cleavage of PARP1 protein|benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [acrolein results in increased cleavage of PARP1 protein],,,PMID:17320762,https://www.ncbi.nlm.nih.gov/pubmed/17320762,17320762,,,15307002,"Tanel A, Averill-Bates DA. Activation of the death receptor pathway of apoptosis by the aldehyde acrolein. Free Radic Biol Med. 2007 Mar 15;42(6):798–810. doi: 10.1016/j.freeradbiomed.2006.12.009. PMID: 17320762."
990331,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of PARP1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of PARP1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,PMC7376215,33827165,2020; 3(1):392
990332,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acrolein results in increased cleavage of PARP1 protein,,,PMID:19596284|PMID:29964147,https://www.ncbi.nlm.nih.gov/pubmed/19596284|https://www.ncbi.nlm.nih.gov/pubmed/29964147,19596284|29964147,,,6748319|29549669,"Huang CH, Chen YT, Lin JH, Wang HT. Acrolein induces ribotoxic stress in human cancer cells regardless of p53 status. Toxicol In Vitro. 2018 Oct;52():265–71. doi: 10.1016/j.tiv.2018.06.022. PMID: 29964147.|Roy J, Pallepati P, Bettaieb A, Tanel A, Averill-Bates DA. Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells. Chem Biol Interact. 2009 Oct 07;181(2):154–67. doi: 10.1016/j.cbi.2009.07.001. PMID: 19596284."
990333,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [acrolein results in increased cleavage of PARP1 protein]|tp53 protein affects the reaction [acrolein results in increased cleavage of PARP1 protein],,,PMID:29964147,https://www.ncbi.nlm.nih.gov/pubmed/29964147,29964147,,,6748319,"Huang CH, Chen YT, Lin JH, Wang HT. Acrolein induces ribotoxic stress in human cancer cells regardless of p53 status. Toxicol In Vitro. 2018 Oct;52():265–71. doi: 10.1016/j.tiv.2018.06.022. PMID: 29964147."
990508,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Acrolein results in increased cleavage of PARP1 protein|3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amide inhibits the reaction [acrolein results in increased cleavage of PARP1 protein]",,,PMID:31639409,https://www.ncbi.nlm.nih.gov/pubmed/31639409,31639409,,,24376592,"Park JH, Choi JY, Jo C, Koh YH. Involvement of ADAM10 in acrolein-induced astrocytic inflammation. Toxicol Lett. 2020 Jan;318():44–9. doi: 10.1016/j.toxlet.2019.10.005. PMID: 31639409."
1018834,7855,Comparative Toxicogenomics Database (CTD),Acrylonitrile,D000181,Acrylonitrile,https://ctdbase.org/detail.go?type=chem&acc=D000181,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [acrylonitrile results in increased cleavage of PARP1 protein]|acrylonitrile results in increased cleavage of PARP1 protein,,,PMID:20981856,https://www.ncbi.nlm.nih.gov/pubmed/20981856,20981856,,,30246948,"Watcharasit P, Suntararuks S, Visitnonthachai D, Thiantanawat A, Satayavivad J. Acrylonitrile induced apoptosis via oxidative stress in neuroblastoma SH-SY5Y cell. J Appl Toxicol. 2010 Oct;30(7):649–55. doi: 10.1002/jat.1535. PMID: 20981856."
883475,7881,Comparative Toxicogenomics Database (CTD),Dibutyl phosphate,C065087,di-n-butylphosphoric acid,https://ctdbase.org/detail.go?type=chem&acc=C065087,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Di-n-butylphosphoric acid affects the expression of PARP1 mRNA,,,PMID:37042841,https://www.ncbi.nlm.nih.gov/pubmed/37042841,37042841,,PMC10094192,35644395,"Ding E, Deng F, Fang J, Li T, Hou M, Liu J, Miao K, Yan W, Fang K, Shi W, Fu Y, Liu Y, Dong H, Dong L, Ding C, Liu X, Pollitt KJG, Ji JS, Shi Y, Cai Y, Tang S, Shi X. Association between Organophosphate Ester Exposure and Insulin Resistance with Glycometabolic Disorders among Older Chinese Adults 60-69 Years of Age: Evidence from the China BAPE Study. Environ Health Perspect. 2023 Apr;131(4):47009. PMID: 37042841; PMCID: PMC10094192."
1007447,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Triphenyl phosphate affects the expression of PARP1 mRNA,,,PMID:37042841,https://www.ncbi.nlm.nih.gov/pubmed/37042841,37042841,,PMC10094192,35644395,"Ding E, Deng F, Fang J, Li T, Hou M, Liu J, Miao K, Yan W, Fang K, Shi W, Fu Y, Liu Y, Dong H, Dong L, Ding C, Liu X, Pollitt KJG, Ji JS, Shi Y, Cai Y, Tang S, Shi X. Association between Organophosphate Ester Exposure and Insulin Resistance with Glycometabolic Disorders among Older Chinese Adults 60-69 Years of Age: Evidence from the China BAPE Study. Environ Health Perspect. 2023 Apr;131(4):47009. PMID: 37042841; PMCID: PMC10094192."
1007448,8289,Comparative Toxicogenomics Database (CTD),Triphenyl phosphate,C005445,triphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005445,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Triphenyl phosphate affects the expression of PARP1 mRNA,,,PMID:30589522,https://www.ncbi.nlm.nih.gov/pubmed/30589522,30589522,,,,
1050350,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7955,Danio rerio (zebrafish),Diethylhexyl phthalate results in increased expression of PARP1 mRNA,,,PMID:33120273,https://www.ncbi.nlm.nih.gov/pubmed/33120273,33120273,,,6096946,"Lu C, Luo J, Liu Y, Yang X. The oxidative stress responses caused by phthalate acid esters increases mRNA abundance of base excision repair (BER) genes in vivo and in vitro. Ecotoxicol Environ Saf. 2021 Jan 15;208():111525. doi: 10.1016/j.ecoenv.2020.111525. PMID: 33120273."
1050351,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [diethylhexyl phthalate results in increased cleavage of PARP1 protein]|prdx5 protein inhibits the reaction [diethylhexyl phthalate results in increased cleavage of PARP1 protein]|diethylhexyl phthalate results in increased cleavage of PARP1 protein,,,PMID:31408635,https://www.ncbi.nlm.nih.gov/pubmed/31408635,31408635,,,10164090,"Lee DG, Kim KM, Lee HS, Bae YC, Huh JW, Lee SR, Lee DS. Peroxiredoxin 5 prevents diethylhexyl phthalate-induced neuronal cell death by inhibiting mitochondrial fission in mouse hippocampal HT-22 cells. Neurotoxicology. 2019 Sep;74():242–51. doi: 10.1016/j.neuro.2019.08.003. PMID: 31408635."
1050352,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Diethylhexyl phthalate results in decreased expression of PARP1 mRNA,,,PMID:33754040,https://www.ncbi.nlm.nih.gov/pubmed/33754040,33754040,,PMC7978297,11539928,"Wang JJ, Tian Y, Li MH, Feng YQ, Kong L, Zhang FL, Shen W. Single-cell transcriptome dissection of the toxic impact of Di (2-ethylhexyl) phthalate on primordial follicle assembly. Theranostics. 2021;11(10):4992–5009. PMID: 33754040; PMCID: PMC7978297."
1050353,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Diethylhexyl phthalate results in increased expression of PARP1 mRNA,,,PMID:34319233|PMID:36423848,https://www.ncbi.nlm.nih.gov/pubmed/34319233|https://www.ncbi.nlm.nih.gov/pubmed/36423848,34319233|36423848,,PMC8318585,9557772|34927261,"Fu H, Zhu X, Di Q, Sun J, Jiang Q, Xu Q. m6A contributes to a pro-survival state in GC-2 cells by facilitating DNA damage repair: Novel perspectives on the mechanism underlying DEHP genotoxicity in male germ cells. Sci Total Environ. 2023 Feb 10;859(Pt 2):160432. doi: 10.1016/j.scitotenv.2022.160432. PMID: 36423848.|Tando Y, Hiura H, Takehara A, Ito-Matsuoka Y, Arima T, Matsui Y. Author response: Epi-mutations for spermatogenic defects by maternal exposure to di(2-ethylhexyl) phthalate. 2021 Jul 15;(). doi: 10.7554/elife.70322.sa2."
907600,8371,Comparative Toxicogenomics Database (CTD),Chloranil,C000591600,tetrachlorobenzoquinone,https://ctdbase.org/detail.go?type=chem&acc=C000591600,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),TNFRSF10B protein promotes the reaction [tetrachlorobenzoquinone results in increased cleavage of PARP1 protein]|tetrachlorobenzoquinone results in increased cleavage of PARP1 protein,,,PMID:27484784,https://www.ncbi.nlm.nih.gov/pubmed/27484784,27484784,,,30387332,"Liu Z, Shi Q, Song X, Wang Y, Wang Y, Song E, Song Y. Activating Transcription Factor 4 (ATF4)-ATF3-C/EBP Homologous Protein (CHOP) Cascade Shows an Essential Role in the ER Stress-Induced Sensitization of Tetrachlorobenzoquinone-Challenged PC12 Cells to ROS-Mediated Apoptosis via Death Receptor 5 (DR5) Signaling. Chem Res Toxicol. 2016 Sep 19;29(9):1510–8. doi: 10.1021/acs.chemrestox.6b00181. PMID: 27484784."
954932,8398,Comparative Toxicogenomics Database (CTD),Bis(2-hydroxy-3-tert-butyl-5-methylphenyl)methane,C008437,"2,2'-methylenebis(4-methyl-6-tert-butylphenol)",https://ctdbase.org/detail.go?type=chem&acc=C008437,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of PARP1 mRNA",,,PMID:38160208,https://www.ncbi.nlm.nih.gov/pubmed/38160208,38160208,,PMC10794370,36642690,2023; 98(2):525-536
908662,8417,Comparative Toxicogenomics Database (CTD),Scoparone,C018145,scoparone,https://ctdbase.org/detail.go?type=chem&acc=C018145,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Scoparone results in increased cleavage of PARP1 protein,,,PMID:37449671,https://www.ncbi.nlm.nih.gov/pubmed/37449671,37449671,,,35668786,"Zhou Y, Han Z, Zhao Z, Zhang J. Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing <scp>RhoA</scp>/<scp>ROCK1</scp> signaling. Environmental Toxicology. 2023 Jul 14;39(2):562–71. doi: 10.1002/tox.23882."
955792,8480,Toxin and Toxin Target Database (T3DB),Carbarsone,T3D0313,[4-(Aminocarbonyl-amino)phenyl] arsonic acid,http://www.t3db.ca/toxins/T3D0313,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1096108,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Pyrazolanthrone inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]",,,PMID:30871965,https://www.ncbi.nlm.nih.gov/pubmed/30871965,30871965,,,29739467,"Xu WT, Shen GN, Luo YH, Piao XJ, Wang JR, Wang H, Zhang Y, Li JQ, Feng YC, Zhang Y, Zhang T, Wang SN, Wang CY, Jin CH. New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways. Chem Biol Interact. 2019 May 01;304():148–57. doi: 10.1016/j.cbi.2019.03.004. PMID: 30871965."
1096109,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Pyrazolanthrone inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased cleavage of PARP1 protein]",,,PMID:24036456,https://www.ncbi.nlm.nih.gov/pubmed/24036456,24036456,,,24927079,"Tan J, Lai Z, Liu L, Long W, Chen T, Zha J, Wang L, Chen M, Ji H, Lai Y. ONTD induces apoptosis of human hepatoma Bel-7402 cells via a MAPK-dependent mitochondrial pathway and the depletion of intracellular glutathione. The International Journal of Biochemistry & Cell Biology. 2013 Nov;45(11):2632–42. doi: 10.1016/j.biocel.2013.08.021."
1096110,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein],,,PMID:23082001,https://www.ncbi.nlm.nih.gov/pubmed/23082001,23082001,,PMC3525753,30952329,"Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y. Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1. 2012 Dec 15;18(24):6690–701. doi: 10.1158/1078-0432.ccr-12-0770."
1096111,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein],,,PMID:16328441,https://www.ncbi.nlm.nih.gov/pubmed/16328441,16328441,,,1004633,2005; 80(6):310-318
1096317,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Pyrazolanthrone inhibits the reaction [[cholix toxin, vibrio cholerae co-treated with TNF protein] results in increased cleavage of PARP1 protein]",,,PMID:28087840,https://www.ncbi.nlm.nih.gov/pubmed/28087840,28087840,,PMC5837519,14162527,"Ogura K, Terasaki Y, Miyoshi-Akiyama T, Terasaki M, Moss J, Noda M, Yahiro K. Vibrio cholerae Cholix Toxin-Induced HepG2 Cell Death is Enhanced by Tumor Necrosis Factor-Alpha Through ROS and Intracellular Signal-Regulated Kinases. Toxicol Sci. 2017 Apr 01;156(2):455–68. PMID: 28087840; PMCID: PMC5837519."
1096318,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [coronarin D results in increased expression of PARP1 protein modified form],,,PMID:29968959,https://www.ncbi.nlm.nih.gov/pubmed/29968959,29968959,,,6752908,"Lin HW, Hsieh MJ, Yeh CB, Hsueh KC, Hsieh YH, Yang SF. Coronarin D induces apoptotic cell death through the JNK pathway in human hepatocellular carcinoma. Environ Toxicol. 2018 Sep;33(9):946–54. doi: 10.1002/tox.22579. PMID: 29968959."
1096319,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [dehydroxymethylepoxyquinomicin results in increased cleavage of PARP1 protein],,,PMID:15501958,https://www.ncbi.nlm.nih.gov/pubmed/15501958,15501958,,,5774978,"Starenki DV, Namba H, Saenko VA, Ohtsuru A, Maeda S, Umezawa K, Yamashita S. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin. Clin Cancer Res. 2004 Oct 15;10(20):6821–9. doi: 10.1158/1078-0432.ccr-04-0463. PMID: 15501958."
1096320,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein],,,PMID:14724571,https://www.ncbi.nlm.nih.gov/pubmed/14724571,14724571,,,975980,"Wang Q, Wieder R. All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene. 2004 Jan 15;23(2):426–33. doi: 10.1038/sj.onc.1207040. PMID: 14724571."
1096321,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,PMC1458365,10558450,"Kim HJ, Chakravarti N, Oridate N, Choe C, Claret FX, Lotan R. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene. 2006 May 04;25(19):2785–94. PMID: 16407847; PMCID: PMC1458365."
1096322,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein],,,PMID:25939952,https://www.ncbi.nlm.nih.gov/pubmed/25939952,25939952,,,26969299,"Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015 Jul 02;236(1):43–59. doi: 10.1016/j.toxlet.2015.04.015. PMID: 25939952."
1096323,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [isoliensinine results in increased cleavage of PARP1 protein],,,PMID:26219228,https://www.ncbi.nlm.nih.gov/pubmed/26219228,26219228,,PMC4518223,33034897,2015; 5(1):12579
1096324,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [licochalcone B results in increased expression of PARP1 protein],,,PMID:35948134,https://www.ncbi.nlm.nih.gov/pubmed/35948134,35948134,,,34627529,"Zhang YY, Feng PP, Wang HF, Zhang H, Liang T, Hao XS, Wang FZ, Fei HR. Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells. Chem Biol Interact. 2022 Sep 25;365():110076. doi: 10.1016/j.cbi.2022.110076. PMID: 35948134."
1096325,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein],,,PMID:34165247,https://www.ncbi.nlm.nih.gov/pubmed/34165247,34165247,,,31166243,"Ho H, Chen P, Lo Y, Lin C, Chuang Y, Hsieh M, Chen M. <scp>Luteolin-7-O</scp>-glucoside inhibits cell proliferation and modulates apoptosis through the <scp>AKT</scp> signaling pathway in human nasopharyngeal carcinoma. Environmental Toxicology. 2021 Jun 24;36(10):2013–24. doi: 10.1002/tox.23319."
1096326,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [LY 293111 results in increased cleavage of PARP1 protein],,,PMID:16151469,https://www.ncbi.nlm.nih.gov/pubmed/16151469,16151469,,,30158352,"Zhang W, McQueen T, Schober W, Rassidakis G, Andreeff M, Konopleva M. Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation. Leukemia. 2005 Nov;19(11):1977–84. doi: 10.1038/sj.leu.2403929. PMID: 16151469."
1096511,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [morusin results in increased cleavage of PARP1 protein],,,PMID:33035517,https://www.ncbi.nlm.nih.gov/pubmed/33035517,33035517,,,6804631,"Wang J, Liu X, Zheng H, Liu Q, Zhang H, Wang X, Shen T, Wang S, Ren D. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells. Chem Biol Interact. 2020 Nov 01;331():109279. doi: 10.1016/j.cbi.2020.109279. PMID: 33035517."
1096512,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein],,,PMID:25446857,https://www.ncbi.nlm.nih.gov/pubmed/25446857,25446857,,,20876534,"Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC, Tsai CW. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. Chem Biol Interact. 2015 Jan 05;225():40–6. doi: 10.1016/j.cbi.2014.11.011. PMID: 25446857."
1096513,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [polyphyllin I results in increased expression of PARP1 protein modified form],,,PMID:31421117,https://www.ncbi.nlm.nih.gov/pubmed/31421117,31421117,,,12866556,"Tian Y, Jia SX, Shi J, Gong GY, Yu JW, Niu Y, Yang CM, Ma XC, Fang MY. Polyphyllin I induces apoptosis and autophagy via modulating JNK and mTOR pathways in human acute myeloid leukemia cells. Chem Biol Interact. 2019 Sep 25;311():108793. doi: 10.1016/j.cbi.2019.108793. PMID: 31421117."
1096514,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:21165570,https://www.ncbi.nlm.nih.gov/pubmed/21165570,21165570,,,1101035,"Lee WJ, Chen YR, Tseng TH. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583–91. doi: 10.3892/or.2010.1097. PMID: 21165570."
1096515,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:19777565,https://www.ncbi.nlm.nih.gov/pubmed/19777565,19777565,,,28863898,"Deng YT, Huang HC, Lin JK. Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol Carcinog. 2010 Feb;49(2):141–51. doi: 10.1002/mc.20583. PMID: 19777565."
1096516,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [[sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein],,,PMID:18281123,https://www.ncbi.nlm.nih.gov/pubmed/18281123,18281123,,,33572505,"Jin HO, Seo SK, Woo SH, Lee HC, Kim ES, Yoo DH, Lee SJ, An S, Choe TB, Kim JI, Hong SI, Rhee CH, Park IC. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation. Lung Cancer. 2008 Sep;61(3):317–27. doi: 10.1016/j.lungcan.2008.01.002. PMID: 18281123."
1096517,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone promotes the reaction [dihydromyricetin results in increased cleavage of PARP1 protein],,,PMID:27539140,https://www.ncbi.nlm.nih.gov/pubmed/27539140,27539140,,,28352053,"Kao S, Lee W, Chang J, Chow J, Chung C, Hung W, Chien M. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer. Environmental Toxicology. 2016 Aug 19;32(4):1426–38. doi: 10.1002/tox.22336."
1096518,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone promotes the reaction [pachastrissamine analog results in increased cleavage of PARP1 protein],,,PMID:35123989,https://www.ncbi.nlm.nih.gov/pubmed/35123989,35123989,,,30530582,"Xu F, Xie Q, Li YW, Jing QQ, Liu XJ, Xu YC, Wang X, Liu L, Kim G, Choi Y, Guo Y, Zhang E, Jin CY. Suppression of JNK/ERK dependent autophagy enhances Jaspine B derivative-induced gastric cancer cell death via attenuation of p62/Keap1/Nrf2 pathways. Toxicol Appl Pharmacol. 2022 Mar 01;438():115908. doi: 10.1016/j.taap.2022.115908. PMID: 35123989."
1096519,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone promotes the reaction [picrasidine I results in increased expression of PARP1 protein modified form],,,PMID:34894061,https://www.ncbi.nlm.nih.gov/pubmed/34894061,34894061,,,20376671,"Yang YT, Hsieh MJ, Chuang YC, Lin CC, Lo YS, Ho HY, Kumar VB, Ko JL. Anticancer effects of picrasidine I on oral squamous cell carcinoma. Environ Toxicol. 2022 Mar;37(3):627–36. doi: 10.1002/tox.23430. PMID: 34894061."
1096520,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone results in increased susceptibility to [[TNFSF10 protein co-treated with kahweol acetate] results in increased cleavage of PARP1 protein],,,PMID:20403343,https://www.ncbi.nlm.nih.gov/pubmed/20403343,20403343,,,24187076,"Um HJ, Oh JH, Kim YN, Choi YH, Kim SH, Park JW, Kwon TK. The coffee diterpene kahweol sensitizes TRAIL-induced apoptosis in renal carcinoma Caki cells through down-regulation of Bcl-2 and c-FLIP. Chem Biol Interact. 2010 Jun 07;186(1):36–42. doi: 10.1016/j.cbi.2010.04.013. PMID: 20403343."
1096811,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Pyrazolanthrone inhibits the reaction [3-dinitrobenzene results in increased cleavage of PARP1 protein],,,PMID:19477251,https://www.ncbi.nlm.nih.gov/pubmed/19477251,19477251,,,20083392,"Lee YS, Yoon HJ, Oh JH, Park HJ, Lee EH, Song CW, Yoon S. 1,3-Dinitrobenzene induces apoptosis in TM4 mouse Sertoli cells: Involvement of the c-Jun N-terminal kinase (JNK) MAPK pathway. Toxicol Lett. 2009 Sep 10;189(2):145–51. doi: 10.1016/j.toxlet.2009.05.014. PMID: 19477251."
1096812,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pyrazolanthrone inhibits the reaction [bakuchiol results in increased cleavage of PARP1 protein],,,PMID:17292878,https://www.ncbi.nlm.nih.gov/pubmed/17292878,17292878,,,3744923,"Park EJ, Zhao YZ, Kim YC, Sohn DH. Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts. Eur J Pharmacol. 2007 Mar 22;559(2-3):115–23. doi: 10.1016/j.ejphar.2007.01.024. PMID: 17292878."
1096813,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pyrazolanthrone inhibits the reaction [cadmium acetate results in increased cleavage of PARP1 protein],,,PMID:24577723|PMID:25043952,https://www.ncbi.nlm.nih.gov/pubmed/24577723|https://www.ncbi.nlm.nih.gov/pubmed/25043952,24577723|25043952,,,10057115|26291509,"Yuan Y, Jiang C, Hu F, Wang Q, Zhang K, Wang Y, Gu J, Liu X, Bian J, Liu Z. The role of mitogen-activated protein kinase in cadmium-induced primary rat cerebral cortical neurons apoptosis via a mitochondrial apoptotic pathway. Journal of Trace Elements in Medicine and Biology. 2015 Jan;29():275–83. doi: 10.1016/j.jtemb.2014.06.006.|2014; 158(2):249-258"
1096814,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pyrazolanthrone inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:23405080,https://www.ncbi.nlm.nih.gov/pubmed/23405080,23405080,,PMC3566170,10002509,"Chang KC, Hsu CC, Liu SH, Su CC, Yen CC, Lee MJ, Chen KL, Ho TJ, Hung DZ, Wu CC, Lu TH, Su YC, Chen YW, Huang CF. Cadmium induces apoptosis in pancreatic ß-cells through a mitochondria-dependent pathway: the role of oxidative stress-mediated c-Jun N-terminal kinase activation. PLoS One. 2013;8(2):e54374. PMID: 23405080; PMCID: PMC3566170."
1096815,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pyrazolanthrone inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein],,,PMID:21843586,https://www.ncbi.nlm.nih.gov/pubmed/21843586,21843586,,,6585663,"Wu HC, Yang CY, Hung DZ, Su CC, Chen KL, Yen CC, Ho TJ, Su YC, Huang CF, Chen CH, Tsai LM, Chen YW. Nickel(II) induced JNK activation-regulated mitochondria-dependent apoptotic pathway leading to cultured rat pancreatic ß-cell death. Toxicology. 2011 Nov 18;289(2-3):103–11. doi: 10.1016/j.tox.2011.07.013. PMID: 21843586."
1096816,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with cadmium chloride co-treated with lead acetate] results in increased expression of PARP1 protein],,,PMID:28283887,https://www.ncbi.nlm.nih.gov/pubmed/28283887,28283887,,,17522612,2017; 55(3):2125-2149
1096817,8515,Comparative Toxicogenomics Database (CTD),"anthra(1,9-cd)pyrazol-6(2H)-one",C432165,pyrazolanthrone,https://ctdbase.org/detail.go?type=chem&acc=C432165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Pyrazolanthrone inhibits the reaction [asbestos, serpentine results in increased expression of PARP1 protein]",,,PMID:25530474,https://www.ncbi.nlm.nih.gov/pubmed/25530474,25530474,,PMC4735687,479370,"Li P, Liu T, Kamp DW, Lin Z, Wang Y, Li D, Yang L, He H, Liu G. The c-Jun N-terminal kinase signaling pathway mediates chrysotile asbestos-induced alveolar epithelial cell apoptosis. Mol Med Rep. 2015 May;11(5):3626–34. PMID: 25530474; PMCID: PMC4735687."
1300988,8530,Comparative Toxicogenomics Database (CTD),"1,4-Naphthoquinone",C035342,"1,4-naphthoquinone",https://ctdbase.org/detail.go?type=chem&acc=C035342,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,4-naphthoquinone analog results in increased cleavage of PARP1 protein|pyrazolanthrone inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]|sb 203580 inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]|gsk690693 promotes the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]|fr 180204 promotes the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]",,,PMID:30871965,https://www.ncbi.nlm.nih.gov/pubmed/30871965,30871965,,,29739467,"Xu WT, Shen GN, Luo YH, Piao XJ, Wang JR, Wang H, Zhang Y, Li JQ, Feng YC, Zhang Y, Zhang T, Wang SN, Wang CY, Jin CH. New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways. Chem Biol Interact. 2019 May 01;304():148–57. doi: 10.1016/j.cbi.2019.03.004. PMID: 30871965."
1010251,8617,Comparative Toxicogenomics Database (CTD),Indole-3-Butyric Acid,C014612,indolebutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C014612,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indolebutyric acid analog results in increased cleavage of PARP1 protein,,,PMID:23499788,https://www.ncbi.nlm.nih.gov/pubmed/23499788,23499788,,PMC3648619,6616389,"Zhang Z, Bi C, Buac D, Fan Y, Zhang X, Zuo J, Zhang P, Zhang N, Dong L, Dou QP. Organic cadmium complexes as proteasome inhibitors and apoptosis inducers in human breast cancer cells. Journal of Inorganic Biochemistry. 2013 Jun;123():1–10. doi: 10.1016/j.jinorgbio.2013.02.004."
957530,8696,Toxin and Toxin Target Database (T3DB),Cobalt bis(2-ethylhexanoate),T3D1403,Cobalt bis(2-ethylhexanoate),http://www.t3db.ca/toxins/T3D1403,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
958888,8774,Toxin and Toxin Target Database (T3DB),Arsphenamine,T3D0312,"4,4-Arsenobis(2-aminophenol) dihydrochloride",http://www.t3db.ca/toxins/T3D0312,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
959970,8948,Toxin and Toxin Target Database (T3DB),Methylarsonic acid,T3D0308,"Methylarsonic acid, disodium salt",http://www.t3db.ca/toxins/T3D0308,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
803139,9001,Comparative Toxicogenomics Database (CTD),Tiron,D014013,"1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt",https://ctdbase.org/detail.go?type=chem&acc=D014013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein]|1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein]",,,PMID:22002103,https://www.ncbi.nlm.nih.gov/pubmed/22002103,22002103,,,19480675,2011; 17(2):200-216
1337817,9064,Comparative Toxicogenomics Database (CTD),Cianidanol,D002392,Catechin,https://ctdbase.org/detail.go?type=chem&acc=D002392,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Catechin inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein]|catechin results in increased expression of PARP1 protein,,,PMID:16753784,https://www.ncbi.nlm.nih.gov/pubmed/16753784,16753784,,,9223569,"Huang Q, Wu L, Tashiro S, Onodera S, Ikejima T. Elevated levels of DNA repair enzymes and antioxidative enzymes by (+)-catechin in murine microglia cells after oxidative stress. Journal of Asian Natural Products Research. 2006 Jan;8(1-2):61–71. doi: 10.1080/10286020500209087."
1260440,9117,Comparative Toxicogenomics Database (CTD),BENZO(ghi)PERYLENE,C006718,"1,12-benzoperylene",https://ctdbase.org/detail.go?type=chem&acc=C006718,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,12-benzoperylene results in increased cleavage of PARP1 protein",,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
999968,9131,Comparative Toxicogenomics Database (CTD),"Indeno[1,2,3-cd]pyrene",C041508,"indeno(1,2,3-cd)pyrene",https://ctdbase.org/detail.go?type=chem&acc=C041508,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Indeno(1,2,3-cd)pyrene results in increased cleavage of PARP1 protein",,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
1074750,9153,Comparative Toxicogenomics Database (CTD),Benzo(B)Fluoranthene,C006703,benzo(b)fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C006703,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzo(b)fluoranthene results in increased cleavage of PARP1 protein,,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
1162457,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fluoranthene results in increased cleavage of PARP1 protein,,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
1275440,9158,Comparative Toxicogenomics Database (CTD),Benzo(K)Fluoranthene,C022921,benzo(k)fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C022921,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzo(k)fluoranthene results in increased cleavage of PARP1 protein,,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
1281049,9161,Comparative Toxicogenomics Database (CTD),Acenaphthylene,C042553,acenaphthylene,https://ctdbase.org/detail.go?type=chem&acc=C042553,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acenaphthylene results in increased cleavage of PARP1 protein,,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
808125,9395,Comparative Toxicogenomics Database (CTD),Paraoxon,D010261,Paraoxon,https://ctdbase.org/detail.go?type=chem&acc=D010261,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Paraoxon results in increased cleavage of PARP1 protein|metoclopramide inhibits the reaction [paraoxon results in increased cleavage of PARP1 protein],,,PMID:29027213,https://www.ncbi.nlm.nih.gov/pubmed/29027213,29027213,,,22929616,"Jaber BM, Petroianu GA, Rizvi SA, Borai A, Saleh NA, Hala SM, Saleh AM. Protective effect of metoclopramide against organophosphate-induced apoptosis in the murine skin fibroblast L929. J Appl Toxicol. 2018 Mar;38(3):329–40. doi: 10.1002/jat.3543. PMID: 29027213."
1167290,9400,Comparative Toxicogenomics Database (CTD),Dexamethasone Phosphate,C004180,dexamethasone 21-phosphate,https://ctdbase.org/detail.go?type=chem&acc=C004180,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dexamethasone 21-phosphate results in increased cleavage of PARP1 protein,,,PMID:25447644,https://www.ncbi.nlm.nih.gov/pubmed/25447644,25447644,,,20877302,"El Zaoui I, Behar-Cohen F, Torriglia A. Glucocorticoids exert direct toxicity on microvasculature: analysis of cell death mechanisms. Toxicol Sci. 2015 Feb;143(2):441–53. doi: 10.1093/toxsci/kfu243. PMID: 25447644."
48143,9444,Comparative Toxicogenomics Database (CTD),Azacitidine,D001374,Azacitidine,https://ctdbase.org/detail.go?type=chem&acc=D001374,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Bleomycin inhibits the reaction [azacitidine results in increased cleavage of PARP1 protein]|azacitidine results in increased cleavage of PARP1 protein,,,PMID:32278510,https://www.ncbi.nlm.nih.gov/pubmed/32278510,32278510,,,28444855,"Fakhrabadi HG, Rabbani-Chadegani A, Ghadam P, Amiri S. Protective effect of bleomycin on 5-azacitidine induced cytotoxicity and apoptosis in mice hematopoietic stem cells via Bcl-2/Bax and HMGB1 signaling pathway. Toxicol Appl Pharmacol. 2020 Jun 01;396():114996. doi: 10.1016/j.taap.2020.114996. PMID: 32278510."
896457,9500,Comparative Toxicogenomics Database (CTD),6-Aminonicotinamide,D015120,6-Aminonicotinamide,https://ctdbase.org/detail.go?type=chem&acc=D015120,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),6-aminonicotinamide inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein],,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,PMC4234881,19518824,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881."
984696,9554,Comparative Toxicogenomics Database (CTD),Perfluorooctanoic acid,C023036,perfluorooctanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C023036,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Perfluorooctanoic acid results in increased cleavage of PARP1 protein,,,PMID:35066053,https://www.ncbi.nlm.nih.gov/pubmed/35066053,35066053,,,31863054,"Xu LL, Chen YK, Zhang QY, Chen LJ, Zhang KK, Li JH, Liu JL, Wang Q, Xie XL. Gestational exposure to GenX induces hepatic alterations by the gut-liver axis in maternal mice: A similar mechanism as PFOA. Sci Total Environ. 2022 May 10;820():153281. doi: 10.1016/j.scitotenv.2022.153281. PMID: 35066053."
1297734,9723,Comparative Toxicogenomics Database (CTD),Cuprizone,D003471,Cuprizone,https://ctdbase.org/detail.go?type=chem&acc=D003471,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cuprizone co-treated with benztropine] results in increased expression of PARP1 protein,,,PMID:34122009,https://www.ncbi.nlm.nih.gov/pubmed/34122009,34122009,,PMC8193732,14955630,"Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JE, Crippa JA, de Almeida V, Martins-de-Souza D. Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021;14():814907. PMID: 34924956; PMCID: PMC8672415."
1383587,9903,Comparative Toxicogenomics Database (CTD),Lithocholic Acid,D008095,Lithocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008095,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lithocholic acid analog results in increased activity of PARP1 protein|3-aminobenzamide inhibits the reaction [lithocholic acid analog results in increased activity of PARP1 protein],,,PMID:2120135,https://www.ncbi.nlm.nih.gov/pubmed/2120135,2120135,,,15702803,Singh N. A comparative study on the effect of tumor promoters on poly ADP-ribosylation in A431 cells. Int J Cancer. 1990 Oct 15;46(4):648–52. doi: 10.1002/ijc.2910460416. PMID: 2120135.
1122853,10133,Comparative Toxicogenomics Database (CTD),Chenodiol,D002635,Chenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002635,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chenodeoxycholic acid results in increased cleavage of PARP1 protein|[chenodeoxycholic acid co-treated with ursodoxicoltaurine] results in increased cleavage of PARP1 protein,,,PMID:14976352,https://www.ncbi.nlm.nih.gov/pubmed/14976352,14976352,,,28797959,2004; 79(1):196-204
1311510,10205,Comparative Toxicogenomics Database (CTD),Plumbagin,C014758,plumbagin,https://ctdbase.org/detail.go?type=chem&acc=C014758,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Plumbagin results in decreased expression of PARP1 protein|plumbagin results in decreased expression of PARP1 mRNA,,,PMID:36336213,https://www.ncbi.nlm.nih.gov/pubmed/36336213,36336213,,,34647434,"Sidhu H, Capalash N. Plumbagin downregulates UHRF1, p-Akt, MMP-2 and suppresses survival, growth and migration of cervical cancer CaSki cells. Toxicol In Vitro. 2023 Feb;86():105512. doi: 10.1016/j.tiv.2022.105512. PMID: 36336213."
829113,10206,Comparative Toxicogenomics Database (CTD),Cepharanthine,C006947,cepharanthine,https://ctdbase.org/detail.go?type=chem&acc=C006947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cepharanthine results in decreased expression of PARP1 protein,,,PMID:31255635,https://www.ncbi.nlm.nih.gov/pubmed/31255635,31255635,,,9507550,"Xu W, Wang X, Tu Y, Masaki H, Tanaka S, Onda K, Sugiyama K, Yamada H, Hirano T. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells. Chem Biol Interact. 2019 Sep 01;310():108726. doi: 10.1016/j.cbi.2019.108726. PMID: 31255635."
1209855,10219,Comparative Toxicogenomics Database (CTD),Emetine,D004640,Emetine,https://ctdbase.org/detail.go?type=chem&acc=D004640,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Emetine results in increased cleavage of PARP1 protein,,,PMID:21256112,https://www.ncbi.nlm.nih.gov/pubmed/21256112,21256112,,,10663198,"Willimott S, Merriam T, Wagner SD. Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia. Biochemical and Biophysical Research Communications. 2011 Feb;405(3):480–5. doi: 10.1016/j.bbrc.2011.01.057."
1096482,10228,Comparative Toxicogenomics Database (CTD),Osthol,C046627,osthol,https://ctdbase.org/detail.go?type=chem&acc=C046627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Osthol results in decreased expression of and results in increased cleavage of PARP1 protein|osthol results in decreased expression of PARP1 protein,,,PMID:31870840,https://www.ncbi.nlm.nih.gov/pubmed/31870840,31870840,,,16947711,"Yang J, Zhu XJ, Jin MZ, Cao ZW, Ren YY, Gu ZW. Osthole induces cell cycle arrest and apoptosis in head and neck squamous cell carcinoma by suppressing the PI3K/AKT signaling pathway. Chem Biol Interact. 2020 Jan 25;316():108934. doi: 10.1016/j.cbi.2019.108934. PMID: 31870840."
1096666,10228,Comparative Toxicogenomics Database (CTD),Osthol,C046627,osthol,https://ctdbase.org/detail.go?type=chem&acc=C046627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Osthol results in increased cleavage of PARP1 protein,,,PMID:29319219,https://www.ncbi.nlm.nih.gov/pubmed/29319219,29319219,,,18249161,"Liu PY, Chang DC, Lo YS, Hsi YT, Lin CC, Chuang YC, Lin SH, Hsieh MJ, Chen MK. Osthole induces human nasopharyngeal cancer cells apoptosis through Fas-Fas ligand and mitochondrial pathway. Environ Toxicol. 2018 Apr;33(4):446–53. doi: 10.1002/tox.22530. PMID: 29319219."
956141,10251,Comparative Toxicogenomics Database (CTD),Flavanone,C028610,flavanone,https://ctdbase.org/detail.go?type=chem&acc=C028610,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Flavanone results in increased cleavage of PARP1 protein,,,PMID:22056764,https://www.ncbi.nlm.nih.gov/pubmed/22056764,22056764,,,5208731,"Kim JH, Kang JW, Kim MS, Bak Y, Park YS, Jung KY, Lim YH, Yoon DY. The apoptotic effects of the flavonoid N101-2 in human cervical cancer cells. Toxicol In Vitro. 2012 Feb;26(1):67–73. doi: 10.1016/j.tiv.2011.10.012. PMID: 22056764."
901821,10255,Comparative Toxicogenomics Database (CTD),Kainic acid,D007608,Kainic Acid,https://ctdbase.org/detail.go?type=chem&acc=D007608,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Kainic acid results in increased activity of PARP1 protein,,,PMID:28704930,https://www.ncbi.nlm.nih.gov/pubmed/28704930,28704930,,PMC5535992,15516226,"Lai YC, Baker JS, Donti T, Graham BH, Craigen WJ, Anderson AE. Mitochondrial Dysfunction Mediated by Poly(ADP-Ribose) Polymerase-1 Activation Contributes to Hippocampal Neuronal Damage Following Status Epilepticus. Int J Mol Sci. 2017 Jul 12;18(7). PMID: 28704930; PMCID: PMC5535992."
1191068,10281,Comparative Toxicogenomics Database (CTD),Thymoquinone,C003466,thymoquinone,https://ctdbase.org/detail.go?type=chem&acc=C003466,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),DDIT3 protein affects the reaction [thymoquinone results in increased cleavage of PARP1 protein]|4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [thymoquinone results in increased activity of PARP1 protein],,,PMID:29981725,https://www.ncbi.nlm.nih.gov/pubmed/29981725,29981725,,,29154984,"Zhang M, Du H, Huang Z, Zhang P, Yue Y, Wang W, Liu W, Zeng J, Ma J, Chen G, Wang X, Fan J. Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway. Chem Biol Interact. 2018 Aug 25;292():65–75. doi: 10.1016/j.cbi.2018.06.013. PMID: 29981725."
1191354,10281,Comparative Toxicogenomics Database (CTD),Thymoquinone,C003466,thymoquinone,https://ctdbase.org/detail.go?type=chem&acc=C003466,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein],,,PMID:34627931,https://www.ncbi.nlm.nih.gov/pubmed/34627931,34627931,,,13642569,"Raut PK, Lee HS, Joo SH, Chun KS. Thymoquinone induces oxidative stress-mediated apoptosis through downregulation of Jak2/STAT3 signaling pathway in human melanoma cells. Food Chem Toxicol. 2021 Nov;157():112604. doi: 10.1016/j.fct.2021.112604. PMID: 34627931."
1191355,10281,Comparative Toxicogenomics Database (CTD),Thymoquinone,C003466,thymoquinone,https://ctdbase.org/detail.go?type=chem&acc=C003466,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of PARP1 protein modified form]|thymoquinone results in increased expression of PARP1 protein modified form,,,PMID:31433961,https://www.ncbi.nlm.nih.gov/pubmed/31433961,31433961,,,12878756,"Park JE, Kim DH, Ha E, Choi SM, Choi JS, Chun KS, Joo SH. Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3. Chem Biol Interact. 2019 Oct 01;312():108799. doi: 10.1016/j.cbi.2019.108799. PMID: 31433961."
1191356,10281,Comparative Toxicogenomics Database (CTD),Thymoquinone,C003466,thymoquinone,https://ctdbase.org/detail.go?type=chem&acc=C003466,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Thymoquinone results in increased cleavage of PARP1 protein,,,PMID:29981725|PMID:31298468|PMID:34627931,https://www.ncbi.nlm.nih.gov/pubmed/29981725|https://www.ncbi.nlm.nih.gov/pubmed/31298468|https://www.ncbi.nlm.nih.gov/pubmed/34627931,29981725|31298468|34627931,,,13642569|29154984|32433736,"Raut PK, Lee HS, Joo SH, Chun KS. Thymoquinone induces oxidative stress-mediated apoptosis through downregulation of Jak2/STAT3 signaling pathway in human melanoma cells. Food Chem Toxicol. 2021 Nov;157():112604. doi: 10.1016/j.fct.2021.112604. PMID: 34627931.|Liou YF, Chen PN, Chu SC, Kao SH, Chang YZ, Hsieh YS, Chang HR. Thymoquinone suppresses the proliferation of renal cell carcinoma cells via reactive oxygen species-induced apoptosis and reduces cell stemness. Environ Toxicol. 2019 Nov;34(11):1208–20. doi: 10.1002/tox.22822. PMID: 31298468.|Zhang M, Du H, Huang Z, Zhang P, Yue Y, Wang W, Liu W, Zeng J, Ma J, Chen G, Wang X, Fan J. Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway. Chem Biol Interact. 2018 Aug 25;292():65–75. doi: 10.1016/j.cbi.2018.06.013. PMID: 29981725."
1127846,10284,Therapeutic Target Database (TTD),Isocarbostyril,D07CRG,2H-Isoquinolin-1-one,https://idrblab.net/ttd/data/drug/details/D07CRG,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
740978,10286,Comparative Toxicogenomics Database (CTD),Chromone,C068515,4-chromone,https://ctdbase.org/detail.go?type=chem&acc=C068515,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [4-chromone analog results in increased expression of PARP1 protein modified form]|acetylcysteine inhibits the reaction [4-chromone analog results in increased expression of PARP1 protein modified form]|4-chromone analog results in increased expression of PARP1 protein modified form,,,PMID:30256521,https://www.ncbi.nlm.nih.gov/pubmed/30256521,30256521,,,20952774,"Tang JY, Wu CY, Shu CW, Wang SC, Chang MY, Chang HW. A novel sulfonyl chromen-4-ones (CHW09) preferentially kills oral cancer cells showing apoptosis, oxidative stress, and DNA damage. Environ Toxicol. 2018 Nov;33(11):1195–203. doi: 10.1002/tox.22625. PMID: 30256521."
1096916,10311,Comparative Toxicogenomics Database (CTD),Melarsoprol,D008549,Melarsoprol,https://ctdbase.org/detail.go?type=chem&acc=D008549,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Melarsoprol results in increased cleavage of PARP1 protein,,,PMID:15314284,https://www.ncbi.nlm.nih.gov/pubmed/15314284,15314284,,,9863746,2004; 9(5):561-571
1193871,10431,Toxin and Toxin Target Database (T3DB),Cacodyl oxide,T3D1306,Cacodyl oxide,http://www.t3db.ca/toxins/T3D1306,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
847009,10461,Comparative Toxicogenomics Database (CTD),Bis(2-chloroethyl)sulfide,D009151,Mustard Gas,https://ctdbase.org/detail.go?type=chem&acc=D009151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),FADD protein affects the reaction [mustard gas results in increased cleavage of PARP1 protein]|acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [mustard gas results in increased cleavage of PARP1 protein]|mustard gas promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein],,,PMID:12482751,https://www.ncbi.nlm.nih.gov/pubmed/12482751,12482751,,,5027934,"Rosenthal DS, Velena A, Chou F, Schlegel R, Ray R, Benton B, Anderson D, Smith WJ, Simbulan-Rosenthal CM. Expression of Dominant-negative Fas-associated Death Domain Blocks Human Keratinocyte Apoptosis and Vesication Induced by Sulfur Mustard. Journal of Biological Chemistry. 2003 Mar;278(10):8531–40. doi: 10.1074/jbc.m209549200."
847010,10461,Comparative Toxicogenomics Database (CTD),Bis(2-chloroethyl)sulfide,D009151,Mustard Gas,https://ctdbase.org/detail.go?type=chem&acc=D009151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BRCA2 protein inhibits the reaction [mustard gas results in increased cleavage of PARP1 protein],,,PMID:20435105,https://www.ncbi.nlm.nih.gov/pubmed/20435105,20435105,,,5181191,"Jowsey PA, Williams FM, Blain PG. The role of homologous recombination in the cellular response to sulphur mustard. Toxicol Lett. 2010 Aug 01;197(1):12–8. doi: 10.1016/j.toxlet.2010.04.020. PMID: 20435105."
847011,10461,Comparative Toxicogenomics Database (CTD),Bis(2-chloroethyl)sulfide,D009151,Mustard Gas,https://ctdbase.org/detail.go?type=chem&acc=D009151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mustard gas results in increased cleavage of and results in increased activity of PARP1 protein|calm1 protein promotes the reaction [mustard gas results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:16935404,https://www.ncbi.nlm.nih.gov/pubmed/16935404,16935404,,,9901309,"Simbulan-Rosenthal CM, Ray R, Benton B, Soeda E, Daher A, Anderson D, Smith WJ, Rosenthal DS. Calmodulin mediates sulfur mustard toxicity in human keratinocytes. Toxicology. 2006 Oct;227(1-2):21–35. doi: 10.1016/j.tox.2006.06.019."
847012,10461,Comparative Toxicogenomics Database (CTD),Bis(2-chloroethyl)sulfide,D009151,Mustard Gas,https://ctdbase.org/detail.go?type=chem&acc=D009151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mustard gas results in decreased expression of PARP1 mRNA,,,PMID:25102026,https://www.ncbi.nlm.nih.gov/pubmed/25102026,25102026,,,12083125,"Jowsey PA, Blain PG. Whole genome expression analysis in primary bronchial epithelial cells after exposure to sulphur mustard. Toxicol Lett. 2014 Nov 04;230(3):393–401. doi: 10.1016/j.toxlet.2014.08.001. PMID: 25102026."
847013,10461,Comparative Toxicogenomics Database (CTD),Bis(2-chloroethyl)sulfide,D009151,Mustard Gas,https://ctdbase.org/detail.go?type=chem&acc=D009151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mustard gas results in increased cleavage of PARP1 protein,,,PMID:11886524|PMID:12482751|PMID:17229443|PMID:20435105|PMID:25448276,https://www.ncbi.nlm.nih.gov/pubmed/11886524|https://www.ncbi.nlm.nih.gov/pubmed/12482751|https://www.ncbi.nlm.nih.gov/pubmed/17229443|https://www.ncbi.nlm.nih.gov/pubmed/20435105|https://www.ncbi.nlm.nih.gov/pubmed/25448276,11886524|12482751|17229443|20435105|25448276,,,5027934|5123694|5181191|13857368|20877918,"Jowsey PA, Blain PG. Checkpoint kinase 1 is activated and promotes cell survival after exposure to sulphur mustard. Toxicol Lett. 2015 Jan 22;232(2):413–21. doi: 10.1016/j.toxlet.2014.11.013. PMID: 25448276.|Jowsey PA, Williams FM, Blain PG. The role of homologous recombination in the cellular response to sulphur mustard. Toxicol Lett. 2010 Aug 01;197(1):12–8. doi: 10.1016/j.toxlet.2010.04.020. PMID: 20435105.|Steinritz D, Emmler J, Hintz M, Worek F, Kreppel H, Szinicz L, Kehe K. Apoptosis in sulfur mustard treated A549 cell cultures. Life Sci. 2007 May 30;80(24-25):2199–201. doi: 10.1016/j.lfs.2006.11.052. PMID: 17229443.|Rosenthal DS, Velena A, Chou F, Schlegel R, Ray R, Benton B, Anderson D, Smith WJ, Simbulan-Rosenthal CM. Expression of Dominant-negative Fas-associated Death Domain Blocks Human Keratinocyte Apoptosis and Vesication Induced by Sulfur Mustard. Journal of Biological Chemistry. 2003 Mar;278(10):8531–40. doi: 10.1074/jbc.m209549200.|Anderson D, Benton B, Wang Z, Smith W, Ray R, Rosenthal DS, Simbulan-Rosenthal CM, Liu WF, Velena A, Smulson ME. PARP Determines the Mode of Cell Death in Skin Fibroblasts, but not Keratinocytes, Exposed to Sulfur Mustard. Journal of Investigative Dermatology. 2001 Dec;117(6):1566–73. doi: 10.1046/j.0022-202x.2001.01578.x."
847185,10461,Comparative Toxicogenomics Database (CTD),Bis(2-chloroethyl)sulfide,D009151,Mustard Gas,https://ctdbase.org/detail.go?type=chem&acc=D009151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein inhibits the reaction [mustard gas results in increased activity of CASP3 protein]|parp1 protein affects the reaction [mustard gas affects the activity of CASP3 protein],,,PMID:11886524,https://www.ncbi.nlm.nih.gov/pubmed/11886524,11886524,,,13857368,"Anderson D, Benton B, Wang Z, Smith W, Ray R, Rosenthal DS, Simbulan-Rosenthal CM, Liu WF, Velena A, Smulson ME. PARP Determines the Mode of Cell Death in Skin Fibroblasts, but not Keratinocytes, Exposed to Sulfur Mustard. Journal of Investigative Dermatology. 2001 Dec;117(6):1566–73. doi: 10.1046/j.0022-202x.2001.01578.x."
847186,10461,Comparative Toxicogenomics Database (CTD),Bis(2-chloroethyl)sulfide,D009151,Mustard Gas,https://ctdbase.org/detail.go?type=chem&acc=D009151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin promotes the reaction [mustard gas results in increased cleavage of PARP1 protein],,,PMID:25448276,https://www.ncbi.nlm.nih.gov/pubmed/25448276,25448276,,,20877918,"Jowsey PA, Blain PG. Checkpoint kinase 1 is activated and promotes cell survival after exposure to sulphur mustard. Toxicol Lett. 2015 Jan 22;232(2):413–21. doi: 10.1016/j.toxlet.2014.11.013. PMID: 25448276."
847187,10461,Comparative Toxicogenomics Database (CTD),Bis(2-chloroethyl)sulfide,D009151,Mustard Gas,https://ctdbase.org/detail.go?type=chem&acc=D009151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Mustard gas results in increased cleavage of PARP1 protein,,,PMID:20659490,https://www.ncbi.nlm.nih.gov/pubmed/20659490,20659490,,PMC3954123,408264,"Malaviya R, Sunil VR, Cervelli J, Anderson DR, Holmes WW, Conti ML, Gordon RE, Laskin JD, Laskin DL. Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicology and Applied Pharmacology. 2010 Oct 15;248(2):89–99. doi: 10.1016/j.taap.2010.07.018."
1200205,10494,Comparative Toxicogenomics Database (CTD),Oleanolic Acid,D009828,Oleanolic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009828,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [oleanolic acid results in increased cleavage of PARP1 protein],,,PMID:22678527,https://www.ncbi.nlm.nih.gov/pubmed/22678527,22678527,,,28256565,"Wei J, Liu M, Liu H, Wang H, Wang F, Zhang Y, Han L, Lin X. Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells. J Appl Toxicol. 2013 Aug;33(8):756–65. doi: 10.1002/jat.2725. PMID: 22678527."
1200422,10494,Comparative Toxicogenomics Database (CTD),Oleanolic Acid,D009828,Oleanolic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009828,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oleanolic acid analog results in increased cleavage of PARP1 protein,,,PMID:26612655,https://www.ncbi.nlm.nih.gov/pubmed/26612655,26612655,,,10065779,"Wu J, Yang C, Guo C, Li X, Yang N, Zhao L, Hang H, Liu S, Chu P, Sun Z, Sun B, Lin Y, Peng J, Han G, Wang S, Tang Z. SZC015, a synthetic oleanolic acid derivative, induces both apoptosis and autophagy in MCF-7 breast cancer cells. Chem Biol Interact. 2016 Jan 25;244():94–104. doi: 10.1016/j.cbi.2015.11.013. PMID: 26612655."
1200423,10494,Comparative Toxicogenomics Database (CTD),Oleanolic Acid,D009828,Oleanolic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009828,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oleanolic acid inhibits the reaction [cisplatin results in increased cleavage of PARP1 protein],,,PMID:31306688,https://www.ncbi.nlm.nih.gov/pubmed/31306688,31306688,,,32441679,"Potocnjak I, Šimic L, Vukelic I, Domitrovic R. Oleanolic acid attenuates cisplatin-induced nephrotoxicity in mice and chemosensitizes human cervical cancer cells to cisplatin cytotoxicity. Food Chem Toxicol. 2019 Oct;132():110676. doi: 10.1016/j.fct.2019.110676. PMID: 31306688."
1200424,10494,Comparative Toxicogenomics Database (CTD),Oleanolic Acid,D009828,Oleanolic Acid,https://ctdbase.org/detail.go?type=chem&acc=D009828,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oleanolic acid results in increased cleavage of PARP1 protein,,,PMID:22678527|PMID:34364837|PMID:35690101,https://www.ncbi.nlm.nih.gov/pubmed/22678527|https://www.ncbi.nlm.nih.gov/pubmed/34364837|https://www.ncbi.nlm.nih.gov/pubmed/35690101,22678527|34364837|35690101,,,28256565|32489902|34251426,"Potocnjak I, Šimic L, Vukelic I, Baticic L, Domitrovic R. Oleanolic acid induces HCT116 colon cancer cell death through the p38/FOXO3a/Sirt6 pathway. Chem Biol Interact. 2022 Aug 25;363():110010. doi: 10.1016/j.cbi.2022.110010. PMID: 35690101.|Woo JS, Yoo ES, Kim SH, Lee JH, Han SH, Jung SH, Jung GH, Jung JY. Anticancer effects of oleanolic acid on human melanoma cells. Chem Biol Interact. 2021 Sep 25;347():109619. doi: 10.1016/j.cbi.2021.109619. PMID: 34364837.|Wei J, Liu M, Liu H, Wang H, Wang F, Zhang Y, Han L, Lin X. Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells. J Appl Toxicol. 2013 Aug;33(8):756–65. doi: 10.1002/jat.2725. PMID: 22678527."
1051630,10565,Toxin and Toxin Target Database (T3DB),Cobaltous carbonate,T3D0655,Cobalt(II) carbonate,http://www.t3db.ca/toxins/T3D0655,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1313099,10607,Comparative Toxicogenomics Database (CTD),Podofilox,D011034,Podophyllotoxin,https://ctdbase.org/detail.go?type=chem&acc=D011034,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Podophyllotoxin results in increased cleavage of PARP1 protein,,,PMID:21916509,https://www.ncbi.nlm.nih.gov/pubmed/21916509,21916509,,,23508225,"Semenova MN, Kiselyov AS, Tsyganov DV, Konyushkin LD, Firgang SI, Semenov RV, Malyshev OR, Raihstat MM, Fuchs F, Stielow A, Lantow M, Philchenkov AA, Zavelevich MP, Zefirov NS, Kuznetsov SA, Semenov VV. Polyalkoxybenzenes from plants. 5. Parsley seed extract in synthesis of azapodophyllotoxins featuring strong tubulin destabilizing activity in the sea urchin embryo and cell culture assays. J Med Chem. 2011 Oct 27;54(20):7138–49. doi: 10.1021/jm200737s. PMID: 21916509."
1098418,10621,Comparative Toxicogenomics Database (CTD),Hesperidin,D006569,Hesperidin,https://ctdbase.org/detail.go?type=chem&acc=D006569,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[hesperidin co-treated with chlorpyrifos] results in increased expression of PARP1 protein|[hesperidin co-treated with chlorpyrifos] results in increased expression of PARP1 mRNA,,,PMID:33908150,https://www.ncbi.nlm.nih.gov/pubmed/33908150,33908150,,,18316735,"Küçükler S, Çomakli S, Özdemir S, Çaglayan C, Kandemir FM. Hesperidin protects against the chlorpyrifos-induced chronic hepato-renal toxicity in rats associated with oxidative stress, inflammation, apoptosis, autophagy, and up-regulation of <i>PARP-1</i>/<i>VEGF</i>. Environmental Toxicology. 2021 Apr 28;36(8):1600–17. doi: 10.1002/tox.23156."
1098419,10621,Comparative Toxicogenomics Database (CTD),Hesperidin,D006569,Hesperidin,https://ctdbase.org/detail.go?type=chem&acc=D006569,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Hesperidin inhibits the reaction [ethanol results in increased activity of PARP1 protein],,,PMID:30368987,https://www.ncbi.nlm.nih.gov/pubmed/30368987,30368987,,,587470,"Gaballah HH, Ghanem HB, Tahoon NM, Mohamed DA, Ebeid AM. Hesperidin promotes lysosomal biogenesis in chronically ethanol-induced cardiotoxicity in rats: A proposed mechanisms of protection. J Biochem Mol Toxicol. 2019 Mar;33(3):e22253. doi: 10.1002/jbt.22253. PMID: 30368987."
983282,10680,Comparative Toxicogenomics Database (CTD),Flavone,C043562,flavone,https://ctdbase.org/detail.go?type=chem&acc=C043562,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Flavone results in decreased activity of PARP1 protein,,,PMID:17643414,https://www.ncbi.nlm.nih.gov/pubmed/17643414,17643414,,,25503363,"Geraets L, Moonen HJJ, Brauers K, Gottschalk RWH, Wouters EFM, Bast A, Hageman GJ. Flavone as PARP-1 inhibitor: Its effect on lipopolysaccharide induced gene-expression. European Journal of Pharmacology. 2007 Nov;573(1-3):241–8. doi: 10.1016/j.ejphar.2007.07.013."
983283,10680,Comparative Toxicogenomics Database (CTD),Flavone,C043562,flavone,https://ctdbase.org/detail.go?type=chem&acc=C043562,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Flavone results in increased cleavage of PARP1 protein,,,PMID:15289867,https://www.ncbi.nlm.nih.gov/pubmed/15289867,15289867,,,17300563,"Chen YC, Shen SC, Chow JM, Ko CH, Tseng SW. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int J Oncol. 2004 Sep;25(3):661–70. PMID: 15289867."
1204267,10749,Toxin and Toxin Target Database (T3DB),Thiacetarsamide,T3D1295,Arsenamide,http://www.t3db.ca/toxins/T3D1295,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1117449,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methamphetamine results in decreased cleavage of PARP1 protein|bbc3 protein affects the reaction [methamphetamine results in decreased cleavage of PARP1 protein],,,PMID:26524635,https://www.ncbi.nlm.nih.gov/pubmed/26524635,26524635,,,32361128,"Chen C, Qincao L, Xu J, Du S, Huang E, Liu C, Lin Z, Xie W, Wang H. Role of PUMA in methamphetamine-induced neuronal apoptosis. Toxicology Letters. 2016 Jan;240(1):149–60. doi: 10.1016/j.toxlet.2015.10.020."
1117450,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PRKCD protein affects the reaction [methamphetamine results in increased cleavage of PARP1 protein]|ginsenoside re inhibits the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:25523949,https://www.ncbi.nlm.nih.gov/pubmed/25523949,25523949,,,16835153,"Nam Y, Wie MB, Shin E, Nguyen TL, Nah S, Ko SK, Jeong JH, Jang C, Kim H. Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C d in human neuroblastoma dopaminergic SH-SY5Y cell lines. J of Applied Toxicology. 2014 Dec 18;35(8):927–44. doi: 10.1002/jat.3093."
1117451,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methamphetamine results in increased cleavage of PARP1 protein,,,PMID:25523949|PMID:31059759,https://www.ncbi.nlm.nih.gov/pubmed/25523949|https://www.ncbi.nlm.nih.gov/pubmed/31059759,25523949|31059759,,,16835153|29074218,"Huang E, Huang H, Guan T, Liu C, Qu D, Xu Y, Yang J, Yan L, Xiong Y, Liang T, Wang Q, Chen L. Involvement of C/EBPß-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis. Toxicol Lett. 2019 Sep 15;312():11–21. doi: 10.1016/j.toxlet.2019.05.003. PMID: 31059759.|Nam Y, Wie MB, Shin E, Nguyen TL, Nah S, Ko SK, Jeong JH, Jang C, Kim H. Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C d in human neuroblastoma dopaminergic SH-SY5Y cell lines. J of Applied Toxicology. 2014 Dec 18;35(8):927–44. doi: 10.1002/jat.3093."
1117452,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SNCA protein affects the reaction [methamphetamine results in increased cleavage of PARP1 protein]|cebpb protein affects the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:31059759,https://www.ncbi.nlm.nih.gov/pubmed/31059759,31059759,,,29074218,"Huang E, Huang H, Guan T, Liu C, Qu D, Xu Y, Yang J, Yan L, Xiong Y, Liang T, Wang Q, Chen L. Involvement of C/EBPß-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis. Toxicol Lett. 2019 Sep 15;312():11–21. doi: 10.1016/j.toxlet.2019.05.003. PMID: 31059759."
1117453,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Chloroquine promotes the reaction [methamphetamine results in increased cleavage of PARP1 protein]|stx17 protein inhibits the reaction [methamphetamine results in increased cleavage of PARP1 protein]|sirolimus inhibits the reaction [methamphetamine results in increased cleavage of PARP1 protein]|bafilomycin A1 promotes the reaction [methamphetamine results in increased cleavage of PARP1 protein]|3-methyladenine promotes the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:34374793,https://www.ncbi.nlm.nih.gov/pubmed/34374793,34374793,,,25810524,2021; 95(10):3263-3284
1117454,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),DDIT3 protein affects the reaction [methamphetamine results in increased cleavage of PARP1 protein]|4-phenylbutyric acid inhibits the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:34214594,https://www.ncbi.nlm.nih.gov/pubmed/34214594,34214594,,,33842765,"Tan X, Cai D, Chen N, Du S, Qiao D, Yue X, Wang T, Li J, Xie W, Wang H. Methamphetamine mediates apoptosis of vascular smooth muscle cells via the chop-related endoplasmic reticulum stress pathway. Toxicol Lett. 2021 Oct 10;350():98–110. doi: 10.1016/j.toxlet.2021.06.019. PMID: 34214594."
1117455,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),CASP4 protein alternative form affects the reaction [methamphetamine results in increased cleavage of PARP1 protein]|wedelolactone inhibits the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:25631491,https://www.ncbi.nlm.nih.gov/pubmed/25631491,25631491,,PMC4833032,24943250,"Huang W, Xie WB, Qiao D, Qiu P, Huang E, Li B, Chen C, Liu C, Wang Q, Lin Z, Wang H. Caspase-11 plays an essential role in methamphetamine-induced dopaminergic neuron apoptosis. Toxicol Sci. 2015 May;145(1):68–79. PMID: 25631491; PMCID: PMC4833032."
1117456,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),DDIT4 protein promotes the reaction [methamphetamine results in increased expression of PARP1 protein modified form],,,PMID:26825372,https://www.ncbi.nlm.nih.gov/pubmed/26825372,26825372,,,5990917,"Chen R, Wang B, Chen L, Cai D, Li B, Chen C, Huang E, Liu C, Lin Z, Xie WB, Wang H. DNA damage-inducible transcript 4 (DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR signaling pathway in cardiomyocytes. Toxicol Appl Pharmacol. 2016 Mar 15;295():1–11. doi: 10.1016/j.taap.2016.01.017. PMID: 26825372."
1117457,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),IGFBP5 mutant form inhibits the reaction [methamphetamine results in increased activity of PARP1 protein]|methamphetamine results in increased activity of PARP1 protein,,,PMID:25127757,https://www.ncbi.nlm.nih.gov/pubmed/25127757,25127757,,,6659457,"Qiao D, Xu J, Le C, Huang E, Liu C, Qiu P, Lin Z, Xie WB, Wang H. Insulin-like growth factor binding protein 5 (IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis. Toxicol Lett. 2014 Nov 04;230(3):444–53. doi: 10.1016/j.toxlet.2014.08.010. PMID: 25127757."
1117644,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Lactulose inhibits the reaction [methamphetamine results in increased expression of PARP1 protein modified form],,,PMID:30450033,https://www.ncbi.nlm.nih.gov/pubmed/30450033,30450033,,PMC6224488,25035371,"Xie XL, Zhou WT, Zhang KK, Chen LJ, Wang Q. METH-Induced Neurotoxicity Is Alleviated by Lactulose Pretreatment Through Suppressing Oxidative Stress and Neuroinflammation in Rat Striatum. Front Neurosci. 2018;12():802. PMID: 30450033; PMCID: PMC6224488."
1117645,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Methamphetamine results in increased cleavage of PARP1 protein,,,PMID:25631491|PMID:31059759|PMID:34214594|PMID:34374793|PMID:36914120,https://www.ncbi.nlm.nih.gov/pubmed/25631491|https://www.ncbi.nlm.nih.gov/pubmed/31059759|https://www.ncbi.nlm.nih.gov/pubmed/34214594|https://www.ncbi.nlm.nih.gov/pubmed/34374793|https://www.ncbi.nlm.nih.gov/pubmed/36914120,25631491|31059759|34214594|34374793|36914120,,PMC4833032,24943250|25810524|29074218|33842765|35161421,"Zhao X, Lu J, Zhang C, Chen C, Zhang M, Zhang J, Du Q, Wang H. Methamphetamine induces cardiomyopathy through GATA4/NF-?B/SASP axis-mediated cellular senescence. Toxicol Appl Pharmacol. 2023 May 01;466():116457. doi: 10.1016/j.taap.2023.116457. PMID: 36914120.|Tan X, Cai D, Chen N, Du S, Qiao D, Yue X, Wang T, Li J, Xie W, Wang H. Methamphetamine mediates apoptosis of vascular smooth muscle cells via the chop-related endoplasmic reticulum stress pathway. Toxicol Lett. 2021 Oct 10;350():98–110. doi: 10.1016/j.toxlet.2021.06.019. PMID: 34214594.|2021; 95(10):3263-3284|Huang E, Huang H, Guan T, Liu C, Qu D, Xu Y, Yang J, Yan L, Xiong Y, Liang T, Wang Q, Chen L. Involvement of C/EBPß-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis. Toxicol Lett. 2019 Sep 15;312():11–21. doi: 10.1016/j.toxlet.2019.05.003. PMID: 31059759.|Huang W, Xie WB, Qiao D, Qiu P, Huang E, Li B, Chen C, Liu C, Wang Q, Lin Z, Wang H. Caspase-11 plays an essential role in methamphetamine-induced dopaminergic neuron apoptosis. Toxicol Sci. 2015 May;145(1):68–79. PMID: 25631491; PMCID: PMC4833032."
1117646,10836,Comparative Toxicogenomics Database (CTD),Methamphetamine,D008694,Methamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D008694,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Methamphetamine results in increased expression of PARP1 protein modified form,,,PMID:26825372|PMID:28341135|PMID:30450033,https://www.ncbi.nlm.nih.gov/pubmed/26825372|https://www.ncbi.nlm.nih.gov/pubmed/28341135|https://www.ncbi.nlm.nih.gov/pubmed/30450033,26825372|28341135|30450033,,PMC6224488,5990917|12808401|25035371,"Xie XL, Zhou WT, Zhang KK, Chen LJ, Wang Q. METH-Induced Neurotoxicity Is Alleviated by Lactulose Pretreatment Through Suppressing Oxidative Stress and Neuroinflammation in Rat Striatum. Front Neurosci. 2018;12():802. PMID: 30450033; PMCID: PMC6224488.|Wang Q, Wei LW, Xiao HQ, Xue Y, Du SH, Liu YG, Xie XL. Methamphetamine induces hepatotoxicity via inhibiting cell division, arresting cell cycle and activating apoptosis: In vivo and in vitro studies. Food Chem Toxicol. 2017 Jul;105():61–72. doi: 10.1016/j.fct.2017.03.030. PMID: 28341135.|Chen R, Wang B, Chen L, Cai D, Li B, Chen C, Huang E, Liu C, Lin Z, Xie WB, Wang H. DNA damage-inducible transcript 4 (DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR signaling pathway in cardiomyocytes. Toxicol Appl Pharmacol. 2016 Mar 15;295():1–11. doi: 10.1016/j.taap.2016.01.017. PMID: 26825372."
1345832,10986,Comparative Toxicogenomics Database (CTD),Cadmium acetate,C028031,cadmium acetate,https://ctdbase.org/detail.go?type=chem&acc=C028031,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cadmium acetate results in increased cleavage of PARP1 protein,,,PMID:15450950,https://www.ncbi.nlm.nih.gov/pubmed/15450950,15450950,,,7179812,"Oh SH, Lee BH, Lim SC. Cadmium induces apoptotic cell death in WI 38 cells via caspase-dependent Bid cleavage and calpain-mediated mitochondrial Bax cleavage by Bcl-2-independent pathway. Biochem Pharmacol. 2004 Nov 01;68(9):1845–55. doi: 10.1016/j.bcp.2004.06.021. PMID: 15450950."
1345833,10986,Comparative Toxicogenomics Database (CTD),Cadmium acetate,C028031,cadmium acetate,https://ctdbase.org/detail.go?type=chem&acc=C028031,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cadmium acetate affects the expression of PARP1 mRNA,,,PMID:16249259,https://www.ncbi.nlm.nih.gov/pubmed/16249259,16249259,,,26797411,"Tan Y, Shi L, Hussain SM, Xu J, Tong W, Frazier JM, Wang C. Integrating time-course microarray gene expression profiles with cytotoxicity for identification of biomarkers in primary rat hepatocytes exposed to cadmium. Bioinformatics. 2006 Jan 01;22(1):77–87. doi: 10.1093/bioinformatics/bti737. PMID: 16249259."
1345834,10986,Comparative Toxicogenomics Database (CTD),Cadmium acetate,C028031,cadmium acetate,https://ctdbase.org/detail.go?type=chem&acc=C028031,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cadmium acetate results in increased cleavage of PARP1 protein,,,PMID:24577723|PMID:25043952|PMID:27717697,https://www.ncbi.nlm.nih.gov/pubmed/24577723|https://www.ncbi.nlm.nih.gov/pubmed/25043952|https://www.ncbi.nlm.nih.gov/pubmed/27717697,24577723|25043952|27717697,,,10057115|26291509|29699080,"Song XB, Liu G, Wang ZY, Wang L. Puerarin protects against cadmium-induced proximal tubular cell apoptosis by restoring mitochondrial function. Chem Biol Interact. 2016 Dec 25;260():219–31. doi: 10.1016/j.cbi.2016.10.006. PMID: 27717697.|Yuan Y, Jiang C, Hu F, Wang Q, Zhang K, Wang Y, Gu J, Liu X, Bian J, Liu Z. The role of mitogen-activated protein kinase in cadmium-induced primary rat cerebral cortical neurons apoptosis via a mitochondrial apoptotic pathway. Journal of Trace Elements in Medicine and Biology. 2015 Jan;29():275–83. doi: 10.1016/j.jtemb.2014.06.006.|2014; 158(2):249-258"
1345835,10986,Comparative Toxicogenomics Database (CTD),Cadmium acetate,C028031,cadmium acetate,https://ctdbase.org/detail.go?type=chem&acc=C028031,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Puerarin inhibits the reaction [cadmium acetate results in increased cleavage of PARP1 protein],,,PMID:27717697,https://www.ncbi.nlm.nih.gov/pubmed/27717697,27717697,,,29699080,"Song XB, Liu G, Wang ZY, Wang L. Puerarin protects against cadmium-induced proximal tubular cell apoptosis by restoring mitochondrial function. Chem Biol Interact. 2016 Dec 25;260():219–31. doi: 10.1016/j.cbi.2016.10.006. PMID: 27717697."
1345836,10986,Comparative Toxicogenomics Database (CTD),Cadmium acetate,C028031,cadmium acetate,https://ctdbase.org/detail.go?type=chem&acc=C028031,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),U 0126 inhibits the reaction [cadmium acetate results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [cadmium acetate results in increased cleavage of PARP1 protein],,,PMID:24577723|PMID:25043952,https://www.ncbi.nlm.nih.gov/pubmed/24577723|https://www.ncbi.nlm.nih.gov/pubmed/25043952,24577723|25043952,,,10057115|26291509,"Yuan Y, Jiang C, Hu F, Wang Q, Zhang K, Wang Y, Gu J, Liu X, Bian J, Liu Z. The role of mitogen-activated protein kinase in cadmium-induced primary rat cerebral cortical neurons apoptosis via a mitochondrial apoptotic pathway. Journal of Trace Elements in Medicine and Biology. 2015 Jan;29():275–83. doi: 10.1016/j.jtemb.2014.06.006.|2014; 158(2):249-258"
997136,10998,Toxin and Toxin Target Database (T3DB),Cobaltous formate,T3D1400,Cobalt(II) formate,http://www.t3db.ca/toxins/T3D1400,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1212219,11057,Comparative Toxicogenomics Database (CTD),Gentian Violet,D005840,Gentian Violet,https://ctdbase.org/detail.go?type=chem&acc=D005840,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gentian violet results in increased cleavage of PARP1 protein,,,PMID:24535435,https://www.ncbi.nlm.nih.gov/pubmed/24535435,24535435,,PMC3977805,31650624,"GARUFI A, D’ORAZI V, ARBISER JL, D’ORAZI G. Gentian violet induces wtp53 transactivation in cancer cells. 2014 Feb 14;44(4):1084–90. doi: 10.3892/ijo.2014.2304."
1408720,11089,Comparative Toxicogenomics Database (CTD),Trimellitic anhydride,C015559,trimellitic anhydride,https://ctdbase.org/detail.go?type=chem&acc=C015559,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Trimellitic anhydride results in increased expression of PARP1 mRNA,,,PMID:19042947,https://www.ncbi.nlm.nih.gov/pubmed/19042947,19042947,,,376686,"Boverhof DR, Gollapudi BB, Hotchkiss JA, Osterloh-Quiroz M, Woolhiser MR. Evaluation of a toxicogenomic approach to the local lymph node assay (LLNA). Toxicol Sci. 2009 Feb;107(2):427–39. doi: 10.1093/toxsci/kfn247. PMID: 19042947."
1071722,11092,Comparative Toxicogenomics Database (CTD),Paeonol,C013638,paeonol,https://ctdbase.org/detail.go?type=chem&acc=C013638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Paeonol inhibits the reaction [epirubicin results in increased cleavage of PARP1 protein],,,PMID:26646421,https://www.ncbi.nlm.nih.gov/pubmed/26646421,26646421,,,12786983,"Wu J, Xue X, Zhang B, Jiang W, Cao H, Wang R, Sun D, Guo R. The protective effects of paeonol against epirubicin-induced hepatotoxicity in 4T1-tumor bearing mice via inhibition of the PI3K/Akt/NF-kB pathway. Chem Biol Interact. 2016 Jan 25;244():1–8. doi: 10.1016/j.cbi.2015.11.025. PMID: 26646421."
1157643,11192,DrugBank,Zinc Acetate,DB14487,Zinc acetate,https://www.drugbank.ca/drugs/DB14487,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:25549802,https://www.ncbi.nlm.nih.gov/pubmed/25549802,25549802,,,497628,"Bossak K, Goch W, Piatek K, Fraczyk T, Poznanski J, Bonna A, Keil C, Hartwig A, Bal W: Unusual Zn(II) Affinities of Zinc Fingers of Poly(ADP-ribose)Polymerase 1 (PARP-1) Nuclear Protein. Chem Res Toxicol. 2015 Feb 16;28(2):191-201."
1046040,11254,Comparative Toxicogenomics Database (CTD),Diepoxybutane,C007366,diepoxybutane,https://ctdbase.org/detail.go?type=chem&acc=C007366,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Diepoxybutane results in increased cleavage of PARP1 protein,,,PMID:14998682,https://www.ncbi.nlm.nih.gov/pubmed/14998682,14998682,,,30821902,"Yadavilli S, Muganda PM. Diepoxybutane induces caspase and p53-mediated apoptosis in human lymphoblasts. Toxicol Appl Pharmacol. 2004 Mar 01;195(2):154–65. doi: 10.1016/j.taap.2003.11.006. PMID: 14998682."
1215309,11333,Comparative Toxicogenomics Database (CTD),Lactulose,D007792,Lactulose,https://ctdbase.org/detail.go?type=chem&acc=D007792,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Lactulose inhibits the reaction [methamphetamine results in increased expression of PARP1 protein modified form],,,PMID:30450033,https://www.ncbi.nlm.nih.gov/pubmed/30450033,30450033,,PMC6224488,25035371,"Xie XL, Zhou WT, Zhang KK, Chen LJ, Wang Q. METH-Induced Neurotoxicity Is Alleviated by Lactulose Pretreatment Through Suppressing Oxidative Stress and Neuroinflammation in Rat Striatum. Front Neurosci. 2018;12():802. PMID: 30450033; PMCID: PMC6224488."
1058160,11349,Comparative Toxicogenomics Database (CTD),3-Hydroxyflavone,D005419,Flavonoids,https://ctdbase.org/detail.go?type=chem&acc=D005419,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Flavonoids results in decreased expression of PARP1 mRNA,,,PMID:15465739,https://www.ncbi.nlm.nih.gov/pubmed/15465739,15465739,,,23387510,"Noé V, Peñuelas S, Ciudad CJ, Lamuela-Raventós RM, Permanyer J, Izquierdo-Pulido M. Epicatechin and a Cocoa Polyphenolic Extract Modulate Gene Expression in Human Caco-2 Cells. The Journal of Nutrition. 2004 Oct;134(10):2509–16. doi: 10.1093/jn/134.10.2509."
1058161,11349,Comparative Toxicogenomics Database (CTD),3-Hydroxyflavone,D005419,Flavonoids,https://ctdbase.org/detail.go?type=chem&acc=D005419,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Flavonoids results in increased cleavage of PARP1 protein,,,PMID:23063593,https://www.ncbi.nlm.nih.gov/pubmed/23063593,23063593,,,28934065,"Qiao Y, Xiang Q, Yuan L, Xu L, Liu Z, Liu X. Herbacetin induces apoptosis in HepG2 cells: Involvements of ROS and PI3K/Akt pathway. Food Chem Toxicol. 2013 Jan;51():426–33. doi: 10.1016/j.fct.2012.09.036. PMID: 23063593."
1058162,11349,Comparative Toxicogenomics Database (CTD),3-Hydroxyflavone,D005419,Flavonoids,https://ctdbase.org/detail.go?type=chem&acc=D005419,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Flavonoids results in increased expression of PARP1 mRNA,,,PMID:18035473,https://www.ncbi.nlm.nih.gov/pubmed/18035473,18035473,,,31526588,"Luceri C, Giovannelli L, Pitozzi V, Toti S, Castagnini C, Routaboul JM, Lepiniec L, Larrosa M, Dolara P. Liver and colon DNA oxidative damage and gene expression profiles of rats fed Arabidopsis thaliana mutant seeds containing contrasted flavonoids. Food Chem Toxicol. 2008 Apr;46(4):1213–20. doi: 10.1016/j.fct.2007.10.007. PMID: 18035473."
1208849,11362,Toxin and Toxin Target Database (T3DB),Adamsite,T3D0275,Adamsite,http://www.t3db.ca/toxins/T3D0275,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1350810,11442,Comparative Toxicogenomics Database (CTD),Allethrins,D000487,Allethrins,https://ctdbase.org/detail.go?type=chem&acc=D000487,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Allethrins results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:25072698,https://www.ncbi.nlm.nih.gov/pubmed/25072698,25072698,,,12773248,"Madhubabu G, Yenugu S. Allethrin induces oxidative stress, apoptosis and calcium release in rat testicular carcinoma cells (LC540). Toxicol In Vitro. 2014 Dec;28(8):1386–95. doi: 10.1016/j.tiv.2014.07.008. PMID: 25072698."
940052,11711,Toxin and Toxin Target Database (T3DB),Ethyldichloroarsine,T3D1309,Ethyldichloroarsine,http://www.t3db.ca/toxins/T3D1309,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
940938,11773,Toxin and Toxin Target Database (T3DB),Triphenylarsine,T3D1314,Triphenylarsine,http://www.t3db.ca/toxins/T3D1314,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1023706,11790,Comparative Toxicogenomics Database (CTD),Alpha-Naphthoflavone,C011512,alpha-naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=C011512,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Alpha-naphthoflavone results in increased cleavage of PARP1 protein,,,PMID:30508555,https://www.ncbi.nlm.nih.gov/pubmed/30508555,30508555,,,2597134,"Yu AR, Jeong YJ, Hwang CY, Yoon KS, Choe W, Ha J, Kim SS, Pak YK, Yeo EJ, Kang I. Alpha-naphthoflavone induces apoptosis through endoplasmic reticulum stress via c-Src-, ROS-, MAPKs-, and arylhydrocarbon receptor-dependent pathways in HT22 hippocampal neuronal cells. Neurotoxicology. 2019 Mar;71():39–51. doi: 10.1016/j.neuro.2018.11.011. PMID: 30508555."
1024659,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [glucose results in increased activity of PARP1 protein],,,PMID:21031461,https://www.ncbi.nlm.nih.gov/pubmed/21031461,21031461,,,11329167,"Pang J, Gong H, Xi C, Fan W, Dai Y, Zhang TM. Poly(ADP-ribose) polymerase 1 is involved in glucose toxicity through SIRT1 modulation in HepG2 hepatocytes. J Cell Biochem. 2011 Jan;112(1):299–306. doi: 10.1002/jcb.22919. PMID: 21031461."
1024819,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7959,Ctenopharyngodon idella (grass carp),Acetylcysteine inhibits the reaction [polystyrenes results in increased expression of and results in increased cleavage of PARP1 protein],,,PMID:38064284,https://www.ncbi.nlm.nih.gov/pubmed/38064284,38064284,,,36298292,"Lu H, Hou L, Zhang Y, Guo T, Wang Y, Xing M. Polystyrene microplastics mediate cell cycle arrest, apoptosis, and autophagy in the <scp>G2</scp>/<scp>M</scp> phase through <scp>ROS</scp> in grass carp kidney cells. Environmental Toxicology. 2023 Dec 08;39(4):1923–35. doi: 10.1002/tox.24068."
1024820,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[acetylcysteine affects the abundance of reactive oxygen species] inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:24100277,https://www.ncbi.nlm.nih.gov/pubmed/24100277,24100277,,,2490832,"Kim Y, Jeong IG, You D, Song SH, Suh N, Jang SW, Kim S, Hwang JJ, Kim CS. Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells. Anticancer Drugs. 2014 Jan;25(1):53–62. doi: 10.1097/cad.0000000000000013. PMID: 24100277."
1024821,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to doxorubicin]] which affects the cleavage of PARP1 protein],,,PMID:25824409,https://www.ncbi.nlm.nih.gov/pubmed/25824409,25824409,,,14794274,"Wang S, Wang L, Chen M, Wang Y. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression. Chem Biol Interact. 2015 Jun 25;235():76–84. doi: 10.1016/j.cbi.2015.03.017. PMID: 25824409."
1024822,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]",,,PMID:30871965,https://www.ncbi.nlm.nih.gov/pubmed/30871965,30871965,,,29739467,"Xu WT, Shen GN, Luo YH, Piao XJ, Wang JR, Wang H, Zhang Y, Li JQ, Feng YC, Zhang Y, Zhang T, Wang SN, Wang CY, Jin CH. New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways. Chem Biol Interact. 2019 May 01;304():148–57. doi: 10.1016/j.cbi.2019.03.004. PMID: 30871965."
1024823,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of PARP1 protein]",,,PMID:38521250,https://www.ncbi.nlm.nih.gov/pubmed/38521250,38521250,,,36973636,"Jiang Y, Xu S, Guo M, Lu Z, Wei X, An F, Xin X. DMC triggers MDA-MB-231 cells apoptosis via inhibiting protective autophagy and PI3K/AKT/mTOR pathway by enhancing ROS level. Toxicol In Vitro. 2024 May;97():105809. doi: 10.1016/j.tiv.2024.105809. PMID: 38521250."
1024824,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein],,,PMID:14660655,https://www.ncbi.nlm.nih.gov/pubmed/14660655,14660655,,,26785117,"Han DC, Lee MY, Shin KD, Jeon SB, Kim JM, Son KH, Kim HC, Kim HM, Kwon BM. 2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species. J Biol Chem. 2004 Feb 20;279(8):6911–20. doi: 10.1074/jbc.m309708200. PMID: 14660655."
1024825,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of PARP1 protein]",,,PMID:30408460,https://www.ncbi.nlm.nih.gov/pubmed/30408460,30408460,,,27723194,"Gil HN, Jung E, Koh D, Lim Y, Lee YH, Shin SY. A synthetic chalcone derivative, 2-hydroxy-3',5,5'-trimethoxychalcone (DK-139), triggers reactive oxygen species-induced apoptosis independently of p53 in A549 lung cancer cells. Chem Biol Interact. 2019 Jan 25;298():72–9. doi: 10.1016/j.cbi.2018.11.003. PMID: 30408460."
1024826,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased cleavage of PARP1 protein]",,,PMID:24036456,https://www.ncbi.nlm.nih.gov/pubmed/24036456,24036456,,,24927079,"Tan J, Lai Z, Liu L, Long W, Chen T, Zha J, Wang L, Chen M, Ji H, Lai Y. ONTD induces apoptosis of human hepatoma Bel-7402 cells via a MAPK-dependent mitochondrial pathway and the depletion of intracellular glutathione. The International Journal of Biochemistry & Cell Biology. 2013 Nov;45(11):2632–42. doi: 10.1016/j.biocel.2013.08.021."
1024984,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [4-chromone analog results in increased expression of PARP1 protein modified form],,,PMID:30256521,https://www.ncbi.nlm.nih.gov/pubmed/30256521,30256521,,,20952774,"Tang JY, Wu CY, Shu CW, Wang SC, Chang MY, Chang HW. A novel sulfonyl chromen-4-ones (CHW09) preferentially kills oral cancer cells showing apoptosis, oxidative stress, and DNA damage. Environ Toxicol. 2018 Nov;33(11):1195–203. doi: 10.1002/tox.22625. PMID: 30256521."
1024985,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein],,,PMID:22002103,https://www.ncbi.nlm.nih.gov/pubmed/22002103,22002103,,,19480675,2011; 17(2):200-216
1024986,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [ABBV-744 results in increased cleavage of PARP1 protein],,,PMID:37769529,https://www.ncbi.nlm.nih.gov/pubmed/37769529,37769529,,PMC10539879,36577683,"Wang K, Tang J, Fan S, Su H, Yu R, Zhang Y, Wu H, Lv Y, Zhang S, Zou X. ABBV-744 induces autophagy in gastric cancer cells by regulating PI3K/AKT/mTOR/p70S6k and MAPK signaling pathways. Neoplasia. 2023 Nov;45():100936. PMID: 37769529; PMCID: PMC10539879."
1024987,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [acetaminophen results in increased expression of PARP1 mrna],,,PMID:33971260,https://www.ncbi.nlm.nih.gov/pubmed/33971260,33971260,,,10880503,"Viswanathan P, Gupta P, Sharma Y, Maisuradze L, Bandi S, Gupta S. Caffeine disrupts ataxia telangiectasia mutated gene-related pathways and exacerbates acetaminophen toxicity in human fetal immortalized hepatocytes. Toxicology. 2021 Jun 15;457():152811. doi: 10.1016/j.tox.2021.152811. PMID: 33971260."
1024988,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [acrylamide results in increased cleavage of PARP1 protein],,,PMID:27634458,https://www.ncbi.nlm.nih.gov/pubmed/27634458,27634458,,,1202792,"Komoike Y, Matsuoka M. Endoplasmic reticulum stress-mediated neuronal apoptosis by acrylamide exposure. Toxicol Appl Pharmacol. 2016 Nov 01;310():68–77. doi: 10.1016/j.taap.2016.09.005. PMID: 27634458."
1024989,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [acrylonitrile results in increased cleavage of PARP1 protein],,,PMID:20981856,https://www.ncbi.nlm.nih.gov/pubmed/20981856,20981856,,,30246948,"Watcharasit P, Suntararuks S, Visitnonthachai D, Thiantanawat A, Satayavivad J. Acrylonitrile induced apoptosis via oxidative stress in neuroblastoma SH-SY5Y cell. J Appl Toxicol. 2010 Oct;30(7):649–55. doi: 10.1002/jat.1535. PMID: 20981856."
1024990,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [antimycin A results in increased cleavage of PARP1 protein],,,PMID:32662599,https://www.ncbi.nlm.nih.gov/pubmed/32662599,32662599,,,1961922,"Yu TJ, Hsieh CY, Tang JY, Lin LC, Huang HW, Wang HR, Yeh YC, Chuang YT, Ou-Yang F, Chang HW. Antimycin A shows selective antiproliferation to oral cancer cells by oxidative stress-mediated apoptosis and DNA damage. Environ Toxicol. 2020 Nov;35(11):1212–24. doi: 10.1002/tox.22986. PMID: 32662599."
1024991,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein],,,PMID:23082001,https://www.ncbi.nlm.nih.gov/pubmed/23082001,23082001,,PMC3525753,30952329,"Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y. Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1. 2012 Dec 15;18(24):6690–701. doi: 10.1158/1078-0432.ccr-12-0770."
1024992,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein],,,PMID:17237268,https://www.ncbi.nlm.nih.gov/pubmed/17237268,17237268,,,3048394,"Park MT, Kang YH, Park IC, Kim CH, Lee YS, Chung HY, Lee SJ. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells. Mol Cancer Ther. 2007 Jan;6(1):82–92. doi: 10.1158/1535-7163.mct-06-0349. PMID: 17237268."
1024993,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [cisplatin promotes the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]]|acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [cisplatin results in increased cleavage of PARP1 protein]],,,PMID:29944906,https://www.ncbi.nlm.nih.gov/pubmed/29944906,29944906,,,12176747,"Wahiduzzaman M, Ota A, Karnan S, Hanamura I, Mizuno S, Kanasugi J, Rahman ML, Hyodo T, Konishi H, Tsuzuki S, Takami A, Hosokawa Y. Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo. Cancer Lett. 2018 Oct 01;433():117–30. doi: 10.1016/j.canlet.2018.06.027. PMID: 29944906."
1025172,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased cleavage of PARP1 protein],,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,PMC4234881,19518824,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881."
1025173,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of PARP1 protein],,,PMID:25972196,https://www.ncbi.nlm.nih.gov/pubmed/25972196,25972196,,,20200909,"Luo Q, Li Y, Lai Y, Zhang Z. The role of NF-?B in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells. J Toxicol Sci. 2015 Jun;40(3):349–63. doi: 10.2131/jts.40.349. PMID: 25972196."
1025174,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [artesunate results in increased cleavage of PARP1 protein],,,PMID:33002460,https://www.ncbi.nlm.nih.gov/pubmed/33002460,33002460,,,12220368,"Zhou X, Chen Y, Wang F, Wu H, Zhang Y, Liu J, Cai Y, Huang S, He N, Hu Z, Jin X. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem Biol Interact. 2020 Nov 01;331():109273. doi: 10.1016/j.cbi.2020.109273. PMID: 33002460."
1025175,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[berberine co-treated with cisplatin] results in increased cleavage of PARP1 protein],,,PMID:36070022,https://www.ncbi.nlm.nih.gov/pubmed/36070022,36070022,,,35282806,2022; 39(4):1297-1317
1025176,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [cadmium chloride results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:18703135,https://www.ncbi.nlm.nih.gov/pubmed/18703135,18703135,,,23465687,"Chen L, Liu L, Huang S. Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5. Free Radic Biol Med. 2008 Oct 01;45(7):1035–44. doi: 10.1016/j.freeradbiomed.2008.07.011. PMID: 18703135."
1025177,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [chloropicrin results in increased cleavage of PARP1 protein],,,PMID:31884112,https://www.ncbi.nlm.nih.gov/pubmed/31884112,31884112,,PMC11249040,598240,"Goswami DG, Kant R, Ammar DA, Agarwal C, Gomez J, Agarwal R, Saba LM, Fritz KS, Tewari-Singh N. Toxic consequences and oxidative protein carbonylation from chloropicrin exposure in human corneal epithelial cells. Toxicology Letters. 2020 Apr;322():1–11. doi: 10.1016/j.toxlet.2019.12.023."
1025178,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [[cholix toxin, vibrio cholerae co-treated with TNF protein] results in increased cleavage of PARP1 protein]",,,PMID:28087840,https://www.ncbi.nlm.nih.gov/pubmed/28087840,28087840,,PMC5837519,14162527,"Ogura K, Terasaki Y, Miyoshi-Akiyama T, Terasaki M, Moss J, Noda M, Yahiro K. Vibrio cholerae Cholix Toxin-Induced HepG2 Cell Death is Enhanced by Tumor Necrosis Factor-Alpha Through ROS and Intracellular Signal-Regulated Kinases. Toxicol Sci. 2017 Apr 01;156(2):455–68. PMID: 28087840; PMCID: PMC5837519."
1025179,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [cisplatin results in increased cleavage of PARP1 protein],,,PMID:15496615,https://www.ncbi.nlm.nih.gov/pubmed/15496615,15496615,,,5770047,2005; 312(2):424-431
1025180,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]]|acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased cleavage of PARP1 protein]]|acetylcysteine inhibits the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein],,,PMID:22172632,https://www.ncbi.nlm.nih.gov/pubmed/22172632,22172632,,,20810526,"Patel E, Lynch C, Ruff V, Reynolds M. Co-exposure to nickel and cobalt chloride enhances cytotoxicity and oxidative stress in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Feb 01;258(3):367–75. doi: 10.1016/j.taap.2011.11.019. PMID: 22172632."
1025370,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[CSC-3436 co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein],,,PMID:34599545,https://www.ncbi.nlm.nih.gov/pubmed/34599545,34599545,,,7523207,"Huang C, Cheng Y, Lin Y, Chou C, Ho C, Wang H, Way T. <scp>CSC</scp>-3436 sensitizes triple negative breast cancer cells to <scp>TRAIL</scp>-induced apoptosis through <scp>ROS</scp>-mediated p38/<scp>CHOP</scp>/death receptor 5 signaling pathways. Environmental Toxicology. 2021 Oct 02;36(12):2578–88. doi: 10.1002/tox.23372."
1025371,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of PARP1 protein],,,PMID:27106530,https://www.ncbi.nlm.nih.gov/pubmed/27106530,27106530,,,16857121,"Ma G, Luo W, Lu J, Ma DL, Leung CH, Wang Y, Chen X. Cucurbitacin E induces caspase-dependent apoptosis and protective autophagy mediated by ROS in lung cancer cells. Chem Biol Interact. 2016 Jun 25;253():1–9. doi: 10.1016/j.cbi.2016.04.028. PMID: 27106530."
1025372,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of PARP1 protein],,,PMID:22578287,https://www.ncbi.nlm.nih.gov/pubmed/22578287,22578287,,PMC3404941,14751864,2012; 19(1):50
1025373,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [morpholines analog results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [divinyl sulfone analog results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [oligopeptides analog results in increased cleavage of PARP1 protein],,,PMID:24875536,https://www.ncbi.nlm.nih.gov/pubmed/24875536,24875536,,,9393305,"Zhang L, Wang H, Xu J, Zhu J, Ding K. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Toxicol Lett. 2014 Aug 04;228(3):248–59. doi: 10.1016/j.toxlet.2014.05.015. PMID: 24875536."
1025374,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein],,,PMID:25939952,https://www.ncbi.nlm.nih.gov/pubmed/25939952,25939952,,,26969299,"Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015 Jul 02;236(1):43–59. doi: 10.1016/j.toxlet.2015.04.015. PMID: 25939952."
1025375,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [frenolicin B results in increased cleavage of PARP1 protein],,,PMID:30661989,https://www.ncbi.nlm.nih.gov/pubmed/30661989,30661989,,PMC6557261,30427533,"Ye Q, Zhang Y, Cao Y, Wang X, Guo Y, Chen J, Horn J, Ponomareva LV, Chaiswing L, Shaaban KA, Wei Q, Anderson BD, St Clair DK, Zhu H, Leggas M, Thorson JS, She Q. Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects. Cell Chemical Biology. 2019 Mar;26(3):366–377.e12. doi: 10.1016/j.chembiol.2018.11.013."
1025376,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:31313457,https://www.ncbi.nlm.nih.gov/pubmed/31313457,31313457,,,32448241,"Choi YJ, Lee CM, Lee JH, Park SH, Nam MJ. Protective effects of hepatocyte growth factor gene overexpression against hydrogen peroxide-induced apoptosis in mesenchymal stem cells. Environ Toxicol. 2019 Nov;34(11):1236–45. doi: 10.1002/tox.22824. PMID: 31313457."
1025377,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [indole-3-carbinol results in increased cleavage of PARP1 protein],,,PMID:33118390,https://www.ncbi.nlm.nih.gov/pubmed/33118390,33118390,,,6095252,"Lim HM, Park SH, Nam MJ. Induction of apoptosis in indole-3-carbinol-treated lung cancer H1299 cells via ROS level elevation. Hum Exp Toxicol. 2021 May;40(5):812–25. doi: 10.1177/0960327120969968. PMID: 33118390."
1025378,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [isoalantolactone results in increased expression of PARP1 protein modified form],,,PMID:29800641,https://www.ncbi.nlm.nih.gov/pubmed/29800641,29800641,,,21616822,"Lu Z, Zhang G, Zhang Y, Hua P, Fang M, Wu M, Liu T. Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells. Toxicol Appl Pharmacol. 2018 Aug 01;352():46–58. doi: 10.1016/j.taap.2018.05.026. PMID: 29800641."
1025379,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [isoliensinine results in increased cleavage of PARP1 protein],,,PMID:26219228,https://www.ncbi.nlm.nih.gov/pubmed/26219228,26219228,,PMC4518223,33034897,2015; 5(1):12579
1025550,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [manumycin results in increased cleavage of PARP1],,,PMID:19409983,https://www.ncbi.nlm.nih.gov/pubmed/19409983,19409983,,,11304507,"Dixit D, Sharma V, Ghosh S, Koul N, Mishra PK, Sen E. Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation. Free Radic Biol Med. 2009 Aug 15;47(4):364–74. doi: 10.1016/j.freeradbiomed.2009.04.031. PMID: 19409983."
1025551,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [methylmercury compounds results in increased cleavage of PARP1 protein],,,PMID:35396826,https://www.ncbi.nlm.nih.gov/pubmed/35396826,35396826,,,34244895,"Hou S, Zhang X, Ning X, Wu H, Li X, Ma K, Hao H, Lv C, Li C, Du Z, Du H, Jin M. Methylmercury induced apoptosis of human neuroblastoma cells through the reactive oxygen species mediated caspase and poly ADP-ribose polymerase/<scp>a</scp>poptosis-inducing factor dependent pathways. Environmental Toxicology. 2022 Apr 09;37(8):1891–901. doi: 10.1002/tox.23535."
1025552,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein],,,PMID:29774349,https://www.ncbi.nlm.nih.gov/pubmed/29774349,29774349,,,32414021,"Maimaitiyiming Y, Wang C, Xu S, Islam K, Chen YJ, Yang C, Wang QQ, Naranmandura H. Role of arsenic (+3 oxidation state) methyltransferase in arsenic mediated APL treatment: an in vitro investigation. Metallomics. 2018 Jun 20;10(6):828–37. doi: 10.1039/c8mt00057c. PMID: 29774349."
1025553,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein],,,PMID:26887594,https://www.ncbi.nlm.nih.gov/pubmed/26887594,26887594,,PMC5423166,24303290,"Cheng X, Kim JY, Ghafoory S, Duvaci T, Rafiee R, Theobald J, Alborzinia H, Holenya P, Fredebohm J, Merz K, Mehrabi A, Hafezi M, Saffari A, Eisenbrand G, Hoheisel J, Wölfl S. Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. Molecular Oncology. 2016 Feb 04;10(6):806–24. doi: 10.1016/j.molonc.2016.01.008."
1025554,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form],,,PMID:28237877,https://www.ncbi.nlm.nih.gov/pubmed/28237877,28237877,,,32395047,"Tang ZH, Cao WX, Su MX, Chen X, Lu JJ. Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells. Toxicol Appl Pharmacol. 2017 Apr 15;321():18–26. doi: 10.1016/j.taap.2017.02.017. PMID: 28237877."
1025555,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [pendulone results in increased cleavage of PARP1 protein],,,PMID:35288263,https://www.ncbi.nlm.nih.gov/pubmed/35288263,35288263,,,4076996,"Cheng WC, Wen Y, Chiu YS, Chou CH, Lim CJ, Lin SH, Chang JM, Lin CC. Pendulone induces apoptosis via the ROS-mediated ER-stress pathway in human non-small cell lung cancer cells. Toxicol In Vitro. 2022 Jun;81():105346. doi: 10.1016/j.tiv.2022.105346. PMID: 35288263."
1025556,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [plant extracts results in increased cleavage of PARP1 protein],,,PMID:31157515,https://www.ncbi.nlm.nih.gov/pubmed/31157515,31157515,,,33797231,"Tang J, Peng S, Cheng Y, Wang C, Farooqi AA, Yu T, Hou M, Wang S, Yen C, Chan L, Ou-Yang F, Chang H. Ethyl acetate extract of <i>Nepenthes adrianii</i> x <i>clipeata</i> induces antiproliferation, apoptosis, and DNA damage against oral cancer cells through oxidative stress. Environmental Toxicology. 2019 Jun 03;34(8):891–901. doi: 10.1002/tox.22748."
1025557,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to cisplatin] which results in increased cleavage of PARP1 protein],,,PMID:25940438,https://www.ncbi.nlm.nih.gov/pubmed/25940438,25940438,,PMC4494929,26969758,"Zagryazhskaya A, Surova O, Akbar NS, Allavena G, Gyuraszova K, Zborovskaya IB, Tchevkina EM, Zhivotovsky B. Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11. Oncotarget. 2015 May 20;6(14):12156–73. PMID: 25940438; PMCID: PMC4494929."
1025558,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [salvin results in increased cleavage of PARP1 protein],,,PMID:28918123,https://www.ncbi.nlm.nih.gov/pubmed/28918123,28918123,,,25013213,"Zhang X, Chen Y, Cai G, Li X, Wang D. Carnosic acid induces apoptosis of hepatocellular carcinoma cells via ROS-mediated mitochondrial pathway. Chem Biol Interact. 2017 Nov 01;277():91–100. doi: 10.1016/j.cbi.2017.09.005. PMID: 28918123."
1025559,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [scutebarbatine A results in increased cleavage of PARP1 protein],,,PMID:37072049,https://www.ncbi.nlm.nih.gov/pubmed/37072049,37072049,,,35743292,"Hao XS, Feng PP, Zhang YY, Wang FZ, Wang GL, Fei HR. Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway. Chem Biol Interact. 2023 Jun 01;378():110487. doi: 10.1016/j.cbi.2023.110487. PMID: 37072049."
1025740,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [shikonin results in increased cleavage of PARP1 protein],,,PMID:24463199,https://www.ncbi.nlm.nih.gov/pubmed/24463199,24463199,,,18167418,"Lee MJ, Kao SH, Hunag JE, Sheu GT, Yeh CW, Hseu YC, Wang CJ, Hsu LS. Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species. Chem Biol Interact. 2014 Mar 25;211():44–53. doi: 10.1016/j.cbi.2014.01.008. PMID: 24463199."
1025741,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:25619640,https://www.ncbi.nlm.nih.gov/pubmed/25619640,25619640,,,27660120,"Han MA, Woo SM, Min KJ, Kim S, Park JW, Kim DE, Kim SH, Choi YH, Kwon TK. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression. Chem Biol Interact. 2015 Feb 25;228():69–78. doi: 10.1016/j.cbi.2015.01.020. PMID: 25619640."
1025742,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [shogaol results in increased cleavage of PARP1 protein],,,PMID:18384088,https://www.ncbi.nlm.nih.gov/pubmed/18384088,18384088,,,8585134,"Pan MH, Hsieh MC, Kuo JM, Lai CS, Wu H, Sang S, Ho CT. 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol Nutr Food Res. 2008 May;52(5):527–37. doi: 10.1002/mnfr.200700157. PMID: 18384088."
1025743,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of PARP1 protein],,,PMID:28548367,https://www.ncbi.nlm.nih.gov/pubmed/28548367,28548367,,,19591133,"Chang YT, Wu CY, Tang JY, Huang CY, Liaw CC, Wu SH, Sheu JH, Chang HW. Sinularin induces oxidative stress-mediated G2/M arrest and apoptosis in oral cancer cells. Environ Toxicol. 2017 Sep;32(9):2124–32. doi: 10.1002/tox.22425. PMID: 28548367."
1025744,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with TNF protein] results in increased cleavage of PARP1 protein],,,PMID:29479036,https://www.ncbi.nlm.nih.gov/pubmed/29479036,29479036,,,33096846,"Singhirunnusorn P, Moolmuang B, Lirdprapamongkol K, Ruchirawat M. Arsenite exposure potentiates apoptosis-inducing effects of tumor necrosis factor-alpha- through reactive oxygen species. J Toxicol Sci. 2018;43(2):159–69. doi: 10.2131/jts.43.159. PMID: 29479036."
1025745,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:19536524,https://www.ncbi.nlm.nih.gov/pubmed/19536524,19536524,,,1069011,2009; 83(10):899-908
1025746,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[sulforaphane co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein],,,PMID:22922937,https://www.ncbi.nlm.nih.gov/pubmed/22922937,22922937,,PMC3981004,31620738,"Doudican NA, Wen SY, Mazumder A, Orlow SJ. Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways. Oncol Rep. 2012 Nov;28(5):1851–8. PMID: 22922937; PMCID: PMC3981004."
1025747,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein],,,PMID:18281123,https://www.ncbi.nlm.nih.gov/pubmed/18281123,18281123,,,33572505,"Jin HO, Seo SK, Woo SH, Lee HC, Kim ES, Yoo DH, Lee SJ, An S, Choe TB, Kim JI, Hong SI, Rhee CH, Park IC. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation. Lung Cancer. 2008 Sep;61(3):317–27. doi: 10.1016/j.lungcan.2008.01.002. PMID: 18281123."
1025748,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein],,,PMID:29111459,https://www.ncbi.nlm.nih.gov/pubmed/29111459,29111459,,,14871116,"Chen H, Song Z, Ying S, Yang X, Wu W, Tan Q, Ju X, Wu W, Zhang X, Qu J, Wang Y. Myeloid differentiation protein 2 induced retinal ischemia reperfusion injury via upregulation of ROS through a TLR4-NOX4 pathway. Toxicol Lett. 2018 Jan 05;282():109–20. doi: 10.1016/j.toxlet.2017.10.018. PMID: 29111459."
1025749,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein],,,PMID:34627931,https://www.ncbi.nlm.nih.gov/pubmed/34627931,34627931,,,13642569,"Raut PK, Lee HS, Joo SH, Chun KS. Thymoquinone induces oxidative stress-mediated apoptosis through downregulation of Jak2/STAT3 signaling pathway in human melanoma cells. Food Chem Toxicol. 2021 Nov;157():112604. doi: 10.1016/j.fct.2021.112604. PMID: 34627931."
1025909,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of PARP1 protein modified form]|acetylcysteine results in decreased expression of PARP1 protein modified form,,,PMID:31433961,https://www.ncbi.nlm.nih.gov/pubmed/31433961,31433961,,,12878756,"Park JE, Kim DH, Ha E, Choi SM, Choi JS, Chun KS, Joo SH. Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3. Chem Biol Interact. 2019 Oct 01;312():108799. doi: 10.1016/j.cbi.2019.108799. PMID: 31433961."
1025910,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein],,,PMID:25034532,https://www.ncbi.nlm.nih.gov/pubmed/25034532,25034532,,PMC4295120,10048252,"Lee D, Kim D, Jung C, Lee YJ, Park D. Gingerol sensitizes TRAIL-induced apoptotic cell death of glioblastoma cells. Toxicology and Applied Pharmacology. 2014 Sep;279(3):253–65. doi: 10.1016/j.taap.2014.06.030."
1025911,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein],,,PMID:26203587,https://www.ncbi.nlm.nih.gov/pubmed/26203587,26203587,,,33020137,"Chang CC, Kuan CP, Lin JY, Lai JS, Ho TF. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines. Chem Res Toxicol. 2015 Aug 17;28(8):1574–83. doi: 10.1021/acs.chemrestox.5b00150. PMID: 26203587."
1025912,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of PARP1 protein modified form],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,,5236518,"Kim YJ, Jung EB, Seo SJ, Park KH, Lee MW, Lee CS. Quercetin-3-O-(2""-galloyl)-a-l-rhamnopyranoside prevents TRAIL-induced apoptosis in human keratinocytes by suppressing the caspase-8- and Bid-pathways and the mitochondrial pathway. Chem Biol Interact. 2013 Aug 25;204(3):144–52. doi: 10.1016/j.cbi.2013.05.009. PMID: 23711929."
1025913,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [tomentosin results in increased cleavage of PARP1 protein],,,PMID:30917517,https://www.ncbi.nlm.nih.gov/pubmed/30917517,30917517,,PMC6471964,10838292,"Lee CM, Lee J, Nam MJ, Choi YS, Park SH. Tomentosin Displays Anti-Carcinogenic Effect in Human Osteosarcoma MG-63 Cells via the Induction of Intracellular Reactive Oxygen Species. Int J Mol Sci. 2019 Mar 26;20(6). PMID: 30917517; PMCID: PMC6471964."
1025914,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [tosylphenylalanyl chloromethyl ketone results in increased cleavage of PARP1 protein],,,PMID:19679660,https://www.ncbi.nlm.nih.gov/pubmed/19679660,19679660,,PMC2788833,26189518,"Jitkaew S, Trebinska A, Grzybowska E, Carlsson G, Nordström A, Lehtiö J, Fröjmark A, Dahl N, Fadeel B. Na-Tosyl-l-phenylalanine Chloromethyl Ketone Induces Caspase-dependent Apoptosis in Transformed Human B Cell Lines with Transcriptional Down-regulation of Anti-apoptotic HS1-associated Protein X-1. Journal of Biological Chemistry. 2009 Oct;284(41):27827–37. doi: 10.1074/jbc.m109.027912."
1025915,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein],,,PMID:24373880,https://www.ncbi.nlm.nih.gov/pubmed/24373880,24373880,,,20173790,"Liu N, Huang H, Liu S, Li X, Yang C, Dou QP, Liu J. Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation. Toxicol In Vitro. 2014 Apr;28(3):419–25. doi: 10.1016/j.tiv.2013.12.008. PMID: 24373880."
1025916,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein],,,PMID:22733624,https://www.ncbi.nlm.nih.gov/pubmed/22733624,22733624,,,26937158,"Benes P, Alexova P, Knopfova L, Spanova A, Smarda J. Redox state alters anti-cancer effects of wedelolactone. Environ Mol Mutagen. 2012 Aug;53(7):515–24. doi: 10.1002/em.21712. PMID: 22733624."
1025917,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of PARP1 protein],,,PMID:27539140,https://www.ncbi.nlm.nih.gov/pubmed/27539140,27539140,,,28352053,"Kao S, Lee W, Chang J, Chow J, Chung C, Hung W, Chien M. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer. Environmental Toxicology. 2016 Aug 19;32(4):1426–38. doi: 10.1002/tox.22336."
1025918,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased cleavage of PARP1 protein]",,,PMID:20674558,https://www.ncbi.nlm.nih.gov/pubmed/20674558,20674558,,,7952771,"Li S, Tai W, Li Y, Zhang L, Zhang W, Ma E, Li J. 1-(3',4',5'-Trimethoxyphenyl)-3-(3'',4''-dimethoxy-2''-hydroxyphenyl)-propane with microtubule-depolymerizing ability induces G2/M phase arrest and apoptosis in HepG2 cells. Chem Biol Interact. 2010 Oct 06;188(1):161–70. doi: 10.1016/j.cbi.2010.07.021. PMID: 20674558."
1026065,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[acetylcysteine results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] which results in increased cleavage of PARP1 protein",,,PMID:38042493,https://www.ncbi.nlm.nih.gov/pubmed/38042493,38042493,,PMC10772734,36412181,"Richartz N, Pietka W, Yadav A, Bostad M, Bhagwat S, Naderi S, Naderi EH, Stokke T, Ruud E, Blomhoff HK. N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells. Journal of Biological Chemistry. 2024 Jan;300(1):105509. doi: 10.1016/j.jbc.2023.105509."
1026066,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[glucose deficiency co-treated with acetylcysteine] results in increased cleavage of PARP1 protein,,,PMID:17309078,https://www.ncbi.nlm.nih.gov/pubmed/17309078,17309078,,,15296321,"Kim CH, Han SI, Lee SY, Youk HS, Moon JY, Duong HQ, Park MJ, Joo YM, Park HG, Kim YJ, Yoo MA, Lim SC, Kang HS. Protein kinase C-ERK1/2 signal pathway switches glucose depletion-induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells. J Cell Physiol. 2007 May;211(2):371–85. doi: 10.1002/jcp.20941. PMID: 17309078."
1026067,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased cleavage of PARP1 protein]",,,PMID:29248572,https://www.ncbi.nlm.nih.gov/pubmed/29248572,29248572,,,20270741,"Xiao C, He P, Han J, Tang M, Wang Z, Mi Y, Liu X. 1,3-Dichloro-2-propanol evokes inflammation and apoptosis in BV-2 microglia via MAPKs and NF-?B signaling pathways mediated by reactive oxygen species. Toxicol Lett. 2018 Mar 01;284():103–12. doi: 10.1016/j.toxlet.2017.12.011. PMID: 29248572."
1026068,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of PARP1 protein],,,PMID:24157283,https://www.ncbi.nlm.nih.gov/pubmed/24157283,24157283,,,22847220,"Lu TH, Tseng TJ, Su CC, Tang FC, Yen CC, Liu YY, Yang CY, Wu CC, Chen KL, Hung DZ, Chen YW. Arsenic induces reactive oxygen species-caused neuronal cell apoptosis through JNK/ERK-mediated mitochondria-dependent and GRP 78/CHOP-regulated pathways. Toxicol Lett. 2014 Jan 03;224(1):130–40. doi: 10.1016/j.toxlet.2013.10.013. PMID: 24157283."
1026069,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein],,,PMID:21565247,https://www.ncbi.nlm.nih.gov/pubmed/21565247,21565247,,,4486504,"Kim YJ, Chung JY, Lee SG, Kim JY, Park JE, Kim WR, Joo BS, Han SH, Yoo KS, Yoo YH, Kim JM. Arsenic trioxide-induced apoptosis in TM4 Sertoli cells: the potential involvement of p21 expression and p53 phosphorylation. Toxicology. 2011 Jul 29;285(3):142–51. doi: 10.1016/j.tox.2011.04.013. PMID: 21565247."
1026070,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein],,,PMID:30796935,https://www.ncbi.nlm.nih.gov/pubmed/30796935,30796935,,,20306548,"Wang S, Ren X, Hu X, Zhou L, Zhang C, Zhang M. Cadmium-induced apoptosis through reactive oxygen species-mediated mitochondrial oxidative stress and the JNK signaling pathway in TM3 cells, a model of mouse Leydig cells. Toxicol Appl Pharmacol. 2019 Apr 01;368():37–48. doi: 10.1016/j.taap.2019.02.012. PMID: 30796935."
1026071,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
1026072,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein],,,PMID:14687664,https://www.ncbi.nlm.nih.gov/pubmed/14687664,14687664,,,20010454,"Rockwell P, Martinez J, Papa L, Gomes E. Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell Signal. 2004 Mar;16(3):343–53. doi: 10.1016/j.cellsig.2003.08.006. PMID: 14687664."
1026073,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [diethylhexyl phthalate results in increased cleavage of PARP1 protein],,,PMID:31408635,https://www.ncbi.nlm.nih.gov/pubmed/31408635,31408635,,,10164090,"Lee DG, Kim KM, Lee HS, Bae YC, Huh JW, Lee SR, Lee DS. Peroxiredoxin 5 prevents diethylhexyl phthalate-induced neuronal cell death by inhibiting mitochondrial fission in mouse hippocampal HT-22 cells. Neurotoxicology. 2019 Sep;74():242–51. doi: 10.1016/j.neuro.2019.08.003. PMID: 31408635."
1026074,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [[mercuric chloride co-treated with prolinedithiocarbamate] results in increased degradation of PARP1 protein],,,PMID:22909951,https://www.ncbi.nlm.nih.gov/pubmed/22909951,22909951,,,10696229,"Huang CF, Liu SH, Lin-Shiau SY. Pyrrolidine dithiocarbamate augments Hg(2+)-mediated induction of macrophage cell death via oxidative stress-induced apoptosis and necrosis signaling pathways. Toxicol Lett. 2012 Oct 02;214(1):33–45. doi: 10.1016/j.toxlet.2012.08.006. PMID: 22909951."
1026226,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of PARP1 protein],,,PMID:31330229,https://www.ncbi.nlm.nih.gov/pubmed/31330229,31330229,,,21642330,"Chung YP, Yen CC, Tang FC, Lee KI, Liu SH, Wu CC, Hsieh SS, Su CC, Kuo CY, Chen YW. Methylmercury exposure induces ROS/Akt inactivation-triggered endoplasmic reticulum stress-regulated neuronal cell apoptosis. Toxicology. 2019 Sep 01;425():152245. doi: 10.1016/j.tox.2019.152245. PMID: 31330229."
1026227,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [zinc oxide analog results in increased cleavage of PARP1 protein],,,PMID:24614525,https://www.ncbi.nlm.nih.gov/pubmed/24614525,24614525,,,33001622,"Roy R, Singh SK, Chauhan LK, Das M, Tripathi A, Dwivedi PD. Zinc oxide nanoparticles induce apoptosis by enhancement of autophagy via PI3K/Akt/mTOR inhibition. Toxicol Lett. 2014 May 16;227(1):29–40. doi: 10.1016/j.toxlet.2014.02.024. PMID: 24614525."
1026228,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine results in increased cleavage of PARP1 protein,,,PMID:15375156,https://www.ncbi.nlm.nih.gov/pubmed/15375156,15375156,,,11892612,"Qanungo S, Wang M, Nieminen AL. N-Acetyl-L-cysteine enhances apoptosis through inhibition of nuclear factor-kappaB in hypoxic murine embryonic fibroblasts. J Biol Chem. 2004 Nov 26;279(48):50455–64. doi: 10.1074/jbc.m406749200. PMID: 15375156."
1026229,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased cleavage of PARP1 protein],,,PMID:25845326,https://www.ncbi.nlm.nih.gov/pubmed/25845326,25845326,,,30331249,2015; 388(8):869-881
1026230,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein],,,PMID:24634002,https://www.ncbi.nlm.nih.gov/pubmed/24634002,24634002,,,13426370,2014; 27(3):483-494
1026231,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Acetylcysteine inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:23405080,https://www.ncbi.nlm.nih.gov/pubmed/23405080,23405080,,PMC3566170,10002509,"Chang KC, Hsu CC, Liu SH, Su CC, Yen CC, Lee MJ, Chen KL, Ho TJ, Hung DZ, Wu CC, Lu TH, Su YC, Chen YW, Huang CF. Cadmium induces apoptosis in pancreatic ß-cells through a mitochondria-dependent pathway: the role of oxidative stress-mediated c-Jun N-terminal kinase activation. PLoS One. 2013;8(2):e54374. PMID: 23405080; PMCID: PMC3566170."
1026232,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Acetylcysteine inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,,18200010,"So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547."
1026233,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Acetylcysteine inhibits the reaction [chlorpyrifos results in increased cleavage of PARP1 protein],,,PMID:22714038,https://www.ncbi.nlm.nih.gov/pubmed/22714038,22714038,,,26921209,"Lee JE, Park JH, Shin IC, Koh HC. Reactive oxygen species regulated mitochondria-mediated apoptosis in PC12 cells exposed to chlorpyrifos. Toxicol Appl Pharmacol. 2012 Sep 01;263(2):148–62. doi: 10.1016/j.taap.2012.06.005. PMID: 22714038."
1026234,12035,Comparative Toxicogenomics Database (CTD),Acetylcysteine,D000111,Acetylcysteine,https://ctdbase.org/detail.go?type=chem&acc=D000111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Acetylcysteine inhibits the reaction [gentamicins results in increased activity of PARP1 protein],,,PMID:11470263,https://www.ncbi.nlm.nih.gov/pubmed/11470263,11470263,,,26728765,"Mazzon E, Britti D, De Sarro A, Caputi AP, Cuzzocrea S. Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Pharmacol. 2001 Jul 13;424(1):75–83. doi: 10.1016/s0014-2999(01)01130-x. PMID: 11470263."
1158537,12062,Comparative Toxicogenomics Database (CTD),"3,5-Diaminobenzoic acid",C017856,"3,5-diaminobenzoic acid",https://ctdbase.org/detail.go?type=chem&acc=C017856,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,5-diaminobenzoic acid analog results in increased cleavage of PARP1 protein",,,PMID:23499788,https://www.ncbi.nlm.nih.gov/pubmed/23499788,23499788,,PMC3648619,6616389,"Zhang Z, Bi C, Buac D, Fan Y, Zhang X, Zuo J, Zhang P, Zhang N, Dong L, Dou QP. Organic cadmium complexes as proteasome inhibitors and apoptosis inducers in human breast cancer cells. Journal of Inorganic Biochemistry. 2013 Jun;123():1–10. doi: 10.1016/j.jinorgbio.2013.02.004."
1242115,12111,Comparative Toxicogenomics Database (CTD),Bisphenol F,C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisphenol F results in increased expression of PARP1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,,1984355,"Schaffert A, Krieg L, Weiner J, Schlichting R, Ueberham E, Karkossa I, Bauer M, Landgraf K, Junge KM, Wabitsch M, Lehmann J, Escher BI, Zenclussen AC, Körner A, Blüher M, Heiker JT, von Bergen M, Schubert K. Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156():106730. doi: 10.1016/j.envint.2021.106730. PMID: 34186270."
1458080,12251,Comparative Toxicogenomics Database (CTD),Methoxyacetic Acid,C013598,methoxyacetic acid,https://ctdbase.org/detail.go?type=chem&acc=C013598,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in increased cleavage of PARP1 protein,,,PMID:26006246,https://www.ncbi.nlm.nih.gov/pubmed/26006246,26006246,,PMC4463728,1167506,"Parajuli KR, Zhang Q, Liu S, You Z. Aminomethylphosphonic acid and methoxyacetic acid induce apoptosis in prostate cancer cells. Int J Mol Sci. 2015 May 22;16(5):11750–65. PMID: 26006246; PMCID: PMC4463728."
823670,12544,Comparative Toxicogenomics Database (CTD),Glycochenodeoxycholic Acid,D005999,Glycochenodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005999,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Glycochenodeoxycholic acid results in increased cleavage of PARP1 protein,,,PMID:25125499,https://www.ncbi.nlm.nih.gov/pubmed/25125499,25125499,,PMC4935323,6657347,"Sellinger M, Xu W, Pathil A, Stremmel W, Chamulitrat W. Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins. Exp Biol Med (Maywood). 2015 Feb;240(2):252–60. PMID: 25125499; PMCID: PMC4935323."
1246455,12688,Comparative Toxicogenomics Database (CTD),Dibutyltin dichloride,C020735,dibutyldichlorotin,https://ctdbase.org/detail.go?type=chem&acc=C020735,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Dibutyldichlorotin results in increased cleavage of PARP1 protein,,,PMID:16181675,https://www.ncbi.nlm.nih.gov/pubmed/16181675,16181675,,,11218737,"Mundy WR, Freudenrich TM. Apoptosis of cerebellar granule cells induced by organotin compounds found in drinking water: involvement of MAP kinases. Neurotoxicology. 2006 Jan;27(1):71–81. doi: 10.1016/j.neuro.2005.07.007. PMID: 16181675."
1162403,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-Methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 gene mutant form results in increased susceptibility to methylnitrosourea,,,PMID:15282315,https://www.ncbi.nlm.nih.gov/pubmed/15282315,15282315,,PMC479728,17293515,"Cortes U, Tong W, Coyle DL, Meyer-Ficca ML, Meyer RG, Petrilli V, Herceg Z, Jacobson EL, Jacobson MK, Wang Z. Depletion of the 110-Kilodalton Isoform of Poly(ADP-Ribose) Glycohydrolase Increases Sensitivity to Genotoxic and Endotoxic Stress in Mice. Molecular and Cellular Biology. 2004 Aug 01;24(16):7163–78. doi: 10.1128/mcb.24.16.7163-7178.2004."
1162404,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-Methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein affects the susceptibility to methylnitrosourea|parp1 protein affects the reaction [methylnitrosourea affects the expression of TRP53 protein]|parp1 protein affects the reaction [methylnitrosourea affects the activity of TRP53 protein],,,PMID:11850828,https://www.ncbi.nlm.nih.gov/pubmed/11850828,11850828,,,1597184,"Valenzuela MT, Guerrero R, Núñez MI, Ruiz De Almodóvar JM, Sarker M, de Murcia G, Oliver FJ. PARP-1 modifies the effectiveness of p53-mediated DNA damage response. Oncogene. 2002 Feb 07;21(7):1108–16. doi: 10.1038/sj.onc.1205169. PMID: 11850828."
1162405,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-Methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein promotes the reaction [methylnitrosourea affects the metabolism of SOD2 protein],,,PMID:16052507,https://www.ncbi.nlm.nih.gov/pubmed/16052507,16052507,,,22702335,"Siles E, Martinez-Lara E, Núñez MI, Muñoz-Gámez JA, Martín-Oliva D, Valenzuela MT, Peinado MA, Ruiz de Almodóvar JM, Javier Oliver F. PARP-1-dependent 3-nitrotyrosine protein modification after DNA damage. J Cell Biochem. 2005 Nov 01;96(4):709–15. doi: 10.1002/jcb.20570. PMID: 16052507."
1162406,12699,Comparative Toxicogenomics Database (CTD),N-Nitroso-N-Methylurea,D008770,Methylnitrosourea,https://ctdbase.org/detail.go?type=chem&acc=D008770,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased activity of PARP1 protein]|methylnitrosourea results in increased activity of PARP1 protein,,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,,30173715,"Uehara N, Miki K, Tsukamoto R, Matsuoka Y, Tsubura A. Nicotinamide blocks N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in rats through poly (ADP-ribose) polymerase activity and Jun N-terminal kinase/activator protein-1 pathway inhibition. Exp Eye Res. 2006 Mar;82(3):488–95. doi: 10.1016/j.exer.2005.08.006. PMID: 16168987."
53048,12733,Comparative Toxicogenomics Database (CTD),2-Chloroethyl ethyl sulfide,C031278,2-chloroethyl ethyl sulfide,https://ctdbase.org/detail.go?type=chem&acc=C031278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-chloroethyl ethyl sulfide results in increased activity of PARP1 protein,,,PMID:26383632,https://www.ncbi.nlm.nih.gov/pubmed/26383632,26383632,,,14122722,"Debiak M, Lex K, Ponath V, Burckhardt-Boer W, Thiermann H, Steinritz D, Schmidt A, Mangerich A, Bürkle A. Immunochemical analysis of poly(ADP-ribosyl)ation in HaCaT keratinocytes induced by the mono-alkylating agent 2-chloroethyl ethyl sulfide (CEES): Impact of experimental conditions. Toxicol Lett. 2016 Feb 26;244():72–80. doi: 10.1016/j.toxlet.2015.09.009. PMID: 26383632."
53049,12733,Comparative Toxicogenomics Database (CTD),2-Chloroethyl ethyl sulfide,C031278,2-chloroethyl ethyl sulfide,https://ctdbase.org/detail.go?type=chem&acc=C031278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-chloroethyl ethyl sulfide results in increased expression of PARP1 protein,,,PMID:20840853,https://www.ncbi.nlm.nih.gov/pubmed/20840853,20840853,,PMC2996832,25557155,"Black AT, Hayden PJ, Casillas RP, Heck DE, Gerecke DR, Sinko PJ, Laskin DL, Laskin JD. Expression of proliferative and inflammatory markers in a full-thickness human skin equivalent following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide. Toxicology and Applied Pharmacology. 2010 Dec 01;249(2):178–87. doi: 10.1016/j.taap.2010.09.005."
53050,12733,Comparative Toxicogenomics Database (CTD),2-Chloroethyl ethyl sulfide,C031278,2-chloroethyl ethyl sulfide,https://ctdbase.org/detail.go?type=chem&acc=C031278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-chloroethyl ethyl sulfide results in increased expression of PARP1 protein modified form,,,PMID:20469912,https://www.ncbi.nlm.nih.gov/pubmed/20469912,20469912,,PMC2891139,3131345,"Tewari-Singh N, Gu M, Agarwal C, White CW, Agarwal R. Biological and Molecular Mechanisms of Sulfur Mustard Analogue-Induced Toxicity in JB6 and HaCaT Cells: Possible Role of Ataxia Telangiectasia-Mutated/Ataxia Telangiectasia-Rad3-Related Cell Cycle Checkpoint Pathway. Chem. Res. Toxicol. 2010 May 14;23(6):1034–44. doi: 10.1021/tx100038b."
53051,12733,Comparative Toxicogenomics Database (CTD),2-Chloroethyl ethyl sulfide,C031278,2-chloroethyl ethyl sulfide,https://ctdbase.org/detail.go?type=chem&acc=C031278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to 2-chloroethyl ethyl sulfide,,,PMID:19111594,https://www.ncbi.nlm.nih.gov/pubmed/19111594,19111594,,,27536756,"Jowsey PA, Williams FM, Blain PG. DNA damage, signalling and repair after exposure of cells to the sulphur mustard analogue 2-chloroethyl ethyl sulphide. Toxicology. 2009 Mar 29;257(3):105–12. doi: 10.1016/j.tox.2008.12.001. PMID: 19111594."
970640,12762,Toxin and Toxin Target Database (T3DB),Phenyldichloroarsine,T3D1312,Phenyldichloroarsine,http://www.t3db.ca/toxins/T3D1312,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1247345,12836,Toxin and Toxin Target Database (T3DB),Diphenylchloroarsine,T3D1307,Diphenylchlorarsine,http://www.t3db.ca/toxins/T3D1307,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1149434,12980,Comparative Toxicogenomics Database (CTD),Acetylenedicarboxylic acid dimethyl ester,C022918,acetylenedicarboxylic acid dimethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C022918,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylenedicarboxylic acid dimethyl ester results in increased cleavage of PARP1 protein,,,PMID:21105742,https://www.ncbi.nlm.nih.gov/pubmed/21105742,21105742,,,20112279,"West JD, Stamm CE, Kingsley PJ. Structure-activity comparison of the cytotoxic properties of diethyl maleate and related molecules: identification of diethyl acetylenedicarboxylate as a thiol cross-linking agent. Chem Res Toxicol. 2011 Jan 14;24(1):81–8. doi: 10.1021/tx100292n. PMID: 21105742."
1082488,13089,Comparative Toxicogenomics Database (CTD),"O,P'-Ddt",C016340,"o,p'-DDT",https://ctdbase.org/detail.go?type=chem&acc=C016340,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"O,p'-DDT affects the expression of PARP1 mRNA",,,PMID:17984292,https://www.ncbi.nlm.nih.gov/pubmed/17984292,17984292,,,29511377,"Kiyosawa N, Kwekel JC, Burgoon LD, Williams KJ, Tashiro C, Chittim B, Zacharewski TR. o,p'-DDT elicits PXR/CAR-, not ER-, mediated responses in the immature ovariectomized rat liver. Toxicol Sci. 2008 Feb;101(2):350–63. doi: 10.1093/toxsci/kfm275. PMID: 17984292."
1376837,13342,Comparative Toxicogenomics Database (CTD),Vinblastine,D014747,Vinblastine,https://ctdbase.org/detail.go?type=chem&acc=D014747,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vinblastine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]|cd40lg protein inhibits the reaction [vinblastine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]],,,PMID:16545138,https://www.ncbi.nlm.nih.gov/pubmed/16545138,16545138,,PMC1435764,13283158,2006; 6(1):75
1041413,13343,Toxin and Toxin Target Database (T3DB),Cobaltous citrate,T3D1392,Cobalt(II) citrate,http://www.t3db.ca/toxins/T3D1392,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1061643,13360,Comparative Toxicogenomics Database (CTD),2-Hydroxyethyl Methacrylate,C005044,hydroxyethyl methacrylate,https://ctdbase.org/detail.go?type=chem&acc=C005044,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hydroxyethyl methacrylate results in increased cleavage of PARP1 protein|3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased cleavage of PARP1 protein],,,PMID:28184909,https://www.ncbi.nlm.nih.gov/pubmed/28184909,28184909,,,8763346,"Yu JJ, Zhu LX, Zhang J, Liu S, Lv FY, Cheng X, Liu GJ, Peng B. From the Cover: Activation of NF-?B-Autophagy Axis by 2-Hydroxyethyl Methacrylate Commits Dental Mesenchymal Cells to Apoptosis. Toxicol Sci. 2017 May 01;157(1):100–11. doi: 10.1093/toxsci/kfx023. PMID: 28184909."
53409,13462,Comparative Toxicogenomics Database (CTD),3-Nitrofluoranthene,C033643,3-nitrofluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C033643,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),3-nitrofluoranthene results in increased cleavage of PARP1 protein,,,PMID:19041363,https://www.ncbi.nlm.nih.gov/pubmed/19041363,19041363,,,375421,"Asare N, Låg M, Lagadic-Gossmann D, Rissel M, Schwarze P, Holme JA. 3-Nitrofluoranthene (3-NF) but not 3-aminofluoranthene (3-AF) elicits apoptosis as well as programmed necrosis in Hepa1c1c7 cells. Toxicology. 2009 Jan 31;255(3):140–50. doi: 10.1016/j.tox.2008.10.021. PMID: 19041363."
1250025,13542,Comparative Toxicogenomics Database (CTD),N-Nitrosodibutylamine,C012279,dibutylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=C012279,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dibutylnitrosamine results in increased cleavage of PARP1 protein,,,PMID:17929238,https://www.ncbi.nlm.nih.gov/pubmed/17929238,17929238,,,1034371,2007; 28(4):455-465
1461320,13637,Comparative Toxicogenomics Database (CTD),Salicylohydrazide,C000687,salicyl hydrazide,https://ctdbase.org/detail.go?type=chem&acc=C000687,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Salicyl hydrazide analog results in increased cleavage of PARP1 protein,,,PMID:25684395,https://www.ncbi.nlm.nih.gov/pubmed/25684395,25684395,,,16152512,"Zhao J, Zhang L, Li J, Wu T, Wang M, Xu G, Zhang F, Liu L, Yang J, Sun S. A novel pyrazolone-based derivative induces apoptosis in human esophageal cells via reactive oxygen species (ROS) generation and caspase-dependent mitochondria-mediated pathway. Chem Biol Interact. 2015 Apr 25;231():1–9. doi: 10.1016/j.cbi.2015.02.004. PMID: 25684395."
1007752,13804,Comparative Toxicogenomics Database (CTD),Citicoline,D003566,Cytidine Diphosphate Choline,https://ctdbase.org/detail.go?type=chem&acc=D003566,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cytidine diphosphate choline results in decreased expression of PARP1 protein modified form,,,PMID:12443983,https://www.ncbi.nlm.nih.gov/pubmed/12443983,12443983,,,24027089,"Barrachina M, Secades J, Lozano R, Gómez-Santos C, Ambrosio S, Ferrer I. Citicoline increases glutathione redox ratio and reduces caspase-3 activation and cell death in staurosporine-treated SH-SY5Y human neuroblastoma cells. Brain Res. 2002 Dec 06;957(1):84–90. doi: 10.1016/s0006-8993(02)03605-3. PMID: 12443983."
1159415,13872,Therapeutic Target Database (TTD),5-Methoxyindole,D01RXM,BZ3,https://idrblab.net/ttd/data/drug/details/D01RXM,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
827808,14017,Comparative Toxicogenomics Database (CTD),1-Aminomethylphosphonic acid,C036423,1-aminomethylphosphonic acid,https://ctdbase.org/detail.go?type=chem&acc=C036423,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in increased cleavage of PARP1 protein,,,PMID:26006246,https://www.ncbi.nlm.nih.gov/pubmed/26006246,26006246,,PMC4463728,1167506,"Parajuli KR, Zhang Q, Liu S, You Z. Aminomethylphosphonic acid and methoxyacetic acid induce apoptosis in prostate cancer cells. Int J Mol Sci. 2015 May 22;16(5):11750–65. PMID: 26006246; PMCID: PMC4463728."
827809,14017,Comparative Toxicogenomics Database (CTD),1-Aminomethylphosphonic acid,C036423,1-aminomethylphosphonic acid,https://ctdbase.org/detail.go?type=chem&acc=C036423,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),1-aminomethylphosphonic acid results in increased cleavage of PARP1 protein,,,PMID:23983455,https://www.ncbi.nlm.nih.gov/pubmed/23983455,23983455,,PMC3749059,27606741,"Li Q, Lambrechts MJ, Zhang Q, Liu S, Ge D, Yin R, Xi M, You Z. Glyphosate and AMPA inhibit cancer cell growth through inhibiting intracellular glycine synthesis. Drug Des Devel Ther. 2013;7():635–43. PMID: 23983455; PMCID: PMC3749059."
1253810,14180,Comparative Toxicogenomics Database (CTD),Nicotinamide Mononucleotide,D009537,Nicotinamide Mononucleotide,https://ctdbase.org/detail.go?type=chem&acc=D009537,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the abundance of nicotinamide mononucleotide,,,PMID:19426698,https://www.ncbi.nlm.nih.gov/pubmed/19426698,19426698,,,28201760,"Formentini L, Moroni F, Chiarugi A. Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo. Biochem Pharmacol. 2009 May 15;77(10):1612–20. doi: 10.1016/j.bcp.2009.02.017. PMID: 19426698."
1253811,14180,Comparative Toxicogenomics Database (CTD),Nicotinamide Mononucleotide,D009537,Nicotinamide Mononucleotide,https://ctdbase.org/detail.go?type=chem&acc=D009537,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[nicotinamide mononucleotide co-treated with cisplatin] results in decreased expression of PARP1 protein,,,PMID:34089817,https://www.ncbi.nlm.nih.gov/pubmed/34089817,34089817,,,13592871,"Zhan T, Xiong H, Pang J, Zhang W, Ye Y, Liang Z, Huang X, He F, Jian B, He W, Gao Y, Min X, Zheng Y, Yang H. Modulation of NAD+ biosynthesis activates SIRT1 and resists cisplatin-induced ototoxicity. Toxicol Lett. 2021 Oct 01;349():115–23. doi: 10.1016/j.toxlet.2021.05.013. PMID: 34089817."
1253812,14180,Comparative Toxicogenomics Database (CTD),Nicotinamide Mononucleotide,D009537,Nicotinamide Mononucleotide,https://ctdbase.org/detail.go?type=chem&acc=D009537,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Nicotinamide mononucleotide inhibits the reaction [zearalenone results in increased expression of PARP1 mrna],,,PMID:38159578,https://www.ncbi.nlm.nih.gov/pubmed/38159578,38159578,,,36699901,"Dai C, Hou M, Yang X, Wang Z, Sun C, Wu X, Wang S. Increased NAD+ levels protect female mouse reproductive system against zearalenone-impaired glycolysis, lipid metabolism, antioxidant capacity and inflammation. Reprod Toxicol. 2024 Mar;124():108530. doi: 10.1016/j.reprotox.2023.108530. PMID: 38159578."
1095496,14219,Comparative Toxicogenomics Database (CTD),Metformin Hydrochloride,D008687,Metformin,https://ctdbase.org/detail.go?type=chem&acc=D008687,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Triciribine promotes the reaction [[epothilone A co-treated with metformin] results in increased expression of PARP1 mrna]|sodium salicylate promotes the reaction [metformin results in increased expression of PARP1 mrna]|[epothilone A co-treated with metformin] results in increased expression of PARP1 mrna|metformin results in increased expression of PARP1 mRNA,,,PMID:29117515,https://www.ncbi.nlm.nih.gov/pubmed/29117515,29117515,,,30394656,"Rogalska A, Bukowska B, Marczak A. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells. Toxicol In Vitro. 2018 Mar;47():48–62. doi: 10.1016/j.tiv.2017.11.001. PMID: 29117515."
1095497,14219,Comparative Toxicogenomics Database (CTD),Metformin Hydrochloride,D008687,Metformin,https://ctdbase.org/detail.go?type=chem&acc=D008687,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Metformin results in increased cleavage of PARP1 protein|plantamajoside promotes the reaction [metformin results in increased cleavage of PARP1 protein],,,PMID:35350904,https://www.ncbi.nlm.nih.gov/pubmed/35350904,35350904,,,5457436,"Wang Z, Zuo J, Zhang L, Zhang Z, Wei Y. Plantamajoside promotes metformin-induced apoptosis, autophagy and proliferation arrest of liver cancer cells via suppressing Akt/GSK3ß signaling. Hum Exp Toxicol. 2022 Jan;41():9603271221078868. doi: 10.1177/09603271221078868. PMID: 35350904."
1095498,14219,Comparative Toxicogenomics Database (CTD),Metformin Hydrochloride,D008687,Metformin,https://ctdbase.org/detail.go?type=chem&acc=D008687,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Metformin inhibits the reaction [arsenic trioxide results in increased expression of PARP1 protein modified form]|deoxyglucose promotes the reaction [metformin inhibits the reaction [arsenic trioxide results in increased expression of PARP1 protein modified form]],,,PMID:29095437,https://www.ncbi.nlm.nih.gov/pubmed/29095437,29095437,,PMC5775401,14856065,"Ling S, Shan Q, Liu P, Feng T, Zhang X, Xiang P, Chen K, Xie H, Song P, Zhou L, Liu J, Zheng S, Xu X. Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I. Cell Death & Disease. 2017 Nov 02;8(11):e3159. doi: 10.1038/cddis.2017.482."
1095499,14219,Comparative Toxicogenomics Database (CTD),Metformin Hydrochloride,D008687,Metformin,https://ctdbase.org/detail.go?type=chem&acc=D008687,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Metformin inhibits the reaction [dietary fats results in increased expression of and results in increased cleavage of PARP1 protein],,,PMID:27551045,https://www.ncbi.nlm.nih.gov/pubmed/27551045,27551045,,PMC5063970,28362078,"Tikoo K, Sharma E, Amara VR, Pamulapati H, Dhawale VS. Metformin Improves Metabolic Memory in High Fat Diet (HFD)-induced Renal Dysfunction. Journal of Biological Chemistry. 2016 Oct;291(42):21848–56. doi: 10.1074/jbc.c116.732990."
1391165,14296,Comparative Toxicogenomics Database (CTD),Ligustrazine,C017953,tetramethylpyrazine,https://ctdbase.org/detail.go?type=chem&acc=C017953,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tetramethylpyrazine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:26404762,https://www.ncbi.nlm.nih.gov/pubmed/26404762,26404762,,PMC4808507,14142239,2015; 90(9):2187-2200
1200786,14410,Comparative Toxicogenomics Database (CTD),Decabromodiphenyl ether,C010902,decabromobiphenyl ether,https://ctdbase.org/detail.go?type=chem&acc=C010902,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Decabromobiphenyl ether results in decreased expression of PARP1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,PMC7024050,5374756,"Sheller-Miller S, Radnaa E, Arita Y, Getahun D, Jones RJ, Peltier MR, Menon R. Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 01;89():42–9. PMID: 31675489; PMCID: PMC7024050."
978265,14451,Comparative Toxicogenomics Database (CTD),Methylmercury hydroxide,C020771,methylmercury hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C020771,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Methylmercury hydroxide results in increased expression of PARP1 mRNA,,,PMID:20493249,https://www.ncbi.nlm.nih.gov/pubmed/20493249,20493249,,PMC2924281,3798481,"Robinson JF, Griffith WC, Yu X, Hong S, Kim E, Faustman EM. Methylmercury induced toxicogenomic response in C57 and SWV mouse embryos undergoing neural tube closure. Reproductive Toxicology. 2010 Sep;30(2):284–91. doi: 10.1016/j.reprotox.2010.05.009."
1257520,14457,Comparative Toxicogenomics Database (CTD),Ammonium iron(III) citrate,C013531,ferric ammonium citrate,https://ctdbase.org/detail.go?type=chem&acc=C013531,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ferric ammonium citrate results in increased abundance of iron] which results in decreased expression of PARP1 protein|parp1 protein affects the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased expression of SIRT1 protein]|parp1 protein affects the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased lipidation of MAP1LC3B protein]|sirt1 protein affects the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in decreased expression of PARP1 protein]|parp1 protein affects the reaction [chloroquine promotes the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased lipidation of MAP1LC3B protein]],,,PMID:34826546,https://www.ncbi.nlm.nih.gov/pubmed/34826546,34826546,,,7531872,"Zhou Y, Zhao X, Zhang L, Xia Q, Peng Y, Zhang H, Yan D, Yang Z, Li J. Iron overload inhibits cell proliferation and promotes autophagy via PARP1/SIRT1 signaling in endometriosis and adenomyosis. Toxicology. 2022 Jan 15;465():153050. doi: 10.1016/j.tox.2021.153050. PMID: 34826546."
1042919,14770,Toxin and Toxin Target Database (T3DB),Gallium arsenide,T3D0287,Gallium arsenide,http://www.t3db.ca/toxins/T3D0287,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1044880,14771,Toxin and Toxin Target Database (T3DB),Arsenic pentoxide,T3D0292,Arsenic pentoxide,http://www.t3db.ca/toxins/T3D0292,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1045944,14785,Toxin and Toxin Target Database (T3DB),cobalt(III) hydroxide,T3D1383,Cobalt(III) hydroxide,http://www.t3db.ca/toxins/T3D1383,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1104233,14786,Toxin and Toxin Target Database (T3DB),Cobalt(II) oxide,T3D0666,Cobalt(II) oxide,http://www.t3db.ca/toxins/T3D0666,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1105013,14794,Comparative Toxicogenomics Database (CTD),Antimony trioxide,C037554,antimony trioxide,https://ctdbase.org/detail.go?type=chem&acc=C037554,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Glutathione deficiency promotes the reaction [antimony trioxide results in increased cleavage of PARP1 protein]|antimony trioxide results in increased cleavage of PARP1 protein,,,PMID:16112521,https://www.ncbi.nlm.nih.gov/pubmed/16112521,16112521,,,18671239,"Mann KK, Davison K, Colombo M, Colosimo AL, Diaz Z, Padovani AM, Guo Q, Scrivens PJ, Gao W, Mader S, Miller WH. Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling. Toxicol Lett. 2006 Jan 05;160(2):158–70. doi: 10.1016/j.toxlet.2005.06.017. PMID: 16112521."
55712,14805,Comparative Toxicogenomics Database (CTD),Nickel Oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nickel monoxide analog results in increased cleavage of PARP1 protein|oxygen deficiency inhibits the reaction [nickel monoxide analog results in increased cleavage of PARP1 protein],,,PMID:27270449,https://www.ncbi.nlm.nih.gov/pubmed/27270449,27270449,,,16167571,"Pandey N, Dhiman S, Srivastava T, Majumder S. Transition metal oxide nanoparticles are effective in inhibiting lung cancer cell survival in the hypoxic tumor microenvironment. Chem Biol Interact. 2016 Jul 25;254():221–30. doi: 10.1016/j.cbi.2016.06.006. PMID: 27270449."
55713,14805,Comparative Toxicogenomics Database (CTD),Nickel Oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nickel monoxide results in increased cleavage of PARP1 protein,,,PMID:21828359,https://www.ncbi.nlm.nih.gov/pubmed/21828359,21828359,,PMC3196652,12018502,"Pietruska JR, Liu X, Smith A, McNeil K, Weston P, Zhitkovich A, Hurt R, Kane AB. Bioavailability, intracellular mobilization of nickel, and HIF-1a activation in human lung epithelial cells exposed to metallic nickel and nickel oxide nanoparticles. Toxicol Sci. 2011 Nov;124(1):138–48. PMID: 21828359; PMCID: PMC3196652."
55714,14805,Comparative Toxicogenomics Database (CTD),Nickel Oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Nickel monoxide results in increased expression of PARP1 protein modified form,,,PMID:35061333,https://www.ncbi.nlm.nih.gov/pubmed/35061333,35061333,,,5451275,"Liu F, Cheng X, Wu S, Hu B, Yang C, Deng S, Shi Q. Nickel oxide nanoparticles induce apoptosis and ferroptosis in airway epithelial cells via <scp>ATF3</scp>. Environmental Toxicology. 2022 Jan 21;37(5):1093–103. doi: 10.1002/tox.23467."
1171734,14806,Comparative Toxicogenomics Database (CTD),Zinc White,D015034,Zinc Oxide,https://ctdbase.org/detail.go?type=chem&acc=D015034,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Zinc oxide analog results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [zinc oxide analog results in increased cleavage of PARP1 protein],,,PMID:24614525,https://www.ncbi.nlm.nih.gov/pubmed/24614525,24614525,,,33001622,"Roy R, Singh SK, Chauhan LK, Das M, Tripathi A, Dwivedi PD. Zinc oxide nanoparticles induce apoptosis by enhancement of autophagy via PI3K/Akt/mTOR inhibition. Toxicol Lett. 2014 May 16;227(1):29–40. doi: 10.1016/j.toxlet.2014.02.024. PMID: 24614525."
1059089,14832,Toxin and Toxin Target Database (T3DB),Cobalt sulfide,T3D1387,Cobalt sulfide,http://www.t3db.ca/toxins/T3D1387,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1045407,14833,Comparative Toxicogenomics Database (CTD),Hematite,C000499,ferric oxide,https://ctdbase.org/detail.go?type=chem&acc=C000499,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ferric oxide analog results in increased cleavage of PARP1 protein,,,PMID:27270449,https://www.ncbi.nlm.nih.gov/pubmed/27270449,27270449,,,16167571,"Pandey N, Dhiman S, Srivastava T, Majumder S. Transition metal oxide nanoparticles are effective in inhibiting lung cancer cell survival in the hypoxic tumor microenvironment. Chem Biol Interact. 2016 Jul 25;254():221–30. doi: 10.1016/j.cbi.2016.06.006. PMID: 27270449."
1045408,14833,Comparative Toxicogenomics Database (CTD),Hematite,C000499,ferric oxide,https://ctdbase.org/detail.go?type=chem&acc=C000499,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Ferric oxide results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:28993115,https://www.ncbi.nlm.nih.gov/pubmed/28993115,28993115,,,25696225,"Manickam V, Periyasamy M, Dhakshinamoorthy V, Panneerselvam L, Perumal E. Recurrent exposure to ferric oxide nanoparticles alters myocardial oxidative stress, apoptosis and necrotic markers in male mice. Chem Biol Interact. 2017 Dec 25;278():54–64. doi: 10.1016/j.cbi.2017.10.003. PMID: 28993115."
1045409,14833,Comparative Toxicogenomics Database (CTD),Hematite,C000499,ferric oxide,https://ctdbase.org/detail.go?type=chem&acc=C000499,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Ferric oxide results in increased cleavage of PARP1 protein,,,PMID:26991130,https://www.ncbi.nlm.nih.gov/pubmed/26991130,26991130,,,3927617,"Sundarraj K, Manickam V, Raghunath A, Periyasamy M, Viswanathan MP, Perumal E. Repeated exposure to iron oxide nanoparticles causes testicular toxicity in mice. Environ Toxicol. 2017 Feb;32(2):594–608. doi: 10.1002/tox.22262. PMID: 26991130."
1047228,14900,Comparative Toxicogenomics Database (CTD),"2,3-Dihydroxypropyl hexadecanoate",C027735,palmitoyl glycerol,https://ctdbase.org/detail.go?type=chem&acc=C027735,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Palmitoyl glycerol results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:37466199,https://www.ncbi.nlm.nih.gov/pubmed/37466199,37466199,,,35703304,"Niu L, Li W, Chen X, Su X, Dong J, Liao Q, Zhou X, Shi S, Sun R. <scp>1-Monopalmitin</scp> promotes lung cancer cells apoptosis through <scp>PI3K</scp>/<scp>A</scp>kt pathway in vitro. Environmental Toxicology. 2023 Jul 19;38(11):2621–31. doi: 10.1002/tox.23897."
1114458,14957,Comparative Toxicogenomics Database (CTD),Antimycin A,D000968,Antimycin A,https://ctdbase.org/detail.go?type=chem&acc=D000968,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [antimycin A results in increased cleavage of PARP1 protein],,,PMID:32662599,https://www.ncbi.nlm.nih.gov/pubmed/32662599,32662599,,,1961922,"Yu TJ, Hsieh CY, Tang JY, Lin LC, Huang HW, Wang HR, Yeh YC, Chuang YT, Ou-Yang F, Chang HW. Antimycin A shows selective antiproliferation to oral cancer cells by oxidative stress-mediated apoptosis and DNA damage. Environ Toxicol. 2020 Nov;35(11):1212–24. doi: 10.1002/tox.22986. PMID: 32662599."
1114459,14957,Comparative Toxicogenomics Database (CTD),Antimycin A,D000968,Antimycin A,https://ctdbase.org/detail.go?type=chem&acc=D000968,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[antimycin A co-treated with paraquat] results in increased cleavage of PARP1 protein,,,PMID:16237197,https://www.ncbi.nlm.nih.gov/pubmed/16237197,16237197,,,28152258,"Bloom SE, Lemley AT, Muscarella DE. Potentiation of apoptosis by heat stress plus pesticide exposure in stress resistant human B-lymphoma cells and its attenuation through interaction with follicular dendritic cells: role for c-Jun N-terminal kinase signaling. Toxicol Sci. 2006 Jan;89(1):214–23. doi: 10.1093/toxsci/kfj021. PMID: 16237197."
1114460,14957,Comparative Toxicogenomics Database (CTD),Antimycin A,D000968,Antimycin A,https://ctdbase.org/detail.go?type=chem&acc=D000968,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Antimycin A results in increased cleavage of PARP1 protein,,,PMID:16237197|PMID:32662599,https://www.ncbi.nlm.nih.gov/pubmed/16237197|https://www.ncbi.nlm.nih.gov/pubmed/32662599,16237197|32662599,,,1961922|28152258,"Yu TJ, Hsieh CY, Tang JY, Lin LC, Huang HW, Wang HR, Yeh YC, Chuang YT, Ou-Yang F, Chang HW. Antimycin A shows selective antiproliferation to oral cancer cells by oxidative stress-mediated apoptosis and DNA damage. Environ Toxicol. 2020 Nov;35(11):1212–24. doi: 10.1002/tox.22986. PMID: 32662599.|Bloom SE, Lemley AT, Muscarella DE. Potentiation of apoptosis by heat stress plus pesticide exposure in stress resistant human B-lymphoma cells and its attenuation through interaction with follicular dendritic cells: role for c-Jun N-terminal kinase signaling. Toxicol Sci. 2006 Jan;89(1):214–23. doi: 10.1093/toxsci/kfj021. PMID: 16237197."
1081290,14969,Comparative Toxicogenomics Database (CTD),Vancomycin,D014640,Vancomycin,https://ctdbase.org/detail.go?type=chem&acc=D014640,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Vancomycin results in increased expression of PARP1 protein|1,5-dihydroxyisoquinoline inhibits the reaction [vancomycin results in increased expression of PARP1 protein]",,,PMID:19833176,https://www.ncbi.nlm.nih.gov/pubmed/19833176,19833176,,,30917735,2010; 192(2):91-96
1121553,14985,Comparative Toxicogenomics Database (CTD),Alpha-Tocopherol,D014810,Vitamin E,https://ctdbase.org/detail.go?type=chem&acc=D014810,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vitamin E inhibits the reaction [benzo(a)pyrene results in increased expression of PARP1 protein],,,PMID:24664296,https://www.ncbi.nlm.nih.gov/pubmed/24664296,24664296,,PMC3963982,28953785,"Zhu W, Cromie MM, Cai Q, Lv T, Singh K, Gao W. Curcumin and Vitamin E Protect against Adverse Effects of Benzo[a]pyrene in Lung Epithelial Cells. PLoS ONE. 2014 Mar 24;9(3):e92992. doi: 10.1371/journal.pone.0092992."
1121554,14985,Comparative Toxicogenomics Database (CTD),Alpha-Tocopherol,D014810,Vitamin E,https://ctdbase.org/detail.go?type=chem&acc=D014810,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vitamin E inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form],,,PMID:28237877,https://www.ncbi.nlm.nih.gov/pubmed/28237877,28237877,,,32395047,"Tang ZH, Cao WX, Su MX, Chen X, Lu JJ. Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells. Toxicol Appl Pharmacol. 2017 Apr 15;321():18–26. doi: 10.1016/j.taap.2017.02.017. PMID: 28237877."
1121739,14985,Comparative Toxicogenomics Database (CTD),Alpha-Tocopherol,D014810,Vitamin E,https://ctdbase.org/detail.go?type=chem&acc=D014810,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vitamin E results in increased expression of PARP1 mRNA,,,PMID:19244175,https://www.ncbi.nlm.nih.gov/pubmed/19244175,19244175,,PMC2734116,25541449,"Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 04;101(5):306–20. PMID: 19244175; PMCID: PMC2734116."
1195096,15096,Comparative Toxicogenomics Database (CTD),Tributyltin chloride,C011559,tributyltin,https://ctdbase.org/detail.go?type=chem&acc=C011559,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tributyltin results in increased cleavage of PARP1 protein|dffb protein promotes the reaction [tributyltin results in increased cleavage of PARP1 protein],,,PMID:31401084,https://www.ncbi.nlm.nih.gov/pubmed/31401084,31401084,,,10156791,"Kulbay M, Johnson B, Bernier J. DNA fragmentation factor 40 expression in T cells confers sensibility to tributyltin-induced apoptosis. Toxicology. 2019 Oct 01;426():152255. doi: 10.1016/j.tox.2019.152255. PMID: 31401084."
1195353,15096,Comparative Toxicogenomics Database (CTD),Tributyltin chloride,C011559,tributyltin,https://ctdbase.org/detail.go?type=chem&acc=C011559,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9544,Macaca mulatta (Rhesus monkey),Tributyltin results in increased expression of PARP1 mRNA,,,PMID:29505797,https://www.ncbi.nlm.nih.gov/pubmed/29505797,29505797,,PMC5898618,13528673,"Midic U, Goheen B, Vincent KA, VandeVoort CA, Latham KE. Changes in gene expression following long-term in vitro exposure of Macaca mulatta trophoblast stem cells to biologically relevant levels of endocrine disruptors. Reproductive Toxicology. 2018 Apr;77():154–65. doi: 10.1016/j.reprotox.2018.02.012."
1195354,15096,Comparative Toxicogenomics Database (CTD),Tributyltin chloride,C011559,tributyltin,https://ctdbase.org/detail.go?type=chem&acc=C011559,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with tributyltin] results in increased expression of PARP1 mRNA,,,PMID:31129395,https://www.ncbi.nlm.nih.gov/pubmed/31129395,31129395,,,1940181,"Yang Z, Shi J, Guo Z, Chen M, Wang C, He C, Zuo Z. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats. Chemosphere. 2019 Sep;231():151–60. doi: 10.1016/j.chemosphere.2019.05.129. PMID: 31129395."
872239,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-Dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9031,Gallus gallus (chicken),Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of PARP1 protein,,,PMID:28536482,https://www.ncbi.nlm.nih.gov/pubmed/28536482,28536482,,PMC5442136,19580237,"Diani-Moore S, Shoots J, Singh R, Zuk JB, Rifkind AB. NAD+ loss, a new player in AhR biology: prevention of thymus atrophy and hepatosteatosis by NAD+ repletion. Scientific Reports. 2017 May 23;7(1):2268. doi: 10.1038/s41598-017-02332-9."
872240,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-Dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tetrachlorodibenzodioxin results in increased ADP-ribosylation of and results in increased activity of PARP1 protein|[3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of nadp]|[coumarin results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of nad]|[benzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of nad]|[benzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of NADP]|[3-aminobenzamide results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of nad]|[coumarin results in decreased activity of PARP1 protein] inhibits the reaction [tetrachlorodibenzodioxin results in decreased abundance of NADP],,,PMID:17669606,https://www.ncbi.nlm.nih.gov/pubmed/17669606,17669606,,,22728614,"Lin PH, Lin CH, Huang CC, Chuang MC, Lin P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 2007 Aug;172(3):146–58. doi: 10.1016/j.toxlet.2007.06.003. PMID: 17669606."
872241,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-Dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tetrachlorodibenzodioxin affects the expression of PARP1 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,PMC3344929,14748046,"Qin X, Kojima Y, Mizuno K, Ueoka K, Muroya K, Miyado M, Zaha H, Akanuma H, Zeng Q, Fukuda T, Yoshinaga J, Yonemoto J, Kohri K, Hayashi Y, Fukami M, Ogata T, Sone H. Identification of Novel Low-Dose Bisphenol A Targets in Human Foreskin Fibroblast Cells Derived from Hypospadias Patients. PLoS ONE. 2012 May 04;7(5):e36711. doi: 10.1371/journal.pone.0036711."
872242,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-Dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of PARP1 mRNA,,,PMID:21570461,https://www.ncbi.nlm.nih.gov/pubmed/21570461,21570461,,PMC3162130,4491396,"Thornley JA, Trask HW, Ridley CJA, Korc M, Gui J, Ringelberg CS, Wang S, Tomlinson CR. Differential regulation of polysome mRNA levels in mouse Hepa-1C1C7 cells exposed to dioxin. Toxicology in Vitro. 2011 Oct;25(7):1457–67. doi: 10.1016/j.tiv.2011.04.020."
872243,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-Dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of PARP1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,,18024134,"Boverhof DR, Burgoon LD, Williams KJ, Zacharewski TR. Inhibition of estrogen-mediated uterine gene expression responses by dioxin. Mol Pharmacol. 2008 Jan;73(1):82–93. doi: 10.1124/mol.107.040451. PMID: 17942748."
872244,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-Dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PARP1 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,PMC2717142,31567380,"Sartor MA, Schnekenburger M, Marlowe JL, Reichard JF, Wang Y, Fan Y, Ma C, Karyala S, Halbleib D, Liu X, Medvedovic M, Puga A. Genomewide analysis of aryl hydrocarbon receptor binding targets reveals an extensive array of gene clusters that control morphogenetic and developmental programs. Environ Health Perspect. 2009 Jul;117(7):1139–46. PMID: 19654925; PMCID: PMC2717142."
872245,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-Dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin results in increased expression of PARP1 mRNA,,,PMID:19465110,https://www.ncbi.nlm.nih.gov/pubmed/19465110,19465110,,PMC2766425,26871289,"Gohlke JM, Stockton PS, Sieber S, Foley J, Portier CJ. AhR-mediated gene expression in the developing mouse telencephalon. Reproductive Toxicology. 2009 Nov;28(3):321–8. doi: 10.1016/j.reprotox.2009.05.067."
872395,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-Dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin affects the expression of PARP1 mRNA,,,PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/34747641,34747641,,PMC8574979,29163447,"Iqbal K, Pierce SH, Kozai K, Dhakal P, Scott RL, Roby KF, Vyhlidal CA, Soares MJ. Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. Environ Health Perspect. 2021 Nov;129(11):117001. PMID: 34747641; PMCID: PMC8574979."
872396,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-Dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin promotes the reaction [camptothecin results in increased cleavage of PARP1 protein],,,PMID:25843524,https://www.ncbi.nlm.nih.gov/pubmed/25843524,25843524,,,14812201,"Svobodová J, Kabátková M, Šmerdová L, Brenerová P, Dvorák Z, Machala M, Vondrácek J. The aryl hydrocarbon receptor-dependent disruption of contact inhibition in rat liver WB-F344 epithelial cells is linked with induction of survivin, but not with inhibition of apoptosis. Toxicology. 2015 Jul 03;333():37–44. doi: 10.1016/j.tox.2015.04.001. PMID: 25843524."
59113,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),6-bromoindirubin-3'-oxime promotes the reaction [paraquat results in increased expression of PARP1 protein modified form],,,PMID:28414160,https://www.ncbi.nlm.nih.gov/pubmed/28414160,28414160,,,6714909,"Hathaichoti S, Visitnonthachai D, Ngamsiri P, Niyomchan A, Tsogtbayar O, Wisessaowapak C, Watcharasit P, Satayavivad J. Paraquat induces extrinsic pathway of apoptosis in A549 cells by induction of DR5 and repression of anti-apoptotic proteins, DDX3 and GSK3 expression. Toxicol In Vitro. 2017 Aug;42():123–9. doi: 10.1016/j.tiv.2017.04.016. PMID: 28414160."
59114,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[antimycin A co-treated with paraquat] results in increased cleavage of PARP1 protein|[pyridaben co-treated with paraquat] results in increased cleavage of PARP1 protein,,,PMID:16237197,https://www.ncbi.nlm.nih.gov/pubmed/16237197,16237197,,,28152258,"Bloom SE, Lemley AT, Muscarella DE. Potentiation of apoptosis by heat stress plus pesticide exposure in stress resistant human B-lymphoma cells and its attenuation through interaction with follicular dendritic cells: role for c-Jun N-terminal kinase signaling. Toxicol Sci. 2006 Jan;89(1):214–23. doi: 10.1093/toxsci/kfj021. PMID: 16237197."
59115,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),LGK974 inhibits the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:30205152,https://www.ncbi.nlm.nih.gov/pubmed/30205152,30205152,,,3971125,"Yang JM, Huang HM, Cheng JJ, Huang CL, Lee YC, Chiou CT, Huang HT, Huang NK, Yang YC. LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/ß-CATENIN pathway. Toxicology. 2018 Dec 01;410():65–72. doi: 10.1016/j.tox.2018.09.003. PMID: 30205152."
59116,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oren gedoku to inhibits the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:33383311,https://www.ncbi.nlm.nih.gov/pubmed/33383311,33383311,,,22380650,"Lee IJ, Chao CY, Yang YC, Cheng JJ, Huang CL, Chiou CT, Huang HT, Kuo YH, Huang NK. Huang Lian Jie Du Tang attenuates paraquat-induced mitophagy in human SH-SY5Y cells: A traditional decoction with a novel therapeutic potential in treating Parkinson's disease. Biomed Pharmacother. 2021 Feb;134():111170. doi: 10.1016/j.biopha.2020.111170. PMID: 33383311."
59117,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Paraquat results in increased activity of PARP1 protein,,,PMID:24130211,https://www.ncbi.nlm.nih.gov/pubmed/24130211,24130211,,,25623077,"Zhou Y, Li F, Tian X, Wang B, Ding M, Pang H. Changes in phosphatidylinositol 3-kinase 55 kDa gamma expression and subcellular localization may be caspase 6 dependent in paraquat-induced SH-SY5Y apoptosis. Hum Exp Toxicol. 2014 Jul;33(7):761–71. doi: 10.1177/0960327113499044. PMID: 24130211."
59118,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Paraquat results in increased cleavage of PARP1 protein,,,PMID:17018646|PMID:18056701|PMID:22043816|PMID:22987761|PMID:28428137|PMID:30205152|PMID:33383311,https://www.ncbi.nlm.nih.gov/pubmed/17018646|https://www.ncbi.nlm.nih.gov/pubmed/18056701|https://www.ncbi.nlm.nih.gov/pubmed/22043816|https://www.ncbi.nlm.nih.gov/pubmed/22987761|https://www.ncbi.nlm.nih.gov/pubmed/28428137|https://www.ncbi.nlm.nih.gov/pubmed/30205152|https://www.ncbi.nlm.nih.gov/pubmed/33383311,17018646|18056701|22043816|22987761|28428137|30205152|33383311,,,3971125|5196702|6501558|6727941|22380650|31546584|32959147,"Lee IJ, Chao CY, Yang YC, Cheng JJ, Huang CL, Chiou CT, Huang HT, Kuo YH, Huang NK. Huang Lian Jie Du Tang attenuates paraquat-induced mitophagy in human SH-SY5Y cells: A traditional decoction with a novel therapeutic potential in treating Parkinson's disease. Biomed Pharmacother. 2021 Feb;134():111170. doi: 10.1016/j.biopha.2020.111170. PMID: 33383311.|Yang JM, Huang HM, Cheng JJ, Huang CL, Lee YC, Chiou CT, Huang HT, Huang NK, Yang YC. LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/ß-CATENIN pathway. Toxicology. 2018 Dec 01;410():65–72. doi: 10.1016/j.tox.2018.09.003. PMID: 30205152.|Zhao X, Wang R, Xiong J, Yan D, Li A, Wang S, Xu J, Zhou J. JWA antagonizes paraquat-induced neurotoxicity via activation of Nrf2. Toxicol Lett. 2017 Aug 05;277():32–40. doi: 10.1016/j.toxlet.2017.04.011. PMID: 28428137.|Li F, Tian X, Zhou Y, Zhu L, Wang B, Ding M, Pang H. Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis. J Neurosci Res. 2012 Dec;90(12):2237–46. doi: 10.1002/jnr.23121. PMID: 22987761.|Fujimori K, Fukuhara A, Inui T, Allhorn M. Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase. Journal of Neurochemistry. 2011 Nov 24;120(2):279–91. doi: 10.1111/j.1471-4159.2011.07570.x.|Fei Q, et al; J Biol Chem 283 (6): 3357-64 (2008)|Ramachandiran S, Hansen JM, Jones DP, Richardson JR, Miller GW. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicol Sci. 2007 Jan;95(1):163–71. doi: 10.1093/toxsci/kfl125. PMID: 17018646."
59119,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Paraquat results in increased expression of PARP1 protein modified form,,,PMID:27003823|PMID:28414160,https://www.ncbi.nlm.nih.gov/pubmed/27003823|https://www.ncbi.nlm.nih.gov/pubmed/28414160,27003823|28414160,,,6714909|15475197,"Hathaichoti S, Visitnonthachai D, Ngamsiri P, Niyomchan A, Tsogtbayar O, Wisessaowapak C, Watcharasit P, Satayavivad J. Paraquat induces extrinsic pathway of apoptosis in A549 cells by induction of DR5 and repression of anti-apoptotic proteins, DDX3 and GSK3 expression. Toxicol In Vitro. 2017 Aug;42():123–9. doi: 10.1016/j.tiv.2017.04.016. PMID: 28414160.|2016; 54(4):2752-2762"
59120,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[PTGDS protein results in decreased susceptibility to paraquat] which results in decreased cleavage of PARP1 protein|ptgds mutant form promotes the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:22043816,https://www.ncbi.nlm.nih.gov/pubmed/22043816,22043816,,,5196702,"Fujimori K, Fukuhara A, Inui T, Allhorn M. Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase. Journal of Neurochemistry. 2011 Nov 24;120(2):279–91. doi: 10.1111/j.1471-4159.2011.07570.x."
59121,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[paraquat co-treated with ST2825] results in increased expression of PARP1 protein|myd88 protein affects the reaction [paraquat results in increased expression of PARP1 protein]|paraquat results in increased expression of PARP1 protein|3-methyladenine affects the reaction [MYD88 protein affects the reaction [paraquat results in increased expression of PARP1 protein]],,,PMID:34811946,https://www.ncbi.nlm.nih.gov/pubmed/34811946,34811946,,PMC8818611,9574078,"Qi M, Liao S, Wang J, Deng Y, Zha A, Shao Y, Cui Z, Song T, Tang Y, Tan B, Yin Y. MyD88 deficiency ameliorates weight loss caused by intestinal oxidative injury in an autophagy-dependent mechanism. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):677–95. PMID: 34811946; PMCID: PMC8818611."
59122,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Paraquat results in increased cleavage of PARP1 protein,,,PMID:21300143|PMID:28428137,https://www.ncbi.nlm.nih.gov/pubmed/21300143|https://www.ncbi.nlm.nih.gov/pubmed/28428137,21300143|28428137,,,6727941|26217545,"Zhao X, Wang R, Xiong J, Yan D, Li A, Wang S, Xu J, Zhou J. JWA antagonizes paraquat-induced neurotoxicity via activation of Nrf2. Toxicol Lett. 2017 Aug 05;277():32–40. doi: 10.1016/j.toxlet.2017.04.011. PMID: 28428137.|Kwon HJ, Heo JY, Shim JH, Park JH, Seo KS, Ryu MJ, Han JS, Shong M, Son JH, Kweon GR. DJ-1 mediates paraquat-induced dopaminergic neuronal cell death. Toxicol Lett. 2011 Apr 25;202(2):85–92. doi: 10.1016/j.toxlet.2011.01.018. PMID: 21300143."
59123,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARK7 protein affects the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:21300143,https://www.ncbi.nlm.nih.gov/pubmed/21300143,21300143,,,26217545,"Kwon HJ, Heo JY, Shim JH, Park JH, Seo KS, Ryu MJ, Han JS, Shong M, Son JH, Kweon GR. DJ-1 mediates paraquat-induced dopaminergic neuronal cell death. Toxicol Lett. 2011 Apr 25;202(2):85–92. doi: 10.1016/j.toxlet.2011.01.018. PMID: 21300143."
59124,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Calpeptin inhibits the reaction [paraquat results in increased cleavage of PARP1 protein]|paraquat results in increased cleavage of PARP1 protein|diphenyleneiodonium inhibits the reaction [paraquat results in increased cleavage of PARP1 protein]|cyclosporine inhibits the reaction [paraquat results in increased cleavage of PARP1 protein]|dibucaine inhibits the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:25947082,https://www.ncbi.nlm.nih.gov/pubmed/25947082,25947082,,,26976018,2015; 53(4):2169-2188
906214,16043,Comparative Toxicogenomics Database (CTD),Tert-Butylhydroquinone,C018855,2-tert-butylhydroquinone,https://ctdbase.org/detail.go?type=chem&acc=C018855,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-tert-butylhydroquinone inhibits the reaction [atorvastatin results in increased cleavage of PARP1 protein],,,PMID:31423616,https://www.ncbi.nlm.nih.gov/pubmed/31423616,31423616,,,12868995,"Li LZ, Zhao ZM, Zhang L, He J, Zhang TF, Guo JB, Yu L, Zhao J, Yuan XY, Peng SQ. Atorvastatin induces mitochondrial dysfunction and cell apoptosis in HepG2 cells via inhibition of the Nrf2 pathway. J Appl Toxicol. 2019 Oct;39(10):1394–404. doi: 10.1002/jat.3825. PMID: 31423616."
1239050,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dronabinol results in decreased expression of PARP1 protein,,,PMID:16818634,https://www.ncbi.nlm.nih.gov/pubmed/16818634,16818634,,,32168266,"Caffarel MM, Sarrió D, Palacios J, Guzmán M, Sánchez C. Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Res. 2006 Jul 01;66(13):6615–21. doi: 10.1158/0008-5472.can-05-4566. PMID: 16818634."
1239051,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dronabinol results in increased cleavage of PARP1 protein,,,PMID:17583570|PMID:19509271,https://www.ncbi.nlm.nih.gov/pubmed/17583570|https://www.ncbi.nlm.nih.gov/pubmed/19509271,17583570|19509271,,,1046822|15996298,"Oesch S, Walter D, Wachtel M, Pretre K, Salazar M, Guzmán M, Velasco G, Schäfer BW. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Mol Cancer Ther. 2009 Jul;8(7):1838–45. doi: 10.1158/1535-7163.mct-08-1147. PMID: 19509271.|Greenhough A, Patsos HA, Williams AC, Paraskeva C. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int J Cancer. 2007 Nov 15;121(10):2172–80. doi: 10.1002/ijc.22917. PMID: 17583570."
1239052,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dronabinol results in increased expression of PARP1 mRNA,,,PMID:29408467,https://www.ncbi.nlm.nih.gov/pubmed/29408467,29408467,,PMC5987162,31750371,"Leishman E, Murphy M, Mackie K, Bradshaw HB. ? 9 -Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2018 May;1863(5):479–92. doi: 10.1016/j.bbalip.2018.02.001."
59559,16231,Comparative Toxicogenomics Database (CTD),Amiloride,D000584,Amiloride,https://ctdbase.org/detail.go?type=chem&acc=D000584,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:15607733|PMID:16059913,https://www.ncbi.nlm.nih.gov/pubmed/15607733|https://www.ncbi.nlm.nih.gov/pubmed/16059913,15607733|16059913,,,5090255|22707845,"Kim KM, Lee YJ. Role of HER-2/neu signaling in sensitivity to tumor necrosis factor-related apoptosis-inducing ligand: enhancement of TRAIL-mediated apoptosis by amiloride. J Cell Biochem. 2005 Oct 01;96(2):376–89. doi: 10.1002/jcb.20512. PMID: 16059913.|Cho YL, Lee KS, Lee SJ, Namkoong S, Kim YM, Lee H, Ha KS, Han JA, Kwon YG, Kim YM. Amiloride potentiates TRAIL-induced tumor cell apoptosis by intracellular acidification-dependent Akt inactivation. Biochem Biophys Res Commun. 2005 Jan 28;326(4):752–8. doi: 10.1016/j.bbrc.2004.11.109. PMID: 15607733."
59560,16231,Comparative Toxicogenomics Database (CTD),Amiloride,D000584,Amiloride,https://ctdbase.org/detail.go?type=chem&acc=D000584,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Okadaic acid inhibits the reaction [amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:16059913,https://www.ncbi.nlm.nih.gov/pubmed/16059913,16059913,,,22707845,"Kim KM, Lee YJ. Role of HER-2/neu signaling in sensitivity to tumor necrosis factor-related apoptosis-inducing ligand: enhancement of TRAIL-mediated apoptosis by amiloride. J Cell Biochem. 2005 Oct 01;96(2):376–89. doi: 10.1002/jcb.20512. PMID: 16059913."
60166,16315,Comparative Toxicogenomics Database (CTD),Diallyl Trisulfide,C042577,diallyl trisulfide,https://ctdbase.org/detail.go?type=chem&acc=C042577,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of PARP1 protein],,,PMID:22578287,https://www.ncbi.nlm.nih.gov/pubmed/22578287,22578287,,PMC3404941,14751864,2012; 19(1):50
60167,16315,Comparative Toxicogenomics Database (CTD),Diallyl Trisulfide,C042577,diallyl trisulfide,https://ctdbase.org/detail.go?type=chem&acc=C042577,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Diallyl trisulfide results in increased cleavage of PARP1 protein,,,PMID:20055834|PMID:22578287|PMID:25205294,https://www.ncbi.nlm.nih.gov/pubmed/20055834|https://www.ncbi.nlm.nih.gov/pubmed/22578287|https://www.ncbi.nlm.nih.gov/pubmed/25205294,20055834|22578287|25205294,,PMC3404941,14751864|23586240|32251473,"Panza E, De Cicco P, Armogida C, Scognamiglio G, Gigantino V, Botti G, Germano D, Napolitano M, Papapetropoulos A, Bucci M, Cirino G, Ianaro A. Role of the cystathionine ? lyase/hydrogen sulfide pathway in human melanoma progression. Pigment Cell Melanoma Res. 2015 Jan;28(1):61–72. doi: 10.1111/pcmr.12312. PMID: 25205294.|2012; 19(1):50|Zhou C, Mao XP, Guo Q, Zeng FQ. Diallyl trisulphide-induced apoptosis in human melanoma cells involves downregulation of Bcl-2 and Bcl-xL expression and activation of caspases. Clin Exp Dermatol. 2009 Dec;34(8):e537–43. doi: 10.1111/j.1365-2230.2009.03594.x. PMID: 20055834."
60532,16590,Comparative Toxicogenomics Database (CTD),Diallyl Disulfide,C028009,diallyl disulfide,https://ctdbase.org/detail.go?type=chem&acc=C028009,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [diallyl disulfide promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|diallyl disulfide promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:30677442,https://www.ncbi.nlm.nih.gov/pubmed/30677442,30677442,,,30441798,"Kim HJ, Kang S, Kim DY, You S, Park D, Oh SC, Lee DH. Diallyl disulfide (DADS) boosts TRAIL-Mediated apoptosis in colorectal cancer cells by inhibiting Bcl-2. Food Chem Toxicol. 2019 Mar;125():354–60. doi: 10.1016/j.fct.2019.01.023. PMID: 30677442."
1223309,16741,Comparative Toxicogenomics Database (CTD),Phenethyl Isothiocyanate,C058305,phenethyl isothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=C058305,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Phenethyl isothiocyanate results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased cleavage of PARP1 protein],,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,PMC4234881,19518824,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881."
976364,16958,Comparative Toxicogenomics Database (CTD),Didecyldimonium,C027118,didecyldimethylammonium,https://ctdbase.org/detail.go?type=chem&acc=C027118,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Didecyldimethylammonium results in decreased expression of PARP1 protein,,,PMID:32763356,https://www.ncbi.nlm.nih.gov/pubmed/32763356,32763356,,PMC7403870,4699115,"Park E, Seong E, Kang M, Lee G, Kim D, Han J, Lim H, Lee SH, Han H. Formation of lamellar body-like structure may be an initiator of didecyldimethylammonium chloride-induced toxic response. Toxicology and Applied Pharmacology. 2020 Oct;404():115182. doi: 10.1016/j.taap.2020.115182."
977326,17142,Comparative Toxicogenomics Database (CTD),"1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(oxiranylmethyl)-",C028786,teroxirone,https://ctdbase.org/detail.go?type=chem&acc=C028786,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TP53 protein results in increased susceptibility to teroxirone] which results in increased cleavage of PARP1 protein|aspartyl-glutamyl-valyl-aspartal inhibits the reaction [teroxirone results in increased cleavage of PARP1 protein],,,PMID:23954467,https://www.ncbi.nlm.nih.gov/pubmed/23954467,23954467,,,8013725,"Wang JP, Lin KH, Liu CY, Yu YC, Wu PT, Chiu CC, Su CL, Chen KM, Fang K. Teroxirone inhibited growth of human non-small cell lung cancer cells by activating p53. Toxicol Appl Pharmacol. 2013 Nov 15;273(1):110–20. doi: 10.1016/j.taap.2013.08.007. PMID: 23954467."
977327,17142,Comparative Toxicogenomics Database (CTD),"1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(oxiranylmethyl)-",C028786,teroxirone,https://ctdbase.org/detail.go?type=chem&acc=C028786,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Teroxirone results in increased cleavage of PARP1 protein,,,PMID:23954467|PMID:29908167,https://www.ncbi.nlm.nih.gov/pubmed/23954467|https://www.ncbi.nlm.nih.gov/pubmed/29908167,23954467|29908167,,,8013725|12858290,"Ni YL, Hsieh CH, Wang JP, Fang K. Teroxirone motivates apoptotic death in tumorspheres of human lung cancer cells. Chem Biol Interact. 2018 Aug 01;291():137–43. doi: 10.1016/j.cbi.2018.06.011. PMID: 29908167.|Wang JP, Lin KH, Liu CY, Yu YC, Wu PT, Chiu CC, Su CL, Chen KM, Fang K. Teroxirone inhibited growth of human non-small cell lung cancer cells by activating p53. Toxicol Appl Pharmacol. 2013 Nov 15;273(1):110–20. doi: 10.1016/j.taap.2013.08.007. PMID: 23954467."
1515823,17513,Comparative Toxicogenomics Database (CTD),Acadesine,C011651,acadesine,https://ctdbase.org/detail.go?type=chem&acc=C011651,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acadesine promotes the reaction [artesunate results in increased cleavage of PARP1 protein],,,PMID:33002460,https://www.ncbi.nlm.nih.gov/pubmed/33002460,33002460,,,12220368,"Zhou X, Chen Y, Wang F, Wu H, Zhang Y, Liu J, Cai Y, Huang S, He N, Hu Z, Jin X. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem Biol Interact. 2020 Nov 01;331():109273. doi: 10.1016/j.cbi.2020.109273. PMID: 33002460."
1144111,18633,Toxin and Toxin Target Database (T3DB),Cobaltous succinate,T3D1401,Cobalt(II) succinate,http://www.t3db.ca/toxins/T3D1401,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
917287,20279,DrugBank,Cladribine,DB00242,Cladribine,https://www.drugbank.ca/drugs/DB00242,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inducer,,,PMID:20634380,https://www.ncbi.nlm.nih.gov/pubmed/20634380,20634380,,,16748051,"Sigal DS, Miller HJ, Schram ED, Saven A: Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Blood. 2010 Oct 21;116(16):2884-96. doi: 10.1182/blood-2010-02-246140. Epub 2010  Jul 15."
1145722,20279,Comparative Toxicogenomics Database (CTD),Cladribine,D017338,Cladribine,https://ctdbase.org/detail.go?type=chem&acc=D017338,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cladribine co-treated with cyclophosphamide co-treated with mitoxantrone] results in decreased expression of PARP1 protein|[cladribine co-treated with cyclophosphamide] results in decreased expression of PARP1 protein,,,PMID:15582267,https://www.ncbi.nlm.nih.gov/pubmed/15582267,15582267,,,24103334,"Rogalinska M, Blonski JZ, Hanausek M, Walaszek Z, Robak T, Kilianska ZM. 2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo. Cancer Detection and Prevention. 2004 Jan;28(6):433–42. doi: 10.1016/j.cdp.2004.08.001."
1145723,20279,Comparative Toxicogenomics Database (CTD),Cladribine,D017338,Cladribine,https://ctdbase.org/detail.go?type=chem&acc=D017338,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cladribine results in increased cleavage of PARP1 protein,,,PMID:15582267|PMID:21679466,https://www.ncbi.nlm.nih.gov/pubmed/15582267|https://www.ncbi.nlm.nih.gov/pubmed/21679466,15582267|21679466,,PMC3141773,24103334|32283340,"2011; 11(1):255|Rogalinska M, Blonski JZ, Hanausek M, Walaszek Z, Robak T, Kilianska ZM. 2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo. Cancer Detection and Prevention. 2004 Jan;28(6):433–42. doi: 10.1016/j.cdp.2004.08.001."
990590,20393,Comparative Toxicogenomics Database (CTD),Mono-(2-ethylhexyl)phthalate,C016599,mono-(2-ethylhexyl)phthalate,https://ctdbase.org/detail.go?type=chem&acc=C016599,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7955,Danio rerio (zebrafish),Mono-(2-ethylhexyl)phthalate results in increased expression of PARP1 mRNA,,,PMID:33120273,https://www.ncbi.nlm.nih.gov/pubmed/33120273,33120273,,,6096946,"Lu C, Luo J, Liu Y, Yang X. The oxidative stress responses caused by phthalate acid esters increases mRNA abundance of base excision repair (BER) genes in vivo and in vitro. Ecotoxicol Environ Saf. 2021 Jan 15;208():111525. doi: 10.1016/j.ecoenv.2020.111525. PMID: 33120273."
61304,21157,Comparative Toxicogenomics Database (CTD),Buthionine sulfoximine,D019328,Buthionine Sulfoximine,https://ctdbase.org/detail.go?type=chem&acc=D019328,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Buthionine sulfoximine promotes the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate affects the cleavage of PARP1 protein]",,,PMID:20962031,https://www.ncbi.nlm.nih.gov/pubmed/20962031,20962031,,PMC3033717,14712832,"Maciag AE, Chakrapani H, Saavedra JE, Morris NL, Holland RJ, Kosak KM, Shami PJ, Anderson LM, Keefer LK. The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species. The Journal of Pharmacology and Experimental Therapeutics. 2011 Feb;336(2):313–20. doi: 10.1124/jpet.110.174904."
61305,21157,Comparative Toxicogenomics Database (CTD),Buthionine sulfoximine,D019328,Buthionine Sulfoximine,https://ctdbase.org/detail.go?type=chem&acc=D019328,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Buthionine sulfoximine promotes the reaction [wedelolactone results in increased cleavage of PARP1 protein],,,PMID:22733624,https://www.ncbi.nlm.nih.gov/pubmed/22733624,22733624,,,26937158,"Benes P, Alexova P, Knopfova L, Spanova A, Smarda J. Redox state alters anti-cancer effects of wedelolactone. Environ Mol Mutagen. 2012 Aug;53(7):515–24. doi: 10.1002/em.21712. PMID: 22733624."
1013798,22273,Toxin and Toxin Target Database (T3DB),Ferric Cacodylate,T3D1320,Iron cacodylate,http://www.t3db.ca/toxins/T3D1320,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1257907,22880,Comparative Toxicogenomics Database (CTD),N-methyl-D-aspartic acid,D016202,N-Methylaspartate,https://ctdbase.org/detail.go?type=chem&acc=D016202,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),N-methylaspartate results in increased ADP-ribosylation of PARP1 protein,,,PMID:16903875,https://www.ncbi.nlm.nih.gov/pubmed/16903875,16903875,,PMC1766941,17330875,"Goebel DJ, Winkler BS. Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina. Journal of Neurochemistry. 2006 Aug 11;98(6):1732–45. doi: 10.1111/j.1471-4159.2006.04065.x."
1420328,23749,Toxin and Toxin Target Database (T3DB),p-AZOBENZENEARSONATE,T3D1303,p-Azobenzenearsonate,http://www.t3db.ca/toxins/T3D1303,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
922017,23925,Comparative Toxicogenomics Database (CTD),Iron,D007501,Iron,https://ctdbase.org/detail.go?type=chem&acc=D007501,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rifampin inhibits the reaction [[acetaminophen co-treated with [ferric nitrate results in increased abundance of iron]] results in increased cleavage of PARP1 protein]|[acetaminophen co-treated with [ferric nitrate results in increased abundance of iron]] results in increased cleavage of PARP1 protein,,,PMID:31678598,https://www.ncbi.nlm.nih.gov/pubmed/31678598,31678598,,,5377777,"Lee EH, Baek SY, Park JY, Kim YW. Rifampicin activates AMPK and alleviates oxidative stress in the liver as mediated with Nrf2 signaling. Chem Biol Interact. 2020 Jan 05;315():108889. doi: 10.1016/j.cbi.2019.108889. PMID: 31678598."
922190,23925,Comparative Toxicogenomics Database (CTD),Iron,D007501,Iron,https://ctdbase.org/detail.go?type=chem&acc=D007501,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[arachidonic acid co-treated with iron] results in increased expression of PARP1 protein modified form|plant extracts inhibits the reaction [[arachidonic acid co-treated with iron] results in increased expression of PARP1 protein modified form],,,PMID:30626086,https://www.ncbi.nlm.nih.gov/pubmed/30626086,30626086,,PMC6357197,14876163,"Yang JH, Choi MH, Na CS, Cho SS, Kim JH, Ku SK, Cho IJ, Shin HJ, Ki SH. Bamboo Stems (Phyllostachys nigra variety henosis) Containing Polyphenol Mixtures Activate Nrf2 and Attenuate Phenylhydrazine-Induced Oxidative Stress and Liver Injury. Nutrients. 2019 Jan 08;11(1). PMID: 30626086; PMCID: PMC6357197."
922191,23925,Comparative Toxicogenomics Database (CTD),Iron,D007501,Iron,https://ctdbase.org/detail.go?type=chem&acc=D007501,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ferric ammonium citrate results in increased abundance of iron] which results in decreased expression of PARP1 protein|parp1 protein affects the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased expression of SIRT1 protein]|parp1 protein affects the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased lipidation of MAP1LC3B protein]|sirt1 protein affects the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in decreased expression of PARP1 protein]|parp1 protein affects the reaction [chloroquine promotes the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased lipidation of MAP1LC3B protein]],,,PMID:34826546,https://www.ncbi.nlm.nih.gov/pubmed/34826546,34826546,,,7531872,"Zhou Y, Zhao X, Zhang L, Xia Q, Peng Y, Zhang H, Yan D, Yang Z, Li J. Iron overload inhibits cell proliferation and promotes autophagy via PARP1/SIRT1 signaling in endometriosis and adenomyosis. Toxicology. 2022 Jan 15;465():153050. doi: 10.1016/j.tox.2021.153050. PMID: 34826546."
1038840,23930,Comparative Toxicogenomics Database (CTD),Manganese,D008345,Manganese,https://ctdbase.org/detail.go?type=chem&acc=D008345,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein|luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein],,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,PMC5746289,30392830,"Wang Y, Su H, Song X, Fiati Kenston SS, Zhao J, Gu Y. Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway. Int J Mol Med. 2018 Jan;41(1):233–41. PMID: 29115570; PMCID: PMC5746289."
1038841,23930,Comparative Toxicogenomics Database (CTD),Manganese,D008345,Manganese,https://ctdbase.org/detail.go?type=chem&acc=D008345,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[manganese co-treated with NGF protein] results in increased cleavage of PARP1 protein|ppm1d protein inhibits the reaction [[manganese co-treated with NGF protein] results in decreased cleavage of PARP1 protein]|ppm1d mutant form promotes the reaction [[manganese co-treated with NGF protein] results in increased cleavage of PARP1 protein],,,PMID:25791630,https://www.ncbi.nlm.nih.gov/pubmed/25791630,25791630,,,18828372,"Ma X, Han J, Wu Q, Liu H, Shi S, Wang C, Wang Y, Xiao J, Zhao J, Jiang J, Wan C. Involvement of dysregulated Wip1 in manganese-induced p53 signaling and neuronal apoptosis. Toxicol Lett. 2015 May 19;235(1):17–27. doi: 10.1016/j.toxlet.2014.12.019. PMID: 25791630."
1038842,23930,Comparative Toxicogenomics Database (CTD),Manganese,D008345,Manganese,https://ctdbase.org/detail.go?type=chem&acc=D008345,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Manganese results in increased cleavage of PARP1 protein,,,PMID:25448048|PMID:25791630,https://www.ncbi.nlm.nih.gov/pubmed/25448048|https://www.ncbi.nlm.nih.gov/pubmed/25791630,25448048|25791630,,,18828372|20877692,"Ma X, Han J, Wu Q, Liu H, Shi S, Wang C, Wang Y, Xiao J, Zhao J, Jiang J, Wan C. Involvement of dysregulated Wip1 in manganese-induced p53 signaling and neuronal apoptosis. Toxicol Lett. 2015 May 19;235(1):17–27. doi: 10.1016/j.toxlet.2014.12.019. PMID: 25791630.|Wan C, Ma X, Shi S, Zhao J, Nie X, Han J, Xiao J, Wang X, Jiang S, Jiang J. Pivotal roles of p53 transcription-dependent and -independent pathways in manganese-induced mitochondrial dysfunction and neuronal apoptosis. Toxicol Appl Pharmacol. 2014 Dec 15;281(3):294–302. doi: 10.1016/j.taap.2014.10.013. PMID: 25448048."
1561394,23931,Comparative Toxicogenomics Database (CTD),Mercury,D008628,Mercury,https://ctdbase.org/detail.go?type=chem&acc=D008628,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein|luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein],,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,PMC5746289,30392830,"Wang Y, Su H, Song X, Fiati Kenston SS, Zhao J, Gu Y. Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway. Int J Mol Med. 2018 Jan;41(1):233–41. PMID: 29115570; PMCID: PMC5746289."
1050376,23939,Comparative Toxicogenomics Database (CTD),Platinum,D010984,Platinum,https://ctdbase.org/detail.go?type=chem&acc=D010984,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cisplatin promotes the reaction [platinum binds to PARP1 protein],,,PMID:21370912,https://www.ncbi.nlm.nih.gov/pubmed/21370912,21370912,,,13366100,"Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ, Casini A. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem. 2011 Apr 14;54(7):2196–206. doi: 10.1021/jm2000135. PMID: 21370912."
1175732,23950,Comparative Toxicogenomics Database (CTD),Ruthenium,D012428,Ruthenium,https://ctdbase.org/detail.go?type=chem&acc=D012428,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(iii) promotes the reaction [ruthenium binds to PARP1 protein]|rapta-T promotes the reaction [ruthenium binds to PARP1 protein],,,PMID:21370912,https://www.ncbi.nlm.nih.gov/pubmed/21370912,21370912,,,13366100,"Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ, Casini A. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem. 2011 Apr 14;54(7):2196–206. doi: 10.1021/jm2000135. PMID: 21370912."
1243675,23964,Comparative Toxicogenomics Database (CTD),Tungsten,D014414,Tungsten,https://ctdbase.org/detail.go?type=chem&acc=D014414,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tungsten results in decreased expression of PARP1 mRNA,,,PMID:30912803,https://www.ncbi.nlm.nih.gov/pubmed/30912803,30912803,,,10833739,"Wu TH, Bolt AM, Chou H, Plourde D, De Jay N, Guilbert C, Young YK, Kleinman CL, Mann KK. Tungsten Blocks Murine B Lymphocyte Differentiation and Proliferation Through Downregulation of IL-7 Receptor/Pax5 Signaling. Toxicol Sci. 2019 Jul 01;170(1):45–56. doi: 10.1093/toxsci/kfz080. PMID: 30912803."
943711,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-bromopalmitate inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased palmitoylation of PARP1 protein]|[cadmium chloride results in increased abundance of cadmium] which results in increased palmitoylation of PARP1 protein,,,PMID:38195004,https://www.ncbi.nlm.nih.gov/pubmed/38195004,38195004,,PMC10923080,36719880,"Lee C, Jarrell ZR, Lee HY, Singer G, Tran VT, Orr M, Jones DP, Go Y. Protein S-palmitoylation enhances profibrotic signaling in response to cadmium. Toxicology and Applied Pharmacology. 2024 Feb;483():116806. doi: 10.1016/j.taap.2024.116806."
943712,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cadmium results in increased activity of and results in increased cleavage of PARP1 protein,,,PMID:24824807,https://www.ncbi.nlm.nih.gov/pubmed/24824807,24824807,,,4540318,"Wang B, Xiao JL, Ling YH, Meng XJ, Wu B, Yang XY, Zou F. BNIP3 upregulation by ERK and JNK mediates cadmium-induced necrosis in neuronal cells. Toxicol Sci. 2014 Aug 01;140(2):393–402. doi: 10.1093/toxsci/kfu091. PMID: 24824807."
943713,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cadmium results in increased cleavage of PARP1 protein,,,PMID:28507149|PMID:30985881|PMID:33857584,https://www.ncbi.nlm.nih.gov/pubmed/28507149|https://www.ncbi.nlm.nih.gov/pubmed/30985881|https://www.ncbi.nlm.nih.gov/pubmed/33857584,28507149|30985881|33857584,,PMC5465913,6013626|20354134|26417983,"Chen J, Lai W, Deng Y, Liu M, Dong M, Liu Z, Wang T, Li X, Zhao Z, Yin X, Yang J, Yu R, Liu L. MicroRNA-363-3p promotes apoptosis in response to cadmium-induced renal injury by down-regulating phosphoinositide 3-kinase expression. Toxicol Lett. 2021 Jul 01;345():12–23. doi: 10.1016/j.toxlet.2021.04.002. PMID: 33857584.|Gu J, Wang Y, Liu Y, Shi M, Yin L, Hou Y, Zhou Y, Chu Wong CK, Chen D, Guo Z, Shi H. Inhibition of Autophagy Alleviates Cadmium-Induced Mouse Spleen and Human B Cells Apoptosis. Toxicol Sci. 2019 Jul 01;170(1):109–22. doi: 10.1093/toxsci/kfz089. PMID: 30985881.|Shin CH, Lee MG, Han J, Jeong SI, Ryu BK, Chi SG. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683–8. PMID: 28507149; PMCID: PMC5465913."
943714,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),VMP1 affects the reaction [cadmium results in increased cleavage of PARP1 protein]|chloroquine inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:30985881,https://www.ncbi.nlm.nih.gov/pubmed/30985881,30985881,,,26417983,"Gu J, Wang Y, Liu Y, Shi M, Yin L, Hou Y, Zhou Y, Chu Wong CK, Chen D, Guo Z, Shi H. Inhibition of Autophagy Alleviates Cadmium-Induced Mouse Spleen and Human B Cells Apoptosis. Toxicol Sci. 2019 Jul 01;170(1):109–22. doi: 10.1093/toxsci/kfz089. PMID: 30985881."
943715,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MT2A protein affects the reaction [EGF protein inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]]|xaf1 protein affects the reaction [cadmium results in increased cleavage of PARP1 protein]|egf protein inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:28507149,https://www.ncbi.nlm.nih.gov/pubmed/28507149,28507149,,PMC5465913,6013626,"Shin CH, Lee MG, Han J, Jeong SI, Ryu BK, Chi SG. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683–8. PMID: 28507149; PMCID: PMC5465913."
943716,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein|luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein],,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,PMC5746289,30392830,"Wang Y, Su H, Song X, Fiati Kenston SS, Zhao J, Gu Y. Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway. Int J Mol Med. 2018 Jan;41(1):233–41. PMID: 29115570; PMCID: PMC5746289."
943883,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 mutant form inhibits the reaction [cadmium results in decreased abundance of adenosine triphosphate],,,PMID:21767558,https://www.ncbi.nlm.nih.gov/pubmed/21767558,21767558,,PMC3439510,9987473,"Son Y, Wang X, Hitron JA, Zhang Z, Cheng S, Budhraja A, Ding S, Lee J, Shi X. Cadmium induces autophagy through ROS-dependent activation of the LKB1–AMPK signaling in skin epidermal cells. Toxicology and Applied Pharmacology. 2011 Sep;255(3):287–96. doi: 10.1016/j.taap.2011.06.024."
943884,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,40674,Mammalia (mammals),Cadmium results in decreased activity of PARP1 protein,,,PMID:16677676,https://www.ncbi.nlm.nih.gov/pubmed/16677676,16677676,,,33535816,"Giaginis C, Gatzidou E, Theocharis S. DNA repair systems as targets of cadmium toxicity. Toxicol Appl Pharmacol. 2006 Jun 15;213(3):282–90. doi: 10.1016/j.taap.2006.03.008. PMID: 16677676."
943886,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|[1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with egtazic acid] inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|sirolimus promotes the reaction [cadmium results in increased cleavage of PARP1 protein]|chloroquine inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|acetylleucyl-leucyl-norleucinal inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|cadmium results in increased cleavage of PARP1 protein|calpeptin inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|bafilomycin A1 inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|atg5 protein affects the reaction [cadmium results in increased cleavage of PARP1 protein]|1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|egtazic acid inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]",,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
943887,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein],,,PMID:30796935,https://www.ncbi.nlm.nih.gov/pubmed/30796935,30796935,,,20306548,"Wang S, Ren X, Hu X, Zhou L, Zhang C, Zhang M. Cadmium-induced apoptosis through reactive oxygen species-mediated mitochondrial oxidative stress and the JNK signaling pathway in TM3 cells, a model of mouse Leydig cells. Toxicol Appl Pharmacol. 2019 Apr 01;368():37–48. doi: 10.1016/j.taap.2019.02.012. PMID: 30796935."
943888,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein,,,PMID:30796935|PMID:37261864,https://www.ncbi.nlm.nih.gov/pubmed/30796935|https://www.ncbi.nlm.nih.gov/pubmed/37261864,30796935|37261864,,,20306548|35528068,"Lee SW, Kim B, Seong JB, Park YH, Lee HJ, Lee DS. ATF6 is a critical regulator of cadmium-mediated apoptosis in spermatocytes. Toxicol Sci. 2023 Jul 28;194(2):167–77. doi: 10.1093/toxsci/kfad055. PMID: 37261864.|Wang S, Ren X, Hu X, Zhou L, Zhang C, Zhang M. Cadmium-induced apoptosis through reactive oxygen species-mediated mitochondrial oxidative stress and the JNK signaling pathway in TM3 cells, a model of mouse Leydig cells. Toxicol Appl Pharmacol. 2019 Apr 01;368():37–48. doi: 10.1016/j.taap.2019.02.012. PMID: 30796935."
943889,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Cadmium results in increased expression of PARP1 mRNA,,,PMID:26187450,https://www.ncbi.nlm.nih.gov/pubmed/26187450,26187450,,PMC4598795,26327282,"Go YM, Sutliff RL, Chandler JD, Khalidur R, Kang BY, Anania FA, Orr M, Hao L, Fowler BA, Jones DP. Low-Dose Cadmium Causes Metabolic and Genetic Dysregulation Associated With Fatty Liver Disease in Mice. Toxicol Sci. 2015 Oct;147(2):524–34. PMID: 26187450; PMCID: PMC4598795."
943890,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|lithium chloride promotes the reaction [cadmium results in increased cleavage of PARP1 protein]|bafilomycin A promotes the reaction [cadmium results in increased cleavage of PARP1 protein]|chloroquine promotes the reaction [cadmium results in increased cleavage of PARP1 protein]|atg5 protein affects the reaction [cadmium results in increased cleavage of PARP1 protein]|gsk3a protein affects the reaction [cadmium results in increased cleavage of PARP1 protein]|gsk3b protein affects the reaction [cadmium results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|rottlerin inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|sb 216763 promotes the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,,18200010,"So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547."
944049,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),AKT activator SC79 inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]]|gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]|anisomycin inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]]|[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein,,,PMID:34767868,https://www.ncbi.nlm.nih.gov/pubmed/34767868,34767868,,,7531521,"Bi A, Guo Z, Yang G, Huang Y, Yin Z, Luo L. ?-glutamylcysteine suppresses cadmium-induced apoptosis in PC12 cells via regulating oxidative stress. Toxicology. 2022 Jan 15;465():153029. doi: 10.1016/j.tox.2021.153029. PMID: 34767868."
944050,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:19433269,https://www.ncbi.nlm.nih.gov/pubmed/19433269,19433269,,,28208092,"Kim J, Soh J. Cadmium-induced apoptosis is mediated by the translocation of AIF to the nucleus in rat testes. Toxicol Lett. 2009 Jul 10;188(1):45–51. doi: 10.1016/j.toxlet.2009.03.006. PMID: 19433269."
944051,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cadmium results in increased cleavage of PARP1 protein,,,PMID:19433269|PMID:23741317|PMID:25643798|PMID:27658547|PMID:33857584,https://www.ncbi.nlm.nih.gov/pubmed/19433269|https://www.ncbi.nlm.nih.gov/pubmed/23741317|https://www.ncbi.nlm.nih.gov/pubmed/25643798|https://www.ncbi.nlm.nih.gov/pubmed/27658547|https://www.ncbi.nlm.nih.gov/pubmed/33857584,19433269|23741317|25643798|27658547|33857584,,PMC3669330,3181779|18200010|20354134|28208092,"Chen J, Lai W, Deng Y, Liu M, Dong M, Liu Z, Wang T, Li X, Zhao Z, Yin X, Yang J, Yu R, Liu L. MicroRNA-363-3p promotes apoptosis in response to cadmium-induced renal injury by down-regulating phosphoinositide 3-kinase expression. Toxicol Lett. 2021 Jul 01;345():12–23. doi: 10.1016/j.toxlet.2021.04.002. PMID: 33857584.|So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547.|Yuan Y, Jiang C, Xu H, Sun Y, Hu F, Bian J, Liu X, Gu J, Liu Z. Cadmium-Induced Apoptosis in Primary Rat Cerebral Cortical Neurons Culture Is Mediated by a Calcium Signaling Pathway. PLoS ONE. 2013 May 31;8(5):e64330. doi: 10.1371/journal.pone.0064330.|Kim J, Soh J. Cadmium-induced apoptosis is mediated by the translocation of AIF to the nucleus in rat testes. Toxicol Lett. 2009 Jul 10;188(1):45–51. doi: 10.1016/j.toxlet.2009.03.006. PMID: 19433269."
944052,23973,Comparative Toxicogenomics Database (CTD),Cadmium,D002104,Cadmium,https://ctdbase.org/detail.go?type=chem&acc=D002104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),Cadmium results in increased cleavage of PARP1 protein|oxalomalic acid promotes the reaction [cadmium results in increased cleavage of PARP1 protein]|glrx protein inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:16785314,https://www.ncbi.nlm.nih.gov/pubmed/16785314,16785314,,,9252676,"Kil IS, Shin SW, Yeo HS, Lee YS, Park JW. Mitochondrial NADP+-dependent isocitrate dehydrogenase protects cadmium-induced apoptosis. Mol Pharmacol. 2006 Sep;70(3):1053–61. doi: 10.1124/mol.106.023515. PMID: 16785314."
1322401,23976,Comparative Toxicogenomics Database (CTD),Chromium,D002857,Chromium,https://ctdbase.org/detail.go?type=chem&acc=D002857,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein|luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein],,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,PMC5746289,30392830,"Wang Y, Su H, Song X, Fiati Kenston SS, Zhao J, Gu Y. Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway. Int J Mol Med. 2018 Jan;41(1):233–41. PMID: 29115570; PMCID: PMC5746289."
1322402,23976,Comparative Toxicogenomics Database (CTD),Chromium,D002857,Chromium,https://ctdbase.org/detail.go?type=chem&acc=D002857,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Chromium results in increased cleavage of PARP1 protein,,,PMID:12423593,https://www.ncbi.nlm.nih.gov/pubmed/12423593,12423593,,,19295227,"Catelas I, Petit A, Zukor DJ, Antoniou J, Huk OL. TNF-alpha secretion and macrophage mortality induced by cobalt and chromium ions in vitro-qualitative analysis of apoptosis. Biomaterials. 2003 Feb;24(3):383–91. doi: 10.1016/s0142-9612(02)00351-4. PMID: 12423593."
1143751,23978,Comparative Toxicogenomics Database (CTD),Copper,D003300,Copper,https://ctdbase.org/detail.go?type=chem&acc=D003300,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[chelating agents binds to copper] which results in decreased expression of PARP1 mrna|[chelating agents binds to copper] which results in increased cleavage of PARP1 protein,,,PMID:30911355,https://www.ncbi.nlm.nih.gov/pubmed/30911355,30911355,,PMC6398008,10832365,"Li X, Chen Y, Zhao J, Shi J, Wang M, Qiu S, Hu Y, Xu Y, Cui Y, Liu C, Liu C. The Specific Inhibition of SOD1 Selectively Promotes Apoptosis of Cancer Cells via Regulation of the ROS Signaling Network. Oxidative Medicine and Cellular Longevity. 2019 Feb 18;2019():1–21. doi: 10.1155/2019/9706792."
1143752,23978,Comparative Toxicogenomics Database (CTD),Copper,D003300,Copper,https://ctdbase.org/detail.go?type=chem&acc=D003300,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[copper co-treated with disulfiram] results in increased cleavage of PARP1 protein,,,PMID:23033007,https://www.ncbi.nlm.nih.gov/pubmed/23033007,23033007,,PMC3493777,13406869,"Liu P, Brown S, Goktug T, Channathodiyil P, Kannappan V, Hugnot J, Guichet P, Bian X, Armesilla AL, Darling JL, Wang W. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. British Journal of Cancer. 2012 Oct 02;107(9):1488–97. doi: 10.1038/bjc.2012.442."
1143753,23978,Comparative Toxicogenomics Database (CTD),Copper,D003300,Copper,https://ctdbase.org/detail.go?type=chem&acc=D003300,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[disulfiram binds to copper] which results in increased cleavage of PARP1 protein,,,PMID:17079463|PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/17079463|https://www.ncbi.nlm.nih.gov/pubmed/24690739,17079463|24690739,,PMC3972204,23413235|30982098,"Cheriyan VT, Wang Y, Muthu M, Jamal S, Chen D, Yang H, Polin LA, Tarca AL, Pass HI, Dou QP, Sharma S, Wali A, Rishi AK. Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis. PLoS ONE. 2014 Apr 01;9(4):e93711. doi: 10.1371/journal.pone.0093711.|2006; 66(21):10425-10433"
1143754,23978,Comparative Toxicogenomics Database (CTD),Copper,D003300,Copper,https://ctdbase.org/detail.go?type=chem&acc=D003300,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein|luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein],,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,PMC5746289,30392830,"Wang Y, Su H, Song X, Fiati Kenston SS, Zhao J, Gu Y. Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway. Int J Mol Med. 2018 Jan;41(1):233–41. PMID: 29115570; PMCID: PMC5746289."
1143755,23978,Comparative Toxicogenomics Database (CTD),Copper,D003300,Copper,https://ctdbase.org/detail.go?type=chem&acc=D003300,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[NSC 689534 binds to copper] which results in decreased expression of PARP1 mrna|[nsc 689534 binds to copper] which results in increased cleavage of PARP1 protein,,,PMID:20971185,https://www.ncbi.nlm.nih.gov/pubmed/20971185,20971185,,PMC3014388,14720498,"Hancock CN, Stockwin LH, Han B, Divelbiss RD, Jun JH, Malhotra SV, Hollingshead MG, Newton DL. A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo. Free Radical Biology and Medicine. 2011 Jan;50(1):110–21. doi: 10.1016/j.freeradbiomed.2010.10.696."
1143756,23978,Comparative Toxicogenomics Database (CTD),Copper,D003300,Copper,https://ctdbase.org/detail.go?type=chem&acc=D003300,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[disulfiram binds to copper] which results in increased cleavage of PARP1 protein,,,PMID:24690739,https://www.ncbi.nlm.nih.gov/pubmed/24690739,24690739,,PMC3972204,30982098,"Cheriyan VT, Wang Y, Muthu M, Jamal S, Chen D, Yang H, Polin LA, Tarca AL, Pass HI, Dou QP, Sharma S, Wali A, Rishi AK. Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis. PLoS ONE. 2014 Apr 01;9(4):e93711. doi: 10.1371/journal.pone.0093711."
1434685,23985,Comparative Toxicogenomics Database (CTD),Gold,D006046,Gold,https://ctdbase.org/detail.go?type=chem&acc=D006046,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gold analog results in decreased expression of PARP1 mRNA,,,PMID:36057382,https://www.ncbi.nlm.nih.gov/pubmed/36057382,36057382,,,35273394,"Li X, Li D, Zhang G, Zeng Y, Monteiro-Riviere NA, Chang YZ, Li Y. Biocorona modulates the inflammatory response induced by gold nanoparticles in human epidermal keratinocytes. Toxicol Lett. 2022 Oct 01;369():34–42. doi: 10.1016/j.toxlet.2022.08.009. PMID: 36057382."
1434882,23985,Comparative Toxicogenomics Database (CTD),Gold,D006046,Gold,https://ctdbase.org/detail.go?type=chem&acc=D006046,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Organogold compounds promotes the reaction [gold binds to PARP1 protein],,,PMID:21370912,https://www.ncbi.nlm.nih.gov/pubmed/21370912,21370912,,,13366100,"Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ, Casini A. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem. 2011 Apr 14;54(7):2196–206. doi: 10.1021/jm2000135. PMID: 21370912."
948485,23992,Comparative Toxicogenomics Database (CTD),Ytterbium,D015018,Ytterbium,https://ctdbase.org/detail.go?type=chem&acc=D015018,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ytterbium analog results in increased cleavage of PARP1 protein,,,PMID:19632212,https://www.ncbi.nlm.nih.gov/pubmed/19632212,19632212,,,10633834,"Shen L, Liu Q, Ni J, Hong G. A proteomic investigation into the human cervical cancer cell line HeLa treated with dicitratoytterbium (III) complex. Chem Biol Interact. 2009 Oct 30;181(3):455–62. doi: 10.1016/j.cbi.2009.07.013. PMID: 19632212."
62852,23994,DrugBank,Zinc,DB01593,Zinc,https://www.drugbank.ca/drugs/DB01593,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:25549802,https://www.ncbi.nlm.nih.gov/pubmed/25549802,25549802,,,497628,"Bossak K, Goch W, Piatek K, Fraczyk T, Poznanski J, Bonna A, Keil C, Hartwig A, Bal W: Unusual Zn(II) Affinities of Zinc Fingers of Poly(ADP-ribose)Polymerase 1 (PARP-1) Nuclear Protein. Chem Res Toxicol. 2015 Feb 16;28(2):191-201."
1307016,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cisplatin inhibits the reaction [zinc binds to PARP1 protein]|organogold compounds inhibits the reaction [zinc binds to PARP1 protein]|imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(iii) inhibits the reaction [zinc binds to PARP1 protein]|rapta-T inhibits the reaction [zinc binds to PARP1 protein],,,PMID:21370912,https://www.ncbi.nlm.nih.gov/pubmed/21370912,21370912,,,13366100,"Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ, Casini A. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem. 2011 Apr 14;54(7):2196–206. doi: 10.1021/jm2000135. PMID: 21370912."
1307195,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc deficiency results in increased cleavage of PARP1 protein|dopamine promotes the reaction [zinc deficiency results in increased cleavage of PARP1 protein]|zinc deficiency promotes the reaction [dopamine results in increased cleavage of PARP1 protein],,,PMID:23377617,https://www.ncbi.nlm.nih.gov/pubmed/23377617,23377617,,PMC3627551,17435572,"Omata Y, Salvador GA, Supasai S, Keenan AH, Oteiza PI. Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain. Toxicol Sci. 2013 May;133(1):90–100. PMID: 23377617; PMCID: PMC3627551."
1307196,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein|luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein],,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,PMC5746289,30392830,"Wang Y, Su H, Song X, Fiati Kenston SS, Zhao J, Gu Y. Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway. Int J Mol Med. 2018 Jan;41(1):233–41. PMID: 29115570; PMCID: PMC5746289."
1307197,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc results in increased folding of PARP1 protein|parp1 protein binds to zinc|sodium arsenite inhibits the reaction [PARP1 protein binds to zinc]|uric acid inhibits the reaction [sodium arsenite inhibits the reaction [PARP1 protein binds to zinc]]|linsidomine inhibits the reaction [PARP1 protein binds to zinc],,,PMID:31152818,https://www.ncbi.nlm.nih.gov/pubmed/31152818,31152818,,PMC6991161,33792783,"Zhou X, Ding X, Shen J, Yang D, Hudson LG, Liu KJ. Peroxynitrite contributes to arsenic-induced PARP-1 inhibition through ROS/RNS generation. Toxicology and Applied Pharmacology. 2019 Sep;378():114602. doi: 10.1016/j.taap.2019.114602."
1307198,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [zinc binds to PARP1 protein]|zinc inhibits the reaction [sodium arsenite inhibits the reaction [zinc binds to PARP1 protein]]",,,PMID:24275069,https://www.ncbi.nlm.nih.gov/pubmed/24275069,24275069,,PMC3891920,30330910,"Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 2014 Jan;274(2):313–8. doi: 10.1016/j.taap.2013.11.010."
1307199,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein modified form binds to zinc,,,PMID:25549802,https://www.ncbi.nlm.nih.gov/pubmed/25549802,25549802,,,497628,"Bossak K, Goch W, Piatek K, Fraczyk T, Poznanski J, Bonna A, Keil C, Hartwig A, Bal W: Unusual Zn(II) Affinities of Zinc Fingers of Poly(ADP-ribose)Polymerase 1 (PARP-1) Nuclear Protein. Chem Res Toxicol. 2015 Feb 16;28(2):191-201."
1307200,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite inhibits the reaction [zinc binds to PARP1 protein],,,PMID:24275069|PMID:28552776|PMID:36087615,https://www.ncbi.nlm.nih.gov/pubmed/24275069|https://www.ncbi.nlm.nih.gov/pubmed/28552776|https://www.ncbi.nlm.nih.gov/pubmed/36087615,24275069|28552776|36087615,,PMC10144522|PMC3891920|PMC5568456,19595254|30330910|34633447,"Volk LB, Cooper KL, Jiang T, Paffett ML, Hudson LG. Impacts of arsenic on Rad18 and translesion synthesis. Toxicology and Applied Pharmacology. 2022 Nov;454():116230. doi: 10.1016/j.taap.2022.116230.|Ding X, Zhou X, Cooper KL, Huestis J, Hudson LG, Liu KJ. Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicology and Applied Pharmacology. 2017 Sep;331():108–15. doi: 10.1016/j.taap.2017.05.031.|Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 2014 Jan;274(2):313–8. doi: 10.1016/j.taap.2013.11.010."
1307201,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc affects the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein],,,PMID:15966574,https://www.ncbi.nlm.nih.gov/pubmed/15966574,15966574,,,15970553,"Rudolf E, Cervinka M, Cerman J. Zinc has ambiguous effects on chromium (VI)-induced oxidative stress and apoptosis. Journal of Trace Elements in Medicine and Biology. 2005 May;18(3):251–60. doi: 10.1016/j.jtemb.2004.09.004."
1307202,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc binds to and results in increased activity of PARP1 protein,,,PMID:28552776,https://www.ncbi.nlm.nih.gov/pubmed/28552776,28552776,,PMC5568456,19595254,"Ding X, Zhou X, Cooper KL, Huestis J, Hudson LG, Liu KJ. Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicology and Applied Pharmacology. 2017 Sep;331():108–15. doi: 10.1016/j.taap.2017.05.031."
1307203,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc binds to PARP1 protein,,,PMID:24275069|PMID:36087615,https://www.ncbi.nlm.nih.gov/pubmed/24275069|https://www.ncbi.nlm.nih.gov/pubmed/36087615,24275069|36087615,,PMC10144522|PMC3891920,30330910|34633447,"Volk LB, Cooper KL, Jiang T, Paffett ML, Hudson LG. Impacts of arsenic on Rad18 and translesion synthesis. Toxicology and Applied Pharmacology. 2022 Nov;454():116230. doi: 10.1016/j.taap.2022.116230.|Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 2014 Jan;274(2):313–8. doi: 10.1016/j.taap.2013.11.010."
1307389,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc inhibits the reaction [arsenite results in decreased activity of PARP1 protein],,,PMID:18707137,https://www.ncbi.nlm.nih.gov/pubmed/18707137,18707137,,PMC3606021,5823358,"Qin XJ, Hudson LG, Liu W, Ding W, Cooper KL, Liu KJ. Dual actions involved in arsenite-induced oxidative DNA damage. Chem Res Toxicol. 2008 Sep;21(9):1806–13. PMID: 18707137; PMCID: PMC3606021."
1307390,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc inhibits the reaction [monomethylarsonous acid results in decreased activity of PARP1 protein],,,PMID:21925530,https://www.ncbi.nlm.nih.gov/pubmed/21925530,21925530,,PMC3220758,23516436,"Wnek SM, Kuhlman CL, Camarillo JM, Medeiros MK, Liu KJ, Lau SS, Gandolfi AJ. Interdependent genotoxic mechanisms of monomethylarsonous acid: Role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicology and Applied Pharmacology. 2011 Nov;257(1):1–13. doi: 10.1016/j.taap.2011.08.029."
1307391,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein],,,PMID:24275069|PMID:28552776,https://www.ncbi.nlm.nih.gov/pubmed/24275069|https://www.ncbi.nlm.nih.gov/pubmed/28552776,24275069|28552776,,PMC3891920|PMC5568456,19595254|30330910,"Ding X, Zhou X, Cooper KL, Huestis J, Hudson LG, Liu KJ. Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicology and Applied Pharmacology. 2017 Sep;331():108–15. doi: 10.1016/j.taap.2017.05.031.|Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 2014 Jan;274(2):313–8. doi: 10.1016/j.taap.2013.11.010."
1307392,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc results in increased cleavage of PARP1 protein,,,PMID:16472982|PMID:16799065|PMID:28507149,https://www.ncbi.nlm.nih.gov/pubmed/16472982|https://www.ncbi.nlm.nih.gov/pubmed/16799065|https://www.ncbi.nlm.nih.gov/pubmed/28507149,16472982|16799065|28507149,,PMC5465913,6013626|8564116|26132218,"Shin CH, Lee MG, Han J, Jeong SI, Ryu BK, Chi SG. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683–8. PMID: 28507149; PMCID: PMC5465913.|Osborne NN, Wood JP. The beta-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3178–86. doi: 10.1167/iovs.05-1370. PMID: 16799065.|Chang KL, Hung TC, Hsieh BS, Chen YH, Chen TF, Cheng HL. Zinc at pharmacologic concentrations affects cytokine expression and induces apoptosis of human peripheral blood mononuclear cells. Nutrition. 2006 May;22(5):465–74. doi: 10.1016/j.nut.2005.11.009. PMID: 16472982."
1307393,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein affects the reaction [zinc results in decreased uptake of excitatory amino acid agents]|parp1 protein affects the reaction [zinc results in decreased abundance of adenosine triphosphate],,,PMID:17728843,https://www.ncbi.nlm.nih.gov/pubmed/17728843,17728843,,PMC1952665,14644235,2007; 13(7-8):344-349
1307394,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Zinc inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein],,,PMID:26443841,https://www.ncbi.nlm.nih.gov/pubmed/26443841,26443841,,PMC4715257,4591904,"Xu H, Zhou X, Wen X, Lauer FT, Liu KJ, Hudson LG, Aleksunes LM, Burchiel SW. Environmentally Relevant Concentrations of Arsenite Induce Dose-Dependent Differential Genotoxicity Through Poly(ADP-Ribose) Polymerase Inhibition and Oxidative Stress in Mouse Thymus Cells. Toxicol Sci. 2016 Jan;149(1):31–41. PMID: 26443841; PMCID: PMC4715257."
1307395,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Metipranolol inhibits the reaction [zinc results in decreased expression of PARP1 protein]|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [zinc results in decreased expression of PARP1 protein]|zinc results in decreased expression of PARP1 protein",,,PMID:16799065,https://www.ncbi.nlm.nih.gov/pubmed/16799065,16799065,,,8564116,"Osborne NN, Wood JP. The beta-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3178–86. doi: 10.1167/iovs.05-1370. PMID: 16799065."
1307396,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[[sodium arsenite results in increased abundance of arsenic] which co-treated with zinc deficiency] results in increased cleavage of PARP1 protein,,,PMID:31542844,https://www.ncbi.nlm.nih.gov/pubmed/31542844,31542844,,PMC6891200,23675274,2019; 32(6):845-859
1600834,23994,Toxin and Toxin Target Database (T3DB),Zinc,T3D0074,Zinc,http://www.t3db.ca/toxins/T3D0074,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:21370912,https://www.ncbi.nlm.nih.gov/pubmed/21370912,21370912,,,13366100,"Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ, Casini A. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem. 2011 Apr 14;54(7):2196–206. doi: 10.1021/jm2000135. PMID: 21370912."
1460538,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[disulfiram co-treated with cupric chloride] results in increased cleavage of PARP1 protein,,,PMID:19789329,https://www.ncbi.nlm.nih.gov/pubmed/19789329,19789329,,,28875025,"Iljin K, Ketola K, Vainio P, Halonen P, Kohonen P, Fey V, Grafström RC, Perälä M, Kallioniemi O. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res. 2009 Oct 01;15(19):6070–8. doi: 10.1158/1078-0432.ccr-09-1035. PMID: 19789329."
1460539,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[prolinedithiocarbamate analog co-treated with cupric chloride] results in increased cleavage of PARP1 protein,,,PMID:21035945,https://www.ncbi.nlm.nih.gov/pubmed/21035945,21035945,,PMC3671753,11333525,"Wang F, Zhai S, Liu X, Li L, Wu S, Dou QP, Yan B. A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells. Cancer Letters. 2011 Jan;300(1):87–95. doi: 10.1016/j.canlet.2010.09.010."
1460540,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Cupric chloride results in increased expression of PARP1 protein,,,PMID:23313662,https://www.ncbi.nlm.nih.gov/pubmed/23313662,23313662,,,32292974,"Mitra S, Keswani T, Ghosh N, Goswami S, Datta A, Das S, Maity S, Bhattacharyya A. Copper induced immunotoxicity promote differential apoptotic pathways in spleen and thymus. Toxicology. 2013 Apr 05;306():74–84. doi: 10.1016/j.tox.2013.01.001. PMID: 23313662."
1073219,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7227,Drosophila melanogaster (fruit fly),Mercuric chloride results in increased cleavage of PARP1 protein,,,PMID:22700419,https://www.ncbi.nlm.nih.gov/pubmed/22700419,22700419,,,28275547,"Paula MT, Zemolin AP, Vargas AP, Golombieski RM, Loreto EL, Saidelles AP, Picoloto RS, Flores EM, Pereira AB, Rocha JB, Merritt TJ, Franco JL, Posser T. Effects of Hg(II) exposure on MAPK phosphorylation and antioxidant system in D. melanogaster. Environ Toxicol. 2014 Jun;29(6):621–30. doi: 10.1002/tox.21788. PMID: 22700419."
1073220,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mercuric chloride results in increased cleavage of PARP1 protein,,,PMID:11068922|PMID:12504520|PMID:12505371,https://www.ncbi.nlm.nih.gov/pubmed/11068922|https://www.ncbi.nlm.nih.gov/pubmed/12504520|https://www.ncbi.nlm.nih.gov/pubmed/12505371,11068922|12504520|12505371,,,2965732|2966531|7770544,"Issa Y, Watts DC, Duxbury AJ, Brunton PA, Watson MB, Waters CM. Mercuric chloride: toxicity and apoptosis in a human oligodendroglial cell line MO3.13. Biomaterials. 2003 Mar;24(6):981–7. doi: 10.1016/s0142-9612(02)00436-2. PMID: 12504520.|Araragi S, Kondoh M, Kawase M, Saito S, Higashimoto M, Sato M. Mercuric chloride induces apoptosis via a mitochondrial-dependent pathway in human leukemia cells. Toxicology. 2003 Feb 14;184(1):1–9. doi: 10.1016/s0300-483x(02)00443-2. PMID: 12505371.|Shenker BJ, Guo TL, Shapiro IM. Mercury-induced apoptosis in human lymphoid cells: evidence that the apoptotic pathway is mercurial species dependent. Environ Res. 2000 Oct;84(2):89–99. doi: 10.1006/enrs.2000.4078. PMID: 11068922."
1073221,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10036,Mesocricetus auratus (golden hamster),Mercuric chloride results in increased activity of PARP1 protein,,,PMID:20006636,https://www.ncbi.nlm.nih.gov/pubmed/20006636,20006636,,,8620139,"Chen YW, Huang CF, Yang CY, Yen CC, Tsai KS, Liu SH. Inorganic mercury causes pancreatic beta-cell death via the oxidative stress-induced apoptotic and necrotic pathways. Toxicol Appl Pharmacol. 2010 Mar 15;243(3):323–31. doi: 10.1016/j.taap.2009.11.024. PMID: 20006636."
1073222,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[mercuric chloride co-treated with prolinedithiocarbamate] results in increased degradation of PARP1 protein|acetylcysteine inhibits the reaction [[mercuric chloride co-treated with prolinedithiocarbamate] results in increased degradation of PARP1 protein],,,PMID:22909951,https://www.ncbi.nlm.nih.gov/pubmed/22909951,22909951,,,10696229,"Huang CF, Liu SH, Lin-Shiau SY. Pyrrolidine dithiocarbamate augments Hg(2+)-mediated induction of macrophage cell death via oxidative stress-induced apoptosis and necrosis signaling pathways. Toxicol Lett. 2012 Oct 02;214(1):33–45. doi: 10.1016/j.toxlet.2012.08.006. PMID: 22909951."
62855,24154,Comparative Toxicogenomics Database (CTD),D-Galactosamine,D005688,Galactosamine,https://ctdbase.org/detail.go?type=chem&acc=D005688,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[[galactosamine co-treated with lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein|gentiopicroside inhibits the reaction [[[galactosamine co-treated with lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein],,,PMID:20558151,https://www.ncbi.nlm.nih.gov/pubmed/20558151,20558151,,,20790301,"Lian LH, Wu YL, Wan Y, Li X, Xie WX, Nan JX. Anti-apoptotic activity of gentiopicroside in D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure. Chem Biol Interact. 2010 Oct 06;188(1):127–33. doi: 10.1016/j.cbi.2010.06.004. PMID: 20558151."
1091232,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Decitabine inhibits the reaction [silicon dioxide results in decreased expression of PARP1 mrna],,,PMID:20123007,https://www.ncbi.nlm.nih.gov/pubmed/20123007,20123007,,,17394426,"Gao A, Song S, Zuo X, Guo W, Niu P, Tian L. Epigenetic mediated transcriptional activation of PARP-1 participates in silica-associated malignant transformation of human bronchial epithelial cells. Toxicol Lett. 2010 Apr 01;193(3):236–41. doi: 10.1016/j.toxlet.2010.01.017. PMID: 20123007."
1091233,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),DNMT1 protein promotes the reaction [silicon dioxide results in increased methylation of PARP1 promoter]|silicon dioxide results in decreased expression of PARP1 protein|silicon dioxide results in increased methylation of PARP1 promoter,,,PMID:22265868,https://www.ncbi.nlm.nih.gov/pubmed/22265868,22265868,,,422090,"Gong C, Tao G, Yang L, Liu J, Liu Q, Li W, Zhuang Z. Methylation of PARP-1 promoter involved in the regulation of nano-SiO2-induced decrease of PARP-1 mRNA expression. Toxicol Lett. 2012 Mar 25;209(3):264–9. doi: 10.1016/j.toxlet.2012.01.007. PMID: 22265868."
1091234,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein inhibits the reaction [silicon dioxide results in increased expression of H2AX protein modified form]|parp1 protein results in decreased susceptibility to silicon dioxide,,,PMID:28757444,https://www.ncbi.nlm.nih.gov/pubmed/28757444,28757444,,,22280449,"Gong C, Yang L, Zhou J, Guo X, Zhuang Z. Possible role of PAPR-1 in protecting human HaCaT cells against cytotoxicity of SiO2 nanoparticles. Toxicol Lett. 2017 Oct 05;280():213–21. doi: 10.1016/j.toxlet.2017.07.213. PMID: 28757444."
1091235,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Silicon dioxide results in decreased expression of PARP1 mRNA,,,PMID:20123007|PMID:22265868,https://www.ncbi.nlm.nih.gov/pubmed/20123007|https://www.ncbi.nlm.nih.gov/pubmed/22265868,20123007|22265868,,,422090|17394426,"Gong C, Tao G, Yang L, Liu J, Liu Q, Li W, Zhuang Z. Methylation of PARP-1 promoter involved in the regulation of nano-SiO2-induced decrease of PARP-1 mRNA expression. Toxicol Lett. 2012 Mar 25;209(3):264–9. doi: 10.1016/j.toxlet.2012.01.007. PMID: 22265868.|Gao A, Song S, Zuo X, Guo W, Niu P, Tian L. Epigenetic mediated transcriptional activation of PARP-1 participates in silica-associated malignant transformation of human bronchial epithelial cells. Toxicol Lett. 2010 Apr 01;193(3):236–41. doi: 10.1016/j.toxlet.2010.01.017. PMID: 20123007."
1091236,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Silicon dioxide results in increased cleavage of PARP1 protein,,,PMID:19783790,https://www.ncbi.nlm.nih.gov/pubmed/19783790,19783790,,,28869793,"Msiska Z, Pacurari M, Mishra A, Leonard SS, Castranova V, Vallyathan V. DNA double-strand breaks by asbestos, silica, and titanium dioxide: possible biomarker of carcinogenic potential? Am J Respir Cell Mol Biol. 2010 Aug;43(2):210–9. doi: 10.1165/rcmb.2009-0062oc. PMID: 19783790."
1091237,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Silicon dioxide results in increased expression of PARP1 protein modified form|sirt1 protein inhibits the reaction [silicon dioxide results in increased expression of PARP1 protein modified form],,,PMID:31082419,https://www.ncbi.nlm.nih.gov/pubmed/31082419,31082419,,,31099072,"Zhao X, Wu Y, Li J, Li D, Jin Y, Zhu P, Liu Y, Zhuang Y, Yu S, Cao W, Wei H, Wang X, Han Y, Chen G. JNK activation-mediated nuclear SIRT1 protein suppression contributes to silica nanoparticle-induced pulmonary damage via p53 acetylation and cytoplasmic localisation. Toxicology. 2019 Jul 01;423():42–53. doi: 10.1016/j.tox.2019.05.003. PMID: 31082419."
1260001,24288,Toxin and Toxin Target Database (T3DB),Cobalt chloride (CoCl2),T3D0659,Cobaltous chloride,http://www.t3db.ca/toxins/T3D0659,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1041368,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [camptothecin results in increased cleavage of PARP1 protein]|6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [camptothecin results in increased cleavage of PARP1 protein]",,,PMID:24726431,https://www.ncbi.nlm.nih.gov/pubmed/24726431,24726431,,,1811061,"Herbert KJ, Cook AL, Snow ET. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes. Toxicol Appl Pharmacol. 2014 Jun 15;277(3):288–97. doi: 10.1016/j.taap.2014.04.001. PMID: 24726431."
1041369,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [camptothecin results in increased cleavage of PARP1 protein],,,PMID:25412314,https://www.ncbi.nlm.nih.gov/pubmed/25412314,25412314,,PMC4260755,15447467,"Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells. Cell Death & Disease. 2014 Nov 20;5(11):e1536. doi: 10.1038/cddis.2014.500."
1041370,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Camptothecin results in increased ADP-ribosylation of and results in increased degradation of PARP1 protein|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [camptothecin results in increased ADP-ribosylation of and results in increased degradation of PARP1 protein]",,,PMID:23376119,https://www.ncbi.nlm.nih.gov/pubmed/23376119,23376119,,,17434127,"Montariello D, Troiano A, Malanga M, Calabrò V, Quesada P. p63 involvement in poly(ADP-ribose) polymerase 1 signaling of topoisomerase I-dependent DNA damage in carcinoma cells. Biochem Pharmacol. 2013 Apr 01;85(7):999–1006. doi: 10.1016/j.bcp.2013.01.019. PMID: 23376119."
1041371,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Camptothecin results in increased cleavage of PARP1 protein,,,PMID:11741290|PMID:15585644|PMID:16962673|PMID:19559722|PMID:24095863|PMID:24726431|PMID:24792648|PMID:24823293|PMID:25412314|PMID:31255635,https://www.ncbi.nlm.nih.gov/pubmed/11741290|https://www.ncbi.nlm.nih.gov/pubmed/15585644|https://www.ncbi.nlm.nih.gov/pubmed/16962673|https://www.ncbi.nlm.nih.gov/pubmed/19559722|https://www.ncbi.nlm.nih.gov/pubmed/24095863|https://www.ncbi.nlm.nih.gov/pubmed/24726431|https://www.ncbi.nlm.nih.gov/pubmed/24792648|https://www.ncbi.nlm.nih.gov/pubmed/24823293|https://www.ncbi.nlm.nih.gov/pubmed/25412314|https://www.ncbi.nlm.nih.gov/pubmed/31255635,11741290|15585644|16962673|19559722|24095863|24726431|24792648|24823293|25412314|31255635,,PMC4260755,1811061|2487008|4538906|5070931|9507550|12616014|13194479|14098040|15447467|18067896,"Xu W, Wang X, Tu Y, Masaki H, Tanaka S, Onda K, Sugiyama K, Yamada H, Hirano T. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells. Chem Biol Interact. 2019 Sep 01;310():108726. doi: 10.1016/j.cbi.2019.108726. PMID: 31255635.|Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells. Cell Death & Disease. 2014 Nov 20;5(11):e1536. doi: 10.1038/cddis.2014.500.|Liou JS, Wu YC, Yen WY, Tang YS, Kakadiya RB, Su TL, Yih LH. Inhibition of autophagy enhances DNA damage-induced apoptosis by disrupting CHK1-dependent S phase arrest. Toxicol Appl Pharmacol. 2014 Aug 01;278(3):249–58. doi: 10.1016/j.taap.2014.04.028. PMID: 24823293.|Martins C, Doran C, Silva IC, Miranda C, Rueff J, Rodrigues AS. Myristicin from nutmeg induces apoptosis via the mitochondrial pathway and down regulates genes of the DNA damage response pathways in human leukaemia K562 cells. Chem Biol Interact. 2014 Jul 25;218():1–9. doi: 10.1016/j.cbi.2014.04.014. PMID: 24792648.|Herbert KJ, Cook AL, Snow ET. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes. Toxicol Appl Pharmacol. 2014 Jun 15;277(3):288–97. doi: 10.1016/j.taap.2014.04.001. PMID: 24726431.|Dinicola S, Morini V, Coluccia P, Proietti S, D'Anselmi F, Pasqualato A, Masiello MG, Palombo A, De Toma G, Bizzarri M, Cucina A. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs. Toxicol In Vitro. 2013 Dec;27(8):2256–63. doi: 10.1016/j.tiv.2013.09.020. PMID: 24095863.|Rusin M, Zajkowicz A, Butkiewicz D. Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1. Mechanisms of Ageing and Development. 2009 Aug;130(8):528–37. doi: 10.1016/j.mad.2009.06.005.|Rath GM, Schneider C, Dedieu S, Rothhut B, Soula-Rothhut M, Ghoneim C, Sid B, Morjani H, El Btaouri H, Martiny L. The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2006 Oct;1763(10):1125–34. doi: 10.1016/j.bbamcr.2006.08.001.|Tonini T, Gabellini C, Bagella L, D'Andrilli G, Masciullo V, Romano G, Scambia G, Zupi G, Giordano A. pRb2/p130 decreases sensitivity to apoptosis induced by camptothecin and doxorubicin but not by taxol. Clin Cancer Res. 2004 Dec 01;10(23):8085–93. doi: 10.1158/1078-0432.ccr-04-0996. PMID: 15585644.|Houser S, Koshlatyi S, Lu T, Gopen T, Bargonetti J. Camptothecin and Zeocin Can Increase p53 Levels during All Cell Cycle Stages. Biochemical and Biophysical Research Communications. 2001 Dec;289(5):998–1009. doi: 10.1006/bbrc.2001.6073."
1041372,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nicotine inhibits the reaction [camptothecin results in increased cleavage of PARP1 protein],,,PMID:24095863,https://www.ncbi.nlm.nih.gov/pubmed/24095863,24095863,,,2487008,"Dinicola S, Morini V, Coluccia P, Proietti S, D'Anselmi F, Pasqualato A, Masiello MG, Palombo A, De Toma G, Bizzarri M, Cucina A. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs. Toxicol In Vitro. 2013 Dec;27(8):2256–63. doi: 10.1016/j.tiv.2013.09.020. PMID: 24095863."
1041373,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to camptothecin,,,PMID:27694308|PMID:35778544,https://www.ncbi.nlm.nih.gov/pubmed/27694308|https://www.ncbi.nlm.nih.gov/pubmed/35778544,27694308|35778544,,PMC10042965|PMC5137445,29679245|34003347,"2022; 39(1):345-364|Rank L, Veith S, Gwosch EC, Demgenski J, Ganz M, Jongmans MC, Vogel C, Fischbach A, Buerger S, Fischer JM, Zubel T, Stier A, Renner C, Schmalz M, Beneke S, Groettrup M, Kuiper RP, Bürkle A, Ferrando-May E, Mangerich A. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells. Nucleic Acids Res. 2016 Dec 01;44(21):10386–405. PMID: 27694308; PMCID: PMC5137445."
1041374,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein promotes the reaction [camptothecin results in increased abundance of poly adenosine diphosphate ribose]|parp1 results in decreased susceptibility to camptothecin,,,PMID:27694308,https://www.ncbi.nlm.nih.gov/pubmed/27694308,27694308,,PMC5137445,29679245,"Rank L, Veith S, Gwosch EC, Demgenski J, Ganz M, Jongmans MC, Vogel C, Fischbach A, Buerger S, Fischer JM, Zubel T, Stier A, Renner C, Schmalz M, Beneke S, Groettrup M, Kuiper RP, Bürkle A, Ferrando-May E, Mangerich A. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells. Nucleic Acids Res. 2016 Dec 01;44(21):10386–405. PMID: 27694308; PMCID: PMC5137445."
1041375,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),RBL2 protein inhibits the reaction [camptothecin results in increased cleavage of PARP1 protein],,,PMID:15585644,https://www.ncbi.nlm.nih.gov/pubmed/15585644,15585644,,,5070931,"Tonini T, Gabellini C, Bagella L, D'Andrilli G, Masciullo V, Romano G, Scambia G, Zupi G, Giordano A. pRb2/p130 decreases sensitivity to apoptosis induced by camptothecin and doxorubicin but not by taxol. Clin Cancer Res. 2004 Dec 01;10(23):8085–93. doi: 10.1158/1078-0432.ccr-04-0996. PMID: 15585644."
1041509,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),THBS1 protein inhibits the reaction [camptothecin results in increased cleavage of PARP1 protein],,,PMID:16962673,https://www.ncbi.nlm.nih.gov/pubmed/16962673,16962673,,,12616014,"Rath GM, Schneider C, Dedieu S, Rothhut B, Soula-Rothhut M, Ghoneim C, Sid B, Morjani H, El Btaouri H, Martiny L. The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2006 Oct;1763(10):1125–34. doi: 10.1016/j.bbamcr.2006.08.001."
1041510,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),XRCC1 protein affects the reaction [PARP1 protein affects the susceptibility to camptothecin],,,PMID:35778544,https://www.ncbi.nlm.nih.gov/pubmed/35778544,35778544,,PMC10042965,34003347,2022; 39(1):345-364
1041511,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[camptothecin co-treated with azoxymethane co-treated with dextran sulfate] results in increased cleavage of PARP1 protein,,,PMID:25449198,https://www.ncbi.nlm.nih.gov/pubmed/25449198,25449198,,,20878823,"Chung KS, Choi HE, Shin JS, Cho EJ, Cho YW, Choi JH, Baek NI, Lee KT. Chemopreventive effects of standardized ethanol extract from the aerial parts of Artemisia princeps Pampanini cv. Sajabal via NF-?B inactivation on colitis-associated colon tumorigenesis in mice. Food Chem Toxicol. 2015 Jan;75():14–23. doi: 10.1016/j.fct.2014.11.007. PMID: 25449198."
1041512,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Camptothecin results in increased cleavage of PARP1 protein,,,PMID:18506790|PMID:29384525,https://www.ncbi.nlm.nih.gov/pubmed/18506790|https://www.ncbi.nlm.nih.gov/pubmed/29384525,18506790|29384525,,PMC5808033,9910300|10814418,"Hassan Z, Schneeweis C, Wirth M, Veltkamp C, Dantes Z, Feuerecker B, Ceyhan GO, Knauer SK, Weichert W, Schmid RM, Stauber R, Arlt A, Krämer OH, Rad R, Reichert M, Saur D, Schneider G. MTOR inhibitor-based combination therapies for pancreatic cancer. British Journal of Cancer. 2018 Jan 02;118(3):366–77. doi: 10.1038/bjc.2017.421.|Liu Y, Templeton DM. Initiation of caspase-independent death in mouse mesangial cells by Cd<sup>2+</sup>: Involvement of p38 kinase and CaMK-II. Journal Cellular Physiology. 2008 May 27;217(2):307–18. doi: 10.1002/jcp.21499."
1041513,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[veliparib results in decreased activity of PARP1 protein] which results in increased susceptibility to camptothecin,,,PMID:22158865,https://www.ncbi.nlm.nih.gov/pubmed/22158865,22158865,,PMC3281688,15401584,"Patel AG, Flatten KS, Schneider PA, Dai NT, McDonald JS, Poirier GG, Kaufmann SH. Enhanced Killing of Cancer Cells by Poly(ADP-ribose) Polymerase Inhibitors and Topoisomerase I Inhibitors Reflects Poisoning of Both Enzymes. Journal of Biological Chemistry. 2012 Feb;287(6):4198–210. doi: 10.1074/jbc.m111.296475."
1041514,24360,Comparative Toxicogenomics Database (CTD),Camptothecin,D002166,Camptothecin,https://ctdbase.org/detail.go?type=chem&acc=D002166,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Camptothecin results in increased cleavage of PARP1 protein|tetrachlorodibenzodioxin promotes the reaction [camptothecin results in increased cleavage of PARP1 protein],,,PMID:25843524,https://www.ncbi.nlm.nih.gov/pubmed/25843524,25843524,,,14812201,"Svobodová J, Kabátková M, Šmerdová L, Brenerová P, Dvorák Z, Machala M, Vondrácek J. The aryl hydrocarbon receptor-dependent disruption of contact inhibition in rat liver WB-F344 epithelial cells is linked with induction of survivin, but not with inhibition of apoptosis. Toxicology. 2015 Jul 03;333():37–44. doi: 10.1016/j.tox.2015.04.001. PMID: 25843524."
1329131,24385,Comparative Toxicogenomics Database (CTD),Nickel Chloride,C022838,nickel chloride,https://ctdbase.org/detail.go?type=chem&acc=C022838,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nickel chloride promotes the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased cleavage of PARP1 protein]]|acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]]|cobaltous chloride promotes the reaction [nickel chloride results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein],,,PMID:22172632,https://www.ncbi.nlm.nih.gov/pubmed/22172632,22172632,,,20810526,"Patel E, Lynch C, Ruff V, Reynolds M. Co-exposure to nickel and cobalt chloride enhances cytotoxicity and oxidative stress in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Feb 01;258(3):367–75. doi: 10.1016/j.taap.2011.11.019. PMID: 22172632."
1329316,24385,Comparative Toxicogenomics Database (CTD),Nickel Chloride,C022838,nickel chloride,https://ctdbase.org/detail.go?type=chem&acc=C022838,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein],,,PMID:38104653,https://www.ncbi.nlm.nih.gov/pubmed/38104653,38104653,,,36378967,"Maeyama R, Segawa R, Onodera R, Hiratsuka M, Hirasawa N. Caspases downregulate nickel and hydrogen peroxide-induced IL-8 production via modification of c-Jun N-terminal kinases. Toxicology. 2024 Jan;501():153710. doi: 10.1016/j.tox.2023.153710. PMID: 38104653."
1329317,24385,Comparative Toxicogenomics Database (CTD),Nickel Chloride,C022838,nickel chloride,https://ctdbase.org/detail.go?type=chem&acc=C022838,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nickel chloride results in increased cleavage of PARP1 protein,,,PMID:21828359|PMID:22172632|PMID:28552779|PMID:38104653,https://www.ncbi.nlm.nih.gov/pubmed/21828359|https://www.ncbi.nlm.nih.gov/pubmed/22172632|https://www.ncbi.nlm.nih.gov/pubmed/28552779|https://www.ncbi.nlm.nih.gov/pubmed/38104653,21828359|22172632|28552779|38104653,,PMC3196652|PMC5568485,12018502|19595257|20810526|36378967,"Maeyama R, Segawa R, Onodera R, Hiratsuka M, Hirasawa N. Caspases downregulate nickel and hydrogen peroxide-induced IL-8 production via modification of c-Jun N-terminal kinases. Toxicology. 2024 Jan;501():153710. doi: 10.1016/j.tox.2023.153710. PMID: 38104653.|Luczak MW, Zhitkovich A. Nickel-induced HIF-1a promotes growth arrest and senescence in normal human cells but lacks toxic effects in transformed cells. Toxicology and Applied Pharmacology. 2017 Sep;331():94–100. doi: 10.1016/j.taap.2017.05.029.|Patel E, Lynch C, Ruff V, Reynolds M. Co-exposure to nickel and cobalt chloride enhances cytotoxicity and oxidative stress in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Feb 01;258(3):367–75. doi: 10.1016/j.taap.2011.11.019. PMID: 22172632.|Pietruska JR, Liu X, Smith A, McNeil K, Weston P, Zhitkovich A, Hurt R, Kane AB. Bioavailability, intracellular mobilization of nickel, and HIF-1a activation in human lung epithelial cells exposed to metallic nickel and nickel oxide nanoparticles. Toxicol Sci. 2011 Nov;124(1):138–48. PMID: 21828359; PMCID: PMC3196652."
1329318,24385,Comparative Toxicogenomics Database (CTD),Nickel Chloride,C022838,nickel chloride,https://ctdbase.org/detail.go?type=chem&acc=C022838,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TP53 mutant form results in decreased susceptibility to nickel chloride] which results in decreased cleavage of PARP1 protein,,,PMID:23566959,https://www.ncbi.nlm.nih.gov/pubmed/23566959,23566959,,PMC3666101,23532928,"Wong VC, Morse JL, Zhitkovich A. p53 activation by Ni(II) is a HIF-1a independent response causing caspases 9/3-mediated apoptosis in human lung cells. Toxicology and Applied Pharmacology. 2013 Jun;269(3):233–9. doi: 10.1016/j.taap.2013.03.023."
1329319,24385,Comparative Toxicogenomics Database (CTD),Nickel Chloride,C022838,nickel chloride,https://ctdbase.org/detail.go?type=chem&acc=C022838,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Alpha-tocopherol inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein]|fumonisin B1 inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein],,,PMID:24448832,https://www.ncbi.nlm.nih.gov/pubmed/24448832,24448832,,,18154228,2014; 88(4):881-892
1329320,24385,Comparative Toxicogenomics Database (CTD),Nickel Chloride,C022838,nickel chloride,https://ctdbase.org/detail.go?type=chem&acc=C022838,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Nickel chloride results in increased cleavage of PARP1 protein,,,PMID:21843586|PMID:24448832,https://www.ncbi.nlm.nih.gov/pubmed/21843586|https://www.ncbi.nlm.nih.gov/pubmed/24448832,21843586|24448832,,,6585663|18154228,"2014; 88(4):881-892|Wu HC, Yang CY, Hung DZ, Su CC, Chen KL, Yen CC, Ho TJ, Su YC, Huang CF, Chen CH, Tsai LM, Chen YW. Nickel(II) induced JNK activation-regulated mitochondria-dependent apoptotic pathway leading to cultured rat pancreatic ß-cell death. Toxicology. 2011 Nov 18;289(2-3):103–11. doi: 10.1016/j.tox.2011.07.013. PMID: 21843586."
1329321,24385,Comparative Toxicogenomics Database (CTD),Nickel Chloride,C022838,nickel chloride,https://ctdbase.org/detail.go?type=chem&acc=C022838,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pyrazolanthrone inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein],,,PMID:21843586,https://www.ncbi.nlm.nih.gov/pubmed/21843586,21843586,,,6585663,"Wu HC, Yang CY, Hung DZ, Su CC, Chen KL, Yen CC, Ho TJ, Su YC, Huang CF, Chen CH, Tsai LM, Chen YW. Nickel(II) induced JNK activation-regulated mitochondria-dependent apoptotic pathway leading to cultured rat pancreatic ß-cell death. Toxicology. 2011 Nov 18;289(2-3):103–11. doi: 10.1016/j.tox.2011.07.013. PMID: 21843586."
63902,24424,Comparative Toxicogenomics Database (CTD),Zinc Sulfate,D019287,Zinc Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D019287,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Metipranolol inhibits the reaction [zinc sulfate results in decreased expression of PARP1 protein]|zinc sulfate results in decreased expression of PARP1 protein|zinc sulfate results in increased cleavage of PARP1 protein|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [zinc sulfate results in decreased expression of PARP1 protein]",,,PMID:16799065,https://www.ncbi.nlm.nih.gov/pubmed/16799065,16799065,,,8564116,"Osborne NN, Wood JP. The beta-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3178–86. doi: 10.1167/iovs.05-1370. PMID: 16799065."
1345867,24462,Comparative Toxicogenomics Database (CTD),Cupric Sulfate,D019327,Copper Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D019327,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Copper sulfate results in decreased expression of PARP1 mRNA,,,PMID:19549813,https://www.ncbi.nlm.nih.gov/pubmed/19549813,19549813,,PMC3774564,18058544,"Song MO, Li J, Freedman JH. Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiological Genomics. 2009 Aug;38(3):386–401. doi: 10.1152/physiolgenomics.00083.2009."
1462822,24501,Toxin and Toxin Target Database (T3DB),Calcium arsenate,T3D0241,Calcium arsenate,http://www.t3db.ca/toxins/T3D0241,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1309293,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nickel sulfate inhibits the reaction [potassium dichromate results in increased cleavage of and results in increased activity of PARP1 protein]|potassium dichromate results in increased cleavage of and results in increased activity of PARP1 protein|parp1 protein results in increased susceptibility to [potassium dichromate co-treated with nickel sulfate]|potassium dichromate inhibits the reaction [nickel sulfate results in increased cleavage of and results in increased activity of PARP1 protein]|3-aminobenzamide inhibits the reaction [PARP1 protein results in increased susceptibility to [potassium dichromate co-treated with nickel sulfate]],,,PMID:20493934,https://www.ncbi.nlm.nih.gov/pubmed/20493934,20493934,,,3799141,"Rudolf E, Cervinka M. Nickel modifies the cytotoxicity of hexavalent chromium in human dermal fibroblasts. Toxicol Lett. 2010 Aug 16;197(2):143–50. doi: 10.1016/j.toxlet.2010.05.011. PMID: 20493934."
1309294,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Potassium dichromate results in increased cleavage of PARP1 protein|ascorbic acid inhibits the reaction [potassium dichromate results in increased cleavage of PARP1 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,PMC3131794,28483642,"Banu SK, Stanley JA, Lee J, Stephen SD, Arosh JA, Hoyer PB, Burghardt RC. Hexavalent chromium-induced apoptosis of granulosa cells involves selective sub-cellular translocation of Bcl-2 members, ERK1/2 and p53. Toxicology and Applied Pharmacology. 2011 Mar;251(3):253–66. doi: 10.1016/j.taap.2011.01.011."
1474874,24570,Toxin and Toxin Target Database (T3DB),Arsenic trichloride,T3D0279,Arsenic trichloride,http://www.t3db.ca/toxins/T3D0279,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1475226,24571,Toxin and Toxin Target Database (T3DB),Arsenic trifluoride,T3D1299,Arsenic trifluoride,http://www.t3db.ca/toxins/T3D1299,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1224190,24572,Toxin and Toxin Target Database (T3DB),Lead Arsenate,T3D0296,Lead arsenate,http://www.t3db.ca/toxins/T3D0296,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1476122,24574,Toxin and Toxin Target Database (T3DB),Ammonium arsenate,T3D0285,Ammonium arsenate,http://www.t3db.ca/toxins/T3D0285,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1477123,24575,Toxin and Toxin Target Database (T3DB),Arsenic triiodide,T3D1300,Arsenic triiodide,http://www.t3db.ca/toxins/T3D1300,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1086735,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Potassium chromate(vi) results in increased cleavage of and results in increased activity of PARP1 protein|epigallocatechin gallate inhibits the reaction [potassium chromate(vi) results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,PMC3259276,3147257,"Wu F, Sun H, Kluz T, Clancy HA, Kiok K, Costa M. Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicology and Applied Pharmacology. 2012 Jan;258(2):166–75. doi: 10.1016/j.taap.2011.10.018."
1086736,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Potassium chromate(vi) results in increased cleavage of PARP1 protein,,,PMID:25977998,https://www.ncbi.nlm.nih.gov/pubmed/25977998,25977998,,PMC4710604,20206467,"Luczak MW, Green SE, Zhitkovich A. Different ATM Signaling in Response to Chromium(VI) Metabolism via Ascorbate and Nonascorbate Reduction: Implications for in Vitro Models and Toxicogenomics. Environ Health Perspect. 2016 Jan;124(1):61–6. PMID: 25977998; PMCID: PMC4710604."
1282574,24610,Toxin and Toxin Target Database (T3DB),Cobaltous bromide,T3D0658,Cobalt(II) bromide,http://www.t3db.ca/toxins/T3D0658,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
66600,24667,Comparative Toxicogenomics Database (CTD),Butylated Hydroxyanisole,D002083,Butylated Hydroxyanisole,https://ctdbase.org/detail.go?type=chem&acc=D002083,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Butylated hydroxyanisole inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,PMC1458365,10558450,"Kim HJ, Chakravarti N, Oridate N, Choe C, Claret FX, Lotan R. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene. 2006 May 04;25(19):2785–94. PMID: 16407847; PMCID: PMC1458365."
953438,24678,Comparative Toxicogenomics Database (CTD),"2,4-D-isoctyl",C046635,"2,4-dichlorophenoxyacetic acid isooctyl ester",https://ctdbase.org/detail.go?type=chem&acc=C046635,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-dichlorophenoxyacetic acid] which results in increased expression of PARP1 mrna]|[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-dichlorophenoxyacetic acid] which results in increased expression of PARP1 mrna|[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-dichlorophenoxyacetic acid] promotes the reaction [ethanol results in increased expression of PARP1 mrna]",,,PMID:36085217,https://www.ncbi.nlm.nih.gov/pubmed/36085217,36085217,,,35015623,2022; 30(4):10710-10723
1245760,24775,Comparative Toxicogenomics Database (CTD),"Poly(oxy-1,2-ethanediyl), alpha-((1,1,3,3-tetramethylbutyl)phenyl)-omega-hydroxy-, potassium salt (1:1)",C010615,Nonidet P-40,https://ctdbase.org/detail.go?type=chem&acc=C010615,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nonidet P-40 results in decreased expression of PARP1 mRNA,,,PMID:26552463,https://www.ncbi.nlm.nih.gov/pubmed/26552463,26552463,,PMC4642017,21561919,"Park S, Hwang IW, Kim JS, Kang HC, Park SY, Gil HW, Song HY, Hong SY. The effects of nonyl phenoxypolyethoxyl ethanol on cell damage pathway gene expression in SK-NSH cells. Korean J Intern Med. 2015 Nov;30(6):873–83. PMID: 26552463; PMCID: PMC4642017."
1284196,24820,Toxin and Toxin Target Database (T3DB),Cobaltous fluoride,T3D0660,Cobalt(II) fluoride,http://www.t3db.ca/toxins/T3D0660,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1503157,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of PARP1 mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of PARP1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of PARP1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,PMC7376215,33827165,2020; 3(1):392
1356838,24937,Comparative Toxicogenomics Database (CTD),Thallous nitrate,C042172,thallium nitrate,https://ctdbase.org/detail.go?type=chem&acc=C042172,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),EGF protein inhibits the reaction [thallium nitrate analog results in increased cleavage of PARP1 protein]|egf protein inhibits the reaction [thallium nitrate results in increased cleavage of PARP1 protein],,,PMID:27412756,https://www.ncbi.nlm.nih.gov/pubmed/27412756,27412756,,,18869664,2016; 91(3):1157-1174
1356839,24937,Comparative Toxicogenomics Database (CTD),Thallous nitrate,C042172,thallium nitrate,https://ctdbase.org/detail.go?type=chem&acc=C042172,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Thallium nitrate results in increased cleavage of PARP1 protein|thallium nitrate analog results in increased cleavage of PARP1 protein,,,PMID:19371624|PMID:27412756,https://www.ncbi.nlm.nih.gov/pubmed/19371624|https://www.ncbi.nlm.nih.gov/pubmed/27412756,19371624|27412756,,,18869664|30235604,"2016; 91(3):1157-1174|Hanzel CE, Verstraeten SV. Tl(I) and Tl(III) activate both mitochondrial and extrinsic pathways of apoptosis in rat pheochromocytoma (PC12) cells. Toxicol Appl Pharmacol. 2009 Apr 01;236(1):59–70. doi: 10.1016/j.taap.2008.12.029. PMID: 19371624."
1115783,24938,Toxin and Toxin Target Database (T3DB),Ferrous arsenate,T3D1318,Ferrous arsenate,http://www.t3db.ca/toxins/T3D1318,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1265168,24943,Toxin and Toxin Target Database (T3DB),Magnesium arsenate,T3D0293,Magnesium arsenate,http://www.t3db.ca/toxins/T3D0293,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1376267,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10029,Cricetulus griseus (Chinese hamster),Cadmium chloride results in increased cleavage of PARP1 protein,,,PMID:28464991,https://www.ncbi.nlm.nih.gov/pubmed/28464991,28464991,,,23618905,"Gobrecht J, McDyre C, Comotto J, Reynolds M. Induction of cytotoxic and genotoxic damage following exposure of V79 cells to cadmium chloride. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2017 Apr;816-817():12–7. doi: 10.1016/j.mrgentox.2017.03.001."
1376268,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Trifluoperazine inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein]|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein]|egtazic acid inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein]",,,PMID:21544200,https://www.ncbi.nlm.nih.gov/pubmed/21544200,21544200,,PMC3081326,14054107,"Xu B, Chen S, Luo Y, Chen Z, Liu L, Zhou H, Chen W, Shen T, Han X, Chen L, Huang S. Calcium Signaling Is Involved in Cadmium-Induced Neuronal Apoptosis via Induction of Reactive Oxygen Species and Activation of MAPK/mTOR Network. PLoS ONE. 2011 Apr 22;6(4):e19052. doi: 10.1371/journal.pone.0019052."
1376269,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-bromopalmitate inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased palmitoylation of PARP1 protein]|[cadmium chloride results in increased abundance of cadmium] which results in increased palmitoylation of PARP1 protein,,,PMID:38195004,https://www.ncbi.nlm.nih.gov/pubmed/38195004,38195004,,PMC10923080,36719880,"Lee C, Jarrell ZR, Lee HY, Singer G, Tran VT, Orr M, Jones DP, Go Y. Protein S-palmitoylation enhances profibrotic signaling in response to cadmium. Toxicology and Applied Pharmacology. 2024 Feb;483():116806. doi: 10.1016/j.taap.2024.116806."
1376270,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [cadmium chloride results in increased cleavage of and results in increased activity of PARP1 protein]|cadmium chloride results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:18703135,https://www.ncbi.nlm.nih.gov/pubmed/18703135,18703135,,,23465687,"Chen L, Liu L, Huang S. Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5. Free Radic Biol Med. 2008 Oct 01;45(7):1035–44. doi: 10.1016/j.freeradbiomed.2008.07.011. PMID: 18703135."
1376271,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BIX 02189 promotes the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:22521884,https://www.ncbi.nlm.nih.gov/pubmed/22521884,22521884,,,18764322,"Kondo M, Inamura H, Matsumura K, Matsuoka M. Cadmium activates extracellular signal-regulated kinase 5 in HK-2 human renal proximal tubular cells. Biochemical and Biophysical Research Communications. 2012 May;421(3):490–3. doi: 10.1016/j.bbrc.2012.04.028."
1376479,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cadmium chloride results in increased cleavage of PARP1 protein,,,PMID:21544200|PMID:21809093|PMID:22521884,https://www.ncbi.nlm.nih.gov/pubmed/21544200|https://www.ncbi.nlm.nih.gov/pubmed/21809093|https://www.ncbi.nlm.nih.gov/pubmed/22521884,21544200|21809093|22521884,,PMC3081326,12717056|14054107|18764322,"Kondo M, Inamura H, Matsumura K, Matsuoka M. Cadmium activates extracellular signal-regulated kinase 5 in HK-2 human renal proximal tubular cells. Biochemical and Biophysical Research Communications. 2012 May;421(3):490–3. doi: 10.1016/j.bbrc.2012.04.028.|2011; 86(1):37-44|Xu B, Chen S, Luo Y, Chen Z, Liu L, Zhou H, Chen W, Shen T, Han X, Chen L, Huang S. Calcium Signaling Is Involved in Cadmium-Induced Neuronal Apoptosis via Induction of Reactive Oxygen Species and Activation of MAPK/mTOR Network. PLoS ONE. 2011 Apr 22;6(4):e19052. doi: 10.1371/journal.pone.0019052."
1376480,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NGFR protein affects the reaction [cadmium chloride results in increased cleavage of PARP1 protein]|cadmium chloride results in increased expression of and results in increased cleavage of PARP1 protein,,,PMID:21796402,https://www.ncbi.nlm.nih.gov/pubmed/21796402,21796402,,,12704916,2011; 25(1):63-74
1376481,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cadmium chloride results in increased expression of PARP1 protein modified form,,,PMID:24291162,https://www.ncbi.nlm.nih.gov/pubmed/24291162,24291162,,,11379394,"Sinha K, Pal PB, Sil PC. Cadmium (Cd(2+)) exposure differentially elicits both cell proliferation and cell death related responses in SK-RC-45. Toxicol In Vitro. 2014 Mar;28(2):307–18. doi: 10.1016/j.tiv.2013.11.011. PMID: 24291162."
1376482,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Salubrinal inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:21809093,https://www.ncbi.nlm.nih.gov/pubmed/21809093,21809093,,,12717056,2011; 86(1):37-44
1376483,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,6573,Mizuhopecten yessoensis (Yesso scallop),Cadmium chloride results in decreased expression of PARP1 mRNA,,,PMID:23741332,https://www.ncbi.nlm.nih.gov/pubmed/23741332,23741332,,PMC3669299,3181793,"Meng X, Liu M, Jiang K, Wang B, Tian X, Sun S, Luo Z, Qiu C, Wang L. De Novo Characterization of Japanese Scallop Mizuhopecten yessoensis Transcriptome and Analysis of Its Gene Expression following Cadmium Exposure. PLoS ONE. 2013 May 31;8(5):e64485. doi: 10.1371/journal.pone.0064485."
1376484,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein]",,,PMID:18850067,https://www.ncbi.nlm.nih.gov/pubmed/18850067,18850067,,PMC11131605,3091971,2008; 65(22):3640-3652
1376485,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein],,,PMID:30796935,https://www.ncbi.nlm.nih.gov/pubmed/30796935,30796935,,,20306548,"Wang S, Ren X, Hu X, Zhou L, Zhang C, Zhang M. Cadmium-induced apoptosis through reactive oxygen species-mediated mitochondrial oxidative stress and the JNK signaling pathway in TM3 cells, a model of mouse Leydig cells. Toxicol Appl Pharmacol. 2019 Apr 01;368():37–48. doi: 10.1016/j.taap.2019.02.012. PMID: 30796935."
1376486,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Arjunolic acid inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:21420465,https://www.ncbi.nlm.nih.gov/pubmed/21420465,21420465,,,28912899,"Pal S, Pal PB, Das J, Sil PC. Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro. Toxicology. 2011 May 10;283(2-3):129–39. doi: 10.1016/j.tox.2011.03.006. PMID: 21420465."
1376487,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Cadmium chloride affects the cleavage of PARP1 protein,,,PMID:18506790,https://www.ncbi.nlm.nih.gov/pubmed/18506790,18506790,,,9910300,"Liu Y, Templeton DM. Initiation of caspase-independent death in mouse mesangial cells by Cd<sup>2+</sup>: Involvement of p38 kinase and CaMK-II. Journal Cellular Physiology. 2008 May 27;217(2):307–18. doi: 10.1002/jcp.21499."
1376488,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein,,,PMID:30796935|PMID:37261864,https://www.ncbi.nlm.nih.gov/pubmed/30796935|https://www.ncbi.nlm.nih.gov/pubmed/37261864,30796935|37261864,,,20306548|35528068,"Lee SW, Kim B, Seong JB, Park YH, Lee HJ, Lee DS. ATF6 is a critical regulator of cadmium-mediated apoptosis in spermatocytes. Toxicol Sci. 2023 Jul 28;194(2):167–77. doi: 10.1093/toxsci/kfad055. PMID: 37261864.|Wang S, Ren X, Hu X, Zhou L, Zhang C, Zhang M. Cadmium-induced apoptosis through reactive oxygen species-mediated mitochondrial oxidative stress and the JNK signaling pathway in TM3 cells, a model of mouse Leydig cells. Toxicol Appl Pharmacol. 2019 Apr 01;368():37–48. doi: 10.1016/j.taap.2019.02.012. PMID: 30796935."
1376666,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Cadmium chloride results in increased cleavage of PARP1 protein,,,PMID:18850067|PMID:21420465,https://www.ncbi.nlm.nih.gov/pubmed/18850067|https://www.ncbi.nlm.nih.gov/pubmed/21420465,18850067|21420465,,PMC11131605,3091971|28912899,"Pal S, Pal PB, Das J, Sil PC. Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro. Toxicology. 2011 May 10;283(2-3):129–39. doi: 10.1016/j.tox.2011.03.006. PMID: 21420465.|2008; 65(22):3640-3652"
1376857,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),2-chloro-5-nitrobenzanilide inhibits the reaction [[lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 protein]|[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 mrna|[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein|pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with cadmium chloride co-treated with lead acetate] results in increased expression of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 mrna]|pparg protein affects the reaction [cadmium chloride results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [cadmium chloride results in increased expression of and results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with cadmium chloride] results in increased expression of PARP1 mrna]|pparg protein affects the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 mrna]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 protein]|3-aminobenzamide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased cleavage of PARP1 protein]|[sodium arsenite co-treated with cadmium chloride] results in increased expression of PARP1 mrna|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with cadmium chloride] results in increased expression of PARP1 protein]|[lead acetate co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein|cadmium chloride results in increased expression of and results in increased cleavage of PARP1 protein|cr8 compound analog inhibits the reaction [[sodium arsenite co-treated with cadmium chloride co-treated with lead acetate] results in increased expression of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [cadmium chloride results in increased expression of PARP1 mrna]|cadmium chloride inhibits the reaction [lead acetate results in increased cleavage of PARP1 protein]|[sodium arsenite co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein|cadmium chloride inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|[lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 mRNA,,,PMID:28283887,https://www.ncbi.nlm.nih.gov/pubmed/28283887,28283887,,,17522612,2017; 55(3):2125-2149
1377169,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pyrazolanthrone inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:23405080,https://www.ncbi.nlm.nih.gov/pubmed/23405080,23405080,,PMC3566170,10002509,"Chang KC, Hsu CC, Liu SH, Su CC, Yen CC, Lee MJ, Chen KL, Ho TJ, Hung DZ, Wu CC, Lu TH, Su YC, Chen YW, Huang CF. Cadmium induces apoptosis in pancreatic ß-cells through a mitochondria-dependent pathway: the role of oxidative stress-mediated c-Jun N-terminal kinase activation. PLoS One. 2013;8(2):e54374. PMID: 23405080; PMCID: PMC3566170."
1377170,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),AKT activator SC79 inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]]|gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]|anisomycin inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]]|[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein,,,PMID:34767868,https://www.ncbi.nlm.nih.gov/pubmed/34767868,34767868,,,7531521,"Bi A, Guo Z, Yang G, Huang Y, Yin Z, Luo L. ?-glutamylcysteine suppresses cadmium-induced apoptosis in PC12 cells via regulating oxidative stress. Toxicology. 2022 Jan 15;465():153029. doi: 10.1016/j.tox.2021.153029. PMID: 34767868."
1377171,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cadmium chloride results in increased cleavage of PARP1 protein,,,PMID:21544200|PMID:23405080|PMID:28283887,https://www.ncbi.nlm.nih.gov/pubmed/21544200|https://www.ncbi.nlm.nih.gov/pubmed/23405080|https://www.ncbi.nlm.nih.gov/pubmed/28283887,21544200|23405080|28283887,,PMC3081326|PMC3566170,10002509|14054107|17522612,"2017; 55(3):2125-2149|Chang KC, Hsu CC, Liu SH, Su CC, Yen CC, Lee MJ, Chen KL, Ho TJ, Hung DZ, Wu CC, Lu TH, Su YC, Chen YW, Huang CF. Cadmium induces apoptosis in pancreatic ß-cells through a mitochondria-dependent pathway: the role of oxidative stress-mediated c-Jun N-terminal kinase activation. PLoS One. 2013;8(2):e54374. PMID: 23405080; PMCID: PMC3566170.|Xu B, Chen S, Luo Y, Chen Z, Liu L, Zhou H, Chen W, Shen T, Han X, Chen L, Huang S. Calcium Signaling Is Involved in Cadmium-Induced Neuronal Apoptosis via Induction of Reactive Oxygen Species and Activation of MAPK/mTOR Network. PLoS ONE. 2011 Apr 22;6(4):e19052. doi: 10.1371/journal.pone.0019052."
1377172,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cadmium chloride results in increased expression of PARP1 mRNA,,,PMID:28283887|PMID:33453195,https://www.ncbi.nlm.nih.gov/pubmed/28283887|https://www.ncbi.nlm.nih.gov/pubmed/33453195,28283887|33453195,,,8190238|17522612,"Saedi S, Jafarzadeh Shirazi MR, Niazi A, Tahmasebi A, Ebrahimie E. Prepubertal exposure to high dose of cadmium induces hypothalamic injury through transcriptome profiling alteration and neuronal degeneration in female rats. Chem Biol Interact. 2021 Mar 01;337():109379. doi: 10.1016/j.cbi.2021.109379. PMID: 33453195.|2017; 55(3):2125-2149"
1377173,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cadmium chloride results in increased expression of PARP1 protein modified form,,,PMID:31348969,https://www.ncbi.nlm.nih.gov/pubmed/31348969,31348969,,,21660167,"Huang CC, Kuo CY, Yang CY, Liu JM, Hsu RJ, Lee KI, Su CC, Wu CC, Lin CT, Liu SH, Huang CF. Cadmium exposure induces pancreatic ß-cell death via a Ca2+-triggered JNK/CHOP-related apoptotic signaling pathway. Toxicology. 2019 Sep 01;425():152252. doi: 10.1016/j.tox.2019.152252. PMID: 31348969."
1377174,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),Cadmium chloride results in increased cleavage of PARP1 protein|oxalomalic acid promotes the reaction [cadmium chloride results in increased cleavage of PARP1 protein]|glrx protein inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:16785314,https://www.ncbi.nlm.nih.gov/pubmed/16785314,16785314,,,9252676,"Kil IS, Shin SW, Yeo HS, Lee YS, Park JW. Mitochondrial NADP+-dependent isocitrate dehydrogenase protects cadmium-induced apoptosis. Mol Pharmacol. 2006 Sep;70(3):1053–61. doi: 10.1124/mol.106.023515. PMID: 16785314."
1555348,24962,Comparative Toxicogenomics Database (CTD),Cadmium Sulfate,C037123,cadmium sulfate,https://ctdbase.org/detail.go?type=chem&acc=C037123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein]|cadmium sulfate results in increased cleavage of PARP1 protein|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein]|diphenyleneiodonium inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein],,,PMID:14687664,https://www.ncbi.nlm.nih.gov/pubmed/14687664,14687664,,,20010454,"Rockwell P, Martinez J, Papa L, Gomes E. Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell Signal. 2004 Mar;16(3):343–53. doi: 10.1016/j.cellsig.2003.08.006. PMID: 14687664."
1321731,24965,Toxin and Toxin Target Database (T3DB),Cobalt Sulfate,T3D0669,Cobalt sulfate,http://www.t3db.ca/toxins/T3D0669,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1288309,24967,Toxin and Toxin Target Database (T3DB),Potassium;arsorite,T3D0290,Potassium arsenite,http://www.t3db.ca/toxins/T3D0290,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1322587,25000,Toxin and Toxin Target Database (T3DB),Cobaltous nitrate,T3D0665,Cobalt(II) nitrate,http://www.t3db.ca/toxins/T3D0665,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1323334,25049,Toxin and Toxin Target Database (T3DB),Cobalt carbonyl,T3D0675,Dicobalt octacarbonyl,http://www.t3db.ca/toxins/T3D0675,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1479512,25130,Toxin and Toxin Target Database (T3DB),Cupric arsenite,T3D0286,Copper(II) arsenite,http://www.t3db.ca/toxins/T3D0286,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1324148,25156,Toxin and Toxin Target Database (T3DB),Zinc arsenite,T3D1459,Zinc arsenite,http://www.t3db.ca/toxins/T3D1459,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1138368,25214,Toxin and Toxin Target Database (T3DB),Strontium arsenite tetrahydrate,T3D1317,Strontium arsenite tetrahydrate,http://www.t3db.ca/toxins/T3D1317,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1481680,25251,Comparative Toxicogenomics Database (CTD),Ferric nitrate,C025302,ferric nitrate,https://ctdbase.org/detail.go?type=chem&acc=C025302,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rifampin inhibits the reaction [[acetaminophen co-treated with [ferric nitrate results in increased abundance of iron]] results in increased cleavage of PARP1 protein]|[acetaminophen co-treated with [ferric nitrate results in increased abundance of iron]] results in increased cleavage of PARP1 protein,,,PMID:31678598,https://www.ncbi.nlm.nih.gov/pubmed/31678598,31678598,,,5377777,"Lee EH, Baek SY, Park JY, Kim YW. Rifampicin activates AMPK and alleviates oxidative stress in the liver as mediated with Nrf2 signaling. Chem Biol Interact. 2020 Jan 05;315():108889. doi: 10.1016/j.cbi.2019.108889. PMID: 31678598."
1003834,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium bichromate results in increased cleavage of PARP1 protein|fbp1 protein promotes the reaction [sodium bichromate results in increased cleavage of PARP1 protein],,,PMID:28624442,https://www.ncbi.nlm.nih.gov/pubmed/28624442,28624442,,PMC5567692,3258359,"Dai J, Ji Y, Wang W, Kim D, Fai LY, Wang L, Luo J, Zhang Z. Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis. Toxicology and Applied Pharmacology. 2017 Sep;331():164–73. doi: 10.1016/j.taap.2017.06.014."
1003835,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),TRP53 mutant form inhibits the reaction [sodium bichromate results in increased cleavage of PARP1 protein]|sodium bichromate results in increased cleavage of PARP1 protein|cat protein inhibits the reaction [sodium bichromate results in increased cleavage of PARP1 protein],,,PMID:20298709,https://www.ncbi.nlm.nih.gov/pubmed/20298709,20298709,,PMC5051966,23482591,"Son Y, Hitron JA, Wang X, Chang Q, Pan J, Zhang Z, Liu J, Wang S, Lee J, Shi X. Cr(VI) induces mitochondrial-mediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells. Toxicology and Applied Pharmacology. 2010 Jun;245(2):226–35. doi: 10.1016/j.taap.2010.03.004."
1003836,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sodium bichromate results in increased expression of PARP1 mRNA,,,PMID:22155349,https://www.ncbi.nlm.nih.gov/pubmed/22155349,22155349,,,15398364,"Kopec AK, Kim S, Forgacs AL, Zacharewski TR, Proctor DM, Harris MA, Haws LC, Thompson CM. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water. Toxicol Appl Pharmacol. 2012 Feb 15;259(1):13–26. doi: 10.1016/j.taap.2011.11.012. PMID: 22155349."
1003837,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Sodium bichromate affects the expression of PARP1 mRNA,,,PMID:11960910,https://www.ncbi.nlm.nih.gov/pubmed/11960910,11960910,,,9147071,"D'Agostini F, Izzotti A, Bennicelli C, Camoirano A, Tampa E, De Flora S. Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium(VI). Carcinogenesis. 2002 Apr;23(4):587–93. doi: 10.1093/carcin/23.4.587. PMID: 11960910."
1174728,25477,Comparative Toxicogenomics Database (CTD),Chrysotile Asbestos,D017632,"Asbestos, Serpentine",https://ctdbase.org/detail.go?type=chem&acc=D017632,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Asbestos, serpentine results in increased expression of PARP1 mrna|pyrazolanthrone inhibits the reaction [asbestos, serpentine results in increased expression of PARP1 protein]|asbestos, serpentine results in increased expression of PARP1 protein",,,PMID:25530474,https://www.ncbi.nlm.nih.gov/pubmed/25530474,25530474,,PMC4735687,479370,"Li P, Liu T, Kamp DW, Lin Z, Wang Y, Li D, Yang L, He H, Liu G. The c-Jun N-terminal kinase signaling pathway mediates chrysotile asbestos-induced alveolar epithelial cell apoptosis. Mol Med Rep. 2015 May;11(5):3626–34. PMID: 25530474; PMCID: PMC4735687."
1562273,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Ammonium chloride results in increased cleavage of PARP1 protein,,,PMID:31310755,https://www.ncbi.nlm.nih.gov/pubmed/31310755,31310755,,,32445610,"Stamenkovic M, Janjetovic K, Paunovic V, Ciric D, Kravic-Stevovic T, Trajkovic V. Comparative analysis of cell death mechanisms induced by lysosomal autophagy inhibitors. Eur J Pharmacol. 2019 Sep 15;859():172540. doi: 10.1016/j.ejphar.2019.172540. PMID: 31310755."
1562274,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Ammonium chloride results in increased cleavage of PARP1 protein|4-aminocrotonic acid inhibits the reaction [ammonium chloride results in increased cleavage of PARP1 protein]|(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid inhibits the reaction [4-aminocrotonic acid inhibits the reaction [ammonium chloride results in increased cleavage of PARP1 protein]]",,,PMID:14535961,https://www.ncbi.nlm.nih.gov/pubmed/14535961,14535961,,,30137740,"Yang L, Omori K, Omori K, Otani H, Suzukawa J, Inagaki C. GABA<sub>C</sub> receptor agonist suppressed ammonia-induced apoptosis in cultured rat hippocampal neurons by restoring phosphorylated BAD level. Journal of Neurochemistry. 2003 Sep 30;87(3):791–800. doi: 10.1046/j.1471-4159.2003.02069.x."
1562275,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of PARP1 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,,26141949,"Bodega G, Suárez I, López-Fernández LA, Almonacid L, Zaballos A, Fernández B. Possible implication of ciliary neurotrophic factor (CNTF) and beta-synuclein in the ammonia effect on cultured rat astroglial cells: a study using DNA and protein microarrays. Neurochem Int. 2006 Jun;48(8):729–38. doi: 10.1016/j.neuint.2005.12.014. PMID: 16483693."
1138759,25892,Comparative Toxicogenomics Database (CTD),"Benzo(a)pyrene 7,8-dihydrodiol",C017228,"benzo(a)pyrene 7,8-dihydrodiol",https://ctdbase.org/detail.go?type=chem&acc=C017228,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased cleavage of PARP1 protein]|benzo(a)pyrene 7,8-dihydrodiol results in increased cleavage of PARP1 protein",,,PMID:15572374,https://www.ncbi.nlm.nih.gov/pubmed/15572374,15572374,,,24094048,"Chen S, Operaña T, Bonzo J, Nguyen N, Tukey RH. ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. J Biol Chem. 2005 Feb 11;280(6):4350–9. doi: 10.1074/jbc.m411554200. PMID: 15572374."
1434822,26041,Comparative Toxicogenomics Database (CTD),Pyrithione Zinc,C010423,pyrithione zinc,https://ctdbase.org/detail.go?type=chem&acc=C010423,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrithione zinc results in increased activity of PARP1 protein|pentetic acid inhibits the reaction [pyrithione zinc results in increased activity of PARP1 protein],,,PMID:21424779,https://www.ncbi.nlm.nih.gov/pubmed/21424779,21424779,,PMC4169675,28916913,2011; 24(5):875-890
1434823,26041,Comparative Toxicogenomics Database (CTD),Pyrithione Zinc,C010423,pyrithione zinc,https://ctdbase.org/detail.go?type=chem&acc=C010423,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein affects the reaction [pyrithione zinc results in decreased abundance of adenosine triphosphate]|parp1 protein affects the susceptibility to pyrithione zinc,,,PMID:19809895,https://www.ncbi.nlm.nih.gov/pubmed/19809895,19809895,,PMC2866994,30897287,2010; 15(3):309-322
1675263,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ferrosoferric oxide binds to titanium dioxide] which results in decreased expression of PARP1 protein|titanium dioxide results in decreased expression of PARP1 protein,,,PMID:30098274,https://www.ncbi.nlm.nih.gov/pubmed/30098274,30098274,,,19626513,"Su H, Li Z, Lazar L, Alhamoud Y, Song X, Li J, Wang Y, Fiati kenston SS, Lqbal MZ, Wu A, Li Z, Hua Q, Ding M, Zhao J. In vitro evaluation of the toxicity and underlying molecular mechanisms of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in human liver cells. Environmental Toxicology. 2018 Aug 11;33(10):1078–88. doi: 10.1002/tox.22631."
1675264,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Titanium dioxide results in increased cleavage of PARP1 protein,,,PMID:20362650|PMID:30126039,https://www.ncbi.nlm.nih.gov/pubmed/20362650|https://www.ncbi.nlm.nih.gov/pubmed/30126039,20362650|30126039,,,19436490|24366165,"Zeng C, Feng Y, Wang W, Zhou F, Liao F, Liu Y, Feng S. The size-dependent apoptotic effect of titanium dioxide nanoparticles on endothelial cells by the intracellular pathway. Environ Toxicol. 2018 Dec;33(12):1221–8. doi: 10.1002/tox.22628. PMID: 30126039.|Shi Y, Wang F, He J, Yadav S, Wang H. Titanium dioxide nanoparticles cause apoptosis in BEAS-2B cells through the caspase 8/t-Bid-independent mitochondrial pathway. Toxicol Lett. 2010 Jun 16;196(1):21–7. doi: 10.1016/j.toxlet.2010.03.014. PMID: 20362650."
1675265,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Titanium dioxide results in increased expression of PARP1 mRNA,,,PMID:20362650,https://www.ncbi.nlm.nih.gov/pubmed/20362650,20362650,,,19436490,"Shi Y, Wang F, He J, Yadav S, Wang H. Titanium dioxide nanoparticles cause apoptosis in BEAS-2B cells through the caspase 8/t-Bid-independent mitochondrial pathway. Toxicol Lett. 2010 Jun 16;196(1):21–7. doi: 10.1016/j.toxlet.2010.03.014. PMID: 20362650."
1675266,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Titanium dioxide results in decreased methylation of PARP1 promoter,,,PMID:35295148,https://www.ncbi.nlm.nih.gov/pubmed/35295148,35295148,,PMC8915839,29167362,"Tachibana K, Kawazoe S, Onoda A, Umezawa M, Takeda K. Effects of Prenatal Exposure to Titanium Dioxide Nanoparticles on DNA Methylation and Gene Expression Profile in the Mouse Brain. Front Toxicol. 2021;3():705910. PMID: 35295148; PMCID: PMC8915839."
1312452,26065,Toxin and Toxin Target Database (T3DB),Copper Arsenate,T3D0288,Copper arsenate,http://www.t3db.ca/toxins/T3D0288,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1151874,26177,Comparative Toxicogenomics Database (CTD),"Tris(1,3-dichloro-2-propyl)phosphate",C016805,"tris(1,3-dichloro-2-propyl)phosphate",https://ctdbase.org/detail.go?type=chem&acc=C016805,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Tris(1,3-dichloro-2-propyl)phosphate results in increased expression of PARP1 protein",,,PMID:38331085,https://www.ncbi.nlm.nih.gov/pubmed/38331085,38331085,,,36787536,"Feng Y, Wang Z, Duan H, Shao B. Tris(1,3-dichloro-2-propyl) phosphate induces endoplasmic reticulum stress and mitochondrial-dependent apoptosis in mouse spermatocyte GC-2 cells. Food Chem Toxicol. 2024 Mar;185():114506. doi: 10.1016/j.fct.2024.114506. PMID: 38331085."
1334488,26398,Toxin and Toxin Target Database (T3DB),Cobaltous sulfamate,T3D1402,Cobalt(II) sulfamate,http://www.t3db.ca/toxins/T3D1402,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1335778,26757,Comparative Toxicogenomics Database (CTD),Selegiline,D012642,Selegiline,https://ctdbase.org/detail.go?type=chem&acc=D012642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Selegiline inhibits the reaction [linsidomine results in decreased expression of PARP1 protein],,,PMID:12880480,https://www.ncbi.nlm.nih.gov/pubmed/12880480,12880480,,,2289928,"Sharma SK, Ebadi M. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons. Antioxid Redox Signal. 2003 Jun;5(3):251–64. doi: 10.1089/152308603322110832. PMID: 12880480."
1359390,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of PARP1 protein]|tetradecanoylphorbol acetate results in increased activity of PARP1 protein,,,PMID:2120135|PMID:2126186,https://www.ncbi.nlm.nih.gov/pubmed/2120135|https://www.ncbi.nlm.nih.gov/pubmed/2126186,2120135|2126186,,PMC2002381,2055236|15702803,Singh N. Effect of tumour promoters on poly ADP-ribosylation in human epidermoid carcinoma HeP2 cells. Int J Exp Pathol. 1990 Dec;71(6):809–14. PMID: 2126186; PMCID: PMC2002381.|Singh N. A comparative study on the effect of tumor promoters on poly ADP-ribosylation in A431 cells. Int J Cancer. 1990 Oct 15;46(4):648–52. doi: 10.1002/ijc.2910460416. PMID: 2120135.
1359391,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Butylated hydroxytoluene inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of PARP1 protein]|indomethacin inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of PARP1 protein]|cat protein inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of PARP1 protein],,,PMID:2126186,https://www.ncbi.nlm.nih.gov/pubmed/2126186,2126186,,PMC2002381,2055236,Singh N. Effect of tumour promoters on poly ADP-ribosylation in human epidermoid carcinoma HeP2 cells. Int J Exp Pathol. 1990 Dec;71(6):809–14. PMID: 2126186; PMCID: PMC2002381.
1359392,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[glucose deficiency co-treated with tetradecanoylphorbol acetate] results in increased cleavage of PARP1 protein,,,PMID:17309078,https://www.ncbi.nlm.nih.gov/pubmed/17309078,17309078,,,15296321,"Kim CH, Han SI, Lee SY, Youk HS, Moon JY, Duong HQ, Park MJ, Joo YM, Park HG, Kim YJ, Yoo MA, Lim SC, Kang HS. Protein kinase C-ERK1/2 signal pathway switches glucose depletion-induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells. J Cell Physiol. 2007 May;211(2):371–85. doi: 10.1002/jcp.20941. PMID: 17309078."
1359393,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to tetradecanoylphorbol acetate,,,PMID:16323285,https://www.ncbi.nlm.nih.gov/pubmed/16323285,16323285,,,1000033,"Harnacke K, Kruhøffer M, Ørntoft TF, Hass R. Down-modulation of poly(ADP-ribose) polymerase-1 (PARP-1) in human TUR leukemia cells restores transcriptional responsiveness for differentiation and cell cycle arrest. European Journal of Cell Biology. 2005 Nov;84(11):885–96. doi: 10.1016/j.ejcb.2005.08.009."
1359394,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Tetradecanoylphorbol acetate promotes the reaction [cholix toxin, vibrio cholerae results in increased cleavage of PARP1 protein]|tetradecanoylphorbol acetate inhibits the reaction [[cholix toxin, vibrio cholerae co-treated with TNF protein] results in increased cleavage of PARP1 protein]",,,PMID:28087840,https://www.ncbi.nlm.nih.gov/pubmed/28087840,28087840,,PMC5837519,14162527,"Ogura K, Terasaki Y, Miyoshi-Akiyama T, Terasaki M, Moss J, Noda M, Yahiro K. Vibrio cholerae Cholix Toxin-Induced HepG2 Cell Death is Enhanced by Tumor Necrosis Factor-Alpha Through ROS and Intracellular Signal-Regulated Kinases. Toxicol Sci. 2017 Apr 01;156(2):455–68. PMID: 28087840; PMCID: PMC5837519."
1359544,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of PARP1 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,PMC4326531,27654044,2015; 16(1):26
1447954,28015,Comparative Toxicogenomics Database (CTD),Sodium hydrosulfide,C025451,sodium bisulfide,https://ctdbase.org/detail.go?type=chem&acc=C025451,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium bisulfide results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:23479079,https://www.ncbi.nlm.nih.gov/pubmed/23479079,23479079,,,12046056,2013; 87(7):1245-1256
1395541,28780,Comparative Toxicogenomics Database (CTD),Benomyl,D001542,Benomyl,https://ctdbase.org/detail.go?type=chem&acc=D001542,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benomyl results in increased cleavage of PARP1 protein,,,PMID:16903866,https://www.ncbi.nlm.nih.gov/pubmed/16903866,16903866,,,17330867,"Rathinasamy K, Panda D. Suppression of microtubule dynamics by benomyl decreases tension across kinetochore pairs and induces apoptosis in cancer cells. FEBS J. 2006 Sep;273(17):4114–28. doi: 10.1111/j.1742-4658.2006.05413.x. PMID: 16903866."
1635356,29131,Comparative Toxicogenomics Database (CTD),Chromium hexavalent ion,C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,,15288833,"Reynolds M, Zhitkovich A. Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53. Carcinogenesis. 2007 Jul;28(7):1613–20. doi: 10.1093/carcin/bgm031. PMID: 17301063."
1635357,29131,Comparative Toxicogenomics Database (CTD),Chromium hexavalent ion,C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chromium hexavalent ion results in increased cleavage of PARP1 protein,,,PMID:15831465|PMID:15966574|PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/15831465|https://www.ncbi.nlm.nih.gov/pubmed/15966574|https://www.ncbi.nlm.nih.gov/pubmed/17301063,15831465|15966574|17301063,,PMC1084304,319149|15288833|15970553,"Reynolds M, Zhitkovich A. Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53. Carcinogenesis. 2007 Jul;28(7):1613–20. doi: 10.1093/carcin/bgm031. PMID: 17301063.|Peterson-Roth E, Reynolds M, Quievryn G, Zhitkovich A. Mismatch Repair Proteins Are Activators of Toxic Responses to Chromium-DNA Damage. Molecular and Cellular Biology. 2005 May 01;25(9):3596–607. doi: 10.1128/mcb.25.9.3596-3607.2005.|Rudolf E, Cervinka M, Cerman J. Zinc has ambiguous effects on chromium (VI)-induced oxidative stress and apoptosis. Journal of Trace Elements in Medicine and Biology. 2005 May;18(3):251–60. doi: 10.1016/j.jtemb.2004.09.004."
1635358,29131,Comparative Toxicogenomics Database (CTD),Chromium hexavalent ion,C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MLH1 protein affects the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein],,,PMID:15831465,https://www.ncbi.nlm.nih.gov/pubmed/15831465,15831465,,PMC1084304,319149,"Peterson-Roth E, Reynolds M, Quievryn G, Zhitkovich A. Mismatch Repair Proteins Are Activators of Toxic Responses to Chromium-DNA Damage. Molecular and Cellular Biology. 2005 May 01;25(9):3596–607. doi: 10.1128/mcb.25.9.3596-3607.2005."
1635359,29131,Comparative Toxicogenomics Database (CTD),Chromium hexavalent ion,C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Zinc affects the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein]|n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine affects the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein]",,,PMID:15966574,https://www.ncbi.nlm.nih.gov/pubmed/15966574,15966574,,,15970553,"Rudolf E, Cervinka M, Cerman J. Zinc has ambiguous effects on chromium (VI)-induced oxidative stress and apoptosis. Journal of Trace Elements in Medicine and Biology. 2005 May;18(3):251–60. doi: 10.1016/j.jtemb.2004.09.004."
1635360,29131,Comparative Toxicogenomics Database (CTD),Chromium hexavalent ion,C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of PARP1 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,PMC5837509,23626008,"Rager JE, Ring CL, Fry RC, Suh M, Proctor DM, Haws LC, Harris MA, Thompson CM. High-Throughput Screening Data Interpretation in the Context of In Vivo Transcriptomic Responses to Oral Cr(VI) Exposure. Toxicol Sci. 2017 Jul 01;158(1):199–212. PMID: 28472532; PMCID: PMC5837509."
1635361,29131,Comparative Toxicogenomics Database (CTD),Chromium hexavalent ion,C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,29158,Mytilus galloprovincialis (Mediterranean mussel),Chromium hexavalent ion results in increased expression of and results in increased activity of PARP1 protein,,,PMID:39116916,https://www.ncbi.nlm.nih.gov/pubmed/39116916,39116916,,,37575947,"Marinaro C, Marino A, Bianchi AR, Berman B, Trifuoggi M, Marano A, Palumbo G, Chianese T, Scudiero R, Rosati L, De Maio A, Lettieri G, Piscopo M. Molecular and toxicological mechanisms behind the effects of chromium (VI) on the male reproductive system of Mytilus galloprovincialis: First evidence for poly-ADP-ribosylation of protamine-like II. Chem Biol Interact. 2024 Sep 25;401():111186. doi: 10.1016/j.cbi.2024.111186. PMID: 39116916."
1371615,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [streptozocin results in increased activity of PARP1 protein]|streptozocin results in increased activity of PARP1 protein",,,PMID:27288104,https://www.ncbi.nlm.nih.gov/pubmed/27288104,27288104,,,2530008,"Zhou X, Patel D, Sen S, Shanmugam V, Sidawy A, Mishra L, Nguyen BN. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis. J Vasc Surg. 2017 Apr;65(4):1161–9. doi: 10.1016/j.jvs.2016.03.407. PMID: 27288104."
1371616,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[streptozocin co-treated with dietary fats] results in increased expression of PARP1 mrna|scutellarin inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of PARP1 mrna],,,PMID:34610774,https://www.ncbi.nlm.nih.gov/pubmed/34610774,34610774,,,25818032,"Huo Y, Mijiti A, Cai R, Gao Z, Aini M, Mijiti A, Wang Z, Qie R. Scutellarin alleviates type 2 diabetes (HFD/low dose STZ)-induced cardiac injury through modulation of oxidative stress, inflammation, apoptosis and fibrosis in mice. Hum Exp Toxicol. 2021 Dec;40(12_suppl):S460–74. doi: 10.1177/09603271211045948. PMID: 34610774."
1371753,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),SIRT1 protein inhibits the reaction [streptozocin promotes the reaction [PARP1 protein binds to MMP9 promoter]]|sirt1 protein inhibits the reaction [streptozocin promotes the reaction [RELA protein binds to PARP1 protein]]|streptozocin promotes the reaction [JUN protein binds to PARP1 protein]|streptozocin promotes the reaction [RELA protein binds to PARP1 protein]|streptozocin promotes the reaction [PARP1 protein binds to MMP9 promoter]|sirt1 protein inhibits the reaction [streptozocin promotes the reaction [JUN protein binds to PARP1 protein]],,,PMID:28478229,https://www.ncbi.nlm.nih.gov/pubmed/28478229,28478229,,PMC5599300,23631398,"Mishra M, Kowluru RA. Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017 Jul;1863(7):1761–9. doi: 10.1016/j.bbadis.2017.04.024."
1371754,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Anthocyanins inhibits the reaction [streptozocin results in increased cleavage of PARP1 protein],,,PMID:28856781,https://www.ncbi.nlm.nih.gov/pubmed/28856781,28856781,,,8116139,"Huang PC, Wang GJ, Fan MJ, Asokan Shibu M, Liu YT, Padma Viswanadha V, Lin YL, Lai CH, Chen YF, Liao HE, Huang CY. Cellular apoptosis and cardiac dysfunction in STZ-induced diabetic rats attenuated by anthocyanins via activation of IGFI-R/PI3K/Akt survival signaling. Environ Toxicol. 2017 Dec;32(12):2471–80. doi: 10.1002/tox.22460. PMID: 28856781."
1371755,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [streptozocin results in increased cleavage of PARP1 protein],,,PMID:25541178,https://www.ncbi.nlm.nih.gov/pubmed/25541178,25541178,,,489391,"Rashid K, Sil PC. Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats. Toxicol Appl Pharmacol. 2015 Feb 01;282(3):297–310. doi: 10.1016/j.taap.2014.12.003. PMID: 25541178."
1371756,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Streptozocin results in increased cleavage of PARP1 protein,,,PMID:25541178|PMID:28856781,https://www.ncbi.nlm.nih.gov/pubmed/25541178|https://www.ncbi.nlm.nih.gov/pubmed/28856781,25541178|28856781,,,489391|8116139,"Huang PC, Wang GJ, Fan MJ, Asokan Shibu M, Liu YT, Padma Viswanadha V, Lin YL, Lai CH, Chen YF, Liao HE, Huang CY. Cellular apoptosis and cardiac dysfunction in STZ-induced diabetic rats attenuated by anthocyanins via activation of IGFI-R/PI3K/Akt survival signaling. Environ Toxicol. 2017 Dec;32(12):2471–80. doi: 10.1002/tox.22460. PMID: 28856781.|Rashid K, Sil PC. Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats. Toxicol Appl Pharmacol. 2015 Feb 01;282(3):297–310. doi: 10.1016/j.taap.2014.12.003. PMID: 25541178."
1696417,29574,Comparative Toxicogenomics Database (CTD),"4-Amino-2,6-dinitrotoluene",C035207,"4-amino-2,6-dinitrotoluene",https://ctdbase.org/detail.go?type=chem&acc=C035207,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"4-amino-2,6-dinitrotoluene affects the expression of PARP1 mRNA",,,PMID:21346803,https://www.ncbi.nlm.nih.gov/pubmed/21346803,21346803,,PMC3035612,32938502,2011; 6(2):e14662
1496079,30323,Comparative Toxicogenomics Database (CTD),Daunorubicin,D003630,Daunorubicin,https://ctdbase.org/detail.go?type=chem&acc=D003630,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Daunorubicin affects the expression of PARP1 mRNA,,,PMID:27780733,https://www.ncbi.nlm.nih.gov/pubmed/27780733,27780733,,,31719000,"Denel-Bobrowska M, Lukawska M, Rogalska A, Forma E, Brys M, Oszczapowicz I, Marczak A. Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors. Toxicol Appl Pharmacol. 2016 Dec 15;313():159–69. doi: 10.1016/j.taap.2016.10.018. PMID: 27780733."
1496080,30323,Comparative Toxicogenomics Database (CTD),Daunorubicin,D003630,Daunorubicin,https://ctdbase.org/detail.go?type=chem&acc=D003630,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[daunorubicin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:12780785,https://www.ncbi.nlm.nih.gov/pubmed/12780785,12780785,,,27422129,"Jones DT, Ganeshaguru K, Mitchell WA, Foroni L, Baker RJ, Prentice HG, Mehta AB, Wickremasinghe RG. Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. Br J Haematol. 2003 Jun;121(5):713–20. doi: 10.1046/j.1365-2141.2003.04340.x. PMID: 12780785."
1496081,30323,Comparative Toxicogenomics Database (CTD),Daunorubicin,D003630,Daunorubicin,https://ctdbase.org/detail.go?type=chem&acc=D003630,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Daunorubicin results in increased cleavage of PARP1 protein,,,PMID:10766178|PMID:11082532|PMID:34963561,https://www.ncbi.nlm.nih.gov/pubmed/10766178|https://www.ncbi.nlm.nih.gov/pubmed/11082532|https://www.ncbi.nlm.nih.gov/pubmed/34963561,10766178|11082532|34963561,,,7783840|19253794|23763018,"Chiou JT, Huang CH, Wu TH, Wang LJ, Lee YC, Huang PW, Chang LS. CREB/Sp1-mediated MCL1 expression and NF?B-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Toxicol Appl Pharmacol. 2022 Jan 15;435():115847. doi: 10.1016/j.taap.2021.115847. PMID: 34963561.|Chen J, Chai M, Chen H, Zhao S, Song J. Regulation of phospholipase D activity and ceramide production in daunorubicin-induced apoptosis in A-431 cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2000 Nov;1488(3):219–32. doi: 10.1016/s1388-1981(00)00125-6.|Ferraro C, Quemeneur L, Prigent AF, Taverne C, Revillard JP, Bonnefoy-Berard N. Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells. Cancer Res. 2000 Apr 01;60(7):1901–7. PMID: 10766178."
1496082,30323,Comparative Toxicogenomics Database (CTD),Daunorubicin,D003630,Daunorubicin,https://ctdbase.org/detail.go?type=chem&acc=D003630,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9986,Oryctolagus cuniculus (rabbit),Daunorubicin results in increased cleavage of PARP1 protein,,,PMID:22252735,https://www.ncbi.nlm.nih.gov/pubmed/22252735,22252735,,,16771775,2012; 28(2):103-114
1390564,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein]|ripk1 mutant form inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein]|fadd mutant form inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein]|methyl-beta-cyclodextrin inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein]|ursodeoxycholic acid results in increased cleavage of PARP1 protein|tnfrsf10b mutant form inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein],,,PMID:21362627,https://www.ncbi.nlm.nih.gov/pubmed/21362627,21362627,,,13359584,"Lim SC, Duong HQ, Choi JE, Lee TB, Kang JH, Oh SH, Han SI. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Carcinogenesis. 2011 May;32(5):723–31. doi: 10.1093/carcin/bgr038. PMID: 21362627."
1390565,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[oxaliplatin co-treated with ursodeoxycholic acid] results in increased cleavage of PARP1 protein,,,PMID:19728331,https://www.ncbi.nlm.nih.gov/pubmed/19728331,19728331,,,32912075,"Lim SC, Choi JE, Kang HS, Han SI, Si H. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. Int J Cancer. 2010 Apr 01;126(7):1582–95. doi: 10.1002/ijc.24853. PMID: 19728331."
1697722,31404,Comparative Toxicogenomics Database (CTD),Butylated Hydroxytoluene,D002084,Butylated Hydroxytoluene,https://ctdbase.org/detail.go?type=chem&acc=D002084,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Butylated hydroxytoluene inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of PARP1 protein]|butylated hydroxytoluene inhibits the reaction [benzoyl peroxide results in increased activity of PARP1 protein],,,PMID:2126186,https://www.ncbi.nlm.nih.gov/pubmed/2126186,2126186,,PMC2002381,2055236,Singh N. Effect of tumour promoters on poly ADP-ribosylation in human epidermoid carcinoma HeP2 cells. Int J Exp Pathol. 1990 Dec;71(6):809–14. PMID: 2126186; PMCID: PMC2002381.
106145,31423,Comparative Toxicogenomics Database (CTD),Pyrene,C030984,pyrene,https://ctdbase.org/detail.go?type=chem&acc=C030984,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrene results in increased cleavage of PARP1 protein,,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
1353244,31477,Comparative Toxicogenomics Database (CTD),Metipranolol,D014290,Metipranolol,https://ctdbase.org/detail.go?type=chem&acc=D014290,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Metipranolol inhibits the reaction [zinc results in decreased expression of PARP1 protein]|metipranolol inhibits the reaction [zinc sulfate results in decreased expression of PARP1 protein],,,PMID:16799065,https://www.ncbi.nlm.nih.gov/pubmed/16799065,16799065,,,8564116,"Osborne NN, Wood JP. The beta-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3178–86. doi: 10.1167/iovs.05-1370. PMID: 16799065."
1501750,31553,Comparative Toxicogenomics Database (CTD),Silybin,D000077385,Silybin,https://ctdbase.org/detail.go?type=chem&acc=D000077385,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [silybin results in increased cleavage of PARP1 protein]|deoxyglucose promotes the reaction [silybin results in increased cleavage of PARP1 protein]|dorsomorphin promotes the reaction [silybin results in increased cleavage of PARP1 protein],,,PMID:34053323,https://www.ncbi.nlm.nih.gov/pubmed/34053323,34053323,,,25816613,"Yang J, Sun Y, Xu F, Liu W, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Autophagy and glycolysis independently attenuate silibinin-induced apoptosis in human hepatocarcinoma HepG2 and Hep3B cells. Hum Exp Toxicol. 2021 Dec;40(12):2048–62. doi: 10.1177/09603271211017609. PMID: 34053323."
1501751,31553,Comparative Toxicogenomics Database (CTD),Silybin,D000077385,Silybin,https://ctdbase.org/detail.go?type=chem&acc=D000077385,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [silybin results in increased cleavage of PARP1 protein]|gdf15 mutant form inhibits the reaction [silybin results in increased cleavage of PARP1 protein],,,PMID:24440808,https://www.ncbi.nlm.nih.gov/pubmed/24440808,24440808,,,18146847,"Woo SM, Min KJ, Kim S, Park JW, Kim DE, Chun KS, Kim YH, Lee TJ, Kim SH, Choi YH, Chang JS, Kwon TK. Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation. Chem Biol Interact. 2014 Mar 25;211():36–43. doi: 10.1016/j.cbi.2014.01.004. PMID: 24440808."
1501752,31553,Comparative Toxicogenomics Database (CTD),Silybin,D000077385,Silybin,https://ctdbase.org/detail.go?type=chem&acc=D000077385,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [silybin results in increased cleavage of PARP1 protein]|silybin results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:16777994,https://www.ncbi.nlm.nih.gov/pubmed/16777994,16777994,,,9245942,"Tyagi A, Singh RP, Agarwal C, Agarwal R. Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: evidence for a regulatory loop between p53 and caspase 2. Carcinogenesis. 2006 Nov;27(11):2269–80. doi: 10.1093/carcin/bgl098. PMID: 16777994."
1501753,31553,Comparative Toxicogenomics Database (CTD),Silybin,D000077385,Silybin,https://ctdbase.org/detail.go?type=chem&acc=D000077385,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Silybin inhibits the reaction [ethanol results in increased cleavage of PARP1 protein]|silybin inhibits the reaction [staurosporine promotes the reaction [acetaldehyde results in increased cleavage of PARP1 protein]]|silybin inhibits the reaction [acetaldehyde results in increased cleavage of PARP1 protein],,,PMID:35158046,https://www.ncbi.nlm.nih.gov/pubmed/35158046,35158046,,,33888318,"Song XY, Liu PC, Liu WW, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Protective effects of silibinin against ethanol- or acetaldehyde-caused damage in liver cell lines involve the repression of mitochondrial fission. Toxicol In Vitro. 2022 Apr;80():105330. doi: 10.1016/j.tiv.2022.105330. PMID: 35158046."
1501754,31553,Comparative Toxicogenomics Database (CTD),Silybin,D000077385,Silybin,https://ctdbase.org/detail.go?type=chem&acc=D000077385,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Silybin results in increased cleavage of PARP1 protein,,,PMID:24440808|PMID:34053323,https://www.ncbi.nlm.nih.gov/pubmed/24440808|https://www.ncbi.nlm.nih.gov/pubmed/34053323,24440808|34053323,,,18146847|25816613,"Yang J, Sun Y, Xu F, Liu W, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Autophagy and glycolysis independently attenuate silibinin-induced apoptosis in human hepatocarcinoma HepG2 and Hep3B cells. Hum Exp Toxicol. 2021 Dec;40(12):2048–62. doi: 10.1177/09603271211017609. PMID: 34053323.|Woo SM, Min KJ, Kim S, Park JW, Kim DE, Chun KS, Kim YH, Lee TJ, Kim SH, Choi YH, Chang JS, Kwon TK. Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation. Chem Biol Interact. 2014 Mar 25;211():36–43. doi: 10.1016/j.cbi.2014.01.004. PMID: 24440808."
1501755,31553,Comparative Toxicogenomics Database (CTD),Silybin,D000077385,Silybin,https://ctdbase.org/detail.go?type=chem&acc=D000077385,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Silybin results in increased expression of PARP1 protein,,,PMID:27402681,https://www.ncbi.nlm.nih.gov/pubmed/27402681,27402681,,,18860178,"Bayram D, Çetin ES, Kara M, Özgöçmen M, Candan IA. The apoptotic effects of silibinin on MDA-MB-231 and MCF-7 human breast carcinoma cells. Hum Exp Toxicol. 2017 Jun;36(6):573–86. doi: 10.1177/0960327116658105. PMID: 27402681."
1049974,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of PARP1 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,PMC4939524,30366479,"Ashikawa Y, Nishimura Y, Okabe S, Sasagawa S, Murakami S, Yuge M, Kawaguchi K, Kawase R, Tanaka T. Activation of Sterol Regulatory Element Binding Factors by Fenofibrate and Gemfibrozil Stimulates Myelination in Zebrafish. Front. Pharmacol. 2016 Jul 11;7(). doi: 10.3389/fphar.2016.00206."
1525043,33184,Comparative Toxicogenomics Database (CTD),Azoxymethane,D001397,Azoxymethane,https://ctdbase.org/detail.go?type=chem&acc=D001397,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[camptothecin co-treated with azoxymethane co-treated with dextran sulfate] results in increased cleavage of PARP1 protein|[plant extracts co-treated with azoxymethane co-treated with dextran sulfate] results in increased cleavage of PARP1 protein,,,PMID:25449198,https://www.ncbi.nlm.nih.gov/pubmed/25449198,25449198,,,20878823,"Chung KS, Choi HE, Shin JS, Cho EJ, Cho YW, Choi JH, Baek NI, Lee KT. Chemopreventive effects of standardized ethanol extract from the aerial parts of Artemisia princeps Pampanini cv. Sajabal via NF-?B inactivation on colitis-associated colon tumorigenesis in mice. Food Chem Toxicol. 2015 Jan;75():14–23. doi: 10.1016/j.fct.2014.11.007. PMID: 25449198."
1699677,34755,Comparative Toxicogenomics Database (CTD),Ademetionine,D012436,S-Adenosylmethionine,https://ctdbase.org/detail.go?type=chem&acc=D012436,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),S-adenosylmethionine inhibits the reaction [arsenic results in decreased expression of PARP1 mrna],,,PMID:35490796,https://www.ncbi.nlm.nih.gov/pubmed/35490796,35490796,,,34037577,"Boonma T, Navasumrit P, Parnlob V, Waraprasit S, Ruchirawat M. SAM and folic acid prevent arsenic-induced oxidative and nitrative DNA damage in human lymphoblast cells by modulating expression of inflammatory and DNA repair genes. Chem Biol Interact. 2022 Jul 01;361():109965. doi: 10.1016/j.cbi.2022.109965. PMID: 35490796."
1699917,35960,Comparative Toxicogenomics Database (CTD),Vinylsyringol,C488411,"4-vinyl-2,6-dimethoxyphenol",https://ctdbase.org/detail.go?type=chem&acc=C488411,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4-vinyl-2,6-dimethoxyphenol results in increased expression of PARP1 protein modified form",,,PMID:30653946,https://www.ncbi.nlm.nih.gov/pubmed/30653946,30653946,,,30419895,"Xia X, Xiang X, Huang F, Zheng M, Zhang Z, Han L. Dietary canolol induces apoptosis in human cervical carcinoma HeLa cells through ROS-MAPK mediated mitochondrial signaling pathway: In vitro and in vivo. Chem Biol Interact. 2019 Feb 25;300():138–50. doi: 10.1016/j.cbi.2019.01.016. PMID: 30653946."
118626,36187,Comparative Toxicogenomics Database (CTD),"3,3',4,4'-Tetrachlorobiphenyl",C028451,"3,4,3',4'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C028451,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[3,4,3',4'-tetrachlorobiphenyl results in increased activity of PARP1 protein] which results in decreased abundance of NAD|3,4,3',4'-tetrachlorobiphenyl results in increased activity of PARP1 protein",,,PMID:19433264,https://www.ncbi.nlm.nih.gov/pubmed/19433264,19433264,,,28208088,"Lin CH, Huang CL, Chuang MC, Wang YJ, Chen DR, Chen ST, Lin PH. Protective role of estrogen receptor-alpha on lower chlorinated PCB congener-induced DNA damage and repair in human tumoral breast cells. Toxicol Lett. 2009 Jul 10;188(1):11–9. doi: 10.1016/j.toxlet.2009.02.009. PMID: 19433264."
1255107,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[3,3'-diindolylmethane co-treated with paclitaxel] results in increased cleavage of and results in increased activity of PARP1 protein",,,PMID:16580691,https://www.ncbi.nlm.nih.gov/pubmed/16580691,16580691,,,28817172,"McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. J Surg Res. 2006 May 15;132(2):208–13. doi: 10.1016/j.jss.2006.02.008. PMID: 16580691."
1255108,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MAPK8 protein affects the reaction [paclitaxel results in increased cleavage of PARP1 protein]|map2k4 protein affects the reaction [paclitaxel results in increased cleavage of PARP1 protein]|akt1 protein affects the reaction [paclitaxel results in increased cleavage of PARP1 protein]|map3k5 protein affects the reaction [paclitaxel results in increased cleavage of PARP1 protein],,,PMID:10075725,https://www.ncbi.nlm.nih.gov/pubmed/10075725,10075725,,,10449645,"Wang TH, Popp DM, Wang HS, Saitoh M, Mural JG, Henley DC, Ichijo H, Wimalasena J. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J Biol Chem. 1999 Mar 19;274(12):8208–16. doi: 10.1074/jbc.274.12.8208. PMID: 10075725."
1255109,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Alvocidib promotes the reaction [paclitaxel results in increased cleavage of PARP1 protein],,,PMID:10430095,https://www.ncbi.nlm.nih.gov/pubmed/10430095,10430095,,,8440206,"Motwani M, Delohery TM, Schwartz GK. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin Cancer Res. 1999 Jul;5(7):1876–83. PMID: 10430095."
1255110,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Paclitaxel promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]|cd40lg protein inhibits the reaction [paclitaxel promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]],,,PMID:16545138,https://www.ncbi.nlm.nih.gov/pubmed/16545138,16545138,,PMC1435764,13283158,2006; 6(1):75
1255111,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[luteolin co-treated with paclitaxel] results in decreased expression of PARP1 protein,,,PMID:24525192,https://www.ncbi.nlm.nih.gov/pubmed/24525192,24525192,,,10728341,"Yang MY, Wang CJ, Chen NF, Ho WH, Lu FJ, Tseng TH. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3. Chem Biol Interact. 2014 Apr 25;213():60–8. doi: 10.1016/j.cbi.2014.02.002. PMID: 24525192."
1255112,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[norcantharidin co-treated with paclitaxel] results in increased cleavage of PARP1 protein|paclitaxel results in increased expression of PARP1 protein modified form|paclitaxel promotes the reaction [norcantharidin results in increased expression of PARP1 protein modified form]|sirt7 protein inhibits the reaction [[norcantharidin co-treated with paclitaxel] results in increased cleavage of PARP1 protein],,,PMID:34272796,https://www.ncbi.nlm.nih.gov/pubmed/34272796,34272796,,,4709364,"Wu M, Hui S, Chen Y, Chiou H, Lin C, Lee C, Hsieh Y. Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting <scp>SIRT7</scp> expression. Environmental Toxicology. 2021 Jul 16;36(11):2206–16. doi: 10.1002/tox.23334."
1255113,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Paclitaxel results in increased cleavage of PARP1 protein,,,PMID:10075725|PMID:10430095|PMID:10502406|PMID:11774260|PMID:15492279|PMID:15585644|PMID:15907805|PMID:17404021|PMID:18071906|PMID:18451153|PMID:20610805|PMID:24126434,https://www.ncbi.nlm.nih.gov/pubmed/10075725|https://www.ncbi.nlm.nih.gov/pubmed/10430095|https://www.ncbi.nlm.nih.gov/pubmed/10502406|https://www.ncbi.nlm.nih.gov/pubmed/11774260|https://www.ncbi.nlm.nih.gov/pubmed/15492279|https://www.ncbi.nlm.nih.gov/pubmed/15585644|https://www.ncbi.nlm.nih.gov/pubmed/15907805|https://www.ncbi.nlm.nih.gov/pubmed/17404021|https://www.ncbi.nlm.nih.gov/pubmed/18071906|https://www.ncbi.nlm.nih.gov/pubmed/18451153|https://www.ncbi.nlm.nih.gov/pubmed/20610805|https://www.ncbi.nlm.nih.gov/pubmed/24126434,10075725|10430095|10502406|11774260|15492279|15585644|15907805|17404021|18071906|18451153|20610805|24126434,,PMC4318573,5070931|5765926|8440206|10449645|16667877|16728108|21273726|21410624|25619599|26162040|27485126|28726289,"Dinnen RD, Mao Y, Qiu W, Cassai N, Slavkovich VN, Nichols G, Su GH, Brandt-Rauf P, Fine RL. Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC. Mol Cancer Ther. 2013 Dec;12(12):2792–803. PMID: 24126434; PMCID: PMC4318573.|Ma J, Lu HY, Xia YK, Dong HB, Gu AH, Li ZY, Li Z, Chen AM, Wang XR, Wang SL. BCL2 Ala43Thr is a functional variant associated with protection against azoospermia in a Han-Chinese population. Biol Reprod. 2010 Oct;83(4):656–62. doi: 10.1095/biolreprod.109.082339. PMID: 20610805.|Shi J, Orth JD, Mitchison T. Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res. 2008 May 01;68(9):3269–76. doi: 10.1158/0008-5472.can-07-6699. PMID: 18451153.|2007; 13(2):259-271|KIM S, JUHNN Y, SONG Y. Akt Involvement in Paclitaxel Chemoresistance of Human Ovarian Cancer Cells. Annals of the New York Academy of Sciences. 2007 Jan;1095(1):82–9. doi: 10.1196/annals.1397.012.|Jeung HC, Che XF, Haraguchi M, Furukawa T, Zheng CL, Sumizawa T, Rha SY, Roh JK, Akiyama S. Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents. Biochem Pharmacol. 2005 Jul 01;70(1):13–21. doi: 10.1016/j.bcp.2005.04.017. PMID: 15907805.|Tonini T, Gabellini C, Bagella L, D'Andrilli G, Masciullo V, Romano G, Scambia G, Zupi G, Giordano A. pRb2/p130 decreases sensitivity to apoptosis induced by camptothecin and doxorubicin but not by taxol. Clin Cancer Res. 2004 Dec 01;10(23):8085–93. doi: 10.1158/1078-0432.ccr-04-0996. PMID: 15585644.|Kikuno N, Moriyama-Gonda N, Yoshino T, Yoneda T, Urakami S, Terashima M, Yoshida M, Kishi H, Shigeno K, Shiina H, Igawa M. Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cells. Cancer Res. 2004 Oct 15;64(20):7526–32. doi: 10.1158/0008-5472.can-04-0996. PMID: 15492279.|Tan G, Heqing L, Jiangbo C, Ming J, Yanhong M, Xianghe L, Hong S, Li G. Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells. Int J Cancer. 2002 Jan 10;97(2):168–72. doi: 10.1002/ijc.1591. PMID: 11774260.|Pucci B, Bellincampi L, Tafani M, Masciullo V, Melino G, Giordano A. Paclitaxel induces apoptosis in Saos-2 cells with CD95L upregulation and Bcl-2 phosphorylation. Exp Cell Res. 1999 Oct 10;252(1):134–43. doi: 10.1006/excr.1999.4591. PMID: 10502406.|Motwani M, Delohery TM, Schwartz GK. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin Cancer Res. 1999 Jul;5(7):1876–83. PMID: 10430095.|Wang TH, Popp DM, Wang HS, Saitoh M, Mural JG, Henley DC, Ichijo H, Wimalasena J. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J Biol Chem. 1999 Mar 19;274(12):8208–16. doi: 10.1074/jbc.274.12.8208. PMID: 10075725."
1255267,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to paclitaxel,,,PMID:19426673,https://www.ncbi.nlm.nih.gov/pubmed/19426673,19426673,,,28201736,"Szanto A, Hellebrand EE, Bognar Z, Tucsek Z, Szabo A, Gallyas F, Sumegi B, Varbiro G. PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol. Biochem Pharmacol. 2009 Apr 15;77(8):1348–57. doi: 10.1016/j.bcp.2009.01.008. PMID: 19426673."
1255268,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[piperine analog co-treated with paclitaxel] results in increased cleavage of PARP1 protein,,,PMID:37244399,https://www.ncbi.nlm.nih.gov/pubmed/37244399,37244399,,,35810314,"Sharma S, Choudhary S, Kaur S, Reddy MV, Thota N, Singh A, Koul S, Khan IA, Ahmed Z, Kumar A. Piperine analog PGP-41 treatment overcomes paclitaxel resistance in NCI/ADR-RES ovarian cells by inhibition of MDR1. Chem Biol Interact. 2023 Aug 25;381():110569. doi: 10.1016/j.cbi.2023.110569. PMID: 37244399."
1255269,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[resveratrol co-treated with paclitaxel] results in increased cleavage of PARP1 protein,,,PMID:14749477,https://www.ncbi.nlm.nih.gov/pubmed/14749477,14749477,,,17975476,"Jazirehi AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. 2004 Jan 01;3(1):71–84. doi: 10.1158/1535-7163.71.3.1."
1255270,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TYMP inhibits the reaction [paclitaxel results in increased cleavage of PARP1 protein],,,PMID:15907805,https://www.ncbi.nlm.nih.gov/pubmed/15907805,15907805,,,27485126,"Jeung HC, Che XF, Haraguchi M, Furukawa T, Zheng CL, Sumizawa T, Rha SY, Roh JK, Akiyama S. Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents. Biochem Pharmacol. 2005 Jul 01;70(1):13–21. doi: 10.1016/j.bcp.2005.04.017. PMID: 15907805."
1255271,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TYMP mutant form promotes the reaction [paclitaxel results in increased cleavage of PARP1 protein],,,PMID:15492279,https://www.ncbi.nlm.nih.gov/pubmed/15492279,15492279,,,5765926,"Kikuno N, Moriyama-Gonda N, Yoshino T, Yoneda T, Urakami S, Terashima M, Yoshida M, Kishi H, Shigeno K, Shiina H, Igawa M. Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cells. Cancer Res. 2004 Oct 15;64(20):7526–32. doi: 10.1158/0008-5472.can-04-0996. PMID: 15492279."
1255272,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[voacamine co-treated with paclitaxel] results in increased cleavage of PARP1 protein,,,PMID:34856211,https://www.ncbi.nlm.nih.gov/pubmed/34856211,34856211,,,12958502,"Pellegrini E, Multari G, Gallo FR, Vecchiotti D, Zazzeroni F, Condello M, Meschini S. A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells. Toxicol Appl Pharmacol. 2022 Jan 01;434():115816. doi: 10.1016/j.taap.2021.115816. PMID: 34856211."
1255273,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[rottlerin co-treated with paclitaxel] results in increased cleavage of PARP1 protein,,,PMID:35995259,https://www.ncbi.nlm.nih.gov/pubmed/35995259,35995259,,,35332872,"Manhas D, Mir KB, Tripathi N, Bharti S, Dhiman S, Wazir P, Sharma DK, Goswami A, Nandi U. Rottlerin promotes anti-metastatic events by ameliorating pharmacological parameters of paclitaxel: An in-vivo investigation in the orthotopic mouse model of breast cancer. Chem Biol Interact. 2022 Oct 01;366():110109. doi: 10.1016/j.cbi.2022.110109. PMID: 35995259."
1474309,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3',4'-dihydroxyflavone analog inhibits the reaction [etoposide results in increased cleavage of PARP1 protein]",,,PMID:16014620,https://www.ncbi.nlm.nih.gov/pubmed/16014620,16014620,,,25466453,"Lee ER, Kang YJ, Kim JH, Lee HT, Cho SG. Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 09;280(36):31498–507. doi: 10.1074/jbc.m505537200. PMID: 16014620."
1474310,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BCL2 protein inhibits the reaction [etoposide results in increased degradation of PARP1 protein]|etoposide results in increased degradation of PARP1 protein|bcl2l1 protein inhibits the reaction [etoposide results in increased degradation of PARP1 protein],,,PMID:8840993,https://www.ncbi.nlm.nih.gov/pubmed/8840993,8840993,,,4251819,"Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res. 1996 Oct 15;56(20):4743–8. PMID: 8840993."
1474311,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:30890322,https://www.ncbi.nlm.nih.gov/pubmed/30890322,30890322,,,29757236,"Yang L, Song L, Zhao S, Ma C, Wu D, Wu YL. Isobavachalcone reveals novel characteristics of methuosis-like cell death in leukemia cells. Chem Biol Interact. 2019 May 01;304():131–8. doi: 10.1016/j.cbi.2019.03.011. PMID: 30890322."
1474479,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[CASP8 co-treated with TP53] affects the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:21801448,https://www.ncbi.nlm.nih.gov/pubmed/21801448,21801448,,PMC3160414,12709756,2011; 10(1):95
1474480,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CD40LG protein inhibits the reaction [etoposide promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]|etoposide promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein],,,PMID:16545138,https://www.ncbi.nlm.nih.gov/pubmed/16545138,16545138,,PMC1435764,13283158,2006; 6(1):75
1474481,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[colforsin co-treated with theophylline] inhibits the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:9454737,https://www.ncbi.nlm.nih.gov/pubmed/9454737,9454737,,,4746394,"García-Bermejo L, Pérez C, Vilaboa NE, de Blas E, Aller P. cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells. J Cell Sci. 1998 Mar;111 ( Pt 5)():637–44. doi: 10.1242/jcs.111.5.637. PMID: 9454737."
1474482,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Etoposide results in increased cleavage of PARP1 protein,,,PMID:12690110|PMID:16014620|PMID:16807353|PMID:16844113|PMID:17935137|PMID:20457658|PMID:21801448|PMID:25447644|PMID:26259609|PMID:28507149|PMID:30890322|PMID:9454737,https://www.ncbi.nlm.nih.gov/pubmed/12690110|https://www.ncbi.nlm.nih.gov/pubmed/16014620|https://www.ncbi.nlm.nih.gov/pubmed/16807353|https://www.ncbi.nlm.nih.gov/pubmed/16844113|https://www.ncbi.nlm.nih.gov/pubmed/17935137|https://www.ncbi.nlm.nih.gov/pubmed/20457658|https://www.ncbi.nlm.nih.gov/pubmed/21801448|https://www.ncbi.nlm.nih.gov/pubmed/25447644|https://www.ncbi.nlm.nih.gov/pubmed/26259609|https://www.ncbi.nlm.nih.gov/pubmed/28507149|https://www.ncbi.nlm.nih.gov/pubmed/30890322|https://www.ncbi.nlm.nih.gov/pubmed/9454737,12690110|16014620|16807353|16844113|17935137|20457658|21801448|25447644|26259609|28507149|30890322|9454737,,PMC1556382|PMC3160414|PMC5465913,241518|1040001|3119660|4746394|6013626|8571897|12709756|20877302|25466453|28980299|29757236|32191935,"Yang L, Song L, Zhao S, Ma C, Wu D, Wu YL. Isobavachalcone reveals novel characteristics of methuosis-like cell death in leukemia cells. Chem Biol Interact. 2019 May 01;304():131–8. doi: 10.1016/j.cbi.2019.03.011. PMID: 30890322.|Shin CH, Lee MG, Han J, Jeong SI, Ryu BK, Chi SG. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683–8. PMID: 28507149; PMCID: PMC5465913.|Kwon HK, Shin HJ, Lee JH, Park SH, Kwon MC, Panneerselvam S, Lee CG, Kim SG, Kim JH, Choi S. Etoposide Induces Necrosis Through p53-Mediated Antiapoptosis in Human Kidney Proximal Tubule Cells. Toxicol Sci. 2015 Nov;148(1):204–19. doi: 10.1093/toxsci/kfv182. PMID: 26259609.|El Zaoui I, Behar-Cohen F, Torriglia A. Glucocorticoids exert direct toxicity on microvasculature: analysis of cell death mechanisms. Toxicol Sci. 2015 Feb;143(2):441–53. doi: 10.1093/toxsci/kfu243. PMID: 25447644.|2011; 10(1):95|Martínez-García E, Irigoyen M, González-Moreno O, Corrales L, Teijeira A, Salvo E, Rouzaut A. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment. Toxicol Sci. 2010 Aug;116(2):467–76. doi: 10.1093/toxsci/kfq138. PMID: 20457658.|Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH, Xu XM, Liu S, Chen J, Liu F, Qi YL, Deng Q, Cao J, Liu SQ, Luo HS, Yu JP. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer. 2008 Jan 15;122(2):433–43. doi: 10.1002/ijc.23049. PMID: 17935137.|Piret JP, Cosse JP, Ninane N, Raes M, Michiels C. Hypoxia protects HepG2 cells against etoposide-induced apoptosis via a HIF-1-independent pathway. Exp Cell Res. 2006 Sep 10;312(15):2908–20. doi: 10.1016/j.yexcr.2006.05.018. PMID: 16844113.|Gil A, Andrés-Pons A, Fernández E, Valiente M, Torres J, Cervera J, Pulido R. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol Biol Cell. 2006 Sep;17(9):4002–13. PMID: 16807353; PMCID: PMC1556382.|Lee ER, Kang YJ, Kim JH, Lee HT, Cho SG. Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 09;280(36):31498–507. doi: 10.1074/jbc.m505537200. PMID: 16014620.|Ragione FD, Cucciolla V, Criniti V, Indaco S, Borriello A, Zappia V. p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect. J Biol Chem. 2003 Jun 27;278(26):23360–8. doi: 10.1074/jbc.m300771200. PMID: 12690110.|García-Bermejo L, Pérez C, Vilaboa NE, de Blas E, Aller P. cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells. J Cell Sci. 1998 Mar;111 ( Pt 5)():637–44. doi: 10.1242/jcs.111.5.637. PMID: 9454737."
1474483,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),HTATIP2 protein promotes the reaction [etoposide results in increased activity of PARP1 protein],,,PMID:16799960,https://www.ncbi.nlm.nih.gov/pubmed/16799960,16799960,,,8564838,"Zhao J, Zhang X, Shi M, Xu H, Jin J, Ni H, Yang S, Dai J, Wu M, Guo Y. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Hepatology. 2006 Jul;44(1):205–15. doi: 10.1002/hep.21213. PMID: 16799960."
1474484,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nicotine inhibits the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:20457658,https://www.ncbi.nlm.nih.gov/pubmed/20457658,20457658,,,3119660,"Martínez-García E, Irigoyen M, González-Moreno O, Corrales L, Teijeira A, Salvo E, Rouzaut A. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment. Toxicol Sci. 2010 Aug;116(2):467–76. doi: 10.1093/toxsci/kfq138. PMID: 20457658."
1474485,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PTEN protein modified form promotes the reaction [etoposide results in increased cleavage of PARP1 protein]|pten protein promotes the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:16807353,https://www.ncbi.nlm.nih.gov/pubmed/16807353,16807353,,PMC1556382,8571897,"Gil A, Andrés-Pons A, Fernández E, Valiente M, Torres J, Cervera J, Pulido R. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol Biol Cell. 2006 Sep;17(9):4002–13. PMID: 16807353; PMCID: PMC1556382."
1474486,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[trigonelline co-treated with etoposide] results in increased cleavage of PARP1 protein,,,PMID:33148531,https://www.ncbi.nlm.nih.gov/pubmed/33148531,33148531,,,19665370,"Fouzder C, Mukhuty A, Mukherjee S, Malick C, Kundu R. Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells. Toxicol In Vitro. 2021 Feb;70():105038. doi: 10.1016/j.tiv.2020.105038. PMID: 33148531."
1474487,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Wortmannin promotes the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:17935137,https://www.ncbi.nlm.nih.gov/pubmed/17935137,17935137,,,1040001,"Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH, Xu XM, Liu S, Chen J, Liu F, Qi YL, Deng Q, Cao J, Liu SQ, Luo HS, Yu JP. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer. 2008 Jan 15;122(2):433–43. doi: 10.1002/ijc.23049. PMID: 17935137."
1474710,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),XAF1 protein affects the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:28507149,https://www.ncbi.nlm.nih.gov/pubmed/28507149,28507149,,PMC5465913,6013626,"Shin CH, Lee MG, Han J, Jeong SI, Ryu BK, Chi SG. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683–8. PMID: 28507149; PMCID: PMC5465913."
1474711,36462,Comparative Toxicogenomics Database (CTD),Etoposide,D005047,Etoposide,https://ctdbase.org/detail.go?type=chem&acc=D005047,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacin deficiency affects the reaction [etoposide results in increased cleavage of PARP1 protein]|etoposide results in increased cleavage of PARP1 protein,,,PMID:17516866,https://www.ncbi.nlm.nih.gov/pubmed/17516866,17516866,,,27505879,"Spronck JC, Nickerson JL, Kirkland JB. Niacin Deficiency Alters p53 Expression and Impairs Etoposide-Induced Cell Cycle Arrest and Apoptosis in Rat Bone Marrow Cells. Nutrition and Cancer. 2007 May 04;57(1):88–99. doi: 10.1080/01635580701268337."
1325564,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of PARP1 protein",,,PMID:16884709,https://www.ncbi.nlm.nih.gov/pubmed/16884709,16884709,,,17312947,"Lin CH, Lin PH. Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells. Chem Biol Interact. 2006 Aug 25;162(2):181–94. doi: 10.1016/j.cbi.2006.06.009. PMID: 16884709."
1239985,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased cleavage of PARP1 protein]",,,PMID:29704545,https://www.ncbi.nlm.nih.gov/pubmed/29704545,29704545,,,9462705,"Kim YA, Kim HY, Oh YJ, Kwon WY, Lee MH, Bae JY, Woo MS, Kim JM, Yoo YH. Polychlorinated biphenyl 138 exposure-mediated lipid droplet enlargement endows adipocytes with resistance to TNF-a-induced cell death. Toxicol Lett. 2018 Aug;292():55–62. doi: 10.1016/j.toxlet.2018.04.029. PMID: 29704545."
1434412,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl results in increased activity of PARP1 protein|[2,5,2',5'-tetrachlorobiphenyl results in increased activity of PARP1 protein] which results in decreased abundance of NAD",,,PMID:19433264,https://www.ncbi.nlm.nih.gov/pubmed/19433264,19433264,,,28208088,"Lin CH, Huang CL, Chuang MC, Wang YJ, Chen DR, Chen ST, Lin PH. Protective role of estrogen receptor-alpha on lower chlorinated PCB congener-induced DNA damage and repair in human tumoral breast cells. Toxicol Lett. 2009 Jul 10;188(1):11–9. doi: 10.1016/j.toxlet.2009.02.009. PMID: 19433264."
157404,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [benzo(a)pyrene results in increased cleavage of PARP1 protein]",,,PMID:20840854,https://www.ncbi.nlm.nih.gov/pubmed/20840854,20840854,,,25557153,"Al-Anati L, Högberg J, Stenius U. Non-dioxin-like PCBs interact with benzo[a]pyrene-induced p53-responses and inhibit apoptosis. Toxicol Appl Pharmacol. 2010 Dec 01;249(2):166–77. doi: 10.1016/j.taap.2010.09.004. PMID: 20840854."
1702920,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein,,,PMID:20946892|PMID:24806433|PMID:25232110|PMID:26102036|PMID:34732784|PMID:36174668,https://www.ncbi.nlm.nih.gov/pubmed/20946892|https://www.ncbi.nlm.nih.gov/pubmed/24806433|https://www.ncbi.nlm.nih.gov/pubmed/25232110|https://www.ncbi.nlm.nih.gov/pubmed/26102036|https://www.ncbi.nlm.nih.gov/pubmed/34732784|https://www.ncbi.nlm.nih.gov/pubmed/36174668,20946892|24806433|25232110|26102036|34732784|36174668,,PMC4166159|PMC8566484,5965716|8235801|10736814|14110355|14698609|35297388,"Yang YL, Lin TK, Huang YH. MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS. Eur J Pharmacol. 2022 Nov 05;934():175302. doi: 10.1016/j.ejphar.2022.175302. PMID: 36174668.|Yang H, Li L, Jiao Y, Zhang Y, Wang Y, Zhu K, Sun C. Thioredoxin-1 mediates neuroprotection of Schisanhenol against MPP+-induced apoptosis via suppression of ASK1-P38-NF-?B pathway in SH-SY5Y cells. Scientific Reports. 2021 Nov 03;11(1):21604. doi: 10.1038/s41598-021-01000-3.|Ye X, Han Y, Zhang L, Liu W, Zuo J. MTERF4 regulates the mitochondrial dysfunction induced by MPP+ in SH-SY5Y cells. Biochemical and Biophysical Research Communications. 2015 Aug;464(1):214–20. doi: 10.1016/j.bbrc.2015.06.119.|Choi DC, Chae Y-, Kabaria S, Chaudhuri AD, Jain MR, Li H, Mouradian MM, Junn E. MicroRNA-7 Protects against 1-Methyl-4-Phenylpyridinium-Induced Cell Death by Targeting RelA. Journal of Neuroscience. 2014 Sep 17;34(38):12725–37. doi: 10.1523/jneurosci.0985-14.2014.|Choi JW, Song MY, Park KS. Quantitative proteomic analysis reveals mitochondrial protein changes in MPP(+)-induced neuronal cells. Mol Biosyst. 2014 Jul;10(7):1940–7. doi: 10.1039/c4mb00026a. PMID: 24806433.|Kim IS, Koppula S, Kim BW, Song MD, Jung JY, Lee G, Lee HS, Choi DK. A novel synthetic compound PHID (8-Phenyl-6a, 7, 8, 9, 9a, 10-hexahydro-6H-isoindolo [5, 6-g] quinoxaline-7, 9-dione) protects SH-SY5Y cells against MPP(+)-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling. Eur J Pharmacol. 2011 Jan 10;650(1):48–57. doi: 10.1016/j.ejphar.2010.09.063. PMID: 20946892."
1702921,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in increased expression of PARP1 protein modified form,,,PMID:28481321|PMID:31342299,https://www.ncbi.nlm.nih.gov/pubmed/28481321|https://www.ncbi.nlm.nih.gov/pubmed/31342299,28481321|31342299,,PMC5454925,21653880|23634377,"2019; 461(1-2):81-89|More SV, Choi DK. Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death. Int J Mol Sci. 2017 May 08;18(5). PMID: 28481321; PMCID: PMC5454925."
1702922,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein|8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein]",,,PMID:20946892,https://www.ncbi.nlm.nih.gov/pubmed/20946892,20946892,,,14698609,"Kim IS, Koppula S, Kim BW, Song MD, Jung JY, Lee G, Lee HS, Choi DK. A novel synthetic compound PHID (8-Phenyl-6a, 7, 8, 9, 9a, 10-hexahydro-6H-isoindolo [5, 6-g] quinoxaline-7, 9-dione) protects SH-SY5Y cells against MPP(+)-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling. Eur J Pharmacol. 2011 Jan 10;650(1):48–57. doi: 10.1016/j.ejphar.2010.09.063. PMID: 20946892."
1702923,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AKT activator SC79 inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of PARP1 protein modified form],,,PMID:31342299,https://www.ncbi.nlm.nih.gov/pubmed/31342299,31342299,,,21653880,2019; 461(1-2):81-89
1702924,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Atractylenolide I inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of PARP1 protein modified form],,,PMID:28481321,https://www.ncbi.nlm.nih.gov/pubmed/28481321,28481321,,PMC5454925,23634377,"More SV, Choi DK. Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death. Int J Mol Sci. 2017 May 08;18(5). PMID: 28481321; PMCID: PMC5454925."
1702925,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Geranylgeranylacetone inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein]|schisanhenol inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein],,,PMID:34732784,https://www.ncbi.nlm.nih.gov/pubmed/34732784,34732784,,PMC8566484,8235801,"Yang H, Li L, Jiao Y, Zhang Y, Wang Y, Zhu K, Sun C. Thioredoxin-1 mediates neuroprotection of Schisanhenol against MPP+-induced apoptosis via suppression of ASK1-P38-NF-?B pathway in SH-SY5Y cells. Scientific Reports. 2021 Nov 03;11(1):21604. doi: 10.1038/s41598-021-01000-3."
1702968,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MIR29A inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein],,,PMID:36174668,https://www.ncbi.nlm.nih.gov/pubmed/36174668,36174668,,,35297388,"Yang YL, Lin TK, Huang YH. MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS. Eur J Pharmacol. 2022 Nov 05;934():175302. doi: 10.1016/j.ejphar.2022.175302. PMID: 36174668."
1702969,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MTERF4 protein inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein],,,PMID:26102036,https://www.ncbi.nlm.nih.gov/pubmed/26102036,26102036,,,10736814,"Ye X, Han Y, Zhang L, Liu W, Zuo J. MTERF4 regulates the mitochondrial dysfunction induced by MPP+ in SH-SY5Y cells. Biochemical and Biophysical Research Communications. 2015 Aug;464(1):214–20. doi: 10.1016/j.bbrc.2015.06.119."
1702970,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in increased expression of PARP1 protein,,,PMID:26558463,https://www.ncbi.nlm.nih.gov/pubmed/26558463,26558463,,,21567619,"Shao Y, Figeys D, Ning Z, Mailloux R, Chan HM. Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. J Toxicol Sci. 2015 Dec;40(6):817–28. doi: 10.2131/jts.40.817. PMID: 26558463."
1702971,39484,Comparative Toxicogenomics Database (CTD),1-Methyl-4-phenylpyridinium,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein|plant preparations inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein]|polysaccharides inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein],,,PMID:24875324,https://www.ncbi.nlm.nih.gov/pubmed/24875324,24875324,,,9393107,"Deng Q, Yang X. Protective effects of Gynostemma pentaphyllum polysaccharides on PC12 cells impaired by MPP+. International Journal of Biological Macromolecules. 2014 Aug;69():171–5. doi: 10.1016/j.ijbiomac.2014.05.049."
1708439,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of PARP1 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,PMC3491419,13407974,2012; 13(10):r91
1189766,39800,Comparative Toxicogenomics Database (CTD),Methylisothiazolinone,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased cleavage of PARP1 protein,,,PMID:29110394,https://www.ncbi.nlm.nih.gov/pubmed/29110394,29110394,,,14870085,"Park EJ, Kim S, Chang J. Methylisothiazolinone may induce cell death and inflammatory response through DNA damage in human liver epithelium cells. Environ Toxicol. 2018 Feb;33(2):156–66. doi: 10.1002/tox.22503. PMID: 29110394."
1031923,39836,Comparative Toxicogenomics Database (CTD),NG-Nitroarginine Methyl Ester,D019331,NG-Nitroarginine Methyl Ester,https://ctdbase.org/detail.go?type=chem&acc=D019331,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),NG-nitroarginine methyl ester inhibits the reaction [AGT protein results in increased activity of PARP1 protein],,,PMID:15502880,https://www.ncbi.nlm.nih.gov/pubmed/15502880,15502880,,PMC1431352,5775817,2004; 10(1-6):28-35
1203767,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Deoxynivalenol results in decreased expression of and results in increased cleavage of PARP1 protein|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone affects the reaction [deoxynivalenol affects the expression of and results in increased cleavage of PARP1 protein]|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in decreased expression of and results in increased cleavage of PARP1 protein]|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in decreased expression of and results in increased cleavage of PARP1 protein]|deoxynivalenol affects the expression of and results in increased cleavage of PARP1 protein|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased cleavage of PARP1 protein]|gsdme protein inhibits the reaction [deoxynivalenol results in increased cleavage of PARP1 protein],,,PMID:35925383,https://www.ncbi.nlm.nih.gov/pubmed/35925383,35925383,,,34609750,2022; 96(11):3091-3112
1203768,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of PARP1 mRNA,,,PMID:34677630,https://www.ncbi.nlm.nih.gov/pubmed/34677630,34677630,,PMC8748346,5447604,2021; 96(1):231-241
1203769,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Deoxynivalenol results in increased cleavage of PARP1 protein,,,PMID:19410639,https://www.ncbi.nlm.nih.gov/pubmed/19410639,19410639,,,28187125,"Marzocco S, Russo R, Bianco G, Autore G, Severino L. Pro-apoptotic effects of nivalenol and deoxynivalenol trichothecenes in J774A.1 murine macrophages. Toxicol Lett. 2009 Aug 25;189(1):21–6. doi: 10.1016/j.toxlet.2009.04.024. PMID: 19410639."
1203770,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),Deoxynivalenol affects the expression of and affects the cleavage of PARP1 protein,,,PMID:38104654,https://www.ncbi.nlm.nih.gov/pubmed/38104654,38104654,,,36400812,"Hou S, Ma J, Cheng Y, Wang Z, Wang G, Jia A, Wang H, Sun J, Yan Y. DON induced DNA damage triggers absence of p53-mediated G2 arrest and apoptosis in IPEC-1 cells. Toxicology. 2024 Jan;501():153707. doi: 10.1016/j.tox.2023.153707. PMID: 38104654."
1571936,40127,Comparative Toxicogenomics Database (CTD),Carteolol Hydrochloride,D002354,Carteolol,https://ctdbase.org/detail.go?type=chem&acc=D002354,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Carteolol affects the expression of PARP1 mRNA,,,PMID:37120125,https://www.ncbi.nlm.nih.gov/pubmed/37120125,37120125,,,35948490,"Jiang GJ, You XG, Fan TJ. Carteolol triggers senescence via activation of ß-arrestin-ERK-NOX4-ROS pathway in human corneal endothelial cells in vitro. Chem Biol Interact. 2023 Aug 01;380():110511. doi: 10.1016/j.cbi.2023.110511. PMID: 37120125."
1574402,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of PARP1 mRNA,,,PMID:25113976,https://www.ncbi.nlm.nih.gov/pubmed/25113976,25113976,,,6646851,"Attia SM, Ahmad SF, Okash RM, Bakheet SA. Aroclor 1254-induced genotoxicity in male gonads through oxidatively damaged DNA and inhibition of DNA repair gene expression. Mutagenesis. 2014 Sep;29(5):379–84. doi: 10.1093/mutage/geu029. PMID: 25113976."
1234970,40516,Toxin and Toxin Target Database (T3DB),Calcium arsenite,T3D1316,Calcium arsenite,http://www.t3db.ca/toxins/T3D1316,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1087078,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of PARP1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,PMC10152924,35907114,"Lesseur C, Kaur K, Kelly SD, Hermetz K, Williams R, Hao K, Marsit CJ, Caudle WM, Chen J. Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. Toxicology. 2023 May 15;490():153498. PMID: 37019170; PMCID: PMC10152924."
1087079,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Decamethrin results in increased activity of PARP1 protein,,,PMID:22889898|PMID:23076637,https://www.ncbi.nlm.nih.gov/pubmed/22889898|https://www.ncbi.nlm.nih.gov/pubmed/23076637,22889898|23076637,,,10677834|28944948,"2012; 65(3):425-432|Ismail MF, Mohamed HM. Deltamethrin-induced genotoxicity and testicular injury in rats: comparison with biopesticide. Food Chem Toxicol. 2012 Oct;50(10):3421–5. doi: 10.1016/j.fct.2012.07.060. PMID: 22889898."
1087080,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Lycopene inhibits the reaction [decamethrin results in increased activity of PARP1 protein],,,PMID:23076637,https://www.ncbi.nlm.nih.gov/pubmed/23076637,23076637,,,28944948,2012; 65(3):425-432
1509704,40600,Comparative Toxicogenomics Database (CTD),"4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid",D017878,"4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid",https://ctdbase.org/detail.go?type=chem&acc=D017878,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4,4'-diisothiocyanostilbene-2,2'-disulfonic acid inhibits the reaction [quinocetone results in increased expression of PARP1 protein modified form]",,,PMID:28343033,https://www.ncbi.nlm.nih.gov/pubmed/28343033,28343033,,,12810228,"Yang X, Tang S, Dai C, Li D, Zhang S, Deng S, Zhou Y, Xiao X. Quinocetone induces mitochondrial apoptosis in HepG2 cells through ROS-dependent promotion of VDAC1 oligomerization and suppression of Wnt1/ß-catenin signaling pathway. Food Chem Toxicol. 2017 Jul;105():161–76. doi: 10.1016/j.fct.2017.03.039. PMID: 28343033."
1665018,40634,Comparative Toxicogenomics Database (CTD),"6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",C010643,"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",https://ctdbase.org/detail.go?type=chem&acc=C010643,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [zinc results in decreased expression of PARP1 protein]|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [zinc sulfate results in decreased expression of PARP1 protein]",,,PMID:16799065,https://www.ncbi.nlm.nih.gov/pubmed/16799065,16799065,,,8564116,"Osborne NN, Wood JP. The beta-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3178–86. doi: 10.1167/iovs.05-1370. PMID: 16799065."
1084068,41867,Comparative Toxicogenomics Database (CTD),Epirubicin,D015251,Epirubicin,https://ctdbase.org/detail.go?type=chem&acc=D015251,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[gossypol co-treated with epirubicin] results in increased cleavage of PARP1 protein,,,PMID:35872041,https://www.ncbi.nlm.nih.gov/pubmed/35872041,35872041,,,35415475,"Jiang W, Wang W, Sun L, Xiao Y, Ma T, Li B, Yan X, Wu Y, Li H, Lian J, He F. (-)-Gossypol enhances the anticancer activity of epirubicin via downregulating survivin in hepatocellular carcinoma. Chem Biol Interact. 2022 Sep 01;364():110060. doi: 10.1016/j.cbi.2022.110060. PMID: 35872041."
1084069,41867,Comparative Toxicogenomics Database (CTD),Epirubicin,D015251,Epirubicin,https://ctdbase.org/detail.go?type=chem&acc=D015251,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Epirubicin results in increased cleavage of PARP1 protein|paeonol inhibits the reaction [epirubicin results in increased cleavage of PARP1 protein],,,PMID:26646421,https://www.ncbi.nlm.nih.gov/pubmed/26646421,26646421,,,12786983,"Wu J, Xue X, Zhang B, Jiang W, Cao H, Wang R, Sun D, Guo R. The protective effects of paeonol against epirubicin-induced hepatotoxicity in 4T1-tumor bearing mice via inhibition of the PI3K/Akt/NF-kB pathway. Chem Biol Interact. 2016 Jan 25;244():1–8. doi: 10.1016/j.cbi.2015.11.025. PMID: 26646421."
1576034,42890,Comparative Toxicogenomics Database (CTD),Idarubicin,D015255,Idarubicin,https://ctdbase.org/detail.go?type=chem&acc=D015255,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dexrazoxane inhibits the reaction [idarubicin results in increased expression of PARP1 protein]|dexrazoxane inhibits the reaction [idarubicin results in increased expression of PARP1 mrna]|idarubicin results in increased expression of PARP1 mrna|idarubicin results in increased expression of PARP1 protein,,,PMID:28973540,https://www.ncbi.nlm.nih.gov/pubmed/28973540,28973540,,,2572704,"Attia SM, Alshahrani AY, Al-Hamamah MA, Attia MM, Saquib Q, Ahmad SF, Ansari MA, Nadeem A, Bakheet SA. Dexrazoxane Averts Idarubicin-Evoked Genomic Damage by Regulating Gene Expression Profiling Associated With the DNA Damage-Signaling Pathway in BALB/c Mice. Toxicol Sci. 2017 Nov 01;160(1):161–72. doi: 10.1093/toxsci/kfx161. PMID: 28973540."
1479639,43957,Toxin and Toxin Target Database (T3DB),Fluomine,T3D1404,Bis(3-fluorosalicylaldehyde)-ethylenediimine-cobalt,http://www.t3db.ca/toxins/T3D1404,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1668925,44073,Comparative Toxicogenomics Database (CTD),Acifluorfen,C018425,acifluorfen,https://ctdbase.org/detail.go?type=chem&acc=C018425,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acifluorfen results in increased expression of PARP1 protein modified form,,,PMID:25944804,https://www.ncbi.nlm.nih.gov/pubmed/25944804,25944804,,,2709984,"Bazzocco S, Dopeso H, Carton-Garcia F, Macaya I, Andretta E, Chionh F, Rodrigues P, Garrido M, Alazzouzi H, Nieto R, Sanchez A, Schwartz S, Bilic J, Mariadason JM, Arango D. Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment. 2015 Aug 13;21(16):3695–704. doi: 10.1158/1078-0432.ccr-14-2457."
1108217,44259,Comparative Toxicogenomics Database (CTD),Staurosporine,D019311,Staurosporine,https://ctdbase.org/detail.go?type=chem&acc=D019311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),EOMES protein inhibits the reaction [staurosporine results in increased cleavage of PARP1 protein],,,PMID:27539959,https://www.ncbi.nlm.nih.gov/pubmed/27539959,27539959,,PMC5035225,28352840,"Wang R, Kang Y, Löhr CV, Fischer KA, Bradford CS, Johnson G, Dashwood WM, Williams DE, Ho E, Dashwood RH. Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer. Cancer Letters. 2016 Oct;381(2):341–8. doi: 10.1016/j.canlet.2016.08.008."
1108218,44259,Comparative Toxicogenomics Database (CTD),Staurosporine,D019311,Staurosporine,https://ctdbase.org/detail.go?type=chem&acc=D019311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Staurosporine promotes the reaction [acetaldehyde results in increased cleavage of PARP1 protein]|silybin inhibits the reaction [staurosporine promotes the reaction [acetaldehyde results in increased cleavage of PARP1 protein]],,,PMID:35158046,https://www.ncbi.nlm.nih.gov/pubmed/35158046,35158046,,,33888318,"Song XY, Liu PC, Liu WW, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Protective effects of silibinin against ethanol- or acetaldehyde-caused damage in liver cell lines involve the repression of mitochondrial fission. Toxicol In Vitro. 2022 Apr;80():105330. doi: 10.1016/j.tiv.2022.105330. PMID: 35158046."
1108383,44259,Comparative Toxicogenomics Database (CTD),Staurosporine,D019311,Staurosporine,https://ctdbase.org/detail.go?type=chem&acc=D019311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Staurosporine results in increased cleavage of PARP1 protein,,,PMID:18451153|PMID:21447800|PMID:24464939|PMID:27539959|PMID:30660566|PMID:36982514|PMID:37268255|PMID:38748041,https://www.ncbi.nlm.nih.gov/pubmed/18451153|https://www.ncbi.nlm.nih.gov/pubmed/21447800|https://www.ncbi.nlm.nih.gov/pubmed/24464939|https://www.ncbi.nlm.nih.gov/pubmed/27539959|https://www.ncbi.nlm.nih.gov/pubmed/30660566|https://www.ncbi.nlm.nih.gov/pubmed/36982514|https://www.ncbi.nlm.nih.gov/pubmed/37268255|https://www.ncbi.nlm.nih.gov/pubmed/38748041,18451153|21447800|24464939|27539959|30660566|36982514|37268255|38748041,,PMC10049531|PMC11324689|PMC3981956|PMC5035225,18169066|21410624|28352840|30426131|30941876|34783977|35936123|37198948,"2024; 98(9):2971-2984|Wenzel CK, von Montfort C, Ebbert L, Klahm NP, Reichert AS, Stahl W, Brenneisen P. The natural chalcone cardamonin selectively induces apoptosis in human neuroblastoma cells. Toxicol In Vitro. 2023 Sep;91():105625. doi: 10.1016/j.tiv.2023.105625. PMID: 37268255.|Deval G, Nedder M, Degrelle S, Rogozarski J, Vignaud ML, Chissey A, Colzin S, Laguillier-Morizot C, Coumoul X, Boland S, Fournier T, Zerrad-Saadi A, Ferecatu I. Benzo(a)pyrene and Cerium Dioxide Nanoparticles in Co-Exposure Impair Human Trophoblast Cell Stress Signaling. Int J Mol Sci. 2023 Mar 12;24(6). PMID: 36982514; PMCID: PMC10049531.|Deng Z, Chai J, Zeng Q, Zhang B, Ye T, Chen X, Xu X. The anticancer properties and mechanism of action of tablysin-15, the RGD-containing disintegrin, in breast cancer cells. International Journal of Biological Macromolecules. 2019 May;129():1155–67. doi: 10.1016/j.ijbiomac.2019.01.073.|Wang R, Kang Y, Löhr CV, Fischer KA, Bradford CS, Johnson G, Dashwood WM, Williams DE, Ho E, Dashwood RH. Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer. Cancer Letters. 2016 Oct;381(2):341–8. doi: 10.1016/j.canlet.2016.08.008.|Yao P, Morales JL, Zhu B, Kang B, Gonzalez FJ, Peters JM. Activation of Peroxisome Proliferator-Activated Receptor-ß/d (PPAR-ß/d) Inhibits Human Breast Cancer Cell Line Tumorigenicity. 2014 Apr 01;13(4):1008–17. doi: 10.1158/1535-7163.mct-13-0836.|Pyndiah S, Tanida S, Ahmed KM, Cassimere EK, Choe C, Sakamuro D. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance. Sci Signal. 2011 Mar 29;4(166):ra19. doi: 10.1126/scisignal.2001556. PMID: 21447800.|Shi J, Orth JD, Mitchison T. Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res. 2008 May 01;68(9):3269–76. doi: 10.1158/0008-5472.can-07-6699. PMID: 18451153."
1108384,44259,Comparative Toxicogenomics Database (CTD),Staurosporine,D019311,Staurosporine,https://ctdbase.org/detail.go?type=chem&acc=D019311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),SOD2 mutant form inhibits the reaction [staurosporine results in increased cleavage of PARP1 protein],,,PMID:24740755,https://www.ncbi.nlm.nih.gov/pubmed/24740755,24740755,,,1824279,2014; 393(1-2):69-76
1108385,44259,Comparative Toxicogenomics Database (CTD),Staurosporine,D019311,Staurosporine,https://ctdbase.org/detail.go?type=chem&acc=D019311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Staurosporine affects the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:11035063,https://www.ncbi.nlm.nih.gov/pubmed/11035063,11035063,,,209792,"Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000 Oct 15;165(8):4290–7. doi: 10.4049/jimmunol.165.8.4290. PMID: 11035063."
1108386,44259,Comparative Toxicogenomics Database (CTD),Staurosporine,D019311,Staurosporine,https://ctdbase.org/detail.go?type=chem&acc=D019311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Staurosporine results in increased cleavage of PARP1 protein,,,PMID:10704466|PMID:11035063|PMID:24740755,https://www.ncbi.nlm.nih.gov/pubmed/10704466|https://www.ncbi.nlm.nih.gov/pubmed/11035063|https://www.ncbi.nlm.nih.gov/pubmed/24740755,10704466|11035063|24740755,,PMC2195860,209792|1824279|23298932,"2014; 393(1-2):69-76|Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000 Oct 15;165(8):4290–7. doi: 10.4049/jimmunol.165.8.4290. PMID: 11035063.|Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA. Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med. 2000 Mar 06;191(5):859–70. PMID: 10704466; PMCID: PMC2195860."
1108387,44259,Comparative Toxicogenomics Database (CTD),Staurosporine,D019311,Staurosporine,https://ctdbase.org/detail.go?type=chem&acc=D019311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Staurosporine results in increased expression of PARP1 protein modified form,,,PMID:22639866,https://www.ncbi.nlm.nih.gov/pubmed/22639866,22639866,,,11343819,"Gerace E, Scartabelli T, Formentini L, Landucci E, Moroni F, Chiarugi A, Pellegrini-Giampietro DE. Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance. Eur J Neurosci. 2012 Jul;36(1):1993–2005. doi: 10.1111/j.1460-9568.2012.08116.x. PMID: 22639866."
1095145,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PARP1 protein|4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PARP1 mrna|nipbl mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PARP1 protein],,,PMID:35435490,https://www.ncbi.nlm.nih.gov/pubmed/35435490,35435490,,,33948194,2022; 96(7):2049-2065
1482531,47364,Toxin and Toxin Target Database (T3DB),Arsenobetaine,T3D0301,Arsenobetaine,http://www.t3db.ca/toxins/T3D0301,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1489796,47576,Comparative Toxicogenomics Database (CTD),Ketoconazole,D007654,Ketoconazole,https://ctdbase.org/detail.go?type=chem&acc=D007654,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ketoconazole results in increased expression of PARP1 mRNA,,,PMID:36621641,https://www.ncbi.nlm.nih.gov/pubmed/36621641,36621641,,,34839382,"Li T, Vazakidou P, Leonards PEG, Damdimopoulos A, Panagiotou EM, Arnelo C, Jansson K, Pettersson K, Papaikonomou K, van Duursen M, Damdimopoulou P. Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485():153425. doi: 10.1016/j.tox.2023.153425. PMID: 36621641."
1713078,47936,Comparative Toxicogenomics Database (CTD),Colforsin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[colforsin co-treated with theophylline] inhibits the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:9454737,https://www.ncbi.nlm.nih.gov/pubmed/9454737,9454737,,,4746394,"García-Bermejo L, Pérez C, Vilaboa NE, de Blas E, Aller P. cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells. J Cell Sci. 1998 Mar;111 ( Pt 5)():637–44. doi: 10.1242/jcs.111.5.637. PMID: 9454737."
1713079,47936,Comparative Toxicogenomics Database (CTD),Colforsin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Colforsin results in increased cleavage of PARP1 protein,,,PMID:31278978,https://www.ncbi.nlm.nih.gov/pubmed/31278978,31278978,,,8828628,"Narciso L, Ietta F, Romagnoli R, Paulesu L, Mantovani A, Tait S. Effects of Bisphenol A on endogenous retroviral envelopes expression and trophoblast fusion in BeWo cells. Reprod Toxicol. 2019 Oct;89():35–44. doi: 10.1016/j.reprotox.2019.07.001. PMID: 31278978."
1391403,49970,Comparative Toxicogenomics Database (CTD),Glu-P-2,C023847,Glu-P-2,https://ctdbase.org/detail.go?type=chem&acc=C023847,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),Glu-P-2 results in decreased activity of PARP1 protein,,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1709156,49971,Comparative Toxicogenomics Database (CTD),"2-Amino-6-methyldipyrido(1,2-a:3',2'-d)imidazole",C023785,"2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole",https://ctdbase.org/detail.go?type=chem&acc=C023785,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole results in decreased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1111634,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lovastatin analog results in increased cleavage of PARP1 protein,,,PMID:26863638,https://www.ncbi.nlm.nih.gov/pubmed/26863638,26863638,,PMC4891124,19567958,"Walther U, Emmrich K, Ramer R, Mittag N, Hinz B. Lovastatin lactone elicits human lung cancer cell apoptosis <i>via</i> a COX-2/PPAR?-dependent pathway. Oncotarget. 2016 Feb 05;7(9):10345–62. doi: 10.18632/oncotarget.7213."
1709553,53462,Comparative Toxicogenomics Database (CTD),"2-Amino-3-methylimidazo(4,5-f)quinoline",C029216,"2-amino-3-methylimidazo(4,5-f)quinoline",https://ctdbase.org/detail.go?type=chem&acc=C029216,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"2-amino-3-methylimidazo(4,5-f)quinoline results in decreased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1709554,53462,Comparative Toxicogenomics Database (CTD),"2-Amino-3-methylimidazo(4,5-f)quinoline",C029216,"2-amino-3-methylimidazo(4,5-f)quinoline",https://ctdbase.org/detail.go?type=chem&acc=C029216,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-amino-3-methylimidazo(4,5-f)quinoline results in increased cleavage of PARP1 protein",,,PMID:35985368,https://www.ncbi.nlm.nih.gov/pubmed/35985368,35985368,,,35324957,"Feng Y, Chen S, Zhao Y, Wu D, Li G. Heterocyclic aromatic amines induce Neuro-2a cells cytotoxicity through oxidative stress-mediated mitochondria-dependent apoptotic signals. Food Chem Toxicol. 2022 Oct;168():113376. doi: 10.1016/j.fct.2022.113376. PMID: 35985368."
1606607,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]|tnfsf10 protein promotes the reaction [simvastatin results in increased cleavage of PARP1 protein]|geranylgeranyl pyrophosphate inhibits the reaction [TNFSF10 protein promotes the reaction [simvastatin results in increased cleavage of PARP1 protein]]|mevalonic acid inhibits the reaction [simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|geranylgeranyl pyrophosphate inhibits the reaction [simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|mevalonic acid inhibits the reaction [TNFSF10 protein promotes the reaction [simvastatin results in increased cleavage of PARP1 protein]]|[simvastatin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:21910007,https://www.ncbi.nlm.nih.gov/pubmed/21910007,21910007,,PMC4372201,23502040,2011; 16(12):1268-1284
1606608,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [simvastatin results in increased cleavage of PARP1 protein]|mevalonic acid inhibits the reaction [simvastatin results in increased cleavage of PARP1 protein],,,PMID:20045437,https://www.ncbi.nlm.nih.gov/pubmed/20045437,20045437,,,32241704,"Ghavami S, Mutawe MM, Hauff K, Stelmack GL, Schaafsma D, Sharma P, McNeill KD, Hynes TS, Kung SK, Unruh H, Klonisch T, Hatch GM, Los M, Halayko AJ. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2010 Apr;1803(4):452–67. doi: 10.1016/j.bbamcr.2009.12.005."
1606609,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Simvastatin inhibits the reaction [coal ash results in increased expression of PARP1 protein modified form],,,PMID:26773838,https://www.ncbi.nlm.nih.gov/pubmed/26773838,26773838,,,23590567,"Ferraro SA, Astort F, Yakisich JS, Tasat DR. Particulate matter cytotoxicity in cultured SH-SY5Y cells is modulated by simvastatin: Toxicological assessment for oxidative damage. Neurotoxicology. 2016 Mar;53():108–14. doi: 10.1016/j.neuro.2016.01.003. PMID: 26773838."
1606610,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Simvastatin results in increased cleavage of PARP1 protein,,,PMID:20045437|PMID:20464445|PMID:21910007,https://www.ncbi.nlm.nih.gov/pubmed/20045437|https://www.ncbi.nlm.nih.gov/pubmed/20464445|https://www.ncbi.nlm.nih.gov/pubmed/21910007,20045437|20464445|21910007,,PMC4372201,3126045|23502040|32241704,"2011; 16(12):1268-1284|2010; 29(5):945-952|Ghavami S, Mutawe MM, Hauff K, Stelmack GL, Schaafsma D, Sharma P, McNeill KD, Hynes TS, Kung SK, Unruh H, Klonisch T, Hatch GM, Los M, Halayko AJ. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2010 Apr;1803(4):452–67. doi: 10.1016/j.bbamcr.2009.12.005."
1606611,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),IGF1 protein inhibits the reaction [simvastatin results in increased cleavage of PARP1 protein]|simvastatin results in increased cleavage of PARP1 protein,,,PMID:27734117,https://www.ncbi.nlm.nih.gov/pubmed/27734117,27734117,,,10767368,2016; 91(5):2223-2234
1606612,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Simvastatin inhibits the reaction [glucose results in increased activity of PARP1 protein],,,PMID:18004065,https://www.ncbi.nlm.nih.gov/pubmed/18004065,18004065,,,10584605,"Lin C, Cheng H, Tung C, Huang W, Chang P, Yang J, Wang J. Simvastatin Reverses High Glucose-Induced Apoptosis of Mesangial Cells via Modulation of Wnt Signaling Pathway. Am J Nephrol. 2007 Nov 14;28(2):290–7. doi: 10.1159/000111142."
1606613,54454,Comparative Toxicogenomics Database (CTD),Simvastatin,D019821,Simvastatin,https://ctdbase.org/detail.go?type=chem&acc=D019821,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Simvastatin results in decreased cleavage of PARP1 mRNA,,,PMID:16054375,https://www.ncbi.nlm.nih.gov/pubmed/16054375,16054375,,,22704055,"Carloni S, Mazzoni E, Cimino M, De Simoni MG, Perego C, Scopa C, Balduini W. Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat. Neurobiol Dis. 2006 Jan;21(1):119–26. doi: 10.1016/j.nbd.2005.06.014. PMID: 16054375."
1675485,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ESR1 protein co-treated with ESR2 protein] affects the reaction [raloxifene hydrochloride results in increased cleavage of PARP1 protein]|raloxifene hydrochloride results in increased cleavage of PARP1 protein,,,PMID:22965848,https://www.ncbi.nlm.nih.gov/pubmed/22965848,22965848,,PMC3541450,26261945,2012; 4(1):24-35
234687,55245,Comparative Toxicogenomics Database (CTD),Mifepristone,D015735,Mifepristone,https://ctdbase.org/detail.go?type=chem&acc=D015735,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mifepristone results in increased cleavage of PARP1 protein,,,PMID:16525653,https://www.ncbi.nlm.nih.gov/pubmed/16525653,16525653,,,32858394,"Fauvet R, Dufournet Etienne C, Poncelet C, Bringuier AF, Feldmann G, Daraï E. Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3. Oncol Rep. 2006 Apr;15(4):743–8. PMID: 16525653."
234688,55245,Comparative Toxicogenomics Database (CTD),Mifepristone,D015735,Mifepristone,https://ctdbase.org/detail.go?type=chem&acc=D015735,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Mifepristone inhibits the reaction [dexamethasone results in increased cleavage of PARP1 protein],,,PMID:16644695,https://www.ncbi.nlm.nih.gov/pubmed/16644695,16644695,,,1675037,"Ranta F, Avram D, Berchtold S, Düfer M, Drews G, Lang F, Ullrich S. Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes. 2006 May;55(5):1380–90. doi: 10.2337/db05-1220. PMID: 16644695."
1373250,57166,Comparative Toxicogenomics Database (CTD),"3-[13-[1-[1-[8,12-Bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21,24-dihydroporphyrin-2-yl]ethoxy]ethyl]-18-(2-carboxyethyl)-8-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid",D017323,Dihematoporphyrin Ether,https://ctdbase.org/detail.go?type=chem&acc=D017323,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dihematoporphyrin ether results in increased cleavage of PARP1 protein|celecoxib promotes the reaction [dihematoporphyrin ether results in increased cleavage of PARP1 protein]|n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [dihematoporphyrin ether results in increased cleavage of PARP1 protein],,,PMID:16230411,https://www.ncbi.nlm.nih.gov/pubmed/16230411,16230411,,,28145768,"Ferrario A, Fisher AM, Rucker N, Gomer CJ. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res. 2005 Oct 15;65(20):9473–8. doi: 10.1158/0008-5472.can-05-1659. PMID: 16230411."
1735297,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [topotecan promotes the reaction [TP53 protein binds to PARP1 protein modified form]]|topotecan results in increased cleavage of PARP1 protein|topotecan promotes the reaction [TP53 protein binds to PARP1 protein modified form]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [topotecan results in increased cleavage of PARP1 protein]|tp53 protein promotes the reaction [[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with topotecan] results in increased cleavage of PARP1 protein]|[n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with topotecan] results in increased cleavage of PARP1 protein|tp63 protein alternative form promotes the reaction [[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with topotecan] results in increased cleavage of PARP1 protein]|[tp63 protein alternative form co-treated with TP53 protein] promotes the reaction [[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with topotecan] results in increased cleavage of PARP1 protein]",,,PMID:25667043,https://www.ncbi.nlm.nih.gov/pubmed/25667043,25667043,,,16136207,"Montariello D, Troiano A, Di Girolamo D, Beneke S, Calabrò V, Quesada P. Effect of poly(ADP-ribose)polymerase and DNA topoisomerase I inhibitors on the p53/p63-dependent survival of carcinoma cells. Biochem Pharmacol. 2015 Apr 01;94(3):212–9. doi: 10.1016/j.bcp.2015.01.012. PMID: 25667043."
1735298,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [topotecan results in increased ADP-ribosylation of and results in increased degradation of PARP1 protein]|topotecan results in increased ADP-ribosylation of and results in increased degradation of and results in increased cleavage of PARP1 protein",,,PMID:23376119,https://www.ncbi.nlm.nih.gov/pubmed/23376119,23376119,,,17434127,"Montariello D, Troiano A, Malanga M, Calabrò V, Quesada P. p63 involvement in poly(ADP-ribose) polymerase 1 signaling of topoisomerase I-dependent DNA damage in carcinoma cells. Biochem Pharmacol. 2013 Apr 01;85(7):999–1006. doi: 10.1016/j.bcp.2013.01.019. PMID: 23376119."
1735299,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of PARP1 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,PMC4325931,25644816,"Davis M, Li J, Knight E, Eldridge SR, Daniels KK, Bushel PR. Toxicogenomics profiling of bone marrow from rats treated with topotecan in combination with oxaliplatin: a mechanistic strategy to inform combination toxicity. Front. Genet. 2015 Feb 12;6(). doi: 10.3389/fgene.2015.00014."
1637624,60750,Comparative Toxicogenomics Database (CTD),Gemcitabine,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[alvocidib co-treated with gemcitabine] results in increased cleavage of PARP1 protein,,,PMID:15770523,https://www.ncbi.nlm.nih.gov/pubmed/15770523,15770523,,,22054282,2005; 90(1):25-31
1637625,60750,Comparative Toxicogenomics Database (CTD),Gemcitabine,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [gemcitabine results in increased cleavage of PARP1 protein],,,PMID:17146438,https://www.ncbi.nlm.nih.gov/pubmed/17146438,17146438,,,19370140,"Feng FY, Varambally S, Tomlins SA, Chun PY, Lopez CA, Li X, Davis MA, Chinnaiyan AM, Lawrence TS, Nyati MK. Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity. Oncogene. 2007 May 17;26(23):3431–9. doi: 10.1038/sj.onc.1210129. PMID: 17146438."
1637626,60750,Comparative Toxicogenomics Database (CTD),Gemcitabine,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gemcitabine results in increased cleavage of PARP1 protein,,,PMID:17146438|PMID:26894857|PMID:38122923,https://www.ncbi.nlm.nih.gov/pubmed/17146438|https://www.ncbi.nlm.nih.gov/pubmed/26894857|https://www.ncbi.nlm.nih.gov/pubmed/38122923,17146438|26894857|38122923,,PMC4951245,19370140|24310209|36425013,"Himura R, Kawano S, Nagata Y, Kawai M, Ota A, Kudo Y, Yoshino Y, Fujimoto N, Miyamoto H, Endo S, Ikari A. Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer. Chem Biol Interact. 2024 Jan 25;388():110840. doi: 10.1016/j.cbi.2023.110840. PMID: 38122923.|Qin L, Dong Z, Zhang JT. 14-3-3s regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression. Oncotarget. 2016 Apr 05;7(14):17726–36. PMID: 26894857; PMCID: PMC4951245.|Feng FY, Varambally S, Tomlins SA, Chun PY, Lopez CA, Li X, Davis MA, Chinnaiyan AM, Lawrence TS, Nyati MK. Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity. Oncogene. 2007 May 17;26(23):3431–9. doi: 10.1038/sj.onc.1210129. PMID: 17146438."
1637627,60750,Comparative Toxicogenomics Database (CTD),Gemcitabine,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SFN protein inhibits the reaction [gemcitabine results in increased cleavage of PARP1 protein]|yap1 protein affects the reaction [gemcitabine results in increased cleavage of PARP1 protein],,,PMID:26894857,https://www.ncbi.nlm.nih.gov/pubmed/26894857,26894857,,PMC4951245,24310209,"Qin L, Dong Z, Zhang JT. 14-3-3s regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression. Oncotarget. 2016 Apr 05;7(14):17726–36. PMID: 26894857; PMCID: PMC4951245."
1125532,60823,Comparative Toxicogenomics Database (CTD),Atorvastatin,D000069059,Atorvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000069059,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-tert-butylhydroquinone inhibits the reaction [atorvastatin results in increased cleavage of PARP1 protein],,,PMID:31423616,https://www.ncbi.nlm.nih.gov/pubmed/31423616,31423616,,,12868995,"Li LZ, Zhao ZM, Zhang L, He J, Zhang TF, Guo JB, Yu L, Zhao J, Yuan XY, Peng SQ. Atorvastatin induces mitochondrial dysfunction and cell apoptosis in HepG2 cells via inhibition of the Nrf2 pathway. J Appl Toxicol. 2019 Oct;39(10):1394–404. doi: 10.1002/jat.3825. PMID: 31423616."
1125533,60823,Comparative Toxicogenomics Database (CTD),Atorvastatin,D000069059,Atorvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000069059,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[atorvastatin co-treated with celecoxib] results in increased cleavage of PARP1 protein,,,PMID:18172863,https://www.ncbi.nlm.nih.gov/pubmed/18172863,18172863,,,28843101,"Xiao H, Zhang Q, Lin Y, Reddy BS, Yang CS. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer. 2008 May 01;122(9):2115–24. doi: 10.1002/ijc.23315. PMID: 18172863."
1125534,60823,Comparative Toxicogenomics Database (CTD),Atorvastatin,D000069059,Atorvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000069059,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Atorvastatin results in increased cleavage of PARP1 protein,,,PMID:16470222|PMID:20876807|PMID:31423616,https://www.ncbi.nlm.nih.gov/pubmed/16470222|https://www.ncbi.nlm.nih.gov/pubmed/20876807|https://www.ncbi.nlm.nih.gov/pubmed/31423616,16470222|20876807|31423616,,,12868995|22790935|26129634,"Li LZ, Zhao ZM, Zhang L, He J, Zhang TF, Guo JB, Yu L, Zhao J, Yuan XY, Peng SQ. Atorvastatin induces mitochondrial dysfunction and cell apoptosis in HepG2 cells via inhibition of the Nrf2 pathway. J Appl Toxicol. 2019 Oct;39(10):1394–404. doi: 10.1002/jat.3825. PMID: 31423616.|Yang PM, Liu YL, Lin YC, Shun CT, Wu MS, Chen CC. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res. 2010 Oct 01;70(19):7699–709. doi: 10.1158/0008-5472.can-10-1626. PMID: 20876807.|Fromigué O, Haÿ E, Modrowski D, Bouvet S, Jacquel A, Auberger P, Marie PJ. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ. 2006 Nov;13(11):1845–56. doi: 10.1038/sj.cdd.4401873. PMID: 16470222."
1125689,60823,Comparative Toxicogenomics Database (CTD),Atorvastatin,D000069059,Atorvastatin,https://ctdbase.org/detail.go?type=chem&acc=D000069059,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bafilomycin A1 promotes the reaction [atorvastatin results in increased cleavage of PARP1 protein]|atg5 mutant form promotes the reaction [atorvastatin results in increased cleavage of PARP1 protein]|atorvastatin results in increased cleavage of PARP1 protein|cdkn1a protein mutant form inhibits the reaction [atorvastatin results in increased cleavage of PARP1 protein],,,PMID:20876807,https://www.ncbi.nlm.nih.gov/pubmed/20876807,20876807,,,22790935,"Yang PM, Liu YL, Lin YC, Shun CT, Wu MS, Chen CC. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res. 2010 Oct 01;70(19):7699–709. doi: 10.1158/0008-5472.can-10-1626. PMID: 20876807."
1486589,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rucaparib inhibits the reaction [irinotecan results in increased expression of PARP1 protein]|irinotecan results in increased expression of PARP1 protein,,,PMID:30612311,https://www.ncbi.nlm.nih.gov/pubmed/30612311,30612311,,,18927893,2019; 37(5):948-960
1249350,61142,Toxin and Toxin Target Database (T3DB),Methyldichloroarsine,T3D1311,Methyldichloroarsine,http://www.t3db.ca/toxins/T3D1311,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1375826,61231,Toxin and Toxin Target Database (T3DB),Cobaltic acetate,T3D0654,Cobalt(III) acetate,http://www.t3db.ca/toxins/T3D0654,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1251699,61477,Toxin and Toxin Target Database (T3DB),Ferric arsenate,T3D1319,Ferric arsenate,http://www.t3db.ca/toxins/T3D1319,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1255306,61492,Toxin and Toxin Target Database (T3DB),Cobalt Co-60,T3D4973,Cobalt-60,http://www.t3db.ca/toxins/T3D4973,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1493955,61675,Toxin and Toxin Target Database (T3DB),COBALT MOLYBDENUM OXIDE (CoMoO4),T3D1385,Cobalt(II) molybdenum(VI) oxide,http://www.t3db.ca/toxins/T3D1385,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1712014,62244,Comparative Toxicogenomics Database (CTD),"2-Amino-3-methyl-9H-pyrido[2,3-b]indole",C017821,"2-amino-3-methyl-9H-pyrido(2,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C017821,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"2-amino-3-methyl-9H-pyrido(2,3-b)indole results in decreased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1712292,62274,Comparative Toxicogenomics Database (CTD),"2-Amino-3,4-dimethylimidazo(4,5-f)quinoline",C036989,"2-amino-3,4-dimethylimidazo(4,5-f)quinoline",https://ctdbase.org/detail.go?type=chem&acc=C036989,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"2-amino-3,4-dimethylimidazo(4,5-f)quinoline results in decreased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1713635,62275,Comparative Toxicogenomics Database (CTD),Meiqx,C036990,"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C036990,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1379297,62748,Toxin and Toxin Target Database (T3DB),Cobalt dihydroxide,T3D0662,Cobalt(II) hydroxide,http://www.t3db.ca/toxins/T3D0662,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1714174,62805,Comparative Toxicogenomics Database (CTD),"2-Amino-9H-pyrido[2,3-b]indole",C017822,"2-amino-9H-pyrido(2,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C017822,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"2-amino-9H-pyrido(2,3-b)indole results in decreased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1737204,62959,Comparative Toxicogenomics Database (CTD),Trovafloxacin,C080163,trovafloxacin,https://ctdbase.org/detail.go?type=chem&acc=C080163,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trovafloxacin results in increased cleavage of PARP1 protein|atg5 protein affects the reaction [trovafloxacin results in increased cleavage of PARP1 protein],,,PMID:33609687,https://www.ncbi.nlm.nih.gov/pubmed/33609687,33609687,,,25788223,"Ahn JH, Jegal H, Choi MS, Kim S, Park SM, Ahn J, Han HY, Cho HS, Yoon S, Oh JH. TNFa enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy. Toxicol Lett. 2021 May 15;342():73–84. doi: 10.1016/j.toxlet.2021.02.009. PMID: 33609687."
1116114,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [benzo(a)pyrene results in increased cleavage of PARP1 protein]",,,PMID:20840854,https://www.ncbi.nlm.nih.gov/pubmed/20840854,20840854,,,25557153,"Al-Anati L, Högberg J, Stenius U. Non-dioxin-like PCBs interact with benzo[a]pyrene-induced p53-responses and inhibit apoptosis. Toxicol Appl Pharmacol. 2010 Dec 01;249(2):166–77. doi: 10.1016/j.taap.2010.09.004. PMID: 20840854."
1116115,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in increased activity of PARP1 protein",,,PMID:16884709,https://www.ncbi.nlm.nih.gov/pubmed/16884709,16884709,,,17312947,"Lin CH, Lin PH. Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells. Chem Biol Interact. 2006 Aug 25;162(2):181–94. doi: 10.1016/j.cbi.2006.06.009. PMID: 16884709."
1116116,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PARP1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,,14081039,2012; 87(4):681-698
1269027,63112,BindingDB,,27504,4-HQN,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27504,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),5888,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
1591161,64506,Toxin and Toxin Target Database (T3DB),Diphenylcyanoarsine,T3D1308,Diphenylcyanoarsine,http://www.t3db.ca/toxins/T3D1308,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1122594,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ginkgo biloba extract inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 mrna],,,PMID:33378118,https://www.ncbi.nlm.nih.gov/pubmed/33378118,33378118,,,22375995,"Ding X, Zhang A, Li C, Ma L, Tang S, Wang Q, Yang G, Li J. The role of <scp>H3K9me2</scp>-regulated base excision repair genes in the repair of <scp>DNA</scp> damage induced by arsenic in <scp>HaCaT</scp> cells and the effects of <scp><i>Ginkgo biloba</i></scp> extract intervention. Environmental Toxicology. 2020 Dec 30;36(5):850–60. doi: 10.1002/tox.23088."
1269676,64961,Comparative Toxicogenomics Database (CTD),Norharman,C010262,norharman,https://ctdbase.org/detail.go?type=chem&acc=C010262,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Norharman results in increased cleavage of PARP1 protein,,,PMID:35985368,https://www.ncbi.nlm.nih.gov/pubmed/35985368,35985368,,,35324957,"Feng Y, Chen S, Zhao Y, Wu D, Li G. Heterocyclic aromatic amines induce Neuro-2a cells cytotoxicity through oxidative stress-mediated mitochondria-dependent apoptotic signals. Food Chem Toxicol. 2022 Oct;168():113376. doi: 10.1016/j.fct.2022.113376. PMID: 35985368."
1737842,64971,Comparative Toxicogenomics Database (CTD),Betulinic Acid,D000094062,Betulinic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000094062,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[betulinic acid co-treated with oxygen] results in increased cleavage of PARP1 protein,,,PMID:33181113,https://www.ncbi.nlm.nih.gov/pubmed/33181113,33181113,,,24409193,"Kutkowska J, Strzadala L, Rapak A. Hypoxia increases the apoptotic response to betulinic acid and betulin in human non-small cell lung cancer cells. Chem Biol Interact. 2021 Jan 05;333():109320. doi: 10.1016/j.cbi.2020.109320. PMID: 33181113."
1737843,64971,Comparative Toxicogenomics Database (CTD),Betulinic Acid,D000094062,Betulinic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000094062,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Betulinic acid promotes the reaction [gefitinib results in increased cleavage of PARP1 protein],,,PMID:30136359,https://www.ncbi.nlm.nih.gov/pubmed/30136359,30136359,,,5341386,"Ko JL, Lin CH, Chen HC, Hung WH, Chien PJ, Chang HY, Wang BY. Effects and mechanisms of betulinic acid on improving EGFR TKI-resistance of lung cancer cells. Environ Toxicol. 2018 Nov;33(11):1153–9. doi: 10.1002/tox.22621. PMID: 30136359."
1737844,64971,Comparative Toxicogenomics Database (CTD),Betulinic Acid,D000094062,Betulinic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000094062,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Betulinic acid results in increased cleavage of PARP1 protein,,,PMID:30136359|PMID:33181113,https://www.ncbi.nlm.nih.gov/pubmed/30136359|https://www.ncbi.nlm.nih.gov/pubmed/33181113,30136359|33181113,,,5341386|24409193,"Kutkowska J, Strzadala L, Rapak A. Hypoxia increases the apoptotic response to betulinic acid and betulin in human non-small cell lung cancer cells. Chem Biol Interact. 2021 Jan 05;333():109320. doi: 10.1016/j.cbi.2020.109320. PMID: 33181113.|Ko JL, Lin CH, Chen HC, Hung WH, Chien PJ, Chang HY, Wang BY. Effects and mechanisms of betulinic acid on improving EGFR TKI-resistance of lung cancer cells. Environ Toxicol. 2018 Nov;33(11):1153–9. doi: 10.1002/tox.22621. PMID: 30136359."
1737845,64971,Comparative Toxicogenomics Database (CTD),Betulinic Acid,D000094062,Betulinic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000094062,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Betulinic acid results in increased expression of PARP1 protein modified form,,,PMID:26540049,https://www.ncbi.nlm.nih.gov/pubmed/26540049,26540049,,PMC4661812,32372832,"Bache M, Münch C, Güttler A, Wichmann H, Theuerkorn K, Emmerich D, Paschke R, Vordermark D. Betulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells. Int J Mol Sci. 2015 Nov 03;16(11):26249–62. PMID: 26540049; PMCID: PMC4661812."
1270519,64987,Comparative Toxicogenomics Database (CTD),Tenofovir (parent),D000068698,Tenofovir,https://ctdbase.org/detail.go?type=chem&acc=D000068698,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Tenofovir results in increased expression of PARP1 protein|melatonin inhibits the reaction [tenofovir results in increased expression of PARP1 protein],,,PMID:33146023,https://www.ncbi.nlm.nih.gov/pubmed/33146023,33146023,,,19663176,"Ramamoorthy H, Abraham P, Isaac B. Melatonin protects against tenofovir-induced nephrotoxicity in rats by targeting multiple cellular pathways. Hum Exp Toxicol. 2021 May;40(5):826–50. doi: 10.1177/0960327120968860. PMID: 33146023."
1394983,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),CAT protein inhibits the reaction [[epigallocatechin gallate co-treated with arsenite] results in increased cleavage of PARP1 protein]|[epigallocatechin gallate co-treated with arsenite] results in increased cleavage of PARP1 protein,,,PMID:26375285,https://www.ncbi.nlm.nih.gov/pubmed/26375285,26375285,,PMC4574201,33717518,"Kim J, Choi J, Lee H, Byun CJ, Park J, Park JH, Cho H, Cho S, Jo SA, Jo I. The Green Tea Component (-)-Epigallocatechin-3-Gallate Sensitizes Primary Endothelial Cells to Arsenite-Induced Apoptosis by Decreasing c-Jun N-Terminal Kinase-Mediated Catalase Activity. PLoS ONE. 2015 Sep 16;10(9):e0138590. doi: 10.1371/journal.pone.0138590."
1394984,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Epigallocatechin gallate affects the cleavage of PARP1 protein,,,PMID:23954321,https://www.ncbi.nlm.nih.gov/pubmed/23954321,23954321,,,8013580,"Kumazaki M, Noguchi S, Yasui Y, Iwasaki J, Shinohara H, Yamada N, Akao Y. Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells. The Journal of Nutritional Biochemistry. 2013 Nov;24(11):1849–58. doi: 10.1016/j.jnutbio.2013.04.006."
1394985,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Epigallocatechin gallate inhibits the reaction [potassium chromate(vi) results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,PMC3259276,3147257,"Wu F, Sun H, Kluz T, Clancy HA, Kiok K, Costa M. Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicology and Applied Pharmacology. 2012 Jan;258(2):166–75. doi: 10.1016/j.taap.2011.10.018."
1394986,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Epigallocatechin gallate results in increased activity of PARP1 protein,,,PMID:15657356,https://www.ncbi.nlm.nih.gov/pubmed/15657356,15657356,,,3699045,"Roy AM, Baliga MS, Katiyar SK. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor–negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. 2005 Jan 01;4(1):81–90. doi: 10.1158/1535-7163.81.4.1."
1394987,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Epigallocatechin gallate results in increased cleavage of PARP1 protein,,,PMID:15705601|PMID:15764647,https://www.ncbi.nlm.nih.gov/pubmed/15705601|https://www.ncbi.nlm.nih.gov/pubmed/15764647,15705601|15764647,,,15280234|22048888,"Hastak K, Agarwal MK, Mukhtar H, Agarwal ML. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J. 2005 May;19(7):789–91. doi: 10.1096/fj.04-2226fje. PMID: 15764647.|Qanungo S, Das M, Haldar S, Basu A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis. 2005 May;26(5):958–67. doi: 10.1093/carcin/bgi040. PMID: 15705601."
1394988,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Epigallocatechin gallate affects the activity of PARP1 protein,,,PMID:25955525,https://www.ncbi.nlm.nih.gov/pubmed/25955525,25955525,,PMC4425400,26984062,"Shen K, Feng X, Su R, Xie H, Zhou L, Zheng S. Epigallocatechin 3-Gallate Ameliorates Bile Duct Ligation Induced Liver Injury in Mice by Modulation of Mitochondrial Oxidative Stress and Inflammation. PLoS ONE. 2015 May 08;10(5):e0126278. doi: 10.1371/journal.pone.0126278."
1738026,65094,Comparative Toxicogenomics Database (CTD),25-Hydroxycholesterol,C007997,25-hydroxycholesterol,https://ctdbase.org/detail.go?type=chem&acc=C007997,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),25-hydroxycholesterol results in increased cleavage of PARP1 protein,,,PMID:39197811,https://www.ncbi.nlm.nih.gov/pubmed/39197811,39197811,,,37652016,"Lee KM, Kim TH, Noh EJ, Han JW, Kim JS, Lee SK. 25-Hydroxycholesterol induces oxidative stress, leading to apoptosis and ferroptosis in extravillous trophoblasts. Chem Biol Interact. 2024 Nov 01;403():111214. doi: 10.1016/j.cbi.2024.111214. PMID: 39197811."
1508971,65126,Comparative Toxicogenomics Database (CTD),Carnosic acid,C018381,salvin,https://ctdbase.org/detail.go?type=chem&acc=C018381,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Salvin results in decreased expression of PARP1 protein|acetylcysteine inhibits the reaction [salvin results in increased cleavage of PARP1 protein]|salvin results in increased cleavage of PARP1 protein,,,PMID:28918123,https://www.ncbi.nlm.nih.gov/pubmed/28918123,28918123,,,25013213,"Zhang X, Chen Y, Cai G, Li X, Wang D. Carnosic acid induces apoptosis of hepatocellular carcinoma cells via ROS-mediated mitochondrial pathway. Chem Biol Interact. 2017 Nov 01;277():91–100. doi: 10.1016/j.cbi.2017.09.005. PMID: 28918123."
1508972,65126,Comparative Toxicogenomics Database (CTD),Carnosic acid,C018381,salvin,https://ctdbase.org/detail.go?type=chem&acc=C018381,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),OPA1 protein affects the reaction [salvin inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein]],,,PMID:31705926,https://www.ncbi.nlm.nih.gov/pubmed/31705926,31705926,,,3322047,"Lin CY, Chen WJ, Fu RH, Tsai CW. Upregulation of OPA1 by carnosic acid is mediated through induction of IKK? ubiquitination by parkin and protects against neurotoxicity. Food Chem Toxicol. 2020 Feb;136():110942. doi: 10.1016/j.fct.2019.110942. PMID: 31705926."
1508973,65126,Comparative Toxicogenomics Database (CTD),Carnosic acid,C018381,salvin,https://ctdbase.org/detail.go?type=chem&acc=C018381,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PINK1 protein affects the reaction [salvin inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein]],,,PMID:30707903,https://www.ncbi.nlm.nih.gov/pubmed/30707903,30707903,,,11504347,"Lin CY, Tsai CW. PINK1/parkin-mediated mitophagy pathway is related to neuroprotection by carnosic acid in SH-SY5Y cells. Food Chem Toxicol. 2019 Mar;125():430–7. doi: 10.1016/j.fct.2019.01.027. PMID: 30707903."
1509092,65126,Comparative Toxicogenomics Database (CTD),Carnosic acid,C018381,salvin,https://ctdbase.org/detail.go?type=chem&acc=C018381,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Salvin inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein],,,PMID:25446857|PMID:30707903|PMID:31705926,https://www.ncbi.nlm.nih.gov/pubmed/25446857|https://www.ncbi.nlm.nih.gov/pubmed/30707903|https://www.ncbi.nlm.nih.gov/pubmed/31705926,25446857|30707903|31705926,,,3322047|11504347|20876534,"Lin CY, Chen WJ, Fu RH, Tsai CW. Upregulation of OPA1 by carnosic acid is mediated through induction of IKK? ubiquitination by parkin and protects against neurotoxicity. Food Chem Toxicol. 2020 Feb;136():110942. doi: 10.1016/j.fct.2019.110942. PMID: 31705926.|Lin CY, Tsai CW. PINK1/parkin-mediated mitophagy pathway is related to neuroprotection by carnosic acid in SH-SY5Y cells. Food Chem Toxicol. 2019 Mar;125():430–7. doi: 10.1016/j.fct.2019.01.027. PMID: 30707903.|Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC, Tsai CW. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. Chem Biol Interact. 2015 Jan 05;225():40–6. doi: 10.1016/j.cbi.2014.11.011. PMID: 25446857."
1509093,65126,Comparative Toxicogenomics Database (CTD),Carnosic acid,C018381,salvin,https://ctdbase.org/detail.go?type=chem&acc=C018381,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Salvin inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein],,,PMID:25446857,https://www.ncbi.nlm.nih.gov/pubmed/25446857,25446857,,,20876534,"Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC, Tsai CW. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. Chem Biol Interact. 2015 Jan 05;225():40–6. doi: 10.1016/j.cbi.2014.11.011. PMID: 25446857."
1692694,65341,Comparative Toxicogenomics Database (CTD),Proadifen Hydrochloride,D011335,Proadifen,https://ctdbase.org/detail.go?type=chem&acc=D011335,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[proadifen co-treated with cisplatin] results in increased cleavage of PARP1 protein,,,PMID:26721606,https://www.ncbi.nlm.nih.gov/pubmed/26721606,26721606,,,6690940,"Jendželovský R, Jendželovská Z, Hilovská L, Koval J, Mikeš J, Fedorocko P. Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin. Toxicol Lett. 2016 Jan 22;243():56–66. doi: 10.1016/j.toxlet.2015.12.002. PMID: 26721606."
1399168,65357,Comparative Toxicogenomics Database (CTD),Peroxynitric acid,C039642,peroxynitric acid,https://ctdbase.org/detail.go?type=chem&acc=C039642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Peroxynitric acid results in increased activity of PARP1 protein,,,PMID:17430113,https://www.ncbi.nlm.nih.gov/pubmed/17430113,17430113,,,329967,Penberthy WT. Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease. Curr Drug Metab. 2007 Apr;8(3):245–66. doi: 10.2174/138920007780362545. PMID: 17430113.
1692827,65399,Comparative Toxicogenomics Database (CTD),Triciribine,C023764,triciribine,https://ctdbase.org/detail.go?type=chem&acc=C023764,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Triciribine promotes the reaction [[epothilone A co-treated with metformin] results in increased expression of PARP1 mrna]|triciribine inhibits the reaction [epothilone A results in increased expression of PARP1 mrna]|triciribine results in increased expression of PARP1 mRNA,,,PMID:29117515,https://www.ncbi.nlm.nih.gov/pubmed/29117515,29117515,,,30394656,"Rogalska A, Bukowska B, Marczak A. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells. Toxicol In Vitro. 2018 Mar;47():48–62. doi: 10.1016/j.tiv.2017.11.001. PMID: 29117515."
1620877,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Triptonide results in increased cleavage of PARP1 protein,,,PMID:28666825,https://www.ncbi.nlm.nih.gov/pubmed/28666825,28666825,,,3944593,"Yang P, Dong F, Zhou Q. Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway. Toxicol Lett. 2017 Aug 15;278():9–17. doi: 10.1016/j.toxlet.2017.06.010. PMID: 28666825."
1620878,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Triptonide results in decreased expression of PARP1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,,6813480,"Zhang X, Chen C, Zhong Y, Zeng X. lncRNA involved in triptonide-induced cytotoxicity in mouse germ cells. Reprod Toxicol. 2020 Dec;98():218–24. doi: 10.1016/j.reprotox.2020.10.004. PMID: 33045310."
1136139,65632,Comparative Toxicogenomics Database (CTD),Erdosteine,C048498,erdosteine,https://ctdbase.org/detail.go?type=chem&acc=C048498,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Erdosteine inhibits the reaction [cisplatin results in increased cleavage of PARP1 protein],,,PMID:26193055,https://www.ncbi.nlm.nih.gov/pubmed/26193055,26193055,,,26332711,"Kim SJ, Park C, Lee JN, Lim H, Hong GY, Moon SK, Lim DJ, Choe SK, Park R. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins. Toxicol Appl Pharmacol. 2015 Oct 15;288(2):192–202. doi: 10.1016/j.taap.2015.07.014. PMID: 26193055."
1136140,65632,Comparative Toxicogenomics Database (CTD),Erdosteine,C048498,erdosteine,https://ctdbase.org/detail.go?type=chem&acc=C048498,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Erdosteine affects the reaction [isoproterenol results in increased expression of PARP1 protein],,,PMID:33210414,https://www.ncbi.nlm.nih.gov/pubmed/33210414,33210414,,,5402141,"Mutneja E, Verma VK, Malik S, Sahu AK, Ray R, Bhatia J, Arya DS. Erdosteine salvages cardiac necrosis: Novel effect through modulation of MAPK and Nrf-2/HO-1 pathway. J Biochem Mol Toxicol. 2020 Dec;34(12):e22590. doi: 10.1002/jbt.22590. PMID: 33210414."
1405640,66208,Toxin and Toxin Target Database (T3DB),Cobaltic fluoride,T3D0670,Cobalt(III) fluoride,http://www.t3db.ca/toxins/T3D0670,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1570654,66414,Comparative Toxicogenomics Database (CTD),2-Methoxyestradiol,D000077584,2-Methoxyestradiol,https://ctdbase.org/detail.go?type=chem&acc=D000077584,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-methoxyestradiol results in increased expression of PARP1 protein modified form,,,PMID:23967052,https://www.ncbi.nlm.nih.gov/pubmed/23967052,23967052,,PMC3742604,8025600,"Kuo KL, Lin WC, Ho IL, Chang HC, Lee PY, Chung YT, Hsieh JT, Pu YS, Shi CS, Huang KH. 2-methoxyestradiol induces mitotic arrest, apoptosis, and synergistic cytotoxicity with arsenic trioxide in human urothelial carcinoma cells. PLoS One. 2013;8(8):e68703. PMID: 23967052; PMCID: PMC3742604."
1513177,66826,Toxin and Toxin Target Database (T3DB),Nitarsone,T3D0315,Nitarsone,http://www.t3db.ca/toxins/T3D0315,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1523195,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7955,Danio rerio (zebrafish),Nonylphenol results in increased expression of PARP1 protein,,,PMID:34843692,https://www.ncbi.nlm.nih.gov/pubmed/34843692,34843692,,,32517980,"Mukherjee U, Samanta A, Biswas S, Ghosh S, Das S, Banerjee S, Maitra S. Chronic exposure to nonylphenol induces oxidative stress and liver damage in male zebrafish (Danio rerio): Mechanistic insight into cellular energy sensors, lipid accumulation and immune modulation. Chem Biol Interact. 2022 Jan 05;351():109762. doi: 10.1016/j.cbi.2021.109762. PMID: 34843692."
1523196,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Nonylphenol results in increased cleavage of PARP1 protein|u 0126 inhibits the reaction [nonylphenol results in increased cleavage of PARP1 protein],,,PMID:23677851,https://www.ncbi.nlm.nih.gov/pubmed/23677851,23677851,,,24242797,"Choi MS, Park HJ, Oh JH, Lee EH, Park SM, Yoon S. Nonylphenol-induced apoptotic cell death in mouse TM4 Sertoli cells via the generation of reactive oxygen species and activation of the ERK signaling pathway. J Appl Toxicol. 2014 Jun;34(6):628–36. doi: 10.1002/jat.2886. PMID: 23677851."
1738242,67516,Comparative Toxicogenomics Database (CTD),"1H-1,2,3-Triazole",D014230,Triazoles,https://ctdbase.org/detail.go?type=chem&acc=D014230,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Triazoles analog results in increased cleavage of PARP1 protein,,,PMID:32217108,https://www.ncbi.nlm.nih.gov/pubmed/32217108,32217108,,,30469350,"Du J, Li J, Gao M, Guan Q, Liu T, Wu Y, Li Z, Zuo D, Zhang W, Wu Y. MAY, a novel tubulin inhibitor, induces cell apoptosis in A549 and A549/Taxol cells and inhibits epithelial-mesenchymal transition in A549/Taxol cells. Chem Biol Interact. 2020 May 25;323():109074. doi: 10.1016/j.cbi.2020.109074. PMID: 32217108."
1154215,68066,Comparative Toxicogenomics Database (CTD),Atranorin,C026304,atranorin,https://ctdbase.org/detail.go?type=chem&acc=C026304,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Atranorin results in increased cleavage of PARP1 protein,,,PMID:26969521,https://www.ncbi.nlm.nih.gov/pubmed/26969521,26969521,,,3907327,"Solár P, Hrcková G, Koptašíková L, Velebný S, Solárová Z, Backor M. Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: Anticancer and hepatoprotective effects of atranorin in vivo. Chem Biol Interact. 2016 Apr 25;250():27–37. doi: 10.1016/j.cbi.2016.03.012. PMID: 26969521."
1716035,68077,Comparative Toxicogenomics Database (CTD),Tangeretin,C059006,tangeretin,https://ctdbase.org/detail.go?type=chem&acc=C059006,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tangeretin results in decreased expression of and results in increased cleavage of PARP1 protein|agn 193109 inhibits the reaction [tangeretin results in decreased expression of and results in increased cleavage of PARP1 protein],,,PMID:33058988,https://www.ncbi.nlm.nih.gov/pubmed/33058988,33058988,,,7488748,"Wang Y, Chen Y, Zhang H, Chen J, Cao J, Chen Q, Li X, Sun C. Polymethoxyflavones from citrus inhibited gastric cancer cell proliferation through inducing apoptosis by upregulating RARß, both in vitro and in vivo. Food Chem Toxicol. 2020 Dec;146():111811. doi: 10.1016/j.fct.2020.111811. PMID: 33058988."
271244,68085,Comparative Toxicogenomics Database (CTD),Dictamnine,C026398,dictamnine,https://ctdbase.org/detail.go?type=chem&acc=C026398,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dictamnine results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:34861243,https://www.ncbi.nlm.nih.gov/pubmed/34861243,34861243,,,19707176,"Yu J, Zhang L, Peng J, Ward R, Hao P, Wang J, Zhang N, Yang Y, Guo X, Xiang C, An S, Xu TR. Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways. Biochem Pharmacol. 2022 Jan;195():114864. doi: 10.1016/j.bcp.2021.114864. PMID: 34861243."
272472,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Delphinidin results in decreased activity of PARP1 protein,,,PMID:17884996,https://www.ncbi.nlm.nih.gov/pubmed/17884996,17884996,,,20060229,"Geraets L, Moonen HJJ, Brauers K, Wouters EFM, Bast A, Hageman GJ. Dietary Flavones and Flavonoles Are Inhibitors of Poly(ADP-ribose)polymerase-1 in Pulmonary Epithelial Cells , The Journal of Nutrition. 2007 Oct;137(10):2190–5. doi: 10.1093/jn/137.10.2190."
272473,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Delphinidin results in increased cleavage of PARP1 protein,,,PMID:29451351,https://www.ncbi.nlm.nih.gov/pubmed/29451351,29451351,,PMC5969316,33070869,"Kang HM, Park BS, Kang HK, Park HR, Yu SB, Kim IR. Delphinidin induces apoptosis and inhibits epithelial-to-mesenchymal transition via the ERK/p38 MAPK-signaling pathway in human osteosarcoma cell lines. Environ Toxicol. 2018 Jun;33(6):640–9. PMID: 29451351; PMCID: PMC5969316."
1547433,68336,Toxin and Toxin Target Database (T3DB),Cobalt(II) cyanide,T3D1395,Cobalt(II) cyanide,http://www.t3db.ca/toxins/T3D1395,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1145915,68740,Comparative Toxicogenomics Database (CTD),Zoledronate,D000077211,Zoledronic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000077211,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenic trioxide promotes the reaction [zoledronic acid results in increased cleavage of PARP1 protein],,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,,30243435,"Abeltino M, Bonomini S, Bolzoni M, Storti P, Colla S, Todoerti K, Agnelli L, Neri A, Rizzoli V, Giuliani N. The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55–65. doi: 10.1016/j.exphem.2010.10.005. PMID: 20977926."
1146077,68740,Comparative Toxicogenomics Database (CTD),Zoledronate,D000077211,Zoledronic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000077211,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zoledronic acid results in increased cleavage of PARP1 protein,,,PMID:10780527|PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/10780527|https://www.ncbi.nlm.nih.gov/pubmed/20977926,10780527|20977926,,PMC2363380,19267778|30243435,"Abeltino M, Bonomini S, Bolzoni M, Storti P, Colla S, Todoerti K, Agnelli L, Neri A, Rizzoli V, Giuliani N. The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55–65. doi: 10.1016/j.exphem.2010.10.005. PMID: 20977926.|Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW. Bisphosphonates induce apoptosis in human breast cancer cell lines. British Journal of Cancer. 2000 Mar 21;82(8):1459–68. doi: 10.1054/bjoc.1999.1131."
1146078,68740,Comparative Toxicogenomics Database (CTD),Zoledronate,D000077211,Zoledronic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000077211,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zoledronic acid results in increased expression of PARP1 mRNA,,,PMID:24714768,https://www.ncbi.nlm.nih.gov/pubmed/24714768,24714768,,,31004536,2014; 89(1):101-106
1549575,68978,Toxin and Toxin Target Database (T3DB),Trimethylarsine,T3D0305,Trimethylarsine,http://www.t3db.ca/toxins/T3D0305,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1274238,69457,Comparative Toxicogenomics Database (CTD),"1,4-Anthraquinone",C416442,"1,4-anthraquinone",https://ctdbase.org/detail.go?type=chem&acc=C416442,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"1,4-anthraquinone analog results in increased cleavage of PARP1 protein",,,PMID:17912452,https://www.ncbi.nlm.nih.gov/pubmed/17912452,17912452,,,1018454,"Battina S, Hua D, Perchellet J, Zhao H, Lou K, Wang Y, Perchellet E. Novel substituted 1,4-anthracenediones with antitumor activity directly induce permeability transition in isolated mitochondria. Int J Oncol. 2007 Nov 01;(). doi: 10.3892/ijo.31.5.1231."
1158146,69509,Comparative Toxicogenomics Database (CTD),Dracorhodin,C060327,dracorhodin,https://ctdbase.org/detail.go?type=chem&acc=C060327,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dracorhodin analog results in increased cleavage of PARP1 protein,,,PMID:15215653|PMID:15684474|PMID:15813022|PMID:16864444,https://www.ncbi.nlm.nih.gov/pubmed/15215653|https://www.ncbi.nlm.nih.gov/pubmed/15684474|https://www.ncbi.nlm.nih.gov/pubmed/15813022|https://www.ncbi.nlm.nih.gov/pubmed/16864444,15215653|15684474|15813022|16864444,,,301895|15260401|21387668|32148332,"Xia M-, Wang M-, Cui Z, Tashiro S-, Onodera S, Minami M, Ikejima T. Dracorhodin perchlorate induces apoptosis in HL-60 cells. Journal of Asian Natural Products Research. 2006 Jun 01;8(4):335–43. doi: 10.1080/10286020500035300.|Xia M, Wang M, Tashiro S, Onodera S, Minami M, Ikejima T. Dracorhodin Perchlorate Induces A375-S2 Cell Apoptosis via Accumulation of p53 and Activation of Caspases. Biological & Pharmaceutical Bulletin. 2005;28(2):226–32. doi: 10.1248/bpb.28.226.|Xia MY, Wang MW, Wang HR, Tashiro S, Ikejima T. [Mechanism of dracorhodin perchlorate-induced Hela cell apoptosis]. Yao Xue Xue Bao. 2004 Dec;39(12):966–70. PMID: 15813022.|Xia M, Wang D, Wang M, Tashiro S, Onodera S, Minami M, Ikejima T. Dracorhodin perchlorate induces apoptosis via activation of caspases and generation of reactive oxygen species. J Pharmacol Sci. 2004 Jun;95(2):273–83. doi: 10.1254/jphs.fpj03102x. PMID: 15215653."
1718230,69785,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonamide,C063900,perfluorooctanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063900,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,7955,Danio rerio (zebrafish),Perfluorooctanesulfonamide results in decreased expression of PARP1 mRNA,,,PMID:39104825,https://www.ncbi.nlm.nih.gov/pubmed/39104825,39104825,,PMC11298493,37560392,"Rericha Y, St Mary L, Truong L, McClure R, Martin JK, Leonard SW, Thunga P, Simonich MT, Waters KM, Field JA, Tanguay RL. Diverse PFAS produce unique transcriptomic changes linked to developmental toxicity in zebrafish. Front Toxicol. 2024;6():1425537. PMID: 39104825; PMCID: PMC11298493."
1707678,70766,Comparative Toxicogenomics Database (CTD),5-Aminoisoquinoline,C549098,5-aminoisoquinoline,https://ctdbase.org/detail.go?type=chem&acc=C549098,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),5-aminoisoquinoline inhibits the reaction [cisplatin results in increased expression of PARP1 protein],,,PMID:29599129,https://www.ncbi.nlm.nih.gov/pubmed/29599129,29599129,,PMC5920139,1912741,"Quesada A, O'Valle F, Montoro-Molina S, Gómez-Morales M, Caba-Molina M, González JF, de Gracia MC, Osuna A, Vargas F, Wangensteen R. 5-aminoisoquinoline improves renal function and fibrosis during recovery phase of cisplatin-induced acute kidney injury in rats. Biosci Rep. 2018 Apr 27;38(2). PMID: 29599129; PMCID: PMC5920139."
1411309,71234,Drug Gene Interaction database (DGIdb),Nicaraven,,NICARAVEN,https://www.dgidb.org/drugs/ncit:C76580,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
1740863,71234,Therapeutic Target Database (TTD),Nicaraven,D0Z2UW,Nicaraven,https://idrblab.net/ttd/data/drug/details/D0Z2UW,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Modulator,,,,,,,,,
1740864,71234,DrugBank,Nicaraven,DB06397,Nicaraven,https://www.drugbank.ca/drugs/DB06397,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Modulator,,,PMID:37713619,https://www.ncbi.nlm.nih.gov/pubmed/37713619,37713619,,PMC10767903,36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751."
1627464,71384,Comparative Toxicogenomics Database (CTD),Dexrazoxane,D064730,Dexrazoxane,https://ctdbase.org/detail.go?type=chem&acc=D064730,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dexrazoxane inhibits the reaction [idarubicin results in increased expression of PARP1 protein]|dexrazoxane inhibits the reaction [idarubicin results in increased expression of PARP1 mrna],,,PMID:28973540,https://www.ncbi.nlm.nih.gov/pubmed/28973540,28973540,,,2572704,"Attia SM, Alshahrani AY, Al-Hamamah MA, Attia MM, Saquib Q, Ahmad SF, Ansari MA, Nadeem A, Bakheet SA. Dexrazoxane Averts Idarubicin-Evoked Genomic Damage by Regulating Gene Expression Profiling Associated With the DNA Damage-Signaling Pathway in BALB/c Mice. Toxicol Sci. 2017 Nov 01;160(1):161–72. doi: 10.1093/toxsci/kfx161. PMID: 28973540."
1629557,71905,Comparative Toxicogenomics Database (CTD),Olaquindox,C013168,olaquindox,https://ctdbase.org/detail.go?type=chem&acc=C013168,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CDKN1A protein affects the reaction [olaquindox results in increased cleavage of PARP1 protein],,,PMID:28757460,https://www.ncbi.nlm.nih.gov/pubmed/28757460,28757460,,,22280463,"Li D, Dai C, Yang X, Wang F, Yu X, Xiao X, Tang S. Critical role of p21 on olaquindox-induced mitochondrial apoptosis and S-phase arrest involves activation of PI3K/AKT and inhibition of Nrf2/HO-1pathway. Food Chem Toxicol. 2017 Oct;108(Pt A):148–60. doi: 10.1016/j.fct.2017.07.054. PMID: 28757460."
1629558,71905,Comparative Toxicogenomics Database (CTD),Olaquindox,C013168,olaquindox,https://ctdbase.org/detail.go?type=chem&acc=C013168,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Olaquindox results in increased cleavage of PARP1 protein,,,PMID:21549799|PMID:28757460,https://www.ncbi.nlm.nih.gov/pubmed/21549799|https://www.ncbi.nlm.nih.gov/pubmed/28757460,21549799|28757460,,,14059463|22280463,"Li D, Dai C, Yang X, Wang F, Yu X, Xiao X, Tang S. Critical role of p21 on olaquindox-induced mitochondrial apoptosis and S-phase arrest involves activation of PI3K/AKT and inhibition of Nrf2/HO-1pathway. Food Chem Toxicol. 2017 Oct;108(Pt A):148–60. doi: 10.1016/j.fct.2017.07.054. PMID: 28757460.|Zou J, Chen Q, Jin X, Tang S, Chen K, Zhang T, Xiao X. Olaquindox induces apoptosis through the mitochondrial pathway in HepG2 cells. Toxicology. 2011 Jul 29;285(3):104–13. doi: 10.1016/j.tox.2011.04.010. PMID: 21549799."
1411832,71942,Toxin and Toxin Target Database (T3DB),Dicobalt Edetate,T3D0674,Dicobalt edetate,http://www.t3db.ca/toxins/T3D0674,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1655468,72271,Comparative Toxicogenomics Database (CTD),7-Hydroxystaurosporine,C054852,7-hydroxystaurosporine,https://ctdbase.org/detail.go?type=chem&acc=C054852,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[alvocidib co-treated with 7-hydroxystaurosporine] results in increased cleavage of PARP1 protein,,,PMID:16012789,https://www.ncbi.nlm.nih.gov/pubmed/16012789,16012789,,,25464732,2005; 23(4):299-309
1655469,72271,Comparative Toxicogenomics Database (CTD),7-Hydroxystaurosporine,C054852,7-hydroxystaurosporine,https://ctdbase.org/detail.go?type=chem&acc=C054852,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein results in decreased susceptibility to 7-hydroxystaurosporine,,,PMID:21840268,https://www.ncbi.nlm.nih.gov/pubmed/21840268,21840268,,PMC3185120,12029770,"Madison DL, Stauffer D, Lundblad JR. The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest. DNA Repair. 2011 Oct;10(10):1003–13. doi: 10.1016/j.dnarep.2011.07.006."
1412517,72291,Comparative Toxicogenomics Database (CTD),Ilimaquinone,C467077,ilimaquinone,https://ctdbase.org/detail.go?type=chem&acc=C467077,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ilimaquinone results in increased cleavage of PARP1 protein|ilimaquinone promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]|[ilimaquinone results in increased susceptibility to TNFSF10 protein] which results in increased cleavage of PARP1 protein,,,PMID:24930757,https://www.ncbi.nlm.nih.gov/pubmed/24930757,24930757,,,32328701,"Do MT, Na M, Kim HG, Khanal T, Choi JH, Jin SW, Oh SH, Hwang IH, Chung YC, Kim HS, Jeong TC, Jeong HG. Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK-CHOP signaling pathways. Food Chem Toxicol. 2014 Sep;71():51–9. doi: 10.1016/j.fct.2014.06.001. PMID: 24930757."
1445317,72303,Comparative Toxicogenomics Database (CTD),Honokiol,C005499,honokiol,https://ctdbase.org/detail.go?type=chem&acc=C005499,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Honokiol results in increased cleavage of PARP1 protein,,,PMID:15802533,https://www.ncbi.nlm.nih.gov/pubmed/15802533,15802533,,,16654564,"Battle TE, Arbiser J, Frank DA. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 2005 Jul 15;106(2):690–7. doi: 10.1182/blood-2004-11-4273. PMID: 15802533."
1406939,72307,Comparative Toxicogenomics Database (CTD),Sesamin,C054125,sesamin,https://ctdbase.org/detail.go?type=chem&acc=C054125,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Sesamin inhibits the reaction [glucose results in increased cleavage of PARP1 protein],,,PMID:22524206,https://www.ncbi.nlm.nih.gov/pubmed/22524206,22524206,,,18766516,"Bournival J, Francoeur MA, Renaud J, Martinoli MG. Quercetin and sesamin protect neuronal PC12 cells from high-glucose-induced oxidation, nitrosative stress, and apoptosis. Rejuvenation Res. 2012 Jun;15(3):322–33. doi: 10.1089/rej.2011.1242. PMID: 22524206."
1741031,72326,Comparative Toxicogenomics Database (CTD),Betulin,C002503,betulin,https://ctdbase.org/detail.go?type=chem&acc=C002503,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Betulin analog promotes the reaction [oxygen deficiency results in increased expression of PARP1 protein modified form],,,PMID:26540049,https://www.ncbi.nlm.nih.gov/pubmed/26540049,26540049,,PMC4661812,32372832,"Bache M, Münch C, Güttler A, Wichmann H, Theuerkorn K, Emmerich D, Paschke R, Vordermark D. Betulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells. Int J Mol Sci. 2015 Nov 03;16(11):26249–62. PMID: 26540049; PMCID: PMC4661812."
1741032,72326,Comparative Toxicogenomics Database (CTD),Betulin,C002503,betulin,https://ctdbase.org/detail.go?type=chem&acc=C002503,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[betulin co-treated with oxygen] results in increased cleavage of PARP1 protein,,,PMID:33181113,https://www.ncbi.nlm.nih.gov/pubmed/33181113,33181113,,,24409193,"Kutkowska J, Strzadala L, Rapak A. Hypoxia increases the apoptotic response to betulinic acid and betulin in human non-small cell lung cancer cells. Chem Biol Interact. 2021 Jan 05;333():109320. doi: 10.1016/j.cbi.2020.109320. PMID: 33181113."
1741033,72326,Comparative Toxicogenomics Database (CTD),Betulin,C002503,betulin,https://ctdbase.org/detail.go?type=chem&acc=C002503,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Betulin results in increased cleavage of PARP1 protein,,,PMID:32190974|PMID:33181113,https://www.ncbi.nlm.nih.gov/pubmed/32190974|https://www.ncbi.nlm.nih.gov/pubmed/33181113,32190974|33181113,,,14927468|24409193,"Kutkowska J, Strzadala L, Rapak A. Hypoxia increases the apoptotic response to betulinic acid and betulin in human non-small cell lung cancer cells. Chem Biol Interact. 2021 Jan 05;333():109320. doi: 10.1016/j.cbi.2020.109320. PMID: 33181113.|Lin YC, Chen HY, Hsieh CP, Huang YF, Chang IL. Betulin inhibits mTOR and induces autophagy to promote apoptosis in human osteosarcoma cell lines. Environ Toxicol. 2020 Aug;35(8):879–87. doi: 10.1002/tox.22924. PMID: 32190974."
1741034,72326,Comparative Toxicogenomics Database (CTD),Betulin,C002503,betulin,https://ctdbase.org/detail.go?type=chem&acc=C002503,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloroquine inhibits the reaction [betulin results in increased cleavage of PARP1 protein],,,PMID:32190974,https://www.ncbi.nlm.nih.gov/pubmed/32190974,32190974,,,14927468,"Lin YC, Chen HY, Hsieh CP, Huang YF, Chang IL. Betulin inhibits mTOR and induces autophagy to promote apoptosis in human osteosarcoma cell lines. Environ Toxicol. 2020 Aug;35(8):879–87. doi: 10.1002/tox.22924. PMID: 32190974."
1552345,72344,Comparative Toxicogenomics Database (CTD),Nobiletin,C008661,nobiletin,https://ctdbase.org/detail.go?type=chem&acc=C008661,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nobiletin results in decreased expression of and results in increased cleavage of PARP1 protein|agn 193109 inhibits the reaction [nobiletin results in decreased expression of and results in increased cleavage of PARP1 protein],,,PMID:33058988,https://www.ncbi.nlm.nih.gov/pubmed/33058988,33058988,,,7488748,"Wang Y, Chen Y, Zhang H, Chen J, Cao J, Chen Q, Li X, Sun C. Polymethoxyflavones from citrus inhibited gastric cancer cell proliferation through inducing apoptosis by upregulating RARß, both in vitro and in vivo. Food Chem Toxicol. 2020 Dec;146():111811. doi: 10.1016/j.fct.2020.111811. PMID: 33058988."
1290662,72356,BindingDB,"5-Iodo-6-amino-1,2-benzopyrone",27505,5-Iabp,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27505,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),8511,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
1183967,72724,Comparative Toxicogenomics Database (CTD),Alantolactone,C004363,alantolactone,https://ctdbase.org/detail.go?type=chem&acc=C004363,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Alantolactone results in increased cleavage of PARP1 protein,,,PMID:22721982,https://www.ncbi.nlm.nih.gov/pubmed/22721982,22721982,,,26927866,"Lei JC, Yu JQ, Yin Y, Liu YW, Zou GL. Alantolactone induces activation of apoptosis in human hepatoma cells. Food Chem Toxicol. 2012 Sep;50(9):3313–9. doi: 10.1016/j.fct.2012.06.014. PMID: 22721982."
1630474,73057,Comparative Toxicogenomics Database (CTD),Schisanhenol,C045309,schisanhenol,https://ctdbase.org/detail.go?type=chem&acc=C045309,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Schisanhenol inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein],,,PMID:34732784,https://www.ncbi.nlm.nih.gov/pubmed/34732784,34732784,,PMC8566484,8235801,"Yang H, Li L, Jiao Y, Zhang Y, Wang Y, Zhu K, Sun C. Thioredoxin-1 mediates neuroprotection of Schisanhenol against MPP+-induced apoptosis via suppression of ASK1-P38-NF-?B pathway in SH-SY5Y cells. Scientific Reports. 2021 Nov 03;11(1):21604. doi: 10.1038/s41598-021-01000-3."
1741133,73078,Comparative Toxicogenomics Database (CTD),Tetrandrine,C009438,tetrandrine,https://ctdbase.org/detail.go?type=chem&acc=C009438,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tetrandrine results in increased cleavage of PARP1 protein,,,PMID:26822499,https://www.ncbi.nlm.nih.gov/pubmed/26822499,26822499,,,5988180,"Lien J, Lin M, Chang S, Lai K, Huang A, Yu F, Chung J. Tetrandrine induces programmed cell death in human oral cancer <scp>CAL</scp> 27 cells through the reactive oxygen species production and caspase-dependent pathways and associated with beclin-1-induced cell autophagy. Environmental Toxicology. 2016 Jan 29;32(1):329–43. doi: 10.1002/tox.22238."
1630983,73147,Comparative Toxicogenomics Database (CTD),Tingenin B,C066185,tingenin B,https://ctdbase.org/detail.go?type=chem&acc=C066185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tingenin B results in increased cleavage of PARP1 protein,,,PMID:27720947,https://www.ncbi.nlm.nih.gov/pubmed/27720947,27720947,,,29701750,"Cevatemre B, Botta B, Mori M, Berardozzi S, Ingallina C, Ulukaya E. The plant-derived triterpenoid tingenin B is a potent anticancer agent due to its cytotoxic activity on cancer stem cells of breast cancer in vitro. Chem Biol Interact. 2016 Dec 25;260():248–55. doi: 10.1016/j.cbi.2016.10.001. PMID: 27720947."
1630989,73285,Comparative Toxicogenomics Database (CTD),Isoalantolactone,C032787,isoalantolactone,https://ctdbase.org/detail.go?type=chem&acc=C032787,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Isoalantolactone results in increased expression of PARP1 protein modified form|acetylcysteine inhibits the reaction [isoalantolactone results in increased expression of PARP1 protein modified form]|isoalantolactone results in increased cleavage of PARP1 protein|tnfrsf10b protein promotes the reaction [isoalantolactone results in increased expression of PARP1 protein modified form]|benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [isoalantolactone results in increased expression of PARP1 protein modified form],,,PMID:29800641,https://www.ncbi.nlm.nih.gov/pubmed/29800641,29800641,,,21616822,"Lu Z, Zhang G, Zhang Y, Hua P, Fang M, Wu M, Liu T. Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells. Toxicol Appl Pharmacol. 2018 Aug 01;352():46–58. doi: 10.1016/j.taap.2018.05.026. PMID: 29800641."
1656482,73292,Comparative Toxicogenomics Database (CTD),Fascaplysine,C069346,fascaplysine,https://ctdbase.org/detail.go?type=chem&acc=C069346,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fascaplysine analog results in increased cleavage of PARP1 protein,,,PMID:28756150,https://www.ncbi.nlm.nih.gov/pubmed/28756150,28756150,,,22279191,"Sharma S, Guru SK, Manda S, Kumar A, Mintoo MJ, Prasad VD, Sharma PR, Mondhe DM, Bharate SB, Bhushan S. A marine sponge alkaloid derivative 4-chloro fascaplysin inhibits tumor growth and VEGF mediated angiogenesis by disrupting PI3K/Akt/mTOR signaling cascade. Chem Biol Interact. 2017 Sep 25;275():47–60. doi: 10.1016/j.cbi.2017.07.017. PMID: 28756150."
1184143,73359,Comparative Toxicogenomics Database (CTD),Alborixin,C012708,alborixin,https://ctdbase.org/detail.go?type=chem&acc=C012708,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Alborixin results in increased cleavage of PARP1 protein,,,PMID:27378626,https://www.ncbi.nlm.nih.gov/pubmed/27378626,27378626,,,22911241,"Shah AM, Wani A, Qazi PH, Rehman SU, Mushtaq S, Ali SA, Hussain A, Shah A, Qazi AK, Makhdoomi US, Hamid A, Kumar A. Isolation and characterization of alborixin from Streptomyces scabrisporus: A potent cytotoxic agent against human colon (HCT-116) cancer cells. Chem Biol Interact. 2016 Aug 25;256():198–208. doi: 10.1016/j.cbi.2016.06.032. PMID: 27378626."
1408905,73364,Comparative Toxicogenomics Database (CTD),Calpeptin,C071482,calpeptin,https://ctdbase.org/detail.go?type=chem&acc=C071482,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Calpeptin inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
1409069,73364,Comparative Toxicogenomics Database (CTD),Calpeptin,C071482,calpeptin,https://ctdbase.org/detail.go?type=chem&acc=C071482,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Calpeptin inhibits the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:25947082,https://www.ncbi.nlm.nih.gov/pubmed/25947082,25947082,,,26976018,2015; 53(4):2169-2188
1184314,73384,Comparative Toxicogenomics Database (CTD),Brazilin,C044362,brazilin,https://ctdbase.org/detail.go?type=chem&acc=C044362,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Brazilin results in increased expression of PARP1 protein modified form|bafilomycin A1 promotes the reaction [brazilin results in increased expression of PARP1 protein modified form]|becn1 inhibits the reaction [brazilin results in increased expression of PARP1 protein modified form],,,PMID:28063998,https://www.ncbi.nlm.nih.gov/pubmed/28063998,28063998,,,33743523,"He ZJ, Zhu FY, Li SS, Zhong L, Tan HY, Wang K. Inhibiting ROS-NF-?B-dependent autophagy enhanced brazilin-induced apoptosis in head and neck squamous cell carcinoma. Food Chem Toxicol. 2017 Mar;101():55–66. doi: 10.1016/j.fct.2017.01.002. PMID: 28063998."
1569836,73432,Comparative Toxicogenomics Database (CTD),Brusatol,C020237,brusatol,https://ctdbase.org/detail.go?type=chem&acc=C020237,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Brusatol results in increased cleavage of PARP1 protein,,,PMID:33465425,https://www.ncbi.nlm.nih.gov/pubmed/33465425,33465425,,,8200398,"Xie J, Lai Z, Zheng X, Liao H, Xian Y, Li Q, Wu J, Ip S, Xie Y, Chen J, Su Z, Lin Z, Yang X. Apoptotic activities of brusatol in human non-small cell lung cancer cells: Involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response. Toxicology. 2021 Mar 15;451():152680. doi: 10.1016/j.tox.2021.152680. PMID: 33465425."
1656819,73481,Comparative Toxicogenomics Database (CTD),Fangchinoline,C060802,fangchinoline,https://ctdbase.org/detail.go?type=chem&acc=C060802,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fangchinoline results in increased cleavage of PARP1 protein,,,PMID:28754437,https://www.ncbi.nlm.nih.gov/pubmed/28754437,28754437,,,22277570,"Lee HS, Safe S, Lee SO. Inactivation of the orphan nuclear receptor NR4A1 contributes to apoptosis induction by fangchinoline in pancreatic cancer cells. Toxicol Appl Pharmacol. 2017 Oct 01;332():32–9. doi: 10.1016/j.taap.2017.07.017. PMID: 28754437."
1446265,73635,Comparative Toxicogenomics Database (CTD),Homoeriodictyol,C503231,homoeriodictyol,https://ctdbase.org/detail.go?type=chem&acc=C503231,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Homoeriodictyol inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:29902531,https://www.ncbi.nlm.nih.gov/pubmed/29902531,29902531,,,12852916,"Shen T, Li HZ, Li AL, Li YR, Wang XN, Ren DM. Homoeriodictyol protects human endothelial cells against oxidative insults through activation of Nrf2 and inhibition of mitochondrial dysfunction. Vascul Pharmacol. 2018 Oct;109():72–82. doi: 10.1016/j.vph.2018.06.007. PMID: 29902531."
1721702,73641,Comparative Toxicogenomics Database (CTD),Arjunolic Acid,C061640,arjunolic acid,https://ctdbase.org/detail.go?type=chem&acc=C061640,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Arjunolic acid inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:21420465,https://www.ncbi.nlm.nih.gov/pubmed/21420465,21420465,,,28912899,"Pal S, Pal PB, Das J, Sil PC. Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro. Toxicology. 2011 May 10;283(2-3):129–39. doi: 10.1016/j.tox.2011.03.006. PMID: 21420465."
1570711,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,bisphenol AF,https://ctdbase.org/detail.go?type=chem&acc=C583074,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisphenol AF results in increased expression of PARP1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,,1984355,"Schaffert A, Krieg L, Weiner J, Schlichting R, Ueberham E, Karkossa I, Bauer M, Landgraf K, Junge KM, Wabitsch M, Lehmann J, Escher BI, Zenclussen AC, Körner A, Blüher M, Heiker JT, von Bergen M, Schubert K. Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156():106730. doi: 10.1016/j.envint.2021.106730. PMID: 34186270."
1579819,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PARP1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,,35532370,"Olsvik PA, Meier S, Zhang X, Goksøyr A, Karlsen OA, Yadetie F. Environmentally realistic concentrations of chlorinated, brominated, and fluorinated persistent organic pollutants induce the unfolded protein response as a shared stress pathway in the liver of Atlantic cod (<scp><i>Gadus morhua</i></scp>). J of Applied Toxicology. 2023 Aug;43(12):1859–71. doi: 10.1002/jat.4519."
1579820,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MIR155 mRNA promotes the reaction [perfluorooctane sulfonic acid results in increased cleavage of PARP1 protein],,,PMID:26844784,https://www.ncbi.nlm.nih.gov/pubmed/26844784,26844784,,,19550088,"Wan C, Han R, Liu L, Zhang F, Li F, Xiang M, Ding W. Role of miR-155 in fluorooctane sulfonate-induced oxidative hepatic damage via the Nrf2-dependent pathway. Toxicol Appl Pharmacol. 2016 Mar 15;295():85–93. doi: 10.1016/j.taap.2016.01.023. PMID: 26844784."
1579821,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased cleavage of PARP1 protein,,,PMID:26844784|PMID:34006824,https://www.ncbi.nlm.nih.gov/pubmed/26844784|https://www.ncbi.nlm.nih.gov/pubmed/34006824,26844784|34006824,,PMC8131593,19550088|31825718,"Wang L, Liu T, Yang S, Sun L, Zhao Z, Li L, She Y, Zheng Y, Ye X, Bao Q, Dong G, Li C, Cui J. Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome. Nature Communications. 2021 May 18;12(1):2915. doi: 10.1038/s41467-021-23201-0.|Wan C, Han R, Liu L, Zhang F, Li F, Xiang M, Ding W. Role of miR-155 in fluorooctane sulfonate-induced oxidative hepatic damage via the Nrf2-dependent pathway. Toxicol Appl Pharmacol. 2016 Mar 15;295():85–93. doi: 10.1016/j.taap.2016.01.023. PMID: 26844784."
1579822,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased cleavage of PARP1 protein,,,PMID:34006824,https://www.ncbi.nlm.nih.gov/pubmed/34006824,34006824,,PMC8131593,31825718,"Wang L, Liu T, Yang S, Sun L, Zhao Z, Li L, She Y, Zheng Y, Ye X, Bao Q, Dong G, Li C, Cui J. Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome. Nature Communications. 2021 May 18;12(1):2915. doi: 10.1038/s41467-021-23201-0."
1579823,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),GSDME protein affects the reaction [perfluorooctane sulfonic acid results in increased cleavage of PARP1 protein]|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [perfluorooctane sulfonic acid results in increased cleavage of PARP1 protein],,,PMID:37955688,https://www.ncbi.nlm.nih.gov/pubmed/37955688,37955688,,PMC10761489,36183122,2023; 98(1):207-221
1579824,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in increased cleavage of PARP1 protein,,,PMID:26844784|PMID:31588057|PMID:35934180|PMID:37955688,https://www.ncbi.nlm.nih.gov/pubmed/26844784|https://www.ncbi.nlm.nih.gov/pubmed/31588057|https://www.ncbi.nlm.nih.gov/pubmed/35934180|https://www.ncbi.nlm.nih.gov/pubmed/37955688,26844784|31588057|35934180|37955688,,PMC10761489,6073502|19550088|34616613|36183122,"2023; 98(1):207-221|Tang L, Yu J, Zhuge S, Chen H, Zhang L, Jiang G. Oxidative stress and Cx43-mediated apoptosis are involved in PFOS-induced nephrotoxicity. Toxicology. 2022 Aug;478():153283. doi: 10.1016/j.tox.2022.153283. PMID: 35934180.|Wu P, Ding C, Yan M, Qian B, Wang W, Sun P, Zhao J. Per?uorooctane sulfonate induces apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins in PC12 cells. J Toxicol Sci. 2019;44(10):657–66. doi: 10.2131/jts.44.657. PMID: 31588057.|Wan C, Han R, Liu L, Zhang F, Li F, Xiang M, Ding W. Role of miR-155 in fluorooctane sulfonate-induced oxidative hepatic damage via the Nrf2-dependent pathway. Toxicol Appl Pharmacol. 2016 Mar 15;295():85–93. doi: 10.1016/j.taap.2016.01.023. PMID: 26844784."
299931,77082,Comparative Toxicogenomics Database (CTD),Bendamustine Hydrochloride,D000069461,Bendamustine Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069461,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bendamustine hydrochloride results in increased cleavage of PARP1 protein,,,PMID:12948851,https://www.ncbi.nlm.nih.gov/pubmed/12948851,12948851,,,22655244,"Chow KU, Nowak D, Boehrer S, Ruthardt M, Knau A, Hoelzer D, Mitrou PS, Weidmann E. Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation. Biochem Pharmacol. 2003 Sep 01;66(5):711–24. doi: 10.1016/s0006-2952(03)00410-6. PMID: 12948851."
1665838,79018,Toxin and Toxin Target Database (T3DB),Cacodyl,T3D1305,Cacodyl,http://www.t3db.ca/toxins/T3D1305,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1593290,79054,Toxin and Toxin Target Database (T3DB),"Arsine, methyl-",T3D0303,Methylarsine,http://www.t3db.ca/toxins/T3D0303,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1593856,79055,Toxin and Toxin Target Database (T3DB),Dimethylarsine,T3D0304,Dimethylarsine,http://www.t3db.ca/toxins/T3D0304,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1153242,82145,Comparative Toxicogenomics Database (CTD),2-Bromopalmitic acid,C022776,2-bromopalmitate,https://ctdbase.org/detail.go?type=chem&acc=C022776,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-bromopalmitate inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased palmitoylation of PARP1 protein],,,PMID:38195004,https://www.ncbi.nlm.nih.gov/pubmed/38195004,38195004,,PMC10923080,36719880,"Lee C, Jarrell ZR, Lee HY, Singer G, Tran VT, Orr M, Jones DP, Go Y. Protein S-palmitoylation enhances profibrotic signaling in response to cadmium. Toxicology and Applied Pharmacology. 2024 Feb;483():116806. doi: 10.1016/j.taap.2024.116806."
1666768,82223,Toxin and Toxin Target Database (T3DB),Arsenic pentafluoride,T3D1297,Arsenic pentafluoride,http://www.t3db.ca/toxins/T3D1297,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1667629,83003,Toxin and Toxin Target Database (T3DB),Yttrium arsenide,T3D1292,Yttrium(III) arsenide,http://www.t3db.ca/toxins/T3D1292,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1668176,83261,Toxin and Toxin Target Database (T3DB),2-Phenylene-bis-dimethylarsine,T3D1304,"1,2-Bis(dimethylarsino)benzene",http://www.t3db.ca/toxins/T3D1304,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1324066,83494,Comparative Toxicogenomics Database (CTD),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of PARP1 protein",,,PMID:33771661,https://www.ncbi.nlm.nih.gov/pubmed/33771661,33771661,,,11554003,"Huang CF, Liu SH, Su CC, Fang KM, Yen CC, Yang CY, Tang FC, Liu JM, Wu CC, Lee KI, Chen YW. Roles of ERK/Akt signals in mitochondria-dependent and endoplasmic reticulum stress-triggered neuronal cell apoptosis induced by 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, a major active metabolite of bisphenol A. Toxicology. 2021 May 15;455():152764. doi: 10.1016/j.tox.2021.152764. PMID: 33771661."
1324067,83494,Comparative Toxicogenomics Database (CTD),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of PARP1 protein",,,PMID:33922211,https://www.ncbi.nlm.nih.gov/pubmed/33922211,33922211,,PMC8122752,18329177,"Huang CC, Yang CY, Su CC, Fang KM, Yen CC, Lin CT, Liu JM, Lee KI, Chen YW, Liu SH, Huang CF. 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, a Major Active Metabolite of Bisphenol A, Triggers Pancreatic ß-Cell Death via a JNK/AMPKa Activation-Regulated Endoplasmic Reticulum Stress-Mediated Apoptotic Pathway. Int J Mol Sci. 2021 Apr 22;22(9). PMID: 33922211; PMCID: PMC8122752."
1664140,86132,Comparative Toxicogenomics Database (CTD),Cyproconazole,C093628,cyproconazole,https://ctdbase.org/detail.go?type=chem&acc=C093628,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cyproconazole affects the cleavage of PARP1 protein,,,PMID:39207506,https://www.ncbi.nlm.nih.gov/pubmed/39207506,39207506,,PMC11489238,37659783,2024; 98(11):3641-3658
1665718,86398,Comparative Toxicogenomics Database (CTD),Fludioxonil,C108339,fludioxonil,https://ctdbase.org/detail.go?type=chem&acc=C108339,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fludioxonil results in increased expression of PARP1 protein,,,PMID:23052036,https://www.ncbi.nlm.nih.gov/pubmed/23052036,23052036,,PMC3537134,28923953,2012; 131(1):71-83
1191135,88293,Comparative Toxicogenomics Database (CTD),"beta-D-Glucopyranose, 1-thio-, 2,3,4,6-tetraacetate",D001310,Auranofin,https://ctdbase.org/detail.go?type=chem&acc=D001310,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Auranofin results in decreased activity of PARP1 protein,,,PMID:21370912,https://www.ncbi.nlm.nih.gov/pubmed/21370912,21370912,,,13366100,"Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ, Casini A. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem. 2011 Apr 14;54(7):2196–206. doi: 10.1021/jm2000135. PMID: 21370912."
1191136,88293,Comparative Toxicogenomics Database (CTD),"beta-D-Glucopyranose, 1-thio-, 2,3,4,6-tetraacetate",D001310,Auranofin,https://ctdbase.org/detail.go?type=chem&acc=D001310,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Auranofin results in increased cleavage of PARP1 protein,,,PMID:15159275,https://www.ncbi.nlm.nih.gov/pubmed/15159275,15159275,,PMC1575039,9211237,"Kim IS, Jin JY, Lee IH, Park SJ: Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro. Br J Pharmacol. 2004 Jun;142(4):749-55. Epub 2004 May 24."
1666380,88708,Comparative Toxicogenomics Database (CTD),Gentiopicrin,C012997,gentiopicroside,https://ctdbase.org/detail.go?type=chem&acc=C012997,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gentiopicroside results in increased expression of and results in increased cleavage of PARP1 protein|gentiopicroside results in increased expression of PARP1 mRNA,,,PMID:38852899,https://www.ncbi.nlm.nih.gov/pubmed/38852899,38852899,,,37306935,"Valenta Šobot A, Drakulic D, Todorovic A, Janic M, Božovic A, Todorovic L, Filipovic Trickovic J. Gentiopicroside and swertiamarin induce non-selective oxidative stress-mediated cytotoxic effects in human peripheral blood mononuclear cells. Chem Biol Interact. 2024 Aug 01;398():111103. doi: 10.1016/j.cbi.2024.111103. PMID: 38852899."
1666381,88708,Comparative Toxicogenomics Database (CTD),Gentiopicrin,C012997,gentiopicroside,https://ctdbase.org/detail.go?type=chem&acc=C012997,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Gentiopicroside inhibits the reaction [[[galactosamine co-treated with lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein],,,PMID:20558151,https://www.ncbi.nlm.nih.gov/pubmed/20558151,20558151,,,20790301,"Lian LH, Wu YL, Wan Y, Li X, Xie WX, Nan JX. Anti-apoptotic activity of gentiopicroside in D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure. Chem Biol Interact. 2010 Oct 06;188(1):127–33. doi: 10.1016/j.cbi.2010.06.004. PMID: 20558151."
1606318,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nicotine inhibits the reaction [aflatoxin B1 results in increased expression of PARP1 protein modified form],,,PMID:22743290,https://www.ncbi.nlm.nih.gov/pubmed/22743290,22743290,,,20146966,"Yang XJ, Lu HY, Li ZY, Bian Q, Qiu LL, Li Z, Liu Q, Li J, Wang X, Wang SL. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells. Toxicology. 2012 Oct 28;300(3):138–48. doi: 10.1016/j.tox.2012.06.010. PMID: 22743290."
1606319,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nicotine inhibits the reaction [camptothecin results in increased cleavage of PARP1 protein]|nicotine inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein],,,PMID:24095863,https://www.ncbi.nlm.nih.gov/pubmed/24095863,24095863,,,2487008,"Dinicola S, Morini V, Coluccia P, Proietti S, D'Anselmi F, Pasqualato A, Masiello MG, Palombo A, De Toma G, Bizzarri M, Cucina A. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs. Toxicol In Vitro. 2013 Dec;27(8):2256–63. doi: 10.1016/j.tiv.2013.09.020. PMID: 24095863."
1606320,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nicotine inhibits the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:20457658,https://www.ncbi.nlm.nih.gov/pubmed/20457658,20457658,,,3119660,"Martínez-García E, Irigoyen M, González-Moreno O, Corrales L, Teijeira A, Salvo E, Rouzaut A. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment. Toxicol Sci. 2010 Aug;116(2):467–76. doi: 10.1093/toxsci/kfq138. PMID: 20457658."
1606321,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Folic acid inhibits the reaction [nicotine results in decreased expression of PARP1 protein]|nicotine results in decreased expression of PARP1 protein,,,PMID:29972271,https://www.ncbi.nlm.nih.gov/pubmed/29972271,29972271,,,6755884,"Bhattacharjee A, Prasad SK, Banerjee O, Singh S, Banerjee A, Bose A, Pal S, Maji BK, Mukherjee S. Targeting mitochondria with folic acid and vitamin B<sub>12</sub>ameliorates nicotine mediated islet cell dysfunction. Environmental Toxicology. 2018 Jul 04;33(9):988–1000. doi: 10.1002/tox.22586."
1679729,89859,Toxin and Toxin Target Database (T3DB),Aluminum arsenide (alas),T3D1289,Aluminium arsenide,http://www.t3db.ca/toxins/T3D1289,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1193580,91458,Comparative Toxicogenomics Database (CTD),Aucubin,C006650,aucubin,https://ctdbase.org/detail.go?type=chem&acc=C006650,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Aucubin inhibits the reaction [cisplatin results in increased cleavage of PARP1 protein],,,PMID:32504734,https://www.ncbi.nlm.nih.gov/pubmed/32504734,32504734,,,26425878,"Potocnjak I, Marinic J, Baticic L, Šimic L, Broznic D, Domitrovic R. Aucubin administered by either oral or parenteral route protects against cisplatin-induced acute kidney injury in mice. Food Chem Toxicol. 2020 Aug;142():111472. doi: 10.1016/j.fct.2020.111472. PMID: 32504734."
1165131,91472,Comparative Toxicogenomics Database (CTD),Friedelin,C060796,friedelin,https://ctdbase.org/detail.go?type=chem&acc=C060796,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Friedelin inhibits the reaction [ethanol results in increased expression of PARP1 protein],,,PMID:37939858,https://www.ncbi.nlm.nih.gov/pubmed/37939858,37939858,,,36361141,"Sandhu M, Irfan HM, Arshad L, Ullah A, Shah SA, Ali H. Friedelin and Glutinol induce neuroprotection against ethanol induced neurotoxicity in pup's brain through reduction of TNF-a, NF-kB, caspase-3 and PARP-1. Neurotoxicology. 2023 Dec;99():274–81. doi: 10.1016/j.neuro.2023.11.002. PMID: 37939858."
1677596,91474,Comparative Toxicogenomics Database (CTD),7-Ketocholesterol,C003001,7-ketocholesterol,https://ctdbase.org/detail.go?type=chem&acc=C003001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),7-ketocholesterol results in increased cleavage of PARP1 protein|bay 11-7085 inhibits the reaction [7-ketocholesterol results in increased cleavage of PARP1 protein]|quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [7-ketocholesterol results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [7-ketocholesterol results in increased cleavage of PARP1 protein],,,PMID:25845326,https://www.ncbi.nlm.nih.gov/pubmed/25845326,25845326,,,30331249,2015; 388(8):869-881
1680487,91500,Toxin and Toxin Target Database (T3DB),Indium arsenide,T3D1291,Indium arsenide,http://www.t3db.ca/toxins/T3D1291,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1725398,91501,Comparative Toxicogenomics Database (CTD),Cadmium telluride,C028337,cadmium telluride,https://ctdbase.org/detail.go?type=chem&acc=C028337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cadmium telluride analog results in increased cleavage of PARP1 protein,,,PMID:23485651,https://www.ncbi.nlm.nih.gov/pubmed/23485651,23485651,,,12052322,"Nguyen KC, Willmore WG, Tayabali AF. Cadmium telluride quantum dots cause oxidative stress leading to extrinsic and intrinsic apoptosis in hepatocellular carcinoma HepG2 cells. Toxicology. 2013 Apr 05;306():114–23. doi: 10.1016/j.tox.2013.02.010. PMID: 23485651."
1679764,91636,Comparative Toxicogenomics Database (CTD),"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",C015929,"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",https://ctdbase.org/detail.go?type=chem&acc=C015929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[acetylcysteine results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] which results in increased cleavage of PARP1 protein",,,PMID:38042493,https://www.ncbi.nlm.nih.gov/pubmed/38042493,38042493,,PMC10772734,36412181,"Richartz N, Pietka W, Yadav A, Bostad M, Bhagwat S, Naderi S, Naderi EH, Stokke T, Ruud E, Blomhoff HK. N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells. Journal of Biological Chemistry. 2024 Jan;300(1):105509. doi: 10.1016/j.jbc.2023.105509."
305365,91754,Comparative Toxicogenomics Database (CTD),Pyridaben,C428725,pyridaben,https://ctdbase.org/detail.go?type=chem&acc=C428725,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[pyridaben co-treated with paraquat] results in increased cleavage of PARP1 protein|pyridaben results in increased cleavage of PARP1 protein,,,PMID:16237197,https://www.ncbi.nlm.nih.gov/pubmed/16237197,16237197,,,28152258,"Bloom SE, Lemley AT, Muscarella DE. Potentiation of apoptosis by heat stress plus pesticide exposure in stress resistant human B-lymphoma cells and its attenuation through interaction with follicular dendritic cells: role for c-Jun N-terminal kinase signaling. Toxicol Sci. 2006 Jan;89(1):214–23. doi: 10.1093/toxsci/kfj021. PMID: 16237197."
1468002,92884,Toxin and Toxin Target Database (T3DB),Cobaltocene,T3D0671,Cobaltocene,http://www.t3db.ca/toxins/T3D0671,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1182704,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PARP1 mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,PMC7596650,22333960,"Dunnick JK, Shockley KR, Morgan DL, Travlos GS, Gerrish K, Ton TT, Wilson R, Brar SS, Brix AE, Waidyanatha S, Mutlu E, Pandiri AKR. Hepatic Transcriptomic Patterns in the Neonatal Rat After Pentabromodiphenyl Ether Exposure. Toxicol Pathol. 2019 Dec 12;48(2):338–49. doi: 10.1177/0192623319888433."
1182705,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PARP1 protein modified form",,,PMID:30029115,https://www.ncbi.nlm.nih.gov/pubmed/30029115,30029115,,,23664985,"Li P, Liu L, Zhou G, Tian Z, Luo C, Xia T, Chen J, Niu Q, Dong L, Zhao Q, Wang A, Zhang S. Perigestational exposure to low doses of PBDE-47 induces excessive ER stress, defective autophagy and the resultant apoptosis contributing to maternal thyroid toxicity. Sci Total Environ. 2018 Dec 15;645():363–71. doi: 10.1016/j.scitotenv.2018.07.138. PMID: 30029115."
1600362,96356,Comparative Toxicogenomics Database (CTD),Phosphoramide Mustard,C030090,phosphoramide mustard,https://ctdbase.org/detail.go?type=chem&acc=C030090,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Phosphoramide mustard affects the expression of PARP1 mRNA,,,PMID:25497287,https://www.ncbi.nlm.nih.gov/pubmed/25497287,25497287,,PMC5044804,16812744,"Ganesan S, Keating AF. Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells. Toxicology and Applied Pharmacology. 2015 Feb;282(3):252–8. doi: 10.1016/j.taap.2014.11.017."
1600363,96356,Comparative Toxicogenomics Database (CTD),Phosphoramide Mustard,C030090,phosphoramide mustard,https://ctdbase.org/detail.go?type=chem&acc=C030090,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Phosphoramide mustard results in increased expression of PARP1 mRNA,,,PMID:26708502,https://www.ncbi.nlm.nih.gov/pubmed/26708502,26708502,,,6679286,"Ganesan S, Keating AF. The ovarian DNA damage repair response is induced prior to phosphoramide mustard-induced follicle depletion, and ataxia telangiectasia mutated inhibition prevents PM-induced follicle depletion. Toxicol Appl Pharmacol. 2016 Feb 01;292():65–74. doi: 10.1016/j.taap.2015.12.010. PMID: 26708502."
1600364,96356,Comparative Toxicogenomics Database (CTD),Phosphoramide Mustard,C030090,phosphoramide mustard,https://ctdbase.org/detail.go?type=chem&acc=C030090,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Phosphoramide mustard results in increased expression of PARP1 protein,,,PMID:25497287|PMID:26708502,https://www.ncbi.nlm.nih.gov/pubmed/25497287|https://www.ncbi.nlm.nih.gov/pubmed/26708502,25497287|26708502,,PMC5044804,6679286|16812744,"Ganesan S, Keating AF. The ovarian DNA damage repair response is induced prior to phosphoramide mustard-induced follicle depletion, and ataxia telangiectasia mutated inhibition prevents PM-induced follicle depletion. Toxicol Appl Pharmacol. 2016 Feb 01;292():65–74. doi: 10.1016/j.taap.2015.12.010. PMID: 26708502.|Ganesan S, Keating AF. Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells. Toxicology and Applied Pharmacology. 2015 Feb;282(3):252–8. doi: 10.1016/j.taap.2014.11.017."
1683649,96539,Comparative Toxicogenomics Database (CTD),Gardenin B,C000591222,gardenin B,https://ctdbase.org/detail.go?type=chem&acc=C000591222,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gardenin B results in increased cleavage of PARP1 protein,,,PMID:27423764,https://www.ncbi.nlm.nih.gov/pubmed/27423764,27423764,,,14814219,"Cabrera J, Saavedra E, Del Rosario H, Perdomo J, Loro JF, Cifuente DA, Tonn CE, García C, Quintana J, Estévez F. Gardenin B-induced cell death in human leukemia cells involves multiple caspases but is independent of the generation of reactive oxygen species. Chem Biol Interact. 2016 Aug 25;256():220–7. doi: 10.1016/j.cbi.2016.07.016. PMID: 27423764."
1198304,98487,Therapeutic Target Database (TTD),3-Methoxybenzamide,D02MPP,3-Methoxybenzamide,https://idrblab.net/ttd/data/drug/details/D02MPP,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1334137,98487,DrugBank,3-Methoxybenzamide,DB03073,3-Methoxybenzamide,https://www.drugbank.ca/drugs/DB03073,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/37713619|https://www.ncbi.nlm.nih.gov/pubmed/10592235,37713619|10592235,,PMC102472|PMC10767903,12499145|36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
1630390,98531,Toxin and Toxin Target Database (T3DB),(mu-(Carbonato(2-)-O:O'))dihydroxydicobalt,T3D1389,Cobalt(II) carbonate hydroxide (1:1),http://www.t3db.ca/toxins/T3D1389,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
308044,99960,Comparative Toxicogenomics Database (CTD),"Dianhydro-3,4-diacetylgalactitol",C027991,"dianhydro-3,4-diacetylgalactitol",https://ctdbase.org/detail.go?type=chem&acc=C027991,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Dianhydro-3,4-diacetylgalactitol results in increased cleavage of PARP1 protein",,,PMID:11978198,https://www.ncbi.nlm.nih.gov/pubmed/11978198,11978198,,,9162426,"Yang JN, Liu CX, Xu H, Pan QC. Caspases promoted DADAG-induced apoptosis in human leukemia HL-60 cells. Acta Pharmacol Sin. 2002 May;23(5):461–6. PMID: 11978198."
1683950,100016,Comparative Toxicogenomics Database (CTD),Zebularine,C009131,pyrimidin-2-one beta-ribofuranoside,https://ctdbase.org/detail.go?type=chem&acc=C009131,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrimidin-2-one beta-ribofuranoside results in increased cleavage of PARP1 protein,,,PMID:19459041,https://www.ncbi.nlm.nih.gov/pubmed/19459041,19459041,,PMC3901992,26865532,2009; 120(3):581-592
308203,100308,Comparative Toxicogenomics Database (CTD),Aeroplysinin I,C042151,aeroplysinin I,https://ctdbase.org/detail.go?type=chem&acc=C042151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aeroplysinin I results in increased cleavage of PARP1 protein,,,PMID:27120392,https://www.ncbi.nlm.nih.gov/pubmed/27120392,27120392,,,507833,"Park S, Kim JH, Kim JE, Song GY, Zhou W, Goh SH, Na M, Oh S. Cytotoxic activity of aeroplysinin-1 against colon cancer cells by promoting ß-catenin degradation. Food Chem Toxicol. 2016 Jul;93():66–72. doi: 10.1016/j.fct.2016.04.019. PMID: 27120392."
1462624,104729,Toxin and Toxin Target Database (T3DB),Cobaltous Cation,T3D0049,Cobalt,http://www.t3db.ca/toxins/T3D0049,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1753106,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein modified form binds to cobalt,,,PMID:25549802,https://www.ncbi.nlm.nih.gov/pubmed/25549802,25549802,,,497628,"Bossak K, Goch W, Piatek K, Fraczyk T, Poznanski J, Bonna A, Keil C, Hartwig A, Bal W: Unusual Zn(II) Affinities of Zinc Fingers of Poly(ADP-ribose)Polymerase 1 (PARP-1) Nuclear Protein. Chem Res Toxicol. 2015 Feb 16;28(2):191-201."
1753107,104730,Comparative Toxicogenomics Database (CTD),Cobalt,D003035,Cobalt,https://ctdbase.org/detail.go?type=chem&acc=D003035,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Cobalt results in increased cleavage of PARP1 protein,,,PMID:12423593,https://www.ncbi.nlm.nih.gov/pubmed/12423593,12423593,,,19295227,"Catelas I, Petit A, Zukor DJ, Antoniou J, Huk OL. TNF-alpha secretion and macrophage mortality induced by cobalt and chromium ions in vitro-qualitative analysis of apoptosis. Biomaterials. 2003 Feb;24(3):383–91. doi: 10.1016/s0142-9612(02)00351-4. PMID: 12423593."
1580774,104734,Toxin and Toxin Target Database (T3DB),Arsenic Cation (3+),T3D0001,Arsenic,http://www.t3db.ca/toxins/T3D0001,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1203681,104739,Comparative Toxicogenomics Database (CTD),4-Methyl meiqx,C045421,"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine",https://ctdbase.org/detail.go?type=chem&acc=C045421,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1619479,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in increased cleavage of PARP1 protein]|fulvestrant inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:21732360,https://www.ncbi.nlm.nih.gov/pubmed/21732360,21732360,,,17416701,"Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, Marino M. The pro-apoptotic effect of quercetin in cancer cell lines requires ERß-dependent signals. Journal Cellular Physiology. 2012 Jan 23;227(5):1891–8. doi: 10.1002/jcp.22917."
1723806,104751,Comparative Toxicogenomics Database (CTD),"1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",C025603,"1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",https://ctdbase.org/detail.go?type=chem&acc=C025603,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased activity of PARP1 protein]",,,PMID:24752504,https://www.ncbi.nlm.nih.gov/pubmed/24752504,24752504,,PMC4081636,1835378,"Zhang F, Xie R, Munoz FM, Lau SS, Monks TJ. PARP-1 Hyperactivation and Reciprocal Elevations in Intracellular Ca2+ During ROS-Induced Nonapoptotic Cell Death. 2014 Apr 20;140(1):118–34. doi: 10.1093/toxsci/kfu073."
1723807,104751,Comparative Toxicogenomics Database (CTD),"1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",C025603,"1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",https://ctdbase.org/detail.go?type=chem&acc=C025603,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with egtazic acid] inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]|1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [cadmium results in increased cleavage of PARP1 protein]",,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
1340126,104775,Comparative Toxicogenomics Database (CTD),Butanoate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib co-treated with butyrates] results in increased degradation of PARP1 protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,,25406599,"Yu C, Rahmani M, Conrad D, Subler M, Dent P, Grant S. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571. Blood. 2003 Nov 15;102(10):3765–74. doi: 10.1182/blood-2003-03-0737. PMID: 12893773."
1340127,104775,Comparative Toxicogenomics Database (CTD),Butanoate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Butyrates results in increased cleavage of PARP1 protein,,,PMID:17431121,https://www.ncbi.nlm.nih.gov/pubmed/17431121,17431121,,,330899,"De los Santos M, Zambrano A, Aranda A. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. Mol Cancer Ther. 2007 Apr;6(4):1425–32. doi: 10.1158/1535-7163.mct-06-0623. PMID: 17431121."
1340128,104775,Comparative Toxicogenomics Database (CTD),Butanoate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Butyrates results in increased degradation of PARP1 protein,,,PMID:15177505,https://www.ncbi.nlm.nih.gov/pubmed/15177505,15177505,,,8527072,"Emanuele S, D'Anneo A, Bellavia G, Vassallo B, Lauricella M, De Blasio A, Vento R, Tesoriere G. Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. Eur J Cancer. 2004 Jun;40(9):1441–52. doi: 10.1016/j.ejca.2004.01.039. PMID: 15177505."
1631593,104820,Toxin and Toxin Target Database (T3DB),Arsenocholine,T3D0302,Arsenocholine,http://www.t3db.ca/toxins/T3D0302,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1753693,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rimonabant results in decreased expression of PARP1 protein,,,PMID:19479993,https://www.ncbi.nlm.nih.gov/pubmed/19479993,19479993,,,20085828,"Santoro A, Pisanti S, Grimaldi C, Izzo AA, Borrelli F, Proto MC, Malfitano AM, Gazzerro P, Laezza C, Bifulco M. Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. Int J Cancer. 2009 Sep 01;125(5):996–1003. doi: 10.1002/ijc.24483. PMID: 19479993."
1632901,104930,Toxin and Toxin Target Database (T3DB),Trimethylarsine oxide,T3D0318,Trimethylarsine oxide,http://www.t3db.ca/toxins/T3D0318,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1479440,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Beta-N-methylamino-L-alanine results in increased cleavage of PARP1 protein|ddit3 protein affects the reaction [beta-N-methylamino-L-alanine results in increased cleavage of PARP1 protein],,,PMID:27748814,https://www.ncbi.nlm.nih.gov/pubmed/27748814,27748814,,,10779849,"Shen H, Kim K, Oh Y, Yoon KS, Baik HH, Kim SS, Ha J, Kang I, Choe W. Neurotoxin ß-N-methylamino-L-alanine induces endoplasmic reticulum stress-mediated neuronal apoptosis. Mol Med Rep. 2016 Nov;14(5):4873–80. doi: 10.3892/mmr.2016.5802. PMID: 27748814."
1439221,107650,Comparative Toxicogenomics Database (CTD),S-Ethyl glutathione,C042431,S-ethyl glutathione,https://ctdbase.org/detail.go?type=chem&acc=C042431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),S-ethyl glutathione inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,PMC4234881,19518824,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881."
1439222,107650,Comparative Toxicogenomics Database (CTD),S-Ethyl glutathione,C042431,S-ethyl glutathione,https://ctdbase.org/detail.go?type=chem&acc=C042431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:25619640,https://www.ncbi.nlm.nih.gov/pubmed/25619640,25619640,,,27660120,"Han MA, Woo SM, Min KJ, Kim S, Park JW, Kim DE, Kim SH, Choi YH, Kwon TK. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression. Chem Biol Interact. 2015 Feb 25;228():69–78. doi: 10.1016/j.cbi.2015.01.020. PMID: 25619640."
1439223,107650,Comparative Toxicogenomics Database (CTD),S-Ethyl glutathione,C042431,S-ethyl glutathione,https://ctdbase.org/detail.go?type=chem&acc=C042431,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),S-ethyl glutathione inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein],,,PMID:22733624,https://www.ncbi.nlm.nih.gov/pubmed/22733624,22733624,,,26937158,"Benes P, Alexova P, Knopfova L, Spanova A, Smarda J. Redox state alters anti-cancer effects of wedelolactone. Environ Mol Mutagen. 2012 Aug;53(7):515–24. doi: 10.1002/em.21712. PMID: 22733624."
1334513,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AM 251 inhibits the reaction [HU 211 results in increased cleavage of PARP1 protein]|hu 211 results in increased cleavage of PARP1 protein,,,PMID:19509271,https://www.ncbi.nlm.nih.gov/pubmed/19509271,19509271,,,1046822,"Oesch S, Walter D, Wachtel M, Pretre K, Salazar M, Guzmán M, Velasco G, Schäfer BW. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Mol Cancer Ther. 2009 Jul;8(7):1838–45. doi: 10.1158/1535-7163.mct-08-1147. PMID: 19509271."
1256197,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Deguelin inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein],,,PMID:17015749,https://www.ncbi.nlm.nih.gov/pubmed/17015749,17015749,,,6498825,"Nair AS, Shishodia S, Ahn KS, Kunnumakkara AB, Sethi G, Aggarwal BB. Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion. J Immunol. 2006 Oct 15;177(8):5612–22. doi: 10.4049/jimmunol.177.8.5612. PMID: 17015749."
1256198,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Deguelin results in increased expression of PARP1 protein modified form|deguelin metabolite results in increased expression of PARP1 protein modified form,,,PMID:19139008,https://www.ncbi.nlm.nih.gov/pubmed/19139008,19139008,,PMC2738643,24833658,"Kim W, Chang DJ, Hennessy B, Kang HJ, Yoo J, Han S, Kim Y, Park H, Geo S, Mills G, Kim K, Hong WK, Suh Y, Lee H. A Novel Derivative of the Natural Agent Deguelin for Cancer Chemoprevention and Therapy. 2008 Dec 01;1(7):577–87. doi: 10.1158/1940-6207.capr-08-0184."
1256199,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Deguelin results in increased cleavage of PARP1 protein,,,PMID:17035597|PMID:22986522,https://www.ncbi.nlm.nih.gov/pubmed/17035597|https://www.ncbi.nlm.nih.gov/pubmed/22986522,17035597|22986522,,PMC3530646,6517545|32958023,"Boreddy SR, Srivastava SK. Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model. Oncogene. 2013 Aug 22;32(34):3980–91. PMID: 22986522; PMCID: PMC3530646.|Peng X, Karna P, O’Regan RM, Liu X, Naithani R, Moriarty RM, Wood WC, Lee H, Yang L. Down-Regulation of Inhibitor of Apoptosis Proteins by Deguelin Selectively Induces Apoptosis in Breast Cancer Cells. Molecular Pharmacology. 2007 Jan;71(1):101–11. doi: 10.1124/mol.106.027367."
1256200,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased cleavage of PARP1 protein,,,PMID:25242579,https://www.ncbi.nlm.nih.gov/pubmed/25242579,25242579,,,19515368,2014; 94(2):201-210
1724520,107969,Comparative Toxicogenomics Database (CTD),Fingolimod Hydrochloride,D000068876,Fingolimod Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000068876,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein]|pifithrin inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein]|necrostatin-1 inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein]|becn1 mutant form inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein]|ripk3 mutant form inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein]|fingolimod hydrochloride results in increased cleavage of PARP1 protein|sqstm1 mutant form inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein],,,PMID:25939952,https://www.ncbi.nlm.nih.gov/pubmed/25939952,25939952,,,26969299,"Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015 Jul 02;236(1):43–59. doi: 10.1016/j.toxlet.2015.04.015. PMID: 25939952."
1480224,107985,Comparative Toxicogenomics Database (CTD),Triptolide,C001899,triptolide,https://ctdbase.org/detail.go?type=chem&acc=C001899,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Mitoquinone inhibits the reaction [triptolide results in increased cleavage of PARP1 protein]|triptolide results in increased cleavage of PARP1 protein,,,PMID:30836114,https://www.ncbi.nlm.nih.gov/pubmed/30836114,30836114,,,649737,"Zhang J, Bao X, Zhang M, Zhu Z, Zhou L, Chen Q, Zhang Q, Ma B. MitoQ ameliorates testis injury from oxidative attack by repairing mitochondria and promoting the Keap1-Nrf2 pathway. Toxicol Appl Pharmacol. 2019 May 01;370():78–92. doi: 10.1016/j.taap.2019.03.001. PMID: 30836114."
1480225,107985,Comparative Toxicogenomics Database (CTD),Triptolide,C001899,triptolide,https://ctdbase.org/detail.go?type=chem&acc=C001899,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Triptolide results in increased expression of PARP1 protein,,,PMID:26990902,https://www.ncbi.nlm.nih.gov/pubmed/26990902,26990902,,,3927408,"Chan S, Chen Y, Lin J, Liao C, Ko Y, Tang N, Kuo C, Liu K, Chung J. Triptolide induced cell death through apoptosis and autophagy in murine leukemia WEHI-3 cells <i>in vitro</i> and promoting immune responses in WEHI-3 generated leukemia mice <i>in vivo</i>. Environmental Toxicology. 2016 Mar 18;32(2):550–68. doi: 10.1002/tox.22259."
1481797,107985,Comparative Toxicogenomics Database (CTD),Triptolide,C001899,triptolide,https://ctdbase.org/detail.go?type=chem&acc=C001899,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Triptolide results in increased cleavage of PARP1 protein,,,PMID:12533674|PMID:15972136|PMID:36990132,https://www.ncbi.nlm.nih.gov/pubmed/12533674|https://www.ncbi.nlm.nih.gov/pubmed/15972136|https://www.ncbi.nlm.nih.gov/pubmed/36990132,12533674|15972136|36990132,,,2322535|3638636|34790336,"Hou Z, Yan M, Li H, Wang W, You S, Wang M, Du T, Gong H, Li W, Guo L, Wei S, Zhang B, Ji M, Chen X. Variable p53/Nrf2 crosstalk contributes to triptolide-induced hepatotoxic process. Toxicol Lett. 2023 Apr 15;379():67–75. doi: 10.1016/j.toxlet.2023.03.011. PMID: 36990132.|Deng J, Jin J. [Study of triptolide-induced apoptosis in MUTZ-1 cells and its allied mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Jun;13(3):434–9. PMID: 15972136.|Yang S, Chen J, Guo Z, Xu XM, Wang L, Pei XF, Yang J, Underhill CB, Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther. 2003 Jan;2(1):65–72. PMID: 12533674."
1481798,107985,Comparative Toxicogenomics Database (CTD),Triptolide,C001899,triptolide,https://ctdbase.org/detail.go?type=chem&acc=C001899,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [[triptolide co-treated with lipopolysaccharides] results in increased expression of PARP1 protein modified form]|[triptolide co-treated with lipopolysaccharides] results in increased expression of PARP1 protein modified form,,,PMID:30633930,https://www.ncbi.nlm.nih.gov/pubmed/30633930,30633930,,,14883340,"Yuan Z, Zhang H, Hasnat M, Ding J, Chen X, Liang P, Sun L, Zhang L, Jiang Z. A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation. Toxicology. 2019 Feb 15;414():45–56. doi: 10.1016/j.tox.2019.01.005. PMID: 30633930."
1582987,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cobaltiprotoporphyrin inhibits the reaction [deoxycholic acid results in increased cleavage of PARP1 protein],,,PMID:21362092,https://www.ncbi.nlm.nih.gov/pubmed/21362092,21362092,,,32952542,"Lawson TE, Redlak MJ, Yager DR. Preconditioning with cobalt protoporphyrin protects human gastric mucosal cells from deoxycholate-induced apoptosis. Wound Repair Regen. 2011 Mar;19(2):241–9. doi: 10.1111/j.1524-475x.2010.00661.x. PMID: 21362092."
1582988,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cobaltiprotoporphyrin inhibits the reaction [FASLG protein results in increased cleavage of PARP1 protein],,,PMID:16051694,https://www.ncbi.nlm.nih.gov/pubmed/16051694,16051694,,,22701581,"Blumenthal SB, Kiemer AK, Tiegs G, Seyfried S, Höltje M, Brandt B, Höltje HD, Zahler S, Vollmar AM. Metalloporphyrins inactivate caspase-3 and -8. FASEB J. 2005 Aug;19(10):1272–9. doi: 10.1096/fj.04-3259com. PMID: 16051694."
1582989,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cobaltiprotoporphyrin results in decreased expression of PARP1 protein modified form,,,PMID:24736402,https://www.ncbi.nlm.nih.gov/pubmed/24736402,24736402,,PMC4039456,1820260,"Luo J, Weaver MS, Cao B, Dennis JE, Van Biber B, Laflamme MA, Allen MD. Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo. Stem Cells Transl Med. 2014 Jun;3(6):734–44. PMID: 24736402; PMCID: PMC4039456."
1582990,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),[cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased activity of CASP7 protein]] which results in decreased cleavage of PARP1 protein|[cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased activity of CASP3 protein]] which results in decreased cleavage of PARP1 protein,,,PMID:18819247,https://www.ncbi.nlm.nih.gov/pubmed/18819247,18819247,,,5146188,"Bosio E, Seveso M, Dedja A, Luca G, Calvitti M, Calafiore R, Rigotti P, Busetto R, Ancona E, Cozzi E. Cobalt protoporpyhrin reduces caspase-3,-7 enzyme activity in neonatal porcine islets, but does not inhibit cell death induced by TNF-alpha. Cell Transplant. 2008;17(6):587–98. doi: 10.3727/096368908786092784. PMID: 18819247."
1634544,108142,Comparative Toxicogenomics Database (CTD),"Propanamide, 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-",C044565,2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide,https://ctdbase.org/detail.go?type=chem&acc=C044565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide results in increased cleavage of PARP1 protein,,,PMID:16142332,https://www.ncbi.nlm.nih.gov/pubmed/16142332,16142332,,,14633586,"Nguyen TH, Ong CK, Wong E, Leong CT, Panasci L, Huynh H. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) exhibits p53-dependent and -independent antiproliferative activity in human nasopharyngeal carcinoma cells in vitro and in vivo. Int J Oncol. 2005 Oct;27(4):1131–40. doi: 10.3892/ijo.27.4.1131. PMID: 16142332."
1440709,108144,Comparative Toxicogenomics Database (CTD),Carboxyamidotriazole,C062058,carboxyamido-triazole,https://ctdbase.org/detail.go?type=chem&acc=C062058,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[LM-1685 co-treated with carboxyamido-triazole] results in increased cleavage of PARP1 protein],,,PMID:15867384,https://www.ncbi.nlm.nih.gov/pubmed/15867384,15867384,,,7883012,"Winters ME, Mehta AI, Petricoin EF, Kohn EC, Liotta LA. Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res. 2005 May 01;65(9):3853–60. doi: 10.1158/0008-5472.can-04-1989. PMID: 15867384."
1440711,108150,Drug Gene Interaction database (DGIdb),Trabectedin,,TRABECTEDIN,https://www.dgidb.org/drugs/rxcui:1716278,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
1484492,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Deoxyglucose inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]|deoxyglucose inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|deoxyglucose results in increased cleavage of PARP1 protein,,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,PMC4234881,19518824,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881."
1484493,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Deoxyglucose promotes the reaction [silybin results in increased cleavage of PARP1 protein],,,PMID:34053323,https://www.ncbi.nlm.nih.gov/pubmed/34053323,34053323,,,25816613,"Yang J, Sun Y, Xu F, Liu W, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Autophagy and glycolysis independently attenuate silibinin-induced apoptosis in human hepatocarcinoma HepG2 and Hep3B cells. Hum Exp Toxicol. 2021 Dec;40(12):2048–62. doi: 10.1177/09603271211017609. PMID: 34053323."
1484494,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Deoxyglucose promotes the reaction [metformin inhibits the reaction [arsenic trioxide results in increased expression of PARP1 protein modified form]],,,PMID:29095437,https://www.ncbi.nlm.nih.gov/pubmed/29095437,29095437,,PMC5775401,14856065,"Ling S, Shan Q, Liu P, Feng T, Zhang X, Xiang P, Chen K, Xie H, Song P, Zhou L, Liu J, Zheng S, Xu X. Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I. Cell Death & Disease. 2017 Nov 02;8(11):e3159. doi: 10.1038/cddis.2017.482."
1317293,114778,Comparative Toxicogenomics Database (CTD),Kahweol,C053401,kahweol,https://ctdbase.org/detail.go?type=chem&acc=C053401,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Kahweol inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:31306736,https://www.ncbi.nlm.nih.gov/pubmed/31306736,31306736,,,32441726,"Fürstenau CR, de Souza ICC, de Oliveira MR. The effects of kahweol, a diterpene present in coffee, on the mitochondria of the human neuroblastoma SH-SY5Y cells exposed to hydrogen peroxide. Toxicol In Vitro. 2019 Dec;61():104601. doi: 10.1016/j.tiv.2019.104601. PMID: 31306736."
1317294,114778,Comparative Toxicogenomics Database (CTD),Kahweol,C053401,kahweol,https://ctdbase.org/detail.go?type=chem&acc=C053401,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Kahweol results in increased cleavage of PARP1 protein,,,PMID:30205135,https://www.ncbi.nlm.nih.gov/pubmed/30205135,30205135,,,3971107,"Oh SH, Hwang YP, Choi JH, Jin SW, Lee GH, Han EH, Chung YH, Chung YC, Jeong HG. Kahweol inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells. Food Chem Toxicol. 2018 Nov;121():326–35. doi: 10.1016/j.fct.2018.09.008. PMID: 30205135."
1685771,115063,Comparative Toxicogenomics Database (CTD),CID 115063,C024603,Geraniin,https://ctdbase.org/detail.go?type=chem&acc=C024603,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Geraniin results in increased cleavage of PARP1 protein,,,PMID:27097871,https://www.ncbi.nlm.nih.gov/pubmed/27097871,27097871,,,16849357,"Zhai JW, Gao C, Ma WD, Wang W, Yao LP, Xia XX, Luo M, Zu YG, Fu YJ. Geraniin induces apoptosis of human breast cancer cells MCF-7 via ROS-mediated stimulation of p38 MAPK. Toxicol Mech Methods. 2016 Jun;26(5):311–8. doi: 10.3109/15376516.2016.1139025. PMID: 27097871."
311346,115205,Comparative Toxicogenomics Database (CTD),BzATP,C033901,3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate,https://ctdbase.org/detail.go?type=chem&acc=C033901,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate results in increased expression of PARP1 protein,,,PMID:22253048,https://www.ncbi.nlm.nih.gov/pubmed/22253048,22253048,,,16772070,"Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 2011 Dec;59(12):1933–45. doi: 10.1002/glia.21235. PMID: 22253048."
1725911,115250,Comparative Toxicogenomics Database (CTD),Taraxasterol,C079988,taraxasterol,https://ctdbase.org/detail.go?type=chem&acc=C079988,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Taraxasterol results in increased cleavage of PARP1 protein,,,PMID:35128947,https://www.ncbi.nlm.nih.gov/pubmed/35128947,35128947,,,8249828,"Liu W, Yu Q, Wang F, Li Y, Zhang G, Tao S. Taraxasterol attenuates melanoma progression via inactivation of reactive oxygen species-mediated PI3K/Akt signaling pathway. Hum Exp Toxicol. 2022 Jan;41():9603271211069034. doi: 10.1177/09603271211069034. PMID: 35128947."
1593058,117158,Comparative Toxicogenomics Database (CTD),"2,3-dihydro-1H-quinolin-4-one",C545227,"2,3-dihydroquinolin-4(1H)-one",https://ctdbase.org/detail.go?type=chem&acc=C545227,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,3-dihydroquinolin-4(1H)-one analog results in increased expression of PARP1 protein modified form",,,PMID:32109484,https://www.ncbi.nlm.nih.gov/pubmed/32109484,32109484,,,22991615,"Drogosz-Stachowicz J, Dlugosz-Pokorska A, Gach-Janczak K, Jaskulska A, Janecki T, Janecka A. Molecular mechanisms of apoptosis induced by a novel synthetic quinolinone derivative in HL-60 human leukemia cells. Chem Biol Interact. 2020 Apr 01;320():109005. doi: 10.1016/j.cbi.2020.109005. PMID: 32109484."
1262599,119104,Comparative Toxicogenomics Database (CTD),1'-Acetoxychavicol Acetate,C047948,1'-acetoxychavicol acetate,https://ctdbase.org/detail.go?type=chem&acc=C047948,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),1'-acetoxychavicol acetate promotes the reaction [TNF protein results in increased cleavage of PARP1 protein],,,PMID:15905586,https://www.ncbi.nlm.nih.gov/pubmed/15905586,15905586,,,27483009,"Ichikawa H, Takada Y, Murakami A, Aggarwal BB. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products. J Immunol. 2005 Jun 01;174(11):7383–92. doi: 10.4049/jimmunol.174.11.7383. PMID: 15905586."
1192637,119182,Comparative Toxicogenomics Database (CTD),Clofarabine,D000077866,Clofarabine,https://ctdbase.org/detail.go?type=chem&acc=D000077866,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[clofarabine co-treated with fludarabine co-treated with busulfan] results in increased cleavage of PARP1 protein,,,PMID:20933509,https://www.ncbi.nlm.nih.gov/pubmed/20933509,20933509,,PMC3006064,18751816,"Valdez BC, Li Y, Murray D, Champlin RE, Andersson BS. The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling. Biochemical Pharmacology. 2011 Jan;81(2):222–32. doi: 10.1016/j.bcp.2010.09.027."
1192638,119182,Comparative Toxicogenomics Database (CTD),Clofarabine,D000077866,Clofarabine,https://ctdbase.org/detail.go?type=chem&acc=D000077866,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MCL1 mutant form promotes the reaction [[resveratrol co-treated with clofarabine] results in increased cleavage of PARP1 protein]|[resveratrol co-treated with clofarabine] results in increased cleavage of PARP1 protein,,,PMID:24924397,https://www.ncbi.nlm.nih.gov/pubmed/24924397,24924397,,PMC4453022,32322776,"Lee Y, Lee Y, Lee S. Resveratrol and clofarabine induces a preferential apoptosis-activating effect on malignant mesothelioma cells by Mcl-1 down-regulation and caspase-3 activation. BMB Reports. 2015 Mar 31;48(3):166–71. doi: 10.5483/bmbrep.2015.48.3.105."
1192639,119182,Comparative Toxicogenomics Database (CTD),Clofarabine,D000077866,Clofarabine,https://ctdbase.org/detail.go?type=chem&acc=D000077866,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[resveratrol co-treated with clofarabine] results in increased expression of PARP1 protein modified form,,,PMID:24239893,https://www.ncbi.nlm.nih.gov/pubmed/24239893,24239893,,,14781027,"Lee YJ, Park IS, Lee YJ, Shim JH, Cho MK, Nam HS, Park JW, Oh MH, Lee SH. Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53. Food Chem Toxicol. 2014 Jan;63():153–60. doi: 10.1016/j.fct.2013.11.004. PMID: 24239893."
1321254,119245,Comparative Toxicogenomics Database (CTD),Dioscin,C019357,dioscin,https://ctdbase.org/detail.go?type=chem&acc=C019357,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dioscin results in decreased expression of PARP1 protein|dioscin results in decreased expression of PARP1 mRNA,,,PMID:33359023,https://www.ncbi.nlm.nih.gov/pubmed/33359023,33359023,,,22358928,"Li XL, Ma RH, Ni ZJ, Thakur K, Cespedes-Acuña CL, Wang S, Zhang JG, Wei ZJ. Dioscin inhibits human endometrial carcinoma proliferation via G0/G1 cell cycle arrest and mitochondrial-dependent signaling pathway. Food Chem Toxicol. 2021 Feb;148():111941. doi: 10.1016/j.fct.2020.111941. PMID: 33359023."
1321255,119245,Comparative Toxicogenomics Database (CTD),Dioscin,C019357,dioscin,https://ctdbase.org/detail.go?type=chem&acc=C019357,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dioscin results in increased expression of PARP1 mRNA,,,PMID:29990575,https://www.ncbi.nlm.nih.gov/pubmed/29990575,29990575,,,7435012,"Zhang YS, Ma YL, Thakur K, Hussain SS, Wang J, Zhang Q, Zhang JG, Wei ZJ. Molecular mechanism and inhibitory targets of dioscin in HepG2 cells. Food Chem Toxicol. 2018 Oct;120():143–54. doi: 10.1016/j.fct.2018.07.016. PMID: 29990575."
1321256,119245,Comparative Toxicogenomics Database (CTD),Dioscin,C019357,dioscin,https://ctdbase.org/detail.go?type=chem&acc=C019357,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dioscin inhibits the reaction [ethanol results in increased expression of PARP1 protein],,,PMID:24146112,https://www.ncbi.nlm.nih.gov/pubmed/24146112,24146112,,,22837839,2013; 88(3):739-753
1263653,119258,Comparative Toxicogenomics Database (CTD),Astilbin,C099069,astilbin,https://ctdbase.org/detail.go?type=chem&acc=C099069,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Astilbin inhibits the reaction [cisplatin results in increased cleavage of PARP1 protein],,,PMID:29471006,https://www.ncbi.nlm.nih.gov/pubmed/29471006,29471006,,,33089178,"Wang SW, Xu Y, Weng YY, Fan XY, Bai YF, Zheng XY, Lou LJ, Zhang F. Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation. Food Chem Toxicol. 2018 Apr;114():227–36. doi: 10.1016/j.fct.2018.02.041. PMID: 29471006."
1748486,119461,Comparative Toxicogenomics Database (CTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,https://ctdbase.org/detail.go?type=chem&acc=C053876,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:19407222,https://www.ncbi.nlm.nih.gov/pubmed/19407222,19407222,,PMC5419188,11301983,"Banu SK, Lee J, Speights VO, Starzinski-Powitz A, Arosh JA. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms. Mol Endocrinol. 2009 Aug;23(8):1291–305. PMID: 19407222; PMCID: PMC5419188."
1194447,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of PARP1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,,25628430,"Laifenfeld D, Qiu L, Swiss R, Park J, Macoritto M, Will Y, Younis HS, Lawton M. Utilization of Causal Reasoning of Hepatic Gene Expression in Rats to Identify Molecular Pathways of Idiosyncratic Drug-Induced Liver Injury. 2013 Oct 17;137(1):234–48. doi: 10.1093/toxsci/kft232."
1347707,120290,Comparative Toxicogenomics Database (CTD),Aspidin,C010302,aspidin BB,https://ctdbase.org/detail.go?type=chem&acc=C010302,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aspidin BB results in increased expression of PARP1 protein modified form,,,PMID:23628508,https://www.ncbi.nlm.nih.gov/pubmed/23628508,23628508,,,19485666,"Sun Y, Mu F, Li C, Wang W, Luo M, Fu Y, Zu Y. Aspidin BB, a phloroglucinol derivative, induces cell cycle arrest and apoptosis in human ovarian HO-8910 cells. Chem Biol Interact. 2013 Jul 05;204(2):88–97. doi: 10.1016/j.cbi.2013.04.008. PMID: 23628508."
1441983,121475,Comparative Toxicogenomics Database (CTD),"rel-(1R,2S,3R,4S)-2,3-Dimethyl-7-oxabicyclo(2.2.1)heptane-2,3-dicarboxylic acid",C000626960,cantharidic acid,https://ctdbase.org/detail.go?type=chem&acc=C000626960,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cantharidic acid results in increased cleavage of PARP1 protein,,,PMID:29159945|PMID:29345422|PMID:31916385,https://www.ncbi.nlm.nih.gov/pubmed/29159945|https://www.ncbi.nlm.nih.gov/pubmed/29345422|https://www.ncbi.nlm.nih.gov/pubmed/31916385,29159945|29345422|31916385,,,8160448|11468084|29722959,"Chen YC, Chen PN, Lin CW, Yang WE, Ho YT, Yang SF, Chuang CY. Cantharidic acid induces apoptosis in human nasopharyngeal carcinoma cells through p38-mediated upregulation of caspase activation. Environ Toxicol. 2020 May;35(5):619–27. doi: 10.1002/tox.22897. PMID: 31916385.|Wang S, Chow J, Chien M, Lin C, Chen H, Hsiao P, Yang S. <scp>C</scp>antharidic acid induces apoptosis of human leukemic HL-60 cells via c-Jun N-terminal kinase-regulated caspase-8/-9/-3 activation pathway. Environmental Toxicology. 2018 Jan 18;33(4):514–22. doi: 10.1002/tox.22537.|Feng IC, Hsieh MJ, Chen PN, Hsieh YH, Ho HY, Yang SF, Yeh CB. Cantharidic acid induces apoptosis through the p38 MAPK signaling pathway in human hepatocellular carcinoma. Environ Toxicol. 2018 Mar;33(3):261–8. doi: 10.1002/tox.22513. PMID: 29159945."
1340420,122121,Comparative Toxicogenomics Database (CTD),Phytosphingosine,C012491,phytosphingosine,https://ctdbase.org/detail.go?type=chem&acc=C012491,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[arsenic trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein|acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]|3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]|[arsenic trioxide co-treated with phytosphingosine] results in increased cleavage of PARP1 protein",,,PMID:17237268,https://www.ncbi.nlm.nih.gov/pubmed/17237268,17237268,,,3048394,"Park MT, Kang YH, Park IC, Kim CH, Lee YS, Chung HY, Lee SJ. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells. Mol Cancer Ther. 2007 Jan;6(1):82–92. doi: 10.1158/1535-7163.mct-06-0349. PMID: 17237268."
1340421,122121,Comparative Toxicogenomics Database (CTD),Phytosphingosine,C012491,phytosphingosine,https://ctdbase.org/detail.go?type=chem&acc=C012491,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Phytosphingosine results in increased activity of PARP1 protein,,,PMID:15486061,https://www.ncbi.nlm.nih.gov/pubmed/15486061,15486061,,,23406215,"Park MT, Kim MJ, Kang YH, Choi SY, Lee JH, Choi JA, Kang CM, Cho CK, Kang S, Bae S, Lee YS, Chung HY, Lee SJ. Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release. Blood. 2005 Feb 15;105(4):1724–33. doi: 10.1182/blood-2004-07-2938. PMID: 15486061."
1340422,122121,Comparative Toxicogenomics Database (CTD),Phytosphingosine,C012491,phytosphingosine,https://ctdbase.org/detail.go?type=chem&acc=C012491,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Phytosphingosine results in increased cleavage of PARP1 protein,,,PMID:37956922,https://www.ncbi.nlm.nih.gov/pubmed/37956922,37956922,,,36429733,"Cai Q, Chen M, Wang B, Wang J, Xia L, Li J. Phytosphingosine inhibits the growth of lung adenocarcinoma cells by inducing G2/M-phase arrest, apoptosis, and mitochondria-dependent pathway cell death in vitro and in vivo. Chem Biol Interact. 2024 Jan 05;387():110795. doi: 10.1016/j.cbi.2023.110795. PMID: 37956922."
1494092,122724,Comparative Toxicogenomics Database (CTD),Celastrol,C050414,celastrol,https://ctdbase.org/detail.go?type=chem&acc=C050414,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Celastrol results in increased cleavage of PARP1 protein,,,PMID:31715269,https://www.ncbi.nlm.nih.gov/pubmed/31715269,31715269,,,3331050,"Zhao Q, Bi Y, Zhong J, Ren Z, Liu Y, Jia J, Yu M, Tan Y, Zhang Q, Yu X. Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/ß-catenin signaling. Toxicol Appl Pharmacol. 2020 Jan 01;386():114813. doi: 10.1016/j.taap.2019.114813. PMID: 31715269."
1494093,122724,Comparative Toxicogenomics Database (CTD),Celastrol,C050414,celastrol,https://ctdbase.org/detail.go?type=chem&acc=C050414,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TNFSF10 protein co-treated with celastrol] results in increased cleavage of PARP1 protein|tnfrsf10a protein promotes the reaction [[TNFSF10 protein co-treated with celastrol] results in increased cleavage of PARP1 protein]|tnfrsf10b protein promotes the reaction [[TNFSF10 protein co-treated with celastrol] results in increased cleavage of PARP1 protein],,,PMID:20605676,https://www.ncbi.nlm.nih.gov/pubmed/20605676,20605676,,,16723242,"Zhu H, Liu XW, Ding WJ, Xu DQ, Zhao YC, Lu W, He QJ, Yang B. Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L. Cancer Lett. 2010 Nov 28;297(2):155–64. doi: 10.1016/j.canlet.2010.04.030. PMID: 20605676."
1443674,123349,Comparative Toxicogenomics Database (CTD),Peroxynitrous Acid,D030421,Peroxynitrous Acid,https://ctdbase.org/detail.go?type=chem&acc=D030421,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Peroxynitrous acid results in increased activity of PARP1 protein|[parp1 protein results in decreased susceptibility to peroxynitrous acid] which results in decreased phosphorylation of BAD protein|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [peroxynitrous acid results in increased activity of PARP1 protein]",,,PMID:18239155,https://www.ncbi.nlm.nih.gov/pubmed/18239155,18239155,,,1703284,"Mathews MT, Berk BC. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):711–7. doi: 10.1161/atvbaha.107.156406. PMID: 18239155."
1599731,123631,Comparative Toxicogenomics Database (CTD),Gefitinib,D000077156,Gefitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077156,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Betulinic acid promotes the reaction [gefitinib results in increased cleavage of PARP1 protein],,,PMID:30136359,https://www.ncbi.nlm.nih.gov/pubmed/30136359,30136359,,,5341386,"Ko JL, Lin CH, Chen HC, Hung WH, Chien PJ, Chang HY, Wang BY. Effects and mechanisms of betulinic acid on improving EGFR TKI-resistance of lung cancer cells. Environ Toxicol. 2018 Nov;33(11):1153–9. doi: 10.1002/tox.22621. PMID: 30136359."
1599732,123631,Comparative Toxicogenomics Database (CTD),Gefitinib,D000077156,Gefitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077156,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gefitinib affects the reaction [oxaliplatin results in increased cleavage of PARP1 protein],,,PMID:16243822,https://www.ncbi.nlm.nih.gov/pubmed/16243822,16243822,,,26792226,"Van Schaeybroeck S, Karaiskou-McCaul A, Kelly D, Longley D, Galligan L, Van Cutsem E, Johnston P. Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy. Clin Cancer Res. 2005 Oct 15;11(20):7480–9. doi: 10.1158/1078-0432.ccr-05-0328. PMID: 16243822."
1599733,123631,Comparative Toxicogenomics Database (CTD),Gefitinib,D000077156,Gefitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077156,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gefitinib results in increased cleavage of PARP1 protein,,,PMID:23523951,https://www.ncbi.nlm.nih.gov/pubmed/23523951,23523951,,,6637275,"Yu SY, Liu HF, Wang SP, Chang CC, Tsai CM, Chao JI. Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells. Chem Biol Interact. 2013 Apr 25;203(2):412–22. doi: 10.1016/j.cbi.2013.03.011. PMID: 23523951."
1599734,123631,Comparative Toxicogenomics Database (CTD),Gefitinib,D000077156,Gefitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077156,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[gefitinib results in increased secretion of CCL2 protein] inhibits the reaction [gefitinib results in increased expression of PARP1 protein modified form]|gefitinib results in increased expression of PARP1 protein modified form,,,PMID:33248157,https://www.ncbi.nlm.nih.gov/pubmed/33248157,33248157,,,3355814,"Du J, Li G, Jiang L, Zhang X, Xu Z, Yan H, Zhou Z, He Q, Yang X, Luo P. Crosstalk between alveolar macrophages and alveolar epithelial cells/fibroblasts contributes to the pulmonary toxicity of gefitinib. Toxicol Lett. 2021 Mar 01;338():1–9. doi: 10.1016/j.toxlet.2020.11.011. PMID: 33248157."
1602497,123917,Comparative Toxicogenomics Database (CTD),"2,3-Bis(3'-hydroxybenzyl)butyrolactone",C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",https://ctdbase.org/detail.go?type=chem&acc=C029497,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,,16019154,"Dip R, Lenz S, Gmuender H, Naegeli H. Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787–95. doi: 10.1016/j.fct.2009.01.008. PMID: 19167446."
1690803,123938,Comparative Toxicogenomics Database (CTD),Gamma-Glutamylcysteine,C017341,gamma-glutamylcysteine,https://ctdbase.org/detail.go?type=chem&acc=C017341,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),AKT activator SC79 inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]]|gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]|anisomycin inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]],,,PMID:34767868,https://www.ncbi.nlm.nih.gov/pubmed/34767868,34767868,,,7531521,"Bi A, Guo Z, Yang G, Huang Y, Yin Z, Luo L. ?-glutamylcysteine suppresses cadmium-induced apoptosis in PC12 cells via regulating oxidative stress. Toxicology. 2022 Jan 15;465():153029. doi: 10.1016/j.tox.2021.153029. PMID: 34767868."
1200475,124052,Comparative Toxicogenomics Database (CTD),Glabridin,C107601,glabridin,https://ctdbase.org/detail.go?type=chem&acc=C107601,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Glabridin results in increased cleavage of PARP1 protein,,,PMID:29663662,https://www.ncbi.nlm.nih.gov/pubmed/29663662,29663662,,,14202013,"Chen CT, Chen YT, Hsieh YH, Weng CJ, Yeh JC, Yang SF, Lin CW, Yang JS. Glabridin induces apoptosis and cell cycle arrest in oral cancer cells through the JNK1/2 signaling pathway. Environ Toxicol. 2018 Jun;33(6):679–85. doi: 10.1002/tox.22555. PMID: 29663662."
1710624,124087,Comparative Toxicogenomics Database (CTD),Desloratadine,C121345,desloratadine,https://ctdbase.org/detail.go?type=chem&acc=C121345,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sorafenib results in increased susceptibility to desloratadine] which results in increased cleavage of PARP1 protein|[desloratadine results in increased susceptibility to sorafenib] which results in increased cleavage of PARP1 protein|desloratadine results in increased cleavage of PARP1 protein,,,PMID:36617552,https://www.ncbi.nlm.nih.gov/pubmed/36617552,36617552,,PMC9826789,35009431,"Tan XP, He Y, Yang J, Wei X, Fan YL, Zhang GG, Zhu YD, Li ZQ, Liao HX, Qin DJ, Guan XY, Li B. Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression. Signal Transduct Target Ther. 2023 Jan 09;8(1):14. PMID: 36617552; PMCID: PMC9826789."
1348303,124219,Comparative Toxicogenomics Database (CTD),Mollugin,C046245,rubimaillin,https://ctdbase.org/detail.go?type=chem&acc=C046245,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BCL2L1 protein inhibits the reaction [rubimaillin results in increased degradation of PARP1 protein]|benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [rubimaillin results in increased degradation of PARP1 protein]|rubimaillin results in increased degradation of PARP1 protein,,,PMID:19716835,https://www.ncbi.nlm.nih.gov/pubmed/19716835,19716835,,,32901316,"Kim SM, Park HS, Jun DY, Woo HJ, Woo MH, Yang CH, Kim YH. Mollugin induces apoptosis in human Jurkat T cells through endoplasmic reticulum stress-mediated activation of JNK and caspase-12 and subsequent activation of mitochondria-dependent caspase cascade regulated by Bcl-xL. Toxicol Appl Pharmacol. 2009 Dec 01;241(2):210–20. doi: 10.1016/j.taap.2009.08.024. PMID: 19716835."
312939,124319,Comparative Toxicogenomics Database (CTD),N-Benzoyl-1-phenylalanyl-1-phenylalaninol acetate,C011670,N-benzoylphenylalanylphenylalinol acetate,https://ctdbase.org/detail.go?type=chem&acc=C011670,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),N-benzoylphenylalanylphenylalinol acetate binds to PARP1 protein,,,PMID:24876881,https://www.ncbi.nlm.nih.gov/pubmed/24876881,24876881,,PMC4021748,9394579,"Chen K, Sun M, Chen CY. <i>In Silico</i> Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine. 2014 Jan;2014(1). doi: 10.1155/2014/917605."
1489579,124820,Comparative Toxicogenomics Database (CTD),"16-Hydroxycleroda-3,13(14)-dien-15,16-olide",C072581,"16-hydroxycleroda-3,13(14)-dien-15,16-olide",https://ctdbase.org/detail.go?type=chem&acc=C072581,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in increased cleavage of PARP1 protein",,,PMID:21530604,https://www.ncbi.nlm.nih.gov/pubmed/21530604,21530604,,,14041237,"Lin YH, Lee CC, Chan WL, Chang WH, Wu YC, Chang JG. 16-Hydroxycleroda-3,13-dien-15,16-olide deregulates PI3K and Aurora B activities that involve in cancer cell apoptosis. Toxicology. 2011 Jul 11;285(1-2):72–80. doi: 10.1016/j.tox.2011.04.004. PMID: 21530604."
1502573,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Glutathione deficiency promotes the reaction [antimony trioxide results in increased cleavage of PARP1 protein],,,PMID:16112521,https://www.ncbi.nlm.nih.gov/pubmed/16112521,16112521,,,18671239,"Mann KK, Davison K, Colombo M, Colosimo AL, Diaz Z, Padovani AM, Guo Q, Scrivens PJ, Gao W, Mader S, Miller WH. Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling. Toxicol Lett. 2006 Jan 05;160(2):158–70. doi: 10.1016/j.toxlet.2005.06.017. PMID: 16112521."
1502736,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Glutathione inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cleavage of PARP1 protein]|glutathione inhibits the reaction [NR4A1 protein affects the cleavage of PARP1 protein]",,,PMID:24515801,https://www.ncbi.nlm.nih.gov/pubmed/24515801,24515801,,PMC4407472,10719701,"Lee SO, Jin UH, Kang JH, Kim SB, Guthrie AS, Sreevalsan S, Lee JS, Safe S. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Mol Cancer Res. 2014 Apr;12(4):527–38. PMID: 24515801; PMCID: PMC4407472."
1502737,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Glutathione inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein],,,PMID:14660655,https://www.ncbi.nlm.nih.gov/pubmed/14660655,14660655,,,26785117,"Han DC, Lee MY, Shin KD, Jeon SB, Kim JM, Son KH, Kim HC, Kim HM, Kwon BM. 2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species. J Biol Chem. 2004 Feb 20;279(8):6911–20. doi: 10.1074/jbc.m309708200. PMID: 14660655."
1502738,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Glutathione inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased cleavage of PARP1 protein]",,,PMID:24036456,https://www.ncbi.nlm.nih.gov/pubmed/24036456,24036456,,,24927079,"Tan J, Lai Z, Liu L, Long W, Chen T, Zha J, Wang L, Chen M, Ji H, Lai Y. ONTD induces apoptosis of human hepatoma Bel-7402 cells via a MAPK-dependent mitochondrial pathway and the depletion of intracellular glutathione. The International Journal of Biochemistry & Cell Biology. 2013 Nov;45(11):2632–42. doi: 10.1016/j.biocel.2013.08.021."
1502739,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Glutathione inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein],,,PMID:26887594,https://www.ncbi.nlm.nih.gov/pubmed/26887594,26887594,,PMC5423166,24303290,"Cheng X, Kim JY, Ghafoory S, Duvaci T, Rafiee R, Theobald J, Alborzinia H, Holenya P, Fredebohm J, Merz K, Mehrabi A, Hafezi M, Saffari A, Eisenbrand G, Hoheisel J, Wölfl S. Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. Molecular Oncology. 2016 Feb 04;10(6):806–24. doi: 10.1016/j.molonc.2016.01.008."
1609255,126274,Comparative Toxicogenomics Database (CTD),Meisoindigo,C047330,N-methylisoindigotin,https://ctdbase.org/detail.go?type=chem&acc=C047330,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dorsomorphin inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein]|n-methylisoindigotin results in increased cleavage of PARP1 protein|glutathione inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein],,,PMID:26887594,https://www.ncbi.nlm.nih.gov/pubmed/26887594,26887594,,PMC5423166,24303290,"Cheng X, Kim JY, Ghafoory S, Duvaci T, Rafiee R, Theobald J, Alborzinia H, Holenya P, Fredebohm J, Merz K, Mehrabi A, Hafezi M, Saffari A, Eisenbrand G, Hoheisel J, Wölfl S. Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. Molecular Oncology. 2016 Feb 04;10(6):806–24. doi: 10.1016/j.molonc.2016.01.008."
1361587,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),ESRRA protein inhibits the reaction [methotrexate results in increased cleavage of PARP1 protein],,,PMID:24967384,https://www.ncbi.nlm.nih.gov/pubmed/24967384,24967384,,PMC4055217,21540259,"Chen P, Wang H, Duan Z, Zou JX, Chen H, He W, Wang J. Estrogen-Related Receptor Alpha Confers Methotrexate Resistance via Attenuation of Reactive Oxygen Species Production and P53 Mediated Apoptosis in Osteosarcoma Cells. BioMed Research International. 2014;2014():1–9. doi: 10.1155/2014/616025."
1361588,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methotrexate results in increased cleavage of PARP1 protein,,,PMID:17286800|PMID:24967384,https://www.ncbi.nlm.nih.gov/pubmed/17286800|https://www.ncbi.nlm.nih.gov/pubmed/24967384,17286800|24967384,,PMC1868870|PMC4055217,3739408|21540259,"Chen P, Wang H, Duan Z, Zou JX, Chen H, He W, Wang J. Estrogen-Related Receptor Alpha Confers Methotrexate Resistance via Attenuation of Reactive Oxygen Species Production and P53 Mediated Apoptosis in Osteosarcoma Cells. BioMed Research International. 2014;2014():1–9. doi: 10.1155/2014/616025.|Nielsen CH, Albertsen L, Bendtzen K, Baslund B. Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells. Clin Exp Immunol. 2007 May;148(2):288–95. PMID: 17286800; PMCID: PMC1868870."
1361589,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Methotrexate results in increased cleavage of PARP1 protein|dhfr protein inhibits the reaction [methotrexate results in increased cleavage of PARP1 protein]|folic acid inhibits the reaction [methotrexate results in increased cleavage of PARP1 protein],,,PMID:30502384,https://www.ncbi.nlm.nih.gov/pubmed/30502384,30502384,,,2591540,"Shao Y, Tan B, Shi J, Zhou Q. Methotrexate induces astrocyte apoptosis by disrupting folate metabolism in the mouse juvenile central nervous system. Toxicol Lett. 2019 Feb;301():146–56. doi: 10.1016/j.toxlet.2018.11.016. PMID: 30502384."
313667,129869,Comparative Toxicogenomics Database (CTD),Atiprimod,C099015,azaspirane,https://ctdbase.org/detail.go?type=chem&acc=C099015,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Azaspirane results in increased cleavage of PARP1 protein,,,PMID:15705788,https://www.ncbi.nlm.nih.gov/pubmed/15705788,15705788,,PMC1895034,15280412,"Hamasaki M, Hideshima T, Tassone P, Neri P, Ishitsuka K, Yasui H, Shiraishi N, Raje N, Kumar S, Picker DH, Jacob GS, Richardson PG, Munshi NC, Anderson KC. Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo. Blood. 2005 Jun 01;105(11):4470–6. PMID: 15705788; PMCID: PMC1895034."
1763479,132519,Comparative Toxicogenomics Database (CTD),Ilomastat,C078131,N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide,https://ctdbase.org/detail.go?type=chem&acc=C078131,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein],,,PMID:22155090,https://www.ncbi.nlm.nih.gov/pubmed/22155090,22155090,,,15398108,"Sarró E, Jacobs-Cachá C, Itarte E, Meseguer A. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275–87. doi: 10.1016/j.taap.2011.11.007. PMID: 22155090."
1616088,132776,Comparative Toxicogenomics Database (CTD),N-Desmethyldauricine,C079980,N-desmethyldauricine,https://ctdbase.org/detail.go?type=chem&acc=C079980,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),N-desmethyldauricine results in increased cleavage of PARP1 protein,,,PMID:38908813,https://www.ncbi.nlm.nih.gov/pubmed/38908813,38908813,,,37417349,"Liu W, Yu Y, Hou T, Wei H, Lv F, Shen A, Liu Y, Wang J, Fu D. N-desmethyldauricine from Menispermum dauricum DC suppresses triple-negative breast cancer growth in 2D and 3D models by downregulating the NF-?B signaling pathway. Chem Biol Interact. 2024 Aug 01;398():111113. doi: 10.1016/j.cbi.2024.111113. PMID: 38908813."
1611765,132862,Comparative Toxicogenomics Database (CTD),Tilarginine,D019323,omega-N-Methylarginine,https://ctdbase.org/detail.go?type=chem&acc=D019323,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Omega-N-methylarginine inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased expression of PARP1 protein],,,PMID:23011206,https://www.ncbi.nlm.nih.gov/pubmed/23011206,23011206,,,32980482,2012; 38(1):50-58
1273548,133145,Comparative Toxicogenomics Database (CTD),Yakuchinone-A,C042566,yakuchinone-A,https://ctdbase.org/detail.go?type=chem&acc=C042566,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Yakuchinone-A results in increased cleavage of PARP1 protein,,,PMID:24070160,https://www.ncbi.nlm.nih.gov/pubmed/24070160,24070160,,PMC3879407,16117922,2013; 13(1):237
1500292,135411,Comparative Toxicogenomics Database (CTD),"6-(4-Hydroxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic acid",C099555,CD 437,https://ctdbase.org/detail.go?type=chem&acc=C099555,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CD 437 results in increased cleavage of PARP1 protein,,,PMID:10374879,https://www.ncbi.nlm.nih.gov/pubmed/10374879,10374879,,,4279879,"Giannì M, de Thé H. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies. Leukemia. 1999 May;13(5):739–49. doi: 10.1038/sj.leu.2401419. PMID: 10374879."
1711631,136132,Toxin and Toxin Target Database (T3DB),Arsabenzene,T3D1294,Arsabenzene,http://www.t3db.ca/toxins/T3D1294,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1359377,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Flame retardants results in decreased expression of PARP1 protein,,,PMID:31241157,https://www.ncbi.nlm.nih.gov/pubmed/31241157,31241157,,PMC6735962,9493512,"Gouesse RJ, Lavoie M, Dianati E, Wade MG, Hales BF, Robaire B, Plante I. Gestational and Lactational Exposure to an Environmentally Relevant Mixture of Brominated Flame Retardants Downregulates Junctional Proteins, Thyroid Hormone Receptor a1 Expression, and the Proliferation-Apoptosis Balance in Mammary Glands Post Puberty. Toxicol Sci. 2019 Sep 01;171(1):13–31. PMID: 31241157; PMCID: PMC6735962."
1353154,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nitric oxide results in increased cleavage of PARP1 protein,,,PMID:15126337|PMID:16024610,https://www.ncbi.nlm.nih.gov/pubmed/15126337|https://www.ncbi.nlm.nih.gov/pubmed/16024610,15126337|16024610,,,4372606|25475805,"McLaughlin LM, Demple B. Nitric oxide-induced apoptosis in lymphoblastoid and fibroblast cells dependent on the phosphorylation and activation of p53. Cancer Res. 2005 Jul 15;65(14):6097–104. doi: 10.1158/0008-5472.can-04-4254. PMID: 16024610.|Li CQ, Robles AI, Hanigan CL, Hofseth LJ, Trudel LJ, Harris CC, Wogan GN. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 01;64(9):3022–9. doi: 10.1158/0008-5472.can-03-1880. PMID: 15126337."
1353155,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[S-nitroso-N-acetylpenicillamine results in increased abundance of nitric oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]],,,PMID:10811113,https://www.ncbi.nlm.nih.gov/pubmed/10811113,10811113,,,24009608,"Melino G, Bernassola F, Catani MV, Rossi A, Corazzari M, Sabatini S, Vilbois F, Green DR. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. Cancer Res. 2000 May 01;60(9):2377–83. PMID: 10811113."
1353156,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 gene mutant form inhibits the reaction [S100B protein results in increased secretion of nitric oxide],,,PMID:27444121,https://www.ncbi.nlm.nih.gov/pubmed/27444121,27444121,,PMC7927976,14832186,"Xu J, Wang H, Won SJ, Basu J, Kapfhamer D, Swanson RA. Microglial activation induced by the alarmin S100B is regulated by poly(ADP-ribose) polymerase-1. Glia. 2016 Nov;64(11):1869–78. PMID: 27444121; PMCID: PMC7927976."
1275891,145726,Comparative Toxicogenomics Database (CTD),"3',4'-Dihydroxyflavone",C028288,"3',4'-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C028288,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3',4'-dihydroxyflavone analog inhibits the reaction [kaempferol results in increased cleavage of PARP1 protein]|3',4'-dihydroxyflavone analog inhibits the reaction [etoposide results in increased cleavage of PARP1 protein]",,,PMID:16014620,https://www.ncbi.nlm.nih.gov/pubmed/16014620,16014620,,,25466453,"Lee ER, Kang YJ, Kim JH, Lee HT, Cho SG. Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 09;280(36):31498–507. doi: 10.1074/jbc.m505537200. PMID: 16014620."
1453767,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Anthocyanins inhibits the reaction [streptozocin results in increased cleavage of PARP1 protein],,,PMID:28856781,https://www.ncbi.nlm.nih.gov/pubmed/28856781,28856781,,,8116139,"Huang PC, Wang GJ, Fan MJ, Asokan Shibu M, Liu YT, Padma Viswanadha V, Lin YL, Lai CH, Chen YF, Liao HE, Huang CY. Cellular apoptosis and cardiac dysfunction in STZ-induced diabetic rats attenuated by anthocyanins via activation of IGFI-R/PI3K/Akt survival signaling. Environ Toxicol. 2017 Dec;32(12):2471–80. doi: 10.1002/tox.22460. PMID: 28856781."
1614358,147004,Comparative Toxicogenomics Database (CTD),Methylselenocysteine,C002979,selenomethylselenocysteine,https://ctdbase.org/detail.go?type=chem&acc=C002979,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Selenomethylselenocysteine metabolite results in increased expression of PARP1 protein modified form|bmf protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of PARP1 protein modified form]|[aminooxyacetic acid results in decreased metabolism of selenomethylselenocysteine] which results in decreased expression of PARP1 protein modified form,,,PMID:25321483,https://www.ncbi.nlm.nih.gov/pubmed/25321483,25321483,,PMC4237248,5265836,"Kang Y, Nian H, Rajendran P, Kim E, Dashwood WM, Pinto JT, Boardman LA, Thibodeau SN, Limburg PJ, Löhr CV, Bisson WH, Williams DE, Ho E, Dashwood RH. HDAC8 and STAT3 repress BMF gene activity in colon cancer cells. Cell Death & Disease. 2014 Oct 16;5(10):e1476. doi: 10.1038/cddis.2014.422."
322539,148124,Comparative Toxicogenomics Database (CTD),Docetaxel,D000077143,Docetaxel,https://ctdbase.org/detail.go?type=chem&acc=D000077143,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein]|2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein],,,PMID:14724571,https://www.ncbi.nlm.nih.gov/pubmed/14724571,14724571,,,975980,"Wang Q, Wieder R. All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene. 2004 Jan 15;23(2):426–33. doi: 10.1038/sj.onc.1207040. PMID: 14724571."
322540,148124,Comparative Toxicogenomics Database (CTD),Docetaxel,D000077143,Docetaxel,https://ctdbase.org/detail.go?type=chem&acc=D000077143,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein],,,PMID:17308071,https://www.ncbi.nlm.nih.gov/pubmed/17308071,17308071,,,15295415,"Mhaidat NM, Wang Y, Kiejda KA, Zhang XD, Hersey P. Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2. Mol Cancer Ther. 2007 Feb;6(2):752–61. doi: 10.1158/1535-7163.mct-06-0564. PMID: 17308071."
322718,148124,Comparative Toxicogenomics Database (CTD),Docetaxel,D000077143,Docetaxel,https://ctdbase.org/detail.go?type=chem&acc=D000077143,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Docetaxel results in increased cleavage of and results in increased expression of PARP1 protein|docetaxel promotes the reaction [celecoxib results in increased cleavage of and results in increased expression of PARP1 protein]|celecoxib promotes the reaction [docetaxel results in increased cleavage of and results in increased expression of PARP1 protein],,,PMID:15688368,https://www.ncbi.nlm.nih.gov/pubmed/15688368,15688368,,,15264006,"Dandekar DS, Lopez M, Carey RI, Lokeshwar BL. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells. Int J Cancer. 2005 Jun 20;115(3):484–92. doi: 10.1002/ijc.20878. PMID: 15688368."
322719,148124,Comparative Toxicogenomics Database (CTD),Docetaxel,D000077143,Docetaxel,https://ctdbase.org/detail.go?type=chem&acc=D000077143,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[docetaxel co-treated with fatostatin] results in increased cleavage of PARP1 protein|docetaxel promotes the reaction [[TP53 protein mutant form results in increased susceptibility to fatostatin] which results in increased cleavage of PARP1 protein],,,PMID:26512780,https://www.ncbi.nlm.nih.gov/pubmed/26512780,26512780,,PMC4747386,32349725,"Li X, Wu JB, Chung LW, Huang WC. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations. Oncotarget. 2015 Dec 01;6(38):41018–32. PMID: 26512780; PMCID: PMC4747386."
322720,148124,Comparative Toxicogenomics Database (CTD),Docetaxel,D000077143,Docetaxel,https://ctdbase.org/detail.go?type=chem&acc=D000077143,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Docetaxel promotes the reaction [apigenin-6,8-di-C-glycopyranoside results in increased cleavage of PARP1 protein]",,,PMID:21803027,https://www.ncbi.nlm.nih.gov/pubmed/21803027,21803027,,PMC3252753,12711278,"Nagaprashantha LD, Vatsyayan R, Singhal J, Fast S, Roby R, Awasthi S, Singhal SS. Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer. Biochemical Pharmacology. 2011 Nov;82(9):1100–9. doi: 10.1016/j.bcp.2011.07.078."
322721,148124,Comparative Toxicogenomics Database (CTD),Docetaxel,D000077143,Docetaxel,https://ctdbase.org/detail.go?type=chem&acc=D000077143,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Docetaxel promotes the reaction [TNFSF10 results in increased cleavage of PARP1 protein],,,PMID:18404675,https://www.ncbi.nlm.nih.gov/pubmed/18404675,18404675,,,8604571,"Yoo J, Park SS, Lee YJ. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells. J Cell Biochem. 2008 Aug 01;104(5):1636–46. doi: 10.1002/jcb.21729. PMID: 18404675."
322722,148124,Comparative Toxicogenomics Database (CTD),Docetaxel,D000077143,Docetaxel,https://ctdbase.org/detail.go?type=chem&acc=D000077143,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Docetaxel results in increased cleavage of PARP1 protein,,,PMID:14724571|PMID:15970518|PMID:17308071|PMID:18186959|PMID:19715609|PMID:20878124,https://www.ncbi.nlm.nih.gov/pubmed/14724571|https://www.ncbi.nlm.nih.gov/pubmed/15970518|https://www.ncbi.nlm.nih.gov/pubmed/17308071|https://www.ncbi.nlm.nih.gov/pubmed/18186959|https://www.ncbi.nlm.nih.gov/pubmed/19715609|https://www.ncbi.nlm.nih.gov/pubmed/20878124,14724571|15970518|17308071|18186959|19715609|20878124,,PMC2741463,975980|15295415|15974305|22792180|28855904|32900114,"Zhang F, Zhang T, Qu Y, Jiang T, Cao YX, Li C, Fan L, Mei QB. Replication-dependent ?-H2AX formation is involved in docetaxel-induced apoptosis in NSCLC A549 cells. Oncol Rep. 2010 Nov;24(5):1297–305. doi: 10.3892/or_00000986. PMID: 20878124.|2009; 8(1):68|Mahaffey CM, Davies AM, Lara PN, Pryde B, Holland W, Mack PC, Gumerlock PH, Gandara DR. Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: rationale for pharmacodynamic separation. Clin Lung Cancer. 2007 Nov;8(9):548–53. doi: 10.3816/clc.2007.n.041. PMID: 18186959.|Mhaidat NM, Wang Y, Kiejda KA, Zhang XD, Hersey P. Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2. Mol Cancer Ther. 2007 Feb;6(2):752–61. doi: 10.1158/1535-7163.mct-06-0564. PMID: 17308071.|Caraglia M, Giuberti G, Marra M, Di Gennaro E, Facchini G, Caponigro F, Iaffaioli R, Budillon A, Abbruzzese A. Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells. Front Biosci. 2005 Sep 01;10():2566–75. doi: 10.2741/1720. PMID: 15970518.|Wang Q, Wieder R. All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene. 2004 Jan 15;23(2):426–33. doi: 10.1038/sj.onc.1207040. PMID: 14724571."
1374842,148140,DrugBank,"3,4-Dihydro-5-methylisoquinolinone",DB03722,"3,4-Dihydro-5-Methyl-Isoquinolinone",https://www.drugbank.ca/drugs/DB03722,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/37713619|https://www.ncbi.nlm.nih.gov/pubmed/10592235,37713619|10592235,,PMC102472|PMC10767903,12499145|36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
1377829,148140,BindingDB,"3,4-Dihydro-5-methylisoquinolinone",27682,"5-methyl-1,2,3,4-tetrahydroisoquinolin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27682,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),160,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
1763901,148140,Therapeutic Target Database (TTD),"3,4-Dihydro-5-methylisoquinolinone",D0E2VC,PD-128763,https://idrblab.net/ttd/data/drug/details/D0E2VC,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1505629,148177,Comparative Toxicogenomics Database (CTD),Perifosine,C105905,perifosine,https://ctdbase.org/detail.go?type=chem&acc=C105905,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [perifosine results in increased cleavage of PARP1 protein]|perifosine results in increased cleavage of PARP1 protein|lat2 protein inhibits the reaction [perifosine results in increased cleavage of PARP1 protein],,,PMID:32587277,https://www.ncbi.nlm.nih.gov/pubmed/32587277,32587277,,PMC7316767,13589569,"Thomé CH, Ferreira GA, Pereira-Martins DA, dos Santos GA, Ortiz CA, de Souza LEB, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Coelho-Silva JL, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, Kerbauy FR, Chauffaille MDL, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports. 2020 Jun 25;10(1):10315. doi: 10.1038/s41598-020-66223-2."
1651562,150664,Therapeutic Target Database (TTD),Quinoline-8-carboxamide,D07AGU,Quinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D07AGU,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1455057,152961,Comparative Toxicogenomics Database (CTD),3-Chloroacetylindole,C056007,3-chloroacetylindole,https://ctdbase.org/detail.go?type=chem&acc=C056007,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),3-chloroacetylindole affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein],,,PMID:31396050,https://www.ncbi.nlm.nih.gov/pubmed/31396050,31396050,,PMC6667551,10151887,"Kim JE, Kang TC. PKC, AKT and ERK1/2-Mediated Modulations of PARP1, NF-?B and PEA15 Activities Distinctly Regulate Regional Specific Astroglial Responses Following Status Epilepticus. Front Mol Neurosci. 2019;12():180. PMID: 31396050; PMCID: PMC6667551."
1620583,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of PARP1 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,PMC6121255,19625190,"Lanza Cariccio V, Scionti D, Raffa A, Iori R, Pollastro F, Diomede F, Bramanti P, Trubiani O, Mazzon E. Treatment of Periodontal Ligament Stem Cells with MOR and CBD Promotes Cell Survival and Neuronal Differentiation via the PI3K/Akt/mTOR Pathway. Int J Mol Sci. 2018 Aug 09;19(8). PMID: 30096889; PMCID: PMC6121255."
1459997,154083,Comparative Toxicogenomics Database (CTD),"2,2',4,4',6-Pentabromodiphenyl ether",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PARP1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,PMC7024050,5374756,"Sheller-Miller S, Radnaa E, Arita Y, Getahun D, Jones RJ, Peltier MR, Menon R. Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 01;89():42–9. PMID: 31675489; PMCID: PMC7024050."
1749890,155166,Comparative Toxicogenomics Database (CTD),Hexabrominated Diphenyl Ether 153,C517828,hexabrominated diphenyl ether 153,https://ctdbase.org/detail.go?type=chem&acc=C517828,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hexabrominated diphenyl ether 153 results in decreased expression of PARP1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,PMC7024050,5374756,"Sheller-Miller S, Radnaa E, Arita Y, Getahun D, Jones RJ, Peltier MR, Menon R. Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 01;89():42–9. PMID: 31675489; PMCID: PMC7024050."
1203646,155173,Comparative Toxicogenomics Database (CTD),Tomentosin,C454646,tomentosin,https://ctdbase.org/detail.go?type=chem&acc=C454646,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [tomentosin results in increased cleavage of PARP1 protein],,,PMID:30917517,https://www.ncbi.nlm.nih.gov/pubmed/30917517,30917517,,PMC6471964,10838292,"Lee CM, Lee J, Nam MJ, Choi YS, Park SH. Tomentosin Displays Anti-Carcinogenic Effect in Human Osteosarcoma MG-63 Cells via the Induction of Intracellular Reactive Oxygen Species. Int J Mol Sci. 2019 Mar 26;20(6). PMID: 30917517; PMCID: PMC6471964."
1203798,155173,Comparative Toxicogenomics Database (CTD),Tomentosin,C454646,tomentosin,https://ctdbase.org/detail.go?type=chem&acc=C454646,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tomentosin results in increased cleavage of PARP1 protein,,,PMID:27922187|PMID:30917517|PMID:32787465,https://www.ncbi.nlm.nih.gov/pubmed/27922187|https://www.ncbi.nlm.nih.gov/pubmed/30917517|https://www.ncbi.nlm.nih.gov/pubmed/32787465,27922187|30917517|32787465,,PMC6471964,9530299|10838292|29023965,"Yu SH, Lee CM, Ha SH, Lee J, Jang KY, Park SH. Induction of cell cycle arrest and apoptosis by tomentosin in hepatocellular carcinoma HepG2 and Huh7 cells. Hum Exp Toxicol. 2021 Feb;40(2):231–44. doi: 10.1177/0960327120943935. PMID: 32787465.|Lee CM, Lee J, Nam MJ, Choi YS, Park SH. Tomentosin Displays Anti-Carcinogenic Effect in Human Osteosarcoma MG-63 Cells via the Induction of Intracellular Reactive Oxygen Species. Int J Mol Sci. 2019 Mar 26;20(6). PMID: 30917517; PMCID: PMC6471964.|Merghoub N, El Btaouri H, Benbacer L, Gmouh S, Trentesaux C, Brassart B, Attaleb M, Madoulet C, Wenner T, Amzazi S, Morjani H, El Mzibri M. Tomentosin Induces Telomere Shortening and Caspase-Dependant Apoptosis in Cervical Cancer Cells. J Cell Biochem. 2017 Jul;118(7):1689–98. doi: 10.1002/jcb.25826. PMID: 27922187."
1623293,156517,Comparative Toxicogenomics Database (CTD),Nectandrin B,C524653,nectandrin-B,https://ctdbase.org/detail.go?type=chem&acc=C524653,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nectandrin-B inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein],,,PMID:27511913,https://www.ncbi.nlm.nih.gov/pubmed/27511913,27511913,,,11445507,"Song JS, Kim EK, Choi YW, Oh WK, Kim YM. Hepatocyte-protective effect of nectandrin B, a nutmeg lignan, against oxidative stress: Role of Nrf2 activation through ERK phosphorylation and AMPK-dependent inhibition of GSK-3ß. Toxicol Appl Pharmacol. 2016 Sep 15;307():138–49. doi: 10.1016/j.taap.2016.08.003. PMID: 27511913."
1731872,157464,Comparative Toxicogenomics Database (CTD),Naphthalenediimide,C542131,naphthalenediimide,https://ctdbase.org/detail.go?type=chem&acc=C542131,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Naphthalenediimide analog results in increased cleavage of PARP1 protein,,,PMID:30840857,https://www.ncbi.nlm.nih.gov/pubmed/30840857,30840857,,,18261158,"Gurung SK, Dana S, Mandal K, Mukhopadhyay P, Mondal N. Downregulation of c-Myc and p21 expression and induction of S phase arrest by naphthalene diimide derivative in gastric adenocarcinoma cells. Chem Biol Interact. 2019 May 01;304():106–23. doi: 10.1016/j.cbi.2019.02.010. PMID: 30840857."
1381122,157914,Comparative Toxicogenomics Database (CTD),Kahweol Acetate,C046438,kahweol acetate,https://ctdbase.org/detail.go?type=chem&acc=C046438,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with kahweol acetate] results in increased cleavage of PARP1 protein]|[tnfsf10 protein co-treated with kahweol acetate] results in increased cleavage of PARP1 protein|pyrazolanthrone results in increased susceptibility to [[TNFSF10 protein co-treated with kahweol acetate] results in increased cleavage of PARP1 protein],,,PMID:20403343,https://www.ncbi.nlm.nih.gov/pubmed/20403343,20403343,,,24187076,"Um HJ, Oh JH, Kim YN, Choi YH, Kim SH, Park JW, Kwon TK. The coffee diterpene kahweol sensitizes TRAIL-induced apoptosis in renal carcinoma Caki cells through down-regulation of Bcl-2 and c-FLIP. Chem Biol Interact. 2010 Jun 07;186(1):36–42. doi: 10.1016/j.cbi.2010.04.013. PMID: 20403343."
1506573,159287,Comparative Toxicogenomics Database (CTD),CID 159287,C065861,malvidin,https://ctdbase.org/detail.go?type=chem&acc=C065861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Malvidin results in increased cleavage of PARP1 protein,,,PMID:15964118,https://www.ncbi.nlm.nih.gov/pubmed/15964118,15964118,,,15968199,"Shih PH, Yeh CT, Yen GC. Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells. Food Chem Toxicol. 2005 Oct;43(10):1557–66. doi: 10.1016/j.fct.2005.05.001. PMID: 15964118."
1507122,159295,Toxin and Toxin Target Database (T3DB),Hexaaminecobalt trichloride,T3D0676,Hexamminecobalt(III) chloride,http://www.t3db.ca/toxins/T3D0676,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1618692,160254,Comparative Toxicogenomics Database (CTD),Cryptotanshinone,C037886,cryptotanshinone,https://ctdbase.org/detail.go?type=chem&acc=C037886,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cryptotanshinone results in increased cleavage of PARP1 protein,,,PMID:26564229,https://www.ncbi.nlm.nih.gov/pubmed/26564229,26564229,,,21573057,2015; 90(9):2275-2286
1732026,160355,Comparative Toxicogenomics Database (CTD),Roscovitine,D000077546,Roscovitine,https://ctdbase.org/detail.go?type=chem&acc=D000077546,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Roscovitine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:18501396,https://www.ncbi.nlm.nih.gov/pubmed/18501396,18501396,,PMC2806883,17364335,"McNeely SC, Taylor BF, States JC. Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent. Toxicology and Applied Pharmacology. 2008 Aug;231(1):61–7. doi: 10.1016/j.taap.2008.03.020."
1337380,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Abrine results in increased cleavage of PARP1 protein,,,PMID:23788630,https://www.ncbi.nlm.nih.gov/pubmed/23788630,23788630,,,3869030,"Saxena N, Yadav P, Kumar O. The Fas/Fas ligand apoptotic pathway is involved in abrin-induced apoptosis. Toxicol Sci. 2013 Sep;135(1):103–18. doi: 10.1093/toxsci/kft139. PMID: 23788630."
1625689,160644,Comparative Toxicogenomics Database (CTD),Liensinine,C080095,liensinine,https://ctdbase.org/detail.go?type=chem&acc=C080095,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Liensinine results in increased cleavage of PARP1 protein,,,PMID:29333179,https://www.ncbi.nlm.nih.gov/pubmed/29333179,29333179,,PMC5733186,29711927,"Kang EJ, Lee SK, Park K, Son SH, Kim KR, Chung W. Liensinine and Nuciferine, Bioactive Components of <i>Nelumbo nucifera</i>, Inhibit the Growth of Breast Cancer Cells and Breast Cancer-Associated Bone Loss. Evidence-Based Complementary and Alternative Medicine. 2017 Jan;2017(1). doi: 10.1155/2017/1583185."
1751139,160921,Comparative Toxicogenomics Database (CTD),Nevadensin,C561747,lysionotin,https://ctdbase.org/detail.go?type=chem&acc=C561747,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lysionotin results in increased cleavage of PARP1 protein|acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [lysionotin results in increased cleavage of PARP1 protein],,,PMID:33989594,https://www.ncbi.nlm.nih.gov/pubmed/33989594,33989594,,,10894746,"Yang A, Zhang P, Sun Z, Liu X, Zhang X, Liu X, Wang D, Meng Z. Lysionotin induces apoptosis of hepatocellular carcinoma cells via caspase-3 mediated mitochondrial pathway. Chem Biol Interact. 2021 Aug 01;344():109500. doi: 10.1016/j.cbi.2021.109500. PMID: 33989594."
1532077,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1490151,161491,Comparative Toxicogenomics Database (CTD),Methylarsonite,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein],,,PMID:29774349,https://www.ncbi.nlm.nih.gov/pubmed/29774349,29774349,,,32414021,"Maimaitiyiming Y, Wang C, Xu S, Islam K, Chen YJ, Yang C, Wang QQ, Naranmandura H. Role of arsenic (+3 oxidation state) methyltransferase in arsenic mediated APL treatment: an in vitro investigation. Metallomics. 2018 Jun 20;10(6):828–37. doi: 10.1039/c8mt00057c. PMID: 29774349."
1490152,161491,Comparative Toxicogenomics Database (CTD),Methylarsonite,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Monomethylarsonous acid inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:17011244,https://www.ncbi.nlm.nih.gov/pubmed/17011244,17011244,,,25134446,"Walter I, Schwerdtle T, Thuy C, Parsons JL, Dianov GL, Hartwig A. Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells. DNA Repair. 2007 Jan;6(1):61–70. doi: 10.1016/j.dnarep.2006.08.008."
1490320,161491,Comparative Toxicogenomics Database (CTD),Methylarsonite,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Monomethylarsonous acid results in decreased activity of PARP1 protein,,,PMID:19699219|PMID:21925530,https://www.ncbi.nlm.nih.gov/pubmed/19699219|https://www.ncbi.nlm.nih.gov/pubmed/21925530,19699219|21925530,,PMC2783778|PMC3220758,23516436|26207752,"Wnek SM, Kuhlman CL, Camarillo JM, Medeiros MK, Liu KJ, Lau SS, Gandolfi AJ. Interdependent genotoxic mechanisms of monomethylarsonous acid: Role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicology and Applied Pharmacology. 2011 Nov;257(1):1–13. doi: 10.1016/j.taap.2011.08.029.|Wnek SM, Medeiros MK, Eblin KE, Gandolfi AJ. Persistence of DNA damage following exposure of human bladder cells to chronic monomethylarsonous acid. Toxicology and Applied Pharmacology. 2009 Dec;241(2):202–9. doi: 10.1016/j.taap.2009.08.016."
1490321,161491,Comparative Toxicogenomics Database (CTD),Methylarsonite,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Monomethylarsonous acid results in increased expression of PARP1 protein|zinc inhibits the reaction [monomethylarsonous acid results in decreased activity of PARP1 protein]|monomethylarsonous acid results in increased expression of PARP1 mRNA,,,PMID:21925530,https://www.ncbi.nlm.nih.gov/pubmed/21925530,21925530,,PMC3220758,23516436,"Wnek SM, Kuhlman CL, Camarillo JM, Medeiros MK, Liu KJ, Lau SS, Gandolfi AJ. Interdependent genotoxic mechanisms of monomethylarsonous acid: Role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicology and Applied Pharmacology. 2011 Nov;257(1):1–13. doi: 10.1016/j.taap.2011.08.029."
1378446,161557,Comparative Toxicogenomics Database (CTD),Dihydromyricetin,C472036,dihydromyricetin,https://ctdbase.org/detail.go?type=chem&acc=C472036,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of PARP1 protein]|u 0126 promotes the reaction [dihydromyricetin results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [dihydromyricetin results in increased cleavage of PARP1 protein]|pyrazolanthrone promotes the reaction [dihydromyricetin results in increased cleavage of PARP1 protein],,,PMID:27539140,https://www.ncbi.nlm.nih.gov/pubmed/27539140,27539140,,,28352053,"Kao S, Lee W, Chang J, Chow J, Chung C, Hung W, Chien M. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer. Environmental Toxicology. 2016 Aug 19;32(4):1426–38. doi: 10.1002/tox.22336."
1378447,161557,Comparative Toxicogenomics Database (CTD),Dihydromyricetin,C472036,dihydromyricetin,https://ctdbase.org/detail.go?type=chem&acc=C472036,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dihydromyricetin results in increased cleavage of PARP1 protein,,,PMID:27539140|PMID:36807944,https://www.ncbi.nlm.nih.gov/pubmed/27539140|https://www.ncbi.nlm.nih.gov/pubmed/36807944,27539140|36807944,,,28352053|35218440,"Li X, Zhou L, Wang R, Zhang Y, Li W. Dihydromyricetin suppresses tumor growth via downregulation of the EGFR/Akt/survivin signaling pathway. J Biochem Mol Toxicol. 2023 Jun;37(6):e23328. doi: 10.1002/jbt.23328. PMID: 36807944.|Kao S, Lee W, Chang J, Chow J, Chung C, Hung W, Chien M. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer. Environmental Toxicology. 2016 Aug 19;32(4):1426–38. doi: 10.1002/tox.22336."
1384756,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of PARP1 protein",,,PMID:18444175,https://www.ncbi.nlm.nih.gov/pubmed/18444175,18444175,,,21404118,"Snyder RM, Yu W, Jia L, Sanders BG, Kline K. Vitamin E Analog a -TEA, Methylseleninic Acid, and<i>Trans</i>-Resveratrol in Combination Synergistically Inhibit Human Breast Cancer Cell Growth. Nutrition and Cancer. 2008 Apr 28;60(3):401–11. doi: 10.1080/01635580701759716."
1384757,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein|akt1 protein modified form inhibits the reaction [[doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]|bcl2l11 protein promotes the reaction [[doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]|sb 216763 inhibits the reaction [[doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein],,,PMID:17339365,https://www.ncbi.nlm.nih.gov/pubmed/17339365,17339365,,,20720181,"Li S, Zhou Y, Wang R, Zhang H, Dong Y, Ip C. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther. 2007 Mar;6(3):1031–8. doi: 10.1158/1535-7163.mct-06-0643. PMID: 17339365."
1384758,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of PARP1 protein],,,PMID:16204082,https://www.ncbi.nlm.nih.gov/pubmed/16204082,16204082,,,11239241,"Wu Y, Zhang H, Dong Y, Park YM, Ip C. Endoplasmic reticulum stress signal mediators are targets of selenium action. Cancer Res. 2005 Oct 01;65(19):9073–9. doi: 10.1158/0008-5472.can-05-2016. PMID: 16204082."
1384759,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methylselenic acid results in increased cleavage of PARP1 protein,,,PMID:15845651|PMID:16204082|PMID:18444175|PMID:28161410,https://www.ncbi.nlm.nih.gov/pubmed/15845651|https://www.ncbi.nlm.nih.gov/pubmed/16204082|https://www.ncbi.nlm.nih.gov/pubmed/18444175|https://www.ncbi.nlm.nih.gov/pubmed/28161410,15845651|16204082|18444175|28161410,,,7862770|9447777|11239241|21404118,"Shigemi Z, Manabe K, Hara N, Baba Y, Hosokawa K, Kagawa H, Watanabe T, Fujimuro M. Methylseleninic acid and sodium selenite induce severe ER stress and subsequent apoptosis through UPR activation in PEL cells. Chem Biol Interact. 2017 Mar 25;266():28–37. doi: 10.1016/j.cbi.2017.01.027. PMID: 28161410.|Snyder RM, Yu W, Jia L, Sanders BG, Kline K. Vitamin E Analog a -TEA, Methylseleninic Acid, and<i>Trans</i>-Resveratrol in Combination Synergistically Inhibit Human Breast Cancer Cell Growth. Nutrition and Cancer. 2008 Apr 28;60(3):401–11. doi: 10.1080/01635580701759716.|Wu Y, Zhang H, Dong Y, Park YM, Ip C. Endoplasmic reticulum stress signal mediators are targets of selenium action. Cancer Res. 2005 Oct 01;65(19):9073–9. doi: 10.1158/0008-5472.can-05-2016. PMID: 16204082.|Hu H, Jiang C, Li G, Lü J. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. Carcinogenesis. 2005 Aug;26(8):1374–81. doi: 10.1093/carcin/bgi094. PMID: 15845651."
1384760,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Methylselenic acid results in increased cleavage of PARP1 protein,,,PMID:19276161,https://www.ncbi.nlm.nih.gov/pubmed/19276161,19276161,,PMC2822709,22771526,"Jiang W, Jiang C, Pei H, Wang L, Zhang J, Hu H, Lu¨ J. <i>In vivo</i> molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of <i>gadd</i> genes. 2009 Mar 01;8(3):682–91. doi: 10.1158/1535-7163.mct-08-0908."
1783792,162859,Comparative Toxicogenomics Database (CTD),Platycodin D,C108953,platycodin D,https://ctdbase.org/detail.go?type=chem&acc=C108953,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[platycodin D co-treated with imatinib mesylate] results in increased cleavage of and results in decreased expression of PARP1 protein,,,PMID:29552859,https://www.ncbi.nlm.nih.gov/pubmed/29552859,29552859,,,31078293,"Dai Q, Ge YQ. [Inhibitory effect and mechanism of platycodin D combined with imatinib on K562/R]. Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(2):385–9. doi: 10.19540/j.cnki.cjcmm.20171027.012. PMID: 29552859."
1783793,162859,Comparative Toxicogenomics Database (CTD),Platycodin D,C108953,platycodin D,https://ctdbase.org/detail.go?type=chem&acc=C108953,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Platycodin D results in increased activity of PARP1 protein,,,PMID:18804340|PMID:20412017,https://www.ncbi.nlm.nih.gov/pubmed/18804340|https://www.ncbi.nlm.nih.gov/pubmed/20412017,18804340|20412017,,,5132209|24195249,"Yu JS, Kim AK. Platycodin D induces apoptosis in MCF-7 human breast cancer cells. J Med Food. 2010 Apr;13(2):298–305. doi: 10.1089/jmf.2009.1226. PMID: 20412017.|Shin DY, Kim GY, Li W, Choi BT, Kim ND, Kang HS, Choi YH. Implication of intracellular ROS formation, caspase-3 activation and Egr-1 induction in platycodon D-induced apoptosis of U937 human leukemia cells. Biomed Pharmacother. 2009 Feb;63(2):86–94. doi: 10.1016/j.biopha.2008.08.001. PMID: 18804340."
1783794,162859,Comparative Toxicogenomics Database (CTD),Platycodin D,C108953,platycodin D,https://ctdbase.org/detail.go?type=chem&acc=C108953,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Platycodin D results in increased cleavage of PARP1 protein,,,PMID:23236765|PMID:24048756|PMID:24641402,https://www.ncbi.nlm.nih.gov/pubmed/23236765|https://www.ncbi.nlm.nih.gov/pubmed/24048756|https://www.ncbi.nlm.nih.gov/pubmed/24641402,23236765|24048756|24641402,,,4531016|13432721|16097970,"Li T, Xu W, Wu G, Chen X, Wang Y, Lu J. Platycodin D Induces Apoptosis, and Inhibits Adhesion, Migration and Invasion in HepG2 Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention. 2014 Feb 28;15(4):1745–9. doi: 10.7314/apjcp.2014.15.4.1745.|2013; 35(2):1267-1274|Dai Q, Chen Z, Ge YQ, Liu P, Wang HB, Ma XQ, Wu BH. [Mechanism of platycodin D-induced apoptosis in A549 human lung cancer cells]. Zhongguo Zhong Yao Za Zhi. 2012 Sep;37(17):2626–9. PMID: 23236765."
1388102,163263,Comparative Toxicogenomics Database (CTD),Sclareol,C070760,sclareol,https://ctdbase.org/detail.go?type=chem&acc=C070760,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sclareol results in increased cleavage of PARP1 protein,,,PMID:37850667,https://www.ncbi.nlm.nih.gov/pubmed/37850667,37850667,,,36091046,"Rah B, Shafarin J, Hamad M, Muhammad JS. Sclareol induces cell cycle arrest and ROS-mediated apoptosis and ferroptosis in lung adenocarcinoma cells. J Biochem Mol Toxicol. 2024 Jan;38(1):e23563. doi: 10.1002/jbt.23563. PMID: 37850667."
1205020,163292,Comparative Toxicogenomics Database (CTD),Frenolicin B,C018066,frenolicin B,https://ctdbase.org/detail.go?type=chem&acc=C018066,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Frenolicin B results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [frenolicin B results in increased cleavage of PARP1 protein],,,PMID:30661989,https://www.ncbi.nlm.nih.gov/pubmed/30661989,30661989,,PMC6557261,30427533,"Ye Q, Zhang Y, Cao Y, Wang X, Guo Y, Chen J, Horn J, Ponomareva LV, Chaiswing L, Shaaban KA, Wei Q, Anderson BD, St Clair DK, Zhu H, Leggas M, Thorson JS, She Q. Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects. Cell Chemical Biology. 2019 Mar;26(3):366–377.e12. doi: 10.1016/j.chembiol.2018.11.013."
1205023,163884,DrugBank,Carba-Nicotinamide-Adenine-Dinucleotide,DB02498,Carba-nicotinamide-adenine-dinucleotide,https://www.drugbank.ca/drugs/DB02498,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/37713619|https://www.ncbi.nlm.nih.gov/pubmed/10592235,37713619|10592235,,PMC102472|PMC10767903,12499145|36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
1283119,163884,Therapeutic Target Database (TTD),Carba-Nicotinamide-Adenine-Dinucleotide,D0JD1O,Carba-Nicotinamide-Adenine-Dinucleotide,https://idrblab.net/ttd/data/drug/details/D0JD1O,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1661368,166987,Toxin and Toxin Target Database (T3DB),Trans-Dichlorobis(ethylenediamine)cobalt(III) chloride,T3D1394,trans-Dichlorobis(ethylenediamine)cobalt(III) chloride,http://www.t3db.ca/toxins/T3D1394,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1732210,167250,Toxin and Toxin Target Database (T3DB),Dimethylarsinate,T3D0075,Dimethylarsinate,http://www.t3db.ca/toxins/T3D0075,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1628022,174863,Comparative Toxicogenomics Database (CTD),Intybin,C001458,intybin,https://ctdbase.org/detail.go?type=chem&acc=C001458,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Intybin results in increased cleavage of PARP1 protein,,,PMID:33322048,https://www.ncbi.nlm.nih.gov/pubmed/33322048,33322048,,PMC7764785,15607469,"Rotondo R, Oliva MA, Staffieri S, Castaldo S, Giangaspero F, Arcella A. Implication of Lactucopicrin in Autophagy, Cell Cycle Arrest and Oxidative Stress to Inhibit U87Mg Glioblastoma Cell Growth. Molecules. 2020 Dec 10;25(24):5843. doi: 10.3390/molecules25245843."
1732308,175805,Comparative Toxicogenomics Database (CTD),Ropivacaine,D000077212,Ropivacaine,https://ctdbase.org/detail.go?type=chem&acc=D000077212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CLU protein inhibits the reaction [ropivacaine results in increased cleavage of PARP1 protein]|ropivacaine results in increased cleavage of PARP1 protein|bcl2 protein inhibits the reaction [ropivacaine results in increased cleavage of PARP1 protein],,,PMID:15538973,https://www.ncbi.nlm.nih.gov/pubmed/15538973,15538973,,,19350084,"Kontargiris E, Kolettas E, Vadalouca A, Trougakos IP, Gonos ES, Kalfakakou V. Ectopic expression of clusterin/apolipoprotein J or Bcl-2 decreases the sensitivity of HaCaT cells to toxic effects of ropivacaine. Cell Res. 2004 Oct;14(5):415–22. doi: 10.1038/sj.cr.7290242. PMID: 15538973."
1732309,175805,Comparative Toxicogenomics Database (CTD),Ropivacaine,D000077212,Ropivacaine,https://ctdbase.org/detail.go?type=chem&acc=D000077212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ropivacaine results in increased expression of PARP1 protein,,,PMID:28079261,https://www.ncbi.nlm.nih.gov/pubmed/28079261,28079261,,,14154713,"Zheng T, Zheng CY, Zheng XC, Zhao RG, Chen YQ. Effect of parthanatos on ropivacaine-induced damage in SH-SY5Y cells. Clin Exp Pharmacol Physiol. 2017 May;44(5):586–94. doi: 10.1111/1440-1681.12730. PMID: 28079261."
1720785,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"SB 203580 inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]",,,PMID:30871965,https://www.ncbi.nlm.nih.gov/pubmed/30871965,30871965,,,29739467,"Xu WT, Shen GN, Luo YH, Piao XJ, Wang JR, Wang H, Zhang Y, Li JQ, Feng YC, Zhang Y, Zhang T, Wang SN, Wang CY, Jin CH. New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways. Chem Biol Interact. 2019 May 01;304():148–57. doi: 10.1016/j.cbi.2019.03.004. PMID: 30871965."
1720786,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"SB 203580 inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased cleavage of PARP1 protein]",,,PMID:24036456,https://www.ncbi.nlm.nih.gov/pubmed/24036456,24036456,,,24927079,"Tan J, Lai Z, Liu L, Long W, Chen T, Zha J, Wang L, Chen M, Ji H, Lai Y. ONTD induces apoptosis of human hepatoma Bel-7402 cells via a MAPK-dependent mitochondrial pathway and the depletion of intracellular glutathione. The International Journal of Biochemistry & Cell Biology. 2013 Nov;45(11):2632–42. doi: 10.1016/j.biocel.2013.08.021."
1720787,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein],,,PMID:16328441,https://www.ncbi.nlm.nih.gov/pubmed/16328441,16328441,,,1004633,2005; 80(6):310-318
1720805,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [TNFSF10 protein promotes the reaction [CSC-3436 results in increased cleavage of PARP1 protein]]|sb 203580 inhibits the reaction [CSC-3436 promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:34599545,https://www.ncbi.nlm.nih.gov/pubmed/34599545,34599545,,,7523207,"Huang C, Cheng Y, Lin Y, Chou C, Ho C, Wang H, Way T. <scp>CSC</scp>-3436 sensitizes triple negative breast cancer cells to <scp>TRAIL</scp>-induced apoptosis through <scp>ROS</scp>-mediated p38/<scp>CHOP</scp>/death receptor 5 signaling pathways. Environmental Toxicology. 2021 Oct 02;36(12):2578–88. doi: 10.1002/tox.23372."
1720806,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:16843435,https://www.ncbi.nlm.nih.gov/pubmed/16843435,16843435,,,32191306,"Grethe S, Coltella N, Di Renzo MF, Pörn-Ares MI. p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis. Biochemical and Biophysical Research Communications. 2006 Sep;347(3):781–90. doi: 10.1016/j.bbrc.2006.06.159."
1720807,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [emodin results in increased cleavage of PARP1 protein],,,PMID:27032576,https://www.ncbi.nlm.nih.gov/pubmed/27032576,27032576,,,20899140,"Cui Y, Lu P, Song G, Liu Q, Zhu D, Liu X. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis. Food Chem Toxicol. 2016 Jun;92():26–37. doi: 10.1016/j.fct.2016.03.013. PMID: 27032576."
1720808,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [[ESR1 protein results in increased susceptibility to quercetin] which results in increased cleavage of PARP1 protein],,,PMID:19194971,https://www.ncbi.nlm.nih.gov/pubmed/19194971,19194971,,,2391269,"Galluzzo P, Martini C, Bulzomi P, Leone S, Bolli A, Pallottini V, Marino M. Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. Mol Nutr Food Res. 2009 Jun;53(6):699–708. doi: 10.1002/mnfr.200800239. PMID: 19194971."
1720809,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [[ESR2 protein results in increased susceptibility to quercetin] which results in increased cleavage of PARP1 protein]|sb 203580 inhibits the reaction [[ESR2 protein results in increased susceptibility to estradiol] which results in increased cleavage of PARP1 protein],,,PMID:21732360,https://www.ncbi.nlm.nih.gov/pubmed/21732360,21732360,,,17416701,"Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, Marino M. The pro-apoptotic effect of quercetin in cancer cell lines requires ERß-dependent signals. Journal Cellular Physiology. 2012 Jan 23;227(5):1891–8. doi: 10.1002/jcp.22917."
1720810,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [isoliensinine results in increased cleavage of PARP1 protein],,,PMID:26219228,https://www.ncbi.nlm.nih.gov/pubmed/26219228,26219228,,PMC4518223,33034897,2015; 5(1):12579
1720811,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [lapatinib inhibits the reaction [sodium arsenite results in decreased cleavage of PARP1 protein]],,,PMID:32890875,https://www.ncbi.nlm.nih.gov/pubmed/32890875,32890875,,,21692211,"Zhou Q, Jin P, Liu J, Li S, Liu W, Xi S. Arsenic-induced HER2 promotes proliferation, migration and angiogenesis of bladder epithelial cells via activation of multiple signaling pathways in vitro and in vivo. Sci Total Environ. 2021 Jan 20;753():141962. doi: 10.1016/j.scitotenv.2020.141962. PMID: 32890875."
1720812,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [oxidopamine results in increased cleavage of PARP1 protein],,,PMID:25446857,https://www.ncbi.nlm.nih.gov/pubmed/25446857,25446857,,,20876534,"Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC, Tsai CW. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. Chem Biol Interact. 2015 Jan 05;225():40–6. doi: 10.1016/j.cbi.2014.11.011. PMID: 25446857."
1720813,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:19777565,https://www.ncbi.nlm.nih.gov/pubmed/19777565,19777565,,,28863898,"Deng YT, Huang HC, Lin JK. Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol Carcinog. 2010 Feb;49(2):141–51. doi: 10.1002/mc.20583. PMID: 19777565."
1720814,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [scutebarbatine A results in increased cleavage of PARP1 protein],,,PMID:37072049,https://www.ncbi.nlm.nih.gov/pubmed/37072049,37072049,,,35743292,"Hao XS, Feng PP, Zhang YY, Wang FZ, Wang GL, Fei HR. Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway. Chem Biol Interact. 2023 Jun 01;378():110487. doi: 10.1016/j.cbi.2023.110487. PMID: 37072049."
1720834,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [tamoxifen results in increased cleavage of PARP1 protein],,,PMID:14645110,https://www.ncbi.nlm.nih.gov/pubmed/14645110,14645110,,,26770578,"Mabuchi S, Ohmichi M, Kimura A, Ikebuchi Y, Hisamoto K, Arimoto-Ishida E, Nishio Y, Takahashi K, Tasaka K, Murata Y. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin. Endocrinology. 2004 Mar;145(3):1302–13. doi: 10.1210/en.2003-0709. PMID: 14645110."
1720835,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 promotes the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein],,,PMID:34165247,https://www.ncbi.nlm.nih.gov/pubmed/34165247,34165247,,,31166243,"Ho H, Chen P, Lo Y, Lin C, Chuang Y, Hsieh M, Chen M. <scp>Luteolin-7-O</scp>-glucoside inhibits cell proliferation and modulates apoptosis through the <scp>AKT</scp> signaling pathway in human nasopharyngeal carcinoma. Environmental Toxicology. 2021 Jun 24;36(10):2013–24. doi: 10.1002/tox.23319."
1720836,176155,Comparative Toxicogenomics Database (CTD),SB 203580,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 promotes the reaction [[sodium arsenite co-treated with TNF protein] results in increased cleavage of PARP1 protein],,,PMID:29479036,https://www.ncbi.nlm.nih.gov/pubmed/29479036,29479036,,,33096846,"Singhirunnusorn P, Moolmuang B, Lirdprapamongkol K, Ruchirawat M. Arsenite exposure potentiates apoptosis-inducing effects of tumor necrosis factor-alpha- through reactive oxygen species. J Toxicol Sci. 2018;43(2):159–69. doi: 10.2131/jts.43.159. PMID: 29479036."
1722110,176158,Comparative Toxicogenomics Database (CTD),SB 216763,C417521,SB 216763,https://ctdbase.org/detail.go?type=chem&acc=C417521,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 216763 inhibits the reaction [[doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein],,,PMID:17339365,https://www.ncbi.nlm.nih.gov/pubmed/17339365,17339365,,,20720181,"Li S, Zhou Y, Wang R, Zhang H, Dong Y, Ip C. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther. 2007 Mar;6(3):1031–8. doi: 10.1158/1535-7163.mct-06-0643. PMID: 17339365."
1722130,176158,Comparative Toxicogenomics Database (CTD),SB 216763,C417521,SB 216763,https://ctdbase.org/detail.go?type=chem&acc=C417521,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 216763 inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:17849503,https://www.ncbi.nlm.nih.gov/pubmed/17849503,17849503,,,26827689,"Watcharasit P, Thiantanawat A, Satayavivad J. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption. J Appl Toxicol. 2008 May;28(4):466–74. doi: 10.1002/jat.1296. PMID: 17849503."
1722131,176158,Comparative Toxicogenomics Database (CTD),SB 216763,C417521,SB 216763,https://ctdbase.org/detail.go?type=chem&acc=C417521,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 216763 promotes the reaction [cinobufagin results in increased expression of PARP1 protein modified form],,,PMID:23164673,https://www.ncbi.nlm.nih.gov/pubmed/23164673,23164673,,,33655286,"Yin JQ, Wen L, Wu LC, Gao ZH, Huang G, Wang J, Zou CY, Tan PX, Yong BC, Jia Q, Shen JN. The glycogen synthase kinase-3ß/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells. Toxicol Lett. 2013 Apr 12;218(2):129–36. doi: 10.1016/j.toxlet.2012.11.006. PMID: 23164673."
1722132,176158,Comparative Toxicogenomics Database (CTD),SB 216763,C417521,SB 216763,https://ctdbase.org/detail.go?type=chem&acc=C417521,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),SB 216763 inhibits the reaction [cisplatin results in increased cleavage of PARP1 protein],,,PMID:24560772,https://www.ncbi.nlm.nih.gov/pubmed/24560772,24560772,,,26276229,"Kim SJ, Lim JY, Lee JN, Choe SK, Kim YI, Song SR, Cho M, So HS, Park R. Activation of ß-catenin by inhibitors of glycogen synthase kinase-3 ameliorates cisplatin-induced cytotoxicity and pro-inflammatory cytokine expression in HEI-OC1 cells. Toxicology. 2014 Jun 05;320():74–82. doi: 10.1016/j.tox.2014.01.013. PMID: 24560772."
1722133,176158,Comparative Toxicogenomics Database (CTD),SB 216763,C417521,SB 216763,https://ctdbase.org/detail.go?type=chem&acc=C417521,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),SB 216763 inhibits the reaction [excitatory amino acid agonists results in increased cleavage of PARP1 protein],,,PMID:24675465,https://www.ncbi.nlm.nih.gov/pubmed/24675465,24675465,,PMC3973229,28964213,"Lin CJ, Chen TH, Yang LY, Shih CM. Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. Cell Death Dis. 2014 Mar 27;5():e1147. PMID: 24675465; PMCID: PMC3973229."
1722134,176158,Comparative Toxicogenomics Database (CTD),SB 216763,C417521,SB 216763,https://ctdbase.org/detail.go?type=chem&acc=C417521,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),SB 216763 promotes the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,,18200010,"So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547."
1518304,176407,Comparative Toxicogenomics Database (CTD),"4-{2-[(7-Amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",C097270,ZM 241385,https://ctdbase.org/detail.go?type=chem&acc=C097270,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),ZM 241385 inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein],,,PMID:24704558,https://www.ncbi.nlm.nih.gov/pubmed/24704558,24704558,,,30995102,"Chen Y, Yang SH, Hueng DY, Syu JP, Liao CC, Wu YC. Cordycepin induces apoptosis of C6 glioma cells through the adenosine 2A receptor-p53-caspase-7-PARP pathway. Chem Biol Interact. 2014 Jun 05;216():17–25. doi: 10.1016/j.cbi.2014.03.010. PMID: 24704558."
1631493,176871,Comparative Toxicogenomics Database (CTD),Erlotinib Hydrochloride,D000069347,Erlotinib Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069347,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Erlotinib hydrochloride results in increased cleavage of PARP1 protein,,,PMID:23125191|PMID:30171258,https://www.ncbi.nlm.nih.gov/pubmed/23125191|https://www.ncbi.nlm.nih.gov/pubmed/30171258,23125191|30171258,,PMC3546138|PMC6358506,1788405|19002035,"2018; 38(5):656-670|Sukhanova A, Gorin A, Serebriiskii IG, Gabitova L, Zheng H, Restifo D, Egleston BL, Cunningham D, Bagnyukova T, Liu H, Nikonova A, Adams GP, Zhou Y, Yang DH, Mehra R, Burtness B, Cai KQ, Klein-Szanto A, Kratz LE, Kelley RI, Weiner LM, Herman GE, Golemis EA, Astsaturov I. Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation. Cancer Discov. 2013 Jan;3(1):96–111. PMID: 23125191; PMCID: PMC3546138."
1631494,176871,Comparative Toxicogenomics Database (CTD),Erlotinib Hydrochloride,D000069347,Erlotinib Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069347,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Erlotinib hydrochloride results in increased expression of PARP1 protein modified form|resveratrol promotes the reaction [erlotinib hydrochloride results in increased expression of PARP1 protein modified form],,,PMID:25895606,https://www.ncbi.nlm.nih.gov/pubmed/25895606,25895606,,,11412158,"Nie P, Hu W, Zhang T, Yang Y, Hou B, Zou Z. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA. Cell Physiol Biochem. 2015;35(6):2255–71. doi: 10.1159/000374030."
1631496,176871,Comparative Toxicogenomics Database (CTD),Erlotinib Hydrochloride,D000069347,Erlotinib Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069347,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TWIST1 protein results in decreased susceptibility to erlotinib hydrochloride] which results in decreased cleavage of PARP1 protein|twist1 protein inhibits the reaction [erlotinib hydrochloride results in increased cleavage of PARP1 protein]|harmine promotes the reaction [erlotinib hydrochloride results in increased cleavage of PARP1 protein],,,PMID:30171258,https://www.ncbi.nlm.nih.gov/pubmed/30171258,30171258,,PMC6358506,19002035,2018; 38(5):656-670
1348692,177238,Comparative Toxicogenomics Database (CTD),"4-[2-[5,5-dimethyl-8-(4-methylphenyl)-6H-naphthalen-2-yl]ethynyl]benzoic acid",C096920,AGN 193109,https://ctdbase.org/detail.go?type=chem&acc=C096920,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AGN 193109 inhibits the reaction [5-demethylnobiletin results in decreased expression of and results in increased cleavage of PARP1 protein]|agn 193109 inhibits the reaction [nobiletin results in decreased expression of and results in increased cleavage of PARP1 protein]|agn 193109 inhibits the reaction [tangeretin results in decreased expression of and results in increased cleavage of PARP1 protein],,,PMID:33058988,https://www.ncbi.nlm.nih.gov/pubmed/33058988,33058988,,,7488748,"Wang Y, Chen Y, Zhang H, Chen J, Cao J, Chen Q, Li X, Sun C. Polymethoxyflavones from citrus inhibited gastric cancer cell proliferation through inducing apoptosis by upregulating RARß, both in vitro and in vivo. Food Chem Toxicol. 2020 Dec;146():111811. doi: 10.1016/j.fct.2020.111811. PMID: 33058988."
1733048,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PARP1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,,27539111,"Takahashi M, Negishi T, Imamura M, Sawano E, Kuroda Y, Yoshikawa Y, Tashiro T. Alterations in gene expression of glutamate receptors and exocytosis-related factors by a hydroxylated-polychlorinated biphenyl in the developing rat brain. Toxicology. 2009 Mar 04;257(1-2):17–24. doi: 10.1016/j.tox.2008.12.003. PMID: 19114083."
1752322,177941,Comparative Toxicogenomics Database (CTD),Etalocib,C094099,LY 293111,https://ctdbase.org/detail.go?type=chem&acc=C094099,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [LY 293111 results in increased cleavage of PARP1 protein]|ly 293111 results in increased cleavage of PARP1 protein,,,PMID:16151469,https://www.ncbi.nlm.nih.gov/pubmed/16151469,16151469,,,30158352,"Zhang W, McQueen T, Schober W, Rassidakis G, Andreeff M, Konopleva M. Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation. Leukemia. 2005 Nov;19(11):1977–84. doi: 10.1038/sj.leu.2403929. PMID: 16151469."
1664836,185617,Comparative Toxicogenomics Database (CTD),Scutellarin,C484876,scutellarin,https://ctdbase.org/detail.go?type=chem&acc=C484876,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Scutellarin inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of PARP1 mrna],,,PMID:34610774,https://www.ncbi.nlm.nih.gov/pubmed/34610774,34610774,,,25818032,"Huo Y, Mijiti A, Cai R, Gao Z, Aini M, Mijiti A, Wang Z, Qie R. Scutellarin alleviates type 2 diabetes (HFD/low dose STZ)-induced cardiac injury through modulation of oxidative stress, inflammation, apoptosis and fibrosis in mice. Hum Exp Toxicol. 2021 Dec;40(12_suppl):S460–74. doi: 10.1177/09603271211045948. PMID: 34610774."
1637185,185792,Comparative Toxicogenomics Database (CTD),Dimethylarsinous acid,C472511,dimethylarsinous acid,https://ctdbase.org/detail.go?type=chem&acc=C472511,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein],,,PMID:29774349,https://www.ncbi.nlm.nih.gov/pubmed/29774349,29774349,,,32414021,"Maimaitiyiming Y, Wang C, Xu S, Islam K, Chen YJ, Yang C, Wang QQ, Naranmandura H. Role of arsenic (+3 oxidation state) methyltransferase in arsenic mediated APL treatment: an in vitro investigation. Metallomics. 2018 Jun 20;10(6):828–37. doi: 10.1039/c8mt00057c. PMID: 29774349."
1637186,185792,Comparative Toxicogenomics Database (CTD),Dimethylarsinous acid,C472511,dimethylarsinous acid,https://ctdbase.org/detail.go?type=chem&acc=C472511,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dimethylarsinous acid inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein]|dimethylarsinous acid results in decreased activity of PARP1 protein,,,PMID:17011244,https://www.ncbi.nlm.nih.gov/pubmed/17011244,17011244,,,25134446,"Walter I, Schwerdtle T, Thuy C, Parsons JL, Dianov GL, Hartwig A. Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells. DNA Repair. 2007 Jan;6(1):61–70. doi: 10.1016/j.dnarep.2006.08.008."
1791948,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9031,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in increased expression of PARP1 protein|aflatoxin B1 results in increased expression of PARP1 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,,21029135,"Zhao L, Deng J, Ma LB, Zhang WP, Khalil MM, Karrow NA, Qi DS, Sun LH. Dietary Se deficiency dysregulates metabolic and cell death signaling in aggravating the AFB1 hepatotoxicity of chicks. Food Chem Toxicol. 2021 Mar;149():111938. doi: 10.1016/j.fct.2020.111938. PMID: 33348051."
1792108,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of PARP1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,,8069441,"Rieswijk L, Claessen SM, Bekers O, van Herwijnen M, Theunissen DH, Jennen DG, de Kok TM, Kleinjans JC, van Breda SG. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma. Toxicology. 2016 Mar 28;350-352():31–9. doi: 10.1016/j.tox.2016.05.002. PMID: 27153756."
1792109,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aflatoxin B1 results in increased cleavage of PARP1 protein,,,PMID:34089297,https://www.ncbi.nlm.nih.gov/pubmed/34089297,34089297,,,33181869,"Dlamini NZ, Somboro AM, Amoako DG, Arhin I, Khumalo HM, Khan RB. Toxicogenicity and mechanistic pathways of aflatoxin<scp>B1</scp>induced renal injury. Environmental Toxicology. 2021 Jun 05;36(9):1857–72. doi: 10.1002/tox.23306."
1792110,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CYP2A13 protein promotes the reaction [aflatoxin B1 results in increased expression of PARP1 protein modified form]|methoxsalen inhibits the reaction [aflatoxin B1 results in increased expression of PARP1 protein modified form]|aflatoxin B1 results in increased expression of PARP1 protein modified form|nicotine inhibits the reaction [aflatoxin B1 results in increased expression of PARP1 protein modified form],,,PMID:22743290,https://www.ncbi.nlm.nih.gov/pubmed/22743290,22743290,,,20146966,"Yang XJ, Lu HY, Li ZY, Bian Q, Qiu LL, Li Z, Liu Q, Li J, Wang X, Wang SL. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells. Toxicology. 2012 Oct 28;300(3):138–48. doi: 10.1016/j.tox.2012.06.010. PMID: 22743290."
1792111,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of PARP1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,,13357082,"Mathijs K, Brauers KJ, Jennen DG, Boorsma A, van Herwijnen MH, Gottschalk RW, Kleinjans JC, van Delft JH. Discrimination for genotoxic and nongenotoxic carcinogens by gene expression profiling in primary mouse hepatocytes improves with exposure time. Toxicol Sci. 2009 Dec;112(2):374–84. doi: 10.1093/toxsci/kfp229. PMID: 19770486."
1739166,197119,Toxin and Toxin Target Database (T3DB),Lead arsenite,T3D0320,Lead arsenite,http://www.t3db.ca/toxins/T3D0320,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1739397,198016,Comparative Toxicogenomics Database (CTD),Saponin,D012503,Saponins,https://ctdbase.org/detail.go?type=chem&acc=D012503,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Saponins results in increased cleavage of PARP1 protein,,,PMID:28088315,https://www.ncbi.nlm.nih.gov/pubmed/28088315,28088315,,,14162977,"Xie ZZ, Li MM, Deng PF, Wang S, Wang L, Lu XP, Hu LB, Chen Z, Jie HY, Wang YF, Liu XX, Liu Z. Paris saponin-induced autophagy promotes breast cancer cell apoptosis via the Akt/mTOR signaling pathway. Chem Biol Interact. 2017 Feb 25;264():1–9. doi: 10.1016/j.cbi.2017.01.004. PMID: 28088315."
1365762,198104,Comparative Toxicogenomics Database (CTD),1'-Hydroxymethyleugenol,C108731,1'-(hydroxymethyl)eugenol,https://ctdbase.org/detail.go?type=chem&acc=C108731,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),1'-(hydroxymethyl)eugenol results in increased cleavage of PARP1 protein,,,PMID:28818686,https://www.ncbi.nlm.nih.gov/pubmed/28818686,28818686,,,548891,"Groh IAM, Esselen M. Methyleugenol and selected oxidative metabolites affect DNA-Damage signalling pathways and induce apoptosis in human colon tumour HT29 cells. Food Chem Toxicol. 2017 Oct;108(Pt A):267–75. doi: 10.1016/j.fct.2017.08.014. PMID: 28818686."
1720431,208908,Comparative Toxicogenomics Database (CTD),Lapatinib,D000077341,Lapatinib,https://ctdbase.org/detail.go?type=chem&acc=D000077341,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [lapatinib results in increased cleavage of PARP1 protein],,,PMID:29387217,https://www.ncbi.nlm.nih.gov/pubmed/29387217,29387217,,PMC5768102,10816814,"Liu L, Zhong L, Zhao Y, Chen M, Yao S, Li L, Xiao C, Shan Z, Gan L, Xu T, Liu B. Effects of lapatinib on cell proliferation and apoptosis in NB4 cells. Oncol Lett. 2018 Jan;15(1):235–42. PMID: 29387217; PMCID: PMC5768102."
1720432,208908,Comparative Toxicogenomics Database (CTD),Lapatinib,D000077341,Lapatinib,https://ctdbase.org/detail.go?type=chem&acc=D000077341,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [lapatinib inhibits the reaction [sodium arsenite results in decreased cleavage of PARP1 protein]]|akt activator SC79 inhibits the reaction [lapatinib inhibits the reaction [sodium arsenite results in decreased cleavage of PARP1 protein]]|lapatinib inhibits the reaction [sodium arsenite results in decreased cleavage of PARP1 protein],,,PMID:32890875,https://www.ncbi.nlm.nih.gov/pubmed/32890875,32890875,,,21692211,"Zhou Q, Jin P, Liu J, Li S, Liu W, Xi S. Arsenic-induced HER2 promotes proliferation, migration and angiogenesis of bladder epithelial cells via activation of multiple signaling pathways in vitro and in vivo. Sci Total Environ. 2021 Jan 20;753():141962. doi: 10.1016/j.scitotenv.2020.141962. PMID: 32890875."
1720480,208908,Comparative Toxicogenomics Database (CTD),Lapatinib,D000077341,Lapatinib,https://ctdbase.org/detail.go?type=chem&acc=D000077341,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lapatinib co-treated with concanamycin A] results in increased cleavage of PARP1 protein|[lapatinib co-treated with bafilomycin A] results in increased cleavage of PARP1 protein,,,PMID:25981168,https://www.ncbi.nlm.nih.gov/pubmed/25981168,25981168,,,20209516,"Jin HO, Hong SE, Kim CS, Park JA, Kim JH, Kim JY, Kim B, Chang YH, Hong SI, Hong YJ, Park IC, Lee JK. Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells. Toxicol Appl Pharmacol. 2015 Aug 15;287(1):17–25. doi: 10.1016/j.taap.2015.05.001. PMID: 25981168."
1720481,208908,Comparative Toxicogenomics Database (CTD),Lapatinib,D000077341,Lapatinib,https://ctdbase.org/detail.go?type=chem&acc=D000077341,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lapatinib results in increased cleavage of PARP1 protein,,,PMID:25221644|PMID:29387217,https://www.ncbi.nlm.nih.gov/pubmed/25221644|https://www.ncbi.nlm.nih.gov/pubmed/29387217,25221644|29387217,,PMC4162138|PMC5768102,5955945|10816814,"Liu L, Zhong L, Zhao Y, Chen M, Yao S, Li L, Xiao C, Shan Z, Gan L, Xu T, Liu B. Effects of lapatinib on cell proliferation and apoptosis in NB4 cells. Oncol Lett. 2018 Jan;15(1):235–42. PMID: 29387217; PMCID: PMC5768102.|Witkiewicz AK, Cox D, Knudsen ES. CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models. Genes Cancer. 2014 Aug 07;5(7-8):261–72. doi: 10.18632/genesandcancer.24."
1734387,216239,Comparative Toxicogenomics Database (CTD),Sorafenib,D000077157,Sorafenib,https://ctdbase.org/detail.go?type=chem&acc=D000077157,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AKT1 protein inhibits the reaction [[bortezomib co-treated with sorafenib] results in increased cleavage of PARP1 protein]|[bortezomib co-treated with sorafenib] results in increased cleavage of PARP1 protein,,,PMID:16985072,https://www.ncbi.nlm.nih.gov/pubmed/16985072,16985072,,,11917398,"Yu C, Friday BB, Lai JP, Yang L, Sarkaria J, Kay NE, Carter CA, Roberts LR, Kaufmann SH, Adjei AA. Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways. Mol Cancer Ther. 2006 Sep;5(9):2378–87. doi: 10.1158/1535-7163.mct-06-0235. PMID: 16985072."
1734389,216239,Comparative Toxicogenomics Database (CTD),Sorafenib,D000077157,Sorafenib,https://ctdbase.org/detail.go?type=chem&acc=D000077157,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sorafenib results in increased susceptibility to desloratadine] which results in increased cleavage of PARP1 protein|[desloratadine results in increased susceptibility to sorafenib] which results in increased cleavage of PARP1 protein,,,PMID:36617552,https://www.ncbi.nlm.nih.gov/pubmed/36617552,36617552,,PMC9826789,35009431,"Tan XP, He Y, Yang J, Wei X, Fan YL, Zhang GG, Zhu YD, Li ZQ, Liao HX, Qin DJ, Guan XY, Li B. Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression. Signal Transduct Target Ther. 2023 Jan 09;8(1):14. PMID: 36617552; PMCID: PMC9826789."
1734390,216239,Comparative Toxicogenomics Database (CTD),Sorafenib,D000077157,Sorafenib,https://ctdbase.org/detail.go?type=chem&acc=D000077157,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol promotes the reaction [sorafenib results in increased cleavage of PARP1 protein],,,PMID:26911335,https://www.ncbi.nlm.nih.gov/pubmed/26911335,26911335,,PMC4766620,5290464,2016; 17(1):19
1734391,216239,Comparative Toxicogenomics Database (CTD),Sorafenib,D000077157,Sorafenib,https://ctdbase.org/detail.go?type=chem&acc=D000077157,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sorafenib co-treated with PRKN protein] results in increased cleavage of PARP1 protein,,,PMID:28673964,https://www.ncbi.nlm.nih.gov/pubmed/28673964,28673964,,PMC5592685,3951097,"Zhang C, Liu Z, Bunker E, Ramirez A, Lee S, Peng Y, Tan A, Eckhardt SG, Chapnick DA, Liu X. Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1–Parkin pathway and modulate cellular drug response. Journal of Biological Chemistry. 2017 Sep;292(36):15105–20. doi: 10.1074/jbc.m117.783175."
1734392,216239,Comparative Toxicogenomics Database (CTD),Sorafenib,D000077157,Sorafenib,https://ctdbase.org/detail.go?type=chem&acc=D000077157,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sorafenib results in increased cleavage of PARP1 protein,,,PMID:20054642|PMID:26911335,https://www.ncbi.nlm.nih.gov/pubmed/20054642|https://www.ncbi.nlm.nih.gov/pubmed/26911335,20054642|26911335,,PMC4766620,5290464|25145955,2016; 17(1):19|2010; 124(1):79-88
1634245,222528,Comparative Toxicogenomics Database (CTD),Deoxycholic Acid,D003840,Deoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003840,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aspirin inhibits the reaction [deoxycholic acid results in increased cleavage of PARP1 protein],,,PMID:17644113,https://www.ncbi.nlm.nih.gov/pubmed/17644113,17644113,,,25504018,"Redlak MJ, Power JJ, Miller TA. Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66–73. doi: 10.1016/j.jss.2007.04.039. PMID: 17644113."
1634246,222528,Comparative Toxicogenomics Database (CTD),Deoxycholic Acid,D003840,Deoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003840,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cobaltiprotoporphyrin inhibits the reaction [deoxycholic acid results in increased cleavage of PARP1 protein],,,PMID:21362092,https://www.ncbi.nlm.nih.gov/pubmed/21362092,21362092,,,32952542,"Lawson TE, Redlak MJ, Yager DR. Preconditioning with cobalt protoporphyrin protects human gastric mucosal cells from deoxycholate-induced apoptosis. Wound Repair Regen. 2011 Mar;19(2):241–9. doi: 10.1111/j.1524-475x.2010.00661.x. PMID: 21362092."
1634376,222528,Comparative Toxicogenomics Database (CTD),Deoxycholic Acid,D003840,Deoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003840,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Deoxycholic acid results in increased cleavage of PARP1 protein,,,PMID:17644113|PMID:21362092,https://www.ncbi.nlm.nih.gov/pubmed/17644113|https://www.ncbi.nlm.nih.gov/pubmed/21362092,17644113|21362092,,,25504018|32952542,"Lawson TE, Redlak MJ, Yager DR. Preconditioning with cobalt protoporphyrin protects human gastric mucosal cells from deoxycholate-induced apoptosis. Wound Repair Regen. 2011 Mar;19(2):241–9. doi: 10.1111/j.1524-475x.2010.00661.x. PMID: 21362092.|Redlak MJ, Power JJ, Miller TA. Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66–73. doi: 10.1016/j.jss.2007.04.039. PMID: 17644113."
1742498,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [estradiol 3-benzoate results in increased cleavage of PARP1 protein]|estradiol 3-benzoate results in increased cleavage of PARP1 protein,,,PMID:24316378,https://www.ncbi.nlm.nih.gov/pubmed/24316378,24316378,,,28285440,"Bharti S, Misro MM, Rai U. Quercetin supplementation restores testicular function and augments germ cell survival in the estrogenized rats. Mol Cell Endocrinol. 2014 Mar 05;383(1-2):10–20. doi: 10.1016/j.mce.2013.11.021. PMID: 24316378."
1539000,236501,BindingDB,4-(4-Carbamoylphenoxy)benzamide,199181,4-[(4-Carbamoylcyclohexyl)oxy]cyclohexane-1-carboxamide (OUL35),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=199181,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>1.00e+5,PMID:27667561|DOI:10.1016/j.chembiol.2016.08.012,https://www.ncbi.nlm.nih.gov/pubmed/27667561|https://doi.org/10.1016/j.chembiol.2016.08.012,27667561,10.1016/j.chembiol.2016.08.012,,18208638,"Venkannagari H, Verheugd P, Koivunen J, Haikarainen T, Obaji E, Ashok Y, Narwal M, Pihlajaniemi T, Lüscher B, Lehtiö L. Small-Molecule Chemical Probe Rescues Cells from Mono-ADP-Ribosyltransferase ARTD10/PARP10-Induced Apoptosis and Sensitizes Cancer Cells to DNA Damage. Cell Chem Biol. 2016 Oct 20;23(10):1251–60. doi: 10.1016/j.chembiol.2016.08.012. PMID: 27667561."
1514078,253602,Comparative Toxicogenomics Database (CTD),Anisomycin,D000841,Anisomycin,https://ctdbase.org/detail.go?type=chem&acc=D000841,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Anisomycin inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]],,,PMID:34767868,https://www.ncbi.nlm.nih.gov/pubmed/34767868,34767868,,,7531521,"Bi A, Guo Z, Yang G, Huang Y, Yin Z, Luo L. ?-glutamylcysteine suppresses cadmium-induced apoptosis in PC12 cells via regulating oxidative stress. Toxicology. 2022 Jan 15;465():153029. doi: 10.1016/j.tox.2021.153029. PMID: 34767868."
1514079,253602,Comparative Toxicogenomics Database (CTD),Anisomycin,D000841,Anisomycin,https://ctdbase.org/detail.go?type=chem&acc=D000841,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[colistin co-treated with anisomycin] results in increased cleavage of PARP1 protein,,,PMID:28842171,https://www.ncbi.nlm.nih.gov/pubmed/28842171,28842171,,,8102274,"Lu Z, Miao Y, Muhammad I, Tian E, Hu W, Wang J, Wang B, Li R, Li J. Colistin-induced autophagy and apoptosis involves the JNK-Bcl2-Bax signaling pathway and JNK-p53-ROS positive feedback loop in PC-12 cells. Chem Biol Interact. 2017 Nov 01;277():62–73. doi: 10.1016/j.cbi.2017.08.011. PMID: 28842171."
1748075,259577,Comparative Toxicogenomics Database (CTD),Hellebrigenin,C001330,hellebrigenin,https://ctdbase.org/detail.go?type=chem&acc=C001330,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hellebrigenin results in increased activity of PARP1 protein,,,PMID:24954031,https://www.ncbi.nlm.nih.gov/pubmed/24954031,24954031,,,21527659,"Deng LJ, Hu LP, Peng QL, Yang XL, Bai LL, Yiu A, Li Y, Tian HY, Ye WC, Zhang DM. Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt. Chem Biol Interact. 2014 Aug 05;219():184–94. doi: 10.1016/j.cbi.2014.06.003. PMID: 24954031."
1546959,265237,Comparative Toxicogenomics Database (CTD),Withaferin A,C009684,withaferin A,https://ctdbase.org/detail.go?type=chem&acc=C009684,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dithiothreitol inhibits the reaction [withaferin A results in increased cleavage of PARP1 protein],,,PMID:20438634,https://www.ncbi.nlm.nih.gov/pubmed/20438634,20438634,,PMC2873443,5184553,2010; 9(1):99
1546960,265237,Comparative Toxicogenomics Database (CTD),Withaferin A,C009684,withaferin A,https://ctdbase.org/detail.go?type=chem&acc=C009684,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MCL1 mutant form promotes the reaction [withaferin A results in increased cleavage of PARP1 protein],,,PMID:24019090,https://www.ncbi.nlm.nih.gov/pubmed/24019090,24019090,,PMC3859703,24911049,"Hahm E, Lee J, Singh SV. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells. Molecular Carcinogenesis. 2013 Sep 09;53(11):907–16. doi: 10.1002/mc.22050."
1546961,265237,Comparative Toxicogenomics Database (CTD),Withaferin A,C009684,withaferin A,https://ctdbase.org/detail.go?type=chem&acc=C009684,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Withaferin A results in increased cleavage of PARP1 protein,,,PMID:20438634|PMID:24019090,https://www.ncbi.nlm.nih.gov/pubmed/20438634|https://www.ncbi.nlm.nih.gov/pubmed/24019090,20438634|24019090,,PMC2873443|PMC3859703,5184553|24911049,"Hahm E, Lee J, Singh SV. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells. Molecular Carcinogenesis. 2013 Sep 09;53(11):907–16. doi: 10.1002/mc.22050.|2010; 9(1):99"
1481691,275196,Comparative Toxicogenomics Database (CTD),Noscapine,D009665,Noscapine,https://ctdbase.org/detail.go?type=chem&acc=D009665,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Noscapine results in increased cleavage of PARP1 protein,,,PMID:22848370,https://www.ncbi.nlm.nih.gov/pubmed/22848370,22848370,,PMC3406069,29589265,"Li S, He J, Li S, Cao G, Tang S, Tong Q, Joshi HC. Noscapine Induced Apoptosis via Downregulation of Survivin in Human Neuroblastoma Cells Having Wild Type or Null p53. PLoS ONE. 2012 Jul 26;7(7):e40076. doi: 10.1371/journal.pone.0040076."
1481998,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of PARP1 protein],,,PMID:29758312,https://www.ncbi.nlm.nih.gov/pubmed/29758312,29758312,,,8812048,"Ameeramja J, Kanagaraj VV, Perumal E. Protocatechuic acid methyl ester modulates fluoride induced pulmonary toxicity in rats. Food Chem Toxicol. 2018 Aug;118():235–44. doi: 10.1016/j.fct.2018.05.031. PMID: 29758312."
1558349,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AKT1 protein modified form inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]],,,PMID:32802178,https://www.ncbi.nlm.nih.gov/pubmed/32802178,32802178,,PMC7415806,9544165,"Yang P, Xie J, Li Y, Lin HP, Fenske W, Clementino M, Jiang Y, Yang C, Wang Z. Deubiquitinase USP7-mediated MCL-1 up-regulation enhances Arsenic and Benzo(a)pyrene co-exposure-induced Cancer Stem Cell-like property and Tumorigenesis. Theranostics. 2020;10(20):9050–65. PMID: 32802178; PMCID: PMC7415806."
1558350,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Wortmannin promotes the reaction [demethoxycurcumin results in increased cleavage of PARP1 protein],,,PMID:34291863,https://www.ncbi.nlm.nih.gov/pubmed/34291863,34291863,,PMC9292507,4722488,"Kao C, Cheng Y, Yang M, Cha T, Sun G, Ho C, Lin Y, Wang H, Wu S, Way T. Demethoxycurcumin induces apoptosis in <scp>HER2</scp> overexpressing bladder cancer cells through degradation of <scp>HER2</scp> and inhibiting the <scp>PI3K</scp>/Akt pathway. Environmental Toxicology. 2021 Jul 22;36(11):2186–95. doi: 10.1002/tox.23332."
1558351,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Wortmannin promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein]|wortmannin promotes the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:17935137,https://www.ncbi.nlm.nih.gov/pubmed/17935137,17935137,,,1040001,"Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH, Xu XM, Liu S, Chen J, Liu F, Qi YL, Deng Q, Cao J, Liu SQ, Luo HS, Yu JP. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer. 2008 Jan 15;122(2):433–43. doi: 10.1002/ijc.23049. PMID: 17935137."
1558352,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Wortmannin promotes the reaction [sodium arsenite results in increased degradation of PARP1 protein],,,PMID:12614848,https://www.ncbi.nlm.nih.gov/pubmed/12614848,12614848,,,20644789,"Hossain K, Akhand AA, Kawamoto Y, Du J, Takeda K, Wu J, Yoshihara M, Tsuboi H, Kato M, Suzuki H, Nakashima I. Caspase activation is accelerated by the inhibition of arsenite-induced, membrane rafts-dependent Akt activation. Free Radic Biol Med. 2003 Mar 01;34(5):598–606. doi: 10.1016/s0891-5849(02)01359-x. PMID: 12614848."
1558353,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Wortmannin inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein],,,PMID:22155090,https://www.ncbi.nlm.nih.gov/pubmed/22155090,22155090,,,15398108,"Sarró E, Jacobs-Cachá C, Itarte E, Meseguer A. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275–87. doi: 10.1016/j.taap.2011.11.007. PMID: 22155090."
1758489,331775,Comparative Toxicogenomics Database (CTD),"5,6-Dichloro-1H-benzimidazole",C110962,"5,6-dichlorobenzimidazole",https://ctdbase.org/detail.go?type=chem&acc=C110962,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]",,,PMID:15688023,https://www.ncbi.nlm.nih.gov/pubmed/15688023,15688023,,,15263686,"Izeradjene K, Douglas L, Delaney A, Houghton JA. Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines. Oncogene. 2005 Mar 17;24(12):2050–8. doi: 10.1038/sj.onc.1208397. PMID: 15688023."
1750051,331783,Comparative Toxicogenomics Database (CTD),Rocaglamide,C107772,rocaglamide,https://ctdbase.org/detail.go?type=chem&acc=C107772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rocaglamide results in decreased expression of PARP1 protein,,,PMID:31433962,https://www.ncbi.nlm.nih.gov/pubmed/31433962,31433962,,,12878757,"Anaya-Eugenio GD, Rebollar-Ramos D, González MDC, Raja H, Mata R, Carcache de Blanco EJ. Apoptotic activity of xanthoquinodin JBIR-99, from Parengyodontium album MEXU 30054, in PC-3 human prostate cancer cells. Chem Biol Interact. 2019 Sep 25;311():108798. doi: 10.1016/j.cbi.2019.108798. PMID: 31433962."
1774607,342403,Therapeutic Target Database (TTD),3-Hydroxybenzamide,D05ZTI,3-Hydroxy-benzamide,https://idrblab.net/ttd/data/drug/details/D05ZTI,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1762045,345678,Therapeutic Target Database (TTD),"1,2,3,4,4a,5-hexahydrophenanthridin-6(10bH)-one",D0FF4M,"1,2,3,4,4a,5-hexahydrophenanthridin-6(10bH)-one",https://idrblab.net/ttd/data/drug/details/D0FF4M,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1771353,354677,Comparative Toxicogenomics Database (CTD),"4-Ethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl aminoacetate hydrochloride",C514334,NSC606985,https://ctdbase.org/detail.go?type=chem&acc=C514334,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NSC606985 results in increased cleavage of PARP1 protein,,,PMID:19747914,https://www.ncbi.nlm.nih.gov/pubmed/19747914,19747914,,,13335768,"Gao FH, Wu YL, Zhao M, Liu CX, Wang LS, Chen GQ. Protein kinase C-delta mediates down-regulation of heterogeneous nuclear ribonucleoprotein K protein: involvement in apoptosis induction. Exp Cell Res. 2009 Nov 15;315(19):3250–8. doi: 10.1016/j.yexcr.2009.09.005. PMID: 19747914."
1759757,358832,Comparative Toxicogenomics Database (CTD),5-o-Desmethylnobiletin,C000604601,5-demethylnobiletin,https://ctdbase.org/detail.go?type=chem&acc=C000604601,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AGN 193109 inhibits the reaction [5-demethylnobiletin results in decreased expression of and results in increased cleavage of PARP1 protein]|5-demethylnobiletin results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:33058988,https://www.ncbi.nlm.nih.gov/pubmed/33058988,33058988,,,7488748,"Wang Y, Chen Y, Zhang H, Chen J, Cao J, Chen Q, Li X, Sun C. Polymethoxyflavones from citrus inhibited gastric cancer cell proliferation through inducing apoptosis by upregulating RARß, both in vitro and in vivo. Food Chem Toxicol. 2020 Dec;146():111811. doi: 10.1016/j.fct.2020.111811. PMID: 33058988."
1771506,360901,Comparative Toxicogenomics Database (CTD),"Cercosporin, pure",C538948,CGP049090,https://ctdbase.org/detail.go?type=chem&acc=C538948,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CGP049090 results in increased cleavage of PARP1 protein,,,PMID:19067737,https://www.ncbi.nlm.nih.gov/pubmed/19067737,19067737,,,7929679,"Minke KS, Staib P, Puetter A, Gehrke I, Gandhirajan RK, Schlösser A, Schmitt EK, Hallek M, Kreuzer KA. Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells. Eur J Haematol. 2009 Mar;82(3):165–75. doi: 10.1111/j.1600-0609.2008.01188.x. PMID: 19067737."
1750724,372976,Comparative Toxicogenomics Database (CTD),"2-(1,7-Dihydroxytetradeca-4,12-dien-8,10-diyn-6-yloxy)-6-(hydroxymethyl)oxane-3,4,5-triol",C521561,lobetyolin,https://ctdbase.org/detail.go?type=chem&acc=C521561,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lobetyolin results in increased cleavage of PARP1 protein,,,PMID:34075790,https://www.ncbi.nlm.nih.gov/pubmed/34075790,34075790,,,25816648,"Chen Y, Tian Y, Jin G, Cui Z, Guo W, Zhang X, Liu X. Lobetyolin inhibits the proliferation of breast cancer cells via ASCT2 down-regulation-induced apoptosis. Hum Exp Toxicol. 2021 Dec;40(12):2074–86. doi: 10.1177/09603271211021476. PMID: 34075790."
1401633,384525,Comparative Toxicogenomics Database (CTD),"4-(1,3-Benzothiazol-2-yl)-2-methylaniline",C122062,NSC 674495,https://ctdbase.org/detail.go?type=chem&acc=C122062,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to NSC 674495,,,PMID:17674193,https://www.ncbi.nlm.nih.gov/pubmed/17674193,17674193,,,22732903,2007; 110(1):57-68
1401970,387042,Comparative Toxicogenomics Database (CTD),Adaphostin,C404397,NSC 680410,https://ctdbase.org/detail.go?type=chem&acc=C404397,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NSC 680410 results in increased degradation of PARP1 protein,,,PMID:14647418,https://www.ncbi.nlm.nih.gov/pubmed/14647418,14647418,,,26772718,"Yu C, Rahmani M, Almenara J, Sausville EA, Dent P, Grant S. Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process. Oncogene. 2004 Feb 19;23(7):1364–76. doi: 10.1038/sj.onc.1207248. PMID: 14647418."
1401971,387042,Comparative Toxicogenomics Database (CTD),Adaphostin,C404397,NSC 680410,https://ctdbase.org/detail.go?type=chem&acc=C404397,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),NSC 680410 results in increased cleavage of PARP1 protein,,,PMID:16481037,https://www.ncbi.nlm.nih.gov/pubmed/16481037,16481037,,,26139503,"Dasmahapatra G, Nguyen TK, Dent P, Grant S. Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl. Leuk Res. 2006 Oct;30(10):1263–72. doi: 10.1016/j.leukres.2006.01.005. PMID: 16481037."
1389136,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AKT1 protein inhibits the reaction [[bortezomib co-treated with sorafenib] results in increased cleavage of PARP1 protein]|[bortezomib co-treated with sorafenib] results in increased cleavage of PARP1 protein,,,PMID:16985072,https://www.ncbi.nlm.nih.gov/pubmed/16985072,16985072,,,11917398,"Yu C, Friday BB, Lai JP, Yang L, Sarkaria J, Kay NE, Carter CA, Roberts LR, Kaufmann SH, Adjei AA. Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways. Mol Cancer Ther. 2006 Sep;5(9):2378–87. doi: 10.1158/1535-7163.mct-06-0235. PMID: 16985072."
1389137,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AKT1 protein inhibits the reaction [[bortezomib co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein],,,PMID:19261616,https://www.ncbi.nlm.nih.gov/pubmed/19261616,19261616,,PMC2670117,22758336,"Chen K, Yeh P, Hsu C, Hsu C, Lu Y, Hsieh H, Chen P, Cheng A. Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway. Journal of Biological Chemistry. 2009 Apr;284(17):11121–33. doi: 10.1074/jbc.m806268200."
1389138,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[alvocidib co-treated with bortezomib] results in increased cleavage of PARP1 protein|[dichlororibofuranosylbenzimidazole co-treated with bortezomib] results in increased cleavage of PARP1 protein,,,PMID:15039284,https://www.ncbi.nlm.nih.gov/pubmed/15039284,15039284,,,1654354,"Dai Y, Rahmani M, Pei XY, Dent P, Grant S. Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms. Blood. 2004 Jul 15;104(2):509–18. doi: 10.1182/blood-2003-12-4121. PMID: 15039284."
1389139,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[arsenic trioxide co-treated with bortezomib] results in increased degradation of PARP1 protein,,,PMID:17495969,https://www.ncbi.nlm.nih.gov/pubmed/17495969,17495969,,,27486567,"Yan H, Wang YC, Li D, Wang Y, Liu W, Wu YL, Chen GQ. Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cdelta. Leukemia. 2007 Jul;21(7):1488–95. doi: 10.1038/sj.leu.2404735. PMID: 17495969."
1389141,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [bortezomib promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]]|bortezomib promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [gambogic acid promotes the reaction [bortezomib results in increased cleavage of PARP1 protein]]|gambogic acid promotes the reaction [bortezomib results in increased cleavage of PARP1 protein],,,PMID:24291039,https://www.ncbi.nlm.nih.gov/pubmed/24291039,24291039,,,11379274,"Liu N, Huang H, Xu L, Hua X, Li X, Liu S, Yang C, Zhao C, Zhao C, Li S, Dou QP, Liu J. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. Toxicol Lett. 2014 Jan 30;224(3):333–40. doi: 10.1016/j.toxlet.2013.11.021. PMID: 24291039."
1389142,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib co-treated with abexinostat] results in increased activity of PARP1 protein,,,PMID:19417023,https://www.ncbi.nlm.nih.gov/pubmed/19417023,19417023,,PMC2704489,28192789,"Bhalla S, Balasubramanian S, David K, Sirisawad M, Buggy J, Mauro L, Prachand S, Miller R, Gordon LI, Evens AM. PCI-24781 Induces Caspase and Reactive Oxygen Species–Dependent Apoptosis Through NF-?B Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells. 2009 May 15;15(10):3354–65. doi: 10.1158/1078-0432.ccr-08-2365."
1389301,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib co-treated with butyrates] results in increased degradation of PARP1 protein|[bortezomib co-treated with vorinostat] results in increased degradation of PARP1 protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,,25406599,"Yu C, Rahmani M, Conrad D, Subler M, Dent P, Grant S. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571. Blood. 2003 Nov 15;102(10):3765–74. doi: 10.1182/blood-2003-03-0737. PMID: 12893773."
1389302,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib co-treated with doxorubicin] results in increased cleavage of PARP1 protein,,,PMID:33775688,https://www.ncbi.nlm.nih.gov/pubmed/33775688,33775688,,,11557155,"Abdin SM, Tolba MF, Zaher DM, Omar HA. Nuclear factor-?B signaling inhibitors revert multidrug-resistance in breast cancer cells. Chem Biol Interact. 2021 May 01;340():109450. doi: 10.1016/j.cbi.2021.109450. PMID: 33775688."
1389303,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[bortezomib co-treated with N,N-dimethylsphingosine] results in increased cleavage of PARP1 protein",,,PMID:21195056,https://www.ncbi.nlm.nih.gov/pubmed/21195056,21195056,,,18104994,"Li Q, Yan J, Zhang K, Yang Y, Xiao F, Wu C, Wang H, Wang L. Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl+ cells sensitive and resistant to STI571 through down-regulation Mcl-1. Biochemical and Biophysical Research Communications. 2011 Feb;405(1):31–6. doi: 10.1016/j.bbrc.2010.12.111."
1389304,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:12902978|PMID:19261616,https://www.ncbi.nlm.nih.gov/pubmed/12902978|https://www.ncbi.nlm.nih.gov/pubmed/19261616,12902978|19261616,,PMC2670117,22758336|25414217,"Chen K, Yeh P, Hsu C, Hsu C, Lu Y, Hsieh H, Chen P, Cheng A. Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway. Journal of Biological Chemistry. 2009 Apr;284(17):11121–33. doi: 10.1074/jbc.m806268200.|Johnson TR, Stone K, Nikrad M, Yeh T, Zong WX, Thompson CB, Nesterov A, Kraft AS. The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells. Oncogene. 2003 Aug 07;22(32):4953–63. doi: 10.1038/sj.onc.1206656. PMID: 12902978."
1389305,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:16904634,https://www.ncbi.nlm.nih.gov/pubmed/16904634,16904634,,,17331594,"Bai J, Demirjian A, Sui J, Marasco W, Callery MP. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. Biochemical and Biophysical Research Communications. 2006 Oct;348(4):1245–53. doi: 10.1016/j.bbrc.2006.07.185."
1389306,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bortezomib promotes the reaction [belinostat results in increased cleavage of PARP1 protein]|bortezomib promotes the reaction [romidepsin results in increased cleavage of PARP1 protein],,,PMID:18223231,https://www.ncbi.nlm.nih.gov/pubmed/18223231,18223231,,,1688119,"Dai Y, Chen S, Kramer LB, Funk VL, Dent P, Grant S. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells. Clin Cancer Res. 2008 Jan 15;14(2):549–58. doi: 10.1158/1078-0432.ccr-07-1934. PMID: 18223231."
1389307,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bortezomib promotes the reaction [capillarisin results in increased cleavage of PARP1 protein],,,PMID:24333736,https://www.ncbi.nlm.nih.gov/pubmed/24333736,24333736,,,28301548,"Lee JH, Chiang SY, Nam D, Chung WS, Lee J, Na YS, Sethi G, Ahn KS. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. Cancer Lett. 2014 Apr 01;345(1):140–8. doi: 10.1016/j.canlet.2013.12.008. PMID: 24333736."
1389308,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bortezomib promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:17510429|PMID:20461078,https://www.ncbi.nlm.nih.gov/pubmed/17510429|https://www.ncbi.nlm.nih.gov/pubmed/20461078,17510429|20461078,,PMC2883696,3122890|27499850,"Lecis D, Drago C, Manzoni L, Seneci P, Scolastico C, Mastrangelo E, Bolognesi M, Anichini A, Kashkar H, Walczak H, Delia D. Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib. Br J Cancer. 2010 May 11;102(12):1707–16. doi: 10.1038/sj.bjc.6605687.|Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Cancer Res. 2007 May 15;67(10):4981–8. doi: 10.1158/0008-5472.can-06-4274. PMID: 17510429."
1389309,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bortezomib promotes the reaction [ZFAND2A protein affects the cleavage of PARP1 protein]|zfand2a protein inhibits the reaction [bortezomib results in increased cleavage of PARP1 protein],,,PMID:31540997,https://www.ncbi.nlm.nih.gov/pubmed/31540997,31540997,,,7479198,"Pizzato Scomazzon S, Riccio A, Santopolo S, Lanzilli G, Coccia M, Rossi A, Santoro MG. The Zinc-Finger AN1-Type Domain 2a Gene Acts as a Regulator of Cell Survival in Human Melanoma: Role of E3-Ligase cIAP2. Mol Cancer Res. 2019 Dec;17(12):2444–56. doi: 10.1158/1541-7786.mcr-19-0243. PMID: 31540997."
1389310,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bortezomib results in increased cleavage of and results in increased activity of PARP1 protein|tnfrsf10b mutant form inhibits the reaction [bortezomib promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|tnfrsf10b mutant form inhibits the reaction [bortezomib results in increased cleavage of PARP1 protein],,,PMID:17510429,https://www.ncbi.nlm.nih.gov/pubmed/17510429,17510429,,,27499850,"Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Cancer Res. 2007 May 15;67(10):4981–8. doi: 10.1158/0008-5472.can-06-4274. PMID: 17510429."
1389496,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bortezomib results in increased cleavage of PARP1 protein,,,PMID:16617327|PMID:17659339|PMID:17898295|PMID:17898787|PMID:18223231|PMID:18723477|PMID:18790767|PMID:20110775|PMID:20383943|PMID:22262760|PMID:24291039|PMID:24333736|PMID:31540997,https://www.ncbi.nlm.nih.gov/pubmed/16617327|https://www.ncbi.nlm.nih.gov/pubmed/17659339|https://www.ncbi.nlm.nih.gov/pubmed/17898295|https://www.ncbi.nlm.nih.gov/pubmed/17898787|https://www.ncbi.nlm.nih.gov/pubmed/18223231|https://www.ncbi.nlm.nih.gov/pubmed/18723477|https://www.ncbi.nlm.nih.gov/pubmed/18790767|https://www.ncbi.nlm.nih.gov/pubmed/20110775|https://www.ncbi.nlm.nih.gov/pubmed/20383943|https://www.ncbi.nlm.nih.gov/pubmed/22262760|https://www.ncbi.nlm.nih.gov/pubmed/24291039|https://www.ncbi.nlm.nih.gov/pubmed/24333736|https://www.ncbi.nlm.nih.gov/pubmed/31540997,16617327|17659339|17898295|17898787|18223231|18723477|18790767|20110775|20383943|22262760|24291039|24333736|31540997,,PMC2903039|PMC3337713,419197|1688119|5838389|7479198|11379274|17384803|20071489|20071928|22719189|24155195|24168753|28301548|30854795,"Pizzato Scomazzon S, Riccio A, Santopolo S, Lanzilli G, Coccia M, Rossi A, Santoro MG. The Zinc-Finger AN1-Type Domain 2a Gene Acts as a Regulator of Cell Survival in Human Melanoma: Role of E3-Ligase cIAP2. Mol Cancer Res. 2019 Dec;17(12):2444–56. doi: 10.1158/1541-7786.mcr-19-0243. PMID: 31540997.|Lee JH, Chiang SY, Nam D, Chung WS, Lee J, Na YS, Sethi G, Ahn KS. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. Cancer Lett. 2014 Apr 01;345(1):140–8. doi: 10.1016/j.canlet.2013.12.008. PMID: 24333736.|Liu N, Huang H, Xu L, Hua X, Li X, Liu S, Yang C, Zhao C, Zhao C, Li S, Dou QP, Liu J. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. Toxicol Lett. 2014 Jan 30;224(3):333–40. doi: 10.1016/j.toxlet.2013.11.021. PMID: 24291039.|Santo L, Hideshima T, Kung AL, Tseng JC, Tamang D, Yang M, Jarpe M, van Duzer JH, Mazitschek R, Ogier WC, Cirstea D, Rodig S, Eda H, Scullen T, Canavese M, Bradner J, Anderson KC, Jones SS, Raje N. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma. Blood. 2012 Mar 15;119(11):2579–89. PMID: 22262760; PMCID: PMC3337713.|Luo P, Lin M, Lin M, Zhu D, Wang Z, Shen J, Yang B, He Q. Bortezomib induces apoptosis in human neuroblastoma CHP126 cells. Pharmazie. 2010 Mar;65(3):213–8. PMID: 20383943.|Periyasamy-Thandavan S, Jackson WH, Samaddar JS, Erickson B, Barrett JR, Raney L, Gopal E, Ganapathy V, Hill WD, Bhalla KN, Schoenlein PV. Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells. Autophagy. 2010 Jan;6(1):19–35. doi: 10.4161/auto.6.1.10323. PMID: 20110775.|Lioni M, Noma K, Snyder A, Klein-Szanto A, Diehl JA, Rustgi AK, Herlyn M, Smalley KSM. Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway. 2008 Sep 01;7(9):2866–75. doi: 10.1158/1535-7163.mct-08-0391.|Gu H, Chen X, Gao G, Dong H. Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells. Mol Cancer Ther. 2008 Aug;7(8):2298–307. doi: 10.1158/1535-7163.mct-08-0186. PMID: 18723477.|Zhao X, Qiu W, Kung J, Zhao X, Peng X, Yegappan M, Yen-Lieberman B, Hsi ED. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Leuk Res. 2008 Feb;32(2):275–85. doi: 10.1016/j.leukres.2007.05.024. PMID: 17659339.|Dai Y, Chen S, Kramer LB, Funk VL, Dent P, Grant S. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells. Clin Cancer Res. 2008 Jan 15;14(2):549–58. doi: 10.1158/1078-0432.ccr-07-1934. PMID: 18223231.|Poulaki V, Mitsiades CS, Kotoula V, Negri J, McMillin D, Miller JW, Mitsiades N. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4706–19. doi: 10.1167/iovs.06-1147. PMID: 17898295.|Wang M, Han XH, Zhang L, Yang J, Qian JF, Shi YK, Kwak LW, Romaguera J, Yi Q. Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo. Leukemia. 2008 Jan;22(1):179–85. doi: 10.1038/sj.leu.2404959. PMID: 17898787.|Navas TA, Nguyen AN, Hideshima T, Reddy M, Ma JY, Haghnazari E, Henson M, Stebbins EG, Kerr I, O'Young G, Kapoun AM, Chakravarty S, Mavunkel B, Perumattam J, Luedtke G, Dugar S, Medicherla S, Protter AA, Schreiner GF, Anderson KC, Higgins LS. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. Leukemia. 2006 Jun;20(6):1017–27. doi: 10.1038/sj.leu.2404200. PMID: 16617327."
1389497,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bortezomib results in increased expression of PARP1 protein,,,PMID:17156654,https://www.ncbi.nlm.nih.gov/pubmed/17156654,17156654,,,19379402,"Fu YB, Sun QX, Meng FY, Xie J, Zhou GB. [Apoptosis of myeloid leukemia cell line HL60 induced by Bortezomib, a proteasome inhibitor]. Zhonghua Yi Xue Za Zhi. 2006 Sep 12;86(34):2413–6. PMID: 17156654."
1389498,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein] which results in increased cleavage of PARP1 protein,,,PMID:17326159,https://www.ncbi.nlm.nih.gov/pubmed/17326159,17326159,,,15311985,"Koschny R, Ganten TM, Sykora J, Haas TL, Sprick MR, Kolb A, Stremmel W, Walczak H. TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window. Hepatology. 2007 Mar;45(3):649–58. doi: 10.1002/hep.21555. PMID: 17326159."
1389499,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[BRCA1 mutant form results in increased susceptibility to bortezomib] which results in increased cleavage of PARP1 protein|tp53bp1 protein affects the reaction [[BRCA1 mutant form results in increased susceptibility to bortezomib] which results in increased cleavage of PARP1 protein]|[rb1 mutant form results in increased susceptibility to bortezomib] which results in increased cleavage of PARP1 protein,,,PMID:25522274,https://www.ncbi.nlm.nih.gov/pubmed/25522274,25522274,,PMC4649846,16833545,"Gu Y, Bouwman P, Greco D, Saarela J, Yadav B, Jonkers J, Kuznetsov SG. Suppression of BRCA1 sensitizes cells to proteasome inhibitors. Cell Death & Disease. 2014 Dec 18;5(12):e1580. doi: 10.1038/cddis.2014.537."
1389500,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[curcumin co-treated with bortezomib] results in increased cleavage of PARP1 protein,,,PMID:19372569,https://www.ncbi.nlm.nih.gov/pubmed/19372569,19372569,,PMC2694943,30236431,"Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S, Aggarwal BB. Curcumin circumvents chemoresistance <i>in vitro</i> and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. 2009 Apr 01;8(4):959–70. doi: 10.1158/1535-7163.mct-08-0905."
1389501,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ricolinostat promotes the reaction [bortezomib results in increased cleavage of PARP1 protein],,,PMID:22262760,https://www.ncbi.nlm.nih.gov/pubmed/22262760,22262760,,PMC3337713,419197,"Santo L, Hideshima T, Kung AL, Tseng JC, Tamang D, Yang M, Jarpe M, van Duzer JH, Mazitschek R, Ogier WC, Cirstea D, Rodig S, Eda H, Scullen T, Canavese M, Bradner J, Anderson KC, Jones SS, Raje N. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma. Blood. 2012 Mar 15;119(11):2579–89. PMID: 22262760; PMCID: PMC3337713."
1389502,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SCIO-469 promotes the reaction [bortezomib results in increased cleavage of PARP1 protein],,,PMID:16617327,https://www.ncbi.nlm.nih.gov/pubmed/16617327,16617327,,,30854795,"Navas TA, Nguyen AN, Hideshima T, Reddy M, Ma JY, Haghnazari E, Henson M, Stebbins EG, Kerr I, O'Young G, Kapoun AM, Chakravarty S, Mavunkel B, Perumattam J, Luedtke G, Dugar S, Medicherla S, Protter AA, Schreiner GF, Anderson KC, Higgins LS. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. Leukemia. 2006 Jun;20(6):1017–27. doi: 10.1038/sj.leu.2404200. PMID: 16617327."
1389503,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TNFSF10 protein promotes the reaction [bortezomib results in increased cleavage of PARP1 protein],,,PMID:17659339,https://www.ncbi.nlm.nih.gov/pubmed/17659339,17659339,,,22719189,"Zhao X, Qiu W, Kung J, Zhao X, Peng X, Yegappan M, Yen-Lieberman B, Hsi ED. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Leuk Res. 2008 Feb;32(2):275–85. doi: 10.1016/j.leukres.2007.05.024. PMID: 17659339."
1389504,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Bortezomib results in increased cleavage of PARP1 protein,,,PMID:29384525,https://www.ncbi.nlm.nih.gov/pubmed/29384525,29384525,,PMC5808033,10814418,"Hassan Z, Schneeweis C, Wirth M, Veltkamp C, Dantes Z, Feuerecker B, Ceyhan GO, Knauer SK, Weichert W, Schmid RM, Stauber R, Arlt A, Krämer OH, Rad R, Reichert M, Saur D, Schneider G. MTOR inhibitor-based combination therapies for pancreatic cancer. British Journal of Cancer. 2018 Jan 02;118(3):366–77. doi: 10.1038/bjc.2017.421."
431588,389710,Comparative Toxicogenomics Database (CTD),Aminoflavone,C413760,aminoflavone,https://ctdbase.org/detail.go?type=chem&acc=C413760,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aminoflavone results in increased cleavage of PARP1 protein,,,PMID:24885022,https://www.ncbi.nlm.nih.gov/pubmed/24885022,24885022,,PMC4037283,9401203,2014; 14(1):344
1860808,392622,Comparative Toxicogenomics Database (CTD),Ritonavir,D019438,Ritonavir,https://ctdbase.org/detail.go?type=chem&acc=D019438,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ritonavir results in increased cleavage of PARP1 protein,,,PMID:19386116|PMID:21270666,https://www.ncbi.nlm.nih.gov/pubmed/19386116|https://www.ncbi.nlm.nih.gov/pubmed/21270666,19386116|21270666,,PMC2691728|PMC3104055,11282218|31589120,"Srirangam A, Milani M, Mitra R, Guo Z, Rodriguez M, Kathuria H, Fukuda S, Rizzardi A, Schmechel S, Skalnik DG, Pelus LM, Potter DA. The Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in Part, by Inhibition of Survivin. Journal of Thoracic Oncology. 2011 Apr;6(4):661–70. doi: 10.1097/jto.0b013e31820c9e3c.|2009; 8(1):26"
1269697,398148,Comparative Toxicogenomics Database (CTD),"6-Cyclohexylmethyloxy-5-nitroso-pyrimidine-2,4-diamine",C475622,"4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine",https://ctdbase.org/detail.go?type=chem&acc=C475622,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine co-treated with 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea] results in increased cleavage of PARP1 protein",,,PMID:26208482,https://www.ncbi.nlm.nih.gov/pubmed/26208482,26208482,,PMC4694865,33024721,"Kuo CY, Chou WC, Wu CC, Wong TS, Kakadiya R, Lee TC, Su TL, Wang HC. Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms. Oncotarget. 2015 Sep 22;6(28):25770–83. PMID: 26208482; PMCID: PMC4694865."
1778183,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone Methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bardoxolone methyl results in increased cleavage of PARP1 protein,,,PMID:17363558|PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/17363558|https://www.ncbi.nlm.nih.gov/pubmed/25246272,17363558|25246272,,PMC4234881,19518824|20742608,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881.|Liby K, Royce DB, Williams CR, Risingsong R, Yore MM, Honda T, Gribble GW, Dmitrovsky E, Sporn TA, Sporn MB. The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice. Cancer Res. 2007 Mar 15;67(6):2414–9. doi: 10.1158/0008-5472.can-06-4534. PMID: 17363558."
1772960,407212,Toxin and Toxin Target Database (T3DB),"Cobalt(1+), chloride, trans-",T3D1393,cis-Dichlorobis(ethylenediamine)cobalt(III) chloride,http://www.t3db.ca/toxins/T3D1393,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1773302,409301,Comparative Toxicogenomics Database (CTD),Methylmercuric chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methylmercuric chloride results in increased cleavage of PARP1 protein,,,PMID:11068922,https://www.ncbi.nlm.nih.gov/pubmed/11068922,11068922,,,7770544,"Shenker BJ, Guo TL, Shapiro IM. Mercury-induced apoptosis in human lymphoid cells: evidence that the apoptotic pathway is mercurial species dependent. Environ Res. 2000 Oct;84(2):89–99. doi: 10.1006/enrs.2000.4078. PMID: 11068922."
1773303,409301,Comparative Toxicogenomics Database (CTD),Methylmercuric chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of PARP1 protein]|methylmercuric chloride results in increased expression of PARP1 protein modified form|akt1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of PARP1 protein modified form],,,PMID:31330229,https://www.ncbi.nlm.nih.gov/pubmed/31330229,31330229,,,21642330,"Chung YP, Yen CC, Tang FC, Lee KI, Liu SH, Wu CC, Hsieh SS, Su CC, Kuo CY, Chen YW. Methylmercury exposure induces ROS/Akt inactivation-triggered endoplasmic reticulum stress-regulated neuronal cell apoptosis. Toxicology. 2019 Sep 01;425():152245. doi: 10.1016/j.tox.2019.152245. PMID: 31330229."
1562339,419951,Toxin and Toxin Target Database (T3DB),Cobalt(ii)iodide,T3D0661,Cobalt(II) iodide,http://www.t3db.ca/toxins/T3D0661,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1786810,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lithium chloride inhibits the reaction [hydroquinone results in increased cleavage of PARP1 protein],,,PMID:28886972,https://www.ncbi.nlm.nih.gov/pubmed/28886972,28886972,,,27711271,"Li J, Jiang S, Chen Y, Ma R, Chen J, Qian S, Shi Y, Han Y, Zhang S, Yu K. Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of ß-catenin signaling. Toxicol In Vitro. 2018 Feb;46():361–9. doi: 10.1016/j.tiv.2017.08.018. PMID: 28886972."
1786811,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lithium chloride inhibits the reaction [quinocetone results in increased expression of PARP1 protein modified form],,,PMID:28343033,https://www.ncbi.nlm.nih.gov/pubmed/28343033,28343033,,,12810228,"Yang X, Tang S, Dai C, Li D, Zhang S, Deng S, Zhou Y, Xiao X. Quinocetone induces mitochondrial apoptosis in HepG2 cells through ROS-dependent promotion of VDAC1 oligomerization and suppression of Wnt1/ß-catenin signaling pathway. Food Chem Toxicol. 2017 Jul;105():161–76. doi: 10.1016/j.fct.2017.03.039. PMID: 28343033."
1786812,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),U 0126 affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein]|[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein|3-chloroacetylindole affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein]|bisindolylmaleimide affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein],,,PMID:31396050,https://www.ncbi.nlm.nih.gov/pubmed/31396050,31396050,,PMC6667551,10151887,"Kim JE, Kang TC. PKC, AKT and ERK1/2-Mediated Modulations of PARP1, NF-?B and PEA15 Activities Distinctly Regulate Regional Specific Astroglial Responses Following Status Epilepticus. Front Mol Neurosci. 2019;12():180. PMID: 31396050; PMCID: PMC6667551."
1786813,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:30377735,https://www.ncbi.nlm.nih.gov/pubmed/30377735,30377735,,,8127370,2018; 93(2):533-546
1786814,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Lithium chloride promotes the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,,18200010,"So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547."
1766365,433636,Comparative Toxicogenomics Database (CTD),"6,7,14-Trihydroxy-7,20-epoxykaur-16-en-15-one",C581034,longikaurin A,https://ctdbase.org/detail.go?type=chem&acc=C581034,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Longikaurin A results in increased expression of PARP1 protein modified form,,,PMID:28801140,https://www.ncbi.nlm.nih.gov/pubmed/28801140,28801140,,,16893745,"Che Y, Wang J, Yuan Z, Li Y, Lu Z, Zhang Z, Zhang J, Wan J, Sun H, Chen Z, Pu J, He J. The therapeutic effects of Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation. Toxicol Lett. 2017 Oct 05;280():106–15. doi: 10.1016/j.toxlet.2017.08.005. PMID: 28801140."
1566232,439196,Comparative Toxicogenomics Database (CTD),"1,4-Dithiothreitol",D004229,Dithiothreitol,https://ctdbase.org/detail.go?type=chem&acc=D004229,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dithiothreitol inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein],,,PMID:18022205,https://www.ncbi.nlm.nih.gov/pubmed/18022205,18022205,,,10601995,"Paul MK, Kumar R, Mukhopadhyay AK. Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells. Toxicol Appl Pharmacol. 2008 Jan 15;226(2):140–52. doi: 10.1016/j.taap.2007.09.020. PMID: 18022205."
1566233,439196,Comparative Toxicogenomics Database (CTD),"1,4-Dithiothreitol",D004229,Dithiothreitol,https://ctdbase.org/detail.go?type=chem&acc=D004229,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dithiothreitol inhibits the reaction [withaferin A results in increased cleavage of PARP1 protein],,,PMID:20438634,https://www.ncbi.nlm.nih.gov/pubmed/20438634,20438634,,PMC2873443,5184553,2010; 9(1):99
1566234,439196,Comparative Toxicogenomics Database (CTD),"1,4-Dithiothreitol",D004229,Dithiothreitol,https://ctdbase.org/detail.go?type=chem&acc=D004229,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dithiothreitol inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:11035063,https://www.ncbi.nlm.nih.gov/pubmed/11035063,11035063,,,209792,"Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000 Oct 15;165(8):4290–7. doi: 10.4049/jimmunol.165.8.4290. PMID: 11035063."
1538734,439224,Comparative Toxicogenomics Database (CTD),Carnosine,D002336,Carnosine,https://ctdbase.org/detail.go?type=chem&acc=D002336,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Carnosine inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased expression of PARP1 protein],,,PMID:23011206,https://www.ncbi.nlm.nih.gov/pubmed/23011206,23011206,,,32980482,2012; 38(1):50-58
439192,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased cleavage of PARP1 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,,9506434,"de Oliveira MR, Custódio de Souza IC, Fürstenau CR. Promotion of mitochondrial protection by naringenin in methylglyoxal-treated SH-SY5Y cells: Involvement of the Nrf2/GSH axis. Chem Biol Interact. 2019 Sep 01;310():108728. doi: 10.1016/j.cbi.2019.108728. PMID: 31254498."
439193,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Naringenin results in increased cleavage of PARP1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,,33046569,"Park HJ, Choi YJ, Lee JH, Nam MJ. Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells. Food Chem Toxicol. 2017 Jan;99():1–8. doi: 10.1016/j.fct.2016.11.008. PMID: 27838343."
1342719,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mitomycin promotes the reaction [ouabain results in increased cleavage of PARP1 protein]|ouabain promotes the reaction [mitomycin results in increased cleavage of PARP1 protein],,,PMID:24124520,https://www.ncbi.nlm.nih.gov/pubmed/24124520,24124520,,PMC3790830,25617769,"Wha Jun D, Hwang M, Kim HJ, Hwang SK, Kim S, Lee C. Ouabain, a Cardiac Glycoside, Inhibits the Fanconi Anemia/BRCA Pathway Activated by DNA Interstrand Cross-Linking Agents. PLoS ONE. 2013 Oct 04;8(10):e75905. doi: 10.1371/journal.pone.0075905."
1342720,439501,Comparative Toxicogenomics Database (CTD),Ouabain,D010042,Ouabain,https://ctdbase.org/detail.go?type=chem&acc=D010042,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ouabain results in increased cleavage of PARP1 protein,,,PMID:24124520|PMID:31436044,https://www.ncbi.nlm.nih.gov/pubmed/24124520|https://www.ncbi.nlm.nih.gov/pubmed/31436044,24124520|31436044,,PMC3790830,12880800|25617769,"Chang YM, Shih YL, Chen CP, Liu KL, Lee MH, Lee MZ, Hou HT, Huang HC, Lu HF, Peng SF, Chen KW, Yeh MY, Chung JG. Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329–39. doi: 10.1002/tox.22834. PMID: 31436044.|Wha Jun D, Hwang M, Kim HJ, Hwang SK, Kim S, Lee C. Ouabain, a Cardiac Glycoside, Inhibits the Fanconi Anemia/BRCA Pathway Activated by DNA Interstrand Cross-Linking Agents. PLoS ONE. 2013 Oct 04;8(10):e75905. doi: 10.1371/journal.pone.0075905."
1388449,439620,Comparative Toxicogenomics Database (CTD),3-Oxalomalic acid,C015407,oxalomalic acid,https://ctdbase.org/detail.go?type=chem&acc=C015407,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),Oxalomalic acid promotes the reaction [cadmium chloride results in increased cleavage of PARP1 protein]|oxalomalic acid promotes the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:16785314,https://www.ncbi.nlm.nih.gov/pubmed/16785314,16785314,,,9252676,"Kil IS, Shin SW, Yeo HS, Lee YS, Park JW. Mitochondrial NADP+-dependent isocitrate dehydrogenase protects cadmium-induced apoptosis. Mol Pharmacol. 2006 Sep;70(3):1053–61. doi: 10.1124/mol.106.023515. PMID: 16785314."
1771879,439647,Comparative Toxicogenomics Database (CTD),N-Tosyl-L-phenylalanyl chloromethyl ketone,D014108,Tosylphenylalanyl Chloromethyl Ketone,https://ctdbase.org/detail.go?type=chem&acc=D014108,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tosylphenylalanyl chloromethyl ketone results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [tosylphenylalanyl chloromethyl ketone results in increased cleavage of PARP1 protein],,,PMID:19679660,https://www.ncbi.nlm.nih.gov/pubmed/19679660,19679660,,PMC2788833,26189518,"Jitkaew S, Trebinska A, Grzybowska E, Carlsson G, Nordström A, Lehtiö J, Fröjmark A, Dahl N, Fadeel B. Na-Tosyl-l-phenylalanine Chloromethyl Ketone Induces Caspase-dependent Apoptosis in Transformed Human B Cell Lines with Transcriptional Down-regulation of Anti-apoptotic HS1-associated Protein X-1. Journal of Biological Chemistry. 2009 Oct;284(41):27827–37. doi: 10.1074/jbc.m109.027912."
1568240,440908,Comparative Toxicogenomics Database (CTD),CID 440908,C038405,nivalenol,https://ctdbase.org/detail.go?type=chem&acc=C038405,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Nivalenol results in increased cleavage of PARP1 protein,,,PMID:19410639,https://www.ncbi.nlm.nih.gov/pubmed/19410639,19410639,,,28187125,"Marzocco S, Russo R, Bianco G, Autore G, Severino L. Pro-apoptotic effects of nivalenol and deoxynivalenol trichothecenes in J774A.1 murine macrophages. Toxicol Lett. 2009 Aug 25;189(1):21–6. doi: 10.1016/j.toxlet.2009.04.024. PMID: 19410639."
1805664,441145,Comparative Toxicogenomics Database (CTD),Monensin,D008985,Monensin,https://ctdbase.org/detail.go?type=chem&acc=D008985,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Monensin results in increased cleavage of PARP1 protein,,,PMID:30718715,https://www.ncbi.nlm.nih.gov/pubmed/30718715,30718715,,PMC6361972,28397724,"Vanneste M, Huang Q, Li M, Moose D, Zhao L, Stamnes MA, Schultz M, Wu M, Henry MD. High content screening identifies monensin as an EMT-selective cytotoxic compound. Scientific Reports. 2019 Feb 04;9(1):1200. doi: 10.1038/s41598-018-38019-y."
1792996,441325,Comparative Toxicogenomics Database (CTD),Amiodarone Hydrochloride,D000638,Amiodarone,https://ctdbase.org/detail.go?type=chem&acc=D000638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[3-methyladenine co-treated with amiodarone] results in increased cleavage of PARP1 protein,,,PMID:23912912,https://www.ncbi.nlm.nih.gov/pubmed/23912912,23912912,,,16806471,"Lee K, Oh S, Choi Y, Oh S, Yang Y, Yang M, Lee K, Lee B. Activation of Autophagy Rescues Amiodarone-Induced Apoptosis of Lung Epithelial Cells and Pulmonary Toxicity in Rats. 2013 Aug 02;136(1):193–204. doi: 10.1093/toxsci/kft168."
1793172,441325,Comparative Toxicogenomics Database (CTD),Amiodarone Hydrochloride,D000638,Amiodarone,https://ctdbase.org/detail.go?type=chem&acc=D000638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TNFSF10 co-treated with amiodarone] results in increased cleavage of PARP1 protein,,,PMID:21292685,https://www.ncbi.nlm.nih.gov/pubmed/21292685,21292685,,PMC3064603,31609290,"Kim IY, Kang YJ, Yoon MJ, Kim EH, Kim SU, Kwon TK, Kim IA, Choi KS. Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol. 2011 Mar;13(3):267–79. PMID: 21292685; PMCID: PMC3064603."
1294242,441921,Comparative Toxicogenomics Database (CTD),Ginsenoside B2,C049864,ginsenoside Re,https://ctdbase.org/detail.go?type=chem&acc=C049864,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ginsenoside re inhibits the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:25523949,https://www.ncbi.nlm.nih.gov/pubmed/25523949,25523949,,,16835153,"Nam Y, Wie MB, Shin E, Nguyen TL, Nah S, Ko SK, Jeong JH, Jang C, Kim H. Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C d in human neuroblastoma dopaminergic SH-SY5Y cell lines. J of Applied Toxicology. 2014 Dec 18;35(8):927–44. doi: 10.1002/jat.3093."
1569141,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Notoginsenoside R1 inhibits the reaction [lipopolysaccharides results in increased expression of PARP1 protein modified form],,,PMID:23170834,https://www.ncbi.nlm.nih.gov/pubmed/23170834,23170834,,PMC3605881,33660589,"Sun B, Xiao J, Sun X, Wu Y. Notoginsenoside <scp>R1</scp> attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and <scp>PI3K</scp>/<scp>Akt</scp> signalling. British J Pharmacology. 2013 Mar 12;168(7):1758–70. doi: 10.1111/bph.12063."
1541724,442009,Comparative Toxicogenomics Database (CTD),Carnosol,C068623,carnosol,https://ctdbase.org/detail.go?type=chem&acc=C068623,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Carnosol inhibits the reaction [palmitic acid results in increased expression of PARP1 protein modified form]|prdx3 protein promotes the reaction [carnosol inhibits the reaction [palmitic acid results in increased expression of PARP1 protein modified form]]|carnosol inhibits the reaction [dietary fats results in increased expression of PARP1 protein modified form],,,PMID:34678374,https://www.ncbi.nlm.nih.gov/pubmed/34678374,34678374,,,26476154,"Geng Y, Wang Y, Sun R, Kang X, Zhao H, Zhu M, Sun Y, Hu Y, Wang Z, Tian X, Zhao Y, Yao J. Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3. Toxicol Appl Pharmacol. 2021 Dec 01;432():115758. doi: 10.1016/j.taap.2021.115758. PMID: 34678374."
1794917,442266,Comparative Toxicogenomics Database (CTD),Lactucin,C516715,lactucin,https://ctdbase.org/detail.go?type=chem&acc=C516715,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [lactucin results in increased cleavage of PARP1 protein]|cflar protein inhibits the reaction [lactucin results in increased cleavage of PARP1 protein],,,PMID:34302634,https://www.ncbi.nlm.nih.gov/pubmed/34302634,34302634,,,25817098,2021; 43(10):1199-1207
1795065,442266,Comparative Toxicogenomics Database (CTD),Lactucin,C516715,lactucin,https://ctdbase.org/detail.go?type=chem&acc=C516715,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lactucin results in increased cleavage of PARP1 protein,,,PMID:34302634|PMID:36364182,https://www.ncbi.nlm.nih.gov/pubmed/34302634|https://www.ncbi.nlm.nih.gov/pubmed/36364182,34302634|36364182,,PMC9657596,25817098|35395423,"Imam KMSU, Tian Y, Xin F, Xie Y, Wen B. Lactucin, a Bitter Sesquiterpene from Cichorium intybus, Inhibits Cancer Cell Proliferation by Downregulating the MAPK and Central Carbon Metabolism Pathway. Molecules. 2022 Oct 29;27(21):7358. doi: 10.3390/molecules27217358.|2021; 43(10):1199-1207"
1744285,442288,Comparative Toxicogenomics Database (CTD),Parthenin,C022097,parthenin,https://ctdbase.org/detail.go?type=chem&acc=C022097,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Parthenin analog results in increased cleavage of PARP1 protein,,,PMID:25196075,https://www.ncbi.nlm.nih.gov/pubmed/25196075,25196075,,,23577680,"Goswami A, Shah BA, Kumar A, Rizvi MA, Kumar S, Bhushan S, Malik FA, Batra N, Joshi A, Singh J. Antiproliferative potential of a novel parthenin analog P16 as evident by apoptosis accompanied by down-regulation of PI3K/AKT and ERK pathways in human acute lymphoblastic leukemia MOLT-4 cells. Chem Biol Interact. 2014 Oct 05;222():60–7. doi: 10.1016/j.cbi.2014.08.011. PMID: 25196075."
451528,442435,Comparative Toxicogenomics Database (CTD),Swertiamarin,C013270,swertiamarin,https://ctdbase.org/detail.go?type=chem&acc=C013270,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Swertiamarin results in increased expression of and results in increased cleavage of PARP1 protein|swertiamarin results in increased expression of PARP1 mRNA,,,PMID:38852899,https://www.ncbi.nlm.nih.gov/pubmed/38852899,38852899,,,37306935,"Valenta Šobot A, Drakulic D, Todorovic A, Janic M, Božovic A, Todorovic L, Filipovic Trickovic J. Gentiopicroside and swertiamarin induce non-selective oxidative stress-mediated cytotoxic effects in human peripheral blood mononuclear cells. Chem Biol Interact. 2024 Aug 01;398():111103. doi: 10.1016/j.cbi.2024.111103. PMID: 38852899."
1776546,442458,Comparative Toxicogenomics Database (CTD),Sanggenone C,C477157,sanggenone C,https://ctdbase.org/detail.go?type=chem&acc=C477157,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sanggenone C results in increased expression of and results in increased cleavage of PARP1 protein|dapk1 protein affects the reaction [sanggenone C results in increased expression of and results in increased cleavage of PARP1 protein]|[sanggenone C co-treated with temozolomide] results in increased expression of and results in increased cleavage of PARP1 protein,,,PMID:37346933,https://www.ncbi.nlm.nih.gov/pubmed/37346933,37346933,,PMC10279945,35751716,"Chang H, Hou J, Shao Y, Xu M, Weng X, Du Y, Shi J, Zhang L, Cui H. Sanggenon C inhibits cell proliferation and induces apoptosis by regulating the MIB1/DAPK1 axis in glioblastoma. MedComm (2020). 2023 Aug;4(4):e281. PMID: 37346933; PMCID: PMC10279945."
1396493,442530,Comparative Toxicogenomics Database (CTD),Ochratoxin A,C025589,ochratoxin A,https://ctdbase.org/detail.go?type=chem&acc=C025589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[aflatoxin M1 co-treated with ochratoxin A] results in increased expression of PARP1 protein|ochratoxin A results in increased expression of PARP1 protein,,,PMID:34126166,https://www.ncbi.nlm.nih.gov/pubmed/34126166,34126166,,,29127678,"Wang Z, Gao Y, Huang X, Huang S, Yang X, Wang J, Zheng N. Metabolomics analysis underlay mechanisms in the renal impairment of mice caused by combination of aflatoxin M1 and ochratoxin A. Toxicology. 2021 Jun 30;458():152835. doi: 10.1016/j.tox.2021.152835. PMID: 34126166."
1396494,442530,Comparative Toxicogenomics Database (CTD),Ochratoxin A,C025589,ochratoxin A,https://ctdbase.org/detail.go?type=chem&acc=C025589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ochratoxin A results in decreased expression of PARP1 mRNA,,,PMID:34481902,https://www.ncbi.nlm.nih.gov/pubmed/34481902,34481902,,,11566248,"Zhu L, Wang H, Yuhan J, Zhang B, Li H, Asakiya C, Huang K, He X, Xu W. Exosomes mediated the delivery of ochratoxin A-induced cytotoxicity in HEK293 cells. Toxicology. 2021 Sep;461():152926. doi: 10.1016/j.tox.2021.152926. PMID: 34481902."
1396495,442530,Comparative Toxicogenomics Database (CTD),Ochratoxin A,C025589,ochratoxin A,https://ctdbase.org/detail.go?type=chem&acc=C025589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ochratoxin A results in increased cleavage of PARP1 protein,,,PMID:25002221,https://www.ncbi.nlm.nih.gov/pubmed/25002221,25002221,,,17479122,2014; 89(8):1313-1327
1396496,442530,Comparative Toxicogenomics Database (CTD),Ochratoxin A,C025589,ochratoxin A,https://ctdbase.org/detail.go?type=chem&acc=C025589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),Ochratoxin A results in increased cleavage of PARP1 protein|atg5 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein]|3-methyladenine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein]|chloroquine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein]|becn1 protein affects the reaction [ochratoxin A results in increased cleavage of PARP1 protein],,,PMID:30287338,https://www.ncbi.nlm.nih.gov/pubmed/30287338,30287338,,,22300257,"Qian G, Liu D, Hou L, Hamid M, Chen X, Gan F, Song S, Huang K. Ochratoxin A induces cytoprotective autophagy via blocking AKT/mTOR signaling pathway in PK-15 cells. Food Chem Toxicol. 2018 Dec;122():120–31. doi: 10.1016/j.fct.2018.09.070. PMID: 30287338."
1396497,442530,Comparative Toxicogenomics Database (CTD),Ochratoxin A,C025589,ochratoxin A,https://ctdbase.org/detail.go?type=chem&acc=C025589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),Ochratoxin A results in increased expression of PARP1 protein,,,PMID:32454083,https://www.ncbi.nlm.nih.gov/pubmed/32454083,32454083,,,10864321,"Zhang TY, Kong L, Hao JX, Wang H, Yan ZH, Sun XF, Shen W. Effects of Ochratoxin A exposure on DNA damage in porcine granulosa cells in vitro. Toxicol Lett. 2020 May 23;330():167–75. doi: 10.1016/j.toxlet.2020.05.011. PMID: 32454083."
1808968,442664,Comparative Toxicogenomics Database (CTD),Vicenin-2,C530449,"apigenin-6,8-di-C-glycopyranoside",https://ctdbase.org/detail.go?type=chem&acc=C530449,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Apigenin-6,8-di-C-glycopyranoside results in increased cleavage of PARP1 protein|docetaxel promotes the reaction [apigenin-6,8-di-C-glycopyranoside results in increased cleavage of PARP1 protein]",,,PMID:21803027,https://www.ncbi.nlm.nih.gov/pubmed/21803027,21803027,,PMC3252753,12711278,"Nagaprashantha LD, Vatsyayan R, Singhal J, Fast S, Roby R, Awasthi S, Singhal SS. Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer. Biochemical Pharmacology. 2011 Nov;82(9):1100–9. doi: 10.1016/j.bcp.2011.07.078."
1777982,442793,Comparative Toxicogenomics Database (CTD),Gingerol,C007845,gingerol,https://ctdbase.org/detail.go?type=chem&acc=C007845,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein]|[tnfsf10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein,,,PMID:25034532,https://www.ncbi.nlm.nih.gov/pubmed/25034532,25034532,,PMC4295120,10048252,"Lee D, Kim D, Jung C, Lee YJ, Park D. Gingerol sensitizes TRAIL-induced apoptotic cell death of glioblastoma cells. Toxicology and Applied Pharmacology. 2014 Sep;279(3):253–65. doi: 10.1016/j.taap.2014.06.030."
1744323,442985,Comparative Toxicogenomics Database (CTD),Solasodine,C012037,solasodine,https://ctdbase.org/detail.go?type=chem&acc=C012037,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Solasodine results in increased cleavage of and results in decreased expression of PARP1 protein,,,PMID:37121296,https://www.ncbi.nlm.nih.gov/pubmed/37121296,37121296,,,35786177,"Su K, Yao X, Guo C, Qian C, Wang Y, Ma X, Wang X, Yang Y. Solasodine suppresses the metastasis of gastric cancer through claudin-2 via the AMPK/STAT3/NF-?B pathway. Chem Biol Interact. 2023 Jul 01;379():110520. doi: 10.1016/j.cbi.2023.110520. PMID: 37121296."
1785938,443013,Comparative Toxicogenomics Database (CTD),Lignans,D017705,Lignans,https://ctdbase.org/detail.go?type=chem&acc=D017705,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lignans analog results in increased cleavage of PARP1 protein,,,PMID:26620693,https://www.ncbi.nlm.nih.gov/pubmed/26620693,26620693,,,10073414,"Bhushan S, Kakkar V, Pal HC, Mondhe DM, Kaur IP. The augmented anticancer potential of AP9-cd loaded solid lipid nanoparticles in human leukemia Molt-4 cells and experimental tumor. Chem Biol Interact. 2016 Jan 25;244():84–93. doi: 10.1016/j.cbi.2015.11.022. PMID: 26620693."
1495584,443027,Comparative Toxicogenomics Database (CTD),Schisandrin C,C031409,schizandrin C,https://ctdbase.org/detail.go?type=chem&acc=C031409,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Schizandrin C inhibits the reaction [regorafenib results in increased cleavage of PARP1 protein],,,PMID:39348200,https://www.ncbi.nlm.nih.gov/pubmed/39348200,39348200,,,37797541,"Xu B, Liu N, Zhou T, Chen J, Jiang L, Wu W, Fu H, Chen X, Yan H, Yang X, Luo P, Yang B, Xu Z, He Q. Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes. Toxicol Sci. 2024 Dec 01;202(2):220–35. doi: 10.1093/toxsci/kfae127. PMID: 39348200."
1774038,443118,Comparative Toxicogenomics Database (CTD),Acetylleucyl-leucyl-norleucinal,C063261,acetylleucyl-leucyl-norleucinal,https://ctdbase.org/detail.go?type=chem&acc=C063261,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Acetylleucyl-leucyl-norleucinal inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
1781101,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chloroquine promotes the reaction [sodium arsenite results in increased activity of PARP1 protein]|sodium arsenite results in increased activity of PARP1 protein|sodium arsenite results in decreased expression of and results in increased cleavage of PARP1 protein|atg5 protein affects the reaction [sodium arsenite results in increased activity of PARP1 protein]|3-aminobenzamide inhibits the reaction [sodium arsenite results in decreased expression of PARP1 protein]|niacinamide inhibits the reaction [sodium arsenite results in decreased expression of PARP1 protein],,,PMID:36958258,https://www.ncbi.nlm.nih.gov/pubmed/36958258,36958258,,,34734926,"So K, Oh S. Arsenite-induced cytotoxicity is regulated by poly-ADP ribose polymerase 1 activation and parthanatos in p53-deficient H1299 cells: The roles of autophagy and p53. Biochemical and Biophysical Research Communications. 2023 May;656():78–85. doi: 10.1016/j.bbrc.2023.03.018."
1781102,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased cleavage of PARP1 protein]|[sodium arsenite results in increased abundance of arsenic] which results in increased cleavage of PARP1 protein,,,PMID:32188015,https://www.ncbi.nlm.nih.gov/pubmed/32188015,32188015,,PMC7139366,14924634,"Wang S, Cheng H, Wang L, Zhao R, Guan D. Overexpression of NRF1-742 or NRF1-772 Reduces Arsenic-Induced Cytotoxicity and Apoptosis in Human HaCaT Keratinocytes. Int J Mol Sci. 2020 Mar 16;21(6). PMID: 32188015; PMCID: PMC7139366."
1781103,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Roscovitine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:18501396,https://www.ncbi.nlm.nih.gov/pubmed/18501396,18501396,,PMC2806883,17364335,"McNeely SC, Taylor BF, States JC. Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent. Toxicology and Applied Pharmacology. 2008 Aug;231(1):61–7. doi: 10.1016/j.taap.2008.03.020."
1781252,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite affects the expression of PARP1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,PMC8241660,5445100,"Banerjee M, Ferragut Cardoso A, Al-Eryani L, Pan J, Kalbfleisch TS, Srivastava S, Rai SN, States JC. Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer. Archives of Toxicology. 2021 May 25;95(7):2351–65. doi: 10.1007/s00204-021-03084-2."
1781253,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc inhibits the reaction [sodium arsenite inhibits the reaction [zinc binds to PARP1 protein]]|sodium arsenite binds to and affects the folding of PARP1 protein,,,PMID:24275069,https://www.ncbi.nlm.nih.gov/pubmed/24275069,24275069,,PMC3891920,30330910,"Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 2014 Jan;274(2):313–8. doi: 10.1016/j.taap.2013.11.010."
1781254,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|[[abt-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein|mcl1 protein inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|usp7 protein affects the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein promotes the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|akt1 protein modified form inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein inhibits the reaction [sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|mcl1 protein affects the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein],,,PMID:32802178,https://www.ncbi.nlm.nih.gov/pubmed/32802178,32802178,,PMC7415806,9544165,"Yang P, Xie J, Li Y, Lin HP, Fenske W, Clementino M, Jiang Y, Yang C, Wang Z. Deubiquitinase USP7-mediated MCL-1 up-regulation enhances Arsenic and Benzo(a)pyrene co-exposure-induced Cancer Stem Cell-like property and Tumorigenesis. Theranostics. 2020;10(20):9050–65. PMID: 32802178; PMCID: PMC7415806."
1781255,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[acetylcysteine affects the abundance of reactive oxygen species] inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:24100277,https://www.ncbi.nlm.nih.gov/pubmed/24100277,24100277,,,2490832,"Kim Y, Jeong IG, You D, Song SH, Suh N, Jang SW, Kim S, Hwang JJ, Kim CS. Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells. Anticancer Drugs. 2014 Jan;25(1):53–62. doi: 10.1097/cad.0000000000000013. PMID: 24100277."
1781256,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sodium arsenite co-treated with TNF protein] results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [[sodium arsenite co-treated with TNF protein] results in increased cleavage of PARP1 protein]|sb 203580 promotes the reaction [[sodium arsenite co-treated with TNF protein] results in increased cleavage of PARP1 protein],,,PMID:29479036,https://www.ncbi.nlm.nih.gov/pubmed/29479036,29479036,,,33096846,"Singhirunnusorn P, Moolmuang B, Lirdprapamongkol K, Ruchirawat M. Arsenite exposure potentiates apoptosis-inducing effects of tumor necrosis factor-alpha- through reactive oxygen species. J Toxicol Sci. 2018;43(2):159–69. doi: 10.2131/jts.43.159. PMID: 29479036."
1781257,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:19536524,https://www.ncbi.nlm.nih.gov/pubmed/19536524,19536524,,,1069011,2009; 83(10):899-908
1781258,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [lapatinib inhibits the reaction [sodium arsenite results in decreased cleavage of PARP1 protein]]|akt activator SC79 inhibits the reaction [lapatinib inhibits the reaction [sodium arsenite results in decreased cleavage of PARP1 protein]]|sodium arsenite results in decreased cleavage of PARP1 protein|lapatinib inhibits the reaction [sodium arsenite results in decreased cleavage of PARP1 protein],,,PMID:32890875,https://www.ncbi.nlm.nih.gov/pubmed/32890875,32890875,,,21692211,"Zhou Q, Jin P, Liu J, Li S, Liu W, Xi S. Arsenic-induced HER2 promotes proliferation, migration and angiogenesis of bladder epithelial cells via activation of multiple signaling pathways in vitro and in vivo. Sci Total Environ. 2021 Jan 20;753():141962. doi: 10.1016/j.scitotenv.2020.141962. PMID: 32890875."
1781420,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:21642427,https://www.ncbi.nlm.nih.gov/pubmed/21642427,21642427,,PMC3143646,8664447,"Shin SY, Kim CG, Lim Y, Lee YH. The ETS Family Transcription Factor ELK-1 Regulates Induction of the Cell Cycle-regulatory Gene p21 and the BAX Gene in Sodium Arsenite-exposed Human Keratinocyte HaCaT Cells. Journal of Biological Chemistry. 2011 Jul;286(30):26860–72. doi: 10.1074/jbc.m110.216721."
1781421,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[EHMT2 protein co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased expression of PARP1 protein|ginkgo biloba extract inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 mrna]|[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 protein|[ehmt2 protein co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased expression of PARP1 mrna|[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 mrna|bix 01294 inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 protein],,,PMID:33378118,https://www.ncbi.nlm.nih.gov/pubmed/33378118,33378118,,,22375995,"Ding X, Zhang A, Li C, Ma L, Tang S, Wang Q, Yang G, Li J. The role of <scp>H3K9me2</scp>-regulated base excision repair genes in the repair of <scp>DNA</scp> damage induced by arsenic in <scp>HaCaT</scp> cells and the effects of <scp><i>Ginkgo biloba</i></scp> extract intervention. Environmental Toxicology. 2020 Dec 30;36(5):850–60. doi: 10.1002/tox.23088."
1781422,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BLVRA protein inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:15741166,https://www.ncbi.nlm.nih.gov/pubmed/15741166,15741166,,,20709168,"Miralem T, Hu Z, Torno MD, Lelli KM, Maines MD. Small Interference RNA-mediated Gene Silencing of Human Biliverdin Reductase, but Not That of Heme Oxygenase-1, Attenuates Arsenite-mediated Induction of the Oxygenase and Increases Apoptosis in 293A Kidney Cells. Journal of Biological Chemistry. 2005 Apr;280(17):17084–92. doi: 10.1074/jbc.m413121200."
1781423,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:23710286,https://www.ncbi.nlm.nih.gov/pubmed/23710286,23710286,,PMC3654359,5234928,"Zhao R, Yang B, Wang L, Xue P, Deng B, Zhang G, Jiang S, Zhang M, Liu M, Pi J, Guan D. Curcumin Protects Human Keratinocytes against Inorganic Arsenite-Induced Acute Cytotoxicity through an NRF2-Dependent Mechanism. Oxidative Medicine and Cellular Longevity. 2013;2013():1–11. doi: 10.1155/2013/412576."
1781424,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),HMOX1 mutant form promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:21910007,https://www.ncbi.nlm.nih.gov/pubmed/21910007,21910007,,PMC4372201,23502040,2011; 16(12):1268-1284
1781425,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 216763 inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|lithium inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:17849503,https://www.ncbi.nlm.nih.gov/pubmed/17849503,17849503,,,26827689,"Watcharasit P, Thiantanawat A, Satayavivad J. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption. J Appl Toxicol. 2008 May;28(4):466–74. doi: 10.1002/jat.1296. PMID: 17849503."
1781426,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite binds to and results in decreased activity of PARP1 protein,,,PMID:28552776,https://www.ncbi.nlm.nih.gov/pubmed/28552776,28552776,,PMC5568456,19595254,"Ding X, Zhou X, Cooper KL, Huestis J, Hudson LG, Liu KJ. Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicology and Applied Pharmacology. 2017 Sep;331():108–15. doi: 10.1016/j.taap.2017.05.031."
1781427,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sodium arsenite co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in increased cleavage of PARP1 protein,,,PMID:15028728,https://www.ncbi.nlm.nih.gov/pubmed/15028728,15028728,,PMC4389905,1644545,"Ivanov VN, Hei TK. Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor a-mediated Pathway. Journal of Biological Chemistry. 2004 May;279(21):22747–58. doi: 10.1074/jbc.m314131200."
1781428,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sodium arsenite co-treated with hydrogen peroxide] results in increased cleavage of PARP1 protein|[sodium arsenite co-treated with FASLG protein] results in increased cleavage of PARP1 protein,,,PMID:18977016,https://www.ncbi.nlm.nih.gov/pubmed/18977016,18977016,,,22109660,"Wen G, Partridge MA, Calaf GM, Meador JA, Hu B, Echiburú-Chau C, Hong M, Hei TK. Increased susceptibility of human small airway epithelial cells to apoptosis after long term arsenate treatment. Sci Total Environ. 2009 Jan 15;407(3):1174–81. doi: 10.1016/j.scitotenv.2008.09.045. PMID: 18977016."
1781570,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sodium arsenite co-treated with vitamin K 3] results in increased cleavage of PARP1 protein,,,PMID:19082730,https://www.ncbi.nlm.nih.gov/pubmed/19082730,19082730,,,7943657,2008; 14(1):108-123
1781571,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite inhibits the reaction [PARP1 protein binds to zinc]|sodium arsenite results in decreased activity of and results in increased nitrosation of PARP1 protein|uric acid inhibits the reaction [sodium arsenite inhibits the reaction [PARP1 protein binds to zinc]]|uric acid inhibits the reaction [sodium arsenite results in decreased activity of and results in increased nitrosation of PARP1 protein],,,PMID:31152818,https://www.ncbi.nlm.nih.gov/pubmed/31152818,31152818,,PMC6991161,33792783,"Zhou X, Ding X, Shen J, Yang D, Hudson LG, Liu KJ. Peroxynitrite contributes to arsenic-induced PARP-1 inhibition through ROS/RNS generation. Toxicology and Applied Pharmacology. 2019 Sep;378():114602. doi: 10.1016/j.taap.2019.114602."
1781572,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite inhibits the reaction [zinc binds to PARP1 protein],,,PMID:24275069|PMID:28552776|PMID:36087615,https://www.ncbi.nlm.nih.gov/pubmed/24275069|https://www.ncbi.nlm.nih.gov/pubmed/28552776|https://www.ncbi.nlm.nih.gov/pubmed/36087615,24275069|28552776|36087615,,PMC10144522|PMC3891920|PMC5568456,19595254|30330910|34633447,"Volk LB, Cooper KL, Jiang T, Paffett ML, Hudson LG. Impacts of arsenic on Rad18 and translesion synthesis. Toxicology and Applied Pharmacology. 2022 Nov;454():116230. doi: 10.1016/j.taap.2022.116230.|Ding X, Zhou X, Cooper KL, Huestis J, Hudson LG, Liu KJ. Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicology and Applied Pharmacology. 2017 Sep;331():108–15. doi: 10.1016/j.taap.2017.05.031.|Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 2014 Jan;274(2):313–8. doi: 10.1016/j.taap.2013.11.010."
1781573,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite results in decreased activity of PARP1 protein,,,PMID:19056730|PMID:20036271|PMID:24275069,https://www.ncbi.nlm.nih.gov/pubmed/19056730|https://www.ncbi.nlm.nih.gov/pubmed/20036271|https://www.ncbi.nlm.nih.gov/pubmed/24275069,19056730|20036271|24275069,,PMC2652344|PMC2830301|PMC3891920,7919891|30330910|32233244,"Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 2014 Jan;274(2):313–8. doi: 10.1016/j.taap.2013.11.010.|Komissarova EV, Rossman TG. Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. Toxicology and Applied Pharmacology. 2010 Mar 15;243(3):399–404. doi: 10.1016/j.taap.2009.12.014.|Ding W, Liu W, Cooper KL, Qin X, de Souza Bergo PL, Hudson LG, Liu KJ. Inhibition of Poly(ADP-ribose) Polymerase-1 by Arsenite Interferes with Repair of Oxidative DNA Damage. Journal of Biological Chemistry. 2009 Mar;284(11):6809–17. doi: 10.1074/jbc.m805566200."
1781574,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PARP1 mRNA,,,PMID:38568856,https://www.ncbi.nlm.nih.gov/pubmed/38568856,38568856,,PMC10990114,37067324,"Sala-Hamrick KE, Tapaswi A, Polemi KM, Nguyen VK, Colacino JA. High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals. Environ Health Perspect. 2024 Apr;132(4):47002. PMID: 38568856; PMCID: PMC10990114."
1781575,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite results in increased cleavage of PARP1 protein,,,PMID:15028728|PMID:15741166|PMID:16614167|PMID:17849503|PMID:18328521|PMID:18501396|PMID:19536524|PMID:21642427|PMID:21910007|PMID:22627131|PMID:23219847|PMID:23710286|PMID:24100277|PMID:25879800|PMID:26404762|PMID:29479036|PMID:33256086|PMID:34798143|PMID:34861471,https://www.ncbi.nlm.nih.gov/pubmed/15028728|https://www.ncbi.nlm.nih.gov/pubmed/15741166|https://www.ncbi.nlm.nih.gov/pubmed/16614167|https://www.ncbi.nlm.nih.gov/pubmed/17849503|https://www.ncbi.nlm.nih.gov/pubmed/18328521|https://www.ncbi.nlm.nih.gov/pubmed/18501396|https://www.ncbi.nlm.nih.gov/pubmed/19536524|https://www.ncbi.nlm.nih.gov/pubmed/21642427|https://www.ncbi.nlm.nih.gov/pubmed/21910007|https://www.ncbi.nlm.nih.gov/pubmed/22627131|https://www.ncbi.nlm.nih.gov/pubmed/23219847|https://www.ncbi.nlm.nih.gov/pubmed/23710286|https://www.ncbi.nlm.nih.gov/pubmed/24100277|https://www.ncbi.nlm.nih.gov/pubmed/25879800|https://www.ncbi.nlm.nih.gov/pubmed/26404762|https://www.ncbi.nlm.nih.gov/pubmed/29479036|https://www.ncbi.nlm.nih.gov/pubmed/33256086|https://www.ncbi.nlm.nih.gov/pubmed/34798143|https://www.ncbi.nlm.nih.gov/pubmed/34861471,15028728|15741166|16614167|17849503|18328521|18501396|19536524|21642427|21910007|22627131|23219847|23710286|24100277|25879800|26404762|29479036|33256086|34798143|34861471,,PMC2474465|PMC2806883|PMC3143646|PMC3593966|PMC3654359|PMC4371809|PMC4372201|PMC4389905|PMC4808507|PMC7729740,1069011|1644545|2490832|3362827|4426469|4515470|5234928|8664447|11336699|11397175|12258402|12958292|14142239|17364335|20709168|23502040|26827689|30851788|33096846,"Lee H, Oh S. Arsenite-induced cytotoxicity is regulated by p38-SQSTM1/p62 and JNK-BNIP3L/Nix signaling in lung cancer cells. Biochemical and Biophysical Research Communications. 2022 Jan;587():16–23. doi: 10.1016/j.bbrc.2021.11.068.|Zhou Q, Yin J, Tan J, Li S, Jiang C, He Y. Up-regulation of PUMA caused the activation of p53 phosphorylation and acetylation, enhancing the interaction between PUMA and Bcl-X and mediating arsenic-induced apoptosis. Toxicol Appl Pharmacol. 2022 Jan 01;434():115800. doi: 10.1016/j.taap.2021.115800. PMID: 34798143.|Lee EJ, Sung JY, Koo KH, Park JB, Kim DH, Shim J, Lee CH, Park J, Kim YN. Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities. Int J Mol Sci. 2020 Nov 26;21(23). PMID: 33256086; PMCID: PMC7729740.|Singhirunnusorn P, Moolmuang B, Lirdprapamongkol K, Ruchirawat M. Arsenite exposure potentiates apoptosis-inducing effects of tumor necrosis factor-alpha- through reactive oxygen species. J Toxicol Sci. 2018;43(2):159–69. doi: 10.2131/jts.43.159. PMID: 29479036.|2015; 90(9):2187-2200|2015; 16(1):212|Kim Y, Jeong IG, You D, Song SH, Suh N, Jang SW, Kim S, Hwang JJ, Kim CS. Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells. Anticancer Drugs. 2014 Jan;25(1):53–62. doi: 10.1097/cad.0000000000000013. PMID: 24100277.|Ivanov VN, Hei TK. Induction of apoptotic death and retardation of neuronal differentiation of human neural stem cells by sodium arsenite treatment. Experimental Cell Research. 2013 Apr;319(6):875–87. doi: 10.1016/j.yexcr.2012.11.019.|Zhao R, Yang B, Wang L, Xue P, Deng B, Zhang G, Jiang S, Zhang M, Liu M, Pi J, Guan D. Curcumin Protects Human Keratinocytes against Inorganic Arsenite-Induced Acute Cytotoxicity through an NRF2-Dependent Mechanism. Oxidative Medicine and Cellular Longevity. 2013;2013():1–11. doi: 10.1155/2013/412576.|Chen H, Hao Y, Wang L, Jia D, Ruan Y, Gu J. Sodium arsenite down-regulates the expression of X-linked inhibitor of apoptosis protein via translational and post-translational mechanisms in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 2012 Jun;422(4):721–6. doi: 10.1016/j.bbrc.2012.05.066.|2011; 16(12):1268-1284|Shin SY, Kim CG, Lim Y, Lee YH. The ETS Family Transcription Factor ELK-1 Regulates Induction of the Cell Cycle-regulatory Gene p21 and the BAX Gene in Sodium Arsenite-exposed Human Keratinocyte HaCaT Cells. Journal of Biological Chemistry. 2011 Jul;286(30):26860–72. doi: 10.1074/jbc.m110.216721.|2009; 83(10):899-908|McNeely SC, Taylor BF, States JC. Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent. Toxicology and Applied Pharmacology. 2008 Aug;231(1):61–7. doi: 10.1016/j.taap.2008.03.020.|McNeely SC, Belshoff AC, Taylor BF, Fan TW, McCabe Jr. MJ, Pinhas AR, States JC. Sensitivity to sodium arsenite in human melanoma cells depends upon susceptibility to arsenite-induced mitotic arrest. Toxicology and Applied Pharmacology. 2008 Jun 01;229(2):252–61. doi: 10.1016/j.taap.2008.01.020.|Watcharasit P, Thiantanawat A, Satayavivad J. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption. J Appl Toxicol. 2008 May;28(4):466–74. doi: 10.1002/jat.1296. PMID: 17849503.|Taylor BF, McNeely SC, Miller HL, Lehmann GM, McCabe MJ, States JC. p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1. The Journal of Pharmacology and Experimental Therapeutics. 2006 Jul;318(1):142–51. doi: 10.1124/jpet.106.103077.|Miralem T, Hu Z, Torno MD, Lelli KM, Maines MD. Small Interference RNA-mediated Gene Silencing of Human Biliverdin Reductase, but Not That of Heme Oxygenase-1, Attenuates Arsenite-mediated Induction of the Oxygenase and Increases Apoptosis in 293A Kidney Cells. Journal of Biological Chemistry. 2005 Apr;280(17):17084–92. doi: 10.1074/jbc.m413121200.|Ivanov VN, Hei TK. Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor a-mediated Pathway. Journal of Biological Chemistry. 2004 May;279(21):22747–58. doi: 10.1074/jbc.m314131200."
1781576,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite results in increased degradation of PARP1 protein|wortmannin promotes the reaction [sodium arsenite results in increased degradation of PARP1 protein],,,PMID:12614848,https://www.ncbi.nlm.nih.gov/pubmed/12614848,12614848,,,20644789,"Hossain K, Akhand AA, Kawamoto Y, Du J, Takeda K, Wu J, Yoshihara M, Tsuboi H, Kato M, Suzuki H, Nakashima I. Caspase activation is accelerated by the inhibition of arsenite-induced, membrane rafts-dependent Akt activation. Free Radic Biol Med. 2003 Mar 01;34(5):598–606. doi: 10.1016/s0891-5849(02)01359-x. PMID: 12614848."
1781577,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PARP1 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,PMC5957280,5313841,"Al-Eryani L, Waigel S, Jala V, Jenkins SF, States JC. Cell cycle pathway dysregulation in human keratinocytes during chronic exposure to low arsenite. Toxicology and Applied Pharmacology. 2017 Sep;331():130–4. doi: 10.1016/j.taap.2017.06.002."
1781740,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PARP1 protein,,,PMID:20036271,https://www.ncbi.nlm.nih.gov/pubmed/20036271,20036271,,PMC2830301,32233244,"Komissarova EV, Rossman TG. Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. Toxicology and Applied Pharmacology. 2010 Mar 15;243(3):399–404. doi: 10.1016/j.taap.2009.12.014."
1781741,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tetramethylpyrazine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:26404762,https://www.ncbi.nlm.nih.gov/pubmed/26404762,26404762,,PMC4808507,14142239,2015; 90(9):2187-2200
1781742,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TP53 protein inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:16614167,https://www.ncbi.nlm.nih.gov/pubmed/16614167,16614167,,,30851788,"Taylor BF, McNeely SC, Miller HL, Lehmann GM, McCabe MJ, States JC. p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1. The Journal of Pharmacology and Experimental Therapeutics. 2006 Jul;318(1):142–51. doi: 10.1124/jpet.106.103077."
1781743,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),XIAP protein inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:22627131,https://www.ncbi.nlm.nih.gov/pubmed/22627131,22627131,,,11336699,"Chen H, Hao Y, Wang L, Jia D, Ruan Y, Gu J. Sodium arsenite down-regulates the expression of X-linked inhibitor of apoptosis protein via translational and post-translational mechanisms in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 2012 Jun;422(4):721–6. doi: 10.1016/j.bbrc.2012.05.066."
1781744,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc chloride inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein],,,PMID:19056730,https://www.ncbi.nlm.nih.gov/pubmed/19056730,19056730,,PMC2652344,7919891,"Ding W, Liu W, Cooper KL, Qin X, de Souza Bergo PL, Hudson LG, Liu KJ. Inhibition of Poly(ADP-ribose) Polymerase-1 by Arsenite Interferes with Repair of Oxidative DNA Damage. Journal of Biological Chemistry. 2009 Mar;284(11):6809–17. doi: 10.1074/jbc.m805566200."
1781745,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein],,,PMID:24275069|PMID:28552776,https://www.ncbi.nlm.nih.gov/pubmed/24275069|https://www.ncbi.nlm.nih.gov/pubmed/28552776,24275069|28552776,,PMC3891920|PMC5568456,19595254|30330910,"Ding X, Zhou X, Cooper KL, Huestis J, Hudson LG, Liu KJ. Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicology and Applied Pharmacology. 2017 Sep;331():108–15. doi: 10.1016/j.taap.2017.05.031.|Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 2014 Jan;274(2):313–8. doi: 10.1016/j.taap.2013.11.010."
1781746,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dithiothreitol inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|staurosporine affects the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|curcumin inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|betadex inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:11035063,https://www.ncbi.nlm.nih.gov/pubmed/11035063,11035063,,,209792,"Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000 Oct 15;165(8):4290–7. doi: 10.4049/jimmunol.165.8.4290. PMID: 11035063."
1781747,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),CDKN1B protein affects the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:20566634,https://www.ncbi.nlm.nih.gov/pubmed/20566634,20566634,,PMC2924005,20798389,"Liu J, Zhang D, Mi X, Xia Q, Yu Y, Zuo Z, Guo W, Zhao X, Cao J, Yang Q, Zhu A, Yang W, Shi X, Li J, Huang C. p27 Suppresses Arsenite-induced Hsp27/Hsp70 Expression through Inhibiting JNK2/c-Jun- and HSF-1-dependent Pathways. Journal of Biological Chemistry. 2010 Aug;285(34):26058–65. doi: 10.1074/jbc.m110.100271."
1781748,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),GADD45A protein promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|mapk9 protein promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|mapk8 protein promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:16973625,https://www.ncbi.nlm.nih.gov/pubmed/16973625,16973625,,,12626031,"Zhang D, Song L, Li J, Wu K, Huang C. Coordination of JNK1 and JNK2 is critical for GADD45alpha induction and its mediated cell apoptosis in arsenite responses. J Biol Chem. 2006 Nov 10;281(45):34113–23. doi: 10.1074/jbc.m602821200. PMID: 16973625."
1781877,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),NCL protein promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:25561743,https://www.ncbi.nlm.nih.gov/pubmed/25561743,25561743,,PMC4335216,8039206,"Zhang D, Liang Y, Xie Q, Gao G, Wei J, Huang H, Li J, Gao J, Huang C. A Novel Post-translational Modification of Nucleolin, SUMOylation at Lys-294, Mediates Arsenite-induced Cell Death by Regulating gadd45a mRNA Stability. Journal of Biological Chemistry. 2015 Feb;290(8):4784–800. doi: 10.1074/jbc.m114.598219."
1781878,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),NFE2L1 protein alternative form inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:28549828,https://www.ncbi.nlm.nih.gov/pubmed/28549828,28549828,,,19592403,"Cui Q, Fu J, Hu Y, Li Y, Yang B, Li L, Sun J, Chen C, Sun G, Xu Y, Zhang Q, Pi J. Deficiency of long isoforms of Nfe2l1 sensitizes MIN6 pancreatic ß cells to arsenite-induced cytotoxicity. Toxicol Appl Pharmacol. 2017 Aug 15;329():67–74. doi: 10.1016/j.taap.2017.05.013. PMID: 28549828."
1781879,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 gene mutant form results in increased susceptibility to sodium arsenite,,,PMID:16322246,https://www.ncbi.nlm.nih.gov/pubmed/16322246,16322246,,,999047,"Poonepalli A, Balakrishnan L, Khaw AK, Low GK, Jayapal M, Bhattacharjee RN, Akira S, Balajee AS, Hande MP. Lack of poly(ADP-ribose) polymerase-1 gene product enhances cellular sensitivity to arsenite. Cancer Res. 2005 Dec 01;65(23):10977–83. doi: 10.1158/0008-5472.can-05-2336. PMID: 16322246."
1781880,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PARP1 protein modified form|sodium arsenite promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein],,,PMID:23143138,https://www.ncbi.nlm.nih.gov/pubmed/23143138,23143138,,PMC3552097,1805296,2012; 18(2):188-200
1781881,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Zinc inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein]|sodium arsenite results in decreased activity of PARP1 protein,,,PMID:26443841,https://www.ncbi.nlm.nih.gov/pubmed/26443841,26443841,,PMC4715257,4591904,"Xu H, Zhou X, Wen X, Lauer FT, Liu KJ, Hudson LG, Aleksunes LM, Burchiel SW. Environmentally Relevant Concentrations of Arsenite Induce Dose-Dependent Differential Genotoxicity Through Poly(ADP-Ribose) Polymerase Inhibition and Oxidative Stress in Mouse Thymus Cells. Toxicol Sci. 2016 Jan;149(1):31–41. PMID: 26443841; PMCID: PMC4715257."
1781882,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sodium arsenite results in increased cleavage of PARP1 protein,,,PMID:11035063|PMID:16973625|PMID:20566634|PMID:25561743|PMID:28549828,https://www.ncbi.nlm.nih.gov/pubmed/11035063|https://www.ncbi.nlm.nih.gov/pubmed/16973625|https://www.ncbi.nlm.nih.gov/pubmed/20566634|https://www.ncbi.nlm.nih.gov/pubmed/25561743|https://www.ncbi.nlm.nih.gov/pubmed/28549828,11035063|16973625|20566634|25561743|28549828,,PMC2924005|PMC4335216,209792|8039206|12626031|19592403|20798389,"Cui Q, Fu J, Hu Y, Li Y, Yang B, Li L, Sun J, Chen C, Sun G, Xu Y, Zhang Q, Pi J. Deficiency of long isoforms of Nfe2l1 sensitizes MIN6 pancreatic ß cells to arsenite-induced cytotoxicity. Toxicol Appl Pharmacol. 2017 Aug 15;329():67–74. doi: 10.1016/j.taap.2017.05.013. PMID: 28549828.|Zhang D, Liang Y, Xie Q, Gao G, Wei J, Huang H, Li J, Gao J, Huang C. A Novel Post-translational Modification of Nucleolin, SUMOylation at Lys-294, Mediates Arsenite-induced Cell Death by Regulating gadd45a mRNA Stability. Journal of Biological Chemistry. 2015 Feb;290(8):4784–800. doi: 10.1074/jbc.m114.598219.|Liu J, Zhang D, Mi X, Xia Q, Yu Y, Zuo Z, Guo W, Zhao X, Cao J, Yang Q, Zhu A, Yang W, Shi X, Li J, Huang C. p27 Suppresses Arsenite-induced Hsp27/Hsp70 Expression through Inhibiting JNK2/c-Jun- and HSF-1-dependent Pathways. Journal of Biological Chemistry. 2010 Aug;285(34):26058–65. doi: 10.1074/jbc.m110.100271.|Zhang D, Song L, Li J, Wu K, Huang C. Coordination of JNK1 and JNK2 is critical for GADD45alpha induction and its mediated cell apoptosis in arsenite responses. J Biol Chem. 2006 Nov 10;281(45):34113–23. doi: 10.1074/jbc.m602821200. PMID: 16973625.|Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000 Oct 15;165(8):4290–7. doi: 10.4049/jimmunol.165.8.4290. PMID: 11035063."
1781883,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PARP1 mRNA,,,PMID:20643705,https://www.ncbi.nlm.nih.gov/pubmed/20643705,20643705,,,393547,"Osmond MJ, Kunz BA, Snow ET. Age and exposure to arsenic alter base excision repair transcript levels in mice. Mutagenesis. 2010 Sep;25(5):517–22. doi: 10.1093/mutage/geq037. PMID: 20643705."
1782037,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 mrna|[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein|pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with cadmium chloride co-treated with lead acetate] results in increased expression of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 mrna]|pparg protein affects the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with cadmium chloride] results in increased expression of PARP1 mrna]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 protein]|3-aminobenzamide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|[sodium arsenite co-treated with cadmium chloride] results in increased expression of PARP1 mrna|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with cadmium chloride] results in increased expression of PARP1 protein]|sodium arsenite results in increased expression of and results in increased cleavage of PARP1 protein|pparg protein affects the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|3-aminobenzamide inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|cr8 compound analog inhibits the reaction [[sodium arsenite co-treated with cadmium chloride co-treated with lead acetate] results in increased expression of PARP1 protein]|sodium arsenite results in increased expression of PARP1 mrna|[lead acetate co-treated with sodium arsenite] results in increased expression of and results in increased cleavage of PARP1 protein|[sodium arsenite co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein|cadmium chloride inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|[sodium arsenite co-treated with lead acetate] results in increased expression of PARP1 mRNA,,,PMID:28283887,https://www.ncbi.nlm.nih.gov/pubmed/28283887,28283887,,,17522612,2017; 55(3):2125-2149
1782038,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Polysaccharides inhibits the reaction [sodium arsenite results in increased expression of PARP1 protein]|sodium arsenite results in increased expression of PARP1 protein|succimer inhibits the reaction [sodium arsenite results in increased expression of PARP1 protein],,,PMID:31163222,https://www.ncbi.nlm.nih.gov/pubmed/31163222,31163222,,,33802699,"Perveen H, Dey A, Nilavar NM, Chandra GK, Islam SS, Chattopadhyay S. Dietary CCPS from bitter gourd attenuates sodium arsenite induced female reproductive ailments cum infertility in wistar rats: anti-inflammatory and anti-apoptotic role. Food Chem Toxicol. 2019 Sep;131():110545. doi: 10.1016/j.fct.2019.05.053. PMID: 31163222."
1782039,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Taurine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|ps1145 inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:19616567,https://www.ncbi.nlm.nih.gov/pubmed/19616567,19616567,,,10619164,"Ghosh J, Das J, Manna P, Sil PC. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. Toxicol Appl Pharmacol. 2009 Oct 01;240(1):73–87. doi: 10.1016/j.taap.2009.07.008. PMID: 19616567."
1782040,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[[sodium arsenite results in increased abundance of arsenic] which co-treated with zinc deficiency] results in increased cleavage of PARP1 protein,,,PMID:31542844,https://www.ncbi.nlm.nih.gov/pubmed/31542844,31542844,,PMC6891200,23675274,2019; 32(6):845-859
1782158,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased cleavage of PARP1 protein,,,PMID:19616567|PMID:28283887,https://www.ncbi.nlm.nih.gov/pubmed/19616567|https://www.ncbi.nlm.nih.gov/pubmed/28283887,19616567|28283887,,,10619164|17522612,"2017; 55(3):2125-2149|Ghosh J, Das J, Manna P, Sil PC. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. Toxicol Appl Pharmacol. 2009 Oct 01;240(1):73–87. doi: 10.1016/j.taap.2009.07.008. PMID: 19616567."
1782159,443495,Comparative Toxicogenomics Database (CTD),Sodium Arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Taurine inhibits the reaction [sodium arsenite results in increased degradation of PARP1 protein]|sodium arsenite results in increased degradation of PARP1 protein,,,PMID:20830294,https://www.ncbi.nlm.nih.gov/pubmed/20830294,20830294,,PMC2935368,25548009,"Das J, Ghosh J, Manna P, Sil PC. Protective Role of Taurine against Arsenic-Induced Mitochondria-Dependent Hepatic Apoptosis via the Inhibition of PKCd-JNK Pathway. PLoS ONE. 2010 Sep 07;5(9):e12602. doi: 10.1371/journal.pone.0012602."
1843995,443495,Toxin and Toxin Target Database (T3DB),Sodium Arsenite,T3D0243,Sodium arsenite,http://www.t3db.ca/toxins/T3D0243,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
510069,443592,Comparative Toxicogenomics Database (CTD),Surfactin,C009365,surfactin peptide,https://ctdbase.org/detail.go?type=chem&acc=C009365,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Surfactin peptide results in increased cleavage of PARP1 protein,,,PMID:34850538,https://www.ncbi.nlm.nih.gov/pubmed/34850538,34850538,,,29828168,"Wang G, Chen J, Chen W, Wei I, Lin S, Liao K, Yang T, Liu J. Surfactin induces <scp>ER</scp> stress-mediated apoptosis via <scp>IRE1-ASK1-JNK</scp> signaling in human osteosarcoma. Environmental Toxicology. 2021 Dec;37(3):574–84. doi: 10.1002/tox.23423."
1460424,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein]|doxorubicin promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein]",,,PMID:20826841,https://www.ncbi.nlm.nih.gov/pubmed/20826841,20826841,,,2440709,"Wallin JJ, Guan J, Prior WW, Edgar KA, Kassees R, Sampath D, Belvin M, Friedman LS. Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer. Sci Transl Med. 2010 Sep 08;2(48):48ra66. doi: 10.1126/scitranslmed.3000630. PMID: 20826841."
1460425,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4-amino-1,8-naphthalimide inhibits the reaction [doxorubicin results in increased activity of PARP1 protein]|doxorubicin results in increased activity of PARP1 protein",,,PMID:15456408,https://www.ncbi.nlm.nih.gov/pubmed/15456408,15456408,,PMC1134773,7184973,"Muñoz-Gámez JA, Martín-Oliva D, Aguilar-Quesada R, Cañuelo A, Nuñez MI, Valenzuela MT, Ruiz de Almodóvar JM, De Murcia G, Oliver FJ. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochem J. 2005 Feb 15;386(Pt 1):119–25. PMID: 15456408; PMCID: PMC1134773."
1460426,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),7-monohydroxyethylrutoside inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:17285121,https://www.ncbi.nlm.nih.gov/pubmed/17285121,17285121,,PMC2360019,8899283,"Bruynzeel AME, Abou El Hassan MA, Torun E, Bast A, van der Vijgh WJF, Kruyt FAE. Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells. British Journal of Cancer. 2007 Feb 06;96(3):450–6. doi: 10.1038/sj.bjc.6603598."
1460427,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ABCB1 protein results in decreased susceptibility to doxorubicin] inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:20438634,https://www.ncbi.nlm.nih.gov/pubmed/20438634,20438634,,PMC2873443,5184553,2010; 9(1):99
1460428,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to doxorubicin]] which affects the cleavage of PARP1 protein]|[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to doxorubicin]] which affects the cleavage of PARP1 protein,,,PMID:25824409,https://www.ncbi.nlm.nih.gov/pubmed/25824409,25824409,,,14794274,"Wang S, Wang L, Chen M, Wang Y. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression. Chem Biol Interact. 2015 Jun 25;235():76–84. doi: 10.1016/j.cbi.2015.03.017. PMID: 25824409."
1460584,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein|akt1 protein modified form inhibits the reaction [[doxorubicin co-treated with selenium] results in increased degradation of PARP1 protein]|[doxorubicin co-treated with selenium] results in increased degradation of PARP1 protein|bcl2l11 protein promotes the reaction [[doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]|bcl2l11 protein promotes the reaction [[doxorubicin co-treated with selenium] results in increased degradation of PARP1 protein]|akt1 protein modified form inhibits the reaction [[doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]|sb 216763 inhibits the reaction [[doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein],,,PMID:17339365,https://www.ncbi.nlm.nih.gov/pubmed/17339365,17339365,,,20720181,"Li S, Zhou Y, Wang R, Zhang H, Dong Y, Ip C. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther. 2007 Mar;6(3):1031–8. doi: 10.1158/1535-7163.mct-06-0643. PMID: 17339365."
1460585,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[pentoxifylline co-treated with doxorubicin] results in increased cleavage of PARP1 protein|[bortezomib co-treated with doxorubicin] results in increased cleavage of PARP1 protein,,,PMID:33775688,https://www.ncbi.nlm.nih.gov/pubmed/33775688,33775688,,,11557155,"Abdin SM, Tolba MF, Zaher DM, Omar HA. Nuclear factor-?B signaling inhibitors revert multidrug-resistance in breast cancer cells. Chem Biol Interact. 2021 May 01;340():109450. doi: 10.1016/j.cbi.2021.109450. PMID: 33775688."
1460586,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CD40LG protein inhibits the reaction [doxorubicin promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]|doxorubicin promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein],,,PMID:16545138,https://www.ncbi.nlm.nih.gov/pubmed/16545138,16545138,,PMC1435764,13283158,2006; 6(1):75
1460587,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]]|cobaltous chloride inhibits the reaction [doxorubicin promotes the reaction [[PARP1 protein binds to TNFRSF10B promoter] which results in increased expression of TNFRSF10B mrna]]|cobaltous chloride inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]|doxorubicin promotes the reaction [PARP1 protein binds to TNFRSF10B promoter],,,PMID:19714248,https://www.ncbi.nlm.nih.gov/pubmed/19714248,19714248,,PMC2729407,32898850,"Nardinocchi L, Puca R, Sacchi A, Rechavi G, Givol D, D'Orazi G. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha. PLoS One. 2009 Aug 28;4(8):e6819. PMID: 19714248; PMCID: PMC2729407."
1460588,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[doxorubicin co-treated with dimethyl sulfone] results in increased expression of PARP1 mrna|doxorubicin affects the reaction [dimethyl sulfone results in increased cleavage of PARP1 protein]|dimethyl sulfone promotes the reaction [doxorubicin results in increased expression of PARP1 mrna]|dimethyl sulfone affects the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:32562081,https://www.ncbi.nlm.nih.gov/pubmed/32562081,32562081,,PMC8012311,20367195,2020; 37(2):261-275
1460589,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[dinaciclib results in increased susceptibility to doxorubicin] which results in increased cleavage of PARP1 protein|dinaciclib promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:27378523,https://www.ncbi.nlm.nih.gov/pubmed/27378523,27378523,,PMC4932496,22911142,"Chen Z, Wang Z, Pang JC, Yu Y, Bieerkehazhi S, Lu J, Hu T, Zhao Y, Xu X, Zhang H, Yi JS, Liu S, Yang J. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Scientific Reports. 2016 Jul 05;6(1):29090. doi: 10.1038/srep29090."
1460590,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Doxorubicin affects the cleavage of PARP1 protein,,,PMID:15870702,https://www.ncbi.nlm.nih.gov/pubmed/15870702,15870702,,,7886057,"Eom YW, Kim MA, Park SS, Goo MJ, Kwon HJ, Sohn S, Kim WH, Yoon G, Choi KS. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene. 2005 Jul 14;24(30):4765–77. doi: 10.1038/sj.onc.1208627. PMID: 15870702."
1460591,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Doxorubicin affects the expression of PARP1 mRNA,,,PMID:27780733,https://www.ncbi.nlm.nih.gov/pubmed/27780733,27780733,,,31719000,"Denel-Bobrowska M, Lukawska M, Rogalska A, Forma E, Brys M, Oszczapowicz I, Marczak A. Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors. Toxicol Appl Pharmacol. 2016 Dec 15;313():159–69. doi: 10.1016/j.taap.2016.10.018. PMID: 27780733."
1460751,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Doxorubicin analog results in increased cleavage of PARP1 protein,,,PMID:15981920,https://www.ncbi.nlm.nih.gov/pubmed/15981920,15981920,,,2331674,"Malugin A, Kopecková P, Kopecek J. HPMA copolymer-bound doxorubicin induces apoptosis in human ovarian carcinoma cells by a Fas-independent pathway. Mol Pharm. 2004 May;1(3):174–82. doi: 10.1021/mp049967q. PMID: 15981920."
1460752,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[doxorubicin binds to TF protein] which results in increased activity of PARP1 protein,,,PMID:24998637,https://www.ncbi.nlm.nih.gov/pubmed/24998637,24998637,,,17475897,"Szwed M, Laroche-Clary A, Robert J, Jozwiak Z. Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines. Chem Biol Interact. 2014 Sep 05;220():140–8. doi: 10.1016/j.cbi.2014.06.013. PMID: 24998637."
1460753,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[doxorubicin co-treated with piperlongumine] results in increased cleavage of PARP1 protein,,,PMID:30611789,https://www.ncbi.nlm.nih.gov/pubmed/30611789,30611789,,,18927378,"Piska K, Koczurkiewicz P, Wnuk D, Karnas E, Bucki A, Wójcik-Pszczola K, Jamrozik M, Michalik M, Kolaczkowski M, Pekala E. Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells - The involvement of carbonyl reductase 1 inhibition. Chem Biol Interact. 2019 Feb 25;300():40–8. doi: 10.1016/j.cbi.2019.01.003. PMID: 30611789."
1460754,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Doxorubicin inhibits the reaction [hydroquinone results in decreased expression of PARP1 protein],,,PMID:26047893,https://www.ncbi.nlm.nih.gov/pubmed/26047893,26047893,,,18181592,"Liu L, Ling X, Tang H, Chen J, Wen Q, Zou F. Poly(ADP-ribosyl)ation enhances H-RAS protein stability and causes abnormal cell cycle progression in human TK6 lymphoblastoid cells treated with hydroquinone. Chem Biol Interact. 2015 Aug 05;238():1–8. doi: 10.1016/j.cbi.2015.05.019. PMID: 26047893."
1460755,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Doxorubicin results in decreased expression of PARP1 mRNA,,,PMID:36634904,https://www.ncbi.nlm.nih.gov/pubmed/36634904,36634904,,,34818715,"de Almeida LC, Calil FA, Moreno NC, Rezende-Teixeira P, de Moraes LAB, Jimenez PC, Menck CFM, Machado-Neto JA, Costa-Lotufo LV. Exploring pradimicin-IRD antineoplastic mechanisms and related DNA repair pathways. Chem Biol Interact. 2023 Feb 01;371():110342. doi: 10.1016/j.cbi.2023.110342. PMID: 36634904."
1460756,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Doxorubicin results in increased cleavage of PARP1 protein,,,PMID:10766178|PMID:15555623|PMID:15557793|PMID:15585644|PMID:16311509|PMID:16843435|PMID:16890185|PMID:16962673|PMID:17283156|PMID:17285121|PMID:17651020|PMID:17935137|PMID:17959036|PMID:18071906|PMID:18281512|PMID:18840609|PMID:19714248|PMID:20826841|PMID:22751436|PMID:23826121|PMID:24287111|PMID:25124555|PMID:25333773|PMID:26208482|PMID:27106762|PMID:27163855|PMID:27378523|PMID:30769864|PMID:32562081|PMID:33775688|PMID:34126102|PMID:39442788,https://www.ncbi.nlm.nih.gov/pubmed/10766178|https://www.ncbi.nlm.nih.gov/pubmed/15555623|https://www.ncbi.nlm.nih.gov/pubmed/15557793|https://www.ncbi.nlm.nih.gov/pubmed/15585644|https://www.ncbi.nlm.nih.gov/pubmed/16311509|https://www.ncbi.nlm.nih.gov/pubmed/16843435|https://www.ncbi.nlm.nih.gov/pubmed/16890185|https://www.ncbi.nlm.nih.gov/pubmed/16962673|https://www.ncbi.nlm.nih.gov/pubmed/17283156|https://www.ncbi.nlm.nih.gov/pubmed/17285121|https://www.ncbi.nlm.nih.gov/pubmed/17651020|https://www.ncbi.nlm.nih.gov/pubmed/17935137|https://www.ncbi.nlm.nih.gov/pubmed/17959036|https://www.ncbi.nlm.nih.gov/pubmed/18071906|https://www.ncbi.nlm.nih.gov/pubmed/18281512|https://www.ncbi.nlm.nih.gov/pubmed/18840609|https://www.ncbi.nlm.nih.gov/pubmed/19714248|https://www.ncbi.nlm.nih.gov/pubmed/20826841|https://www.ncbi.nlm.nih.gov/pubmed/22751436|https://www.ncbi.nlm.nih.gov/pubmed/23826121|https://www.ncbi.nlm.nih.gov/pubmed/24287111|https://www.ncbi.nlm.nih.gov/pubmed/25124555|https://www.ncbi.nlm.nih.gov/pubmed/25333773|https://www.ncbi.nlm.nih.gov/pubmed/26208482|https://www.ncbi.nlm.nih.gov/pubmed/27106762|https://www.ncbi.nlm.nih.gov/pubmed/27163855|https://www.ncbi.nlm.nih.gov/pubmed/27378523|https://www.ncbi.nlm.nih.gov/pubmed/30769864|https://www.ncbi.nlm.nih.gov/pubmed/32562081|https://www.ncbi.nlm.nih.gov/pubmed/33775688|https://www.ncbi.nlm.nih.gov/pubmed/34126102|https://www.ncbi.nlm.nih.gov/pubmed/39442788,10766178|15555623|15557793|15585644|16311509|16843435|16890185|16962673|17283156|17285121|17651020|17935137|17959036|18071906|18281512|18840609|19714248|20826841|22751436|23826121|24287111|25124555|25333773|26208482|27106762|27163855|27378523|30769864|32562081|33775688|34126102|39442788,,PMC2360019|PMC2662249|PMC2729407|PMC3409014|PMC3691183|PMC4227146|PMC4694865|PMC4932496|PMC6406907|PMC8012311,989073|1040001|2440709|2697723|3083712|3735930|5070931|5277266|8079050|8899283|11375532|11557155|12616014|16857347|17318136|18039589|19253794|20153767|20367195|20836639|22911142|24078123|24080217|25510696|26162040|27079677|29127627|32191306|32898850|33024721|33572886|37896714,"Xiao H, Liang S, Cai Q, Liu J, Jin L, Chen X. Bag2 protects against doxorubicin-induced cardiotoxicity by maintaining Pink1-mediated mitophagy. Toxicology. 2024 Dec;509():153980. doi: 10.1016/j.tox.2024.153980.|Zhang Y, Yapryntseva MA, Vdovin A, Maximchik P, Zhivotovsky B, Gogvadze V. Modeling hypoxia facilitates cancer cell survival through downregulation of p53 expression. Chem Biol Interact. 2021 Aug 25;345():109553. doi: 10.1016/j.cbi.2021.109553. PMID: 34126102.|Abdin SM, Tolba MF, Zaher DM, Omar HA. Nuclear factor-?B signaling inhibitors revert multidrug-resistance in breast cancer cells. Chem Biol Interact. 2021 May 01;340():109450. doi: 10.1016/j.cbi.2021.109450. PMID: 33775688.|2020; 37(2):261-275|Sekhar SC, Venkatesh J, Cheriyan VT, Muthu M, Levi E, Assad H, Meister P, Undyala VV, Gauld JW, Rishi AK. A H2AX?CARP-1 Interaction Regulates Apoptosis Signaling Following DNA Damage. Cancers (Basel). 2019 Feb 14;11(2). PMID: 30769864; PMCID: PMC6406907.|Chen Z, Wang Z, Pang JC, Yu Y, Bieerkehazhi S, Lu J, Hu T, Zhao Y, Xu X, Zhang H, Yi JS, Liu S, Yang J. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Scientific Reports. 2016 Jul 05;6(1):29090. doi: 10.1038/srep29090.|Reddy ND, Shoja MH, Biswas S, Nayak PG, Kumar N, Rao CM. An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells. Chem Biol Interact. 2016 Jun 25;253():112–24. doi: 10.1016/j.cbi.2016.05.008. PMID: 27163855.|Weeks A, Agnihotri S, Lymer J, Chalil A, Diaz R, Isik S, Smith C, Rutka JT. Epithelial Cell Transforming 2 and Aurora Kinase B Modulate Formation of Stress Granule–Containing Transcripts from Diverse Cellular Pathways in Astrocytoma Cells. The American Journal of Pathology. 2016 Jun;186(6):1674–87. doi: 10.1016/j.ajpath.2016.02.013.|Kuo CY, Chou WC, Wu CC, Wong TS, Kakadiya R, Lee TC, Su TL, Wang HC. Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms. Oncotarget. 2015 Sep 22;6(28):25770–83. PMID: 26208482; PMCID: PMC4694865.|Cohen Z, Maimon Y, Yoeli-Lerner M, Yang P, Samuels N, Berger R. Selective anticancer effects and protection from chemotherapy by the botanical compound LCS101: Implications for cancer treatment. Int J Oncol. 2015 Jan;46(1):308–16. doi: 10.3892/ijo.2014.2711. PMID: 25333773.|Lezina L, Aksenova V, Ivanova T, Purmessur N, Antonov AV, Tentler D, Fedorova O, Garabadgiu AV, Talianidis I, Melino G, Barlev NA. KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress. Cell Death Differ. 2014 Aug 15;21(12):1889–99. doi: 10.1038/cdd.2014.108.|Gajek A, Denel M, Bukowska B, Rogalska A, Marczak A. Pro-apoptotic activity of new analog of anthracyclines--WP 631 in advanced ovarian cancer cell line. Toxicol In Vitro. 2014 Mar;28(2):273–81. doi: 10.1016/j.tiv.2013.11.006. PMID: 24287111.|Ashour AE, Jamal S, Cheryan VT, Muthu M, Zoheir KMA, Alafeefy AM, Abd-Allah AR, Levi E, Tarca AL, Polin LA, Rishi AK. CARP-1 Functional Mimetics: A Novel Class of Small Molecule Inhibitors of Medulloblastoma Cell Growth. PLoS ONE. 2013 Jun 24;8(6):e66733. doi: 10.1371/journal.pone.0066733.|McClendon AK, Dean JL, Rivadeneira DB, Yu JE, Reed CA, Gao E, Farber JL, Force T, Koch WJ, Knudsen ES. CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy. Cell Cycle. 2012 Jul 15;11(14):2747–55. PMID: 22751436; PMCID: PMC3409014.|Wallin JJ, Guan J, Prior WW, Edgar KA, Kassees R, Sampath D, Belvin M, Friedman LS. Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer. Sci Transl Med. 2010 Sep 08;2(48):48ra66. doi: 10.1126/scitranslmed.3000630. PMID: 20826841.|Nardinocchi L, Puca R, Sacchi A, Rechavi G, Givol D, D'Orazi G. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha. PLoS One. 2009 Aug 28;4(8):e6819. PMID: 19714248; PMCID: PMC2729407.|Lim Y, Park TJ, Lim IK. B Cell Translocation Gene 2 Enhances Susceptibility of HeLa Cells to Doxorubicin-induced Oxidative Damage. Journal of Biological Chemistry. 2008 Nov;283(48):33110–8. doi: 10.1074/jbc.m804255200.|Liu H, Liu Y, Zhang JT. A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction. Mol Cancer Ther. 2008 Feb;7(2):263–70. doi: 10.1158/1535-7163.mct-07-0445. PMID: 18281512.|2007; 13(2):259-271|Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH, Xu XM, Liu S, Chen J, Liu F, Qi YL, Deng Q, Cao J, Liu SQ, Luo HS, Yu JP. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer. 2008 Jan 15;122(2):433–43. doi: 10.1002/ijc.23049. PMID: 17935137.|Yuan XW, Zhu XF, Huang XF, Sheng PY, He AS, Yang ZB, Deng R, Feng GK, Liao WM. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis. Acta Pharmacol Sin. 2007 Nov;28(11):1835–41. doi: 10.1111/j.1745-7254.2007.00662.x. PMID: 17959036.|Chiosi E, Spina A, Sorrentino A, Romano M, Sorvillo L, Senatore G, D'Auria R, Abbruzzese A, Caraglia M, Naviglio S, Illiano G. Change in TNF-<i>a</i>Receptor Expression Is a Relevant Event in Doxorubicin-Induced H9c2 Cardiomyocyte Cell Death. Journal of Interferon & Cytokine Research. 2007 Jul;27(7):589–98. doi: 10.1089/jir.2006.0161.|Bruynzeel AME, Abou El Hassan MA, Torun E, Bast A, van der Vijgh WJF, Kruyt FAE. Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells. British Journal of Cancer. 2007 Feb 06;96(3):450–6. doi: 10.1038/sj.bjc.6603598.|Xu J, Zhou JY, Tainsky MA, Wu GS. Evidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-Aza-2'-deoxycytidine sensitizes human breast cancer cells to adriamycin. Cancer Res. 2007 Feb 01;67(3):1203–11. doi: 10.1158/0008-5472.can-06-2310. PMID: 17283156.|Rath GM, Schneider C, Dedieu S, Rothhut B, Soula-Rothhut M, Ghoneim C, Sid B, Morjani H, El Btaouri H, Martiny L. The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2006 Oct;1763(10):1125–34. doi: 10.1016/j.bbamcr.2006.08.001.|Grethe S, Coltella N, Di Renzo MF, Pörn-Ares MI. p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis. Biochemical and Biophysical Research Communications. 2006 Sep;347(3):781–90. doi: 10.1016/j.bbrc.2006.06.159.|Sharma A, Patrick B, Li J, Sharma R, Jeyabal PVS, Reddy PMRV, Awasthi S, Awasthi YC. Glutathione S-transferases as antioxidant enzymes: Small cell lung cancer (H69) cells transfected with hGSTA1 resist doxorubicin-induced apoptosis. Archives of Biochemistry and Biophysics. 2006 Aug;452(2):165–73. doi: 10.1016/j.abb.2006.04.006.|2005; 13(9):1434-1441|Tonini T, Gabellini C, Bagella L, D'Andrilli G, Masciullo V, Romano G, Scambia G, Zupi G, Giordano A. pRb2/p130 decreases sensitivity to apoptosis induced by camptothecin and doxorubicin but not by taxol. Clin Cancer Res. 2004 Dec 01;10(23):8085–93. doi: 10.1158/1078-0432.ccr-04-0996. PMID: 15585644.|Wu J, Harris NL, Inge TH. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells. Journal of Surgical Research. 2004 Dec;122(2):231–9. doi: 10.1016/j.jss.2004.05.017.|Niiya M, Niiya K, Shibakura M, Asaumi N, Yoshida C, Shinagawa K, Teshima T, Ishimaru F, Ikeda K, Tanimoto M. Involvement of ERK1/2 and p38 MAP Kinase in Doxorubicin-Induced uPA Expression in Human RC-K8 Lymphoma and NCI-H69 Small Cell Lung Carcinoma Cells. Oncology. 2004;67(3-4):310–9. doi: 10.1159/000081332.|Ferraro C, Quemeneur L, Prigent AF, Taverne C, Revillard JP, Bonnefoy-Berard N. Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells. Cancer Res. 2000 Apr 01;60(7):1901–7. PMID: 10766178."
1460757,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Doxorubicin results in increased degradation of PARP1 protein|tgfb1 protein promotes the reaction [doxorubicin results in increased degradation of PARP1 protein],,,PMID:17418594,https://www.ncbi.nlm.nih.gov/pubmed/17418594,17418594,,,16681122,"Filyak Y, Filyak O, Stoika R. Transforming growth factor beta-1 enhances cytotoxic effect of doxorubicin in human lung adenocarcinoma cells of A549 line. Cell Biol Int. 2007 Aug;31(8):851–5. doi: 10.1016/j.cellbi.2007.02.008. PMID: 17418594."
1460908,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Doxorubicin results in increased expression of PARP1 mRNA,,,PMID:29803840|PMID:32562081,https://www.ncbi.nlm.nih.gov/pubmed/29803840|https://www.ncbi.nlm.nih.gov/pubmed/32562081,29803840|32562081,,PMC8012311,20367195|21619931,"2020; 37(2):261-275|Verheijen M, Schrooders Y, Gmuender H, Nudischer R, Clayton O, Hynes J, Niederer S, Cordes H, Kuepfer L, Kleinjans J, Caiment F. Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294():184–92. doi: 10.1016/j.toxlet.2018.05.029. PMID: 29803840."
1460909,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Doxorubicin results in increased expression of PARP1 protein modified form,,,PMID:31101655,https://www.ncbi.nlm.nih.gov/pubmed/31101655,31101655,,PMC6597808,31117715,"Wang X, Ji C, Zhang H, Shan Y, Ren Y, Hu Y, Shi L, Guo L, Zhu W, Xia Y, Liu B, Rong Z, Wu B, Ming Z, Ren X, Song J, Yang J, Zhang Y. Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents. Journal of Biological Chemistry. 2019 Jun;294(25):10006–17. doi: 10.1074/jbc.ra119.007664."
1460910,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),DPP4 protein promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:15753397,https://www.ncbi.nlm.nih.gov/pubmed/15753397,15753397,,,22038343,"Yamochi T, Yamochi T, Aytac U, Sato T, Sato K, Ohnuma K, McKee KS, Morimoto C, Dang NH. Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin. Cancer Res. 2005 Mar 01;65(5):1973–83. doi: 10.1158/0008-5472.can-04-2611. PMID: 15753397."
1460911,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),ECT2 protein inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:27106762,https://www.ncbi.nlm.nih.gov/pubmed/27106762,27106762,,,16857347,"Weeks A, Agnihotri S, Lymer J, Chalil A, Diaz R, Isik S, Smith C, Rutka JT. Epithelial Cell Transforming 2 and Aurora Kinase B Modulate Formation of Stress Granule–Containing Transcripts from Diverse Cellular Pathways in Astrocytoma Cells. The American Journal of Pathology. 2016 Jun;186(6):1674–87. doi: 10.1016/j.ajpath.2016.02.013."
1460912,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[estradiol results in increased expression of PARP1 mrna] which results in increased susceptibility to doxorubicin,,,PMID:28323900,https://www.ncbi.nlm.nih.gov/pubmed/28323900,28323900,,PMC5360320,10102322,"Chang Y, Singh KP. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells. PLoS ONE. 2017 Mar 21;12(3):e0174227. doi: 10.1371/journal.pone.0174227."
1460913,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),FASN protein inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:18281512,https://www.ncbi.nlm.nih.gov/pubmed/18281512,18281512,,,33572886,"Liu H, Liu Y, Zhang JT. A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction. Mol Cancer Ther. 2008 Feb;7(2):263–70. doi: 10.1158/1535-7163.mct-07-0445. PMID: 18281512."
1460914,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Geldanamycin inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:16311509,https://www.ncbi.nlm.nih.gov/pubmed/16311509,16311509,,,989073,2005; 13(9):1434-1441
1460915,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),GSTA1 protein inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:16890185,https://www.ncbi.nlm.nih.gov/pubmed/16890185,16890185,,,17318136,"Sharma A, Patrick B, Li J, Sharma R, Jeyabal PVS, Reddy PMRV, Awasthi S, Awasthi YC. Glutathione S-transferases as antioxidant enzymes: Small cell lung cancer (H69) cells transfected with hGSTA1 resist doxorubicin-induced apoptosis. Archives of Biochemistry and Biophysics. 2006 Aug;452(2):165–73. doi: 10.1016/j.abb.2006.04.006."
1460916,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),IFNA1 protein promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:17959036,https://www.ncbi.nlm.nih.gov/pubmed/17959036,17959036,,,18039589,"Yuan XW, Zhu XF, Huang XF, Sheng PY, He AS, Yang ZB, Deng R, Feng GK, Liao WM. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis. Acta Pharmacol Sin. 2007 Nov;28(11):1835–41. doi: 10.1111/j.1745-7254.2007.00662.x. PMID: 17959036."
1460917,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),LCS101 inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:25333773,https://www.ncbi.nlm.nih.gov/pubmed/25333773,25333773,,,5277266,"Cohen Z, Maimon Y, Yoeli-Lerner M, Yang P, Samuels N, Berger R. Selective anticancer effects and protection from chemotherapy by the botanical compound LCS101: Implications for cancer treatment. Int J Oncol. 2015 Jan;46(1):308–16. doi: 10.3892/ijo.2014.2711. PMID: 25333773."
1461059,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),RB1 protein affects the reaction [palbociclib inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]]|palbociclib inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:22751436,https://www.ncbi.nlm.nih.gov/pubmed/22751436,22751436,,PMC3409014,20153767,"McClendon AK, Dean JL, Rivadeneira DB, Yu JE, Reed CA, Gao E, Farber JL, Force T, Koch WJ, Knudsen ES. CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy. Cell Cycle. 2012 Jul 15;11(14):2747–55. PMID: 22751436; PMCID: PMC3409014."
1461060,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),RBL2 protein inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:15585644,https://www.ncbi.nlm.nih.gov/pubmed/15585644,15585644,,,5070931,"Tonini T, Gabellini C, Bagella L, D'Andrilli G, Masciullo V, Romano G, Scambia G, Zupi G, Giordano A. pRb2/p130 decreases sensitivity to apoptosis induced by camptothecin and doxorubicin but not by taxol. Clin Cancer Res. 2004 Dec 01;10(23):8085–93. doi: 10.1158/1078-0432.ccr-04-0996. PMID: 15585644."
1461061,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:16843435,https://www.ncbi.nlm.nih.gov/pubmed/16843435,16843435,,,32191306,"Grethe S, Coltella N, Di Renzo MF, Pörn-Ares MI. p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis. Biochemical and Biophysical Research Communications. 2006 Sep;347(3):781–90. doi: 10.1016/j.bbrc.2006.06.159."
1461062,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),THBS1 protein inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:16962673,https://www.ncbi.nlm.nih.gov/pubmed/16962673,16962673,,,12616014,"Rath GM, Schneider C, Dedieu S, Rothhut B, Soula-Rothhut M, Ghoneim C, Sid B, Morjani H, El Btaouri H, Martiny L. The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2006 Oct;1763(10):1125–34. doi: 10.1016/j.bbamcr.2006.08.001."
1461063,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:15557793,https://www.ncbi.nlm.nih.gov/pubmed/15557793,15557793,,,24080217,"Niiya M, Niiya K, Shibakura M, Asaumi N, Yoshida C, Shinagawa K, Teshima T, Ishimaru F, Ikeda K, Tanimoto M. Involvement of ERK1/2 and p38 MAP Kinase in Doxorubicin-Induced uPA Expression in Human RC-K8 Lymphoma and NCI-H69 Small Cell Lung Carcinoma Cells. Oncology. 2004;67(3-4):310–9. doi: 10.1159/000081332."
1461064,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Wortmannin promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:17935137,https://www.ncbi.nlm.nih.gov/pubmed/17935137,17935137,,,1040001,"Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH, Xu XM, Liu S, Chen J, Liu F, Qi YL, Deng Q, Cao J, Liu SQ, Luo HS, Yu JP. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer. 2008 Jan 15;122(2):433–43. doi: 10.1002/ijc.23049. PMID: 17935137."
1461065,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[XAF1 protein results in increased susceptibility to doxorubicin] which results in increased cleavage of PARP1 protein,,,PMID:28507149,https://www.ncbi.nlm.nih.gov/pubmed/28507149,28507149,,PMC5465913,6013626,"Shin CH, Lee MG, Han J, Jeong SI, Ryu BK, Chi SG. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683–8. PMID: 28507149; PMCID: PMC5465913."
1461066,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"5,10,15,20-tetrakis(n-methyl-4'-pyridyl)porphyrinato-iron(iii) inhibits the reaction [doxorubicin results in increased activity of PARP1 protein]|tetrakis(n-methyl-4-pyridiniumyl)porphine manganese(iii) complex inhibits the reaction [doxorubicin results in increased activity of PARP1 protein]|doxorubicin results in increased activity of PARP1 protein",,,PMID:19286953,https://www.ncbi.nlm.nih.gov/pubmed/19286953,19286953,,PMC2685360,18707299,"Mukhopadhyay P, Rajesh M, Bátkai S, Kashiwaya Y, Haskó G, Liaudet L, Szabó C, Pacher P. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. American Journal of Physiology-Heart and Circulatory Physiology. 2009 May;296(5):H1466–83. doi: 10.1152/ajpheart.00795.2008."
1461067,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),ABCC1 gene mutant form promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:26822305,https://www.ncbi.nlm.nih.gov/pubmed/26822305,26822305,,PMC4914793,5987990,"Zhang W, St Clair D, Butterfield A, Vore M. Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts. Toxicol Sci. 2016 May;151(1):44–56. PMID: 26822305; PMCID: PMC4914793."
1461185,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[doxorubicin co-treated with curcumin] results in increased cleavage of PARP1 protein,,,PMID:18006147,https://www.ncbi.nlm.nih.gov/pubmed/18006147,18006147,,,10586499,"Choi BH, Kim CG, Lim Y, Shin SY, Lee YH. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett. 2008 Jan 18;259(1):111–8. doi: 10.1016/j.canlet.2007.10.003. PMID: 18006147."
1461186,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Doxorubicin promotes the reaction [AZD 6244 results in increased cleavage of PARP1 protein],,,PMID:17876044,https://www.ncbi.nlm.nih.gov/pubmed/17876044,17876044,,,20051917,"Huynh H, Chow PK, Soo KC. AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma. Mol Cancer Ther. 2007 Sep;6(9):2468–76. doi: 10.1158/1535-7163.mct-07-0162. PMID: 17876044."
1461187,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Doxorubicin results in decreased activity of PARP1 protein,,,PMID:20656019,https://www.ncbi.nlm.nih.gov/pubmed/20656019,20656019,,,405003,"Bar-Joseph H, Ben-Aharon I, Rizel S, Stemmer SM, Tzabari M, Shalgi R. Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes. Reprod Toxicol. 2010 Dec;30(4):566–72. doi: 10.1016/j.reprotox.2010.07.003. PMID: 20656019."
1461188,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Doxorubicin results in increased cleavage of PARP1 protein,,,PMID:10704466|PMID:20363884|PMID:24812279|PMID:26822305|PMID:29653124|PMID:37257577,https://www.ncbi.nlm.nih.gov/pubmed/10704466|https://www.ncbi.nlm.nih.gov/pubmed/20363884|https://www.ncbi.nlm.nih.gov/pubmed/24812279|https://www.ncbi.nlm.nih.gov/pubmed/26822305|https://www.ncbi.nlm.nih.gov/pubmed/29653124|https://www.ncbi.nlm.nih.gov/pubmed/37257577,10704466|20363884|24812279|26822305|29653124|37257577,,PMC2195860|PMC2886633|PMC4133592|PMC4914793,5987990|14115767|14192377|19437657|23298932|35655984,"Syamprasad NP, Jain S, Rajdev B, Panda SR, Gangasani JK, Challa VS, Vaidya JR, Kundu GC, Naidu VGM. AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis. Chem Biol Interact. 2023 Aug 25;381():110566. doi: 10.1016/j.cbi.2023.110566. PMID: 37257577.|Cunha-Oliveira T, Ferreira LL, Coelho AR, Deus CM, Oliveira PJ. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2018 Jun 01;348():1–13. doi: 10.1016/j.taap.2018.04.009. PMID: 29653124.|Zhang W, St Clair D, Butterfield A, Vore M. Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts. Toxicol Sci. 2016 May;151(1):44–56. PMID: 26822305; PMCID: PMC4914793.|Zhu W, Zhang W, Shou W, Field LJ. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity. Cardiovasc Res. 2014 Jul 01;103(1):81–9. PMID: 24812279; PMCID: PMC4133592.|Vedam K, Nishijima Y, Druhan LJ, Khan M, Moldovan NI, Zweier JL, Ilangovan G. Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice. American Journal of Physiology-Heart and Circulatory Physiology. 2010 Jun;298(6):H1832–41. doi: 10.1152/ajpheart.01047.2009.|Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA. Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med. 2000 Mar 06;191(5):859–70. PMID: 10704466; PMCID: PMC2195860."
1461189,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Doxorubicin results in increased expression of PARP1 protein,,,PMID:20144634|PMID:31174020,https://www.ncbi.nlm.nih.gov/pubmed/20144634|https://www.ncbi.nlm.nih.gov/pubmed/31174020,20144634|31174020,,,9955480|14210405,"2019; 71(4):591-602|Patel N, Joseph C, Corcoran GB, Ray SD. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicol Appl Pharmacol. 2010 Jun 01;245(2):143–52. doi: 10.1016/j.taap.2010.02.002. PMID: 20144634."
1461190,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Epalrestat inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]|epalrestat analog inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:37257577,https://www.ncbi.nlm.nih.gov/pubmed/37257577,37257577,,,35655984,"Syamprasad NP, Jain S, Rajdev B, Panda SR, Gangasani JK, Challa VS, Vaidya JR, Kundu GC, Naidu VGM. AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis. Chem Biol Interact. 2023 Aug 25;381():110566. doi: 10.1016/j.cbi.2023.110566. PMID: 37257577."
1461191,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 gene mutant form promotes the reaction [doxorubicin results in increased activity of CASP3 protein]|parp1 protein results in increased uptake of doxorubicin|parp1 gene mutant form inhibits the reaction [doxorubicin results in increased phosphorylation of CDK2 protein]|verapamil inhibits the reaction [PARP1 gene mutant form results in decreased uptake of doxorubicin]|parp1 gene mutant form promotes the reaction [doxorubicin results in increased activity of CASP7 protein],,,PMID:15861398,https://www.ncbi.nlm.nih.gov/pubmed/15861398,15861398,,,7877358,Wesierska-Gadek J. Major contribution of the multidrug transporter P-glycoprotein to reduced susceptibility of poly(ADP-ribose) polymerase-1 knock-out cells to doxorubicin action. J Cell Biochem. 2005 Aug 01;95(5):1012–28. doi: 10.1002/jcb.20467. PMID: 15861398.
1461192,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein affects the susceptibility to doxorubicin,,,PMID:11861791,https://www.ncbi.nlm.nih.gov/pubmed/11861791,11861791,,,33437211,"Pacher P, Liaudet L, Bai P, Virag L, Mabley JG, Haskó G, Szabó C. Activation of Poly(ADP-Ribose) Polymerase Contributes to Development of Doxorubicin-Induced Heart Failure. The Journal of Pharmacology and Experimental Therapeutics. 2002 Mar;300(3):862–7. doi: 10.1124/jpet.300.3.862."
1461193,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein promotes the reaction [doxorubicin results in increased expression of BECN1 protein]|parp1 protein promotes the reaction [doxorubicin results in increased expression of CTSB mrna]|parp1 protein promotes the reaction [doxorubicin results in increased expression of BNIP3 mrna]|parp1 protein promotes the reaction [doxorubicin results in increased expression of CTSL mrna]|parp1 protein promotes the reaction [doxorubicin results in increased expression of BECN1 mrna],,,PMID:19001878,https://www.ncbi.nlm.nih.gov/pubmed/19001878,19001878,,,16701046,"Muñoz-Gámez JA, Rodríguez-Vargas JM, Quiles-Pérez R, Aguilar-Quesada R, Martín-Oliva D, de Murcia G, Menissier de Murcia J, Almendros A, Ruiz de Almodóvar M, Oliver FJ. PARP-1 is involved in autophagy induced by DNA damage. Autophagy. 2009 Jan;5(1):61–74. doi: 10.4161/auto.5.1.7272. PMID: 19001878."
1461349,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Silymarin inhibits the reaction [doxorubicin results in increased expression of PARP1 protein],,,PMID:20144634,https://www.ncbi.nlm.nih.gov/pubmed/20144634,20144634,,,9955480,"Patel N, Joseph C, Corcoran GB, Ray SD. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicol Appl Pharmacol. 2010 Jun 01;245(2):143–52. doi: 10.1016/j.taap.2010.02.002. PMID: 20144634."
1461350,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),STAT3 gene mutant form promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein]|[stat3 gene mutant form results in increased susceptibility to doxorubicin] which results in increased cleavage of PARP1 protein|trp53 protein mutant form affects the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:24812279,https://www.ncbi.nlm.nih.gov/pubmed/24812279,24812279,,PMC4133592,14115767,"Zhu W, Zhang W, Shou W, Field LJ. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity. Cardiovasc Res. 2014 Jul 01;103(1):81–9. PMID: 24812279; PMCID: PMC4133592."
1461351,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]|u 0126 inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:18775851,https://www.ncbi.nlm.nih.gov/pubmed/18775851,18775851,,PMC2614569,24141278,"Liu J, Mao W, Ding B, Liang C. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 2008 Nov;295(5):H1956–65. doi: 10.1152/ajpheart.00407.2008."
1461352,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"FOXO1 protein affects the reaction [doxorubicin results in increased cleavage of PARP1 protein]|5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]",,,PMID:32075913,https://www.ncbi.nlm.nih.gov/pubmed/32075913,32075913,,PMC7105316,25761002,"Xia P, Chen J, Liu Y, Fletcher M, Jensen BC, Cheng Z. Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2–mediated activation of forkhead box O1. Journal of Biological Chemistry. 2020 Mar;295(13):4265–76. doi: 10.1074/jbc.ra119.011571."
1461353,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Caffeine inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]|lithium chloride inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]|doxorubicin inhibits the reaction [SFRP1 protein binds to PARP1 protein]|heparin promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein]|parp1 protein inhibits the reaction [SFRP1 protein inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]]|sfrp1 protein inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:30377735,https://www.ncbi.nlm.nih.gov/pubmed/30377735,30377735,,,8127370,2018; 93(2):533-546
1461355,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Caryophyllene inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]|iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]],,,PMID:30836069,https://www.ncbi.nlm.nih.gov/pubmed/30836069,30836069,,,18256531,"Meeran MFN, Al Taee H, Azimullah S, Tariq S, Adeghate E, Ojha S. ß-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB2) receptors in rats. Chem Biol Interact. 2019 May 01;304():158–67. doi: 10.1016/j.cbi.2019.02.028. PMID: 30836069."
1461356,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Doxorubicin results in increased cleavage of PARP1 protein,,,PMID:16687611|PMID:17285121|PMID:17651020|PMID:18775851|PMID:22155320|PMID:24902966|PMID:30377735|PMID:30836069|PMID:32075913|PMID:36309171,https://www.ncbi.nlm.nih.gov/pubmed/16687611|https://www.ncbi.nlm.nih.gov/pubmed/17285121|https://www.ncbi.nlm.nih.gov/pubmed/17651020|https://www.ncbi.nlm.nih.gov/pubmed/18775851|https://www.ncbi.nlm.nih.gov/pubmed/22155320|https://www.ncbi.nlm.nih.gov/pubmed/24902966|https://www.ncbi.nlm.nih.gov/pubmed/30377735|https://www.ncbi.nlm.nih.gov/pubmed/30836069|https://www.ncbi.nlm.nih.gov/pubmed/32075913|https://www.ncbi.nlm.nih.gov/pubmed/36309171,16687611|17285121|17651020|18775851|22155320|24902966|30377735|30836069|32075913|36309171,,PMC2360019|PMC2614569|PMC4209150|PMC7105316,8127370|8716327|8899283|15398335|18256531|24141278|25510696|25761002|33545051|34356280,"Zhang C, Dan Q, Lai S, Zhang Y, Gao E, Luo H, Yang L, Gao X, Lu C. Rab10 protects against DOX-induced cardiotoxicity by alleviating the oxidative stress and apoptosis of cardiomyocytes. Toxicol Lett. 2023 Jan 15;373():84–93. doi: 10.1016/j.toxlet.2022.10.005. PMID: 36309171.|Xia P, Chen J, Liu Y, Fletcher M, Jensen BC, Cheng Z. Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2–mediated activation of forkhead box O1. Journal of Biological Chemistry. 2020 Mar;295(13):4265–76. doi: 10.1074/jbc.ra119.011571.|Meeran MFN, Al Taee H, Azimullah S, Tariq S, Adeghate E, Ojha S. ß-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB2) receptors in rats. Chem Biol Interact. 2019 May 01;304():158–67. doi: 10.1016/j.cbi.2019.02.028. PMID: 30836069.|2018; 93(2):533-546|Dong Q, Chen L, Lu Q, Sharma S, Li L, Morimoto S, Wang G. Quercetin attenuates doxorubicin cardiotoxicity by modulating <scp>B</scp>mi-1 expression. British J Pharmacology. 2014 Aug 14;171(19):4440–54. doi: 10.1111/bph.12795.|Xiao J, Sun GB, Sun B, Wu Y, He L, Wang X, Chen RC, Cao L, Ren XY, Sun XB. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology. 2012 Feb 06;292(1):53–62. doi: 10.1016/j.tox.2011.11.018. PMID: 22155320.|Liu J, Mao W, Ding B, Liang C. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 2008 Nov;295(5):H1956–65. doi: 10.1152/ajpheart.00407.2008.|Chiosi E, Spina A, Sorrentino A, Romano M, Sorvillo L, Senatore G, D'Auria R, Abbruzzese A, Caraglia M, Naviglio S, Illiano G. Change in TNF-<i>a</i>Receptor Expression Is a Relevant Event in Doxorubicin-Induced H9c2 Cardiomyocyte Cell Death. Journal of Interferon & Cytokine Research. 2007 Jul;27(7):589–98. doi: 10.1089/jir.2006.0161.|Bruynzeel AME, Abou El Hassan MA, Torun E, Bast A, van der Vijgh WJF, Kruyt FAE. Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells. British Journal of Cancer. 2007 Feb 06;96(3):450–6. doi: 10.1038/sj.bjc.6603598.|Chua CC, Liu X, Gao J, Hamdy RC, Chua BHL. Multiple actions of pifithrin-a on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. American Journal of Physiology-Heart and Circulatory Physiology. 2006 Jun;290(6):H2606–13. doi: 10.1152/ajpheart.01138.2005."
1461484,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Doxorubicin results in increased expression of and results in increased cleavage of PARP1 protein,,,PMID:21194538,https://www.ncbi.nlm.nih.gov/pubmed/21194538,21194538,,,18104491,"Tikoo K, Sane MS, Gupta C. Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: potential role of tannins in cancer chemotherapy. Toxicol Appl Pharmacol. 2011 Mar 15;251(3):191–200. doi: 10.1016/j.taap.2010.12.012. PMID: 21194538."
1461485,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Doxorubicin results in increased expression of PARP1 protein,,,PMID:12967636|PMID:21194538,https://www.ncbi.nlm.nih.gov/pubmed/12967636|https://www.ncbi.nlm.nih.gov/pubmed/21194538,12967636|21194538,,,18104491|18597057,"Tikoo K, Sane MS, Gupta C. Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: potential role of tannins in cancer chemotherapy. Toxicol Appl Pharmacol. 2011 Mar 15;251(3):191–200. doi: 10.1016/j.taap.2010.12.012. PMID: 21194538.|Shan YX, Liu TJ, Su HF, Samsamshariat A, Mestril R, Wang PH. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J Mol Cell Cardiol. 2003 Sep;35(9):1135–43. doi: 10.1016/s0022-2828(03)00229-3. PMID: 12967636."
1461486,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Doxorubicin results in increased expression of PARP1 protein modified form|melatonin inhibits the reaction [doxorubicin results in increased expression of PARP1 protein modified form],,,PMID:29966675,https://www.ncbi.nlm.nih.gov/pubmed/29966675,29966675,,,6750795,"Govender J, Loos B, Marais E, Engelbrecht AM. Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity? Toxicol Appl Pharmacol. 2018 Nov 01;358():86–101. doi: 10.1016/j.taap.2018.06.031. PMID: 29966675."
1461487,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),HSPE1 protein inhibits the reaction [doxorubicin results in increased expression of PARP1 protein]|hspd1 protein inhibits the reaction [doxorubicin results in increased expression of PARP1 protein],,,PMID:12967636,https://www.ncbi.nlm.nih.gov/pubmed/12967636,12967636,,,18597057,"Shan YX, Liu TJ, Su HF, Samsamshariat A, Mestril R, Wang PH. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J Mol Cell Cardiol. 2003 Sep;35(9):1135–43. doi: 10.1016/s0022-2828(03)00229-3. PMID: 12967636."
1461488,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Kaempferol inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:22155320,https://www.ncbi.nlm.nih.gov/pubmed/22155320,22155320,,,15398335,"Xiao J, Sun GB, Sun B, Wu Y, He L, Wang X, Chen RC, Cao L, Ren XY, Sun XB. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology. 2012 Feb 06;292(1):53–62. doi: 10.1016/j.tox.2011.11.018. PMID: 22155320."
1461489,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pifithrin inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:16687611,https://www.ncbi.nlm.nih.gov/pubmed/16687611,16687611,,,33545051,"Chua CC, Liu X, Gao J, Hamdy RC, Chua BHL. Multiple actions of pifithrin-a on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. American Journal of Physiology-Heart and Circulatory Physiology. 2006 Jun;290(6):H2606–13. doi: 10.1152/ajpheart.01138.2005."
1461490,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:24902966,https://www.ncbi.nlm.nih.gov/pubmed/24902966,24902966,,PMC4209150,8716327,"Dong Q, Chen L, Lu Q, Sharma S, Li L, Morimoto S, Wang G. Quercetin attenuates doxorubicin cardiotoxicity by modulating <scp>B</scp>mi-1 expression. British J Pharmacology. 2014 Aug 14;171(19):4440–54. doi: 10.1111/bph.12795."
1461491,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),RAB10 protein inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:36309171,https://www.ncbi.nlm.nih.gov/pubmed/36309171,36309171,,,34356280,"Zhang C, Dan Q, Lai S, Zhang Y, Gao E, Luo H, Yang L, Gao X, Lu C. Rab10 protects against DOX-induced cardiotoxicity by alleviating the oxidative stress and apoptosis of cardiomyocytes. Toxicol Lett. 2023 Jan 15;373():84–93. doi: 10.1016/j.toxlet.2022.10.005. PMID: 36309171."
1461492,443939,Comparative Toxicogenomics Database (CTD),Doxorubicin Hydrochloride,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),TNF protein promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:17651020,https://www.ncbi.nlm.nih.gov/pubmed/17651020,17651020,,,25510696,"Chiosi E, Spina A, Sorrentino A, Romano M, Sorvillo L, Senatore G, D'Auria R, Abbruzzese A, Caraglia M, Naviglio S, Illiano G. Change in TNF-<i>a</i>Receptor Expression Is a Relevant Event in Doxorubicin-Induced H9c2 Cardiomyocyte Cell Death. Journal of Interferon & Cytokine Research. 2007 Jul;27(7):589–98. doi: 10.1089/jir.2006.0161."
532371,444041,Comparative Toxicogenomics Database (CTD),Betadex,C031215,betadex,https://ctdbase.org/detail.go?type=chem&acc=C031215,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Betadex inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:11035063,https://www.ncbi.nlm.nih.gov/pubmed/11035063,11035063,,,209792,"Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000 Oct 15;165(8):4290–7. doi: 10.4049/jimmunol.165.8.4290. PMID: 11035063."
1339094,444732,Comparative Toxicogenomics Database (CTD),Trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:16904634,https://www.ncbi.nlm.nih.gov/pubmed/16904634,16904634,,,17331594,"Bai J, Demirjian A, Sui J, Marasco W, Callery MP. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. Biochemical and Biophysical Research Communications. 2006 Oct;348(4):1245–53. doi: 10.1016/j.bbrc.2006.07.185."
1339224,444732,Comparative Toxicogenomics Database (CTD),Trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trichostatin A inhibits the reaction [benzene results in decreased expression of PARP1 mrna]|trichostatin A inhibits the reaction [benzene results in increased methylation of PARP1 promoter],,,PMID:20230882,https://www.ncbi.nlm.nih.gov/pubmed/20230882,20230882,,,6562335,"Gao A, Zuo X, Liu Q, Lu X, Guo W, Tian L. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. Toxicol Lett. 2010 Jun 02;195(2-3):114–8. doi: 10.1016/j.toxlet.2010.03.005. PMID: 20230882."
1339225,444732,Comparative Toxicogenomics Database (CTD),Trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trichostatin A results in increased acetylation of PARP1 protein,,,PMID:27064363,https://www.ncbi.nlm.nih.gov/pubmed/27064363,27064363,,PMC5007632,22246967,"Robert C, Nagaria PK, Pawar N, Adewuyi A, Gojo I, Meyers DJ, Cole PA, Rassool FV. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin. Leukemia Research. 2016 Jun;45():14–23. doi: 10.1016/j.leukres.2016.03.007."
1339226,444732,Comparative Toxicogenomics Database (CTD),Trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trichostatin A results in increased cleavage of PARP1 protein,,,PMID:17431121,https://www.ncbi.nlm.nih.gov/pubmed/17431121,17431121,,,330899,"De los Santos M, Zambrano A, Aranda A. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. Mol Cancer Ther. 2007 Apr;6(4):1425–32. doi: 10.1158/1535-7163.mct-06-0623. PMID: 17431121."
1339227,444732,Comparative Toxicogenomics Database (CTD),Trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trichostatin A results in increased degradation of PARP1 protein,,,PMID:16010430,https://www.ncbi.nlm.nih.gov/pubmed/16010430,16010430,,,25462523,"Choi Y. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. Int J Oncol. 2005 Aug 01;(). doi: 10.3892/ijo.27.2.473."
1339228,444732,Comparative Toxicogenomics Database (CTD),Trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[trichostatin A results in increased expression of GDF15 protein] which results in increased cleavage of PARP1 protein,,,PMID:18801729,https://www.ncbi.nlm.nih.gov/pubmed/18801729,18801729,,PMC2586275,24165324,"Yoshioka H, Kamitani H, Watanabe T, Eling TE. Nonsteroidal Anti-inflammatory Drug-activated Gene (NAG-1/GDF15) Expression Is Increased by the Histone Deacetylase Inhibitor Trichostatin A. Journal of Biological Chemistry. 2008 Nov;283(48):33129–37. doi: 10.1074/jbc.m805248200."
1339229,444732,Comparative Toxicogenomics Database (CTD),Trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trichostatin A results in increased expression of PARP1 protein modified form,,,PMID:23770000,https://www.ncbi.nlm.nih.gov/pubmed/23770000,23770000,,,3853549,"Liu Y, He G, Wang Y, Guan X, Pang X, Zhang B. MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. Toxicol Lett. 2013 Jul 31;221(1):23–30. doi: 10.1016/j.toxlet.2013.05.643. PMID: 23770000."
1439334,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),Tretinoin results in increased cleavage of PARP1 protein|ltf protein inhibits the reaction [tretinoin results in increased cleavage of PARP1 protein],,,PMID:16168621,https://www.ncbi.nlm.nih.gov/pubmed/16168621,16168621,,,30173366,"Baumrucker CR, Schanbacher F, Shang Y, Green MH. Lactoferrin interaction with retinoid signaling: cell growth and apoptosis in mammary cells. Domest Anim Endocrinol. 2006 May;30(4):289–303. doi: 10.1016/j.domaniend.2005.07.009. PMID: 16168621."
1439335,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[IDH1 protein affects the susceptibility to tretinoin] which affects the cleavage of PARP1 protein,,,PMID:26951332,https://www.ncbi.nlm.nih.gov/pubmed/26951332,26951332,,PMC4821643,3244730,"Boutzen H, Saland E, Larrue C, de Toni F, Gales L, Castelli FA, Cathebas M, Zaghdoudi S, Stuani L, Kaoma T, Riscal R, Yang G, Hirsch P, David M, De Mas-Mansat V, Delabesse E, Vallar L, Delhommeau F, Jouanin I, Ouerfelli O, Le Cam L, Linares LK, Junot C, Portais JC, Vergez F, Récher C, Sarry JE. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia. J Exp Med. 2016 Apr 04;213(4):483–97. PMID: 26951332; PMCID: PMC4821643."
1439478,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[IFNB1 protein co-treated with tretinoin] results in increased cleavage of PARP1 protein,,,PMID:16826196,https://www.ncbi.nlm.nih.gov/pubmed/16826196,16826196,,,32175219,"Huang G, Chen Y, Lu H, Cao X. Coupling mitochondrial respiratory chain to cell death: an essential role of mitochondrial complex I in the interferon-beta and retinoic acid-induced cancer cell death. Cell Death Differ. 2007 Feb;14(2):327–37. doi: 10.1038/sj.cdd.4402004. PMID: 16826196."
1439479,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tretinoin inhibits the reaction [geldanamycin results in increased degradation of PARP1 protein],,,PMID:17293044,https://www.ncbi.nlm.nih.gov/pubmed/17293044,17293044,,,3745086,"Shen JH, Zhang Y, Wu NH, Shen YF. Resistance to geldanamycin-induced apoptosis in differentiated neuroblastoma SH-SY5Y cells. Neurosci Lett. 2007 Mar 06;414(2):110–4. doi: 10.1016/j.neulet.2006.06.050. PMID: 17293044."
1439480,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tretinoin results in decreased expression of PARP1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,PMC7716236,19682112,"Albanesi J, Noguera NI, Banella C, Colangelo T, De Marinis E, Leone S, Palumbo O, Voso MT, Ascenzi P, Nervi C, Bianchi F, di Masi A. Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 05;9(11). PMID: 33167477; PMCID: PMC7716236."
1439481,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tretinoin results in increased cleavage of PARP1 protein,,,PMID:14519626|PMID:17387344,https://www.ncbi.nlm.nih.gov/pubmed/14519626|https://www.ncbi.nlm.nih.gov/pubmed/17387344,14519626|17387344,,PMC2360155,22082605|30122569,"Patel JB, Mehta J, Belosay A, Sabnis G, Khandelwal A, Brodie AMH, Soprano DR, Njar VCO. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. British Journal of Cancer. 2007 Mar 27;96(8):1204–15. doi: 10.1038/sj.bjc.6603705.|Gumireddy K, Sutton LN, Phillips PC, Reddy CD. All-trans-retinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway. Clin Cancer Res. 2003 Sep 15;9(11):4052–9. PMID: 14519626."
1439482,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tretinoin promotes the reaction [pevonedistat results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:22110742,https://www.ncbi.nlm.nih.gov/pubmed/22110742,22110742,,PMC3217012,3822174,"Tan M, Li Y, Yang R, Xi N, Sun Y. Inactivation of SAG E3 Ubiquitin Ligase Blocks Embryonic Stem Cell Differentiation and Sensitizes Leukemia Cells to Retinoid Acid. PLoS ONE. 2011 Nov 15;6(11):e27726. doi: 10.1371/journal.pone.0027726."
1439483,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tretinoin results in increased cleavage of PARP1 protein,,,PMID:21626648|PMID:29767511,https://www.ncbi.nlm.nih.gov/pubmed/21626648|https://www.ncbi.nlm.nih.gov/pubmed/29767511,21626648|29767511,,,8650603|32407785,"Yuan W, Chen J, Huang H, Cai Z, Ling Q, Huang F, Huang Z. Low-Dose Arsenic Trioxide Modulates the Differentiation of Mouse Embryonic Stem Cells. Chem Res Toxicol. 2018 Jun 18;31(6):472–81. doi: 10.1021/acs.chemrestox.8b00027. PMID: 29767511.|Huang FJ, Lan KC, Kang HY, Lin PY, Chan WH, Hsu YC, Liu YC, Huang KE. Retinoic acid influences the embryoid body formation in mouse embryonic stem cells by induction of caspase and p38 MAPK/JNK-mediated apoptosis. Environ Toxicol. 2013 Apr;28(4):190–200. doi: 10.1002/tox.20709. PMID: 21626648."
1533253,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [arachidonic acid results in increased cleavage of PARP1 protein]",,,PMID:19540902,https://www.ncbi.nlm.nih.gov/pubmed/19540902,19540902,,,1073205,"Chen KC, Chang LS. Arachidonic acid-induced apoptosis of human neuroblastoma SK-N-SH cells is mediated through mitochondrial alteration elicited by ROS and Ca(2+)-evoked activation of p38alpha MAPK and JNK1. Toxicology. 2009 Aug 21;262(3):199–206. doi: 10.1016/j.tox.2009.06.009. PMID: 19540902."
1533254,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[arachidonic acid co-treated with iron] results in increased expression of PARP1 protein modified form|plant extracts inhibits the reaction [[arachidonic acid co-treated with iron] results in increased expression of PARP1 protein modified form],,,PMID:30626086,https://www.ncbi.nlm.nih.gov/pubmed/30626086,30626086,,PMC6357197,14876163,"Yang JH, Choi MH, Na CS, Cho SS, Kim JH, Ku SK, Cho IJ, Shin HJ, Ki SH. Bamboo Stems (Phyllostachys nigra variety henosis) Containing Polyphenol Mixtures Activate Nrf2 and Attenuate Phenylhydrazine-Induced Oxidative Stress and Liver Injury. Nutrients. 2019 Jan 08;11(1). PMID: 30626086; PMCID: PMC6357197."
1533255,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arachidonic acid results in increased cleavage of PARP1 protein,,,PMID:19540902|PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/19540902|https://www.ncbi.nlm.nih.gov/pubmed/21132278,19540902|21132278,,PMC4741309,1073205|20136636,"2010; 85(6):623-634|Chen KC, Chang LS. Arachidonic acid-induced apoptosis of human neuroblastoma SK-N-SH cells is mediated through mitochondrial alteration elicited by ROS and Ca(2+)-evoked activation of p38alpha MAPK and JNK1. Toxicology. 2009 Aug 21;262(3):199–206. doi: 10.1016/j.tox.2009.06.009. PMID: 19540902."
1533256,444899,Comparative Toxicogenomics Database (CTD),Arachidonic Acid,D016718,Arachidonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D016718,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Arachidonic acid results in increased cleavage of PARP1 protein,,,PMID:10403056,https://www.ncbi.nlm.nih.gov/pubmed/10403056,10403056,,,9115318,1999; 30(3):353-368
1361385,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of PARP1 protein",,,PMID:18444175,https://www.ncbi.nlm.nih.gov/pubmed/18444175,18444175,,,21404118,"Snyder RM, Yu W, Jia L, Sanders BG, Kline K. Vitamin E Analog a -TEA, Methylseleninic Acid, and<i>Trans</i>-Resveratrol in Combination Synergistically Inhibit Human Breast Cancer Cell Growth. Nutrition and Cancer. 2008 Apr 28;60(3):401–11. doi: 10.1080/01635580701759716."
1361386,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BECN1 protein affects the reaction [resveratrol inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]]|3-methyladenine inhibits the reaction [resveratrol inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]]|resveratrol inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:21778691,https://www.ncbi.nlm.nih.gov/pubmed/21778691,21778691,,PMC3699815,9998083,"Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T. Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease. Neurosignals. 2011;19(3):163–74. doi: 10.1159/000328516."
1361387,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]]|bcl2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein],,,PMID:19631782,https://www.ncbi.nlm.nih.gov/pubmed/19631782,19631782,,,10633424,"Lee JS, Jeong SH, Soung YH, Kim TH, Choi HJ, Park BS, Kwon TK, Yoo YH. SAHA treatment overcomes the anti-apoptotic effects of Bcl-2 and is associated with the formation of mature PML nuclear bodies in human leukemic U937 cells. Chem Biol Interact. 2009 Sep 14;181(1):61–70. doi: 10.1016/j.cbi.2009.02.007. PMID: 19631782."
1361388,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CASP12 mutant form inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]|thermozymocidin inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]|cycloserine inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein],,,PMID:24264887,https://www.ncbi.nlm.nih.gov/pubmed/24264887,24264887,,,30321197,2013; 19(3):527-541
1361566,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of PARP1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,,16019154,"Dip R, Lenz S, Gmuender H, Naegeli H. Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787–95. doi: 10.1016/j.fct.2009.01.008. PMID: 19167446."
1361567,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MCL1 mutant form promotes the reaction [[resveratrol co-treated with clofarabine] results in increased cleavage of PARP1 protein]|[resveratrol co-treated with clofarabine] results in increased cleavage of PARP1 protein,,,PMID:24924397,https://www.ncbi.nlm.nih.gov/pubmed/24924397,24924397,,PMC4453022,32322776,"Lee Y, Lee Y, Lee S. Resveratrol and clofarabine induces a preferential apoptosis-activating effect on malignant mesothelioma cells by Mcl-1 down-regulation and caspase-3 activation. BMB Reports. 2015 Mar 31;48(3):166–71. doi: 10.5483/bmbrep.2015.48.3.105."
1361568,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[resveratrol promotes the reaction [PARP1 protein binds to YARS1 protein]] which results in increased ADP-ribosylation of PARP1 protein|parp1 protein affects the reaction [resveratrol results in increased expression of NAMPT protein]|yars1 protein affects the reaction [resveratrol results in increased ADP-ribosylation of PARP1 protein]|parp1 protein affects the reaction [resveratrol results in increased expression of CDKN2A protein]|parp1 protein affects the reaction [resveratrol results in increased expression of SIRT6 protein]|resveratrol results in increased ADP-ribosylation of PARP1 protein|parp1 protein affects the reaction [resveratrol results in increased expression of SIRT1 protein]|parp1 protein affects the reaction [resveratrol results in increased expression of FOXO3 protein]|resveratrol promotes the reaction [PARP1 protein binds to YARS1 protein]|1-(4-dimethylaminomethylphenyl)-8,9-dihydro-7H-2,7,9a-benzo(cd)azulen-6-one inhibits the reaction [resveratrol promotes the reaction [PARP1 protein binds to YARS1 protein]]|parp1 protein affects the reaction [resveratrol results in increased expression of SESN2 protein]|parp1 protein affects the reaction [resveratrol results in increased acetylation of and results in increased phosphorylation of TP53 protein]|parp1 protein affects the reaction [resveratrol results in increased expression of BRCA1 protein]",,,PMID:25533949,https://www.ncbi.nlm.nih.gov/pubmed/25533949,25533949,,PMC4368482,482646,"Sajish M, Schimmel P: A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature. 2015 Mar 19;519(7543):370-3. doi: 10.1038/nature14028. Epub 2014 Dec 22."
1361569,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol analog results in increased cleavage of PARP1 protein,,,PMID:24044363,https://www.ncbi.nlm.nih.gov/pubmed/24044363,24044363,,,24934492,"Banaganapalli B, Mulakayala C, Pulaganti M, Mulakayala N, Anuradha C, Suresh Kumar C, Shaik NA, Yousuf Al-Aama J, Gudla D. Experimental and Computational Studies on Newly Synthesized Resveratrol Derivative: A New Method for Cancer Chemoprevention and Therapeutics? OMICS: A Journal of Integrative Biology. 2013 Nov;17(11):568–83. doi: 10.1089/omi.2013.0014."
1361570,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[resveratrol co-treated with clofarabine] results in increased expression of PARP1 protein modified form,,,PMID:24239893,https://www.ncbi.nlm.nih.gov/pubmed/24239893,24239893,,,14781027,"Lee YJ, Park IS, Lee YJ, Shim JH, Cho MK, Nam HS, Park JW, Oh MH, Lee SH. Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53. Food Chem Toxicol. 2014 Jan;63():153–60. doi: 10.1016/j.fct.2013.11.004. PMID: 24239893."
1361571,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[resveratrol co-treated with paclitaxel] results in increased cleavage of PARP1 protein,,,PMID:14749477,https://www.ncbi.nlm.nih.gov/pubmed/14749477,14749477,,,17975476,"Jazirehi AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. 2004 Jan 01;3(1):71–84. doi: 10.1158/1535-7163.71.3.1."
1361572,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[vorinostat co-treated with resveratrol] results in increased cleavage of PARP1 protein|[resveratrol co-treated with panobinostat] results in increased cleavage of PARP1 protein,,,PMID:22923501,https://www.ncbi.nlm.nih.gov/pubmed/22923501,22923501,,PMC3502626,31621272,"Yaseen A, Chen S, Hock S, Rosato R, Dent P, Dai Y, Grant S. Resveratrol Sensitizes Acute Myelogenous Leukemia Cells to Histone Deacetylase Inhibitors through Reactive Oxygen Species-Mediated Activation of the Extrinsic Apoptotic Pathway. Molecular Pharmacology. 2012 Dec;82(6):1030–41. doi: 10.1124/mol.112.079624."
1361573,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[resveratrol co-treated with quercetin] results in increased cleavage of PARP1 protein,,,PMID:23530649,https://www.ncbi.nlm.nih.gov/pubmed/23530649,23530649,,,6643657,"Del Follo-Martinez A, Banerjee N, Li X, Safe S, Mertens-Talcott S. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a. Nutr Cancer. 2013;65(3):494–504. doi: 10.1080/01635581.2012.725194. PMID: 23530649."
1361733,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol inhibits the reaction [dopamine results in increased cleavage of PARP1 protein],,,PMID:17603292,https://www.ncbi.nlm.nih.gov/pubmed/17603292,17603292,,,2361708,"Lee MK, Kang SJ, Poncz M, Song K, Park KS. Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Experimental & Molecular Medicine. 2007 Jun 01;39(3):376–84. doi: 10.1038/emm.2007.42."
1361734,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol inhibits the reaction [glucose results in increased expression of PARP1 protein modified form],,,PMID:24218232,https://www.ncbi.nlm.nih.gov/pubmed/24218232,24218232,,PMC3889681,14761924,2013; 25(1):110-123
1361735,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein],,,PMID:17404069|PMID:17959154,https://www.ncbi.nlm.nih.gov/pubmed/17404069|https://www.ncbi.nlm.nih.gov/pubmed/17959154,17404069|17959154,,,16667923|18039671,"Csaki C, Keshishzadeh N, Fischer K, Shakibaei M: Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol. 2008 Feb 1;75(3):677-87. Epub 2007 Sep 18.|SHAKIBAEI M, JOHN T, SEIFARTH C, MOBASHERI A. Resveratrol Inhibits IL-1ß–Induced Stimulation of Caspase-3 and Cleavage of PARP in Human Articular Chondrocytes <i>in Vitro</i>. Annals of the New York Academy of Sciences. 2007 Jan;1095(1):554–63. doi: 10.1196/annals.1397.060."
1361736,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol promotes the reaction [erlotinib hydrochloride results in increased expression of PARP1 protein modified form],,,PMID:25895606,https://www.ncbi.nlm.nih.gov/pubmed/25895606,25895606,,,11412158,"Nie P, Hu W, Zhang T, Yang Y, Hou B, Zou Z. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA. Cell Physiol Biochem. 2015;35(6):2255–71. doi: 10.1159/000374030."
1361737,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol promotes the reaction [sorafenib results in increased cleavage of PARP1 protein],,,PMID:26911335,https://www.ncbi.nlm.nih.gov/pubmed/26911335,26911335,,PMC4766620,5290464,2016; 17(1):19
1361738,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:17823925,https://www.ncbi.nlm.nih.gov/pubmed/17823925,17823925,,,28169347,"Gill C, Walsh SE, Morrissey C, Fitzpatrick JM, Watson RW. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate. 2007 Nov 01;67(15):1641–53. doi: 10.1002/pros.20653. PMID: 17823925."
1361739,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:32621571,https://www.ncbi.nlm.nih.gov/pubmed/32621571,32621571,,,31127354,"Chen L, Xia J, Wu J, Chen Y, Qiu C. Resveratrol inhibits oral squamous cell carcinoma cells proliferation while promoting apoptosis through inhibition of <scp>CBX7</scp> protein. Environmental Toxicology. 2020 Jul 04;35(11):1234–40. doi: 10.1002/tox.22988."
1361740,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein,,,PMID:19561642,https://www.ncbi.nlm.nih.gov/pubmed/19561642,19561642,,,18069731,"Reis-Sobreiro M, Gajate C, Mollinedo F. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene. 2009 Sep 10;28(36):3221–34. doi: 10.1038/onc.2009.183. PMID: 19561642."
1361741,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of PARP1 protein,,,PMID:16628003,https://www.ncbi.nlm.nih.gov/pubmed/16628003,16628003,,,1659905,"Kolthur-Seetharam U, Dantzer F, McBurney MW, de Murcia G, Sassone-Corsi P. Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle. 2006 Apr;5(8):873–7. doi: 10.4161/cc.5.8.2690. PMID: 16628003."
1361742,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol results in increased cleavage of PARP1 protein,,,PMID:12690110|PMID:16617056|PMID:16814113|PMID:17007014|PMID:17164350|PMID:17534123|PMID:17554206|PMID:18222423|PMID:18444175|PMID:19631782|PMID:21184191|PMID:22923501|PMID:23152798|PMID:23594881|PMID:23954321|PMID:24090995|PMID:24264887|PMID:26911335|PMID:27064016,https://www.ncbi.nlm.nih.gov/pubmed/12690110|https://www.ncbi.nlm.nih.gov/pubmed/16617056|https://www.ncbi.nlm.nih.gov/pubmed/16814113|https://www.ncbi.nlm.nih.gov/pubmed/17007014|https://www.ncbi.nlm.nih.gov/pubmed/17164350|https://www.ncbi.nlm.nih.gov/pubmed/17534123|https://www.ncbi.nlm.nih.gov/pubmed/17554206|https://www.ncbi.nlm.nih.gov/pubmed/18222423|https://www.ncbi.nlm.nih.gov/pubmed/18444175|https://www.ncbi.nlm.nih.gov/pubmed/19631782|https://www.ncbi.nlm.nih.gov/pubmed/21184191|https://www.ncbi.nlm.nih.gov/pubmed/22923501|https://www.ncbi.nlm.nih.gov/pubmed/23152798|https://www.ncbi.nlm.nih.gov/pubmed/23594881|https://www.ncbi.nlm.nih.gov/pubmed/23954321|https://www.ncbi.nlm.nih.gov/pubmed/24090995|https://www.ncbi.nlm.nih.gov/pubmed/24264887|https://www.ncbi.nlm.nih.gov/pubmed/26911335|https://www.ncbi.nlm.nih.gov/pubmed/27064016,12690110|16617056|16814113|17007014|17164350|17534123|17554206|18222423|18444175|19631782|21184191|22923501|23152798|23594881|23954321|24090995|24264887|26911335|27064016,,PMC3078954|PMC3495968|PMC3502626|PMC3707971|PMC3738302|PMC4088162|PMC4766620,241518|2482918|5290464|5913545|8013580|8578256|10633424|11938187|18095168|19386561|21404118|22246633|24791306|24809814|30321197|30854546|30892116|31621272|33643937,"Baek SH, Ko JH, Lee H, Jung J, Kong M, Lee JW, Lee J, Chinnathambi A, Zayed ME, Alharbi SA, Lee SG, Shim BS, Sethi G, Kim SH, Yang WM, Um JY, Ahn KS. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. Phytomedicine. 2016 May 15;23(5):566–77. doi: 10.1016/j.phymed.2016.02.011. PMID: 27064016.|2016; 17(1):19|Suzuki Y, Ito S, Sasaki R, Asahi M, Ishida Y. Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells. Leuk Res. 2013 Dec;37(12):1674–9. doi: 10.1016/j.leukres.2013.09.010. PMID: 24090995.|2013; 19(3):527-541|Kumazaki M, Noguchi S, Yasui Y, Iwasaki J, Shinohara H, Yamada N, Akao Y. Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells. The Journal of Nutritional Biochemistry. 2013 Nov;24(11):1849–58. doi: 10.1016/j.jnutbio.2013.04.006.|Yu XM, Jaskula-Sztul R, Ahmed K, Harrison AD, Kunnimalaiyaan M, Chen H. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Mol Cancer Ther. 2013 Jul;12(7):1276–87. PMID: 23594881; PMCID: PMC3707971.|Yaseen A, Chen S, Hock S, Rosato R, Dent P, Dai Y, Grant S. Resveratrol Sensitizes Acute Myelogenous Leukemia Cells to Histone Deacetylase Inhibitors through Reactive Oxygen Species-Mediated Activation of the Extrinsic Apoptotic Pathway. Molecular Pharmacology. 2012 Dec;82(6):1030–41. doi: 10.1124/mol.112.079624.|Ferraz da Costa DC, Casanova FA, Quarti J, Malheiros MS, Sanches D, dos Santos PS, Fialho E, Silva JL. Transient Transfection of a Wild-Type p53 Gene Triggers Resveratrol-Induced Apoptosis in Cancer Cells. PLoS ONE. 2012 Nov 12;7(11):e48746. doi: 10.1371/journal.pone.0048746.|2010; 18(5):1506-1511|Lee JS, Jeong SH, Soung YH, Kim TH, Choi HJ, Park BS, Kwon TK, Yoo YH. SAHA treatment overcomes the anti-apoptotic effects of Bcl-2 and is associated with the formation of mature PML nuclear bodies in human leukemic U937 cells. Chem Biol Interact. 2009 Sep 14;181(1):61–70. doi: 10.1016/j.cbi.2009.02.007. PMID: 19631782.|Snyder RM, Yu W, Jia L, Sanders BG, Kline K. Vitamin E Analog a -TEA, Methylseleninic Acid, and<i>Trans</i>-Resveratrol in Combination Synergistically Inhibit Human Breast Cancer Cell Growth. Nutrition and Cancer. 2008 Apr 28;60(3):401–11. doi: 10.1080/01635580701759716.|Ivanov VN, Partridge MA, Johnson GE, Huang SXL, Zhou H, Hei TK. Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Experimental Cell Research. 2008 Mar;314(5):1163–76. doi: 10.1016/j.yexcr.2007.12.012.|Alkhalaf M. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation. Eur J Cancer Prev. 2007 Aug;16(4):334–41. doi: 10.1097/01.cej.0000228413.06471.4c. PMID: 17554206.|Alkhalaf M. Resveratrol-Induced Apoptosis Is Associated with Activation of p53 and Inhibition of Protein Translation in T47D Human Breast Cancer Cells. Pharmacology. 2007;80(2-3):134–43. doi: 10.1159/000103253.|Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S, Aggarwal BB. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood. 2007 Mar 15;109(6):2293–302. doi: 10.1182/blood-2006-02-003988. PMID: 17164350.|Riles WL, Erickson J, Nayyar S, Atten MJ, Attar BM, Holian O. Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells. World J Gastroenterol. 2006 Sep 21;12(35):5628–34. PMID: 17007014; PMCID: PMC4088162.|Alkhalaf M, Jaffal S. Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: Novel cellular mechanisms involving the ERKs/p53 cascade. Free Radic Biol Med. 2006 Jul 15;41(2):318–25. doi: 10.1016/j.freeradbiomed.2006.04.019. PMID: 16814113.|Mohan J, Gandhi AA, Bhavya BC, Rashmi R, Karunagaran D, Indu R, Santhoshkumar TR. Caspase-2 Triggers Bax-Bak-dependent and -independent Cell Death in Colon Cancer Cells Treated with Resveratrol. Journal of Biological Chemistry. 2006 Jun;281(26):17599–611. doi: 10.1074/jbc.m602641200.|Ragione FD, Cucciolla V, Criniti V, Indaco S, Borriello A, Zappia V. p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect. J Biol Chem. 2003 Jun 27;278(26):23360–8. doi: 10.1074/jbc.m300771200. PMID: 12690110."
1361918,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol results in increased degradation of PARP1 protein,,,PMID:20028382,https://www.ncbi.nlm.nih.gov/pubmed/20028382,20028382,,PMC11159480,8640334,"Bai Y, Mao Q, Qin J, Zheng X, Wang Y, Yang K, Shen H, Xie L. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>. Cancer Science. 2010 Jan 29;101(2):488–93. doi: 10.1111/j.1349-7006.2009.01415.x."
1361919,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Resveratrol results in increased expression of PARP1 protein modified form,,,PMID:9680369,https://www.ncbi.nlm.nih.gov/pubmed/9680369,9680369,,,2218774,"Cle´ment M, Hirpara JL, Chawdhury S, Pervaiz S. Chemopreventive Agent Resveratrol, a Natural Product Derived From Grapes, Triggers CD95 Signaling-Dependent Apoptosis in Human Tumor Cells. 1998 Aug 01;92(3):996–1002. doi: 10.1182/blood.v92.3.996.415k23_996_1002."
1361920,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [bisphenol A promotes the reaction [cholesterol results in increased cleavage of PARP1 protein]],,,PMID:33239236,https://www.ncbi.nlm.nih.gov/pubmed/33239236,33239236,,,3347969,"Yang Y, Liu C, Yang J, Yuan F, Cheng R, Chen R, Shen Y, Huang L. Impairment of sirtuin 1-mediated DNA repair is involved in bisphenol A-induced aggravation of macrophage inflammation and atherosclerosis. Chemosphere. 2021 Feb;265():128997. doi: 10.1016/j.chemosphere.2020.128997. PMID: 33239236."
1361921,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [PPT1 gene mutant form results in increased expression of PARP1 protein modified form],,,PMID:21224254,https://www.ncbi.nlm.nih.gov/pubmed/21224254,21224254,,PMC3043662,29579352,"Wei H, Zhang Z, Saha A, Peng S, Chandra G, Quezado Z, Mukherjee AB. Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. 2010 Dec 24;20(6):1111–21. doi: 10.1093/hmg/ddq555."
1361922,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [sodium fluoride results in increased cleavage of PARP1 protein],,,PMID:24296261,https://www.ncbi.nlm.nih.gov/pubmed/24296261,24296261,,PMC3913072,11384282,"Suzuki M, Bartlett JD. Sirtuin1 and autophagy protect cells from fluoride-induced cell stress. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2014 Feb;1842(2):245–55. doi: 10.1016/j.bbadis.2013.11.023."
1361923,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Resveratrol results in increased cleavage of PARP1 protein,,,PMID:16675471|PMID:17872969|PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/16675471|https://www.ncbi.nlm.nih.gov/pubmed/17872969|https://www.ncbi.nlm.nih.gov/pubmed/25505154,16675471|17872969|25505154,,PMC4350028|PMC4796949,16820079|26848292|33533836,"Ren X, Bai X, Zhang X, Li Z, Tang L, Zhao X, Li Z, Ren Y, Wei S, Wang Q, Liu C, Ji J. Quantitative Nuclear Proteomics Identifies that miR-137-mediated EZH2 Reduction Regulates Resveratrol-induced Apoptosis of Neuroblastoma Cells*. Molecular & Cellular Proteomics. 2015 Feb;14(2):316–28. doi: 10.1074/mcp.m114.041905.|Singh NP, Hegde VL, Hofseth LJ, Nagarkatti M, Nagarkatti P. Resveratrol (trans-3,5,4'-Trihydroxystilbene) Ameliorates Experimental Allergic Encephalomyelitis, Primarily via Induction of Apoptosis in T Cells Involving Activation of Aryl Hydrocarbon Receptor and Estrogen Receptor. Molecular Pharmacology. 2007 Dec;72(6):1508–21. doi: 10.1124/mol.107.038984.|Lee EO, Lee HJ, Hwang HS, Ahn KS, Chae C, Kang KS, Lu J, Kim SH. Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis. 2006 Oct;27(10):2059–69. doi: 10.1093/carcin/bgl055. PMID: 16675471."
1361924,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [estradiol results in decreased cleavage of PARP1 protein],,,PMID:24894866,https://www.ncbi.nlm.nih.gov/pubmed/24894866,24894866,,PMC4123650,8708839,"Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, Bhat HK. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis. 2014 Aug;35(8):1872–80. PMID: 24894866; PMCID: PMC4123650."
1361925,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Resveratrol results in decreased cleavage of PARP1 protein|resveratrol inhibits the reaction [excitatory amino acid agonists results in increased cleavage of PARP1 protein],,,PMID:24675465,https://www.ncbi.nlm.nih.gov/pubmed/24675465,24675465,,PMC3973229,28964213,"Lin CJ, Chen TH, Yang LY, Shih CM. Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. Cell Death Dis. 2014 Mar 27;5():e1147. PMID: 24675465; PMCID: PMC3973229."
1361926,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [testosterone results in increased expression of PARP1 protein],,,PMID:25714330,https://www.ncbi.nlm.nih.gov/pubmed/25714330,25714330,,,2527546,"Chung K, Cheon S, An H. Effects of Resveratrol on Benign Prostatic Hyperplasia by the Regulation of Inflammatory and Apoptotic Proteins. J. Nat. Prod. 2015 Feb 25;78(4):689–94. doi: 10.1021/np500810c."
1361927,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of PARP1 mRNA,,,PMID:33775663,https://www.ncbi.nlm.nih.gov/pubmed/33775663,33775663,,,11557131,"Kilarkaje N, Al-Qaryyan M, Al-Bader MD. Trans-resveratrol imparts disparate effects on transcription of DNA damage sensing/repair pathway genes in euglycemic and hyperglycemic rat testis. Toxicol Appl Pharmacol. 2021 May 01;418():115510. doi: 10.1016/j.taap.2021.115510. PMID: 33775663."
1362106,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Resveratrol results in increased cleavage of PARP1 protein,,,PMID:24304514|PMID:24894866,https://www.ncbi.nlm.nih.gov/pubmed/24304514|https://www.ncbi.nlm.nih.gov/pubmed/24894866,24304514|24894866,,PMC3956533|PMC4123650,8708839|11392078,"Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, Bhat HK. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis. 2014 Aug;35(8):1872–80. PMID: 24894866; PMCID: PMC4123650.|Alayev A, Sun Y, Snyder RB, Berger SM, Yu JJ, Holz MK. Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell Cycle. 2014;13(3):371–82. PMID: 24304514; PMCID: PMC3956533."
1362107,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[sirolimus co-treated with resveratrol] results in increased cleavage of PARP1 protein|tsc2 protein inhibits the reaction [[sirolimus co-treated with resveratrol] results in increased cleavage of PARP1 protein]|tsc2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein],,,PMID:24304514,https://www.ncbi.nlm.nih.gov/pubmed/24304514,24304514,,PMC3956533,11392078,"Alayev A, Sun Y, Snyder RB, Berger SM, Yu JJ, Holz MK. Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell Cycle. 2014;13(3):371–82. PMID: 24304514; PMCID: PMC3956533."
1490421,445434,Comparative Toxicogenomics Database (CTD),microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cyanoginosin LR inhibits the reaction [PARP1 protein binds to TIMELESS protein]|cyanoginosin LR promotes the reaction [CGAS protein binds to PARP1 protein]|blk protein inhibits the reaction [cyanoginosin LR inhibits the reaction [PARP1 protein binds to TIMELESS protein]]|[cyanoginosin LR inhibits the reaction [PARP1 protein binds to TIMELESS protein]] promotes the reaction [CGAS protein binds to PARP1 protein],,,PMID:36435412,https://www.ncbi.nlm.nih.gov/pubmed/36435412,36435412,,,34916487,"Wang X, Zhu Y, Lu W, Guo X, Chen L, Zhang N, Chen S, Ge C, Xu S. Microcystin-LR-induced nuclear translocation of cGAS promotes mutagenesis in human hepatocytes by impeding homologous recombination repair. Toxicol Lett. 2023 Jan 15;373():94–104. doi: 10.1016/j.toxlet.2022.11.015. PMID: 36435412."
1490422,445434,Comparative Toxicogenomics Database (CTD),microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sulforaphane inhibits the reaction [cyanoginosin LR results in increased cleavage of PARP1 protein]|cyanoginosin LR results in increased cleavage of PARP1 protein,,,PMID:21684301,https://www.ncbi.nlm.nih.gov/pubmed/21684301,21684301,,PMC3577421,21464766,"Sun X, Mi L, Liu J, Song L, Chung F, Gan N. Sulforaphane prevents microcystin-LR-induced oxidative damage and apoptosis in BALB/c mice. Toxicology and Applied Pharmacology. 2011 Aug;255(1):9–17. doi: 10.1016/j.taap.2011.05.011."
1490423,445434,Comparative Toxicogenomics Database (CTD),microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pifithrin inhibits the reaction [cyanoginosin LR results in increased cleavage of PARP1 protein]|cyanoginosin LR results in increased cleavage of PARP1 protein,,,PMID:31157505,https://www.ncbi.nlm.nih.gov/pubmed/31157505,31157505,,,33797221,"Wu J, Liu H, Huang H, Yuan L, Liu C, Wang Y, Cheng X, Zhuang D, Xu M, Chen X, Losiewicz MD, Zhang H. <i>p53</i>-Dependent pathway and the opening of mPTP mediate the apoptosis of co-cultured Sertoli-germ cells induced by microcystin-LR. Environmental Toxicology. 2019 Jun 03;34(10):1074–84. doi: 10.1002/tox.22808."
567235,445580,Comparative Toxicogenomics Database (CTD),Doconexent,D004281,Docosahexaenoic Acids,https://ctdbase.org/detail.go?type=chem&acc=D004281,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cypermethrin inhibits the reaction [docosahexaenoic acids results in increased degradation of PARP1 protein]|tautomycin inhibits the reaction [docosahexaenoic acids results in increased degradation of PARP1 protein]|docosahexaenoic acids results in increased degradation of PARP1 protein,,,PMID:11341974,https://www.ncbi.nlm.nih.gov/pubmed/11341974,11341974,,,14541089,"Siddiqui RA, Jenski LJ, Neff K, Harvey K, Kovacs RJ, Stillwell W. Docosahexaenoic acid induces apoptosis in Jurkat cells by a protein phosphatase-mediated process. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2001 Jan;1499(3):265–75. doi: 10.1016/s0167-4889(00)00128-2."
567236,445580,Comparative Toxicogenomics Database (CTD),Doconexent,D004281,Docosahexaenoic Acids,https://ctdbase.org/detail.go?type=chem&acc=D004281,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Docosahexaenoic acids analog results in increased cleavage of PARP1 protein,,,PMID:27041074,https://www.ncbi.nlm.nih.gov/pubmed/27041074,27041074,,,20907214,"Skibinski CG, Das A, Chen KM, Liao J, Manni A, Kester M, El-Bayoumy K. A novel biologically active acid stable liposomal formulation of docosahexaenoic acid in human breast cancer cell lines. Chem Biol Interact. 2016 May 25;252():1–8. doi: 10.1016/j.cbi.2016.03.035. PMID: 27041074."
567237,445580,Comparative Toxicogenomics Database (CTD),Doconexent,D004281,Docosahexaenoic Acids,https://ctdbase.org/detail.go?type=chem&acc=D004281,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Docosahexaenoic acids inhibits the reaction [ethanol results in increased expression of PARP1 protein],,,PMID:25029343,https://www.ncbi.nlm.nih.gov/pubmed/25029343,25029343,,PMC4100731,10043632,"Tajuddin N, Moon K, Marshall SA, Nixon K, Neafsey EJ, Kim H, Collins MA. Neuroinflammation and Neurodegeneration in Adult Rat Brain from Binge Ethanol Exposure: Abrogation by Docosahexaenoic Acid. PLoS ONE. 2014 Jul 16;9(7):e101223. doi: 10.1371/journal.pone.0101223."
1854136,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oleic acid results in increased cleavage of PARP1 protein,,,PMID:21132278,https://www.ncbi.nlm.nih.gov/pubmed/21132278,21132278,,PMC4741309,20136636,2010; 85(6):623-634
1854954,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [oleic acid results in increased activity of PARP1 protein]|parp1 protein affects the reaction [oleic acid results in decreased phosphorylation of GSK3B protein]|parp1 protein affects the reaction [oleic acid results in decreased phosphorylation of AKT1 protein]|[nad co-treated with oleic acid] results in increased activity of PARP1 protein|parp1 protein affects the reaction [oleic acid results in decreased phosphorylation of INSR protein]|oleic acid results in increased activity of PARP1 protein|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[NAD co-treated with oleic acid] results in increased activity of PARP1 protein]",,,PMID:25536389,https://www.ncbi.nlm.nih.gov/pubmed/25536389,25536389,,,484878,"Pang J, Cui J, Gong H, Xi C, Zhang TM. Effect of NAD on PARP-mediated insulin sensitivity in oleic acid treated hepatocytes. J Cell Physiol. 2015 Jul;230(7):1607–13. doi: 10.1002/jcp.24907. PMID: 25536389."
1854955,445639,Comparative Toxicogenomics Database (CTD),Oleic Acid,D019301,Oleic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019301,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [oleic acid results in increased activity of PARP1 protein]|oleic acid results in increased activity of PARP1 protein",,,PMID:30165350,https://www.ncbi.nlm.nih.gov/pubmed/30165350,30165350,,,3287389,"Pang J, Cui J, Xi C, Shen T, Gong H, Dou L, Lin Y, Zhang T. Inhibition of Poly(ADP-Ribose) Polymerase Increased Lipid Accumulation Through SREBP1 Modulation. Cell Physiol Biochem. 2018;49(2):645–52. doi: 10.1159/000493028."
1585247,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Cocaine affects the expression of PARP1 mRNA,,,PMID:15681117,https://www.ncbi.nlm.nih.gov/pubmed/15681117,15681117,,,3721163,"Novikova SI, He F, Bai J, Badan I, Lidow IA, Lidow MS. Cocaine-induced changes in the expression of apoptosis-related genes in the fetal mouse cerebral wall. Neurotoxicol Teratol. 2005 Jan;27(1):3–14. doi: 10.1016/j.ntt.2004.08.004. PMID: 15681117."
1585248,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cocaine results in increased cleavage of PARP1 protein,,,PMID:17084983,https://www.ncbi.nlm.nih.gov/pubmed/17084983,17084983,,PMC2562674,23418160,"Dey S, Mactutus CF, Booze RM, Snow DM. Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons by altering the Bax/Bcl-2 ratio and through caspase-3 apoptotic signaling. Neuroscience. 2007 Jan;144(2):509–21. doi: 10.1016/j.neuroscience.2006.09.047."
1873153,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[orlistat co-treated with thapsigargin] results in increased cleavage of PARP1 protein,,,PMID:17283163,https://www.ncbi.nlm.nih.gov/pubmed/17283163,17283163,,,3735936,"Little JL, Wheeler FB, Fels DR, Koumenis C, Kridel SJ. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Res. 2007 Feb 01;67(3):1262–9. doi: 10.1158/0008-5472.can-06-1794. PMID: 17283163."
1873154,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Apigenin inhibits the reaction [thapsigargin results in increased cleavage of PARP1 protein]|thapsigargin results in increased cleavage of PARP1 protein,,,PMID:20493918,https://www.ncbi.nlm.nih.gov/pubmed/20493918,20493918,,,3799125,"Choi AY, Choi JH, Lee JY, Yoon KS, Choe W, Ha J, Yeo EJ, Kang I. Apigenin protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis. Neurochem Int. 2010 Sep;57(2):143–52. doi: 10.1016/j.neuint.2010.05.006. PMID: 20493918."
1873155,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Thapsigargin results in decreased expression of PARP1 protein,,,PMID:35544339,https://www.ncbi.nlm.nih.gov/pubmed/35544339,35544339,,PMC9671082,34028373,"Weldemariam MM, Woo J, Zhang Q. Pancreatic INS-1 ß-Cell Response to Thapsigargin and Rotenone: A Comparative Proteomics Analysis Uncovers Key Pathways of ß-Cell Dysfunction. Chem. Res. Toxicol. 2022 May 11;35(6):1080–94. doi: 10.1021/acs.chemrestox.2c00058."
1391042,446512,Comparative Toxicogenomics Database (CTD),Okadaic Acid,D019319,Okadaic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019319,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Okadaic acid inhibits the reaction [amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:16059913,https://www.ncbi.nlm.nih.gov/pubmed/16059913,16059913,,,22707845,"Kim KM, Lee YJ. Role of HER-2/neu signaling in sensitivity to tumor necrosis factor-related apoptosis-inducing ligand: enhancement of TRAIL-mediated apoptosis by amiloride. J Cell Biochem. 2005 Oct 01;96(2):376–89. doi: 10.1002/jcb.20512. PMID: 16059913."
1816658,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Lycopene inhibits the reaction [decamethrin results in increased activity of PARP1 protein],,,PMID:23076637,https://www.ncbi.nlm.nih.gov/pubmed/23076637,23076637,,,28944948,2012; 65(3):425-432
1836107,447277,Comparative Toxicogenomics Database (CTD),Geranylgeranyl pyrophosphate,C002963,geranylgeranyl pyrophosphate,https://ctdbase.org/detail.go?type=chem&acc=C002963,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Geranylgeranyl pyrophosphate inhibits the reaction [simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|geranylgeranyl pyrophosphate inhibits the reaction [TNFSF10 protein promotes the reaction [simvastatin results in increased cleavage of PARP1 protein]],,,PMID:21910007,https://www.ncbi.nlm.nih.gov/pubmed/21910007,21910007,,PMC4372201,23502040,2011; 16(12):1268-1284
1670403,447905,Comparative Toxicogenomics Database (CTD),GW-3965,C473027,GW 3965,https://ctdbase.org/detail.go?type=chem&acc=C473027,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),GW 3965 inhibits the reaction [palmitates results in increased cleavage of PARP1 protein],,,PMID:21209018,https://www.ncbi.nlm.nih.gov/pubmed/21209018,21209018,,,29566128,"Choi SE, Jung IR, Lee YJ, Lee SJ, Lee JH, Kim Y, Jun HS, Lee KW, Park CB, Kang Y. Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 beta-cell death. Endocrinology. 2011 Mar;152(3):816–27. doi: 10.1210/en.2010-0924. PMID: 21209018."
1848569,447912,Comparative Toxicogenomics Database (CTD),"N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide",C423915,T0901317,https://ctdbase.org/detail.go?type=chem&acc=C423915,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),T0901317 promotes the reaction [PARP1 protein binds to ABCA1 promoter]|t0901317 promotes the reaction [PARP1 protein binds to ABCG1 promoter]|parp1 protein inhibits the reaction [T0901317 results in increased expression of ABCA1 mrna]|t0901317 promotes the reaction [PARP1 protein binds to SREBF1 promoter],,,PMID:27026705,https://www.ncbi.nlm.nih.gov/pubmed/27026705,27026705,,PMC4900266,20893705,"Shrestha E, Hussein MA, Savas JN, Ouimet M, Barrett TJ, Leone S, Yates JR, Moore KJ, Fisher EA, Garabedian MJ. Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages. Journal of Biological Chemistry. 2016 May;291(21):11172–84. doi: 10.1074/jbc.m116.726729."
1848570,447912,Comparative Toxicogenomics Database (CTD),"N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide",C423915,T0901317,https://ctdbase.org/detail.go?type=chem&acc=C423915,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),T0901317 inhibits the reaction [palmitates results in increased cleavage of PARP1 protein],,,PMID:21209018,https://www.ncbi.nlm.nih.gov/pubmed/21209018,21209018,,,29566128,"Choi SE, Jung IR, Lee YJ, Lee SJ, Lee JH, Kim Y, Jun HS, Lee KW, Park CB, Kang Y. Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 beta-cell death. Endocrinology. 2011 Mar;152(3):816–27. doi: 10.1210/en.2010-0924. PMID: 21209018."
1456722,448042,Comparative Toxicogenomics Database (CTD),Y-27632 dihydrochloride,C108830,Y 27632,https://ctdbase.org/detail.go?type=chem&acc=C108830,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Y 27632 results in decreased expression of PARP1 protein,,,PMID:24676941,https://www.ncbi.nlm.nih.gov/pubmed/24676941,24676941,,,28965560,"Kuang J, Wang YL, Xiao M, Tang Y, Chen WW, Song GL, Yang X, Li M. Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells. Oncol Rep. 2014 May;31(5):2335–43. doi: 10.3892/or.2014.3100. PMID: 24676941."
1418184,448087,DrugBank,RB106,DB02669,RB106,https://www.drugbank.ca/drugs/DB02669,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619,https://www.ncbi.nlm.nih.gov/pubmed/37713619,37713619,,PMC10767903,36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751."
1819879,448087,Therapeutic Target Database (TTD),RB106,D0E7UW,TI3,https://idrblab.net/ttd/data/drug/details/D0E7UW,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1596773,448457,Comparative Toxicogenomics Database (CTD),Prostaglandin D2,D015230,Prostaglandin D2,https://ctdbase.org/detail.go?type=chem&acc=D015230,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Prostaglandin D2 results in increased cleavage of PARP1 protein,,,PMID:15843042,https://www.ncbi.nlm.nih.gov/pubmed/15843042,15843042,,,7860293,"Chen Y, Shen S, Tsai S. Prostaglandin D2 and J2 induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2005 Apr;1743(3):291–304. doi: 10.1016/j.bbamcr.2004.10.016."
1596774,448457,Comparative Toxicogenomics Database (CTD),Prostaglandin D2,D015230,Prostaglandin D2,https://ctdbase.org/detail.go?type=chem&acc=D015230,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Prostaglandin D2 results in increased cleavage of PARP1 protein,,,PMID:23973622,https://www.ncbi.nlm.nih.gov/pubmed/23973622,23973622,,PMC3904641,8031651,"Liu H, Li W, Rose ME, Pascoe JL, Miller TM, Ahmad M, Poloyac SM, Hickey RW, Graham SH. Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. Neurotoxicology. 2013 Dec;39():35–44. PMID: 23973622; PMCID: PMC3904641."
1459295,448799,Comparative Toxicogenomics Database (CTD),Epothilone A,C093787,epothilone A,https://ctdbase.org/detail.go?type=chem&acc=C093787,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Triciribine promotes the reaction [[epothilone A co-treated with metformin] results in increased expression of PARP1 mrna]|[epothilone A co-treated with metformin] results in increased expression of PARP1 mrna|epothilone A results in increased expression of PARP1 mrna|triciribine inhibits the reaction [epothilone A results in increased expression of PARP1 mrna]|sodium salicylate inhibits the reaction [epothilone A results in increased expression of PARP1 mrna],,,PMID:29117515,https://www.ncbi.nlm.nih.gov/pubmed/29117515,29117515,,,30394656,"Rogalska A, Bukowska B, Marczak A. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells. Toxicol In Vitro. 2018 Mar;47():48–62. doi: 10.1016/j.tiv.2017.11.001. PMID: 29117515."
1538710,448889,BindingDB,,27709,"2-{3-[4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridin-1-yl]propyl}-8-methyl-3,4-dihydroquinazolin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27709,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),16,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
1538712,448890,BindingDB,"5-Fluoro-1-[4-(4-phenyl-3,6-dihydropyridin-1(2H)-YL)butyl]quinazoline-2,4(1H,3H)-dione",27714,"5-fluoro-1-[4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)butyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27714,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),60,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
1544880,448890,DrugBank,"5-Fluoro-1-[4-(4-phenyl-3,6-dihydropyridin-1(2H)-YL)butyl]quinazoline-2,4(1H,3H)-dione",DB07787,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",https://www.drugbank.ca/drugs/DB07787,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,PMC102472,12499145,"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
1539549,448949,Comparative Toxicogenomics Database (CTD),6-Bromoindirubin-3'-oxime,C483321,6-bromoindirubin-3'-oxime,https://ctdbase.org/detail.go?type=chem&acc=C483321,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),6-bromoindirubin-3'-oxime promotes the reaction [paraquat results in increased expression of PARP1 protein modified form],,,PMID:28414160,https://www.ncbi.nlm.nih.gov/pubmed/28414160,28414160,,,6714909,"Hathaichoti S, Visitnonthachai D, Ngamsiri P, Niyomchan A, Tsogtbayar O, Wisessaowapak C, Watcharasit P, Satayavivad J. Paraquat induces extrinsic pathway of apoptosis in A549 cells by induction of DR5 and repression of anti-apoptotic proteins, DDX3 and GSK3 expression. Toxicol In Vitro. 2017 Aug;42():123–9. doi: 10.1016/j.tiv.2017.04.016. PMID: 28414160."
1677636,449171,Comparative Toxicogenomics Database (CTD),Alitretinoin,D000077556,Alitretinoin,https://ctdbase.org/detail.go?type=chem&acc=D000077556,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Alitretinoin results in increased cleavage of PARP1 protein,,,PMID:16449964,https://www.ncbi.nlm.nih.gov/pubmed/16449964,16449964,,,31509599,"Yin W, Rossin A, Clifford JL, Gronemeyer H. Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene. 2006 Jun 22;25(26):3735–44. doi: 10.1038/sj.onc.1209410. PMID: 16449964."
1821388,451415,Comparative Toxicogenomics Database (CTD),Aclarubicin,D015250,Aclarubicin,https://ctdbase.org/detail.go?type=chem&acc=D015250,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aclarubicin affects the activity of PARP1 protein,,,PMID:20399885,https://www.ncbi.nlm.nih.gov/pubmed/20399885,20399885,,,24183800,"Rogalska A, Szwed M, Józwiak Z. Aclarubicin-induced apoptosis and necrosis in cells derived from human solid tumours. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2010 Jul;700(1-2):1–10. doi: 10.1016/j.mrgentox.2010.04.013."
1935931,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the reaction [decitabine results in increased expression of EGFL7 mrna]|decitabine affects the reaction [PARP1 protein affects the expression of DNMT1 mrna]|decitabine results in decreased expression of PARP1 protein|decitabine affects the reaction [PARP1 protein affects the expression of MIR222 mrna]|decitabine affects the reaction [PARP1 protein affects the expression of MIR126 mrna]|[parp1 protein co-treated with decitabine] affects the expression of EGFL7 mrna|parp1 protein affects the reaction [decitabine affects the expression of MIR222 mrna],,,PMID:32006662,https://www.ncbi.nlm.nih.gov/pubmed/32006662,32006662,,,16243267,"Gaetani S, Monaco F, Alessandrini F, Tagliabracci A, Sabbatini A, Bracci M, Valentino M, Neuzil J, Amati M, Santarelli L, Tomasetti M. Mechanism of miR-222 and miR-126 regulation and its role in asbestos-induced malignancy. The International Journal of Biochemistry & Cell Biology. 2020 Apr;121():105700. doi: 10.1016/j.biocel.2020.105700."
1935932,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [[decitabine co-treated with busulfan] results in increased cleavage of PARP1 protein]|[decitabine co-treated with busulfan] results in increased cleavage of PARP1 protein,,,PMID:19732952,https://www.ncbi.nlm.nih.gov/pubmed/19732952,19732952,,PMC2823987,32916323,"Valdez BC, Li Y, Murray D, Corn P, Champlin RE, Andersson BS. 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis. Leukemia Research. 2010 Mar;34(3):364–72. doi: 10.1016/j.leukres.2009.08.014."
1935933,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[decitabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:18636160,https://www.ncbi.nlm.nih.gov/pubmed/18636160,18636160,,,6552046,"Festuccia C, Gravina GL, D'Alessandro AM, Millimaggi D, Di Rocco C, Dolo V, Ricevuto E, Vicentini C, Bologna M. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells. Int J Oncol. 2008 Aug;33(2):381–8. PMID: 18636160."
1935934,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Decitabine inhibits the reaction [benzene results in decreased expression of PARP1 mrna]|decitabine inhibits the reaction [benzene results in increased methylation of PARP1 promoter],,,PMID:20230882,https://www.ncbi.nlm.nih.gov/pubmed/20230882,20230882,,,6562335,"Gao A, Zuo X, Liu Q, Lu X, Guo W, Tian L. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. Toxicol Lett. 2010 Jun 02;195(2-3):114–8. doi: 10.1016/j.toxlet.2010.03.005. PMID: 20230882."
1935935,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Decitabine inhibits the reaction [silicon dioxide results in decreased expression of PARP1 mrna]|decitabine results in decreased methylation of PARP1 gene,,,PMID:20123007,https://www.ncbi.nlm.nih.gov/pubmed/20123007,20123007,,,17394426,"Gao A, Song S, Zuo X, Guo W, Niu P, Tian L. Epigenetic mediated transcriptional activation of PARP-1 participates in silica-associated malignant transformation of human bronchial epithelial cells. Toxicol Lett. 2010 Apr 01;193(3):236–41. doi: 10.1016/j.toxlet.2010.01.017. PMID: 20123007."
1935936,451668,Comparative Toxicogenomics Database (CTD),Decitabine,D000077209,Decitabine,https://ctdbase.org/detail.go?type=chem&acc=D000077209,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Decitabine results in increased cleavage of PARP1 protein,,,PMID:23300844,https://www.ncbi.nlm.nih.gov/pubmed/23300844,23300844,,PMC3531428,8697120,"Biswal BK, Beyrouthy MJ, Hever-Jardine MP, Armstrong D, Tomlinson CR, Christensen BC, Marsit CJ, Spinella MJ. Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation. PLoS ONE. 2012 Dec 27;7(12):e53003. doi: 10.1371/journal.pone.0053003."
1837862,452707,Comparative Toxicogenomics Database (CTD),Gallotannin,D047348,Hydrolyzable Tannins,https://ctdbase.org/detail.go?type=chem&acc=D047348,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Hydrolyzable tannins inhibits the reaction [[hydrogen peroxide results in increased activity of PARP1 protein] which results in decreased abundance of nad]|hydrolyzable tannins inhibits the reaction [[methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of NAD],,,PMID:11593040,https://www.ncbi.nlm.nih.gov/pubmed/11593040,11593040,,PMC59796,29402615,"Ying W, Sevigny MB, Chen Y, Swanson RA. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. U.S.A. 2001 Oct 09;98(21):12227–32. doi: 10.1073/pnas.211202598."
1422838,457193,Comparative Toxicogenomics Database (CTD),Dactinomycin,D003609,Dactinomycin,https://ctdbase.org/detail.go?type=chem&acc=D003609,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10029,Cricetulus griseus (Chinese hamster),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [dactinomycin results in increased cleavage of PARP1 protein]|pld2 protein inhibits the reaction [dactinomycin results in increased cleavage of PARP1 protein]|dactinomycin results in increased cleavage of PARP1 protein|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [dactinomycin results in increased cleavage of PARP1 protein]|pld1 protein inhibits the reaction [dactinomycin results in increased cleavage of PARP1 protein],,,PMID:14640974,https://www.ncbi.nlm.nih.gov/pubmed/14640974,14640974,,PMC1223985,26766801,"Yamada M, Banno Y, Takuwa Y, Koda M, Hara A, Nozawa Y. Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells. Biochem J. 2004 Mar 01;378(Pt 2):649–56. PMID: 14640974; PMCID: PMC1223985."
1423020,457193,Comparative Toxicogenomics Database (CTD),Dactinomycin,D003609,Dactinomycin,https://ctdbase.org/detail.go?type=chem&acc=D003609,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[dactinomycin co-treated with nutlin 3] results in increased secretion of PARP1 protein,,,PMID:38460933,https://www.ncbi.nlm.nih.gov/pubmed/38460933,38460933,,,36974505,"Lasut-Szyszka B, Gdowicz-Klosok A, Malachowska B, Krzesniak M, Bedzinska A, Gawin M, Pietrowska M, Rusin M. Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes. Chem Biol Interact. 2024 Apr 01;392():110946. doi: 10.1016/j.cbi.2024.110946. PMID: 38460933."
1423021,457193,Comparative Toxicogenomics Database (CTD),Dactinomycin,D003609,Dactinomycin,https://ctdbase.org/detail.go?type=chem&acc=D003609,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TNF co-treated with dactinomycin] results in increased cleavage of PARP1 protein|dactinomycin promotes the reaction [TNF results in increased cleavage of PARP1 protein],,,PMID:16492401,https://www.ncbi.nlm.nih.gov/pubmed/16492401,16492401,,,26150244,"López-Armada MJ, Caramés B, Lires-Deán M, Cillero-Pastor B, Ruiz-Romero C, Galdo F, Blanco FJ. Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthritis Cartilage. 2006 Jul;14(7):660–9. doi: 10.1016/j.joca.2006.01.005. PMID: 16492401."
1572705,462382,Comparative Toxicogenomics Database (CTD),MG 132,C072553,benzyloxycarbonylleucyl-leucyl-leucine aldehyde,https://ctdbase.org/detail.go?type=chem&acc=C072553,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of PARP1 protein,,,PMID:15498850|PMID:16051428|PMID:18790767,https://www.ncbi.nlm.nih.gov/pubmed/15498850|https://www.ncbi.nlm.nih.gov/pubmed/16051428|https://www.ncbi.nlm.nih.gov/pubmed/18790767,15498850|16051428|18790767,,PMC2903039,5772104|22701327|24155195,"Lioni M, Noma K, Snyder A, Klein-Szanto A, Diehl JA, Rustgi AK, Herlyn M, Smalley KSM. Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway. 2008 Sep 01;7(9):2866–75. doi: 10.1158/1535-7163.mct-08-0391.|Vanderlaag K, Samudio I, Burghardt R, Barhoumi R, Safe S. Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3'-indolyl)methane (DIM) and 5,5'-dibromoDIM. Cancer Lett. 2006 May 18;236(2):198–212. doi: 10.1016/j.canlet.2005.05.036. PMID: 16051428.|Piva R, Gianferretti P, Ciucci A, Taulli R, Belardo G, Santoro MG. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins. Blood. 2005 Feb 15;105(4):1750–8. doi: 10.1182/blood-2004-04-1360. PMID: 15498850."
1572706,462382,Comparative Toxicogenomics Database (CTD),MG 132,C072553,benzyloxycarbonylleucyl-leucyl-leucine aldehyde,https://ctdbase.org/detail.go?type=chem&acc=C072553,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of PARP1 protein,,,PMID:20100472|PMID:34418242,https://www.ncbi.nlm.nih.gov/pubmed/20100472|https://www.ncbi.nlm.nih.gov/pubmed/34418242,20100472|34418242,,,7530018|17375936,"Wang J, Wang Y, He S, Wang Z, Deng Q, Liang H. Proteasome inhibition induces macrophage apoptosis via mitochondrial dysfunction. J Biochem Mol Toxicol. 2021 Nov;35(11):e22894. doi: 10.1002/jbt.22894. PMID: 34418242.|Han YH, Park WH. The changes of reactive oxygen species and glutathione by MG132, a proteasome inhibitor affect As4.1 juxtaglomerular cell growth and death. Chem Biol Interact. 2010 Mar 30;184(3):319–27. doi: 10.1016/j.cbi.2010.01.033. PMID: 20100472."
1694547,467315,Comparative Toxicogenomics Database (CTD),Theasinensin B,C576796,epigallocatechin-3-O-gallate epigallocatechin dimer,https://ctdbase.org/detail.go?type=chem&acc=C576796,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Epigallocatechin-3-O-gallate epigallocatechin dimer results in increased cleavage of PARP1 protein,,,PMID:35970427,https://www.ncbi.nlm.nih.gov/pubmed/35970427,35970427,,,34753396,"Sun XL, Xiang ZM, Xie YR, Zhang N, Wang LX, Wu YL, Zhang DY, Wang XJ, Sheng J, Zi CT. Dimeric-(-)-epigallocatechin-3-gallate inhibits the proliferation of lung cancer cells by inhibiting the EGFR signaling pathway. Chem Biol Interact. 2022 Sep 25;365():110084. doi: 10.1016/j.cbi.2022.110084. PMID: 35970427."
1558067,479503,Comparative Toxicogenomics Database (CTD),Shikonin,C016101,shikonin,https://ctdbase.org/detail.go?type=chem&acc=C016101,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [shikonin results in increased cleavage of PARP1 protein],,,PMID:24463199,https://www.ncbi.nlm.nih.gov/pubmed/24463199,24463199,,,18167418,"Lee MJ, Kao SH, Hunag JE, Sheu GT, Yeh CW, Hseu YC, Wang CJ, Hsu LS. Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species. Chem Biol Interact. 2014 Mar 25;211():44–53. doi: 10.1016/j.cbi.2014.01.008. PMID: 24463199."
1558068,479503,Comparative Toxicogenomics Database (CTD),Shikonin,C016101,shikonin,https://ctdbase.org/detail.go?type=chem&acc=C016101,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Shikonin results in increased cleavage of PARP1 protein,,,PMID:24463199|PMID:37268198,https://www.ncbi.nlm.nih.gov/pubmed/24463199|https://www.ncbi.nlm.nih.gov/pubmed/37268198,24463199|37268198,,,18167418|35714382,"Qian X, Zhu L, Xu M, Liu H, Yu X, Shao Q, Qin J. Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation. Chem Biol Interact. 2023 Sep 01;382():110588. doi: 10.1016/j.cbi.2023.110588. PMID: 37268198.|Lee MJ, Kao SH, Hunag JE, Sheu GT, Yeh CW, Hseu YC, Wang CJ, Hsu LS. Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species. Chem Biol Interact. 2014 Mar 25;211():44–53. doi: 10.1016/j.cbi.2014.01.008. PMID: 24463199."
1765876,480865,Comparative Toxicogenomics Database (CTD),Licoricidin,C401293,licoricidin,https://ctdbase.org/detail.go?type=chem&acc=C401293,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Licoricidin results in increased cleavage of PARP1 protein,,,PMID:37013980,https://www.ncbi.nlm.nih.gov/pubmed/37013980,37013980,,,35633542,"Wu P, Chiou H, Hsieh Y, Lin C, Lee H, Liu I, Ying T. Induction of immunogenic cell death effect of licoricidin in cervical cancer cells by enhancing <scp>endoplasmic reticulum</scp> stress-mediated high mobility group box 1 expression. Environmental Toxicology. 2023 Apr 04;38(7):1641–50. doi: 10.1002/tox.23793."
1626280,493570,Comparative Toxicogenomics Database (CTD),Riboflavin,D012256,Riboflavin,https://ctdbase.org/detail.go?type=chem&acc=D012256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[niacin co-treated with ubiquinone co-treated with riboflavin] results in increased expression of PARP1 protein,,,PMID:18377693,https://www.ncbi.nlm.nih.gov/pubmed/18377693,18377693,,,9280470,"Premkumar VG, Yuvaraj S, Shanthi P, Sachdanandam P. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. Br J Nutr. 2008 Dec;100(6):1179–82. doi: 10.1017/s0007114508968276. PMID: 18377693."
1626281,493570,Comparative Toxicogenomics Database (CTD),Riboflavin,D012256,Riboflavin,https://ctdbase.org/detail.go?type=chem&acc=D012256,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Riboflavin analog results in increased cleavage of PARP1 protein,,,PMID:20688149,https://www.ncbi.nlm.nih.gov/pubmed/20688149,20688149,,,7965538,"Chaves Neto AH, Yano CL, Paredes-Gamero EJ, Machado D, Justo GZ, Peppelenbosch MP, Ferreira CV. Riboflavin and photoproducts in MC3T3-E1 differentiation. Toxicol In Vitro. 2010 Oct;24(7):1911–9. doi: 10.1016/j.tiv.2010.07.026. PMID: 20688149."
1839519,499980,Toxin and Toxin Target Database (T3DB),"Ethane-1,2-diamine; trichlorocobalt",T3D0682,Tris(ethylenediamine)cobalt(III) chloride,http://www.t3db.ca/toxins/T3D0682,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1847413,516881,Toxin and Toxin Target Database (T3DB),Potassium arsenate,T3D0297,Potassium arsenate,http://www.t3db.ca/toxins/T3D0297,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1600946,517165,Comparative Toxicogenomics Database (CTD),Ammonium Acetate,C018824,ammonium acetate,https://ctdbase.org/detail.go?type=chem&acc=C018824,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Dizocilpine maleate inhibits the reaction [ammonium acetate results in increased expression of PARP1 protein]|ammonium acetate results in increased expression of PARP1 protein|cycloheximide inhibits the reaction [ammonium acetate results in increased expression of PARP1 protein],,,PMID:15147502,https://www.ncbi.nlm.nih.gov/pubmed/15147502,15147502,,,9200090,"Kosenko E, Montoliu C, Giordano G, Kaminsky Y, Venediktova N, Buryanov Y, Felipo V. Acute ammonia intoxication induces an NMDA receptor-mediated increase in poly(ADP-ribose) polymerase level and NAD<sup>+</sup> metabolism in nuclei of rat brain cells. Journal of Neurochemistry. 2004 Apr 27;89(5):1101–10. doi: 10.1111/j.1471-4159.2004.02426.x."
1898716,518740,Toxin and Toxin Target Database (T3DB),"2,4,5-Trioxa-1,3-diarsabicyclo[1.1.1]pentane",T3D0224,Arsenic trioxide,http://www.t3db.ca/toxins/T3D0224,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1841875,568416,Comparative Toxicogenomics Database (CTD),4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide,C554680,4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide,https://ctdbase.org/detail.go?type=chem&acc=C554680,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide results in increased degradation of PARP1 protein,,,PMID:20446019,https://www.ncbi.nlm.nih.gov/pubmed/20446019,20446019,,PMC4450253,3108840,2010; 342(1-2):133-142
1560874,616651,BindingDB,4-Benzyl-1(2H)-phthalazinone,27660,4-Benzyl-2H-phthalazin-1-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27660,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),770,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
1845753,616651,Therapeutic Target Database (TTD),4-Benzyl-1(2H)-phthalazinone,D08QWR,4-benzylphthalazin-1(2H)-one,https://idrblab.net/ttd/data/drug/details/D08QWR,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1902672,637511,Comparative Toxicogenomics Database (CTD),Cinnamaldehyde,C012843,cinnamaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C012843,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cinnamaldehyde analog results in increased cleavage of PARP1 protein,,,PMID:16343908,https://www.ncbi.nlm.nih.gov/pubmed/16343908,16343908,,,17995971,doi:10.1016/j.bmc.2005.11.028
1632425,637563,Comparative Toxicogenomics Database (CTD),Anethole,C006578,anethole,https://ctdbase.org/detail.go?type=chem&acc=C006578,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Anethole inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein],,,PMID:10871845,https://www.ncbi.nlm.nih.gov/pubmed/10871845,10871845,,,2950406,"Chainy GB, Manna SK, Chaturvedi MM, Aggarwal BB. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. Oncogene. 2000 Jun 08;19(25):2943–50. doi: 10.1038/sj.onc.1203614. PMID: 10871845."
1765888,637760,Comparative Toxicogenomics Database (CTD),Chalcone,D002599,Chalcone,https://ctdbase.org/detail.go?type=chem&acc=D002599,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MYC protein affects the susceptibility to [chalcone results in increased cleavage of PARP1 protein]|chalcone results in increased cleavage of PARP1 protein,,,PMID:20620131,https://www.ncbi.nlm.nih.gov/pubmed/20620131,20620131,,,16734558,"Kim TH, Seo WD, Ryu HW, Seo HR, Jin YB, Lee M, Ji YH, Park KH, Lee YS. Anti-tumor effects by a synthetic chalcone compound is mediated by c-Myc-mediated reactive oxygen species production. Chem Biol Interact. 2010 Oct 06;188(1):111–8. doi: 10.1016/j.cbi.2010.06.016. PMID: 20620131."
1602633,637858,Comparative Toxicogenomics Database (CTD),Piperlongumine,C498077,piperlongumine,https://ctdbase.org/detail.go?type=chem&acc=C498077,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[doxorubicin co-treated with piperlongumine] results in increased cleavage of PARP1 protein,,,PMID:30611789,https://www.ncbi.nlm.nih.gov/pubmed/30611789,30611789,,,18927378,"Piska K, Koczurkiewicz P, Wnuk D, Karnas E, Bucki A, Wójcik-Pszczola K, Jamrozik M, Michalik M, Kolaczkowski M, Pekala E. Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells - The involvement of carbonyl reductase 1 inhibition. Chem Biol Interact. 2019 Feb 25;300():40–8. doi: 10.1016/j.cbi.2019.01.003. PMID: 30611789."
1904474,638014,Comparative Toxicogenomics Database (CTD),beta-Ionone,C008157,beta-ionone,https://ctdbase.org/detail.go?type=chem&acc=C008157,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein]|hydroxychloroquine inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein]|beta-ionone results in increased cleavage of PARP1 protein|stk11 protein affects the reaction [beta-ionone results in increased cleavage of PARP1 protein]|dorsomorphin inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein],,,PMID:36843289,https://www.ncbi.nlm.nih.gov/pubmed/36843289,36843289,,,34977749,"Hou T, Wang Y, Dan W, Wei Y, Liu B, Que T, Lei Y, Yu B, Zeng J, Fan Y, Li L. ß-Ionone represses renal cell carcinoma progression through activating LKB1/AMPK-triggered autophagy. J Biochem Mol Toxicol. 2023 Jun;37(6):e23331. doi: 10.1002/jbt.23331. PMID: 36843289."
1974483,638015,Comparative Toxicogenomics Database (CTD),Retinal,D012172,Retinaldehyde,https://ctdbase.org/detail.go?type=chem&acc=D012172,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Retinaldehyde results in increased cleavage of PARP1 protein,,,PMID:25331497,https://www.ncbi.nlm.nih.gov/pubmed/25331497,25331497,,,5275128,"Li J, Cai X, Xia Q, Yao K, Chen J, Zhang Y, Naranmandura H, Liu X, Wu Y. Involvement of endoplasmic reticulum stress in all-trans-retinal-induced retinal pigment epithelium degeneration. Toxicol Sci. 2015 Jan;143(1):196–208. doi: 10.1093/toxsci/kfu223. PMID: 25331497."
1604330,638024,Comparative Toxicogenomics Database (CTD),Piperine,C008922,piperine,https://ctdbase.org/detail.go?type=chem&acc=C008922,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[piperine analog co-treated with paclitaxel] results in increased cleavage of PARP1 protein,,,PMID:37244399,https://www.ncbi.nlm.nih.gov/pubmed/37244399,37244399,,,35810314,"Sharma S, Choudhary S, Kaur S, Reddy MV, Thota N, Singh A, Koul S, Khan IA, Ahmed Z, Kumar A. Piperine analog PGP-41 treatment overcomes paclitaxel resistance in NCI/ADR-RES ovarian cells by inhibition of MDR1. Chem Biol Interact. 2023 Aug 25;381():110569. doi: 10.1016/j.cbi.2023.110569. PMID: 37244399."
1887864,638144,Comparative Toxicogenomics Database (CTD),Diethyl fumarate,C035088,diethyl fumarate,https://ctdbase.org/detail.go?type=chem&acc=C035088,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Diethyl fumarate results in increased cleavage of PARP1 protein,,,PMID:21105742,https://www.ncbi.nlm.nih.gov/pubmed/21105742,21105742,,,20112279,"West JD, Stamm CE, Kingsley PJ. Structure-activity comparison of the cytotoxic properties of diethyl maleate and related molecules: identification of diethyl acetylenedicarboxylate as a thiol cross-linking agent. Chem Res Toxicol. 2011 Jan 14;24(1):81–8. doi: 10.1021/tx100292n. PMID: 21105742."
1915787,638278,Comparative Toxicogenomics Database (CTD),Trihydroxychalcone,C040920,isoliquiritigenin,https://ctdbase.org/detail.go?type=chem&acc=C040920,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Isoliquiritigenin results in increased cleavage of PARP1 protein|benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [isoliquiritigenin results in increased cleavage of PARP1 protein],,,PMID:23747687,https://www.ncbi.nlm.nih.gov/pubmed/23747687,23747687,,,3187826,"Li Y, Zhao H, Wang Y, Zheng H, Yu W, Chai H, Zhang J, Falck JR, Guo AM, Yue J, Peng R, Yang J. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicol Appl Pharmacol. 2013 Oct 01;272(1):37–48. doi: 10.1016/j.taap.2013.05.031. PMID: 23747687."
1889831,639665,Comparative Toxicogenomics Database (CTD),Xanthohumol,C104536,xanthohumol,https://ctdbase.org/detail.go?type=chem&acc=C104536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Xanthohumol results in increased cleavage of PARP1 protein,,,PMID:15995977|PMID:35229981,https://www.ncbi.nlm.nih.gov/pubmed/15995977|https://www.ncbi.nlm.nih.gov/pubmed/35229981,15995977|35229981,,,2344858|22387023,"Hsieh MY, Hsieh MJ, Lo YS, Lin CC, Chuang YC, Chen MK, Chou MC. Xanthohumol targets the JNK1/2 signaling pathway in apoptosis of human nasopharyngeal carcinoma cells. Environ Toxicol. 2022 Jun;37(6):1509–20. doi: 10.1002/tox.23502. PMID: 35229981.|Pan L, Becker H, Gerhäuser C. Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Mol Nutr Food Res. 2005 Sep;49(9):837–43. doi: 10.1002/mnfr.200500065. PMID: 15995977."
1634086,641785,Comparative Toxicogenomics Database (CTD),Cardamomin,C436747,cardamonin,https://ctdbase.org/detail.go?type=chem&acc=C436747,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cardamonin results in increased cleavage of PARP1 protein,,,PMID:37268255,https://www.ncbi.nlm.nih.gov/pubmed/37268255,37268255,,,35936123,"Wenzel CK, von Montfort C, Ebbert L, Klahm NP, Reichert AS, Stahl W, Brenneisen P. The natural chalcone cardamonin selectively induces apoptosis in human neuroblastoma cells. Toxicol In Vitro. 2023 Sep;91():105625. doi: 10.1016/j.tiv.2023.105625. PMID: 37268255."
610753,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of PARP1 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,PMC6121255,19625190,"Lanza Cariccio V, Scionti D, Raffa A, Iori R, Pollastro F, Diomede F, Bramanti P, Trubiani O, Mazzon E. Treatment of Periodontal Ligament Stem Cells with MOR and CBD Promotes Cell Survival and Neuronal Differentiation via the PI3K/Akt/mTOR Pathway. Int J Mol Sci. 2018 Aug 09;19(8). PMID: 30096889; PMCID: PMC6121255."
610754,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cannabidiol results in decreased expression of PARP1 mRNA,,,PMID:33244087,https://www.ncbi.nlm.nih.gov/pubmed/33244087,33244087,,PMC7692486,3352261,"Go YY, Kim SR, Kim DY, Chae S, Song J. Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Scientific Reports. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y."
610755,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cannabidiol results in increased cleavage of PARP1 protein,,,PMID:29441458|PMID:31699976|PMID:33244087,https://www.ncbi.nlm.nih.gov/pubmed/29441458|https://www.ncbi.nlm.nih.gov/pubmed/31699976|https://www.ncbi.nlm.nih.gov/pubmed/33244087,29441458|31699976|33244087,,PMC6838113|PMC7692486,3316302|3352261|26382916,"Go YY, Kim SR, Kim DY, Chae S, Song J. Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Scientific Reports. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.|2019; 10(11):846|2018; 74(2):261-272"
610756,644019,Comparative Toxicogenomics Database (CTD),Cannabidiol,D002185,Cannabidiol,https://ctdbase.org/detail.go?type=chem&acc=D002185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),DIABLO protein affects the reaction [cannabidiol results in increased cleavage of PARP1 protein]|ddit3 protein affects the reaction [cannabidiol results in increased cleavage of PARP1 protein],,,PMID:31699976,https://www.ncbi.nlm.nih.gov/pubmed/31699976,31699976,,PMC6838113,3316302,2019; 10(11):846
1447868,644213,Comparative Toxicogenomics Database (CTD),2-chloro-5-nitro-N-phenylbenzamide,C457499,2-chloro-5-nitrobenzanilide,https://ctdbase.org/detail.go?type=chem&acc=C457499,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),2-chloro-5-nitrobenzanilide inhibits the reaction [[lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in increased expression of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 mrna]|2-chloro-5-nitrobenzanilide inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [cadmium chloride results in increased expression of PARP1 mrna]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in increased expression of and results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in increased expression of PARP1 mrna]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with cadmium chloride] results in increased expression of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [lead acetate results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [cadmium chloride results in increased expression of and results in increased cleavage of PARP1 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with cadmium chloride] results in increased expression of PARP1 mrna]|2-chloro-5-nitrobenzanilide inhibits the reaction [[lead acetate co-treated with cadmium chloride] results in increased expression of PARP1 mrna],,,PMID:28283887,https://www.ncbi.nlm.nih.gov/pubmed/28283887,28283887,,,17522612,2017; 55(3):2125-2149
1921123,644241,Comparative Toxicogenomics Database (CTD),Nilotinib,C498826,nilotinib,https://ctdbase.org/detail.go?type=chem&acc=C498826,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nilotinib results in increased cleavage of PARP1 protein|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [nilotinib results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [nilotinib results in increased cleavage of PARP1 protein],,,PMID:26549707,https://www.ncbi.nlm.nih.gov/pubmed/26549707,26549707,,,12254132,"Chen TC, Yu MC, Chien CC, Wu MS, Lee YC, Chen YC. Nilotinib reduced the viability of human ovarian cancer cells via mitochondria-dependent apoptosis, independent of JNK activation. Toxicol In Vitro. 2016 Mar;31():1–11. doi: 10.1016/j.tiv.2015.11.002. PMID: 26549707."
1566935,644312,Comparative Toxicogenomics Database (CTD),"benzyl N-[(2S)-1-[(3-bromo-4,5-dihydro-1,2-oxazol-5-yl)methylamino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamate",C510621,KCC 009,https://ctdbase.org/detail.go?type=chem&acc=C510621,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),KCC 009 results in increased cleavage of PARP1 protein,,,PMID:16170020,https://www.ncbi.nlm.nih.gov/pubmed/16170020,16170020,,,30174710,"Yuan L, Choi K, Khosla C, Zheng X, Higashikubo R, Chicoine MR, Rich KM. Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas. Mol Cancer Ther. 2005 Sep;4(9):1293–302. doi: 10.1158/1535-7163.mct-04-0328. PMID: 16170020."
1567442,644345,Comparative Toxicogenomics Database (CTD),Ac-DEVD-CHO,C099158,acetyl-aspartyl-glutamyl-valyl-aspartal,https://ctdbase.org/detail.go?type=chem&acc=C099158,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [cucurbitacin E results in increased cleavage of PARP1 protein],,,PMID:27106530,https://www.ncbi.nlm.nih.gov/pubmed/27106530,27106530,,,16857121,"Ma G, Luo W, Lu J, Ma DL, Leung CH, Wang Y, Chen X. Cucurbitacin E induces caspase-dependent apoptosis and protective autophagy mediated by ROS in lung cancer cells. Chem Biol Interact. 2016 Jun 25;253():1–9. doi: 10.1016/j.cbi.2016.04.028. PMID: 27106530."
1567443,644345,Comparative Toxicogenomics Database (CTD),Ac-DEVD-CHO,C099158,acetyl-aspartyl-glutamyl-valyl-aspartal,https://ctdbase.org/detail.go?type=chem&acc=C099158,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [lysionotin results in increased cleavage of PARP1 protein],,,PMID:33989594,https://www.ncbi.nlm.nih.gov/pubmed/33989594,33989594,,,10894746,"Yang A, Zhang P, Sun Z, Liu X, Zhang X, Liu X, Wang D, Meng Z. Lysionotin induces apoptosis of hepatocellular carcinoma cells via caspase-3 mediated mitochondrial pathway. Chem Biol Interact. 2021 Aug 01;344():109500. doi: 10.1016/j.cbi.2021.109500. PMID: 33989594."
1568456,644345,Comparative Toxicogenomics Database (CTD),Ac-DEVD-CHO,C099158,acetyl-aspartyl-glutamyl-valyl-aspartal,https://ctdbase.org/detail.go?type=chem&acc=C099158,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [mustard gas results in increased cleavage of PARP1 protein],,,PMID:12482751,https://www.ncbi.nlm.nih.gov/pubmed/12482751,12482751,,,5027934,"Rosenthal DS, Velena A, Chou F, Schlegel R, Ray R, Benton B, Anderson D, Smith WJ, Simbulan-Rosenthal CM. Expression of Dominant-negative Fas-associated Death Domain Blocks Human Keratinocyte Apoptosis and Vesication Induced by Sulfur Mustard. Journal of Biological Chemistry. 2003 Mar;278(10):8531–40. doi: 10.1074/jbc.m209549200."
1568457,644345,Comparative Toxicogenomics Database (CTD),Ac-DEVD-CHO,C099158,acetyl-aspartyl-glutamyl-valyl-aspartal,https://ctdbase.org/detail.go?type=chem&acc=C099158,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein],,,PMID:24704558,https://www.ncbi.nlm.nih.gov/pubmed/24704558,24704558,,,30995102,"Chen Y, Yang SH, Hueng DY, Syu JP, Liao CC, Wu YC. Cordycepin induces apoptosis of C6 glioma cells through the adenosine 2A receptor-p53-caspase-7-PARP pathway. Chem Biol Interact. 2014 Jun 05;216():17–25. doi: 10.1016/j.cbi.2014.03.010. PMID: 24704558."
1608268,656725,Comparative Toxicogenomics Database (CTD),cibacron blue F 3GA,C012842,Cibacron Blue F 3GA,https://ctdbase.org/detail.go?type=chem&acc=C012842,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Cibacron blue F 3GA inhibits the reaction [zinc chloride results in increased expression of PARP1 protein],,,PMID:22253048,https://www.ncbi.nlm.nih.gov/pubmed/22253048,22253048,,,16772070,"Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 2011 Dec;59(12):1933–45. doi: 10.1002/glia.21235. PMID: 22253048."
1469963,657038,Therapeutic Target Database (TTD),3-(4-Chlorophenyl)quinoxaline-5-carboxamide,D08ZVM,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,https://idrblab.net/ttd/data/drug/details/D08ZVM,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1568822,657038,BindingDB,3-(4-Chlorophenyl)quinoxaline-5-carboxamide,27720,3-(4-chlorophenyl)quinoxaline-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27720,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),33,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
1608274,657038,DrugBank,3-(4-Chlorophenyl)quinoxaline-5-carboxamide,DB03509,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,https://www.drugbank.ca/drugs/DB03509,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/37713619|https://www.ncbi.nlm.nih.gov/pubmed/10592235,37713619|10592235,,PMC102472|PMC10767903,12499145|36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
1995207,657237,Comparative Toxicogenomics Database (CTD),Fludarabine,C024352,fludarabine,https://ctdbase.org/detail.go?type=chem&acc=C024352,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[clofarabine co-treated with fludarabine co-treated with busulfan] results in increased cleavage of PARP1 protein,,,PMID:20933509,https://www.ncbi.nlm.nih.gov/pubmed/20933509,20933509,,PMC3006064,18751816,"Valdez BC, Li Y, Murray D, Champlin RE, Andersson BS. The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling. Biochemical Pharmacology. 2011 Jan;81(2):222–32. doi: 10.1016/j.bcp.2010.09.027."
1995208,657237,Comparative Toxicogenomics Database (CTD),Fludarabine,C024352,fludarabine,https://ctdbase.org/detail.go?type=chem&acc=C024352,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[fludarabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:12780785,https://www.ncbi.nlm.nih.gov/pubmed/12780785,12780785,,,27422129,"Jones DT, Ganeshaguru K, Mitchell WA, Foroni L, Baker RJ, Prentice HG, Mehta AB, Wickremasinghe RG. Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. Br J Haematol. 2003 Jun;121(5):713–20. doi: 10.1046/j.1365-2141.2003.04340.x. PMID: 12780785."
656489,667639,Comparative Toxicogenomics Database (CTD),Piceatannol,C041525,"3,3',4,5'-tetrahydroxystilbene",https://ctdbase.org/detail.go?type=chem&acc=C041525,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,3',4,5'-tetrahydroxystilbene results in increased cleavage of PARP1 protein",,,PMID:30940561,https://www.ncbi.nlm.nih.gov/pubmed/30940561,30940561,,,31773391,"Siedlecka-Kroplewska K, Slebioda T, Kmiec Z. Induction of autophagy, apoptosis and aquisition of resistance in response to piceatannol toxicity in MOLT-4 human leukemia cells. Toxicol In Vitro. 2019 Sep;59():12–25. doi: 10.1016/j.tiv.2019.03.040. PMID: 30940561."
1732025,688674,Comparative Toxicogenomics Database (CTD),"3',4'-Dimethoxyflavone",C509288,"3',4'-dimethoxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C509288,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3',4'-dimethoxyflavone analog results in increased cleavage of PARP1 protein",,,PMID:29630880,https://www.ncbi.nlm.nih.gov/pubmed/29630880,29630880,,,33773099,"Estévez-Sarmiento F, Hernández E, Brouard I, León F, García C, Quintana J, Estévez F. 3'-Hydroxy-3,4'-dimethoxyflavone-induced cell death in human leukaemia cells is dependent on caspases and reactive oxygen species and attenuated by the inhibition of JNK/SAPK. Chem Biol Interact. 2018 May 25;288():1–11. doi: 10.1016/j.cbi.2018.04.006. PMID: 29630880."
1865098,689075,Comparative Toxicogenomics Database (CTD),Caffeic acid methyl ester,C042405,methyl caffeate,https://ctdbase.org/detail.go?type=chem&acc=C042405,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methyl caffeate binds to and results in increased activity of PARP1 protein,,,PMID:26415618,https://www.ncbi.nlm.nih.gov/pubmed/26415618,26415618,,,4565340,"Balachandran C, Emi N, Arun Y, Yamamoto Y, Ahilan B, Sangeetha B, Duraipandiyan V, Inaguma Y, Okamoto A, Ignacimuthu S, Al-Dhabi NA, Perumal PT. In vitro anticancer activity of methyl caffeate isolated from Solanum torvum Swartz. fruit. Chem Biol Interact. 2015 Dec 05;242():81–90. doi: 10.1016/j.cbi.2015.09.023. PMID: 26415618."
1865104,690181,Therapeutic Target Database (TTD),2-Cinnamamido-4-phenylthiazole,D04ZQJ,(E)-N-(4-Phenylthiazol-2-yl) cinnamamide,https://idrblab.net/ttd/data/drug/details/D04ZQJ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1869571,790259,Therapeutic Target Database (TTD),"N-(4-phenyl-1,3-thiazol-2-yl)pyridine-4-carboxamide",D00WMC,N-(4-Phenylthiazol-2-yl)isonicotinamide,https://idrblab.net/ttd/data/drug/details/D00WMC,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1872687,906426,Comparative Toxicogenomics Database (CTD),Heliotrine,C010178,heliotrine,https://ctdbase.org/detail.go?type=chem&acc=C010178,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Heliotrine results in decreased expression of PARP1 protein,,,PMID:29458164,https://www.ncbi.nlm.nih.gov/pubmed/29458164,29458164,,,33077163,"Waizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras S. Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: Single versus repeated exposure. Food Chem Toxicol. 2018 Apr;114():215–26. doi: 10.1016/j.fct.2018.02.036. PMID: 29458164."
2012845,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [dieldrin results in increased cleavage of PARP1 protein]|dieldrin results in increased cleavage of PARP1 protein,,,PMID:15183012,https://www.ncbi.nlm.nih.gov/pubmed/15183012,15183012,,,8532294,"Kitazawa M, Anantharam V, Kanthasamy A, Kanthasamy AG. Dieldrin promotes proteolytic cleavage of poly(ADP-ribose) polymerase and apoptosis in dopaminergic cells: protective effect of mitochondrial anti-apoptotic protein Bcl-2. Neurotoxicology. 2004 Jun;25(4):589–98. doi: 10.1016/j.neuro.2003.09.014. PMID: 15183012."
1538409,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenic trioxide promotes the reaction [curcumin results in increased expression of PARP1 protein modified form]|curcumin promotes the reaction [arsenic trioxide results in increased expression of PARP1 protein modified form]|curcumin results in increased expression of PARP1 protein modified form,,,PMID:27430728,https://www.ncbi.nlm.nih.gov/pubmed/27430728,27430728,,PMC5001835,14819927,"Zeng Y, Weng G, Fan J, Li Z, Wu J, Li Y, Zheng R, Xia P, Guo K. Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells. Oncol Rep. 2016 Sep;36(3):1233–42. PMID: 27430728; PMCID: PMC5001835."
1538558,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin analog results in decreased expression of PARP1 mRNA,,,PMID:26409325,https://www.ncbi.nlm.nih.gov/pubmed/26409325,26409325,,,14146545,"Bhullar KS, Jha A, Rupasinghe HP. Novel carbocyclic curcumin analog CUR3d modulates genes involved in multiple apoptosis pathways in human hepatocellular carcinoma cells. Chem Biol Interact. 2015 Dec 05;242():107–22. doi: 10.1016/j.cbi.2015.09.020. PMID: 26409325."
1538559,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[curcumin co-treated with bortezomib] results in increased cleavage of PARP1 protein|[curcumin co-treated with thalidomide] results in increased cleavage of PARP1 protein,,,PMID:19372569,https://www.ncbi.nlm.nih.gov/pubmed/19372569,19372569,,PMC2694943,30236431,"Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S, Aggarwal BB. Curcumin circumvents chemoresistance <i>in vitro</i> and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. 2009 Apr 01;8(4):959–70. doi: 10.1158/1535-7163.mct-08-0905."
1538560,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin inhibits the reaction [arsenic results in decreased expression of PARP1 mrna]|curcumin inhibits the reaction [arsenic results in decreased expression of PARP1 protein],,,PMID:21332098,https://www.ncbi.nlm.nih.gov/pubmed/21332098,21332098,,,32924784,"Roy M, Sinha D, Mukherjee S, Biswas J. Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur J Cancer Prev. 2011 Mar;20(2):123–31. doi: 10.1097/cej.0b013e328341017a. PMID: 21332098."
1538561,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin inhibits the reaction [benzo(a)pyrene results in increased expression of PARP1 protein],,,PMID:24664296,https://www.ncbi.nlm.nih.gov/pubmed/24664296,24664296,,PMC3963982,28953785,"Zhu W, Cromie MM, Cai Q, Lv T, Singh K, Gao W. Curcumin and Vitamin E Protect against Adverse Effects of Benzo[a]pyrene in Lung Epithelial Cells. PLoS ONE. 2014 Mar 24;9(3):e92992. doi: 10.1371/journal.pone.0092992."
1538562,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein],,,PMID:14724571,https://www.ncbi.nlm.nih.gov/pubmed/14724571,14724571,,,975980,"Wang Q, Wieder R. All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene. 2004 Jan 15;23(2):426–33. doi: 10.1038/sj.onc.1207040. PMID: 14724571."
1538563,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:23710286,https://www.ncbi.nlm.nih.gov/pubmed/23710286,23710286,,PMC3654359,5234928,"Zhao R, Yang B, Wang L, Xue P, Deng B, Zhang G, Jiang S, Zhang M, Liu M, Pi J, Guan D. Curcumin Protects Human Keratinocytes against Inorganic Arsenite-Induced Acute Cytotoxicity through an NRF2-Dependent Mechanism. Oxidative Medicine and Cellular Longevity. 2013;2013():1–11. doi: 10.1155/2013/412576."
1538564,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin promotes the reaction [arsenite results in increased expression of PARP1 protein],,,PMID:18392098,https://www.ncbi.nlm.nih.gov/pubmed/18392098,18392098,,PMC2274986,8592709,"Mukherjee S, Roy M, Dey S, Bhattacharya RK. A Mechanistic Approach for Modulation of Arsenic Toxicity in Human Lymphocytes by Curcumin, an Active Constituent of Medicinal Herb Curcuma longa Linn. J Clin Biochem Nutr. 2007 Jul;41(1):32–42. PMID: 18392098; PMCID: PMC2274986."
1538565,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:16173963,https://www.ncbi.nlm.nih.gov/pubmed/16173963,16173963,,,30178442,"Kim K, Ryu K, Ko Y, Park C. Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells. Br J Haematol. 2005 Oct;131(1):59–66. doi: 10.1111/j.1365-2141.2005.05720.x. PMID: 16173963."
1538566,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin results in increased cleavage of PARP1 protein,,,PMID:14555224|PMID:16023083|PMID:17671742|PMID:18593936|PMID:19235267|PMID:19401701|PMID:21594647,https://www.ncbi.nlm.nih.gov/pubmed/14555224|https://www.ncbi.nlm.nih.gov/pubmed/16023083|https://www.ncbi.nlm.nih.gov/pubmed/17671742|https://www.ncbi.nlm.nih.gov/pubmed/18593936|https://www.ncbi.nlm.nih.gov/pubmed/19235267|https://www.ncbi.nlm.nih.gov/pubmed/19401701|https://www.ncbi.nlm.nih.gov/pubmed/21594647,14555224|16023083|17671742|18593936|19235267|19401701|21594647,,PMC2587449|PMC2644749|PMC2694438|PMC3809898,9322482|11296803|11960028|22730687|25474361|25533186|30141216,"2011; 357(1-2):83-94|Sahu RP, Batra S, Srivastava SK. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. British Journal of Cancer. 2009 Apr 28;100(9):1425–33. doi: 10.1038/sj.bjc.6605039.|2009; 10(2):93-102|Chadalapaka G, Jutooru I, Chintharlapalli S, Papineni S, Smith R, Li X, Safe S. Curcumin Decreases Specificity Protein Expression in Bladder Cancer Cells. 2008 Jul 01;68(13):5345–54. doi: 10.1158/0008-5472.can-07-6805.|Park C, Moon DO, Choi IW, Choi BT, Nam TJ, Rhu CH, Kwon TK, Lee WH, Kim GY, Choi YH. Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med. 2007 Sep;20(3):365–72. PMID: 17671742.|Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005 Sep 01;70(5):700–13. doi: 10.1016/j.bcp.2005.04.043. PMID: 16023083.|Duvoix A, Morceau F, Delhalle S, Schmitz M, Schnekenburger M, Galteau MM, Dicato M, Diederich M. Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochem Pharmacol. 2003 Oct 15;66(8):1475–83. doi: 10.1016/s0006-2952(03)00501-x. PMID: 14555224."
1538567,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin results in increased degradation of PARP1,,,PMID:21595920,https://www.ncbi.nlm.nih.gov/pubmed/21595920,21595920,,PMC3118333,9323641,2011; 9(1):71
1538698,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Curcumin inhibits the reaction [cisplatin results in increased expression of PARP1 protein],,,PMID:36178099,https://www.ncbi.nlm.nih.gov/pubmed/36178099,36178099,,,35299861,"Gao J, Liu Y, Chen J, Tong C, Wang Q, Piao Y. Curcumin treatment attenuates cisplatin-induced gastric mucosal inflammation and apoptosis through the NF- ? B and MAPKs signaling pathway. Hum Exp Toxicol. 2022 Jan;41():9603271221128738. doi: 10.1177/09603271221128738. PMID: 36178099."
1538699,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Curcumin inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:11035063,https://www.ncbi.nlm.nih.gov/pubmed/11035063,11035063,,,209792,"Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000 Oct 15;165(8):4290–7. doi: 10.4049/jimmunol.165.8.4290. PMID: 11035063."
1538700,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Curcumin results in increased cleavage of PARP1 protein,,,PMID:21594647,https://www.ncbi.nlm.nih.gov/pubmed/21594647,21594647,,PMC3809898,9322482,2011; 357(1-2):83-94
1538701,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[doxorubicin co-treated with curcumin] results in increased cleavage of PARP1 protein,,,PMID:18006147,https://www.ncbi.nlm.nih.gov/pubmed/18006147,18006147,,,10586499,"Choi BH, Kim CG, Lim Y, Shin SY, Lee YH. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett. 2008 Jan 18;259(1):111–8. doi: 10.1016/j.canlet.2007.10.003. PMID: 18006147."
1538702,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [AGT protein modified form results in increased cleavage of PARP1 protein]|curcumin results in decreased cleavage of PARP1 protein|carboxymethyl-chitosan analog promotes the reaction [curcumin results in decreased cleavage of PARP1 protein],,,PMID:26612707,https://www.ncbi.nlm.nih.gov/pubmed/26612707,26612707,,,10065830,"Ray A, Rana S, Banerjee D, Mitra A, Datta R, Naskar S, Sarkar S. Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment. Toxicol Appl Pharmacol. 2016 Jan 01;290():54–65. doi: 10.1016/j.taap.2015.11.011. PMID: 26612707."
1538703,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [streptozocin results in increased cleavage of PARP1 protein],,,PMID:25541178,https://www.ncbi.nlm.nih.gov/pubmed/25541178,25541178,,,489391,"Rashid K, Sil PC. Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats. Toxicol Appl Pharmacol. 2015 Feb 01;282(3):297–310. doi: 10.1016/j.taap.2014.12.003. PMID: 25541178."
1538704,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein],,,PMID:15569404,https://www.ncbi.nlm.nih.gov/pubmed/15569404,15569404,,,24091207,"Zhu YG, Chen XC, Chen ZZ, Zeng YQ, Shi GB, Su YH, Peng X. Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons. Acta Pharmacol Sin. 2004 Dec;25(12):1606–12. PMID: 15569404."
1780640,1201549,Comparative Toxicogenomics Database (CTD),Benztropine,D001590,Benztropine,https://ctdbase.org/detail.go?type=chem&acc=D001590,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benztropine results in decreased expression of PARP1 protein|[cuprizone co-treated with benztropine] results in increased expression of PARP1 protein,,,PMID:34122009,https://www.ncbi.nlm.nih.gov/pubmed/34122009,34122009,,PMC8193732,14955630,"Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JE, Crippa JA, de Almeida V, Martins-de-Souza D. Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021;14():814907. PMID: 34924956; PMCID: PMC8672415."
1966099,1285941,Comparative Toxicogenomics Database (CTD),"4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid",C584509,"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid",https://ctdbase.org/detail.go?type=chem&acc=C584509,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in decreased acetylation of PARP1 protein",,,PMID:27064363,https://www.ncbi.nlm.nih.gov/pubmed/27064363,27064363,,PMC5007632,22246967,"Robert C, Nagaria PK, Pawar N, Adewuyi A, Gojo I, Meyers DJ, Cole PA, Rassool FV. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin. Leukemia Research. 2016 Jun;45():14–23. doi: 10.1016/j.leukres.2016.03.007."
1919832,1383884,Comparative Toxicogenomics Database (CTD),Urb-597,C500528,cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester,https://ctdbase.org/detail.go?type=chem&acc=C500528,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester inhibits the reaction [cisplatin results in increased cleavage of PARP1 protein],,,PMID:31256211,https://www.ncbi.nlm.nih.gov/pubmed/31256211,31256211,,,9508121,2019; 93(8):2335-2346
1917082,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [[sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [[sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]|[sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein,,,PMID:18281123,https://www.ncbi.nlm.nih.gov/pubmed/18281123,18281123,,,33572505,"Jin HO, Seo SK, Woo SH, Lee HC, Kim ES, Yoo DH, Lee SJ, An S, Choe TB, Kim JI, Hong SI, Rhee CH, Park IC. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation. Lung Cancer. 2008 Sep;61(3):317–27. doi: 10.1016/j.lungcan.2008.01.002. PMID: 18281123."
1917083,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sulindac promotes the reaction [deferoxamine results in increased cleavage of PARP1 protein],,,PMID:21882223,https://www.ncbi.nlm.nih.gov/pubmed/21882223,21882223,,,7282905,"Liu C, Tsai AL, Chen YC, Fan SC, Huang CH, Wu CC, Chang CH. Facilitation of human osteoblast apoptosis by sulindac and indomethacin under hypoxic injury. J Cell Biochem. 2012 Jan;113(1):148–55. doi: 10.1002/jcb.23338. PMID: 21882223."
1917084,1548887,Comparative Toxicogenomics Database (CTD),Sulindac,D013467,Sulindac,https://ctdbase.org/detail.go?type=chem&acc=D013467,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sulindac results in increased activity of PARP1 protein,,,PMID:15713900,https://www.ncbi.nlm.nih.gov/pubmed/15713900,15713900,,,15288002,"Oida Y, Gopalan B, Miyahara R, Inoue S, Branch CD, Mhashilkar AM, Lin E, Bekele BN, Roth JA, Chada S, Ramesh R. Sulindac enhances adenoviral vector expressing <i>mda-7/IL-24</i>–mediated apoptosis in human lung cancer. 2005 Feb 01;4(2):291–304. doi: 10.1158/1535-7163.291.4.2."
1870818,1548943,Comparative Toxicogenomics Database (CTD),Capsaicin,D002211,Capsaicin,https://ctdbase.org/detail.go?type=chem&acc=D002211,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Capsaicin results in increased expression of PARP1 protein|capsaicin results in increased ADP-ribosylation of PARP1 protein modified form|pifithrin promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]|3-aminobenzamide promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]|2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]|capsaicin results in increased cleavage of and results in increased activity of PARP1 protein|3-aminobenzamide promotes the reaction [capsaicin results in increased expression of PARP1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein]|3-aminobenzamide inhibits the reaction [capsaicin results in increased ADP-ribosylation of PARP1 protein modified form]|caffeine promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:22226932,https://www.ncbi.nlm.nih.gov/pubmed/22226932,22226932,,,22176951,"Yoon JH, Ahn SG, Lee BH, Jung SH, Oh SH. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. Biochem Pharmacol. 2012 Mar 15;83(6):747–57. doi: 10.1016/j.bcp.2011.12.029. PMID: 22226932."
1870988,1548943,Comparative Toxicogenomics Database (CTD),Capsaicin,D002211,Capsaicin,https://ctdbase.org/detail.go?type=chem&acc=D002211,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Capsaicin promotes the reaction [TNFSF10 results in increased cleavage of PARP1 protein],,,PMID:22200406,https://www.ncbi.nlm.nih.gov/pubmed/22200406,22200406,,,22154024,"Moon DO, Kang CH, Kang SH, Choi YH, Hyun JW, Chang WY, Kang HK, Koh YS, Maeng YH, Kim YR, Kim GY. Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca(2+) influx. Toxicol Appl Pharmacol. 2012 Feb 15;259(1):87–95. doi: 10.1016/j.taap.2011.12.010. PMID: 22200406."
1870989,1548943,Comparative Toxicogenomics Database (CTD),Capsaicin,D002211,Capsaicin,https://ctdbase.org/detail.go?type=chem&acc=D002211,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Capsaicin results in increased cleavage of PARP1 protein,,,PMID:17505005|PMID:19855437,https://www.ncbi.nlm.nih.gov/pubmed/17505005|https://www.ncbi.nlm.nih.gov/pubmed/19855437,17505005|19855437,,,1733032|27494844,"Thoennissen NH, O'Kelly J, Lu D, Iwanski GB, La DT, Abbassi S, Leiter A, Karlan B, Mehta R, Koeffler HP. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene. 2010 Jan 14;29(2):285–96. doi: 10.1038/onc.2009.335. PMID: 19855437.|Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G, Aggarwal BB. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin Cancer Res. 2007 May 15;13(10):3024–32. doi: 10.1158/1078-0432.ccr-06-2575. PMID: 17505005."
1870990,1548943,Comparative Toxicogenomics Database (CTD),Capsaicin,D002211,Capsaicin,https://ctdbase.org/detail.go?type=chem&acc=D002211,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Capsaicin results in increased cleavage of PARP1 protein,,,PMID:17295509,https://www.ncbi.nlm.nih.gov/pubmed/17295509,17295509,,,3747393,"Hsu CL, Yen GC. Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells. J Agric Food Chem. 2007 Mar 07;55(5):1730–6. doi: 10.1021/jf062912b. PMID: 17295509."
717381,1549120,Comparative Toxicogenomics Database (CTD),Epalrestat,C038131,epalrestat,https://ctdbase.org/detail.go?type=chem&acc=C038131,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Epalrestat inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]|epalrestat analog inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:37257577,https://www.ncbi.nlm.nih.gov/pubmed/37257577,37257577,,,35655984,"Syamprasad NP, Jain S, Rajdev B, Panda SR, Gangasani JK, Challa VS, Vaidya JR, Kundu GC, Naidu VGM. AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis. Chem Biol Interact. 2023 Aug 25;381():110566. doi: 10.1016/j.cbi.2023.110566. PMID: 37257577."
1798888,1889993,Comparative Toxicogenomics Database (CTD),Fatostatin,C545733,fatostatin,https://ctdbase.org/detail.go?type=chem&acc=C545733,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[docetaxel co-treated with fatostatin] results in increased cleavage of PARP1 protein|[tp53 protein mutant form results in increased susceptibility to fatostatin] which results in increased cleavage of PARP1 protein|docetaxel promotes the reaction [[TP53 protein mutant form results in increased susceptibility to fatostatin] which results in increased cleavage of PARP1 protein],,,PMID:26512780,https://www.ncbi.nlm.nih.gov/pubmed/26512780,26512780,,PMC4747386,32349725,"Li X, Wu JB, Chung LW, Huang WC. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations. Oncotarget. 2015 Dec 01;6(38):41018–32. PMID: 26512780; PMCID: PMC4747386."
1798889,1889993,Comparative Toxicogenomics Database (CTD),Fatostatin,C545733,fatostatin,https://ctdbase.org/detail.go?type=chem&acc=C545733,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fatostatin results in increased cleavage of PARP1 protein,,,PMID:24493696|PMID:29436682|PMID:30140005,https://www.ncbi.nlm.nih.gov/pubmed/24493696|https://www.ncbi.nlm.nih.gov/pubmed/29436682|https://www.ncbi.nlm.nih.gov/pubmed/30140005,24493696|29436682|30140005,,PMC4084917|PMC6107643,5344773|26378658|29644078,"2018; 7(8):66|Gao S, Shi Z, Li X, Li W, Wang Y, Liu Z, Jiang J. Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma. Oncol Rep. 2018 Apr;39(4):1919–29. doi: 10.3892/or.2018.6265. PMID: 29436682.|Li X, Chen YT, Hu P, Huang WC. Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling. Mol Cancer Ther. 2014 Apr;13(4):855–66. PMID: 24493696; PMCID: PMC4084917."
1510634,2724354,Comparative Toxicogenomics Database (CTD),Succimer,D004113,Succimer,https://ctdbase.org/detail.go?type=chem&acc=D004113,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Succimer inhibits the reaction [sodium arsenite results in increased expression of PARP1 protein],,,PMID:31163222,https://www.ncbi.nlm.nih.gov/pubmed/31163222,31163222,,,33802699,"Perveen H, Dey A, Nilavar NM, Chandra GK, Islam SS, Chattopadhyay S. Dietary CCPS from bitter gourd attenuates sodium arsenite induced female reproductive ailments cum infertility in wistar rats: anti-inflammatory and anti-apoptotic role. Food Chem Toxicol. 2019 Sep;131():110545. doi: 10.1016/j.fct.2019.05.053. PMID: 31163222."
1927959,2724361,Comparative Toxicogenomics Database (CTD),Aflatoxin G1,C027955,aflatoxin G1,https://ctdbase.org/detail.go?type=chem&acc=C027955,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aflatoxin G1 results in increased expression of PARP1 protein modified form,,,PMID:23907605,https://www.ncbi.nlm.nih.gov/pubmed/23907605,23907605,,,16801364,2013; 87(9):1697-1707
1899723,2724943,Toxin and Toxin Target Database (T3DB),Cobalt Carbonyl (Stabilized with 1-5% Hexane),T3D1388,Tetracobalt dodecacarbonyl,http://www.t3db.ca/toxins/T3D1388,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1928677,2732983,Comparative Toxicogenomics Database (CTD),Pichromene,C557120,8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene,https://ctdbase.org/detail.go?type=chem&acc=C557120,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene results in increased cleavage of PARP1 protein,,,PMID:24831963,https://www.ncbi.nlm.nih.gov/pubmed/24831963,24831963,,,4546662,"Shi M, Zhou X, Zhang Z, Wang M, Chen G, Han K, Cao B, Liu Z, Mao X. A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3. Toxicol Lett. 2014 Aug 04;228(3):133–9. doi: 10.1016/j.toxlet.2014.05.003. PMID: 24831963."
1694739,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin B1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fumonisin B1 results in decreased cleavage of PARP1 protein,,,PMID:25800559,https://www.ncbi.nlm.nih.gov/pubmed/25800559,25800559,,,18836858,"Chuturgoon AA, Phulukdaree A, Moodley D. Fumonisin B1 inhibits apoptosis in HepG2 cells by inducing Birc-8/ILP-2. Toxicol Lett. 2015 Jun 01;235(2):67–74. doi: 10.1016/j.toxlet.2015.03.006. PMID: 25800559."
1694740,2733487,Comparative Toxicogenomics Database (CTD),Fumonisin B1,C056933,fumonisin B1,https://ctdbase.org/detail.go?type=chem&acc=C056933,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Fumonisin B1 inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein],,,PMID:24448832,https://www.ncbi.nlm.nih.gov/pubmed/24448832,24448832,,,18154228,2014; 88(4):881-892
1568519,2810830,Comparative Toxicogenomics Database (CTD),ethyl 2-amino-6-chloro-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate,C000614067,AKT activator SC79,https://ctdbase.org/detail.go?type=chem&acc=C000614067,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AKT activator SC79 inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of PARP1 protein modified form],,,PMID:31342299,https://www.ncbi.nlm.nih.gov/pubmed/31342299,31342299,,,21653880,2019; 461(1-2):81-89
1568520,2810830,Comparative Toxicogenomics Database (CTD),ethyl 2-amino-6-chloro-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate,C000614067,AKT activator SC79,https://ctdbase.org/detail.go?type=chem&acc=C000614067,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AKT activator SC79 inhibits the reaction [lapatinib inhibits the reaction [sodium arsenite results in decreased cleavage of PARP1 protein]],,,PMID:32890875,https://www.ncbi.nlm.nih.gov/pubmed/32890875,32890875,,,21692211,"Zhou Q, Jin P, Liu J, Li S, Liu W, Xi S. Arsenic-induced HER2 promotes proliferation, migration and angiogenesis of bladder epithelial cells via activation of multiple signaling pathways in vitro and in vivo. Sci Total Environ. 2021 Jan 20;753():141962. doi: 10.1016/j.scitotenv.2020.141962. PMID: 32890875."
1568521,2810830,Comparative Toxicogenomics Database (CTD),ethyl 2-amino-6-chloro-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate,C000614067,AKT activator SC79,https://ctdbase.org/detail.go?type=chem&acc=C000614067,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),AKT activator SC79 inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased cleavage of PARP1 protein]],,,PMID:34767868,https://www.ncbi.nlm.nih.gov/pubmed/34767868,34767868,,,7531521,"Bi A, Guo Z, Yang G, Huang Y, Yin Z, Luo L. ?-glutamylcysteine suppresses cadmium-induced apoptosis in PC12 cells via regulating oxidative stress. Toxicology. 2022 Jan 15;465():153029. doi: 10.1016/j.tox.2021.153029. PMID: 34767868."
1601024,2821065,BindingDB,,27686,"4,6-dimethyl-11-thia-2,4,5-triazatricyclo[7.3.0.0^{3,7}]dodeca-1(9),3(7),5-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27686,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
1951852,2828334,Comparative Toxicogenomics Database (CTD),5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone,C507699,necrostatin-1,https://ctdbase.org/detail.go?type=chem&acc=C507699,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Necrostatin-1 inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein],,,PMID:25939952,https://www.ncbi.nlm.nih.gov/pubmed/25939952,25939952,,,26969299,"Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015 Jul 02;236(1):43–59. doi: 10.1016/j.toxlet.2015.04.015. PMID: 25939952."
1999115,2940609,Comparative Toxicogenomics Database (CTD),4-(Di(1H-indol-3-yl)methyl)phenol,C552530,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",https://ctdbase.org/detail.go?type=chem&acc=C552530,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cleavage of PARP1 protein",,,PMID:20660371|PMID:24515801|PMID:26035713,https://www.ncbi.nlm.nih.gov/pubmed/20660371|https://www.ncbi.nlm.nih.gov/pubmed/24515801|https://www.ncbi.nlm.nih.gov/pubmed/26035713,20660371|24515801|26035713,,PMC2988472|PMC4407472|PMC4452731,409107|10719701|18170096,"Hedrick E, Lee S, Kim G, Abdelrahim M, Jin U, Safe S, Abudayyeh A. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma. PLoS ONE. 2015 Jun 02;10(6):e0128308. doi: 10.1371/journal.pone.0128308.|Lee SO, Jin UH, Kang JH, Kim SB, Guthrie AS, Sreevalsan S, Lee JS, Safe S. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Mol Cancer Res. 2014 Apr;12(4):527–38. PMID: 24515801; PMCID: PMC4407472.|Lee S, Abdelrahim M, Yoon K, Chintharlapalli S, Papineni S, Kim K, Wang H, Safe S. Inactivation of the Orphan Nuclear Receptor TR3/Nur77 Inhibits Pancreatic Cancer Cell and Tumor Growth. 2010 Aug 31;70(17):6824–36. doi: 10.1158/0008-5472.can-10-1992."
1999116,2940609,Comparative Toxicogenomics Database (CTD),4-(Di(1H-indol-3-yl)methyl)phenol,C552530,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",https://ctdbase.org/detail.go?type=chem&acc=C552530,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Glutathione inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cleavage of PARP1 protein]",,,PMID:24515801,https://www.ncbi.nlm.nih.gov/pubmed/24515801,24515801,,PMC4407472,10719701,"Lee SO, Jin UH, Kang JH, Kim SB, Guthrie AS, Sreevalsan S, Lee JS, Safe S. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Mol Cancer Res. 2014 Apr;12(4):527–38. PMID: 24515801; PMCID: PMC4407472."
1999260,2940609,Comparative Toxicogenomics Database (CTD),4-(Di(1H-indol-3-yl)methyl)phenol,C552530,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",https://ctdbase.org/detail.go?type=chem&acc=C552530,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"NR4A1 protein inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cleavage of PARP1 protein]",,,PMID:20660371|PMID:24515801,https://www.ncbi.nlm.nih.gov/pubmed/20660371|https://www.ncbi.nlm.nih.gov/pubmed/24515801,20660371|24515801,,PMC2988472|PMC4407472,409107|10719701,"Lee SO, Jin UH, Kang JH, Kim SB, Guthrie AS, Sreevalsan S, Lee JS, Safe S. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Mol Cancer Res. 2014 Apr;12(4):527–38. PMID: 24515801; PMCID: PMC4407472.|Lee S, Abdelrahim M, Yoon K, Chintharlapalli S, Papineni S, Kim K, Wang H, Safe S. Inactivation of the Orphan Nuclear Receptor TR3/Nur77 Inhibits Pancreatic Cancer Cell and Tumor Growth. 2010 Aug 31;70(17):6824–36. doi: 10.1158/0008-5472.can-10-1992."
1974785,3001055,Comparative Toxicogenomics Database (CTD),Zantac,D011899,Ranitidine,https://ctdbase.org/detail.go?type=chem&acc=D011899,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ranitidine inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:19723537,https://www.ncbi.nlm.nih.gov/pubmed/19723537,19723537,,,32907541,"Park HJ, Kim HJ, Park HK, Chung JH. Protective effect of histamine H2 receptor antagonist ranitidine against rotenone-induced apoptosis. Neurotoxicology. 2009 Nov;30(6):1114–9. doi: 10.1016/j.neuro.2009.08.005. PMID: 19723537."
1916205,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [emodin results in increased cleavage of PARP1 protein]|[u 0126 co-treated with emodin] results in increased cleavage of PARP1 protein,,,PMID:27032576,https://www.ncbi.nlm.nih.gov/pubmed/27032576,27032576,,,20899140,"Cui Y, Lu P, Song G, Liu Q, Zhu D, Liu X. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis. Food Chem Toxicol. 2016 Jun;92():26–37. doi: 10.1016/j.fct.2016.03.013. PMID: 27032576."
1916206,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [BPDE-II results in increased cleavage of PARP1 protein],,,PMID:15572374,https://www.ncbi.nlm.nih.gov/pubmed/15572374,15572374,,,24094048,"Chen S, Operaña T, Bonzo J, Nguyen N, Tukey RH. ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. J Biol Chem. 2005 Feb 11;280(6):4350–9. doi: 10.1074/jbc.m411554200. PMID: 15572374."
1916207,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"U 0126 inhibits the reaction [[cholix toxin, vibrio cholerae co-treated with TNF protein] results in increased cleavage of PARP1 protein]",,,PMID:28087840,https://www.ncbi.nlm.nih.gov/pubmed/28087840,28087840,,PMC5837519,14162527,"Ogura K, Terasaki Y, Miyoshi-Akiyama T, Terasaki M, Moss J, Noda M, Yahiro K. Vibrio cholerae Cholix Toxin-Induced HepG2 Cell Death is Enhanced by Tumor Necrosis Factor-Alpha Through ROS and Intracellular Signal-Regulated Kinases. Toxicol Sci. 2017 Apr 01;156(2):455–68. PMID: 28087840; PMCID: PMC5837519."
1916208,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,PMC4234881,19518824,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881."
1916209,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein],,,PMID:34165247,https://www.ncbi.nlm.nih.gov/pubmed/34165247,34165247,,,31166243,"Ho H, Chen P, Lo Y, Lin C, Chuang Y, Hsieh M, Chen M. <scp>Luteolin-7-O</scp>-glucoside inhibits cell proliferation and modulates apoptosis through the <scp>AKT</scp> signaling pathway in human nasopharyngeal carcinoma. Environmental Toxicology. 2021 Jun 24;36(10):2013–24. doi: 10.1002/tox.23319."
1916210,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [morusin results in increased cleavage of PARP1 protein],,,PMID:33035517,https://www.ncbi.nlm.nih.gov/pubmed/33035517,33035517,,,6804631,"Wang J, Liu X, Zheng H, Liu Q, Zhang H, Wang X, Shen T, Wang S, Ren D. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells. Chem Biol Interact. 2020 Nov 01;331():109279. doi: 10.1016/j.cbi.2020.109279. PMID: 33035517."
1916211,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [nimbolide results in increased expression of PARP1 protein modified form],,,PMID:29962003,https://www.ncbi.nlm.nih.gov/pubmed/29962003,29962003,,,6746544,"Hsueh KC, Lin CL, Tung JN, Yang SF, Hsieh YH. Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells. Environ Toxicol. 2018 Sep;33(9):913–22. doi: 10.1002/tox.22576. PMID: 29962003."
1916346,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:14688022,https://www.ncbi.nlm.nih.gov/pubmed/14688022,14688022,,,20010805,"Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004 May;25(5):647–59. doi: 10.1093/carcin/bgh052. PMID: 14688022."
1916347,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 promotes the reaction [dihydromyricetin results in increased cleavage of PARP1 protein],,,PMID:27539140,https://www.ncbi.nlm.nih.gov/pubmed/27539140,27539140,,,28352053,"Kao S, Lee W, Chang J, Chow J, Chung C, Hung W, Chien M. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer. Environmental Toxicology. 2016 Aug 19;32(4):1426–38. doi: 10.1002/tox.22336."
1916348,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein]|u 0126 results in increased cleavage of PARP1 protein,,,PMID:15557793,https://www.ncbi.nlm.nih.gov/pubmed/15557793,15557793,,,24080217,"Niiya M, Niiya K, Shibakura M, Asaumi N, Yoshida C, Shinagawa K, Teshima T, Ishimaru F, Ikeda K, Tanimoto M. Involvement of ERK1/2 and p38 MAP Kinase in Doxorubicin-Induced uPA Expression in Human RC-K8 Lymphoma and NCI-H69 Small Cell Lung Carcinoma Cells. Oncology. 2004;67(3-4):310–9. doi: 10.1159/000081332."
1916349,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 promotes the reaction [flavanones results in increased cleavage of PARP1 protein],,,PMID:21616090,https://www.ncbi.nlm.nih.gov/pubmed/21616090,21616090,,,9342382,"Shin SY, Hyun J, Yu JR, Lim Y, Lee YH. 5-Methoxyflavanone induces cell cycle arrest at the G2/M phase, apoptosis and autophagy in HCT116 human colon cancer cells. Toxicol Appl Pharmacol. 2011 Aug 01;254(3):288–98. doi: 10.1016/j.taap.2011.05.003. PMID: 21616090."
1916350,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),U 0126 inhibits the reaction [nonylphenol results in increased cleavage of PARP1 protein],,,PMID:23677851,https://www.ncbi.nlm.nih.gov/pubmed/23677851,23677851,,,24242797,"Choi MS, Park HJ, Oh JH, Lee EH, Park SM, Yoon S. Nonylphenol-induced apoptotic cell death in mouse TM4 Sertoli cells via the generation of reactive oxygen species and activation of the ERK signaling pathway. J Appl Toxicol. 2014 Jun;34(6):628–36. doi: 10.1002/jat.2886. PMID: 23677851."
1916351,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),U 0126 affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein],,,PMID:31396050,https://www.ncbi.nlm.nih.gov/pubmed/31396050,31396050,,PMC6667551,10151887,"Kim JE, Kang TC. PKC, AKT and ERK1/2-Mediated Modulations of PARP1, NF-?B and PEA15 Activities Distinctly Regulate Regional Specific Astroglial Responses Following Status Epilepticus. Front Mol Neurosci. 2019;12():180. PMID: 31396050; PMCID: PMC6667551."
1916352,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),U 0126 inhibits the reaction [cadmium acetate results in increased cleavage of PARP1 protein],,,PMID:24577723|PMID:25043952,https://www.ncbi.nlm.nih.gov/pubmed/24577723|https://www.ncbi.nlm.nih.gov/pubmed/25043952,24577723|25043952,,,10057115|26291509,"Yuan Y, Jiang C, Hu F, Wang Q, Zhang K, Wang Y, Gu J, Liu X, Bian J, Liu Z. The role of mitogen-activated protein kinase in cadmium-induced primary rat cerebral cortical neurons apoptosis via a mitochondrial apoptotic pathway. Journal of Trace Elements in Medicine and Biology. 2015 Jan;29():275–83. doi: 10.1016/j.jtemb.2014.06.006.|2014; 158(2):249-258"
1916353,3006531,Comparative Toxicogenomics Database (CTD),"1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene",C113580,U 0126,https://ctdbase.org/detail.go?type=chem&acc=C113580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),U 0126 inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:18775851,https://www.ncbi.nlm.nih.gov/pubmed/18775851,18775851,,PMC2614569,24141278,"Liu J, Mao W, Ding B, Liang C. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 2008 Nov;295(5):H1956–65. doi: 10.1152/ajpheart.00407.2008."
1977097,3007855,DrugBank,Zincchloride,DB14533,Zinc chloride,https://www.drugbank.ca/drugs/DB14533,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Component of,,,PMID:25549802,https://www.ncbi.nlm.nih.gov/pubmed/25549802,25549802,,,497628,"Bossak K, Goch W, Piatek K, Fraczyk T, Poznanski J, Bonna A, Keil C, Hartwig A, Bal W: Unusual Zn(II) Affinities of Zinc Fingers of Poly(ADP-ribose)Polymerase 1 (PARP-1) Nuclear Protein. Chem Res Toxicol. 2015 Feb 16;28(2):191-201."
1979795,3008895,Comparative Toxicogenomics Database (CTD),4-Methylbenzyl-N-bis[daunomycin],C104426,WP 631,https://ctdbase.org/detail.go?type=chem&acc=C104426,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),WP 631 results in increased cleavage of PARP1 protein,,,PMID:24287111,https://www.ncbi.nlm.nih.gov/pubmed/24287111,24287111,,,11375532,"Gajek A, Denel M, Bukowska B, Rogalska A, Marczak A. Pro-apoptotic activity of new analog of anthracyclines--WP 631 in advanced ovarian cancer cell line. Toxicol In Vitro. 2014 Mar;28(2):273–81. doi: 10.1016/j.tiv.2013.11.006. PMID: 24287111."
1924395,3025961,Comparative Toxicogenomics Database (CTD),2-Methyl-6-(phenylethynyl)pyridine,C121465,6-methyl-2-(phenylethynyl)pyridine,https://ctdbase.org/detail.go?type=chem&acc=C121465,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),GOPC protein affects the reaction [6-methyl-2-(phenylethynyl)pyridine promotes the reaction [oxidopamine results in increased cleavage of PARP1 protein]]|6-methyl-2-(phenylethynyl)pyridine promotes the reaction [oxidopamine results in increased cleavage of PARP1 protein],,,PMID:33571554,https://www.ncbi.nlm.nih.gov/pubmed/33571554,33571554,,,660076,"Wang Y, Gu L, Yang HM, Zhang H. Cystic fibrosis transmembrane conductance regulator-associated ligand protects dopaminergic neurons by differentially regulating metabotropic glutamate receptor 5 in the progression of neurotoxin 6-hydroxydopamine-induced Parkinson's disease model. Neurotoxicology. 2021 May;84():14–29. doi: 10.1016/j.neuro.2021.02.003. PMID: 33571554."
1984710,3028194,Comparative Toxicogenomics Database (CTD),Lithium,D008094,Lithium,https://ctdbase.org/detail.go?type=chem&acc=D008094,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lithium inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:17849503,https://www.ncbi.nlm.nih.gov/pubmed/17849503,17849503,,,26827689,"Watcharasit P, Thiantanawat A, Satayavivad J. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption. J Appl Toxicol. 2008 May;28(4):466–74. doi: 10.1002/jat.1296. PMID: 17849503."
1863440,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nickel chloride promotes the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased cleavage of PARP1 protein]]|acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]]|cobaltous chloride promotes the reaction [nickel chloride results in increased cleavage of PARP1 protein],,,PMID:22172632,https://www.ncbi.nlm.nih.gov/pubmed/22172632,22172632,,,20810526,"Patel E, Lynch C, Ruff V, Reynolds M. Co-exposure to nickel and cobalt chloride enhances cytotoxicity and oxidative stress in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Feb 01;258(3):367–75. doi: 10.1016/j.taap.2011.11.019. PMID: 22172632."
1863441,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[chromium alloys co-treated with cobaltous chloride] results in increased cleavage of PARP1 protein,,,PMID:25281833,https://www.ncbi.nlm.nih.gov/pubmed/25281833,25281833,,,24265017,"Posada OM, Gilmour D, Tate RJ, Grant MH. CoCr wear particles generated from CoCr alloy metal-on-metal hip replacements, and cobalt ions stimulate apoptosis and expression of general toxicology-related genes in monocyte-like U937 cells. Toxicol Appl Pharmacol. 2014 Nov 15;281(1):125–35. doi: 10.1016/j.taap.2014.09.010. PMID: 25281833."
1863442,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]]|cobaltous chloride inhibits the reaction [doxorubicin promotes the reaction [[PARP1 protein binds to TNFRSF10B promoter] which results in increased expression of TNFRSF10B mrna]]|cobaltous chloride inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:19714248,https://www.ncbi.nlm.nih.gov/pubmed/19714248,19714248,,PMC2729407,32898850,"Nardinocchi L, Puca R, Sacchi A, Rechavi G, Givol D, D'Orazi G. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha. PLoS One. 2009 Aug 28;4(8):e6819. PMID: 19714248; PMCID: PMC2729407."
1863443,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cobaltous chloride results in decreased expression of PARP1 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,PMC2678155,14673686,2009; 10(1):126
1863444,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cobaltous chloride results in increased activity of PARP1 protein|lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in increased activity of PARP1 protein],,,PMID:25125499,https://www.ncbi.nlm.nih.gov/pubmed/25125499,25125499,,PMC4935323,6657347,"Sellinger M, Xu W, Pathil A, Stremmel W, Chamulitrat W. Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins. Exp Biol Med (Maywood). 2015 Feb;240(2):252–60. PMID: 25125499; PMCID: PMC4935323."
1863581,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cobaltous chloride results in increased cleavage of PARP1 protein,,,PMID:21882223|PMID:22172632,https://www.ncbi.nlm.nih.gov/pubmed/21882223|https://www.ncbi.nlm.nih.gov/pubmed/22172632,21882223|22172632,,,7282905|20810526,"Patel E, Lynch C, Ruff V, Reynolds M. Co-exposure to nickel and cobalt chloride enhances cytotoxicity and oxidative stress in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Feb 01;258(3):367–75. doi: 10.1016/j.taap.2011.11.019. PMID: 22172632.|Liu C, Tsai AL, Chen YC, Fan SC, Huang CH, Wu CC, Chang CH. Facilitation of human osteoblast apoptosis by sulindac and indomethacin under hypoxic injury. J Cell Biochem. 2012 Jan;113(1):148–55. doi: 10.1002/jcb.23338. PMID: 21882223."
2076300,3034010,Comparative Toxicogenomics Database (CTD),Orlistat,D000077403,Orlistat,https://ctdbase.org/detail.go?type=chem&acc=D000077403,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[orlistat co-treated with thapsigargin] results in increased cleavage of PARP1 protein,,,PMID:17283163,https://www.ncbi.nlm.nih.gov/pubmed/17283163,17283163,,,3735936,"Little JL, Wheeler FB, Fels DR, Koumenis C, Kridel SJ. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Res. 2007 Feb 01;67(3):1262–9. doi: 10.1158/0008-5472.can-06-1794. PMID: 17283163."
2076301,3034010,Comparative Toxicogenomics Database (CTD),Orlistat,D000077403,Orlistat,https://ctdbase.org/detail.go?type=chem&acc=D000077403,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Orlistat results in increased cleavage of PARP1 protein,,,PMID:15870086|PMID:17283163,https://www.ncbi.nlm.nih.gov/pubmed/15870086|https://www.ncbi.nlm.nih.gov/pubmed/17283163,15870086|17283163,,,3735936|7885487,"Little JL, Wheeler FB, Fels DR, Koumenis C, Kridel SJ. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Res. 2007 Feb 01;67(3):1262–9. doi: 10.1158/0008-5472.can-06-1794. PMID: 17283163.|Menendez JA, Vellon L, Lupu R: Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene. Ann Oncol. 2005 Aug;16(8):1253-67. Epub 2005 May 3."
1942395,3034747,Comparative Toxicogenomics Database (CTD),"1,2-Bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",C070379,"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",https://ctdbase.org/detail.go?type=chem&acc=C070379,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [arachidonic acid results in increased cleavage of PARP1 protein]",,,PMID:19540902,https://www.ncbi.nlm.nih.gov/pubmed/19540902,19540902,,,1073205,"Chen KC, Chang LS. Arachidonic acid-induced apoptosis of human neuroblastoma SK-N-SH cells is mediated through mitochondrial alteration elicited by ROS and Ca(2+)-evoked activation of p38alpha MAPK and JNK1. Toxicology. 2009 Aug 21;262(3):199–206. doi: 10.1016/j.tox.2009.06.009. PMID: 19540902."
1942396,3034747,Comparative Toxicogenomics Database (CTD),"1,2-Bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",C070379,"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",https://ctdbase.org/detail.go?type=chem&acc=C070379,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein]",,,PMID:21544200,https://www.ncbi.nlm.nih.gov/pubmed/21544200,21544200,,PMC3081326,14054107,"Xu B, Chen S, Luo Y, Chen Z, Liu L, Zhou H, Chen W, Shen T, Han X, Chen L, Huang S. Calcium Signaling Is Involved in Cadmium-Induced Neuronal Apoptosis via Induction of Reactive Oxygen Species and Activation of MAPK/mTOR Network. PLoS ONE. 2011 Apr 22;6(4):e19052. doi: 10.1371/journal.pone.0019052."
1942397,3034747,Comparative Toxicogenomics Database (CTD),"1,2-Bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",C070379,"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",https://ctdbase.org/detail.go?type=chem&acc=C070379,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [gallic acid results in increased cleavage of PARP1 protein]",,,PMID:27060209,https://www.ncbi.nlm.nih.gov/pubmed/27060209,27060209,,,22243021,"Hsu SS, Chou CT, Liao WC, Shieh P, Kuo DH, Kuo CC, Jan CR, Liang WZ. The effect of gallic acid on cytotoxicity, Ca(2+) homeostasis and ROS production in DBTRG-05MG human glioblastoma cells and CTX TNA2 rat astrocytes. Chem Biol Interact. 2016 May 25;252():61–73. doi: 10.1016/j.cbi.2016.04.010. PMID: 27060209."
1942398,3034747,Comparative Toxicogenomics Database (CTD),"1,2-Bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",C070379,"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",https://ctdbase.org/detail.go?type=chem&acc=C070379,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [niclosamide results in increased cleavage of PARP1 protein]",,,PMID:30258081,https://www.ncbi.nlm.nih.gov/pubmed/30258081,30258081,,PMC6158291,20954282,"Kumar R, Coronel L, Somalanka B, Raju A, Aning OA, An O, Ho YS, Chen S, Mak SY, Hor PY, Yang H, Lakshmanan M, Itoh H, Tan SY, Lim YK, Wong APC, Chew SH, Huynh TH, Goh BC, Lim CY, Tergaonkar V, Cheok CF. Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers. Nature Communications. 2018 Sep 26;9(1):3931. doi: 10.1038/s41467-018-05805-1."
1942399,3034747,Comparative Toxicogenomics Database (CTD),"1,2-Bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",C070379,"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",https://ctdbase.org/detail.go?type=chem&acc=C070379,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein]",,,PMID:18850067,https://www.ncbi.nlm.nih.gov/pubmed/18850067,18850067,,PMC11131605,3091971,2008; 65(22):3640-3652
1942400,3034747,Comparative Toxicogenomics Database (CTD),"1,2-Bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",C070379,"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester",https://ctdbase.org/detail.go?type=chem&acc=C070379,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]",,,PMID:22253048,https://www.ncbi.nlm.nih.gov/pubmed/22253048,22253048,,,16772070,"Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 2011 Dec;59(12):1933–45. doi: 10.1002/glia.21235. PMID: 22253048."
1944464,3034761,Comparative Toxicogenomics Database (CTD),Tautomycin,C053079,tautomycin,https://ctdbase.org/detail.go?type=chem&acc=C053079,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tautomycin inhibits the reaction [docosahexaenoic acids results in increased degradation of PARP1 protein],,,PMID:11341974,https://www.ncbi.nlm.nih.gov/pubmed/11341974,11341974,,,14541089,"Siddiqui RA, Jenski LJ, Neff K, Harvey K, Kovacs RJ, Stillwell W. Docosahexaenoic acid induces apoptosis in Jurkat cells by a protein phosphatase-mediated process. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2001 Jan;1499(3):265–75. doi: 10.1016/s0167-4889(00)00128-2."
1576616,3035211,Comparative Toxicogenomics Database (CTD),Brassinin,C089020,brassinin,https://ctdbase.org/detail.go?type=chem&acc=C089020,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Brassinin analog results in increased cleavage of PARP1 protein,,,PMID:24747292,https://www.ncbi.nlm.nih.gov/pubmed/24747292,24747292,,,1830436,"Chripkova M, Drutovic D, Pilatova M, Mikes J, Budovska M, Vaskova J, Broggini M, Mirossay L, Mojzis J. Brassinin and its derivatives as potential anticancer agents. Toxicol In Vitro. 2014 Aug;28(5):909–15. doi: 10.1016/j.tiv.2014.04.002. PMID: 24747292."
1928971,3045788,Toxin and Toxin Target Database (T3DB),"Arsenic acid, manganese(2+) salt, hydrate (2:3:6)",T3D0294,Manganese arsenate,http://www.t3db.ca/toxins/T3D0294,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1583237,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dasatinib results in increased cleavage of PARP1 protein|arsenic trioxide promotes the reaction [dasatinib results in increased cleavage of PARP1 protein]|dasatinib promotes the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]|[dasatinib co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein,,,PMID:29266867,https://www.ncbi.nlm.nih.gov/pubmed/29266867,29266867,,PMC5824394,1222856,"Wang T, Cheng C, Peng L, Gao M, Xi M, Rousseaux S, Khochbin S, Wang J, Mi J. Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia. J Cellular Molecular Medi. 2017 Dec 20;22(3):1614–26. doi: 10.1111/jcmm.13436."
1583238,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[rucaparib co-treated with dasatinib co-treated with CPI-0610] results in increased cleavage of PARP1 protein,,,PMID:32927276,https://www.ncbi.nlm.nih.gov/pubmed/32927276,32927276,,PMC7494677,10174929,"Lui GYL, Shaw R, Schaub FX, Stork IN, Gurley KE, Bridgwater C, Diaz RL, Rosati R, Swan HA, Ince TA, Harding TC, Gadi VK, Goff BA, Kemp CJ, Swisher EM, Grandori C. BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer. EBioMedicine. 2020 Oct;60():102988. PMID: 32927276; PMCID: PMC7494677."
1930184,3080685,Toxin and Toxin Target Database (T3DB),Copper arsenate hydroxide (Cu2(AsO4)(OH)),T3D0289,Copper arsenate hydroxide,http://www.t3db.ca/toxins/T3D0289,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
779313,3081364,Comparative Toxicogenomics Database (CTD),Dicyclanil,C121718,dicyclanil,https://ctdbase.org/detail.go?type=chem&acc=C121718,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Dicyclanil results in decreased expression of PARP1 mRNA,,,PMID:15664270,https://www.ncbi.nlm.nih.gov/pubmed/15664270,15664270,,,3705498,"Moto M, Okamura M, Muto T, Kashida Y, Machida N, Mistumori K. Molecular pathological analysis on the mechanism of liver carcinogenesis in dicyclanil-treated mice. Toxicology. 2005 Feb 27;207(3):419–36. doi: 10.1016/j.tox.2004.10.011. PMID: 15664270."
1932537,3084152,Toxin and Toxin Target Database (T3DB),Trinickel bis(arsenate),T3D1409,Nickel arsenate,http://www.t3db.ca/toxins/T3D1409,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1947150,3085092,Comparative Toxicogenomics Database (CTD),Salinomycin,C010327,salinomycin,https://ctdbase.org/detail.go?type=chem&acc=C010327,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Salinomycin results in increased cleavage of PARP1 protein,,,PMID:30273566,https://www.ncbi.nlm.nih.gov/pubmed/30273566,30273566,,,20968546,"Liu L, Wang Q, Mao J, Qin T, Sun Y, Yang J, Han Y, Li L, Li Q. Salinomycin suppresses cancer cell stemness and attenuates TGF-ß-induced epithelial-mesenchymal transition of renal cell carcinoma cells. Chem Biol Interact. 2018 Dec 25;296():145–53. doi: 10.1016/j.cbi.2018.09.018. PMID: 30273566."
1983022,3086673,Comparative Toxicogenomics Database (CTD),Pegorgotein,C063471,polyethylene glycol-superoxide dismutase,https://ctdbase.org/detail.go?type=chem&acc=C063471,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[polyethylene glycol-superoxide dismutase co-treated with acetovanillone] inhibits the reaction [EDN1 protein results in increased expression of and results in increased cleavage of PARP1 protein],,,PMID:24932781,https://www.ncbi.nlm.nih.gov/pubmed/24932781,24932781,,PMC4116760,32330629,"Yilmaz B, Sahin P, Ordueri E, Celik-Ozenci C, Tasatargil A. Poly(ADP-ribose) polymerase inhibition improves endothelin-1-induced endothelial dysfunction in rat thoracic aorta. Upsala Journal of Medical Sciences. 2014 Jun 16;119(3):215–22. doi: 10.3109/03009734.2014.908253."
1983526,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [erastin results in increased cleavage of PARP1 protein],,,PMID:38641223,https://www.ncbi.nlm.nih.gov/pubmed/38641223,38641223,,,37138187,"Kou Z, Tran F, Colon T, Shteynfeld Y, Noh S, Chen F, Choi BH, Dai W. AhR signaling modulates Ferroptosis by regulating SLC7A11 expression. Toxicol Appl Pharmacol. 2024 May;486():116936. doi: 10.1016/j.taap.2024.116936. PMID: 38641223."
1952416,3495594,Comparative Toxicogenomics Database (CTD),"(3,4-Dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone",C071721,Ro 41-0960,https://ctdbase.org/detail.go?type=chem&acc=C071721,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Ro 41-0960 results in decreased expression of PARP1 protein,,,PMID:21896544,https://www.ncbi.nlm.nih.gov/pubmed/21896544,21896544,,PMC3196875,7295545,"Hassan MH, Fouad H, Bahashwan S, Al-Hendy A. Towards non-surgical therapy for uterine fibroids: catechol-O-methyl transferase inhibitor shrinks uterine fibroid lesions in the Eker rat model. Hum Reprod. 2011 Nov;26(11):3008–18. PMID: 21896544; PMCID: PMC3196875."
1514242,3645780,Comparative Toxicogenomics Database (CTD),alpha-Amino-2-chloro-5-hydroxybenzeneacetic acid,C107349,2-chloro-5-hydroxyphenylglycine,https://ctdbase.org/detail.go?type=chem&acc=C107349,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),2-chloro-5-hydroxyphenylglycine affects the reaction [oxidopamine results in increased cleavage of PARP1 protein]|gopc protein affects the reaction [2-chloro-5-hydroxyphenylglycine affects the reaction [oxidopamine results in increased cleavage of PARP1 protein]],,,PMID:33571554,https://www.ncbi.nlm.nih.gov/pubmed/33571554,33571554,,,660076,"Wang Y, Gu L, Yang HM, Zhang H. Cystic fibrosis transmembrane conductance regulator-associated ligand protects dopaminergic neurons by differentially regulating metabotropic glutamate receptor 5 in the progression of neurotoxin 6-hydroxydopamine-induced Parkinson's disease model. Neurotoxicology. 2021 May;84():14–29. doi: 10.1016/j.neuro.2021.02.003. PMID: 33571554."
792979,4210951,Comparative Toxicogenomics Database (CTD),SB 415286,C417520,"3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione",https://ctdbase.org/detail.go?type=chem&acc=C417520,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein]",,,PMID:22155090,https://www.ncbi.nlm.nih.gov/pubmed/22155090,22155090,,,15398108,"Sarró E, Jacobs-Cachá C, Itarte E, Meseguer A. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275–87. doi: 10.1016/j.taap.2011.11.007. PMID: 22155090."
2006736,4302963,Comparative Toxicogenomics Database (CTD),Iodopravadoline,C094023,iodopravadoline,https://ctdbase.org/detail.go?type=chem&acc=C094023,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Iodopravadoline results in increased cleavage of PARP1 protein|iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]],,,PMID:30836069,https://www.ncbi.nlm.nih.gov/pubmed/30836069,30836069,,,18256531,"Meeran MFN, Al Taee H, Azimullah S, Tariq S, Adeghate E, Ojha S. ß-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB2) receptors in rats. Chem Biol Interact. 2019 May 01;304():158–67. doi: 10.1016/j.cbi.2019.02.028. PMID: 30836069."
1642624,5113032,Comparative Toxicogenomics Database (CTD),"6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",C550547,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide",https://ctdbase.org/detail.go?type=chem&acc=C550547,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [camptothecin results in increased cleavage of PARP1 protein]|6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [camptothecin results in increased cleavage of PARP1 protein]",,,PMID:24726431,https://www.ncbi.nlm.nih.gov/pubmed/24726431,24726431,,,1811061,"Herbert KJ, Cook AL, Snow ET. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes. Toxicol Appl Pharmacol. 2014 Jun 15;277(3):288–97. doi: 10.1016/j.taap.2014.04.001. PMID: 24726431."
1633728,5271565,Comparative Toxicogenomics Database (CTD),Dimethyl maleate,C004780,dimethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C004780,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dimethyl maleate results in increased cleavage of PARP1 protein,,,PMID:21105742,https://www.ncbi.nlm.nih.gov/pubmed/21105742,21105742,,,20112279,"West JD, Stamm CE, Kingsley PJ. Structure-activity comparison of the cytotoxic properties of diethyl maleate and related molecules: identification of diethyl acetylenedicarboxylate as a thiol cross-linking agent. Chem Res Toxicol. 2011 Jan 14;24(1):81–8. doi: 10.1021/tx100292n. PMID: 21105742."
1893190,5271566,Comparative Toxicogenomics Database (CTD),Diethyl Maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Diethyl maleate results in increased cleavage of PARP1 protein,,,PMID:21105742,https://www.ncbi.nlm.nih.gov/pubmed/21105742,21105742,,,20112279,"West JD, Stamm CE, Kingsley PJ. Structure-activity comparison of the cytotoxic properties of diethyl maleate and related molecules: identification of diethyl acetylenedicarboxylate as a thiol cross-linking agent. Chem Res Toxicol. 2011 Jan 14;24(1):81–8. doi: 10.1021/tx100292n. PMID: 21105742."
1982796,5271569,Comparative Toxicogenomics Database (CTD),Dibutyl maleate,C048074,dibutyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C048074,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dibutyl maleate results in increased cleavage of PARP1 protein,,,PMID:21105742,https://www.ncbi.nlm.nih.gov/pubmed/21105742,21105742,,,20112279,"West JD, Stamm CE, Kingsley PJ. Structure-activity comparison of the cytotoxic properties of diethyl maleate and related molecules: identification of diethyl acetylenedicarboxylate as a thiol cross-linking agent. Chem Res Toxicol. 2011 Jan 14;24(1):81–8. doi: 10.1021/tx100292n. PMID: 21105742."
1545900,5273569,Comparative Toxicogenomics Database (CTD),Fraxetin,C105671,fraxetin,https://ctdbase.org/detail.go?type=chem&acc=C105671,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fraxetin results in increased cleavage of PARP1 protein,,,PMID:37867445,https://www.ncbi.nlm.nih.gov/pubmed/37867445,37867445,,,36105578,"Weng M, Deng Z, Huang S, Lin X, Xu N, Sun X, Wu W, Lu J, Wang D. Fraxetin inhibits proliferation and induces apoptosis of bladder cancer through the Akt pathway in vitro and in vivo. J Biochem Mol Toxicol. 2024 Jan;38(1):e23556. doi: 10.1002/jbt.23556. PMID: 37867445."
2064603,5274591,Comparative Toxicogenomics Database (CTD),Isoliensinine,C499779,isoliensinine,https://ctdbase.org/detail.go?type=chem&acc=C499779,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [isoliensinine results in increased cleavage of PARP1 protein]|isoliensinine results in increased cleavage of PARP1 protein|sb 203580 inhibits the reaction [isoliensinine results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [isoliensinine results in increased cleavage of PARP1 protein],,,PMID:26219228,https://www.ncbi.nlm.nih.gov/pubmed/26219228,26219228,,PMC4518223,33034897,2015; 5(1):12579
1879283,5278396,Comparative Toxicogenomics Database (CTD),KU-55933,C495818,2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C495818,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one co-treated with 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea] results in increased cleavage of PARP1 protein,,,PMID:26208482,https://www.ncbi.nlm.nih.gov/pubmed/26208482,26208482,,PMC4694865,33024721,"Kuo CY, Chou WC, Wu CC, Wong TS, Kakadiya R, Lee TC, Su TL, Wang HC. Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms. Oncotarget. 2015 Sep 22;6(28):25770–83. PMID: 26208482; PMCID: PMC4694865."
1879284,5278396,Comparative Toxicogenomics Database (CTD),KU-55933,C495818,2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C495818,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:22226932,https://www.ncbi.nlm.nih.gov/pubmed/22226932,22226932,,,22176951,"Yoon JH, Ahn SG, Lee BH, Jung SH, Oh SH. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. Biochem Pharmacol. 2012 Mar 15;83(6):747–57. doi: 10.1016/j.bcp.2011.12.029. PMID: 22226932."
1879285,5278396,Comparative Toxicogenomics Database (CTD),KU-55933,C495818,2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C495818,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein affects the reaction [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased activity of ATM protein]|parp1 protein affects the susceptibility to 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one,,,PMID:16556909,https://www.ncbi.nlm.nih.gov/pubmed/16556909,16556909,,PMC1410911,13294148,"Bryant HE, Helleday T. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Nucleic Acids Res. 2006;34(6):1685–91. PMID: 16556909; PMCID: PMC1410911."
1565184,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:14688022|PMID:21165570,https://www.ncbi.nlm.nih.gov/pubmed/14688022|https://www.ncbi.nlm.nih.gov/pubmed/21165570,14688022|21165570,,,1101035|20010805,"Lee WJ, Chen YR, Tseng TH. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583–91. doi: 10.3892/or.2010.1097. PMID: 21165570.|Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004 May;25(5):647–59. doi: 10.1093/carcin/bgh052. PMID: 14688022."
1565185,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ABCB1 protein results in decreased susceptibility to doxorubicin] inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:20438634,https://www.ncbi.nlm.nih.gov/pubmed/20438634,20438634,,PMC2873443,5184553,2010; 9(1):99
1565317,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AKT1 protein inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:20386985,https://www.ncbi.nlm.nih.gov/pubmed/20386985,20386985,,,24171575,2010; 15(7):850-863
1565318,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[BAX protein results in increased susceptibility to quercetin] which results in increased cleavage of PARP1 protein,,,PMID:18455702,https://www.ncbi.nlm.nih.gov/pubmed/18455702,18455702,,PMC3266687,21414903,"Lee D, Szczepanski M, Lee YJ. Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochemical Pharmacology. 2008 Jun;75(12):2345–55. doi: 10.1016/j.bcp.2008.03.013."
1565319,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:20096292,https://www.ncbi.nlm.nih.gov/pubmed/20096292,20096292,,PMC3003259,17372034,"Jung Y, Heo J, Lee YJ, Kwon TK, Kim Y. Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sciences. 2010 Feb;86(9-10):351–7. doi: 10.1016/j.lfs.2010.01.008."
1565320,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [quercetin results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:14688022,https://www.ncbi.nlm.nih.gov/pubmed/14688022,14688022,,,20010805,"Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004 May;25(5):647–59. doi: 10.1093/carcin/bgh052. PMID: 14688022."
1565321,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:28251795,https://www.ncbi.nlm.nih.gov/pubmed/28251795,28251795,,,21585601,"Chang J, Chow J, Chang J, Wen Y, Lin Y, Yang S, Lee W, Chien M. Quercetin simultaneously induces G<sub>0</sub>/G<sub>1</sub>-phase arrest and caspase-mediated crosstalk between apoptosis and autophagy in human leukemia HL-60 cells. Environmental Toxicology. 2017 Mar 02;32(7):1857–68. doi: 10.1002/tox.22408."
1565322,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TNFSF10 protein co-treated with quercetin] results in increased cleavage of PARP1 protein|ddit3 protein affects the reaction [[TNFSF10 protein co-treated with quercetin] results in increased cleavage of PARP1 protein],,,PMID:24612139,https://www.ncbi.nlm.nih.gov/pubmed/24612139,24612139,,PMC4317845,32999346,"Yi L, Zongyuan Y, Cheng G, Lingyun Z, GuiLian Y, Wei G. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated <scp>CCAAT</scp> enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway. Cancer Science. 2014 Apr 11;105(5):520–7. doi: 10.1111/cas.12395."
1565323,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ESR1 protein results in increased susceptibility to quercetin] which results in increased cleavage of PARP1 protein|sb 203580 inhibits the reaction [[ESR1 protein results in increased susceptibility to quercetin] which results in increased cleavage of PARP1 protein],,,PMID:19194971,https://www.ncbi.nlm.nih.gov/pubmed/19194971,19194971,,,2391269,"Galluzzo P, Martini C, Bulzomi P, Leone S, Bolli A, Pallottini V, Marino M. Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. Mol Nutr Food Res. 2009 Jun;53(6):699–708. doi: 10.1002/mnfr.200800239. PMID: 19194971."
1565324,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ESR2 protein results in increased susceptibility to quercetin] which results in increased cleavage of PARP1 protein|sb 203580 inhibits the reaction [[ESR2 protein results in increased susceptibility to quercetin] which results in increased cleavage of PARP1 protein]|fulvestrant inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:21732360,https://www.ncbi.nlm.nih.gov/pubmed/21732360,21732360,,,17416701,"Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, Marino M. The pro-apoptotic effect of quercetin in cancer cell lines requires ERß-dependent signals. Journal Cellular Physiology. 2012 Jan 23;227(5):1891–8. doi: 10.1002/jcp.22917."
1565325,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NFE2L2 protein inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:25896339,https://www.ncbi.nlm.nih.gov/pubmed/25896339,25896339,,PMC4443283,11412843,"Lee Y, Lee DM, Lee S. Nrf2 Expression and Apoptosis in Quercetin-treated Malignant Mesothelioma Cells. Molecules and Cells. 2015 May;38(5):416–25. doi: 10.14348/molcells.2015.2268."
1565474,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:21165570,https://www.ncbi.nlm.nih.gov/pubmed/21165570,21165570,,,1101035,"Lee WJ, Chen YR, Tseng TH. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583–91. doi: 10.3892/or.2010.1097. PMID: 21165570."
1565475,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[quercetin co-treated with hyperoside] results in increased cleavage of PARP1 protein,,,PMID:24173369|PMID:25354548,https://www.ncbi.nlm.nih.gov/pubmed/24173369|https://www.ncbi.nlm.nih.gov/pubmed/25354548,24173369|25354548,,,3213371|22861707,"Yang FQ, Liu M, Li W, Che JP, Wang GC, Zheng JH. Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA-21. Mol Med Rep. 2015 Feb;11(2):1085–92. doi: 10.3892/mmr.2014.2813. PMID: 25354548.|Li W, Liu M, Xu YF, Feng Y, Che JP, Wang GC, Zheng JH. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a. Oncol Rep. 2014 Jan;31(1):117–24. doi: 10.3892/or.2013.2811. PMID: 24173369."
1565476,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein]|quercetin inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein],,,PMID:22002103,https://www.ncbi.nlm.nih.gov/pubmed/22002103,22002103,,,19480675,2011; 17(2):200-216
1565477,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein],,,PMID:27050144,https://www.ncbi.nlm.nih.gov/pubmed/27050144,27050144,,,20915893,"Wang A, Wang S, Jiang Y, Chen M, Wang Y, Lin L. Bio-assay guided identification of hepatoprotective polyphenols from Penthorum chinense Pursh on t-BHP induced oxidative stress injured L02 cells. Food Funct. 2016 Apr;7(4):2074–83. doi: 10.1039/c6fo00110f. PMID: 27050144."
1565478,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin metabolite results in increased cleavage of PARP1 protein,,,PMID:19138980,https://www.ncbi.nlm.nih.gov/pubmed/19138980,19138980,,PMC2609748,24833630,"Olson ER, Melton T, Dong Z, Bowden GT. Stabilization of Quercetin Paradoxically Reduces Its Proapoptotic Effect on UVB-Irradiated Human Keratinocytes. 2008 Oct 01;1(5):362–8. doi: 10.1158/1940-6207.capr-08-0101."
1565479,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin metabolite results in increased expression of PARP1 protein,,,PMID:16280456,https://www.ncbi.nlm.nih.gov/pubmed/16280456,16280456,,,20026540,"Yang JH, Hsia TC, Kuo HM, Chao PD, Chou CC, Wei YH, Chung JG. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos. 2006 Feb;34(2):296–304. doi: 10.1124/dmd.105.005280. PMID: 16280456."
1565480,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin promotes the reaction [manumycin results in increased cleavage of PARP1 protein],,,PMID:14625852,https://www.ncbi.nlm.nih.gov/pubmed/14625852,14625852,,,28119795,"Hu W, Wu W, Verschraegen CF, Chen L, Mao L, Yeung SC, Kudelka AP, Freedman RS, Kavanagh JJ. Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor. Proteomics. 2003 Oct;3(10):1904–11. doi: 10.1002/pmic.200300547. PMID: 14625852."
1565481,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:17548900|PMID:17876056|PMID:18377872|PMID:20096292,https://www.ncbi.nlm.nih.gov/pubmed/17548900|https://www.ncbi.nlm.nih.gov/pubmed/17876056|https://www.ncbi.nlm.nih.gov/pubmed/18377872|https://www.ncbi.nlm.nih.gov/pubmed/20096292,17548900|17876056|18377872|20096292,,PMC2430102|PMC3003259,9280643|17372034|20051928|24804946,"Jung Y, Heo J, Lee YJ, Kwon TK, Kim Y. Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sciences. 2010 Feb;86(9-10):351–7. doi: 10.1016/j.lfs.2010.01.008.|Kim Y, Lee D, Jeong J, Guo ZS, Lee YJ. Quercetin augments TRAIL-induced apoptotic death: Involvement of the ERK signal transduction pathway. Biochemical Pharmacology. 2008 May;75(10):1946–58. doi: 10.1016/j.bcp.2008.02.016.|Psahoulia FH et al; Mol Cancer Ther 6(9):2591-9 (2007)|Chen W, Wang X, Zhuang J, Zhang L, Lin Y. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis. 2007 Oct;28(10):2114–21. doi: 10.1093/carcin/bgm133. PMID: 17548900."
1565482,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin results in decreased activity of PARP1 protein,,,PMID:17884996,https://www.ncbi.nlm.nih.gov/pubmed/17884996,17884996,,,20060229,"Geraets L, Moonen HJJ, Brauers K, Wouters EFM, Bast A, Hageman GJ. Dietary Flavones and Flavonoles Are Inhibitors of Poly(ADP-ribose)polymerase-1 in Pulmonary Epithelial Cells , The Journal of Nutrition. 2007 Oct;137(10):2190–5. doi: 10.1093/jn/137.10.2190."
1565483,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin results in decreased expression of PARP1 mRNA,,,PMID:20596804|PMID:30152185,https://www.ncbi.nlm.nih.gov/pubmed/20596804|https://www.ncbi.nlm.nih.gov/pubmed/30152185,20596804|30152185,,,5355923|22144301,"Shang HS, Lu HF, Lee CH, Chiang HS, Chu YL, Chen A, Lin YF, Chung JG. Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol. 2018 Nov;33(11):1168–81. doi: 10.1002/tox.22623. PMID: 30152185.|2010; 28(4):1395-1404"
1565646,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin results in increased cleavage of PARP1 protein,,,PMID:12168845|PMID:12874837|PMID:14688022|PMID:15741050|PMID:18455702|PMID:18787224|PMID:19138980|PMID:20096292|PMID:20386985|PMID:20438634|PMID:20658310|PMID:21165570|PMID:21732360|PMID:22555976|PMID:23094058|PMID:23727915|PMID:23918355|PMID:24275163|PMID:24647664|PMID:25830055|PMID:25896339|PMID:27175602|PMID:28251795,https://www.ncbi.nlm.nih.gov/pubmed/12168845|https://www.ncbi.nlm.nih.gov/pubmed/12874837|https://www.ncbi.nlm.nih.gov/pubmed/14688022|https://www.ncbi.nlm.nih.gov/pubmed/15741050|https://www.ncbi.nlm.nih.gov/pubmed/18455702|https://www.ncbi.nlm.nih.gov/pubmed/18787224|https://www.ncbi.nlm.nih.gov/pubmed/19138980|https://www.ncbi.nlm.nih.gov/pubmed/20096292|https://www.ncbi.nlm.nih.gov/pubmed/20386985|https://www.ncbi.nlm.nih.gov/pubmed/20438634|https://www.ncbi.nlm.nih.gov/pubmed/20658310|https://www.ncbi.nlm.nih.gov/pubmed/21165570|https://www.ncbi.nlm.nih.gov/pubmed/21732360|https://www.ncbi.nlm.nih.gov/pubmed/22555976|https://www.ncbi.nlm.nih.gov/pubmed/23094058|https://www.ncbi.nlm.nih.gov/pubmed/23727915|https://www.ncbi.nlm.nih.gov/pubmed/23918355|https://www.ncbi.nlm.nih.gov/pubmed/24275163|https://www.ncbi.nlm.nih.gov/pubmed/24647664|https://www.ncbi.nlm.nih.gov/pubmed/25830055|https://www.ncbi.nlm.nih.gov/pubmed/25896339|https://www.ncbi.nlm.nih.gov/pubmed/27175602|https://www.ncbi.nlm.nih.gov/pubmed/28251795,12168845|12874837|14688022|15741050|18455702|18787224|19138980|20096292|20386985|20438634|20658310|21165570|21732360|22555976|23094058|23727915|23918355|24275163|24647664|25830055|25896339|27175602|28251795,,PMC2597612|PMC2609748|PMC2873443|PMC3003259|PMC3266687|PMC3475699|PMC3761568|PMC4379472|PMC4443283|PMC4899028,407156|449600|1101035|2284584|3169148|5184553|8089762|11364282|11412843|12532314|13437956|14730781|14799663|17372034|17416701|20010805|20709052|21414903|21585601|24151831|24171575|24833630|30963706,"Chang J, Chow J, Chang J, Wen Y, Lin Y, Yang S, Lee W, Chien M. Quercetin simultaneously induces G<sub>0</sub>/G<sub>1</sub>-phase arrest and caspase-mediated crosstalk between apoptosis and autophagy in human leukemia HL-60 cells. Environmental Toxicology. 2017 Mar 02;32(7):1857–68. doi: 10.1002/tox.22408.|Seo HS, Ku JM, Choi HS, Choi YK, Woo JK, Kim M, Kim I, Na CH, Hur H, Jang BH, Shin YC, Ko SG. Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells. Oncol Rep. 2016 Jul;36(1):31–42. PMID: 27175602; PMCID: PMC4899028.|Lee Y, Lee DM, Lee S. Nrf2 Expression and Apoptosis in Quercetin-treated Malignant Mesothelioma Cells. Molecules and Cells. 2015 May;38(5):416–25. doi: 10.14348/molcells.2015.2268.|Mukherjee A, Khuda-Bukhsh AR. Quercetin Down-regulates IL-6/STAT-3 Signals to Induce Mitochondrial-mediated Apoptosis in a Nonsmall- cell Lung-cancer Cell Line, A549. J Pharmacopuncture. 2015 Mar;18(1):19–26. PMID: 25830055; PMCID: PMC4379472.|Kim MC, Lee HJ, Lim B, Ha KT, Kim SY, So I, Kim BJ. Quercetin induces apoptosis by inhibiting MAPKs and TRPM7 channels in AGS cells. Int J Mol Med. 2014 Jun;33(6):1657–63. doi: 10.3892/ijmm.2014.1704. PMID: 24647664.|Cao HH, Tse AK, Kwan HY, Yu H, Cheng CY, Su T, Fong WF, Yu ZL. Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol. 2014 Feb 01;87(3):424–34. doi: 10.1016/j.bcp.2013.11.008. PMID: 24275163.|Lee MO, Moon SH, Jeong HC, Yi JY, Lee TH, Shim SH, Rhee YH, Lee SH, Oh SJ, Lee MY, Han MJ, Cho YS, Chung HM, Kim KS, Cha HJ. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):E3281–90. PMID: 23918355; PMCID: PMC3761568.|Youn H, Jeong J, Jeong YS, Kim E, Um S. Quercetin Potentiates Apoptosis by Inhibiting Nuclear Factor-kappaB Signaling in H460 Lung Cancer Cells. Biological & Pharmaceutical Bulletin. 2013;36(6):944–51. doi: 10.1248/bpb.b12-01004.|Pratheeshkumar P, Budhraja A, Son Y, Wang X, Zhang Z, Ding S, Wang L, Hitron A, Lee J, Xu M, Chen G, Luo J, Shi X. Quercetin Inhibits Angiogenesis Mediated Human Prostate Tumor Growth by Targeting VEGFR- 2 Regulated AKT/mTOR/P70S6K Signaling Pathways. PLoS ONE. 2012 Oct 18;7(10):e47516. doi: 10.1371/journal.pone.0047516.|2012; 39(7):7785-7793|Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, Marino M. The pro-apoptotic effect of quercetin in cancer cell lines requires ERß-dependent signals. Journal Cellular Physiology. 2012 Jan 23;227(5):1891–8. doi: 10.1002/jcp.22917.|Lee WJ, Chen YR, Tseng TH. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583–91. doi: 10.3892/or.2010.1097. PMID: 21165570.|2010; 344(1-2):173-184|2010; 9(1):99|2010; 15(7):850-863|Jung Y, Heo J, Lee YJ, Kwon TK, Kim Y. Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sciences. 2010 Feb;86(9-10):351–7. doi: 10.1016/j.lfs.2010.01.008.|Gelebart P, Anand M, Armanious H, Peters AC, Dien Bard J, Amin HM, Lai R. Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. Blood. 2008 Dec 15;112(13):5171–9. PMID: 18787224; PMCID: PMC2597612.|Olson ER, Melton T, Dong Z, Bowden GT. Stabilization of Quercetin Paradoxically Reduces Its Proapoptotic Effect on UVB-Irradiated Human Keratinocytes. 2008 Oct 01;1(5):362–8. doi: 10.1158/1940-6207.capr-08-0101.|Lee D, Szczepanski M, Lee YJ. Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochemical Pharmacology. 2008 Jun;75(12):2345–55. doi: 10.1016/j.bcp.2008.03.013.|KIM W, BANG M, KIM E, KANG N, JUNG K, CHO H, PARK J. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. The Journal of Nutritional Biochemistry. 2005 Mar;16(3):155–62. doi: 10.1016/j.jnutbio.2004.10.010.|Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004 May;25(5):647–59. doi: 10.1093/carcin/bgh052. PMID: 14688022.|Shen SC, Chen YC, Hsu FL, Lee WR. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. J Cell Biochem. 2003 Aug 01;89(5):1044–55. doi: 10.1002/jcb.10559. PMID: 12874837.|Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res. 2002 May;22(3):1615–27. PMID: 12168845."
1565647,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin results in increased degradation of PARP1 protein,,,PMID:16059641,https://www.ncbi.nlm.nih.gov/pubmed/16059641,16059641,,,22707598,"Duraj J, Zazrivcova K, Bodo J, Sulikova M, Sedlak J. Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. Neoplasma. 2005;52(4):273–9. PMID: 16059641."
1565648,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quercetin results in increased expression of PARP1 protein modified form,,,PMID:19017364|PMID:28251795,https://www.ncbi.nlm.nih.gov/pubmed/19017364|https://www.ncbi.nlm.nih.gov/pubmed/28251795,19017364|28251795,,PMC4515069,16715387|21585601,"Chang J, Chow J, Chang J, Wen Y, Lin Y, Yang S, Lee W, Chien M. Quercetin simultaneously induces G<sub>0</sub>/G<sub>1</sub>-phase arrest and caspase-mediated crosstalk between apoptosis and autophagy in human leukemia HL-60 cells. Environmental Toxicology. 2017 Mar 02;32(7):1857–68. doi: 10.1002/tox.22408.|Li M, Wang J, Jing J, Hua H, Luo T, Xu L, Wang R, Liu D, Jiang Y. Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70. J Cellular Molecular Medi. 2009 Nov;13(11-12):4540–50. doi: 10.1111/j.1582-4934.2008.00575.x."
1565649,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[resveratrol co-treated with quercetin] results in increased cleavage of PARP1 protein,,,PMID:23530649,https://www.ncbi.nlm.nih.gov/pubmed/23530649,23530649,,,6643657,"Del Follo-Martinez A, Banerjee N, Li X, Safe S, Mertens-Talcott S. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a. Nutr Cancer. 2013;65(3):494–504. doi: 10.1080/01635581.2012.725194. PMID: 23530649."
1565650,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10036,Mesocricetus auratus (golden hamster),"Quercetin inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased cleavage of PARP1 protein]",,,PMID:21294050,https://www.ncbi.nlm.nih.gov/pubmed/21294050,21294050,,,31610521,"Priyadarsini RV, Vinothini G, Murugan RS, Manikandan P, Nagini S. The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors. Nutr Cancer. 2011;63(2):218–26. doi: 10.1080/01635581.2011.523503. PMID: 21294050."
1565651,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Quercetin inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:15876423,https://www.ncbi.nlm.nih.gov/pubmed/15876423,15876423,,,27455432,"Chow JM, Shen SC, Huan SK, Lin HY, Chen YC. Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem Pharmacol. 2005 Jun 15;69(12):1839–51. doi: 10.1016/j.bcp.2005.03.017. PMID: 15876423."
1565789,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Quercetin results in decreased expression of PARP1 protein,,,PMID:17039455,https://www.ncbi.nlm.nih.gov/pubmed/17039455,17039455,,,6521060,"Hsu CL, Yen GC. Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity. Mol Nutr Food Res. 2006 Nov;50(11):1072–9. doi: 10.1002/mnfr.200600040. PMID: 17039455."
1565790,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Quercetin results in increased cleavage of PARP1 protein,,,PMID:26076811,https://www.ncbi.nlm.nih.gov/pubmed/26076811,26076811,,,29657824,2015; 36(11):8913-8924
1565791,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:24902966,https://www.ncbi.nlm.nih.gov/pubmed/24902966,24902966,,PMC4209150,8716327,"Dong Q, Chen L, Lu Q, Sharma S, Li L, Morimoto S, Wang G. Quercetin attenuates doxorubicin cardiotoxicity by modulating <scp>B</scp>mi-1 expression. British J Pharmacology. 2014 Aug 14;171(19):4440–54. doi: 10.1111/bph.12795."
1565792,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [estradiol 3-benzoate results in increased cleavage of PARP1 protein],,,PMID:24316378,https://www.ncbi.nlm.nih.gov/pubmed/24316378,24316378,,,28285440,"Bharti S, Misro MM, Rai U. Quercetin supplementation restores testicular function and augments germ cell survival in the estrogenized rats. Mol Cell Endocrinol. 2014 Mar 05;383(1-2):10–20. doi: 10.1016/j.mce.2013.11.021. PMID: 24316378."
1565793,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [glucose results in increased cleavage of PARP1 protein],,,PMID:22524206,https://www.ncbi.nlm.nih.gov/pubmed/22524206,22524206,,,18766516,"Bournival J, Francoeur MA, Renaud J, Martinoli MG. Quercetin and sesamin protect neuronal PC12 cells from high-glucose-induced oxidation, nitrosative stress, and apoptosis. Rejuvenation Res. 2012 Jun;15(3):322–33. doi: 10.1089/rej.2011.1242. PMID: 22524206."
1565794,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:14505808,https://www.ncbi.nlm.nih.gov/pubmed/14505808,14505808,,,14592968,"Park C, So HS, Shin CH, Baek SH, Moon BS, Shin SH, Lee HS, Lee DW, Park R. Quercetin protects the hydrogen peroxide-induced apoptosis via inhibition of mitochondrial dysfunction in H9c2 cardiomyoblast cells. Biochem Pharmacol. 2003 Oct 01;66(7):1287–95. doi: 10.1016/s0006-2952(03)00478-7. PMID: 14505808."
1565795,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein],,,PMID:23138875,https://www.ncbi.nlm.nih.gov/pubmed/23138875,23138875,,,1801178,"Dai X, Ding Y, Zhang Z, Cai X, Li Y. Quercetin and quercitrin protect against cytokine-induced injuries in RINm5F ß-cells via the mitochondrial pathway and NF-?B signaling. Int J Mol Med. 2013 Jan;31(1):265–71. doi: 10.3892/ijmm.2012.1177. PMID: 23138875."
1947414,5280352,Comparative Toxicogenomics Database (CTD),Bilirubin,D001663,Bilirubin,https://ctdbase.org/detail.go?type=chem&acc=D001663,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bilirubin results in increased expression of PARP1 protein modified form|4-phenylbutyric acid inhibits the reaction [bilirubin results in increased expression of PARP1 protein modified form],,,PMID:27578021,https://www.ncbi.nlm.nih.gov/pubmed/27578021,27578021,,,27019438,2016; 91(4):1847-1858
1647536,5280360,Comparative Toxicogenomics Database (CTD),Dinoprostone,D015232,Dinoprostone,https://ctdbase.org/detail.go?type=chem&acc=D015232,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dinoprostone inhibits the reaction [baohuoside I results in increased cleavage of PARP1 protein],,,PMID:19289254,https://www.ncbi.nlm.nih.gov/pubmed/19289254,19289254,,,18709460,"Lee KS, Lee HJ, Ahn KS, Kim SH, Nam D, Kim DK, Choi DY, Ahn KS, Lu J, Kim SH. Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer Lett. 2009 Jul 18;280(1):93–100. doi: 10.1016/j.canlet.2009.02.024. PMID: 19289254."
1953533,5280373,Comparative Toxicogenomics Database (CTD),Biochanin A,C004541,biochanin A,https://ctdbase.org/detail.go?type=chem&acc=C004541,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Biochanin A results in increased cleavage of PARP1 protein,,,PMID:12791511,https://www.ncbi.nlm.nih.gov/pubmed/12791511,12791511,,,24703878,"Su SJ, Chow NH, Kung ML, Hung TC, Chang KL. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer. 2003;45(1):113–23. doi: 10.1207/s15327914nc4501_13. PMID: 12791511."
2065472,5280442,Comparative Toxicogenomics Database (CTD),Acacetin,C023717,acacetin,https://ctdbase.org/detail.go?type=chem&acc=C023717,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acacetin results in increased expression of PARP1 protein,,,PMID:36740148,https://www.ncbi.nlm.nih.gov/pubmed/36740148,36740148,,,34840593,"Kandhari K, Mishra JPN, Agarwal R, Singh RP. Acacetin induces sustained ERK1/2 activation and RIP1-dependent necroptotic death in breast cancer cells. Toxicol Appl Pharmacol. 2023 Mar 01;462():116409. doi: 10.1016/j.taap.2023.116409. PMID: 36740148."
2121503,5280443,Comparative Toxicogenomics Database (CTD),Apigenin,D047310,Apigenin,https://ctdbase.org/detail.go?type=chem&acc=D047310,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[apigenin co-treated with 3-(4-methylphenylsulfonyl)-2-propenenitrile] results in increased cleavage of PARP1 protein|apigenin results in increased cleavage of PARP1 protein,,,PMID:24148603,https://www.ncbi.nlm.nih.gov/pubmed/24148603,24148603,,,22840164,"Wu DG, Yu P, Li JW, Jiang P, Sun J, Wang HZ, Zhang LD, Wen MB, Bie P. Apigenin potentiates the growth inhibitory effects by IKK-ß-mediated NF-?B activation in pancreatic cancer cells. Toxicol Lett. 2014 Jan 03;224(1):157–64. doi: 10.1016/j.toxlet.2013.10.007. PMID: 24148603."
2121504,5280443,Comparative Toxicogenomics Database (CTD),Apigenin,D047310,Apigenin,https://ctdbase.org/detail.go?type=chem&acc=D047310,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[polylactic acid-polyglycolic acid copolymer co-treated with apigenin] results in increased cleavage of PARP1 protein,,,PMID:24070738,https://www.ncbi.nlm.nih.gov/pubmed/24070738,24070738,,,16118447,"Das S, Das J, Samadder A, Paul A, Khuda-Bukhsh AR. Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro. Toxicol Lett. 2013 Nov 25;223(2):124–38. doi: 10.1016/j.toxlet.2013.09.012. PMID: 24070738."
2121505,5280443,Comparative Toxicogenomics Database (CTD),Apigenin,D047310,Apigenin,https://ctdbase.org/detail.go?type=chem&acc=D047310,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TNFSF10 protein results in increased susceptibility to apigenin] which results in increased cleavage of PARP1 protein,,,PMID:29247770,https://www.ncbi.nlm.nih.gov/pubmed/29247770,29247770,,,20269977,"Kang CH, Molagoda IMN, Choi YH, Park C, Moon DO, Kim GY. Apigenin promotes TRAIL-mediated apoptosis regardless of ROS generation. Food Chem Toxicol. 2018 Jan;111():623–30. doi: 10.1016/j.fct.2017.12.018. PMID: 29247770."
2121506,5280443,Comparative Toxicogenomics Database (CTD),Apigenin,D047310,Apigenin,https://ctdbase.org/detail.go?type=chem&acc=D047310,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Apigenin inhibits the reaction [brefeldin A results in increased cleavage of PARP1 protein]|apigenin inhibits the reaction [thapsigargin results in increased cleavage of PARP1 protein],,,PMID:20493918,https://www.ncbi.nlm.nih.gov/pubmed/20493918,20493918,,,3799125,"Choi AY, Choi JH, Lee JY, Yoon KS, Choe W, Ha J, Yeo EJ, Kang I. Apigenin protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis. Neurochem Int. 2010 Sep;57(2):143–52. doi: 10.1016/j.neuint.2010.05.006. PMID: 20493918."
2121507,5280443,Comparative Toxicogenomics Database (CTD),Apigenin,D047310,Apigenin,https://ctdbase.org/detail.go?type=chem&acc=D047310,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Apigenin inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein],,,PMID:22155090,https://www.ncbi.nlm.nih.gov/pubmed/22155090,22155090,,,15398108,"Sarró E, Jacobs-Cachá C, Itarte E, Meseguer A. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275–87. doi: 10.1016/j.taap.2011.11.007. PMID: 22155090."
1939438,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CYP1A2 protein promotes the reaction [luteolin results in increased cleavage of PARP1 protein]|cyp1a1 protein promotes the reaction [luteolin results in increased cleavage of PARP1 protein],,,PMID:33727136,https://www.ncbi.nlm.nih.gov/pubmed/33727136,33727136,,PMC8045014,30479673,"Li X, He X, Chen S, Le Y, Bryant MS, Guo L, Witt KL, Mei N. The genotoxicity potential of luteolin is enhanced by CYP1A1 and CYP1A2 in human lymphoblastoid TK6 cells. Toxicology Letters. 2021 Jun;344():58–68. doi: 10.1016/j.toxlet.2021.03.006."
1939439,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[luteolin co-treated with paclitaxel] results in decreased expression of PARP1 protein,,,PMID:24525192,https://www.ncbi.nlm.nih.gov/pubmed/24525192,24525192,,,10728341,"Yang MY, Wang CJ, Chen NF, Ho WH, Lu FJ, Tseng TH. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3. Chem Biol Interact. 2014 Apr 25;213():60–8. doi: 10.1016/j.cbi.2014.02.002. PMID: 24525192."
1939440,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein]|luteolin inhibits the reaction [metals, heavy results in increased cleavage of PARP1 protein]",,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,PMC5746289,30392830,"Wang Y, Su H, Song X, Fiati Kenston SS, Zhao J, Gu Y. Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway. Int J Mol Med. 2018 Jan;41(1):233–41. PMID: 29115570; PMCID: PMC5746289."
1939441,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Luteolin results in increased cleavage of PARP1 protein,,,PMID:12168845|PMID:32268164|PMID:33727136,https://www.ncbi.nlm.nih.gov/pubmed/12168845|https://www.ncbi.nlm.nih.gov/pubmed/32268164|https://www.ncbi.nlm.nih.gov/pubmed/33727136,12168845|32268164|33727136,,PMC8045014,12532314|28434914|30479673,"Li X, He X, Chen S, Le Y, Bryant MS, Guo L, Witt KL, Mei N. The genotoxicity potential of luteolin is enhanced by CYP1A1 and CYP1A2 in human lymphoblastoid TK6 cells. Toxicology Letters. 2021 Jun;344():58–68. doi: 10.1016/j.toxlet.2021.03.006.|Potocnjak I, Šimic L, Gobin I, Vukelic I, Domitrovic R. Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway. Toxicol In Vitro. 2020 Aug;66():104852. doi: 10.1016/j.tiv.2020.104852. PMID: 32268164.|Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res. 2002 May;22(3):1615–27. PMID: 12168845."
1939442,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mirdametinib promotes the reaction [luteolin results in increased cleavage of PARP1 protein],,,PMID:32268164,https://www.ncbi.nlm.nih.gov/pubmed/32268164,32268164,,,28434914,"Potocnjak I, Šimic L, Gobin I, Vukelic I, Domitrovic R. Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway. Toxicol In Vitro. 2020 Aug;66():104852. doi: 10.1016/j.tiv.2020.104852. PMID: 32268164."
1939443,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Luteolin inhibits the reaction [tunicamycin results in increased expression of PARP1 protein modified form],,,PMID:32407927,https://www.ncbi.nlm.nih.gov/pubmed/32407927,32407927,,,29765151,"Jegal KH, Kim EO, Kim JK, Park SM, Jung DH, Lee GH, Ki SH, Byun SH, Ku SK, Cho IJ, Kim SC. Luteolin prevents liver from tunicamycin-induced endoplasmic reticulum stress via nuclear factor erythroid 2-related factor 2-dependent sestrin 2 induction. Toxicol Appl Pharmacol. 2020 Jul 15;399():115036. doi: 10.1016/j.taap.2020.115036. PMID: 32407927."
1939444,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Luteolin results in increased cleavage of PARP1 protein,,,PMID:31201582,https://www.ncbi.nlm.nih.gov/pubmed/31201582,31201582,,,14236955,2019; 36(1):31-49
1825884,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Calcitriol results in increased cleavage of PARP1 protein,,,PMID:37792677,https://www.ncbi.nlm.nih.gov/pubmed/37792677,37792677,,,36596603,"Jie L, Hengyue W, Ting H. RETRACTED: Calcitriol suppresses gastric cancer progression and cisplatin resistance by inhibiting glycolysis and <scp>M2</scp> macrophage polarization through inhibition of <scp>mTOR</scp> activation. Environmental Toxicology. 2023 Oct 04;39(2):830–9. doi: 10.1002/tox.23975."
1785378,5280459,Comparative Toxicogenomics Database (CTD),Quercitrin,C012526,quercitrin,https://ctdbase.org/detail.go?type=chem&acc=C012526,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein],,,PMID:23138875,https://www.ncbi.nlm.nih.gov/pubmed/23138875,23138875,,,1801178,"Dai X, Ding Y, Zhang Z, Cai X, Li Y. Quercetin and quercitrin protect against cytokine-induced injuries in RINm5F ß-cells via the mitochondrial pathway and NF-?B signaling. Int J Mol Med. 2013 Jan;31(1):265–71. doi: 10.3892/ijmm.2012.1177. PMID: 23138875."
1968242,5280460,Comparative Toxicogenomics Database (CTD),Scopoletin,D012603,Scopoletin,https://ctdbase.org/detail.go?type=chem&acc=D012603,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Scopoletin inhibits the reaction [glucose results in decreased expression of PARP1 protein],,,PMID:37619648,https://www.ncbi.nlm.nih.gov/pubmed/37619648,37619648,,,36349969,"Park JE, Han JS. Scopoletin protects INS-1 pancreatic ß cells from glucotoxicity by reducing oxidative stress and apoptosis. Toxicol In Vitro. 2023 Dec;93():105665. doi: 10.1016/j.tiv.2023.105665. PMID: 37619648."
1956026,5280637,Comparative Toxicogenomics Database (CTD),Luteolin 7-O-glucoside,C066408,luteolin-7-glucoside,https://ctdbase.org/detail.go?type=chem&acc=C066408,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein]|luteolin-7-glucoside results in increased cleavage of PARP1 protein|u 0126 inhibits the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein]|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein]|sb 203580 promotes the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein],,,PMID:34165247,https://www.ncbi.nlm.nih.gov/pubmed/34165247,34165247,,,31166243,"Ho H, Chen P, Lo Y, Lin C, Chuang Y, Hsieh M, Chen M. <scp>Luteolin-7-O</scp>-glucoside inhibits cell proliferation and modulates apoptosis through the <scp>AKT</scp> signaling pathway in human nasopharyngeal carcinoma. Environmental Toxicology. 2021 Jun 24;36(10):2013–24. doi: 10.1002/tox.23319."
1956346,5280647,Comparative Toxicogenomics Database (CTD),Gossypetin,C059922,gossypetin,https://ctdbase.org/detail.go?type=chem&acc=C059922,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Gossypetin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased cleavage of PARP1 protein]",,,PMID:25622137,https://www.ncbi.nlm.nih.gov/pubmed/25622137,25622137,,,27662511,Lin HH. In Vitro and in Vivo Atheroprotective Effects of Gossypetin against Endothelial Cell Injury by Induction of Autophagy. Chem Res Toxicol. 2015 Feb 16;28(2):202–15. doi: 10.1021/tx5003518. PMID: 25622137.
1956347,5280647,Comparative Toxicogenomics Database (CTD),Gossypetin,C059922,gossypetin,https://ctdbase.org/detail.go?type=chem&acc=C059922,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gossypetin results in decreased activity of PARP1 protein,,,PMID:17884996,https://www.ncbi.nlm.nih.gov/pubmed/17884996,17884996,,,20060229,"Geraets L, Moonen HJJ, Brauers K, Wouters EFM, Bast A, Hageman GJ. Dietary Flavones and Flavonoles Are Inhibitors of Poly(ADP-ribose)polymerase-1 in Pulmonary Epithelial Cells , The Journal of Nutrition. 2007 Oct;137(10):2190–5. doi: 10.1093/jn/137.10.2190."
1972155,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cholecalciferol affects the expression of PARP1 protein,,,PMID:18628207,https://www.ncbi.nlm.nih.gov/pubmed/18628207,18628207,,,6544513,"Wang J, Lian H, Zhao Y, Kauss MA, Spindel S. Vitamin D3 Induces Autophagy of Human Myeloid Leukemia Cells. Journal of Biological Chemistry. 2008 Sep;283(37):25596–605. doi: 10.1074/jbc.m801716200."
1972156,5280795,Comparative Toxicogenomics Database (CTD),Cholecalciferol,D002762,Cholecalciferol,https://ctdbase.org/detail.go?type=chem&acc=D002762,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of PARP1 protein modified form|parp1 mRNA promotes the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of RUNX2 mrna]|parg mRNA inhibits the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of PARP1 protein],,,PMID:22940495,https://www.ncbi.nlm.nih.gov/pubmed/22940495,22940495,,,31637292,"Robaszkiewicz A, Erdélyi K, Kovács K, Kovács I, Bai P, Rajnavölgyi E, Virág L. Hydrogen peroxide-induced poly(ADP-ribosyl)ation regulates osteogenic differentiation-associated cell death. Free Radic Biol Med. 2012 Oct 15;53(8):1552–64. doi: 10.1016/j.freeradbiomed.2012.08.567. PMID: 22940495."
2068905,5280863,Comparative Toxicogenomics Database (CTD),Kaempferol,C006552,kaempferol,https://ctdbase.org/detail.go?type=chem&acc=C006552,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3',4'-dihydroxyflavone analog inhibits the reaction [kaempferol results in increased cleavage of PARP1 protein]|kaempferol results in increased cleavage of PARP1 protein",,,PMID:16014620,https://www.ncbi.nlm.nih.gov/pubmed/16014620,16014620,,,25466453,"Lee ER, Kang YJ, Kim JH, Lee HT, Cho SG. Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 09;280(36):31498–507. doi: 10.1074/jbc.m505537200. PMID: 16014620."
2068906,5280863,Comparative Toxicogenomics Database (CTD),Kaempferol,C006552,kaempferol,https://ctdbase.org/detail.go?type=chem&acc=C006552,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Kaempferol inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:22155320,https://www.ncbi.nlm.nih.gov/pubmed/22155320,22155320,,,15398335,"Xiao J, Sun GB, Sun B, Wu Y, He L, Wang X, Chen RC, Cao L, Ren XY, Sun XB. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology. 2012 Feb 06;292(1):53–62. doi: 10.1016/j.tox.2011.11.018. PMID: 22155320."
1975026,5280884,Comparative Toxicogenomics Database (CTD),prostaglandin J2,C037112,9-deoxy-delta-9-prostaglandin D2,https://ctdbase.org/detail.go?type=chem&acc=C037112,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),9-deoxy-delta-9-prostaglandin D2 results in increased cleavage of PARP1 protein,,,PMID:15843042,https://www.ncbi.nlm.nih.gov/pubmed/15843042,15843042,,,7860293,"Chen Y, Shen S, Tsai S. Prostaglandin D2 and J2 induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2005 Apr;1743(3):291–304. doi: 10.1016/j.bbamcr.2004.10.016."
1975027,5280884,Comparative Toxicogenomics Database (CTD),prostaglandin J2,C037112,9-deoxy-delta-9-prostaglandin D2,https://ctdbase.org/detail.go?type=chem&acc=C037112,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"[delta(12)-prostaglandin J(2) co-treated with 9-deoxy-delta-9-prostaglandin D2 co-treated with 15-deoxy-delta(12,14)-prostaglandin J2] results in increased cleavage of PARP1 protein",,,PMID:23973622,https://www.ncbi.nlm.nih.gov/pubmed/23973622,23973622,,PMC3904641,8031651,"Liu H, Li W, Rose ME, Pascoe JL, Miller TM, Ahmad M, Poloyac SM, Hickey RW, Graham SH. Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. Neurotoxicology. 2013 Dec;39():35–44. PMID: 23973622; PMCID: PMC3904641."
846392,5280885,Comparative Toxicogenomics Database (CTD),delta-12-Prostaglandin J2,C499810,delta(12)-prostaglandin J(2),https://ctdbase.org/detail.go?type=chem&acc=C499810,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"[delta(12)-prostaglandin J(2) co-treated with 9-deoxy-delta-9-prostaglandin D2 co-treated with 15-deoxy-delta(12,14)-prostaglandin J2] results in increased cleavage of PARP1 protein",,,PMID:23973622,https://www.ncbi.nlm.nih.gov/pubmed/23973622,23973622,,PMC3904641,8031651,"Liu H, Li W, Rose ME, Pascoe JL, Miller TM, Ahmad M, Poloyac SM, Hickey RW, Graham SH. Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. Neurotoxicology. 2013 Dec;39():35–44. PMID: 23973622; PMCID: PMC3904641."
2124084,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Senecionine results in decreased expression of PARP1 protein,,,PMID:29458164,https://www.ncbi.nlm.nih.gov/pubmed/29458164,29458164,,,33077163,"Waizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras S. Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: Single versus repeated exposure. Food Chem Toxicol. 2018 Apr;114():215–26. doi: 10.1016/j.fct.2018.02.036. PMID: 29458164."
2124085,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Senecionine results in decreased expression of PARP1 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,PMC9151551,6856890,2022; 96(7):2003-2019
2032526,5280933,Comparative Toxicogenomics Database (CTD),gamma-Linolenic acid,D017965,gamma-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017965,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Gamma-linolenic acid results in increased cleavage of PARP1 protein,,,PMID:10403056,https://www.ncbi.nlm.nih.gov/pubmed/10403056,10403056,,,9115318,1999; 30(3):353-368
1975956,5280953,Comparative Toxicogenomics Database (CTD),Harmine,D006247,Harmine,https://ctdbase.org/detail.go?type=chem&acc=D006247,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Harmine promotes the reaction [erlotinib hydrochloride results in increased cleavage of PARP1 protein],,,PMID:30171258,https://www.ncbi.nlm.nih.gov/pubmed/30171258,30171258,,PMC6358506,19002035,2018; 38(5):656-670
1666353,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[fluorouracil co-treated with genistein] results in increased cleavage of PARP1 protein,,,PMID:15896711,https://www.ncbi.nlm.nih.gov/pubmed/15896711,15896711,,,27474486,"Hwang J, Ha J, Park OJ. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochemical and Biophysical Research Communications. 2005 Jul;332(2):433–40. doi: 10.1016/j.bbrc.2005.04.143."
1666354,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[genistein co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein,,,PMID:21078540,https://www.ncbi.nlm.nih.gov/pubmed/21078540,21078540,,,26888802,"Ma Y, Wang J, Liu L, Zhu H, Chen X, Pan S, Sun X, Jiang H. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-?B. Cancer Lett. 2011 Feb 01;301(1):75–84. doi: 10.1016/j.canlet.2010.10.022. PMID: 21078540."
1666459,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Genistein results in increased cleavage of PARP1 protein,,,PMID:12791511|PMID:21078540,https://www.ncbi.nlm.nih.gov/pubmed/12791511|https://www.ncbi.nlm.nih.gov/pubmed/21078540,12791511|21078540,,,24703878|26888802,"Ma Y, Wang J, Liu L, Zhu H, Chen X, Pan S, Sun X, Jiang H. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-?B. Cancer Lett. 2011 Feb 01;301(1):75–84. doi: 10.1016/j.canlet.2010.10.022. PMID: 21078540.|Su SJ, Chow NH, Kung ML, Hung TC, Chang KL. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer. 2003;45(1):113–23. doi: 10.1207/s15327914nc4501_13. PMID: 12791511."
1666460,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Genistein results in increased cleavage of PARP1 protein,,,PMID:21078540|PMID:25756279,https://www.ncbi.nlm.nih.gov/pubmed/21078540|https://www.ncbi.nlm.nih.gov/pubmed/25756279,21078540|25756279,,PMC4355578,22870816|26888802,"Pfarr K, Danciu C, Arlt O, Neske C, Dehelean C, Pfeilschifter JM, Radeke HH. Simultaneous and Dose Dependent Melanoma Cytotoxic and Immune Stimulatory Activity of Betulin. PLoS ONE. 2015 Mar 10;10(3):e0118802. doi: 10.1371/journal.pone.0118802.|Ma Y, Wang J, Liu L, Zhu H, Chen X, Pan S, Sun X, Jiang H. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-?B. Cancer Lett. 2011 Feb 01;301(1):75–84. doi: 10.1016/j.canlet.2010.10.022. PMID: 21078540."
1666461,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Genistein inhibits the reaction [bisphenol A results in decreased cleavage of PARP1 protein]|genistein results in increased cleavage of PARP1 protein,,,PMID:24884420,https://www.ncbi.nlm.nih.gov/pubmed/24884420,24884420,,PMC4049406,9400635,2014; 14(1):379
1646052,5281220,Comparative Toxicogenomics Database (CTD),Aureusidin,C416232,aureusidin,https://ctdbase.org/detail.go?type=chem&acc=C416232,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aureusidin inhibits the reaction [oxidopamine affects the cleavage of PARP1 protein],,,PMID:38056806,https://www.ncbi.nlm.nih.gov/pubmed/38056806,38056806,,,36430919,"Hu K, Zhu S, Wu F, Zhang Y, Li M, Yuan L, Huang W, Zhang Y, Wang J, Ren J, Yang H. Aureusidin ameliorates 6-OHDA-induced neurotoxicity via activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway in SH-SY5Y cells and Caenorhabditis elegans. Chem Biol Interact. 2024 Jan 05;387():110824. doi: 10.1016/j.cbi.2023.110824. PMID: 38056806."
847158,5281222,Comparative Toxicogenomics Database (CTD),Butein,C040918,butein,https://ctdbase.org/detail.go?type=chem&acc=C040918,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Butein results in increased cleavage of PARP1 protein,,,PMID:24931875,https://www.ncbi.nlm.nih.gov/pubmed/24931875,24931875,,,32329758,"Huang YT, Lin CI, Chien PH, Tang TT, Lin J, Chao JI. The depletion of securin enhances butein-induced apoptosis and tumor inhibition in human colorectal cancer. Chem Biol Interact. 2014 Sep 05;220():41–50. doi: 10.1016/j.cbi.2014.06.006. PMID: 24931875."
1675974,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MYCN protein inhibits the reaction [crocin results in increased cleavage of PARP1 protein]|crocin results in increased cleavage of PARP1 protein,,,PMID:30672053,https://www.ncbi.nlm.nih.gov/pubmed/30672053,30672053,,,30436789,"Deng L, Li J, Lu S, Su Y. Crocin inhibits proliferation and induces apoptosis through suppressing MYCN expression in retinoblastoma. J Biochem Mol Toxicol. 2019 May;33(5):e22292. doi: 10.1002/jbt.22292. PMID: 30672053."
2034681,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [fucoxanthin results in increased cleavage of PARP1 protein]|bcl2l1 protein inhibits the reaction [fucoxanthin results in increased cleavage of PARP1 protein]|stat3 protein inhibits the reaction [fucoxanthin results in increased cleavage of PARP1 protein]|fucoxanthin results in increased cleavage of PARP1 protein,,,PMID:38444163,https://www.ncbi.nlm.nih.gov/pubmed/38444163,38444163,,,36894997,"Kuo M, Dai W, Chang J, Chang J, Lee T, Chang C. Fucoxanthin induces human melanoma cytotoxicity by thwarting the <scp>JAK2</scp>/<scp>STAT3</scp>/<scp>BCL-xL</scp> signaling axis. Environmental Toxicology. 2024 Mar 05;39(6):3356–66. doi: 10.1002/tox.24193."
1985248,5281255,Comparative Toxicogenomics Database (CTD),Isobavachalcone,C468754,isobavachalcone,https://ctdbase.org/detail.go?type=chem&acc=C468754,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Isobavachalcone results in increased cleavage of PARP1 protein,,,PMID:30890322,https://www.ncbi.nlm.nih.gov/pubmed/30890322,30890322,,,29757236,"Yang L, Song L, Zhao S, Ma C, Wu D, Wu YL. Isobavachalcone reveals novel characteristics of methuosis-like cell death in leukemia cells. Chem Biol Interact. 2019 May 01;304():131–8. doi: 10.1016/j.cbi.2019.03.011. PMID: 30890322."
1899261,5281319,Comparative Toxicogenomics Database (CTD),Cucurbitacin E,C102326,cucurbitacin E,https://ctdbase.org/detail.go?type=chem&acc=C102326,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of PARP1 protein]|cucurbitacin E results in increased cleavage of PARP1 protein|acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [cucurbitacin E results in increased cleavage of PARP1 protein],,,PMID:27106530,https://www.ncbi.nlm.nih.gov/pubmed/27106530,27106530,,,16857121,"Ma G, Luo W, Lu J, Ma DL, Leung CH, Wang Y, Chen X. Cucurbitacin E induces caspase-dependent apoptosis and protective autophagy mediated by ROS in lung cancer cells. Chem Biol Interact. 2016 Jun 25;253():1–9. doi: 10.1016/j.cbi.2016.04.028. PMID: 27106530."
1899262,5281319,Comparative Toxicogenomics Database (CTD),Cucurbitacin E,C102326,cucurbitacin E,https://ctdbase.org/detail.go?type=chem&acc=C102326,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cucurbitacin E results in increased cleavage of PARP1 protein,,,PMID:27363783,https://www.ncbi.nlm.nih.gov/pubmed/27363783,27363783,,,22897061,"Wu YL, Zhang YJ, Yao YL, Li ZM, Han X, Lian LH, Zhao YQ, Nan JX. Cucurbitacin E ameliorates hepatic fibrosis in vivo and in vitro through activation of AMPK and blocking mTOR-dependent signaling pathway. Toxicol Lett. 2016 Sep 06;258():147–58. doi: 10.1016/j.toxlet.2016.06.2102. PMID: 27363783."
1899539,5281321,Comparative Toxicogenomics Database (CTD),Cucurbitacin I,C038106,cucurbitacin I,https://ctdbase.org/detail.go?type=chem&acc=C038106,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cucurbitacin I results in increased cleavage of PARP1 protein,,,PMID:24858077,https://www.ncbi.nlm.nih.gov/pubmed/24858077,24858077,,,9378509,"Kim HJ, Park JH, Kim JK. Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer. Chem Biol Interact. 2014 Aug 05;219():1–8. doi: 10.1016/j.cbi.2014.05.005. PMID: 24858077."
2071116,5281342,Comparative Toxicogenomics Database (CTD),Capillarisin,C011185,capillarisin,https://ctdbase.org/detail.go?type=chem&acc=C011185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PTPN11 protein affects the reaction [capillarisin results in increased cleavage of PARP1 protein]|capillarisin results in increased cleavage of PARP1 protein|ptpn6 protein affects the reaction [capillarisin results in increased cleavage of PARP1 protein]|bortezomib promotes the reaction [capillarisin results in increased cleavage of PARP1 protein],,,PMID:24333736,https://www.ncbi.nlm.nih.gov/pubmed/24333736,24333736,,,28301548,"Lee JH, Chiang SY, Nam D, Chung WS, Lee J, Na YS, Sethi G, Ahn KS. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. Cancer Lett. 2014 Apr 01;345(1):140–8. doi: 10.1016/j.canlet.2013.12.008. PMID: 24333736."
1977748,5281404,Comparative Toxicogenomics Database (CTD),Harman,C005010,harman,https://ctdbase.org/detail.go?type=chem&acc=C005010,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Harman results in increased cleavage of PARP1 protein,,,PMID:35985368,https://www.ncbi.nlm.nih.gov/pubmed/35985368,35985368,,,35324957,"Feng Y, Chen S, Zhao Y, Wu D, Li G. Heterocyclic aromatic amines induce Neuro-2a cells cytotoxicity through oxidative stress-mediated mitochondria-dependent apoptotic signals. Food Chem Toxicol. 2022 Oct;168():113376. doi: 10.1016/j.fct.2022.113376. PMID: 35985368."
2036094,5281416,Comparative Toxicogenomics Database (CTD),Esculetin,C007628,esculetin,https://ctdbase.org/detail.go?type=chem&acc=C007628,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Esculetin results in increased cleavage of PARP1 protein,,,PMID:26388407|PMID:31313495,https://www.ncbi.nlm.nih.gov/pubmed/26388407|https://www.ncbi.nlm.nih.gov/pubmed/31313495,26388407|31313495,,,14127285|32448278,"Choi YJ, Lee CM, Park SH, Nam MJ. Esculetin induces cell cycle arrest and apoptosis in human colon cancer LoVo cells. Environ Toxicol. 2019 Oct;34(10):1129–36. doi: 10.1002/tox.22815. PMID: 31313495.|Pan H, Wang BH, Lv W, Jiang Y, He L. Esculetin induces apoptosis in human gastric cancer cells through a cyclophilin D-mediated mitochondrial permeability transition pore associated with ROS. Chem Biol Interact. 2015 Dec 05;242():51–60. doi: 10.1016/j.cbi.2015.09.015. PMID: 26388407."
1985658,5281515,Comparative Toxicogenomics Database (CTD),Caryophyllene,C024714,caryophyllene,https://ctdbase.org/detail.go?type=chem&acc=C024714,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Caryophyllene inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]|iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]],,,PMID:30836069,https://www.ncbi.nlm.nih.gov/pubmed/30836069,30836069,,,18256531,"Meeran MFN, Al Taee H, Azimullah S, Tariq S, Adeghate E, Ojha S. ß-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB2) receptors in rats. Chem Biol Interact. 2019 May 01;304():158–67. doi: 10.1016/j.cbi.2019.02.028. PMID: 30836069."
1889870,5281576,Comparative Toxicogenomics Database (CTD),Zearalenone,D015025,Zearalenone,https://ctdbase.org/detail.go?type=chem&acc=D015025,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Nicotinamide mononucleotide inhibits the reaction [zearalenone results in increased expression of PARP1 mrna]|zearalenone results in increased expression of PARP1 mRNA,,,PMID:38159578,https://www.ncbi.nlm.nih.gov/pubmed/38159578,38159578,,,36699901,"Dai C, Hou M, Yang X, Wang Z, Sun C, Wu X, Wang S. Increased NAD+ levels protect female mouse reproductive system against zearalenone-impaired glycolysis, lipid metabolism, antioxidant capacity and inflammation. Reprod Toxicol. 2024 Mar;124():108530. doi: 10.1016/j.reprotox.2023.108530. PMID: 38159578."
1889952,5281576,Comparative Toxicogenomics Database (CTD),Zearalenone,D015025,Zearalenone,https://ctdbase.org/detail.go?type=chem&acc=D015025,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Zearalenone results in decreased expression of PARP1 protein,,,PMID:28089945,https://www.ncbi.nlm.nih.gov/pubmed/28089945,28089945,,,14164564,"Zhang GL, Sun XF, Feng YZ, Li B, Li YP, Yang F, Nyachoti CM, Shen W, Sun SD, Li L. Zearalenone exposure impairs ovarian primordial follicle formation via down-regulation of Lhx8 expression in vitro. Toxicol Appl Pharmacol. 2017 Feb 15;317():33–40. doi: 10.1016/j.taap.2017.01.004. PMID: 28089945."
1889953,5281576,Comparative Toxicogenomics Database (CTD),Zearalenone,D015025,Zearalenone,https://ctdbase.org/detail.go?type=chem&acc=D015025,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Zearalenone results in increased cleavage of PARP1 protein,,,PMID:24530352,https://www.ncbi.nlm.nih.gov/pubmed/24530352,24530352,,,31645873,"Wang Y, Zheng W, Bian X, Yuan Y, Gu J, Liu X, Liu Z, Bian J. Zearalenone induces apoptosis and cytoprotective autophagy in primary Leydig cells. Toxicol Lett. 2014 Apr 21;226(2):182–91. doi: 10.1016/j.toxlet.2014.02.003. PMID: 24530352."
1795439,5281607,Comparative Toxicogenomics Database (CTD),Chrysin,C043561,chrysin,https://ctdbase.org/detail.go?type=chem&acc=C043561,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cisplatin co-treated with chrysin] results in increased cleavage of PARP1 protein|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[cisplatin co-treated with chrysin] results in increased cleavage of PARP1 protein],,,PMID:25770930,https://www.ncbi.nlm.nih.gov/pubmed/25770930,25770930,,,22884660,"Li X, Huang JM, Wang JN, Xiong XK, Yang XF, Zou F. Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53. Chem Biol Interact. 2015 May 05;232():12–20. doi: 10.1016/j.cbi.2015.03.003. PMID: 25770930."
1795440,5281607,Comparative Toxicogenomics Database (CTD),Chrysin,C043561,chrysin,https://ctdbase.org/detail.go?type=chem&acc=C043561,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Chrysin results in increased cleavage of PARP1 protein,,,PMID:18455702|PMID:25770930,https://www.ncbi.nlm.nih.gov/pubmed/18455702|https://www.ncbi.nlm.nih.gov/pubmed/25770930,18455702|25770930,,PMC3266687,21414903|22884660,"Li X, Huang JM, Wang JN, Xiong XK, Yang XF, Zou F. Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53. Chem Biol Interact. 2015 May 05;232():12–20. doi: 10.1016/j.cbi.2015.03.003. PMID: 25770930.|Lee D, Szczepanski M, Lee YJ. Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochemical Pharmacology. 2008 Jun;75(12):2345–55. doi: 10.1016/j.bcp.2008.03.013."
1795441,5281607,Comparative Toxicogenomics Database (CTD),Chrysin,C043561,chrysin,https://ctdbase.org/detail.go?type=chem&acc=C043561,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Chrysin inhibits the reaction [cyclophosphamide results in increased expression of PARP1 protein],,,PMID:37263553,https://www.ncbi.nlm.nih.gov/pubmed/37263553,37263553,,,35714303,"Saleh DO, El-Nasr NMEA, Fayez AM, Ahmed KA, Mohamed RA. Uro-protective role of chrysin against cyclophosphamide-induced hemorrhagic cystitis in rats involving the turning-off NF-?B/P38-MAPK, NO/PARP-1 and STAT-3 signaling cascades. Chem Biol Interact. 2023 Sep 01;382():110585. doi: 10.1016/j.cbi.2023.110585. PMID: 37263553."
1676767,5281612,Comparative Toxicogenomics Database (CTD),Diosmetin,C039602,diosmetin,https://ctdbase.org/detail.go?type=chem&acc=C039602,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of PARP1 protein modified form]]|nfe2l2 protein promotes the reaction [diosmetin inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of PARP1 protein modified form]]|diosmetin inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of PARP1 protein modified form],,,PMID:35191607,https://www.ncbi.nlm.nih.gov/pubmed/35191607,35191607,,,7536038,"Shi M, Wang J, Bi F, Bai Z. Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition. Environmental Toxicology. 2022 Feb 22;37(6):1529–42. doi: 10.1002/tox.23504."
1677073,5281613,Comparative Toxicogenomics Database (CTD),Diosmin,D004145,Diosmin,https://ctdbase.org/detail.go?type=chem&acc=D004145,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Diosmin inhibits the reaction [benzo(a)pyrene results in increased cleavage of PARP1 protein],,,PMID:32061149,https://www.ncbi.nlm.nih.gov/pubmed/32061149,32061149,,,2641332,"Islam J, Shree A, Afzal SM, Vafa A, Sultana S. Protective effect of Diosmin against benzo(a)pyrene-induced lung injury in Swiss Albino Mice. Environ Toxicol. 2020 Jul;35(7):747–57. doi: 10.1002/tox.22909. PMID: 32061149."
1896980,5281614,Comparative Toxicogenomics Database (CTD),Fisetin,C017875,fisetin,https://ctdbase.org/detail.go?type=chem&acc=C017875,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fisetin results in decreased activity of PARP1 protein,,,PMID:17884996,https://www.ncbi.nlm.nih.gov/pubmed/17884996,17884996,,,20060229,"Geraets L, Moonen HJJ, Brauers K, Wouters EFM, Bast A, Hageman GJ. Dietary Flavones and Flavonoles Are Inhibitors of Poly(ADP-ribose)polymerase-1 in Pulmonary Epithelial Cells , The Journal of Nutrition. 2007 Oct;137(10):2190–5. doi: 10.1093/jn/137.10.2190."
1978553,5281616,Comparative Toxicogenomics Database (CTD),Galangin,C037032,galangin,https://ctdbase.org/detail.go?type=chem&acc=C037032,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Galangin results in increased cleavage of PARP1 protein,,,PMID:18455702,https://www.ncbi.nlm.nih.gov/pubmed/18455702,18455702,,PMC3266687,21414903,"Lee D, Szczepanski M, Lee YJ. Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochemical Pharmacology. 2008 Jun;75(12):2345–55. doi: 10.1016/j.bcp.2008.03.013."
1978225,5281621,Comparative Toxicogenomics Database (CTD),Gossypin,C022944,gossypin,https://ctdbase.org/detail.go?type=chem&acc=C022944,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gossypin results in increased cleavage of PARP1 protein,,,PMID:30536456,https://www.ncbi.nlm.nih.gov/pubmed/30536456,30536456,,PMC6416069,25729111,"Wang L, Wang X, Chen H, Zu X, Ma F, Liu K, Bode AM, Dong Z, Kim DJ. Gossypin inhibits gastric cancer growth by direct targeting of <scp>AURKA</scp> and <scp>RSK2</scp>. Phytotherapy Research. 2018 Dec 10;33(3):640–50. doi: 10.1002/ptr.6253."
848909,5281623,Comparative Toxicogenomics Database (CTD),Bellidifolin,C091291,bellidifolin,https://ctdbase.org/detail.go?type=chem&acc=C091291,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bellidifolin results in decreased expression of PARP1 protein,,,PMID:33299414,https://www.ncbi.nlm.nih.gov/pubmed/33299414,33299414,,PMC7703469,15587448,"Yan L, Yali L, Chenghao L, Caiqin F, Zhongbo Z, Weiyu R, Yu M, Xiaotian Z, Biwen W, Xiaojie J, Yongqi L. Bellidifolin Inhibits Proliferation of A549 Cells by Regulating STAT3/COX-2 Expression and Protein Activity. Journal of Oncology. 2020 Nov 21;2020():1–17. doi: 10.1155/2020/1723791."
2126679,5281643,Comparative Toxicogenomics Database (CTD),Hyperoside,C021304,hyperoside,https://ctdbase.org/detail.go?type=chem&acc=C021304,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[quercetin co-treated with hyperoside] results in increased cleavage of PARP1 protein,,,PMID:24173369|PMID:25354548,https://www.ncbi.nlm.nih.gov/pubmed/24173369|https://www.ncbi.nlm.nih.gov/pubmed/25354548,24173369|25354548,,,3213371|22861707,"Yang FQ, Liu M, Li W, Che JP, Wang GC, Zheng JH. Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA-21. Mol Med Rep. 2015 Feb;11(2):1085–92. doi: 10.3892/mmr.2014.2813. PMID: 25354548.|Li W, Liu M, Xu YF, Feng Y, Che JP, Wang GC, Zheng JH. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a. Oncol Rep. 2014 Jan;31(1):117–24. doi: 10.3892/or.2013.2811. PMID: 24173369."
1900989,5281650,Comparative Toxicogenomics Database (CTD),Mangostin,C021053,mangostin,https://ctdbase.org/detail.go?type=chem&acc=C021053,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mangostin results in increased cleavage of PARP1 protein,,,PMID:23954321,https://www.ncbi.nlm.nih.gov/pubmed/23954321,23954321,,,8013580,"Kumazaki M, Noguchi S, Yasui Y, Iwasaki J, Shinohara H, Yamada N, Akao Y. Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells. The Journal of Nutritional Biochemistry. 2013 Nov;24(11):1849–58. doi: 10.1016/j.jnutbio.2013.04.006."
850246,5281654,Comparative Toxicogenomics Database (CTD),Isorhamnetin,C047368,3-methylquercetin,https://ctdbase.org/detail.go?type=chem&acc=C047368,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methylquercetin results in increased cleavage of PARP1 protein,,,PMID:22992727,https://www.ncbi.nlm.nih.gov/pubmed/22992727,22992727,,PMC3488073,32963708,"Ramachandran L, Manu KA, Shanmugam MK, Li F, Siveen KS, Vali S, Kapoor S, Abbasi T, Surana R, Smoot DT, Ashktorab H, Tan P, Ahn KS, Yap CW, Kumar AP, Sethi G. Isorhamnetin Inhibits Proliferation and Invasion and Induces Apoptosis through the Modulation of Peroxisome Proliferator-activated Receptor ? Activation Pathway in Gastric Cancer. Journal of Biological Chemistry. 2012 Nov;287(45):38028–40. doi: 10.1074/jbc.m112.388702."
2048977,5281670,Comparative Toxicogenomics Database (CTD),Morin,C008548,morin,https://ctdbase.org/detail.go?type=chem&acc=C008548,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Morin results in increased expression of PARP1 mRNA,,,PMID:28689916,https://www.ncbi.nlm.nih.gov/pubmed/28689916,28689916,,,15502171,"Zhang Q, Zhang F, Thakur K, Wang J, Wang H, Hu F, Zhang JG, Wei ZJ. Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells. Food Chem Toxicol. 2018 Feb;112():466–75. doi: 10.1016/j.fct.2017.07.002. PMID: 28689916."
1953897,5281671,Comparative Toxicogenomics Database (CTD),Morusin,C057451,morusin,https://ctdbase.org/detail.go?type=chem&acc=C057451,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [morusin results in increased cleavage of PARP1 protein]|u 0126 inhibits the reaction [morusin results in increased cleavage of PARP1 protein]|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [morusin results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [morusin results in increased cleavage of PARP1 protein],,,PMID:33035517,https://www.ncbi.nlm.nih.gov/pubmed/33035517,33035517,,,6804631,"Wang J, Liu X, Zheng H, Liu Q, Zhang H, Wang X, Shen T, Wang S, Ren D. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells. Chem Biol Interact. 2020 Nov 01;331():109279. doi: 10.1016/j.cbi.2020.109279. PMID: 33035517."
1953898,5281671,Comparative Toxicogenomics Database (CTD),Morusin,C057451,morusin,https://ctdbase.org/detail.go?type=chem&acc=C057451,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Morusin results in increased cleavage of PARP1 protein,,,PMID:33035517|PMID:37443484,https://www.ncbi.nlm.nih.gov/pubmed/33035517|https://www.ncbi.nlm.nih.gov/pubmed/37443484,33035517|37443484,,PMC10344534,6804631|35854130,"Li H, Xiao J, Li X, Huang Q, Liu Q, Zhang Q. Mechanism of morusin on breast cancer via network pharmacology and in vitro experiments. 2023 Jul 14;102(28):e34300. doi: 10.1097/md.0000000000034300.|Wang J, Liu X, Zheng H, Liu Q, Zhang H, Wang X, Shen T, Wang S, Ren D. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells. Chem Biol Interact. 2020 Nov 01;331():109279. doi: 10.1016/j.cbi.2020.109279. PMID: 33035517."
1569660,5281672,Comparative Toxicogenomics Database (CTD),Myricetin,C040015,myricetin,https://ctdbase.org/detail.go?type=chem&acc=C040015,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Myricetin results in decreased activity of PARP1 protein,,,PMID:17884996,https://www.ncbi.nlm.nih.gov/pubmed/17884996,17884996,,,20060229,"Geraets L, Moonen HJJ, Brauers K, Wouters EFM, Bast A, Hageman GJ. Dietary Flavones and Flavonoles Are Inhibitors of Poly(ADP-ribose)polymerase-1 in Pulmonary Epithelial Cells , The Journal of Nutrition. 2007 Oct;137(10):2190–5. doi: 10.1093/jn/137.10.2190."
1569661,5281672,Comparative Toxicogenomics Database (CTD),Myricetin,C040015,myricetin,https://ctdbase.org/detail.go?type=chem&acc=C040015,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Myricetin results in increased cleavage of PARP1 protein,,,PMID:15748703|PMID:29698783,https://www.ncbi.nlm.nih.gov/pubmed/15748703|https://www.ncbi.nlm.nih.gov/pubmed/29698783,15748703|29698783,,,4648421|22033829,"Lee JH, Choi YJ, Park SH, Nam MJ. Potential role of nucleoside diphosphate kinase in myricetin-induced selective apoptosis in colon cancer HCT-15 cells. Food Chem Toxicol. 2018 Jun;116(Pt B):315–22. doi: 10.1016/j.fct.2018.04.053. PMID: 29698783.|Ko CH, Shen SC, Hsu CS, Chen YC. Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade. Biochem Pharmacol. 2005 Mar 15;69(6):913–27. doi: 10.1016/j.bcp.2004.12.005. PMID: 15748703."
2050345,5281701,Comparative Toxicogenomics Database (CTD),Tricetin,C469689,tricetin,https://ctdbase.org/detail.go?type=chem&acc=C469689,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tricetin inhibits the reaction [oxidopamine results in increased expression of PARP1 protein],,,PMID:31176653,https://www.ncbi.nlm.nih.gov/pubmed/31176653,31176653,,,14212967,"Ren J, Yuan L, Wang W, Zhang M, Wang Q, Li S, Zhang L, Hu K. Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway. Toxicol Appl Pharmacol. 2019 Sep 01;378():114617. doi: 10.1016/j.taap.2019.114617. PMID: 31176653."
2050346,5281701,Comparative Toxicogenomics Database (CTD),Tricetin,C469689,tricetin,https://ctdbase.org/detail.go?type=chem&acc=C469689,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tricetin results in decreased activity of PARP1 protein,,,PMID:17884996,https://www.ncbi.nlm.nih.gov/pubmed/17884996,17884996,,,20060229,"Geraets L, Moonen HJJ, Brauers K, Wouters EFM, Bast A, Hageman GJ. Dietary Flavones and Flavonoles Are Inhibitors of Poly(ADP-ribose)polymerase-1 in Pulmonary Epithelial Cells , The Journal of Nutrition. 2007 Oct;137(10):2190–5. doi: 10.1093/jn/137.10.2190."
1628218,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP1 mrna|[coumestrol co-treated with resveratrol] results in increased expression of PARP1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,,16019154,"Dip R, Lenz S, Gmuender H, Naegeli H. Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787–95. doi: 10.1016/j.fct.2009.01.008. PMID: 19167446."
1574433,5281708,Comparative Toxicogenomics Database (CTD),Daidzein,C004742,daidzein,https://ctdbase.org/detail.go?type=chem&acc=C004742,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Daidzein results in increased cleavage of PARP1 protein,,,PMID:12791511,https://www.ncbi.nlm.nih.gov/pubmed/12791511,12791511,,,24703878,"Su SJ, Chow NH, Kung ML, Hung TC, Chang KL. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer. 2003;45(1):113–23. doi: 10.1207/s15327914nc4501_13. PMID: 12791511."
2037148,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pterostilbene inhibits the reaction [pyruvaldehyde results in increased cleavage of PARP1 protein],,,PMID:33930484,https://www.ncbi.nlm.nih.gov/pubmed/33930484,33930484,,,18336339,"Tang D, Xiao W, Gu WT, Zhang ZT, Xu SH, Chen ZQ, Xu YH, Zhang LY, Wang SM, Nie H. Pterostilbene prevents methylglyoxal-induced cytotoxicity in endothelial cells by regulating glyoxalase, oxidative stress and apoptosis. Food Chem Toxicol. 2021 Jul;153():112244. doi: 10.1016/j.fct.2021.112244. PMID: 33930484."
2037149,5281727,Comparative Toxicogenomics Database (CTD),Pterostilbene,C107773,pterostilbene,https://ctdbase.org/detail.go?type=chem&acc=C107773,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pterostilbene results in increased expression of PARP1 protein modified form,,,PMID:19549798,https://www.ncbi.nlm.nih.gov/pubmed/19549798,19549798,,PMC2753521,18058529,"Paul S, Rimando AM, Lee HJ, Ji Y, Reddy BS, Suh N. Anti-inflammatory Action of Pterostilbene Is Mediated through the p38 Mitogen-Activated Protein Kinase Pathway in Colon Cancer Cells. 2009 Jul 01;2(7):650–7. doi: 10.1158/1940-6207.capr-08-0224."
1979396,5281729,Comparative Toxicogenomics Database (CTD),Echimidine,C000615871,echimidine,https://ctdbase.org/detail.go?type=chem&acc=C000615871,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Echimidine results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:29458164,https://www.ncbi.nlm.nih.gov/pubmed/29458164,29458164,,,33077163,"Waizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras S. Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: Single versus repeated exposure. Food Chem Toxicol. 2018 Apr;114():215–26. doi: 10.1016/j.fct.2018.02.036. PMID: 29458164."
1853744,5281788,Comparative Toxicogenomics Database (CTD),Plantamajoside,C421173,plantamajoside,https://ctdbase.org/detail.go?type=chem&acc=C421173,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Plantamajoside promotes the reaction [metformin results in increased cleavage of PARP1 protein],,,PMID:35350904,https://www.ncbi.nlm.nih.gov/pubmed/35350904,35350904,,,5457436,"Wang Z, Zuo J, Zhang L, Zhang Z, Wei Y. Plantamajoside promotes metformin-induced apoptosis, autophagy and proliferation arrest of liver cancer cells via suppressing Akt/GSK3ß signaling. Hum Exp Toxicol. 2022 Jan;41():9603271221078868. doi: 10.1177/09603271221078868. PMID: 35350904."
2006756,5281793,Comparative Toxicogenomics Database (CTD),Salvianolic acid A,C066201,salvianolic acid A,https://ctdbase.org/detail.go?type=chem&acc=C066201,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Salvianolic acid A inhibits the reaction [arsenic trioxide results in increased expression of PARP1 protein],,,PMID:28391263,https://www.ncbi.nlm.nih.gov/pubmed/28391263,28391263,,,12140016,"Zhang J, Sun G, Luo Y, Wang M, Wang W, Du Y, Yu Y, Sun X. Salvianolic Acid A Protects H9c2 Cells from Arsenic Trioxide-Induced Injury via Inhibition of the MAPK Signaling Pathway. Cell Physiol Biochem. 2017;41(5):1957–69. doi: 10.1159/000472409."
1683203,5281794,Comparative Toxicogenomics Database (CTD),Shogaol,C040115,shogaol,https://ctdbase.org/detail.go?type=chem&acc=C040115,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|s-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|cflar protein modified form inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:25619640,https://www.ncbi.nlm.nih.gov/pubmed/25619640,25619640,,,27660120,"Han MA, Woo SM, Min KJ, Kim S, Park JW, Kim DE, Kim SH, Choi YH, Kwon TK. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression. Chem Biol Interact. 2015 Feb 25;228():69–78. doi: 10.1016/j.cbi.2015.01.020. PMID: 25619640."
1683204,5281794,Comparative Toxicogenomics Database (CTD),Shogaol,C040115,shogaol,https://ctdbase.org/detail.go?type=chem&acc=C040115,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [shogaol results in increased cleavage of PARP1 protein],,,PMID:18384088,https://www.ncbi.nlm.nih.gov/pubmed/18384088,18384088,,,8585134,"Pan MH, Hsieh MC, Kuo JM, Lai CS, Wu H, Sang S, Ho CT. 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol Nutr Food Res. 2008 May;52(5):527–37. doi: 10.1002/mnfr.200700157. PMID: 18384088."
1683205,5281794,Comparative Toxicogenomics Database (CTD),Shogaol,C040115,shogaol,https://ctdbase.org/detail.go?type=chem&acc=C040115,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Shogaol results in increased cleavage of PARP1 protein,,,PMID:18384088|PMID:25619640,https://www.ncbi.nlm.nih.gov/pubmed/18384088|https://www.ncbi.nlm.nih.gov/pubmed/25619640,18384088|25619640,,,8585134|27660120,"Han MA, Woo SM, Min KJ, Kim S, Park JW, Kim DE, Kim SH, Choi YH, Kwon TK. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression. Chem Biol Interact. 2015 Feb 25;228():69–78. doi: 10.1016/j.cbi.2015.01.020. PMID: 25619640.|Pan MH, Hsieh MC, Kuo JM, Lai CS, Wu H, Sang S, Ho CT. 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol Nutr Food Res. 2008 May;52(5):527–37. doi: 10.1002/mnfr.200700157. PMID: 18384088."
1801231,5281807,Comparative Toxicogenomics Database (CTD),Puerarin,C033607,puerarin,https://ctdbase.org/detail.go?type=chem&acc=C033607,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Puerarin inhibits the reaction [carbon tetrachloride results in increased expression of PARP1 protein],,,PMID:27318789,https://www.ncbi.nlm.nih.gov/pubmed/27318789,27318789,,,2554722,"Wang S, Shi XL, Feng M, Wang X, Zhang ZH, Zhao X, Han B, Ma HC, Dai B, Ding YT. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition. Int Immunopharmacol. 2016 Sep;38():238–45. doi: 10.1016/j.intimp.2016.06.008. PMID: 27318789."
1801232,5281807,Comparative Toxicogenomics Database (CTD),Puerarin,C033607,puerarin,https://ctdbase.org/detail.go?type=chem&acc=C033607,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Puerarin inhibits the reaction [[dietary fats co-treated with dietary sucrose] results in increased expression of PARP1 protein],,,PMID:31273855,https://www.ncbi.nlm.nih.gov/pubmed/31273855,31273855,,,8823622,"Wang S, Yang FJ, Shang LC, Zhang YH, Zhou Y, Shi XL. Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis. Phytother Res. 2019 Sep;33(9):2347–59. doi: 10.1002/ptr.6417. PMID: 31273855."
1801233,5281807,Comparative Toxicogenomics Database (CTD),Puerarin,C033607,puerarin,https://ctdbase.org/detail.go?type=chem&acc=C033607,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Puerarin inhibits the reaction [cadmium acetate results in increased cleavage of PARP1 protein],,,PMID:27717697,https://www.ncbi.nlm.nih.gov/pubmed/27717697,27717697,,,29699080,"Song XB, Liu G, Wang ZY, Wang L. Puerarin protects against cadmium-induced proximal tubular cell apoptosis by restoring mitochondrial function. Chem Biol Interact. 2016 Dec 25;260():219–31. doi: 10.1016/j.cbi.2016.10.006. PMID: 27717697."
1912974,5281813,Comparative Toxicogenomics Database (CTD),Wedelolactone,C051122,wedelolactone,https://ctdbase.org/detail.go?type=chem&acc=C051122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]|buthionine sulfoximine promotes the reaction [wedelolactone results in increased cleavage of PARP1 protein]|wedelolactone results in increased cleavage of PARP1 protein|s-ethyl glutathione inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]|cat protein inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein],,,PMID:22733624,https://www.ncbi.nlm.nih.gov/pubmed/22733624,22733624,,,26937158,"Benes P, Alexova P, Knopfova L, Spanova A, Smarda J. Redox state alters anti-cancer effects of wedelolactone. Environ Mol Mutagen. 2012 Aug;53(7):515–24. doi: 10.1002/em.21712. PMID: 22733624."
1913054,5281813,Comparative Toxicogenomics Database (CTD),Wedelolactone,C051122,wedelolactone,https://ctdbase.org/detail.go?type=chem&acc=C051122,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Wedelolactone inhibits the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:25631491,https://www.ncbi.nlm.nih.gov/pubmed/25631491,25631491,,PMC4833032,24943250,"Huang W, Xie WB, Qiao D, Qiu P, Huang E, Li B, Chen C, Liu C, Wang Q, Lin Z, Wang H. Caspase-11 plays an essential role in methamphetamine-induced dopaminergic neuron apoptosis. Toxicol Sci. 2015 May;145(1):68–79. PMID: 25631491; PMCID: PMC4833032."
1803305,5281847,Comparative Toxicogenomics Database (CTD),Rottlerin,C085746,rottlerin,https://ctdbase.org/detail.go?type=chem&acc=C085746,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rottlerin results in increased cleavage of PARP1 protein,,,PMID:22902833,https://www.ncbi.nlm.nih.gov/pubmed/22902833,22902833,,,10689925,"Singh BN, Kumar D, Shankar S, Srivastava RK. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol. 2012 Nov 01;84(9):1154–63. doi: 10.1016/j.bcp.2012.08.007. PMID: 22902833."
1803306,5281847,Comparative Toxicogenomics Database (CTD),Rottlerin,C085746,rottlerin,https://ctdbase.org/detail.go?type=chem&acc=C085746,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[rottlerin co-treated with paclitaxel] results in increased cleavage of PARP1 protein,,,PMID:35995259,https://www.ncbi.nlm.nih.gov/pubmed/35995259,35995259,,,35332872,"Manhas D, Mir KB, Tripathi N, Bharti S, Dhiman S, Wazir P, Sharma DK, Goswami A, Nandi U. Rottlerin promotes anti-metastatic events by ameliorating pharmacological parameters of paclitaxel: An in-vivo investigation in the orthotopic mouse model of breast cancer. Chem Biol Interact. 2022 Oct 01;366():110109. doi: 10.1016/j.cbi.2022.110109. PMID: 35995259."
1803307,5281847,Comparative Toxicogenomics Database (CTD),Rottlerin,C085746,rottlerin,https://ctdbase.org/detail.go?type=chem&acc=C085746,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Rottlerin inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,,18200010,"So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547."
2051295,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:25247703,https://www.ncbi.nlm.nih.gov/pubmed/25247703,25247703,,,19520169,"Kabiraj P, Marin JE, Varela-Ramirez A, Zubia E, Narayan M. Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers. ACS Chem Neurosci. 2014 Dec 17;5(12):1209–20. doi: 10.1021/cn500214k. PMID: 25247703."
1981819,5281915,Comparative Toxicogenomics Database (CTD),Ubidecarenone,D014451,Ubiquinone,https://ctdbase.org/detail.go?type=chem&acc=D014451,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[niacin co-treated with ubiquinone co-treated with riboflavin] results in increased expression of PARP1 protein,,,PMID:18377693,https://www.ncbi.nlm.nih.gov/pubmed/18377693,18377693,,,9280470,"Premkumar VG, Yuvaraj S, Shanthi P, Sachdanandam P. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. Br J Nutr. 2008 Dec;100(6):1179–82. doi: 10.1017/s0007114508968276. PMID: 18377693."
851203,5281929,Comparative Toxicogenomics Database (CTD),Methyl Jasmonate,C072239,methyl jasmonate,https://ctdbase.org/detail.go?type=chem&acc=C072239,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:22079975,https://www.ncbi.nlm.nih.gov/pubmed/22079975,22079975,,,3147963,"Park C, Jin CY, Hwang HJ, Kim GY, Jung JH, Kim WJ, Yoo YH, Choi YH. J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells. Toxicol In Vitro. 2012 Feb;26(1):86–93. doi: 10.1016/j.tiv.2011.10.016. PMID: 22079975."
1654337,5281969,Comparative Toxicogenomics Database (CTD),Anandamide,C078814,anandamide,https://ctdbase.org/detail.go?type=chem&acc=C078814,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Anandamide results in increased cleavage of PARP1 protein,,,PMID:29441458,https://www.ncbi.nlm.nih.gov/pubmed/29441458,29441458,,,26382916,2018; 74(2):261-272
1984397,5282199,Comparative Toxicogenomics Database (CTD),Teprenone,C031049,geranylgeranylacetone,https://ctdbase.org/detail.go?type=chem&acc=C031049,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Geranylgeranylacetone inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein],,,PMID:34732784,https://www.ncbi.nlm.nih.gov/pubmed/34732784,34732784,,PMC8566484,8235801,"Yang H, Li L, Jiao Y, Zhang Y, Wang Y, Zhu K, Sun C. Thioredoxin-1 mediates neuroprotection of Schisanhenol against MPP+-induced apoptosis via suppression of ASK1-P38-NF-?B pathway in SH-SY5Y cells. Scientific Reports. 2021 Nov 03;11(1):21604. doi: 10.1038/s41598-021-01000-3."
1961896,5282280,Comparative Toxicogenomics Database (CTD),2-Arachidonoylglycerol,C094503,glyceryl 2-arachidonate,https://ctdbase.org/detail.go?type=chem&acc=C094503,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Glyceryl 2-arachidonate results in increased cleavage of PARP1 protein,,,PMID:29441458|PMID:32357311,https://www.ncbi.nlm.nih.gov/pubmed/29441458|https://www.ncbi.nlm.nih.gov/pubmed/32357311,29441458|32357311,,PMC7354702,1290516|26382916,"Almada M, Costa L, Fonseca B, Alves P, Braga J, Gonçalves D, Teixeira N, Correia-da-Silva G. The endocannabinoid 2-arachidonoylglycerol promotes endoplasmic reticulum stress in placental cells. Reproduction. 2020 Aug;160(2):171–80. PMID: 32357311; PMCID: PMC7354702.|2018; 74(2):261-272"
1961897,5282280,Comparative Toxicogenomics Database (CTD),2-Arachidonoylglycerol,C094503,glyceryl 2-arachidonate,https://ctdbase.org/detail.go?type=chem&acc=C094503,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),GSK2656157 inhibits the reaction [glyceryl 2-arachidonate results in increased cleavage of PARP1 protein],,,PMID:32357311,https://www.ncbi.nlm.nih.gov/pubmed/32357311,32357311,,PMC7354702,1290516,"Almada M, Costa L, Fonseca B, Alves P, Braga J, Gonçalves D, Teixeira N, Correia-da-Silva G. The endocannabinoid 2-arachidonoylglycerol promotes endoplasmic reticulum stress in placental cells. Reproduction. 2020 Aug;160(2):171–80. PMID: 32357311; PMCID: PMC7354702."
1900982,5282309,Comparative Toxicogenomics Database (CTD),"N,N-dimethylsphingosine",C061800,"N,N-dimethylsphingosine",https://ctdbase.org/detail.go?type=chem&acc=C061800,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[bortezomib co-treated with N,N-dimethylsphingosine] results in increased cleavage of PARP1 protein",,,PMID:21195056,https://www.ncbi.nlm.nih.gov/pubmed/21195056,21195056,,,18104994,"Li Q, Yan J, Zhang K, Yang Y, Xiao F, Wu C, Wang H, Wang L. Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl+ cells sensitive and resistant to STI571 through down-regulation Mcl-1. Biochemical and Biophysical Research Communications. 2011 Feb;405(1):31–6. doi: 10.1016/j.bbrc.2010.12.111."
2075952,5282452,Comparative Toxicogenomics Database (CTD),Pitavastatin,C108475,pitavastatin,https://ctdbase.org/detail.go?type=chem&acc=C108475,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pitavastatin results in increased cleavage of PARP1 protein,,,PMID:37956312|PMID:38053498,https://www.ncbi.nlm.nih.gov/pubmed/37956312|https://www.ncbi.nlm.nih.gov/pubmed/38053498,37956312|38053498,,PMC10704957,36263541|36361934,"Juarez D, Buono R, Matulis SM, Gupta VA, Duong M, Yudiono J, Paul M, Mallya S, Diep G, Hsin P, Lu A, Suh SM, Dong VM, Roberts AW, Leverson JD, Jalaluddin M, Liu Z, Bueno OF, Boise LH, Fruman DA. Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors. Cancer Res Commun. 2023 Dec 08;3(12):2497–509. PMID: 37956312; PMCID: PMC10704957.|Haciseyitoglu AÖ, Dogan TÇ, Dilsiz SA, Canpinar H, Eken A, Bucurgat ÜÜ. Pitavastatin induces caspase-mediated apoptotic death through oxidative stress and DNA damage in combined with cisplatin in human cervical cancer cell line. J Appl Toxicol. 2024 Apr;44(4):623–40. doi: 10.1002/jat.4565. PMID: 38053498."
1857836,5283344,Comparative Toxicogenomics Database (CTD),4-Hydroxynonenal,C027576,4-hydroxy-2-nonenal,https://ctdbase.org/detail.go?type=chem&acc=C027576,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-hydroxy-2-nonenal results in increased degradation of PARP1 protein,,,PMID:11488593,https://www.ncbi.nlm.nih.gov/pubmed/11488593,11488593,,,19947055,"Cheng JZ, Singhal SS, Sharma A, Saini M, Yang Y, Awasthi S, Zimniak P, Awasthi YC. Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling. Arch Biochem Biophys. 2001 Aug 15;392(2):197–207. doi: 10.1006/abbi.2001.2452. PMID: 11488593."
1902250,5283437,Comparative Toxicogenomics Database (CTD),2-Methylarachidonoyl-(2'-fluoroethyl)amide,C443759,2-methylarachidonyl-2'-fluoroethylamide,https://ctdbase.org/detail.go?type=chem&acc=C443759,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-methylarachidonyl-2'-fluoroethylamide results in increased cleavage of PARP1 protein,,,PMID:19509271,https://www.ncbi.nlm.nih.gov/pubmed/19509271,19509271,,,1046822,"Oesch S, Walter D, Wachtel M, Pretre K, Salazar M, Guzmán M, Velasco G, Schäfer BW. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Mol Cancer Ther. 2009 Jul;8(7):1838–45. doi: 10.1158/1535-7163.mct-08-1147. PMID: 19509271."
1875184,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Cyclosporine results in decreased expression of PARP1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,,8039566,"Van den Hof WF, Ruiz-Aracama A, Van Summeren A, Jennen DG, Gaj S, Coonen ML, Brauers K, Wodzig WK, van Delft JH, Kleinjans JC. Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489–501. doi: 10.1016/j.tiv.2014.12.016. PMID: 25562108."
1875185,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Cyclosporine results in increased cleavage of PARP1 protein|2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein]|salubrinal inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein]|wortmannin inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein]|3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein]|apigenin inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein]|bisindolylmaleimide I inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein]|n-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein]",,,PMID:22155090,https://www.ncbi.nlm.nih.gov/pubmed/22155090,22155090,,,15398108,"Sarró E, Jacobs-Cachá C, Itarte E, Meseguer A. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275–87. doi: 10.1016/j.taap.2011.11.007. PMID: 22155090."
1875307,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Cyclosporine inhibits the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:25947082,https://www.ncbi.nlm.nih.gov/pubmed/25947082,25947082,,,26976018,2015; 53(4):2169-2188
2127754,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),T-2 toxin results in increased expression of PARP1 mRNA,,,PMID:28697680,https://www.ncbi.nlm.nih.gov/pubmed/28697680,28697680,,,15509535,"Zhang YF, Su PK, Wang LJ, Zheng HQ, Bai XF, Li P, Meng XP, Yang JY. T-2 toxin induces apoptosis via the Bax-dependent caspase-3 activation in mouse primary Leydig cells. Toxicology Mechanisms and Methods. 2017 Aug 03;28(1):23–8. doi: 10.1080/15376516.2017.1354413."
2127755,5284461,Comparative Toxicogenomics Database (CTD),T-2 Toxin,D013605,T-2 Toxin,https://ctdbase.org/detail.go?type=chem&acc=D013605,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),T-2 toxin results in increased expression of PARP1 protein,,,PMID:29432840,https://www.ncbi.nlm.nih.gov/pubmed/29432840,29432840,,,26375073,"Zhang X, Wang Y, Velkov T, Tang S, Dai C. T-2 toxin-induced toxicity in neuroblastoma-2a cells involves the generation of reactive oxygen, mitochondrial dysfunction and inhibition of Nrf2/HO-1 pathway. Food Chem Toxicol. 2018 Apr;114():88–97. doi: 10.1016/j.fct.2018.02.010. PMID: 29432840."
1932414,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in decreased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1932415,5284474,Comparative Toxicogenomics Database (CTD),"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019132,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"Methylcholanthrene inhibits the reaction [3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in increased cleavage of PARP1 protein]|3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in increased cleavage of PARP1 protein",,,PMID:11999409,https://www.ncbi.nlm.nih.gov/pubmed/11999409,11999409,,,8480595,"SHIOTANI B, NONAKA Y, KANAZAWA K, DANNO G, ASHIDA H. Evoking Cytochrome P450 1A Activity Interferes with Apoptosis Induced by 3-Amino-1,4-dimethyl-5<i>H</i>-pyrido [4,3-<i>b</i>]indole (Trp-P-1) in Rat Hepatocytes under the<i>Ex Vivo</i>System. Bioscience, Biotechnology, and Biochemistry. 2002 Jan;66(2):356–62. doi: 10.1271/bbb.66.356."
1932805,5284476,Comparative Toxicogenomics Database (CTD),"3-Amino-1-methyl-5H-pyrido(4,3-b)indole",C019133,"3-amino-1-methyl-5H-pyrido(4,3-b)indole",https://ctdbase.org/detail.go?type=chem&acc=C019133,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of PARP1 protein|3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased activity of PARP1 protein",,,PMID:17072025,https://www.ncbi.nlm.nih.gov/pubmed/17072025,17072025,,,7212332,"Banasik M, Stedeford T, Strosznajder RP, Hsu CH, Tanaka S, Ueda K. Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A. J Physiol Pharmacol. 2006 Sep;57 Suppl 4():15–22. PMID: 17072025."
1987982,5284513,Comparative Toxicogenomics Database (CTD),Acitretin,D017255,Acitretin,https://ctdbase.org/detail.go?type=chem&acc=D017255,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acitretin results in increased activity of PARP1 protein,,,PMID:18624760,https://www.ncbi.nlm.nih.gov/pubmed/18624760,18624760,,PMC4498944,6541393,"Lin X, He C, Xiao T, Jin X, Chen J, Wang Y, Liu M, Wang K, Jiang Y, Wei H, Chen H. Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1. J Cellular Molecular Medi. 2009 Sep;13(9a):2888–98. doi: 10.1111/j.1582-4934.2008.00397.x."
1649849,5287620,Comparative Toxicogenomics Database (CTD),Brefeldin A,D020126,Brefeldin A,https://ctdbase.org/detail.go?type=chem&acc=D020126,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Brefeldin A results in increased cleavage of PARP1 protein|apigenin inhibits the reaction [brefeldin A results in increased cleavage of PARP1 protein],,,PMID:20493918,https://www.ncbi.nlm.nih.gov/pubmed/20493918,20493918,,,3799125,"Choi AY, Choi JH, Lee JY, Yoon KS, Choe W, Ha J, Yeo EJ, Kang I. Apigenin protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis. Neurochem Int. 2010 Sep;57(2):143–52. doi: 10.1016/j.neuint.2010.05.006. PMID: 20493918."
1995052,5287969,Comparative Toxicogenomics Database (CTD),Alvocidib,C077990,alvocidib,https://ctdbase.org/detail.go?type=chem&acc=C077990,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[alvocidib co-treated with 7-hydroxystaurosporine] results in increased cleavage of PARP1 protein,,,PMID:16012789,https://www.ncbi.nlm.nih.gov/pubmed/16012789,16012789,,,25464732,2005; 23(4):299-309
1995053,5287969,Comparative Toxicogenomics Database (CTD),Alvocidib,C077990,alvocidib,https://ctdbase.org/detail.go?type=chem&acc=C077990,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[alvocidib co-treated with bortezomib] results in increased cleavage of PARP1 protein,,,PMID:15039284,https://www.ncbi.nlm.nih.gov/pubmed/15039284,15039284,,,1654354,"Dai Y, Rahmani M, Pei XY, Dent P, Grant S. Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms. Blood. 2004 Jul 15;104(2):509–18. doi: 10.1182/blood-2003-12-4121. PMID: 15039284."
1995442,5287969,Comparative Toxicogenomics Database (CTD),Alvocidib,C077990,alvocidib,https://ctdbase.org/detail.go?type=chem&acc=C077990,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[alvocidib co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased cleavage of PARP1 protein,,,PMID:15634644,https://www.ncbi.nlm.nih.gov/pubmed/15634644,15634644,,,3032332,"Pei X, Dai Y, Grant S. The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH2-terminal kinase–dependent mechanism. 2004 Dec 01;3(12):1513–24. doi: 10.1158/1535-7163.1513.3.12."
1995443,5287969,Comparative Toxicogenomics Database (CTD),Alvocidib,C077990,alvocidib,https://ctdbase.org/detail.go?type=chem&acc=C077990,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[alvocidib co-treated with gemcitabine] results in increased cleavage of PARP1 protein,,,PMID:15770523,https://www.ncbi.nlm.nih.gov/pubmed/15770523,15770523,,,22054282,2005; 90(1):25-31
1995444,5287969,Comparative Toxicogenomics Database (CTD),Alvocidib,C077990,alvocidib,https://ctdbase.org/detail.go?type=chem&acc=C077990,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Alvocidib promotes the reaction [paclitaxel results in increased cleavage of PARP1 protein],,,PMID:10430095,https://www.ncbi.nlm.nih.gov/pubmed/10430095,10430095,,,8440206,"Motwani M, Delohery TM, Schwartz GK. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin Cancer Res. 1999 Jul;5(7):1876–83. PMID: 10430095."
1995445,5287969,Comparative Toxicogenomics Database (CTD),Alvocidib,C077990,alvocidib,https://ctdbase.org/detail.go?type=chem&acc=C077990,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Alvocidib results in increased cleavage of PARP1 protein,,,PMID:12170773|PMID:12517783|PMID:15972445|PMID:20663931,https://www.ncbi.nlm.nih.gov/pubmed/12170773|https://www.ncbi.nlm.nih.gov/pubmed/12517783|https://www.ncbi.nlm.nih.gov/pubmed/15972445|https://www.ncbi.nlm.nih.gov/pubmed/20663931,12170773|12517783|15972445|20663931,,PMC1895272,412480|2322833|2978305|12534166,"Parry D, Guzi T, Shanahan F, Davis N, Prabhavalkar D, Wiswell D, Seghezzi W, Paruch K, Dwyer MP, Doll R, Nomeir A, Windsor W, Fischmann T, Wang Y, Oft M, Chen T, Kirschmeier P, Lees EM. Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor. Mol Cancer Ther. 2010 Aug;9(8):2344–53. doi: 10.1158/1535-7163.mct-10-0324. PMID: 20663931.|Chen R, Keating MJ, Gandhi V, Plunkett W. Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death. Blood. 2005 Oct 01;106(7):2513–9. PMID: 15972445; PMCID: PMC1895272.|Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R, Wang HG, Bhalla K. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. Cancer Res. 2003 Jan 01;63(1):93–9. PMID: 12517783.|Decker RH, Wang S, Dai Y, Dent P, Grant S. Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosis. Cancer Biol Ther. 2002 Mar;1(2):136–44. doi: 10.4161/cbt.58. PMID: 12170773."
1995446,5287969,Comparative Toxicogenomics Database (CTD),Alvocidib,C077990,alvocidib,https://ctdbase.org/detail.go?type=chem&acc=C077990,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BCL2 protein mutant form inhibits the reaction [alvocidib results in increased cleavage of PARP1 protein],,,PMID:12170773,https://www.ncbi.nlm.nih.gov/pubmed/12170773,12170773,,,12534166,"Decker RH, Wang S, Dai Y, Dent P, Grant S. Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosis. Cancer Biol Ther. 2002 Mar;1(2):136–44. doi: 10.4161/cbt.58. PMID: 12170773."
2003929,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bisindolylmaleimide I inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|ascorbic acid inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|butylated hydroxyanisole inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|mapk8 protein promotes the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,PMC1458365,10558450,"Kim HJ, Chakravarti N, Oridate N, Choe C, Claret FX, Lotan R. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene. 2006 May 04;25(19):2785–94. PMID: 16407847; PMCID: PMC1458365."
2003930,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|s-ethyl glutathione inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|bi D1870 inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|deoxyglucose inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,PMC4234881,19518824,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881."
2003931,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fenretinide affects the expression of PARP1 mRNA,,,PMID:16570282,https://www.ncbi.nlm.nih.gov/pubmed/16570282,16570282,,,28807420,"Brewer M, Kirkpatrick ND, Wharton JT, Wang J, Hatch K, Auersperg N, Utzinger U, Gershenson D, Bast R, Zou C. 4-HPR modulates gene expression in ovarian cells. Int J Cancer. 2006 Sep 01;119(5):1005–13. doi: 10.1002/ijc.21797. PMID: 16570282."
2003932,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[fenretinide co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein,,,PMID:17273769,https://www.ncbi.nlm.nih.gov/pubmed/17273769,17273769,,,3726909,"Kouhara J, Yoshida T, Nakata S, Horinaka M, Wakada M, Ueda Y, Yamagishi H, Sakai T. Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines. Int J Oncol. 2007 Mar 01;(). doi: 10.3892/ijo.30.3.679."
2003933,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fenretinide promotes the reaction [TNF protein results in increased cleavage of PARP1 protein],,,PMID:16230421,https://www.ncbi.nlm.nih.gov/pubmed/16230421,16230421,,,28145778,"Shishodia S, Gutierrez AM, Lotan R, Aggarwal BB. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Cancer Res. 2005 Oct 15;65(20):9555–65. doi: 10.1158/0008-5472.can-05-1585. PMID: 16230421."
2003934,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fenretinide results in decreased cleavage of PARP1 protein,,,PMID:17159502,https://www.ncbi.nlm.nih.gov/pubmed/17159502,17159502,,,19382109,"Shentu J, Zhang B, Fan L, He Q, Yang B, Chen Z. Anti-proliferative activity of fenretinide in human hepatoma cells in vitro and in vivo. Anticancer Drugs. 2007 Jan;18(1):47–53. doi: 10.1097/cad.0b013e32800feeb5. PMID: 17159502."
2004020,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fenretinide results in increased cleavage of PARP1 protein,,,PMID:15735044|PMID:16407847|PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/15735044|https://www.ncbi.nlm.nih.gov/pubmed/16407847|https://www.ncbi.nlm.nih.gov/pubmed/25246272,15735044|16407847|25246272,,PMC1458365|PMC4234881,10558450|19518824|20703318,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881.|Kim HJ, Chakravarti N, Oridate N, Choe C, Claret FX, Lotan R. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene. 2006 May 04;25(19):2785–94. PMID: 16407847; PMCID: PMC1458365.|Puduvalli VK, Li JT, Chen L, McCutcheon IE. Induction of apoptosis in primary meningioma cultures by fenretinide. Cancer Res. 2005 Feb 15;65(4):1547–53. doi: 10.1158/0008-5472.can-04-0786. PMID: 15735044."
1906073,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Geldanamycin inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:16311509,https://www.ncbi.nlm.nih.gov/pubmed/16311509,16311509,,,989073,2005; 13(9):1434-1441
1906074,5288382,Comparative Toxicogenomics Database (CTD),Geldanamycin,C001277,geldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C001277,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tretinoin inhibits the reaction [geldanamycin results in increased degradation of PARP1 protein]|geldanamycin results in increased degradation of PARP1 protein,,,PMID:17293044,https://www.ncbi.nlm.nih.gov/pubmed/17293044,17293044,,,3745086,"Shen JH, Zhang Y, Wu NH, Shen YF. Resistance to geldanamycin-induced apoptosis in differentiated neuroblastoma SH-SY5Y cells. Neurosci Lett. 2007 Mar 06;414(2):110–4. doi: 10.1016/j.neulet.2006.06.050. PMID: 17293044."
1691933,5288674,Comparative Toxicogenomics Database (CTD),Alvespimycin,C448659,17-(dimethylaminoethylamino)-17-demethoxygeldanamycin,https://ctdbase.org/detail.go?type=chem&acc=C448659,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [arsenic trioxide results in increased cleavage of PARP1 protein],,,PMID:19371599,https://www.ncbi.nlm.nih.gov/pubmed/19371599,19371599,,,30235584,"Wu YC, Yen WY, Lee TC, Yih LH. Heat shock protein inhibitors, 17-DMAG and KNK437, enhance arsenic trioxide-induced mitotic apoptosis. Toxicol Appl Pharmacol. 2009 Apr 15;236(2):231–8. doi: 10.1016/j.taap.2009.02.003. PMID: 19371599."
1594638,5289469,DrugBank,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",DB02597,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",https://www.drugbank.ca/drugs/DB02597,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619,https://www.ncbi.nlm.nih.gov/pubmed/37713619,37713619,,PMC10767903,36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751."
1989499,5289469,Therapeutic Target Database (TTD),"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",D09SZG,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",https://idrblab.net/ttd/data/drug/details/D09SZG,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2079288,5310987,Comparative Toxicogenomics Database (CTD),(E)-4-Amino-2-butenoic acid,C055331,4-aminocrotonic acid,https://ctdbase.org/detail.go?type=chem&acc=C055331,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"4-aminocrotonic acid inhibits the reaction [ammonium chloride results in increased cleavage of PARP1 protein]|(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid inhibits the reaction [4-aminocrotonic acid inhibits the reaction [ammonium chloride results in increased cleavage of PARP1 protein]]",,,PMID:14535961,https://www.ncbi.nlm.nih.gov/pubmed/14535961,14535961,,,30137740,"Yang L, Omori K, Omori K, Otani H, Suzukawa J, Inagaki C. GABA<sub>C</sub> receptor agonist suppressed ammonia-induced apoptosis in cultured rat hippocampal neurons by restoring phosphorylated BAD level. Journal of Neurochemistry. 2003 Sep 30;87(3):791–800. doi: 10.1046/j.1471-4159.2003.02069.x."
1879742,5311006,Comparative Toxicogenomics Database (CTD),Arachidonyl-2-chloroethylamide,C119325,arachidonyl-2-chloroethylamide,https://ctdbase.org/detail.go?type=chem&acc=C119325,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Arachidonyl-2-chloroethylamide inhibits the reaction [cisplatin results in increased cleavage of PARP1 protein],,,PMID:31256211,https://www.ncbi.nlm.nih.gov/pubmed/31256211,31256211,,,9508121,2019; 93(8):2335-2346
1652770,5311102,Comparative Toxicogenomics Database (CTD),Herbimycin,C020754,herbimycin,https://ctdbase.org/detail.go?type=chem&acc=C020754,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Herbimycin results in increased cleavage of PARP1 protein,,,PMID:11035063,https://www.ncbi.nlm.nih.gov/pubmed/11035063,11035063,,,209792,"Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000 Oct 15;165(8):4290–7. doi: 10.4049/jimmunol.165.8.4290. PMID: 11035063."
2037576,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"15-deoxy-delta(12,14)-prostaglandin J2 results in increased cleavage of PARP1 protein",,,PMID:15498850,https://www.ncbi.nlm.nih.gov/pubmed/15498850,15498850,,,5772104,"Piva R, Gianferretti P, Ciucci A, Taulli R, Belardo G, Santoro MG. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins. Blood. 2005 Feb 15;105(4):1750–8. doi: 10.1182/blood-2004-04-1360. PMID: 15498850."
2037577,5311211,Comparative Toxicogenomics Database (CTD),"15-Deoxy-delta-12,14-prostaglandin J2",C097240,"15-deoxy-delta(12,14)-prostaglandin J2",https://ctdbase.org/detail.go?type=chem&acc=C097240,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"15-deoxy-delta(12,14)-prostaglandin J2 results in increased cleavage of PARP1 protein|[delta(12)-prostaglandin J(2) co-treated with 9-deoxy-delta-9-prostaglandin D2 co-treated with 15-deoxy-delta(12,14)-prostaglandin J2] results in increased cleavage of PARP1 protein",,,PMID:23973622,https://www.ncbi.nlm.nih.gov/pubmed/23973622,23973622,,PMC3904641,8031651,"Liu H, Li W, Rose ME, Pascoe JL, Miller TM, Ahmad M, Poloyac SM, Hickey RW, Graham SH. Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. Neurotoxicology. 2013 Dec;39():35–44. PMID: 23973622; PMCID: PMC3904641."
1734671,5311501,Comparative Toxicogenomics Database (CTD),Win 55212-2,C070417,"(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone",https://ctdbase.org/detail.go?type=chem&acc=C070417,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in decreased expression of PARP1 protein",,,PMID:30776504,https://www.ncbi.nlm.nih.gov/pubmed/30776504,30776504,,,20287340,"Silva AG, Lopes CFB, Carvalho Júnior CG, Thomé RG, Dos Santos HB, Reis R, Ribeiro RIMA. WIN55,212-2 induces caspase-independent apoptosis on human glioblastoma cells by regulating HSP70, p53 and Cathepsin D. Toxicol In Vitro. 2019 Jun;57():233–43. doi: 10.1016/j.tiv.2019.02.009. PMID: 30776504."
2004453,5315263,Comparative Toxicogenomics Database (CTD),Casticin,C054133,casticin,https://ctdbase.org/detail.go?type=chem&acc=C054133,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Casticin results in increased expression of PARP1 protein,,,PMID:32270916,https://www.ncbi.nlm.nih.gov/pubmed/32270916,32270916,,,28437556,"Cheng ZY, Chueh FS, Peng SF, Lin CH, Kuo CL, Huang WW, Chen PY, Way TD, Chung JG. Combinational treatment of 5-fluorouracil and casticin induces apoptosis in mouse leukemia WEHI-3 cells in vitro. Environ Toxicol. 2020 Sep;35(9):911–21. doi: 10.1002/tox.22927. PMID: 32270916."
2023505,5317480,Comparative Toxicogenomics Database (CTD),Lupiwighteone,C000602100,lupiwighteone,https://ctdbase.org/detail.go?type=chem&acc=C000602100,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lupiwighteone results in increased cleavage of PARP1 protein,,,PMID:31604113,https://www.ncbi.nlm.nih.gov/pubmed/31604113,31604113,,,19629981,"Won YS, Seo KI. Lupiwighteone induces caspase-dependent and -independent apoptosis on human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway. Food Chem Toxicol. 2020 Jan;135():110863. doi: 10.1016/j.fct.2019.110863. PMID: 31604113."
1715997,5318517,Comparative Toxicogenomics Database (CTD),Andrographolide,C030419,andrographolide,https://ctdbase.org/detail.go?type=chem&acc=C030419,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Andrographolide results in increased cleavage of PARP1 protein,,,PMID:35917943,https://www.ncbi.nlm.nih.gov/pubmed/35917943,35917943,,,34577947,"Huang H, Lu Q, Yuan X, Zhang P, Ye C, Wei M, Yang C, Zhang L, Huang Y, Luo X, Luo J. Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/ß-catenin, PI3K/AKT and NF-?B signaling pathways. Chem Biol Interact. 2022 Sep 25;365():110068. doi: 10.1016/j.cbi.2022.110068. PMID: 35917943."
1883921,5318998,Comparative Toxicogenomics Database (CTD),Licochalcone A,C070840,licochalcone A,https://ctdbase.org/detail.go?type=chem&acc=C070840,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),HSPA5 protein affects the reaction [licochalcone A results in increased cleavage of PARP1 protein],,,PMID:38308464,https://www.ncbi.nlm.nih.gov/pubmed/38308464,38308464,,,36763901,"Wu MH, Hsieh YH, Lin CL, Ying TH, Hsia SM, Hsieh SC, Lee CH, Lin CL. Licochalcone A induces endoplasmic reticulum stress-mediated apoptosis of endometrial cancer cells via upregulation of GRP78 expression. Environ Toxicol. 2024 May;39(5):2961–9. doi: 10.1002/tox.24156. PMID: 38308464."
1883922,5318998,Comparative Toxicogenomics Database (CTD),Licochalcone A,C070840,licochalcone A,https://ctdbase.org/detail.go?type=chem&acc=C070840,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Licochalcone A results in increased cleavage of PARP1 protein,,,PMID:30983163|PMID:38308464,https://www.ncbi.nlm.nih.gov/pubmed/30983163|https://www.ncbi.nlm.nih.gov/pubmed/38308464,30983163|38308464,,,26415370|36763901,"Wu MH, Hsieh YH, Lin CL, Ying TH, Hsia SM, Hsieh SC, Lee CH, Lin CL. Licochalcone A induces endoplasmic reticulum stress-mediated apoptosis of endometrial cancer cells via upregulation of GRP78 expression. Environ Toxicol. 2024 May;39(5):2961–9. doi: 10.1002/tox.24156. PMID: 38308464.|Chuang CY, Tang CM, Ho HY, Hsin CH, Weng CJ, Yang SF, Chen PN, Lin CW. Licochalcone A induces apoptotic cell death via JNK/p38 activation in human nasopharyngeal carcinoma cells. Environ Toxicol. 2019 Jul;34(7):853–60. doi: 10.1002/tox.22753. PMID: 30983163."
1918691,5318999,Comparative Toxicogenomics Database (CTD),Licochalcone B,C541528,licochalcone B,https://ctdbase.org/detail.go?type=chem&acc=C541528,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TNFRSF10B protein promotes the reaction [licochalcone B results in increased cleavage of PARP1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [licochalcone B results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [licochalcone B results in increased expression of PARP1 protein]|licochalcone B results in increased cleavage of PARP1 protein,,,PMID:35948134,https://www.ncbi.nlm.nih.gov/pubmed/35948134,35948134,,,34627529,"Zhang YY, Feng PP, Wang HF, Zhang H, Liang T, Hao XS, Wang FZ, Fei HR. Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells. Chem Biol Interact. 2022 Sep 25;365():110076. doi: 10.1016/j.cbi.2022.110076. PMID: 35948134."
1990746,5319493,Comparative Toxicogenomics Database (CTD),Sappanchalcone,C044363,sappanchalcone,https://ctdbase.org/detail.go?type=chem&acc=C044363,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sappanchalcone results in increased cleavage of PARP1 protein,,,PMID:32590072,https://www.ncbi.nlm.nih.gov/pubmed/32590072,32590072,,,13592137,"Seo HW, No H, Cheon HJ, Kim JK. Sappanchalcone, a flavonoid isolated from Caesalpinia sappan L., induces caspase-dependent and AIF-dependent apoptosis in human colon cancer cells. Chem Biol Interact. 2020 Aug 25;327():109185. doi: 10.1016/j.cbi.2020.109185. PMID: 32590072."
1994675,5320315,Comparative Toxicogenomics Database (CTD),Oroxylin A,C080669,"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one",https://ctdbase.org/detail.go?type=chem&acc=C080669,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in increased degradation of PARP1 protein",,,PMID:19135124,https://www.ncbi.nlm.nih.gov/pubmed/19135124,19135124,,,24829965,"Li HN, Nie FF, Liu W, Dai QS, Lu N, Qi Q, Li ZY, You QD, Guo QL. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. Toxicology. 2009 Mar 04;257(1-2):80–5. doi: 10.1016/j.tox.2008.12.011. PMID: 19135124."
1595778,5320464,Comparative Toxicogenomics Database (CTD),Pendulone,C569898,pendulone,https://ctdbase.org/detail.go?type=chem&acc=C569898,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [pendulone results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [pendulone results in increased cleavage of PARP1 protein]|pendulone results in increased cleavage of PARP1 protein,,,PMID:35288263,https://www.ncbi.nlm.nih.gov/pubmed/35288263,35288263,,,4076996,"Cheng WC, Wen Y, Chiu YS, Chou CH, Lim CJ, Lin SH, Chang JM, Lin CC. Pendulone induces apoptosis via the ROS-mediated ER-stress pathway in human non-small cell lung cancer cells. Toxicol In Vitro. 2022 Jun;81():105346. doi: 10.1016/j.tiv.2022.105346. PMID: 35288263."
2132050,5321010,Comparative Toxicogenomics Database (CTD),Oridonin,C011959,oridonin,https://ctdbase.org/detail.go?type=chem&acc=C011959,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oridonin analog results in decreased expression of and results in increased cleavage of PARP1 protein,,,PMID:31594861,https://www.ncbi.nlm.nih.gov/pubmed/31594861,31594861,,PMC6873189,6080055,"Shen X, Zhao L, Chen P, Gong Y, Liu D, Zhang X, Dai L, Sun Q, Lou J, Jin Z, Zhang B, Niu D, Chen C, Qi X, Jia D. A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3. Journal of Biological Chemistry. 2019 Nov;294(46):17471–86. doi: 10.1074/jbc.ra119.009801."
2132051,5321010,Comparative Toxicogenomics Database (CTD),Oridonin,C011959,oridonin,https://ctdbase.org/detail.go?type=chem&acc=C011959,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oridonin results in increased cleavage of PARP1 protein,,,PMID:16019488,https://www.ncbi.nlm.nih.gov/pubmed/16019488,16019488,,,25471069,"Liu J, Huang R, Lin D, Wu X, Peng J, Lin Q, Pan X, Zhang M, Hou M, Chen F. Apoptotic effect of oridonin on NB4 cells and its mechanism. Leuk Lymphoma. 2005 Apr;46(4):593–7. doi: 10.1080/10428190400019800. PMID: 16019488."
1716131,5321018,Comparative Toxicogenomics Database (CTD),Atractylenolide I,C424804,atractylenolide I,https://ctdbase.org/detail.go?type=chem&acc=C424804,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Atractylenolide I inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of PARP1 protein modified form],,,PMID:28481321,https://www.ncbi.nlm.nih.gov/pubmed/28481321,28481321,,PMC5454925,23634377,"More SV, Choi DK. Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death. Int J Mol Sci. 2017 May 08;18(5). PMID: 28481321; PMCID: PMC5454925."
1596210,5323714,Comparative Toxicogenomics Database (CTD),Furazolidone,D005664,Furazolidone,https://ctdbase.org/detail.go?type=chem&acc=D005664,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CDKN1A protein inhibits the reaction [furazolidone results in increased phosphorylation of PARP1 protein]|furazolidone results in increased cleavage of PARP1 protein,,,PMID:26687534,https://www.ncbi.nlm.nih.gov/pubmed/26687534,26687534,,,12107542,"Deng S, Tang S, Dai C, Zhou Y, Yang X, Li D, Xiao X. P21(Waf1/Cip1) plays a critical role in furazolidone-induced apoptosis in HepG2 cells through influencing the caspase-3 activation and ROS generation. Food Chem Toxicol. 2016 Feb;88():1–12. doi: 10.1016/j.fct.2015.12.004. PMID: 26687534."
2005805,5324360,Comparative Toxicogenomics Database (CTD),Picrasidine I,C000625506,picrasidine I,https://ctdbase.org/detail.go?type=chem&acc=C000625506,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [picrasidine I results in increased expression of PARP1 protein modified form]|picrasidine I results in increased expression of PARP1 protein modified form|pyrazolanthrone promotes the reaction [picrasidine I results in increased expression of PARP1 protein modified form],,,PMID:34894061,https://www.ncbi.nlm.nih.gov/pubmed/34894061,34894061,,,20376671,"Yang YT, Hsieh MJ, Chuang YC, Lin CC, Lo YS, Ho HY, Kumar VB, Ko JL. Anticancer effects of picrasidine I on oral squamous cell carcinoma. Environ Toxicol. 2022 Mar;37(3):627–36. doi: 10.1002/tox.23430. PMID: 34894061."
901681,5326976,Comparative Toxicogenomics Database (CTD),"2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole",C492322,"2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole",https://ctdbase.org/detail.go?type=chem&acc=C492322,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein]",,,PMID:22155090,https://www.ncbi.nlm.nih.gov/pubmed/22155090,22155090,,,15398108,"Sarró E, Jacobs-Cachá C, Itarte E, Meseguer A. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275–87. doi: 10.1016/j.taap.2011.11.007. PMID: 22155090."
1725379,5328940,Comparative Toxicogenomics Database (CTD),Bosutinib,C471992,bosutinib,https://ctdbase.org/detail.go?type=chem&acc=C471992,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bosutinib co-treated with linsidomine] affects the expression of PARP1 protein|bosutinib affects the reaction [linsidomine results in increased cleavage of PARP1 protein],,,PMID:34519134,https://www.ncbi.nlm.nih.gov/pubmed/34519134,34519134,,,4753466,"Yilmaz S, Alkan T, Ballar Kirmizibayrak P. A new underlying mechanism for the neuroprotective effect of bosutinib: Reverting toxicity-induced PARylation in SIN1-mediated neurotoxicity. J Biochem Mol Toxicol. 2021 Dec;35(12):e22915. doi: 10.1002/jbt.22915. PMID: 34519134."
2083506,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sunitinib results in decreased expression of PARP1 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,,7471628,"Matsui T, Miyamoto K, Yamanaka K, Okai Y, Kaushik EP, Harada K, Wagoner M, Shinozawa T. Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383():114761. doi: 10.1016/j.taap.2019.114761. PMID: 31533062."
1924032,5330286,Comparative Toxicogenomics Database (CTD),Palbociclib,C500026,palbociclib,https://ctdbase.org/detail.go?type=chem&acc=C500026,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),RB1 protein affects the reaction [palbociclib inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]]|palbociclib inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:22751436,https://www.ncbi.nlm.nih.gov/pubmed/22751436,22751436,,PMC3409014,20153767,"McClendon AK, Dean JL, Rivadeneira DB, Yu JE, Reed CA, Gao E, Farber JL, Force T, Koch WJ, Knudsen ES. CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy. Cell Cycle. 2012 Jul 15;11(14):2747–55. PMID: 22751436; PMCID: PMC3409014."
1924033,5330286,Comparative Toxicogenomics Database (CTD),Palbociclib,C500026,palbociclib,https://ctdbase.org/detail.go?type=chem&acc=C500026,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[palbociclib results in increased susceptibility to idelalisib] which results in increased cleavage of PARP1 protein,,,PMID:23676220,https://www.ncbi.nlm.nih.gov/pubmed/23676220,23676220,,PMC3735703,24241274,"Chiron D, Martin P, Di Liberto M, Huang X, Ely S, Lannutti BJ, Leonard JP, Mason CE, Chen-Kiang S. Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kd inhibition through PIK3IP1. Cell Cycle. 2013 Jun 15;12(12):1892–900. PMID: 23676220; PMCID: PMC3735703."
2001370,5351344,Comparative Toxicogenomics Database (CTD),Combretastatin A4,C058728,fosbretabulin,https://ctdbase.org/detail.go?type=chem&acc=C058728,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein]|bafilomycin A1 promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein]|[3-methyladenine co-treated with fosbretabulin] results in increased cleavage of PARP1 protein,,,PMID:24321340,https://www.ncbi.nlm.nih.gov/pubmed/24321340,24321340,,,28290116,"Li Y, Luo P, Wang J, Dai J, Yang X, Wu H, Yang B, He Q. Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway. Toxicol Appl Pharmacol. 2014 Jan 15;274(2):319–27. doi: 10.1016/j.taap.2013.11.018. PMID: 24321340."
2001371,5351344,Comparative Toxicogenomics Database (CTD),Combretastatin A4,C058728,fosbretabulin,https://ctdbase.org/detail.go?type=chem&acc=C058728,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NDRG1 protein affects the reaction [chloroquine promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein]]|ndrg1 protein affects the reaction [fosbretabulin results in increased cleavage of PARP1 protein]|chloroquine promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein],,,PMID:28906492,https://www.ncbi.nlm.nih.gov/pubmed/28906492,28906492,,PMC5636982,25001871,"Wang H, Li W, Xu J, Zhang T, Zuo D, Zhou Z, Lin B, Wang G, Wang Z, Sun W, Sun M, Chang S, Cai Z, Hua Y. NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy. Cell Death & Disease. 2017 Sep 14;8(9):e3048. doi: 10.1038/cddis.2017.438."
2001372,5351344,Comparative Toxicogenomics Database (CTD),Combretastatin A4,C058728,fosbretabulin,https://ctdbase.org/detail.go?type=chem&acc=C058728,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fosbretabulin results in increased cleavage of PARP1 protein,,,PMID:24321340|PMID:28906492,https://www.ncbi.nlm.nih.gov/pubmed/24321340|https://www.ncbi.nlm.nih.gov/pubmed/28906492,24321340|28906492,,PMC5636982,25001871|28290116,"Wang H, Li W, Xu J, Zhang T, Zuo D, Zhou Z, Lin B, Wang G, Wang Z, Sun W, Sun M, Chang S, Cai Z, Hua Y. NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy. Cell Death & Disease. 2017 Sep 14;8(9):e3048. doi: 10.1038/cddis.2017.438.|Li Y, Luo P, Wang J, Dai J, Yang X, Wu H, Yang B, He Q. Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway. Toxicol Appl Pharmacol. 2014 Jan 15;274(2):319–27. doi: 10.1016/j.taap.2013.11.018. PMID: 24321340."
2041683,5352062,Comparative Toxicogenomics Database (CTD),Romidepsin,C087123,romidepsin,https://ctdbase.org/detail.go?type=chem&acc=C087123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bortezomib promotes the reaction [romidepsin results in increased cleavage of PARP1 protein],,,PMID:18223231,https://www.ncbi.nlm.nih.gov/pubmed/18223231,18223231,,,1688119,"Dai Y, Chen S, Kramer LB, Funk VL, Dent P, Grant S. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells. Clin Cancer Res. 2008 Jan 15;14(2):549–58. doi: 10.1158/1078-0432.ccr-07-1934. PMID: 18223231."
2041684,5352062,Comparative Toxicogenomics Database (CTD),Romidepsin,C087123,romidepsin,https://ctdbase.org/detail.go?type=chem&acc=C087123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[romidepsin co-treated with MK 2206] results in increased cleavage of PARP1 protein|romidepsin promotes the reaction [mirdametinib results in increased cleavage of PARP1 protein]|romidepsin promotes the reaction [[mirdametinib co-treated with MK 2206] results in increased cleavage of PARP1 protein],,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,PMC5340114,1203163,"Bahr JC, Robey RW, Luchenko V, Basseville A, Chakraborty AR, Kozlowski H, Pauly GT, Patel P, Schneider JP, Gottesman MM, Bates SE. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016 Oct 25;7(43):69804–15. PMID: 27634878; PMCID: PMC5340114."
2041805,5352062,Comparative Toxicogenomics Database (CTD),Romidepsin,C087123,romidepsin,https://ctdbase.org/detail.go?type=chem&acc=C087123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Romidepsin results in increased cleavage of PARP1 protein,,,PMID:18223231|PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/18223231|https://www.ncbi.nlm.nih.gov/pubmed/27634878,18223231|27634878,,PMC5340114,1203163|1688119,"Bahr JC, Robey RW, Luchenko V, Basseville A, Chakraborty AR, Kozlowski H, Pauly GT, Patel P, Schneider JP, Gottesman MM, Bates SE. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016 Oct 25;7(43):69804–15. PMID: 27634878; PMCID: PMC5340114.|Dai Y, Chen S, Kramer LB, Funk VL, Dent P, Grant S. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells. Clin Cancer Res. 2008 Jan 15;14(2):549–58. doi: 10.1158/1078-0432.ccr-07-1934. PMID: 18223231."
1862312,5352089,Comparative Toxicogenomics Database (CTD),4-Nerolidylcatechol,C110583,4-nerolidylcatechol,https://ctdbase.org/detail.go?type=chem&acc=C110583,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-nerolidylcatechol results in increased cleavage of PARP1 protein,,,PMID:32334110,https://www.ncbi.nlm.nih.gov/pubmed/32334110,32334110,,,20332209,"Alves-Fernandes DK, Oliveira ÉA, Hastreiter AA, Faião-Flores F, Felipe-Silva AS, Turato W, Fock RA, Maria-Engler SS, Barros SBM. In vivo antitumoral effect of 4-nerolidylcatechol (4-NC) in NRAS-mutant human melanoma. Food Chem Toxicol. 2020 Jul;141():111371. doi: 10.1016/j.fct.2020.111371. PMID: 32334110."
2047978,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lead affects the expression of PARP1 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,PMC6372217,24999019,"Jiang P, Hou Z, Bolin JM, Thomson JA, Stewart R. RNA-Seq of Human Neural Progenitor Cells Exposed to Lead (Pb) Reveals Transcriptome Dynamics, Splicing Alterations and Disease Risk Associations. Toxicol Sci. 2017 Sep 01;159(1):251–65. PMID: 28903495; PMCID: PMC6372217."
2047979,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein|luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of PARP1 protein],,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,PMC5746289,30392830,"Wang Y, Su H, Song X, Fiati Kenston SS, Zhao J, Gu Y. Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway. Int J Mol Med. 2018 Jan;41(1):233–41. PMID: 29115570; PMCID: PMC5746289."
2022197,5352624,Comparative Toxicogenomics Database (CTD),Sulindac Sulfide,C025462,sulindac sulfide,https://ctdbase.org/detail.go?type=chem&acc=C025462,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid promotes the reaction [sulindac sulfide results in increased cleavage of PARP1 protein]",,,PMID:21400612,https://www.ncbi.nlm.nih.gov/pubmed/21400612,21400612,,PMC3482838,28894176,"Foreman JE, Chang WL, Palkar PS, Zhu B, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM. Functional characterization of peroxisome proliferator-activated receptor-ß/d expression in colon cancer. Molecular Carcinogenesis. 2011 Mar 11;50(11):884–900. doi: 10.1002/mc.20757."
2022330,5352624,Comparative Toxicogenomics Database (CTD),Sulindac Sulfide,C025462,sulindac sulfide,https://ctdbase.org/detail.go?type=chem&acc=C025462,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sulindac sulfide results in decreased expression of PARP1 mRNA,,,PMID:16184548,https://www.ncbi.nlm.nih.gov/pubmed/16184548,16184548,,,11221373,"Jang TJ, Jung KH, Choi EA. Id-1 gene downregulation by sulindac sulfide and its upregulation during tumor development in gastric cancer. Int J Cancer. 2006 Mar 15;118(6):1356–63. doi: 10.1002/ijc.21503. PMID: 16184548."
2022331,5352624,Comparative Toxicogenomics Database (CTD),Sulindac Sulfide,C025462,sulindac sulfide,https://ctdbase.org/detail.go?type=chem&acc=C025462,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sulindac sulfide results in increased cleavage of PARP1 protein,,,PMID:12663503|PMID:18678619|PMID:21400612,https://www.ncbi.nlm.nih.gov/pubmed/12663503|https://www.ncbi.nlm.nih.gov/pubmed/18678619|https://www.ncbi.nlm.nih.gov/pubmed/21400612,12663503|18678619|21400612,,PMC3482838,16578829|23443312|28894176,"Foreman JE, Chang WL, Palkar PS, Zhu B, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM. Functional characterization of peroxisome proliferator-activated receptor-ß/d expression in colon cancer. Molecular Carcinogenesis. 2011 Mar 11;50(11):884–900. doi: 10.1002/mc.20757.|Liou JY, Wu CC, Chen BR, Yen LB, Wu KK. Nonsteroidal anti-inflammatory drugs induced endothelial apoptosis by perturbing peroxisome proliferator-activated receptor-delta transcriptional pathway. Mol Pharmacol. 2008 Nov;74(5):1399–406. doi: 10.1124/mol.108.049569. PMID: 18678619.|Reinacher-Schick A, Schoeneck A, Graeven U, Schwarte-Waldhoff I, Schmiegel W. Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis. 2003 Mar;24(3):443–51. doi: 10.1093/carcin/24.3.443. PMID: 12663503."
2022332,5352624,Comparative Toxicogenomics Database (CTD),Sulindac Sulfide,C025462,sulindac sulfide,https://ctdbase.org/detail.go?type=chem&acc=C025462,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sulindac sulfide results in increased cleavage of PARP1 protein,,,PMID:16886631,https://www.ncbi.nlm.nih.gov/pubmed/16886631,16886631,,,17314777,"Flis S, Soltysiak-Pawluczuk D, Jedrych A, Jastrzebski Z, Remiszewska M, Splawinski J. Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest. Anticancer Res. 2006 Jul;26(4B):3033–41. PMID: 16886631."
2098299,5353431,Comparative Toxicogenomics Database (CTD),(2E)-3-(4-methylbenzenesulfonyl)prop-2-enenitrile,C434003,3-(4-methylphenylsulfonyl)-2-propenenitrile,https://ctdbase.org/detail.go?type=chem&acc=C434003,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [FAM168A results in decreased susceptibility to cisplatin]] which results in increased cleavage of PARP1 protein,,,PMID:23251525,https://www.ncbi.nlm.nih.gov/pubmed/23251525,23251525,,PMC3519677,9352407,"Peng B, Gu Y, Xiong Y, Zheng G, He Z. Microarray-Assisted Pathway Analysis Identifies MT1X & NF?B as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma. PLoS ONE. 2012 Dec 10;7(12):e51413. doi: 10.1371/journal.pone.0051413."
2098300,5353431,Comparative Toxicogenomics Database (CTD),(2E)-3-(4-methylbenzenesulfonyl)prop-2-enenitrile,C434003,3-(4-methylphenylsulfonyl)-2-propenenitrile,https://ctdbase.org/detail.go?type=chem&acc=C434003,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased cleavage of PARP1 protein],,,PMID:28184909,https://www.ncbi.nlm.nih.gov/pubmed/28184909,28184909,,,8763346,"Yu JJ, Zhu LX, Zhang J, Liu S, Lv FY, Cheng X, Liu GJ, Peng B. From the Cover: Activation of NF-?B-Autophagy Axis by 2-Hydroxyethyl Methacrylate Commits Dental Mesenchymal Cells to Apoptosis. Toxicol Sci. 2017 May 01;157(1):100–11. doi: 10.1093/toxsci/kfx023. PMID: 28184909."
2098396,5353431,Comparative Toxicogenomics Database (CTD),(2E)-3-(4-methylbenzenesulfonyl)prop-2-enenitrile,C434003,3-(4-methylphenylsulfonyl)-2-propenenitrile,https://ctdbase.org/detail.go?type=chem&acc=C434003,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-(4-methylphenylsulfonyl)-2-propenenitrile results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:16173963,https://www.ncbi.nlm.nih.gov/pubmed/16173963,16173963,,,30178442,"Kim K, Ryu K, Ko Y, Park C. Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells. Br J Haematol. 2005 Oct;131(1):59–66. doi: 10.1111/j.1365-2141.2005.05720.x. PMID: 16173963."
2098397,5353431,Comparative Toxicogenomics Database (CTD),(2E)-3-(4-methylbenzenesulfonyl)prop-2-enenitrile,C434003,3-(4-methylphenylsulfonyl)-2-propenenitrile,https://ctdbase.org/detail.go?type=chem&acc=C434003,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[apigenin co-treated with 3-(4-methylphenylsulfonyl)-2-propenenitrile] results in increased cleavage of PARP1 protein,,,PMID:24148603,https://www.ncbi.nlm.nih.gov/pubmed/24148603,24148603,,,22840164,"Wu DG, Yu P, Li JW, Jiang P, Sun J, Wang HZ, Zhang LD, Wen MB, Bie P. Apigenin potentiates the growth inhibitory effects by IKK-ß-mediated NF-?B activation in pancreatic cancer cells. Toxicol Lett. 2014 Jan 03;224(1):157–64. doi: 10.1016/j.toxlet.2013.10.007. PMID: 24148603."
1760183,5353432,Comparative Toxicogenomics Database (CTD),Bay11-7085,C416282,BAY 11-7085,https://ctdbase.org/detail.go?type=chem&acc=C416282,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),BAY 11-7085 inhibits the reaction [7-ketocholesterol results in increased cleavage of PARP1 protein],,,PMID:25845326,https://www.ncbi.nlm.nih.gov/pubmed/25845326,25845326,,,30331249,2015; 388(8):869-881
1943515,5353484,Comparative Toxicogenomics Database (CTD),Carboxycinnamic Acid Bishydroxamide,C111238,carboxycinnamic acid bishydroxamide,https://ctdbase.org/detail.go?type=chem&acc=C111238,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Carboxycinnamic acid bishydroxamide results in increased cleavage of PARP1 protein,,,PMID:15897598,https://www.ncbi.nlm.nih.gov/pubmed/15897598,15897598,,,27475350,"Mitsiades CS, Poulaki V, McMullan C, Negri J, Fanourakis G, Goudopoulou A, Richon VM, Marks PA, Mitsiades N. Novel histone deacetylase inhibitors in the treatment of thyroid cancer. Clin Cancer Res. 2005 May 15;11(10):3958–65. doi: 10.1158/1078-0432.ccr-03-0776. PMID: 15897598."
1871222,5356121,Comparative Toxicogenomics Database (CTD),Flavokawain B,C452039,flavokawain B,https://ctdbase.org/detail.go?type=chem&acc=C452039,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[flavokawain B co-treated with 3-methyladenine] results in increased cleavage of PARP1 protein|[atg5 protein affects the susceptibility to flavokawain B] which affects the cleavage of PARP1 protein|[atg7 protein affects the susceptibility to flavokawain B] which affects the cleavage of PARP1 protein,,,PMID:30025493,https://www.ncbi.nlm.nih.gov/pubmed/30025493,30025493,,PMC6152528,23661645,"Wang J, Qi Q, Zhou W, Feng Z, Huang B, Chen A, Zhang D, Li W, Zhang Q, Jiang Z, Bjerkvig R, Prestegarden L, Thorsen F, Wang X, Li X, Wang J. Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy. Autophagy. 2018 Aug 17;14(11):2007–22. doi: 10.1080/15548627.2018.1501133."
1773582,5358846,Comparative Toxicogenomics Database (CTD),Auriculasin,C516713,auriculasin,https://ctdbase.org/detail.go?type=chem&acc=C516713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[auriculasin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein|tnfrsf10b protein affects the reaction [[auriculasin co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein],,,PMID:30817944,https://www.ncbi.nlm.nih.gov/pubmed/30817944,30817944,,,1262106,"Cho HD, Gu IA, Won YS, Moon KD, Park KH, Seo KI. Auriculasin sensitizes primary prostate cancer cells to TRAIL-mediated apoptosis through up-regulation of the DR5-dependent pathway. Food Chem Toxicol. 2019 Apr;126():223–32. doi: 10.1016/j.fct.2019.02.030. PMID: 30817944."
2027423,5359595,Toxin and Toxin Target Database (T3DB),CID 5359595,T3D0276,Arsenic trisulfide,http://www.t3db.ca/toxins/T3D0276,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2079651,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,59899,Clarias batrachus (walking catfish),Arsenic results in increased cleavage of PARP1 protein,,,PMID:19782097,https://www.ncbi.nlm.nih.gov/pubmed/19782097,19782097,,,28868134,"Datta S, Mazumder S, Ghosh D, Dey S, Bhattacharya S. Low concentration of arsenic could induce caspase-3 mediated head kidney macrophage apoptosis with JNK-p38 activation in Clarias batrachus. Toxicol Appl Pharmacol. 2009 Dec 15;241(3):329–38. doi: 10.1016/j.taap.2009.09.007. PMID: 19782097."
2079720,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|[[abt-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein|mcl1 protein inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|usp7 protein affects the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein promotes the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|akt1 protein modified form inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein inhibits the reaction [sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|mcl1 protein affects the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein],,,PMID:32802178,https://www.ncbi.nlm.nih.gov/pubmed/32802178,32802178,,PMC7415806,9544165,"Yang P, Xie J, Li Y, Lin HP, Fenske W, Clementino M, Jiang Y, Yang C, Wang Z. Deubiquitinase USP7-mediated MCL-1 up-regulation enhances Arsenic and Benzo(a)pyrene co-exposure-induced Cancer Stem Cell-like property and Tumorigenesis. Theranostics. 2020;10(20):9050–65. PMID: 32802178; PMCID: PMC7415806."
2079721,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenic results in decreased expression of PARP1 mRNA,,,PMID:21332098|PMID:35490796,https://www.ncbi.nlm.nih.gov/pubmed/21332098|https://www.ncbi.nlm.nih.gov/pubmed/35490796,21332098|35490796,,,32924784|34037577,"Boonma T, Navasumrit P, Parnlob V, Waraprasit S, Ruchirawat M. SAM and folic acid prevent arsenic-induced oxidative and nitrative DNA damage in human lymphoblast cells by modulating expression of inflammatory and DNA repair genes. Chem Biol Interact. 2022 Jul 01;361():109965. doi: 10.1016/j.cbi.2022.109965. PMID: 35490796.|Roy M, Sinha D, Mukherjee S, Biswas J. Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur J Cancer Prev. 2011 Mar;20(2):123–31. doi: 10.1097/cej.0b013e328341017a. PMID: 21332098."
2079722,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Curcumin inhibits the reaction [arsenic results in decreased expression of PARP1 mrna]|curcumin inhibits the reaction [arsenic results in decreased expression of PARP1 protein]|arsenic results in decreased expression of PARP1 protein,,,PMID:21332098,https://www.ncbi.nlm.nih.gov/pubmed/21332098,21332098,,,32924784,"Roy M, Sinha D, Mukherjee S, Biswas J. Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur J Cancer Prev. 2011 Mar;20(2):123–31. doi: 10.1097/cej.0b013e328341017a. PMID: 21332098."
2079723,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[EHMT2 protein co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased expression of PARP1 protein|ginkgo biloba extract inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 mrna]|[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 protein|[ehmt2 protein co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased expression of PARP1 mrna|[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 mrna|bix 01294 inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 protein],,,PMID:33378118,https://www.ncbi.nlm.nih.gov/pubmed/33378118,33378118,,,22375995,"Ding X, Zhang A, Li C, Ma L, Tang S, Wang Q, Yang G, Li J. The role of <scp>H3K9me2</scp>-regulated base excision repair genes in the repair of <scp>DNA</scp> damage induced by arsenic in <scp>HaCaT</scp> cells and the effects of <scp><i>Ginkgo biloba</i></scp> extract intervention. Environmental Toxicology. 2020 Dec 30;36(5):850–60. doi: 10.1002/tox.23088."
2079724,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased cleavage of PARP1 protein]|[sodium arsenite results in increased abundance of arsenic] which results in increased cleavage of PARP1 protein,,,PMID:32188015,https://www.ncbi.nlm.nih.gov/pubmed/32188015,32188015,,PMC7139366,14924634,"Wang S, Cheng H, Wang L, Zhao R, Guan D. Overexpression of NRF1-742 or NRF1-772 Reduces Arsenic-Induced Cytotoxicity and Apoptosis in Human HaCaT Keratinocytes. Int J Mol Sci. 2020 Mar 16;21(6). PMID: 32188015; PMCID: PMC7139366."
2079725,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),S-adenosylmethionine inhibits the reaction [arsenic results in decreased expression of PARP1 mrna],,,PMID:35490796,https://www.ncbi.nlm.nih.gov/pubmed/35490796,35490796,,,34037577,"Boonma T, Navasumrit P, Parnlob V, Waraprasit S, Ruchirawat M. SAM and folic acid prevent arsenic-induced oxidative and nitrative DNA damage in human lymphoblast cells by modulating expression of inflammatory and DNA repair genes. Chem Biol Interact. 2022 Jul 01;361():109965. doi: 10.1016/j.cbi.2022.109965. PMID: 35490796."
2079822,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),BDNF protein inhibits the reaction [arsenic results in increased cleavage of PARP1 protein]|staurosporine aglycone inhibits the reaction [NOG protein inhibits the reaction [arsenic results in increased cleavage of PARP1 protein]]|arsenic results in increased cleavage of PARP1 protein|nog protein inhibits the reaction [arsenic results in increased cleavage of PARP1 protein],,,PMID:28903487,https://www.ncbi.nlm.nih.gov/pubmed/28903487,28903487,,,24999010,"Pandey R, Rai V, Mishra J, Mandrah K, Kumar Roy S, Bandyopadhyay S. From the Cover: Arsenic Induces Hippocampal Neuronal Apoptosis and Cognitive Impairments via an Up-Regulated BMP2/Smad-Dependent Reduced BDNF/TrkB Signaling in Rats. Toxicol Sci. 2017 Sep 01;159(1):137–58. doi: 10.1093/toxsci/kfx124. PMID: 28903487."
2079823,5359596,Comparative Toxicogenomics Database (CTD),Arsenic,D001151,Arsenic,https://ctdbase.org/detail.go?type=chem&acc=D001151,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[[sodium arsenite results in increased abundance of arsenic] which co-treated with zinc deficiency] results in increased cleavage of PARP1 protein,,,PMID:31542844,https://www.ncbi.nlm.nih.gov/pubmed/31542844,31542844,,PMC6891200,23675274,2019; 32(6):845-859
2101413,5360373,Comparative Toxicogenomics Database (CTD),Bleomycin,D001761,Bleomycin,https://ctdbase.org/detail.go?type=chem&acc=D001761,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Bleomycin inhibits the reaction [azacitidine results in increased cleavage of PARP1 protein],,,PMID:32278510,https://www.ncbi.nlm.nih.gov/pubmed/32278510,32278510,,,28444855,"Fakhrabadi HG, Rabbani-Chadegani A, Ghadam P, Amiri S. Protective effect of bleomycin on 5-azacitidine induced cytotoxicity and apoptosis in mice hematopoietic stem cells via Bcl-2/Bax and HMGB1 signaling pathway. Toxicol Appl Pharmacol. 2020 Jun 01;396():114996. doi: 10.1016/j.taap.2020.114996. PMID: 32278510."
2101414,5360373,Comparative Toxicogenomics Database (CTD),Bleomycin,D001761,Bleomycin,https://ctdbase.org/detail.go?type=chem&acc=D001761,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Bleomycin results in increased expression of PARP1 protein,,,PMID:16317386,https://www.ncbi.nlm.nih.gov/pubmed/16317386,16317386,,,994559,2005; 24(6):547-555
2101573,5360373,Comparative Toxicogenomics Database (CTD),Bleomycin,D001761,Bleomycin,https://ctdbase.org/detail.go?type=chem&acc=D001761,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bleomycin results in increased cleavage of PARP1 protein,,,PMID:15371238,https://www.ncbi.nlm.nih.gov/pubmed/15371238,15371238,,,11888901,"Zhao HW, Hu SY, Barger MW, Ma JKH, Castranova V, Ma JYC. TIME-DEPENDENT APOPTOSIS OF ALVEOLAR MACROPHAGES FROM RATS EXPOSED TO BLEOMYCIN: INVOLVEMENT OF TNF RECEPTOR 2. Journal of Toxicology and Environmental Health, Part A. 2004 Sep;67(17):1391–406. doi: 10.1080/15287390490471569."
2094728,5362420,Comparative Toxicogenomics Database (CTD),Visudyne,D000077362,Verteporfin,https://ctdbase.org/detail.go?type=chem&acc=D000077362,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Verteporfin results in increased cleavage of PARP1 protein,,,PMID:31494105,https://www.ncbi.nlm.nih.gov/pubmed/31494105,31494105,,,6773123,"Sanna L, Piredda R, Marchesi I, Bordoni V, Forcales SV, Calvisi DF, Bagella L. ""Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines"". Chem Biol Interact. 2019 Oct 01;312():108813. doi: 10.1016/j.cbi.2019.108813. PMID: 31494105."
2003816,5362494,Toxin and Toxin Target Database (T3DB),Cobalt;carbonate;hydroxide,T3D1390,Cobalt(II) carbonate hydroxide (2:3),http://www.t3db.ca/toxins/T3D1390,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1893777,5371562,Comparative Toxicogenomics Database (CTD),Monocrotophos,D008999,Monocrotophos,https://ctdbase.org/detail.go?type=chem&acc=D008999,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Monocrotophos results in increased expression of PARP1 mrna|monocrotophos results in increased expression of PARP1 protein,,,PMID:28887667,https://www.ncbi.nlm.nih.gov/pubmed/28887667,28887667,,,27711936,2017; 441(1-2):201-216
1766023,5372798,Toxin and Toxin Target Database (T3DB),Lewisite,T3D1310,Lewisite,http://www.t3db.ca/toxins/T3D1310,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
965734,5379096,Comparative Toxicogenomics Database (CTD),Jaceosidin,C477508,jaceosidin,https://ctdbase.org/detail.go?type=chem&acc=C477508,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Jaceosidin results in increased cleavage of PARP1 protein|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [jaceosidin results in increased cleavage of PARP1 protein]|cflar protein inhibits the reaction [jaceosidin results in increased cleavage of PARP1 protein]|mcl1 protein inhibits the reaction [jaceosidin results in increased cleavage of PARP1 protein],,,PMID:27729209,https://www.ncbi.nlm.nih.gov/pubmed/27729209,27729209,,,10763155,"Woo SM, Kwon TK. Jaceosidin induces apoptosis through Bax activation and down-regulation of Mcl-1 and c-FLIP expression in human renal carcinoma Caki cells. Chem Biol Interact. 2016 Dec 25;260():168–75. doi: 10.1016/j.cbi.2016.10.011. PMID: 27729209."
1763853,5386591,Comparative Toxicogenomics Database (CTD),Ajoene,C048980,ajoene,https://ctdbase.org/detail.go?type=chem&acc=C048980,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ajoene analog results in increased cleavage of PARP1 protein,,,PMID:27449564,https://www.ncbi.nlm.nih.gov/pubmed/27449564,27449564,,,14837279,"Hwang JW, Cho H, Lee JY, Jeon Y, Kim SN, Lee SJ, Bae GU, Yoon S, Jeon R, Kim YK. The synthetic ajoene analog SPA3015 induces apoptotic cell death through crosstalk between NF-?B and PPAR? in multidrug-resistant cancer cells. Food Chem Toxicol. 2016 Oct;96():35–42. doi: 10.1016/j.fct.2016.07.020. PMID: 27449564."
1896374,5387181,Comparative Toxicogenomics Database (CTD),Quinocetone,C502851,quinocetone,https://ctdbase.org/detail.go?type=chem&acc=C502851,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4,4'-diisothiocyanostilbene-2,2'-disulfonic acid inhibits the reaction [quinocetone results in increased expression of PARP1 protein modified form]|lithium chloride inhibits the reaction [quinocetone results in increased expression of PARP1 protein modified form]|quinocetone results in increased expression of PARP1 protein modified form",,,PMID:28343033,https://www.ncbi.nlm.nih.gov/pubmed/28343033,28343033,,,12810228,"Yang X, Tang S, Dai C, Li D, Zhang S, Deng S, Zhou Y, Xiao X. Quinocetone induces mitochondrial apoptosis in HepG2 cells through ROS-dependent promotion of VDAC1 oligomerization and suppression of Wnt1/ß-catenin signaling pathway. Food Chem Toxicol. 2017 Jul;105():161–76. doi: 10.1016/j.fct.2017.03.039. PMID: 28343033."
1775298,5388065,Comparative Toxicogenomics Database (CTD),"3,4,5,4'-Tetramethoxystilbene",C482492,"3,4,5,4'-tetramethoxystilbene",https://ctdbase.org/detail.go?type=chem&acc=C482492,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,4,5,4'-tetramethoxystilbene results in increased cleavage of PARP1 protein",,,PMID:24055891,https://www.ncbi.nlm.nih.gov/pubmed/24055891,24055891,,,16104705,"Piotrowska H, Myszkowski K, Amarowicz R, Murias M, Kulcenty K, Wierzchowski M, Jodynis-Liebert J. Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue. Toxicol In Vitro. 2013 Dec;27(8):2127–34. doi: 10.1016/j.tiv.2013.09.012. PMID: 24055891."
1775299,5388065,Comparative Toxicogenomics Database (CTD),"3,4,5,4'-Tetramethoxystilbene",C482492,"3,4,5,4'-tetramethoxystilbene",https://ctdbase.org/detail.go?type=chem&acc=C482492,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,4,5,4'-tetramethoxystilbene results in increased expression of PARP1 protein modified form",,,PMID:23770989,https://www.ncbi.nlm.nih.gov/pubmed/23770989,23770989,,PMC3764339,3854508,"Chen LK, Qiang PF, Xu QP, Zhao YH, Dai F, Zhang L. Trans-3,4,5,4'-tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivo. Acta Pharmacol Sin. 2013 Sep;34(9):1174–82. PMID: 23770989; PMCID: PMC3764339."
1943304,5388993,Comparative Toxicogenomics Database (CTD),Citomid,D014750,Vincristine,https://ctdbase.org/detail.go?type=chem&acc=D014750,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[CEP 33779 results in increased susceptibility to vincristine] which results in increased cleavage of PARP1 protein|[nvp-BSK805 results in increased susceptibility to vincristine] which results in increased cleavage of PARP1 protein,,,PMID:28669723,https://www.ncbi.nlm.nih.gov/pubmed/28669723,28669723,,,3947378,"Cheon JH, Kim KS, Yadav DK, Kim M, Kim HS, Yoon S. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine. Biochemical and Biophysical Research Communications. 2017 Sep;490(4):1176–82. doi: 10.1016/j.bbrc.2017.06.178."
2055776,5458823,Comparative Toxicogenomics Database (CTD),Coumarin derivative,D003374,Coumarins,https://ctdbase.org/detail.go?type=chem&acc=D003374,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Coumarins analog results in increased cleavage of PARP1 protein,,,PMID:25231984,https://www.ncbi.nlm.nih.gov/pubmed/25231984,25231984,,PMC4231667,5965599,"Keerthy HK, Mohan CD, Siveen KS, Fuchs JE, Rangappa S, Sundaram MS, Li F, Girish KS, Sethi G, Basappa, Bender A, Rangappa KS. Novel Synthetic Biscoumarins Target Tumor Necrosis Factor-a in Hepatocellular Carcinoma in Vitro and in Vivo. Journal of Biological Chemistry. 2014 Nov;289(46):31879–90. doi: 10.1074/jbc.m114.593855."
2006316,5459840,Comparative Toxicogenomics Database (CTD),20-Hydroxyecdysone,D004441,Ecdysterone,https://ctdbase.org/detail.go?type=chem&acc=D004441,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ecdysterone results in increased cleavage of PARP1 protein,,,PMID:33878320,https://www.ncbi.nlm.nih.gov/pubmed/33878320,33878320,,,1311724,"Romaniuk-Drapala A, Lisiak N, Toton E, Matysiak A, Nawrot J, Nowak G, Kaczmarek M, Rybczynska M, Rubis B. Proapoptotic and proautophagic activity of 20-hydroxyecdysone in breast cancer cells in vitro. Chem Biol Interact. 2021 Jun 01;342():109479. doi: 10.1016/j.cbi.2021.109479. PMID: 33878320."
1949162,5460341,Comparative Toxicogenomics Database (CTD),Calcium,D002118,Calcium,https://ctdbase.org/detail.go?type=chem&acc=D002118,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein promotes the reaction [hydrogen peroxide results in increased uptake of calcium],,,PMID:20878536,https://www.ncbi.nlm.nih.gov/pubmed/20878536,20878536,,PMC3064896,22792573,2010; 68(8):1455-1466
2064671,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D037742,"Nanotubes, Carbon",https://ctdbase.org/detail.go?type=chem&acc=D037742,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Nanotubes, carbon results in increased cleavage of PARP1 protein",,,PMID:24929217,https://www.ncbi.nlm.nih.gov/pubmed/24929217,24929217,,,32327233,"Park EJ, Zahari NE, Kang MS, Lee Sj, Lee K, Lee BS, Yoon C, Cho MH, Kim Y, Kim JH. Toxic response of HIPCO single-walled carbon nanotubes in mice and RAW264.7 macrophage cells. Toxicol Lett. 2014 Aug 17;229(1):167–77. doi: 10.1016/j.toxlet.2014.06.015. PMID: 24929217."
2072154,5468522,Comparative Toxicogenomics Database (CTD),Bakuchiol,C012765,bakuchiol,https://ctdbase.org/detail.go?type=chem&acc=C012765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TNFSF10 protein co-treated with bakuchiol] results in increased cleavage of PARP1 protein,,,PMID:27033605,https://www.ncbi.nlm.nih.gov/pubmed/27033605,27033605,,,20900127,"Park MH, Kim JH, Chung Y, Lee SH. Bakuchiol sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins. Biochemical and Biophysical Research Communications. 2016 Apr;473(2):586–92. doi: 10.1016/j.bbrc.2016.03.127."
2072155,5468522,Comparative Toxicogenomics Database (CTD),Bakuchiol,C012765,bakuchiol,https://ctdbase.org/detail.go?type=chem&acc=C012765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [bakuchiol results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [bakuchiol results in increased cleavage of PARP1 protein]|bakuchiol results in increased cleavage of PARP1 protein,,,PMID:17292878,https://www.ncbi.nlm.nih.gov/pubmed/17292878,17292878,,,3744923,"Park EJ, Zhao YZ, Kim YC, Sohn DH. Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts. Eur J Pharmacol. 2007 Mar 22;559(2-3):115–23. doi: 10.1016/j.ejphar.2007.01.024. PMID: 17292878."
1958178,5469424,Comparative Toxicogenomics Database (CTD),Demethoxycurcumin,C050229,demethoxycurcumin,https://ctdbase.org/detail.go?type=chem&acc=C050229,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Demethoxycurcumin results in increased cleavage of PARP1 protein|wortmannin promotes the reaction [demethoxycurcumin results in increased cleavage of PARP1 protein],,,PMID:34291863,https://www.ncbi.nlm.nih.gov/pubmed/34291863,34291863,,PMC9292507,4722488,"Kao C, Cheng Y, Yang M, Cha T, Sun G, Ho C, Lin Y, Wang H, Wu S, Way T. Demethoxycurcumin induces apoptosis in <scp>HER2</scp> overexpressing bladder cancer cells through degradation of <scp>HER2</scp> and inhibiting the <scp>PI3K</scp>/Akt pathway. Environmental Toxicology. 2021 Jul 22;36(11):2186–95. doi: 10.1002/tox.23332."
1794667,5469528,Comparative Toxicogenomics Database (CTD),"1,1-bis(2-pyridylmethyl)-3-[(E)-2-pyridylmethyleneamino]thiourea",C558013,NSC 689534,https://ctdbase.org/detail.go?type=chem&acc=C558013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[NSC 689534 binds to copper] which results in decreased expression of PARP1 mrna|nsc 689534 results in increased cleavage of PARP1 protein|[nsc 689534 binds to copper] which results in increased cleavage of PARP1 protein,,,PMID:20971185,https://www.ncbi.nlm.nih.gov/pubmed/20971185,20971185,,PMC3014388,14720498,"Hancock CN, Stockwin LH, Han B, Divelbiss RD, Jun JH, Malhotra SV, Hollingshead MG, Newton DL. A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo. Free Radical Biology and Medicine. 2011 Jan;50(1):110–21. doi: 10.1016/j.freeradbiomed.2010.10.696."
2111205,5470187,Comparative Toxicogenomics Database (CTD),Zerumbone,C403304,zerumbone,https://ctdbase.org/detail.go?type=chem&acc=C403304,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zerumbone analog results in increased cleavage of PARP1 protein,,,PMID:28987329,https://www.ncbi.nlm.nih.gov/pubmed/28987329,28987329,,,2585647,"Saranya J, Dhanya BP, Greeshma G, Radhakrishnan KV, Priya S. Effects of a new synthetic zerumbone pendant derivative (ZPD) on apoptosis induction and anti-migratory effects in human cervical cancer cells. Chem Biol Interact. 2017 Dec 25;278():32–9. doi: 10.1016/j.cbi.2017.10.006. PMID: 28987329."
2111206,5470187,Comparative Toxicogenomics Database (CTD),Zerumbone,C403304,zerumbone,https://ctdbase.org/detail.go?type=chem&acc=C403304,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zerumbone results in decreased expression of PARP1 mRNA,,,PMID:36122806,https://www.ncbi.nlm.nih.gov/pubmed/36122806,36122806,,,35202069,"Rondina DBL, de Lima LVA, da Silva MF, Zanetti TA, Felicidade I, Marques LA, Coatti GC, Mantovani MS. Differential mRNA expression in the induction of DNA damage, G2/M arrest, and cell death by zerumbone in HepG2/C3A cells. Toxicol In Vitro. 2022 Dec;85():105474. doi: 10.1016/j.tiv.2022.105474. PMID: 36122806."
2111207,5470187,Comparative Toxicogenomics Database (CTD),Zerumbone,C403304,zerumbone,https://ctdbase.org/detail.go?type=chem&acc=C403304,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Zerumbone results in increased cleavage of PARP1 protein,,,PMID:16007145,https://www.ncbi.nlm.nih.gov/pubmed/16007145,16007145,,,25459462,"Takada Y, Murakami A, Aggarwal BB. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene. 2005 Oct 20;24(46):6957–69. doi: 10.1038/sj.onc.1208845. PMID: 16007145."
1980481,5477029,Comparative Toxicogenomics Database (CTD),Sinularin,C574383,sinularin,https://ctdbase.org/detail.go?type=chem&acc=C574383,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of PARP1 protein]|sinularin results in increased cleavage of PARP1 protein,,,PMID:28548367,https://www.ncbi.nlm.nih.gov/pubmed/28548367,28548367,,,19591133,"Chang YT, Wu CY, Tang JY, Huang CY, Liaw CC, Wu SH, Sheu JH, Chang HW. Sinularin induces oxidative stress-mediated G2/M arrest and apoptosis in oral cancer cells. Environ Toxicol. 2017 Sep;32(9):2124–32. doi: 10.1002/tox.22425. PMID: 28548367."
2108662,5477248,Comparative Toxicogenomics Database (CTD),Bornyl caffeate,C115950,bornyl caffeate,https://ctdbase.org/detail.go?type=chem&acc=C115950,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bornyl caffeate results in increased cleavage of PARP1 protein,,,PMID:24907532,https://www.ncbi.nlm.nih.gov/pubmed/24907532,24907532,,,8720632,"Yang C, Zhao J, Pei W, Zheng X, Rong J. Biochemical mechanisms of bornyl caffeate induced cytotoxicity in rat pheochromocytoma PC12 cells. Chem Biol Interact. 2014 Aug 05;219():133–42. doi: 10.1016/j.cbi.2014.05.018. PMID: 24907532."
1778770,5478883,Comparative Toxicogenomics Database (CTD),Pepstatin,C031375,pepstatin,https://ctdbase.org/detail.go?type=chem&acc=C031375,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pepstatin inhibits the reaction [glucosamine results in increased cleavage of PARP1 protein],,,PMID:16850161,https://www.ncbi.nlm.nih.gov/pubmed/16850161,16850161,,,21374198,2006; 11(10):1851-1860
2142408,5481948,Comparative Toxicogenomics Database (CTD),Semilicoisoflavone B,C554447,semilicoisoflavone B,https://ctdbase.org/detail.go?type=chem&acc=C554447,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Semilicoisoflavone B results in increased cleavage of PARP1 protein|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [semilicoisoflavone B results in increased cleavage of PARP1 protein]|birc5 protein inhibits the reaction [semilicoisoflavone B results in increased cleavage of PARP1 protein],,,PMID:36901935,https://www.ncbi.nlm.nih.gov/pubmed/36901935,36901935,,PMC10003514,35155758,"Hsieh MJ, Ho HY, Lo YS, Lin CC, Chuang YC, Abomughaid MM, Hsieh MC, Chen MK. Semilicoisoflavone B Induces Apoptosis of Oral Cancer Cells by Inducing ROS Production and Downregulating MAPK and Ras/Raf/MEK Signaling. Int J Mol Sci. 2023 Feb 24;24(5). PMID: 36901935; PMCID: PMC10003514."
2007938,5484385,Comparative Toxicogenomics Database (CTD),Pachymic acid,C102487,pachymic acid,https://ctdbase.org/detail.go?type=chem&acc=C102487,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pachymic acid results in increased cleavage of PARP1 protein|tp53inp2 protein promotes the reaction [pachymic acid results in increased cleavage of PARP1 protein]|traf6 protein promotes the reaction [pachymic acid results in increased cleavage of PARP1 protein],,,PMID:38560766,https://www.ncbi.nlm.nih.gov/pubmed/38560766,38560766,,,37019670,"Li X, He A, Liu C, Li Y, Luo Y, Xiong W, Nian W, Zuo D. RETRACTED: Pachymic acid activates <scp>TP53INP2</scp>/<scp>TRAF6</scp>/caspase-8 pathway to promote apoptosis in renal cell carcinoma cells. Environmental Toxicology. 2024 Apr;(). doi: 10.1002/tox.24195."
2103374,5486195,Comparative Toxicogenomics Database (CTD),tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex,C050950,tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex,https://ctdbase.org/detail.go?type=chem&acc=C050950,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tetrakis(n-methyl-4-pyridiniumyl)porphine manganese(iii) complex inhibits the reaction [doxorubicin results in increased activity of PARP1 protein],,,PMID:19286953,https://www.ncbi.nlm.nih.gov/pubmed/19286953,19286953,,PMC2685360,18707299,"Mukhopadhyay P, Rajesh M, Bátkai S, Kashiwaya Y, Haskó G, Liaudet L, Szabó C, Pacher P. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. American Journal of Physiology-Heart and Circulatory Physiology. 2009 May;296(5):H1466–83. doi: 10.1152/ajpheart.00795.2008."
2073784,5488822,Comparative Toxicogenomics Database (CTD),Baohuoside I,C060988,baohuoside I,https://ctdbase.org/detail.go?type=chem&acc=C060988,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Baohuoside I results in increased cleavage of PARP1 protein,,,PMID:19289254|PMID:22687635,https://www.ncbi.nlm.nih.gov/pubmed/19289254|https://www.ncbi.nlm.nih.gov/pubmed/22687635,19289254|22687635,,,18709460|28264184,"Song J, Shu L, Zhang Z, Tan X, Sun E, Jin X, Chen Y, Jia X. Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer. Chem Biol Interact. 2012 Jul 30;199(1):9–17. doi: 10.1016/j.cbi.2012.05.005. PMID: 22687635.|Lee KS, Lee HJ, Ahn KS, Kim SH, Nam D, Kim DK, Choi DY, Ahn KS, Lu J, Kim SH. Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer Lett. 2009 Jul 18;280(1):93–100. doi: 10.1016/j.canlet.2009.02.024. PMID: 19289254."
2073876,5488822,Comparative Toxicogenomics Database (CTD),Baohuoside I,C060988,baohuoside I,https://ctdbase.org/detail.go?type=chem&acc=C060988,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dinoprostone inhibits the reaction [baohuoside I results in increased cleavage of PARP1 protein]|ptgs2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein],,,PMID:19289254,https://www.ncbi.nlm.nih.gov/pubmed/19289254,19289254,,,18709460,"Lee KS, Lee HJ, Ahn KS, Kim SH, Nam D, Kim DK, Choi DY, Ahn KS, Lu J, Kim SH. Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer Lett. 2009 Jul 18;280(1):93–100. doi: 10.1016/j.canlet.2009.02.024. PMID: 19289254."
2024799,5490139,Comparative Toxicogenomics Database (CTD),Alpinumisoflavone,C000154,alpinumisoflavone,https://ctdbase.org/detail.go?type=chem&acc=C000154,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Alpinumisoflavone results in increased cleavage of PARP1 protein,,,PMID:23850732,https://www.ncbi.nlm.nih.gov/pubmed/23850732,23850732,,,20860053,"Kumar S, Pathania AS, Saxena AK, Vishwakarma RA, Ali A, Bhushan S. The anticancer potential of flavonoids isolated from the stem bark of Erythrina suberosa through induction of apoptosis and inhibition of STAT signaling pathway in human leukemia HL-60 cells. Chem Biol Interact. 2013 Sep 25;205(2):128–37. doi: 10.1016/j.cbi.2013.06.020. PMID: 23850732."
2108861,5490884,Comparative Toxicogenomics Database (CTD),Garcinol,C054597,garcinol,https://ctdbase.org/detail.go?type=chem&acc=C054597,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Garcinol results in increased cleavage of PARP1 protein,,,PMID:16052481,https://www.ncbi.nlm.nih.gov/pubmed/16052481,16052481,,,22702311,"Liao CH, Sang S, Ho CT, Lin JK. Garcinol modulates tyrosine phosphorylation of FAK and subsequently induces apoptosis through down-regulation of Src, ERK, and Akt survival signaling in human colon cancer cells. J Cell Biochem. 2005 Sep 01;96(1):155–69. doi: 10.1002/jcb.20540. PMID: 16052481."
2144313,5497136,Comparative Toxicogenomics Database (CTD),N-acetylsphingosine,C064769,N-acetylsphingosine,https://ctdbase.org/detail.go?type=chem&acc=C064769,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),N-acetylsphingosine results in increased activity of PARP1 protein,,,PMID:24420784,https://www.ncbi.nlm.nih.gov/pubmed/24420784,24420784,,PMC4181317,1151605,2014; 50(1):26-37
2027401,5497171,Comparative Toxicogenomics Database (CTD),Z-Val-Ala-Asp fluoromethyl ketone,C103712,benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,https://ctdbase.org/detail.go?type=chem&acc=C103712,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10029,Cricetulus griseus (Chinese hamster),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [dactinomycin results in increased cleavage of PARP1 protein],,,PMID:14640974,https://www.ncbi.nlm.nih.gov/pubmed/14640974,14640974,,PMC1223985,26766801,"Yamada M, Banno Y, Takuwa Y, Koda M, Hara A, Nozawa Y. Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells. Biochem J. 2004 Mar 01;378(Pt 2):649–56. PMID: 14640974; PMCID: PMC1223985."
2027511,5497171,Comparative Toxicogenomics Database (CTD),Z-Val-Ala-Asp fluoromethyl ketone,C103712,benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,https://ctdbase.org/detail.go?type=chem&acc=C103712,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [4-chromone analog results in increased expression of PARP1 protein modified form],,,PMID:30256521,https://www.ncbi.nlm.nih.gov/pubmed/30256521,30256521,,,20952774,"Tang JY, Wu CY, Shu CW, Wang SC, Chang MY, Chang HW. A novel sulfonyl chromen-4-ones (CHW09) preferentially kills oral cancer cells showing apoptosis, oxidative stress, and DNA damage. Environ Toxicol. 2018 Nov;33(11):1195–203. doi: 10.1002/tox.22625. PMID: 30256521."
2027512,5497171,Comparative Toxicogenomics Database (CTD),Z-Val-Ala-Asp fluoromethyl ketone,C103712,benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,https://ctdbase.org/detail.go?type=chem&acc=C103712,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:30890322,https://www.ncbi.nlm.nih.gov/pubmed/30890322,30890322,,,29757236,"Yang L, Song L, Zhao S, Ma C, Wu D, Wu YL. Isobavachalcone reveals novel characteristics of methuosis-like cell death in leukemia cells. Chem Biol Interact. 2019 May 01;304():131–8. doi: 10.1016/j.cbi.2019.03.011. PMID: 30890322."
2027513,5497171,Comparative Toxicogenomics Database (CTD),Z-Val-Ala-Asp fluoromethyl ketone,C103712,benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,https://ctdbase.org/detail.go?type=chem&acc=C103712,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [isoalantolactone results in increased expression of PARP1 protein modified form],,,PMID:29800641,https://www.ncbi.nlm.nih.gov/pubmed/29800641,29800641,,,21616822,"Lu Z, Zhang G, Zhang Y, Hua P, Fang M, Wu M, Liu T. Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells. Toxicol Appl Pharmacol. 2018 Aug 01;352():46–58. doi: 10.1016/j.taap.2018.05.026. PMID: 29800641."
2027514,5497171,Comparative Toxicogenomics Database (CTD),Z-Val-Ala-Asp fluoromethyl ketone,C103712,benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,https://ctdbase.org/detail.go?type=chem&acc=C103712,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:28251795,https://www.ncbi.nlm.nih.gov/pubmed/28251795,28251795,,,21585601,"Chang J, Chow J, Chang J, Wen Y, Lin Y, Yang S, Lee W, Chien M. Quercetin simultaneously induces G<sub>0</sub>/G<sub>1</sub>-phase arrest and caspase-mediated crosstalk between apoptosis and autophagy in human leukemia HL-60 cells. Environmental Toxicology. 2017 Mar 02;32(7):1857–68. doi: 10.1002/tox.22408."
2027515,5497171,Comparative Toxicogenomics Database (CTD),Z-Val-Ala-Asp fluoromethyl ketone,C103712,benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,https://ctdbase.org/detail.go?type=chem&acc=C103712,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [[triptolide co-treated with lipopolysaccharides] results in increased expression of PARP1 protein modified form],,,PMID:30633930,https://www.ncbi.nlm.nih.gov/pubmed/30633930,30633930,,,14883340,"Yuan Z, Zhang H, Hasnat M, Ding J, Chen X, Liang P, Sun L, Zhang L, Jiang Z. A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation. Toxicology. 2019 Feb 15;414():45–56. doi: 10.1016/j.tox.2019.01.005. PMID: 30633930."
1779638,5497174,Comparative Toxicogenomics Database (CTD),Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone,C476093,z-Val-Ala-Asp(Ome)-fluoromethylketone,https://ctdbase.org/detail.go?type=chem&acc=C476093,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Z-val-ala-asp(ome)-fluoromethylketone inhibits the reaction [CX 3543 results in increased cleavage of PARP1 protein],,,PMID:19738048,https://www.ncbi.nlm.nih.gov/pubmed/19738048,19738048,,,32921121,"Drygin D, Siddiqui-Jain A, O'Brien S, Schwaebe M, Lin A, Bliesath J, Ho CB, Proffitt C, Trent K, Whitten JP, Lim JK, Von Hoff D, Anderes K, Rice WG. Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res. 2009 Oct 01;69(19):7653–61. doi: 10.1158/0008-5472.can-09-1304. PMID: 19738048."
2144455,5702538,Comparative Toxicogenomics Database (CTD),Bafilomycin A,C057620,bafilomycin A,https://ctdbase.org/detail.go?type=chem&acc=C057620,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bafilomycin A promotes the reaction [BO-1012 results in increased cleavage of PARP1 protein],,,PMID:24823293,https://www.ncbi.nlm.nih.gov/pubmed/24823293,24823293,,,4538906,"Liou JS, Wu YC, Yen WY, Tang YS, Kakadiya RB, Su TL, Yih LH. Inhibition of autophagy enhances DNA damage-induced apoptosis by disrupting CHK1-dependent S phase arrest. Toxicol Appl Pharmacol. 2014 Aug 01;278(3):249–58. doi: 10.1016/j.taap.2014.04.028. PMID: 24823293."
2144456,5702538,Comparative Toxicogenomics Database (CTD),Bafilomycin A,C057620,bafilomycin A,https://ctdbase.org/detail.go?type=chem&acc=C057620,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lapatinib co-treated with bafilomycin A] results in increased cleavage of PARP1 protein,,,PMID:25981168,https://www.ncbi.nlm.nih.gov/pubmed/25981168,25981168,,,20209516,"Jin HO, Hong SE, Kim CS, Park JA, Kim JH, Kim JY, Kim B, Chang YH, Hong SI, Hong YJ, Park IC, Lee JK. Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells. Toxicol Appl Pharmacol. 2015 Aug 15;287(1):17–25. doi: 10.1016/j.taap.2015.05.001. PMID: 25981168."
2144457,5702538,Comparative Toxicogenomics Database (CTD),Bafilomycin A,C057620,bafilomycin A,https://ctdbase.org/detail.go?type=chem&acc=C057620,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bafilomycin A promotes the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,,18200010,"So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547."
2111586,5702613,Comparative Toxicogenomics Database (CTD),N-Hexanoylsphingosine,C101954,N-caproylsphingosine,https://ctdbase.org/detail.go?type=chem&acc=C101954,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]|[s-nitroso-N-acetylpenicillamine results in increased abundance of nitric oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]],,,PMID:10811113,https://www.ncbi.nlm.nih.gov/pubmed/10811113,10811113,,,24009608,"Melino G, Bernassola F, Catani MV, Rossi A, Corazzari M, Sabatini S, Vilbois F, Green DR. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. Cancer Res. 2000 May 01;60(9):2377–83. PMID: 10811113."
2104694,5717801,Comparative Toxicogenomics Database (CTD),Salubrinal,C496827,salubrinal,https://ctdbase.org/detail.go?type=chem&acc=C496827,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Salubrinal inhibits the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:21809093,https://www.ncbi.nlm.nih.gov/pubmed/21809093,21809093,,,12717056,2011; 86(1):37-44
2104747,5717801,Comparative Toxicogenomics Database (CTD),Salubrinal,C496827,salubrinal,https://ctdbase.org/detail.go?type=chem&acc=C496827,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Salubrinal inhibits the reaction [cyclosporine results in increased cleavage of PARP1 protein],,,PMID:22155090,https://www.ncbi.nlm.nih.gov/pubmed/22155090,22155090,,,15398108,"Sarró E, Jacobs-Cachá C, Itarte E, Meseguer A. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275–87. doi: 10.1016/j.taap.2011.11.007. PMID: 22155090."
2029355,5720188,Comparative Toxicogenomics Database (CTD),"2-[(5Z)-5-[(4-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-methylbutanoic acid",C503945,5-(4-bromobenzylidene)-alpha-isopropyl-4-oxo-2-thioxo-3-thazolidineacetic acid,https://ctdbase.org/detail.go?type=chem&acc=C503945,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),5-(4-bromobenzylidene)-alpha-isopropyl-4-oxo-2-thioxo-3-thazolidineacetic acid results in increased cleavage of PARP1 protein,,,PMID:30031050,https://www.ncbi.nlm.nih.gov/pubmed/30031050,30031050,,,23666858,"Stucki D, Brenneisen P, Reichert AS, Stahl W. The BH3 mimetic compound BH3I-1 impairs mitochondrial dynamics and promotes stress response in addition to its pro-apoptotic key function. Toxicol Lett. 2018 Oct 01;295():369–78. doi: 10.1016/j.toxlet.2018.07.017. PMID: 30031050."
2077702,6018993,Comparative Toxicogenomics Database (CTD),"(2E,6E)-2,6-bis(pyridin-4-ylmethylene)cyclohexanone",C000598518,SC-66 compound,https://ctdbase.org/detail.go?type=chem&acc=C000598518,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [SC-66 compound results in increased cleavage of PARP1 protein]|chloroquine promotes the reaction [SC-66 compound results in increased cleavage of PARP1 protein]|sc-66 compound results in increased cleavage of PARP1 protein|ddit3 protein affects the reaction [SC-66 compound results in increased cleavage of PARP1 protein]|4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased cleavage of PARP1 protein],,,PMID:37741534,https://www.ncbi.nlm.nih.gov/pubmed/37741534,37741534,,,36551503,"Wang L, Song R, Ma M, Chen Y, Jiang Y, Li J, Yang Z, Zhang L, Jing M, Wang X, Zhang M, Fan J. Inhibition of autophagy can promote the apoptosis of bladder cancer cells induced by SC66 through the endoplasmic reticulum stress pathway. Chem Biol Interact. 2023 Oct 01;384():110725. doi: 10.1016/j.cbi.2023.110725. PMID: 37741534."
1964778,6326970,Comparative Toxicogenomics Database (CTD),Selenium,D012643,Selenium,https://ctdbase.org/detail.go?type=chem&acc=D012643,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9031,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in increased expression of PARP1 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,,21029135,"Zhao L, Deng J, Ma LB, Zhang WP, Khalil MM, Karrow NA, Qi DS, Sun LH. Dietary Se deficiency dysregulates metabolic and cell death signaling in aggravating the AFB1 hepatotoxicity of chicks. Food Chem Toxicol. 2021 Mar;149():111938. doi: 10.1016/j.fct.2020.111938. PMID: 33348051."
1964779,6326970,Comparative Toxicogenomics Database (CTD),Selenium,D012643,Selenium,https://ctdbase.org/detail.go?type=chem&acc=D012643,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BCL2L11 protein promotes the reaction [[doxorubicin co-treated with selenium] results in increased degradation of PARP1 protein]|akt1 protein modified form inhibits the reaction [[doxorubicin co-treated with selenium] results in increased degradation of PARP1 protein]|[doxorubicin co-treated with selenium] results in increased degradation of PARP1 protein,,,PMID:17339365,https://www.ncbi.nlm.nih.gov/pubmed/17339365,17339365,,,20720181,"Li S, Zhou Y, Wang R, Zhang H, Dong Y, Ip C. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther. 2007 Mar;6(3):1031–8. doi: 10.1158/1535-7163.mct-06-0643. PMID: 17339365."
2084831,6328537,Toxin and Toxin Target Database (T3DB),Thioarsinous acid,T3D0277,Arsenic disulfide,http://www.t3db.ca/toxins/T3D0277,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
982460,6328620,Comparative Toxicogenomics Database (CTD),Trimethyltin hydroxide,C037718,trimethyltin hydroxide,https://ctdbase.org/detail.go?type=chem&acc=C037718,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Trimethyltin hydroxide results in increased cleavage of PARP1 protein,,,PMID:16181675,https://www.ncbi.nlm.nih.gov/pubmed/16181675,16181675,,,11218737,"Mundy WR, Freudenrich TM. Apoptosis of cerebellar granule cells induced by organotin compounds found in drinking water: involvement of MAP kinases. Neurotoxicology. 2006 Jan;27(1):71–81. doi: 10.1016/j.neuro.2005.07.007. PMID: 16181675."
1975253,6333920,Comparative Toxicogenomics Database (CTD),Brilliant Acid Blue G,C004692,coomassie Brilliant Blue,https://ctdbase.org/detail.go?type=chem&acc=C004692,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Coomassie brilliant blue inhibits the reaction [zinc chloride results in increased expression of PARP1 protein],,,PMID:22253048,https://www.ncbi.nlm.nih.gov/pubmed/22253048,22253048,,,16772070,"Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 2011 Dec;59(12):1933–45. doi: 10.1002/glia.21235. PMID: 22253048."
2130495,6368502,Comparative Toxicogenomics Database (CTD),"(3Z,5E)-1-acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one",C569633,"3,5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one",https://ctdbase.org/detail.go?type=chem&acc=C569633,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[vemurafenib co-treated with 3,5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one] results in increased cleavage of PARP1 protein",,,PMID:35648318,https://www.ncbi.nlm.nih.gov/pubmed/35648318,35648318,,,34070509,2022; 39(5):2381-2399
2036018,6391215,Toxin and Toxin Target Database (T3DB),Cadmium arsenide,T3D0367,Cadmium arsenide,http://www.t3db.ca/toxins/T3D0367,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2088017,6398625,Toxin and Toxin Target Database (T3DB),Arsole,T3D1302,Arsole,http://www.t3db.ca/toxins/T3D1302,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1983842,6432046,Toxin and Toxin Target Database (T3DB),Cobalt oxide,T3D0668,"Cobalt(II, III) oxide",http://www.t3db.ca/toxins/T3D0668,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2109868,6432469,Comparative Toxicogenomics Database (CTD),"Isomenthone, (+/-)-",C575995,isomenthone,https://ctdbase.org/detail.go?type=chem&acc=C575995,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Isomenthone inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein],,,PMID:22796318,https://www.ncbi.nlm.nih.gov/pubmed/22796318,22796318,,,1121122,"Jung E, Byun S, Kim S, Kim M, Park D, Lee J. Isomenthone protects human dermal fibroblasts from TNF-a-induced death possibly by preventing activation of JNK and p38 MAPK. Food Chem Toxicol. 2012 Oct;50(10):3514–20. doi: 10.1016/j.fct.2012.07.002. PMID: 22796318."
2090905,6433206,Comparative Toxicogenomics Database (CTD),Sulforaphen,C473643,sulphoraphene,https://ctdbase.org/detail.go?type=chem&acc=C473643,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sulphoraphene results in increased cleavage of PARP1 protein,,,PMID:29247643,https://www.ncbi.nlm.nih.gov/pubmed/29247643,29247643,,,20269852,"Wang H, Wang F, Wu S, Liu Z, Li T, Mao L, Zhang J, Li C, Liu C, Yang Y. Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activation. Chem Biol Interact. 2018 Feb 01;281():11–23. doi: 10.1016/j.cbi.2017.12.017. PMID: 29247643."
1991274,6433207,Comparative Toxicogenomics Database (CTD),"S-(1,2-Dichlorovinyl)-L-cysteine",C039961,"S-(1,2-dichlorovinyl)cysteine",https://ctdbase.org/detail.go?type=chem&acc=C039961,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"S-(1,2-dichlorovinyl)cysteine results in increased cleavage of PARP1 protein",,,PMID:15967204,https://www.ncbi.nlm.nih.gov/pubmed/15967204,15967204,,,15971152,"Lash LH, Putt DA, Hueni SE, Horwitz BP. Molecular markers of trichloroethylene-induced toxicity in human kidney cells. Toxicol Appl Pharmacol. 2005 Aug 07;206(2):157–68. doi: 10.1016/j.taap.2004.09.023. PMID: 15967204."
2047668,6434191,Comparative Toxicogenomics Database (CTD),Mezerein,C011309,mezerein,https://ctdbase.org/detail.go?type=chem&acc=C011309,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-aminobenzamide inhibits the reaction [mezerein results in increased activity of PARP1 protein],,,PMID:2120135,https://www.ncbi.nlm.nih.gov/pubmed/2120135,2120135,,,15702803,Singh N. A comparative study on the effect of tumor promoters on poly ADP-ribosylation in A431 cells. Int J Cancer. 1990 Oct 15;46(4):648–52. doi: 10.1002/ijc.2910460416. PMID: 2120135.
2047669,6434191,Comparative Toxicogenomics Database (CTD),Mezerein,C011309,mezerein,https://ctdbase.org/detail.go?type=chem&acc=C011309,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mezerein results in increased activity of PARP1 protein,,,PMID:2120135|PMID:2126186,https://www.ncbi.nlm.nih.gov/pubmed/2120135|https://www.ncbi.nlm.nih.gov/pubmed/2126186,2120135|2126186,,PMC2002381,2055236|15702803,Singh N. Effect of tumour promoters on poly ADP-ribosylation in human epidermoid carcinoma HeP2 cells. Int J Exp Pathol. 1990 Dec;71(6):809–14. PMID: 2126186; PMCID: PMC2002381.|Singh N. A comparative study on the effect of tumor promoters on poly ADP-ribosylation in A431 cells. Int J Cancer. 1990 Oct 15;46(4):648–52. doi: 10.1002/ijc.2910460416. PMID: 2120135.
1997023,6436143,Toxin and Toxin Target Database (T3DB),Adenosylcobalamin,T3D0672,Adenosylcobalamin,http://www.t3db.ca/toxins/T3D0672,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2148421,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bafilomycin A1 promotes the reaction [atorvastatin results in increased cleavage of PARP1 protein],,,PMID:20876807,https://www.ncbi.nlm.nih.gov/pubmed/20876807,20876807,,,22790935,"Yang PM, Liu YL, Lin YC, Shun CT, Wu MS, Chen CC. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res. 2010 Oct 01;70(19):7699–709. doi: 10.1158/0008-5472.can-10-1626. PMID: 20876807."
2148422,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bafilomycin A1 promotes the reaction [brazilin results in increased expression of PARP1 protein modified form]|bafilomycin A1 results in increased expression of PARP1 protein modified form,,,PMID:28063998,https://www.ncbi.nlm.nih.gov/pubmed/28063998,28063998,,,33743523,"He ZJ, Zhu FY, Li SS, Zhong L, Tan HY, Wang K. Inhibiting ROS-NF-?B-dependent autophagy enhanced brazilin-induced apoptosis in head and neck squamous cell carcinoma. Food Chem Toxicol. 2017 Mar;101():55–66. doi: 10.1016/j.fct.2017.01.002. PMID: 28063998."
2148423,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cysteine proteinase inhibitors results in decreased activity of USP8 protein] promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]|bafilomycin A1 promotes the reaction [[cysteine proteinase inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein],,,PMID:35022897,https://www.ncbi.nlm.nih.gov/pubmed/35022897,35022897,,,10229733,2022; 39(5):2011-2032
2148424,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bafilomycin A1 promotes the reaction [flavanones results in increased cleavage of PARP1 protein],,,PMID:21616090,https://www.ncbi.nlm.nih.gov/pubmed/21616090,21616090,,,9342382,"Shin SY, Hyun J, Yu JR, Lim Y, Lee YH. 5-Methoxyflavanone induces cell cycle arrest at the G2/M phase, apoptosis and autophagy in HCT116 human colon cancer cells. Toxicol Appl Pharmacol. 2011 Aug 01;254(3):288–98. doi: 10.1016/j.taap.2011.05.003. PMID: 21616090."
2148425,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bafilomycin A1 promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein],,,PMID:24321340,https://www.ncbi.nlm.nih.gov/pubmed/24321340,24321340,,,28290116,"Li Y, Luo P, Wang J, Dai J, Yang X, Wu H, Yang B, He Q. Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway. Toxicol Appl Pharmacol. 2014 Jan 15;274(2):319–27. doi: 10.1016/j.taap.2013.11.018. PMID: 24321340."
2148426,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bafilomycin A1 results in increased cleavage of PARP1 protein,,,PMID:21616090|PMID:25981168|PMID:35022897,https://www.ncbi.nlm.nih.gov/pubmed/21616090|https://www.ncbi.nlm.nih.gov/pubmed/25981168|https://www.ncbi.nlm.nih.gov/pubmed/35022897,21616090|25981168|35022897,,,9342382|10229733|20209516,"2022; 39(5):2011-2032|Jin HO, Hong SE, Kim CS, Park JA, Kim JH, Kim JY, Kim B, Chang YH, Hong SI, Hong YJ, Park IC, Lee JK. Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells. Toxicol Appl Pharmacol. 2015 Aug 15;287(1):17–25. doi: 10.1016/j.taap.2015.05.001. PMID: 25981168.|Shin SY, Hyun J, Yu JR, Lim Y, Lee YH. 5-Methoxyflavanone induces cell cycle arrest at the G2/M phase, apoptosis and autophagy in HCT116 human colon cancer cells. Toxicol Appl Pharmacol. 2011 Aug 01;254(3):288–98. doi: 10.1016/j.taap.2011.05.003. PMID: 21616090."
2148427,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),HIF1A mutant form promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]|bnip3 mutant form promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein],,,PMID:25981168,https://www.ncbi.nlm.nih.gov/pubmed/25981168,25981168,,,20209516,"Jin HO, Hong SE, Kim CS, Park JA, Kim JH, Kim JY, Kim B, Chang YH, Hong SI, Hong YJ, Park IC, Lee JK. Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells. Toxicol Appl Pharmacol. 2015 Aug 15;287(1):17–25. doi: 10.1016/j.taap.2015.05.001. PMID: 25981168."
2148428,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Bafilomycin A1 inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
2148429,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Bafilomycin A1 results in increased cleavage of PARP1 protein,,,PMID:31310755,https://www.ncbi.nlm.nih.gov/pubmed/31310755,31310755,,,32445610,"Stamenkovic M, Janjetovic K, Paunovic V, Ciric D, Kravic-Stevovic T, Trajkovic V. Comparative analysis of cell death mechanisms induced by lysosomal autophagy inhibitors. Eur J Pharmacol. 2019 Sep 15;859():172540. doi: 10.1016/j.ejphar.2019.172540. PMID: 31310755."
2148430,6436223,Comparative Toxicogenomics Database (CTD),Bafilomycin A1,C040929,bafilomycin A1,https://ctdbase.org/detail.go?type=chem&acc=C040929,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Bafilomycin A1 promotes the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:34374793,https://www.ncbi.nlm.nih.gov/pubmed/34374793,34374793,,,25810524,2021; 95(10):3263-3284
1997469,6436232,Toxin and Toxin Target Database (T3DB),"Cobinamide, Co-methyl-, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole, stereoisomer",T3D0679,Methylcobalamin,http://www.t3db.ca/toxins/T3D0679,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2025766,6436805,Comparative Toxicogenomics Database (CTD),Sarcophine,C014804,sarcophine,https://ctdbase.org/detail.go?type=chem&acc=C014804,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sarcophine results in decreased activity of PARP1 protein,,,PMID:24689276,https://www.ncbi.nlm.nih.gov/pubmed/24689276,24689276,,,28977093,"Szymanski PT, Ahmed SA, Radwan MM, Khalifa SI, Fahmy H. Evaluation of the anti-melanoma activities of sarcophine, (+)-7alpha,8beta-dihydroxydeepoxysarcophine and sarcophytolide from the Red Sea soft coral Sarcophyton glaucum. Nat Prod Commun. 2014 Feb;9(2):151–4. PMID: 24689276."
1976006,6438151,Comparative Toxicogenomics Database (CTD),Concanamycin A,C036978,concanamycin A,https://ctdbase.org/detail.go?type=chem&acc=C036978,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[lapatinib co-treated with concanamycin A] results in increased cleavage of PARP1 protein,,,PMID:25981168,https://www.ncbi.nlm.nih.gov/pubmed/25981168,25981168,,,20209516,"Jin HO, Hong SE, Kim CS, Park JA, Kim JH, Kim JY, Kim B, Chang YH, Hong SI, Hong YJ, Park IC, Lee JK. Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells. Toxicol Appl Pharmacol. 2015 Aug 15;287(1):17–25. doi: 10.1016/j.taap.2015.05.001. PMID: 25981168."
2092211,6438330,Comparative Toxicogenomics Database (CTD),Manumycin A,C054474,manumycin,https://ctdbase.org/detail.go?type=chem&acc=C054474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [manumycin results in increased cleavage of parp1]|manumycin results in increased cleavage of PARP1,,,PMID:19409983,https://www.ncbi.nlm.nih.gov/pubmed/19409983,19409983,,,11304507,"Dixit D, Sharma V, Ghosh S, Koul N, Mishra PK, Sen E. Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation. Free Radic Biol Med. 2009 Aug 15;47(4):364–74. doi: 10.1016/j.freeradbiomed.2009.04.031. PMID: 19409983."
2092212,6438330,Comparative Toxicogenomics Database (CTD),Manumycin A,C054474,manumycin,https://ctdbase.org/detail.go?type=chem&acc=C054474,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Manumycin results in increased cleavage of PARP1 protein|quercetin promotes the reaction [manumycin results in increased cleavage of PARP1 protein],,,PMID:14625852,https://www.ncbi.nlm.nih.gov/pubmed/14625852,14625852,,,28119795,"Hu W, Wu W, Verschraegen CF, Chen L, Mao L, Yeung SC, Kudelka AP, Freedman RS, Kavanagh JJ. Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor. Proteomics. 2003 Oct;3(10):1904–11. doi: 10.1002/pmic.200300547. PMID: 14625852."
2110374,6438394,Comparative Toxicogenomics Database (CTD),Myriocin,C001996,thermozymocidin,https://ctdbase.org/detail.go?type=chem&acc=C001996,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Thermozymocidin inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein],,,PMID:24264887,https://www.ncbi.nlm.nih.gov/pubmed/24264887,24264887,,,30321197,2013; 19(3):527-541
2148624,6438825,Comparative Toxicogenomics Database (CTD),Broussochalcone A,C106525,broussochalcone A,https://ctdbase.org/detail.go?type=chem&acc=C106525,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Broussochalcone A results in increased cleavage of PARP1 protein,,,PMID:31163223,https://www.ncbi.nlm.nih.gov/pubmed/31163223,31163223,,,33802700,"Shin S, Son Y, Liu KH, Kang W, Oh S. Cytotoxic activity of broussochalcone a against colon and liver cancer cells by promoting destruction complex-independent ß-catenin degradation. Food Chem Toxicol. 2019 Sep;131():110550. doi: 10.1016/j.fct.2019.05.058. PMID: 31163223."
2048850,6440856,Comparative Toxicogenomics Database (CTD),Goniothalamin,C103280,goniothalamin,https://ctdbase.org/detail.go?type=chem&acc=C103280,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Goniothalamin results in increased cleavage of PARP1 protein,,,PMID:18771661|PMID:21810437,https://www.ncbi.nlm.nih.gov/pubmed/18771661|https://www.ncbi.nlm.nih.gov/pubmed/21810437,18771661|21810437,,,12718275|24137356,"Kuo KK, Chen YL, Chen LR, Li CF, Lan YH, Chang FR, Wu YC, Shiue YL. Involvement of phorbol-12-myristate-13-acetate-induced protein 1 in goniothalamin-induced TP53-dependent and -independent apoptosis in hepatocellular carcinoma-derived cells. Toxicol Appl Pharmacol. 2011 Oct 01;256(1):8–23. doi: 10.1016/j.taap.2011.07.002. PMID: 21810437.|de Fátima A, Zambuzzi WF, Modolo LV, Tarsitano CA, Gadelha FR, Hyslop S, de Carvalho JE, Salgado I, Ferreira CV, Pilli RA. Cytotoxicity of goniothalamin enantiomers in renal cancer cells: involvement of nitric oxide, apoptosis and autophagy. Chem Biol Interact. 2008 Nov 25;176(2-3):143–50. doi: 10.1016/j.cbi.2008.08.003. PMID: 18771661."
2048851,6440856,Comparative Toxicogenomics Database (CTD),Goniothalamin,C103280,goniothalamin,https://ctdbase.org/detail.go?type=chem&acc=C103280,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [goniothalamin results in increased cleavage of PARP1 protein]|tp53 mutant form inhibits the reaction [goniothalamin results in increased cleavage of PARP1 protein],,,PMID:21810437,https://www.ncbi.nlm.nih.gov/pubmed/21810437,21810437,,,12718275,"Kuo KK, Chen YL, Chen LR, Li CF, Lan YH, Chang FR, Wu YC, Shiue YL. Involvement of phorbol-12-myristate-13-acetate-induced protein 1 in goniothalamin-induced TP53-dependent and -independent apoptosis in hepatocellular carcinoma-derived cells. Toxicol Appl Pharmacol. 2011 Oct 01;256(1):8–23. doi: 10.1016/j.taap.2011.07.002. PMID: 21810437."
2111533,6441595,Comparative Toxicogenomics Database (CTD),4-O-Methylascochlorin,C031515,4-O-methylascochlorin,https://ctdbase.org/detail.go?type=chem&acc=C031515,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),HIF1A protein affects the reaction [4-O-methylascochlorin results in increased cleavage of PARP1 protein]|4-O-methylascochlorin results in increased cleavage of PARP1 protein,,,PMID:35248696,https://www.ncbi.nlm.nih.gov/pubmed/35248696,35248696,,,4075847,"Jeong YJ, Hwang SK, Yu MH, Cho Y, Song KH, Magae J, Jeon EJ, Chang YC. 4-O-methylascochlorin-stimulated HIF-1a expression induces the epithelial mesenchymal transition and cell survival in breast cancer cells. Toxicol In Vitro. 2022 Jun;81():105342. doi: 10.1016/j.tiv.2022.105342. PMID: 35248696."
2118480,6451139,Comparative Toxicogenomics Database (CTD),Pyrimidifen,C476509,pyrimidifen,https://ctdbase.org/detail.go?type=chem&acc=C476509,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrimidifen results in increased expression of PARP1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,PMC7870626,25085642,2021; 95(2):591-615
2092935,6451221,Toxin and Toxin Target Database (T3DB),CID 6451221,T3D0278,Arsenic pentasulfide,http://www.t3db.ca/toxins/T3D0278,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2028396,6451222,Toxin and Toxin Target Database (T3DB),Zinc arsenate,T3D0299,Zinc arsenate,http://www.t3db.ca/toxins/T3D0299,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2120036,6475943,Comparative Toxicogenomics Database (CTD),Pseudolaric Acid B,C058391,pseudolaric acid B,https://ctdbase.org/detail.go?type=chem&acc=C058391,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Pseudolaric acid B results in increased cleavage of PARP1 protein,,,PMID:37244295,https://www.ncbi.nlm.nih.gov/pubmed/37244295,37244295,,,35916101,"Liu Z, Wang N, Meng Z, Lu S, Peng G. Pseudolaric acid B triggers cell apoptosis by activating AMPK/JNK/DRP1/mitochondrial fission pathway in hepatocellular carcinoma. Toxicology. 2023 Jul;493():153556. doi: 10.1016/j.tox.2023.153556. PMID: 37244295."
1992277,6483648,Comparative Toxicogenomics Database (CTD),Panduratin A,C482884,panduratin A,https://ctdbase.org/detail.go?type=chem&acc=C482884,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Panduratin A results in increased cleavage of PARP1 protein,,,PMID:16497706,https://www.ncbi.nlm.nih.gov/pubmed/16497706,16497706,,,26155197,"Yun JM, Kweon MH, Kwon H, Hwang JK, Mukhtar H. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145. Carcinogenesis. 2006 Jul;27(7):1454–64. doi: 10.1093/carcin/bgi348. PMID: 16497706."
2111798,6505803,Comparative Toxicogenomics Database (CTD),Tanespimycin,C112765,tanespimycin,https://ctdbase.org/detail.go?type=chem&acc=C112765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tanespimycin results in increased cleavage of PARP1 protein,,,PMID:22810956,https://www.ncbi.nlm.nih.gov/pubmed/22810956,22810956,,,18110606,"Chen MH, Lin KJ, Yang WL, Kao YW, Chen TW, Chao SC, Chang PM, Liu CY, Tzeng CH, Chao Y, Chen MH, Yeh CN, Huang CY. Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma. Cancer. 2013 Jan 15;119(2):293–303. doi: 10.1002/cncr.27743. PMID: 22810956."
1810984,6537679,Toxin and Toxin Target Database (T3DB),,T3D1313,Thorin,http://www.t3db.ca/toxins/T3D1313,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1818050,6603945,Comparative Toxicogenomics Database (CTD),S-Nitroso-N-Acetylpenicillamine,D026423,S-Nitroso-N-Acetylpenicillamine,https://ctdbase.org/detail.go?type=chem&acc=D026423,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[S-nitroso-N-acetylpenicillamine results in increased abundance of nitric oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]],,,PMID:10811113,https://www.ncbi.nlm.nih.gov/pubmed/10811113,10811113,,,24009608,"Melino G, Bernassola F, Catani MV, Rossi A, Corazzari M, Sabatini S, Vilbois F, Green DR. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. Cancer Res. 2000 May 01;60(9):2377–83. PMID: 10811113."
2004371,6912226,Comparative Toxicogenomics Database (CTD),Ionomycin,D015759,Ionomycin,https://ctdbase.org/detail.go?type=chem&acc=D015759,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of PARP1 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,PMC4326531,27654044,2015; 16(1):26
2070240,6917874,Comparative Toxicogenomics Database (CTD),Maduramycin,C018091,maduramicin,https://ctdbase.org/detail.go?type=chem&acc=C018091,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [maduramicin results in increased cleavage of PARP1 protein]|maduramicin results in increased cleavage of PARP1 protein,,,PMID:29047155,https://www.ncbi.nlm.nih.gov/pubmed/29047155,29047155,,PMC5783728,22948522,"Chen X, Chen L, Jiang S, Huang S. Maduramicin induces apoptosis and necrosis, and blocks autophagic flux in myocardial H9c2 cells. J of Applied Toxicology. 2017 Oct 19;38(3):366–75. doi: 10.1002/jat.3546."
1026878,6918638,Comparative Toxicogenomics Database (CTD),Belinostat,C487081,belinostat,https://ctdbase.org/detail.go?type=chem&acc=C487081,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Belinostat results in increased cleavage of PARP1 protein,,,PMID:18223231|PMID:25537862,https://www.ncbi.nlm.nih.gov/pubmed/18223231|https://www.ncbi.nlm.nih.gov/pubmed/25537862,18223231|25537862,,PMC4332026,486255|1688119,"Kim DE, Kim Y, Cho D, Jeong S, Kim S, Suh N, Lee JS, Choi EK, Koh J, Hwang JJ, Kim C. Raloxifene Induces Autophagy-Dependent Cell Death in Breast Cancer Cells via the Activation of AMP-Activated Protein Kinase. Molecules and Cells. 2015 Feb;38(2):138–44. doi: 10.14348/molcells.2015.2193.|Dai Y, Chen S, Kramer LB, Funk VL, Dent P, Grant S. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells. Clin Cancer Res. 2008 Jan 15;14(2):549–58. doi: 10.1158/1078-0432.ccr-07-1934. PMID: 18223231."
1026879,6918638,Comparative Toxicogenomics Database (CTD),Belinostat,C487081,belinostat,https://ctdbase.org/detail.go?type=chem&acc=C487081,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Bortezomib promotes the reaction [belinostat results in increased cleavage of PARP1 protein],,,PMID:18223231,https://www.ncbi.nlm.nih.gov/pubmed/18223231,18223231,,,1688119,"Dai Y, Chen S, Kramer LB, Funk VL, Dent P, Grant S. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells. Clin Cancer Res. 2008 Jan 15;14(2):549–58. doi: 10.1158/1078-0432.ccr-07-1934. PMID: 18223231."
1026880,6918638,Comparative Toxicogenomics Database (CTD),Belinostat,C487081,belinostat,https://ctdbase.org/detail.go?type=chem&acc=C487081,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Belinostat results in increased expression of PARP1 mrna|belinostat results in increased expression of PARP1 protein,,,PMID:29733868,https://www.ncbi.nlm.nih.gov/pubmed/29733868,29733868,,,8789259,"Attia SM, Al-Hamamah MA, Alotaibi MR, Harisa GI, Attia MM, Ahmad SF, Ansari MA, Nadeem A, Bakheet SA. Investigation of belinostat-induced genomic instability by molecular cytogenetic analysis and pathway-focused gene expression profiling. Toxicol Appl Pharmacol. 2018 Jul 01;350():43–51. doi: 10.1016/j.taap.2018.05.002. PMID: 29733868."
2016647,6918736,Comparative Toxicogenomics Database (CTD),Rigosertib,C507134,ON 01910,https://ctdbase.org/detail.go?type=chem&acc=C507134,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Imatinib mesylate promotes the reaction [ON 01910 results in increased cleavage of PARP1 protein]|on 01910 promotes the reaction [imatinib mesylate results in increased cleavage of PARP1 protein],,,PMID:26008977,https://www.ncbi.nlm.nih.gov/pubmed/26008977,26008977,,PMC4653000,1168522,"Okabe S, Tauchi T, Tanaka Y, Sakuta J, Ohyashiki K. Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with Abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells. Oncotarget. 2015 Aug 21;6(24):20231–40. PMID: 26008977; PMCID: PMC4653000."
2016648,6918736,Comparative Toxicogenomics Database (CTD),Rigosertib,C507134,ON 01910,https://ctdbase.org/detail.go?type=chem&acc=C507134,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),ON 01910 results in increased cleavage of PARP1 protein,,,PMID:19198627|PMID:21812421|PMID:24471873|PMID:25316768|PMID:25472472|PMID:25580850|PMID:26008977,https://www.ncbi.nlm.nih.gov/pubmed/19198627|https://www.ncbi.nlm.nih.gov/pubmed/21812421|https://www.ncbi.nlm.nih.gov/pubmed/24471873|https://www.ncbi.nlm.nih.gov/pubmed/25316768|https://www.ncbi.nlm.nih.gov/pubmed/25472472|https://www.ncbi.nlm.nih.gov/pubmed/25580850|https://www.ncbi.nlm.nih.gov/pubmed/26008977,19198627|21812421|24471873|25316768|25472472|25580850|26008977,,PMC4255183|PMC4376437|PMC4503467|PMC4653000,1168522|2394735|5261433|8056925|12003463|22218098|29623955,"Okabe S, Tauchi T, Tanaka Y, Sakuta J, Ohyashiki K. Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with Abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells. Oncotarget. 2015 Aug 21;6(24):20231–40. PMID: 26008977; PMCID: PMC4653000.|Hyoda T, Tsujioka T, Nakahara T, Suemori S, Okamoto S, Kataoka M, Tohyama K. Rigosertib induces cell death of a myelodysplastic syndrome-derived cell line by <scp>DNA</scp> damage-induced G2/M arrest. Cancer Science. 2015 Feb 20;106(3):287–93. doi: 10.1111/cas.12605.|Lu T, Laughton CA, Wang S, Bradshaw TD. In vitro antitumor mechanism of (E)-N-(2-methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)pyridin-3-yl)methanesulfonamide. Mol Pharmacol. 2015 Jan;87(1):18–30. doi: 10.1124/mol.114.093245. PMID: 25316768.|Xu F, He Q, Li X, Chang CK, Wu LY, Zhang Z, Liu L, Shi WH, Zhu Y, Zhao YS, Gu SC, Fei CM, Guo J, Wu D, Zhou L. Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome. Sci Rep. 2014 Dec 04;4():7310. PMID: 25472472; PMCID: PMC4255183.|doi:10.1021/jm4019614|Reddy MVR, Venkatapuram P, Mallireddigari MR, Pallela VR, Cosenza SC, Robell KA, Akula B, Hoffman BS, Reddy EP. Discovery of a Clinical Stage Multi-Kinase Inhibitor Sodium (<i>E</i>)-2-{2-Methoxy-5-[(2',4',6'-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): Synthesis, Structure–Activity Relationship, and Biological Activity. J. Med. Chem. 2011 Aug 17;54(18):6254–76. doi: 10.1021/jm200570p.|Prasad A, Park IW, Allen H, Zhang X, Reddy MV, Boominathan R, Reddy EP, Groopman JE. Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells. Oncogene. 2009 Mar 26;28(12):1518–28. doi: 10.1038/onc.2008.502. PMID: 19198627."
2116792,6918837,Comparative Toxicogenomics Database (CTD),Panobinostat,D000077767,Panobinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077767,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[resveratrol co-treated with panobinostat] results in increased cleavage of PARP1 protein,,,PMID:22923501,https://www.ncbi.nlm.nih.gov/pubmed/22923501,22923501,,PMC3502626,31621272,"Yaseen A, Chen S, Hock S, Rosato R, Dent P, Dai Y, Grant S. Resveratrol Sensitizes Acute Myelogenous Leukemia Cells to Histone Deacetylase Inhibitors through Reactive Oxygen Species-Mediated Activation of the Extrinsic Apoptotic Pathway. Molecular Pharmacology. 2012 Dec;82(6):1030–41. doi: 10.1124/mol.112.079624."
2123206,7433743,Comparative Toxicogenomics Database (CTD),"(3aS,4R,9bR)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline",C568862,"4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline",https://ctdbase.org/detail.go?type=chem&acc=C568862,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in increased cleavage of PARP1 protein",,,PMID:24161432,https://www.ncbi.nlm.nih.gov/pubmed/24161432,24161432,,,22850787,"Bai LY, Weng JR, Hu JL, Wang D, Sargeant AM, Chiu CF. G15, a GPR30 antagonist, induces apoptosis and autophagy in human oral squamous carcinoma cells. Chem Biol Interact. 2013 Nov 25;206(2):375–84. doi: 10.1016/j.cbi.2013.10.014. PMID: 24161432."
1936641,9107452,BindingDB,,103556,ME0355,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=103556,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),9.1e+3,PMID:23742272|DOI:10.1021/cb4002014,https://www.ncbi.nlm.nih.gov/pubmed/23742272|https://doi.org/10.1021/cb4002014,23742272,10.1021/cb4002014,,3182686,"Lindgren AE, Karlberg T, Thorsell AG, Hesse M, Spjut S, Ekblad T, Andersson CD, Pinto AF, Weigelt J, Hottiger MO, Linusson A, Elofsson M, Schüler H. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3. ACS Chem Biol. 2013 Aug 16;8(8):1698–703. doi: 10.1021/cb4002014. PMID: 23742272."
1936644,9107457,BindingDB,,103555,ME0354,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=103555,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),9e+2,PMID:23742272|DOI:10.1021/cb4002014,https://www.ncbi.nlm.nih.gov/pubmed/23742272|https://doi.org/10.1021/cb4002014,23742272,10.1021/cb4002014,,3182686,"Lindgren AE, Karlberg T, Thorsell AG, Hesse M, Spjut S, Ekblad T, Andersson CD, Pinto AF, Weigelt J, Hottiger MO, Linusson A, Elofsson M, Schüler H. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3. ACS Chem Biol. 2013 Aug 16;8(8):1698–703. doi: 10.1021/cb4002014. PMID: 23742272."
2059963,9547215,Comparative Toxicogenomics Database (CTD),Bufalin,C022777,bufalin,https://ctdbase.org/detail.go?type=chem&acc=C022777,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),HSPB1 protein inhibits the reaction [bufalin results in increased cleavage of PARP1 protein]|bufalin results in increased cleavage of PARP1 protein,,,PMID:23091618,https://www.ncbi.nlm.nih.gov/pubmed/23091618,23091618,,PMC3473020,30961439,"Xie XB, Yin JQ, Wen LL, Gao ZH, Zou CY, Wang J, Huang G, Tang QL, Colombo C, He WL, Jia Q, Shen JN. Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based research. PLoS One. 2012;7(10):e47375. PMID: 23091618; PMCID: PMC3473020."
1045149,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Particulate matter results in decreased expression of PARP1 mRNA,,,PMID:32891722,https://www.ncbi.nlm.nih.gov/pubmed/32891722,32891722,,,21693027,"Kim HS, Kim HJ, Kim N, Song JJ, Son BS, Yang JH, Lee CM, Park MK, Seo YR. Toxicogenomic study to identify potential signaling alterations related to nasal inflammatory damages induced by diesel exhaust particles in primary human nasal epithelial cells. Toxicol In Vitro. 2020 Dec;69():104994. doi: 10.1016/j.tiv.2020.104994. PMID: 32891722."
1045483,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),IL7R mRNA alternative form inhibits the reaction [particulate matter results in increased cleavage of PARP1 protein]|particulate matter results in increased cleavage of PARP1 protein,,,PMID:35303175,https://www.ncbi.nlm.nih.gov/pubmed/35303175,35303175,,,29169260,2022; 38(6):1097-1120
1045484,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Particulate matter results in decreased expression of PARP1 mRNA,,,PMID:32873817,https://www.ncbi.nlm.nih.gov/pubmed/32873817,32873817,,PMC7462977,21676451,"Gangwar RS, Vinayachandran V, Rengasamy P, Chan R, Park B, Diamond-Zaluski R, Cara EA, Cha A, Das L, Asase C, Maiseyeu A, Deiuliis J, Zhong J, Mitzner W, Biswal S, Rajagopalan S. Differential contribution of bone marrow-derived infiltrating monocytes and resident macrophages to persistent lung inflammation in chronic air pollution exposure. Scientific Reports. 2020 Sep 01;10(1):14348. doi: 10.1038/s41598-020-71144-1."
1045485,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[particulate matter results in increased abundance of nitrates] which results in increased expression of PARP1 mRNA,,,PMID:35964746,https://www.ncbi.nlm.nih.gov/pubmed/35964746,35964746,,,34748668,"Zhang J, Cheng H, Di Narzo A, Zhu Y, Shan M, Zhang Z, Shao X, Chen J, Wang C, Hao K. Within- and cross-tissue gene regulations were disrupted by PM2.5 nitrate exposure and associated with respiratory functions. Sci Total Environ. 2022 Dec 01;850():157977. doi: 10.1016/j.scitotenv.2022.157977. PMID: 35964746."
1045486,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Particulate matter results in increased cleavage of PARP1 protein,,,PMID:27187980,https://www.ncbi.nlm.nih.gov/pubmed/27187980,27187980,,PMC5047762,27667466,"Cheng H, Saffari A, Sioutas C, Forman HJ, Morgan TE, Finch CE. Nanoscale Particulate Matter from Urban Traffic Rapidly Induces Oxidative Stress and Inflammation in Olfactory Epithelium with Concomitant Effects on Brain. Environ Health Perspect. 2016 Oct;124(10):1537–46. PMID: 27187980; PMCID: PMC5047762."
1045487,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Particulate matter results in increased expression of PARP1 mRNA,,,PMID:37483094,https://www.ncbi.nlm.nih.gov/pubmed/37483094,37483094,,,35723201,"Jin Y, Li Y, He S, Ge Y, Zhao Y, Zhu K, He A, Li S, Yan S, Cao C. <scp>ATM</scp> participates in fine particulate matter-induced airway inflammation through regulating <scp>DNA</scp> damage and <scp>DNA</scp> damage response. Environmental Toxicology. 2023 Jul 23;38(11):2668–78. doi: 10.1002/tox.23901."
1045488,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Particulate matter results in increased expression of PARP1 mRNA,,,PMID:24216475,https://www.ncbi.nlm.nih.gov/pubmed/24216475,24216475,,,14760283,"Srivastava A, Sharma A, Yadav S, Flora SJS, Dwivedi UN, Parmar D. Gene expression profiling of candidate genes in peripheral blood mononuclear cells for predicting toxicity of diesel exhaust particles. Free Radical Biology and Medicine. 2014 Feb;67():188–94. doi: 10.1016/j.freeradbiomed.2013.10.820."
1880746,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Particulate matter results in decreased expression of PARP1 protein,,,PMID:37278136,https://www.ncbi.nlm.nih.gov/pubmed/37278136,37278136,,,35972015,"Nan B, Sun X, Yang S, Huang Q, Shen H. Integrative proteomics and metabolomics analysis of non-observable acute effect level PM<sub>2.5</sub> induced accumulative effects in AC16 cells. J of Applied Toxicology. 2023 Jun 05;43(11):1613–29. doi: 10.1002/jat.4500."
1966242,9572720,Comparative Toxicogenomics Database (CTD),"Ethyl 4-(2-(2,4-dinitrophenoxy)-1-oxidodiazenyl)-1-piperazinecarboxylate",C474958,"O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate",https://ctdbase.org/detail.go?type=chem&acc=C474958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate analog results in increased cleavage of PARP1 protein|atf3 mutant form inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in increased cleavage of PARP1 protein]",,,PMID:22003962,https://www.ncbi.nlm.nih.gov/pubmed/22003962,22003962,,PMC3422893,19482442,"Maciag AE, Nandurdikar RS, Hong SY, Chakrapani H, Diwan B, Morris NL, Shami PJ, Shiao Y, Anderson LM, Keefer LK, Saavedra JE. Activation of the c-Jun N-terminal Kinase/Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs. J. Med. Chem. 2011 Oct 28;54(22):7751–8. doi: 10.1021/jm2004128."
1966243,9572720,Comparative Toxicogenomics Database (CTD),"Ethyl 4-(2-(2,4-dinitrophenoxy)-1-oxidodiazenyl)-1-piperazinecarboxylate",C474958,"O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate",https://ctdbase.org/detail.go?type=chem&acc=C474958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate affects the cleavage of PARP1 protein|buthionine sulfoximine promotes the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate affects the cleavage of PARP1 protein]",,,PMID:20962031,https://www.ncbi.nlm.nih.gov/pubmed/20962031,20962031,,PMC3033717,14712832,"Maciag AE, Chakrapani H, Saavedra JE, Morris NL, Holland RJ, Kosak KM, Shami PJ, Anderson LM, Keefer LK. The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species. The Journal of Pharmacology and Experimental Therapeutics. 2011 Feb;336(2):313–20. doi: 10.1124/jpet.110.174904."
1966244,9572720,Comparative Toxicogenomics Database (CTD),"Ethyl 4-(2-(2,4-dinitrophenoxy)-1-oxidodiazenyl)-1-piperazinecarboxylate",C474958,"O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate",https://ctdbase.org/detail.go?type=chem&acc=C474958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in increased cleavage of PARP1 protein",,,PMID:20962031|PMID:22003962,https://www.ncbi.nlm.nih.gov/pubmed/20962031|https://www.ncbi.nlm.nih.gov/pubmed/22003962,20962031|22003962,,PMC3033717|PMC3422893,14712832|19482442,"Maciag AE, Nandurdikar RS, Hong SY, Chakrapani H, Diwan B, Morris NL, Shami PJ, Shiao Y, Anderson LM, Keefer LK, Saavedra JE. Activation of the c-Jun N-terminal Kinase/Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs. J. Med. Chem. 2011 Oct 28;54(22):7751–8. doi: 10.1021/jm2004128.|Maciag AE, Chakrapani H, Saavedra JE, Morris NL, Holland RJ, Kosak KM, Shami PJ, Anderson LM, Keefer LK. The Nitric Oxide Prodrug JS-K Is Effective against Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species. The Journal of Pharmacology and Experimental Therapeutics. 2011 Feb;336(2):313–20. doi: 10.1124/jpet.110.174904."
1891512,9794411,BindingDB,,27700,"3,5-dimethyl-4,5,7-triazatricyclo[7.4.0.0^{2,6}]trideca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27700,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),2.2,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
1789062,9795674,BindingDB,"2-(piperidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27099,"2-(piperidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27099,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),11,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
1790052,9796068,Drug Gene Interaction database (DGIdb),Iniparib,,INIPARIB,https://www.dgidb.org/drugs/ncit:C62526,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
1885865,9796068,Drug Gene Interaction database (DGIdb),Iniparib,,INIPARIB,https://www.dgidb.org/drugs/ncit:C62526,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
1892052,9796068,Drug Gene Interaction database (DGIdb),Iniparib,,INIPARIB,https://www.dgidb.org/drugs/ncit:C62526,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Other/unknown,,,,,,,,,
1892053,9796068,DrugBank,Iniparib,DB13877,Iniparib,https://www.drugbank.ca/drugs/DB13877,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2128074,9796068,Drug Gene Interaction database (DGIdb),Iniparib,,INIPARIB,https://www.dgidb.org/drugs/ncit:C62526,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2096781,9797108,Therapeutic Target Database (TTD),"2-[4-[(Dimethylamino)methyl]phenyl]-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7-tetraen-9-one",D05XMG,AG-014376,https://idrblab.net/ttd/data/drug/details/D05XMG,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2007720,9803963,Comparative Toxicogenomics Database (CTD),Cardarine,C425931,GW 501516,https://ctdbase.org/detail.go?type=chem&acc=C425931,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),GW 501516 promotes the reaction [indomethacin results in increased cleavage of PARP1 protein],,,PMID:21400612,https://www.ncbi.nlm.nih.gov/pubmed/21400612,21400612,,PMC3482838,28894176,"Foreman JE, Chang WL, Palkar PS, Zhu B, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM. Functional characterization of peroxisome proliferator-activated receptor-ß/d expression in colon cancer. Molecular Carcinogenesis. 2011 Mar 11;50(11):884–900. doi: 10.1002/mc.20757."
2146212,9804302,Comparative Toxicogenomics Database (CTD),"(9Beta,13alpha,14beta,17alpha)-2-methoxyestra-1,3,5(10)-triene-3,17-diyl disulfamate",C500344,"2-methoxyestradiol-3,17-bis-O,O-sulfamate",https://ctdbase.org/detail.go?type=chem&acc=C500344,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-methoxyestradiol-3,17-bis-O,O-sulfamate results in increased cleavage of PARP1 protein",,,PMID:15258464,https://www.ncbi.nlm.nih.gov/pubmed/15258464,15258464,,,21364699,2004; 9(3):323-332
1897281,9813758,Comparative Toxicogenomics Database (CTD),BMS-345541 free base,C471109,"4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C471109,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]",,,PMID:23143138,https://www.ncbi.nlm.nih.gov/pubmed/23143138,23143138,,PMC3552097,1805296,2012; 18(2):188-200
1897704,9813758,Comparative Toxicogenomics Database (CTD),BMS-345541 free base,C471109,"4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C471109,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in increased cleavage of PARP1 protein",,,PMID:23219847,https://www.ncbi.nlm.nih.gov/pubmed/23219847,23219847,,PMC3593966,4515470,"Ivanov VN, Hei TK. Induction of apoptotic death and retardation of neuronal differentiation of human neural stem cells by sodium arsenite treatment. Experimental Cell Research. 2013 Apr;319(6):875–87. doi: 10.1016/j.yexcr.2012.11.019."
2075167,9814817,Comparative Toxicogenomics Database (CTD),Pachastrissamine,C468594,pachastrissamine,https://ctdbase.org/detail.go?type=chem&acc=C468594,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BECN1 protein affects the reaction [pachastrissamine analog results in increased cleavage of PARP1 protein]|pachastrissamine analog results in increased cleavage of PARP1 protein|pyrazolanthrone promotes the reaction [pachastrissamine analog results in increased cleavage of PARP1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [pachastrissamine analog results in increased cleavage of PARP1 protein],,,PMID:35123989,https://www.ncbi.nlm.nih.gov/pubmed/35123989,35123989,,,30530582,"Xu F, Xie Q, Li YW, Jing QQ, Liu XJ, Xu YC, Wang X, Liu L, Kim G, Choi Y, Guo Y, Zhang E, Jin CY. Suppression of JNK/ERK dependent autophagy enhances Jaspine B derivative-induced gastric cancer cell death via attenuation of p62/Keap1/Nrf2 pathways. Toxicol Appl Pharmacol. 2022 Mar 01;438():115908. doi: 10.1016/j.taap.2022.115908. PMID: 35123989."
1853061,9817104,Drug Gene Interaction database (DGIdb),"3-Pyridinecarboximidamide, N-(2-hydroxy-3-(1-piperidinyl)propoxy)-",,BGP-15,https://www.dgidb.org/drugs/chembl:CHEMBL4747845,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
1793421,9817572,BindingDB,"2-(1-methylpiperidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27116,"2-(1-methylpiperidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27116,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),30,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2147548,9818919,Comparative Toxicogenomics Database (CTD),NO-aspirin,C498045,NCX 4040,https://ctdbase.org/detail.go?type=chem&acc=C498045,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NCX 4040 results in increased cleavage of PARP1 protein,,,PMID:16282376,https://www.ncbi.nlm.nih.gov/pubmed/16282376,16282376,,PMC1287992,20028219,"Gao J, Liu X, Rigas B. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17207–12. PMID: 16282376; PMCID: PMC1287992."
2156765,9818919,Comparative Toxicogenomics Database (CTD),NO-aspirin,C488176,N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester,https://ctdbase.org/detail.go?type=chem&acc=C488176,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester results in increased cleavage of PARP1 protein,,,PMID:21097689,https://www.ncbi.nlm.nih.gov/pubmed/21097689,21097689,,,26906616,"Razavi R, Gehrke I, Gandhirajan RK, Poll-Wolbeck SJ, Hallek M, Kreuzer KA. Nitric oxide-donating acetylsalicylic acid induces apoptosis in chronic lymphocytic leukemia cells and shows strong antitumor efficacy in vivo. Clin Cancer Res. 2011 Jan 15;17(2):286–93. doi: 10.1158/1078-0432.ccr-10-1030. PMID: 21097689."
2078241,9823233,Comparative Toxicogenomics Database (CTD),Ethylbisiminomethylguaiacol manganese chloride,C433928,EUK-134,https://ctdbase.org/detail.go?type=chem&acc=C433928,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),EUK-134 inhibits the reaction [evodiamine results in increased cleavage of PARP1 protein],,,PMID:34808100,https://www.ncbi.nlm.nih.gov/pubmed/34808100,34808100,,,32517841,"Liu L, Sun X, Guo Y, Ge K. Evodiamine induces ROS-Dependent cytotoxicity in human gastric cancer cells via TRPV1/Ca2+ pathway. Chem Biol Interact. 2022 Jan 05;351():109756. doi: 10.1016/j.cbi.2021.109756. PMID: 34808100."
1944823,9826528,Comparative Toxicogenomics Database (CTD),Mirdametinib,C506614,mirdametinib,https://ctdbase.org/detail.go?type=chem&acc=C506614,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[mirdametinib co-treated with NVP-BKM120] results in increased cleavage of PARP1 protein|kras protein affects the susceptibility to [[mirdametinib co-treated with NVP-BKM120] results in increased cleavage of PARP1 protein],,,PMID:24576621,https://www.ncbi.nlm.nih.gov/pubmed/24576621,24576621,,PMC4118771,26290510,"Roper J, Sinnamon MJ, Coffee EM, Belmont P, Keung L, Georgeon-Richard L, Wang WV, Faber AC, Yun J, Yilmaz ÖH, Bronson RT, Martin ES, Tsichlis PN, Hung KE. Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer. Cancer Letters. 2014 Jun;347(2):204–11. doi: 10.1016/j.canlet.2014.02.018."
1944824,9826528,Comparative Toxicogenomics Database (CTD),Mirdametinib,C506614,mirdametinib,https://ctdbase.org/detail.go?type=chem&acc=C506614,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Romidepsin promotes the reaction [mirdametinib results in increased cleavage of PARP1 protein]|romidepsin promotes the reaction [[mirdametinib co-treated with MK 2206] results in increased cleavage of PARP1 protein]|[mirdametinib co-treated with MK 2206] results in increased cleavage of PARP1 protein,,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,PMC5340114,1203163,"Bahr JC, Robey RW, Luchenko V, Basseville A, Chakraborty AR, Kozlowski H, Pauly GT, Patel P, Schneider JP, Gottesman MM, Bates SE. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016 Oct 25;7(43):69804–15. PMID: 27634878; PMCID: PMC5340114."
1944825,9826528,Comparative Toxicogenomics Database (CTD),Mirdametinib,C506614,mirdametinib,https://ctdbase.org/detail.go?type=chem&acc=C506614,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mirdametinib promotes the reaction [luteolin results in increased cleavage of PARP1 protein],,,PMID:32268164,https://www.ncbi.nlm.nih.gov/pubmed/32268164,32268164,,,28434914,"Potocnjak I, Šimic L, Gobin I, Vukelic I, Domitrovic R. Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway. Toxicol In Vitro. 2020 Aug;66():104852. doi: 10.1016/j.tiv.2020.104852. PMID: 32268164."
1944826,9826528,Comparative Toxicogenomics Database (CTD),Mirdametinib,C506614,mirdametinib,https://ctdbase.org/detail.go?type=chem&acc=C506614,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mirdametinib results in increased cleavage of PARP1 protein,,,PMID:27634878|PMID:32268164,https://www.ncbi.nlm.nih.gov/pubmed/27634878|https://www.ncbi.nlm.nih.gov/pubmed/32268164,27634878|32268164,,PMC5340114,1203163|28434914,"Potocnjak I, Šimic L, Gobin I, Vukelic I, Domitrovic R. Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway. Toxicol In Vitro. 2020 Aug;66():104852. doi: 10.1016/j.tiv.2020.104852. PMID: 32268164.|Bahr JC, Robey RW, Luchenko V, Basseville A, Chakraborty AR, Kozlowski H, Pauly GT, Patel P, Schneider JP, Gottesman MM, Bates SE. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016 Oct 25;7(43):69804–15. PMID: 27634878; PMCID: PMC5340114."
2133345,9840076,Therapeutic Target Database (TTD),AG-14361,D09NTC,CC-486,https://idrblab.net/ttd/data/drug/details/D09NTC,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2136192,9840076,Comparative Toxicogenomics Database (CTD),AG-14361,C479234,"1-(4-dimethylaminomethylphenyl)-8,9-dihydro-7H-2,7,9a-benzo(cd)azulen-6-one",https://ctdbase.org/detail.go?type=chem&acc=C479234,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"1-(4-dimethylaminomethylphenyl)-8,9-dihydro-7H-2,7,9a-benzo(cd)azulen-6-one inhibits the reaction [resveratrol promotes the reaction [PARP1 protein binds to YARS1 protein]]",,,PMID:25533949,https://www.ncbi.nlm.nih.gov/pubmed/25533949,25533949,,PMC4368482,482646,"Sajish M, Schimmel P: A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature. 2015 Mar 19;519(7543):370-3. doi: 10.1038/nature14028. Epub 2014 Dec 22."
2137004,9840076,Comparative Toxicogenomics Database (CTD),AG-14361,C479234,"1-(4-dimethylaminomethylphenyl)-8,9-dihydro-7H-2,7,9a-benzo(cd)azulen-6-one",https://ctdbase.org/detail.go?type=chem&acc=C479234,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"1-(4-dimethylaminomethylphenyl)-8,9-dihydro-7H-2,7,9a-benzo(cd)azulen-6-one results in decreased activity of PARP1 protein",,,PMID:31022188,https://www.ncbi.nlm.nih.gov/pubmed/31022188,31022188,,PMC6483187,13537138,"Callizot N, Combes M, Henriques A, Poindron P. Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins. PLoS ONE. 2019 Apr 25;14(4):e0215277. doi: 10.1371/journal.pone.0215277."
2137007,9840076,IUPHAR/BPS Guide to PHARMACOLOGY,AG-14361,8094,AG14361,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8094,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pKi,8.24,PMID:12519059,https://www.ncbi.nlm.nih.gov/pubmed/12519059,12519059,,,2979518,"Skalitzky DJ, Marakovits JT, Maegley KA, Ekker A, Yu XH, Hostomsky Z, Webber SE, Eastman BW, Almassy R, Li J, Curtin NJ, Newell DR, Calvert AH, Griffin RJ, Golding BT. Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J Med Chem. 2003 Jan 16;46(2):210–3. doi: 10.1021/jm0255769. PMID: 12519059."
1905672,9843777,BindingDB,,27708,"8-chloro-2-{3-[4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridin-1-yl]propyl}-3,4-dihydroquinazolin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27708,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),13,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2083226,9848818,Comparative Toxicogenomics Database (CTD),Tauroursodeoxycholic acid,C031655,ursodoxicoltaurine,https://ctdbase.org/detail.go?type=chem&acc=C031655,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[chenodeoxycholic acid co-treated with ursodoxicoltaurine] results in increased cleavage of PARP1 protein,,,PMID:14976352,https://www.ncbi.nlm.nih.gov/pubmed/14976352,14976352,,,28797959,2004; 79(1):196-204
1908508,9852086,Comparative Toxicogenomics Database (CTD),Ginsenoside K,C482402,20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol,https://ctdbase.org/detail.go?type=chem&acc=C482402,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol results in increased cleavage of PARP1 protein,,,PMID:12963989,https://www.ncbi.nlm.nih.gov/pubmed/12963989,12963989,,,18594163,"Choi HH, Jong HS, Park JH, Choi S, Lee JW, Kim TY, Otsuki T, Namba M, Bang YJ. A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells. Int J Oncol. 2003 Oct;23(4):1087–93. PMID: 12963989."
2138405,9852185,Comparative Toxicogenomics Database (CTD),Gambogic Acid,C052659,gambogic acid,https://ctdbase.org/detail.go?type=chem&acc=C052659,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to doxorubicin]] which affects the cleavage of PARP1 protein]|[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to doxorubicin]] which affects the cleavage of PARP1 protein,,,PMID:25824409,https://www.ncbi.nlm.nih.gov/pubmed/25824409,25824409,,,14794274,"Wang S, Wang L, Chen M, Wang Y. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression. Chem Biol Interact. 2015 Jun 25;235():76–84. doi: 10.1016/j.cbi.2015.03.017. PMID: 25824409."
2138406,9852185,Comparative Toxicogenomics Database (CTD),Gambogic Acid,C052659,gambogic acid,https://ctdbase.org/detail.go?type=chem&acc=C052659,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein]|[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein],,,PMID:24373880,https://www.ncbi.nlm.nih.gov/pubmed/24373880,24373880,,,20173790,"Liu N, Huang H, Liu S, Li X, Yang C, Dou QP, Liu J. Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation. Toxicol In Vitro. 2014 Apr;28(3):419–25. doi: 10.1016/j.tiv.2013.12.008. PMID: 24373880."
2138417,9852185,Comparative Toxicogenomics Database (CTD),Gambogic Acid,C052659,gambogic acid,https://ctdbase.org/detail.go?type=chem&acc=C052659,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [bortezomib promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]]|bortezomib promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [gambogic acid promotes the reaction [bortezomib results in increased cleavage of PARP1 protein]]|gambogic acid promotes the reaction [bortezomib results in increased cleavage of PARP1 protein],,,PMID:24291039,https://www.ncbi.nlm.nih.gov/pubmed/24291039,24291039,,,11379274,"Liu N, Huang H, Xu L, Hua X, Li X, Liu S, Yang C, Zhao C, Zhao C, Li S, Dou QP, Liu J. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. Toxicol Lett. 2014 Jan 30;224(3):333–40. doi: 10.1016/j.toxlet.2013.11.021. PMID: 24291039."
2138418,9852185,Comparative Toxicogenomics Database (CTD),Gambogic Acid,C052659,gambogic acid,https://ctdbase.org/detail.go?type=chem&acc=C052659,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Fluorouracil promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]|gambogic acid results in decreased expression of PARP1 mrna|fluorouracil promotes the reaction [gambogic acid results in decreased expression of PARP1 mrna],,,PMID:19084572,https://www.ncbi.nlm.nih.gov/pubmed/19084572,19084572,,,7945427,"Wang J, Liu W, Zhao Q, Qi Q, Lu N, Yang Y, Nei FF, Rong JJ, You QD, Guo QL. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. Toxicology. 2009 Feb 04;256(1-2):135–40. doi: 10.1016/j.tox.2008.11.014. PMID: 19084572."
2138419,9852185,Comparative Toxicogenomics Database (CTD),Gambogic Acid,C052659,gambogic acid,https://ctdbase.org/detail.go?type=chem&acc=C052659,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Gambogic acid results in increased cleavage of PARP1 protein,,,PMID:19084572|PMID:19464570|PMID:24291039,https://www.ncbi.nlm.nih.gov/pubmed/19084572|https://www.ncbi.nlm.nih.gov/pubmed/19464570|https://www.ncbi.nlm.nih.gov/pubmed/24291039,19084572|19464570|24291039,,,7945427|11379274|26870756,"Liu N, Huang H, Xu L, Hua X, Li X, Liu S, Yang C, Zhao C, Zhao C, Li S, Dou QP, Liu J. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. Toxicol Lett. 2014 Jan 30;224(3):333–40. doi: 10.1016/j.toxlet.2013.11.021. PMID: 24291039.|Nie F, Zhang X, Qi Q, Yang L, Yang Y, Liu W, Lu N, Wu Z, You Q, Guo Q. Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells. Toxicology. 2009 Jun 16;260(1-3):60–7. doi: 10.1016/j.tox.2009.03.010. PMID: 19464570.|Wang J, Liu W, Zhao Q, Qi Q, Lu N, Yang Y, Nei FF, Rong JJ, You QD, Guo QL. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. Toxicology. 2009 Feb 04;256(1-2):135–40. doi: 10.1016/j.tox.2008.11.014. PMID: 19084572."
2084256,9852585,Comparative Toxicogenomics Database (CTD),Monoxerutin,C522803,7-monohydroxyethylrutoside,https://ctdbase.org/detail.go?type=chem&acc=C522803,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),7-monohydroxyethylrutoside inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:17285121,https://www.ncbi.nlm.nih.gov/pubmed/17285121,17285121,,PMC2360019,8899283,"Bruynzeel AME, Abou El Hassan MA, Torun E, Bast A, van der Vijgh WJF, Kruyt FAE. Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells. British Journal of Cancer. 2007 Feb 06;96(3):450–6. doi: 10.1038/sj.bjc.6603598."
2107545,9854230,Comparative Toxicogenomics Database (CTD),"(3beta,16beta)-16-[[2-O-Acetyl-3-O-[2-O-(4-methoxybenzoyl)-beta-D-xylopyranosyl]-alpha-L-arabinopyranosyl]oxy]-3,17-dihydroxycholest-5-en-22-one",C106408,OSW 1,https://ctdbase.org/detail.go?type=chem&acc=C106408,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),OSW 1 analog results in increased cleavage of PARP1 protein|osw 1 analog results in increased expression of PARP1 protein,,,PMID:21438635,https://www.ncbi.nlm.nih.gov/pubmed/21438635,21438635,,,30933347,"Maj J, Morzycki JW, Rárová L, Oklest'ková J, Strnad M, Wojtkielewicz A. Synthesis and biological activity of 22-deoxo-23-oxa analogues of saponin OSW-1. J Med Chem. 2011 May 12;54(9):3298–305. doi: 10.1021/jm101648h. PMID: 21438635."
1950134,9855813,Comparative Toxicogenomics Database (CTD),CID 9855813,D014800,Vitallium,https://ctdbase.org/detail.go?type=chem&acc=D014800,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vitallium analog results in decreased expression of PARP1 mRNA,,,PMID:23825117,https://www.ncbi.nlm.nih.gov/pubmed/23825117,23825117,,PMC3730696,20835693,"Tsaryk R, Peters K, Unger RE, Feldmann M, Hoffmann B, Heidenau F, Kirkpatrick CJ. Improving cytocompatibility of Co28Cr6Mo by TiO <sub>2</sub> coating: gene expression study in human endothelial cells. J. R. Soc. Interface. 2013 Sep 06;10(86):20130428. doi: 10.1098/rsif.2013.0428."
2015554,9859662,Comparative Toxicogenomics Database (CTD),"N-Formyl-3,4-methylenedioxy-benzylidine-gamma-butyrolactam",C410027,KNK 437,https://ctdbase.org/detail.go?type=chem&acc=C410027,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),KNK 437 promotes the reaction [arsenic trioxide results in increased cleavage of PARP1 protein],,,PMID:19371599,https://www.ncbi.nlm.nih.gov/pubmed/19371599,19371599,,,30235584,"Wu YC, Yen WY, Lee TC, Yih LH. Heat shock protein inhibitors, 17-DMAG and KNK437, enhance arsenic trioxide-induced mitotic apoptosis. Toxicol Appl Pharmacol. 2009 Apr 15;236(2):231–8. doi: 10.1016/j.taap.2009.02.003. PMID: 19371599."
2016186,9860529,Comparative Toxicogenomics Database (CTD),2-(Morpholin-4-yl)-benzo[h]chromen-4-one,C479235,2-(morpholin-4-yl)benzo(h)chromen-4-one,https://ctdbase.org/detail.go?type=chem&acc=C479235,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),PARP1 protein affects the reaction [2-(morpholin-4-yl)benzo(h)chromen-4-one results in decreased activity of PRKDC protein]|parp1 protein affects the susceptibility to 2-(morpholin-4-yl)benzo(h)chromen-4-one,,,PMID:16556909,https://www.ncbi.nlm.nih.gov/pubmed/16556909,16556909,,PMC1410911,13294148,"Bryant HE, Helleday T. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Nucleic Acids Res. 2006;34(6):1685–91. PMID: 16556909; PMCID: PMC1410911."
1861108,9869652,Comparative Toxicogenomics Database (CTD),"(4Z)-7-[(1S,2S,5R)-5-[([1,1'-biphenyl]-4-yl)methoxy]-2-(morpholin-4-yl)-3-oxocyclopentyl]hept-4-enoic acid",C046926,AH 23848,https://ctdbase.org/detail.go?type=chem&acc=C046926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:19407222,https://www.ncbi.nlm.nih.gov/pubmed/19407222,19407222,,PMC5419188,11301983,"Banu SK, Lee J, Speights VO, Starzinski-Powitz A, Arosh JA. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms. Mol Endocrinol. 2009 Aug;23(8):1291–305. PMID: 19407222; PMCID: PMC5419188."
1952334,9871074,Comparative Toxicogenomics Database (CTD),Talmapimod,C499748,SCIO-469,https://ctdbase.org/detail.go?type=chem&acc=C499748,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SCIO-469 promotes the reaction [bortezomib results in increased cleavage of PARP1 protein],,,PMID:16617327,https://www.ncbi.nlm.nih.gov/pubmed/16617327,16617327,,,30854795,"Navas TA, Nguyen AN, Hideshima T, Reddy M, Ma JY, Haghnazari E, Henson M, Stebbins EG, Kerr I, O'Young G, Kapoun AM, Chakravarty S, Mavunkel B, Perumattam J, Luedtke G, Dugar S, Medicherla S, Protter AA, Schreiner GF, Anderson KC, Higgins LS. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. Leukemia. 2006 Jun;20(6):1017–27. doi: 10.1038/sj.leu.2404200. PMID: 16617327."
1893834,9871899,Therapeutic Target Database (TTD),EB-47,D04AYN,EB-47,https://idrblab.net/ttd/data/drug/details/D04AYN,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2136384,9874191,Comparative Toxicogenomics Database (CTD),K 7174,C410337,K 7174,https://ctdbase.org/detail.go?type=chem&acc=C410337,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),K 7174 results in decreased expression of PARP1 mRNA,,,PMID:24086573,https://www.ncbi.nlm.nih.gov/pubmed/24086573,24086573,,PMC3785497,2479543,"Fujiwara T, Ikeda T, Nagasaka Y, Okitsu Y, Katsuoka Y, Fukuhara N, Onishi Y, Ishizawa K, Ichinohasama R, Tomosugi N, Harigae H. A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy against Anemia of Chronic Disease. PLoS ONE. 2013 Sep 27;8(9):e75568. doi: 10.1371/journal.pone.0075568."
2140640,9874591,Comparative Toxicogenomics Database (CTD),Berubicin Hydrochloride,C451735,WP 744,https://ctdbase.org/detail.go?type=chem&acc=C451735,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),WP 744 results in increased cleavage of PARP1 protein,,,PMID:15555623,https://www.ncbi.nlm.nih.gov/pubmed/15555623,15555623,,,24078123,"Wu J, Harris NL, Inge TH. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells. Journal of Surgical Research. 2004 Dec;122(2):231–9. doi: 10.1016/j.jss.2004.05.017."
1953236,9877482,Comparative Toxicogenomics Database (CTD),Norcantharidin,C069741,norcantharidin,https://ctdbase.org/detail.go?type=chem&acc=C069741,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Norcantharidin results in increased expression of PARP1 protein modified form|[norcantharidin co-treated with paclitaxel] results in increased cleavage of PARP1 protein|paclitaxel promotes the reaction [norcantharidin results in increased expression of PARP1 protein modified form]|sirt7 protein inhibits the reaction [[norcantharidin co-treated with paclitaxel] results in increased cleavage of PARP1 protein],,,PMID:34272796,https://www.ncbi.nlm.nih.gov/pubmed/34272796,34272796,,,4709364,"Wu M, Hui S, Chen Y, Chiou H, Lin C, Lee C, Hsieh Y. Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting <scp>SIRT7</scp> expression. Environmental Toxicology. 2021 Jul 16;36(11):2206–16. doi: 10.1002/tox.23334."
1919345,9881187,BindingDB,"1,11b-Dihydro-[2h]benzopyrano[4,3,2-de]isoquinolin-3-one",27499,"1,11b-dihydro-[2H]benzopyrano[4,3,2-de]isoquinolin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27499,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),83,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
1082557,9881652,Comparative Toxicogenomics Database (CTD),Dehydroxymethylepoxyquinomicin,C464444,dehydroxymethylepoxyquinomicin,https://ctdbase.org/detail.go?type=chem&acc=C464444,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [dehydroxymethylepoxyquinomicin results in increased cleavage of PARP1 protein]|dehydroxymethylepoxyquinomicin results in increased cleavage of PARP1 protein,,,PMID:15501958,https://www.ncbi.nlm.nih.gov/pubmed/15501958,15501958,,,5774978,"Starenki DV, Namba H, Saenko VA, Ohtsuru A, Maeda S, Umezawa K, Yamashita S. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin. Clin Cancer Res. 2004 Oct 15;10(20):6821–9. doi: 10.1158/1078-0432.ccr-04-0463. PMID: 15501958."
2154558,9885748,Comparative Toxicogenomics Database (CTD),EF-24,C524042,"3,5-bis(2-fluorobenzylidene)piperidin-4-one",https://ctdbase.org/detail.go?type=chem&acc=C524042,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,5-bis(2-fluorobenzylidene)piperidin-4-one results in increased cleavage of PARP1 protein|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [3,5-bis(2-fluorobenzylidene)piperidin-4-one results in increased cleavage of PARP1 protein]|pten protein affects the reaction [3,5-bis(2-fluorobenzylidene)piperidin-4-one results in increased cleavage of PARP1 protein]",,,PMID:17684018,https://www.ncbi.nlm.nih.gov/pubmed/17684018,17684018,,PMC4610350,22742225,"Selvendiran K, Tong L, Vishwanath S, Bratasz A, Trigg NJ, Kutala VK, Hideg K, Kuppusamy P. EF24 Induces G2/M Arrest and Apoptosis in Cisplatin-resistant Human Ovarian Cancer Cells by Increasing PTEN Expression. Journal of Biological Chemistry. 2007 Sep;282(39):28609–18. doi: 10.1074/jbc.m703796200."
1919955,9886153,BindingDB,,27710,"5-Chloro-2-[3-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)-propyl]-3H-quinazolin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27710,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),68,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2093311,9887054,Comparative Toxicogenomics Database (CTD),Oxaliplatin,D000077150,Oxaliplatin,https://ctdbase.org/detail.go?type=chem&acc=D000077150,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of PARP1 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,PMC4325931,25644816,"Davis M, Li J, Knight E, Eldridge SR, Daniels KK, Bushel PR. Toxicogenomics profiling of bone marrow from rats treated with topotecan in combination with oxaliplatin: a mechanistic strategy to inform combination toxicity. Front. Genet. 2015 Feb 12;6(). doi: 10.3389/fgene.2015.00014."
2093375,9887054,Comparative Toxicogenomics Database (CTD),Oxaliplatin,D000077150,Oxaliplatin,https://ctdbase.org/detail.go?type=chem&acc=D000077150,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oxaliplatin results in increased cleavage of PARP1 protein|gefitinib affects the reaction [oxaliplatin results in increased cleavage of PARP1 protein],,,PMID:16243822,https://www.ncbi.nlm.nih.gov/pubmed/16243822,16243822,,,26792226,"Van Schaeybroeck S, Karaiskou-McCaul A, Kelly D, Longley D, Galligan L, Van Cutsem E, Johnston P. Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy. Clin Cancer Res. 2005 Oct 15;11(20):7480–9. doi: 10.1158/1078-0432.ccr-05-0328. PMID: 16243822."
2093376,9887054,Comparative Toxicogenomics Database (CTD),Oxaliplatin,D000077150,Oxaliplatin,https://ctdbase.org/detail.go?type=chem&acc=D000077150,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[oxaliplatin co-treated with ursodeoxycholic acid] results in increased cleavage of PARP1 protein,,,PMID:19728331,https://www.ncbi.nlm.nih.gov/pubmed/19728331,19728331,,,32912075,"Lim SC, Choi JE, Kang HS, Han SI, Si H. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. Int J Cancer. 2010 Apr 01;126(7):1582–95. doi: 10.1002/ijc.24853. PMID: 19728331."
2093377,9887054,Comparative Toxicogenomics Database (CTD),Oxaliplatin,D000077150,Oxaliplatin,https://ctdbase.org/detail.go?type=chem&acc=D000077150,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[S100A11 mutant form results in increased susceptibility to oxaliplatin] which results in increased cleavage of PARP1 protein,,,PMID:25940438,https://www.ncbi.nlm.nih.gov/pubmed/25940438,25940438,,PMC4494929,26969758,"Zagryazhskaya A, Surova O, Akbar NS, Allavena G, Gyuraszova K, Zborovskaya IB, Tchevkina EM, Zhivotovsky B. Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11. Oncotarget. 2015 May 20;6(14):12156–73. PMID: 25940438; PMCID: PMC4494929."
1930529,9889396,BindingDB,INO-1001 free base,27525,"N-[3-(morpholin-4-yl)propyl]-8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27525,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),1,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2141637,9892144,Comparative Toxicogenomics Database (CTD),Lamellarin D,C455554,lamellarin D,https://ctdbase.org/detail.go?type=chem&acc=C455554,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lamellarin D results in increased cleavage of PARP1 protein,,,PMID:34560126,https://www.ncbi.nlm.nih.gov/pubmed/34560126,34560126,,,29819082,"Sopha P, Phutubtim N, Chantrathonkul B, Ploypradith P, Ruchirawat S, Chittchang M. Roles of autophagy in relation to mitochondrial stress responses of HeLa cells to lamellarin cytotoxicity. Toxicology. 2021 Oct;462():152963. doi: 10.1016/j.tox.2021.152963. PMID: 34560126."
2057201,9893571,Comparative Toxicogenomics Database (CTD),GW 4064,C412815,GW 4064,https://ctdbase.org/detail.go?type=chem&acc=C412815,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),GW 4064 results in decreased phosphorylation of PARP1 protein,,,PMID:23178280,https://www.ncbi.nlm.nih.gov/pubmed/23178280,23178280,,PMC3774161,14064589,"Zhu Y, Li G, Dong Y, Zhou HH, Kong B, Aleksunes LM, Richardson JR, Li F, Guo GL. Modulation of farnesoid X receptor results in post-translational modification of poly (ADP-ribose) polymerase 1 in the liver. Toxicology and Applied Pharmacology. 2013 Jan;266(2):260–6. doi: 10.1016/j.taap.2012.11.012."
1895933,9899130,Comparative Toxicogenomics Database (CTD),"Thieno(2,3-c)isoquinolin-5(4H)-one",C475227,"thieno(2,3-c)isoquinolin-5-one",https://ctdbase.org/detail.go?type=chem&acc=C475227,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9913,Bos taurus (cattle),"Thieno(2,3-c)isoquinolin-5-one results in decreased activity of PARP1 protein",,,PMID:13679179,https://www.ncbi.nlm.nih.gov/pubmed/13679179,13679179,,,21319916,"Pellicciari R, Camaioni E, Costantino G, Marinozzi M, Macchiarulo A, Moroni F, Natalini B. Towards new neuroprotective agents: design and synthesis of 4H-thieno[2,3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitors. Farmaco. 2003 Sep;58(9):851–8. doi: 10.1016/s0014-827x(03)00143-5. PMID: 13679179."
1895934,9899130,Comparative Toxicogenomics Database (CTD),"Thieno(2,3-c)isoquinolin-5(4H)-one",C475227,"thieno(2,3-c)isoquinolin-5-one",https://ctdbase.org/detail.go?type=chem&acc=C475227,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Thieno(2,3-c)isoquinolin-5-one results in decreased activity of PARP1 protein",,,PMID:17438151,https://www.ncbi.nlm.nih.gov/pubmed/17438151,17438151,,,337498,"Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation. 2007 May 08;115(18):2442–50. doi: 10.1161/circulationaha.106.668756. PMID: 17438151."
1895935,9899130,Comparative Toxicogenomics Database (CTD),"Thieno(2,3-c)isoquinolin-5(4H)-one",C475227,"thieno(2,3-c)isoquinolin-5-one",https://ctdbase.org/detail.go?type=chem&acc=C475227,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Thieno(2,3-c)isoquinolin-5-one results in decreased activity of PARP1 protein",,,PMID:12606624|PMID:17579050|PMID:18261157|PMID:19124646,https://www.ncbi.nlm.nih.gov/pubmed/12606624|https://www.ncbi.nlm.nih.gov/pubmed/17579050|https://www.ncbi.nlm.nih.gov/pubmed/18261157|https://www.ncbi.nlm.nih.gov/pubmed/19124646,12606624|17579050|18261157|19124646,,PMC2670599|PMC2740645,15992016|20637065|24820736|33553516,"Hans CP, Zerfaoui M, Naura AS, Troxclair D, Strong JP, Matrougui K, Boulares AH. Thieno[2,3-c]Isoquinolin-5-one, a Potent Poly(ADP-Ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High-Fat Diet-Fed Apolipoprotein E-Deficient Mice: Effects on Inflammatory Markers and Lipid Content. The Journal of Pharmacology and Experimental Therapeutics. 2009 Apr;329(1):150–8. doi: 10.1124/jpet.108.145938.|Naura AS, Hans CP, Zerfaoui M, You D, Cormier SA, Oumouna M, Boulares AH. Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation. Clin Experimental Allergy. 2008 Feb 04;38(5):839–46. doi: 10.1111/j.1365-2222.2008.02943.x.|Aldinucci A, Gerlini G, Fossati S, Cipriani G, Ballerini C, Biagioli T, Pimpinelli N, Borgognoni L, Massacesi L, Moroni F, Chiarugi A. A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation. J Immunol. 2007 Jul 01;179(1):305–12. doi: 10.4049/jimmunol.179.1.305. PMID: 17579050.|Chiarugi A, Meli E, Calvani M, Picca R, Baronti R, Camaioni E, Costantino G, Marinozzi M, Pellegrini-Giampietro DE, Pellicciari R, Moroni F. Novel Isoquinolinone-Derived Inhibitors of Poly(ADP-ribose) Polymerase-1: Pharmacological Characterization and Neuroprotective Effects in an in Vitro Model of Cerebral Ischemia. The Journal of Pharmacology and Experimental Therapeutics. 2003 Jun;305(3):943–9. doi: 10.1124/jpet.103.048934."
1932596,9900574,Comparative Toxicogenomics Database (CTD),"2-(1-(Hydroxymethyl)-2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione",C494620,CPS 11,https://ctdbase.org/detail.go?type=chem&acc=C494620,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CPS 11 results in increased cleavage of PARP1 protein,,,PMID:15858615,https://www.ncbi.nlm.nih.gov/pubmed/15858615,15858615,,,7874809,"Kumar S, Raje N, Hideshima T, Ishitsuka K, Roccaro A, Shiraishi N, Hamasaki M, Yasui H, Munshi NC, Richardson P, Figg WD, Anderson KC. Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs. Leukemia. 2005 Jul;19(7):1253–61. doi: 10.1038/sj.leu.2403776. PMID: 15858615."
1801967,9903811,BindingDB,"2-(piperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27100,"2-(piperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27100,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),5,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2143686,9904141,Comparative Toxicogenomics Database (CTD),4-(4-Isopropoxyphenylsulfonyl)phenol,C000613560,4-hydroxyphenyl 4-isopropoxyphenylsulfone,https://ctdbase.org/detail.go?type=chem&acc=C000613560,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),4-hydroxyphenyl 4-isopropoxyphenylsulfone results in increased expression of PARP1 mRNA,,,PMID:39298647,https://www.ncbi.nlm.nih.gov/pubmed/39298647,39298647,,PMC11412574,37758763,"Wang Q, Gao S, Chen B, Zhao J, Li W, Wu L. Evaluating the Effects of Perinatal Exposures to BPSIP on Hepatic Cholesterol Metabolism in Female and Male Offspring ICR Mice. Environ Health Perspect. 2024 Sep;132(9):97011. PMID: 39298647; PMCID: PMC11412574."
1932984,9905583,Comparative Toxicogenomics Database (CTD),Cps 49,C494622,CPS 49,https://ctdbase.org/detail.go?type=chem&acc=C494622,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CPS 49 results in increased cleavage of PARP1 protein,,,PMID:15858615,https://www.ncbi.nlm.nih.gov/pubmed/15858615,15858615,,,7874809,"Kumar S, Raje N, Hideshima T, Ishitsuka K, Roccaro A, Shiraishi N, Hamasaki M, Yasui H, Munshi NC, Richardson P, Figg WD, Anderson KC. Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs. Leukemia. 2005 Jul;19(7):1253–61. doi: 10.1038/sj.leu.2403776. PMID: 15858615."
2141732,9913401,Comparative Toxicogenomics Database (CTD),Alpha-tocopheryloxyacetic Acid,C488288,"2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid",https://ctdbase.org/detail.go?type=chem&acc=C488288,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid results in increased cleavage of PARP1 protein|[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of PARP1 protein",,,PMID:18444175,https://www.ncbi.nlm.nih.gov/pubmed/18444175,18444175,,,21404118,"Snyder RM, Yu W, Jia L, Sanders BG, Kline K. Vitamin E Analog a -TEA, Methylseleninic Acid, and<i>Trans</i>-Resveratrol in Combination Synergistically Inhibit Human Breast Cancer Cell Growth. Nutrition and Cancer. 2008 Apr 28;60(3):401–11. doi: 10.1080/01635580701759716."
1806540,9918693,Comparative Toxicogenomics Database (CTD),Ginsenoside Rg3,C097367,ginsenoside Rg3,https://ctdbase.org/detail.go?type=chem&acc=C097367,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ginsenoside rg3 results in increased cleavage of PARP1 protein,,,PMID:22101440,https://www.ncbi.nlm.nih.gov/pubmed/22101440,22101440,,,3813561,2011; 66(3):476-485
1807318,9918693,Comparative Toxicogenomics Database (CTD),Ginsenoside Rg3,C097367,ginsenoside Rg3,https://ctdbase.org/detail.go?type=chem&acc=C097367,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ginsenoside rg3 analog inhibits the reaction [TGFB1 protein results in increased cleavage of PARP1 protein],,,PMID:24793912,https://www.ncbi.nlm.nih.gov/pubmed/24793912,24793912,,,14099228,"Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K, Kim TJ, Ham J, Jang HJ, Kang KS, Ko H. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-ß1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Toxicology. 2014 Aug 01;322():23–33. doi: 10.1016/j.tox.2014.04.002. PMID: 24793912."
1807319,9918693,Comparative Toxicogenomics Database (CTD),Ginsenoside Rg3,C097367,ginsenoside Rg3,https://ctdbase.org/detail.go?type=chem&acc=C097367,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ginsenoside rg3 co-treated with osimertinib] results in increased cleavage of PARP1 protein,,,PMID:31916386,https://www.ncbi.nlm.nih.gov/pubmed/31916386,31916386,,,8160449,"Tan Q, Lin S, Zeng Y, Yao M, Liu K, Yuan H, Liu C, Jiang G. Ginsenoside Rg3 attenuates the osimertinib resistance by reducing the stemness of non-small cell lung cancer cells. Environ Toxicol. 2020 Jun;35(6):643–51. doi: 10.1002/tox.22899. PMID: 31916386."
1807320,9918693,Comparative Toxicogenomics Database (CTD),Ginsenoside Rg3,C097367,ginsenoside Rg3,https://ctdbase.org/detail.go?type=chem&acc=C097367,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Ginsenoside rg3 inhibits the reaction [caga protein, helicobacter pylori results in decreased cleavage of PARP1 protein]",,,PMID:26427350,https://www.ncbi.nlm.nih.gov/pubmed/26427350,26427350,,,4576322,"Aziz F, Wang X, Liu J, Yan Q. Ginsenoside Rg3 induces FUT4-mediated apoptosis in H. pylori CagA-treated gastric cancer cells by regulating SP1 and HSF1 expressions. Toxicol In Vitro. 2016 Mar;31():158–66. doi: 10.1016/j.tiv.2015.09.025. PMID: 26427350."
1938672,9922953,BindingDB,3-[4-(Trifluoromethyl)phenyl]quinoxaline-5-carboxamide,27722,3-[4-(trifluoromethyl)phenyl]quinoxaline-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27722,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),118,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
1808776,9925900,BindingDB,"2-(1-acetylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27126,"2-(1-acetylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27126,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),59,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
1808777,9925908,BindingDB,"1H-Benzimidazole-7-carboxamide, 2-(1-propyl-4-piperidinyl)-",27119,"2-(1-propylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27119,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),8,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2138169,9925908,DrugBank,"1H-Benzimidazole-7-carboxamide, 2-(1-propyl-4-piperidinyl)-",DB07330,A-620223,https://www.drugbank.ca/drugs/DB07330,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/37713619|https://www.ncbi.nlm.nih.gov/pubmed/10592235,37713619|10592235,,PMC102472|PMC10767903,12499145|36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
2142399,9925908,Therapeutic Target Database (TTD),"1H-Benzimidazole-7-carboxamide, 2-(1-propyl-4-piperidinyl)-",D0VY5O,A-620223,https://idrblab.net/ttd/data/drug/details/D0VY5O,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2146645,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[pifithrin co-treated with arsenic trioxide] results in decreased expression of PARP1 protein|[pifithrin co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein,,,PMID:35030298,https://www.ncbi.nlm.nih.gov/pubmed/35030298,35030298,,PMC8886521,7557222,"Wang H, Wang X, Xu L, Zhang J. TP53 inhibitor PFTa increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells. FEBS Open Bio. 2022 Mar;12(3):616–26. PMID: 35030298; PMCID: PMC8886521."
2146646,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [[cysteine proteinase inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein],,,PMID:35022897,https://www.ncbi.nlm.nih.gov/pubmed/35022897,35022897,,,10229733,2022; 39(5):2011-2032
2146647,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [[decitabine co-treated with busulfan] results in increased cleavage of PARP1 protein],,,PMID:19732952,https://www.ncbi.nlm.nih.gov/pubmed/19732952,19732952,,PMC2823987,32916323,"Valdez BC, Li Y, Murray D, Corn P, Champlin RE, Andersson BS. 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis. Leukemia Research. 2010 Mar;34(3):364–72. doi: 10.1016/j.leukres.2009.08.014."
2146648,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein],,,PMID:25939952,https://www.ncbi.nlm.nih.gov/pubmed/25939952,25939952,,,26969299,"Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015 Jul 02;236(1):43–59. doi: 10.1016/j.toxlet.2015.04.015. PMID: 25939952."
2146649,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [goniothalamin results in increased cleavage of PARP1 protein],,,PMID:21810437,https://www.ncbi.nlm.nih.gov/pubmed/21810437,21810437,,,12718275,"Kuo KK, Chen YL, Chen LR, Li CF, Lan YH, Chang FR, Wu YC, Shiue YL. Involvement of phorbol-12-myristate-13-acetate-induced protein 1 in goniothalamin-induced TP53-dependent and -independent apoptosis in hepatocellular carcinoma-derived cells. Toxicol Appl Pharmacol. 2011 Oct 01;256(1):8–23. doi: 10.1016/j.taap.2011.07.002. PMID: 21810437."
2146650,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [silybin results in increased cleavage of PARP1 protein],,,PMID:16777994,https://www.ncbi.nlm.nih.gov/pubmed/16777994,16777994,,,9245942,"Tyagi A, Singh RP, Agarwal C, Agarwal R. Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: evidence for a regulatory loop between p53 and caspase 2. Carcinogenesis. 2006 Nov;27(11):2269–80. doi: 10.1093/carcin/bgl098. PMID: 16777994."
2146651,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin inhibits the reaction [simvastatin results in increased cleavage of PARP1 protein],,,PMID:20045437,https://www.ncbi.nlm.nih.gov/pubmed/20045437,20045437,,,32241704,"Ghavami S, Mutawe MM, Hauff K, Stelmack GL, Schaafsma D, Sharma P, McNeill KD, Hynes TS, Kung SK, Unruh H, Klonisch T, Hatch GM, Los M, Halayko AJ. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2010 Apr;1803(4):452–67. doi: 10.1016/j.bbamcr.2009.12.005."
2146652,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin promotes the reaction [capsaicin results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:22226932,https://www.ncbi.nlm.nih.gov/pubmed/22226932,22226932,,,22176951,"Yoon JH, Ahn SG, Lee BH, Jung SH, Oh SH. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. Biochem Pharmacol. 2012 Mar 15;83(6):747–57. doi: 10.1016/j.bcp.2011.12.029. PMID: 22226932."
2146653,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pifithrin promotes the reaction [mustard gas results in increased cleavage of PARP1 protein],,,PMID:25448276,https://www.ncbi.nlm.nih.gov/pubmed/25448276,25448276,,,20877918,"Jowsey PA, Blain PG. Checkpoint kinase 1 is activated and promotes cell survival after exposure to sulphur mustard. Toxicol Lett. 2015 Jan 22;232(2):413–21. doi: 10.1016/j.toxlet.2014.11.013. PMID: 25448276."
2146654,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[pifithrin results in increased susceptibility to plant preparations] which results in increased cleavage of PARP1 protein,,,PMID:29698619,https://www.ncbi.nlm.nih.gov/pubmed/29698619,29698619,,,4648258,"Yao GD, Sun Q, Song XY, Huang XX, Song SJ. Flavan enantiomers from Daphne giraldii selectively induce apoptotic cell death in p53-null hepatocarcinoma cells in vitro. Chem Biol Interact. 2018 Jun 01;289():1–8. doi: 10.1016/j.cbi.2018.04.014. PMID: 29698619."
2146655,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pifithrin inhibits the reaction [cordycepin results in increased cleavage of PARP1 protein],,,PMID:24704558,https://www.ncbi.nlm.nih.gov/pubmed/24704558,24704558,,,30995102,"Chen Y, Yang SH, Hueng DY, Syu JP, Liao CC, Wu YC. Cordycepin induces apoptosis of C6 glioma cells through the adenosine 2A receptor-p53-caspase-7-PARP pathway. Chem Biol Interact. 2014 Jun 05;216():17–25. doi: 10.1016/j.cbi.2014.03.010. PMID: 24704558."
2146656,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pifithrin inhibits the reaction [cyanoginosin LR results in increased cleavage of PARP1 protein],,,PMID:31157505,https://www.ncbi.nlm.nih.gov/pubmed/31157505,31157505,,,33797221,"Wu J, Liu H, Huang H, Yuan L, Liu C, Wang Y, Cheng X, Zhuang D, Xu M, Chen X, Losiewicz MD, Zhang H. <i>p53</i>-Dependent pathway and the opening of mPTP mediate the apoptosis of co-cultured Sertoli-germ cells induced by microcystin-LR. Environmental Toxicology. 2019 Jun 03;34(10):1074–84. doi: 10.1002/tox.22808."
2146666,9929138,Comparative Toxicogenomics Database (CTD),Pifithrin,C121565,pifithrin,https://ctdbase.org/detail.go?type=chem&acc=C121565,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Pifithrin inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:16687611,https://www.ncbi.nlm.nih.gov/pubmed/16687611,16687611,,,33545051,"Chua CC, Liu X, Gao J, Hamdy RC, Chua BHL. Multiple actions of pifithrin-a on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. American Journal of Physiology-Heart and Circulatory Physiology. 2006 Jun;290(6):H2606–13. doi: 10.1152/ajpheart.01138.2005."
1939745,9931953,Comparative Toxicogenomics Database (CTD),"8-fluoro-5-(4-((methylamino)methyl)phenyl)-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one phosphate",C531549,rucaparib,https://ctdbase.org/detail.go?type=chem&acc=C531549,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rucaparib binds to and results in decreased activity of PARP1 protein,,,PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
1939746,9931953,Comparative Toxicogenomics Database (CTD),"8-fluoro-5-(4-((methylamino)methyl)phenyl)-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one phosphate",C531549,rucaparib,https://ctdbase.org/detail.go?type=chem&acc=C531549,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[rucaparib co-treated with dasatinib co-treated with CPI-0610] results in increased cleavage of PARP1 protein|rucaparib promotes the reaction [navitoclax results in increased cleavage of PARP1 protein],,,PMID:32927276,https://www.ncbi.nlm.nih.gov/pubmed/32927276,32927276,,PMC7494677,10174929,"Lui GYL, Shaw R, Schaub FX, Stork IN, Gurley KE, Bridgwater C, Diaz RL, Rosati R, Swan HA, Ince TA, Harding TC, Gadi VK, Goff BA, Kemp CJ, Swisher EM, Grandori C. BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer. EBioMedicine. 2020 Oct;60():102988. PMID: 32927276; PMCID: PMC7494677."
1939747,9931953,Comparative Toxicogenomics Database (CTD),"8-fluoro-5-(4-((methylamino)methyl)phenyl)-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one phosphate",C531549,rucaparib,https://ctdbase.org/detail.go?type=chem&acc=C531549,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rucaparib inhibits the reaction [irinotecan results in increased expression of PARP1 protein]|rucaparib results in decreased expression of PARP1 protein,,,PMID:30612311,https://www.ncbi.nlm.nih.gov/pubmed/30612311,30612311,,,18927893,2019; 37(5):948-960
2145241,9931953,Drug Gene Interaction database (DGIdb),"8-fluoro-5-(4-((methylamino)methyl)phenyl)-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one phosphate",,RUCAPARIB PHOSPHATE,https://www.dgidb.org/drugs/ncit:C78186,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1955701,9931954,Drug Gene Interaction database (DGIdb),Rucaparib,,RUCAPARIB,https://www.dgidb.org/drugs/rxcui:1862579,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
1955702,9931954,Drug Gene Interaction database (DGIdb),Rucaparib,,RUCAPARIB,https://www.dgidb.org/drugs/rxcui:1862579,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2058741,9931954,Drug Gene Interaction database (DGIdb),Rucaparib,,RUCAPARIB,https://www.dgidb.org/drugs/rxcui:1862579,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Other/unknown,,,,,,,,,
2058743,9931954,Drug Gene Interaction database (DGIdb),Rucaparib,,RUCAPARIB,https://www.dgidb.org/drugs/rxcui:1862579,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2063476,9931954,DrugBank,Rucaparib,DB12332,Rucaparib,https://www.drugbank.ca/drugs/DB12332,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:27087632|PMID:28790837,https://www.ncbi.nlm.nih.gov/pubmed/27087632|https://www.ncbi.nlm.nih.gov/pubmed/28790837,27087632|28790837,,PMC4976841|PMC5488752,16840138|16883915,"Dockery LE, Gunderson CC, Moore KN: Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer. Onco Targets Ther. 2017 Jun 19;10:3029-3037. doi: 10.2147/OTT.S114714. eCollection 2017.|Jenner ZB, Sood AK, Coleman RL: Evaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy. Future Oncol. 2016 Jun;12(12):1439-56. doi: 10.2217/fon-2016-0002. Epub 2016 Apr 18."
2138187,9931954,IUPHAR/BPS Guide to PHARMACOLOGY,Rucaparib,7736,rucaparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7736,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pKi,8.85,PMID:17363489,https://www.ncbi.nlm.nih.gov/pubmed/17363489,17363489,,,20742542,"Thomas HD, Calabrese CR, Batey MA, Canan S, Hostomsky Z, Kyle S, Maegley KA, Newell DR, Skalitzky D, Wang LZ, Webber SE, Curtin NJ. Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial. Mol Cancer Ther. 2007 Mar;6(3):945–56. doi: 10.1158/1535-7163.mct-06-0552. PMID: 17363489."
2138188,9931954,BindingDB,Rucaparib,50446130,AG-014699,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50446130,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),3.1,PMID:27866910|DOI:10.1016/j.chembiol.2016.10.011,https://www.ncbi.nlm.nih.gov/pubmed/27866910|https://doi.org/10.1016/j.chembiol.2016.10.011,27866910,10.1016/j.chembiol.2016.10.011,PMC5182133,33069478,"Knezevic CE, Wright G, Remsing Rix LL, Kim W, Kuenzi BM, Luo Y, Watters JM, Koomen JM, Haura EB, Monteiro AN, Radu C, Lawrence HR, Rix U. Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Cell Chemical Biology. 2016 Dec;23(12):1490–503. doi: 10.1016/j.chembiol.2016.10.011."
2102593,9932254,Comparative Toxicogenomics Database (CTD),Glutinol,C506419,glutinol,https://ctdbase.org/detail.go?type=chem&acc=C506419,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Glutinol inhibits the reaction [ethanol results in increased expression of PARP1 protein],,,PMID:37939858,https://www.ncbi.nlm.nih.gov/pubmed/37939858,37939858,,,36361141,"Sandhu M, Irfan HM, Arshad L, Ullah A, Shah SA, Ali H. Friedelin and Glutinol induce neuroprotection against ethanol induced neurotoxicity in pup's brain through reduction of TNF-a, NF-kB, caspase-3 and PARP-1. Neurotoxicology. 2023 Dec;99():274–81. doi: 10.1016/j.neuro.2023.11.002. PMID: 37939858."
1940688,9934458,Comparative Toxicogenomics Database (CTD),"{4-[({2-[3-Fluoro-4-(Trifluoromethyl)phenyl]-4-Methyl-1,3-Thiazol-5-Yl}methyl)sulfanyl]-2-Methylphenoxy}acetic Acid",C479979,"(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid",https://ctdbase.org/detail.go?type=chem&acc=C479979,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid promotes the reaction [sulindac sulfide results in increased cleavage of PARP1 protein]|(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid promotes the reaction [indomethacin results in increased cleavage of PARP1 protein]",,,PMID:21400612,https://www.ncbi.nlm.nih.gov/pubmed/21400612,21400612,,PMC3482838,28894176,"Foreman JE, Chang WL, Palkar PS, Zhu B, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM. Functional characterization of peroxisome proliferator-activated receptor-ß/d expression in colon cancer. Molecular Carcinogenesis. 2011 Mar 11;50(11):884–900. doi: 10.1002/mc.20757."
1940755,9934458,Comparative Toxicogenomics Database (CTD),"{4-[({2-[3-Fluoro-4-(Trifluoromethyl)phenyl]-4-Methyl-1,3-Thiazol-5-Yl}methyl)sulfanyl]-2-Methylphenoxy}acetic Acid",C479979,"(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid",https://ctdbase.org/detail.go?type=chem&acc=C479979,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid results in increased cleavage of PARP1 protein",,,PMID:27427494,https://www.ncbi.nlm.nih.gov/pubmed/27427494,27427494,,PMC5278792,14816820,"Balandaram G, Kramer LR, Kang BH, Murray IA, Perdew GH, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-ß/d suppresses liver tumorigenesis in hepatitis B transgenic mice. Toxicology. 2016 Jul 01;363-364():1–9. PMID: 27427494; PMCID: PMC5278792."
2120150,9936746,Comparative Toxicogenomics Database (CTD),Birabresib,C000605331,OTX015,https://ctdbase.org/detail.go?type=chem&acc=C000605331,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),OTX015 affects the cleavage of PARP1 protein,,,PMID:26051217,https://www.ncbi.nlm.nih.gov/pubmed/26051217,26051217,,PMC4475452,18184770,"Lu J, Qian Y, Altieri M, Dong H, Wang J, Raina K, Hines J, Winkler J, Crew A, Coleman K, Crews C. Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chemistry & Biology. 2015 Jun;22(6):755–63. doi: 10.1016/j.chembiol.2015.05.009."
2120151,9936746,Comparative Toxicogenomics Database (CTD),Birabresib,C000605331,OTX015,https://ctdbase.org/detail.go?type=chem&acc=C000605331,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),OTX015 results in increased expression of and results in increased cleavage of PARP1 protein|pten protein promotes the reaction [OTX015 results in increased cleavage of PARP1 protein],,,PMID:33806232,https://www.ncbi.nlm.nih.gov/pubmed/33806232,33806232,,PMC8059141,28470375,"Megiorni F, Camero S, Pontecorvi P, Camicia L, Marampon F, Ceccarelli S, Anastasiadou E, Bernabò N, Perniola G, Pizzuti A, Benedetti Panici P, Tombolini V, Marchese C. OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence. Cancers (Basel). 2021 Mar 25;13(7). PMID: 33806232; PMCID: PMC8059141."
1897987,9937902,Comparative Toxicogenomics Database (CTD),Dy-9760e,C109602,"3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate",https://ctdbase.org/detail.go?type=chem&acc=C109602,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate results in decreased cleavage of PARP1 protein",,,PMID:16987238,https://www.ncbi.nlm.nih.gov/pubmed/16987238,16987238,,,11919481,"Han F, Shirasaki Y, Fukunaga K. Microsphere embolism-induced endothelial nitric oxide synthase expression mediates disruption of the blood–brain barrier in rat brain. Journal of Neurochemistry. 2006 Jul 24;99(1):97–106. doi: 10.1111/j.1471-4159.2006.04048.x."
1899131,9939609,Comparative Toxicogenomics Database (CTD),Darapladib,C529040,darapladib,https://ctdbase.org/detail.go?type=chem&acc=C529040,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Darapladib results in increased expression of PARP1 protein modified form,,,PMID:32668280,https://www.ncbi.nlm.nih.gov/pubmed/32668280,32668280,,,1967176,"Wang YJ, Chang SB, Wang CY, Huang HT, Tzeng SF. The selective lipoprotein-associated phospholipase A2 inhibitor darapladib triggers irreversible actions on glioma cell apoptosis and mitochondrial dysfunction. Toxicol Appl Pharmacol. 2020 Sep 01;402():115133. doi: 10.1016/j.taap.2020.115133. PMID: 32668280."
1899821,9948349,Comparative Toxicogenomics Database (CTD),"3,4-Dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",C108729,"3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",https://ctdbase.org/detail.go?type=chem&acc=C108729,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]",,,PMID:17237268,https://www.ncbi.nlm.nih.gov/pubmed/17237268,17237268,,,3048394,"Park MT, Kang YH, Park IC, Kim CH, Lee YS, Chung HY, Lee SJ. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells. Mol Cancer Ther. 2007 Jan;6(1):82–92. doi: 10.1158/1535-7163.mct-06-0349. PMID: 17237268."
1899822,9948349,Comparative Toxicogenomics Database (CTD),"3,4-Dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",C108729,"3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",https://ctdbase.org/detail.go?type=chem&acc=C108729,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased expression of PARP1 protein]",,,PMID:23011206,https://www.ncbi.nlm.nih.gov/pubmed/23011206,23011206,,,32980482,2012; 38(1):50-58
1899823,9948349,Comparative Toxicogenomics Database (CTD),"3,4-Dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",C108729,"3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",https://ctdbase.org/detail.go?type=chem&acc=C108729,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone results in decreased activity of PARP1 protein",,,PMID:15486061,https://www.ncbi.nlm.nih.gov/pubmed/15486061,15486061,,,23406215,"Park MT, Kim MJ, Kang YH, Choi SY, Lee JH, Choi JA, Kang CM, Cho CK, Kang S, Bae S, Lee YS, Chung HY, Lee SJ. Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release. Blood. 2005 Feb 15;105(4):1724–33. doi: 10.1182/blood-2004-07-2938. PMID: 15486061."
1899974,9948349,Comparative Toxicogenomics Database (CTD),"3,4-Dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",C108729,"3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",https://ctdbase.org/detail.go?type=chem&acc=C108729,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone results in decreased activity of PARP1 protein",,,PMID:14769338|PMID:21417348,https://www.ncbi.nlm.nih.gov/pubmed/14769338|https://www.ncbi.nlm.nih.gov/pubmed/21417348,14769338|21417348,,,28909941|29442128,"Sunderland PT, Woon EC, Dhami A, Bergin AB, Mahon MF, Wood PJ, Jones LA, Tully SR, Lloyd MD, Thompson AS, Javaid H, Martin NM, Threadgill MD. 5-Benzamidoisoquinolin-1-ones and 5-(?-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2). J Med Chem. 2011 Apr 14;54(7):2049–59. doi: 10.1021/jm1010918. PMID: 21417348.|Putt KS, Hergenrother PJ. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors. Anal Biochem. 2004 Mar 01;326(1):78–86. doi: 10.1016/j.ab.2003.11.015. PMID: 14769338."
1945225,9948349,BindingDB,"3,4-Dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",27502,"3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27502,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),372,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
2002126,9948440,Therapeutic Target Database (TTD),Cep-6800,D02GPJ,CEP-6800,https://idrblab.net/ttd/data/drug/details/D02GPJ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1956568,9949093,Comparative Toxicogenomics Database (CTD),"N-(6-chloro-9h-pyrido[3,4-b]indol-8-yl)-3-pyridinecarboxamide",C456319,PS1145,https://ctdbase.org/detail.go?type=chem&acc=C456319,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),PS1145 inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:19616567,https://www.ncbi.nlm.nih.gov/pubmed/19616567,19616567,,,10619164,"Ghosh J, Das J, Manna P, Sil PC. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. Toxicol Appl Pharmacol. 2009 Oct 01;240(1):73–87. doi: 10.1016/j.taap.2009.07.008. PMID: 19616567."
2110594,9952396,Comparative Toxicogenomics Database (CTD),GI254023X,C555398,"3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amide",https://ctdbase.org/detail.go?type=chem&acc=C555398,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amide inhibits the reaction [acrolein results in increased cleavage of PARP1 protein]",,,PMID:31639409,https://www.ncbi.nlm.nih.gov/pubmed/31639409,31639409,,,24376592,"Park JH, Choi JY, Jo C, Koh YH. Involvement of ADAM10 in acrolein-induced astrocytic inflammation. Toxicol Lett. 2020 Jan;318():44–9. doi: 10.1016/j.toxlet.2019.10.005. PMID: 31639409."
2160133,9952605,Comparative Toxicogenomics Database (CTD),Dimethoxycurcumin,C521105,dimethoxycurcumin,https://ctdbase.org/detail.go?type=chem&acc=C521105,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dimethoxycurcumin results in increased expression of PARP1 mRNA,,,PMID:31513842,https://www.ncbi.nlm.nih.gov/pubmed/31513842,31513842,,,7453040,"Zanetti TA, Biazi BI, Coatti GC, Baranoski A, Marques LA, Corveloni AC, Mantovani MS. Mitotic spindle defects and DNA damage induced by dimethoxycurcumin lead to an intrinsic apoptosis pathway in HepG2/C3A cells. Toxicol In Vitro. 2019 Dec;61():104643. doi: 10.1016/j.tiv.2019.104643. PMID: 31513842."
1948544,9965481,BindingDB,3-(4-Methoxyphenyl)quinoxaline-5-carboxamide,27723,3-(4-methoxyphenyl)quinoxaline-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27723,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),71,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2110776,9965481,Therapeutic Target Database (TTD),3-(4-Methoxyphenyl)quinoxaline-5-carboxamide,D0L1RZ,3-(4-methoxyphenyl)quinoxaline-5-carboxamide,https://idrblab.net/ttd/data/drug/details/D0L1RZ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2113848,9988135,Comparative Toxicogenomics Database (CTD),Menaquinone 10,D024482,Vitamin K 2,https://ctdbase.org/detail.go?type=chem&acc=D024482,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Vitamin K 2 results in increased cleavage of PARP1 protein,,,PMID:29432837,https://www.ncbi.nlm.nih.gov/pubmed/29432837,29432837,,PMC5935569,26375070,"Dasari S, Samy ALPA, Kajdacsy-Balla A, Bosland MC, Munirathinam G. Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling. Food and Chemical Toxicology. 2018 May;115():218–27. doi: 10.1016/j.fct.2018.02.018."
1951247,10002219,BindingDB,"N-[3-(1H-imidazol-1-yl)propyl]-8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide",27526,"N-[3-(1H-imidazol-1-yl)propyl]-8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27526,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),394,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2060715,10032582,Comparative Toxicogenomics Database (CTD),Z-LEHD-fmk,C403754,benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C403754,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [isoliquiritigenin results in increased cleavage of PARP1 protein],,,PMID:23747687,https://www.ncbi.nlm.nih.gov/pubmed/23747687,23747687,,,3187826,"Li Y, Zhao H, Wang Y, Zheng H, Yu W, Chai H, Zhang J, Falck JR, Guo AM, Yue J, Peng R, Yang J. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicol Appl Pharmacol. 2013 Oct 01;272(1):37–48. doi: 10.1016/j.taap.2013.05.031. PMID: 23747687."
2060716,10032582,Comparative Toxicogenomics Database (CTD),Z-LEHD-fmk,C403754,benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C403754,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein],,,PMID:24264887,https://www.ncbi.nlm.nih.gov/pubmed/24264887,24264887,,,30321197,2013; 19(3):527-541
2060717,10032582,Comparative Toxicogenomics Database (CTD),Z-LEHD-fmk,C403754,benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C403754,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [rubimaillin results in increased degradation of PARP1 protein],,,PMID:19716835,https://www.ncbi.nlm.nih.gov/pubmed/19716835,19716835,,,32901316,"Kim SM, Park HS, Jun DY, Woo HJ, Woo MH, Yang CH, Kim YH. Mollugin induces apoptosis in human Jurkat T cells through endoplasmic reticulum stress-mediated activation of JNK and caspase-12 and subsequent activation of mitochondria-dependent caspase cascade regulated by Bcl-xL. Toxicol Appl Pharmacol. 2009 Dec 01;241(2):210–20. doi: 10.1016/j.taap.2009.08.024. PMID: 19716835."
2119845,10043230,Comparative Toxicogenomics Database (CTD),Hemistepsin,C000626944,hemistepsin,https://ctdbase.org/detail.go?type=chem&acc=C000626944,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Hemistepsin results in increased cleavage of PARP1 protein,,,PMID:31830547,https://www.ncbi.nlm.nih.gov/pubmed/31830547,31830547,,,22337585,"Kim JK, Han NR, Park SM, Jegal KH, Jung JY, Jung EH, Kim EO, Kim D, Jung DH, Lee JR, Park CA, Ku SK, Cho IJ, Kim SC. Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-?B and Akt. Food Chem Toxicol. 2020 Jan;135():111044. doi: 10.1016/j.fct.2019.111044. PMID: 31830547."
2146689,10068193,Comparative Toxicogenomics Database (CTD),LM-1685,C501175,LM-1685,https://ctdbase.org/detail.go?type=chem&acc=C501175,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[LM-1685 co-treated with carboxyamido-triazole] results in increased cleavage of PARP1 protein],,,PMID:15867384,https://www.ncbi.nlm.nih.gov/pubmed/15867384,15867384,,,7883012,"Winters ME, Mehta AI, Petricoin EF, Kohn EC, Liotta LA. Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res. 2005 May 01;65(9):3853–60. doi: 10.1158/0008-5472.can-04-1989. PMID: 15867384."
1956437,10105388,BindingDB,"5,6-dihydro-5-oxo-11H-indeno [1,2-c]isoquinoline",27508,"9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27508,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>3000,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2147448,10127622,Comparative Toxicogenomics Database (CTD),Selumetinib,C517975,AZD 6244,https://ctdbase.org/detail.go?type=chem&acc=C517975,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AZD 6244 inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of PARP1 protein]],,,PMID:27222248,https://www.ncbi.nlm.nih.gov/pubmed/27222248,27222248,,PMC4879700,24967577,"Oh YT, Deng J, Yue P, Sun SY. Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells. Sci Rep. 2016 May 25;6():26803. PMID: 27222248; PMCID: PMC4879700."
2147449,10127622,Comparative Toxicogenomics Database (CTD),Selumetinib,C517975,AZD 6244,https://ctdbase.org/detail.go?type=chem&acc=C517975,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),AZD 6244 results in increased cleavage of PARP1 protein|doxorubicin promotes the reaction [AZD 6244 results in increased cleavage of PARP1 protein],,,PMID:17876044,https://www.ncbi.nlm.nih.gov/pubmed/17876044,17876044,,,20051917,"Huynh H, Chow PK, Soo KC. AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma. Mol Cancer Ther. 2007 Sep;6(9):2468–76. doi: 10.1158/1535-7163.mct-07-0162. PMID: 17876044."
1819007,10130109,BindingDB,1H-Benzimidazole-4-carboxamide,27088,"1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27088,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),240,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2127345,10130246,Therapeutic Target Database (TTD),"3-Azatricyclo[7.3.1.0,5,13]trideca-1(12),5(13),6,8,10-pentaen-2-one",D05HJG,"2,3-dihydro-1H-benzo[de]isoquinolin-1-one",https://idrblab.net/ttd/data/drug/details/D05HJG,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1959840,10134539,BindingDB,,27711,"2-{3-[4-(4-chlorophenyl)piperazin-1-yl]propyl}-3,4-dihydroquinazolin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27711,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),11,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2065008,10176285,Toxin and Toxin Target Database (T3DB),Oxo(oxocobaltiooxy)cobalt,T3D0667,Cobalt(III) oxide,http://www.t3db.ca/toxins/T3D0667,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1964063,10216071,BindingDB,"2-(3-(4-phenyl-5,6-dihydropyridin-1(2H)-yl)propyl)phenanthridin-6(5H)-one",27718,"2-(3-(4-phenyl-5,6-dihydropyridin-1(2H)-yl)propyl)phenanthridin-6(5H)-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27718,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),82,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
1823951,10221158,BindingDB,"2-(4-methoxycyclohexyl)-1H-1,3-benzodiazole-4-carboxamide",27090,"2-(4-methoxycyclohexyl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27090,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),44,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2167729,10226415,Comparative Toxicogenomics Database (CTD),"4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]-N-[1-(dimethylamino)propan-2-yl]benzamide",C512484,AG-012986,https://ctdbase.org/detail.go?type=chem&acc=C512484,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AG-012986 results in increased cleavage of PARP1 protein,,,PMID:22095879,https://www.ncbi.nlm.nih.gov/pubmed/22095879,22095879,,,3162774,"Lee DU, Jessen B. Off-target immune cell toxicity caused by AG-012986, a pan-CDK inhibitor, is associated with inhibition of p38 MAPK phosphorylation. J Biochem Mol Toxicol. 2012 Mar;26(3):101–8. doi: 10.1002/jbt.20415. PMID: 22095879."
2172369,10236627,Comparative Toxicogenomics Database (CTD),Paecilaminol,C507616,"2-amino-14,16-dimethyloctadecan-3-ol",https://ctdbase.org/detail.go?type=chem&acc=C507616,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of PARP1 protein",,,PMID:32044396,https://www.ncbi.nlm.nih.gov/pubmed/32044396,32044396,,,2625401,"Solhaug A, Torgersen ML, Holme JA, Wiik-Nilsen J, Thiede B, Eriksen GS. The Fusarium mycotoxin, 2-Amino-14,16-dimethyloctadecan-3-ol (AOD) induces vacuolization in HepG2 cells. Toxicology. 2020 Mar 30;433-434():152405. doi: 10.1016/j.tox.2020.152405. PMID: 32044396."
1964922,10236918,BindingDB,,27705,"2-[3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)propyl]-3,4-dihydroquinazolin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27705,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),21,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
1964923,10237099,BindingDB,"4-(4-(4-phenyl-5,6-dihydropyridin-1(2H)-yl)butyl)phthalazin-1(2H)-one",27716,"4-(4-(4-phenyl-5,6-dihydropyridin-1(2H)-yl)butyl)phthalazin-1(2H)-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27716,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),120,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2170997,10285774,Toxin and Toxin Target Database (T3DB),Arsinoborane,T3D1290,Boron arsenide,http://www.t3db.ca/toxins/T3D1290,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2171788,10323834,Comparative Toxicogenomics Database (CTD),Erufosine,C472787,"erucylphospho-N,N,N-trimethylpropylammonium",https://ctdbase.org/detail.go?type=chem&acc=C472787,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Erucylphospho-N,N,N-trimethylpropylammonium results in decreased expression of PARP1 mRNA",,,PMID:29464035,https://www.ncbi.nlm.nih.gov/pubmed/29464035,29464035,,PMC5814175,33082763,"Ansari SS, Sharma AK, Zepp M, Ivanova E, Bergmann F, König R, Berger MR. Upregulation of cell cycle genes in head and neck cancer patients may be antagonized by erufosine's down regulation of cell cycle processes in OSCC cells. Oncotarget. 2018 Jan 19;9(5):5797–810. PMID: 29464035; PMCID: PMC5814175."
2082685,10334137,Comparative Toxicogenomics Database (CTD),"Iron Chelator, Dp44mT",C539263,"di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone",https://ctdbase.org/detail.go?type=chem&acc=C539263,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of PARP1 protein modified form|ndrg1 protein promotes the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of PARP1 protein modified form]",,,PMID:24532803,https://www.ncbi.nlm.nih.gov/pubmed/24532803,24532803,,PMC3975018,31648133,"Sahni S, Bae D, Lane DJR, Kovacevic Z, Kalinowski DS, Jansson PJ, Richardson DR. The Metastasis Suppressor, N-myc Downstream-regulated Gene 1 (NDRG1), Inhibits Stress-induced Autophagy in Cancer Cells. Journal of Biological Chemistry. 2014 Apr;289(14):9692–709. doi: 10.1074/jbc.m113.529511."
2037560,10337896,Comparative Toxicogenomics Database (CTD),Demethoxyfumitremorgin C,C100698,demethoxyfumitremorgin C,https://ctdbase.org/detail.go?type=chem&acc=C100698,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Demethoxyfumitremorgin C results in increased cleavage of PARP1 protein,,,PMID:28359723,https://www.ncbi.nlm.nih.gov/pubmed/28359723,28359723,,,12826156,"Kim YS, Kim SK, Park SJ. Apoptotic effect of demethoxyfumitremorgin C from marine fungus Aspergillus fumigatus on PC3 human prostate cancer cells. Chem Biol Interact. 2017 May 01;269():18–24. doi: 10.1016/j.cbi.2017.03.015. PMID: 28359723."
1975455,10423087,BindingDB,"2-(4-methoxyphenyl)-1H-1,3-benzodiazole-4-carboxamide",27684,"2-(4-methoxyphenyl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27684,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),60,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
1916797,10424762,Comparative Toxicogenomics Database (CTD),"2',4'-Dihydroxy-6'-methoxy-3',5'-dimethylchalcone",C501649,"2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone",https://ctdbase.org/detail.go?type=chem&acc=C501649,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of PARP1 protein]|2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of PARP1 protein",,,PMID:38521250,https://www.ncbi.nlm.nih.gov/pubmed/38521250,38521250,,,36973636,"Jiang Y, Xu S, Guo M, Lu Z, Wei X, An F, Xin X. DMC triggers MDA-MB-231 cells apoptosis via inhibiting protective autophagy and PI3K/AKT/mTOR pathway by enhancing ROS level. Toxicol In Vitro. 2024 May;97():105809. doi: 10.1016/j.tiv.2024.105809. PMID: 38521250."
2070649,10429470,Comparative Toxicogenomics Database (CTD),Calycopterin,C533734,calycopterin,https://ctdbase.org/detail.go?type=chem&acc=C533734,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Calycopterin results in decreased susceptibility to [hydrogen peroxide results in increased cleavage of PARP1 protein]|calycopterin results in decreased susceptibility to [hydrogen peroxide results in increased expression of PARP1 protein modified form],,,PMID:22081883,https://www.ncbi.nlm.nih.gov/pubmed/22081883,22081883,,,3149788,"Farimani MM, Sarvestani NN, Ansari N, Khodagholi F. Calycopterin promotes survival and outgrowth of neuron-like PC12 cells by attenuation of oxidative- and ER-stress-induced apoptosis along with inflammatory response. Chem Res Toxicol. 2011 Dec 19;24(12):2280–92. doi: 10.1021/tx200420a. PMID: 22081883."
2092006,10460379,Comparative Toxicogenomics Database (CTD),(S)-6-acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide,D056572,Histone Deacetylase Inhibitors,https://ctdbase.org/detail.go?type=chem&acc=D056572,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Histone deacetylase inhibitors results in increased cleavage of PARP1 protein,,,PMID:34929181,https://www.ncbi.nlm.nih.gov/pubmed/34929181,34929181,,,12258724,"Lee HY, Tang DW, Liu CY, Cho EC. A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation. Chem Biol Interact. 2022 Jan 25;352():109778. doi: 10.1016/j.cbi.2021.109778. PMID: 34929181."
1830649,10467367,Comparative Toxicogenomics Database (CTD),2-(3-Oxoprop-1-en-1-yl)phenyl benzoate,C484327,2'-benzoyloxycinnamaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C484327,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein|glutathione inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein],,,PMID:14660655,https://www.ncbi.nlm.nih.gov/pubmed/14660655,14660655,,,26785117,"Han DC, Lee MY, Shin KD, Jeon SB, Kim JM, Son KH, Kim HC, Kim HM, Kwon BM. 2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species. J Biol Chem. 2004 Feb 20;279(8):6911–20. doi: 10.1074/jbc.m309708200. PMID: 14660655."
2040740,10471963,Comparative Toxicogenomics Database (CTD),Glaucocalyxin A,C055124,glaucocalyxin A,https://ctdbase.org/detail.go?type=chem&acc=C055124,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Glaucocalyxin A promotes the reaction [TNF protein results in increased cleavage of PARP1 protein]|stat3 protein inhibits the reaction [glaucocalyxin A promotes the reaction [TNF protein results in increased cleavage of PARP1 protein]],,,PMID:33798506,https://www.ncbi.nlm.nih.gov/pubmed/33798506,33798506,,,28462864,"Zhang C, Ma K, Yang Y, Wang F, Li W. Glaucocalyxin A suppresses inflammatory responses and induces apoptosis in TNF-a-induced human rheumatoid arthritis via modulation of the STAT3 pathway. Chem Biol Interact. 2021 May 25;341():109451. doi: 10.1016/j.cbi.2021.109451. PMID: 33798506."
2161249,10535869,Therapeutic Target Database (TTD),"benzo[c][1,5]naphthyridin-6(5H)-one",D0M6WJ,"Benzo[c][1,5]naphthyridin-6(5H)-one",https://idrblab.net/ttd/data/drug/details/D0M6WJ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2184829,10806655,Comparative Toxicogenomics Database (CTD),"7alpha,8beta-Dihydroxydeepoxysarcophine",C000588503,"7alpha,8beta-dihydroxydeepoxysarcophine",https://ctdbase.org/detail.go?type=chem&acc=C000588503,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"7alpha,8beta-dihydroxydeepoxysarcophine results in decreased activity of PARP1 protein",,,PMID:24689276,https://www.ncbi.nlm.nih.gov/pubmed/24689276,24689276,,,28977093,"Szymanski PT, Ahmed SA, Radwan MM, Khalifa SI, Fahmy H. Evaluation of the anti-melanoma activities of sarcophine, (+)-7alpha,8beta-dihydroxydeepoxysarcophine and sarcophytolide from the Red Sea soft coral Sarcophyton glaucum. Nat Prod Commun. 2014 Feb;9(2):151–4. PMID: 24689276."
1855029,10823781,BindingDB,2-Phenylbenzimidazole-4-carboxamide,27091,"2-phenyl-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27091,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),17,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
1993060,10980119,BindingDB,"2-{4-[(Dimethylamino)methyl]phenyl}-3,10-diazatricyclo[6.4.1.0^{4,13}]trideca-1,4(13),5,7-tetraen-9-one",27685,"2-{4-[(dimethylamino)methyl]phenyl}-3,10-diazatricyclo[6.4.1.0^{4,13}]trideca-1,4(13),5,7-tetraen-9-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27685,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),5,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2075001,11012797,Toxin and Toxin Target Database (T3DB),CID 11012797,T3D0680,Salcomine,http://www.t3db.ca/toxins/T3D0680,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2162230,11018329,Comparative Toxicogenomics Database (CTD),Polyphyllin I,C556217,polyphyllin I,https://ctdbase.org/detail.go?type=chem&acc=C556217,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [polyphyllin I results in increased expression of PARP1 protein modified form]|polyphyllin I results in increased expression of PARP1 protein modified form|pyrazolanthrone inhibits the reaction [polyphyllin I results in increased expression of PARP1 protein modified form],,,PMID:31421117,https://www.ncbi.nlm.nih.gov/pubmed/31421117,31421117,,,12866556,"Tian Y, Jia SX, Shi J, Gong GY, Yu JW, Niu Y, Yang CM, Ma XC, Fang MY. Polyphyllin I induces apoptosis and autophagy via modulating JNK and mTOR pathways in human acute myeloid leukemia cells. Chem Biol Interact. 2019 Sep 25;311():108793. doi: 10.1016/j.cbi.2019.108793. PMID: 31421117."
2162231,11018329,Comparative Toxicogenomics Database (CTD),Polyphyllin I,C556217,polyphyllin I,https://ctdbase.org/detail.go?type=chem&acc=C556217,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Polyphyllin I results in increased cleavage of PARP1 protein,,,PMID:26821882|PMID:32208876,https://www.ncbi.nlm.nih.gov/pubmed/26821882|https://www.ncbi.nlm.nih.gov/pubmed/32208876,26821882|32208876,,,5987596|30461497,"Zeng Y, Zhang Z, Wang W, You L, Dong X, Yin X, Qu C, Ni J. Underlying mechanisms of apoptosis in HepG2 cells induced by polyphyllin I through Fas death and mitochondrial pathways. Toxicology Mechanisms and Methods. 2020 Apr 14;30(6):397–406. doi: 10.1080/15376516.2020.1747125.|Liang Y, Li X, He X, Qiu X, Jin X, Zhao X, Xu R. Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating <i>ß</i>-catenin signaling pathway. European J of Haematology. 2016 Mar 18;97(4):371–8. doi: 10.1111/ejh.12741."
1137093,11105942,Comparative Toxicogenomics Database (CTD),alpha-D-Fructofuranose,D005632,Fructose,https://ctdbase.org/detail.go?type=chem&acc=D005632,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Fructose results in increased expression of PARP1 protein,,,PMID:28257781,https://www.ncbi.nlm.nih.gov/pubmed/28257781,28257781,,PMC5499254,21591192,"Choi Y, Abdelmegeed MA, Song B. Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress. Food and Chemical Toxicology. 2017 May;103():111–21. doi: 10.1016/j.fct.2017.02.039."
2204520,11124817,Comparative Toxicogenomics Database (CTD),Destruxin B,C040424,destruxin B,https://ctdbase.org/detail.go?type=chem&acc=C040424,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Destruxin B results in increased cleavage of PARP1 protein,,,PMID:22465936,https://www.ncbi.nlm.nih.gov/pubmed/22465936,22465936,,,25586753,"Yeh CT, Rao YK, Ye M, Wu WS, Chang TC, Wang LS, Wu CH, Wu AT, Tzeng YM. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging. Toxicol Appl Pharmacol. 2012 May 15;261(1):31–41. doi: 10.1016/j.taap.2012.03.007. PMID: 22465936."
1996872,11157496,BindingDB,"Indeno[1,2-c]isoquinolinone, 14",27532,"4-methyl-4-[3-({8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-}sulfonamido)propyl]morpholin-4-ium iodide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27532,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),800,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
1997598,11165585,BindingDB,"4-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl}butanamide",27519,"4-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl}butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27519,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),400,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2187663,11167602,Comparative Toxicogenomics Database (CTD),Regorafenib,C559147,regorafenib,https://ctdbase.org/detail.go?type=chem&acc=C559147,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [regorafenib results in increased cleavage of PARP1 protein]|regorafenib results in increased cleavage of PARP1 protein|schizandrin C inhibits the reaction [regorafenib results in increased cleavage of PARP1 protein],,,PMID:39348200,https://www.ncbi.nlm.nih.gov/pubmed/39348200,39348200,,,37797541,"Xu B, Liu N, Zhou T, Chen J, Jiang L, Wu W, Fu H, Chen X, Yan H, Yang X, Luo P, Yang B, Xu Z, He Q. Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes. Toxicol Sci. 2024 Dec 01;202(2):220–35. doi: 10.1093/toxsci/kfae127. PMID: 39348200."
2187664,11167602,Comparative Toxicogenomics Database (CTD),Regorafenib,C559147,regorafenib,https://ctdbase.org/detail.go?type=chem&acc=C559147,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Regorafenib results in increased cleavage of PARP1 protein,,,PMID:30801954|PMID:39348200,https://www.ncbi.nlm.nih.gov/pubmed/30801954|https://www.ncbi.nlm.nih.gov/pubmed/39348200,30801954|39348200,,PMC6594039,20311125|37797541,"Xu B, Liu N, Zhou T, Chen J, Jiang L, Wu W, Fu H, Chen X, Yan H, Yang X, Luo P, Yang B, Xu Z, He Q. Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes. Toxicol Sci. 2024 Dec 01;202(2):220–35. doi: 10.1093/toxsci/kfae127. PMID: 39348200.|Chiang CH, Chung JG, Hsu FT. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-?B-modulated tumor progression in bladder cancer in vitro and in vivo. Environ Toxicol. 2019 Jun;34(6):679–88. PMID: 30801954; PMCID: PMC6594039."
2187701,11168203,Comparative Toxicogenomics Database (CTD),3-ACETYL-11-KETO-beta-BOSWELLIC ACID,C094432,acetyl-11-ketoboswellic acid,https://ctdbase.org/detail.go?type=chem&acc=C094432,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetyl-11-ketoboswellic acid results in increased cleavage of PARP1 protein,,,PMID:20692244,https://www.ncbi.nlm.nih.gov/pubmed/20692244,20692244,,,7969491,"Liu H, Liu YQ, Liu YQ, Xu AH, Young CY, Yuan HQ, Lou HX. A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells. Chem Biol Interact. 2010 Dec 05;188(3):598–606. doi: 10.1016/j.cbi.2010.07.024. PMID: 20692244."
2165138,11178236,Comparative Toxicogenomics Database (CTD),Sepantronium bromide,C523798,sepantronium,https://ctdbase.org/detail.go?type=chem&acc=C523798,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sepantronium promotes the reaction [PI-3065 results in increased cleavage of PARP1 protein],,,PMID:36623716,https://www.ncbi.nlm.nih.gov/pubmed/36623716,36623716,,,34818642,"Wei Y, Ke W, Lu Z, Ren Y. PI3K d inhibitor PI-3065 induces apoptosis in hepatocellular carcinoma cells by targeting survivin. Chem Biol Interact. 2023 Feb 01;371():110343. doi: 10.1016/j.cbi.2023.110343. PMID: 36623716."
2165139,11178236,Comparative Toxicogenomics Database (CTD),Sepantronium bromide,C523798,sepantronium,https://ctdbase.org/detail.go?type=chem&acc=C523798,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[venetoclax co-treated with sepantronium] results in increased cleavage of PARP1 protein|sepantronium results in increased cleavage of PARP1 protein,,,PMID:31837377,https://www.ncbi.nlm.nih.gov/pubmed/31837377,31837377,,,22344188,"Chiou JT, Lee YC, Huang CH, Shi YJ, Wang LJ, Chang LS. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells. Toxicol Appl Pharmacol. 2020 Jan 15;387():114857. doi: 10.1016/j.taap.2019.114857. PMID: 31837377."
1999656,11184249,BindingDB,3-Phenylquinoxaline-5-carboxamide,27719,3-phenylquinoxaline-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27719,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),131,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2002713,11202184,BindingDB,"2-[4-(4-fluorophenyl)piperazin-1-yl]-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}acetamide",27521,"2-[4-(4-fluorophenyl)piperazin-1-yl]-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27521,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),80,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2165422,11210478,Comparative Toxicogenomics Database (CTD),Wp 1066,C519885,WP1066,https://ctdbase.org/detail.go?type=chem&acc=C519885,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),WP1066 results in increased cleavage of PARP1 protein,,,PMID:18056455|PMID:18245540,https://www.ncbi.nlm.nih.gov/pubmed/18056455|https://www.ncbi.nlm.nih.gov/pubmed/18245540,18056455|18245540,,,1709307|31546357,"Verstovsek S, Manshouri T, Quintás-Cardama A, Harris D, Cortes J, Giles FJ, Kantarjian H, Priebe W, Estrov Z. WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation. Clin Cancer Res. 2008 Feb 01;14(3):788–96. doi: 10.1158/1078-0432.ccr-07-0524. PMID: 18245540.|Ferrajoli A, Faderl S, Van Q, Koch P, Harris D, Liu Z, Hazan-Halevy I, Wang Y, Kantarjian HM, Priebe W, Estrov Z. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res. 2007 Dec 01;67(23):11291–9. doi: 10.1158/0008-5472.can-07-0593. PMID: 18056455."
1929363,11214940,Comparative Toxicogenomics Database (CTD),Erastin,C477224,erastin,https://ctdbase.org/detail.go?type=chem&acc=C477224,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Erastin results in increased cleavage of PARP1 protein|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [erastin results in increased cleavage of PARP1 protein],,,PMID:38641223,https://www.ncbi.nlm.nih.gov/pubmed/38641223,38641223,,,37138187,"Kou Z, Tran F, Colon T, Shteynfeld Y, Noh S, Chen F, Choi BH, Dai W. AhR signaling modulates Ferroptosis by regulating SLC7A11 expression. Toxicol Appl Pharmacol. 2024 May;486():116936. doi: 10.1016/j.taap.2024.116936. PMID: 38641223."
1929966,11226684,Comparative Toxicogenomics Database (CTD),Epoxomicin,C078846,epoxomicin,https://ctdbase.org/detail.go?type=chem&acc=C078846,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quinoline-val-asp(ome)-CH2-OPH inhibits the reaction [epoxomicin results in increased cleavage of PARP1 protein]|epoxomicin results in increased cleavage of PARP1 protein,,,PMID:20153345,https://www.ncbi.nlm.nih.gov/pubmed/20153345,20153345,,PMC2849852,9963601,"Bolt AM, Byrd RM, Klimecki WT. Autophagy is the predominant process induced by arsenite in human lymphoblastoid cell lines. Toxicology and Applied Pharmacology. 2010 May;244(3):366–73. doi: 10.1016/j.taap.2010.01.019."
2159655,11228183,Comparative Toxicogenomics Database (CTD),Abt-737,C501332,ABT-737,https://ctdbase.org/detail.go?type=chem&acc=C501332,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|[[abt-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein|mcl1 protein inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|usp7 protein affects the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein promotes the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|akt1 protein modified form inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein inhibits the reaction [sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|mcl1 protein affects the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein],,,PMID:32802178,https://www.ncbi.nlm.nih.gov/pubmed/32802178,32802178,,PMC7415806,9544165,"Yang P, Xie J, Li Y, Lin HP, Fenske W, Clementino M, Jiang Y, Yang C, Wang Z. Deubiquitinase USP7-mediated MCL-1 up-regulation enhances Arsenic and Benzo(a)pyrene co-exposure-induced Cancer Stem Cell-like property and Tumorigenesis. Theranostics. 2020;10(20):9050–65. PMID: 32802178; PMCID: PMC7415806."
2159656,11228183,Comparative Toxicogenomics Database (CTD),Abt-737,C501332,ABT-737,https://ctdbase.org/detail.go?type=chem&acc=C501332,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ABT-737 co-treated with hydroquinone] results in increased cleavage of PARP1 protein|abt-737 inhibits the reaction [hydroquinone affects the localization of PARP1 protein],,,PMID:28843007,https://www.ncbi.nlm.nih.gov/pubmed/28843007,28843007,,,8103080,"Chen Y, Chen S, Liang H, Yang H, Liu L, Zhou K, Xu L, Liu J, Yun L, Lai B, Song L, Luo H, Peng J, Liu Z, Xiao Y, Chen W, Tang H. Bcl-2 protects TK6 cells against hydroquinone-induced apoptosis through PARP-1 cytoplasm translocation and stabilizing mitochondrial membrane potential. Environ Mol Mutagen. 2018 Jan;59(1):49–59. doi: 10.1002/em.22126. PMID: 28843007."
2006909,11248095,BindingDB,"13-fluoro-N-[3-(morpholin-4-yl)propyl]-8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide",27528,"13-fluoro-N-[3-(morpholin-4-yl)propyl]-8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27528,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),10,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2008615,11257357,BindingDB,"2-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl}acetamide",27517,"2-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl}acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27517,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>3000,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2009617,11269254,BindingDB,"2-(4-methylpiperazin-1-yl)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl}acetamide",27518,"2-(4-methylpiperazin-1-yl)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl}acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27518,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>3000,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2106394,11272610,Comparative Toxicogenomics Database (CTD),Ino-1001,C491685,INO 1001,https://ctdbase.org/detail.go?type=chem&acc=C491685,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),INO 1001 inhibits the reaction [AGT protein results in increased activity of PARP1 protein],,,PMID:15502880,https://www.ncbi.nlm.nih.gov/pubmed/15502880,15502880,,PMC1431352,5775817,2004; 10(1-6):28-35
2106395,11272610,Comparative Toxicogenomics Database (CTD),Ino-1001,C491685,INO 1001,https://ctdbase.org/detail.go?type=chem&acc=C491685,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[INO 1001 results in decreased activity of PARP1 protein] which results in decreased abundance of poly adenosine diphosphate ribose|ino 1001 results in decreased activity of PARP1 protein,,,PMID:15829224,https://www.ncbi.nlm.nih.gov/pubmed/15829224,15829224,,,317011,"Besson VC, Zsengellér Z, Plotkine M, Szabó C, Marchand-Verrecchia C. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat. Brain Res. 2005 Apr 18;1041(2):149–56. doi: 10.1016/j.brainres.2005.01.096. PMID: 15829224."
2191244,11272610,Drug Gene Interaction database (DGIdb),Ino-1001,,INO-1001,https://www.dgidb.org/drugs/ncit:C61315,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2012163,11288114,BindingDB,"9-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one",27515,"14-amino-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27515,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),98,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2200879,11288114,Therapeutic Target Database (TTD),"9-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one",D04UPQ,"9-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one",https://idrblab.net/ttd/data/drug/details/D04UPQ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2012164,11290531,BindingDB,"2-(dimethylamino)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl}acetamide",27516,"2-(dimethylamino)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl}acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27516,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),800,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2012167,11291932,BindingDB,"4-(3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one",27533,"4-(3-(1,4-diazepane-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27533,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),7,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2050397,11291932,DrugBank,"4-(3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one",DB08058,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",https://www.drugbank.ca/drugs/DB08058,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619,https://www.ncbi.nlm.nih.gov/pubmed/37713619,37713619,,PMC10767903,36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751."
2171978,11291932,IUPHAR/BPS Guide to PHARMACOLOGY,"4-(3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one",13125,KU0058948,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13125,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pKd,7.72,PMID:19354255,https://www.ncbi.nlm.nih.gov/pubmed/19354255,19354255,,,30220611,"Lehtiö L, Jemth A, Collins R, Loseva O, Johansson A, Markova N, Hammarström M, Flores A, Holmberg-Schiavone L, Weigelt J, Helleday T, Schüler H, Karlberg T. Structural Basis for Inhibitor Specificity in Human Poly(ADP-ribose) Polymerase-3. J. Med. Chem. 2009 Apr 08;52(9):3108–11. doi: 10.1021/jm900052j."
2188384,11291932,Therapeutic Target Database (TTD),"4-(3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one",D09LSX,KU-0058948,https://idrblab.net/ttd/data/drug/details/D09LSX,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2196619,11291932,Drug Gene Interaction database (DGIdb),"4-(3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one",,"4-[3-(1,4-DIAZEPAN-1-YLCARBONYL)-4-FLUOROBENZYL]PHTHALAZIN-1(2H)-ONE",https://www.dgidb.org/drugs/drugbank:DB08058,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2200883,11291932,Drug Gene Interaction database (DGIdb),"4-(3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one",,"4-[3-(1,4-DIAZEPAN-1-YLCARBONYL)-4-FLUOROBENZYL]PHTHALAZIN-1(2H)-ONE",https://www.dgidb.org/drugs/drugbank:DB08058,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2014877,11336543,BindingDB,"1-{8-Oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}-3-propylurea",27524,"1-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}-3-propylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27524,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),100,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2015649,11338625,BindingDB,"4-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}butanamide",27522,"4-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27522,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),105,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2192841,11381519,Comparative Toxicogenomics Database (CTD),Sarcophytolide,C117040,sarcophytolide,https://ctdbase.org/detail.go?type=chem&acc=C117040,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sarcophytolide results in decreased activity of PARP1 protein,,,PMID:24689276,https://www.ncbi.nlm.nih.gov/pubmed/24689276,24689276,,,28977093,"Szymanski PT, Ahmed SA, Radwan MM, Khalifa SI, Fahmy H. Evaluation of the anti-melanoma activities of sarcophine, (+)-7alpha,8beta-dihydroxydeepoxysarcophine and sarcophytolide from the Red Sea soft coral Sarcophyton glaucum. Nat Prod Commun. 2014 Feb;9(2):151–4. PMID: 24689276."
2175199,11388332,Comparative Toxicogenomics Database (CTD),Mitoquinone,C429014,mitoquinone,https://ctdbase.org/detail.go?type=chem&acc=C429014,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Mitoquinone inhibits the reaction [triptolide results in increased cleavage of PARP1 protein],,,PMID:30836114,https://www.ncbi.nlm.nih.gov/pubmed/30836114,30836114,,,649737,"Zhang J, Bao X, Zhang M, Zhu Z, Zhou L, Chen Q, Zhang Q, Ma B. MitoQ ameliorates testis injury from oxidative attack by repairing mitochondria and promoting the Keap1-Nrf2 pathway. Toxicol Appl Pharmacol. 2019 May 01;370():78–92. doi: 10.1016/j.taap.2019.03.001. PMID: 30836114."
2021601,11392596,BindingDB,"2-hydroxy-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}acetamide",27523,"2-hydroxy-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27523,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),110,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2031245,11439016,BindingDB,"2-(dimethylamino)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}acetamide",27520,"2-(dimethylamino)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-14-yl}acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27520,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),107,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2032829,11464583,BindingDB,"8-oxo-N-(3-phenylpropyl)-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide",27527,"8-oxo-N-(3-phenylpropyl)-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27527,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>3000,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2196766,11493598,Comparative Toxicogenomics Database (CTD),"5-(2-Phenylpyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine",C505241,FR 180204,https://ctdbase.org/detail.go?type=chem&acc=C505241,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"FR 180204 promotes the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]",,,PMID:30871965,https://www.ncbi.nlm.nih.gov/pubmed/30871965,30871965,,,29739467,"Xu WT, Shen GN, Luo YH, Piao XJ, Wang JR, Wang H, Zhang Y, Li JQ, Feng YC, Zhang Y, Zhang T, Wang SN, Wang CY, Jin CH. New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways. Chem Biol Interact. 2019 May 01;304():148–57. doi: 10.1016/j.cbi.2019.03.004. PMID: 30871965."
2068787,11506860,Therapeutic Target Database (TTD),"1,7,8,9-Tetrahydro-1,5-diaza-trindene-4,6-dione",D0NU5Z,"1,7,8,9-tetrahydro-1,5-diaza-trindene-4,6-dione",https://idrblab.net/ttd/data/drug/details/D0NU5Z,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2071408,11524144,Comparative Toxicogenomics Database (CTD),Dorsomorphin,C516138,dorsomorphin,https://ctdbase.org/detail.go?type=chem&acc=C516138,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dorsomorphin inhibits the reaction [artesunate results in increased cleavage of PARP1 protein],,,PMID:33002460,https://www.ncbi.nlm.nih.gov/pubmed/33002460,33002460,,,12220368,"Zhou X, Chen Y, Wang F, Wu H, Zhang Y, Liu J, Cai Y, Huang S, He N, Hu Z, Jin X. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem Biol Interact. 2020 Nov 01;331():109273. doi: 10.1016/j.cbi.2020.109273. PMID: 33002460."
2071409,11524144,Comparative Toxicogenomics Database (CTD),Dorsomorphin,C516138,dorsomorphin,https://ctdbase.org/detail.go?type=chem&acc=C516138,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dorsomorphin inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein],,,PMID:36843289,https://www.ncbi.nlm.nih.gov/pubmed/36843289,36843289,,,34977749,"Hou T, Wang Y, Dan W, Wei Y, Liu B, Que T, Lei Y, Yu B, Zeng J, Fan Y, Li L. ß-Ionone represses renal cell carcinoma progression through activating LKB1/AMPK-triggered autophagy. J Biochem Mol Toxicol. 2023 Jun;37(6):e23331. doi: 10.1002/jbt.23331. PMID: 36843289."
2072637,11524144,Comparative Toxicogenomics Database (CTD),Dorsomorphin,C516138,dorsomorphin,https://ctdbase.org/detail.go?type=chem&acc=C516138,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dorsomorphin promotes the reaction [silybin results in increased cleavage of PARP1 protein],,,PMID:34053323,https://www.ncbi.nlm.nih.gov/pubmed/34053323,34053323,,,25816613,"Yang J, Sun Y, Xu F, Liu W, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Autophagy and glycolysis independently attenuate silibinin-induced apoptosis in human hepatocarcinoma HepG2 and Hep3B cells. Hum Exp Toxicol. 2021 Dec;40(12):2048–62. doi: 10.1177/09603271211017609. PMID: 34053323."
2076812,11524144,Comparative Toxicogenomics Database (CTD),Dorsomorphin,C516138,dorsomorphin,https://ctdbase.org/detail.go?type=chem&acc=C516138,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dorsomorphin inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein],,,PMID:26887594,https://www.ncbi.nlm.nih.gov/pubmed/26887594,26887594,,PMC5423166,24303290,"Cheng X, Kim JY, Ghafoory S, Duvaci T, Rafiee R, Theobald J, Alborzinia H, Holenya P, Fredebohm J, Merz K, Mehrabi A, Hafezi M, Saffari A, Eisenbrand G, Hoheisel J, Wölfl S. Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. Molecular Oncology. 2016 Feb 04;10(6):806–24. doi: 10.1016/j.molonc.2016.01.008."
2226181,11524144,Comparative Toxicogenomics Database (CTD),Dorsomorphin,C516138,dorsomorphin,https://ctdbase.org/detail.go?type=chem&acc=C516138,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dorsomorphin results in increased cleavage of PARP1 protein,,,PMID:23274516|PMID:31900833,https://www.ncbi.nlm.nih.gov/pubmed/23274516|https://www.ncbi.nlm.nih.gov/pubmed/31900833,23274516|31900833,,,614163|8672656,"2020; 36(4):315-331|Huang SW, Wu CY, Wang YT, Kao JK, Lin CC, Chang CC, Mu SW, Chen YY, Chiu HW, Chang CH, Liang SM, Chen YJ, Huang JL, Shieh JJ. p53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells. Toxicol Appl Pharmacol. 2013 Feb 15;267(1):113–24. doi: 10.1016/j.taap.2012.12.016. PMID: 23274516."
2226317,11524144,Comparative Toxicogenomics Database (CTD),Dorsomorphin,C516138,dorsomorphin,https://ctdbase.org/detail.go?type=chem&acc=C516138,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TP53 mutant form inhibits the reaction [dorsomorphin results in increased cleavage of PARP1 protein],,,PMID:23274516,https://www.ncbi.nlm.nih.gov/pubmed/23274516,23274516,,,8672656,"Huang SW, Wu CY, Wang YT, Kao JK, Lin CC, Chang CC, Mu SW, Chen YY, Chiu HW, Chang CH, Liang SM, Chen YJ, Huang JL, Shieh JJ. p53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells. Toxicol Appl Pharmacol. 2013 Feb 15;267(1):113–24. doi: 10.1016/j.taap.2012.12.016. PMID: 23274516."
2168091,11545682,Comparative Toxicogenomics Database (CTD),"2,5-Dimethylcelecoxib",C506698,"2,5-dimethylcelecoxib",https://ctdbase.org/detail.go?type=chem&acc=C506698,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,5-dimethylcelecoxib results in increased cleavage of PARP1 protein",,,PMID:16123214|PMID:18485224,https://www.ncbi.nlm.nih.gov/pubmed/16123214|https://www.ncbi.nlm.nih.gov/pubmed/18485224,16123214|18485224,,PMC2396175,14615843|17349085,"2008; 7(1):38|Kardosh A, Soriano N, Liu YT, Uddin J, Petasis NA, Hofman FM, Chen TC, Schönthal AH. Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib. Blood. 2005 Dec 15;106(13):4330–8. doi: 10.1182/blood-2005-07-2819. PMID: 16123214."
2063595,11553859,BindingDB,2-({3-[(4-Cyclopentanecarbonylpiperazin-1-yl)carbonyl]phenyl}methoxy)benzamide,27665,2-({3-[(4-cyclopentanecarbonylpiperazin-1-yl)carbonyl]phenyl}methoxy)benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27665,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),188,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2237087,11625818,Comparative Toxicogenomics Database (CTD),Idelalisib,C552946,idelalisib,https://ctdbase.org/detail.go?type=chem&acc=C552946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[palbociclib results in increased susceptibility to idelalisib] which results in increased cleavage of PARP1 protein,,,PMID:23676220,https://www.ncbi.nlm.nih.gov/pubmed/23676220,23676220,,PMC3735703,24241274,"Chiron D, Martin P, Di Liberto M, Huang X, Ely S, Lannutti BJ, Leonard JP, Mason CE, Chen-Kiang S. Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kd inhibition through PIK3IP1. Cell Cycle. 2013 Jun 15;12(12):1892–900. PMID: 23676220; PMCID: PMC3735703."
2073661,11626560,Comparative Toxicogenomics Database (CTD),Crizotinib,D000077547,Crizotinib,https://ctdbase.org/detail.go?type=chem&acc=D000077547,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [crizotinib results in increased cleavage of PARP1 protein],,,PMID:31706006,https://www.ncbi.nlm.nih.gov/pubmed/31706006,31706006,,,3322128,"Hu Y, Zhang X, Zhao Z, Chen X, Zhou Z, Yang X, Yang B, He Q, Luo P. Keratinocytes apoptosis contributes to crizotinib induced-erythroderma. Toxicol Lett. 2020 Feb 01;319():102–10. doi: 10.1016/j.toxlet.2019.11.007. PMID: 31706006."
2074399,11626560,Comparative Toxicogenomics Database (CTD),Crizotinib,D000077547,Crizotinib,https://ctdbase.org/detail.go?type=chem&acc=D000077547,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Crizotinib results in increased cleavage of PARP1 protein,,,PMID:31639374|PMID:31706006,https://www.ncbi.nlm.nih.gov/pubmed/31639374|https://www.ncbi.nlm.nih.gov/pubmed/31706006,31639374|31706006,,,3322128|24376558,"Hu Y, Zhang X, Zhao Z, Chen X, Zhou Z, Yang X, Yang B, He Q, Luo P. Keratinocytes apoptosis contributes to crizotinib induced-erythroderma. Toxicol Lett. 2020 Feb 01;319():102–10. doi: 10.1016/j.toxlet.2019.11.007. PMID: 31706006.|Yan H, Du J, Chen X, Yang B, He Q, Yang X, Luo P. ROS-dependent DNA damage contributes to crizotinib-induced hepatotoxicity via the apoptotic pathway. Toxicol Appl Pharmacol. 2019 Nov 15;383():114768. doi: 10.1016/j.taap.2019.114768. PMID: 31639374."
2187462,11635763,Comparative Toxicogenomics Database (CTD),Quarfloxin,C545184,CX 3543,https://ctdbase.org/detail.go?type=chem&acc=C545184,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CX 3543 results in increased cleavage of PARP1 protein|z-val-ala-asp(ome)-fluoromethylketone inhibits the reaction [CX 3543 results in increased cleavage of PARP1 protein],,,PMID:19738048,https://www.ncbi.nlm.nih.gov/pubmed/19738048,19738048,,,32921121,"Drygin D, Siddiqui-Jain A, O'Brien S, Schwaebe M, Lin A, Bliesath J, Ho CB, Proffitt C, Trent K, Whitten JP, Lim JK, Von Hoff D, Anderes K, Rice WG. Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res. 2009 Oct 01;69(19):7653–61. doi: 10.1158/0008-5472.can-09-1304. PMID: 19738048."
1964512,11660296,Drug Gene Interaction database (DGIdb),"Benzopyrano(4,3,2-de)phthalazin-3(2H)-one, 10-((4-hydroxy-1-piperidinyl)methyl)-",,PARP INHIBITOR E7016,https://www.dgidb.org/drugs/ncit:C91387,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
1964513,11660296,Drug Gene Interaction database (DGIdb),"Benzopyrano(4,3,2-de)phthalazin-3(2H)-one, 10-((4-hydroxy-1-piperidinyl)methyl)-",,E-7016,https://www.dgidb.org/drugs/chembl:CHEMBL3527000,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2081770,11670314,BindingDB,2-[(3-{[4-(2-Phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)methoxy]benzamide,27667,2-[(3-{[4-(2-phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)methoxy]benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27667,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),36,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
1961304,11683005,Comparative Toxicogenomics Database (CTD),Darinaparsin,C515055,darinaparsin,https://ctdbase.org/detail.go?type=chem&acc=C515055,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Darinaparsin results in increased cleavage of PARP1 protein,,,PMID:25316819,https://www.ncbi.nlm.nih.gov/pubmed/25316819,25316819,,PMC4281835,5261481,"Ravi D, Bhalla S, Gartenhaus RB, Crombie J, Kandela I, Sharma J, Mazar A, Evens AM. The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models. Clin Cancer Res. 2014 Dec 01;20(23):6023–33. PMID: 25316819; PMCID: PMC4281835."
2208781,11707110,Comparative Toxicogenomics Database (CTD),Trametinib,C560077,trametinib,https://ctdbase.org/detail.go?type=chem&acc=C560077,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Trametinib promotes the reaction [physapubescin B results in increased cleavage of PARP1 protein],,,PMID:33035574,https://www.ncbi.nlm.nih.gov/pubmed/33035574,33035574,,,6804682,"Dai C, Shen L, Jin W, Lv B, Liu P, Wang X, Yin Y, Fu Y, Liang L, Ma Z, Zhang X, Wang Y, Xu D, Chen Z. Physapubescin B enhances the sensitivity of gastric cancer cells to trametinib by inhibiting the STAT3 signaling pathway. Toxicol Appl Pharmacol. 2020 Dec 01;408():115273. doi: 10.1016/j.taap.2020.115273. PMID: 33035574."
1962437,11724959,Comparative Toxicogenomics Database (CTD),"10'(Z),13'(E),15'(E)-Heptadecatrienylhydroquinone",C471674,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",https://ctdbase.org/detail.go?type=chem&acc=C471674,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased cleavage of PARP1 protein",,,PMID:23088786,https://www.ncbi.nlm.nih.gov/pubmed/23088786,23088786,,,30958779,"Lin TY, Huang CP, Au LC, Chang YW, Hu CY, Lin SB. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIa, enhances DNA breakage, and induces apoptosis in cancer cells. Chem Res Toxicol. 2012 Nov 19;25(11):2340–51. doi: 10.1021/tx3002302. PMID: 23088786."
2240180,11725479,Therapeutic Target Database (TTD),"1-(2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)phenyl)pyrrolidine-2,5-dione",D07QPV,KU-58684,https://idrblab.net/ttd/data/drug/details/D07QPV,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1985105,11725801,Comparative Toxicogenomics Database (CTD),Sauchinone,C410958,sauchinone,https://ctdbase.org/detail.go?type=chem&acc=C410958,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sauchinone results in increased cleavage of PARP1 protein,,,PMID:27871897,https://www.ncbi.nlm.nih.gov/pubmed/27871897,27871897,,,13480580,"Kim YW, Jang EJ, Kim CH, Lee JH. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells. Chem Biol Interact. 2017 Jan 05;261():108–17. doi: 10.1016/j.cbi.2016.11.016. PMID: 27871897."
2095352,11726399,BindingDB,"4-((4-Fluoro-3-(piperazine-1-carbonyl)phenyl)methyl)-1,2-dihydrophthalazin-1-one",27543,"4-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27543,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),5,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2095353,11736764,BindingDB,"13-Amino-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",27514,"13-amino-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27514,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),300,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2240904,11736764,Therapeutic Target Database (TTD),"13-Amino-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",D04ATU,"8-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one",https://idrblab.net/ttd/data/drug/details/D04ATU,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2095418,11749305,BindingDB,,27706,"8-chloro-2-[3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)propyl]-3,4-dihydroquinazolin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27706,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),23,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2216775,11749858,Comparative Toxicogenomics Database (CTD),Abexinostat,C512352,abexinostat,https://ctdbase.org/detail.go?type=chem&acc=C512352,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Abexinostat results in increased cleavage of PARP1 protein|quinoline-val-asp(ome)-CH2-OPH inhibits the reaction [abexinostat results in increased cleavage of PARP1 protein],,,PMID:18042714,https://www.ncbi.nlm.nih.gov/pubmed/18042714,18042714,,PMC2148315,31533350,"Adimoolam S, Sirisawad M, Chen J, Thiemann P, Ford JM, Buggy JJ. HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Proc Natl Acad Sci U S A. 2007 Dec 04;104(49):19482–7. PMID: 18042714; PMCID: PMC2148315."
2241356,11749858,Comparative Toxicogenomics Database (CTD),Abexinostat,C512352,abexinostat,https://ctdbase.org/detail.go?type=chem&acc=C512352,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[bortezomib co-treated with abexinostat] results in increased activity of PARP1 protein,,,PMID:19417023,https://www.ncbi.nlm.nih.gov/pubmed/19417023,19417023,,PMC2704489,28192789,"Bhalla S, Balasubramanian S, David K, Sirisawad M, Buggy J, Mauro L, Prachand S, Miller R, Gordon LI, Evens AM. PCI-24781 Induces Caspase and Reactive Oxygen Species–Dependent Apoptosis Through NF-?B Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells. 2009 May 15;15(10):3354–65. doi: 10.1158/1078-0432.ccr-08-2365."
1972031,11751549,Comparative Toxicogenomics Database (CTD),Losartan Potassium,D019808,Losartan,https://ctdbase.org/detail.go?type=chem&acc=D019808,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Losartan inhibits the reaction [AGT protein results in increased activity of PARP1 protein],,,PMID:15502880,https://www.ncbi.nlm.nih.gov/pubmed/15502880,15502880,,PMC1431352,5775817,2004; 10(1-6):28-35
1972032,11751549,Comparative Toxicogenomics Database (CTD),Losartan Potassium,D019808,Losartan,https://ctdbase.org/detail.go?type=chem&acc=D019808,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Losartan inhibits the reaction [AGT protein results in increased expression of PARP1 protein],,,PMID:21613793,https://www.ncbi.nlm.nih.gov/pubmed/21613793,21613793,,,9340212,"Zhu H, Jiang Z, Lei P, Huang W, Yu X. Poly(ADP-Ribose) Polymerase-1 Mediates Angiotensin II-Induced Expression of Plasminogen Activator Inhibitor-1 and Fibronectin in Rat Mesangial Cells. Kidney Blood Press Res. 2011;34(5):320–7. doi: 10.1159/000327344."
2097394,11773441,BindingDB,"13-fluoro-14-(1H-imidazole-1-sulfonyl)-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",27530,"13-fluoro-14-(1H-imidazole-1-sulfonyl)-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27530,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),500,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2138287,11784642,Comparative Toxicogenomics Database (CTD),Ganoderic acid DM,C584306,"3,7-dioxolanosta-8,24-dien-26-oic acid",https://ctdbase.org/detail.go?type=chem&acc=C584306,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"AKT1 protein inhibits the reaction [3,7-dioxolanosta-8,24-dien-26-oic acid results in increased cleavage of PARP1 protein]|3-methyladenine inhibits the reaction [3,7-dioxolanosta-8,24-dien-26-oic acid results in increased cleavage of PARP1 protein]|3,7-dioxolanosta-8,24-dien-26-oic acid results in increased cleavage of PARP1 protein",,,PMID:31874162,https://www.ncbi.nlm.nih.gov/pubmed/31874162,31874162,,,16950886,"Xia J, Dai L, Wang L, Zhu J. Ganoderic acid DM induces autophagic apoptosis in non-small cell lung cancer cells by inhibiting the PI3K/Akt/mTOR activity. Chem Biol Interact. 2020 Jan 25;316():108932. doi: 10.1016/j.cbi.2019.108932. PMID: 31874162."
1966500,11842604,BindingDB,2-[(2s)-2-Methylpyrrolidin-2-Yl]-1h-Benzimidazole-7-Carboxamide,27136,"2-[(2S)-2-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27136,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),5,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2103205,11953931,Comparative Toxicogenomics Database (CTD),Vocamine,C005891,voacamine,https://ctdbase.org/detail.go?type=chem&acc=C005891,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[voacamine co-treated with paclitaxel] results in increased cleavage of PARP1 protein,,,PMID:34856211,https://www.ncbi.nlm.nih.gov/pubmed/34856211,34856211,,,12958502,"Pellegrini E, Multari G, Gallo FR, Vecchiotti D, Zazzeroni F, Condello M, Meschini S. A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells. Toxicol Appl Pharmacol. 2022 Jan 01;434():115816. doi: 10.1016/j.taap.2021.115816. PMID: 34856211."
1968721,11959733,BindingDB,"2-[(2R)-2-methyl-5-oxopyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27155,"2-[(2R)-2-methyl-5-oxopyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27155,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),23,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1968722,11960528,BindingDB,2-(2-methyl-2-pyrrolidinyl)-1H-benzimidazole-4-carboxamide,27149,"2-(2-methylpyrrolidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27149,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),4,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1209698,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1964726,11960529,Chemical Probes Portal,Veliparib,Veliparib,Veliparib,https://www.chemicalprobes.org/veliparib,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),"Catalytic inhibitor, PARP-DNA complex trapping",,"5.2 nM, 3.3 nM, 2.9 nM, 17.5 nM",PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
1968723,11960529,BindingDB,Veliparib,27135,"2-[(2R)-2-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27135,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),5,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1977055,11960529,Comparative Toxicogenomics Database (CTD),Veliparib,C521013,veliparib,https://ctdbase.org/detail.go?type=chem&acc=C521013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the susceptibility to [temozolomide co-treated with veliparib],,,PMID:19825992,https://www.ncbi.nlm.nih.gov/pubmed/19825992,19825992,,,30911884,"Liu X, Han EK, Anderson M, Shi Y, Semizarov D, Wang G, McGonigal T, Roberts L, Lasko L, Palma J, Zhu GD, Penning T, Rosenberg S, Giranda VL, Luo Y, Leverson J, Johnson EF, Shoemaker AR. Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways. Mol Cancer Res. 2009 Oct;7(10):1686–92. doi: 10.1158/1541-7786.mcr-09-0299. PMID: 19825992."
1977056,11960529,Comparative Toxicogenomics Database (CTD),Veliparib,C521013,veliparib,https://ctdbase.org/detail.go?type=chem&acc=C521013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Veliparib binds to and results in decreased activity of PARP1 protein,,,PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
1977057,11960529,Comparative Toxicogenomics Database (CTD),Veliparib,C521013,veliparib,https://ctdbase.org/detail.go?type=chem&acc=C521013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Veliparib inhibits the reaction [hydrogen peroxide affects the reaction [PARP1 protein mutant form affects the abundance of nad]]|veliparib results in increased expression of PARP1 protein mutant form|veliparib inhibits the reaction [PARP1 protein mutant form results in increased expression of H2AX protein modified form]|veliparib inhibits the reaction [PARP1 protein mutant form affects the abundance of nad]|veliparib inhibits the reaction [PARP1 protein mutant form results in increased expression of RPA2 protein modified form],,,PMID:27694308,https://www.ncbi.nlm.nih.gov/pubmed/27694308,27694308,,PMC5137445,29679245,"Rank L, Veith S, Gwosch EC, Demgenski J, Ganz M, Jongmans MC, Vogel C, Fischbach A, Buerger S, Fischer JM, Zubel T, Stier A, Renner C, Schmalz M, Beneke S, Groettrup M, Kuiper RP, Bürkle A, Ferrando-May E, Mangerich A. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells. Nucleic Acids Res. 2016 Dec 01;44(21):10386–405. PMID: 27694308; PMCID: PMC5137445."
1977058,11960529,Comparative Toxicogenomics Database (CTD),Veliparib,C521013,veliparib,https://ctdbase.org/detail.go?type=chem&acc=C521013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Veliparib results in decreased activity of PARP1 protein,,,PMID:17505006|PMID:19143569|PMID:21300766|PMID:21917757|PMID:22041887,https://www.ncbi.nlm.nih.gov/pubmed/17505006|https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://www.ncbi.nlm.nih.gov/pubmed/21300766|https://www.ncbi.nlm.nih.gov/pubmed/21917757|https://www.ncbi.nlm.nih.gov/pubmed/22041887,17505006|19143569|21300766|21917757|22041887,,PMC3280908|PMC3407272|PMC4348156,5194874|23509371|24837969|26218140|27494845,"Neri P, Ren L, Gratton K, Stebner E, Johnson J, Klimowicz A, Duggan P, Tassone P, Mansoor A, Stewart DA, Lonial S, Boise LH, Bahlis NJ. Bortezomib-induced ""BRCAness"" sensitizes multiple myeloma cells to PARP inhibitors. Blood. 2011 Dec 08;118(24):6368–79. PMID: 21917757; PMCID: PMC4348156.|Martinez-Outschoorn UE, Goldberg AF, Lin Z, Ko Y, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP. Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells. Cancer Biology & Therapy. 2011 Nov 15;12(10):924–38. doi: 10.4161/cbt.12.10.17780.|Vilar E, Bartnik CM, Stenzel SL, Raskin L, Ahn J, Moreno V, Mukherjee B, Iniesta MD, Morgan MA, Rennert G, Gruber SB. <i>MRE11</i>Deficiency Increases Sensitivity to Poly(ADP-ribose) Polymerase Inhibition in Microsatellite Unstable Colorectal Cancers. 2011 Mar 31;71(7):2632–42. doi: 10.1158/0008-5472.can-10-1120.|Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569.|Albert JM, Cao C, Kim KW, Willey CD, Geng L, Xiao D, Wang H, Sandler A, Johnson DH, Colevas AD, Low J, Rothenberg ML, Lu B. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res. 2007 May 15;13(10):3033–42. doi: 10.1158/1078-0432.ccr-06-2872. PMID: 17505006."
1977059,11960529,Comparative Toxicogenomics Database (CTD),Veliparib,C521013,veliparib,https://ctdbase.org/detail.go?type=chem&acc=C521013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Veliparib results in increased expression of PARP1 protein,,,PMID:19823047,https://www.ncbi.nlm.nih.gov/pubmed/19823047,19823047,,,30909104,"Yang SX, Kummar S, Steinberg SM, Murgo AJ, Gutierrez M, Rubinstein L, Nguyen D, Kaur G, Chen AP, Giranda VL, Tomaszewski JE, Doroshow JH; National Cancer Institute Phase 0 Working Group. Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomas. Cancer Biol Ther. 2009 Nov;8(21):2004–9. doi: 10.4161/cbt.8.21.9917. PMID: 19823047."
1977060,11960529,Comparative Toxicogenomics Database (CTD),Veliparib,C521013,veliparib,https://ctdbase.org/detail.go?type=chem&acc=C521013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[veliparib results in increased expression of PARP1 protein] which results in increased expression of H2AX protein,,,PMID:17505006,https://www.ncbi.nlm.nih.gov/pubmed/17505006,17505006,,,27494845,"Albert JM, Cao C, Kim KW, Willey CD, Geng L, Xiao D, Wang H, Sandler A, Johnson DH, Colevas AD, Low J, Rothenberg ML, Lu B. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res. 2007 May 15;13(10):3033–42. doi: 10.1158/1078-0432.ccr-06-2872. PMID: 17505006."
1977061,11960529,Comparative Toxicogenomics Database (CTD),Veliparib,C521013,veliparib,https://ctdbase.org/detail.go?type=chem&acc=C521013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[veliparib results in decreased activity of PARP1 protein] which results in increased susceptibility to camptothecin|veliparib results in decreased activity of PARP1 protein,,,PMID:22158865,https://www.ncbi.nlm.nih.gov/pubmed/22158865,22158865,,PMC3281688,15401584,"Patel AG, Flatten KS, Schneider PA, Dai NT, McDonald JS, Poirier GG, Kaufmann SH. Enhanced Killing of Cancer Cells by Poly(ADP-ribose) Polymerase Inhibitors and Topoisomerase I Inhibitors Reflects Poisoning of Both Enzymes. Journal of Biological Chemistry. 2012 Feb;287(6):4198–210. doi: 10.1074/jbc.m111.296475."
1977189,11960529,Comparative Toxicogenomics Database (CTD),Veliparib,C521013,veliparib,https://ctdbase.org/detail.go?type=chem&acc=C521013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Veliparib results in decreased activity of PARP1 protein,,,PMID:17473206|PMID:21417348|PMID:30157956,https://www.ncbi.nlm.nih.gov/pubmed/17473206|https://www.ncbi.nlm.nih.gov/pubmed/21417348|https://www.ncbi.nlm.nih.gov/pubmed/30157956,17473206|21417348|30157956,,PMC6114235,5361163|7900236|28909941,"2018; 6(1):84|Sunderland PT, Woon EC, Dhami A, Bergin AB, Mahon MF, Wood PJ, Jones LA, Tully SR, Lloyd MD, Thompson AS, Javaid H, Martin NM, Threadgill MD. 5-Benzamidoisoquinolin-1-ones and 5-(?-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2). J Med Chem. 2011 Apr 14;54(7):2049–59. doi: 10.1021/jm1010918. PMID: 21417348.|Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, Ferguson DC, Ghoreishi-Haack NS, Grimm DR, Guan R, Han EK, Holley-Shanks RR, Hristov B, Idler KB, Jarvis K, Johnson EF, Kleinberg LR, Klinghofer V, Lasko LM, Liu X, Marsh KC, McGonigal TP, Meulbroek JA, Olson AM, Palma JP, Rodriguez LE, Shi Y, Stavropoulos JA, Tsurutani AC, Zhu GD, Rosenberg SH, Giranda VL, Frost DJ. ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models. Clin Cancer Res. 2007 May 01;13(9):2728–37. doi: 10.1158/1078-0432.ccr-06-3039. PMID: 17473206."
2067599,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2067600,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2141870,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2178000,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2192491,11960529,DrugBank,Veliparib,DB07232,Veliparib,https://www.drugbank.ca/drugs/DB07232,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,PMC102472,12499145,"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
2192814,11960529,BindingDB,Veliparib,209932,2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=209932,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),10.3,PMID:27866910|DOI:10.1016/j.chembiol.2016.10.011,https://www.ncbi.nlm.nih.gov/pubmed/27866910|https://doi.org/10.1016/j.chembiol.2016.10.011,27866910,10.1016/j.chembiol.2016.10.011,PMC5182133,33069478,"Knezevic CE, Wright G, Remsing Rix LL, Kim W, Kuenzi BM, Luo Y, Watters JM, Koomen JM, Haura EB, Monteiro AN, Radu C, Lawrence HR, Rix U. Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Cell Chemical Biology. 2016 Dec;23(12):1490–503. doi: 10.1016/j.chembiol.2016.10.011."
2220897,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2245547,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Other/unknown,,,,,,,,,
1969356,11960530,BindingDB,"2-(1,2-dimethylpyrrolidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27137,"2-(1,2-dimethylpyrrolidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27137,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),6,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969357,11960533,BindingDB,"2-[2-methyl-1-(propan-2-yl)pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27150,"2-[2-methyl-1-(propan-2-yl)pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27150,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),17,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969358,11960630,BindingDB,"2-(1-cyclobutyl-2-methylpyrrolidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27151,"2-(1-cyclobutyl-2-methylpyrrolidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27151,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),31,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969359,11960631,BindingDB,"2-(3-methylpyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27139,"2-(3-methylpyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27139,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),4,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969360,11960635,BindingDB,"2-[3-methyl-1-(propan-2-yl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",27140,"2-[3-methyl-1-(propan-2-yl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27140,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),6,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969361,11960733,BindingDB,"2-[3-methyl-1-(2-phenylethyl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",27154,"2-[3-methyl-1-(2-phenylethyl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27154,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),10,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969362,11960735,BindingDB,"2-(2-methylazetidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27146,"2-(2-methylazetidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27146,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),13,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969471,11960736,BindingDB,"2-[2-methyl-1-(propan-2-yl)azetidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27147,"2-[2-methyl-1-(propan-2-yl)azetidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27147,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),42,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969472,11960831,BindingDB,"2-(3-methylazetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27134,"2-(3-methylazetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27134,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),4,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969473,11960919,BindingDB,"2-(2-methylpiperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27141,"2-(2-methylpiperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27141,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),5,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969474,11960920,BindingDB,"2-(2-methyl-1-propylpiperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27143,"2-(2-methyl-1-propylpiperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27143,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),19,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969475,11960923,BindingDB,"2-[4-methyl-1-(propan-2-yl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",27162,"2-[4-methyl-1-(propan-2-yl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27162,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),8,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969476,11960925,BindingDB,"2-(4-methylazepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27145,"2-(4-methylazepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27145,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),3,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1969477,11960926,BindingDB,"2-(1-cyclopentyl-4-methylazepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27163,"2-(1-cyclopentyl-4-methylazepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27163,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),7,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1970250,11961002,BindingDB,"2-{1-[(2-fluorophenyl)methyl]-3-methylpyrrolidin-3-yl}-1H-1,3-benzodiazole-4-carboxamide",27153,"2-{1-[(2-fluorophenyl)methyl]-3-methylpyrrolidin-3-yl}-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27153,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),9,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1970251,11961006,BindingDB,"2-(2-methylpyrrolidin-2-yl)-6-(trifluoromethyl)-1H-1,3-benzodiazole-4-carboxamide",27160,"2-(2-methylpyrrolidin-2-yl)-6-(trifluoromethyl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27160,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),3300,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1970252,11961010,BindingDB,"6-chloro-2-[(2R)-2-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27159,"6-chloro-2-[(2R)-2-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27159,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),10,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
1970253,11961092,BindingDB,"6-fluoro-2-[(2R)-2-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27158,"6-fluoro-2-[(2R)-2-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27158,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),3,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2212031,11969542,Comparative Toxicogenomics Database (CTD),Cinobufagin,C002471,cinobufagin,https://ctdbase.org/detail.go?type=chem&acc=C002471,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 216763 promotes the reaction [cinobufagin results in increased expression of PARP1 protein modified form]|gsk3b protein mutant form inhibits the reaction [cinobufagin results in increased expression of PARP1 protein modified form]|cinobufagin results in increased expression of PARP1 protein modified form,,,PMID:23164673,https://www.ncbi.nlm.nih.gov/pubmed/23164673,23164673,,,33655286,"Yin JQ, Wen L, Wu LC, Gao ZH, Huang G, Wang J, Zou CY, Tan PX, Yong BC, Jia Q, Shen JN. The glycogen synthase kinase-3ß/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells. Toxicol Lett. 2013 Apr 12;218(2):129–36. doi: 10.1016/j.toxlet.2012.11.006. PMID: 23164673."
1973876,11977753,Comparative Toxicogenomics Database (CTD),Dactolisib,C531198,dactolisib,https://ctdbase.org/detail.go?type=chem&acc=C531198,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dactolisib results in increased cleavage of PARP1 protein,,,PMID:21464613,https://www.ncbi.nlm.nih.gov/pubmed/21464613,21464613,,PMC3127046,1752982,"Leung E, Kim JE, Rewcastle GW, Finlay GJ, Baguley BC. Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells. Cancer Biology & Therapy. 2011 Jun;11(11):938–46. doi: 10.4161/cbt.11.11.15527."
2221778,11986239,Toxin and Toxin Target Database (T3DB),"Cobalt, dicarbonyl-pi-cyclopentadienyl-",T3D1398,Cyclopentadienylcobalt dicarbonyl,http://www.t3db.ca/toxins/T3D1398,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2143658,12000657,Comparative Toxicogenomics Database (CTD),Cysteine Protease inhibitor,D015853,Cysteine Proteinase Inhibitors,https://ctdbase.org/detail.go?type=chem&acc=D015853,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cysteine proteinase inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein|[cysteine proteinase inhibitors results in decreased activity of USP8 protein] promotes the reaction [chloroquine results in increased cleavage of PARP1 protein]|pifithrin inhibits the reaction [[cysteine proteinase inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]|[cysteine proteinase inhibitors results in decreased activity of USP8 protein] promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]|chloroquine promotes the reaction [[cysteine proteinase inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]|bafilomycin A1 promotes the reaction [[cysteine proteinase inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein],,,PMID:35022897,https://www.ncbi.nlm.nih.gov/pubmed/35022897,35022897,,,10229733,2022; 39(5):2011-2032
2181323,12313376,Comparative Toxicogenomics Database (CTD),CID 12313376,C042198,nimbolide,https://ctdbase.org/detail.go?type=chem&acc=C042198,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nimbolide results in increased expression of PARP1 protein modified form,,,PMID:28383207|PMID:29962003,https://www.ncbi.nlm.nih.gov/pubmed/28383207|https://www.ncbi.nlm.nih.gov/pubmed/29962003,28383207|29962003,,,6746544|12132360,"Hsueh KC, Lin CL, Tung JN, Yang SF, Hsieh YH. Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells. Environ Toxicol. 2018 Sep;33(9):913–22. doi: 10.1002/tox.22576. PMID: 29962003.|Chien SY, Hsu CH, Lin CC, Chuang YC, Lo YS, Hsi YT, Hsieh MJ, Chen MK. Nimbolide induces apoptosis in human nasopharyngeal cancer cells. Environ Toxicol. 2017 Aug;32(8):2085–92. doi: 10.1002/tox.22423. PMID: 28383207."
2181324,12313376,Comparative Toxicogenomics Database (CTD),CID 12313376,C042198,nimbolide,https://ctdbase.org/detail.go?type=chem&acc=C042198,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),U 0126 inhibits the reaction [nimbolide results in increased expression of PARP1 protein modified form],,,PMID:29962003,https://www.ncbi.nlm.nih.gov/pubmed/29962003,29962003,,,6746544,"Hsueh KC, Lin CL, Tung JN, Yang SF, Hsieh YH. Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells. Environ Toxicol. 2018 Sep;33(9):913–22. doi: 10.1002/tox.22576. PMID: 29962003."
1973477,12968471,Comparative Toxicogenomics Database (CTD),Haplophytin A,C554291,"10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one",https://ctdbase.org/detail.go?type=chem&acc=C554291,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in increased cleavage of PARP1 protein",,,PMID:20833157,https://www.ncbi.nlm.nih.gov/pubmed/20833157,20833157,,,25550760,"Won KJ, Chung KS, Lee YS, Alia MS, Pervez MK, Fatima S, Choi JH, Lee KT. Haplophytin-A induces caspase-8-mediated apoptosis via the formation of death-inducing signaling complex in human promyelocytic leukemia HL-60 cells. Chem Biol Interact. 2010 Dec 05;188(3):505–11. doi: 10.1016/j.cbi.2010.09.001. PMID: 20833157."
2111121,13352211,BindingDB,,27694,"3,5-dimethyl-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27694,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),29.8,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2111122,13352215,BindingDB,,27704,"3,5-diphenyl-4,5,7-triazatricyclo[7.4.0.0^{2,6}]trideca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27704,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2257311,13643880,Toxin and Toxin Target Database (T3DB),Pentachloroarsorane,T3D1296,Arsenic pentachloride,http://www.t3db.ca/toxins/T3D1296,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2105617,14048876,Toxin and Toxin Target Database (T3DB),Cobaltous 2-naphthenic acid,T3D0663,Cobalt(II) naphthenate,http://www.t3db.ca/toxins/T3D0663,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2183031,14101198,Comparative Toxicogenomics Database (CTD),Ubo-Qic,C000607068,FR900359,https://ctdbase.org/detail.go?type=chem&acc=C000607068,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),FR900359 results in increased phosphorylation of PARP1 protein,,,PMID:37730182,https://www.ncbi.nlm.nih.gov/pubmed/37730182,37730182,,PMC10616553,36541327,"Onken MD, Erdmann-Gilmore P, Zhang Q, Thapa K, King E, Kaltenbronn KM, Noda SE, Makepeace CM, Goldfarb D, Babur Ö, Townsend RR, Blumer KJ. Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic Analyses. Molecular & Cellular Proteomics. 2023 Nov;22(11):100649. doi: 10.1016/j.mcpro.2023.100649."
2147732,14132199,Comparative Toxicogenomics Database (CTD),Riccardin D,C547185,riccardin D,https://ctdbase.org/detail.go?type=chem&acc=C547185,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Riccardin D results in increased cleavage of PARP1 protein,,,PMID:24069304,https://www.ncbi.nlm.nih.gov/pubmed/24069304,24069304,,PMC3775815,16117129,"Hu Z, Kong F, Si M, Tian K, Yu LX, Young CYF, Yuan H, Lou H. Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In Vivo. PLoS ONE. 2013 Sep 17;8(9):e74387. doi: 10.1371/journal.pone.0074387."
2233212,14485504,Comparative Toxicogenomics Database (CTD),Euptox A,C098165,"9-oxo-10,11-dehydroagerophorone",https://ctdbase.org/detail.go?type=chem&acc=C098165,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"9-oxo-10,11-dehydroagerophorone results in increased cleavage of PARP1 protein",,,PMID:33132240,https://www.ncbi.nlm.nih.gov/pubmed/33132240,33132240,,,6107674,"Okyere SK, Mo Q, Pei G, Ren Z, Deng J, Hu Y. Euptox A Induces G0 /GI arrest and apoptosis of hepatocyte via ROS, mitochondrial dysfunction and caspases-dependent pathways in vivo. J Toxicol Sci. 2020;45(11):661–71. doi: 10.2131/jts.45.661. PMID: 33132240."
1994138,14771682,Comparative Toxicogenomics Database (CTD),"Guanidine, N,N'-dibutyl-",C060540,polyhexamethyleneguanidine,https://ctdbase.org/detail.go?type=chem&acc=C060540,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Polyhexamethyleneguanidine results in increased cleavage of PARP1 protein,,,PMID:29309811|PMID:31168028,https://www.ncbi.nlm.nih.gov/pubmed/29309811|https://www.ncbi.nlm.nih.gov/pubmed/31168028,29309811|31168028,,,18240454|33807317,"Park JS, Park YJ, Kim HR, Chung KH. Polyhexamethylene guanidine phosphate-induced ROS-mediated DNA damage caused cell cycle arrest and apoptosis in lung epithelial cells. J Toxicol Sci. 2019;44(6):415–24. doi: 10.2131/jts.44.415. PMID: 31168028.|Park EJ, Park SJ, Kim S, Lee K, Chang J. Lung fibroblasts may play an important role in clearing apoptotic bodies of bronchial epithelial cells generated by exposure to PHMG-P-containing solution. Toxicol Lett. 2018 Apr;286():108–19. doi: 10.1016/j.toxlet.2018.01.003. PMID: 29309811."
2000892,15241817,Comparative Toxicogenomics Database (CTD),CID 15241817,C058317,arsenic disulfide,https://ctdbase.org/detail.go?type=chem&acc=C058317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenic disulfide results in increased cleavage of PARP1 protein|arsenic disulfide promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased cleavage of PARP1 protein],,,PMID:30542770,https://www.ncbi.nlm.nih.gov/pubmed/30542770,30542770,,,25734843,2018; 83(3):519-530
2000893,15241817,Comparative Toxicogenomics Database (CTD),CID 15241817,C058317,arsenic disulfide,https://ctdbase.org/detail.go?type=chem&acc=C058317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Arsenic disulfide results in increased degradation of PARP1 protein,,,PMID:17615687,https://www.ncbi.nlm.nih.gov/pubmed/17615687,17615687,,,2373275,2007; 30(5):653-658
2000894,15241817,Comparative Toxicogenomics Database (CTD),CID 15241817,C058317,arsenic disulfide,https://ctdbase.org/detail.go?type=chem&acc=C058317,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Arsenic disulfide results in increased expression of PARP1 protein,,,PMID:33878415,https://www.ncbi.nlm.nih.gov/pubmed/33878415,33878415,,,665622,"Zhang S, Li C, Feng T, Cao S, Zhou H, Li L, Hu Q, Mao X, Ji S. Proteomics analysis in the kidney of mice following oral feeding Realgar. J Ethnopharmacol. 2021 Jul 15;275():114118. doi: 10.1016/j.jep.2021.114118. PMID: 33878415."
2115240,15285131,BindingDB,"4,5-Dihydro-2-[4-(4-methyl-1H-imidazol-5-yl)-1-piperidinyl]-6H-imidazo[4,5,1-ij]quinolin-6-one",27493,"2-[4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl]-1,3-diazatricyclo[6.3.1.0^{4,12}]dodeca-2,4,6,8(12)-tetraen-9-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27493,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),4.4,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
2269432,15558498,Comparative Toxicogenomics Database (CTD),Aflatoxin M1,D016607,Aflatoxin M1,https://ctdbase.org/detail.go?type=chem&acc=D016607,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[aflatoxin M1 co-treated with ochratoxin A] results in increased expression of PARP1 protein,,,PMID:34126166,https://www.ncbi.nlm.nih.gov/pubmed/34126166,34126166,,,29127678,"Wang Z, Gao Y, Huang X, Huang S, Yang X, Wang J, Zheng N. Metabolomics analysis underlay mechanisms in the renal impairment of mice caused by combination of aflatoxin M1 and ochratoxin A. Toxicology. 2021 Jun 30;458():152835. doi: 10.1016/j.tox.2021.152835. PMID: 34126166."
2086182,15558620,Comparative Toxicogenomics Database (CTD),Alisol B,C457232,alisol B,https://ctdbase.org/detail.go?type=chem&acc=C457232,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Alisol B results in increased cleavage of PARP1 protein,,,PMID:20197400,https://www.ncbi.nlm.nih.gov/pubmed/20197400,20197400,,,11978317,"Law BY, Wang M, Ma DL, Al-Mousa F, Michelangeli F, Cheng SH, Ng MH, To KF, Mok AY, Ko RY, Lam SK, Chen F, Che CM, Chiu P, Ko BC. Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase pump, induces autophagy, endoplasmic reticulum stress, and apoptosis. Mol Cancer Ther. 2010 Mar;9(3):718–30. doi: 10.1158/1535-7163.mct-09-0700. PMID: 20197400."
2155001,15571694,Comparative Toxicogenomics Database (CTD),Diacetoxyscirpenol,C001809,diacetoxyscirpenol,https://ctdbase.org/detail.go?type=chem&acc=C001809,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Diacetoxyscirpenol results in decreased expression of PARP1 mRNA,,,PMID:31836554,https://www.ncbi.nlm.nih.gov/pubmed/31836554,31836554,,,22343387,"Nakajima K, Ito Y, Kikuchi S, Okano H, Takashima K, Woo GH, Yoshida T, Yoshinari T, Sugita-Konishi Y, Shibutani M. Developmental exposure to diacetoxyscirpenol reversibly disrupts hippocampal neurogenesis by inducing oxidative cellular injury and suppressed differentiation of granule cell lineages in mice. Food Chem Toxicol. 2020 Feb;136():111046. doi: 10.1016/j.fct.2019.111046. PMID: 31836554."
2116339,15637614,Comparative Toxicogenomics Database (CTD),DIM-C-pPhCO2Me,C000610380,"p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane",https://ctdbase.org/detail.go?type=chem&acc=C000610380,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"P-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane results in increased cleavage of PARP1 protein",,,PMID:26035713,https://www.ncbi.nlm.nih.gov/pubmed/26035713,26035713,,PMC4452731,18170096,"Hedrick E, Lee S, Kim G, Abdelrahim M, Jin U, Safe S, Abudayyeh A. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma. PLoS ONE. 2015 Jun 02;10(6):e0128308. doi: 10.1371/journal.pone.0128308."
1221139,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[enzalutamide co-treated with GSK-2816126] results in increased cleavage of PARP1 protein,,,PMID:32805266,https://www.ncbi.nlm.nih.gov/pubmed/32805266,32805266,,,8846504,"Shankar E, Franco D, Iqbal O, Moreton S, Kanwal R, Gupta S. Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer. Toxicol Appl Pharmacol. 2020 Oct 01;404():115200. doi: 10.1016/j.taap.2020.115200. PMID: 32805266."
1221140,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Enzalutamide results in decreased cleavage of PARP1 protein|enzalutamide promotes the reaction [NVP-BHG712 results in increased cleavage of PARP1 protein]|ephb4 protein affects the reaction [enzalutamide results in decreased cleavage of PARP1 protein],,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,PMC7170517,14921158,"Li C, Lanman NA, Kong Y, He D, Mao F, Farah E, Zhang Y, Liu J, Wang C, Wei Q, Liu X. Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance. Journal of Biological Chemistry. 2020 Apr;295(16):5470–83. doi: 10.1074/jbc.ra119.011385."
1221141,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[NOTCH1 protein affects the susceptibility to enzalutamide] which affects the cleavage of PARP1 protein|[nirogacestat results in increased susceptibility to enzalutamide] which results in increased cleavage of PARP1 protein,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,PMC6544854,31773549,"Farah E, Li C, Cheng L, Kong Y, Lanman NA, Pascuzzi P, Lorenz GR, Zhang Y, Ahmad N, Li L, Ratliff T, Liu X. NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. Journal of Biological Chemistry. 2019 May;294(21):8543–54. doi: 10.1074/jbc.ra118.006983."
2196407,15953832,Comparative Toxicogenomics Database (CTD),"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide",C523799,MRK 003,https://ctdbase.org/detail.go?type=chem&acc=C523799,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MRK 003 results in increased cleavage of PARP1 protein,,,PMID:17804716,https://www.ncbi.nlm.nih.gov/pubmed/17804716,17804716,,,11268517,"Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP, Dang TP. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res. 2007 Sep 01;67(17):8051–7. doi: 10.1158/0008-5472.can-07-1022. PMID: 17804716."
2133001,16129627,Comparative Toxicogenomics Database (CTD),Melitten,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Melitten inhibits the reaction [TGFB1 protein results in increased cleavage of PARP1 protein],,,PMID:21871910,https://www.ncbi.nlm.nih.gov/pubmed/21871910,21871910,,,6612206,"Lee WR, Park JH, Kim KH, Park YY, Han SM, Park KK. Protective effects of melittin on transforming growth factor-ß1 injury to hepatocytes via anti-apoptotic mechanism. Toxicol Appl Pharmacol. 2011 Oct 15;256(2):209–15. doi: 10.1016/j.taap.2011.08.012. PMID: 21871910."
2205375,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oenothein B results in increased expression of PARP1 protein,,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,,25037992,"Pei X, Xiao J, Wei G, Zhang Y, Lin F, Xiong Z, Lu L, Wang X, Pang G, Jiang Y, Jiang L. Oenothein B inhibits human non-small cell lung cancer A549 cell proliferation by ROS-mediated PI3K/Akt/NF-?B signaling pathway. Chem Biol Interact. 2019 Jan 25;298():112–20. doi: 10.1016/j.cbi.2018.09.021. PMID: 30452899."
2117076,16211641,Toxin and Toxin Target Database (T3DB),Sodium hexanitritocobaltate(III),T3D0681,Sodium cobaltinitrite,http://www.t3db.ca/toxins/T3D0681,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2164395,16211978,Comparative Toxicogenomics Database (CTD),Iron Oxide Black,D052203,Ferrosoferric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D052203,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ferrosoferric oxide binds to titanium dioxide] which results in decreased expression of PARP1 protein,,,PMID:30098274,https://www.ncbi.nlm.nih.gov/pubmed/30098274,30098274,,,19626513,"Su H, Li Z, Lazar L, Alhamoud Y, Song X, Li J, Wang Y, Fiati kenston SS, Lqbal MZ, Wu A, Li Z, Hua Q, Ding M, Zhao J. In vitro evaluation of the toxicity and underlying molecular mechanisms of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in human liver cells. Environmental Toxicology. 2018 Aug 11;33(10):1078–88. doi: 10.1002/tox.22631."
2158542,16217806,Comparative Toxicogenomics Database (CTD),Methylmethionine Sulfonium Chloride,D014814,Vitamin U,https://ctdbase.org/detail.go?type=chem&acc=D014814,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Vitamin U inhibits the reaction [valproic acid results in decreased cleavage of PARP1 protein],,,PMID:34420476,https://www.ncbi.nlm.nih.gov/pubmed/34420476,34420476,,,21714550,"Celik E, Tunali S, Gezginci-Oktayoglu S, Bolkent S, Can A, Yanardag R. Vitamin U prevents valproic acid-induced liver injury through supporting enzymatic antioxidant system and increasing hepatocyte proliferation triggered by inflammation and apoptosis. Toxicology Mechanisms and Methods. 2021 Aug 22;31(8):600–8. doi: 10.1080/15376516.2021.1943089."
2240415,16221809,Therapeutic Target Database (TTD),"3-aminobenzo[c][1,5]naphthyridin-6(5H)-one",D0EI6X,"3-aminobenzo[c][1,5]naphthyridin-6(5H)-one",https://idrblab.net/ttd/data/drug/details/D0EI6X,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2142652,16222096,Comparative Toxicogenomics Database (CTD),Cobimetinib,C574276,cobimetinib,https://ctdbase.org/detail.go?type=chem&acc=C574276,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Cobimetinib results in increased cleavage of PARP1 protein|cobimetinib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein]|2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in increased cleavage of PARP1 protein]",,,PMID:22084396,https://www.ncbi.nlm.nih.gov/pubmed/22084396,22084396,,,3152129,"Hoeflich KP, Merchant M, Orr C, Chan J, Den Otter D, Berry L, Kasman I, Koeppen H, Rice K, Yang NY, Engst S, Johnston S, Friedman LS, Belvin M. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. Cancer Res. 2012 Jan 01;72(1):210–9. doi: 10.1158/0008-5472.can-11-1515. PMID: 22084396."
2230946,16394563,Comparative Toxicogenomics Database (CTD),"4-oxo-4-{[(5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid",D000077332,Artesunate,https://ctdbase.org/detail.go?type=chem&acc=D000077332,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acadesine promotes the reaction [artesunate results in increased cleavage of PARP1 protein]|dorsomorphin inhibits the reaction [artesunate results in increased cleavage of PARP1 protein]|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [artesunate results in increased cleavage of PARP1 protein]|3-methyladenine inhibits the reaction [artesunate results in increased cleavage of PARP1 protein]|acetylcysteine inhibits the reaction [artesunate results in increased cleavage of PARP1 protein]|sirolimus promotes the reaction [artesunate results in increased cleavage of PARP1 protein],,,PMID:33002460,https://www.ncbi.nlm.nih.gov/pubmed/33002460,33002460,,,12220368,"Zhou X, Chen Y, Wang F, Wu H, Zhang Y, Liu J, Cai Y, Huang S, He N, Hu Z, Jin X. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem Biol Interact. 2020 Nov 01;331():109273. doi: 10.1016/j.cbi.2020.109273. PMID: 33002460."
2230947,16394563,Comparative Toxicogenomics Database (CTD),"4-oxo-4-{[(5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid",D000077332,Artesunate,https://ctdbase.org/detail.go?type=chem&acc=D000077332,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Artesunate results in increased cleavage of PARP1 protein,,,PMID:24704559|PMID:33002460,https://www.ncbi.nlm.nih.gov/pubmed/24704559|https://www.ncbi.nlm.nih.gov/pubmed/33002460,24704559|33002460,,,12220368|30995103,"Zhou X, Chen Y, Wang F, Wu H, Zhang Y, Liu J, Cai Y, Huang S, He N, Hu Z, Jin X. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem Biol Interact. 2020 Nov 01;331():109273. doi: 10.1016/j.cbi.2020.109273. PMID: 33002460.|Wang Y, Yang J, Chen L, Wang J, Wang Y, Luo J, Pan L, Zhang X. Artesunate induces apoptosis through caspase-dependent and -independent mitochondrial pathways in human myelodysplastic syndrome SKM-1 cells. Chem Biol Interact. 2014 Aug 05;219():28–36. doi: 10.1016/j.cbi.2014.03.011. PMID: 24704559."
2160615,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[mirdametinib co-treated with NVP-BKM120] results in increased cleavage of PARP1 protein|nvp-BKM120 results in increased cleavage of PARP1 protein|kras protein affects the susceptibility to [[mirdametinib co-treated with NVP-BKM120] results in increased cleavage of PARP1 protein],,,PMID:24576621,https://www.ncbi.nlm.nih.gov/pubmed/24576621,24576621,,PMC4118771,26290510,"Roper J, Sinnamon MJ, Coffee EM, Belmont P, Keung L, Georgeon-Richard L, Wang WV, Faber AC, Yun J, Yilmaz ÖH, Bronson RT, Martin ES, Tsichlis PN, Hung KE. Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer. Cancer Letters. 2014 Jun;347(2):204–11. doi: 10.1016/j.canlet.2014.02.018."
2021719,16679812,Comparative Toxicogenomics Database (CTD),Tubocapsenolide A,C000721052,tubocapsenolide A,https://ctdbase.org/detail.go?type=chem&acc=C000721052,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tubocapsenolide A results in increased cleavage of PARP1 protein|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [tubocapsenolide A results in increased cleavage of PARP1 protein],,,PMID:18442981,https://www.ncbi.nlm.nih.gov/pubmed/18442981,18442981,,,32226575,"Chen WY, Chang FR, Huang ZY, Chen JH, Wu YC, Wu CC. Tubocapsenolide A, a novel withanolide, inhibits proliferation and induces apoptosis in MDA-MB-231 cells by thiol oxidation of heat shock proteins. J Biol Chem. 2008 Jun 20;283(25):17184–93. doi: 10.1074/jbc.m709447200. PMID: 18442981."
2156702,16720766,Comparative Toxicogenomics Database (CTD),Pevonedistat,C539933,pevonedistat,https://ctdbase.org/detail.go?type=chem&acc=C539933,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pevonedistat results in increased cleavage of PARP1 protein,,,PMID:24634471,https://www.ncbi.nlm.nih.gov/pubmed/24634471,24634471,,PMC3960291,13426796,"Godbersen JC, Humphries LA, Danilova OV, Kebbekus PE, Brown JR, Eastman A, Danilov AV. The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-?B activation and induces apoptosis in chronic lymphocytic leukemia B cells. Clin Cancer Res. 2014 Mar 15;20(6):1576–89. PMID: 24634471; PMCID: PMC3960291."
2156703,16720766,Comparative Toxicogenomics Database (CTD),Pevonedistat,C539933,pevonedistat,https://ctdbase.org/detail.go?type=chem&acc=C539933,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tretinoin promotes the reaction [pevonedistat results in increased cleavage of and results in increased activity of PARP1 protein]|pevonedistat results in increased cleavage of and results in increased activity of PARP1 protein,,,PMID:22110742,https://www.ncbi.nlm.nih.gov/pubmed/22110742,22110742,,PMC3217012,3822174,"Tan M, Li Y, Yang R, Xi N, Sun Y. Inactivation of SAG E3 Ubiquitin Ligase Blocks Embryonic Stem Cell Differentiation and Sensitizes Leukemia Cells to Retinoid Acid. PLoS ONE. 2011 Nov 15;6(11):e27726. doi: 10.1371/journal.pone.0027726."
2163483,16725726,Comparative Toxicogenomics Database (CTD),Gsk-690693,C528328,GSK690693,https://ctdbase.org/detail.go?type=chem&acc=C528328,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"GSK690693 promotes the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]",,,PMID:30871965,https://www.ncbi.nlm.nih.gov/pubmed/30871965,30871965,,,29739467,"Xu WT, Shen GN, Luo YH, Piao XJ, Wang JR, Wang H, Zhang Y, Li JQ, Feng YC, Zhang Y, Zhang T, Wang SN, Wang CY, Jin CH. New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways. Chem Biol Interact. 2019 May 01;304():148–57. doi: 10.1016/j.cbi.2019.03.004. PMID: 30871965."
2198019,16747388,Comparative Toxicogenomics Database (CTD),"4-methyl-3-(1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide",C000604219,NVP-BHG712,https://ctdbase.org/detail.go?type=chem&acc=C000604219,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Enzalutamide promotes the reaction [NVP-BHG712 results in increased cleavage of PARP1 protein]|nvp-BHG712 results in increased cleavage of PARP1 protein,,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,PMC7170517,14921158,"Li C, Lanman NA, Kong Y, He D, Mao F, Farah E, Zhang Y, Liu J, Wang C, Wei Q, Liu X. Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance. Journal of Biological Chemistry. 2020 Apr;295(16):5470–83. doi: 10.1074/jbc.ra119.011385."
2199025,16755649,Comparative Toxicogenomics Database (CTD),Nutlin-3b,C482205,nutlin 3,https://ctdbase.org/detail.go?type=chem&acc=C482205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[dactinomycin co-treated with nutlin 3] results in increased secretion of PARP1 protein,,,PMID:38460933,https://www.ncbi.nlm.nih.gov/pubmed/38460933,38460933,,,36974505,"Lasut-Szyszka B, Gdowicz-Klosok A, Malachowska B, Krzesniak M, Bedzinska A, Gawin M, Pietrowska M, Rusin M. Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes. Chem Biol Interact. 2024 Apr 01;392():110946. doi: 10.1016/j.cbi.2024.110946. PMID: 38460933."
2199026,16755649,Comparative Toxicogenomics Database (CTD),Nutlin-3b,C482205,nutlin 3,https://ctdbase.org/detail.go?type=chem&acc=C482205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Nutlin 3 results in increased cleavage of PARP1 protein|tp53 mutant form inhibits the reaction [nutlin 3 results in increased cleavage of PARP1 protein],,,PMID:22260869,https://www.ncbi.nlm.nih.gov/pubmed/22260869,22260869,,,16779507,"Keim A, Rössler OG, Rothhaar TL, Thiel G. Arsenite-induced apoptosis of human neuroblastoma cells requires p53 but occurs independently of c-Jun. Neuroscience. 2012 Mar 29;206():25–38. doi: 10.1016/j.neuroscience.2012.01.001. PMID: 22260869."
2158254,16756850,Comparative Toxicogenomics Database (CTD),t-TUCB,C572961,4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid,https://ctdbase.org/detail.go?type=chem&acc=C572961,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid results in decreased cleavage of PARP1 protein,,,PMID:25377915,https://www.ncbi.nlm.nih.gov/pubmed/25377915,25377915,,PMC4338924,3880464,"Kim J, Yoon SP, Toews ML, Imig JD, Hwang SH, Hammock BD, Padanilam BJ. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy. American Journal of Physiology-Renal Physiology. 2015 Jan 15;308(2):F131–9. doi: 10.1152/ajprenal.00531.2014."
2123802,16760394,Comparative Toxicogenomics Database (CTD),Z-Devd-fmk,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C110772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:21642427,https://www.ncbi.nlm.nih.gov/pubmed/21642427,21642427,,PMC3143646,8664447,"Shin SY, Kim CG, Lim Y, Lee YH. The ETS Family Transcription Factor ELK-1 Regulates Induction of the Cell Cycle-regulatory Gene p21 and the BAX Gene in Sodium Arsenite-exposed Human Keratinocyte HaCaT Cells. Journal of Biological Chemistry. 2011 Jul;286(30):26860–72. doi: 10.1074/jbc.m110.216721."
2123803,16760394,Comparative Toxicogenomics Database (CTD),Z-Devd-fmk,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C110772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [bakuchiol results in increased cleavage of PARP1 protein],,,PMID:17292878,https://www.ncbi.nlm.nih.gov/pubmed/17292878,17292878,,,3744923,"Park EJ, Zhao YZ, Kim YC, Sohn DH. Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts. Eur J Pharmacol. 2007 Mar 22;559(2-3):115–23. doi: 10.1016/j.ejphar.2007.01.024. PMID: 17292878."
2123804,16760394,Comparative Toxicogenomics Database (CTD),Z-Devd-fmk,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C110772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [perfluorooctane sulfonic acid results in increased cleavage of PARP1 protein],,,PMID:37955688,https://www.ncbi.nlm.nih.gov/pubmed/37955688,37955688,,PMC10761489,36183122,2023; 98(1):207-221
2123903,16760394,Comparative Toxicogenomics Database (CTD),Z-Devd-fmk,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C110772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [cetylpyridinium results in increased cleavage of PARP1 protein]|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [benzalkonium compounds analog results in increased cleavage of PARP1 protein],,,PMID:31982400,https://www.ncbi.nlm.nih.gov/pubmed/31982400,31982400,,,25060943,"Kanno S, Hirano S, Kato H, Fukuta M, Mukai T, Aoki Y. Benzalkonium chloride and cetylpyridinium chloride induce apoptosis in human lung epithelial cells and alter surface activity of pulmonary surfactant monolayers. Chem Biol Interact. 2020 Feb 01;317():108962. doi: 10.1016/j.cbi.2020.108962. PMID: 31982400."
2123904,16760394,Comparative Toxicogenomics Database (CTD),Z-Devd-fmk,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C110772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone affects the reaction [deoxynivalenol affects the expression of and results in increased cleavage of PARP1 protein]|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in decreased expression of and results in increased cleavage of PARP1 protein],,,PMID:35925383,https://www.ncbi.nlm.nih.gov/pubmed/35925383,35925383,,,34609750,2022; 96(11):3091-3112
2123905,16760394,Comparative Toxicogenomics Database (CTD),Z-Devd-fmk,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C110772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein],,,PMID:17404069,https://www.ncbi.nlm.nih.gov/pubmed/17404069,17404069,,,16667923,"SHAKIBAEI M, JOHN T, SEIFARTH C, MOBASHERI A. Resveratrol Inhibits IL-1ß–Induced Stimulation of Caspase-3 and Cleavage of PARP in Human Articular Chondrocytes <i>in Vitro</i>. Annals of the New York Academy of Sciences. 2007 Jan;1095(1):554–63. doi: 10.1196/annals.1397.060."
2123906,16760394,Comparative Toxicogenomics Database (CTD),Z-Devd-fmk,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C110772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [nilotinib results in increased cleavage of PARP1 protein],,,PMID:26549707,https://www.ncbi.nlm.nih.gov/pubmed/26549707,26549707,,,12254132,"Chen TC, Yu MC, Chien CC, Wu MS, Lee YC, Chen YC. Nilotinib reduced the viability of human ovarian cancer cells via mitochondria-dependent apoptosis, independent of JNK activation. Toxicol In Vitro. 2016 Mar;31():1–11. doi: 10.1016/j.tiv.2015.11.002. PMID: 26549707."
2123907,16760394,Comparative Toxicogenomics Database (CTD),Z-Devd-fmk,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C110772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein],,,PMID:24264887,https://www.ncbi.nlm.nih.gov/pubmed/24264887,24264887,,,30321197,2013; 19(3):527-541
2200415,16760394,Comparative Toxicogenomics Database (CTD),Z-Devd-fmk,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C110772,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [dieldrin results in increased cleavage of PARP1 protein],,,PMID:15183012,https://www.ncbi.nlm.nih.gov/pubmed/15183012,15183012,,,8532294,"Kitazawa M, Anantharam V, Kanthasamy A, Kanthasamy AG. Dieldrin promotes proteolytic cleavage of poly(ADP-ribose) polymerase and apoptosis in dopaminergic cells: protective effect of mitochondrial anti-apoptotic protein Bcl-2. Neurotoxicology. 2004 Jun;25(4):589–98. doi: 10.1016/j.neuro.2003.09.014. PMID: 15183012."
2107009,16760658,Comparative Toxicogenomics Database (CTD),Sodium Salicylate,D012980,Sodium Salicylate,https://ctdbase.org/detail.go?type=chem&acc=D012980,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium salicylate results in increased expression of PARP1 mrna|sodium salicylate inhibits the reaction [epothilone A results in increased expression of PARP1 mrna]|sodium salicylate promotes the reaction [metformin results in increased expression of PARP1 mrna],,,PMID:29117515,https://www.ncbi.nlm.nih.gov/pubmed/29117515,29117515,,,30394656,"Rogalska A, Bukowska B, Marczak A. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells. Toxicol In Vitro. 2018 Mar;47():48–62. doi: 10.1016/j.tiv.2017.11.001. PMID: 29117515."
2107010,16760658,Comparative Toxicogenomics Database (CTD),Sodium Salicylate,D012980,Sodium Salicylate,https://ctdbase.org/detail.go?type=chem&acc=D012980,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sodium salicylate results in increased cleavage of PARP1 protein,,,PMID:10090950|PMID:9694730,https://www.ncbi.nlm.nih.gov/pubmed/10090950|https://www.ncbi.nlm.nih.gov/pubmed/9694730,10090950|9694730,,,25337060|31376740,"Klampfer L, Cammenga J, Wisniewski H, Nimer SD. Sodium Salicylate Activates Caspases and Induces Apoptosis of Myeloid Leukemia Cell Lines. 1999 Apr 01;93(7):2386–94. doi: 10.1182/blood.v93.7.2386.407k15_2386_2394.|Bellosillo B, Pique´ M, Barraga´n M, Castan~o E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J. Aspirin and Salicylate Induce Apoptosis and Activation of Caspases in B-Cell Chronic Lymphocytic Leukemia Cells. 1998 Aug 15;92(4):1406–14. doi: 10.1182/blood.v92.4.1406.416k17_1406_1414."
2061343,17755052,Comparative Toxicogenomics Database (CTD),Pictilisib,C532162,"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine",https://ctdbase.org/detail.go?type=chem&acc=C532162,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Cobimetinib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein]|2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [cobimetinib results in increased cleavage of PARP1 protein]",,,PMID:22084396,https://www.ncbi.nlm.nih.gov/pubmed/22084396,22084396,,,3152129,"Hoeflich KP, Merchant M, Orr C, Chan J, Den Otter D, Berry L, Kasman I, Koeppen H, Rice K, Yang NY, Engst S, Johnston S, Friedman LS, Belvin M. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. Cancer Res. 2012 Jan 01;72(1):210–9. doi: 10.1158/0008-5472.can-11-1515. PMID: 22084396."
2061344,17755052,Comparative Toxicogenomics Database (CTD),Pictilisib,C532162,"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine",https://ctdbase.org/detail.go?type=chem&acc=C532162,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein]|doxorubicin promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein]",,,PMID:20826841,https://www.ncbi.nlm.nih.gov/pubmed/20826841,20826841,,,2440709,"Wallin JJ, Guan J, Prior WW, Edgar KA, Kassees R, Sampath D, Belvin M, Friedman LS. Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer. Sci Transl Med. 2010 Sep 08;2(48):48ra66. doi: 10.1126/scitranslmed.3000630. PMID: 20826841."
2061345,17755052,Comparative Toxicogenomics Database (CTD),Pictilisib,C532162,"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine",https://ctdbase.org/detail.go?type=chem&acc=C532162,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein",,,PMID:19411071|PMID:19584227|PMID:20826841|PMID:22084396|PMID:23136191|PMID:23318440,https://www.ncbi.nlm.nih.gov/pubmed/19411071|https://www.ncbi.nlm.nih.gov/pubmed/19584227|https://www.ncbi.nlm.nih.gov/pubmed/20826841|https://www.ncbi.nlm.nih.gov/pubmed/22084396|https://www.ncbi.nlm.nih.gov/pubmed/23136191|https://www.ncbi.nlm.nih.gov/pubmed/23318440,19411071|19584227|20826841|22084396|23136191|23318440,,PMC2718129,1798684|2440709|3152129|28187322|29538616|32297339,"Munugalavadla V, Mariathasan S, Slaga D, Du C, Berry L, Del Rosario G, Yan Y, Boe M, Sun L, Friedman LS, Chesi M, Leif Bergsagel P, Ebens A. The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma. Oncogene. 2014 Jan 16;33(3):316–25. doi: 10.1038/onc.2012.594. PMID: 23318440.|Spoerke JM, O'Brien C, Huw L, Koeppen H, Fridlyand J, Brachmann RK, Haverty PM, Pandita A, Mohan S, Sampath D, Friedman LS, Ross L, Hampton GM, Amler LC, Shames DS, Lackner MR. Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models. Clin Cancer Res. 2012 Dec 15;18(24):6771–83. doi: 10.1158/1078-0432.ccr-12-2347. PMID: 23136191.|Hoeflich KP, Merchant M, Orr C, Chan J, Den Otter D, Berry L, Kasman I, Koeppen H, Rice K, Yang NY, Engst S, Johnston S, Friedman LS, Belvin M. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. Cancer Res. 2012 Jan 01;72(1):210–9. doi: 10.1158/0008-5472.can-11-1515. PMID: 22084396.|Wallin JJ, Guan J, Prior WW, Edgar KA, Kassees R, Sampath D, Belvin M, Friedman LS. Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer. Sci Transl Med. 2010 Sep 08;2(48):48ra66. doi: 10.1126/scitranslmed.3000630. PMID: 20826841.|Raynaud FI, Eccles SA, Patel S, Alix S, Box G, Chuckowree I, Folkes A, Gowan S, De Haven Brandon A, Di Stefano F, Hayes A, Henley AT, Lensun L, Pergl-Wilson G, Robson A, Saghir N, Zhyvoloup A, McDonald E, Sheldrake P, Shuttleworth S, Valenti M, Wan NC, Clarke PA, Workman P. Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941. 2009 Jul 01;8(7):1725–38. doi: 10.1158/1535-7163.mct-08-1200.|Junttila TT, Akita RW, Parsons K, Fields C, Lewis Phillips GD, Friedman LS, Sampath D, Sliwkowski MX. Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941. Cancer Cell. 2009 May 05;15(5):429–40. doi: 10.1016/j.ccr.2009.03.020. PMID: 19411071."
2061454,17755052,Comparative Toxicogenomics Database (CTD),Pictilisib,C532162,"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine",https://ctdbase.org/detail.go?type=chem&acc=C532162,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Dexamethasone promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of PARP1 protein]",,,PMID:23318440,https://www.ncbi.nlm.nih.gov/pubmed/23318440,23318440,,,32297339,"Munugalavadla V, Mariathasan S, Slaga D, Du C, Berry L, Del Rosario G, Yan Y, Boe M, Sun L, Friedman LS, Chesi M, Leif Bergsagel P, Ebens A. The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma. Oncogene. 2014 Jan 16;33(3):316–25. doi: 10.1038/onc.2012.594. PMID: 23318440."
2061455,17755052,Comparative Toxicogenomics Database (CTD),Pictilisib,C532162,"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine",https://ctdbase.org/detail.go?type=chem&acc=C532162,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[PTEN gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in increased cleavage of PARP1 protein|[pik3ca gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in increased cleavage of PARP1 protein|[erbb2 gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in increased cleavage of PARP1 protein",,,PMID:20453058,https://www.ncbi.nlm.nih.gov/pubmed/20453058,20453058,,,3115341,"O'Brien C, Wallin JJ, Sampath D, GuhaThakurta D, Savage H, Punnoose EA, Guan J, Berry L, Prior WW, Amler LC, Belvin M, Friedman LS, Lackner MR. Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models. Clin Cancer Res. 2010 Jul 15;16(14):3670–83. doi: 10.1158/1078-0432.ccr-09-2828. PMID: 20453058."
2007213,17756618,Comparative Toxicogenomics Database (CTD),"(3S,3'S,6S,6'S,10aS,10a'S)-N,N'-((1S,1'S)-((1,4-phenylenebis(butane-4,1-diyl))bis(1H-1,2,3-triazole-1,4-diyl))bis(phenylmethylene))bis(6-((S)-2-(methylamino)propanamido)-5-oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide)",C533467,SM 164,https://ctdbase.org/detail.go?type=chem&acc=C533467,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[TNF protein co-treated with SM 164] results in increased cleavage of PARP1 protein|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [[TNF protein co-treated with SM 164] results in increased cleavage of PARP1 protein],,,PMID:34523043,https://www.ncbi.nlm.nih.gov/pubmed/34523043,34523043,,,12239920,2021; 39(1):183-199
2243711,18369509,Therapeutic Target Database (TTD),"5-amino-3,4-dihydroisoquinolin-1(2H)-one",D05RXG,"5-amino-3,4-dihydroisoquinolin-1(2H)-one",https://idrblab.net/ttd/data/drug/details/D05RXG,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2175613,18382004,Therapeutic Target Database (TTD),"pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione",D0R7HU,"Pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione",https://idrblab.net/ttd/data/drug/details/D0R7HU,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2016710,18428022,BindingDB,"2-(piperazin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27130,"2-(piperazin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27130,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),26,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2016711,18428039,BindingDB,"2-(1-propylpyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27110,"2-(1-propylpyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27110,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),8,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2016712,18428049,BindingDB,"2-[1-(propan-2-yl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",27120,"2-[1-(propan-2-yl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27120,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),7,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2016905,18428130,BindingDB,"2-[1-(propan-2-yl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",27111,"2-[1-(propan-2-yl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27111,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),9,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2016906,18428130,BindingDB,"2-[1-(propan-2-yl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",27111,"2-[1-(propan-2-yl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27111,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),9,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2016907,18428167,BindingDB,"2-(pyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27096,"2-(pyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27096,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),4,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2016908,18428167,BindingDB,"2-(pyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27096,"2-(pyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27096,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),4,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2016909,18428182,BindingDB,"2-[1-(propan-2-yl)piperidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",27117,"2-[1-(propan-2-yl)piperidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27117,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),22,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2016910,18428218,BindingDB,"2-(1-methylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27118,"2-(1-methylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27118,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),19,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2016911,18428266,BindingDB,"2-(1,4-dimethylpiperazin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27131,"2-(1,4-dimethylpiperazin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27131,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),35,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2213374,18477728,Comparative Toxicogenomics Database (CTD),CID 18477728,D000068338,Everolimus,https://ctdbase.org/detail.go?type=chem&acc=D000068338,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[navitoclax co-treated with everolimus] results in increased cleavage of PARP1 protein,,,PMID:28947240,https://www.ncbi.nlm.nih.gov/pubmed/28947240,28947240,,,16200510,"Lee EY, Gong EY, Shin JS, Moon JH, Shim HJ, Kim SM, Lee S, Jeong J, Gong JH, Kim MJ, Lee DH, Park YS, Shin J, Hong SW, Kim YS, Jin DH. Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin. Toxicol In Vitro. 2018 Feb;46():229–36. doi: 10.1016/j.tiv.2017.09.023. PMID: 28947240."
2155060,19087731,BindingDB,"1-[4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)butyl]-2,4(1H,3H)-quinazolinedione",27713,"1-[4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)butyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27713,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),120,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2120392,19617626,Comparative Toxicogenomics Database (CTD),"[(E)-(2,3-dibromo-4,5-dimethoxyphenyl)methylideneamino]thiourea",C000717808,PARP-1 inhibitor DHC-1,https://ctdbase.org/detail.go?type=chem&acc=C000717808,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP-1 inhibitor DHC-1 results in decreased activity of PARP1 protein,,,PMID:33271260,https://www.ncbi.nlm.nih.gov/pubmed/33271260,33271260,,,4024655,"Wu X, Li Q, Zhang F, Wang L, Wang J, Fan J, Di G, Guo C. Novel poly (ADP-ribose) polymerases inhibitor DHC-1 exhibits in vitro and in vivo anticancer activity on BRCA-deficient pancreatic cancer cells. Food Chem Toxicol. 2021 Jan;147():111892. doi: 10.1016/j.fct.2020.111892. PMID: 33271260."
2272007,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [tamoxifen results in increased cleavage of PARP1 protein]|tamoxifen results in increased cleavage of PARP1 protein|alpha-tocopherol inhibits the reaction [tamoxifen results in increased cleavage of PARP1 protein],,,PMID:14645110,https://www.ncbi.nlm.nih.gov/pubmed/14645110,14645110,,,26770578,"Mabuchi S, Ohmichi M, Kimura A, Ikebuchi Y, Hisamoto K, Arimoto-Ishida E, Nishio Y, Takahashi K, Tasaka K, Murata Y. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin. Endocrinology. 2004 Mar;145(3):1302–13. doi: 10.1210/en.2003-0709. PMID: 14645110."
2223528,20854918,IUPHAR/BPS Guide to PHARMACOLOGY,"2-(3-Methoxypropyl)-3-Oxo-2,3-Dihydro-1h-Isoindole-4-Carboxamide",8731,compound 10b [PMID: 26222319],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8731,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pKd,7.06,PMID:26222319,https://www.ncbi.nlm.nih.gov/pubmed/26222319,26222319,,,33037760,"Papeo G, Posteri H, Borghi D, Busel AA, Caprera F, Casale E, Ciomei M, Cirla A, Corti E, D'Anello M, Fasolini M, Forte B, Galvani A, Isacchi A, Khvat A, Krasavin MY, Lupi R, Orsini P, Perego R, Pesenti E, Pezzetta D, Rainoldi S, Riccardi-Sirtori F, Scolaro A, Sola F, Zuccotto F, Felder ER, Donati D, Montagnoli A. Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy. J Med Chem. 2015 Sep 10;58(17):6875–98. doi: 10.1021/acs.jmedchem.5b00680. PMID: 26222319."
2251630,21195867,Therapeutic Target Database (TTD),2-Methylquinoline-8-carboxamide,D0S8HZ,2-Methylquinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D0S8HZ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2180451,21583537,Comparative Toxicogenomics Database (CTD),Dideoxypetrosynol A,C499970,dideoxypetrosynol A,https://ctdbase.org/detail.go?type=chem&acc=C499970,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dideoxypetrosynol A results in increased cleavage of PARP1 protein,,,PMID:15547680,https://www.ncbi.nlm.nih.gov/pubmed/15547680,15547680,,,19358152,"Choi H, Bae S, Kim N, Jung J, Choi Y. Induction of apoptosis by dideoxypetrosynol A, a polyacetylene from the sponge Petrosia sp., in human skin melanoma cells. Int J Mol Med. 2004 Dec 01;(). doi: 10.3892/ijmm.14.6.1091."
2305072,21896087,Toxin and Toxin Target Database (T3DB),Arsenic(3+);tribromide,T3D1298,Arsenic tribromide,http://www.t3db.ca/toxins/T3D1298,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2245332,21940935,Comparative Toxicogenomics Database (CTD),1-Phenylpropan-2-amine;sulfate,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of PARP1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,PMC6380594,20290399,"Camacho L, Silva CS, Hanig JP, Schleimer RP, George NI, Bowyer JF. Identification of whole blood mRNA and microRNA biomarkers of tissue damage and immune function resulting from amphetamine exposure or heat stroke in adult male rats. PLoS ONE. 2019 Feb 19;14(2):e0210273. doi: 10.1371/journal.pone.0210273."
2161638,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),ATG5 protein affects the reaction [sirolimus inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]]|sirolimus inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:19682553,https://www.ncbi.nlm.nih.gov/pubmed/19682553,19682553,,,26192256,"Pan T, Rawal P, Wu Y, Xie W, Jankovic J, Le W. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience. 2009 Dec 01;164(2):541–51. doi: 10.1016/j.neuroscience.2009.08.014. PMID: 19682553."
2161639,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]|mcl1 protein inhibits the reaction [sirolimus inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]],,,PMID:32802178,https://www.ncbi.nlm.nih.gov/pubmed/32802178,32802178,,PMC7415806,9544165,"Yang P, Xie J, Li Y, Lin HP, Fenske W, Clementino M, Jiang Y, Yang C, Wang Z. Deubiquitinase USP7-mediated MCL-1 up-regulation enhances Arsenic and Benzo(a)pyrene co-exposure-induced Cancer Stem Cell-like property and Tumorigenesis. Theranostics. 2020;10(20):9050–65. PMID: 32802178; PMCID: PMC7415806."
2161640,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[sirolimus co-treated with ovatodiolide] results in increased cleavage of PARP1 protein|sirolimus promotes the reaction [ovatodiolide results in increased cleavage of PARP1 protein],,,PMID:38000454,https://www.ncbi.nlm.nih.gov/pubmed/38000454,38000454,,,36430276,"Xia Q, Xie J, Zhang J, Zhang L, Zhou Y, Zhu B, Wu Y, Yang Z, Li J. Ovatodiolide induces autophagy-mediated cell death through the p62-Keap1-Nrf2 signaling pathway in chronic myeloid leukemia cells. Chem Biol Interact. 2024 Jan 05;387():110819. doi: 10.1016/j.cbi.2023.110819. PMID: 38000454."
2161641,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sirolimus inhibits the reaction [ethanol results in increased cleavage of PARP1 protein],,,PMID:21410490,https://www.ncbi.nlm.nih.gov/pubmed/21410490,21410490,,,28903644,"von Haefen C, Sifringer M, Menk M, Spies CD. Ethanol enhances susceptibility to apoptotic cell death via down-regulation of autophagy-related proteins. Alcohol Clin Exp Res. 2011 Aug;35(8):1381–91. doi: 10.1111/j.1530-0277.2011.01473.x. PMID: 21410490."
2161642,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sirolimus promotes the reaction [artesunate results in increased cleavage of PARP1 protein],,,PMID:33002460,https://www.ncbi.nlm.nih.gov/pubmed/33002460,33002460,,,12220368,"Zhou X, Chen Y, Wang F, Wu H, Zhang Y, Liu J, Cai Y, Huang S, He N, Hu Z, Jin X. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem Biol Interact. 2020 Nov 01;331():109273. doi: 10.1016/j.cbi.2020.109273. PMID: 33002460."
2161643,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sirolimus results in increased cleavage of PARP1 protein,,,PMID:25307878,https://www.ncbi.nlm.nih.gov/pubmed/25307878,25307878,,PMC4824295,5253012,"Lee DH, Qi J, Bradner JE, Said JW, Doan NB, Forscher C, Yang H, Koeffler HP. Synergistic effect of <scp>JQ</scp>1 and rapamycin for treatment of human osteosarcoma. Intl Journal of Cancer. 2014 Oct 30;136(9):2055–64. doi: 10.1002/ijc.29269."
2161644,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Sirolimus promotes the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
2161645,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[sirolimus co-treated with resveratrol] results in increased cleavage of PARP1 protein|tsc2 protein inhibits the reaction [[sirolimus co-treated with resveratrol] results in increased cleavage of PARP1 protein],,,PMID:24304514,https://www.ncbi.nlm.nih.gov/pubmed/24304514,24304514,,PMC3956533,11392078,"Alayev A, Sun Y, Snyder RB, Berger SM, Yu JJ, Holz MK. Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell Cycle. 2014;13(3):371–82. PMID: 24304514; PMCID: PMC3956533."
2161646,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Sirolimus inhibits the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:34374793,https://www.ncbi.nlm.nih.gov/pubmed/34374793,34374793,,,25810524,2021; 95(10):3263-3284
2161647,21944094,Comparative Toxicogenomics Database (CTD),Rapamycin (Sirolimus),D020123,Sirolimus,https://ctdbase.org/detail.go?type=chem&acc=D020123,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Sirolimus results in increased expression of PARP1 protein modified form,,,PMID:26825372,https://www.ncbi.nlm.nih.gov/pubmed/26825372,26825372,,,5990917,"Chen R, Wang B, Chen L, Cai D, Li B, Chen C, Huang E, Liu C, Lin Z, Xie WB, Wang H. DNA damage-inducible transcript 4 (DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR signaling pathway in cardiomyocytes. Toxicol Appl Pharmacol. 2016 Mar 15;295():1–11. doi: 10.1016/j.taap.2016.01.017. PMID: 26825372."
2258403,22833492,Toxin and Toxin Target Database (T3DB),Tetracopper;oxoarsinite;diacetate,T3D1219,Copper(II) acetoarsenite,http://www.t3db.ca/toxins/T3D1219,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2191958,23584940,Comparative Toxicogenomics Database (CTD),Cep 8983,C523456,CEP 8983,https://ctdbase.org/detail.go?type=chem&acc=C523456,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[cisplatin co-treated with CEP 8983] results in decreased activity of PARP1 protein|cep 8983 results in decreased activity of PARP1 protein,,,PMID:23410825,https://www.ncbi.nlm.nih.gov/pubmed/23410825,23410825,,,10007975,"Olaussen KA, Adam J, Vanhecke E, Vielh P, Pirker R, Friboulet L, Popper H, Robin A, Commo F, Thomale J, Kayitalire L, Filipits M, Le Chevalier T, André F, Brambilla E, Soria JC. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs. Lung Cancer. 2013 May;80(2):216–22. doi: 10.1016/j.lungcan.2013.01.014. PMID: 23410825."
2264983,23615615,Toxin and Toxin Target Database (T3DB),"Cacodylic acid, sodium salt",T3D0317,Sodium dimethylarsinate,http://www.t3db.ca/toxins/T3D0317,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2270398,23626877,Comparative Toxicogenomics Database (CTD),R-7277,C568912,"3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid",https://ctdbase.org/detail.go?type=chem&acc=C568912,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid results in increased cleavage of PARP1 protein",,,PMID:37657595,https://www.ncbi.nlm.nih.gov/pubmed/37657595,37657595,,,36474461,"Tang S, Zhang F, Li J, Dong H, Yang Q, Liu J, Fu Y. The selective activator protein-1 inhibitor T-5224 regulates the IRF4/MYC axis and exerts cooperative antimyeloma activity with bortezomib. Chem Biol Interact. 2023 Oct 01;384():110687. doi: 10.1016/j.cbi.2023.110687. PMID: 37657595."
2268652,23664719,Toxin and Toxin Target Database (T3DB),Monosodium methanearsonate,T3D0309,"Methylarsonic acid, monosodium salt",http://www.t3db.ca/toxins/T3D0309,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2268693,23665572,Toxin and Toxin Target Database (T3DB),Tryparsamide,T3D0314,Tryparsamide,http://www.t3db.ca/toxins/T3D0314,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2268790,23670523,Toxin and Toxin Target Database (T3DB),Sodium Arsanilate,T3D0316,Sodium arsanilate,http://www.t3db.ca/toxins/T3D0316,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2269746,23677060,Toxin and Toxin Target Database (T3DB),"Arsenic acid (H3AsO4), sodium salt (1:?)",T3D0298,Sodium arsenate,http://www.t3db.ca/toxins/T3D0298,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
1270834,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2023330,23725625,Chemical Probes Portal,Olaparib,Olaparib,Olaparib,https://www.chemicalprobes.org/olaparib,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),"Catalytic inhibitor, PARP-DNA complex trapping",,"5 nM, 1.4 nM, 1 nM, 12.3 nM",PMID:28001384|PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/28001384|https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
2152918,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2177062,23725625,BindingDB,Olaparib,27566,"4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27566,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),5,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2216700,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2228025,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Other/unknown,,,,,,,,,
2230273,23725625,IUPHAR/BPS Guide to PHARMACOLOGY,Olaparib,7519,olaparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7519,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,8.3,PMID:18800822|PMID:12857389,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://www.ncbi.nlm.nih.gov/pubmed/12857389,18800822|12857389,,,2270180|24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822.|Dillon KJ, Smith GCM, Martin NMB. Technical Note: A FlashPlate Assay for the Identification of PARP-1 Inhibitors. SLAS Discovery. 2003 Jun;8(3):347–52. doi: 10.1177/1087057103008003013."
2230275,23725625,BindingDB,Olaparib,27566,"4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27566,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),4.2,PMID:27866910|DOI:10.1016/j.chembiol.2016.10.011,https://www.ncbi.nlm.nih.gov/pubmed/27866910|https://doi.org/10.1016/j.chembiol.2016.10.011,27866910,10.1016/j.chembiol.2016.10.011,PMC5182133,33069478,"Knezevic CE, Wright G, Remsing Rix LL, Kim W, Kuenzi BM, Luo Y, Watters JM, Koomen JM, Haura EB, Monteiro AN, Radu C, Lawrence HR, Rix U. Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Cell Chemical Biology. 2016 Dec;23(12):1490–503. doi: 10.1016/j.chembiol.2016.10.011."
2250681,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2250691,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2250692,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2270317,23725625,DrugBank,Olaparib,DB09074,Olaparib,https://www.drugbank.ca/drugs/DB09074,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:30069770|PMID:33114555|PMID:25981132,https://www.ncbi.nlm.nih.gov/pubmed/30069770|https://www.ncbi.nlm.nih.gov/pubmed/33114555|https://www.ncbi.nlm.nih.gov/pubmed/25981132,30069770|33114555|25981132,,PMC7693014,6058179|6091610|20209480,"Tavares TS, Hofman J, Lekesova A, Zelazkova J, Wsol V: Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3. Cancers (Basel). 2020 Oct 26;12(11). pii: cancers12113127. doi: 10.3390/cancers12113127.|Bochum S, Berger S, Martens UM: Olaparib. Recent Results Cancer Res. 2018;211:217-233. doi: 10.1007/978-3-319-91442-8_15.|Verhagen CV, de Haan R, Hageman F, Oostendorp TP, Carli AL, O'Connor MJ, Jonkers J, Verheij M, van den Brekel MW, Vens C: Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells. Radiother Oncol. 2015 Sep;116(3):358-65. doi: 10.1016/j.radonc.2015.03.028. Epub  2015 May 13."
2273098,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2312581,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[BRD4 protein affects the susceptibility to olaparib] which affects the cleavage of PARP1 protein|(+)-JQ1 compound promotes the reaction [olaparib results in increased cleavage of PARP1 protein]|olaparib promotes the reaction [INCB054329 results in increased cleavage of PARP1 protein]|incb054329 promotes the reaction [olaparib results in increased cleavage of PARP1 protein]|olaparib results in increased cleavage of PARP1 protein,,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,PMC5986599,31091351,"Wilson AJ, Stubbs M, Liu P, Ruggeri B, Khabele D. The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer. Gynecologic Oncology. 2018 Jun;149(3):575–84. doi: 10.1016/j.ygyno.2018.03.049."
2312582,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Olaparib inhibits the reaction [methylmercury compounds results in increased cleavage of PARP1 protein],,,PMID:35396826,https://www.ncbi.nlm.nih.gov/pubmed/35396826,35396826,,,34244895,"Hou S, Zhang X, Ning X, Wu H, Li X, Ma K, Hao H, Lv C, Li C, Du Z, Du H, Jin M. Methylmercury induced apoptosis of human neuroblastoma cells through the reactive oxygen species mediated caspase and poly ADP-ribose polymerase/<scp>a</scp>poptosis-inducing factor dependent pathways. Environmental Toxicology. 2022 Apr 09;37(8):1891–901. doi: 10.1002/tox.23535."
2312583,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Olaparib results in decreased activity of PARP1 protein,,,PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
2312584,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Olaparib inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:24814482,https://www.ncbi.nlm.nih.gov/pubmed/24814482,24814482,,PMC4047186,2692609,"Pirinen E, Cantó C, Jo YS, Morato L, Zhang H, Menzies KJ, Williams EG, Mouchiroud L, Moullan N, Hagberg C, Li W, Timmers S, Imhof R, Verbeek J, Pujol A, van Loon B, Viscomi C, Zeviani M, Schrauwen P, Sauve AA, Schoonjans K, Auwerx J. Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 2014 Jun 03;19(6):1034–41. PMID: 24814482; PMCID: PMC4047186."
2312585,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Olaparib results in decreased activity of PARP1 protein,,,PMID:21417348,https://www.ncbi.nlm.nih.gov/pubmed/21417348,21417348,,,28909941,"Sunderland PT, Woon EC, Dhami A, Bergin AB, Mahon MF, Wood PJ, Jones LA, Tully SR, Lloyd MD, Thompson AS, Javaid H, Martin NM, Threadgill MD. 5-Benzamidoisoquinolin-1-ones and 5-(?-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2). J Med Chem. 2011 Apr 14;54(7):2049–59. doi: 10.1021/jm1010918. PMID: 21417348."
1272661,24721570,Comparative Toxicogenomics Database (CTD),beta-Elemonic acid,C000709525,beta-elemonic acid,https://ctdbase.org/detail.go?type=chem&acc=C000709525,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Beta-elemonic acid results in increased cleavage of PARP1 protein,,,PMID:33878321,https://www.ncbi.nlm.nih.gov/pubmed/33878321,33878321,,,1311725,"Bao X, Zhu J, Ren C, Zhao A, Zhang M, Zhu Z, Lu X, Zhang Y, Li X, Sima X, Li J, Zhang Q, Ma B. ß-elemonic acid inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells through the suppression of JAK2/STAT3/MCL-1 and NF-?B signal pathways. Chem Biol Interact. 2021 Jun 01;342():109477. doi: 10.1016/j.cbi.2021.109477. PMID: 33878321."
2314490,24771867,Comparative Toxicogenomics Database (CTD),Alisertib,C550258,MLN 8237,https://ctdbase.org/detail.go?type=chem&acc=C550258,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),MLN 8237 results in increased cleavage of PARP1 protein,,,PMID:21291867,https://www.ncbi.nlm.nih.gov/pubmed/21291867,21291867,,PMC3792566,31608509,"Qi W, Cooke LS, Liu X, Rimsza L, Roe DJ, Manziolli A, Persky DO, Miller TP, Mahadevan D. Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma. Biochem Pharmacol. 2011 Apr 01;81(7):881–90. PMID: 21291867; PMCID: PMC3792566."
2031273,24772860,Comparative Toxicogenomics Database (CTD),"4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide",C534922,SNX 2112,https://ctdbase.org/detail.go?type=chem&acc=C534922,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SNX 2112 results in increased cleavage of PARP1 protein,,,PMID:23777986,https://www.ncbi.nlm.nih.gov/pubmed/23777986,23777986,,,3861207,"Wang R, Shao F, Liu Z, Zhang J, Wang S, Liu J, Liu H, Chen H, Liu K, Xia M, Wang Y. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-?B and disruption of mitochondria-dependent pathways. Chem Biol Interact. 2013 Sep 05;205(1):1–10. doi: 10.1016/j.cbi.2013.06.007. PMID: 23777986."
2032319,24780387,Drug Gene Interaction database (DGIdb),Cep-9722,,CEP-9722,https://www.dgidb.org/drugs/drugbank:DB14882,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2064742,24794416,Comparative Toxicogenomics Database (CTD),Q-VD-OPh hydrate,C468548,quinoline-val-asp(OMe)-CH2-OPH,https://ctdbase.org/detail.go?type=chem&acc=C468548,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quinoline-val-asp(ome)-CH2-OPH inhibits the reaction [abexinostat results in increased cleavage of PARP1 protein],,,PMID:18042714,https://www.ncbi.nlm.nih.gov/pubmed/18042714,18042714,,PMC2148315,31533350,"Adimoolam S, Sirisawad M, Chen J, Thiemann P, Ford JM, Buggy JJ. HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Proc Natl Acad Sci U S A. 2007 Dec 04;104(49):19482–7. PMID: 18042714; PMCID: PMC2148315."
2064743,24794416,Comparative Toxicogenomics Database (CTD),Q-VD-OPh hydrate,C468548,quinoline-val-asp(OMe)-CH2-OPH,https://ctdbase.org/detail.go?type=chem&acc=C468548,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quinoline-val-asp(ome)-CH2-OPH inhibits the reaction [epoxomicin results in increased cleavage of PARP1 protein],,,PMID:20153345,https://www.ncbi.nlm.nih.gov/pubmed/20153345,20153345,,PMC2849852,9963601,"Bolt AM, Byrd RM, Klimecki WT. Autophagy is the predominant process induced by arsenite in human lymphoblastoid cell lines. Toxicology and Applied Pharmacology. 2010 May;244(3):366–73. doi: 10.1016/j.taap.2010.01.019."
2074337,24808138,Comparative Toxicogenomics Database (CTD),"(2R,4'R,8a'R)-1-(2-(4-(2-(2,4-dichlorophenoxy)acetamido)phenyl)acetyl)-6'-oxotetrahydro-2'H,6'H-spiro[pyrrolidine-2,7'-pyrrolo[2,1-b][1,3]thiazine]-4'-carboxamide",C525002,ST2825,https://ctdbase.org/detail.go?type=chem&acc=C525002,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[paraquat co-treated with ST2825] results in increased expression of PARP1 protein,,,PMID:34811946,https://www.ncbi.nlm.nih.gov/pubmed/34811946,34811946,,PMC8818611,9574078,"Qi M, Liao S, Wang J, Deng Y, Zha A, Shao Y, Cui Z, Song T, Tang Y, Tan B, Yin Y. MyD88 deficiency ameliorates weight loss caused by intestinal oxidative injury in an autophagy-dependent mechanism. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):677–95. PMID: 34811946; PMCID: PMC8818611."
2234385,24826799,Comparative Toxicogenomics Database (CTD),Ponatinib,C545373,ponatinib,https://ctdbase.org/detail.go?type=chem&acc=C545373,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),(+)-JQ1 compound promotes the reaction [ponatinib results in increased cleavage of PARP1 protein]|ponatinib promotes the reaction [(+)-JQ1 compound results in increased cleavage of PARP1 protein],,,PMID:25053825,https://www.ncbi.nlm.nih.gov/pubmed/25053825,25053825,,PMC4185220,12756748,"Fiskus W, Sharma S, Qi J, Shah B, Devaraj SG, Leveque C, Portier BP, Iyer S, Bradner JE, Bhalla KN. BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD. Mol Cancer Ther. 2014 Oct;13(10):2315–27. PMID: 25053825; PMCID: PMC4185220."
2234386,24826799,Comparative Toxicogenomics Database (CTD),Ponatinib,C545373,ponatinib,https://ctdbase.org/detail.go?type=chem&acc=C545373,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ponatinib results in increased cleavage of PARP1 protein,,,PMID:21482694|PMID:22875613|PMID:25053825,https://www.ncbi.nlm.nih.gov/pubmed/21482694|https://www.ncbi.nlm.nih.gov/pubmed/22875613|https://www.ncbi.nlm.nih.gov/pubmed/25053825,21482694|22875613|25053825,,PMC3236248|PMC3533670|PMC4185220,1769570|12756748|29611134,"Fiskus W, Sharma S, Qi J, Shah B, Devaraj SG, Leveque C, Portier BP, Iyer S, Bradner JE, Bhalla KN. BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD. Mol Cancer Ther. 2014 Oct;13(10):2315–27. PMID: 25053825; PMCID: PMC4185220.|Chase A, Bryant C, Score J, Cross NCP. Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome. Haematologica. 2012 Aug 08;98(1):103–6. doi: 10.3324/haematol.2012.066407.|Gozgit JM, Wong MJ, Wardwell S, Tyner JW, Loriaux MM, Mohemmad QK, Narasimhan NI, Shakespeare WC, Wang F, Druker BJ, Clackson T, Rivera VM. Potent Activity of Ponatinib (AP24534) in Models of FLT3-Driven Acute Myeloid Leukemia and Other Hematologic Malignancies. 2011 Jun 01;10(6):1028–35. doi: 10.1158/1535-7163.mct-10-1044."
2034775,24836820,Comparative Toxicogenomics Database (CTD),10-Nitrooleic acid,C521487,10-nitro-oleic acid,https://ctdbase.org/detail.go?type=chem&acc=C521487,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),10-nitro-oleic acid results in increased cleavage of PARP1 protein|probenecid promotes the reaction [10-nitro-oleic acid results in increased cleavage of PARP1 protein],,,PMID:29158255,https://www.ncbi.nlm.nih.gov/pubmed/29158255,29158255,,PMC5787792,11466637,"Woodcock CC, Huang Y, Woodcock SR, Salvatore SR, Singh B, Golin-Bisello F, Davidson NE, Neumann CA, Freeman BA, Wendell SG. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth. Journal of Biological Chemistry. 2018 Jan;293(4):1120–37. doi: 10.1074/jbc.m117.814368."
2036376,24850296,Comparative Toxicogenomics Database (CTD),Erigeroflavanone,C529414,erigeroflavanone,https://ctdbase.org/detail.go?type=chem&acc=C529414,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Erigeroflavanone inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:19557877,https://www.ncbi.nlm.nih.gov/pubmed/19557877,19557877,,,18066132,"Kim OS, Kim YS, Jang DS, Yoo NH, Kim JS. Cytoprotection against hydrogen peroxide-induced cell death in cultured mouse mesangial cells by erigeroflavanone, a novel compound from the flowers of Erigeron annuus. Chem Biol Interact. 2009 Aug 14;180(3):414–20. doi: 10.1016/j.cbi.2009.03.021. PMID: 19557877."
2147293,24867970,Toxin and Toxin Target Database (T3DB),"2-benzyl-3-(3-chloro-4-methoxyphenyl)-7-methyl-3a,6,7,7a-tetrahydro-3H-isoindol-1-one",T3D0678,Lithium cobalt oxide,http://www.t3db.ca/toxins/T3D0678,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2277752,24889392,Comparative Toxicogenomics Database (CTD),Quizartinib,C544967,quizartinib,https://ctdbase.org/detail.go?type=chem&acc=C544967,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Quizartinib results in increased cleavage of PARP1 protein|quizartinib promotes the reaction [(+)-JQ1 compound results in increased cleavage of PARP1 protein]|(+)-JQ1 compound promotes the reaction [quizartinib results in increased cleavage of PARP1 protein],,,PMID:25053825,https://www.ncbi.nlm.nih.gov/pubmed/25053825,25053825,,PMC4185220,12756748,"Fiskus W, Sharma S, Qi J, Shah B, Devaraj SG, Leveque C, Portier BP, Iyer S, Bradner JE, Bhalla KN. BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD. Mol Cancer Ther. 2014 Oct;13(10):2315–27. PMID: 25053825; PMCID: PMC4185220."
2206078,24937012,Comparative Toxicogenomics Database (CTD),PI-3065,C000726939,PI-3065,https://ctdbase.org/detail.go?type=chem&acc=C000726939,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BIRC5 protein inhibits the reaction [PI-3065 results in increased cleavage of PARP1 protein]|pi-3065 results in increased cleavage of PARP1 protein|sepantronium promotes the reaction [PI-3065 results in increased cleavage of PARP1 protein]|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [PI-3065 results in increased cleavage of PARP1 protein],,,PMID:36623716,https://www.ncbi.nlm.nih.gov/pubmed/36623716,36623716,,,34818642,"Wei Y, Ke W, Lu Z, Ren Y. PI3K d inhibitor PI-3065 induces apoptosis in hepatocellular carcinoma cells by targeting survivin. Chem Biol Interact. 2023 Feb 01;371():110343. doi: 10.1016/j.cbi.2023.110343. PMID: 36623716."
2190852,24945792,BindingDB,,27701,"5-methyl-3-phenyl-4,5,7-triazatricyclo[7.4.0.0^{2,6}]trideca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27701,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),7.3,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2190853,24947284,BindingDB,,27702,"5-methyl-3-(thiophen-2-yl)-4,5,7-triazatricyclo[7.4.0.0^{2,6}]trideca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27702,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),6.9,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2190854,24948224,BindingDB,,27696,"5-methyl-3-(thiophen-2-yl)-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27696,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),148.6,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2044432,24958200,Chemical Probes Portal,Niraparib,Niraparib,Niraparib,https://www.chemicalprobes.org/niraparib,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),"Catalytic inhibitor, PARP-DNA complex trapping",,"3.2 nM, 3.8 nM, 16.7 nM, 2.1 nM, 15.3 nM",PMID:28001384|PMID:19873981|DOI:10.1021/jm901188v,https://www.ncbi.nlm.nih.gov/pubmed/28001384|https://www.ncbi.nlm.nih.gov/pubmed/19873981|https://doi.org/10.1021/jm901188v,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
2044436,24958200,Comparative Toxicogenomics Database (CTD),Niraparib,C545685,niraparib,https://ctdbase.org/detail.go?type=chem&acc=C545685,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niraparib binds to and results in decreased activity of PARP1 protein,,,PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
2147857,24958200,DrugBank,Niraparib,DB11793,Niraparib,https://www.drugbank.ca/drugs/DB11793,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:30073633,https://www.ncbi.nlm.nih.gov/pubmed/30073633,30073633,,,19603737,"Heo YA, Duggan ST: Niraparib: A Review in Ovarian Cancer. Target Oncol. 2018 Aug;13(4):533-539. doi: 10.1007/s11523-018-0582-1."
2190856,24958200,Drug Gene Interaction database (DGIdb),Niraparib,,NIRAPARIB,https://www.dgidb.org/drugs/rxcui:1918231,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Other/unknown,,,,,,,,,
2201339,24958200,ChEMBL,Niraparib,CHEMBL1094636,NIRAPARIB,https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1094636,CHEMBL3105,Poly [ADP-ribose] polymerase-1,https://www.ebi.ac.uk/chembl/explore/target/CHEMBL3105,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Poly [ADP-ribose] polymerase-1 inhibitor,,,PMID:19873981,https://www.ncbi.nlm.nih.gov/pubmed/19873981,19873981,,,33579805,"Jones P, Altamura S, Boueres J, Ferrigno F, Fonsi M, Giomini C, Lamartina S, Monteagudo E, Ontoria JM, Orsale MV, Palumbi MC, Pesci S, Roscilli G, Scarpelli R, Schultz-Fademrecht C, Toniatti C, Rowley M. Discovery of 2-{4-[(3<i>S</i>)-Piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors. J. Med. Chem. 2009 Oct 29;52(22):7170–85. doi: 10.1021/jm901188v."
2235064,24958200,IUPHAR/BPS Guide to PHARMACOLOGY,Niraparib,8275,niraparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8275,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,8.42,PMID:19873981,https://www.ncbi.nlm.nih.gov/pubmed/19873981,19873981,,,33579805,"Jones P, Altamura S, Boueres J, Ferrigno F, Fonsi M, Giomini C, Lamartina S, Monteagudo E, Ontoria JM, Orsale MV, Palumbi MC, Pesci S, Roscilli G, Scarpelli R, Schultz-Fademrecht C, Toniatti C, Rowley M. Discovery of 2-{4-[(3<i>S</i>)-Piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors. J. Med. Chem. 2009 Oct 29;52(22):7170–85. doi: 10.1021/jm901188v."
2235068,24958200,BindingDB,Niraparib,50316226,(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50316226,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),11.7,PMID:27866910|DOI:10.1016/j.chembiol.2016.10.011,https://www.ncbi.nlm.nih.gov/pubmed/27866910|https://doi.org/10.1016/j.chembiol.2016.10.011,27866910,10.1016/j.chembiol.2016.10.011,PMC5182133,33069478,"Knezevic CE, Wright G, Remsing Rix LL, Kim W, Kuenzi BM, Luo Y, Watters JM, Koomen JM, Haura EB, Monteiro AN, Radu C, Lawrence HR, Rix U. Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Cell Chemical Biology. 2016 Dec;23(12):1490–503. doi: 10.1016/j.chembiol.2016.10.011."
2236815,24958200,Drug Gene Interaction database (DGIdb),Niraparib,,NIRAPARIB,https://www.dgidb.org/drugs/rxcui:1918231,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2236816,24958200,Drug Gene Interaction database (DGIdb),Niraparib,,NIRAPARIB,https://www.dgidb.org/drugs/rxcui:1918231,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2255287,24958200,Drug Gene Interaction database (DGIdb),Niraparib,,NIRAPARIB,https://www.dgidb.org/drugs/rxcui:1918231,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2255288,24958200,Drug Gene Interaction database (DGIdb),Niraparib,,NIRAPARIB,https://www.dgidb.org/drugs/rxcui:1918231,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2275453,24958200,Drug Gene Interaction database (DGIdb),Niraparib,,NIRAPARIB,https://www.dgidb.org/drugs/rxcui:1918231,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2235426,24964624,Comparative Toxicogenomics Database (CTD),Akt Inhibitor MK2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[romidepsin co-treated with MK 2206] results in increased cleavage of PARP1 protein|romidepsin promotes the reaction [[mirdametinib co-treated with MK 2206] results in increased cleavage of PARP1 protein]|[mirdametinib co-treated with MK 2206] results in increased cleavage of PARP1 protein,,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,PMC5340114,1203163,"Bahr JC, Robey RW, Luchenko V, Basseville A, Chakraborty AR, Kozlowski H, Pauly GT, Patel P, Schneider JP, Gottesman MM, Bates SE. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016 Oct 25;7(43):69804–15. PMID: 27634878; PMCID: PMC5340114."
1282032,24978538,Comparative Toxicogenomics Database (CTD),Navitoclax,C528561,navitoclax,https://ctdbase.org/detail.go?type=chem&acc=C528561,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[MTOR protein affects the susceptibility to navitoclax] which affects the cleavage of PARP1 protein|[navitoclax co-treated with everolimus] results in increased cleavage of PARP1 protein,,,PMID:28947240,https://www.ncbi.nlm.nih.gov/pubmed/28947240,28947240,,,16200510,"Lee EY, Gong EY, Shin JS, Moon JH, Shim HJ, Kim SM, Lee S, Jeong J, Gong JH, Kim MJ, Lee DH, Park YS, Shin J, Hong SW, Kim YS, Jin DH. Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin. Toxicol In Vitro. 2018 Feb;46():229–36. doi: 10.1016/j.tiv.2017.09.023. PMID: 28947240."
1282033,24978538,Comparative Toxicogenomics Database (CTD),Navitoclax,C528561,navitoclax,https://ctdbase.org/detail.go?type=chem&acc=C528561,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Navitoclax results in increased cleavage of PARP1 protein,,,PMID:28947240|PMID:32927276,https://www.ncbi.nlm.nih.gov/pubmed/28947240|https://www.ncbi.nlm.nih.gov/pubmed/32927276,28947240|32927276,,PMC7494677,10174929|16200510,"Lui GYL, Shaw R, Schaub FX, Stork IN, Gurley KE, Bridgwater C, Diaz RL, Rosati R, Swan HA, Ince TA, Harding TC, Gadi VK, Goff BA, Kemp CJ, Swisher EM, Grandori C. BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer. EBioMedicine. 2020 Oct;60():102988. PMID: 32927276; PMCID: PMC7494677.|Lee EY, Gong EY, Shin JS, Moon JH, Shim HJ, Kim SM, Lee S, Jeong J, Gong JH, Kim MJ, Lee DH, Park YS, Shin J, Hong SW, Kim YS, Jin DH. Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin. Toxicol In Vitro. 2018 Feb;46():229–36. doi: 10.1016/j.tiv.2017.09.023. PMID: 28947240."
1282034,24978538,Comparative Toxicogenomics Database (CTD),Navitoclax,C528561,navitoclax,https://ctdbase.org/detail.go?type=chem&acc=C528561,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rucaparib promotes the reaction [navitoclax results in increased cleavage of PARP1 protein],,,PMID:32927276,https://www.ncbi.nlm.nih.gov/pubmed/32927276,32927276,,PMC7494677,10174929,"Lui GYL, Shaw R, Schaub FX, Stork IN, Gurley KE, Bridgwater C, Diaz RL, Rosati R, Swan HA, Ince TA, Harding TC, Gadi VK, Goff BA, Kemp CJ, Swisher EM, Grandori C. BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer. EBioMedicine. 2020 Oct;60():102988. PMID: 32927276; PMCID: PMC7494677."
2239631,25018558,Comparative Toxicogenomics Database (CTD),3-[[4-[bis(2-chloroethyl)amino]phenyl]carbamoylamino]-N-[2-(dimethylamino)ethyl]benzamide,C582286,1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea,https://ctdbase.org/detail.go?type=chem&acc=C582286,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine co-treated with 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea] results in increased cleavage of PARP1 protein|[2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one co-treated with 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea] results in increased cleavage of PARP1 protein",,,PMID:26208482,https://www.ncbi.nlm.nih.gov/pubmed/26208482,26208482,,PMC4694865,33024721,"Kuo CY, Chou WC, Wu CC, Wong TS, Kakadiya R, Lee TC, Su TL, Wang HC. Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms. Oncotarget. 2015 Sep 22;6(28):25770–83. PMID: 26208482; PMCID: PMC4694865."
2315777,25021269,Toxin and Toxin Target Database (T3DB),Arsenic(III)selenide,T3D1301,Arsenic triselenide,http://www.t3db.ca/toxins/T3D1301,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2275766,25022080,Toxin and Toxin Target Database (T3DB),Tripotassium;cobalt(3+);hexanitrite;hydrate,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2166113,25023738,Comparative Toxicogenomics Database (CTD),"2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one",C516541,BI D1870,https://ctdbase.org/detail.go?type=chem&acc=C516541,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BI D1870 inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein]|bi D1870 results in increased cleavage of PARP1 protein,,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,PMC4234881,19518824,"Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710–22. PMID: 25246272; PMCID: PMC4234881."
2236801,25033539,Comparative Toxicogenomics Database (CTD),PF-04691502,C570662,"2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one",https://ctdbase.org/detail.go?type=chem&acc=C570662,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one results in increased cleavage of and results in increased activity of PARP1 protein",,,PMID:23639247,https://www.ncbi.nlm.nih.gov/pubmed/23639247,23639247,,,19495342,"Wang FZ, Peng-Jiao, Yang NN, Chuang-Yuan, Zhao YL, Liu QQ, Fei HR, Zhang JG. PF-04691502 triggers cell cycle arrest, apoptosis and inhibits the angiogenesis in hepatocellular carcinoma cells. Toxicol Lett. 2013 Jul 04;220(2):150–6. doi: 10.1016/j.toxlet.2013.04.018. PMID: 23639247."
2150640,25108681,Comparative Toxicogenomics Database (CTD),Z-IETD-fmk,C403753,benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C403753,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10029,Cricetulus griseus (Chinese hamster),Benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [acrolein results in increased cleavage of PARP1 protein],,,PMID:17320762,https://www.ncbi.nlm.nih.gov/pubmed/17320762,17320762,,,15307002,"Tanel A, Averill-Bates DA. Activation of the death receptor pathway of apoptosis by the aldehyde acrolein. Free Radic Biol Med. 2007 Mar 15;42(6):798–810. doi: 10.1016/j.freeradbiomed.2006.12.009. PMID: 17320762."
2150641,25108681,Comparative Toxicogenomics Database (CTD),Z-IETD-fmk,C403753,benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C403753,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ciglitazone promotes the reaction [niflumic acid results in increased cleavage of PARP1 protein]]|benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [niflumic acid promotes the reaction [ciglitazone results in increased cleavage of PARP1 protein]],,,PMID:21067863,https://www.ncbi.nlm.nih.gov/pubmed/21067863,21067863,,,28245364,"Kim BM, Maeng K, Lee KH, Hong SH. Combined treatment with the Cox-2 inhibitor niflumic acid and PPAR? ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells. Cancer Lett. 2011 Jan 28;300(2):134–44. doi: 10.1016/j.canlet.2010.09.014. PMID: 21067863."
2150650,25108681,Comparative Toxicogenomics Database (CTD),Z-IETD-fmk,C403753,benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C403753,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [N,N-dimethylphytosphingosine results in increased cleavage of PARP1 protein]",,,PMID:19481559,https://www.ncbi.nlm.nih.gov/pubmed/19481559,19481559,,,20087336,"Kim BM, Choi YJ, Han Y, Yun YS, Hong SH. N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells. Toxicol Appl Pharmacol. 2009 Aug 15;239(1):87–97. doi: 10.1016/j.taap.2009.05.020. PMID: 19481559."
2150651,25108681,Comparative Toxicogenomics Database (CTD),Z-IETD-fmk,C403753,benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C403753,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein],,,PMID:21362627,https://www.ncbi.nlm.nih.gov/pubmed/21362627,21362627,,,13359584,"Lim SC, Duong HQ, Choi JE, Lee TB, Kang JH, Oh SH, Han SI. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Carcinogenesis. 2011 May;32(5):723–31. doi: 10.1093/carcin/bgr038. PMID: 21362627."
2150652,25108681,Comparative Toxicogenomics Database (CTD),Z-IETD-fmk,C403753,benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C403753,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [manganese chloride results in increased cleavage of PARP1 protein],,,PMID:21704098,https://www.ncbi.nlm.nih.gov/pubmed/21704098,21704098,,,21483681,"Alaimo A, Gorojod RM, Kotler ML. The extrinsic and intrinsic apoptotic pathways are involved in manganese toxicity in rat astrocytoma C6 cells. Neurochem Int. 2011 Aug;59(2):297–308. doi: 10.1016/j.neuint.2011.06.001. PMID: 21704098."
2150821,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein],,,PMID:17308071,https://www.ncbi.nlm.nih.gov/pubmed/17308071,17308071,,,15295415,"Mhaidat NM, Wang Y, Kiejda KA, Zhang XD, Hersey P. Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2. Mol Cancer Ther. 2007 Feb;6(2):752–61. doi: 10.1158/1535-7163.mct-06-0564. PMID: 17308071."
2150822,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [flavanones results in increased cleavage of PARP1 protein],,,PMID:21616090,https://www.ncbi.nlm.nih.gov/pubmed/21616090,21616090,,,9342382,"Shin SY, Hyun J, Yu JR, Lim Y, Lee YH. 5-Methoxyflavanone induces cell cycle arrest at the G2/M phase, apoptosis and autophagy in HCT116 human colon cancer cells. Toxicol Appl Pharmacol. 2011 Aug 01;254(3):288–98. doi: 10.1016/j.taap.2011.05.003. PMID: 21616090."
2192683,25113762,BindingDB,"2-[4-(Pyridin-2-yl)phenyl]-1,3-diazatricyclo[6.3.1.0^{4,12}]dodeca-2,4(12),5,7-tetraen-9-one",27494,"2-[4-(pyridin-2-yl)phenyl]-1,3-diazatricyclo[6.3.1.0^{4,12}]dodeca-2,4(12),5,7-tetraen-9-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27494,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),15.4,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
2192686,25113763,BindingDB,"6-Chloro-2,3-dimethylimidazo[1,2-a]pyridin-8-ol",27495,"6-chloro-2,3-dimethylimidazo[1,2-a]pyridin-8-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27495,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),398,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
2192687,25113764,BindingDB,"4-[(1-Methyl-1H-pyrrol-2-yl)methylene]-1,3(2H,4H)-isoquinolinedione",27496,"(4Z)-4-[(1-methyl-1H-pyrrol-2-yl)methylidene]-1,2,3,4-tetrahydroisoquinoline-1,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27496,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),45,PMID:18809672|DOI:10.1124/mol.108.048751,https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://doi.org/10.1124/mol.108.048751,18809672,10.1124/mol.108.048751,,5137304,"Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol Pharmacol. 2008 Dec;74(6):1587–98. doi: 10.1124/mol.108.048751. PMID: 18809672."
2192702,25128834,BindingDB,"4-[(4-Fluoro-3-{[4-(oxolan-3-ylcarbonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27570,"4-[(4-fluoro-3-{[4-(oxolan-3-ylcarbonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27570,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),2,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192703,25132257,BindingDB,"4-[(3-{[4-(2-Hydroxyethyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27534,"4-[(3-{[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27534,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),18,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192704,25132258,BindingDB,"4-[(4-Fluoro-3-{[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27535,"4-[(4-fluoro-3-{[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27535,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),7,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192705,25132259,BindingDB,"4-({3-[(4-Benzyl-1,4-diazepan-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",27536,"4-({3-[(4-benzyl-1,4-diazepan-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27536,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),18,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192706,25132260,BindingDB,"4-[(3-{[4-(Ethanesulfonyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27537,"4-[(3-{[4-(ethanesulfonyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27537,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),23,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192707,25132261,BindingDB,"4-[(3-{[4-(Morpholin-4-ylcarbonyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27538,"4-[(3-{[4-(morpholin-4-ylcarbonyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27538,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),20,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192725,25132609,BindingDB,"4-[(4-Fluoro-3-{[4-(morpholin-4-ylcarbonyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27539,"4-[(4-fluoro-3-{[4-(morpholin-4-ylcarbonyl)-1,4-diazepan-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27539,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),8,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192726,25132610,BindingDB,"4-({3-[(4-Acetyl-1,4-diazepan-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",27540,"4-({3-[(4-acetyl-1,4-diazepan-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27540,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),12,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192727,25132611,BindingDB,"4-({3-[(4-Cyclopropanecarbonyl-1,4-diazepan-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",27541,"4-({3-[(4-cyclopropanecarbonyl-1,4-diazepan-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27541,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),12,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192728,25132612,BindingDB,4-[[3-(Piperazine-1-carbonyl)phenyl]methyl]-2H-phthalazin-1-one,27542,4-(3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27542,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),2,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192729,25132612,BindingDB,4-[[3-(Piperazine-1-carbonyl)phenyl]methyl]-2H-phthalazin-1-one,27542,4-(3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27542,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),2,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2192730,25132613,BindingDB,"4-[(3-{[4-(Pyridin-2-yl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27544,"4-[(3-{[4-(pyridin-2-yl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27544,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),10,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192731,25132952,BindingDB,"4-[(4-Fluoro-3-{[4-(pyridin-2-yl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27545,"4-[(4-fluoro-3-{[4-(pyridin-2-yl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27545,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),2,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192742,25132953,BindingDB,"4-[(3-{[4-(Pyrimidin-2-yl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27546,"4-[(3-{[4-(pyrimidin-2-yl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27546,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),2,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192743,25132954,BindingDB,"4-[(4-Fluoro-3-{[4-(pyrimidin-2-yl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27547,"4-[(4-fluoro-3-{[4-(pyrimidin-2-yl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27547,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),3,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192744,25132955,BindingDB,"4-[(3-{[4-(Ethanesulfonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27548,"4-[(3-{[4-(ethanesulfonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27548,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),12,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192745,25132956,BindingDB,"4-[(3-{[4-(Ethanesulfonyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]-1,2-dihydrophthalazin-1-one",27549,"4-[(3-{[4-(ethanesulfonyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27549,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),8,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192746,25132957,BindingDB,"4-[(3-{[4-(Morpholin-4-ylcarbonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27550,"4-[(3-{[4-(morpholin-4-ylcarbonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27550,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),8,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2192747,25133278,BindingDB,"4-[(4-Fluoro-3-{[4-(morpholin-4-ylcarbonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27551,"4-[(4-fluoro-3-{[4-(morpholin-4-ylcarbonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27551,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),6,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193030,25133279,BindingDB,"4-({3-[(4-Phenylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",27552,"4-({3-[(4-phenylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27552,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),51,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193031,25133280,BindingDB,"4-({4-Fluoro-3-[(4-phenylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",27553,"4-({4-fluoro-3-[(4-phenylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27553,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),5,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193032,25133281,BindingDB,"4-({3-[(4-Benzoylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",27554,"4-({3-[(4-benzoylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27554,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),11,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193033,25133282,BindingDB,"4-({3-[(4-Benzoylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",27555,"4-({3-[(4-benzoylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27555,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),6,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193034,25133283,BindingDB,"4-[(3-{[4-(2-Hydroxyethyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27556,"4-[(3-{[4-(2-hydroxyethyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27556,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),39,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193035,25133629,BindingDB,"4-[(4-Fluoro-3-{[4-(2-hydroxyethyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27557,"4-[(4-fluoro-3-{[4-(2-hydroxyethyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27557,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),12,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193036,25133630,BindingDB,"4-({3-[(4-Methylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",27558,"4-({3-[(4-methylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27558,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),88,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193037,25133631,BindingDB,"4-({4-Fluoro-3-[(4-methylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",27559,"4-({4-fluoro-3-[(4-methylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27559,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),13,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193038,25133632,BindingDB,"4-({3-[(4-Ethylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",27560,"4-({3-[(4-ethylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27560,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),6,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193039,25133633,BindingDB,"4-({4-Fluoro-3-[(4-propylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",27561,"4-({4-fluoro-3-[(4-propylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27561,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),6,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193040,25133634,BindingDB,"4-({3-[(4-Butylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",27562,"4-({3-[(4-butylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27562,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),5,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193041,25133974,BindingDB,"4-[(3-{[4-(Cyclopropylmethyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]-1,2-dihydrophthalazin-1-one",27563,"4-[(3-{[4-(cyclopropylmethyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27563,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),4,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193042,25133975,BindingDB,"4-({3-[(4-Acetylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",27564,"4-({3-[(4-acetylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27564,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),6,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193043,25133976,BindingDB,"4-({4-Fluoro-3-[(4-propanoylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",27565,"4-({4-fluoro-3-[(4-propanoylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27565,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),5,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193044,25133977,BindingDB,"4-({3-[(4-Cyclopentanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",27567,"4-({3-[(4-cyclopentanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27567,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),2,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193045,25133978,BindingDB,"4-[(4-Fluoro-3-{[4-(oxolan-2-ylcarbonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27569,"4-[(4-fluoro-3-{[4-(oxolan-2-ylcarbonyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27569,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),3,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2193046,25133979,BindingDB,"4-({3-[(4-Cyclohexanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",27568,"4-({3-[(4-cyclohexanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27568,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),15,PMID:18800822|DOI:10.1021/jm8001263,https://www.ncbi.nlm.nih.gov/pubmed/18800822|https://doi.org/10.1021/jm8001263,18800822,10.1021/jm8001263,,24164502,"Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT, Moore S, O'Connor MJ, Smith GC, Martin NM. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J Med Chem. 2008 Oct 23;51(20):6581–91. doi: 10.1021/jm8001263. PMID: 18800822."
2206073,25147458,Toxin and Toxin Target Database (T3DB),Zinc arsenide,T3D0722,Zinc arsenide,http://www.t3db.ca/toxins/T3D0722,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2317271,25150857,Comparative Toxicogenomics Database (CTD),Bix-01294,C518299,BIX 01294,https://ctdbase.org/detail.go?type=chem&acc=C518299,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BIX 01294 inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of PARP1 protein],,,PMID:33378118,https://www.ncbi.nlm.nih.gov/pubmed/33378118,33378118,,,22375995,"Ding X, Zhang A, Li C, Ma L, Tang S, Wang Q, Yang G, Li J. The role of <scp>H3K9me2</scp>-regulated base excision repair genes in the repair of <scp>DNA</scp> damage induced by arsenic in <scp>HaCaT</scp> cells and the effects of <scp><i>Ginkgo biloba</i></scp> extract intervention. Environmental Toxicology. 2020 Dec 30;36(5):850–60. doi: 10.1002/tox.23088."
2317272,25150857,Comparative Toxicogenomics Database (CTD),Bix-01294,C518299,BIX 01294,https://ctdbase.org/detail.go?type=chem&acc=C518299,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[BIX 01294 results in increased susceptibility to imatinib mesylate] which results in increased cleavage of PARP1 protein|[bix 01294 results in increased susceptibility to IFNA2 protein alternative form] which results in increased cleavage of PARP1 protein,,,PMID:25079219,https://www.ncbi.nlm.nih.gov/pubmed/25079219,25079219,,PMC4117596,12063054,"Loh SW, Ng WL, Yeo KS, Lim Y, Ea C. Inhibition of Euchromatic Histone Methyltransferase 1 and 2 Sensitizes Chronic Myeloid Leukemia Cells to Interferon Treatment. PLoS ONE. 2014 Jul 31;9(7):e103915. doi: 10.1371/journal.pone.0103915."
2207201,25167777,Comparative Toxicogenomics Database (CTD),Omipalisib,C561454,omipalisib,https://ctdbase.org/detail.go?type=chem&acc=C561454,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Omipalisib results in decreased phosphorylation of PARP1 protein|omipalisib results in increased cleavage of PARP1 protein,,,PMID:21464613,https://www.ncbi.nlm.nih.gov/pubmed/21464613,21464613,,PMC3127046,1752982,"Leung E, Kim JE, Rewcastle GW, Finlay GJ, Baguley BC. Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells. Cancer Biology & Therapy. 2011 Jun;11(11):938–46. doi: 10.4161/cbt.11.11.15527."
2101674,25190716,BindingDB,"2-(azetidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27092,"2-(azetidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27092,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),34,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101675,25190717,BindingDB,"2-(azetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27093,"2-(azetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27093,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),6,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101765,25190717,BindingDB,"2-(azetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27093,"2-(azetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27093,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),6,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2101766,25190718,BindingDB,"2-[(2R)-pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27094,"2-[(2R)-pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27094,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),7,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2101767,25190718,BindingDB,"2-[(2R)-pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27094,"2-[(2R)-pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27094,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),7,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101768,25190719,BindingDB,"2-[(2S)-pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27095,"2-[(2S)-pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27095,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),30,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101769,25190719,BindingDB,"2-[(2S)-pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27095,"2-[(2S)-pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27095,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),30,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2101770,25190720,BindingDB,"2-[(2R)-piperidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27097,"2-[(2R)-piperidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27097,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),37,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101771,25190721,BindingDB,"2-[(2S)-piperidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27098,"2-[(2S)-piperidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27098,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),41,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101866,25190722,BindingDB,"2-(azepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27101,"2-(azepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27101,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),5,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101867,25190722,BindingDB,"2-(azepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27101,"2-(azepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27101,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),5,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2101868,25190723,BindingDB,"2-[1-(propan-2-yl)azetidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27102,"2-[1-(propan-2-yl)azetidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27102,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),110,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101869,25190724,BindingDB,"2-(1-cyclopentylazetidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27103,"2-(1-cyclopentylazetidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27103,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),180,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101870,25190725,BindingDB,"2-(1-propylazetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27104,"2-(1-propylazetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27104,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),17,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101871,25190726,BindingDB,"2-(1-cyclopentylazetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27105,"2-(1-cyclopentylazetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27105,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),15,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101872,25190727,BindingDB,"2-[(2R)-1-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27106,"2-[(2R)-1-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27106,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),8,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101955,25190728,BindingDB,"2-[(2S)-1-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27107,"2-[(2S)-1-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27107,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),26,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101956,25190729,BindingDB,"2-[(2R)-1-(propan-2-yl)pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27108,"2-[(2R)-1-(propan-2-yl)pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27108,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),21,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101957,25190730,BindingDB,"2-[(2S)-1-(propan-2-yl)pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27109,"2-[(2S)-1-(propan-2-yl)pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27109,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),20,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101958,25190731,BindingDB,"2-(1-cyclopentylpyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27112,"2-(1-cyclopentylpyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27112,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),5,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101959,25190732,BindingDB,"2-[1-(2-phenylethyl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",27113,"2-[1-(2-phenylethyl)pyrrolidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27113,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),9,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101960,25190733,BindingDB,"2-(1-methylpiperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27114,"2-(1-methylpiperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27114,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),29,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2101961,25190734,BindingDB,"2-[1-(propan-2-yl)piperidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27115,"2-[1-(propan-2-yl)piperidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27115,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),45,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102053,25190735,BindingDB,"2-(1-cyclopentylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27121,"2-(1-cyclopentylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27121,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),6,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102054,25190736,BindingDB,"2-[1-(4-cyanophenyl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",27122,"2-[1-(4-cyanophenyl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27122,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),3,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102055,25190737,BindingDB,"2-[1-(propan-2-yl)azepan-4-yl]-1H-1,3-benzodiazole-4-carboxamide",27123,"2-[1-(propan-2-yl)azepan-4-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27123,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),5,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102056,25190738,BindingDB,"2-(1-cyclopentylazepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27124,"2-(1-cyclopentylazepan-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27124,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),4,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102057,25190739,BindingDB,"2-[(2S)-5-oxopyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27125,"2-[(2S)-5-oxopyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27125,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),16,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102058,25190740,BindingDB,"2-[1-(benzenesulfonyl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",27127,"2-[1-(benzenesulfonyl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27127,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),27,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102059,25190741,BindingDB,"2-[1-(dimethylsulfamoyl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",27128,"2-[1-(dimethylsulfamoyl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27128,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),28,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102150,25190742,BindingDB,"2-{1-[2-(diethylamino)ethyl]piperidin-4-yl}-1H-1,3-benzodiazole-4-carboxamide",27129,"2-{1-[2-(diethylamino)ethyl]piperidin-4-yl}-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27129,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),31,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102151,25190743,BindingDB,"6-chloro-2-[1-(propan-2-yl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",27132,"6-chloro-2-[1-(propan-2-yl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27132,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),18,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102152,25190744,BindingDB,"1-methyl-2-(1-propylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27133,"1-methyl-2-(1-propylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27133,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),34,PMID:18541433|DOI:10.1016/j.bmc.2008.05.044,https://www.ncbi.nlm.nih.gov/pubmed/18541433|https://doi.org/10.1016/j.bmc.2008.05.044,18541433,10.1016/j.bmc.2008.05.044,,9937209,"Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Olson AM, Marsh KC, Luo Y, Rosenberg SH, Giranda VL. Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorg Med Chem. 2008 Jul 15;16(14):6965–75. doi: 10.1016/j.bmc.2008.05.044. PMID: 18541433."
2102153,25190745,BindingDB,"2-(1-methylpyrrolidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27138,"2-(1-methylpyrrolidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27138,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),15,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2102154,25190746,BindingDB,"2-(piperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27142,"2-(piperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27142,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),25,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2102155,25190747,BindingDB,"2-(1-propylpiperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27144,"2-(1-propylpiperidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27144,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),130,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2102156,25190748,BindingDB,"2-[3-methyl-1-(propan-2-yl)azetidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",27148,"2-[3-methyl-1-(propan-2-yl)azetidin-3-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27148,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),9,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2102233,25190749,BindingDB,"2-(1,3-dimethylpyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",27152,"2-(1,3-dimethylpyrrolidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27152,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),5,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2102234,25190750,BindingDB,"2-(2-ethylpyrrolidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",27156,"2-(2-ethylpyrrolidin-2-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27156,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),13,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2102235,25190751,BindingDB,"2-[2-ethyl-1-(propan-2-yl)pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",27157,"2-[2-ethyl-1-(propan-2-yl)pyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27157,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),69,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2102236,25190752,BindingDB,"2-(4-methylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",27161,"2-(4-methylpiperidin-4-yl)-1H-1,3-benzodiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27161,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,Ki (nM),4,PMID:19143569|DOI:10.1021/jm801171j,https://www.ncbi.nlm.nih.gov/pubmed/19143569|https://doi.org/10.1021/jm801171j,19143569,10.1021/jm801171j,,24837969,"Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer. J Med Chem. 2009 Jan 22;52(2):514–23. doi: 10.1021/jm801171j. PMID: 19143569."
2194836,25190929,BindingDB,"13-Nitro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",27510,"13-nitro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27510,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),500,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2290972,25190929,Therapeutic Target Database (TTD),"13-Nitro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",D0E0QT,"8-Nitro-6H,11H-indeno[1,2-c]isoquinolin-5-one",https://idrblab.net/ttd/data/drug/details/D0E0QT,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2194846,25190930,BindingDB,"14-Nitro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",27511,"14-nitro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27511,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),300,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2194847,25190931,BindingDB,"13-Fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",27512,"13-fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27512,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),500,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2290973,25190931,Therapeutic Target Database (TTD),"13-Fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",D0O0GA,"8-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one",https://idrblab.net/ttd/data/drug/details/D0O0GA,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2194848,25190932,BindingDB,"14-Fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",27513,"14-fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27513,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),650,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2290974,25190932,Therapeutic Target Database (TTD),"14-Fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",D07BBR,"9-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one",https://idrblab.net/ttd/data/drug/details/D07BBR,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2194849,25190933,BindingDB,"13-fluoro-N-(morpholin-4-yl)-8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide",27529,"13-fluoro-N-(morpholin-4-yl)-8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27529,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),450,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2278337,25208596,Therapeutic Target Database (TTD),3-Phenylquinoline-8-carboxamide,D0L1NQ,3-Phenylquinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D0L1NQ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2278338,25208598,Therapeutic Target Database (TTD),3-Methylquinoline-8-carboxamide,D08XPZ,3-Methylquinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D08XPZ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2278339,25208746,Therapeutic Target Database (TTD),3-Ethynylquinoline-8-carboxamide,D00OZA,3-Ethynylquinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D00OZA,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2278340,25208747,Therapeutic Target Database (TTD),3-Ethenylquinoline-8-carboxamide,D0K7JT,3-Ethenylquinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D0K7JT,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2278341,25208752,Therapeutic Target Database (TTD),2-Ethylquinoline-8-carboxamide,D0Z3PB,2-ethylquinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D0Z3PB,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2278342,25208904,Therapeutic Target Database (TTD),3-Ethyl-8-quinolinecarboxamide,D0UF0U,3-Ethylquinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D0UF0U,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2278343,25208905,Therapeutic Target Database (TTD),3-Prop-1-ynylquinoline-8-carboxamide,D0T5TT,3-Prop-1-ynylquinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D0T5TT,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2278344,25209058,Therapeutic Target Database (TTD),2-(4-Methoxyphenyl)quinoline-8-carboxamide,D04TDX,2-(4-methoxyphenyl)quinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D04TDX,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2194959,25218483,BindingDB,"4-({3-[(4-Cyclopentanecarbonylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",27661,"4-({3-[(4-cyclopentanecarbonylpiperazin-1-yl)carbonyl]phenyl}methyl)-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27661,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),8,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194960,25218484,BindingDB,"4-[(3-{[4-(2-Phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",27662,"4-[(3-{[4-(2-phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)methyl]-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27662,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),5,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194961,25218485,BindingDB,2-{[3-(Piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide,27663,2-{[3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27663,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),18,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194962,25218486,BindingDB,2-{[4-Fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide,27664,2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27664,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),61,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194963,25218487,BindingDB,2-({3-[(4-Cyclopentanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methoxy)benzamide,27666,2-({3-[(4-cyclopentanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methoxy)benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27666,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),24,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194964,25218488,BindingDB,2-[(4-Fluoro-3-{[4-(2-phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)methoxy]benzamide,27668,2-[(4-fluoro-3-{[4-(2-phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)methoxy]benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27668,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),50,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194965,25218489,BindingDB,2-{2-[3-(Piperazin-1-ylcarbonyl)phenyl]ethoxy}benzamide,27669,2-{2-[3-(piperazin-1-ylcarbonyl)phenyl]ethoxy}benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27669,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),970,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194966,25218490,BindingDB,2-{2-[4-Fluoro-3-(piperazin-1-ylcarbonyl)phenyl]ethoxy}benzamide,27670,2-{2-[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]ethoxy}benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27670,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194967,25218491,BindingDB,2-(2-{3-[(4-Cyclopentanecarbonylpiperazin-1-yl)carbonyl]phenyl}ethoxy)benzamide,27671,2-(2-{3-[(4-cyclopentanecarbonylpiperazin-1-yl)carbonyl]phenyl}ethoxy)benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27671,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),200,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194968,25218492,BindingDB,2-(2-{3-[(4-Cyclopentanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}ethoxy)benzamide,27672,2-(2-{3-[(4-cyclopentanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}ethoxy)benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27672,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),103,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194969,25218493,BindingDB,2-[2-(3-{[4-(2-Phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)ethoxy]benzamide,27673,2-[2-(3-{[4-(2-phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)ethoxy]benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27673,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),200,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194970,25218494,BindingDB,2-[2-(4-Fluoro-3-{[4-(2-phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)ethoxy]benzamide,27674,2-[2-(4-fluoro-3-{[4-(2-phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)ethoxy]benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27674,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),19,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194971,25218495,BindingDB,5-Fluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide,27675,5-fluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27675,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),29,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194980,25218496,BindingDB,"4,5-Difluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide",27676,"4,5-difluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27676,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),240,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194981,25218497,BindingDB,4-Fluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide,27677,4-fluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27677,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),250,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194982,25218498,BindingDB,"3,5-Difluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide",27678,"3,5-difluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27678,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),1500,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194983,25218499,BindingDB,"3,6-Difluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide",27679,"3,6-difluoro-2-{[4-fluoro-3-(piperazin-1-ylcarbonyl)phenyl]methoxy}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27679,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194984,25218500,BindingDB,2-({3-[(4-Cyclopentanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methoxy)-5-fluorobenzamide,27680,2-({3-[(4-cyclopentanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methoxy)-5-fluorobenzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27680,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),12,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194985,25218501,BindingDB,5-Fluoro-2-[(4-fluoro-3-{[4-(2-phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)methoxy]benzamide,27681,5-fluoro-2-[(4-fluoro-3-{[4-(2-phenoxypropanoyl)piperazin-1-yl]carbonyl}phenyl)methoxy]benzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27681,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),14,PMID:18579376|DOI:10.1016/j.bmcl.2008.06.025,https://www.ncbi.nlm.nih.gov/pubmed/18579376|https://doi.org/10.1016/j.bmcl.2008.06.025,18579376,10.1016/j.bmcl.2008.06.025,,11946283,"Menear KA, Adcock C, Alonso FC, Blackburn K, Copsey L, Drzewiecki J, Fundo A, Le Gall A, Gomez S, Javaid H, Lence CF, Martin NMB, Mydlowski C, Smith GCM. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 2008 Jul;18(14):3942–5. doi: 10.1016/j.bmcl.2008.06.025."
2194986,25218502,BindingDB,,27687,"4,6-dimethyl-2,4,5-triazatricyclo[7.3.0.0^{3,7}]dodeca-1(9),3(7),5-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27687,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),7000,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194987,25218503,BindingDB,,27688,"1,3-dimethyl-1H,4H,5H,6H,7H,8H,9H-pyrazolo[3,4-b]quinolin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27688,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194988,25218504,BindingDB,,27689,"3,5-dimethyl-11-thia-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27689,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),92.7,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194989,25218505,BindingDB,,27690,"5-methyl-3-phenyl-11-thia-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27690,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),110.3,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194990,25218506,BindingDB,,27691,"5-methyl-3-(thiophen-2-yl)-11-thia-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27691,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),428.1,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194991,25218507,BindingDB,,27692,"5-tert-butyl-3-methyl-11-thia-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27692,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),1841.5,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194992,25218508,BindingDB,,27693,"3-methyl-5-phenyl-11-thia-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27693,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194993,25218509,BindingDB,,27695,"5-methyl-3-phenyl-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27695,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),106,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194994,25218510,BindingDB,,27697,"5-tert-butyl-3-methyl-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27697,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),519.2,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194995,25218511,BindingDB,,27698,"3-methyl-5-phenyl-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27698,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194996,25218512,BindingDB,,27699,"3,5-diphenyl-4,5,7-triazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27699,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194997,25218513,BindingDB,,27703,"3-methyl-5-phenyl-4,5,7-triazatricyclo[7.4.0.0^{2,6}]trideca-1(9),2(6),3-trien-8-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27703,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),9720,PMID:18713665|DOI:10.1016/j.bmcl.2008.07.091,https://www.ncbi.nlm.nih.gov/pubmed/18713665|https://doi.org/10.1016/j.bmcl.2008.07.091,18713665,10.1016/j.bmcl.2008.07.091,,5829366,"Moree WJ, Goldman P, Demaggio AJ, Christenson E, Herendeen D, Eksterowicz J, Kesicki EA, McElligott DL, Beaton G. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2008 Sep;18(18):5126–9. doi: 10.1016/j.bmcl.2008.07.091."
2194998,25218514,BindingDB,,27707,"4-{1-[3-(8-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)propyl]-1,2,3,6-tetrahydropyridin-4-yl}benzonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27707,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),3,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2195001,25218515,BindingDB,,27712,"5-chloro-2-methyl-3,4-dihydroquinazolin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27712,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),1200,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2195002,25218516,BindingDB,"5-Fluoro-1-[4-(4-phenylcyclohex-3-en-1-yl)butyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione",27715,"5-fluoro-1-[4-(4-phenylcyclohex-3-en-1-yl)butyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27715,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),>1000,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2195003,25218517,BindingDB,"4-{4-[4-(4-Fluorophenyl)-1,2,3,6-tetrahydropyridin-1-yl]butyl}-1,2-dihydrophthalazin-1-one",27717,"4-{4-[4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridin-1-yl]butyl}-1,2-dihydrophthalazin-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27717,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),49,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2195006,25218518,BindingDB,3-(4-Cyanophenyl)quinoxaline-5-carboxamide,27721,3-(4-cyanophenyl)quinoxaline-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27721,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),101,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2278348,25218518,Therapeutic Target Database (TTD),3-(4-Cyanophenyl)quinoxaline-5-carboxamide,D0M9TW,3-(4-cyanophenyl)quinoxaline-5-carboxamide,https://idrblab.net/ttd/data/drug/details/D0M9TW,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2195007,25218519,BindingDB,3-(4-Aminophenyl)quinoxaline-5-carboxamide,27724,3-(4-aminophenyl)quinoxaline-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27724,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),87,PMID:16288880|DOI:10.1016/j.bmc.2005.09.061,https://www.ncbi.nlm.nih.gov/pubmed/16288880|https://doi.org/10.1016/j.bmc.2005.09.061,16288880,10.1016/j.bmc.2005.09.061,,20034267,"Ishida J, Yamamoto H, Kido Y, Kamijo K, Murano K, Miyake H, Ohkubo M, Kinoshita T, Warizaya M, Iwashita A, Mihara K, Matsuoka N, Hattori K. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling. Bioorg Med Chem. 2006 Mar 01;14(5):1378–90. doi: 10.1016/j.bmc.2005.09.061. PMID: 16288880."
2278349,25218519,Therapeutic Target Database (TTD),3-(4-Aminophenyl)quinoxaline-5-carboxamide,D08GMO,3-(4-aminophenyl)quinoxaline-5-carboxamide,https://idrblab.net/ttd/data/drug/details/D08GMO,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2191072,25227462,Comparative Toxicogenomics Database (CTD),PF-3758309,C550923,PF 3758309,https://ctdbase.org/detail.go?type=chem&acc=C550923,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PF 3758309 results in increased cleavage of PARP1 protein,,,PMID:29048629,https://www.ncbi.nlm.nih.gov/pubmed/29048629,29048629,,PMC5780023,22949934,"Li Z, Li X, Xu L, Tao Y, Yang C, Chen X, Fang F, Wu Y, Ding X, Zhao H, Li M, Qian G, Xu Y, Ren J, Du W, Wang J, Lu J, Hu S, Pan J. Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4. Oncol Rep. 2017 Nov;38(5):2705–16. PMID: 29048629; PMCID: PMC5780023."
2145035,25254071,Comparative Toxicogenomics Database (CTD),Apitolisib,C569670,"1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one",https://ctdbase.org/detail.go?type=chem&acc=C569670,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one results in increased cleavage of PARP1 protein",,,PMID:21998291|PMID:23136191,https://www.ncbi.nlm.nih.gov/pubmed/21998291|https://www.ncbi.nlm.nih.gov/pubmed/23136191,21998291|23136191,,,1798684|19477066,"Spoerke JM, O'Brien C, Huw L, Koeppen H, Fridlyand J, Brachmann RK, Haverty PM, Pandita A, Mohan S, Sampath D, Friedman LS, Ross L, Hampton GM, Amler LC, Shames DS, Lackner MR. Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models. Clin Cancer Res. 2012 Dec 15;18(24):6771–83. doi: 10.1158/1078-0432.ccr-12-2347. PMID: 23136191.|Wallin JJ, Edgar KA, Guan J, Berry M, Prior WW, Lee L, Lesnick JD, Lewis C, Nonomiya J, Pang J, Salphati L, Olivero AG, Sutherlin DP, O'Brien C, Spoerke JM, Patel S, Lensun L, Kassees R, Ross L, Lackner MR, Sampath D, Belvin M, Friedman LS. GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway. Mol Cancer Ther. 2011 Dec;10(12):2426–36. doi: 10.1158/1535-7163.mct-11-0446. PMID: 21998291."
2237698,25257557,Comparative Toxicogenomics Database (CTD),Cx-5461,C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CX 5461 results in increased cleavage of PARP1 protein,,,PMID:32799625,https://www.ncbi.nlm.nih.gov/pubmed/32799625,32799625,,,9541736,"Okamoto S, Miyano K, Kajikawa M, Yamauchi A, Kuribayashi F. The rRNA synthesis inhibitor CX-5461 may induce autophagy that inhibits anticancer drug-induced cell damage to leukemia cells. Biosci Biotechnol Biochem. 2020 Nov;84(11):2319–26. doi: 10.1080/09168451.2020.1801378. PMID: 32799625."
2211184,36689305,Comparative Toxicogenomics Database (CTD),Mahanine,C465290,mahanine,https://ctdbase.org/detail.go?type=chem&acc=C465290,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mahanine results in increased cleavage of PARP1 protein,,,PMID:30468732,https://www.ncbi.nlm.nih.gov/pubmed/30468732,30468732,,,16212200,"Chen M, Yin X, Lu C, Chen X, Ba H, Cai J, Sun J. Mahanine induces apoptosis, cell cycle arrest, inhibition of cell migration, invasion and PI3K/AKT/mTOR signalling pathway in glioma cells and inhibits tumor growth in vivo. Chem Biol Interact. 2019 Feb 01;299():1–7. doi: 10.1016/j.cbi.2018.11.009. PMID: 30468732."
2196559,38347030,Comparative Toxicogenomics Database (CTD),Ovatodiolide,C432447,ovatodiolide,https://ctdbase.org/detail.go?type=chem&acc=C432447,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [ovatodiolide results in increased cleavage of PARP1 protein]|ovatodiolide results in increased cleavage of PARP1 protein|map1lc3b protein affects the reaction [ovatodiolide results in increased cleavage of PARP1 protein]|imatinib mesylate promotes the reaction [ovatodiolide results in increased cleavage of PARP1 protein]|sqstm1 protein affects the reaction [ovatodiolide results in increased cleavage of PARP1 protein]|trehalose promotes the reaction [ovatodiolide results in increased cleavage of PARP1 protein]|sirolimus promotes the reaction [ovatodiolide results in increased cleavage of PARP1 protein]|[sirolimus co-treated with ovatodiolide] results in increased cleavage of PARP1 protein|ovatodiolide promotes the reaction [imatinib mesylate results in increased cleavage of PARP1 protein],,,PMID:38000454,https://www.ncbi.nlm.nih.gov/pubmed/38000454,38000454,,,36430276,"Xia Q, Xie J, Zhang J, Zhang L, Zhou Y, Zhu B, Wu Y, Yang Z, Li J. Ovatodiolide induces autophagy-mediated cell death through the p62-Keap1-Nrf2 signaling pathway in chronic myeloid leukemia cells. Chem Biol Interact. 2024 Jan 05;387():110819. doi: 10.1016/j.cbi.2023.110819. PMID: 38000454."
2295615,41673734,Therapeutic Target Database (TTD),4-(Imidazol-1-ylmethyl)-3-(4-methoxyphenyl)-1-phenyl-pyrazole,D04LDH,BZ6,https://idrblab.net/ttd/data/drug/details/D04LDH,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2152889,42611257,Comparative Toxicogenomics Database (CTD),Vemurafenib,D000077484,Vemurafenib,https://ctdbase.org/detail.go?type=chem&acc=D000077484,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),RAF1 protein affects the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of PARP1 protein]]|azd 6244 inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of PARP1 protein]]|[kras protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of PARP1 protein],,,PMID:27222248,https://www.ncbi.nlm.nih.gov/pubmed/27222248,27222248,,PMC4879700,24967577,"Oh YT, Deng J, Yue P, Sun SY. Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells. Sci Rep. 2016 May 25;6():26803. PMID: 27222248; PMCID: PMC4879700."
2152890,42611257,Comparative Toxicogenomics Database (CTD),Vemurafenib,D000077484,Vemurafenib,https://ctdbase.org/detail.go?type=chem&acc=D000077484,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[vemurafenib co-treated with 3,5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one] results in increased cleavage of PARP1 protein",,,PMID:35648318,https://www.ncbi.nlm.nih.gov/pubmed/35648318,35648318,,,34070509,2022; 39(5):2381-2399
2178949,44144393,Comparative Toxicogenomics Database (CTD),Colistin,D003091,Colistin,https://ctdbase.org/detail.go?type=chem&acc=D003091,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),[colistin co-treated with anisomycin] results in increased cleavage of PARP1 protein,,,PMID:28842171,https://www.ncbi.nlm.nih.gov/pubmed/28842171,28842171,,,8102274,"Lu Z, Miao Y, Muhammad I, Tian E, Hu W, Wang J, Wang B, Li R, Li J. Colistin-induced autophagy and apoptosis involves the JNK-Bcl2-Bax signaling pathway and JNK-p53-ROS positive feedback loop in PC-12 cells. Chem Biol Interact. 2017 Nov 01;277():62–73. doi: 10.1016/j.cbi.2017.08.011. PMID: 28842171."
2283232,44156952,Therapeutic Target Database (TTD),2-Phenylquinoline-8-carboxamide,D0Z9DY,2-phenylquinoline-8-carboxamide,https://idrblab.net/ttd/data/drug/details/D0Z9DY,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1310006,44159258,Comparative Toxicogenomics Database (CTD),Cddo-EA,C518860,"2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide",https://ctdbase.org/detail.go?type=chem&acc=C518860,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased cleavage of PARP1 protein",,,PMID:17363558,https://www.ncbi.nlm.nih.gov/pubmed/17363558,17363558,,,20742608,"Liby K, Royce DB, Williams CR, Risingsong R, Yore MM, Honda T, Gribble GW, Dmitrovsky E, Sporn TA, Sporn MB. The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice. Cancer Res. 2007 Mar 15;67(6):2414–9. doi: 10.1158/0008-5472.can-06-4534. PMID: 17363558."
2158385,44176380,Toxin and Toxin Target Database (T3DB),Bevidox,T3D0673,Cyanocobalamin,http://www.t3db.ca/toxins/T3D0673,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
2307076,44403357,Therapeutic Target Database (TTD),3-Morpholin-4-ylmethyl-5H-phenanthridin-6-one,D0F8ZI,3-Morpholin-4-ylmethyl-5H-phenanthridin-6-one,https://idrblab.net/ttd/data/drug/details/D0F8ZI,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2307078,44403402,Therapeutic Target Database (TTD),4-(5-Morpholin-4-yl-pentyl)-2H-phthalazin-1-one,D05WYN,4-(5-Morpholin-4-yl-pentyl)-2H-phthalazin-1-one,https://idrblab.net/ttd/data/drug/details/D05WYN,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2307079,44403404,Therapeutic Target Database (TTD),4-(4-Morpholin-4-yl-butyl)-2H-phthalazin-1-one,D0GJ8U,4-(4-Morpholin-4-yl-butyl)-2H-phthalazin-1-one,https://idrblab.net/ttd/data/drug/details/D0GJ8U,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2230446,44407565,Therapeutic Target Database (TTD),"5-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione",D02XLC,"5-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione",https://idrblab.net/ttd/data/drug/details/D02XLC,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2230447,44407566,Therapeutic Target Database (TTD),"4-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione",D05GMW,"4-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione",https://idrblab.net/ttd/data/drug/details/D05GMW,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2230540,44407700,Therapeutic Target Database (TTD),"pyrrolo[3,4-e]indole-1,3(2H,6H)-dione",D03VNZ,"Pyrrolo[3,4-e]indole-1,3(2H,6H)-dione",https://idrblab.net/ttd/data/drug/details/D03VNZ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2084939,44421641,Comparative Toxicogenomics Database (CTD),Inflexinol,C530049,"ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate",https://ctdbase.org/detail.go?type=chem&acc=C530049,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate results in increased cleavage of PARP1 protein",,,PMID:19509257,https://www.ncbi.nlm.nih.gov/pubmed/19509257,19509257,,,1046808,"Ban JO, Oh JH, Hwang BY, Moon DC, Jeong HS, Lee S, Kim S, Lee H, Kim KB, Han SB, Hong JT. Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-kappaB activity via direct interaction with p50. Mol Cancer Ther. 2009 Jun;8(6):1613–24. doi: 10.1158/1535-7163.mct-08-0694. PMID: 19509257."
2165743,44475014,Toxin and Toxin Target Database (T3DB),Hydroxocobalamin,T3D0677,Hydroxocobalamin,http://www.t3db.ca/toxins/T3D0677,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,PMC1241248,19297578,"Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ Health Perspect. 2002 Oct;110 Suppl 5():797–9. PMID: 12426134; PMCID: PMC1241248."
1317508,44537943,Comparative Toxicogenomics Database (CTD),Hydamtiq,C000595230,"2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one",https://ctdbase.org/detail.go?type=chem&acc=C000595230,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one results in decreased activity of PARP1 protein",,,PMID:27704718,https://www.ncbi.nlm.nih.gov/pubmed/27704718,27704718,,PMC5264150,29688401,"Lucarini L, Durante M, Lanzi C, Pini A, Boccalini G, Calosi L, Moroni F, Masini E, Mannaioni G. <scp>HYDAMTIQ</scp>, a selective <scp>PARP</scp>-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the <scp>TGF</scp>-ß/<scp>SMAD</scp> signalling pathway. J Cellular Molecular Medi. 2016 Oct 04;21(2):324–35. doi: 10.1111/jcmm.12967."
2290250,44549251,Therapeutic Target Database (TTD),2-phenyl-2H-indazole-7-carboxamide,D0IX3I,2-phenyl-2H-indazole-7-carboxamide,https://idrblab.net/ttd/data/drug/details/D0IX3I,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2290251,44549372,Therapeutic Target Database (TTD),2-Benzyl-2H-indazole-7-carboxamide,D02QZF,2-Benzyl-2H-indazole-7-carboxamide,https://idrblab.net/ttd/data/drug/details/D02QZF,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2290252,44549373,Therapeutic Target Database (TTD),2-(2-Chlorophenyl)-2H-indazole-7-carboxamide,D0TH7S,2-(2-Chlorophenyl)-2H-indazole-7-carboxamide,https://idrblab.net/ttd/data/drug/details/D0TH7S,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2290601,44549374,Therapeutic Target Database (TTD),2-(3-Chlorophenyl)-2H-indazole-7-carboxamide,D0XZ5D,2-(3-Chlorophenyl)-2H-indazole-7-carboxamide,https://idrblab.net/ttd/data/drug/details/D0XZ5D,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2290602,44549375,Therapeutic Target Database (TTD),2-(4-Chlorophenyl)-2H-indazole-7-carboxamide,D0PT1K,2-(4-Chlorophenyl)-2H-indazole-7-carboxamide,https://idrblab.net/ttd/data/drug/details/D0PT1K,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2290603,44549505,Therapeutic Target Database (TTD),"2-phenyl-2H-benzo[d][1,2,3]triazole-4-carboxamide",D0I2AF,"2-phenyl-2H-benzo[d][1,2,3]triazole-4-carboxamide",https://idrblab.net/ttd/data/drug/details/D0I2AF,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2242225,44575511,Comparative Toxicogenomics Database (CTD),excavatolide B,C574336,excavatolide B,https://ctdbase.org/detail.go?type=chem&acc=C574336,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Excavatolide B results in increased cleavage of PARP1 protein,,,PMID:26790859,https://www.ncbi.nlm.nih.gov/pubmed/26790859,26790859,,,23605618,"Velmurugan BK, Yang H, Sung P, Weng C. Excavatolide B inhibits nonsmall cell lung cancer proliferation by altering peroxisome proliferator activated receptor gamma expression and <scp>PTEN/AKT/NF-Kß</scp> expression. Environmental Toxicology. 2016 Jan 20;32(1):290–301. doi: 10.1002/tox.22235."
2243575,44614261,Comparative Toxicogenomics Database (CTD),tartrolon D,C546306,tartrolon D,https://ctdbase.org/detail.go?type=chem&acc=C546306,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Tartrolon D results in increased cleavage of PARP1 protein,,,PMID:39097071,https://www.ncbi.nlm.nih.gov/pubmed/39097071,39097071,,,37551764,"Brito TL, Edson EA, Dias Florêncio KG, Machado-Neto JA, Garnique ADMB, Mesquita Luiz JP, Cunha FQ, Alves-Filho JC, Haygood M, Wilke DV. Tartrolon D induces immunogenic cell death in melanoma. Chem Biol Interact. 2024 Sep 01;400():111177. doi: 10.1016/j.cbi.2024.111177. PMID: 39097071."
2293991,45110781,Comparative Toxicogenomics Database (CTD),Scutebarbatine A,C000595501,scutebarbatine A,https://ctdbase.org/detail.go?type=chem&acc=C000595501,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [scutebarbatine A results in increased cleavage of PARP1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [scutebarbatine A results in increased cleavage of PARP1 protein]|sb 203580 inhibits the reaction [scutebarbatine A results in increased cleavage of PARP1 protein],,,PMID:37072049,https://www.ncbi.nlm.nih.gov/pubmed/37072049,37072049,,,35743292,"Hao XS, Feng PP, Zhang YY, Wang FZ, Wang GL, Fei HR. Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway. Chem Biol Interact. 2023 Jun 01;378():110487. doi: 10.1016/j.cbi.2023.110487. PMID: 37072049."
2293992,45110781,Comparative Toxicogenomics Database (CTD),Scutebarbatine A,C000595501,scutebarbatine A,https://ctdbase.org/detail.go?type=chem&acc=C000595501,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Scutebarbatine A results in increased cleavage of PARP1 protein,,,PMID:33512038|PMID:37072049,https://www.ncbi.nlm.nih.gov/pubmed/33512038|https://www.ncbi.nlm.nih.gov/pubmed/37072049,33512038|37072049,,,25085249|35743292,"Hao XS, Feng PP, Zhang YY, Wang FZ, Wang GL, Fei HR. Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway. Chem Biol Interact. 2023 Jun 01;378():110487. doi: 10.1016/j.cbi.2023.110487. PMID: 37072049.|Feng PP, Qi YK, Li N, Fei HR. Scutebarbatine A induces cytotoxicity in hepatocellular carcinoma via activation of the MAPK and ER stress signaling pathways. J Biochem Mol Toxicol. 2021 May;35(5):e22731. doi: 10.1002/jbt.22731. PMID: 33512038."
2297567,45375953,Comparative Toxicogenomics Database (CTD),Sapanisertib,C572449,sapanisertib,https://ctdbase.org/detail.go?type=chem&acc=C572449,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sapanisertib results in increased cleavage of PARP1 protein,,,PMID:26536665,https://www.ncbi.nlm.nih.gov/pubmed/26536665,26536665,,PMC4872734,32369629,"Kannan A, Lin Z, Shao Q, Zhao S, Fang B, Moreno MA, Vural E, Stack BC, Suen JY, Kannan K, Gao L. Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth. Oncotarget. 2016 Feb 09;7(6):6576–92. PMID: 26536665; PMCID: PMC4872734."
2170056,46181428,Comparative Toxicogenomics Database (CTD),Pf-04991532,C571532,6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid,https://ctdbase.org/detail.go?type=chem&acc=C571532,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid results in increased cleavage of PARP1 protein,,,PMID:25316768,https://www.ncbi.nlm.nih.gov/pubmed/25316768,25316768,,,5261433,"Lu T, Laughton CA, Wang S, Bradshaw TD. In vitro antitumor mechanism of (E)-N-(2-methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)pyridin-3-yl)methanesulfonamide. Mol Pharmacol. 2015 Jan;87(1):18–30. doi: 10.1124/mol.114.093245. PMID: 25316768."
2082443,46224413,Comparative Toxicogenomics Database (CTD),Nirogacestat,C550722,nirogacestat,https://ctdbase.org/detail.go?type=chem&acc=C550722,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[nirogacestat results in increased susceptibility to enzalutamide] which results in increased cleavage of PARP1 protein|nirogacestat results in increased cleavage of PARP1 protein,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,PMC6544854,31773549,"Farah E, Li C, Cheng L, Kong Y, Lanman NA, Pascuzzi P, Lorenz GR, Zhang Y, Ahmad N, Li L, Ratliff T, Liu X. NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. Journal of Biological Chemistry. 2019 May;294(21):8543–54. doi: 10.1074/jbc.ra118.006983."
2308324,46241905,Therapeutic Target Database (TTD),"(1r,2r,4s,5r)-2-(Benzo[b]thiophen-5-Yl)methyl-1,4,5-Trihydroxy-3-Oxocyclohexane-1-Carboxylic Acid",D0ZK3L,BZ5,https://idrblab.net/ttd/data/drug/details/D0ZK3L,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2249587,46398810,Comparative Toxicogenomics Database (CTD),"4-(2,6-difluoro-4-(3-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxalin-5-yl)benzyl)morpholine",C553194,NVP-BSK805,https://ctdbase.org/detail.go?type=chem&acc=C553194,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[NVP-BSK805 results in increased susceptibility to vincristine] which results in increased cleavage of PARP1 protein,,,PMID:28669723,https://www.ncbi.nlm.nih.gov/pubmed/28669723,28669723,,,3947378,"Cheon JH, Kim KS, Yadav DK, Kim M, Kim HS, Yoon S. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine. Biochemical and Biophysical Research Communications. 2017 Sep;490(4):1176–82. doi: 10.1016/j.bbrc.2017.06.178."
2306740,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[BCL2L1 protein co-treated with RAD51 protein] inhibits the reaction [[GNAQ gene mutant form results in increased susceptibility to (+)-JQ1 compound] which results in increased cleavage of PARP1 protein]|[gnaq gene mutant form results in increased susceptibility to (+)-JQ1 compound] which results in increased cleavage of PARP1 protein,,,PMID:26397223,https://www.ncbi.nlm.nih.gov/pubmed/26397223,26397223,,PMC4741774,14135294,"Ambrosini G, Sawle AD, Musi E, Schwartz GK. BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells. Oncotarget. 2015 Oct 20;6(32):33397–409. PMID: 26397223; PMCID: PMC4741774."
2306741,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CDKN1C mutant form inhibits the reaction [[(+)-JQ1 compound co-treated with vorinostat] results in increased cleavage of PARP1 protein]|[(+)-JQ1 compound co-treated with vorinostat] results in increased cleavage of PARP1 protein,,,PMID:26390243,https://www.ncbi.nlm.nih.gov/pubmed/26390243,26390243,,PMC4959788,14128717,2015; 21(10):1163-1171
2306742,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),(+)-JQ1 compound affects the cleavage of PARP1 protein,,,PMID:26051217,https://www.ncbi.nlm.nih.gov/pubmed/26051217,26051217,,PMC4475452,18184770,"Lu J, Qian Y, Altieri M, Dong H, Wang J, Raina K, Hines J, Winkler J, Crew A, Coleman K, Crews C. Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chemistry & Biology. 2015 Jun;22(6):755–63. doi: 10.1016/j.chembiol.2015.05.009."
2306743,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),(+)-JQ1 compound analog promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]|(+)-JQ1 compound promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein],,,PMID:26415225,https://www.ncbi.nlm.nih.gov/pubmed/26415225,26415225,,PMC4741481,4564950,"Yao W, Yue P, Khuri FR, Sun SY. The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition. Oncotarget. 2015 Oct 27;6(33):34669–79. PMID: 26415225; PMCID: PMC4741481."
2306744,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),(+)-JQ1 compound promotes the reaction [olaparib results in increased cleavage of PARP1 protein],,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,PMC5986599,31091351,"Wilson AJ, Stubbs M, Liu P, Ruggeri B, Khabele D. The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer. Gynecologic Oncology. 2018 Jun;149(3):575–84. doi: 10.1016/j.ygyno.2018.03.049."
2306746,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),(+)-JQ1 compound promotes the reaction [ponatinib results in increased cleavage of PARP1 protein]|ponatinib promotes the reaction [(+)-JQ1 compound results in increased cleavage of PARP1 protein]|(+)-JQ1 compound promotes the reaction [quizartinib results in increased cleavage of PARP1 protein]|quizartinib promotes the reaction [(+)-JQ1 compound results in increased cleavage of PARP1 protein],,,PMID:25053825,https://www.ncbi.nlm.nih.gov/pubmed/25053825,25053825,,PMC4185220,12756748,"Fiskus W, Sharma S, Qi J, Shah B, Devaraj SG, Leveque C, Portier BP, Iyer S, Bradner JE, Bhalla KN. BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD. Mol Cancer Ther. 2014 Oct;13(10):2315–27. PMID: 25053825; PMCID: PMC4185220."
2306747,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),(+)-JQ1 compound results in increased cleavage of PARP1 protein,,,PMID:22904298|PMID:23129625|PMID:23872705|PMID:24435446|PMID:24646477|PMID:25049379|PMID:25053825|PMID:26390243|PMID:27006472,https://www.ncbi.nlm.nih.gov/pubmed/22904298|https://www.ncbi.nlm.nih.gov/pubmed/23129625|https://www.ncbi.nlm.nih.gov/pubmed/23872705|https://www.ncbi.nlm.nih.gov/pubmed/24435446|https://www.ncbi.nlm.nih.gov/pubmed/24646477|https://www.ncbi.nlm.nih.gov/pubmed/25049379|https://www.ncbi.nlm.nih.gov/pubmed/25053825|https://www.ncbi.nlm.nih.gov/pubmed/26390243|https://www.ncbi.nlm.nih.gov/pubmed/27006472,22904298|23129625|23872705|24435446|24646477|25049379|25053825|26390243|27006472,,PMC3466965|PMC3511085|PMC3730202|PMC4128109|PMC4185220|PMC4959788|PMC5029689,1792595|10691294|12752572|12756748|13436878|14128717|15477744|16326407|18142134,"Jacques C, Lamoureux F, Baud'huin M, Rodriguez Calleja L, Quillard T, Amiaud J, Tirode F, Rédini F, Bradner JE, Heymann D, Ory B. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1. Oncotarget. 2016 Apr 26;7(17):24125–40. PMID: 27006472; PMCID: PMC5029689.|2015; 21(10):1163-1171|Fiskus W, Sharma S, Qi J, Shah B, Devaraj SG, Leveque C, Portier BP, Iyer S, Bradner JE, Bhalla KN. BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD. Mol Cancer Ther. 2014 Oct;13(10):2315–27. PMID: 25053825; PMCID: PMC4185220.|Ceribelli M, Kelly PN, Shaffer AL, Wright GW, Xiao W, Yang Y, Mathews Griner LA, Guha R, Shinn P, Keller JM, Liu D, Patel PR, Ferrer M, Joshi S, Nerle S, Sandy P, Normant E, Thomas CJ, Staudt LM. Blockade of oncogenic I?B kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors. Proc. Natl. Acad. Sci. U.S.A. 2014 Jul 21;111(31):11365–70. doi: 10.1073/pnas.1411701111.|Fiskus W, Sharma S, Qi J, Valenta JA, Schaub LJ, Shah B, Peth K, Portier BP, Rodriguez M, Devaraj SG, Zhan M, Sheng J, Iyer SP, Bradner JE, Bhalla KN. Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells. Mol Cancer Ther. 2014 May;13(5):1142–54. doi: 10.1158/1535-7163.mct-13-0770. PMID: 24435446.|Lamoureux F, Baud'huin M, Rodriguez Calleja L, Jacques C, Berreur M, Rédini F, Lecanda F, Bradner JE, Heymann D, Ory B. Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle. Nat Commun. 2014 Mar 19;5():3511. doi: 10.1038/ncomms4511. PMID: 24646477.|Da Costa D, Agathanggelou A, Perry T, Weston V, Petermann E, Zlatanou A, Oldreive C, Wei W, Stewart G, Longman J, Smith E, Kearns P, Knapp S, Stankovic T. BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia. Blood Cancer Journal. 2013 Jul 19;3(7):e126. doi: 10.1038/bcj.2013.24.|Lockwood WW, Zejnullahu K, Bradner JE, Varmus H. Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19408–13. PMID: 23129625; PMCID: PMC3511085.|Ott CJ, Kopp N, Bird L, Paranal RM, Qi J, Bowman T, Rodig SJ, Kung AL, Bradner JE, Weinstock DM. BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. Blood. 2012 Oct 04;120(14):2843–52. PMID: 22904298; PMCID: PMC3466965."
2306748,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[KRAS gene mutant form results in increased susceptibility to (+)-JQ1 compound] which results in increased cleavage of PARP1 protein|[stk11 protein results in increased susceptibility to (+)-JQ1 compound] which results in increased cleavage of PARP1 protein|stk11 gene mutant form inhibits the reaction [[KRAS gene mutant form results in increased susceptibility to (+)-JQ1 compound] which results in increased cleavage of PARP1 protein],,,PMID:24045185,https://www.ncbi.nlm.nih.gov/pubmed/24045185,24045185,,PMC3838895,16094669,"Shimamura T, Chen Z, Soucheray M, Carretero J, Kikuchi E, Tchaicha JH, Gao Y, Cheng KA, Cohoon TJ, Qi J, Akbay E, Kimmelman AC, Kung AL, Bradner JE, Wong KK. Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer. Clin Cancer Res. 2013 Nov 15;19(22):6183–92. PMID: 24045185; PMCID: PMC3838895."
2306749,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[THZ1 compound co-treated with (+)-JQ1 compound] results in increased cleavage of PARP1 protein,,,PMID:30127528,https://www.ncbi.nlm.nih.gov/pubmed/30127528,30127528,,PMC6386470,19001713,2018; 50(9):1240-1246
2123333,46926350,Comparative Toxicogenomics Database (CTD),Dinaciclib,C553669,dinaciclib,https://ctdbase.org/detail.go?type=chem&acc=C553669,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[dinaciclib results in increased susceptibility to doxorubicin] which results in increased cleavage of PARP1 protein|dinaciclib promotes the reaction [doxorubicin results in increased cleavage of PARP1 protein],,,PMID:27378523,https://www.ncbi.nlm.nih.gov/pubmed/27378523,27378523,,PMC4932496,22911142,"Chen Z, Wang Z, Pang JC, Yu Y, Bieerkehazhi S, Lu J, Hu T, Zhao Y, Xu X, Zhang H, Yi JS, Liu S, Yang J. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Scientific Reports. 2016 Jul 05;6(1):29090. doi: 10.1038/srep29090."
2123334,46926350,Comparative Toxicogenomics Database (CTD),Dinaciclib,C553669,dinaciclib,https://ctdbase.org/detail.go?type=chem&acc=C553669,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Dinaciclib results in increased cleavage of PARP1 protein,,,PMID:20663931|PMID:27378523,https://www.ncbi.nlm.nih.gov/pubmed/20663931|https://www.ncbi.nlm.nih.gov/pubmed/27378523,20663931|27378523,,PMC4932496,412480|22911142,"Chen Z, Wang Z, Pang JC, Yu Y, Bieerkehazhi S, Lu J, Hu T, Zhao Y, Xu X, Zhang H, Yi JS, Liu S, Yang J. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Scientific Reports. 2016 Jul 05;6(1):29090. doi: 10.1038/srep29090.|Parry D, Guzi T, Shanahan F, Davis N, Prabhavalkar D, Wiswell D, Seghezzi W, Paruch K, Dwyer MP, Doll R, Nomeir A, Windsor W, Fischmann T, Wang Y, Oft M, Chen T, Kirschmeier P, Lees EM. Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor. Mol Cancer Ther. 2010 Aug;9(8):2344–53. doi: 10.1158/1535-7163.mct-10-0324. PMID: 20663931."
2250973,46926973,Comparative Toxicogenomics Database (CTD),"2-(2',3-Dimethyl-[2,4'-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide",C586458,LGK974,https://ctdbase.org/detail.go?type=chem&acc=C586458,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),LGK974 inhibits the reaction [paraquat results in increased cleavage of PARP1 protein],,,PMID:30205152,https://www.ncbi.nlm.nih.gov/pubmed/30205152,30205152,,,3971125,"Yang JM, Huang HM, Cheng JJ, Huang CL, Lee YC, Chiou CT, Huang HT, Huang NK, Yang YC. LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/ß-CATENIN pathway. Toxicology. 2018 Dec 01;410():65–72. doi: 10.1016/j.tox.2018.09.003. PMID: 30205152."
2307033,49799912,Therapeutic Target Database (TTD),"2-Phenylpyrazolo-[1,5-a]pyridine-7-carboxamide",D08OUR,"2-phenylpyrazolo-[1,5-a]pyridine-7-carboxamide",https://idrblab.net/ttd/data/drug/details/D08OUR,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2177543,49800159,Comparative Toxicogenomics Database (CTD),"6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide",C576268,"6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide",https://ctdbase.org/detail.go?type=chem&acc=C576268,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide analog results in increased cleavage of PARP1 protein|akt1 protein inhibits the reaction [6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide analog results in increased cleavage of PARP1 protein]",,,PMID:27720946,https://www.ncbi.nlm.nih.gov/pubmed/27720946,27720946,,,29701751,"Choi HE, Shin JS, Leem DG, Kim SD, Cho WJ, Lee KT. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells. Chem Biol Interact. 2016 Dec 25;260():196–207. doi: 10.1016/j.cbi.2016.10.008. PMID: 27720946."
1327096,49817544,Comparative Toxicogenomics Database (CTD),CID 49817544,C553370,JBIR-99,https://ctdbase.org/detail.go?type=chem&acc=C553370,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),JBIR-99 results in decreased expression of PARP1 protein,,,PMID:31433962,https://www.ncbi.nlm.nih.gov/pubmed/31433962,31433962,,,12878757,"Anaya-Eugenio GD, Rebollar-Ramos D, González MDC, Raja H, Mata R, Carcache de Blanco EJ. Apoptotic activity of xanthoquinodin JBIR-99, from Parengyodontium album MEXU 30054, in PC-3 human prostate cancer cells. Chem Biol Interact. 2019 Sep 25;311():108798. doi: 10.1016/j.cbi.2019.108798. PMID: 31433962."
2310450,49835991,Comparative Toxicogenomics Database (CTD),"6H-Indeno[1,2-e]tetrazolo[1,5-b][1,2,4]triazin-6-one",C501199,KP372-1,https://ctdbase.org/detail.go?type=chem&acc=C501199,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),KP372-1 results in increased cleavage of PARP1 protein,,,PMID:16412023,https://www.ncbi.nlm.nih.gov/pubmed/16412023,16412023,,,10562268,"Georgakis GV, Li Y, Rassidakis GZ, Medeiros LJ, Mills GB, Younes A. Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma. Br J Haematol. 2006 Feb;132(4):503–11. doi: 10.1111/j.1365-2141.2005.05881.x. PMID: 16412023."
2209963,49843531,Chemical Probes Portal,Nms-P118,NMS-P118,NMS-P118,https://www.chemicalprobes.org/nms-p118,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,0.009 uM,PMID:26222319|DOI:10.1021/acs.jmedchem.5b00680,https://www.ncbi.nlm.nih.gov/pubmed/26222319|https://doi.org/10.1021/acs.jmedchem.5b00680,26222319,,,33037760,"Papeo G, Posteri H, Borghi D, Busel AA, Caprera F, Casale E, Ciomei M, Cirla A, Corti E, D'Anello M, Fasolini M, Forte B, Galvani A, Isacchi A, Khvat A, Krasavin MY, Lupi R, Orsini P, Perego R, Pesenti E, Pezzetta D, Rainoldi S, Riccardi-Sirtori F, Scolaro A, Sola F, Zuccotto F, Felder ER, Donati D, Montagnoli A. Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy. J Med Chem. 2015 Sep 10;58(17):6875–98. doi: 10.1021/acs.jmedchem.5b00680. PMID: 26222319."
2192496,49846579,Comparative Toxicogenomics Database (CTD),Venetoclax,C579720,venetoclax,https://ctdbase.org/detail.go?type=chem&acc=C579720,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[mivebresib co-treated with venetoclax] results in increased cleavage of PARP1 protein,,,PMID:30647404,https://www.ncbi.nlm.nih.gov/pubmed/30647404,30647404,,PMC6333829,14895960,2019; 9(2):4
2192497,49846579,Comparative Toxicogenomics Database (CTD),Venetoclax,C579720,venetoclax,https://ctdbase.org/detail.go?type=chem&acc=C579720,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[venetoclax co-treated with sepantronium] results in increased cleavage of PARP1 protein,,,PMID:31837377,https://www.ncbi.nlm.nih.gov/pubmed/31837377,31837377,,,22344188,"Chiou JT, Lee YC, Huang CH, Shi YJ, Wang LJ, Chang LS. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells. Toxicol Appl Pharmacol. 2020 Jan 15;387():114857. doi: 10.1016/j.taap.2019.114857. PMID: 31837377."
2192498,49846579,Comparative Toxicogenomics Database (CTD),Venetoclax,C579720,venetoclax,https://ctdbase.org/detail.go?type=chem&acc=C579720,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),ZCL-082 promotes the reaction [venetoclax results in increased cleavage of PARP1 protein]|venetoclax promotes the reaction [ZCL-082 results in increased cleavage of PARP1 protein]|venetoclax results in increased cleavage of PARP1 protein,,,PMID:34861246,https://www.ncbi.nlm.nih.gov/pubmed/34861246,34861246,,,32518165,"Ma C, Liu M, Zhang J, Cai H, Wu Y, Zhang Y, Ji Y, Shan H, Zou Z, Yang L, Liu L, Xu H, Lei H, Liu C, Zhou L, Cao Y, Zhou H, Wu Y. ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-?B signaling pathway. Chem Biol Interact. 2022 Jan 05;351():109770. doi: 10.1016/j.cbi.2021.109770. PMID: 34861246."
2345619,50915233,Comparative Toxicogenomics Database (CTD),"8-Phenyl-6,6a,9a,10-tetrahydroisoindolo[5,6-g]quinoxaline-7,9-dione",C556801,"8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione",https://ctdbase.org/detail.go?type=chem&acc=C556801,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione inhibits the reaction [1-methyl-4-phenylpyridinium results in increased cleavage of PARP1 protein]",,,PMID:20946892,https://www.ncbi.nlm.nih.gov/pubmed/20946892,20946892,,,14698609,"Kim IS, Koppula S, Kim BW, Song MD, Jung JY, Lee G, Lee HS, Choi DK. A novel synthetic compound PHID (8-Phenyl-6a, 7, 8, 9, 9a, 10-hexahydro-6H-isoindolo [5, 6-g] quinoxaline-7, 9-dione) protects SH-SY5Y cells against MPP(+)-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling. Eur J Pharmacol. 2011 Jan 10;650(1):48–57. doi: 10.1016/j.ejphar.2010.09.063. PMID: 20946892."
2307638,51051622,Comparative Toxicogenomics Database (CTD),Methyl beta-cyclodextrin,C108732,methyl-beta-cyclodextrin,https://ctdbase.org/detail.go?type=chem&acc=C108732,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Methyl-beta-cyclodextrin inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein],,,PMID:21362627,https://www.ncbi.nlm.nih.gov/pubmed/21362627,21362627,,,13359584,"Lim SC, Duong HQ, Choi JE, Lee TB, Kang JH, Oh SH, Han SI. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Carcinogenesis. 2011 May;32(5):723–31. doi: 10.1093/carcin/bgr038. PMID: 21362627."
2096258,52918385,Comparative Toxicogenomics Database (CTD),Eprenetapopt,C533410,eprenetapopt,https://ctdbase.org/detail.go?type=chem&acc=C533410,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[eprenetapopt co-treated with phenanthridone] results in increased cleavage of PARP1 protein,,,PMID:29416738,https://www.ncbi.nlm.nih.gov/pubmed/29416738,29416738,,PMC5788606,31757916,"Yin ZX, Hang W, Liu G, Wang YS, Shen XF, Sun QH, Li DD, Jian YP, Zhang YH, Quan CS, Zeng Q, Li YL, Zhao RX, Ding Q, Xu ZX. PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation. Oncotarget. 2018 Jan 05;9(2):1885–97. PMID: 29416738; PMCID: PMC5788606."
2217293,53248909,Comparative Toxicogenomics Database (CTD),"2-(1-Hydroxy-4-oxo-cyclohexa-2,5-dienyl)-pyran-4-one",C574037,"2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one",https://ctdbase.org/detail.go?type=chem&acc=C574037,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[MCU protein co-treated with ru 360] inhibits the reaction [2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one results in increased cleavage of PARP1 protein]|mcu protein affects the reaction [2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one results in increased cleavage of PARP1 protein]|2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one results in increased cleavage of PARP1 protein",,,PMID:34717963,https://www.ncbi.nlm.nih.gov/pubmed/34717963,34717963,,,31845316,"Xue P, Chen Q, Ren X, Liu D, Yang X. A novel protoapigenone analog RY10-4 induces apoptosis of breast cancer cells by exacerbating mitochondrial Ca2+ influx through mitochondrial calcium uniporter. Toxicol Appl Pharmacol. 2021 Dec 15;433():115776. doi: 10.1016/j.taap.2021.115776. PMID: 34717963."
2312076,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [acetylbritannilatone analog results in increased cleavage of PARP1 protein],,,PMID:27262408,https://www.ncbi.nlm.nih.gov/pubmed/27262408,27262408,,,16160945,"Han YY, Tang JJ, Gao RF, Guo X, Lei M, Gao JM. A new semisynthetic 1-O-acetyl-6-O-lauroylbritannilactone induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway. Toxicol In Vitro. 2016 Sep;35():112–20. doi: 10.1016/j.tiv.2016.05.019. PMID: 27262408."
2312077,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [acrolein results in increased cleavage of PARP1 protein],,,PMID:29964147,https://www.ncbi.nlm.nih.gov/pubmed/29964147,29964147,,,6748319,"Huang CH, Chen YT, Lin JH, Wang HT. Acrolein induces ribotoxic stress in human cancer cells regardless of p53 status. Toxicol In Vitro. 2018 Oct;52():265–71. doi: 10.1016/j.tiv.2018.06.022. PMID: 29964147."
2312078,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[arsenic trioxide co-treated with ethacrynic acid] results in increased cleavage of PARP1 protein],,,PMID:23082001,https://www.ncbi.nlm.nih.gov/pubmed/23082001,23082001,,PMC3525753,30952329,"Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y. Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1. 2012 Dec 15;18(24):6690–701. doi: 10.1158/1078-0432.ccr-12-0770."
2312079,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein],,,PMID:29774349,https://www.ncbi.nlm.nih.gov/pubmed/29774349,29774349,,,32414021,"Maimaitiyiming Y, Wang C, Xu S, Islam K, Chen YJ, Yang C, Wang QQ, Naranmandura H. Role of arsenic (+3 oxidation state) methyltransferase in arsenic mediated APL treatment: an in vitro investigation. Metallomics. 2018 Jun 20;10(6):828–37. doi: 10.1039/c8mt00057c. PMID: 29774349."
2312080,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [bortezomib promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [gambogic acid promotes the reaction [bortezomib results in increased cleavage of PARP1 protein]],,,PMID:24291039,https://www.ncbi.nlm.nih.gov/pubmed/24291039,24291039,,,11379274,"Liu N, Huang H, Xu L, Hua X, Li X, Liu S, Yang C, Zhao C, Zhao C, Li S, Dou QP, Liu J. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. Toxicol Lett. 2014 Jan 30;224(3):333–40. doi: 10.1016/j.toxlet.2013.11.021. PMID: 24291039."
2312081,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[cisplatin co-treated with chrysin] results in increased cleavage of PARP1 protein],,,PMID:25770930,https://www.ncbi.nlm.nih.gov/pubmed/25770930,25770930,,,22884660,"Li X, Huang JM, Wang JN, Xiong XK, Yang XF, Zou F. Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53. Chem Biol Interact. 2015 May 05;232():12–20. doi: 10.1016/j.cbi.2015.03.003. PMID: 25770930."
2312082,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [diallyl disulfide promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:30677442,https://www.ncbi.nlm.nih.gov/pubmed/30677442,30677442,,,30441798,"Kim HJ, Kang S, Kim DY, You S, Park D, Oh SC, Lee DH. Diallyl disulfide (DADS) boosts TRAIL-Mediated apoptosis in colorectal cancer cells by inhibiting Bcl-2. Food Chem Toxicol. 2019 Mar;125():354–60. doi: 10.1016/j.fct.2019.01.023. PMID: 30677442."
2312083,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [dihydromyricetin results in increased cleavage of PARP1 protein],,,PMID:27539140,https://www.ncbi.nlm.nih.gov/pubmed/27539140,27539140,,,28352053,"Kao S, Lee W, Chang J, Chow J, Chung C, Hung W, Chien M. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer. Environmental Toxicology. 2016 Aug 19;32(4):1426–38. doi: 10.1002/tox.22336."
2312084,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [jaceosidin results in increased cleavage of PARP1 protein],,,PMID:27729209,https://www.ncbi.nlm.nih.gov/pubmed/27729209,27729209,,,10763155,"Woo SM, Kwon TK. Jaceosidin induces apoptosis through Bax activation and down-regulation of Mcl-1 and c-FLIP expression in human renal carcinoma Caki cells. Chem Biol Interact. 2016 Dec 25;260():168–75. doi: 10.1016/j.cbi.2016.10.011. PMID: 27729209."
2312085,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [nilotinib results in increased cleavage of PARP1 protein],,,PMID:26549707,https://www.ncbi.nlm.nih.gov/pubmed/26549707,26549707,,,12254132,"Chen TC, Yu MC, Chien CC, Wu MS, Lee YC, Chen YC. Nilotinib reduced the viability of human ovarian cancer cells via mitochondria-dependent apoptosis, independent of JNK activation. Toxicol In Vitro. 2016 Mar;31():1–11. doi: 10.1016/j.tiv.2015.11.002. PMID: 26549707."
2312086,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein],,,PMID:26887594,https://www.ncbi.nlm.nih.gov/pubmed/26887594,26887594,,PMC5423166,24303290,"Cheng X, Kim JY, Ghafoory S, Duvaci T, Rafiee R, Theobald J, Alborzinia H, Holenya P, Fredebohm J, Merz K, Mehrabi A, Hafezi M, Saffari A, Eisenbrand G, Hoheisel J, Wölfl S. Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. Molecular Oncology. 2016 Feb 04;10(6):806–24. doi: 10.1016/j.molonc.2016.01.008."
2312087,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:20096292,https://www.ncbi.nlm.nih.gov/pubmed/20096292,20096292,,PMC3003259,17372034,"Jung Y, Heo J, Lee YJ, Kwon TK, Kim Y. Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sciences. 2010 Feb;86(9-10):351–7. doi: 10.1016/j.lfs.2010.01.008."
2312088,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [quercetin results in increased cleavage of PARP1 protein],,,PMID:14688022,https://www.ncbi.nlm.nih.gov/pubmed/14688022,14688022,,,20010805,"Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004 May;25(5):647–59. doi: 10.1093/carcin/bgh052. PMID: 14688022."
2312089,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]],,,PMID:25619640,https://www.ncbi.nlm.nih.gov/pubmed/25619640,25619640,,,27660120,"Han MA, Woo SM, Min KJ, Kim S, Park JW, Kim DE, Kim SH, Choi YH, Kwon TK. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression. Chem Biol Interact. 2015 Feb 25;228():69–78. doi: 10.1016/j.cbi.2015.01.020. PMID: 25619640."
2312090,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [silybin results in increased cleavage of PARP1 protein],,,PMID:24440808,https://www.ncbi.nlm.nih.gov/pubmed/24440808,24440808,,,18146847,"Woo SM, Min KJ, Kim S, Park JW, Kim DE, Chun KS, Kim YH, Lee TJ, Kim SH, Choi YH, Chang JS, Kwon TK. Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation. Chem Biol Interact. 2014 Mar 25;211():36–43. doi: 10.1016/j.cbi.2014.01.004. PMID: 24440808."
2312091,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:21642427,https://www.ncbi.nlm.nih.gov/pubmed/21642427,21642427,,PMC3143646,8664447,"Shin SY, Kim CG, Lim Y, Lee YH. The ETS Family Transcription Factor ELK-1 Regulates Induction of the Cell Cycle-regulatory Gene p21 and the BAX Gene in Sodium Arsenite-exposed Human Keratinocyte HaCaT Cells. Journal of Biological Chemistry. 2011 Jul;286(30):26860–72. doi: 10.1074/jbc.m110.216721."
2312092,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [thymoquinone results in increased activity of PARP1 protein],,,PMID:29981725,https://www.ncbi.nlm.nih.gov/pubmed/29981725,29981725,,,29154984,"Zhang M, Du H, Huang Z, Zhang P, Yue Y, Wang W, Liu W, Zeng J, Ma J, Chen G, Wang X, Fan J. Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway. Chem Biol Interact. 2018 Aug 25;292():65–75. doi: 10.1016/j.cbi.2018.06.013. PMID: 29981725."
2312093,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of PARP1 protein]",,,PMID:30408460,https://www.ncbi.nlm.nih.gov/pubmed/30408460,30408460,,,27723194,"Gil HN, Jung E, Koh D, Lim Y, Lee YH, Shin SY. A synthetic chalcone derivative, 2-hydroxy-3',5,5'-trimethoxychalcone (DK-139), triggers reactive oxygen species-induced apoptosis independently of p53 in A549 lung cancer cells. Chem Biol Interact. 2019 Jan 25;298():72–9. doi: 10.1016/j.cbi.2018.11.003. PMID: 30408460."
2312094,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein],,,PMID:25939952,https://www.ncbi.nlm.nih.gov/pubmed/25939952,25939952,,,26969299,"Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015 Jul 02;236(1):43–59. doi: 10.1016/j.toxlet.2015.04.015. PMID: 25939952."
2312095,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [gemcitabine results in increased cleavage of PARP1 protein],,,PMID:17146438,https://www.ncbi.nlm.nih.gov/pubmed/17146438,17146438,,,19370140,"Feng FY, Varambally S, Tomlins SA, Chun PY, Lopez CA, Li X, Davis MA, Chinnaiyan AM, Lawrence TS, Nyati MK. Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity. Oncogene. 2007 May 17;26(23):3431–9. doi: 10.1038/sj.onc.1210129. PMID: 17146438."
2312096,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [multi-kinase inhibitor 108600 results in increased cleavage of PARP1 protein],,,PMID:34344863,https://www.ncbi.nlm.nih.gov/pubmed/34344863,34344863,,PMC8333338,8882105,"Sato K, Padgaonkar AA, Baker SJ, Cosenza SC, Rechkoblit O, Subbaiah DRCV, Domingo-Domenech J, Bartkowski A, Port ER, Aggarwal AK, Ramana Reddy MV, Irie HY, Reddy EP. Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease. Nature Communications. 2021 Aug 03;12(1):4671. doi: 10.1038/s41467-021-24878-z."
2312097,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [oligopeptides analog results in increased cleavage of PARP1 protein],,,PMID:24875536,https://www.ncbi.nlm.nih.gov/pubmed/24875536,24875536,,,9393305,"Zhang L, Wang H, Xu J, Zhu J, Ding K. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Toxicol Lett. 2014 Aug 04;228(3):248–59. doi: 10.1016/j.toxlet.2014.05.015. PMID: 24875536."
2312098,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to fluorouracil] which results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to cisplatin] which results in increased cleavage of PARP1 protein],,,PMID:25940438,https://www.ncbi.nlm.nih.gov/pubmed/25940438,25940438,,PMC4494929,26969758,"Zagryazhskaya A, Surova O, Akbar NS, Allavena G, Gyuraszova K, Zborovskaya IB, Tchevkina EM, Zhivotovsky B. Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11. Oncotarget. 2015 May 20;6(14):12156–73. PMID: 25940438; PMCID: PMC4494929."
2312099,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein],,,PMID:24373880,https://www.ncbi.nlm.nih.gov/pubmed/24373880,24373880,,,20173790,"Liu N, Huang H, Liu S, Li X, Yang C, Dou QP, Liu J. Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation. Toxicol In Vitro. 2014 Apr;28(3):419–25. doi: 10.1016/j.tiv.2013.12.008. PMID: 24373880."
2312100,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:29111403,https://www.ncbi.nlm.nih.gov/pubmed/29111403,29111403,,,14871063,"So KY, Lee BH, Oh SH. The critical role of autophagy in cadmium-induced immunosuppression regulated by endoplasmic reticulum stress-mediated calpain activation in RAW264.7 mouse monocytes. Toxicology. 2018 Jan 15;393():15–25. doi: 10.1016/j.tox.2017.10.016. PMID: 29111403."
2312101,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein],,,PMID:11035063,https://www.ncbi.nlm.nih.gov/pubmed/11035063,11035063,,,209792,"Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000 Oct 15;165(8):4290–7. doi: 10.4049/jimmunol.165.8.4290. PMID: 11035063."
2312102,53308705,Comparative Toxicogenomics Database (CTD),2-[(2-Amino-3-methylbutanoyl)-(2-aminopropanoyl)amino]-2-phenylmethoxycarbonylbutanedioic acid,C517629,benzyloxycarbonyl-valyl-alanyl-aspartic acid,https://ctdbase.org/detail.go?type=chem&acc=C517629,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:27658547,https://www.ncbi.nlm.nih.gov/pubmed/27658547,27658547,,,18200010,"So KY, Oh SH. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-d and PKB/Akt activation in NRK52E kidney cells. Toxicology. 2016 Aug 31;370():49–59. doi: 10.1016/j.tox.2016.09.010. PMID: 27658547."
2285429,53319374,Comparative Toxicogenomics Database (CTD),Retigeric Acid B,C540615,retigeric acid B,https://ctdbase.org/detail.go?type=chem&acc=C540615,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Retigeric acid B results in increased cleavage of PARP1 protein,,,PMID:20692244,https://www.ncbi.nlm.nih.gov/pubmed/20692244,20692244,,,7969491,"Liu H, Liu YQ, Liu YQ, Xu AH, Young CY, Yuan HQ, Lou HX. A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells. Chem Biol Interact. 2010 Dec 05;188(3):598–606. doi: 10.1016/j.cbi.2010.07.024. PMID: 20692244."
2210912,53340666,Comparative Toxicogenomics Database (CTD),Ricolinostat,C572255,ricolinostat,https://ctdbase.org/detail.go?type=chem&acc=C572255,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ricolinostat promotes the reaction [bortezomib results in increased cleavage of PARP1 protein],,,PMID:22262760,https://www.ncbi.nlm.nih.gov/pubmed/22262760,22262760,,PMC3337713,419197,"Santo L, Hideshima T, Kung AL, Tseng JC, Tamang D, Yang M, Jarpe M, van Duzer JH, Mazitschek R, Ogier WC, Cirstea D, Rodig S, Eda H, Scullen T, Canavese M, Bradner J, Anderson KC, Jones SS, Raje N. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma. Blood. 2012 Mar 15;119(11):2579–89. PMID: 22262760; PMCID: PMC3337713."
2260424,53469059,Comparative Toxicogenomics Database (CTD),"1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoroindolin-1-yl)-2-(6-methylpyridin-2-yl)ethanone",C000597302,GSK2656157,https://ctdbase.org/detail.go?type=chem&acc=C000597302,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),GSK2656157 inhibits the reaction [glyceryl 2-arachidonate results in increased cleavage of PARP1 protein],,,PMID:32357311,https://www.ncbi.nlm.nih.gov/pubmed/32357311,32357311,,PMC7354702,1290516,"Almada M, Costa L, Fonseca B, Alves P, Braga J, Gonçalves D, Teixeira N, Correia-da-Silva G. The endocannabinoid 2-arachidonoylglycerol promotes endoplasmic reticulum stress in placental cells. Reproduction. 2020 Aug;160(2):171–80. PMID: 32357311; PMCID: PMC7354702."
2288668,53474706,Comparative Toxicogenomics Database (CTD),Antrocin,C558369,antrocin,https://ctdbase.org/detail.go?type=chem&acc=C558369,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Antrocin results in increased cleavage of PARP1 protein,,,PMID:21158420,https://www.ncbi.nlm.nih.gov/pubmed/21158420,21158420,,,1094451,"Rao YK, Wu AT, Geethangili M, Huang MT, Chao WJ, Wu CH, Deng WP, Yeh CT, Tzeng YM. Identification of antrocin from Antrodia camphorata as a selective and novel class of small molecule inhibitor of Akt/mTOR signaling in metastatic breast cancer MDA-MB-231 cells. Chem Res Toxicol. 2011 Feb 18;24(2):238–45. doi: 10.1021/tx100318m. PMID: 21158420."
2304113,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,PMC1458365,10558450,"Kim HJ, Chakravarti N, Oridate N, Choe C, Claret FX, Lotan R. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene. 2006 May 04;25(19):2785–94. PMID: 16407847; PMCID: PMC1458365."
2304114,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [oleanolic acid results in increased cleavage of PARP1 protein],,,PMID:22678527,https://www.ncbi.nlm.nih.gov/pubmed/22678527,22678527,,,28256565,"Wei J, Liu M, Liu H, Wang H, Wang F, Zhang Y, Han L, Lin X. Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells. J Appl Toxicol. 2013 Aug;33(8):756–65. doi: 10.1002/jat.2725. PMID: 22678527."
2304115,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,,15288833,"Reynolds M, Zhitkovich A. Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53. Carcinogenesis. 2007 Jul;28(7):1613–20. doi: 10.1093/carcin/bgm031. PMID: 17301063."
2304116,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased degradation of PARP1 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,,7436917,"Gaikwad S, Chakraborty A, Salwe S, Patel V, Kulkarni S, Banerjee S. Juglone-ascorbic acid synergy inhibits metastasis and induces apoptotic cell death in poorly differentiated thyroid carcinoma by perturbing SOD and catalase activities. J Biochem Mol Toxicol. 2018 Sep;32(9):e22176. doi: 10.1002/jbt.22176. PMID: 29992683."
2304117,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,PMC4632778,8743897,"Kishi Y, Fujihara H, Kawaguchi K, Yamada H, Nakayama R, Yamamoto N, Fujihara Y, Hamada Y, Satomura K, Masutani M. PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway. Int J Mol Sci. 2015 Oct 19;16(10):24820–38. PMID: 26492236; PMCID: PMC4632778."
2304118,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:19433269,https://www.ncbi.nlm.nih.gov/pubmed/19433269,19433269,,,28208092,"Kim J, Soh J. Cadmium-induced apoptosis is mediated by the translocation of AIF to the nucleus in rat testes. Toxicol Lett. 2009 Jul 10;188(1):45–51. doi: 10.1016/j.toxlet.2009.03.006. PMID: 19433269."
2304119,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased cleavage of PARP1 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,PMC3131794,28483642,"Banu SK, Stanley JA, Lee J, Stephen SD, Arosh JA, Hoyer PB, Burghardt RC. Hexavalent chromium-induced apoptosis of granulosa cells involves selective sub-cellular translocation of Bcl-2 members, ERK1/2 and p53. Toxicology and Applied Pharmacology. 2011 Mar;251(3):253–66. doi: 10.1016/j.taap.2011.01.011."
2188085,54678486,Comparative Toxicogenomics Database (CTD),Warfarin,D014859,Warfarin,https://ctdbase.org/detail.go?type=chem&acc=D014859,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Warfarin results in increased expression of PARP1 protein modified form,,,PMID:26206560,https://www.ncbi.nlm.nih.gov/pubmed/26206560,26206560,,PMC4572915,33022907,"Kirane A, Ludwig KF, Sorrelle N, Haaland G, Sandal T, Ranaweera R, Toombs JE, Wang M, Dineen SP, Micklem D, Dellinger MT, Lorens JB, Brekken RA. Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Cancer Res. 2015 Sep 15;75(18):3699–705. PMID: 26206560; PMCID: PMC4572915."
2216008,54678924,Comparative Toxicogenomics Database (CTD),Metastat,C117155,tetracycline CMT-3,https://ctdbase.org/detail.go?type=chem&acc=C117155,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tetracycline CMT-3 results in increased cleavage of and results in increased expression of PARP1 protein|tetracycline CMT-3 promotes the reaction [celecoxib results in increased cleavage of and results in increased expression of PARP1 protein]|celecoxib promotes the reaction [tetracycline CMT-3 results in increased cleavage of and results in increased expression of PARP1 protein],,,PMID:15688368,https://www.ncbi.nlm.nih.gov/pubmed/15688368,15688368,,,15264006,"Dandekar DS, Lopez M, Carey RI, Lokeshwar BL. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells. Int J Cancer. 2005 Jun 20;115(3):484–92. doi: 10.1002/ijc.20878. PMID: 15688368."
2108090,54679073,Comparative Toxicogenomics Database (CTD),Ascorbate-2-phosphate,C011669,ascorbate-2-phosphate,https://ctdbase.org/detail.go?type=chem&acc=C011669,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of PARP1 protein modified form|parp1 mRNA promotes the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of RUNX2 mrna]|parg mRNA inhibits the reaction [[dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with cholecalciferol] results in increased expression of PARP1 protein],,,PMID:22940495,https://www.ncbi.nlm.nih.gov/pubmed/22940495,22940495,,,31637292,"Robaszkiewicz A, Erdélyi K, Kovács K, Kovács I, Bai P, Rajnavölgyi E, Virág L. Hydrogen peroxide-induced poly(ADP-ribosyl)ation regulates osteogenic differentiation-associated cell death. Free Radic Biol Med. 2012 Oct 15;53(8):1552–64. doi: 10.1016/j.freeradbiomed.2012.08.567. PMID: 22940495."
2229067,54679285,Comparative Toxicogenomics Database (CTD),"2(5H)-Furanone, 5-(9-(5-(3-furanylmethyl)-3-furanyl)-2,6-dimethyl-6-nonenylidene)-",C506002,ircinin-1,https://ctdbase.org/detail.go?type=chem&acc=C506002,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ircinin-1 results in increased cleavage of PARP1 protein,,,PMID:16163705,https://www.ncbi.nlm.nih.gov/pubmed/16163705,16163705,,,30169265,"Choi HJ, Choi YH, Yee SB, Im E, Jung JH, Kim ND. Ircinin-1 induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells. Mol Carcinog. 2005 Nov;44(3):162–73. doi: 10.1002/mc.20084. PMID: 16163705."
2250887,54756938,Comparative Toxicogenomics Database (CTD),o-F-amidine,C568519,N-alpha-(2-carboxyl)benzoyl-N5-(2-fluoro-1-iminoethyl)ornithine amide,https://ctdbase.org/detail.go?type=chem&acc=C568519,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),N-alpha-(2-carboxyl)benzoyl-N5-(2-fluoro-1-iminoethyl)ornithine amide results in increased cleavage of PARP1 protein,,,PMID:21882827,https://www.ncbi.nlm.nih.gov/pubmed/21882827,21882827,,PMC3196593,7283428,"Causey CP, Jones JE, Slack JL, Kamei D, Jones LE, Subramanian V, Knuckley B, Ebrahimi P, Chumanevich AA, Luo Y, Hashimoto H, Sato M, Hofseth LJ, Thompson PR. The Development of <i>N-a</i>-(2-Carboxyl)benzoyl-<i>N</i><sup>5</sup>-(2-fluoro-1-iminoethyl)-<scp>l</scp>-ornithine Amide (<i>o</i>-F-amidine) and <i>N-a</i>-(2-Carboxyl)benzoyl-<i>N</i><sup>5</sup>-(2-chloro-1-iminoethyl)-<scp>l</scp>-ornithine Amide (<i>o</i>-Cl-amidine) As Second Generation Protein Arginine Deiminase (PAD) Inhibitors. J. Med. Chem. 2011 Sep 16;54(19):6919–35. doi: 10.1021/jm2008985."
2243204,56649281,Comparative Toxicogenomics Database (CTD),Narazaciclib,C000594117,ON123300,https://ctdbase.org/detail.go?type=chem&acc=C000594117,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),ON123300 results in increased cleavage of PARP1 protein,,,PMID:26174628,https://www.ncbi.nlm.nih.gov/pubmed/26174628,26174628,,PMC4703501,26315234,"Divakar SKA, Ramana Reddy MV, Cosenza SC, Baker SJ, Perumal D, Antonelli AC, Brody J, Akula B, Parekh S, Premkumar Reddy E. Dual inhibition of CDK4/Rb and PI3K/AKT/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas. Leukemia. 2015 Jul 15;30(1):86–93. doi: 10.1038/leu.2015.185."
2258459,56649297,IUPHAR/BPS Guide to PHARMACOLOGY,Fluzoparib,13763,fluzoparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13763,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,8.05,PMID:37843892,https://www.ncbi.nlm.nih.gov/pubmed/37843892,37843892,,,36085229,"Zhou J, Du T, Wang X, Yao H, Deng J, Li Y, Chen X, Sheng L, Ji M, Xu B. Discovery of Quinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors-Design, Synthesis, <i>In Vivo</i> Antitumor Activity, and X-ray Crystal Structure Analysis. J. Med. Chem. 2023 Oct 16;66(20):14095–115. doi: 10.1021/acs.jmedchem.3c01152."
2301078,56649297,Therapeutic Target Database (TTD),Fluzoparib,D02KMI,PMID27841036-Compound-33,https://idrblab.net/ttd/data/drug/details/D02KMI,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2268582,57336812,Comparative Toxicogenomics Database (CTD),"N-(3-(4-methylpiperazin-1-yl)phenyl)-8-(4-(methylsulfonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine",C567989,CEP 33779,https://ctdbase.org/detail.go?type=chem&acc=C567989,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[CEP 33779 results in increased susceptibility to vincristine] which results in increased cleavage of PARP1 protein,,,PMID:28669723,https://www.ncbi.nlm.nih.gov/pubmed/28669723,28669723,,,3947378,"Cheon JH, Kim KS, Yadav DK, Kim M, Kim HS, Yoon S. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine. Biochemical and Biophysical Research Communications. 2017 Sep;490(4):1176–82. doi: 10.1016/j.bbrc.2017.06.178."
2241500,57389999,Comparative Toxicogenomics Database (CTD),CPI-0610 anhydrous,C000623150,CPI-0610,https://ctdbase.org/detail.go?type=chem&acc=C000623150,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[rucaparib co-treated with dasatinib co-treated with CPI-0610] results in increased cleavage of PARP1 protein,,,PMID:32927276,https://www.ncbi.nlm.nih.gov/pubmed/32927276,32927276,,PMC7494677,10174929,"Lui GYL, Shaw R, Schaub FX, Stork IN, Gurley KE, Bridgwater C, Diaz RL, Rosati R, Swan HA, Ince TA, Harding TC, Gadi VK, Goff BA, Kemp CJ, Swisher EM, Grandori C. BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer. EBioMedicine. 2020 Oct;60():102988. PMID: 32927276; PMCID: PMC7494677."
2307193,57406853,Comparative Toxicogenomics Database (CTD),Ro-5045337,C579783,RG7112,https://ctdbase.org/detail.go?type=chem&acc=C579783,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),RG7112 results in increased cleavage of PARP1 protein,,,PMID:30022047,https://www.ncbi.nlm.nih.gov/pubmed/30022047,30022047,,PMC6052082,23658470,2018; 9(8):792
2310260,59663666,Therapeutic Target Database (TTD),Quinazolinedione derivative 3,D08KAH,Quinazolinedione derivative 3,https://idrblab.net/ttd/data/drug/details/D08KAH,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2312380,66546486,Therapeutic Target Database (TTD),Quinazolinedione derivative 1,D0J2SR,Quinazolinedione derivative 1,https://idrblab.net/ttd/data/drug/details/D0J2SR,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2314957,66575373,Comparative Toxicogenomics Database (CTD),A-1210477,C000611392,A-1210477,https://ctdbase.org/detail.go?type=chem&acc=C000611392,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[A-1210477 co-treated with mivebresib] results in increased cleavage of PARP1 protein,,,PMID:30647404,https://www.ncbi.nlm.nih.gov/pubmed/30647404,30647404,,PMC6333829,14895960,2019; 9(2):4
2315995,67418816,Comparative Toxicogenomics Database (CTD),"5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) Imidazol",C000622812,"5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl)imidazole",https://ctdbase.org/detail.go?type=chem&acc=C000622812,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl)imidazole results in increased cleavage of PARP1 protein",,,PMID:31682804,https://www.ncbi.nlm.nih.gov/pubmed/31682804,31682804,,,5381882,"Bai Z, Liu X, Guan Q, Ding N, Wei Q, Tong B, Zhao M, Zhang W, Ma L. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells. Chem Biol Interact. 2020 Jan 05;315():108886. doi: 10.1016/j.cbi.2019.108886. PMID: 31682804."
2315423,68019246,Comparative Toxicogenomics Database (CTD),Flll32,C548902,FLLL 32,https://ctdbase.org/detail.go?type=chem&acc=C548902,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),FLLL 32 results in increased cleavage of PARP1 protein,,,PMID:20712901,https://www.ncbi.nlm.nih.gov/pubmed/20712901,20712901,,PMC2936338,27554128,2010; 9(1):217
2275075,68210102,Comparative Toxicogenomics Database (CTD),"(S)-1-(sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide",C577920,GSK-2816126,https://ctdbase.org/detail.go?type=chem&acc=C577920,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[enzalutamide co-treated with GSK-2816126] results in increased cleavage of PARP1 protein,,,PMID:32805266,https://www.ncbi.nlm.nih.gov/pubmed/32805266,32805266,,,8846504,"Shankar E, Franco D, Iqbal O, Moreton S, Kanwal R, Gupta S. Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer. Toxicol Appl Pharmacol. 2020 Oct 01;404():115200. doi: 10.1016/j.taap.2020.115200. PMID: 32805266."
2316366,68388735,Therapeutic Target Database (TTD),Quinazolinedione derivative 2,D0IX2C,Quinazolinedione derivative 2,https://idrblab.net/ttd/data/drug/details/D0IX2C,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
1369343,68389008,Drug Gene Interaction database (DGIdb),Senaparib,,SENAPARIB,https://www.dgidb.org/drugs/ncit:C168601,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2251831,68389008,ChEMBL,Senaparib,CHEMBL4802152,SENAPARIB,https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL4802152,CHEMBL3105,Poly [ADP-ribose] polymerase-1,https://www.ebi.ac.uk/chembl/explore/target/CHEMBL3105,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Poly [ADP-ribose] polymerase-1 inhibitor,,,PMID:34167572,https://www.ncbi.nlm.nih.gov/pubmed/34167572,34167572,,PMC8228511,672306,"Wang Y, Zheng K, Huang Y, Xiong H, Su J, Chen R, Zou Y. PARP inhibitors in gastric cancer: beacon of hope. Journal of Experimental & Clinical Cancer Research. 2021 Jun 24;40(1):211. doi: 10.1186/s13046-021-02005-6."
2222662,70089113,Comparative Toxicogenomics Database (CTD),"4-(3,5-Dimethoxystyryl)phenyl acetate",C000602001,"4-(3,5-dimethoxystyryl)phenyl acetate",https://ctdbase.org/detail.go?type=chem&acc=C000602001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"4-(3,5-dimethoxystyryl)phenyl acetate results in increased cleavage of PARP1 protein",,,PMID:26138072,https://www.ncbi.nlm.nih.gov/pubmed/26138072,26138072,,PMC4551051,31680710,"Chelsky ZL, Yue P, Kondratyuk TP, Paladino D, Pezzuto JM, Cushman M, Turkson J. A Resveratrol Analogue Promotes ERKMAPK–Dependent Stat3 Serine and Tyrosine Phosphorylation Alterations and Antitumor Effects In Vitro against Human Tumor Cells. Molecular Pharmacology. 2015 Sep;88(3):524–33. doi: 10.1124/mol.115.099093."
2195652,70678557,Toxin and Toxin Target Database (T3DB),Insulin,T3D2477,Insulin,http://www.t3db.ca/toxins/T3D2477,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Arsenic binding of PARP-1 is believed to induce carcinogenesis by affecting DNA repair. (A17),,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,,28834896,"Kitchin KT, Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. Journal of Inorganic Biochemistry. 2008 Mar;102(3):532–9. doi: 10.1016/j.jinorgbio.2007.10.021."
2223872,71306969,Comparative Toxicogenomics Database (CTD),Carboxymethyl chitosan,C514968,carboxymethyl-chitosan,https://ctdbase.org/detail.go?type=chem&acc=C514968,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Carboxymethyl-chitosan analog promotes the reaction [curcumin results in decreased cleavage of PARP1 protein],,,PMID:26612707,https://www.ncbi.nlm.nih.gov/pubmed/26612707,26612707,,,10065830,"Ray A, Rana S, Banerjee D, Mitra A, Datta R, Naskar S, Sarkar S. Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment. Toxicol Appl Pharmacol. 2016 Jan 01;290():54–65. doi: 10.1016/j.taap.2015.11.011. PMID: 26612707."
2149064,71463826,Comparative Toxicogenomics Database (CTD),CID 71463826,C062916,protopanaxadiol,https://ctdbase.org/detail.go?type=chem&acc=C062916,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Protopanaxadiol results in increased expression of PARP1 mRNA,,,PMID:31805304,https://www.ncbi.nlm.nih.gov/pubmed/31805304,31805304,,,20995287,"Zhang T, Liang Y, Zuo P, Jing S, Li T, Wang Y, Lv C, Li D, Zhang J, Wei Z. 20(S)-Protopanaxadiol blocks cell cycle progression by targeting epidermal growth factor receptor. Food Chem Toxicol. 2020 Jan;135():111017. doi: 10.1016/j.fct.2019.111017. PMID: 31805304."
2318218,71496458,Comparative Toxicogenomics Database (CTD),Osimertinib,C000596361,osimertinib,https://ctdbase.org/detail.go?type=chem&acc=C000596361,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Osimertinib results in increased expression of PARP1 protein modified form|cat protein inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form]|acetylcysteine inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form]|vitamin E inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form],,,PMID:28237877,https://www.ncbi.nlm.nih.gov/pubmed/28237877,28237877,,,32395047,"Tang ZH, Cao WX, Su MX, Chen X, Lu JJ. Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells. Toxicol Appl Pharmacol. 2017 Apr 15;321():18–26. doi: 10.1016/j.taap.2017.02.017. PMID: 28237877."
2318219,71496458,Comparative Toxicogenomics Database (CTD),Osimertinib,C000596361,osimertinib,https://ctdbase.org/detail.go?type=chem&acc=C000596361,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[ginsenoside rg3 co-treated with osimertinib] results in increased cleavage of PARP1 protein,,,PMID:31916386,https://www.ncbi.nlm.nih.gov/pubmed/31916386,31916386,,,8160449,"Tan Q, Lin S, Zeng Y, Yao M, Liu K, Yuan H, Liu C, Jiang G. Ginsenoside Rg3 attenuates the osimertinib resistance by reducing the stemness of non-small cell lung cancer cells. Environ Toxicol. 2020 Jun;35(6):643–51. doi: 10.1002/tox.22899. PMID: 31916386."
2318220,71496458,Comparative Toxicogenomics Database (CTD),Osimertinib,C000596361,osimertinib,https://ctdbase.org/detail.go?type=chem&acc=C000596361,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Osimertinib results in increased cleavage of PARP1 protein|twist1 protein inhibits the reaction [osimertinib results in increased cleavage of PARP1 protein]|[twist1 protein results in decreased susceptibility to osimertinib] which results in decreased cleavage of PARP1 protein,,,PMID:30171258,https://www.ncbi.nlm.nih.gov/pubmed/30171258,30171258,,PMC6358506,19002035,2018; 38(5):656-670
2258302,71509211,Comparative Toxicogenomics Database (CTD),6-bromo-8-ethoxy-3-nitro-2H-chromene,C584755,6-bromo-8-ethoxy-3-nitro-2H-chromene,https://ctdbase.org/detail.go?type=chem&acc=C584755,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PTEN protein inhibits the reaction [6-bromo-8-ethoxy-3-nitro-2H-chromene results in increased cleavage of PARP1 protein]|6-bromo-8-ethoxy-3-nitro-2H-chromene results in increased cleavage of PARP1 protein,,,PMID:24831963,https://www.ncbi.nlm.nih.gov/pubmed/24831963,24831963,,,4546662,"Shi M, Zhou X, Zhang Z, Wang M, Chen G, Han K, Cao B, Liu Z, Mao X. A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3. Toxicol Lett. 2014 Aug 04;228(3):133–9. doi: 10.1016/j.toxlet.2014.05.003. PMID: 24831963."
2258181,71521142,Comparative Toxicogenomics Database (CTD),Nms-873,C000623013,NMS-873,https://ctdbase.org/detail.go?type=chem&acc=C000623013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),NMS-873 results in increased cleavage of PARP1 protein,,,PMID:23892893|PMID:29693262,https://www.ncbi.nlm.nih.gov/pubmed/23892893|https://www.ncbi.nlm.nih.gov/pubmed/29693262,23892893|29693262,,,4643287|16787403,"Duscharla D, Reddy Kami Reddy K, Dasari C, Bhukya S, Ummanni R. Interleukin-6 induced overexpression of valosin-containing protein (VCP)/p97 is associated with androgen-independent prostate cancer (AIPC) progression. Journal Cellular Physiology. 2018 Apr 25;233(10):7148–64. doi: 10.1002/jcp.26639.|10.1038/nchembio.1313"
2150227,71544003,Comparative Toxicogenomics Database (CTD),"(2E)-6-[(2,6-dichlorophenyl)methylsulfonyl]-2-[(4-hydroxy-3-nitrophenyl)methylidene]-4H-1,4-benzothiazin-3-one",C000718871,multi-kinase inhibitor 108600,https://ctdbase.org/detail.go?type=chem&acc=C000718871,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Multi-kinase inhibitor 108600 results in increased cleavage of PARP1 protein|benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [multi-kinase inhibitor 108600 results in increased cleavage of PARP1 protein],,,PMID:34344863,https://www.ncbi.nlm.nih.gov/pubmed/34344863,34344863,,PMC8333338,8882105,"Sato K, Padgaonkar AA, Baker SJ, Cosenza SC, Rechkoblit O, Subbaiah DRCV, Domingo-Domenech J, Bartkowski A, Port ER, Aggarwal AK, Ramana Reddy MV, Irie HY, Reddy EP. Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease. Nature Communications. 2021 Aug 03;12(1):4671. doi: 10.1038/s41467-021-24878-z."
2292985,71568253,Comparative Toxicogenomics Database (CTD),1-(3-Chloro-4-((trifluoromethyl)thio)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea,C000705932,FND-4b,https://ctdbase.org/detail.go?type=chem&acc=C000705932,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),FND-4b results in increased cleavage of PARP1 protein,,,PMID:30875375,https://www.ncbi.nlm.nih.gov/pubmed/30875375,30875375,,PMC6420029,29742780,"Johnson J, Rychahou P, Sviripa VM, Weiss HL, Liu C, Watt DS, Evers BM. Induction of AMPK activation by N,N’-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers. PLoS ONE. 2019 Mar 15;14(3):e0209392. doi: 10.1371/journal.pone.0209392."
2150229,71571526,BindingDB,,103558,ME0328,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=103558,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),6.3e+3,PMID:23742272|DOI:10.1021/cb4002014,https://www.ncbi.nlm.nih.gov/pubmed/23742272|https://doi.org/10.1021/cb4002014,23742272,10.1021/cb4002014,,3182686,"Lindgren AE, Karlberg T, Thorsell AG, Hesse M, Spjut S, Ekblad T, Andersson CD, Pinto AF, Weigelt J, Hottiger MO, Linusson A, Elofsson M, Schüler H. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3. ACS Chem Biol. 2013 Aug 16;8(8):1698–703. doi: 10.1021/cb4002014. PMID: 23742272."
2323342,71571973,Therapeutic Target Database (TTD),Phthalazine ketone derivative 2,D0B4FV,Phthalazine ketone derivative 2,https://idrblab.net/ttd/data/drug/details/D0B4FV,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2323389,71598692,Therapeutic Target Database (TTD),Phthalazine ketone derivative 3,D0AN7Z,Phthalazine ketone derivative 3,https://idrblab.net/ttd/data/drug/details/D0AN7Z,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2277358,71600087,Comparative Toxicogenomics Database (CTD),Mivebresib,C000621792,mivebresib,https://ctdbase.org/detail.go?type=chem&acc=C000621792,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[A-1210477 co-treated with mivebresib] results in increased cleavage of PARP1 protein|[mivebresib co-treated with venetoclax] results in increased cleavage of PARP1 protein|mivebresib results in increased cleavage of PARP1 protein,,,PMID:30647404,https://www.ncbi.nlm.nih.gov/pubmed/30647404,30647404,,PMC6333829,14895960,2019; 9(2):4
2326051,71626523,Therapeutic Target Database (TTD),"3,3-Dimethyl-16-(2-piperidin-1-ylethyl)-6,7,16-triazatetracyclo[11.2.1.05,15.09,14]hexadeca-1(15),5,9(14),10,12-pentaen-8-one",D0P3YA,Dihydrodiazepinocarbazolone derivative 1,https://idrblab.net/ttd/data/drug/details/D0P3YA,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2266522,71661804,ChEMBL,Amelparib dihydrochloride dihydrate,CHEMBL5314421,AMELPARIB DIHYDROCHLORIDE DIHYDRATE,https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL5314421,CHEMBL3105,Poly [ADP-ribose] polymerase-1,https://www.ebi.ac.uk/chembl/explore/target/CHEMBL3105,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Poly [ADP-ribose] polymerase-1 inhibitor,,,PMID:29383691,https://www.ncbi.nlm.nih.gov/pubmed/29383691,29383691,,,10813651,2018; 55(9):7153-7163
2326944,71678316,Therapeutic Target Database (TTD),Phthalazine derivative 3,D0M9TG,Phthalazine derivative 3,https://idrblab.net/ttd/data/drug/details/D0M9TG,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2296325,71715374,Comparative Toxicogenomics Database (CTD),Tak-243,C000622638,TAK-243,https://ctdbase.org/detail.go?type=chem&acc=C000622638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),TAK-243 affects the sumoylation of PARP1 protein,,,PMID:31285264,https://www.ncbi.nlm.nih.gov/pubmed/31285264,31285264,,PMC6802522,8834745,"Sha Z, Blyszcz T, González-Prieto R, Vertegaal ACO, Goldberg AL. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. Journal of Biological Chemistry. 2019 Oct;294(42):15218–34. doi: 10.1074/jbc.ra119.009147."
2255014,71773126,Comparative Toxicogenomics Database (CTD),Ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ziyuglycoside II results in increased cleavage of PARP1 protein,,,PMID:31029785,https://www.ncbi.nlm.nih.gov/pubmed/31029785,31029785,,,13544520,"Lkhagvasuren K, Kim JK. Ziyuglycoside II induces caspases-dependent and caspases-independent apoptosis in human colon cancer cells. Toxicol In Vitro. 2019 Sep;59():255–62. doi: 10.1016/j.tiv.2019.04.028. PMID: 31029785."
2320237,72193864,Comparative Toxicogenomics Database (CTD),"5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",C553926,"5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",https://ctdbase.org/detail.go?type=chem&acc=C553926,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid inhibits the reaction [doxorubicin results in increased cleavage of PARP1 protein]",,,PMID:32075913,https://www.ncbi.nlm.nih.gov/pubmed/32075913,32075913,,PMC7105316,25761002,"Xia P, Chen J, Liu Y, Fletcher M, Jensen BC, Cheng Z. Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2–mediated activation of forkhead box O1. Journal of Biological Chemistry. 2020 Mar;295(13):4265–76. doi: 10.1074/jbc.ra119.011571."
2159264,72699312,BindingDB,,103557,ME0327,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=103557,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),1.0e+3,PMID:23742272|DOI:10.1021/cb4002014,https://www.ncbi.nlm.nih.gov/pubmed/23742272|https://doi.org/10.1021/cb4002014,23742272,10.1021/cb4002014,,3182686,"Lindgren AE, Karlberg T, Thorsell AG, Hesse M, Spjut S, Ekblad T, Andersson CD, Pinto AF, Weigelt J, Hottiger MO, Linusson A, Elofsson M, Schüler H. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3. ACS Chem Biol. 2013 Aug 16;8(8):1698–703. doi: 10.1021/cb4002014. PMID: 23742272."
2320448,73073981,Comparative Toxicogenomics Database (CTD),CID 73073981,C532843,coronarin D,https://ctdbase.org/detail.go?type=chem&acc=C532843,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Coronarin D results in increased cleavage of PARP1 protein,,,PMID:30623577,https://www.ncbi.nlm.nih.gov/pubmed/30623577,30623577,,,14873719,"Liu YT, Hsieh MJ, Lin JT, Chen G, Lin CC, Lo YS, Chuang YC, Hsi YT, Chen MK, Chou MC. Coronarin D induces human oral cancer cell apoptosis though upregulate JNK1/2 signaling pathway. Environ Toxicol. 2019 Apr;34(4):513–20. doi: 10.1002/tox.22705. PMID: 30623577."
2320465,73073981,Comparative Toxicogenomics Database (CTD),CID 73073981,C532843,coronarin D,https://ctdbase.org/detail.go?type=chem&acc=C532843,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [coronarin D results in increased expression of PARP1 protein modified form]|coronarin D results in increased expression of PARP1 protein modified form,,,PMID:29968959,https://www.ncbi.nlm.nih.gov/pubmed/29968959,29968959,,,6752908,"Lin HW, Hsieh MJ, Yeh CB, Hsueh KC, Hsieh YH, Yang SF. Coronarin D induces apoptotic cell death through the JNK pathway in human hepatocellular carcinoma. Environ Toxicol. 2018 Sep;33(9):946–54. doi: 10.1002/tox.22579. PMID: 29968959."
2331610,73669300,Therapeutic Target Database (TTD),"6-[4-(Piperidin-1-ylmethyl)phenyl]pyrrolo[2,3-b]pyridine-1-carboxamide",D09WUA,7-azaindole derivative 8,https://idrblab.net/ttd/data/drug/details/D09WUA,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2320584,73755142,Comparative Toxicogenomics Database (CTD),Lysophosphatidylethanolamine,C008301,lysophosphatidylethanolamine,https://ctdbase.org/detail.go?type=chem&acc=C008301,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in increased activity of PARP1 protein],,,PMID:25125499,https://www.ncbi.nlm.nih.gov/pubmed/25125499,25125499,,PMC4935323,6657347,"Sellinger M, Xu W, Pathil A, Stremmel W, Chamulitrat W. Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins. Exp Biol Med (Maywood). 2015 Feb;240(2):252–60. PMID: 25125499; PMCID: PMC4935323."
2258433,74763937,ChEMBL,Niraparib Tosylate Monohydrate,CHEMBL3989922,NIRAPARIB TOSYLATE MONOHYDRATE,https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL3989922,CHEMBL3105,Poly [ADP-ribose] polymerase-1,https://www.ebi.ac.uk/chembl/explore/target/CHEMBL3105,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Poly [ADP-ribose] polymerase-1 inhibitor,,,PMID:19873981,https://www.ncbi.nlm.nih.gov/pubmed/19873981,19873981,,,33579805,"Jones P, Altamura S, Boueres J, Ferrigno F, Fonsi M, Giomini C, Lamartina S, Monteagudo E, Ontoria JM, Orsale MV, Palumbi MC, Pesci S, Roscilli G, Scarpelli R, Schultz-Fademrecht C, Toniatti C, Rowley M. Discovery of 2-{4-[(3<i>S</i>)-Piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors. J. Med. Chem. 2009 Oct 29;52(22):7170–85. doi: 10.1021/jm901188v."
2330401,74763937,Drug Gene Interaction database (DGIdb),Niraparib Tosylate Monohydrate,,NIRAPARIB TOSYLATE,https://www.dgidb.org/drugs/rxcui:2637447,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2353184,74763937,Drug Gene Interaction database (DGIdb),Niraparib Tosylate Monohydrate,,NIRAPARIB TOSYLATE,https://www.dgidb.org/drugs/rxcui:2637447,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2259692,76968809,Comparative Toxicogenomics Database (CTD),Mafosfamide,C048341,mafosfamide,https://ctdbase.org/detail.go?type=chem&acc=C048341,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Mafosfamide results in increased cleavage of PARP1 protein|bcl2 protein inhibits the reaction [mafosfamide results in increased cleavage of PARP1 protein],,,PMID:11723234,https://www.ncbi.nlm.nih.gov/pubmed/11723234,11723234,,,32771093,"Schwartz PS, Waxman DJ. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. Mol Pharmacol. 2001 Dec;60(6):1268–79. doi: 10.1124/mol.60.6.1268. PMID: 11723234."
2322236,78357761,Therapeutic Target Database (TTD),Niraparib tosylate,D0DN0W,Niraparib Tosylate,https://idrblab.net/ttd/data/drug/details/D0DN0W,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Modulator,,,,,,,,,
2177804,85051117,Comparative Toxicogenomics Database (CTD),Devd-cho,C108637,aspartyl-glutamyl-valyl-aspartal,https://ctdbase.org/detail.go?type=chem&acc=C108637,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aspartyl-glutamyl-valyl-aspartal inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:14976342,https://www.ncbi.nlm.nih.gov/pubmed/14976342,14976342,,,28797949,"Newhouse K, Hsuan SL, Chang SH, Cai B, Wang Y, Xia Z: Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells. Toxicol Sci. 2004 May;79(1):137-46. Epub 2004 Feb 19."
2177805,85051117,Comparative Toxicogenomics Database (CTD),Devd-cho,C108637,aspartyl-glutamyl-valyl-aspartal,https://ctdbase.org/detail.go?type=chem&acc=C108637,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aspartyl-glutamyl-valyl-aspartal inhibits the reaction [teroxirone results in increased cleavage of PARP1 protein],,,PMID:23954467,https://www.ncbi.nlm.nih.gov/pubmed/23954467,23954467,,,8013725,"Wang JP, Lin KH, Liu CY, Yu YC, Wu PT, Chiu CC, Su CL, Chen KM, Fang K. Teroxirone inhibited growth of human non-small cell lung cancer cells by activating p53. Toxicol Appl Pharmacol. 2013 Nov 15;273(1):110–20. doi: 10.1016/j.taap.2013.08.007. PMID: 23954467."
2323939,86276168,Comparative Toxicogenomics Database (CTD),"(E)-3-methoxy-6-((2,4,6-trimethoxystyrylsulfonyl)methyl)pyridin-2-amine",C000588582,"3-methoxy-6-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)pyridin-2-amine",https://ctdbase.org/detail.go?type=chem&acc=C000588582,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3-methoxy-6-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)pyridin-2-amine results in increased cleavage of PARP1 protein",,,PMID:24471873,https://www.ncbi.nlm.nih.gov/pubmed/24471873,24471873,,,29623955,doi:10.1021/jm4019614
1420714,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3-aminobenzamide inhibits the reaction [asbestos, crocidolite results in increased activity of PARP1 protein]",,,PMID:21543585,https://www.ncbi.nlm.nih.gov/pubmed/21543585,21543585,,,14053556,"Tomasetti M, Amati M, Nocchi L, Saccucci F, Strafella E, Staffolani S, Tarquini LM, Carbonari D, Alleva R, Borghi B, Neuzil J, Bracci M, Santarelli L. Asbestos exposure affects poly(ADP-ribose) polymerase-1 activity: role in asbestos-induced carcinogenesis. Mutagenesis. 2011 Sep;26(5):585–91. doi: 10.1093/mutage/ger020. PMID: 21543585."
1420715,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Asbestos, crocidolite results in decreased expression of PARP1 mrna|asbestos, crocidolite results in decreased expression of PARP1 protein",,,PMID:32006662,https://www.ncbi.nlm.nih.gov/pubmed/32006662,32006662,,,16243267,"Gaetani S, Monaco F, Alessandrini F, Tagliabracci A, Sabbatini A, Bracci M, Valentino M, Neuzil J, Amati M, Santarelli L, Tomasetti M. Mechanism of miR-222 and miR-126 regulation and its role in asbestos-induced malignancy. The International Journal of Biochemistry & Cell Biology. 2020 Apr;121():105700. doi: 10.1016/j.biocel.2020.105700."
1420716,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Asbestos, crocidolite results in increased cleavage of PARP1 protein",,,PMID:17191120|PMID:19783790,https://www.ncbi.nlm.nih.gov/pubmed/17191120|https://www.ncbi.nlm.nih.gov/pubmed/19783790,17191120|19783790,,,24124317|28869793,"Msiska Z, Pacurari M, Mishra A, Leonard SS, Castranova V, Vallyathan V. DNA double-strand breaks by asbestos, silica, and titanium dioxide: possible biomarker of carcinogenic potential? Am J Respir Cell Mol Biol. 2010 Aug;43(2):210–9. doi: 10.1165/rcmb.2009-0062oc. PMID: 19783790.|2006; 12(2):433-447"
1420717,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Asbestos, crocidolite results in increased expression of and results in increased activity of PARP1 protein",,,PMID:20616036|PMID:21543585,https://www.ncbi.nlm.nih.gov/pubmed/20616036|https://www.ncbi.nlm.nih.gov/pubmed/21543585,20616036|21543585,,PMC2906549,14053556|16730770,"Tomasetti M, Amati M, Nocchi L, Saccucci F, Strafella E, Staffolani S, Tarquini LM, Carbonari D, Alleva R, Borghi B, Neuzil J, Bracci M, Santarelli L. Asbestos exposure affects poly(ADP-ribose) polymerase-1 activity: role in asbestos-induced carcinogenesis. Mutagenesis. 2011 Sep;26(5):585–91. doi: 10.1093/mutage/ger020. PMID: 21543585.|Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12611–6. PMID: 20616036; PMCID: PMC2906549."
1420885,86278622,Comparative Toxicogenomics Database (CTD),Crocidolite Asbestos,D017638,"Asbestos, Crocidolite",https://ctdbase.org/detail.go?type=chem&acc=D017638,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Asbestos, crocidolite results in increased expression of PARP1 mRNA",,,PMID:20616036,https://www.ncbi.nlm.nih.gov/pubmed/20616036,20616036,,PMC2906549,16730770,"Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12611–6. PMID: 20616036; PMCID: PMC2906549."
2324352,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [3,5-bis(2-fluorobenzylidene)piperidin-4-one results in increased cleavage of PARP1 protein]",,,PMID:17684018,https://www.ncbi.nlm.nih.gov/pubmed/17684018,17684018,,PMC4610350,22742225,"Selvendiran K, Tong L, Vishwanath S, Bratasz A, Trigg NJ, Kutala VK, Hideg K, Kuppusamy P. EF24 Induces G2/M Arrest and Apoptosis in Cisplatin-resistant Human Ovarian Cancer Cells by Increasing PTEN Expression. Journal of Biological Chemistry. 2007 Sep;282(39):28609–18. doi: 10.1074/jbc.m703796200."
2324353,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [artesunate results in increased cleavage of PARP1 protein],,,PMID:33002460,https://www.ncbi.nlm.nih.gov/pubmed/33002460,33002460,,,12220368,"Zhou X, Chen Y, Wang F, Wu H, Zhang Y, Liu J, Cai Y, Huang S, He N, Hu Z, Jin X. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem Biol Interact. 2020 Nov 01;331():109273. doi: 10.1016/j.cbi.2020.109273. PMID: 33002460."
2324354,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [camptothecin results in increased cleavage of PARP1 protein],,,PMID:25412314,https://www.ncbi.nlm.nih.gov/pubmed/25412314,25412314,,PMC4260755,15447467,"Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells. Cell Death & Disease. 2014 Nov 20;5(11):e1536. doi: 10.1038/cddis.2014.500."
2324355,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [crizotinib results in increased cleavage of PARP1 protein],,,PMID:31706006,https://www.ncbi.nlm.nih.gov/pubmed/31706006,31706006,,,3322128,"Hu Y, Zhang X, Zhao Z, Chen X, Zhou Z, Yang X, Yang B, He Q, Luo P. Keratinocytes apoptosis contributes to crizotinib induced-erythroderma. Toxicol Lett. 2020 Feb 01;319():102–10. doi: 10.1016/j.toxlet.2019.11.007. PMID: 31706006."
2324356,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased cleavage of PARP1 protein]|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in decreased expression of and results in increased cleavage of PARP1 protein],,,PMID:35925383,https://www.ncbi.nlm.nih.gov/pubmed/35925383,35925383,,,34609750,2022; 96(11):3091-3112
2324357,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [fucoxanthin results in increased cleavage of PARP1 protein],,,PMID:38444163,https://www.ncbi.nlm.nih.gov/pubmed/38444163,38444163,,,36894997,"Kuo M, Dai W, Chang J, Chang J, Lee T, Chang C. Fucoxanthin induces human melanoma cytotoxicity by thwarting the <scp>JAK2</scp>/<scp>STAT3</scp>/<scp>BCL-xL</scp> signaling axis. Environmental Toxicology. 2024 Mar 05;39(6):3356–66. doi: 10.1002/tox.24193."
2324358,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein]|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [hydrogen peroxide results in increased cleavage of PARP1 protein],,,PMID:38104653,https://www.ncbi.nlm.nih.gov/pubmed/38104653,38104653,,,36378967,"Maeyama R, Segawa R, Onodera R, Hiratsuka M, Hirasawa N. Caspases downregulate nickel and hydrogen peroxide-induced IL-8 production via modification of c-Jun N-terminal kinases. Toxicology. 2024 Jan;501():153710. doi: 10.1016/j.tox.2023.153710. PMID: 38104653."
2324359,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [lactucin results in increased cleavage of PARP1 protein],,,PMID:34302634,https://www.ncbi.nlm.nih.gov/pubmed/34302634,34302634,,,25817098,2021; 43(10):1199-1207
2324360,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein],,,PMID:34165247,https://www.ncbi.nlm.nih.gov/pubmed/34165247,34165247,,,31166243,"Ho H, Chen P, Lo Y, Lin C, Chuang Y, Hsieh M, Chen M. <scp>Luteolin-7-O</scp>-glucoside inhibits cell proliferation and modulates apoptosis through the <scp>AKT</scp> signaling pathway in human nasopharyngeal carcinoma. Environmental Toxicology. 2021 Jun 24;36(10):2013–24. doi: 10.1002/tox.23319."
2324361,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [morusin results in increased cleavage of PARP1 protein],,,PMID:33035517,https://www.ncbi.nlm.nih.gov/pubmed/33035517,33035517,,,6804631,"Wang J, Liu X, Zheng H, Liu Q, Zhang H, Wang X, Shen T, Wang S, Ren D. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells. Chem Biol Interact. 2020 Nov 01;331():109279. doi: 10.1016/j.cbi.2020.109279. PMID: 33035517."
2324362,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [perifosine results in increased cleavage of PARP1 protein],,,PMID:32587277,https://www.ncbi.nlm.nih.gov/pubmed/32587277,32587277,,PMC7316767,13589569,"Thomé CH, Ferreira GA, Pereira-Martins DA, dos Santos GA, Ortiz CA, de Souza LEB, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Coelho-Silva JL, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, Kerbauy FR, Chauffaille MDL, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports. 2020 Jun 25;10(1):10315. doi: 10.1038/s41598-020-66223-2."
2324363,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [PI-3065 results in increased cleavage of PARP1 protein],,,PMID:36623716,https://www.ncbi.nlm.nih.gov/pubmed/36623716,36623716,,,34818642,"Wei Y, Ke W, Lu Z, Ren Y. PI3K d inhibitor PI-3065 induces apoptosis in hepatocellular carcinoma cells by targeting survivin. Chem Biol Interact. 2023 Feb 01;371():110343. doi: 10.1016/j.cbi.2023.110343. PMID: 36623716."
2324364,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [picrasidine I results in increased expression of PARP1 protein modified form],,,PMID:34894061,https://www.ncbi.nlm.nih.gov/pubmed/34894061,34894061,,,20376671,"Yang YT, Hsieh MJ, Chuang YC, Lin CC, Lo YS, Ho HY, Kumar VB, Ko JL. Anticancer effects of picrasidine I on oral squamous cell carcinoma. Environ Toxicol. 2022 Mar;37(3):627–36. doi: 10.1002/tox.23430. PMID: 34894061."
2324365,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [plant extracts results in increased cleavage of PARP1 protein],,,PMID:31157515,https://www.ncbi.nlm.nih.gov/pubmed/31157515,31157515,,,33797231,"Tang J, Peng S, Cheng Y, Wang C, Farooqi AA, Yu T, Hou M, Wang S, Yen C, Chan L, Ou-Yang F, Chang H. Ethyl acetate extract of <i>Nepenthes adrianii</i> x <i>clipeata</i> induces antiproliferation, apoptosis, and DNA damage against oral cancer cells through oxidative stress. Environmental Toxicology. 2019 Jun 03;34(8):891–901. doi: 10.1002/tox.22748."
2324366,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [regorafenib results in increased cleavage of PARP1 protein],,,PMID:39348200,https://www.ncbi.nlm.nih.gov/pubmed/39348200,39348200,,,37797541,"Xu B, Liu N, Zhou T, Chen J, Jiang L, Wu W, Fu H, Chen X, Yan H, Yang X, Luo P, Yang B, Xu Z, He Q. Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes. Toxicol Sci. 2024 Dec 01;202(2):220–35. doi: 10.1093/toxsci/kfae127. PMID: 39348200."
2324367,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [semilicoisoflavone B results in increased cleavage of PARP1 protein],,,PMID:36901935,https://www.ncbi.nlm.nih.gov/pubmed/36901935,36901935,,PMC10003514,35155758,"Hsieh MJ, Ho HY, Lo YS, Lin CC, Chuang YC, Abomughaid MM, Hsieh MC, Chen MK. Semilicoisoflavone B Induces Apoptosis of Oral Cancer Cells by Inducing ROS Production and Downregulating MAPK and Ras/Raf/MEK Signaling. Int J Mol Sci. 2023 Feb 24;24(5). PMID: 36901935; PMCID: PMC10003514."
2324368,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [stephanthraniline A results in increased cleavage of PARP1 protein],,,PMID:31378763,https://www.ncbi.nlm.nih.gov/pubmed/31378763,31378763,,,17595372,"Wang L, Yao L, Li X, Chen J, Lou C, Wang Y. Stephanthraniline A suppresses proliferation of HCT116 human colon cancer cells through induction of caspase-dependent apoptosis, dysregulation of mitochondrial function, cell cycle arrest and regulation of Akt/p38 signaling pathways. J Toxicol Sci. 2019;44(8):523–33. doi: 10.2131/jts.44.523. PMID: 31378763."
2324369,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [[TNF protein co-treated with SM 164] results in increased cleavage of PARP1 protein],,,PMID:34523043,https://www.ncbi.nlm.nih.gov/pubmed/34523043,34523043,,,12239920,2021; 39(1):183-199
2324370,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [tubocapsenolide A results in increased cleavage of PARP1 protein],,,PMID:18442981,https://www.ncbi.nlm.nih.gov/pubmed/18442981,18442981,,,32226575,"Chen WY, Chang FR, Huang ZY, Chen JH, Wu YC, Wu CC. Tubocapsenolide A, a novel withanolide, inhibits proliferation and induces apoptosis in MDA-MB-231 cells by thiol oxidation of heat shock proteins. J Biol Chem. 2008 Jun 20;283(25):17184–93. doi: 10.1074/jbc.m709447200. PMID: 18442981."
2324371,87687659,Comparative Toxicogenomics Database (CTD),"3-[2-Aminopropanoyl-[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-6-fluoro-4,5-dioxohexanoic acid",C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C096713,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [maduramicin results in increased cleavage of PARP1 protein],,,PMID:29047155,https://www.ncbi.nlm.nih.gov/pubmed/29047155,29047155,,PMC5783728,22948522,"Chen X, Chen L, Jiang S, Huang S. Maduramicin induces apoptosis and necrosis, and blocks autophagic flux in myocardial H9c2 cells. J of Applied Toxicology. 2017 Oct 19;38(3):366–75. doi: 10.1002/jat.3546."
2218962,88776687,Comparative Toxicogenomics Database (CTD),Trap,D001335,Vehicle Emissions,https://ctdbase.org/detail.go?type=chem&acc=D001335,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Vehicle emissions results in decreased methylation of PARP1 gene,,,PMID:25560391,https://www.ncbi.nlm.nih.gov/pubmed/25560391,25560391,,,8037934,"Tachibana K, Takayanagi K, Akimoto A, Ueda K, Shinkai Y, Umezawa M, Takeda K. Prenatal diesel exhaust exposure disrupts the DNA methylation profile in the brain of mouse offspring. J Toxicol Sci. 2015 Feb;40(1):1–11. doi: 10.2131/jts.40.1. PMID: 25560391."
2218963,88776687,Comparative Toxicogenomics Database (CTD),Trap,D001335,Vehicle Emissions,https://ctdbase.org/detail.go?type=chem&acc=D001335,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Vehicle emissions results in increased expression of PARP1 mRNA,,,PMID:24216475,https://www.ncbi.nlm.nih.gov/pubmed/24216475,24216475,,,14760283,"Srivastava A, Sharma A, Yadav S, Flora SJS, Dwivedi UN, Parmar D. Gene expression profiling of candidate genes in peripheral blood mononuclear cells for predicting toxicity of diesel exhaust particles. Free Radical Biology and Medicine. 2014 Feb;67():188–94. doi: 10.1016/j.freeradbiomed.2013.10.820."
2342539,89588629,Therapeutic Target Database (TTD),4-(2-aminoethoxy)-3-(4-bromophenyl)-7-fluoro-2H-isoquinolin-1-one;hydrochloride,D0TD8R,3-phenyl isoquinolin-1(2H) derivative 1,https://idrblab.net/ttd/data/drug/details/D0TD8R,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2342679,89608436,Therapeutic Target Database (TTD),Phthalazine ketone derivative 1,D05ZBB,Phthalazine ketone derivative 1,https://idrblab.net/ttd/data/drug/details/D05ZBB,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2343959,90410660,Comparative Toxicogenomics Database (CTD),"(11S)-7-(3,5-dimethyl-1,2-oxazol-4-yl)-11-pyridin-2-yl-9-oxa-1,3-diazatricyclo[6.3.1.04,12]dodeca-4(12),5,7-trien-2-one",C000627927,INCB054329,https://ctdbase.org/detail.go?type=chem&acc=C000627927,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),INCB054329 results in increased cleavage of PARP1 protein|incb054329 promotes the reaction [olaparib results in increased cleavage of PARP1 protein]|olaparib promotes the reaction [INCB054329 results in increased cleavage of PARP1 protein],,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,PMC5986599,31091351,"Wilson AJ, Stubbs M, Liu P, Ruggeri B, Khabele D. The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer. Gynecologic Oncology. 2018 Jun;149(3):575–84. doi: 10.1016/j.ygyno.2018.03.049."
2267935,91746265,Comparative Toxicogenomics Database (CTD),"D-Glucaric acid, 1,4-lactone",C571832,"D-Glucaric acid, 1,4-lactone",https://ctdbase.org/detail.go?type=chem&acc=C571832,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),"D-glucaric acid, 1,4-lactone inhibits the reaction [alloxan results in increased degradation of PARP1 protein]",,,PMID:21982801,https://www.ncbi.nlm.nih.gov/pubmed/21982801,21982801,,,19463044,"Bhattacharya S, Manna P, Gachhui R, Sil PC. D-saccharic acid-1,4-lactone ameliorates alloxan-induced diabetes mellitus and oxidative stress in rats through inhibiting pancreatic ß-cells from apoptosis via mitochondrial dependent pathway. Toxicol Appl Pharmacol. 2011 Dec 01;257(2):272–83. doi: 10.1016/j.taap.2011.09.013. PMID: 21982801."
2328730,91808049,Therapeutic Target Database (TTD),"(2r,3s,5r,7s)-2-(Pyridin-3-Yl)-1-Azatricyclo[3.3.1.1~3,7~]decane",D0L6LO,TI4,https://idrblab.net/ttd/data/drug/details/D0L6LO,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2278010,91896051,BindingDB,"Sodium 8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonate",27531,"indeno[1,2-c]isoquinolinone, 13",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27531,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),700,PMID:16078828|DOI:10.1021/jm0502891,https://www.ncbi.nlm.nih.gov/pubmed/16078828|https://doi.org/10.1021/jm0502891,16078828,10.1021/jm0502891,,22714053,"Jagtap PG, Baloglu E, Southan GJ, Mabley JG, Li H, Zhou J, van Duzer J, Salzman AL, Szabó C. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100–3. doi: 10.1021/jm0502891. PMID: 16078828."
2346103,92044400,Comparative Toxicogenomics Database (CTD),"2-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethoxy)ethoxy)phenyl)acetamide",C000606252,ARV-825,https://ctdbase.org/detail.go?type=chem&acc=C000606252,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),ARV-825 results in increased cleavage of PARP1 protein,,,PMID:26051217,https://www.ncbi.nlm.nih.gov/pubmed/26051217,26051217,,PMC4475452,18184770,"Lu J, Qian Y, Altieri M, Dong H, Wang J, Raina K, Hines J, Winkler J, Crew A, Coleman K, Crews C. Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chemistry & Biology. 2015 Jun;22(6):755–63. doi: 10.1016/j.chembiol.2015.05.009."
2343490,101644674,Comparative Toxicogenomics Database (CTD),"2,3,5-(Triglutathion-S-yl)hydroquinone",C078765,"2,3,5-(triglutathion-S-yl)hydroquinone",https://ctdbase.org/detail.go?type=chem&acc=C078765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased activity of PARP1 protein]|2,3,5-(triglutathion-S-yl)hydroquinone results in increased activity of PARP1 protein",,,PMID:24752504,https://www.ncbi.nlm.nih.gov/pubmed/24752504,24752504,,PMC4081636,1835378,"Zhang F, Xie R, Munoz FM, Lau SS, Monks TJ. PARP-1 Hyperactivation and Reciprocal Elevations in Intracellular Ca2+ During ROS-Induced Nonapoptotic Cell Death. 2014 Apr 20;140(1):118–34. doi: 10.1093/toxsci/kfu073."
2343491,101644674,Comparative Toxicogenomics Database (CTD),"2,3,5-(Triglutathion-S-yl)hydroquinone",C078765,"2,3,5-(triglutathion-S-yl)hydroquinone",https://ctdbase.org/detail.go?type=chem&acc=C078765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,3,5-(triglutathion-S-yl)hydroquinone results in decreased ADP-ribosylation of PARP1 protein",,,PMID:31165168,https://www.ncbi.nlm.nih.gov/pubmed/31165168,31165168,,,33804602,"Islas-Robles A, Yedlapudi D, Lau SS, Monks TJ. Toxicoproteomic Analysis of Poly(ADP-Ribose)-Associated Proteins Induced by Oxidative Stress in Human Proximal Tubule Cells. Toxicol Sci. 2019 Sep 01;171(1):117–31. doi: 10.1093/toxsci/kfz131. PMID: 31165168."
2343492,101644674,Comparative Toxicogenomics Database (CTD),"2,3,5-(Triglutathion-S-yl)hydroquinone",C078765,"2,3,5-(triglutathion-S-yl)hydroquinone",https://ctdbase.org/detail.go?type=chem&acc=C078765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"[2,3,5-(triglutathion-S-yl)hydroquinone results in increased abundance of reactive oxygen species] which results in increased activity of PARP1 protein",,,PMID:24752504|PMID:28525621|PMID:31165168,https://www.ncbi.nlm.nih.gov/pubmed/24752504|https://www.ncbi.nlm.nih.gov/pubmed/28525621|https://www.ncbi.nlm.nih.gov/pubmed/31165168,24752504|28525621|31165168,,PMC4081636|PMC5837598,1835378|6029164|33804602,"Islas-Robles A, Yedlapudi D, Lau SS, Monks TJ. Toxicoproteomic Analysis of Poly(ADP-Ribose)-Associated Proteins Induced by Oxidative Stress in Human Proximal Tubule Cells. Toxicol Sci. 2019 Sep 01;171(1):117–31. doi: 10.1093/toxsci/kfz131. PMID: 31165168.|Munoz FM, Zhang F, Islas-Robles A, Lau SS, Monks TJ. From the Cover: ROS-Induced Store-Operated Ca2+ Entry Coupled to PARP-1 Hyperactivation Is Independent of PARG Activity in Necrotic Cell Death. Toxicol Sci. 2017 Aug 01;158(2):444–53. PMID: 28525621; PMCID: PMC5837598.|Zhang F, Xie R, Munoz FM, Lau SS, Monks TJ. PARP-1 Hyperactivation and Reciprocal Elevations in Intracellular Ca2+ During ROS-Induced Nonapoptotic Cell Death. 2014 Apr 20;140(1):118–34. doi: 10.1093/toxsci/kfu073."
2343493,101644674,Comparative Toxicogenomics Database (CTD),"2,3,5-(Triglutathion-S-yl)hydroquinone",C078765,"2,3,5-(triglutathion-S-yl)hydroquinone",https://ctdbase.org/detail.go?type=chem&acc=C078765,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,3,5-(triglutathion-S-yl)hydroquinone results in increased expression of PARP1 protein modified form|parp1 protein promotes the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased cleavage of CASP3 protein]",,,PMID:22523229,https://www.ncbi.nlm.nih.gov/pubmed/22523229,22523229,,PMC3491962,18765568,"Zhang F, Lau SS, Monks TJ. A dual role for poly(ADP-ribose) polymerase-1 during caspase-dependent apoptosis. Toxicol Sci. 2012 Jul;128(1):103–14. PMID: 22523229; PMCID: PMC3491962."
2183357,102601509,Comparative Toxicogenomics Database (CTD),Protein Kinase Inhibitor,D047428,Protein Kinase Inhibitors,https://ctdbase.org/detail.go?type=chem&acc=D047428,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Protein kinase inhibitors results in increased cleavage of PARP1 protein,,,PMID:21878655,https://www.ncbi.nlm.nih.gov/pubmed/21878655,21878655,,PMC3213302,7279512,"Ewton DZ, Hu J, Vilenchik M, Deng X, Luk K, Polonskaia A, Hoffman AF, Zipf K, Boylan JF, Friedman EA. Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells. 2011 Nov 01;10(11):2104–14. doi: 10.1158/1535-7163.mct-11-0498."
2291908,112500518,Comparative Toxicogenomics Database (CTD),4-acetylantroquinonol B,C555021,4-acetylantroquinonol B,https://ctdbase.org/detail.go?type=chem&acc=C555021,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),4-acetylantroquinonol B results in increased cleavage of PARP1 protein,,,PMID:33727089,https://www.ncbi.nlm.nih.gov/pubmed/33727089,33727089,,,30479637,"Satriyo PB, Su CM, Ong JR, Huang WC, Fong IH, Lin CC, Aryandono T, Haryana SM, Deng L, Huang CC, Tzeng YM, Chao TY, Liu HW, Yeh CT. 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells. Toxicol Appl Pharmacol. 2021 Jul 01;422():115493. doi: 10.1016/j.taap.2021.115493. PMID: 33727089."
2292011,117955898,IUPHAR/BPS Guide to PHARMACOLOGY,Venadaparib,11184,venadaparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11184,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,8.3,,,,,,,
2292795,118910268,Comparative Toxicogenomics Database (CTD),Tapotoclax,C000720001,tapotoclax,https://ctdbase.org/detail.go?type=chem&acc=C000720001,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Tapotoclax results in increased cleavage of PARP1 protein,,,PMID:36346691,https://www.ncbi.nlm.nih.gov/pubmed/36346691,36346691,,PMC9852224,34464814,"Tantawy SI, Sarkar A, Hubner S, Tan Z, Wierda WG, Eldeib A, Zhang S, Kornblau S, Gandhi V. Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies. Clin Cancer Res. 2023 Jan 17;29(2):446–57. PMID: 36346691; PMCID: PMC9852224."
2237345,118986645,Comparative Toxicogenomics Database (CTD),Ilk-IN-2,C562238,"N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide",https://ctdbase.org/detail.go?type=chem&acc=C562238,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide results in increased cleavage of PARP1 protein",,,PMID:21823616,https://www.ncbi.nlm.nih.gov/pubmed/21823616,21823616,,PMC3182772,12013954,"Lee S, Hsu E, Chou C, Chuang H, Bai L, Kulp SK, Chen C. Identification and Characterization of a Novel Integrin-Linked Kinase Inhibitor. J. Med. Chem. 2011 Aug 24;54(18):6364–74. doi: 10.1021/jm2007744."
2293136,121280087,Comparative Toxicogenomics Database (CTD),Aumolertinib,C000718108,aumolertinib,https://ctdbase.org/detail.go?type=chem&acc=C000718108,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Aumolertinib results in increased cleavage of PARP1 protein,,,PMID:34219533,https://www.ncbi.nlm.nih.gov/pubmed/34219533,34219533,,,1346913,"Ge X, Zhang Y, Huang F, Wu Y, Pang J, Li X, Fan F, Liu H, Li S. EGFR tyrosine kinase inhibitor Almonertinib induces apoptosis and autophagy mediated by reactive oxygen species in non-small cell lung cancer cells. Hum Exp Toxicol. 2021 Dec;40(12_suppl):S49–62. doi: 10.1177/09603271211030554. PMID: 34219533."
2333582,121304016,Comparative Toxicogenomics Database (CTD),Remdesivir,C000606551,remdesivir,https://ctdbase.org/detail.go?type=chem&acc=C000606551,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Remdesivir results in increased expression of PARP1 protein,,,PMID:35417658,https://www.ncbi.nlm.nih.gov/pubmed/35417658,35417658,,,34201119,"Lee CM, Kang MA, Bae JS, Park K, Yang YH, Lee J, Jang KY, Park SH. An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species. Hum Exp Toxicol. 2022 Jan;41():9603271221089257. doi: 10.1177/09603271221089257. PMID: 35417658."
2332403,121490161,Drug Gene Interaction database (DGIdb),Rucaparib Camsylate,,RUCAPARIB CAMSYLATE,https://www.dgidb.org/drugs/rxcui:1862578,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2214813,122423373,Chemical Probes Portal,AZ0108,AZ0108,AZ0108,https://www.chemicalprobes.org/az0108,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),NAD+ competitive inhibitor,,"<30nM, <30 nM, 83 nM",PMID:26546219,https://www.ncbi.nlm.nih.gov/pubmed/26546219,26546219,,,21555891,"Johannes JW, Almeida L, Daly K, Ferguson AD, Grosskurth SE, Guan H, Howard T, Ioannidis S, Kazmirski S, Lamb ML, Larsen NA, Lyne PD, Mikule K, Ogoe C, Peng B, Petteruti P, Read JA, Su N, Sylvester M, Throner S, Wang W, Wang X, Wu J, Ye Q, Yu Y, Zheng X, Scott DA. Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering. Bioorganic & Medicinal Chemistry Letters. 2015 Dec;25(24):5743–7. doi: 10.1016/j.bmcl.2015.10.079."
2350733,123424371,Comparative Toxicogenomics Database (CTD),"2-Hydroxy-3',5,5'-trimethoxychalcone",C576975,"2-hydroxy-3',5,5'-trimethoxychalcone",https://ctdbase.org/detail.go?type=chem&acc=C576975,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of PARP1 protein]|2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of PARP1 protein|benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of PARP1 protein]",,,PMID:30408460,https://www.ncbi.nlm.nih.gov/pubmed/30408460,30408460,,,27723194,"Gil HN, Jung E, Koh D, Lim Y, Lee YH, Shin SY. A synthetic chalcone derivative, 2-hydroxy-3',5,5'-trimethoxychalcone (DK-139), triggers reactive oxygen species-induced apoptosis independently of p53 in A549 lung cancer cells. Chem Biol Interact. 2019 Jan 25;298():72–9. doi: 10.1016/j.cbi.2018.11.003. PMID: 30408460."
2299029,124081212,BindingDB,c-Niraparib,209929,c-Niraparib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=209929,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),48.4,PMID:27866910|DOI:10.1016/j.chembiol.2016.10.011,https://www.ncbi.nlm.nih.gov/pubmed/27866910|https://doi.org/10.1016/j.chembiol.2016.10.011,27866910,10.1016/j.chembiol.2016.10.011,PMC5182133,33069478,"Knezevic CE, Wright G, Remsing Rix LL, Kim W, Kuenzi BM, Luo Y, Watters JM, Koomen JM, Haura EB, Monteiro AN, Radu C, Lawrence HR, Rix U. Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Cell Chemical Biology. 2016 Dec;23(12):1490–503. doi: 10.1016/j.chembiol.2016.10.011."
2299162,124081213,BindingDB,c-Olaparib,209930,c-Olaparib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=209930,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),5.9,PMID:27866910|DOI:10.1016/j.chembiol.2016.10.011,https://www.ncbi.nlm.nih.gov/pubmed/27866910|https://doi.org/10.1016/j.chembiol.2016.10.011,27866910,10.1016/j.chembiol.2016.10.011,PMC5182133,33069478,"Knezevic CE, Wright G, Remsing Rix LL, Kim W, Kuenzi BM, Luo Y, Watters JM, Koomen JM, Haura EB, Monteiro AN, Radu C, Lawrence HR, Rix U. Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Cell Chemical Biology. 2016 Dec;23(12):1490–503. doi: 10.1016/j.chembiol.2016.10.011."
2299163,124081214,BindingDB,c-Rucaparib,209931,c-Rucaparib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=209931,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),4.4,PMID:27866910|DOI:10.1016/j.chembiol.2016.10.011,https://www.ncbi.nlm.nih.gov/pubmed/27866910|https://doi.org/10.1016/j.chembiol.2016.10.011,27866910,10.1016/j.chembiol.2016.10.011,PMC5182133,33069478,"Knezevic CE, Wright G, Remsing Rix LL, Kim W, Kuenzi BM, Luo Y, Watters JM, Koomen JM, Haura EB, Monteiro AN, Radu C, Lawrence HR, Rix U. Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Cell Chemical Biology. 2016 Dec;23(12):1490–503. doi: 10.1016/j.chembiol.2016.10.011."
2299164,124081215,BindingDB,c-Veliparib,209933,c-Veliparib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=209933,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),8.4,PMID:27866910|DOI:10.1016/j.chembiol.2016.10.011,https://www.ncbi.nlm.nih.gov/pubmed/27866910|https://doi.org/10.1016/j.chembiol.2016.10.011,27866910,10.1016/j.chembiol.2016.10.011,PMC5182133,33069478,"Knezevic CE, Wright G, Remsing Rix LL, Kim W, Kuenzi BM, Luo Y, Watters JM, Koomen JM, Haura EB, Monteiro AN, Radu C, Lawrence HR, Rix U. Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Cell Chemical Biology. 2016 Dec;23(12):1490–503. doi: 10.1016/j.chembiol.2016.10.011."
2322301,129737846,Comparative Toxicogenomics Database (CTD),"2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone",C117776,"2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone",https://ctdbase.org/detail.go?type=chem&acc=C117776,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone analog results in increased cleavage of PARP1 protein",,,PMID:26630137,https://www.ncbi.nlm.nih.gov/pubmed/26630137,26630137,,,19022521,"Stulpinas A, Imbrasaite A, Krestnikova N, Šarlauskas J, Cenas N, Kalvelyte AV. Study of Bioreductive Anticancer Agent RH-1-Induced Signals Leading the Wild-Type p53-Bearing Lung Cancer A549 Cells to Apoptosis. Chem Res Toxicol. 2016 Jan 19;29(1):26–39. doi: 10.1021/acs.chemrestox.5b00336. PMID: 26630137."
2305397,129851388,Comparative Toxicogenomics Database (CTD),2-(3-Hydroxyphenyl)-5-methylnaphthyridin-4-one,C000706936,CSC-3436,https://ctdbase.org/detail.go?type=chem&acc=C000706936,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[CSC-3436 co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein|sb 203580 inhibits the reaction [CSC-3436 promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]|tnfsf10 protein promotes the reaction [CSC-3436 results in increased cleavage of PARP1 protein]|csc-3436 results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [[CSC-3436 co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein]|csc-3436 promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]|sb 203580 inhibits the reaction [TNFSF10 protein promotes the reaction [CSC-3436 results in increased cleavage of PARP1 protein]],,,PMID:34599545,https://www.ncbi.nlm.nih.gov/pubmed/34599545,34599545,,,7523207,"Huang C, Cheng Y, Lin Y, Chou C, Ho C, Wang H, Way T. <scp>CSC</scp>-3436 sensitizes triple negative breast cancer cells to <scp>TRAIL</scp>-induced apoptosis through <scp>ROS</scp>-mediated p38/<scp>CHOP</scp>/death receptor 5 signaling pathways. Environmental Toxicology. 2021 Oct 02;36(12):2578–88. doi: 10.1002/tox.23372."
2351047,131633415,Comparative Toxicogenomics Database (CTD),[Dioxido-[oxo(trioxidosilyloxy)silyl]oxysilyl]oxy-[[dioxido-[oxo(trioxidosilyloxy)silyl]oxysilyl]oxy-oxosilyl]oxy-dioxidosilane;iron(2+);dihydroxide,D017639,"Asbestos, Amosite",https://ctdbase.org/detail.go?type=chem&acc=D017639,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"CAT protein inhibits the reaction [asbestos, amosite results in increased activity of PARP1 protein]|3-aminobenzamide inhibits the reaction [asbestos, amosite results in increased activity of PARP1 protein]|asbestos, amosite results in increased activity of PARP1 protein|[smoke analog co-treated with asbestos, amosite] results in increased activity of PARP1 protein|phytic acid inhibits the reaction [asbestos, amosite results in increased activity of PARP1 protein]",,,PMID:11217149,https://www.ncbi.nlm.nih.gov/pubmed/11217149,11217149,,,2257485,"Kamp DW, Srinivasan M, Weitzman SA. Cigarette Smoke and Asbestos Activate Poly-ADP-Ribose Polymerase in Alveolar Epithelial Cells. Journal of Investigative Medicine. 2001 Jan;49(1):68–76. doi: 10.2310/6650.2001.34092."
2324324,131634760,Comparative Toxicogenomics Database (CTD),Azd-5991,C000629704,AZD5991,https://ctdbase.org/detail.go?type=chem&acc=C000629704,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),AZD5991 results in increased cleavage of PARP1 protein,,,PMID:36346691,https://www.ncbi.nlm.nih.gov/pubmed/36346691,36346691,,PMC9852224,34464814,"Tantawy SI, Sarkar A, Hubner S, Tan Z, Wierda WG, Eldeib A, Zhang S, Kornblau S, Gandhi V. Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies. Clin Cancer Res. 2023 Jan 17;29(2):446–57. PMID: 36346691; PMCID: PMC9852224."
2333483,132010322,Comparative Toxicogenomics Database (CTD),"N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide",C000706695,ABBV-744,https://ctdbase.org/detail.go?type=chem&acc=C000706695,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [ABBV-744 results in increased cleavage of PARP1 protein]|abbv-744 results in increased cleavage of PARP1 protein,,,PMID:37769529,https://www.ncbi.nlm.nih.gov/pubmed/37769529,37769529,,PMC10539879,36577683,"Wang K, Tang J, Fan S, Su H, Yu R, Zhang Y, Wu H, Lv Y, Zhang S, Zou X. ABBV-744 induces autophagy in gastric cancer cells by regulating PI3K/AKT/mTOR/p70S6k and MAPK signaling pathways. Neoplasia. 2023 Nov;45():100936. PMID: 37769529; PMCID: PMC10539879."
2351216,133082692,Comparative Toxicogenomics Database (CTD),Nami-A,C113661,imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III),https://ctdbase.org/detail.go?type=chem&acc=C113661,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(iii) promotes the reaction [ruthenium binds to PARP1 protein]|imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(iii) inhibits the reaction [zinc binds to PARP1 protein]|imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(iii) results in decreased activity of PARP1 protein,,,PMID:21370912,https://www.ncbi.nlm.nih.gov/pubmed/21370912,21370912,,,13366100,"Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ, Casini A. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem. 2011 Apr 14;54(7):2196–206. doi: 10.1021/jm2000135. PMID: 21370912."
2347529,135122017,Comparative Toxicogenomics Database (CTD),"1-(3,4-Dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one",C000603962,"1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one",https://ctdbase.org/detail.go?type=chem&acc=C000603962,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-butylhydroperoxide results in increased cleavage of PARP1 protein]",,,PMID:29111459,https://www.ncbi.nlm.nih.gov/pubmed/29111459,29111459,,,14871116,"Chen H, Song Z, Ying S, Yang X, Wu W, Tan Q, Ju X, Wu W, Zhang X, Qu J, Wang Y. Myeloid differentiation protein 2 induced retinal ischemia reperfusion injury via upregulation of ROS through a TLR4-NOX4 pathway. Toxicol Lett. 2018 Jan 05;282():109–20. doi: 10.1016/j.toxlet.2017.10.018. PMID: 29111459."
2354808,135222620,Comparative Toxicogenomics Database (CTD),1-(4-((8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)sulfonyl)phenyl)-3-(pyridin-4-ylmethyl)urea,C000718572,SBI-797812,https://ctdbase.org/detail.go?type=chem&acc=C000718572,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SBI-797812 results in increased activity of PARP1 protein,,,PMID:33051211,https://www.ncbi.nlm.nih.gov/pubmed/33051211,33051211,,PMC7834058,7481708,"Heer CD, Sanderson DJ, Voth LS, Alhammad YMO, Schmidt MS, Trammell SAJ, Perlman S, Cohen MS, Fehr AR, Brenner C. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. Journal of Biological Chemistry. 2020 Dec;295(52):17986–96. doi: 10.1074/jbc.ra120.015138."
2210068,135398517,DrugBank,Nu 1025,DB02690,NU1025,https://www.drugbank.ca/drugs/DB02690,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/37713619|https://www.ncbi.nlm.nih.gov/pubmed/10592235,37713619|10592235,,PMC102472|PMC10767903,12499145|36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
2345919,135398517,Therapeutic Target Database (TTD),Nu 1025,D0O3FX,NU1025,https://idrblab.net/ttd/data/drug/details/D0O3FX,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2341160,135398658,Comparative Toxicogenomics Database (CTD),Folic Acid,D005492,Folic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005492,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Folic acid results in decreased expression of PARP1 mRNA,,,PMID:36354958,https://www.ncbi.nlm.nih.gov/pubmed/36354958,36354958,,PMC10314330,34420865,"Kandel R, Singh KP. Higher Concentrations of Folic Acid Cause Oxidative Stress, Acute Cytotoxicity, and Long-Term Fibrogenic Changes in Kidney Epithelial Cells. Chem. Res. Toxicol. 2022 Nov 10;35(11):2168–79. doi: 10.1021/acs.chemrestox.2c00258."
2341161,135398658,Comparative Toxicogenomics Database (CTD),Folic Acid,D005492,Folic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005492,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Folic acid results in increased cleavage of PARP1 protein,,,PMID:16728583,https://www.ncbi.nlm.nih.gov/pubmed/16728583,16728583,,,4392072,"Attias Z, Werner H, Vaisman N. Folic acid and its metabolites modulate IGF-I receptor gene expression in colon cancer cells in a p53-dependent manner. Endocr Relat Cancer. 2006 Jun;13(2):571–81. doi: 10.1677/erc.1.01156. PMID: 16728583."
2341162,135398658,Comparative Toxicogenomics Database (CTD),Folic Acid,D005492,Folic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005492,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),"Folic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of PARP1 mrna]",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,PMC3259116,22158599,2011; 30(1):116
2341163,135398658,Comparative Toxicogenomics Database (CTD),Folic Acid,D005492,Folic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005492,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Folic acid inhibits the reaction [methotrexate results in increased cleavage of PARP1 protein],,,PMID:30502384,https://www.ncbi.nlm.nih.gov/pubmed/30502384,30502384,,,2591540,"Shao Y, Tan B, Shi J, Zhou Q. Methotrexate induces astrocyte apoptosis by disrupting folate metabolism in the mouse juvenile central nervous system. Toxicol Lett. 2019 Feb;301():146–56. doi: 10.1016/j.toxlet.2018.11.016. PMID: 30502384."
2341164,135398658,Comparative Toxicogenomics Database (CTD),Folic Acid,D005492,Folic Acid,https://ctdbase.org/detail.go?type=chem&acc=D005492,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Folic acid inhibits the reaction [nicotine results in decreased expression of PARP1 protein],,,PMID:29972271,https://www.ncbi.nlm.nih.gov/pubmed/29972271,29972271,,,6755884,"Bhattacharjee A, Prasad SK, Banerjee O, Singh S, Banerjee A, Bose A, Pal S, Maji BK, Mukherjee S. Targeting mitochondria with folic acid and vitamin B<sub>12</sub>ameliorates nicotine mediated islet cell dysfunction. Environmental Toxicology. 2018 Jul 04;33(9):988–1000. doi: 10.1002/tox.22586."
1512582,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[3-methyladenine co-treated with amiodarone] results in increased cleavage of PARP1 protein,,,PMID:23912912,https://www.ncbi.nlm.nih.gov/pubmed/23912912,23912912,,,16806471,"Lee K, Oh S, Choi Y, Oh S, Yang Y, Yang M, Lee K, Lee B. Activation of Autophagy Rescues Amiodarone-Induced Apoptosis of Lung Epithelial Cells and Pulmonary Toxicity in Rats. 2013 Aug 02;136(1):193–204. doi: 10.1093/toxsci/kft168."
1512583,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein]|[3-methyladenine co-treated with fosbretabulin] results in increased cleavage of PARP1 protein,,,PMID:24321340,https://www.ncbi.nlm.nih.gov/pubmed/24321340,24321340,,,28290116,"Li Y, Luo P, Wang J, Dai J, Yang X, Wu H, Yang B, He Q. Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway. Toxicol Appl Pharmacol. 2014 Jan 15;274(2):319–27. doi: 10.1016/j.taap.2013.11.018. PMID: 24321340."
1512584,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"3-methyladenine inhibits the reaction [3,7-dioxolanosta-8,24-dien-26-oic acid results in increased cleavage of PARP1 protein]",,,PMID:31874162,https://www.ncbi.nlm.nih.gov/pubmed/31874162,31874162,,,16950886,"Xia J, Dai L, Wang L, Zhu J. Ganoderic acid DM induces autophagic apoptosis in non-small cell lung cancer cells by inhibiting the PI3K/Akt/mTOR activity. Chem Biol Interact. 2020 Jan 25;316():108932. doi: 10.1016/j.cbi.2019.108932. PMID: 31874162."
1512585,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [artesunate results in increased cleavage of PARP1 protein],,,PMID:33002460,https://www.ncbi.nlm.nih.gov/pubmed/33002460,33002460,,,12220368,"Zhou X, Chen Y, Wang F, Wu H, Zhang Y, Liu J, Cai Y, Huang S, He N, Hu Z, Jin X. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem Biol Interact. 2020 Nov 01;331():109273. doi: 10.1016/j.cbi.2020.109273. PMID: 33002460."
1512586,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein],,,PMID:36843289,https://www.ncbi.nlm.nih.gov/pubmed/36843289,36843289,,,34977749,"Hou T, Wang Y, Dan W, Wei Y, Liu B, Que T, Lei Y, Yu B, Zeng J, Fan Y, Li L. ß-Ionone represses renal cell carcinoma progression through activating LKB1/AMPK-triggered autophagy. J Biochem Mol Toxicol. 2023 Jun;37(6):e23331. doi: 10.1002/jbt.23331. PMID: 36843289."
1512587,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [divinyl sulfone analog results in increased cleavage of PARP1 protein]|3-methyladenine inhibits the reaction [oligopeptides analog results in increased cleavage of PARP1 protein]|3-methyladenine inhibits the reaction [morpholines analog results in increased cleavage of PARP1 protein],,,PMID:24875536,https://www.ncbi.nlm.nih.gov/pubmed/24875536,24875536,,,9393305,"Zhang L, Wang H, Xu J, Zhu J, Ding K. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Toxicol Lett. 2014 Aug 04;228(3):248–59. doi: 10.1016/j.toxlet.2014.05.015. PMID: 24875536."
1512761,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [fingolimod hydrochloride results in increased cleavage of PARP1 protein],,,PMID:25939952,https://www.ncbi.nlm.nih.gov/pubmed/25939952,25939952,,,26969299,"Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015 Jul 02;236(1):43–59. doi: 10.1016/j.toxlet.2015.04.015. PMID: 25939952."
1512762,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [ovatodiolide results in increased cleavage of PARP1 protein],,,PMID:38000454,https://www.ncbi.nlm.nih.gov/pubmed/38000454,38000454,,,36430276,"Xia Q, Xie J, Zhang J, Zhang L, Zhou Y, Zhu B, Wu Y, Yang Z, Li J. Ovatodiolide induces autophagy-mediated cell death through the p62-Keap1-Nrf2 signaling pathway in chronic myeloid leukemia cells. Chem Biol Interact. 2024 Jan 05;387():110819. doi: 10.1016/j.cbi.2023.110819. PMID: 38000454."
1512763,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [polyphyllin I results in increased expression of PARP1 protein modified form],,,PMID:31421117,https://www.ncbi.nlm.nih.gov/pubmed/31421117,31421117,,,12866556,"Tian Y, Jia SX, Shi J, Gong GY, Yu JW, Niu Y, Yang CM, Ma XC, Fang MY. Polyphyllin I induces apoptosis and autophagy via modulating JNK and mTOR pathways in human acute myeloid leukemia cells. Chem Biol Interact. 2019 Sep 25;311():108793. doi: 10.1016/j.cbi.2019.108793. PMID: 31421117."
1512764,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine inhibits the reaction [resveratrol inhibits the reaction [rotenone results in increased cleavage of PARP1 protein]],,,PMID:21778691,https://www.ncbi.nlm.nih.gov/pubmed/21778691,21778691,,PMC3699815,9998083,"Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T. Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease. Neurosignals. 2011;19(3):163–74. doi: 10.1159/000328516."
1512765,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [BO-1012 results in increased cleavage of PARP1 protein],,,PMID:24823293,https://www.ncbi.nlm.nih.gov/pubmed/24823293,24823293,,,4538906,"Liou JS, Wu YC, Yen WY, Tang YS, Kakadiya RB, Su TL, Yih LH. Inhibition of autophagy enhances DNA damage-induced apoptosis by disrupting CHK1-dependent S phase arrest. Toxicol Appl Pharmacol. 2014 Aug 01;278(3):249–58. doi: 10.1016/j.taap.2014.04.028. PMID: 24823293."
1512766,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [embelin results in increased cleavage of PARP1 protein],,,PMID:28722333,https://www.ncbi.nlm.nih.gov/pubmed/28722333,28722333,,PMC6472881,20929699,"Lee Y, Park B, Park H, Yu S, Kang H, Kim I. <scp>XIAP</scp> inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells. Environmental Toxicology. 2017 Jul 19;32(11):2371–8. doi: 10.1002/tox.22450."
1512767,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine results in increased cleavage of PARP1 protein|3-methyladenine promotes the reaction [flavanones results in increased cleavage of PARP1 protein],,,PMID:21616090,https://www.ncbi.nlm.nih.gov/pubmed/21616090,21616090,,,9342382,"Shin SY, Hyun J, Yu JR, Lim Y, Lee YH. 5-Methoxyflavanone induces cell cycle arrest at the G2/M phase, apoptosis and autophagy in HCT116 human colon cancer cells. Toxicol Appl Pharmacol. 2011 Aug 01;254(3):288–98. doi: 10.1016/j.taap.2011.05.003. PMID: 21616090."
1512768,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein],,,PMID:19116755,https://www.ncbi.nlm.nih.gov/pubmed/19116755,19116755,,,27541600,2008; 16(3):761-771
1512769,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [SC-66 compound results in increased cleavage of PARP1 protein],,,PMID:37741534,https://www.ncbi.nlm.nih.gov/pubmed/37741534,37741534,,,36551503,"Wang L, Song R, Ma M, Chen Y, Jiang Y, Li J, Yang Z, Zhang L, Jing M, Wang X, Zhang M, Fan J. Inhibition of autophagy can promote the apoptosis of bladder cancer cells induced by SC66 through the endoplasmic reticulum stress pathway. Chem Biol Interact. 2023 Oct 01;384():110725. doi: 10.1016/j.cbi.2023.110725. PMID: 37741534."
1512770,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-methyladenine promotes the reaction [silybin results in increased cleavage of PARP1 protein],,,PMID:34053323,https://www.ncbi.nlm.nih.gov/pubmed/34053323,34053323,,,25816613,"Yang J, Sun Y, Xu F, Liu W, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Autophagy and glycolysis independently attenuate silibinin-induced apoptosis in human hepatocarcinoma HepG2 and Hep3B cells. Hum Exp Toxicol. 2021 Dec;40(12):2048–62. doi: 10.1177/09603271211017609. PMID: 34053323."
1512921,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[flavokawain B co-treated with 3-methyladenine] results in increased cleavage of PARP1 protein|[chloroquine co-treated with 3-methyladenine] results in increased cleavage of PARP1 protein,,,PMID:30025493,https://www.ncbi.nlm.nih.gov/pubmed/30025493,30025493,,PMC6152528,23661645,"Wang J, Qi Q, Zhou W, Feng Z, Huang B, Chen A, Zhang D, Li W, Zhang Q, Jiang Z, Bjerkvig R, Prestegarden L, Thorsen F, Wang X, Li X, Wang J. Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy. Autophagy. 2018 Aug 17;14(11):2007–22. doi: 10.1080/15548627.2018.1501133."
1512922,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),3-methyladenine inhibits the reaction [aristolochic acid I results in increased cleavage of PARP1 protein],,,PMID:23939141,https://www.ncbi.nlm.nih.gov/pubmed/23939141,23939141,,,469151,"Yang CC, Wu CT, Chen LP, Hung KY, Liu SH, Chiang CK. Autophagy induction promotes aristolochic acid-I-induced renal injury in vivo and in vitro. Toxicology. 2013 Oct 04;312():63–73. doi: 10.1016/j.tox.2013.07.017. PMID: 23939141."
1512923,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),3-methyladenine promotes the reaction [methamphetamine results in increased cleavage of PARP1 protein],,,PMID:34374793,https://www.ncbi.nlm.nih.gov/pubmed/34374793,34374793,,,25810524,2021; 95(10):3263-3284
1512924,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),3-methyladenine affects the reaction [MYD88 protein affects the reaction [paraquat results in increased expression of PARP1 protein]],,,PMID:34811946,https://www.ncbi.nlm.nih.gov/pubmed/34811946,34811946,,PMC8818611,9574078,"Qi M, Liao S, Wang J, Deng Y, Zha A, Shao Y, Cui Z, Song T, Tang Y, Tan B, Yin Y. MyD88 deficiency ameliorates weight loss caused by intestinal oxidative injury in an autophagy-dependent mechanism. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):677–95. PMID: 34811946; PMCID: PMC8818611."
1512925,135398661,Comparative Toxicogenomics Database (CTD),3-Methyladenine,C025946,3-methyladenine,https://ctdbase.org/detail.go?type=chem&acc=C025946,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9823,Sus scrofa (pig),3-methyladenine promotes the reaction [ochratoxin A results in increased cleavage of PARP1 protein],,,PMID:30287338,https://www.ncbi.nlm.nih.gov/pubmed/30287338,30287338,,,22300257,"Qian G, Liu D, Hou L, Hamid M, Chen X, Gan F, Song S, Huang K. Ochratoxin A induces cytoprotective autophagy via blocking AKT/mTOR signaling pathway in PK-15 cells. Food Chem Toxicol. 2018 Dec;122():120–31. doi: 10.1016/j.fct.2018.09.070. PMID: 30287338."
2255963,135398735,Comparative Toxicogenomics Database (CTD),Rifampin,D012293,Rifampin,https://ctdbase.org/detail.go?type=chem&acc=D012293,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Rifampin inhibits the reaction [[acetaminophen co-treated with [ferric nitrate results in increased abundance of iron]] results in increased cleavage of PARP1 protein],,,PMID:31678598,https://www.ncbi.nlm.nih.gov/pubmed/31678598,31678598,,,5377777,"Lee EH, Baek SY, Park JY, Kim YW. Rifampicin activates AMPK and alleviates oxidative stress in the liver as mediated with Nrf2 signaling. Chem Biol Interact. 2020 Jan 05;315():108889. doi: 10.1016/j.cbi.2019.108889. PMID: 31678598."
2213045,135403795,Comparative Toxicogenomics Database (CTD),"(3,4,6-Trihydroxy-5-oxo-5H-benzo[7]annulene-1,8-diyl)bis[(2R,3R)-5,7-dihydroxy-3,4-dihydro-2H-chromene-2,3-diyl] bis(3,4,5-trihydroxybenzoate)",C585473,"theaflavin-3,3'-digallate",https://ctdbase.org/detail.go?type=chem&acc=C585473,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"Theaflavin-3,3'-digallate results in increased cleavage of PARP1 protein",,,PMID:30769778,https://www.ncbi.nlm.nih.gov/pubmed/30769778,30769778,,PMC6412557,27079591,"Gao Y, Yin J, Tu Y, Chen YC. Theaflavin-3,3'-Digallate Suppresses Human Ovarian Carcinoma OVCAR-3 Cells by Regulating the Checkpoint Kinase 2 and p27 kip1 Pathways. Molecules. 2019 Feb 14;24(4):673. doi: 10.3390/molecules24040673."
2342100,135407310,Therapeutic Target Database (TTD),2-(4-Methoxy-phenyl)-8-methyl-3H-quinazolin-4-one,D0B2WX,2-(4-Methoxy-phenyl)-8-methyl-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0B2WX,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2303689,135408511,Comparative Toxicogenomics Database (CTD),Prodigiosin,D011353,Prodigiosin,https://ctdbase.org/detail.go?type=chem&acc=D011353,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Prodigiosin results in increased cleavage of PARP1 protein,,,PMID:15746575|PMID:19133282,https://www.ncbi.nlm.nih.gov/pubmed/15746575|https://www.ncbi.nlm.nih.gov/pubmed/19133282,15746575|19133282,,,22031803|24828686,"Ho TF, Peng YT, Chuang SM, Lin SC, Feng BL, Lu CH, Yu WJ, Chang JS, Chang CC. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines. Toxicol Appl Pharmacol. 2009 Mar 01;235(2):253–60. doi: 10.1016/j.taap.2008.12.009. PMID: 19133282.|Llagostera E, Soto-Cerrato V, Joshi R, Montaner B, Gimenez-Bonafé P, Pérez-Tomás R. High cytotoxic sensitivity of the human small cell lung doxorubicin-resistant carcinoma (GLC4/ADR) cell line to prodigiosin through apoptosis activation. Anticancer Drugs. 2005 Apr;16(4):393–9. doi: 10.1097/00001813-200504000-00005. PMID: 15746575."
2342103,135411146,Therapeutic Target Database (TTD),8-Methoxy-2-methyl-3H-quinazolin-4-one,D0T3SY,8-Methoxy-2-methyl-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0T3SY,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2348964,135412725,Comparative Toxicogenomics Database (CTD),Spermine NONOate,C091861,spermine nitric oxide complex,https://ctdbase.org/detail.go?type=chem&acc=C091861,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Spermine nitric oxide complex results in increased cleavage of PARP1 protein,,,PMID:16024610,https://www.ncbi.nlm.nih.gov/pubmed/16024610,16024610,,,25475805,"McLaughlin LM, Demple B. Nitric oxide-induced apoptosis in lymphoblastoid and fibroblast cells dependent on the phosphorylation and activation of p53. Cancer Res. 2005 Jul 15;65(14):6097–104. doi: 10.1158/0008-5472.can-04-4254. PMID: 16024610."
2342350,135417274,Therapeutic Target Database (TTD),8-Methoxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one,D0OF1I,8-Methoxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0OF1I,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2338323,135418940,Chemical Probes Portal,Xav939,XAV939,XAV939,https://www.chemicalprobes.org/xav939,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,"99 nM, 93 nM",PMID:28001384|PMID:19759537,https://www.ncbi.nlm.nih.gov/pubmed/28001384|https://www.ncbi.nlm.nih.gov/pubmed/19759537,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
2349049,135418940,Comparative Toxicogenomics Database (CTD),Xav939,C544261,XAV939,https://ctdbase.org/detail.go?type=chem&acc=C544261,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),XAV939 binds to and results in decreased activity of PARP1 protein,,,PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
1533265,135436526,Comparative Toxicogenomics Database (CTD),N-Methyl-N'-nitro-N-nitrosoguanidine,D008769,Methylnitronitrosoguanidine,https://ctdbase.org/detail.go?type=chem&acc=D008769,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein results in increased susceptibility to methylnitronitrosoguanidine,,,PMID:22001597,https://www.ncbi.nlm.nih.gov/pubmed/22001597,22001597,,,19480191,"Chen YC, Lu PH, Hsu JL, Yu CC, Guh JH. ICAM-1 and AMPK regulate cell detachment and apoptosis by N-methyl-N'-nitro-N-nitrosoguanidine, a widely spread environmental chemical, in human hormone-refractory prostate cancers. Toxicol Appl Pharmacol. 2011 Dec 15;257(3):412–9. doi: 10.1016/j.taap.2011.09.025. PMID: 22001597."
1533266,135436526,Comparative Toxicogenomics Database (CTD),N-Methyl-N'-nitro-N-nitrosoguanidine,D008769,Methylnitronitrosoguanidine,https://ctdbase.org/detail.go?type=chem&acc=D008769,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),[methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of nad|benzamide inhibits the reaction [[methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of nad]|[benzamide results in decreased activity of PARP1 protein] which results in decreased susceptibility to methylnitronitrosoguanidine|hydrolyzable tannins inhibits the reaction [[methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of nad]|methylnitronitrosoguanidine results in increased activity of PARP1 protein,,,PMID:11593040,https://www.ncbi.nlm.nih.gov/pubmed/11593040,11593040,,PMC59796,29402615,"Ying W, Sevigny MB, Chen Y, Swanson RA. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. U.S.A. 2001 Oct 09;98(21):12227–32. doi: 10.1073/pnas.211202598."
1533436,135436526,Comparative Toxicogenomics Database (CTD),N-Methyl-N'-nitro-N-nitrosoguanidine,D008769,Methylnitronitrosoguanidine,https://ctdbase.org/detail.go?type=chem&acc=D008769,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Eugenol affects the reaction [methylnitronitrosoguanidine affects the cleavage of PARP1 protein]|methylnitronitrosoguanidine affects the cleavage of PARP1 protein,,,PMID:20434464,https://www.ncbi.nlm.nih.gov/pubmed/20434464,20434464,,,5180562,"Manikandan P, Murugan RS, Priyadarsini RV, Vinothini G, Nagini S. Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. Life Sci. 2010 Jun 19;86(25-26):936–41. doi: 10.1016/j.lfs.2010.04.010. PMID: 20434464."
1533437,135436526,Comparative Toxicogenomics Database (CTD),N-Methyl-N'-nitro-N-nitrosoguanidine,D008769,Methylnitronitrosoguanidine,https://ctdbase.org/detail.go?type=chem&acc=D008769,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10090,Mus musculus (house mouse),Methylnitronitrosoguanidine results in increased expression of PARP1 protein|mutyh protein promotes the reaction [methylnitronitrosoguanidine results in increased expression of PARP1 protein],,,PMID:26954031,https://www.ncbi.nlm.nih.gov/pubmed/26954031,26954031,,PMC4783034,3247120,"Shen Y, McMackin MZ, Shan Y, Raetz A, David S, Cortopassi G. Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34. PLoS ONE. 2016 Mar 08;11(3):e0151026. doi: 10.1371/journal.pone.0151026."
2342510,135439437,Therapeutic Target Database (TTD),8-Methoxy-2-phenylquinazolin-4(3H)-one,D06NKJ,8-Methoxy-2-phenyl-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D06NKJ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2342226,135444661,Comparative Toxicogenomics Database (CTD),E67FD8JH4V,C498146,"5-chloro-2-(3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl)-4(3H)-quinazolinone",https://ctdbase.org/detail.go?type=chem&acc=C498146,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"5-chloro-2-(3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl)-4(3H)-quinazolinone inhibits the reaction [PARP1 protein results in decreased abundance of NAD]|5-chloro-2-(3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl)-4(3H)-quinazolinone inhibits the reaction [PARP1 protein results in increased abundance of poly adenosine diphosphate ribose]|5-chloro-2-(3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl)-4(3H)-quinazolinone results in decreased activity of PARP1 protein",,,PMID:15075382,https://www.ncbi.nlm.nih.gov/pubmed/15075382,15075382,,,13914481,"Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S. A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia. The Journal of Pharmacology and Experimental Therapeutics. 2004 Aug;310(2):425–36. doi: 10.1124/jpet.104.066944."
2342553,135457978,Therapeutic Target Database (TTD),8-Methyl-2-(4-nitro-phenyl)-3H-quinazolin-4-one,D07BPT,8-Methyl-2-(4-nitro-phenyl)-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D07BPT,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2216691,135460986,DrugBank,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",DB03072,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",https://www.drugbank.ca/drugs/DB03072,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,PMC102472,12499145,"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
2342555,135463574,Therapeutic Target Database (TTD),"2,8-Dimethyl-3H-quinazolin-4-one",D07SRJ,"2,8-Dimethyl-3H-quinazolin-4-one",https://idrblab.net/ttd/data/drug/details/D07SRJ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2301164,135463623,Therapeutic Target Database (TTD),2-(4-Amino-phenyl)-8-methyl-3H-quinazolin-4-one,D0GA0Y,2-(4-Amino-phenyl)-8-methyl-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0GA0Y,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2342596,135471354,Therapeutic Target Database (TTD),2-(4-Hydroxy-phenyl)-8-methyl-3H-quinazolin-4-one,D0Y1MH,2-(4-Hydroxy-phenyl)-8-methyl-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0Y1MH,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2342597,135471356,Therapeutic Target Database (TTD),2-(4-Amino-phenyl)-8-hydroxy-3H-quinazolin-4-one,D00TUB,2-(4-Amino-phenyl)-8-hydroxy-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D00TUB,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2331605,135489933,Comparative Toxicogenomics Database (CTD),N'-(3-bromo-4-hydroxybenzylidene)-2-(9-oxo-10(9H)-acridinyl)acetohydrazide,C000594115,N'-(3-bromo-4-hydroxybenzylidene)-2-(9-oxo-10(9H)-acridinyl)acetohydrazide,https://ctdbase.org/detail.go?type=chem&acc=C000594115,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),N'-(3-bromo-4-hydroxybenzylidene)-2-(9-oxo-10(9H)-acridinyl)acetohydrazide affects the cleavage of PARP1 protein,,,PMID:24748653,https://www.ncbi.nlm.nih.gov/pubmed/24748653,24748653,,,1831728,"Mäki-Jouppila JH, Laine LJ, Rehnberg J, Narvi E, Tiikkainen P, Hukasova E, Halonen P, Lindqvist A, Kallio L, Poso A, Kallio MJ. Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na. Mol Cancer Ther. 2014 May;13(5):1054–66. doi: 10.1158/1535-7163.mct-13-0685. PMID: 24748653."
2304261,135492389,Therapeutic Target Database (TTD),8-Hydroxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one,D0G5VD,8-Hydroxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0G5VD,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2355137,135508369,Therapeutic Target Database (TTD),2-(3-Piperidin-1-yl-propyl)-3H-quinazolin-4-one,D0U5WY,2-(3-Piperidin-1-yl-propyl)-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0U5WY,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2305214,135522417,DrugBank,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano(4,3-d)pyrimidin-4-one",DB07677,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",https://www.drugbank.ca/drugs/DB07677,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:37713619,https://www.ncbi.nlm.nih.gov/pubmed/37713619,37713619,,PMC10767903,36526393,"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751."
2314671,135522417,Therapeutic Target Database (TTD),"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano(4,3-d)pyrimidin-4-one",D0W7XH,DR2313,https://idrblab.net/ttd/data/drug/details/D0W7XH,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2342892,135528341,Therapeutic Target Database (TTD),8-Hydroxy-2-phenyl-3H-quinazolin-4-one,D0O6WW,8-Hydroxy-2-phenyl-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0O6WW,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2342893,135531482,Therapeutic Target Database (TTD),8-Methyl-2-phenylquinazolin-4(3H)-one,D0E5EW,8-Methyl-2-phenyl-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0E5EW,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2342832,135539077,Comparative Toxicogenomics Database (CTD),Luminespib,C528044,"5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide",https://ctdbase.org/detail.go?type=chem&acc=C528044,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),"5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide results in increased cleavage of PARP1 protein",,,PMID:22810956,https://www.ncbi.nlm.nih.gov/pubmed/22810956,22810956,,,18110606,"Chen MH, Lin KJ, Yang WL, Kao YW, Chen TW, Chao SC, Chang PM, Liu CY, Tzeng CH, Chao Y, Chen MH, Yeh CN, Huang CY. Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma. Cancer. 2013 Jan 15;119(2):293–303. doi: 10.1002/cncr.27743. PMID: 22810956."
2342895,135547083,Therapeutic Target Database (TTD),2-(4-Azido-phenyl)-8-methoxy-3H-quinazolin-4-one,D0WO3P,2-(4-Azido-phenyl)-8-methoxy-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D0WO3P,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2218317,135564985,Comparative Toxicogenomics Database (CTD),Ganetespib,C533237,STA 9090,https://ctdbase.org/detail.go?type=chem&acc=C533237,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[propofol results in increased susceptibility to STA 9090] which results in increased cleavage of PARP1 protein|[ugt1a9 protein affects the susceptibility to STA 9090] which affects the cleavage of PARP1 protein|[ugt1a10 protein affects the susceptibility to STA 9090] which affects the cleavage of PARP1 protein,,,PMID:24784839,https://www.ncbi.nlm.nih.gov/pubmed/24784839,24784839,,,33693246,"Acquaviva J, He S, Zhang C, Jimenez JP, Nagai M, Sang J, Sequeira M, Smith DL, Ogawa LS, Inoue T, Tatsuta N, Knowles MA, Bates RC, Proia DA. FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism. Mol Cancer Res. 2014 Jul;12(7):1042–54. doi: 10.1158/1541-7786.mcr-14-0004. PMID: 24784839."
2218348,135565082,Drug Gene Interaction database (DGIdb),Talazoparib,,TALAZOPARIB,https://www.dgidb.org/drugs/rxcui:2099704,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2218349,135565082,Drug Gene Interaction database (DGIdb),Talazoparib,,TALAZOPARIB,https://www.dgidb.org/drugs/rxcui:2099704,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2264066,135565082,DrugBank,Talazoparib,DB11760,Talazoparib,https://www.drugbank.ca/drugs/DB11760,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,PMID:26652717,https://www.ncbi.nlm.nih.gov/pubmed/26652717,26652717,,,12792620,"Wang B, Chu D, Feng Y, Shen Y, Aoyagi-Scharber M, Post LE: Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-te trahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent. J Med Chem. 2016 Jan 14;59(1):335-57. doi: 10.1021/acs.jmedchem.5b01498. Epub 2015 Dec 23."
2289712,135565082,ChEMBL,Talazoparib,CHEMBL3137320,TALAZOPARIB,https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL3137320,CHEMBL3105,Poly [ADP-ribose] polymerase-1,https://www.ebi.ac.uk/chembl/explore/target/CHEMBL3105,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Poly [ADP-ribose] polymerase-1 inhibitor,,,PMID:23881923,https://www.ncbi.nlm.nih.gov/pubmed/23881923,23881923,,PMC6485449,16326504,"Shen Y, Rehman FL, Feng Y, Boshuizen J, Bajrami I, Elliott R, Wang B, Lord CJ, Post LE, Ashworth A. BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency. 2013 Sep 15;19(18):5003–15. doi: 10.1158/1078-0432.ccr-13-1391."
2306508,135565082,Drug Gene Interaction database (DGIdb),Talazoparib,,TALAZOPARIB,https://www.dgidb.org/drugs/rxcui:2099704,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2312920,135565082,IUPHAR/BPS Guide to PHARMACOLOGY,Talazoparib,8313,talazoparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8313,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,,8.4,PMID:25195882,https://www.ncbi.nlm.nih.gov/pubmed/25195882,25195882,,PMC4157409,23577503,"Aoyagi-Scharber M, Gardberg AS, Yip BK, Wang B, Shen Y, Fitzpatrick PA. Structural basis for the inhibition of poly(ADP-ribose) polymerases 1 and 2 by BMN 673, a potent inhibitor derived from dihydropyridophthalazinone. Acta Crystallogr F Struct Biol Commun. 2014 Sep;70(Pt 9):1143–9. PMID: 25195882; PMCID: PMC4157409."
2338655,135565082,Comparative Toxicogenomics Database (CTD),Talazoparib,C586365,talazoparib,https://ctdbase.org/detail.go?type=chem&acc=C586365,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Talazoparib binds to and results in decreased activity of PARP1 protein,,,PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
2338660,135565082,Chemical Probes Portal,Talazoparib,Talazoparib,Talazoparib,https://www.chemicalprobes.org/talazoparib,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,"1.2 nM, 0.57 nM, 0.29 nM, 1.1 nM, 0.85 nM, 4.1 nM",PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,PMC5934274,1871501,"Thorsell A, Ekblad T, Karlberg T, Löw M, Pinto AF, Trésaugues L, Moche M, Cohen MS, Schüler H. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J. Med. Chem. 2016 Dec 21;60(4):1262–71. doi: 10.1021/acs.jmedchem.6b00990."
2353011,135565082,Drug Gene Interaction database (DGIdb),Talazoparib,,TALAZOPARIB,https://www.dgidb.org/drugs/rxcui:2099704,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2289716,135565554,Drug Gene Interaction database (DGIdb),Pamiparib,,PAMIPARIB,https://www.dgidb.org/drugs/ncit:C120553,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2311770,135565554,ChEMBL,Pamiparib,CHEMBL4112930,PAMIPARIB,https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL4112930,CHEMBL3105,Poly [ADP-ribose] polymerase-1,https://www.ebi.ac.uk/chembl/explore/target/CHEMBL3105,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Poly [ADP-ribose] polymerase-1 inhibitor,,,PMID:32652442|PMID:33264017,https://www.ncbi.nlm.nih.gov/pubmed/32652442|https://www.ncbi.nlm.nih.gov/pubmed/33264017,32652442|33264017,,PMC7350150,1952424|4018016,"Wang H, Ren B, Liu Y, Jiang B, Guo Y, Wei M, Luo L, Kuang X, Qiu M, Lv L, Xu H, Qi R, Yan H, Xu D, Wang Z, Huo CX, Zhu Y, Zhao Y, Wu Y, Qin Z, Su D, Tang T, Wang F, Sun X, Feng Y, Peng H, Wang X, Gao Y, Liu Y, Gong W, Yu F, Liu X, Wang L, Zhou C. Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development. J Med Chem. 2020 Dec 24;63(24):15541–63. doi: 10.1021/acs.jmedchem.0c01346. PMID: 33264017.|Xiong Y, Guo Y, Liu Y, Wang H, Gong W, Liu Y, Wang X, Gao Y, Yu F, Su D, Wang F, Zhu Y, Zhao Y, Wu Y, Qin Z, Sun X, Ren B, Jiang B, Jin W, Shen Z, Tang Z, Song X, Wang L, Liu X, Zhou C, Jiang B. Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor. Neoplasia. 2020 Sep;22(9):431–40. PMID: 32652442; PMCID: PMC7350150."
2312923,135565554,IUPHAR/BPS Guide to PHARMACOLOGY,Pamiparib,12345,pamiparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12345,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,8.89,PMID:33264017,https://www.ncbi.nlm.nih.gov/pubmed/33264017,33264017,,,4018016,"Wang H, Ren B, Liu Y, Jiang B, Guo Y, Wei M, Luo L, Kuang X, Qiu M, Lv L, Xu H, Qi R, Yan H, Xu D, Wang Z, Huo CX, Zhu Y, Zhao Y, Wu Y, Qin Z, Su D, Tang T, Wang F, Sun X, Feng Y, Peng H, Wang X, Gao Y, Liu Y, Gong W, Yu F, Liu X, Wang L, Zhou C. Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development. J Med Chem. 2020 Dec 24;63(24):15541–63. doi: 10.1021/acs.jmedchem.0c01346. PMID: 33264017."
2355154,135565554,Drug Gene Interaction database (DGIdb),Pamiparib,,PAMIPARIB,https://www.dgidb.org/drugs/ncit:C120553,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,,,
2218354,135565654,Drug Gene Interaction database (DGIdb),Talazoparib Tosylate,,TALAZOPARIB TOSYLATE,https://www.dgidb.org/drugs/rxcui:2099703,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2289863,135565654,ChEMBL,Talazoparib Tosylate,CHEMBL3137318,TALAZOPARIB TOSYLATE,https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL3137318,CHEMBL3105,Poly [ADP-ribose] polymerase-1,https://www.ebi.ac.uk/chembl/explore/target/CHEMBL3105,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Poly [ADP-ribose] polymerase-1 inhibitor,,,PMID:23881923,https://www.ncbi.nlm.nih.gov/pubmed/23881923,23881923,,PMC6485449,16326504,"Shen Y, Rehman FL, Feng Y, Boshuizen J, Bajrami I, Elliott R, Wang B, Lord CJ, Post LE, Ashworth A. BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency. 2013 Sep 15;19(18):5003–15. doi: 10.1158/1078-0432.ccr-13-1391."
2242770,135565981,Chemical Probes Portal,2X-121,E7449,E7449,https://www.chemicalprobes.org/e7449,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,"1.0 nM, 1.2 nM, 115 nM",PMID:26513298,https://www.ncbi.nlm.nih.gov/pubmed/26513298,26513298,,PMC4747407,32350195,"McGonigle S, Chen Z, Wu J, Chang P, Kolber-Simonds D, Ackermann K, Twine NC, Shie JL, Miu JT, Huang KC, Moniz GA, Nomoto K. E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling. Oncotarget. 2015 Dec 01;6(38):41307–23. PMID: 26513298; PMCID: PMC4747407."
2311920,135565981,ChEMBL,2X-121,CHEMBL3644587,2X-121,https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL3644587,CHEMBL3105,Poly [ADP-ribose] polymerase-1,https://www.ebi.ac.uk/chembl/explore/target/CHEMBL3105,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Poly [ADP-ribose] polymerase-1 inhibitor,,,PMID:26513298|PMID:32523090,https://www.ncbi.nlm.nih.gov/pubmed/26513298|https://www.ncbi.nlm.nih.gov/pubmed/32523090,26513298|32523090,,PMC4747407|PMC7434893,26443173|32350195,"2020; 123(4):525-533|McGonigle S, Chen Z, Wu J, Chang P, Kolber-Simonds D, Ackermann K, Twine NC, Shie JL, Miu JT, Huang KC, Moniz GA, Nomoto K. E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling. Oncotarget. 2015 Dec 01;6(38):41307–23. PMID: 26513298; PMCID: PMC4747407."
2349506,135565981,Therapeutic Target Database (TTD),2X-121,D0F5TD,PMID27841036-Compound-37,https://idrblab.net/ttd/data/drug/details/D0F5TD,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2314522,135566764,IUPHAR/BPS Guide to PHARMACOLOGY,ME0328,8468,ME0328,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8468,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,5.2,PMID:24188023,https://www.ncbi.nlm.nih.gov/pubmed/24188023,24188023,,,18800911,"Lindgren AE, Karlberg T, Ekblad T, Spjut S, Thorsell AG, Andersson CD, Nhan TT, Hellsten V, Weigelt J, Linusson A, Schüler H, Elofsson M. Chemical probes to study ADP-ribosylation: synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3/PARP3. J Med Chem. 2013 Dec 12;56(23):9556–68. doi: 10.1021/jm401394u. PMID: 24188023."
2349591,135566764,Therapeutic Target Database (TTD),ME0328,D04QRM,ME0328,https://idrblab.net/ttd/data/drug/details/D04QRM,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2343649,135580376,Comparative Toxicogenomics Database (CTD),5-[(4-Methylphenyl)methylene]-2-(phenylamino)-4(5h)-thiazolone,C503119,5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone,https://ctdbase.org/detail.go?type=chem&acc=C503119,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased cleavage of PARP1 protein,,,PMID:15831436,https://www.ncbi.nlm.nih.gov/pubmed/15831436,15831436,,,319121,"Teraishi F, Wu S, Sasaki J, Zhang L, Zhu H, Davis JJ, Fang B. P-Glycoprotein-Independent Apoptosis Induction by a Novel Synthetic Compound, MMPT [5-[(4-Methylphenyl)methylene]-2-(phenylamino)-4(5 H)-thiazolone]. The Journal of Pharmacology and Experimental Therapeutics. 2005 Jul;314(1):355–62. doi: 10.1124/jpet.105.085654."
2243028,135659013,Comparative Toxicogenomics Database (CTD),Orbitazine,C000619853,SM-1 compound,https://ctdbase.org/detail.go?type=chem&acc=C000619853,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),SM-1 compound promotes the reaction [fluorouracil results in increased expression of PARP1 mrna]|[sm-1 compound co-treated with fluorouracil] results in increased expression of PARP1 protein|sm-1 compound results in increased expression of PARP1 mRNA,,,PMID:28599477,https://www.ncbi.nlm.nih.gov/pubmed/28599477,28599477,,PMC5452999,5317112,"Wang Y, Yuan S, Li L, Yang D, Xu C, Wang S, Zhang D. Novel proapoptotic agent SM-1 enhances the inhibitory effect of 5-fluorouracil on colorectal cancer cells in vitro and in vivo. Oncol Lett. 2017 Jun;13(6):4762–8. PMID: 28599477; PMCID: PMC5452999."
2243035,135659031,Comparative Toxicogenomics Database (CTD),(E)-3-[2-[3-(1-adamantyl)-4-hydroxyphenyl]pyrimidin-5-yl]prop-2-enoic acid,C556168,3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid,https://ctdbase.org/detail.go?type=chem&acc=C556168,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid results in increased cleavage of PARP1 protein,,,PMID:21548569,https://www.ncbi.nlm.nih.gov/pubmed/21548569,21548569,,,14058275,"Xia Z, Farhana L, Correa RG, Das JK, Castro DJ, Yu J, Oshima RG, Reed JC, Fontana JA, Dawson MI. Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid. J Med Chem. 2011 Jun 09;54(11):3793–816. doi: 10.1021/jm200051z. PMID: 21548569."
2355189,135659062,Comparative Toxicogenomics Database (CTD),"(Z)-3-((3-((dimethylamino)methyl)phenylamino)(phenyl)methylene)-N,N-dimethyl-2-oxoindoline-6-carboxamide",C533207,BIX 02189,https://ctdbase.org/detail.go?type=chem&acc=C533207,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),BIX 02189 promotes the reaction [cadmium chloride results in increased cleavage of PARP1 protein],,,PMID:22521884,https://www.ncbi.nlm.nih.gov/pubmed/22521884,22521884,,,18764322,"Kondo M, Inamura H, Matsumura K, Matsuoka M. Cadmium activates extracellular signal-regulated kinase 5 in HK-2 human renal proximal tubular cells. Biochemical and Biophysical Research Communications. 2012 May;421(3):490–3. doi: 10.1016/j.bbrc.2012.04.028."
2343746,135875707,Therapeutic Target Database (TTD),5-Chloro-2-methylquinazolin-4(3H)-one,D01EVX,5-Chloro-2-methyl-3H-quinazolin-4-one,https://idrblab.net/ttd/data/drug/details/D01EVX,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2314062,136189563,Comparative Toxicogenomics Database (CTD),Crt 0066101,C551536,CRT 0066101,https://ctdbase.org/detail.go?type=chem&acc=C551536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),CRT 0066101 results in increased cleavage of PARP1 protein,,,PMID:24634417|PMID:37562720,https://www.ncbi.nlm.nih.gov/pubmed/24634417|https://www.ncbi.nlm.nih.gov/pubmed/37562720,24634417|37562720,,PMC4019967,13426747|35919627,"Tyagi K, Roy A, Mandal S. Pharmacological inhibition of protein kinase D suppresses epithelial ovarian cancer via MAPK/ERK1/2/Runx2 signalling axis. Cell Signal. 2023 Oct;110():110849. doi: 10.1016/j.cellsig.2023.110849. PMID: 37562720.|Wei N, Chu E, Wipf P, Schmitz JC. Protein kinase d as a potential chemotherapeutic target for colorectal cancer. Mol Cancer Ther. 2014 May;13(5):1130–41. PMID: 24634417; PMCID: PMC4019967."
2315066,136201717,IUPHAR/BPS Guide to PHARMACOLOGY,2-[2-(4-pyridin-2-ylpiperazin-1-yl)ethylsulfanyl]-3H-quinazolin-4-one,10671,MC2050,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10671,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,6.92,PMID:21365766,https://www.ncbi.nlm.nih.gov/pubmed/21365766,21365766,,,13361555,"Mosca L, Rotili D, Tempera I, Masci A, Fontana M, Chiaraluce R, Mastromarino P, d'Erme M, Mai A. Biological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cells. ChemMedChem. 2011 Apr 04;6(4):606–11. doi: 10.1002/cmdc.201000536. PMID: 21365766."
2315067,136201717,IUPHAR/BPS Guide to PHARMACOLOGY,2-[2-(4-pyridin-2-ylpiperazin-1-yl)ethylsulfanyl]-3H-quinazolin-4-one,10671,MC2050,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10671,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,8.03,,,,,,,
2353057,136265073,Therapeutic Target Database (TTD),"7-Fluoro-12-(4-fluorophenyl)-13-(2-methyl-1,2,4-triazol-3-yl)-2,3,10-triazatricyclo[7.4.1.05,14]tetradeca-1,5(14),6,8-tetraen-4-one",D0B3QI,Dihydropyrido phthalazinone derivative 1,https://idrblab.net/ttd/data/drug/details/D0B3QI,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2353060,136334008,Therapeutic Target Database (TTD),"9-fluoro-3-(4-fluorophenyl)-4-(1-methyl-1H-1,2,4-triazol-5-yl)-1,2,3,4-tetrahydro-[1,2]diazepino[5,4,3-de]phthalazin-7(6H)-one",D0J4GY,Dihydropyrido phthalazinone derivative 2,https://idrblab.net/ttd/data/drug/details/D0J4GY,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2315477,137213562,IUPHAR/BPS Guide to PHARMACOLOGY,8-(hydroxymethyl)-2-[4-[6-(2-methoxyethylamino)-4-methylpyridin-3-yl]phenyl]-3H-quinazolin-4-one,10676,AZ1366,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10676,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,6.25,PMID:25815142,https://www.ncbi.nlm.nih.gov/pubmed/25815142,25815142,,PMC4360163,14785468,"Johannes JW, Almeida L, Barlaam B, Boriack-Sjodin PA, Casella R, Croft RA, Dishington AP, Gingipalli L, Gu C, Hawkins JL, Holmes JL, Howard T, Huang J, Ioannidis S, Kazmirski S, Lamb ML, McGuire TM, Moore JE, Ogg D, Patel A, Pike KG, Pontz T, Robb GR, Su N, Wang H, Wu X, Zhang HJ, Zhang Y, Zheng X, Wang T. Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology. ACS Med Chem Lett. 2015 Mar 12;6(3):254–9. PMID: 25815142; PMCID: PMC4360163."
2273182,139087999,Comparative Toxicogenomics Database (CTD),Sesquiterpenes,D012717,Sesquiterpenes,https://ctdbase.org/detail.go?type=chem&acc=D012717,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Sesquiterpenes results in increased cleavage of PARP1 protein,,,PMID:18070620,https://www.ncbi.nlm.nih.gov/pubmed/18070620,18070620,,,26160809,"Kumar A, Malik F, Bhushan S, Sethi VK, Shahi AK, Kaur J, Taneja SC, Qazi GN, Singh J. An essential oil and its major constituent isointermedeol induce apoptosis by increased expression of mitochondrial cytochrome c and apical death receptors in human leukaemia HL-60 cells. Chem Biol Interact. 2008 Feb 15;171(3):332–47. doi: 10.1016/j.cbi.2007.10.003. PMID: 18070620."
2318260,145996538,IUPHAR/BPS Guide to PHARMACOLOGY,"2-{[2-(4-{2-[(4-Oxo-3,4-dihydroquinazolin-2-yl)sulfanyl]ethyl}piperazin-1-yl)ethyl]sulfanyl}-3,4-dihydroquinazolin-4-one",10672,"compound 5 [Tomassi et al., 2020]",https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10672,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,7.05,,,,,,,
2320165,155033943,IUPHAR/BPS Guide to PHARMACOLOGY,Lerzeparib,12885,lerzeparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12885,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,8.55,,,,,,,
2258789,155586901,Chemical Probes Portal,Azd5305,AZD5305,AZD5305,https://www.chemicalprobes.org/azd5305,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,"3 nM, 0.13 nM",,,,,,,
2320202,155586901,IUPHAR/BPS Guide to PHARMACOLOGY,Azd5305,11526,saruparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11526,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,8.4,,,,,,,
2356050,155586901,Therapeutic Target Database (TTD),Azd5305,D0YTM9,AZD5305,https://idrblab.net/ttd/data/drug/details/D0YTM9,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,,,,,,,,
2315580,155906967,Comparative Toxicogenomics Database (CTD),"N-[3-[(3-amino-3-oxoprop-1-en-2-yl)amino]-3-oxoprop-1-en-2-yl]-2-[(1R,8S,11Z,15S,18S,25S,26S,35S,37R,40R,46R,53R,59R)-37-[(2R)-butan-2-yl]-18-[(2S,3R)-2,3-dihydroxybutan-2-yl]-11-ethylidene-59-hydroxy-8,31-bis[(1R)-1-hydroxyethyl]-26,40,46-trimethyl-43-methylidene-6,9,16,23,28,38,41,44,47-nonaoxo-27-oxa-3,13,20,56-tetrathia-7,10,17,24,36,39,42,45,48,52,58,61,62,63,64-pentadecazanonacyclo[23.23.9.329,35.12,5.112,15.119,22.154,57.01,53.032,60]tetrahexaconta-2(64),4,12(63),19(62),21,29(61),30,32(60),33,51,54,57-dodecaen-51-yl]-1,3-thiazole-4-carboxamide",D013883,Thiostrepton,https://ctdbase.org/detail.go?type=chem&acc=D013883,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),[thiostrepton co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein,,,PMID:18297286,https://www.ncbi.nlm.nih.gov/pubmed/18297286,18297286,,PMC2749296,13984754,2008; 63(1):37-43
2273285,162524593,Chemical Probes Portal,Azd9574,AZD9574,AZD9574,https://www.chemicalprobes.org/azd9574,,PARP1,,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibitor,,5.5 nM,,,,,,,
2320947,162524593,IUPHAR/BPS Guide to PHARMACOLOGY,Azd9574,11946,palacaparib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11946,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,8.3,,,,,,,
2323942,168433309,IUPHAR/BPS Guide to PHARMACOLOGY,Antitumor agent-104,12806,"compound 9 [Lin et al., 2023]",https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12806,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,,7.05,,,,,,,
2323945,168510442,IUPHAR/BPS Guide to PHARMACOLOGY,Vegfr/parp-IN-1,12905,dual VEGFR/PARP inhibitor 14b,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12905,2771,poly(ADP-ribose) polymerase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Inhibition,pIC50,7.22,PMID:37616488,https://www.ncbi.nlm.nih.gov/pubmed/37616488,37616488,,,36346883,"Li Y, Liu Y, Zhang D, Chen J, Yang G, Tang P, Yang C, Liu J, Zhang J, Ouyang L. Discovery, Synthesis, and Evaluation of Novel Dual Inhibitors of a Vascular Endothelial Growth Factor Receptor and Poly(ADP-Ribose) Polymerase for BRCA Wild-Type Breast Cancer Therapy. J Med Chem. 2023 Sep 14;66(17):12069–100. doi: 10.1021/acs.jmedchem.3c00640. PMID: 37616488."
